Age 0 3 0 3 B-age
21 4 6 4 6 B-lower_bound
to 7 9 7 9 O
90 10 12 10 12 B-upper_bound
years 13 18 13 18 I-upper_bound

Males 0 5 19 24 B-gender

Speaker 0 7 25 32 B-language_fluency
of 8 10 33 35 I-language_fluency
English 11 18 36 43 I-language_fluency
since 19 24 44 49 O
childhood 25 34 50 59 O

Stroke 0 6 60 66 B-chronic_disease
survivor 7 15 67 75 O
who 16 19 76 79 O
is 20 22 80 82 O
at 23 25 83 85 O
least 26 31 86 91 O
6 32 33 92 93 B-lower_bound
months 34 40 94 100 I-lower_bound
post 41 45 101 105 B-chronic_disease
- 45 46 105 106 I-chronic_disease
stroke 46 52 106 112 I-chronic_disease

females 0 7 113 120 B-gender

history 0 7 121 128 O
of 8 10 129 131 O
speech 11 17 132 138 B-chronic_disease
/ 17 18 138 139 I-chronic_disease
language 18 26 139 147 I-chronic_disease
problems 27 35 148 156 I-chronic_disease
prior 36 41 157 162 O
to 42 44 163 165 O
stroke 45 51 166 172 B-chronic_disease

neurological 0 12 173 185 B-chronic_disease
condition 13 22 186 195 I-chronic_disease
other 23 28 196 201 O
than 29 33 202 206 O
stroke 34 40 207 213 B-chronic_disease

untreated 0 9 214 223 B-chronic_disease
psychopathology 10 25 224 239 I-chronic_disease

Ambulatory 0 10 0 10 O
or 11 13 11 13 O
able 14 18 14 18 O
to 19 21 19 21 O
engage 22 28 22 28 O
in 29 31 29 31 O
walking 32 39 32 39 O
for 40 43 40 43 O
at 44 46 44 46 O
least 47 52 47 52 O
15 53 55 53 55 B-lower_bound
minutes 56 63 56 63 I-lower_bound

Concurrent 0 10 64 74 O
diagnosis 11 20 75 84 O
of 21 23 85 87 O
organic 24 31 88 95 B-chronic_disease
brain 32 37 96 101 I-chronic_disease
syndrome 38 46 102 110 I-chronic_disease
, 46 47 110 111 O
dementia 48 56 112 120 B-chronic_disease
, 56 57 120 121 O
mental 58 64 122 128 B-chronic_disease
retardation 65 76 129 140 I-chronic_disease
, 76 77 140 141 O
or 78 80 142 144 O
significant 81 92 145 156 O
sensory 93 100 157 164 B-chronic_disease
deficit 101 108 165 172 I-chronic_disease

Currently 0 9 173 182 O
( 10 11 183 184 O
previous 11 19 184 192 B-upper_bound
6 20 21 193 194 I-upper_bound
months 22 28 195 201 I-upper_bound
) 28 29 201 202 O
engaged 30 37 203 210 O
in 38 40 211 213 O
structured 41 51 214 224 O
exercise 52 60 225 233 O
either 61 67 234 240 O
aerobic 68 75 241 248 O
or 76 78 249 251 O
yoga 79 83 252 256 O
based 84 89 257 262 O

English 0 7 263 270 B-language_fluency
speaking 8 16 271 279 I-language_fluency

Major 0 5 280 285 B-chronic_disease
mental 6 12 286 292 I-chronic_disease
illness 13 20 293 300 I-chronic_disease
( 21 22 301 302 O
e.g. 22 26 302 306 O
, 26 27 306 307 O
schizophrenia 28 41 308 321 B-chronic_disease
, 41 42 321 322 O
major 43 48 323 328 B-chronic_disease
depressive 49 59 329 339 I-chronic_disease
disorder 60 68 340 348 I-chronic_disease
) 68 69 348 349 O

No 0 2 350 352 O
prior 3 8 353 358 O
type 9 13 359 363 B-cancer
I 14 15 364 365 I-cancer
endometrial 16 27 366 377 I-cancer
cancer 28 34 378 384 I-cancer
diagnosis 35 44 385 394 O

Overweight 0 10 395 405 B-clinical_variable
or 11 13 406 408 O
obese 14 19 409 414 B-chronic_disease
( 20 21 415 416 O
> 21 22 416 417 O
25 23 25 418 420 B-lower_bound
kg 26 28 421 423 I-lower_bound
/ 28 29 423 424 I-lower_bound
m^2 29 32 424 427 I-lower_bound
) 32 33 427 428 O

Previous 0 8 429 437 O
diagnosis 9 18 438 447 O
of 19 21 448 450 O
grade 22 27 451 456 B-cancer
1 28 29 457 458 I-cancer
or 30 32 459 461 I-cancer
2 33 34 462 463 I-cancer
, 34 35 463 464 I-cancer
stage 36 41 465 470 I-cancer
I 42 43 471 472 I-cancer
or 44 46 473 475 I-cancer
II 47 49 476 478 I-cancer
endometrioid 50 62 479 491 I-cancer
endometrial 63 74 492 503 I-cancer
cancers 75 82 504 511 I-cancer
( 83 84 512 513 O
type 84 88 513 517 B-cancer
I 89 90 518 519 I-cancer
cancers 91 98 520 527 I-cancer
) 98 99 527 528 O
as 100 102 529 531 O
confirmed 103 112 532 541 O
during 113 119 542 548 O
surgical 120 128 549 557 B-treatment
intervention 129 141 558 570 I-treatment
for 142 145 571 574 O
treatment 146 155 575 584 B-treatment

Prior 0 5 585 590 O
diagnosis 6 15 591 600 O
of 16 18 601 603 O
other 19 24 604 609 O
cancer 25 31 610 616 B-cancer

Sedentary 0 9 617 626 O
lifestyle 10 19 627 636 O
, 19 20 636 637 O
as 21 23 638 640 O
engaging 24 32 641 649 O
in 33 35 650 652 O
less 36 40 653 657 O
than 41 45 658 662 O
100 46 49 663 666 B-upper_bound
minutes 50 57 667 674 I-upper_bound
structured 58 68 675 685 O
aerobic 69 76 686 693 O
walking 77 84 694 701 O

Severe 0 6 702 708 O
heart 7 12 709 714 O
or 13 15 715 717 O
systemic 16 24 718 726 B-chronic_disease
disease 25 32 727 734 I-chronic_disease
: 32 33 734 735 O
evidence 34 42 736 744 O
of 43 45 745 747 O
documented 46 56 748 758 O
myocardial 57 67 759 769 B-chronic_disease
infarction 68 78 770 780 I-chronic_disease
, 78 79 780 781 O
chronic 80 87 782 789 O
unstable 88 96 790 798 B-chronic_disease
angina 97 103 799 805 I-chronic_disease
, 103 104 805 806 O
symptomatic 105 116 807 818 O
congestive 117 127 819 829 B-chronic_disease
heart 128 133 830 835 I-chronic_disease
failure 134 141 836 843 I-chronic_disease
, 141 142 843 844 O
uncontrolled 143 155 845 857 B-chronic_disease
hypertension 156 168 858 870 I-chronic_disease

Severe 0 6 871 877 O
musculoskeletal 7 22 878 893 B-chronic_disease
disease 23 30 894 901 I-chronic_disease
: 30 31 901 902 O
severe 32 38 903 909 O
muscle 39 45 910 916 B-chronic_disease
or 46 48 917 919 I-chronic_disease
joint 49 54 920 925 I-chronic_disease
disorders 55 64 926 935 I-chronic_disease
due 65 68 936 939 O
to 69 71 940 942 O
disease 72 79 943 950 O
or 80 82 951 953 O
trauma 83 89 954 960 O
, 89 90 960 961 O
amputations 91 102 962 973 O
, 102 103 973 974 O
or 104 106 975 977 O
any 107 110 978 981 O
condition 111 120 982 991 O
that 121 125 992 996 O
significantly 126 139 997 1010 O
impair 140 146 1011 1017 O
physical 147 155 1018 1026 O
capabilities 156 168 1027 1039 O
, 168 169 1039 1040 O
as 170 172 1041 1043 O
defined 173 180 1044 1051 O
by 181 183 1052 1054 O
the 184 187 1055 1058 O
physician 188 197 1059 1068 O

10 0 2 0 2 B-lower_bound
- 2 3 2 3 O
19 3 5 3 5 B-upper_bound
% 5 6 5 6 I-upper_bound
blasts 7 13 7 13 O
in 14 16 14 16 O
marrow 17 23 17 23 O
by 24 26 24 26 O
morphology 27 37 27 37 O
or 38 40 38 40 O
flow 41 45 41 45 O
cytometry 46 55 46 55 O
or 56 58 56 58 O
blood 59 64 59 64 O

AML 0 3 65 68 B-cancer
( 4 5 69 70 O
acute 5 10 70 75 B-cancer
promyelocytic 11 24 76 89 I-cancer
leukemia 25 33 90 98 I-cancer
[ 34 35 99 100 I-cancer
APL 35 38 100 103 I-cancer
] 38 39 103 104 I-cancer
excepted 40 48 105 113 O
) 48 49 113 114 O
or 50 52 115 117 O
high 53 57 118 122 O
- 57 58 122 123 O
risk 58 62 123 127 O
MDS 63 66 128 131 B-cancer

Adequate 0 8 132 140 O
cardiac 9 16 141 148 O
function 17 25 149 157 O
as 26 28 158 160 O
demonstrated 29 41 161 173 O
by 42 44 174 176 O
left 45 49 177 181 B-clinical_variable
ventricular 50 61 182 193 I-clinical_variable
ejection 62 70 194 202 I-clinical_variable
fraction 71 79 203 211 I-clinical_variable
( 80 81 212 213 I-clinical_variable
LVEF 81 85 213 217 I-clinical_variable
) 85 86 217 218 I-clinical_variable
of 87 89 219 221 O
45 90 92 222 224 B-lower_bound
% 92 93 224 225 I-lower_bound
or 94 96 226 228 O
greater 97 104 229 236 O
, 104 105 236 237 O
by 106 108 238 240 O
multiple 109 117 241 249 O
gated 118 123 250 255 O
acquisition 124 135 256 267 O
( 136 137 268 269 O
MUGA 137 141 269 273 O
) 141 142 273 274 O
or 143 145 275 277 O
echocardiogram 146 160 278 292 O

Afebrile 0 8 293 301 O
with 9 13 302 306 O
clear 14 19 307 312 O
chest 20 25 313 318 O
imaging 26 33 319 326 O
and 34 37 327 330 O
no 38 40 331 333 O
signs 41 46 334 339 O
of 47 49 340 342 O
active 50 56 343 349 B-chronic_disease
viral 57 62 350 355 I-chronic_disease
, 62 63 355 356 O
bacterial 64 73 357 366 B-chronic_disease
, 73 74 366 367 O
fungal 75 81 368 374 B-chronic_disease
infection 82 91 375 384 I-chronic_disease
unless 92 98 385 391 O
determined 99 109 392 402 O
to 110 112 403 405 O
be 113 115 406 408 O
, 115 116 408 409 O
at 117 119 410 412 O
the 120 123 413 416 O
discretion 124 134 417 427 O
of 135 137 428 430 O
the 138 141 431 434 O
investigator 142 154 435 447 O
, 154 155 447 448 O
not 156 159 449 452 O
clinically 160 170 453 463 O
significant 171 182 464 475 O
in 183 185 476 478 O
the 186 189 479 482 O
context 190 197 483 490 O
of 198 200 491 493 O
this 201 205 494 498 O
study 206 211 499 504 O

Blast 0 5 505 510 B-clinical_variable
count 6 11 511 516 I-clinical_variable
= 12 13 517 518 O
< 13 14 518 519 O
10,000 15 21 520 526 B-upper_bound

Fibrinogen 0 10 527 537 B-clinical_variable
> 11 12 538 539 O
200 13 16 540 543 B-lower_bound

Patient 0 7 544 551 O
must 8 12 552 556 O
live 13 17 557 561 O
within 18 24 562 568 O
30 25 27 569 571 B-upper_bound
minutes 28 35 572 579 I-upper_bound
of 36 38 580 582 O
the 39 42 583 586 O
treating 43 51 587 595 O
physician 52 61 596 605 O
's 61 63 605 607 O
office 64 70 608 614 O
during 71 77 615 621 O
outpatient 78 88 622 632 O
treatment 89 98 633 642 O

The 0 3 643 646 O
benefits 4 12 647 655 O
/ 12 13 655 656 O
risks 13 18 656 661 O
of 19 21 662 664 O
the 22 25 665 668 O
induction 26 35 669 678 B-treatment
chemotherapy 36 48 679 691 I-treatment
regimen 49 56 692 699 I-treatment
will 57 61 700 704 O
be 62 64 705 707 O
reviewed 65 73 708 716 O

Treatment 0 9 717 726 B-clinical_variable
- 9 10 726 727 I-clinical_variable
related 10 17 727 734 I-clinical_variable
mortality 18 27 735 744 I-clinical_variable
( 28 29 745 746 I-clinical_variable
TRM 29 32 746 749 I-clinical_variable
) 32 33 749 750 I-clinical_variable
score 34 39 751 756 I-clinical_variable
< 40 41 757 758 O
9.21 42 46 759 763 B-upper_bound
corresponding 47 60 764 777 O
to 61 63 778 780 O
a 64 65 781 782 O
TRM 66 69 783 786 B-clinical_variable
rate 70 74 787 791 I-clinical_variable
of 75 77 792 794 O
3 78 79 795 796 O
% 79 80 796 797 O
when 81 85 798 802 O
chemotherapy 86 98 803 815 B-treatment
of 99 101 816 818 O
similar 102 109 819 826 O
intensity 110 119 827 836 O
as 120 122 837 839 O
proposed 123 131 840 848 O
here 132 136 849 853 O
is 137 139 854 856 O
administered 140 152 857 869 O
to 153 155 870 872 O
inpatients 156 166 873 883 O

no 0 2 884 886 O
ongoing 3 10 887 894 O
cardiac 11 18 895 902 O
issues 19 25 903 909 O
such 26 30 910 914 O
as 31 33 915 917 O
uncontrolled 34 46 918 930 O
arrhythmias 47 58 931 942 B-chronic_disease
or 59 61 943 945 O
unstable 62 70 946 954 B-chronic_disease
angina 71 77 955 961 I-chronic_disease
or 78 80 962 964 O
congestive 81 91 965 975 B-chronic_disease
heart 92 97 976 981 I-chronic_disease
failure 98 105 982 989 I-chronic_disease

Non 0 3 0 3 B-clinical_variable
- 3 4 3 4 I-clinical_variable
viable 4 10 4 10 I-clinical_variable
newborns 11 19 11 19 I-clinical_variable

Prenatally 0 10 20 30 O
diagnosed 11 20 31 40 O
congenital 21 31 41 51 B-chronic_disease
diaphragmatic 32 45 52 65 I-chronic_disease
hernia 46 52 66 72 I-chronic_disease

Prenatally 0 10 73 83 O
diagnosed 11 20 84 93 O
cyanotic 21 29 94 102 B-chronic_disease
congenital 30 40 103 113 I-chronic_disease
heart 41 46 114 119 I-chronic_disease
disease 47 54 120 127 I-chronic_disease

age 0 3 128 131 B-age
23 4 6 132 134 B-lower_bound
- 6 7 134 135 O
30 7 9 135 137 B-upper_bound
weeks 10 15 138 143 I-upper_bound

Adequate 0 8 0 8 O
renal 9 14 9 14 O
function 15 23 15 23 O
to 24 26 24 26 O
tolerate 27 35 27 35 O
intravenous 36 47 36 47 B-treatment
gadolinium 48 58 48 58 I-treatment
contrast 59 67 59 67 I-treatment
injection 68 77 68 77 I-treatment

Deemed 0 6 78 84 O
to 7 9 85 87 O
be 10 12 88 90 O
a 13 14 91 92 O
candidate 15 24 93 102 O
for 25 28 103 106 O
stereotactic 29 41 107 119 B-treatment
body 42 46 120 124 I-treatment
radiation 47 56 125 134 I-treatment
therapy 57 64 135 142 I-treatment
for 65 68 143 146 O
NSCLC 69 74 147 152 B-cancer

Histologically 0 14 153 167 O
confirmed 15 24 168 177 O
non 25 28 178 181 B-cancer
- 28 29 181 182 I-cancer
small 29 34 182 187 I-cancer
cell 35 39 188 192 I-cancer
lung 40 44 193 197 I-cancer
cancer 45 51 198 204 I-cancer

Implanted 0 9 205 214 B-treatment
pacemaker 10 19 215 224 I-treatment
or 20 22 225 227 O
cardiac 23 30 228 235 B-treatment
defibrillator 31 44 236 249 I-treatment

No 0 2 250 252 O
evidence 3 11 253 261 O
of 12 14 262 264 O
nodal 15 20 265 270 B-cancer
involvement 21 32 271 282 I-cancer
or 33 35 283 285 O
distant 36 43 286 293 B-cancer
metastases 44 54 294 304 I-cancer

Pregnant 0 8 305 313 B-pregnancy
or 9 11 314 316 O
breastfeeding 12 25 317 330 O

Prior 0 5 331 336 B-treatment
thoracic 6 14 337 345 I-treatment
radiotherapy 15 27 346 358 I-treatment
or 28 30 359 361 O
surgery 31 38 362 369 B-treatment

Tumor 0 5 370 375 B-cancer
between 6 13 376 383 O
1 14 15 384 385 B-lower_bound
cm 16 18 386 388 I-lower_bound
and 19 22 389 392 O
6 23 24 393 394 B-upper_bound
cm 25 27 395 397 I-upper_bound

Absence 0 7 0 7 O
of 8 10 8 10 O
focal 11 16 11 16 B-chronic_disease
neurologic 17 27 17 27 I-chronic_disease
signs 28 33 28 33 O
or 34 36 34 36 O
symptoms 37 45 37 45 O
related 46 53 46 53 O
to 54 56 54 56 O
thoracic 57 65 57 65 B-chronic_disease
radiculopathy 66 79 66 79 I-chronic_disease

Age 0 3 80 83 B-age
18 4 6 84 86 B-lower_bound
or 7 9 87 89 O
older 10 15 90 95 O

Chronic 0 7 96 103 O
thoracic 8 16 104 112 O
spine 17 22 113 118 O
mediated 23 31 119 127 O
back 32 36 128 132 O
pain 37 41 133 137 O
of 42 44 138 140 O
3 45 46 141 142 B-lower_bound
months 47 53 143 149 I-lower_bound
duration 54 62 150 158 O
or 63 65 159 161 O
longer 66 72 162 168 O

Concomitant 0 11 169 180 O
medical 12 19 181 188 O
( 20 21 189 190 O
e.g. 21 25 190 194 O
uncontrolled 26 38 195 207 O
cardiac 39 46 208 215 B-chronic_disease
condition 47 56 216 225 I-chronic_disease
) 56 57 225 226 O
or 58 60 227 229 O
psychiatric 61 72 230 241 B-chronic_disease
illness 73 80 242 249 I-chronic_disease
( 81 82 250 251 O
e.g. 82 86 251 255 O
, 86 87 255 256 O
untreated 88 97 257 266 O
depression 98 108 267 277 B-chronic_disease
) 108 109 277 278 O
likely 110 116 279 285 O
to 117 119 286 288 O
endanger 120 128 289 297 O
the 129 132 298 301 O
patient 133 140 302 309 O
or 141 143 310 312 O
compromise 144 154 313 323 B-treatment
treatment 155 164 324 333 I-treatment
outcomes 165 173 334 342 O

Failure 0 7 343 350 O
to 8 10 351 353 O
respond 11 18 354 361 O
to 19 21 362 364 O
conservative 22 34 365 377 O
measures 35 43 378 386 O
in 44 46 387 389 O
the 47 50 390 393 O
form 51 55 394 398 O
of 56 58 399 401 O
oral 59 63 402 406 B-treatment
medication 64 74 407 417 I-treatment
and 75 78 418 421 O
physical 79 87 422 430 B-treatment
therapy 88 95 431 438 I-treatment

Malignancy 0 10 439 449 B-cancer

More 0 4 450 454 O
than 5 9 455 459 O
50 10 12 460 462 B-lower_bound
% 12 13 462 463 I-lower_bound
reduction 14 23 464 473 O
in 24 26 474 476 O
their 27 32 477 482 O
pain 33 37 483 487 O
less 38 42 488 492 O
than 43 47 493 497 O
2 48 49 498 499 B-upper_bound
months 50 56 500 506 I-upper_bound
duration 57 65 507 515 O
following 66 75 516 525 O
a 76 77 526 527 O
series 78 84 528 534 O
of 85 87 535 537 O
2 88 89 538 539 O
diagnostic 90 100 540 550 O
thoracic 101 109 551 559 B-treatment
medial 110 116 560 566 I-treatment
branch 117 123 567 573 I-treatment
blocks 124 130 574 580 I-treatment
of 131 133 581 583 O
the 134 137 584 587 O
affected 138 146 588 596 O
joints 147 153 597 603 O
using 154 159 604 609 O
1 160 161 610 611 O
ml 162 164 612 614 O
of 165 167 615 617 O
1 168 169 618 619 O
% 169 170 619 620 O
lidocaine 171 180 621 630 B-treatment
in 181 183 631 633 O
the 184 187 634 637 O
first 188 193 638 643 O
procedure 194 203 644 653 O
and 204 207 654 657 O
bupivacaine 208 219 658 669 B-treatment
0.5 220 223 670 673 O
% 224 225 674 675 O
in 226 228 676 678 O
the 229 232 679 682 O
second 233 239 683 689 O
time 240 244 690 694 O

Pregnancy 0 9 695 704 B-pregnancy

Systemic 0 8 705 713 B-chronic_disease
or 9 11 714 716 I-chronic_disease
local 12 17 717 722 I-chronic_disease
infection 18 27 723 732 I-chronic_disease

Untreated 0 9 733 742 O
coagulopathy 10 22 743 755 B-chronic_disease

Age 0 3 0 3 B-age
: 3 4 3 4 O
35 5 7 5 7 B-lower_bound
- 7 8 7 8 O
64 8 10 8 10 B-upper_bound
at 11 13 11 13 O
enrollment 14 24 14 24 O

BMI 0 3 25 28 B-bmi
: 3 4 28 29 O
30 5 7 30 32 B-lower_bound
- 7 8 32 33 O
50 8 10 33 35 B-upper_bound

Fluent 0 6 36 42 B-language_fluency
in 7 9 43 45 I-language_fluency
English 10 17 46 53 I-language_fluency
( 18 19 54 55 I-language_fluency
Nashville 19 28 55 64 I-language_fluency
and 29 32 65 68 I-language_fluency
Miami 33 38 69 74 I-language_fluency
) 38 39 74 75 I-language_fluency
or 40 42 76 78 I-language_fluency
Spanish 43 50 79 86 I-language_fluency
( 51 52 87 88 I-language_fluency
Miami 52 57 88 93 I-language_fluency
) 57 58 93 94 I-language_fluency

Prior 0 5 95 100 B-treatment
or 6 8 101 103 I-treatment
planned 9 16 104 111 I-treatment
bariatric 17 26 112 121 I-treatment
surgery 27 34 122 129 I-treatment

Race/ 0 5 130 135 O
ethnicity 6 15 136 145 O
: 15 16 145 146 O
African 17 24 147 154 B-ethnicity
American/ 25 34 155 164 I-ethnicity
Black 35 40 165 170 B-ethnicity
or 41 43 171 173 O
Latino/ 44 51 174 181 B-ethnicity
Hispanic 52 60 182 190 B-ethnicity

Weight 0 6 191 197 B-clinical_variable
less 7 11 198 202 O
than 12 16 203 207 O
400 17 20 208 211 B-upper_bound
pounds 21 27 212 218 I-upper_bound

Age 0 3 0 3 B-age
: 3 4 3 4 O
≥18 5 8 5 8 O
- 9 10 9 10 O
≤ 11 12 11 12 O
40 13 15 13 15 B-upper_bound
years 16 21 16 21 I-upper_bound
of 22 24 22 24 O
age 25 28 25 28 B-age

BMI 0 3 29 32 B-bmi
< 4 5 33 34 O
25 5 7 34 36 B-upper_bound
kg 8 10 37 39 I-upper_bound
/ 10 11 39 40 I-upper_bound
m2 11 13 40 42 I-upper_bound
( 14 15 43 44 O
Lean 15 19 44 48 O
control 20 27 49 56 O
) 27 28 56 57 O
and 29 32 58 61 O
≥30 33 36 62 65 O
kg 37 39 66 68 I-lower_bound
/ 39 40 68 69 I-lower_bound
m2 40 42 69 71 I-lower_bound
( 43 44 72 73 O
Obese 44 49 73 78 O
subjects 50 58 79 87 O
) 58 59 87 88 O

Blood 0 5 89 94 B-clinical_variable
pressure 6 14 95 103 I-clinical_variable
systolic 15 23 104 112 I-clinical_variable
≤125 24 28 113 117 O
and 29 32 118 121 O
diastolic 33 42 122 131 B-clinical_variable
≤85 43 46 132 135 O
mmHg 47 51 136 140 I-upper_bound
( 52 53 141 142 I-upper_bound
Lean 53 57 142 146 I-upper_bound
control 58 65 147 154 I-upper_bound
) 65 66 154 155 I-upper_bound
and 67 70 156 159 O
< 71 72 160 161 O
140 72 75 161 164 B-upper_bound
and 76 79 165 168 O
diastolic 80 89 169 178 O
< 90 91 179 180 O
90 91 93 180 182 B-upper_bound
mmHg 94 98 183 187 I-upper_bound
( 99 100 188 189 O
Obese 100 105 189 194 O
subjects 106 114 195 203 O
) 114 115 203 204 O

Females 0 7 205 212 B-gender
: 7 8 212 213 O
Self 9 13 214 218 O
- 13 14 218 219 O
reported 14 22 219 227 O
pregnancy 23 32 228 237 B-pregnancy
and/or 33 39 238 244 O
breastfeeding 40 53 245 258 O
, 53 54 258 259 O
diagnosed 55 64 260 269 O
with 65 69 270 274 O
polycystic 70 80 275 285 B-chronic_disease
ovarian 81 88 286 293 I-chronic_disease
syndrome 89 97 294 302 I-chronic_disease
, 97 98 302 303 O
or 99 101 304 306 O
without 102 109 307 314 O
regular 110 117 315 322 O
menses 118 124 323 329 O

Must 0 4 330 334 O
be 5 7 335 337 O
studied 8 15 338 345 O
in 16 18 346 348 O
the 19 22 349 352 O
early 23 28 353 358 O
follicular 29 39 359 369 B-clinical_variable
phase 40 45 370 375 I-clinical_variable
( 46 47 376 377 O
day 47 50 377 380 B-lower_bound
1 51 52 381 382 I-lower_bound
- 52 53 382 383 O
5 53 54 383 384 B-upper_bound
) 54 55 384 385 O
of 56 58 386 388 O
their 59 64 389 394 O
menstrual 65 74 395 404 B-clinical_variable
cycle 75 80 405 410 I-clinical_variable
or 81 83 411 413 O
the 84 87 414 417 O
low 88 91 418 421 O
hormone 92 99 422 429 O
phase 100 105 430 435 O
of 106 108 436 438 O
oral 109 113 439 443 O
contraceptive 114 127 444 457 O
use 128 131 458 461 O

Negative 0 8 462 470 B-pregnancy
pregnancy 9 18 471 480 I-pregnancy
test 19 23 481 485 O

Participation 0 13 486 499 O
in 14 16 500 502 O
vigorous 17 25 503 511 O
aerobic 26 33 512 519 O
exercise 34 42 520 528 O
> 43 44 529 530 O
90 44 46 530 532 B-lower_bound
minutes 47 54 533 540 I-lower_bound
per 55 58 541 544 I-lower_bound
week 59 63 545 549 I-lower_bound

Regularly 0 9 550 559 O
( 10 11 560 561 O
≥5 11 13 561 563 O
days 14 18 564 568 I-lower_bound
/ 18 19 568 569 I-lower_bound
week 19 23 569 573 I-lower_bound
) 23 24 573 574 O
take 25 29 575 579 O
acetylsalicylic 30 45 580 595 B-treatment
acid 46 50 596 600 I-treatment

Self 0 4 601 605 O
- 4 5 605 606 O
reported 5 13 606 614 O
current 14 21 615 622 O
diagnosis 22 31 623 632 O
of 32 34 633 635 O
exhibiting 35 45 636 646 O
obstructive 46 57 647 658 B-chronic_disease
sleep 58 63 659 664 I-chronic_disease
apnea 64 69 665 670 I-chronic_disease

Self 0 4 671 675 O
- 4 5 675 676 O
reported 5 13 676 684 O
history 14 21 685 692 O
of 22 24 693 695 O
hematologic 25 36 696 707 B-chronic_disease
disease 37 44 708 715 I-chronic_disease

Self 0 4 716 720 O
- 4 5 720 721 O
reported 5 13 721 729 O
history 14 21 730 737 O
of 22 24 738 740 O
hepatic 25 32 741 748 B-chronic_disease
disease 33 40 749 756 I-chronic_disease

Self 0 4 757 761 O
- 4 5 761 762 O
reported 5 13 762 770 O
history 14 21 771 778 O
of 22 24 779 781 O
peripheral 25 35 782 792 B-chronic_disease
vascular 36 44 793 801 I-chronic_disease
disease 45 52 802 809 I-chronic_disease

Self 0 4 810 814 O
- 4 5 814 815 O
reported 5 13 815 823 O
history 14 21 824 831 O
of 22 24 832 834 O
renal 25 30 835 840 B-chronic_disease
disease 31 38 841 848 I-chronic_disease

Sensitivity 0 11 849 860 O
to 12 14 861 863 O
lidocaine 15 24 864 873 B-treatment

Specific 0 8 874 882 O
to 9 11 883 885 O
obese 12 17 886 891 O
subjects 18 26 892 900 O
only 27 31 901 905 O
( 32 33 906 907 O
to 33 35 907 909 O
exclude 36 43 910 917 O
obese 44 49 918 923 O
subjects 50 58 924 932 O
with 59 63 933 937 O
metabolic 64 73 938 947 B-chronic_disease
syndrome 74 82 948 956 I-chronic_disease
) 82 83 956 957 O

Taking 0 6 958 964 O
cardiovascular 7 21 965 979 B-treatment
medications 22 33 980 991 I-treatment
( 34 35 992 993 O
anti 35 39 993 997 B-treatment
- 39 40 997 998 I-treatment
hypertensives 40 53 998 1011 I-treatment
, 53 54 1011 1012 O
statins 55 62 1013 1020 B-treatment
, 62 63 1020 1021 O
platelet 64 72 1022 1030 B-treatment
inhibitors 73 83 1031 1041 I-treatment
, 83 84 1041 1042 O
etc 85 88 1043 1046 O
. 88 89 1046 1047 O
) 89 90 1047 1048 O
or 91 93 1049 1051 O
metabolic 94 103 1052 1061 B-treatment
medications 104 115 1062 1073 I-treatment
( 116 117 1074 1075 O
insulin 117 124 1075 1082 B-treatment
- 124 125 1082 1083 I-treatment
sensitizing 125 136 1083 1094 I-treatment
) 136 137 1094 1095 O

non 0 3 1096 1099 B-treatment
- 3 4 1099 1100 I-treatment
steroidal 4 13 1100 1109 I-treatment
anti 14 18 1110 1114 I-treatment
- 18 19 1114 1115 I-treatment
inflammatory 19 31 1115 1127 I-treatment
drugs 32 37 1128 1133 I-treatment
( 38 39 1134 1135 I-treatment
NSAIDs 39 45 1135 1141 I-treatment
) 45 46 1141 1142 I-treatment

Active 0 6 0 6 B-cancer
central 7 14 7 14 I-cancer
nervous 15 22 15 22 I-cancer
system 23 29 23 29 I-cancer
metastases 30 40 30 40 I-cancer
at 41 43 41 43 O
the 44 47 44 47 O
time 48 52 48 52 O
of 53 55 53 55 O
treatment 56 65 56 65 O

Active 0 6 66 72 B-chronic_disease
infection 7 16 73 82 I-chronic_disease
or 17 19 83 85 O
other 20 25 86 91 O
active 26 32 92 98 O
medical 33 40 99 106 O
condition 41 50 107 116 O
that 51 55 117 121 O
could 56 61 122 127 O
be 62 64 128 130 O
eminently 65 74 131 140 O
life 75 79 141 145 O
- 79 80 145 146 O
threatening 80 91 146 157 O
, 91 92 157 158 O
including 93 102 159 168 O
active 103 109 169 175 O
blood 110 115 176 181 B-chronic_disease
clotting 116 124 182 190 I-chronic_disease
or 125 127 191 193 O
bleeding 128 136 194 202 B-chronic_disease
diathesis 137 146 203 212 I-chronic_disease

Diagnosis 0 9 213 222 O
of 10 12 223 225 O
any 13 16 226 229 O
other 17 22 230 235 O
invasive 23 31 236 244 B-cancer
cancer 32 38 245 251 I-cancer
or 39 41 252 254 O
other 42 47 255 260 O
disease 48 55 261 268 O
process 56 63 269 276 O
which 64 69 277 282 O
is 70 72 283 285 O
considered 73 83 286 296 O
to 84 86 297 299 O
be 87 89 300 302 O
life 90 94 303 307 O
- 94 95 307 308 O
threatening 95 106 308 319 O
within 107 113 320 326 O
the 114 117 327 330 O
next 118 122 331 335 B-upper_bound
five 123 127 336 340 I-upper_bound
years 128 133 341 346 I-upper_bound

ECOG 0 4 347 351 B-clinical_variable
performance 5 16 352 363 I-clinical_variable
status 17 23 364 370 I-clinical_variable
greater 24 31 371 378 O
than 32 36 379 383 O
1 37 38 384 385 B-lower_bound
( 39 40 386 387 O
Karnofsky 40 49 387 396 B-clinical_variable
score 50 55 397 402 I-clinical_variable
less 56 60 403 407 O
than 61 65 408 412 O
70 66 68 413 415 B-upper_bound
% 68 69 415 416 I-upper_bound
) 69 70 416 417 O

ECOG 0 4 418 422 B-clinical_variable
performance 5 16 423 434 I-clinical_variable
status 17 23 435 441 I-clinical_variable
of 24 26 442 444 I-clinical_variable
0 27 28 445 446 I-clinical_variable
- 28 29 446 447 I-clinical_variable
1 29 30 447 448 I-clinical_variable
( 31 32 449 450 O
Karnofsky 32 41 450 459 B-clinical_variable
score 42 47 460 465 I-clinical_variable
of 48 50 466 468 O
70 51 53 469 471 B-lower_bound
- 53 54 471 472 O
100 54 57 472 475 B-upper_bound
% 57 58 475 476 I-upper_bound
) 58 59 476 477 O

Have 0 4 478 482 O
undergone 5 14 483 492 O
leukapheresis 15 28 493 506 B-treatment
from 29 33 507 511 O
which 34 39 512 517 O
sufficient 40 50 518 528 O
provided 51 59 529 537 O
PBMC 60 64 538 542 O
were 65 69 543 547 O
obtained 70 78 548 556 O
to 79 81 557 559 O
produce 82 89 560 567 O
an 90 92 568 570 O
investigational 93 108 571 586 B-treatment
treatment 109 118 587 596 I-treatment

Known 0 5 597 602 O
autoimmune 6 16 603 613 B-chronic_disease
disease 17 24 614 621 I-chronic_disease
, 24 25 621 622 O
immunodeficiency 26 42 623 639 B-chronic_disease
, 42 43 639 640 O
or 44 46 641 643 O
disease 47 54 644 651 O
process 55 62 652 659 O
that 63 67 660 664 O
involves 68 76 665 673 O
the 77 80 674 677 O
use 81 84 678 681 O
of 85 87 682 684 O
immunosuppressive 88 105 685 702 B-treatment
therapy 106 113 703 710 I-treatment

Known 0 5 711 716 O
hypersensitivity 6 22 717 733 O
to 23 25 734 736 O
GM 26 28 737 739 B-allergy_name
- 28 29 739 740 I-allergy_name
CSF 29 32 740 743 I-allergy_name

Known 0 5 744 749 O
to 6 8 750 752 O
have 9 13 753 757 O
active 14 20 758 764 B-chronic_disease
hepatitis 21 30 765 774 I-chronic_disease
B 31 32 775 776 I-chronic_disease
or 33 35 777 779 I-chronic_disease
C 36 37 780 781 I-chronic_disease
or 38 40 782 784 O
HIV 41 44 785 788 B-chronic_disease

Known 0 5 789 794 O
underlying 6 16 795 805 O
cardiac 17 24 806 813 B-chronic_disease
disease 25 32 814 821 I-chronic_disease
associated 33 43 822 832 O
with 44 48 833 837 O
myocardial 49 59 838 848 B-chronic_disease
dysfunction 60 71 849 860 I-chronic_disease
that 72 76 861 865 O
requires 77 85 866 874 O
active 86 92 875 881 B-treatment
medical 93 100 882 889 I-treatment
treatment 101 110 890 899 I-treatment

Patients 0 8 900 908 O
must 9 13 909 913 O
previously 14 24 914 924 O
have 25 29 925 929 O
been 30 34 930 934 O
staged 35 41 935 941 O
as 42 44 942 944 O
having 45 51 945 951 O
stage 52 57 952 957 B-cancer
III 58 61 958 961 I-cancer
[ 62 63 962 963 I-cancer
intraperitoneal 63 78 963 978 I-cancer
( 79 80 979 980 I-cancer
IP 80 82 980 982 I-cancer
) 82 83 982 983 I-cancer
] 83 84 983 984 I-cancer
or 85 87 985 987 I-cancer
Stage 88 93 988 993 I-cancer
IV 94 96 994 996 I-cancer
( 97 98 997 998 I-cancer
distant 98 105 998 1005 I-cancer
metastatic 106 116 1006 1016 I-cancer
) 116 117 1016 1017 I-cancer
ovarian 118 125 1018 1025 I-cancer
, 125 126 1025 1026 O
fallopian 127 136 1027 1036 B-cancer
tube 137 141 1037 1041 I-cancer
, 141 142 1041 1042 O
or 143 145 1043 1045 O
primary 146 153 1046 1053 O
peritoneal 154 164 1054 1064 B-cancer
cancer 165 171 1065 1071 I-cancer
, 171 172 1071 1072 O
have 173 177 1073 1077 O
undergone 178 187 1078 1087 O
surgical 188 196 1088 1096 B-treatment
debulking 197 206 1097 1106 I-treatment
, 206 207 1106 1107 O
and 208 211 1108 1111 O
have 212 216 1112 1116 O
initiated 217 226 1117 1126 O
or 227 229 1127 1129 O
completed 230 239 1130 1139 O
standard 240 248 1140 1148 O
adjuvant 249 257 1149 1157 B-treatment
chemotherapy 258 270 1158 1170 I-treatment
, 270 271 1170 1171 O
which 272 277 1172 1177 O
may 278 281 1178 1181 O
include 282 289 1182 1189 O
intravenous 290 301 1190 1201 B-treatment
( 302 303 1202 1203 I-treatment
IV 303 305 1203 1205 I-treatment
) 305 306 1205 1206 I-treatment
and/or 307 313 1207 1213 O
IP 314 316 1214 1216 B-treatment
chemotherapy 317 329 1217 1229 I-treatment
using 330 335 1230 1235 O
standard 336 344 1236 1244 O
regimens 345 353 1245 1253 O

Patients 0 8 1254 1262 O
with 9 13 1263 1267 O
one 14 17 1268 1271 O
or 18 20 1272 1274 O
a 21 22 1275 1276 O
few 23 26 1277 1280 O
brain 27 32 1281 1286 B-cancer
metastases 33 43 1287 1297 I-cancer
that 44 48 1298 1302 O
have 49 53 1303 1307 O
been 54 58 1308 1312 O
treated 59 66 1313 1320 O
with 67 71 1321 1325 O
stereotactic 72 84 1326 1338 B-treatment
radiotherapy 85 97 1339 1351 I-treatment
consisting 98 108 1352 1362 O
of 109 111 1363 1365 O
a 112 113 1366 1367 O
single 114 120 1368 1374 O
dose 121 125 1375 1379 O
, 125 126 1379 1380 O
such 127 131 1381 1385 O
as 132 134 1386 1388 O
Gamma 135 140 1389 1394 B-treatment
Knife 141 146 1395 1400 I-treatment
or 147 149 1401 1403 O
Cyberknife 150 160 1404 1414 B-treatment
, 160 161 1414 1415 O
are 162 165 1416 1419 O
allowed 166 173 1420 1427 O
to 174 176 1428 1430 O
be 177 179 1431 1433 O
included 180 188 1434 1442 O
in 189 191 1443 1445 O
the 192 195 1446 1449 O
study 196 201 1450 1455 O
, 201 202 1455 1456 O
but 203 206 1457 1460 O
need 207 211 1461 1465 O
wait 212 216 1466 1470 O
one 217 220 1471 1474 O
week 221 225 1475 1479 O
after 226 231 1480 1485 O
such 232 236 1486 1490 O
treatment 237 246 1491 1500 B-treatment

Received 0 8 1501 1509 O
another 9 16 1510 1517 O
investigational 17 32 1518 1533 O
drug 33 37 1534 1538 O
within 38 44 1539 1545 O
28 45 47 1546 1548 B-upper_bound
days 48 52 1549 1553 I-upper_bound
of 53 55 1554 1556 O
the 56 59 1557 1560 O
first 60 65 1561 1566 O
dose 66 70 1567 1571 O
or 71 73 1572 1574 O
are 74 77 1575 1578 O
planning 78 86 1579 1587 O
to 87 89 1588 1590 O
receive 90 97 1591 1598 O
another 98 105 1599 1606 O
investigational 106 121 1607 1622 O
drug 122 126 1623 1627 O
while 127 132 1628 1633 O
receiving 133 142 1634 1643 O
this 143 147 1644 1648 O
investigational 148 163 1649 1664 O
treatment 164 173 1665 1674 O

Successful 0 10 1675 1685 O
establishment 11 24 1686 1699 O
of 25 27 1700 1702 O
an 28 30 1703 1705 O
autologous 31 41 1706 1716 O
epithelial 42 52 1717 1727 O
ovarian 53 60 1728 1735 O
, 60 61 1735 1736 O
fallopian 62 71 1737 1746 O
tube 72 76 1747 1751 O
, 76 77 1751 1752 O
or 78 80 1753 1755 O
primary 81 88 1756 1763 B-cancer
peritoneal 89 99 1764 1774 I-cancer
cancer 100 106 1775 1781 I-cancer
cell 107 111 1782 1786 O
line 112 116 1787 1791 O
by 117 119 1792 1794 O
AIVITA 120 126 1795 1801 O
Biomedical 127 137 1802 1812 O
, 137 138 1812 1813 O
Inc 139 142 1814 1817 O

taking 0 6 1818 1824 O
anti 7 11 1825 1829 B-treatment
- 11 12 1829 1830 I-treatment
cancer 12 18 1830 1836 I-treatment
therapy 19 26 1837 1844 I-treatment
for 27 30 1845 1848 O
cancer 31 37 1849 1855 O
other 38 43 1856 1861 O
than 44 48 1862 1866 O
ovarian 49 56 1867 1874 O
( 57 58 1875 1876 O
such 58 62 1876 1880 O
as 63 65 1881 1883 O
continuation 66 78 1884 1896 O
of 79 81 1897 1899 O
hormonal 82 90 1900 1908 B-treatment
therapy 91 98 1909 1916 I-treatment
for 99 102 1917 1920 O
prostate 103 111 1921 1929 B-cancer
or 112 114 1930 1932 O
breast 115 121 1933 1939 B-cancer
cancer 122 128 1940 1946 I-cancer
diagnosed 129 138 1947 1956 O
more 139 143 1957 1961 O
than 144 148 1962 1966 O
five 149 153 1967 1971 B-lower_bound
years 154 159 1972 1977 I-lower_bound
earlier 160 167 1978 1985 O
) 167 168 1985 1986 O

under 0 5 1987 1992 O
treatment 6 15 1993 2002 B-treatment
for 16 19 2003 2006 O
arterial 20 28 2007 2015 O
or 29 31 2016 2018 O
venous 32 38 2019 2025 O
peripheral 39 49 2026 2036 B-chronic_disease
vascular 50 58 2037 2045 I-chronic_disease
disease 59 66 2046 2053 I-chronic_disease

unstable 0 8 2054 2062 B-chronic_disease
angina 9 15 2063 2069 I-chronic_disease
related 16 23 2070 2077 O
to 24 26 2078 2080 O
atherosclerotic 27 42 2081 2096 B-chronic_disease
cardiovascular 43 57 2097 2111 I-chronic_disease
disease 58 65 2112 2119 I-chronic_disease

Diagnosed 0 9 0 9 O
with 10 14 10 14 O
PKU 15 18 15 18 B-chronic_disease
or 19 21 19 21 O
other 22 27 22 27 O
aminoacidopathy 28 43 28 43 B-chronic_disease

age 0 3 44 47 B-age
11 4 6 48 50 B-lower_bound
or 7 9 51 53 O
older 10 15 54 59 O

female 0 6 60 66 B-gender

< 0 1 0 1 O
24 2 4 2 4 B-upper_bound
mL 5 7 5 7 I-upper_bound
/ 7 8 7 8 I-upper_bound
kg 8 10 8 10 I-upper_bound
/ 10 11 10 11 I-upper_bound
min 11 14 11 14 I-upper_bound
in 15 17 15 17 O
men 18 21 18 21 B-gender

< 0 1 22 23 O
21 1 3 23 25 B-upper_bound
mL 4 6 26 28 I-upper_bound
/ 6 7 28 29 I-upper_bound
kg 7 9 29 31 I-upper_bound
/ 9 10 31 32 I-upper_bound
min 10 13 32 35 I-upper_bound
in 14 16 36 38 O
women 17 22 39 44 B-gender

Any 0 3 45 48 O
patient 4 11 49 56 O
recently 12 20 57 65 O
hospitalized 21 33 66 78 O
for 34 37 79 82 O
heart 38 43 83 88 B-chronic_disease
failure 44 51 89 96 I-chronic_disease
will 52 56 97 101 O
have 57 61 102 106 O
to 62 64 107 109 O
wait 65 69 110 114 O
at 70 72 115 117 O
least 73 78 118 123 O
2 79 80 124 125 B-lower_bound
weeks 81 86 126 131 I-lower_bound
before 87 93 132 138 O
starting 94 102 139 147 O
CR 103 105 148 150 O

Atrial 0 6 151 157 B-chronic_disease
fibrillation 7 19 158 170 I-chronic_disease

NYHA 0 4 171 175 B-clinical_variable
class 5 10 176 181 I-clinical_variable
II 11 13 182 184 B-lower_bound
or 14 16 185 187 O
III 17 20 188 191 B-upper_bound
symptoms 21 29 192 200 O

Patients 0 8 201 209 O
with 9 13 210 214 O
exercise 14 22 215 223 O
induced 23 30 224 231 O
angina 31 37 232 238 B-chronic_disease
during 38 44 239 245 O
CR 45 47 246 248 O

Pregnant 0 8 249 257 B-pregnancy

Referred 0 8 258 266 O
by 9 11 267 269 O
physician 12 21 270 279 O
to 22 24 280 282 O
CR 25 27 283 285 O
with 28 32 286 290 O
echocardiographic 33 50 291 308 B-treatment
evidence 51 59 309 317 O
of 60 62 318 320 O
HFpEF 63 68 321 326 O
defined 69 76 327 334 O
as 77 79 335 337 O
an 80 82 338 340 O
ejection 83 91 341 349 B-clinical_variable
fraction 92 100 350 358 I-clinical_variable
≥ 101 102 359 360 O
50 103 105 361 363 B-lower_bound
% 106 107 364 365 I-lower_bound

moderate 0 8 366 374 B-chronic_disease
to 9 11 375 377 I-chronic_disease
severe 12 18 378 384 I-chronic_disease
( 19 20 385 386 I-chronic_disease
grade 20 25 386 391 I-chronic_disease
II 26 28 392 394 I-chronic_disease
- 28 29 394 395 I-chronic_disease
III 29 32 395 398 I-chronic_disease
) 32 33 398 399 I-chronic_disease
diastolic 34 43 400 409 I-chronic_disease
dysfunction 44 55 410 421 I-chronic_disease

planning 0 8 422 430 B-pregnancy
to 9 11 431 433 I-pregnancy
become 12 18 434 440 I-pregnancy
pregnant 19 27 441 449 I-pregnancy

those 0 5 450 455 O
with 6 10 456 460 O
mild 11 15 461 465 O
( 16 17 466 467 O
grade 17 22 467 472 O
I 23 24 473 474 O
) 24 25 474 475 O
diastolic 26 35 476 485 B-chronic_disease
dysfunction 36 47 486 497 I-chronic_disease

≥ 0 1 498 499 O
50 2 4 500 502 B-lower_bound
years 5 10 503 508 I-lower_bound
of 11 13 509 511 O
age 14 17 512 515 B-age

Known 0 5 0 5 O
Celiac 6 12 6 12 B-chronic_disease
disease 13 20 13 20 I-chronic_disease

Patients 0 8 21 29 O
unable 9 15 30 36 B-language_fluency
to 16 18 37 39 I-language_fluency
speak 19 24 40 45 I-language_fluency
English 25 32 46 53 I-language_fluency

Patients 0 8 54 62 O
with 9 13 63 67 O
mild 14 18 68 72 O
to 19 21 73 75 O
moderate 22 30 76 84 O
Irritable 31 40 85 94 B-chronic_disease
Bowel 41 46 95 100 I-chronic_disease
Syndrome 47 55 101 109 I-chronic_disease
( 56 57 110 111 I-chronic_disease
IBS 57 60 111 114 I-chronic_disease
) 60 61 114 115 I-chronic_disease
and 62 65 116 119 O
mild 66 70 120 124 O
to 71 73 125 127 O
moderate 74 82 128 136 O
anxiety 83 90 137 144 B-chronic_disease
or 91 93 145 147 O
depression 94 104 148 158 B-chronic_disease

Pregnant 0 8 159 167 B-pregnancy

Uncontrolled 0 12 168 180 O
thyroid 13 20 181 188 B-chronic_disease
disease 21 28 189 196 I-chronic_disease
as 29 31 197 199 O
indicated 32 41 200 209 O
by 42 44 210 212 O
an 45 47 213 215 O
abnormal 48 56 216 224 B-clinical_variable
thyroid 57 64 225 232 I-clinical_variable
stimulating 65 76 233 244 I-clinical_variable
hormone 77 84 245 252 I-clinical_variable
( 85 86 253 254 I-clinical_variable
TSH 86 89 254 257 I-clinical_variable
) 89 90 257 258 I-clinical_variable
level 91 96 259 264 I-clinical_variable

nursing 0 7 265 272 O
women 8 13 273 278 B-gender

Any 0 3 0 3 O
disease 4 11 4 11 O
, 11 12 11 12 O
diagnosis 13 22 13 22 O
, 22 23 22 23 O
or 24 26 24 26 O
condition 27 36 27 36 O
( 37 38 37 38 O
medical 38 45 38 45 O
or 46 48 46 48 O
surgical 49 57 49 57 O
) 57 58 57 58 O
that 59 63 59 63 O
, 63 64 63 64 O
in 65 67 65 67 O
the 68 71 68 71 O
opinion 72 79 72 79 O
of 80 82 80 82 O
the 83 86 83 86 O
Principal 87 96 87 96 O
Investigator 97 109 97 109 O
, 109 110 109 110 O
would 111 116 111 116 O
place 117 122 117 122 O
the 123 126 123 126 O
subject 127 134 127 134 O
at 135 137 135 137 O
increased 138 147 138 147 O
risk 148 152 148 152 O
( 153 154 153 154 O
active 154 160 154 160 O
gynecologic 161 172 161 172 B-chronic_disease
disease 173 180 173 180 I-chronic_disease
in 181 183 181 183 O
which 184 189 184 189 O
increased 190 199 190 199 O
tone 200 204 200 204 O
would 205 210 205 210 O
be 211 213 211 213 O
detrimental 214 225 214 225 O
e.g. 226 230 226 230 O
, 230 231 230 231 O
uterine 232 239 232 239 B-chronic_disease
fibroids 240 248 240 248 I-chronic_disease
with 249 253 249 253 O
ongoing 254 261 254 261 O
bleeding 262 270 262 270 O
) 270 271 270 271 O
, 271 272 271 272 O
compromise 273 283 273 283 O
the 284 287 284 287 O
subject 288 295 288 295 O
's 295 297 295 297 O
compliance 298 308 298 308 O
with 309 313 309 313 O
study 314 319 314 319 O
procedures 320 330 320 330 O
, 330 331 330 331 O
or 332 334 332 334 O
compromise 335 345 335 345 O
the 346 349 346 349 O
quality 350 357 350 357 O
of 358 360 358 360 O
the 361 364 361 364 O
dat 365 368 365 368 O

Neuropathic 0 11 369 380 B-chronic_disease
pain 12 16 381 385 I-chronic_disease
for 17 20 386 389 O
> 21 22 390 391 O
6 23 24 392 393 B-lower_bound
months 25 31 394 400 I-lower_bound

Pregnancy 0 9 401 410 B-pregnancy

Weight 0 6 411 417 B-clinical_variable
< 7 8 418 419 O
or 9 11 420 422 O
equal 12 17 423 428 O
to 18 20 429 431 O
240 21 24 432 435 B-upper_bound
pounds 25 31 436 442 I-upper_bound

chronic 0 7 443 450 O
intrathecal 8 19 451 462 B-treatment
drug 20 24 463 467 I-treatment
therapy 25 32 468 475 I-treatment

oral 0 4 476 480 B-treatment
opioid 5 11 481 487 I-treatment
treatment 12 21 488 497 I-treatment
for 22 25 498 501 O
> 26 27 502 503 O
3 28 29 504 505 B-lower_bound
months 30 36 506 512 I-lower_bound
at 37 39 513 515 O
a 40 41 516 517 O
current 42 49 518 525 O
dose 50 54 526 530 O
of 55 57 531 533 O
> 58 59 534 535 O
100 60 63 536 539 B-lower_bound
milligram 64 73 540 549 I-lower_bound
( 74 75 550 551 I-lower_bound
mg 75 77 551 553 I-lower_bound
) 77 78 553 554 I-lower_bound
morphine 79 87 555 563 B-treatment
per 88 91 564 567 O
day 92 95 568 571 O
or 96 98 572 574 O
equivalent 99 109 575 585 O

significant 0 11 586 597 O
reaction 12 20 598 606 O
to 21 23 607 609 O
any 24 27 610 613 O
ingredient 28 38 614 624 O
of 39 41 625 627 O
the 42 45 628 631 O
study 46 51 632 637 B-allergy_name
drug 52 56 638 642 I-allergy_name
or 57 59 643 645 O
lidocaine 60 69 646 655 B-allergy_name

Adult 0 5 0 5 O
subjects 6 14 6 14 O
with 15 19 15 19 O
brain 20 25 20 25 O
, 25 26 25 26 O
head 27 31 27 31 B-cancer
and 32 35 32 35 O
neck 36 40 36 40 B-cancer
, 40 41 40 41 O
and 42 45 42 45 O
skull 46 51 46 51 B-cancer
base 52 56 52 56 I-cancer
tumors 57 63 57 63 I-cancer
receiving 64 73 64 73 O
external 74 82 74 82 O
beam 83 87 83 87 O
proton 88 94 88 94 O
radiotherapy 95 107 95 107 B-treatment
at 108 110 108 110 O
the 111 114 111 114 O
Francis 115 122 115 122 O
H. 123 125 123 125 O
Burr 126 130 126 130 O
Proton 131 137 131 137 O
Therapy 138 145 138 145 O
Center 146 152 146 152 O
at 153 155 153 155 O
MGH 156 159 156 159 O

Age 0 3 160 163 B-age
18 4 6 164 166 B-lower_bound
or 7 9 167 169 O
over 10 14 170 174 O

ECOG 0 4 175 179 B-clinical_variable
Performance 5 16 180 191 I-clinical_variable
status 17 23 192 198 I-clinical_variable
0 24 25 199 200 B-lower_bound
, 25 26 200 201 O
1 27 28 202 203 O
or 29 31 204 206 O
2 32 33 207 208 B-upper_bound

Uncontrolled 0 12 209 221 O
intercurrent 13 25 222 234 B-chronic_disease
illness 26 33 235 242 I-chronic_disease
that 34 38 243 247 O
, 38 39 247 248 O
in 40 42 249 251 O
the 43 46 252 255 O
opinion 47 54 256 263 O
of 55 57 264 266 O
the 58 61 267 270 O
investigator 62 74 271 283 O
, 74 75 283 284 O
would 76 81 285 290 O
limit 82 87 291 296 O
the 88 91 297 300 O
participant 92 103 301 312 O
's 103 105 312 314 O
compliance 106 116 315 325 O
with 117 121 326 330 O
study 122 127 331 336 O
requirements 128 140 337 349 O

> 0 1 0 1 O
2 2 3 2 3 B-lower_bound
lines 4 9 4 9 O
of 10 12 10 12 O
prior 13 18 13 18 B-treatment
chemotherapy 19 31 19 31 I-treatment
in 32 34 32 34 I-treatment
the 35 38 35 38 I-treatment
metastatic 39 49 39 49 I-treatment
setting 50 57 50 57 I-treatment

Absolute 0 8 58 66 B-clinical_variable
neutrophil 9 19 67 77 I-clinical_variable
count 20 25 78 83 I-clinical_variable
( 26 27 84 85 I-clinical_variable
ANC 27 30 85 88 I-clinical_variable
) 30 31 88 89 I-clinical_variable
≥ 32 33 90 91 O
1,500 34 39 92 97 B-lower_bound
/μL 40 43 98 101 I-lower_bound

Aspartate 0 9 102 111 B-clinical_variable
aminotransferase 10 26 112 128 I-clinical_variable
( 27 28 129 130 I-clinical_variable
AST 28 31 130 133 I-clinical_variable
) 31 32 133 134 I-clinical_variable
( 33 34 135 136 O
SGOT 34 38 136 140 B-clinical_variable
) 38 39 140 141 O
and 40 43 142 145 O
alanine 44 51 146 153 B-clinical_variable
aminotransferase 52 68 154 170 I-clinical_variable
ALT 69 72 171 174 I-clinical_variable
( 73 74 175 176 O
SGPT 74 78 176 180 B-clinical_variable
) 78 79 180 181 O
≤ 80 81 182 183 O
2.5 82 85 184 187 B-upper_bound
x 86 87 188 189 I-upper_bound
ULN 88 91 190 193 I-upper_bound
, 91 92 193 194 O
≤ 93 94 195 196 O
5 95 96 197 198 O
x 97 98 199 200 O
ULN 99 102 201 204 O
if 103 105 205 207 O
liver 106 111 208 213 B-cancer
metastasis 112 122 214 224 I-cancer

Clinically 0 10 225 235 O
significant 11 22 236 247 O
cardiac 23 30 248 255 B-chronic_disease
arrhythmia 31 41 256 266 I-chronic_disease

Clinically 0 10 267 277 O
significant 11 22 278 289 O
congestive 23 33 290 300 B-chronic_disease
heart 34 39 301 306 I-chronic_disease
failure 40 47 307 314 I-chronic_disease
, 47 48 314 315 O
unstable 49 57 316 324 B-chronic_disease
angina 58 64 325 331 I-chronic_disease
pectoris 65 73 332 340 O

Concomitant 0 11 341 352 O
use 12 15 353 356 O
of 16 18 357 359 O
bisphosphonates 19 34 360 375 B-treatment
or 35 37 376 378 O
RANK 38 42 379 383 B-treatment
- 42 43 383 384 I-treatment
ligand 43 49 384 390 I-treatment
inhibitors 50 60 391 401 I-treatment
is 61 63 402 404 O
allowed 64 71 405 412 O

Congenitally 0 12 413 425 O
long 13 17 426 430 B-chronic_disease
QT 18 20 431 433 I-chronic_disease
syndrome 21 29 434 442 I-chronic_disease
, 29 30 442 443 O
and/or 31 37 444 450 O
current 38 45 451 458 O
anti 46 50 459 463 B-treatment
- 50 51 463 464 I-treatment
arrhythmic 51 61 464 474 I-treatment
therapy 62 69 475 482 I-treatment
, 69 70 482 483 O
a 71 72 484 485 O
n 73 74 486 487 O
d 75 76 488 489 O
/ 77 78 490 491 O
o 79 80 492 493 O
r 81 82 494 495 O
has 83 86 496 499 O
received 87 95 500 508 O
any 96 99 509 512 O
marketed 100 108 513 521 O
or 109 111 522 524 O
experimental 112 124 525 537 O
compound 125 133 538 546 O
in 134 136 547 549 O
the 137 140 550 553 O
last 141 145 554 558 B-upper_bound
1 146 147 559 560 I-upper_bound
week 148 152 561 565 I-upper_bound
prior 153 158 566 571 I-upper_bound
to 159 161 572 574 O
entering 162 170 575 583 O
the 171 174 584 587 O
study 175 180 588 593 O
with 181 185 594 598 O
known 186 191 599 604 O
effects 192 199 605 612 O
of 200 202 613 615 O
QT 203 205 616 618 B-treatment
prolongation 206 218 619 631 I-treatment
( 219 220 632 633 O
Refer 220 225 633 638 O
to 226 228 639 641 O
AZCERT 229 235 642 648 O
website 236 243 649 656 O
) 243 244 656 657 O

Female 0 6 658 664 B-gender
patient 7 14 665 672 I-gender
of 15 17 673 675 O
childbearing 18 30 676 688 O
potential 31 40 689 698 O
must 41 45 699 703 O
have 46 50 704 708 O
a 51 52 709 710 O
negative 53 61 711 719 B-pregnancy
serum 62 67 720 725 I-pregnancy
or 68 70 726 728 I-pregnancy
urine 71 76 729 734 I-pregnancy
pregnancy 77 86 735 744 I-pregnancy
test 87 91 745 749 O
β 92 93 750 751 B-clinical_variable
- 93 94 751 752 I-clinical_variable
hCG 94 97 752 755 I-clinical_variable
within 98 104 756 762 O
72 105 107 763 765 B-upper_bound
hours 108 113 766 771 I-upper_bound
prior 114 119 772 777 I-upper_bound
to 120 122 778 780 O
first 123 128 781 786 O
doses 129 134 787 792 O
of 135 137 793 795 O
study 138 143 796 801 O
medication 144 154 802 812 O
. 155 156 813 814 O
If 157 159 815 817 O
the 160 163 818 821 O
urine 164 169 822 827 O
test 170 174 828 832 O
is 175 177 833 835 O
positive 178 186 836 844 O
or 187 189 845 847 O
can 190 193 848 851 O
not 193 196 851 854 O
be 197 199 855 857 O
confirmed 200 209 858 867 O
as 210 212 868 870 O
negative 213 221 871 879 O
, 221 222 879 880 O
a 223 224 881 882 O
serum 225 230 883 888 B-pregnancy
pregnancy 231 240 889 898 I-pregnancy
test 241 245 899 903 O
will 246 250 904 908 O
be 251 253 909 911 O
required 254 262 912 920 O

Female 0 6 921 927 B-gender
subjects 7 15 928 936 O
of 16 18 937 939 O
childbearing 19 31 940 952 O
potential 32 41 953 962 O
must 42 46 963 967 O
be 47 49 968 970 O
willing 50 57 971 978 O
to 58 60 979 981 O
use 61 64 982 985 B-contraception_consent
an 65 67 986 988 I-contraception_consent
adequate 68 76 989 997 I-contraception_consent
method 77 83 998 1004 I-contraception_consent
of 84 86 1005 1007 I-contraception_consent
contraception 87 100 1008 1021 I-contraception_consent
for 101 104 1022 1025 O
the 105 108 1026 1029 O
course 109 115 1030 1036 O
of 116 118 1037 1039 O
the 119 122 1040 1043 O
study 123 128 1044 1049 O
through 129 136 1050 1057 O
120 137 140 1058 1061 B-upper_bound
days 141 145 1062 1066 I-upper_bound
after 146 151 1067 1072 O
the 152 155 1073 1076 O
last 156 160 1077 1081 O
dose 161 165 1082 1086 O
of 166 168 1087 1089 O
study 169 174 1090 1095 O
medication 175 185 1096 1106 B-treatment

Has 0 3 1107 1110 O
received 4 12 1111 1119 O
a 13 14 1120 1121 O
live 15 19 1122 1126 B-treatment
vaccine 20 27 1127 1134 I-treatment
within 28 34 1135 1141 O
30 35 37 1142 1144 B-upper_bound
days 38 42 1145 1149 I-upper_bound
of 43 45 1150 1152 O
planned 46 53 1153 1160 O
start 54 59 1161 1166 O
of 60 62 1167 1169 O
study 63 68 1170 1175 O
therapy 69 76 1176 1183 B-treatment

Hemoglobin 0 10 1184 1194 B-clinical_variable
≥ 11 12 1195 1196 O
9 13 14 1197 1198 B-lower_bound
g 15 16 1199 1200 I-lower_bound
/ 16 17 1200 1201 I-lower_bound
dL 17 19 1201 1203 I-lower_bound

Histologically 0 14 1204 1218 O
documented 15 25 1219 1229 O
metastatic 26 36 1230 1240 B-cancer
or 37 39 1241 1243 O
locally 40 47 1244 1251 O
advanced 48 56 1252 1260 O
unresectable 57 69 1261 1273 O
breast 70 76 1274 1280 B-cancer
cancer 77 83 1281 1287 I-cancer
that 84 88 1288 1292 O
is 89 91 1293 1295 O
ER 92 94 1296 1298 B-clinical_variable
and 95 98 1299 1302 O
PR 99 101 1303 1305 B-clinical_variable
< 102 103 1306 1307 O
10 103 105 1307 1309 B-upper_bound
% 105 106 1309 1310 I-upper_bound
expression 107 117 1311 1321 O
and 118 121 1322 1325 O
does 122 126 1326 1330 O
not 127 130 1331 1334 O
over 131 135 1335 1339 O
- 135 136 1339 1340 O
express 136 143 1340 1347 O
HER2 144 148 1348 1352 B-clinical_variable
protein 149 156 1353 1360 O
( 157 158 1361 1362 O
IHC 158 161 1362 1365 B-clinical_variable
0 162 163 1366 1367 O
, 163 164 1367 1368 O
1 165 166 1369 1370 O
+ 166 167 1370 1371 O
, 167 168 1371 1372 O
or 169 171 1373 1375 O
2 172 173 1376 1377 B-upper_bound
+ 173 174 1377 1378 I-upper_bound
and 175 178 1379 1382 O
FISH 179 183 1383 1387 B-clinical_variable
< 184 185 1388 1389 O
2.0 185 188 1389 1392 B-upper_bound
) 188 189 1392 1393 O

Histologically 0 14 1394 1408 O
or 15 17 1409 1411 O
cytologically 18 31 1412 1425 O
documented 32 42 1426 1436 O
, 42 43 1436 1437 O
incurable 44 53 1438 1447 O
, 53 54 1447 1448 O
unresectable 55 67 1449 1461 O
locally 68 75 1462 1469 O
advanced 76 84 1470 1478 O
, 84 85 1478 1479 O
or 86 88 1480 1482 O
metastatic 89 99 1483 1493 B-cancer
breast 100 106 1494 1500 I-cancer
cancer 107 113 1501 1507 I-cancer

Myocardial 0 10 1508 1518 B-chronic_disease
infarction 11 21 1519 1529 I-chronic_disease
during 22 28 1530 1536 O
the 29 32 1537 1540 O
last 33 37 1541 1545 B-upper_bound
6 38 39 1546 1547 I-upper_bound
months 40 46 1548 1554 I-upper_bound
, 46 47 1554 1555 O
and/or 48 54 1556 1562 O
a 55 56 1563 1564 O
current 57 64 1565 1572 O
ECG 65 68 1573 1576 B-treatment
tracing 69 76 1577 1584 I-treatment
that 77 81 1585 1589 O
is 82 84 1590 1592 O
abnormal 85 93 1593 1601 O
in 94 96 1602 1604 O
the 97 100 1605 1608 O
opinion 101 108 1609 1616 O
of 109 111 1617 1619 O
the 112 115 1620 1623 O
treating 116 124 1624 1632 O
Investigator 125 137 1633 1645 O

Partial 0 7 1646 1653 B-clinical_variable
thromboplastin 8 22 1654 1668 I-clinical_variable
time 23 27 1669 1673 I-clinical_variable
( 28 29 1674 1675 I-clinical_variable
PTT 29 32 1675 1678 I-clinical_variable
) 32 33 1678 1679 I-clinical_variable
≤ 34 35 1680 1681 O
1.2 36 39 1682 1685 B-upper_bound
x 40 41 1686 1687 I-upper_bound
ULN 42 45 1688 1691 I-upper_bound

Patient 0 7 1692 1699 O
has 8 11 1700 1703 O
a 12 13 1704 1705 O
diagnosis 14 23 1706 1715 O
of 24 26 1716 1718 O
immunodeficiency 27 43 1719 1735 B-chronic_disease
or 44 46 1736 1738 O
is 47 49 1739 1741 O
receiving 50 59 1742 1751 O
ongoing 60 67 1752 1759 O
immunosuppressive 68 85 1760 1777 B-treatment
therapy 86 93 1778 1785 I-treatment
, 93 94 1785 1786 O
including 95 104 1787 1796 O
systemic 105 113 1797 1805 B-treatment
or 114 116 1806 1808 I-treatment
enteric 117 124 1809 1816 I-treatment
corticosteroids 125 140 1817 1832 I-treatment
except 141 147 1833 1839 O
for 148 151 1840 1843 O
non 152 155 1844 1847 B-treatment
- 155 156 1847 1848 I-treatment
systemically 156 168 1848 1860 I-treatment
absorbed 169 177 1861 1869 I-treatment
treatments 178 188 1870 1880 I-treatment
( 189 190 1881 1882 O
such 190 194 1882 1886 O
as 195 197 1887 1889 O
inhaled 198 205 1890 1897 O
or 206 208 1898 1900 O
topical 209 216 1901 1908 O
steroid 217 224 1909 1916 B-treatment
therapy 225 232 1917 1924 I-treatment
for 233 236 1925 1928 O
asthma 237 243 1929 1935 B-chronic_disease
, 243 244 1935 1936 O
chronic 245 252 1937 1944 B-chronic_disease
obstructive 253 264 1945 1956 I-chronic_disease
pulmonary 265 274 1957 1966 I-chronic_disease
disease 275 282 1967 1974 I-chronic_disease
, 282 283 1974 1975 O
allergic 284 292 1976 1984 B-chronic_disease
rhinitis 293 301 1985 1993 I-chronic_disease
) 301 302 1993 1994 O
. 302 303 1994 1995 O
Patient 304 311 1996 2003 O
must 312 316 2004 2008 O
be 317 319 2009 2011 O
off 320 323 2012 2015 O
systemic 324 332 2016 2024 B-treatment
steroid 333 340 2025 2032 I-treatment
or 341 343 2033 2035 O
any 344 347 2036 2039 O
other 348 353 2040 2045 O
form 354 358 2046 2050 O
of 359 361 2051 2053 O
immunosuppressive 362 379 2054 2071 O
therapy 380 387 2072 2079 O
within 388 394 2080 2086 O
7 395 396 2087 2088 B-upper_bound
days 397 401 2089 2093 I-upper_bound
prior 402 407 2094 2099 I-upper_bound
to 408 410 2100 2102 O
first 411 416 2103 2108 O
dose 417 421 2109 2113 O
of 422 424 2114 2116 O
trial 425 430 2117 2122 B-treatment
treatment 431 440 2123 2132 I-treatment

Patient 0 7 2133 2140 O
has 8 11 2141 2144 O
a 12 13 2145 2146 O
history 14 21 2147 2154 O
or 22 24 2155 2157 O
current 25 32 2158 2165 O
evidence 33 41 2166 2174 O
of 42 44 2175 2177 O
any 45 48 2178 2181 O
condition 49 58 2182 2191 O
, 58 59 2191 2192 O
therapy 60 67 2193 2200 B-treatment
, 67 68 2200 2201 O
or 69 71 2202 2204 O
lab 72 75 2205 2208 O
abnormality 76 87 2209 2220 O
that 88 92 2221 2225 O
might 93 98 2226 2231 O
confound 99 107 2232 2240 O
the 108 111 2241 2244 O
results 112 119 2245 2252 O
of 120 122 2253 2255 O
the 123 126 2256 2259 O
study 127 132 2260 2265 O
, 132 133 2265 2266 O
interfere 134 143 2267 2276 O
with 144 148 2277 2281 O
the 149 152 2282 2285 O
patient 153 160 2286 2293 O
's 160 162 2293 2295 O
participation 163 176 2296 2309 O
for 177 180 2310 2313 O
the 181 184 2314 2317 O
full 185 189 2318 2322 O
duration 190 198 2323 2331 O
of 199 201 2332 2334 O
the 202 205 2335 2338 O
study 206 211 2339 2344 O
, 211 212 2344 2345 O
or 213 215 2346 2348 O
is 216 218 2349 2351 O
not 219 222 2352 2355 O
in 223 225 2356 2358 O
the 226 229 2359 2362 O
best 230 234 2363 2367 O
interest 235 243 2368 2376 O
of 244 246 2377 2379 O
the 247 250 2380 2383 O
patient 251 258 2384 2391 O
to 259 261 2392 2394 O
participate 262 273 2395 2406 O
, 273 274 2406 2407 O
in 275 277 2408 2410 O
the 278 281 2411 2414 O
opinion 282 289 2415 2422 O
of 290 292 2423 2425 O
the 293 296 2426 2429 O
treating 297 305 2430 2438 O
investigator 306 318 2439 2451 O

Patient 0 7 2452 2459 O
has 8 11 2460 2463 O
a 12 13 2464 2465 O
history 14 21 2466 2473 O
or 22 24 2474 2476 O
current 25 32 2477 2484 O
evidence 33 41 2485 2493 O
of 42 44 2494 2496 O
clinically 45 55 2497 2507 O
significant 56 67 2508 2519 O
heart 68 73 2520 2525 B-chronic_disease
disease 74 81 2526 2533 I-chronic_disease

Patient 0 7 2534 2541 O
has 8 11 2542 2545 O
a 12 13 2546 2547 O
primary 14 21 2548 2555 O
central 22 29 2556 2563 B-cancer
nervous 30 37 2564 2571 I-cancer
system 38 44 2572 2578 I-cancer
tumor 45 50 2579 2584 I-cancer

Patient 0 7 2585 2592 O
has 8 11 2593 2596 O
history 12 19 2597 2604 O
of 20 22 2605 2607 O
interstitial 23 35 2608 2620 B-chronic_disease
lung 36 40 2621 2625 I-chronic_disease
disease 41 48 2626 2633 I-chronic_disease
or 49 51 2634 2636 O
known 52 57 2637 2642 O
history 58 65 2643 2650 O
of 66 68 2651 2653 O
, 68 69 2653 2654 O
or 70 72 2655 2657 O
any 73 76 2658 2661 O
evidence 77 85 2662 2670 O
of 86 88 2671 2673 O
active 89 95 2674 2680 O
, 95 96 2680 2681 O
noninfectious 97 110 2682 2695 B-chronic_disease
pneumonitis 111 122 2696 2707 I-chronic_disease

Patient 0 7 2708 2715 O
has 8 11 2716 2719 O
history 12 19 2720 2727 O
of 20 22 2728 2730 O
severe 23 29 2731 2737 B-chronic_disease
allergic 30 38 2738 2746 I-chronic_disease
, 38 39 2746 2747 O
anaphylactic 40 52 2748 2760 B-chronic_disease
, 52 53 2760 2761 O
or 54 56 2762 2764 O
other 57 62 2765 2770 O
hypersensitivity 63 79 2771 2787 O
reactions 80 89 2788 2797 O
to 90 92 2798 2800 O
chimeric 93 101 2801 2809 B-allergy_name
or 102 104 2810 2812 O
humanized 105 114 2813 2822 B-allergy_name
antibodies 115 125 2823 2833 I-allergy_name
or 126 128 2834 2836 O
prior 129 134 2837 2842 O
allogeneic 135 145 2843 2853 B-allergy_name
bone 146 150 2854 2858 I-allergy_name
marrow 151 157 2859 2865 I-allergy_name
transplantation 158 173 2866 2881 I-allergy_name
or 174 176 2882 2884 O
prior 177 182 2885 2890 O
solid 183 188 2891 2896 B-allergy_name
organ 189 194 2897 2902 I-allergy_name
transplantation 195 210 2903 2918 I-allergy_name

Patient 0 7 2919 2926 O
has 8 11 2927 2930 O
known 12 17 2931 2936 O
active 18 24 2937 2943 O
CNS 25 28 2944 2947 B-cancer
metastases 29 39 2948 2958 I-cancer
and/or 40 46 2959 2965 O
carcinomatous 47 60 2966 2979 B-cancer
meningitis 61 71 2980 2990 I-cancer

Patient 0 7 2991 2998 O
has 8 11 2999 3002 O
known 12 17 3003 3008 O
history 18 25 3009 3016 O
of 26 28 3017 3019 O
active 29 35 3020 3026 O
Hepatitis 36 45 3027 3036 B-chronic_disease
A 46 47 3037 3038 I-chronic_disease
, 47 48 3038 3039 I-chronic_disease
B 49 50 3040 3041 I-chronic_disease
, 50 51 3041 3042 I-chronic_disease
or 52 54 3043 3045 I-chronic_disease
C 55 56 3046 3047 I-chronic_disease

Patient 0 7 3048 3055 O
has 8 11 3056 3059 O
known 12 17 3060 3065 O
hypersensitivity 18 34 3066 3082 O
to 35 37 3083 3085 O
the 38 41 3086 3089 O
components 42 52 3090 3100 B-allergy_name
of 53 55 3101 3103 I-allergy_name
study 56 61 3104 3109 I-allergy_name
drug 62 66 3110 3114 I-allergy_name
or 67 69 3115 3117 I-allergy_name
its 70 73 3118 3121 I-allergy_name
analogs 74 81 3122 3129 I-allergy_name

Patient 0 7 3130 3137 O
has 8 11 3138 3141 O
known 12 17 3142 3147 O
psychiatric 18 29 3148 3159 B-chronic_disease
or 30 32 3160 3162 O
substance 33 42 3163 3172 B-chronic_disease
abuse 43 48 3173 3178 I-chronic_disease
disorders 49 58 3179 3188 I-chronic_disease
that 59 63 3189 3193 O
would 64 69 3194 3199 O
interfere 70 79 3200 3209 O
with 80 84 3210 3214 O
cooperation 85 96 3215 3226 O
with 97 101 3227 3231 O
the 102 105 3232 3235 O
requirements 106 118 3236 3248 O
of 119 121 3249 3251 O
the 122 125 3252 3255 O
trial 126 131 3256 3261 O

Patient 0 7 3262 3269 O
is 8 10 3270 3272 O
currently 11 20 3273 3282 O
participating 21 34 3283 3296 O
in 35 37 3297 3299 O
a 38 39 3300 3301 O
study 40 45 3302 3307 O
with 46 50 3308 3312 O
an 51 53 3313 3315 O
investigational 54 69 3316 3331 B-treatment
compound 70 78 3332 3340 I-treatment
or 79 81 3341 3343 I-treatment
device 82 88 3344 3350 I-treatment

Patient 0 7 3351 3358 O
is 8 10 3359 3361 O
diagnosed 11 20 3362 3371 O
with 21 25 3372 3376 O
active 26 32 3377 3383 O
autoimmune 33 43 3384 3394 B-chronic_disease
disease 44 51 3395 3402 I-chronic_disease
that 52 56 3403 3407 O
has 57 60 3408 3411 O
required 61 69 3412 3420 O
systemic 70 78 3421 3429 B-treatment
treatment 79 88 3430 3439 I-treatment
in 89 91 3440 3442 O
past 92 96 3443 3447 B-upper_bound
2 97 98 3448 3449 I-upper_bound
years 99 104 3450 3455 I-upper_bound
( 105 106 3456 3457 O
i.e. 106 110 3457 3461 O
, 110 111 3461 3462 O
with 112 116 3463 3467 O
use 117 120 3468 3471 O
of 121 123 3472 3474 O
disease 124 131 3475 3482 B-treatment
modifying 132 141 3483 3492 I-treatment
agents 142 148 3493 3499 I-treatment
, 148 149 3499 3500 O
corticosteroids 150 165 3501 3516 B-treatment
or 166 168 3517 3519 O
immunosuppressive 169 186 3520 3537 B-treatment
drugs 187 192 3538 3543 I-treatment
) 192 193 3543 3544 O
. 193 194 3544 3545 O
Note 195 199 3546 3550 O
: 199 200 3550 3551 O
replacement 201 212 3552 3563 B-treatment
therapy 213 220 3564 3571 I-treatment
( 221 222 3572 3573 O
e.g. 222 226 3573 3577 O
, 226 227 3577 3578 O
thyroxine 228 237 3579 3588 B-treatment
, 237 238 3588 3589 O
insulin 239 246 3590 3597 B-treatment
, 246 247 3597 3598 O
or 248 250 3599 3601 O
physiologic 251 262 3602 3613 B-treatment
corticosteroid 263 277 3614 3628 I-treatment
replacement 278 289 3629 3640 I-treatment
therapy 290 297 3641 3648 I-treatment
for 298 301 3649 3652 O
adrenal 302 309 3653 3660 B-chronic_disease
or 310 312 3661 3663 I-chronic_disease
pituitary 313 322 3664 3673 I-chronic_disease
insufficiency 323 336 3674 3687 I-chronic_disease
) 336 337 3687 3688 O
is 338 340 3689 3691 O
not 341 344 3692 3695 O
considered 345 355 3696 3706 O
a 356 357 3707 3708 O
form 358 362 3709 3713 O
of 363 365 3714 3716 O
systemic 366 374 3717 3725 O
treatment 375 384 3726 3735 O

Patient 0 7 3736 3743 O
is 8 10 3744 3746 O
known 11 16 3747 3752 O
to 17 19 3753 3755 O
be 20 22 3756 3758 O
Human 23 28 3759 3764 B-chronic_disease
Immunodeficiency 29 45 3765 3781 I-chronic_disease
Virus 46 51 3782 3787 I-chronic_disease
( 52 53 3788 3789 I-chronic_disease
HIV)-positive 53 66 3789 3802 I-chronic_disease

Patient 0 7 3803 3810 O
is 8 10 3811 3813 O
male 11 15 3814 3818 B-gender
or 16 18 3819 3821 I-gender
female 19 25 3822 3828 I-gender
and 26 29 3829 3832 O
≥18 30 33 3833 3836 O
years 34 39 3837 3842 I-lower_bound
of 40 42 3843 3845 O
age 43 46 3846 3849 B-age
on 47 49 3850 3852 O
the 50 53 3853 3856 O
day 54 57 3857 3860 O
of 58 60 3861 3863 O
signing 61 68 3864 3871 O
informed 69 77 3872 3880 O
consent 78 85 3881 3888 O

Patient 0 7 3889 3896 O
is 8 10 3897 3899 O
pregnant 11 19 3900 3908 B-pregnancy
or 20 22 3909 3911 O
breastfeeding 23 36 3912 3925 O
, 36 37 3925 3926 O
or 38 40 3927 3929 O
expecting 41 50 3930 3939 O
to 51 53 3940 3942 O
conceive 54 62 3943 3951 O
or 63 65 3952 3954 O
father 66 72 3955 3961 O
children 73 81 3962 3970 O
within 82 88 3971 3977 O
the 89 92 3978 3981 O
projected 93 102 3982 3991 O
duration 103 111 3992 4000 O
of 112 114 4001 4003 O
the 115 118 4004 4007 O
study 119 124 4008 4013 O

Patient 0 7 4014 4021 O
must 8 12 4022 4026 O
consent 13 20 4027 4034 O
to 21 23 4035 4037 O
a 24 25 4038 4039 O
biopsy 26 32 4040 4046 B-treatment
of 33 35 4047 4049 O
a 36 37 4050 4051 O
site 38 42 4052 4056 O
of 43 45 4057 4059 O
disease 46 53 4060 4067 O
unless 54 60 4068 4074 O
the 61 64 4075 4078 O
only 65 69 4079 4083 O
site 70 74 4084 4088 O
of 75 77 4089 4091 O
disease 78 85 4092 4099 O
is 86 88 4100 4102 O
lung 89 93 4103 4107 O
/ 93 94 4107 4108 O
pleura 94 100 4108 4114 O
, 100 101 4114 4115 O
bone 102 106 4116 4120 O
, 106 107 4120 4121 O
or 108 110 4122 4124 O
deemed 111 117 4125 4131 O
unsafe 118 124 4132 4138 O
by 125 127 4139 4141 O
the 128 131 4142 4145 O
principal 132 141 4146 4155 O
investigator 142 154 4156 4168 O

Patient 0 7 4169 4176 O
must 8 12 4177 4181 O
have 13 17 4182 4186 O
performance 18 29 4187 4198 B-clinical_variable
status 30 36 4199 4205 I-clinical_variable
of 37 39 4206 4208 O
0 40 41 4209 4210 B-lower_bound
- 41 42 4210 4211 O
1 42 43 4211 4212 B-upper_bound
on 44 46 4213 4215 O
the 47 50 4216 4219 O
ECOG 51 55 4220 4224 B-clinical_variable
Performance 56 67 4225 4236 I-clinical_variable
Scale 68 73 4237 4242 I-clinical_variable
and 74 77 4243 4246 O
life 78 82 4247 4251 B-clinical_variable
expectancy 83 93 4252 4262 I-clinical_variable
> 94 95 4263 4264 O
3 96 97 4265 4266 B-lower_bound
months 98 104 4267 4273 I-lower_bound

Patient 0 7 4274 4281 O
who 8 11 4282 4285 O
has 12 15 4286 4289 O
had 16 19 4290 4293 O
radiotherapy 20 32 4294 4306 B-treatment
within 33 39 4307 4313 O
1 40 41 4314 4315 B-upper_bound
week 42 46 4316 4320 I-upper_bound
( 47 48 4321 4322 O
or 48 50 4322 4324 O
unresolved 51 61 4325 4335 O
radiation 62 71 4336 4345 O
- 71 72 4345 4346 O
related 72 79 4346 4353 O
toxicities 80 90 4354 4364 O
) 90 91 4364 4365 O
, 91 92 4365 4366 O
chemotherapy 93 105 4367 4379 B-treatment
within 106 112 4380 4386 O
2 113 114 4387 4388 B-upper_bound
weeks 115 120 4389 4394 I-upper_bound
or 121 123 4395 4397 O
5 124 125 4398 4399 B-upper_bound
half 126 130 4400 4404 I-upper_bound
- 130 131 4404 4405 I-upper_bound
lives 131 136 4405 4410 I-upper_bound
, 136 137 4410 4411 O
whichever 138 147 4412 4421 O
is 148 150 4422 4424 O
longer 151 157 4425 4431 O
( 158 159 4432 4433 O
6 159 160 4433 4434 O
weeks 161 166 4435 4440 O
for 167 170 4441 4444 O
nitrosoureas 171 183 4445 4457 B-treatment
, 183 184 4457 4458 O
mitomycin 185 194 4459 4468 B-treatment
C 195 196 4469 4470 I-treatment
or 197 199 4471 4473 O
bevacizumab 200 211 4474 4485 B-treatment
) 211 212 4485 4486 O
, 212 213 4486 4487 O
anti 214 218 4488 4492 B-clinical_variable
- 218 219 4492 4493 I-clinical_variable
cancer 219 225 4493 4499 I-clinical_variable
monoclonal 226 236 4500 4510 I-clinical_variable
antibody 237 245 4511 4519 I-clinical_variable
for 246 249 4520 4523 O
direct 250 256 4524 4530 O
anti 257 261 4531 4535 B-treatment
- 261 262 4535 4536 I-treatment
neoplastic 262 272 4536 4546 I-treatment
treatment 273 282 4547 4556 I-treatment
within 283 289 4557 4563 O
3 290 291 4564 4565 B-upper_bound
weeks 292 297 4566 4571 I-upper_bound
, 297 298 4571 4572 O
or 299 301 4573 4575 O
who 302 305 4576 4579 O
has 306 309 4580 4583 O
not 310 313 4584 4587 O
recovered 314 323 4588 4597 O
from 324 328 4598 4602 O
toxicity 329 337 4603 4611 O
due 338 341 4612 4615 O
to 342 344 4616 4618 O
previous 345 353 4619 4627 O
agents 354 360 4628 4634 O
administered 361 373 4635 4647 O
. 373 374 4647 4648 O
If 375 377 4649 4651 O
the 378 381 4652 4655 O
patient 382 389 4656 4663 O
has 390 393 4664 4667 O
residual 394 402 4668 4676 O
toxicity 403 411 4677 4685 O
from 412 416 4686 4690 O
prior 417 422 4691 4696 B-treatment
treatment 423 432 4697 4706 I-treatment
, 432 433 4706 4707 O
toxicity 434 442 4708 4716 O
must 443 447 4717 4721 O
be 448 450 4722 4724 O
≤ 451 452 4725 4726 O
Grade 453 458 4727 4732 B-upper_bound
1 459 460 4733 4734 I-upper_bound
( 461 462 4735 4736 O
except 462 468 4736 4742 O
for 469 472 4743 4746 O
neuropathy 473 483 4747 4757 B-chronic_disease
and 484 487 4758 4761 O
alopecia 488 496 4762 4770 B-chronic_disease
) 496 497 4770 4771 O

Patients 0 8 4772 4780 O
less 9 13 4781 4785 O
than 14 18 4786 4790 O
2 19 20 4791 4792 B-upper_bound
weeks 21 26 4793 4798 I-upper_bound
post 27 31 4799 4803 B-treatment
major 32 37 4804 4809 I-treatment
surgical 38 46 4810 4818 I-treatment
procedure 47 56 4819 4828 I-treatment
( 57 58 4829 4830 O
all 58 61 4830 4833 O
surgical 62 70 4834 4842 O
wounds 71 77 4843 4849 O
must 78 82 4850 4854 O
be 83 85 4855 4857 O
fully 86 91 4858 4863 O
healed 92 98 4864 4870 O
) 98 99 4870 4871 O
. 99 100 4871 4872 O
For 101 104 4873 4876 O
the 105 108 4877 4880 O
purpose 109 116 4881 4888 O
of 117 119 4889 4891 O
this 120 124 4892 4896 O
criterion 125 134 4897 4906 O
, 134 135 4906 4907 O
a 136 137 4908 4909 O
major 138 143 4910 4915 O
surgical 144 152 4916 4924 O
procedure 153 162 4925 4934 O
is 163 165 4935 4937 O
defined 166 173 4938 4945 O
as 174 176 4946 4948 O
one 177 180 4949 4952 O
requiring 181 190 4953 4962 O
the 191 194 4963 4966 O
administration 195 209 4967 4981 O
of 210 212 4982 4984 O
general 213 220 4985 4992 B-treatment
anesthesia 221 231 4993 5003 I-treatment

Patients 0 8 5004 5012 O
requiring 9 18 5013 5022 O
warfarin 19 27 5023 5031 B-treatment
therapy 28 35 5032 5039 I-treatment
are 36 39 5040 5043 O
excluded 40 48 5044 5052 O
, 48 49 5052 5053 O
low 50 53 5054 5057 B-treatment
molecular 54 63 5058 5067 I-treatment
weight 64 70 5068 5074 I-treatment
heparin 71 78 5075 5082 I-treatment
is 79 81 5083 5085 O
permitted 82 91 5086 5095 O

Patients 0 8 5096 5104 O
who 9 12 5105 5108 O
have 13 17 5109 5113 O
discontinued 18 30 5114 5126 O
any 31 34 5127 5130 O
of 35 37 5131 5133 O
these 38 43 5134 5139 O
medications 44 55 5140 5151 B-treatment
must 56 60 5152 5156 O
have 61 65 5157 5161 O
a 66 67 5162 5163 O
wash 68 72 5164 5168 O
- 72 73 5168 5169 O
out 73 76 5169 5172 O
period 77 83 5173 5179 O
of 84 86 5180 5182 O
at 87 89 5183 5185 O
least 90 95 5186 5191 O
5 96 97 5192 5193 B-lower_bound
days 98 102 5194 5198 I-lower_bound
or 103 105 5199 5201 O
at 106 108 5202 5204 O
least 109 114 5205 5210 O
5 115 116 5211 5212 B-lower_bound
half 117 121 5213 5217 I-lower_bound
- 121 122 5217 5218 I-lower_bound
lives 122 127 5218 5223 I-lower_bound
of 128 130 5224 5226 O
the 131 134 5227 5230 O
drug 135 139 5231 5235 O
( 140 141 5236 5237 O
whichever 141 150 5237 5246 O
is 151 153 5247 5249 O
longer 154 160 5250 5256 O
) 160 161 5256 5257 O
prior 162 167 5258 5263 O
to 168 170 5264 5266 O
the 171 174 5267 5270 O
first 175 180 5271 5276 O
dose 181 185 5277 5281 O
of 186 188 5282 5284 O
dinaciclib 189 199 5285 5295 B-treatment
( 200 201 5296 5297 O
Refer 201 206 5297 5302 O
to 207 209 5303 5305 O
Appendix 210 218 5306 5314 O
2 219 220 5315 5316 O
Drugs 221 226 5317 5322 O
that 227 231 5323 5327 O
interact 232 240 5328 5336 O
strongly 241 249 5337 5345 O
with 250 254 5346 5350 O
CYP3A4 255 261 5351 5357 O
) 261 262 5357 5358 O

Patients 0 8 5359 5367 O
who 9 12 5368 5371 O
have 13 17 5372 5376 O
known 18 23 5377 5382 O
allergic 24 32 5383 5391 O
reactions 33 42 5392 5401 O
to 43 45 5402 5404 O
IV 46 48 5405 5407 B-allergy_name
contrast 49 57 5408 5416 I-allergy_name
dye 58 61 5417 5420 I-allergy_name
despite 62 69 5421 5428 O
standard 70 78 5429 5437 O
prophylaxis 79 90 5438 5449 O

Patients 0 8 5450 5458 O
who 9 12 5459 5462 O
require 13 20 5463 5470 O
medications 21 32 5471 5482 B-treatment
that 33 37 5483 5487 O
are 38 41 5488 5491 O
strong 42 48 5492 5498 O
CYP3A4 49 55 5499 5505 B-treatment
inhibitors 56 66 5506 5516 I-treatment
or 67 69 5517 5519 I-treatment
inducers 70 78 5520 5528 I-treatment

Platelets 0 9 5529 5538 B-clinical_variable
≥ 10 11 5539 5540 O
100,000 12 19 5541 5548 B-lower_bound
/μL 20 23 5549 5552 I-lower_bound

Prothrombin 0 11 5553 5564 B-clinical_variable
time 12 16 5565 5569 I-clinical_variable
( 17 18 5570 5571 I-clinical_variable
PT)/International 18 35 5571 5588 I-clinical_variable
Normalized 36 46 5589 5599 I-clinical_variable
Ratio 47 52 5600 5605 I-clinical_variable
( 53 54 5606 5607 I-clinical_variable
INR 54 57 5607 5610 I-clinical_variable
) 57 58 5610 5611 I-clinical_variable
≤ 59 60 5612 5613 O
1.2 61 64 5614 5617 B-upper_bound
x 65 66 5618 5619 I-upper_bound
ULN 67 70 5620 5623 B-clinical_variable

QTc 0 3 5624 5627 B-clinical_variable
prolongation 4 16 5628 5640 I-clinical_variable
> 17 18 5641 5642 O
480 18 21 5642 5645 B-lower_bound
msec 22 26 5646 5650 I-lower_bound
( 27 28 5651 5652 O
Bazett 28 34 5652 5658 O
's 34 36 5658 5660 O
Formula 37 44 5661 5668 O
) 44 45 5668 5669 O

Serum 0 5 5670 5675 B-clinical_variable
LDH 6 9 5676 5679 I-clinical_variable
> 10 11 5680 5681 O
1.5x 12 16 5682 5686 B-lower_bound
institutional 17 30 5687 5700 I-lower_bound
ULN 31 34 5701 5704 I-lower_bound

Serum 0 5 5705 5710 B-clinical_variable
creatinine 6 16 5711 5721 I-clinical_variable
or 17 19 5722 5724 O
calculated 20 30 5725 5735 B-clinical_variable
creatinine 31 41 5736 5746 I-clinical_variable
clearance 42 51 5747 5756 I-clinical_variable
≤ 52 53 5757 5758 O
1.5 54 57 5759 5762 B-upper_bound
x 58 59 5763 5764 I-upper_bound
upper 60 65 5765 5770 I-upper_bound
limit 66 71 5771 5776 I-upper_bound
of 72 74 5777 5779 I-upper_bound
normal 75 81 5780 5786 I-upper_bound
( 82 83 5787 5788 I-upper_bound
ULN 83 86 5788 5791 I-upper_bound
) 86 87 5791 5792 I-upper_bound

Serum 0 5 5793 5798 O
total 6 11 5799 5804 O
bilirubin 12 21 5805 5814 B-clinical_variable
≤ 22 23 5815 5816 O
1.5 24 27 5817 5820 O
x 28 29 5821 5822 O
ULN 30 33 5823 5826 B-clinical_variable
OR 34 36 5827 5829 O
direct 37 43 5830 5836 O
bilirubin 44 53 5837 5846 O
≤ 54 55 5847 5848 O
ULN 56 59 5849 5852 O
for 60 63 5853 5856 O
patients 64 72 5857 5865 O
with 73 77 5866 5870 O
total 78 83 5871 5876 O
bilirubin 84 93 5877 5886 O
levels 94 100 5887 5893 O
> 101 102 5894 5895 O
1.5 103 106 5896 5899 O
x 107 108 5900 5901 O
ULN 109 112 5902 5905 O

≥ 0 1 5906 5907 O
60 2 4 5908 5910 B-lower_bound
mL 5 7 5911 5913 I-lower_bound
/ 7 8 5913 5914 I-lower_bound
min 8 11 5914 5917 I-lower_bound
for 12 15 5918 5921 O
patients 16 24 5922 5930 O
with 25 29 5931 5935 O
creatinine 30 40 5936 5946 B-clinical_variable
levels 41 47 5947 5953 I-clinical_variable
> 48 49 5954 5955 O
1.5 50 53 5956 5959 B-lower_bound
x 54 55 5960 5961 I-lower_bound
institutional 56 69 5962 5975 I-lower_bound
ULN 70 73 5976 5979 I-lower_bound

Anticoagulant 0 13 0 13 B-treatment
medications 14 25 14 25 I-treatment

Bleeding 0 8 26 34 B-chronic_disease
disorder 9 17 35 43 I-chronic_disease

History 0 7 44 51 O
of 8 10 52 54 O
syncope 11 18 55 62 B-chronic_disease
with 19 23 63 67 O
venipuncture 24 36 68 80 B-treatment

Local 0 5 81 86 B-chronic_disease
auricular 6 15 87 96 I-chronic_disease
infection 16 25 97 106 I-chronic_disease

Patients 0 8 107 115 O
naïve 9 14 116 121 O
to 15 17 122 124 O
acupuncture 18 29 125 136 B-treatment

Patients 0 8 137 145 O
will 9 13 146 150 O
be 14 16 151 153 O
withdrawn 17 26 154 163 O
from 27 31 164 168 O
the 32 35 169 172 O
study 36 41 173 178 O
if 42 44 179 181 O
surgery 45 52 182 189 B-treatment
time 53 57 190 194 O
exceeds 58 65 195 202 O
90 66 68 203 205 B-lower_bound
minutes 69 76 206 213 I-lower_bound
or 77 79 214 216 O
the 80 83 217 220 O
laparoscopic 84 96 221 233 B-treatment
procedure 97 106 234 243 O
turned 107 113 244 250 O
into 114 118 251 255 O
an 119 121 256 258 O
open 122 126 259 263 B-treatment
surgery 127 134 264 271 I-treatment

Prosthetic 0 10 272 282 B-treatment
cardiac 11 18 283 290 I-treatment
valves 19 25 291 297 I-treatment

Current 0 7 0 7 O
Grade 8 13 8 13 B-lower_bound
1 14 15 14 15 I-lower_bound
or 16 18 16 18 O
greater 19 26 19 26 O
abnormal 27 35 27 35 O
creatinine 36 46 36 46 B-clinical_variable
or 47 49 47 49 O
glomerular 50 60 50 60 B-clinical_variable
filtration 61 71 61 71 I-clinical_variable
rate 72 76 72 76 I-clinical_variable
( 77 78 77 78 I-clinical_variable
GFR 78 81 78 81 I-clinical_variable
) 81 82 81 82 I-clinical_variable
< 83 84 83 84 O
55 84 86 84 86 B-upper_bound

Current 0 7 87 94 O
major 8 13 95 100 B-chronic_disease
disease 14 21 101 108 I-chronic_disease
or 22 24 109 111 I-chronic_disease
disorder 25 33 112 120 I-chronic_disease
other 34 39 121 126 O
than 40 44 127 131 O
MS 45 47 132 134 B-chronic_disease
( 48 49 135 136 O
e.g. 49 53 136 140 O
, 53 54 140 141 O
cancer 55 61 142 148 B-cancer
, 61 62 148 149 O
renal 63 68 150 155 B-chronic_disease
disease 69 76 156 163 I-chronic_disease
, 76 77 163 164 O
end 78 81 165 168 O
- 81 82 168 169 O
stage 82 87 169 174 O
cardiopulmonary 88 103 175 190 B-chronic_disease
disease 104 111 191 198 I-chronic_disease
, 111 112 198 199 O
post 113 117 200 204 B-chronic_disease
- 117 118 204 205 I-chronic_disease
traumatic 118 127 205 214 I-chronic_disease
stress 128 134 215 221 I-chronic_disease
disorder 135 143 222 230 I-chronic_disease
, 143 144 230 231 O
etc 145 148 232 235 O
. 148 149 235 236 O
) 149 150 236 237 O
that 151 155 238 242 O
may 156 159 243 246 O
interfere 160 169 247 256 O
with 170 174 257 261 O
study 175 180 262 267 O
procedures 181 191 268 278 O

Expanded 0 8 279 287 B-clinical_variable
Disability 9 19 288 298 I-clinical_variable
Status 20 26 299 305 I-clinical_variable
Scale 27 32 306 311 I-clinical_variable
( 33 34 312 313 I-clinical_variable
EDSS 34 38 313 317 I-clinical_variable
) 38 39 317 318 I-clinical_variable
3.0 40 43 319 322 I-lower_bound
- 44 45 323 324 I-lower_bound
6.5 46 49 325 328 I-lower_bound
: 49 50 328 329 O
ambulatory 51 61 330 340 O
for 62 65 341 344 O
at 66 68 345 347 O
least 69 74 348 353 O
20 75 77 354 356 B-lower_bound
meters 78 84 357 363 I-lower_bound
without 85 92 364 371 O
rest 93 97 372 376 O
and 98 101 377 380 O
use 102 105 381 384 O
of 106 108 385 387 O
bilateral 109 118 388 397 O
aids 119 123 398 402 O
( 124 125 403 404 O
canes 125 130 404 409 O
, 130 131 409 410 O
crutches 132 140 411 419 O
, 140 141 419 420 O
walker 142 148 421 427 O
) 148 149 427 428 O
or 150 152 429 431 O
better 153 159 432 438 O

IV 0 2 439 441 B-treatment
or 3 5 442 444 O
oral 6 10 445 449 B-treatment
steroids 11 19 450 458 I-treatment
in 20 22 459 461 O
the 23 26 462 465 O
60 27 29 466 468 B-upper_bound
days 30 34 469 473 I-upper_bound
prior 35 40 474 479 I-upper_bound
to 41 43 480 482 O
enrolment 44 53 483 492 O

Insulin 0 7 493 500 B-chronic_disease
- 7 8 500 501 I-chronic_disease
dependent 8 17 501 510 I-chronic_disease
diabetes 18 26 511 519 I-chronic_disease
or 27 29 520 522 O
diabetes 30 38 523 531 O
not 39 42 532 535 O
controlled 43 53 536 546 O
on 54 56 547 549 O
oral 57 61 550 554 B-treatment
diabetes 62 70 555 563 I-treatment
medications 71 82 564 575 I-treatment

Pregnant 0 8 576 584 B-pregnancy

Scheduled 0 9 585 594 O
( 10 11 595 596 O
every 11 16 596 601 O
3 17 18 602 603 O
months 19 25 604 610 O
or 26 28 611 613 O
more 29 33 614 618 O
frequently 34 44 619 629 O
) 44 45 629 630 O
IV 46 48 631 633 O
or 49 51 634 636 O
oral 52 56 637 641 B-treatment
steroids 57 65 642 650 I-treatment
in 66 68 651 653 O
the 69 72 654 657 O
year 73 77 658 662 O
prior 78 83 663 668 O
to 84 86 669 671 O
enrolment 87 96 672 681 O

Unable 0 6 682 688 B-language_fluency
to 7 9 689 691 I-language_fluency
follow 10 16 692 698 I-language_fluency
directions 17 27 699 709 I-language_fluency
in 28 30 710 712 I-language_fluency
English 31 38 713 720 I-language_fluency
as 39 41 721 723 O
standardized 42 54 724 736 O
scales 55 61 737 743 O
are 62 65 744 747 O
not 66 69 748 751 O
all 70 73 752 755 O
validated 74 83 756 765 O
in 84 86 766 768 O
other 87 92 769 774 O
languages 93 102 775 784 O

Unable 0 6 785 791 O
to 7 9 792 794 O
undergo 10 17 795 802 O
MRI 18 21 803 806 B-treatment

Use 0 3 807 810 O
of 4 6 811 813 O
LA 7 9 814 816 O
in 10 12 817 819 O
the 13 16 820 823 O
prior 17 22 824 829 B-upper_bound
2 23 24 830 831 I-upper_bound
years 25 30 832 837 I-upper_bound
exceeding 31 40 838 847 O
the 41 44 848 851 O
equivalent 45 55 852 862 O
of 56 58 863 865 O
1200 59 63 866 870 O
mg 63 65 870 872 O
daily 66 71 873 878 O
for 72 75 879 882 O
3 76 77 883 884 O
months 78 84 885 891 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
cells 41 46 41 46 I-lower_bound
/ 46 47 46 47 I-lower_bound
mm^3 47 51 47 51 I-lower_bound
obtained 52 60 52 60 O
within 61 67 61 67 O
30 68 70 68 70 B-upper_bound
days 71 75 71 75 I-upper_bound
prior 76 81 76 81 I-upper_bound
to 82 84 82 84 O
registration 85 97 85 97 O

Acquired 0 8 98 106 B-chronic_disease
immune 9 15 107 113 I-chronic_disease
deficiency 16 26 114 124 I-chronic_disease
syndrome 27 35 125 133 I-chronic_disease
( 36 37 134 135 I-chronic_disease
AIDS 37 41 135 139 I-chronic_disease
) 41 42 139 140 I-chronic_disease
based 43 48 141 146 O
upon 49 53 147 151 O
current 54 61 152 159 O
Centers 62 69 160 167 O
for 70 73 168 171 O
Disease 74 81 172 179 O
Control 82 89 180 187 O
and 90 93 188 191 O
Prevention 94 104 192 202 O
( 105 106 203 204 O
CDC 106 109 204 207 O
) 109 110 207 208 O
definition 111 121 209 219 O
; 121 122 219 220 O
note 123 127 221 225 O
, 127 128 225 226 O
however 129 136 227 234 O
, 136 137 234 235 O
that 138 142 236 240 O
human 143 148 241 246 B-chronic_disease
immunodeficiency 149 165 247 263 I-chronic_disease
virus 166 171 264 269 I-chronic_disease
( 172 173 270 271 I-chronic_disease
HIV 173 176 271 274 I-chronic_disease
) 176 177 274 275 I-chronic_disease
testing 178 185 276 283 O
is 186 188 284 286 O
not 189 192 287 290 O
required 193 201 291 299 O
for 202 205 300 303 O
entry 206 211 304 309 O
into 212 216 310 314 O
this 217 221 315 319 O
protocol 222 230 320 328 O

Appropriate 0 11 329 340 O
stage 12 17 341 346 O
for 18 21 347 350 O
protocol 22 30 351 359 O
entry 31 36 360 365 O
, 36 37 365 366 O
including 38 47 367 376 O
no 48 50 377 379 O
distant 51 58 380 387 B-cancer
metastases 59 69 388 398 I-cancer
, 69 70 398 399 O
based 71 76 400 405 O
upon 77 81 406 410 O
the 82 85 411 414 O
following 86 95 415 424 O
minimum 96 103 425 432 O
diagnostic 104 114 433 443 O
workup 115 121 444 450 O

Chronic 0 7 451 458 B-chronic_disease
obstructive 8 19 459 470 I-chronic_disease
pulmonary 20 29 471 480 I-chronic_disease
disease 30 37 481 488 I-chronic_disease
exacerbation 38 50 489 501 O
or 51 53 502 504 O
other 54 59 505 510 O
respiratory 60 71 511 522 B-chronic_disease
illness 72 79 523 530 I-chronic_disease
other 80 85 531 536 O
than 86 90 537 541 O
the 91 94 542 545 O
diagnosed 95 104 546 555 O
lung 105 109 556 560 B-cancer
cancer 110 116 561 567 I-cancer
requiring 117 126 568 577 O
hospitalization 127 142 578 593 O
or 143 145 594 596 O
precluding 146 156 597 607 O
study 157 162 608 613 B-treatment
therapy 163 170 614 621 I-treatment
within 171 177 622 628 O
30 178 180 629 631 B-upper_bound
days 181 185 632 636 I-upper_bound
before 186 192 637 643 O
registration 193 205 644 656 O

Exudative 0 9 657 666 B-chronic_disease
pleural 10 17 667 674 I-chronic_disease
effusions 18 27 675 684 I-chronic_disease
are 28 31 685 688 O
excluded 32 40 689 697 O
, 40 41 697 698 O
regardless 42 52 699 709 O
of 53 55 710 712 O
cytology 56 64 713 721 O

Fludeoxyglucose 0 15 722 737 B-treatment
F 16 17 738 739 I-treatment
18 18 20 740 742 I-treatment
( 21 22 743 744 I-treatment
FDG)-positron 22 35 744 757 I-treatment
emission 36 44 758 766 I-treatment
tomography 45 55 767 777 I-treatment
( 56 57 778 779 I-treatment
PET)/computed 57 70 779 792 I-treatment
tomography 71 81 793 803 I-treatment
( 82 83 804 805 I-treatment
CT 83 85 805 807 I-treatment
) 85 86 807 808 I-treatment
scan 87 91 809 813 I-treatment
for 92 95 814 817 O
staging 96 103 818 825 O
within 104 110 826 832 O
60 111 113 833 835 B-upper_bound
days 114 118 836 840 I-upper_bound
prior 119 124 841 846 I-upper_bound
to 125 127 847 849 O
registration 128 140 850 862 O

Forced 0 6 863 869 B-clinical_variable
expiratory 7 17 870 880 I-clinical_variable
volume 18 24 881 887 I-clinical_variable
in 25 27 888 890 I-clinical_variable
one 28 31 891 894 I-clinical_variable
second 32 38 895 901 I-clinical_variable
( 39 40 902 903 I-clinical_variable
FEV1 40 44 903 907 I-clinical_variable
) 44 45 907 908 I-clinical_variable
> 46 47 909 910 O
= 47 48 910 911 O
0.8 49 52 912 915 B-lower_bound
liter 53 58 916 921 I-lower_bound
or 59 61 922 924 O
> 62 63 925 926 O
= 63 64 926 927 O
35 65 67 928 930 B-lower_bound
% 67 68 930 931 I-lower_bound
predicted 69 78 932 941 O
with 79 83 942 946 O
or 84 86 947 949 O
without 87 94 950 957 O
bronchodilator 95 109 958 972 B-treatment
within 110 116 973 979 O
90 117 119 980 982 B-upper_bound
days 120 124 983 987 I-upper_bound
prior 125 130 988 993 O
to 131 133 994 996 O
registration 134 146 997 1009 O

Hemoglobin 0 10 1010 1020 B-clinical_variable
> 11 12 1021 1022 O
= 12 13 1022 1023 O
9.0 14 17 1024 1027 B-lower_bound
g 18 19 1028 1029 I-lower_bound
/ 19 20 1029 1030 I-lower_bound
dl 20 22 1030 1032 I-lower_bound
( 23 24 1033 1034 O
note 24 28 1034 1038 O
: 28 29 1038 1039 O
the 30 33 1040 1043 O
use 34 37 1044 1047 O
of 38 40 1048 1050 O
transfusion 41 52 1051 1062 B-treatment
or 53 55 1063 1065 O
other 56 61 1066 1071 O
intervention 62 74 1072 1084 O
to 75 77 1085 1087 O
achieve 78 85 1088 1095 O
hemoglobin 86 96 1096 1106 B-clinical_variable
[ 97 98 1107 1108 I-clinical_variable
Hgb 98 101 1108 1111 I-clinical_variable
] 101 102 1111 1112 I-clinical_variable
> 103 104 1113 1114 O
= 104 105 1114 1115 O
9.0 106 109 1116 1119 O
g 110 111 1120 1121 O
/ 111 112 1121 1122 O
dl 112 114 1122 1124 O
is 115 117 1125 1127 O
acceptable 118 128 1128 1138 O
) 128 129 1138 1139 O
, 129 130 1139 1140 O
obtained 131 139 1141 1149 O
within 140 146 1150 1156 O
30 147 149 1157 1159 B-upper_bound
days 150 154 1160 1164 I-upper_bound
prior 155 160 1165 1170 I-upper_bound
to 161 163 1171 1173 O
registration 164 176 1174 1186 O

Histologically 0 14 1187 1201 O
or 15 17 1202 1204 O
cytologically 18 31 1205 1218 O
proven 32 38 1219 1225 O
diagnosis 39 48 1226 1235 O
of 49 51 1236 1238 O
non 52 55 1239 1242 B-cancer
- 55 56 1242 1243 I-cancer
small 56 61 1243 1248 I-cancer
cell 62 66 1249 1253 I-cancer
lung 67 71 1254 1258 I-cancer
cancer 72 78 1259 1265 I-cancer

History 0 7 1266 1273 O
/ 7 8 1273 1274 O
physical 8 16 1274 1282 O
examination 17 28 1283 1294 O
within 29 35 1295 1301 O
30 36 38 1302 1304 B-upper_bound
days 39 43 1305 1309 I-upper_bound
prior 44 49 1310 1315 I-upper_bound
to 50 52 1316 1318 O
registration 53 65 1319 1331 O
including 66 75 1332 1341 O
resting 76 83 1342 1349 B-clinical_variable
heart 84 89 1350 1355 I-clinical_variable
rate 90 94 1356 1360 I-clinical_variable

It 0 2 1361 1363 O
is 3 5 1364 1366 O
highly 6 12 1367 1373 O
recommended 13 24 1374 1385 O
but 25 28 1386 1389 O
not 29 32 1390 1393 O
required 33 41 1394 1402 O
that 42 46 1403 1407 O
SGOT 47 51 1408 1412 B-clinical_variable
or 52 54 1413 1415 O
SGPT 55 59 1416 1420 B-clinical_variable
be 60 62 1421 1423 O
= 63 64 1424 1425 O
< 64 65 1425 1426 O
1.5 66 69 1427 1430 B-upper_bound
upper 70 75 1431 1436 I-upper_bound
limit 76 81 1437 1442 I-upper_bound
of 82 84 1443 1445 I-upper_bound
normal 85 91 1446 1452 I-upper_bound

It 0 2 1453 1455 O
is 3 5 1456 1458 O
highly 6 12 1459 1465 O
recommended 13 24 1466 1477 O
but 25 28 1478 1481 O
not 29 32 1482 1485 O
required 33 41 1486 1494 O
that 42 46 1495 1499 O
total 47 52 1500 1505 B-clinical_variable
bilirubin 53 62 1506 1515 I-clinical_variable
be 63 65 1516 1518 O
= 66 67 1519 1520 O
< 67 68 1520 1521 O
1.5 69 72 1522 1525 B-upper_bound
upper 73 78 1526 1531 I-upper_bound
limit 79 84 1532 1537 I-upper_bound
of 85 87 1538 1540 I-upper_bound
normal 88 94 1541 1547 I-upper_bound

Magnetic 0 8 1548 1556 B-treatment
resonance 9 18 1557 1566 I-treatment
imaging 19 26 1567 1574 I-treatment
( 27 28 1575 1576 I-treatment
MRI 28 31 1576 1579 I-treatment
) 31 32 1579 1580 I-treatment
scan 33 37 1581 1585 I-treatment
with 38 42 1586 1590 O
contrast 43 51 1591 1599 O
of 52 54 1600 1602 O
the 55 58 1603 1606 O
brain 59 64 1607 1612 O
( 65 66 1613 1614 O
preferred 66 75 1614 1623 O
) 75 76 1623 1624 O
or 77 79 1625 1627 O
CT 80 82 1628 1630 B-treatment
scan 83 87 1631 1635 I-treatment
of 88 90 1636 1638 I-treatment
the 91 94 1639 1642 I-treatment
brain 95 100 1643 1648 I-treatment
with 101 105 1649 1653 O
contrast 106 114 1654 1662 O
within 115 121 1663 1669 O
60 122 124 1670 1672 B-upper_bound
days 125 129 1673 1677 I-upper_bound
prior 130 135 1678 1683 I-upper_bound
to 136 138 1684 1686 O
registration 139 151 1687 1699 O

Patients 0 8 1700 1708 O
who 9 12 1709 1712 O
develop 13 20 1713 1720 O
local 21 26 1721 1726 O
recurrence 27 37 1727 1737 O
after 38 43 1738 1743 O
surgery 44 51 1744 1751 B-treatment
and 52 55 1752 1755 O
rendered 56 64 1756 1764 O
candidate 65 74 1765 1774 O
for 75 78 1775 1778 O
definitive 79 89 1779 1789 O
concurrent 90 100 1790 1800 O
chemoradiation 101 115 1801 1815 B-treatment

Patients 0 8 1816 1824 O
who 9 12 1825 1828 O
have 13 17 1829 1833 O
received 18 26 1834 1842 O
systemic 27 35 1843 1851 B-treatment
treatment 36 45 1852 1861 I-treatment
( 46 47 1862 1863 O
up 47 49 1863 1865 O
to 50 52 1866 1868 O
4 53 54 1869 1870 B-upper_bound
cycles 55 61 1871 1877 O
of 62 64 1878 1880 O
induction 65 74 1881 1890 B-treatment
chemotherapy 75 87 1891 1903 I-treatment
, 87 88 1903 1904 O
or 89 91 1905 1907 O
up 92 94 1908 1910 O
to 95 97 1911 1913 O
6 98 99 1914 1915 B-upper_bound
months 100 106 1916 1922 I-upper_bound
of 107 109 1923 1925 O
targeted 110 118 1926 1934 B-treatment
therapy 119 126 1935 1942 I-treatment
) 126 127 1942 1943 O

Patients 0 8 1944 1952 O
who 9 12 1953 1956 O
meet 13 17 1957 1961 O
the 18 21 1962 1965 O
criterion 22 31 1966 1975 O
above 32 37 1976 1981 O
without 38 45 1982 1989 O
oxygen 46 52 1990 1996 O
( 53 54 1997 1998 O
O2 54 56 1998 2000 O
) 56 57 2000 2001 O
, 57 58 2001 2002 O
but 59 62 2003 2006 O
who 63 66 2007 2010 O
need 67 71 2011 2015 O
acute 72 77 2016 2021 O
( 78 79 2022 2023 O
started 79 86 2023 2030 O
within 87 93 2031 2037 O
10 94 96 2038 2040 B-upper_bound
days 97 101 2041 2045 I-upper_bound
prior 102 107 2046 2051 I-upper_bound
to 108 110 2052 2054 O
registration 111 123 2055 2067 O
) 123 124 2067 2068 O
supplemental 125 137 2069 2081 O
oxygen 138 144 2082 2088 O
due 145 148 2089 2092 O
to 149 151 2093 2095 O
tumor 152 157 2096 2101 B-cancer
- 157 158 2101 2102 O
caused 158 164 2102 2108 O
obstruction 165 176 2109 2120 O
/ 176 177 2120 2121 O
hypoxia 177 184 2121 2128 B-chronic_disease
are 185 188 2129 2132 O
eligible 189 197 2133 2141 O
, 197 198 2141 2142 O
provided 199 207 2143 2151 O
the 208 211 2152 2155 O
amount 212 218 2156 2162 O
of 219 221 2163 2165 O
the 222 225 2166 2169 O
O2 226 228 2170 2172 O
needed 229 235 2173 2179 O
has 236 239 2180 2183 O
been 240 244 2184 2188 O
stable 245 251 2189 2195 O

Patients 0 8 2196 2204 O
who 9 12 2205 2208 O
present 13 20 2209 2216 O
with 21 25 2217 2221 O
N2 26 28 2222 2224 B-cancer
or 29 31 2225 2227 I-cancer
N3 32 34 2228 2230 I-cancer
disease 35 42 2231 2238 I-cancer
and 43 46 2239 2242 O
an 47 49 2243 2245 O
undetectable 50 62 2246 2258 O
NSCLC 63 68 2259 2264 B-cancer
primary 69 76 2265 2272 B-cancer
tumor 77 82 2273 2278 I-cancer

Patients 0 8 2279 2287 O
who 9 12 2288 2291 O
refuse 13 19 2292 2298 O
surgery 20 27 2299 2306 B-treatment

Patients 0 8 2307 2315 O
with 9 13 2316 2320 O
non 14 17 2321 2324 B-chronic_disease
- 17 18 2324 2325 I-chronic_disease
malignant 18 27 2325 2334 I-chronic_disease
pleural 28 35 2335 2342 I-chronic_disease
effusion 36 44 2343 2351 I-chronic_disease

Patients 0 8 2352 2360 O
with 9 13 2361 2365 O
prior 14 19 2366 2371 O
history 20 27 2372 2379 O
of 28 30 2380 2382 O
either 31 37 2383 2389 O
small 38 43 2390 2395 B-cancer
cell 44 48 2396 2400 I-cancer
lung 49 53 2401 2405 I-cancer
cancer 54 60 2406 2412 I-cancer
or 61 63 2413 2415 O
NSCLC 64 69 2416 2421 B-cancer
regardless 70 80 2422 2432 O
of 81 83 2433 2435 O
the 84 87 2436 2439 O
treatment 88 97 2440 2449 B-treatment
received 98 106 2450 2458 O

Peripheral 0 10 2459 2469 B-clinical_variable
neuropathy 11 21 2470 2480 I-clinical_variable
= 22 23 2481 2482 O
< 23 24 2482 2483 O
grade 25 30 2484 2489 B-upper_bound
1 31 32 2490 2491 I-upper_bound
at 33 35 2492 2494 O
the 36 39 2495 2498 O
time 40 44 2499 2503 O
of 45 47 2504 2506 O
registration 48 60 2507 2519 O

Platelets 0 9 2520 2529 B-clinical_variable
> 10 11 2530 2531 O
= 11 12 2531 2532 O
100,000 13 20 2533 2540 B-lower_bound
cells 21 26 2541 2546 I-lower_bound
/ 26 27 2546 2547 I-lower_bound
mm^3 27 31 2547 2551 I-lower_bound
obtained 32 40 2552 2560 O
within 41 47 2561 2567 O
30 48 50 2568 2570 B-upper_bound
days 51 55 2571 2575 I-upper_bound
prior 56 61 2576 2581 O
to 62 64 2582 2584 O
registration 65 77 2585 2597 O

Pregnancy 0 9 2598 2607 B-pregnancy

Prior 0 5 2608 2613 O
invasive 6 14 2614 2622 O
malignancy 15 25 2623 2633 B-cancer
unless 26 32 2634 2640 O
disease 33 40 2641 2648 O
free 41 45 2649 2653 O
for 46 49 2654 2657 O
a 50 51 2658 2659 O
minimum 52 59 2660 2667 O
of 60 62 2668 2670 O
3 63 64 2671 2672 B-lower_bound
years 65 70 2673 2678 I-lower_bound

Prior 0 5 2679 2684 B-treatment
radiotherapy 6 18 2685 2697 I-treatment
to 19 21 2698 2700 O
the 22 25 2701 2704 O
region 26 32 2705 2711 O
of 33 35 2712 2714 O
the 36 39 2715 2718 O
study 40 45 2719 2724 O
cancer 46 52 2725 2731 B-cancer
that 53 57 2732 2736 O
would 58 63 2737 2742 O
result 64 70 2743 2749 O
in 71 73 2750 2752 O
overlap 74 81 2753 2760 O
of 82 84 2761 2763 O
radiation 85 94 2764 2773 B-treatment
therapy 95 102 2774 2781 I-treatment
fields 103 109 2782 2788 O

Prior 0 5 2789 2794 B-treatment
systemic 6 14 2795 2803 I-treatment
chemotherapy 15 27 2804 2816 I-treatment
for 28 31 2817 2820 O
the 32 35 2821 2824 O
study 36 41 2825 2830 O
cancer 42 48 2831 2837 B-cancer
, 48 49 2837 2838 O
if 50 52 2839 2841 O
more 53 57 2842 2846 O
than 58 62 2847 2851 O
4 63 64 2852 2853 B-lower_bound
cycles 65 71 2854 2860 O
of 72 74 2861 2863 O
induction 75 84 2864 2873 B-treatment
chemotherapy 85 97 2874 2886 I-treatment
or 98 100 2887 2889 O
more 101 105 2890 2894 O
than 106 110 2895 2899 O
6 111 112 2900 2901 B-lower_bound
months 113 119 2902 2908 I-lower_bound
of 120 122 2909 2911 O
targeted 123 131 2912 2920 B-treatment
therapy 132 139 2921 2928 I-treatment

Serum 0 5 2929 2934 B-clinical_variable
creatinine 6 16 2935 2945 I-clinical_variable
< 17 18 2946 2947 O
1.5 19 22 2948 2951 B-clinical_variable
mg 23 25 2952 2954 I-clinical_variable
/ 25 26 2954 2955 I-clinical_variable
dL 26 28 2955 2957 I-clinical_variable
or 29 31 2958 2960 O
calculated 32 42 2961 2971 B-clinical_variable
creatinine 43 53 2972 2982 I-clinical_variable
clearance 54 63 2983 2992 I-clinical_variable
> 64 65 2993 2994 O
= 65 66 2994 2995 O
50 67 69 2996 2998 B-lower_bound
mL 70 72 2999 3001 I-lower_bound
/ 72 73 3001 3002 I-lower_bound
min 73 76 3002 3005 I-lower_bound
within 77 83 3006 3012 O
30 84 86 3013 3015 B-upper_bound
days 87 91 3016 3020 I-upper_bound
prior 92 97 3021 3026 I-upper_bound
to 98 100 3027 3029 O
registration 101 113 3030 3042 O
estimated 114 123 3043 3052 O
by 124 126 3053 3055 O
the 127 130 3056 3059 O
Cockcroft 131 140 3060 3069 B-clinical_variable
- 140 141 3069 3070 I-clinical_variable
Gault 141 146 3070 3075 I-clinical_variable
formula 147 154 3076 3083 I-clinical_variable

Serum 0 5 3084 3089 B-clinical_variable
glutamic 6 14 3090 3098 I-clinical_variable
oxaloacetic 15 26 3099 3110 I-clinical_variable
transaminase 27 39 3111 3123 I-clinical_variable
( 40 41 3124 3125 I-clinical_variable
SGOT 41 45 3125 3129 I-clinical_variable
) 45 46 3129 3130 I-clinical_variable
or 47 49 3131 3133 O
serum 50 55 3134 3139 B-clinical_variable
glutamate 56 65 3140 3149 I-clinical_variable
pyruvate 66 74 3150 3158 I-clinical_variable
transaminase 75 87 3159 3171 I-clinical_variable
( 88 89 3172 3173 I-clinical_variable
SGPT 89 93 3173 3177 I-clinical_variable
) 93 94 3177 3178 I-clinical_variable
within 95 101 3179 3185 O
30 102 104 3186 3188 B-upper_bound
days 105 109 3189 3193 I-upper_bound
prior 110 115 3194 3199 I-upper_bound
to 116 118 3200 3202 O
registration 119 131 3203 3215 O

Total 0 5 3216 3221 B-clinical_variable
bilirubin 6 15 3222 3231 I-clinical_variable
= 16 17 3232 3233 O
< 17 18 3233 3234 O
1.5 19 22 3235 3238 B-upper_bound
within 23 29 3239 3245 O
30 30 32 3246 3248 B-upper_bound
days 33 37 3249 3253 I-upper_bound
prior 38 43 3254 3259 I-upper_bound
to 44 46 3260 3262 O
registration 47 59 3263 3275 O

Transmural 0 10 3276 3286 B-chronic_disease
myocardial 11 21 3287 3297 I-chronic_disease
infarction 22 32 3298 3308 I-chronic_disease
within 33 39 3309 3315 O
the 40 43 3316 3319 O
last 44 48 3320 3324 B-upper_bound
6 49 50 3325 3326 I-upper_bound
months 51 57 3327 3333 I-upper_bound

Unintentional 0 13 3334 3347 B-clinical_variable
weight 14 20 3348 3354 I-clinical_variable
loss 21 25 3355 3359 I-clinical_variable
> 26 27 3360 3361 O
10 28 30 3362 3364 B-lower_bound
% 30 31 3364 3365 I-lower_bound
within 32 38 3366 3372 O
30 39 41 3373 3375 B-upper_bound
days 42 46 3376 3380 I-upper_bound
prior 47 52 3381 3386 I-upper_bound
to 53 55 3387 3389 O
registration 56 68 3390 3402 O

Unstable 0 8 3403 3411 B-chronic_disease
angina 9 15 3412 3418 I-chronic_disease
and/or 16 22 3419 3425 O
congestive 23 33 3426 3436 B-chronic_disease
heart 34 39 3437 3442 I-chronic_disease
failure 40 47 3443 3450 I-chronic_disease
requiring 48 57 3451 3460 O
hospitalization 58 73 3461 3476 B-treatment
within 74 80 3477 3483 O
the 81 84 3484 3487 O
last 85 89 3488 3492 B-upper_bound
6 90 91 3493 3494 I-upper_bound
months 92 98 3495 3501 I-upper_bound

When 0 4 3502 3506 O
pleural 5 12 3507 3514 O
fluid 13 18 3515 3520 O
is 19 21 3521 3523 O
visible 22 29 3524 3531 O
on 30 32 3532 3534 O
both 33 37 3535 3539 O
the 38 41 3540 3543 O
CT 42 44 3544 3546 B-treatment
scan 45 49 3547 3551 I-treatment
and 50 53 3552 3555 O
on 54 56 3556 3558 O
a 57 58 3559 3560 O
chest 59 64 3561 3566 B-treatment
x 65 66 3567 3568 I-treatment
- 66 67 3568 3569 I-treatment
ray 67 70 3569 3572 I-treatment
, 70 71 3572 3573 O
a 72 73 3574 3575 O
pleuracentesis 74 88 3576 3590 O
is 89 91 3591 3593 O
required 92 100 3594 3602 O
to 101 103 3603 3605 O
confirm 104 111 3606 3613 O
that 112 116 3614 3618 O
the 117 120 3619 3622 O
pleural 121 128 3623 3630 O
fluid 129 134 3631 3636 O
is 135 137 3637 3639 O
cytologically 138 151 3640 3653 O
negative 152 160 3654 3662 O

Women 0 5 3663 3668 B-gender
of 6 8 3669 3671 O
childbearing 9 21 3672 3684 O
potential 22 31 3685 3694 O
and 32 35 3695 3698 O
male 36 40 3699 3703 B-gender
participants 41 53 3704 3716 I-gender
must 54 58 3717 3721 O
practice 59 67 3722 3730 O
adequate 68 76 3731 3739 O
contraception 77 90 3740 3753 B-contraception_consent

Women 0 5 3754 3759 B-gender
of 6 8 3760 3762 O
childbearing 9 21 3763 3775 O
potential 22 31 3776 3785 O
must 32 36 3786 3790 O
have 37 41 3791 3795 O
a 42 43 3796 3797 O
negative 44 52 3798 3806 B-pregnancy
serum 53 58 3807 3812 I-pregnancy
pregnancy 59 68 3813 3822 I-pregnancy
test 69 73 3823 3827 O
within 74 80 3828 3834 O
14 81 83 3835 3837 B-upper_bound
days 84 88 3838 3842 I-upper_bound
prior 89 94 3843 3848 I-upper_bound
to 95 97 3849 3851 O
registration 98 110 3852 3864 O

Zubrod 0 6 3865 3871 B-clinical_variable
performance 7 18 3872 3883 I-clinical_variable
status 19 25 3884 3890 I-clinical_variable
0 26 27 3891 3892 B-lower_bound
- 27 28 3892 3893 O
1 28 29 3893 3894 B-upper_bound
within 30 36 3895 3901 O
30 37 39 3902 3904 B-upper_bound
days 40 44 3905 3909 I-upper_bound
prior 45 50 3910 3915 I-upper_bound
to 51 53 3916 3918 O
registration 54 66 3919 3931 O

for 0 3 3932 3935 O
patients 4 12 3936 3944 O
who 13 16 3945 3948 O
are 17 20 3949 3952 O
clearly 21 28 3953 3960 O
nonresectable 29 42 3961 3974 O
, 42 43 3974 3975 O
the 44 47 3976 3979 O
case 48 52 3980 3984 O
can 53 56 3985 3988 O
be 57 59 3989 3991 O
determined 60 70 3992 4002 O
by 71 73 4003 4005 O
the 74 77 4006 4009 O
treating 78 86 4010 4018 O
radiation 87 96 4019 4028 B-treatment
oncologist 97 107 4029 4039 O
and/or 108 114 4040 4046 O
a 115 116 4047 4048 O
medical 117 124 4049 4056 O
oncologist 125 135 4057 4067 O
or 136 138 4068 4070 O
pulmonologist 139 152 4071 4084 O

men 0 3 4085 4088 B-gender
who 4 7 4089 4092 O
are 8 11 4093 4096 O
sexually 12 20 4097 4105 O
active 21 27 4106 4112 O

non 0 3 4113 4116 O
- 3 4 4116 4117 O
operable 4 12 4117 4125 O
disease 13 20 4126 4133 O
will 21 25 4134 4138 O
be 26 28 4139 4141 O
determined 29 39 4142 4152 O
by 40 42 4153 4155 O
a 43 44 4156 4157 O
multi 45 50 4158 4163 B-treatment
- 50 51 4163 4164 I-treatment
disciplinary 51 63 4164 4176 I-treatment
treatment 64 73 4177 4186 I-treatment
team 74 78 4187 4191 O
within 79 85 4192 4198 O
60 86 88 4199 4201 B-upper_bound
days 89 93 4202 4206 I-upper_bound
prior 94 99 4207 4212 I-upper_bound
to 100 102 4213 4215 O
registration 103 115 4216 4228 O

not 0 3 4229 4232 B-contraception_consent
willing 4 11 4233 4240 I-contraception_consent
/ 11 12 4240 4241 I-contraception_consent
able 12 16 4241 4245 I-contraception_consent
to 17 19 4246 4248 I-contraception_consent
use 20 23 4249 4252 I-contraception_consent
medically 24 33 4253 4262 I-contraception_consent
acceptable 34 44 4263 4273 I-contraception_consent
forms 45 50 4274 4279 I-contraception_consent
of 51 53 4280 4282 I-contraception_consent
contraception 54 67 4283 4296 I-contraception_consent

prior 0 5 4297 4302 B-treatment
chemotherapy 6 18 4303 4315 I-treatment
for 19 22 4316 4319 O
a 23 24 4320 4321 O
different 25 34 4322 4331 O
cancer 35 41 4332 4338 B-cancer

skin 0 4 4339 4343 B-cancer
cancer 5 11 4344 4350 I-cancer
and 12 15 4351 4354 O
in 16 18 4355 4357 B-cancer
situ 19 23 4358 4362 I-cancer
carcinomas 24 34 4363 4373 I-cancer
of 35 37 4374 4376 I-cancer
the 38 41 4377 4380 I-cancer
breast 42 48 4381 4387 I-cancer
, 48 49 4387 4388 O
oral 50 54 4389 4393 B-cancer
cavity 55 61 4394 4400 I-cancer
, 61 62 4400 4401 O
cervix 63 69 4402 4408 B-cancer
, 69 70 4408 4409 O
and 71 74 4410 4413 O
other 75 80 4414 4419 O
organs 81 87 4420 4426 O
and 88 91 4427 4430 O
are 92 95 4431 4434 O
permissible 96 107 4435 4446 O

women 0 5 4447 4452 B-gender
of 6 8 4453 4455 O
childbearing 9 21 4456 4468 O
potential 22 31 4469 4478 O

Admission 0 9 0 9 O
to 10 12 10 12 O
Labor 13 18 13 18 O
and 19 22 19 22 O
Delivery 23 31 23 31 O
with 32 36 32 36 O
a 37 38 37 38 O
plan 39 43 39 43 O
for 44 47 44 47 O
delivery 48 56 48 56 O
( 57 58 57 58 O
women 58 63 58 63 B-gender
in 64 66 64 66 O
both 67 71 67 71 O
latent 72 78 72 78 O
and 79 82 79 82 O
active 83 89 83 89 O
labor 90 95 90 95 O
will 96 100 96 100 O
be 101 103 101 103 O
eligible 104 112 104 112 O
) 112 113 112 113 O

Allergy 0 7 114 121 O
or 8 10 122 124 O
Contraindication 11 27 125 141 O
to 28 30 142 144 O
contraceptive 31 44 145 158 B-allergy_name
implant 45 52 159 166 I-allergy_name

Diabetes 0 8 167 175 B-chronic_disease
( 9 10 176 177 O
gestational 10 21 177 188 O
or 22 24 189 191 O
pre 25 28 192 195 O
- 28 29 195 196 O
gestational 29 40 196 207 O
) 40 41 207 208 O

Expected 0 8 209 217 O
delivery 9 17 218 226 O
prior 18 23 227 232 O
to 24 26 233 235 O
34 27 29 236 238 B-upper_bound
weeks 30 35 239 244 I-upper_bound

Intention 0 9 245 254 O
to 10 12 255 257 O
use 13 16 258 261 B-contraception_consent
a 17 18 262 263 I-contraception_consent
contraceptive 19 32 264 277 I-contraception_consent
implant 33 40 278 285 I-contraception_consent
postpartum 41 51 286 296 I-contraception_consent

Live 0 4 297 301 O
pregnancy 5 14 302 311 B-pregnancy
of 15 17 312 314 O
at 18 20 315 317 O
least 21 26 318 323 O
24 27 29 324 326 B-lower_bound
weeks 30 35 327 332 I-lower_bound
gestation 36 45 333 342 O

Obesity 0 7 343 350 B-chronic_disease
( 8 9 351 352 O
pre 9 12 352 355 O
- 12 13 355 356 O
pregnancy 13 22 356 365 O
BMI 23 26 366 369 B-bmi
> 27 28 370 371 O
35 28 30 371 373 B-lower_bound
) 30 31 373 374 O

Polycystic 0 10 375 385 B-chronic_disease
Ovarian 11 18 386 393 I-chronic_disease
Syndrome 19 27 394 402 I-chronic_disease

ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
= 6 7 6 7 O
1,000 8 13 8 13 B-lower_bound
/ 13 14 13 14 I-lower_bound
uL 14 16 14 16 I-lower_bound

AST(SGOT)/ALT(SGPT 0 18 17 35 B-clinical_variable
) 18 19 35 36 I-clinical_variable
< 20 21 37 38 O
= 22 23 39 40 O
2.5 24 27 41 44 B-upper_bound
X 28 29 45 46 I-upper_bound
upper 30 35 47 52 I-upper_bound
limit 36 41 53 58 I-upper_bound
of 42 44 59 61 I-upper_bound
normal 45 51 62 68 I-upper_bound

Age 0 3 69 72 B-age
> 4 5 73 74 O
= 6 7 75 76 O
18 8 10 77 79 B-lower_bound
years 11 16 80 85 I-lower_bound

All 0 3 86 89 O
patients 4 12 90 98 O
who 13 16 99 102 O
participate 17 28 103 114 O
in 29 31 115 117 O
this 32 36 118 122 O
study 37 42 123 128 O
must 43 47 129 133 O
be 48 50 134 136 O
willing 51 58 137 144 O
and 59 62 145 148 O
able 63 67 149 153 O
to 68 70 154 156 O
tolerate 71 79 157 165 O
prophylactic 80 92 166 178 B-treatment
anticoagulation 93 108 179 194 I-treatment
with 109 113 195 199 I-treatment
low 114 117 200 203 I-treatment
- 117 118 203 204 I-treatment
molecular 118 127 204 213 I-treatment
weight 128 134 214 220 I-treatment
heparin 135 142 221 228 I-treatment
( 143 144 229 230 I-treatment
LMWH 144 148 230 234 I-treatment
) 148 149 234 235 I-treatment
for 150 153 236 239 O
the 154 157 240 243 O
required 158 166 244 252 O
dates 167 172 253 258 O
in 173 175 259 261 O
treatment 176 185 262 271 B-treatment
protocol 186 194 272 280 I-treatment

Cardiac 0 7 281 288 B-clinical_variable
Ejection 8 16 289 297 I-clinical_variable
Fraction 17 25 298 306 I-clinical_variable
> 26 27 307 308 O
= 28 29 309 310 O
45 30 32 311 313 B-lower_bound
% 33 34 314 315 I-lower_bound

Creatinine 0 10 316 326 B-clinical_variable
clearance 11 20 327 336 I-clinical_variable
> 21 22 337 338 O
60 23 25 339 341 B-lower_bound
cc 26 28 342 344 I-lower_bound
/ 28 29 344 345 I-lower_bound
min 29 32 345 348 I-lower_bound

ECOG 0 4 349 353 B-clinical_variable
performance 5 16 354 365 I-clinical_variable
status 17 23 366 372 I-clinical_variable
> 24 25 373 374 O
= 26 27 375 376 O
2 28 29 377 378 B-lower_bound

FCBP 0 4 379 383 O
must 5 9 384 388 O
also 10 14 389 393 O
agree 15 20 394 399 O
to 21 23 400 402 O
ongoing 24 31 403 410 O
pregnancy 32 41 411 420 B-pregnancy
testing 42 49 421 428 O

Females 0 7 429 436 B-gender
of 8 10 437 439 O
childbearing 11 23 440 452 O
potential 24 33 453 462 O
( 34 35 463 464 O
FCBP 35 39 464 468 O
) 39 40 468 469 O
must 41 45 470 474 O
have 46 50 475 479 O
a 51 52 480 481 O
negative 53 61 482 490 B-pregnancy
serum 62 67 491 496 I-pregnancy
or 68 70 497 499 I-pregnancy
urine 71 76 500 505 I-pregnancy
pregnancy 77 86 506 515 I-pregnancy
test 87 91 516 520 O
with 92 96 521 525 O
a 97 98 526 527 O
sensitivity 99 110 528 539 O
of 111 113 540 542 O
at 114 116 543 545 O
least 117 122 546 551 O
50 123 125 552 554 B-lower_bound
mIU 126 129 555 558 I-lower_bound
/ 129 130 558 559 I-lower_bound
mL 130 132 559 561 I-lower_bound
within 133 139 562 568 O
10 140 142 569 571 B-lower_bound
- 143 144 572 573 O
14 145 147 574 576 B-upper_bound
days 148 152 577 581 I-upper_bound
and 153 156 582 585 O
again 157 162 586 591 O
within 163 169 592 598 O
24 170 172 599 601 B-upper_bound
hours 173 178 602 607 I-upper_bound
prior 179 184 608 613 I-upper_bound
to 185 187 614 616 O
prescribing 188 199 617 628 O
lenalidomide 200 212 629 641 B-treatment
( 213 214 642 643 O
prescriptions 214 227 643 656 O
must 228 232 657 661 O
be 233 235 662 664 O
filled 236 242 665 671 O
within 243 249 672 678 O
7 250 251 679 680 B-upper_bound
days 252 256 681 685 I-upper_bound
) 256 257 685 686 O

History 0 7 687 694 O
of 8 10 695 697 O
allergic 11 19 698 706 O
reactions 20 29 707 716 O
attributed 30 40 717 727 O
to 41 43 728 730 O
compounds 44 53 731 740 O
of 54 56 741 743 O
similar 57 64 744 751 O
chemical 65 73 752 760 O
or 74 76 761 763 O
biologic 77 85 764 772 O
composition 86 97 773 784 O
to 98 100 785 787 O
lenalidomide 101 113 788 800 B-allergy_name
( 114 115 801 802 O
including 115 124 802 811 O
thalidomide 125 136 812 823 B-allergy_name
) 136 137 823 824 O
or 138 140 825 827 O
melphalan 141 150 828 837 B-allergy_name

History 0 7 838 845 O
of 8 10 846 848 O
thrombosis 11 21 849 859 B-chronic_disease
or 22 24 860 862 O
thromboembolic 25 39 863 877 B-chronic_disease
event 40 45 878 883 I-chronic_disease
within 46 52 884 890 O
last 53 57 891 895 B-upper_bound
60 58 60 896 898 I-upper_bound
days 61 65 899 903 I-upper_bound
prior 66 71 904 909 I-upper_bound
to 72 74 910 912 O
study 75 80 913 918 O
entry 81 86 919 924 O

Known 0 5 925 930 O
positive 6 14 931 939 O
for 15 18 940 943 O
HIV 19 22 944 947 B-chronic_disease
or 23 25 948 950 O
infectious 26 36 951 961 O
hepatitis 37 46 962 971 B-chronic_disease
, 46 47 971 972 I-chronic_disease
type 48 52 973 977 I-chronic_disease
B 53 54 978 979 I-chronic_disease
or 55 57 980 982 I-chronic_disease
C 58 59 983 984 I-chronic_disease

Lenalidomide 0 12 985 997 B-treatment
has 13 16 998 1001 O
been 17 21 1002 1006 O
shown 22 27 1007 1012 O
to 28 30 1013 1015 O
carry 31 36 1016 1021 O
a 37 38 1022 1023 O
risk 39 43 1024 1028 O
of 44 46 1029 1031 O
thromboembolic 47 61 1032 1046 B-chronic_disease
events 62 68 1047 1053 I-chronic_disease
, 68 69 1053 1054 O
especially 70 80 1055 1065 O
when 81 85 1066 1070 O
used 86 90 1071 1075 O
in 91 93 1076 1078 O
combination 94 105 1079 1090 O
with 106 110 1091 1095 O
either 111 117 1096 1102 O
corticosteroids 118 133 1103 1118 B-treatment
or 134 136 1119 1121 O
alkylating 137 147 1122 1132 B-treatment
chemotherapeutic 148 164 1133 1149 I-treatment
agents 165 171 1150 1156 I-treatment

Life 0 4 1157 1161 B-clinical_variable
expectancy 5 15 1162 1172 I-clinical_variable
of 16 18 1173 1175 O
greater 19 26 1176 1183 O
than 27 31 1184 1188 O
12 32 34 1189 1191 B-lower_bound
weeks 35 40 1192 1197 I-lower_bound

Men 0 3 1198 1201 B-gender
must 4 8 1202 1206 O
agree 9 14 1207 1212 B-contraception_consent
to 15 17 1213 1215 I-contraception_consent
use 18 21 1216 1219 I-contraception_consent
a 22 23 1220 1221 I-contraception_consent
latex 24 29 1222 1227 I-contraception_consent
condom 30 36 1228 1234 I-contraception_consent
during 37 43 1235 1241 O
sexual 44 50 1242 1248 O
contact 51 58 1249 1256 O
with 59 63 1257 1261 O
a 64 65 1262 1263 O
FCBP 66 70 1264 1268 B-clinical_variable
even 71 75 1269 1273 O
if 76 78 1274 1276 O
they 79 83 1277 1281 O
have 84 88 1282 1286 O
had 89 92 1287 1290 O
a 93 94 1291 1292 O
successful 95 105 1293 1303 O
vasectomy 106 115 1304 1313 B-treatment

Patients 0 8 1314 1322 O
also 9 13 1323 1327 O
must 14 18 1328 1332 O
be 19 21 1333 1335 O
able 22 26 1336 1340 O
to 27 29 1341 1343 O
tolerate 30 38 1344 1352 O
low 39 42 1353 1356 O
- 42 43 1356 1357 O
dose 43 47 1357 1361 O
aspirin 48 55 1362 1369 B-treatment
, 55 56 1369 1370 O
81 57 59 1371 1373 O
mg 60 62 1374 1376 O
daily 63 68 1377 1382 O
, 68 69 1382 1383 O
during 70 76 1384 1390 O
the 77 80 1391 1394 O
maintenance 81 92 1395 1406 O
phase 93 98 1407 1412 O
of 99 101 1413 1415 O
the 102 105 1416 1419 O
treatment 106 115 1420 1429 B-treatment
protocol 116 124 1430 1438 O

Patients 0 8 1439 1447 O
may 9 12 1448 1451 O
have 13 17 1452 1456 O
received 18 26 1457 1465 O
bisphosphonate 27 41 1466 1480 B-treatment
therapy 42 49 1481 1488 I-treatment
as 50 52 1489 1491 O
part 53 57 1492 1496 O
of 58 60 1497 1499 O
routine 61 68 1500 1507 O
myeloma 69 76 1508 1515 B-cancer
care 77 81 1516 1520 O
at 82 84 1521 1523 O
any 85 88 1524 1527 O
time 89 93 1528 1532 O
prior 94 99 1533 1538 O
to 100 102 1539 1541 O
study 103 108 1542 1547 O
entry 109 114 1548 1553 O

Patients 0 8 1554 1562 O
may 9 12 1563 1566 O
not 13 16 1567 1570 O
be 17 19 1571 1573 O
receiving 20 29 1574 1583 O
any 30 33 1584 1587 O
other 34 39 1588 1593 O
investigational 40 55 1594 1609 B-treatment
agents 56 62 1610 1616 I-treatment

Patients 0 8 1617 1625 O
must 9 13 1626 1630 O
have 14 18 1631 1635 O
an 19 21 1636 1638 O
adequate 22 30 1639 1647 O
number 31 37 1648 1654 O
of 38 40 1655 1657 O
CD34 41 45 1658 1662 O
+ 45 46 1662 1663 O
stem 47 51 1664 1668 O
cells 52 57 1669 1674 O
collected 58 67 1675 1684 O
to 68 70 1685 1687 O
allow 71 76 1688 1693 O
for 77 80 1694 1697 O
transplantation 81 96 1698 1713 B-treatment

Patients 0 8 1714 1722 O
must 9 13 1723 1727 O
have 14 18 1728 1732 O
histologically 19 33 1733 1747 O
or 34 36 1748 1750 O
cytologically 37 50 1751 1764 O
confirmed 51 60 1765 1774 O
relapsed 61 69 1775 1783 B-cancer
, 69 70 1783 1784 O
primary 71 78 1785 1792 B-cancer
refractory 79 89 1793 1803 I-cancer
, 89 90 1803 1804 O
or 91 93 1805 1807 O
relapsed 94 102 1808 1816 B-cancer
and 103 106 1817 1820 I-cancer
refractory 107 117 1821 1831 I-cancer
multiple 118 126 1832 1840 I-cancer
myeloma 127 134 1841 1848 I-cancer

Patients 0 8 1849 1857 O
who 9 12 1858 1861 O
have 13 17 1862 1866 O
had 18 21 1867 1870 O
myeloma 22 29 1871 1878 B-treatment
therapy 30 37 1879 1886 I-treatment
within 38 44 1887 1893 O
14 45 47 1894 1896 B-upper_bound
days 48 52 1897 1901 I-upper_bound
prior 53 58 1902 1907 I-upper_bound
to 59 61 1908 1910 O
entering 62 70 1911 1919 O
the 71 74 1920 1923 O
study 75 80 1924 1929 O
or 81 83 1930 1932 O
those 84 89 1933 1938 O
who 90 93 1939 1942 O
have 94 98 1943 1947 O
not 99 102 1948 1951 O
recovered 103 112 1952 1961 O
from 113 117 1962 1966 O
adverse 118 125 1967 1974 O
events 126 132 1975 1981 O
due 133 136 1982 1985 O
to 137 139 1986 1988 O
agents 140 146 1989 1995 O
administered 147 159 1996 2008 O
more 160 164 2009 2013 O
than 165 169 2014 2018 O
2 170 171 2019 2020 B-lower_bound
weeks 172 177 2021 2026 I-lower_bound
earlier 178 185 2027 2034 O

Pregnant 0 8 2035 2043 B-pregnancy
and 9 12 2044 2047 O
lactating 13 22 2048 2057 O
women 23 28 2058 2063 B-gender
are 29 32 2064 2067 O
excluded 33 41 2068 2076 O
from 42 46 2077 2081 O
the 47 50 2082 2085 O
study 51 56 2086 2091 O
because 57 64 2092 2099 O
the 65 68 2100 2103 O
risks 69 74 2104 2109 O
to 75 77 2110 2112 O
an 78 80 2113 2115 O
unborn 81 87 2116 2122 O
fetus 88 93 2123 2128 O
or 94 96 2129 2131 O
potential 97 106 2132 2141 O
risks 107 112 2142 2147 O
in 113 115 2148 2150 O
nursing 116 123 2151 2158 O
infants 124 131 2159 2166 O
are 132 135 2167 2170 O
unknown 136 143 2171 2178 O

Should 0 6 2179 2185 O
a 7 8 2186 2187 O
woman 9 14 2188 2193 B-gender
become 15 21 2194 2200 B-pregnancy
pregnant 22 30 2201 2209 I-pregnancy
or 31 33 2210 2212 O
suspect 34 41 2213 2220 O
she 42 45 2221 2224 O
is 46 48 2225 2227 O
pregnant 49 57 2228 2236 O
while 58 63 2237 2242 O
participating 64 77 2243 2256 O
in 78 80 2257 2259 O
this 81 85 2260 2264 O
study 86 91 2265 2270 O
, 91 92 2270 2271 O
she 93 96 2272 2275 O
should 97 103 2276 2282 O
inform 104 110 2283 2289 O
her 111 114 2290 2293 O
treating 115 123 2294 2302 O
physician 124 133 2303 2312 O
immediately 134 145 2313 2324 O

The 0 3 2325 2328 O
effects 4 11 2329 2336 O
of 12 14 2337 2339 O
lenalidomide 15 27 2340 2352 B-treatment
on 28 30 2353 2355 O
the 31 34 2356 2359 O
developing 35 45 2360 2370 O
human 46 51 2371 2376 O
fetus 52 57 2377 2382 O
at 58 60 2383 2385 O
the 61 64 2386 2389 O
recommended 65 76 2390 2401 O
therapeutic 77 88 2402 2413 O
dose 89 93 2414 2418 O
are 94 97 2419 2422 O
unknown 98 105 2423 2430 O
; 105 106 2430 2431 O
however 107 114 2432 2439 O
, 114 115 2439 2440 O
it 116 118 2441 2443 O
has 119 122 2444 2447 O
been 123 127 2448 2452 O
shown 128 133 2453 2458 O
to 134 136 2459 2461 O
be 137 139 2462 2464 O
teratogenic 140 151 2465 2476 B-treatment
other 152 157 2477 2482 O
primates 158 166 2483 2491 O

The 0 3 2492 2495 O
treating 4 12 2496 2504 O
physician 13 22 2505 2514 O
will 23 27 2515 2519 O
follow 28 34 2520 2526 O
the 35 38 2527 2530 O
adverse 39 46 2531 2538 O
reporting 47 56 2539 2548 O
guidelines 57 67 2549 2559 O
as 68 70 2560 2562 O
outlined 71 79 2563 2571 O
in 80 82 2572 2574 O
further 83 90 2575 2582 O
detail 91 97 2583 2589 O
below 98 103 2590 2595 O
for 104 107 2596 2599 O
pregnancies 108 119 2600 2611 B-pregnancy

This 0 4 2612 2616 O
number 5 11 2617 2623 O
is 12 14 2624 2626 O
defined 15 22 2627 2634 O
as 23 25 2635 2637 O
≥ 26 27 2638 2639 O
2 28 29 2640 2641 B-lower_bound
x 30 31 2642 2643 I-lower_bound
106 32 35 2644 2647 I-lower_bound
CD34 36 40 2648 2652 I-lower_bound
+ 40 41 2652 2653 I-lower_bound
cells 42 47 2654 2659 I-lower_bound
/ 48 49 2660 2661 I-lower_bound
kg 50 52 2662 2664 I-lower_bound
body 53 57 2665 2669 B-clinical_variable
weight 58 64 2670 2676 I-clinical_variable

Uncontrolled 0 12 2677 2689 B-chronic_disease
illness 13 20 2690 2697 I-chronic_disease
including 21 30 2698 2707 O
, 30 31 2707 2708 O
but 32 35 2709 2712 O
not 36 39 2713 2716 O
limited 40 47 2717 2724 O
to 48 50 2725 2727 O
, 50 51 2727 2728 O
ongoing 52 59 2729 2736 O
or 60 62 2737 2739 O
active 63 69 2740 2746 B-chronic_disease
infection 70 79 2747 2756 I-chronic_disease
, 79 80 2756 2757 O
symptomatic 81 92 2758 2769 O
congestive 93 103 2770 2780 B-chronic_disease
heart 104 109 2781 2786 I-chronic_disease
failure 110 117 2787 2794 I-chronic_disease
, 117 118 2794 2795 O
unstable 119 127 2796 2804 B-chronic_disease
angina 128 134 2805 2811 I-chronic_disease
pectoris 135 143 2812 2820 I-chronic_disease
, 143 144 2820 2821 O
cardiac 145 152 2822 2829 B-chronic_disease
arrhythmia 153 163 2830 2840 I-chronic_disease
, 163 164 2840 2841 O
or 165 167 2842 2844 O
psychiatric 168 179 2845 2856 B-chronic_disease
illness 180 187 2857 2864 I-chronic_disease
/ 187 188 2864 2865 I-chronic_disease
social 188 194 2865 2871 I-chronic_disease
situations 195 205 2872 2882 I-chronic_disease
that 206 210 2883 2887 O
would 211 216 2888 2893 O
limit 217 222 2894 2899 O
compliance 223 233 2900 2910 O
with 234 238 2911 2915 O
study 239 244 2916 2921 O
requirements 245 257 2922 2934 O

at 0 2 2935 2937 O
least 3 8 2938 2943 O
28 9 11 2944 2946 B-lower_bound
days 12 16 2947 2951 I-lower_bound
before 17 23 2952 2958 O
she 24 27 2959 2962 O
starts 28 34 2963 2969 O
taking 35 41 2970 2976 O
lenalidomide 42 54 2977 2989 B-treatment

involved 0 8 2990 2998 O
free 9 13 2999 3003 B-clinical_variable
light 14 19 3004 3009 I-clinical_variable
chain 20 25 3010 3015 I-clinical_variable
> 26 27 3016 3017 O
= 28 29 3018 3019 O
10mg 30 34 3020 3024 B-lower_bound
/ 34 35 3024 3025 I-lower_bound
dL 35 37 3025 3027 I-lower_bound
provided 38 46 3028 3036 O
serum 47 52 3037 3042 B-clinical_variable
free 53 57 3043 3047 I-clinical_variable
light 58 63 3048 3053 I-clinical_variable
chain 64 69 3054 3059 I-clinical_variable
ratio 70 75 3060 3065 O
is 76 78 3066 3068 O
abnormal 79 87 3069 3077 O

must 0 4 3078 3082 O
either 5 11 3083 3089 O
commit 12 18 3090 3096 B-contraception_consent
to 19 21 3097 3099 I-contraception_consent
continued 22 31 3100 3109 I-contraception_consent
abstinence 32 42 3110 3120 I-contraception_consent
from 43 47 3121 3125 I-contraception_consent
heterosexual 48 60 3126 3138 I-contraception_consent
intercourse 61 72 3139 3150 I-contraception_consent
or 73 75 3151 3153 O
begin 76 81 3154 3159 B-contraception_consent
TWO 82 85 3160 3163 I-contraception_consent
acceptable 86 96 3164 3174 I-contraception_consent
methods 97 104 3175 3182 I-contraception_consent
of 105 107 3183 3185 I-contraception_consent
birth 108 113 3186 3191 I-contraception_consent
control 114 121 3192 3199 I-contraception_consent
, 121 122 3199 3200 O
one 123 126 3201 3204 O
highly 127 133 3205 3211 O
effective 134 143 3212 3221 O
method 144 150 3222 3228 O
and 151 154 3229 3232 O
one 155 158 3233 3236 O
additional 159 169 3237 3247 O
effective 170 179 3248 3257 O
method 180 186 3258 3264 O
AT 187 189 3265 3267 O
THE 190 193 3268 3271 O
SAME 194 198 3272 3276 O
TIME 199 203 3277 3281 O

platelets 0 9 3282 3291 B-clinical_variable
> 10 11 3292 3293 O
= 12 13 3294 3295 O
50,000 14 20 3296 3302 B-lower_bound
/ 20 21 3302 3303 I-lower_bound
uL 21 23 3303 3305 I-lower_bound

serum 0 5 3306 3311 B-clinical_variable
M 6 7 3312 3313 I-clinical_variable
- 7 8 3313 3314 I-clinical_variable
protein 8 15 3314 3321 I-clinical_variable
of 16 18 3322 3324 O
> 19 20 3325 3326 O
= 21 22 3327 3328 O
500mg 23 28 3329 3334 B-lower_bound
/ 28 29 3334 3335 I-lower_bound
dL 29 31 3335 3337 I-lower_bound

total 0 5 3338 3343 B-clinical_variable
bilirubin 6 15 3344 3353 I-clinical_variable
< 16 17 3354 3355 O
= 18 19 3356 3357 O
1.5 20 23 3358 3361 B-upper_bound
X 24 25 3362 3363 I-upper_bound
upper 26 31 3364 3369 I-upper_bound
limit 32 37 3370 3375 I-upper_bound
of 38 40 3376 3378 I-upper_bound
normal 41 47 3379 3385 I-upper_bound

urine 0 5 3386 3391 B-clinical_variable
M 6 7 3392 3393 I-clinical_variable
- 7 8 3393 3394 I-clinical_variable
protein 8 15 3394 3401 I-clinical_variable
of 16 18 3402 3404 O
> 19 20 3405 3406 O
= 21 22 3407 3408 O
200mg/ 23 29 3409 3415 B-lower_bound
24 30 32 3416 3418 I-lower_bound
hours 33 38 3419 3424 I-lower_bound

1 0 1 0 1 B-lower_bound
year-50 2 9 2 9 I-lower_bound
years 10 15 10 15 I-upper_bound

> 0 1 16 17 O
6 2 3 18 19 B-lower_bound
months 4 10 20 26 I-lower_bound
must 11 15 27 31 O
have 16 20 32 36 O
elapsed 21 28 37 44 O
from 29 33 45 49 O
start 34 39 50 55 O
of 40 42 56 58 O
last 43 47 59 63 B-treatment
BMT 48 51 64 67 I-treatment

ALT 0 3 68 71 B-clinical_variable
, 3 4 71 72 O
AST 5 8 73 76 B-clinical_variable
, 8 9 76 77 O
and 10 13 78 81 O
Alkaline 14 22 82 90 B-clinical_variable
Phosphatase 23 34 91 102 I-clinical_variable
< 35 36 103 104 O
5 37 38 105 106 B-upper_bound
x 39 40 107 108 I-upper_bound
ULN 41 44 109 112 I-upper_bound

Age 0 3 113 116 B-age
> 4 5 117 118 O
0.5 5 8 118 121 B-lower_bound
years 9 14 122 127 I-lower_bound

Any 0 3 128 131 O
other 4 9 132 137 O
solid 10 15 138 143 B-cancer
tumor 16 21 144 149 I-cancer
and 22 25 150 153 O
soft 26 30 154 158 B-cancer
tissue 31 37 159 165 I-cancer
sarcoma 38 45 166 173 I-cancer
with 46 50 174 178 O
an 51 53 179 181 O
estimated 54 63 182 191 O
< 64 65 192 193 O
10 65 67 193 195 B-upper_bound
% 67 68 195 196 I-upper_bound
chance 69 75 197 203 O
of 76 78 204 206 O
survival 79 87 207 215 O
will 88 92 216 220 O
be 93 95 221 223 O
considered 96 106 224 234 O
on 107 109 235 237 O
a 110 111 238 239 O
case 112 116 240 244 O
by 117 119 245 247 O
case 120 124 248 252 O
basis 125 130 253 258 O
at 131 133 259 261 O
the 134 137 262 265 O
departmental 138 150 266 278 O
tumor 151 156 279 284 O
board 157 162 285 290 O
and/or 163 169 291 297 O
sarcoma 170 177 298 305 O
meeting 178 185 306 313 O

Bilirubin 0 9 314 323 B-clinical_variable
≤ 10 11 324 325 O
3.0 12 15 326 329 B-upper_bound
mg 16 18 330 332 I-upper_bound
/ 18 19 332 333 I-upper_bound
dL 19 21 333 335 I-upper_bound

Cardiac 0 7 336 343 B-chronic_disease

Desmoplastic 0 12 344 356 B-cancer
small 13 18 357 362 I-cancer
round 19 24 363 368 I-cancer
cell 25 29 369 373 I-cancer
tumor 30 35 374 379 I-cancer

FEV1 0 4 380 384 B-clinical_variable
, 4 5 384 385 O
FVC 6 9 386 389 B-clinical_variable
, 9 10 389 390 O
DLCO 11 15 391 395 B-clinical_variable
( 16 17 396 397 O
diffusion 17 26 397 406 B-clinical_variable
capacity 27 35 407 415 I-clinical_variable
) 35 36 415 416 O
> 37 38 417 418 O
50 39 41 419 421 B-lower_bound
% 41 42 421 422 I-lower_bound
predicted 43 52 423 432 O
( 53 54 433 434 O
corrected 54 63 434 443 O
for 64 67 444 447 O
hemoglobin 68 78 448 458 B-clinical_variable
) 78 79 458 459 O

Failure 0 7 460 467 O
to 8 10 468 470 O
achieve 11 18 471 478 O
at 19 21 479 481 O
least 22 27 482 487 O
a 28 29 488 489 O
PR 30 32 490 492 O
after 33 38 493 498 O
induction 39 48 499 508 B-treatment
therapy 49 56 509 516 I-treatment
with 57 61 517 521 I-treatment
COG 62 65 522 525 I-treatment
ANBL0532 66 74 526 534 I-treatment
or 75 77 535 537 O
standard 78 86 538 546 B-treatment
chemotherapy 87 99 547 559 I-treatment

For 0 3 560 563 O
CMV 4 7 564 567 B-chronic_disease
seronegative 8 20 568 580 O
recipients 21 31 581 591 O
, 31 32 591 592 O
a 33 34 593 594 O
CMV 35 38 595 598 O
seronegative 39 51 599 611 O
donor 52 57 612 617 O

Good 0 4 618 622 O
performance 5 16 623 634 O
status 17 23 635 641 O
( 24 25 642 643 O
Karnofsky 25 34 643 652 B-clinical_variable
/ 34 35 652 653 O
Lansky 35 41 653 659 B-clinical_variable
60 42 44 660 662 B-lower_bound
- 44 45 662 663 O
100 45 48 663 666 B-upper_bound
) 48 49 666 667 O

HIV 0 3 668 671 B-chronic_disease
- 3 4 671 672 O
positive 4 12 672 680 O

HLA 0 3 681 684 B-treatment
- 3 4 684 685 O
mismatched 4 14 685 695 O
donors 15 21 696 702 O
will 22 26 703 707 O
be 27 29 708 710 O
prioritized 30 41 711 722 O
over 42 46 723 727 O
HLA 47 50 728 731 O
- 50 51 731 732 O
matched 51 58 732 739 O
to 59 61 740 742 O
maximize 62 70 743 751 O
an 71 73 752 754 O
allogeneic 74 84 755 765 O
benefit 85 92 766 773 O

Hepatic 0 7 774 781 B-chronic_disease

It 0 2 782 784 O
is 3 5 785 787 O
expected 6 14 788 796 O
that 15 19 797 801 O
patients 20 28 802 810 O
will 29 33 811 815 O
have 34 38 816 820 O
received 39 47 821 829 O
upfront 48 55 830 837 O
standard 56 64 838 846 O
of 65 67 847 849 O
care 68 72 850 854 O
therapy 73 80 855 862 B-treatment
for 81 84 863 866 O
their 85 90 867 872 O
respected 91 100 873 882 O
disease 101 108 883 890 O

Left 0 4 891 895 B-clinical_variable
ventricular 5 16 896 907 I-clinical_variable
ejection 17 25 908 916 I-clinical_variable
fraction 26 34 917 925 I-clinical_variable
at 35 37 926 928 O
rest 38 42 929 933 O
must 43 47 934 938 O
be 48 50 939 941 O
≥ 51 52 942 943 O
35 53 55 944 946 B-lower_bound
% 55 56 946 947 I-lower_bound

Major 0 5 948 953 O
ABO 6 9 954 957 B-chronic_disease
incompatibility 10 25 958 973 I-chronic_disease

Metastatic 0 10 974 984 B-cancer
Ewing 11 16 985 990 I-cancer
Sarcoma 17 24 991 998 I-cancer

Minor 0 5 999 1004 O
ABO 6 9 1005 1008 B-chronic_disease
incompatibility 10 25 1009 1024 I-chronic_disease

Neuroblastoma 0 13 1025 1038 B-cancer

Osteosarcoma 0 12 1039 1051 B-cancer
with 13 17 1052 1056 O
metastatic 18 28 1057 1067 O
disease 29 36 1068 1075 O
beyond 37 43 1076 1082 O
the 44 47 1083 1086 O
lungs 48 53 1087 1092 O

Patients 0 8 1093 1101 O
( 9 10 1102 1103 O
Parents 10 17 1103 1110 O
/ 17 18 1110 1111 O
guardians 18 27 1111 1120 O
for 28 31 1121 1124 O
those 32 37 1125 1130 O
< 38 39 1131 1132 O
18 39 41 1132 1134 B-upper_bound
) 41 42 1134 1135 O
and 43 46 1136 1139 O
donors 47 53 1140 1146 O
must 54 58 1147 1151 O
be 59 61 1152 1154 O
able 62 66 1155 1159 O
to 67 69 1160 1162 O
sign 70 74 1163 1167 O
consent 75 82 1168 1175 O
forms 83 88 1176 1181 O

Patients 0 8 1182 1190 O
must 9 13 1191 1195 O
be 14 16 1196 1198 O
recovered 17 26 1199 1208 O
from 27 31 1209 1213 O
the 32 35 1214 1217 O
acute 36 41 1218 1223 O
toxicities 42 52 1224 1234 O
of 53 55 1235 1237 O
any 56 59 1238 1241 O
prior 60 65 1242 1247 B-treatment
chemo 66 71 1248 1253 I-treatment
/ 71 72 1253 1254 O
radio 72 77 1254 1259 B-treatment
/ 77 78 1259 1260 O
immunotherapy 78 91 1260 1273 B-treatment
or 92 94 1274 1276 O
BMT 95 98 1277 1280 B-treatment

Patients 0 8 1281 1289 O
must 9 13 1290 1294 O
be 14 16 1295 1297 O
willing 17 24 1298 1305 O
to 25 27 1306 1308 O
participate 28 39 1309 1320 O
in 40 42 1321 1323 O
all 43 46 1324 1327 O
stages 47 53 1328 1334 O
of 54 56 1335 1337 O
treatment 57 66 1338 1347 B-treatment

Patients 0 8 1348 1356 O
who 9 12 1357 1360 O
relapse 13 20 1361 1368 O
after 21 26 1369 1374 O
either 27 33 1375 1381 O
single 34 40 1382 1388 O
or 41 43 1389 1391 O
tandem 44 50 1392 1398 O
autologous 51 61 1399 1409 B-treatment
BMT 62 65 1410 1413 I-treatment
are 66 69 1414 1417 O
eligible 70 78 1418 1426 O

Patients 0 8 1427 1435 O
with 9 13 1436 1440 O
> 14 15 1441 1442 O
5 15 16 1442 1443 B-lower_bound
identified 17 27 1444 1454 O
lesions 28 35 1455 1462 B-clinical_variable
on 36 38 1463 1465 O
the 39 42 1466 1469 O
end 43 46 1470 1473 O
of 47 49 1474 1476 O
induction 50 59 1477 1486 B-treatment
( 60 61 1487 1488 O
COG 61 64 1488 1491 B-treatment
ANBL0532 65 73 1492 1500 I-treatment
or 74 76 1501 1503 O
standard 77 85 1504 1512 B-treatment
chemotherapy 86 98 1513 1525 I-treatment
) 98 99 1525 1526 O
MIBG 100 104 1527 1531 B-treatment
scan 105 109 1532 1536 I-treatment

Patients 0 8 1537 1545 O
with 9 13 1546 1550 O
high 14 18 1551 1555 O
risk 19 23 1556 1560 O
disease 24 31 1561 1568 O
as 32 34 1569 1571 O
defined 35 42 1572 1579 O
in 43 45 1580 1582 O
Appendix 46 54 1583 1591 O
1 55 56 1592 1593 O
who 57 60 1594 1597 O
do 61 63 1598 1600 O
not 64 67 1601 1604 O
meet 68 72 1605 1609 O
eligibility 73 84 1610 1621 O
requirements 85 97 1622 1634 O
/ 97 98 1634 1635 O
organ 98 103 1635 1640 O
function 104 112 1641 1649 O
requirements 113 125 1650 1662 O
for 126 129 1663 1666 O
myeloablative 130 143 1667 1680 B-chronic_disease
conditioning 144 156 1681 1693 O

Patients 0 8 1694 1702 O
with 9 13 1703 1707 O
high 14 18 1708 1712 O
risk 19 23 1713 1717 O
disease 24 31 1718 1725 O
as 32 34 1726 1728 O
defined 35 42 1729 1736 O
in 43 45 1737 1739 O
Appendix 46 54 1740 1748 O
1 55 56 1749 1750 O
whose 57 62 1751 1756 O
autologous 63 73 1757 1767 O
peripheral 74 84 1768 1778 O
blood 85 90 1779 1784 O
stem 91 95 1785 1789 O
cell 96 100 1790 1794 O
product 101 108 1795 1802 O
is 109 111 1803 1805 O
contaminated 112 124 1806 1818 O
with 125 129 1819 1823 O
neuroblastoma 130 143 1824 1837 B-cancer
or 144 146 1838 1840 O
who 147 150 1841 1844 O
do 151 153 1845 1847 O
not 154 157 1848 1851 O
have 158 162 1852 1856 O
an 163 165 1857 1859 O
autologous 166 176 1860 1870 O
product 177 184 1871 1878 O
available 185 194 1879 1888 O

Patients 0 8 1889 1897 O
with 9 13 1898 1902 O
measurable 14 24 1903 1913 O
disease 25 32 1914 1921 O
must 33 37 1922 1926 O
have 38 42 1927 1931 O
stable 43 49 1932 1938 O
disease 50 57 1939 1946 O
by 58 60 1947 1949 O
RECIST 61 67 1950 1956 O
criteria 68 76 1957 1965 O
on 77 79 1966 1968 O
two 80 83 1969 1972 O
scans 84 89 1973 1978 O
at 90 92 1979 1981 O
least 93 98 1982 1987 O
6 99 100 1988 1989 B-lower_bound
weeks 101 106 1990 1995 I-lower_bound
apart 107 112 1996 2001 O

Positive 0 8 2002 2010 O
leukocytotoxic 9 23 2011 2025 B-treatment
crossmatch 24 34 2026 2036 I-treatment

Refractory 0 10 2037 2047 O
to 11 13 2048 2050 O
induction 14 23 2051 2060 B-treatment
chemotherapy 24 36 2061 2073 I-treatment
with 37 41 2074 2078 O
COG 42 45 2079 2082 B-treatment
ANBL0532 46 54 2083 2091 I-treatment
or 55 57 2092 2094 O
standard 58 66 2095 2103 B-treatment
chemotherapy 67 79 2104 2116 I-treatment

Serum 0 5 2117 2122 B-clinical_variable
creatinine 6 16 2123 2133 I-clinical_variable
within 17 23 2134 2140 O
normal 24 30 2141 2147 O
range 31 36 2148 2153 O
for 37 40 2154 2157 O
age 41 44 2158 2161 B-age

Stage 0 5 2162 2167 B-cancer
4 6 7 2168 2169 I-cancer
rhabdomyosarcoma 8 24 2170 2186 I-cancer

The 0 3 2187 2190 O
donor 4 9 2191 2196 O
and 10 13 2197 2200 O
recipient 14 23 2201 2210 O
must 24 28 2211 2215 O
be 29 31 2216 2218 O
identical 32 41 2219 2228 O
at 42 44 2229 2231 O
at 45 47 2232 2234 O
least 48 53 2235 2240 O
one 54 57 2241 2244 B-lower_bound
allele 58 64 2245 2251 O
of 65 67 2252 2254 O
each 68 72 2255 2259 O
of 73 75 2260 2262 O
the 76 79 2263 2266 O
following 80 89 2267 2276 O
genetic 90 97 2277 2284 O
loci 98 102 2285 2289 O
: 102 103 2289 2290 O
HLA 104 107 2291 2294 O
- 107 108 2294 2295 O
A 108 109 2295 2296 O
, 109 110 2296 2297 O
HLA 111 114 2298 2301 O
- 114 115 2301 2302 O
B 115 116 2302 2303 O
, 116 117 2303 2304 O
HLA 118 121 2305 2308 O
- 121 122 2308 2309 O
Cw 122 124 2309 2311 O
, 124 125 2311 2312 O
HLA 126 129 2313 2316 O
- 129 130 2316 2317 O
DRB1 130 134 2317 2321 O
, 134 135 2321 2322 O
and 136 139 2323 2326 O
HLA 140 143 2327 2330 O
- 143 144 2330 2331 O
DQB1 144 148 2331 2335 O

Uncontrolled 0 12 2336 2348 O
viral 13 18 2349 2354 B-chronic_disease
, 18 19 2354 2355 O
bacterial 20 29 2356 2365 B-chronic_disease
, 29 30 2365 2366 O
or 31 33 2367 2369 O
fungal 34 40 2370 2376 B-chronic_disease
infections 41 51 2377 2387 I-chronic_disease

Women 0 5 2388 2393 B-gender
of 6 8 2394 2396 O
childbearing 9 21 2397 2409 O
potential 22 31 2410 2419 O
who 32 35 2420 2423 O
currently 36 45 2424 2433 O
are 46 49 2434 2437 B-pregnancy
pregnant 50 58 2438 2446 I-pregnancy
( 59 60 2447 2448 O
HCG+ 60 64 2448 2452 B-clinical_variable
) 64 65 2452 2453 O

be 0 2 2454 2456 O
classified 3 13 2457 2467 O
as 14 16 2468 2470 O
high 17 21 2471 2475 O
risk 22 26 2476 2480 O
defined 27 34 2481 2488 O
by 35 37 2489 2491 O
having 38 44 2492 2498 O
an 45 47 2499 2501 O
expected 48 56 2502 2510 B-clinical_variable
survival 57 65 2511 2519 I-clinical_variable
of 66 68 2520 2522 O
< 69 70 2523 2524 O
10 71 73 2525 2527 B-upper_bound
% 73 74 2527 2528 I-upper_bound

ganglioneuroblastoma 0 20 2529 2549 B-cancer

shortening 0 10 2550 2560 B-clinical_variable
fraction 11 19 2561 2569 I-clinical_variable
> 20 21 2570 2571 O
25 22 24 2572 2574 B-lower_bound
% 24 25 2574 2575 I-lower_bound

who 0 3 2576 2579 O
are 4 7 2580 2583 O
not 8 11 2584 2587 O
practicing 12 22 2588 2598 B-contraception_consent
adequate 23 31 2599 2607 I-contraception_consent
contraception 32 45 2608 2621 I-contraception_consent

with 0 4 2622 2626 O
lung 5 9 2627 2631 B-cancer
metastases 10 20 2632 2642 I-cancer
not 21 24 2643 2646 O
amenable 25 33 2647 2655 O
to 34 36 2656 2658 O
resection 37 46 2659 2668 B-treatment

Adequate 0 8 0 8 O
renal 9 14 9 14 O
function 15 23 15 23 O
as 24 26 24 26 O
defined 27 34 27 34 O
by 35 37 35 37 O
creatinine 38 48 38 48 B-clinical_variable
≤ 49 50 49 50 O
1.5 51 54 51 54 B-upper_bound
mg 55 57 55 57 I-upper_bound
/dl 58 61 58 61 I-upper_bound

Eastern 0 7 62 69 B-clinical_variable
Cooperative 8 19 70 81 I-clinical_variable
Oncology 20 28 82 90 I-clinical_variable
Group 29 34 91 96 I-clinical_variable
( 35 36 97 98 I-clinical_variable
ECOG 36 40 98 102 I-clinical_variable
) 40 41 102 103 I-clinical_variable
performance 42 53 104 115 I-clinical_variable
status 54 60 116 122 I-clinical_variable
of 61 63 123 125 O
0 64 65 126 127 B-lower_bound
or 66 68 128 130 O
1 69 70 131 132 B-upper_bound

Expected 0 8 133 141 B-clinical_variable
survival 9 17 142 150 I-clinical_variable
≥ 18 19 151 152 O
8 20 21 153 154 B-lower_bound
months 22 28 155 161 I-lower_bound

Gleason 0 7 162 169 B-clinical_variable
score 8 13 170 175 I-clinical_variable
≥ 14 15 176 177 O
8 16 17 178 179 B-lower_bound
at 18 20 180 182 O
initial 21 28 183 190 O
diagnosis 29 38 191 200 O

Males 0 5 201 206 B-gender

Mental 0 6 207 213 B-chronic_disease
incapacity 7 17 214 224 I-chronic_disease
or 18 20 225 227 O
psychiatric 21 32 228 239 B-chronic_disease
illness 33 40 240 247 I-chronic_disease
that 41 45 248 252 O
would 46 51 253 258 O
interfere 52 61 259 268 O
with 62 66 269 273 O
the 67 70 274 277 O
subject 71 78 278 285 O
's 78 80 285 287 O
ability 81 88 288 295 O
to 89 91 296 298 O
understand 92 102 299 309 O
and 103 106 310 313 O
give 107 111 314 318 O
informed 112 120 319 327 O
consent 121 128 328 335 O
or 129 131 336 338 O
to 132 134 339 341 O
complete 135 143 342 350 O
follow 144 150 351 357 O
- 150 151 357 358 O
up 151 153 358 360 O
visits 154 160 361 367 O

On 0 2 368 370 O
- 2 3 370 371 O
going 3 8 371 376 O
therapy 9 16 377 384 B-treatment
with 17 21 385 389 O
a 22 23 390 391 O
photosensitizing 24 40 392 408 B-treatment
agent 41 46 409 414 I-treatment

Porphyria 0 9 415 424 B-chronic_disease
or 10 12 425 427 O
other 13 18 428 433 O
diseases 19 27 434 442 O
exacerbated 28 39 443 454 O
by 40 42 455 457 O
light 43 48 458 463 O

Sufficient 0 10 464 474 O
bone 11 15 475 479 O
marrow 16 22 480 486 O
reserve 23 30 487 494 O
as 31 33 495 497 O
indicated 34 43 498 507 O
by 44 46 508 510 O
; 46 47 510 511 O
granulocyte 48 59 512 523 B-clinical_variable
count 60 65 524 529 I-clinical_variable
≥ 66 67 530 531 O
1500 68 72 532 536 B-lower_bound
/ 72 73 536 537 I-lower_bound
mm3 73 76 537 540 I-lower_bound
, 76 77 540 541 O
platelet 78 86 542 550 B-clinical_variable
count 87 92 551 556 I-clinical_variable
≥ 93 94 557 558 O
100,000 95 102 559 566 B-lower_bound
/ 102 103 566 567 I-lower_bound
mm3 103 106 567 570 I-lower_bound

gone 0 4 571 575 O
through 5 12 576 583 O
external 13 21 584 592 O
or 22 24 593 595 O
internal 25 33 596 604 O
, 33 34 604 605 O
high 35 39 606 610 O
dose 40 44 611 615 O
rate 45 49 616 620 O
( 50 51 621 622 O
brachy 51 57 622 628 O
) 57 58 628 629 O
radiation 59 68 630 639 B-treatment
therapy 69 76 640 647 I-treatment
for 77 80 648 651 O
localized 81 90 652 661 O
prostate 91 99 662 670 B-cancer
cancer 100 106 671 677 I-cancer
with 107 111 678 682 O
histopathologically 112 131 683 702 O
verified 132 140 703 711 O
local 141 146 712 717 O
recurrence 147 157 718 728 O

history 0 7 729 736 O
of 8 10 737 739 O
CTCAE 11 16 740 745 B-clinical_variable
v4 17 19 746 748 I-clinical_variable
grade 20 25 749 754 B-lower_bound
3 26 27 755 756 I-lower_bound
or 28 30 757 759 O
greater 31 38 760 767 O
or 39 41 768 770 O
persistent 42 52 771 781 O
( 53 54 782 783 O
> 54 55 783 784 O
1 55 56 784 785 B-lower_bound
separate 57 65 786 794 O
episode 66 73 795 802 O
or 74 76 803 805 O
symptoms 77 85 806 814 O
lasting 86 93 815 822 O
more 94 98 823 827 O
than 99 103 828 832 O
3 104 105 833 834 B-lower_bound
months 106 112 835 841 I-lower_bound
after 113 118 842 847 O
initiation 119 129 848 858 O
of 130 132 859 861 O
medical 133 140 862 869 B-treatment
intervention 141 153 870 882 I-treatment
) 153 154 882 883 O
grade 155 160 884 889 B-chronic_disease
2 161 162 890 891 I-chronic_disease
proctitis 163 172 892 901 I-chronic_disease
attributed 173 183 902 912 O
to 184 186 913 915 O
radiation 187 196 916 925 B-treatment

locally 0 7 926 933 O
advanced 8 16 934 942 O
( 17 18 943 944 O
AJCC 18 22 944 948 B-cancer
7th 23 26 949 952 I-cancer
edition 27 34 953 960 I-cancer
T3 35 37 961 963 I-cancer
/ 37 38 963 964 I-cancer
T4 38 40 964 966 I-cancer
) 40 41 966 967 O
or 42 44 968 970 O
metastatic 45 55 971 981 B-cancer
disease 56 63 982 989 I-cancer

not 0 3 990 993 O
eligible 4 12 994 1002 O
for 13 16 1003 1006 O
surgery 17 24 1007 1014 B-treatment
or 25 27 1015 1017 O
curative 28 36 1018 1026 B-treatment
radiotherapy 37 49 1027 1039 I-treatment

other 0 5 1040 1045 O
severe 6 12 1046 1052 B-chronic_disease
concurrent 13 23 1053 1063 I-chronic_disease
disease 24 31 1064 1071 I-chronic_disease

total 0 5 1072 1077 O
bilirubin 6 15 1078 1087 B-clinical_variable
≤ 16 17 1088 1089 O
1.5 18 21 1090 1093 B-upper_bound
mg 22 24 1094 1096 I-upper_bound
/ 24 25 1096 1097 I-upper_bound
dl 25 27 1097 1099 I-upper_bound

treated 0 7 1100 1107 O
with 8 12 1108 1112 O
seed 13 17 1113 1117 B-treatment
implantation 18 30 1118 1130 I-treatment
brachytherapy 31 44 1131 1144 B-treatment

be 0 2 0 2 O
18 3 5 3 5 B-lower_bound
years 6 11 6 11 I-lower_bound
or 12 14 12 14 O
older 15 20 15 20 O

currently 0 9 21 30 O
be 10 12 31 33 O
receiving 13 22 34 43 O
daily 23 28 44 49 O
treatment 29 38 50 59 B-treatment
with 39 43 60 64 O
a 44 45 65 66 O
prescription 46 58 67 79 O
opioid 59 65 80 86 B-treatment
for 66 69 87 90 O
chronic 70 77 91 98 O
pain 78 82 99 103 O

have 0 4 104 108 B-technology_access
a 5 6 109 110 I-technology_access
cell 7 11 111 115 I-technology_access
phone 12 17 116 121 I-technology_access
capable 18 25 122 129 I-technology_access
of 26 28 130 132 I-technology_access
receiving 29 38 133 142 I-technology_access
text 39 43 143 147 I-technology_access
messages 44 52 148 156 I-technology_access

have 0 4 157 161 O
a 5 6 162 163 O
current 7 14 164 171 O
psychotic 15 24 172 181 B-chronic_disease
disorder 25 33 182 190 I-chronic_disease
severe 34 40 191 197 O
enough 41 47 198 204 O
to 48 50 205 207 O
require 51 58 208 215 O
inpatient 59 68 216 225 O
treatment 69 78 226 235 O

willing 0 7 236 243 O
to 8 10 244 246 O
be 11 13 247 249 O
in 14 16 250 252 O
a 17 18 253 254 O
study 19 24 255 260 O
where 25 30 261 266 O
they 31 35 267 271 O
might 36 41 272 277 O
receive 42 49 278 285 O
text 50 54 286 290 B-technology_access
messages 55 63 291 299 I-technology_access

Admitted 0 8 0 8 O
to 9 11 9 11 O
an 12 14 12 14 O
ICU 15 18 15 18 O
in 19 21 19 21 O
the 22 25 22 25 O
University 26 36 26 36 O
of 37 39 37 39 O
Michigan 40 48 40 48 O
with 49 53 49 53 O
Acute 54 59 54 59 B-chronic_disease
Brain 60 65 60 65 I-chronic_disease
Injury 66 72 66 72 I-chronic_disease

Pre 0 3 73 76 B-chronic_disease
- 3 4 76 77 I-chronic_disease
existing 4 12 77 85 I-chronic_disease
ocular 13 19 86 92 I-chronic_disease
pathology 20 29 93 102 I-chronic_disease
other 30 35 103 108 O
than 36 40 109 113 O
refractive 41 51 114 124 B-chronic_disease
error 52 57 125 130 I-chronic_disease

18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
65 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

Advanced 0 8 22 30 O
hematologic 9 20 31 42 B-chronic_disease
, 20 21 42 43 O
renal 22 27 44 49 B-chronic_disease
, 27 28 49 50 O
hepatic 29 36 51 58 B-chronic_disease
, 36 37 58 59 O
non 38 41 60 63 B-chronic_disease
- 41 42 63 64 I-chronic_disease
LAM 42 45 64 67 I-chronic_disease
lung 46 50 68 72 I-chronic_disease
disease 51 58 73 80 I-chronic_disease
or 59 61 81 83 O
metabolic 62 71 84 93 B-chronic_disease
diseases 72 80 94 102 I-chronic_disease
; 80 81 102 103 O
or 82 84 104 106 O
BMI 85 88 107 110 B-bmi
of 89 91 111 113 O
> 92 93 114 115 O
35 93 95 115 117 B-lower_bound

All 0 3 118 121 O
patients 4 12 122 130 O
must 13 17 131 135 O
have 18 22 136 140 O
a 23 24 141 142 O
diagnosis 25 34 143 152 O
of 35 37 153 155 O
LAM 38 41 156 159 B-chronic_disease
as 42 44 160 162 O
defined 45 52 163 170 O
by 53 55 171 173 O
compatible 56 66 174 184 O
cystic 67 73 185 191 O
changes 74 81 192 199 O
on 82 84 200 202 O
chest 85 90 203 208 B-treatment
computed 91 99 209 217 I-treatment
tomography 100 110 218 228 I-treatment
( 111 112 229 230 I-treatment
CT 112 114 230 232 I-treatment
) 114 115 232 233 I-treatment

Clinical 0 8 234 242 O
findings 9 17 243 251 O
of 18 20 252 254 O
tuberous 21 29 255 263 B-cancer
scleroma 30 38 264 272 I-cancer
complex 39 46 273 280 I-cancer
( 47 48 281 282 I-cancer
TSC 48 51 282 285 I-cancer
) 51 52 285 286 I-cancer
, 52 53 286 287 O
renal 54 59 288 293 B-cancer
angiomyolipoma 60 74 294 308 I-cancer
, 74 75 308 309 O
cystic 76 82 310 316 B-chronic_disease
abdominal 83 92 317 326 I-chronic_disease
lymphangiomas 93 106 327 340 I-chronic_disease
, 106 107 340 341 O
or 108 110 342 344 O
history 111 118 345 352 O
of 119 121 353 355 O
chylous 122 129 356 363 B-chronic_disease
effusion 130 138 364 372 I-chronic_disease
in 139 141 373 375 I-chronic_disease
the 142 145 376 379 I-chronic_disease
chest 146 151 380 385 I-chronic_disease
or 152 154 386 388 O
abdome 155 161 389 395 O

Current 0 7 396 403 O
infection 8 17 404 413 B-chronic_disease

Current 0 7 414 421 B-pregnancy
or 8 10 422 424 I-pregnancy
planned 11 18 425 432 I-pregnancy
pregnancy 19 28 433 442 I-pregnancy

Female 0 6 443 449 B-gender
patients 7 15 450 458 O

Major 0 5 459 464 B-treatment
surgery 6 13 465 472 I-treatment
within 14 20 473 479 O
the 21 24 480 483 O
past 25 29 484 488 B-upper_bound
2 30 31 489 490 I-upper_bound
months 32 38 491 497 I-upper_bound

Not 0 3 498 501 O
using 4 9 502 507 O
adequate 10 18 508 516 O
contraception 19 32 517 530 O
( 33 34 531 532 O
in 34 36 532 534 O
woman 37 42 535 540 B-gender
of 43 45 541 543 O
childbearing 46 58 544 556 O
potential 59 68 557 566 O
) 68 69 566 567 O

Open 0 4 568 572 B-treatment
or 5 7 573 575 I-treatment
needle 8 14 576 582 I-treatment
abdominal 15 24 583 592 I-treatment
biopsy 25 31 593 599 I-treatment
findings 32 40 600 608 O
consistent 41 51 609 619 O
with 52 56 620 624 O
LAM 57 60 625 628 B-chronic_disease

Previous 0 8 629 637 O
lung 9 13 638 642 B-treatment
transplantation 14 29 643 658 I-treatment

Significant 0 11 659 670 O
clinical 12 20 671 679 O
change 21 27 680 686 O
in 28 30 687 689 O
health 31 37 690 696 O
in 38 40 697 699 O
the 41 44 700 703 O
past 45 49 704 708 B-upper_bound
30 50 52 709 711 I-upper_bound
days 53 57 712 716 I-upper_bound

Subjects 0 8 717 725 O
must 9 13 726 730 O
have 14 18 731 735 O
had 19 22 736 739 O
a 23 24 740 741 O
recent 25 31 742 748 O
reduction 32 41 749 758 O
in 42 44 759 761 O
forced 45 51 762 768 B-clinical_variable
expiratory 52 62 769 779 I-clinical_variable
volume 63 69 780 786 I-clinical_variable
at 70 72 787 789 I-clinical_variable
1 73 74 790 791 I-clinical_variable
- 74 75 791 792 I-clinical_variable
second 75 81 792 798 I-clinical_variable
( 82 83 799 800 I-clinical_variable
FEV1 83 87 800 804 I-clinical_variable
) 87 88 804 805 I-clinical_variable
of 89 91 806 808 O
> 92 93 809 810 O
50ml 94 98 811 815 B-lower_bound
/ 98 99 815 816 I-lower_bound
year 99 103 816 820 I-lower_bound
, 103 104 820 821 O
as 105 107 822 824 O
shown 108 113 825 830 O
by 114 116 831 833 O
at 117 119 834 836 O
least 120 125 837 842 O
two 126 129 843 846 B-lower_bound
pulmonary 130 139 847 856 B-clinical_variable
function 140 148 857 865 I-clinical_variable
testing 149 156 866 873 I-clinical_variable
( 157 158 874 875 I-clinical_variable
PFT 158 161 875 878 I-clinical_variable
) 161 162 878 879 I-clinical_variable
measured 163 171 880 888 O
at 172 174 889 891 O
least 175 180 892 897 O
6 181 182 898 899 B-lower_bound
months 183 189 900 906 I-lower_bound
apart 190 195 907 912 O
in 196 198 913 915 O
the 199 202 916 919 O
last 203 207 920 924 O
24 208 210 925 927 B-upper_bound
months 211 217 928 934 I-upper_bound
prior 218 223 935 940 I-upper_bound
to 224 226 941 943 O
enrolling 227 236 944 953 O
study 237 242 954 959 O

The 0 3 960 963 O
use 4 7 964 967 O
of 8 10 968 970 O
another 11 18 971 978 O
investigational 19 34 979 994 O
drug 35 39 995 999 O
within 40 46 1000 1006 O
30 47 49 1007 1009 B-upper_bound
days 50 54 1010 1014 I-upper_bound

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 6 7 6 7 O
60 7 9 7 9 B-upper_bound

Body 0 4 10 14 B-bmi
Mass 5 9 15 19 I-bmi
Index 10 15 20 25 I-bmi
( 16 17 26 27 O
BMI 17 20 27 30 B-bmi
) 20 21 30 31 O
< 22 23 32 33 O
18kg 24 28 34 38 B-upper_bound
/ 28 29 38 39 I-upper_bound
m2 29 31 39 41 I-upper_bound
. 31 32 41 42 O
( 33 34 43 44 O
amphetamine 34 45 44 55 O
may 46 49 56 59 O
produce 50 57 60 67 O
weigh 58 63 68 73 O
loss 64 68 74 78 O
thus 69 73 79 83 O
a 74 75 84 85 O
minimum 76 83 86 93 O
BMI 84 87 94 97 O
cut 88 91 98 101 O
- 91 92 101 102 O
off 92 95 102 105 O
is 96 98 106 108 O
being 99 104 109 114 O
used 105 109 115 119 O
for 110 113 120 123 O
study 114 119 124 129 O
inclusion 120 129 130 139 O
) 129 130 139 140 O

Coronary 0 8 141 149 B-chronic_disease
vascular 9 17 150 158 I-chronic_disease
disease 18 25 159 166 I-chronic_disease

Currently 0 9 167 176 O
being 10 15 177 182 O
prescribed 16 26 183 193 O
psychotropic 27 39 194 206 B-treatment
medication 40 50 207 217 I-treatment
by 51 53 218 220 O
another 54 61 221 228 O
physician 62 71 229 238 O

Elevated 0 8 239 247 B-clinical_variable
transaminase 9 21 248 260 I-clinical_variable
levels 22 28 261 267 I-clinical_variable
( 29 30 268 269 O
> 30 31 269 270 O
3x 32 34 271 273 B-lower_bound
the 35 38 274 277 I-lower_bound
normal 39 45 278 284 I-lower_bound
limit 46 51 285 290 I-lower_bound
) 51 52 290 291 O

History 0 7 292 299 O
of 8 10 300 302 O
allergic 11 19 303 311 O
reaction 20 28 312 320 O
to 29 31 321 323 O
candidate 32 41 324 333 B-allergy_name
medication 42 52 334 344 I-allergy_name
( 53 54 345 346 O
amphetamine 54 65 346 357 B-allergy_name
) 65 66 357 358 O

History 0 7 359 366 O
of 8 10 367 369 O
seizures 11 19 370 378 B-chronic_disease
, 19 20 378 379 O
unexplained 21 32 380 391 O
loss 33 37 392 396 B-chronic_disease
of 38 40 397 399 I-chronic_disease
consciousness 41 54 400 413 I-chronic_disease
, 54 55 413 414 O
or 56 58 415 417 O
traumatic 59 68 418 427 B-chronic_disease
brain 69 74 428 433 I-chronic_disease
injury 75 81 434 440 I-chronic_disease

Meets 0 5 441 446 O
DSM 6 9 447 450 O
- 9 10 450 451 O
V 10 11 451 452 O
criteria 12 20 453 461 O
for 21 24 462 465 O
bipolar 25 32 466 473 B-chronic_disease
disorder 33 41 474 482 I-chronic_disease
, 41 42 482 483 O
schizophrenia 43 56 484 497 B-chronic_disease
or 57 59 498 500 O
any 60 63 501 504 O
psychotic 64 73 505 514 B-chronic_disease
disorder 74 82 515 523 I-chronic_disease
other 83 88 524 529 O
than 89 93 530 534 O
transient 94 103 535 544 O
psychosis 104 113 545 554 O
due 114 117 555 558 O
to 118 120 559 561 O
drug 121 125 562 566 O
abuse 126 131 567 572 O

Participants 0 12 573 585 O
with 13 17 586 590 O
MDD 18 21 591 594 B-chronic_disease
, 21 22 594 595 O
with 23 27 596 600 O
symptom 28 35 601 608 O
severity 36 44 609 617 O
that 45 49 618 622 O
exceeds 50 57 623 630 O
a 58 59 631 632 O
HAM 60 63 633 636 B-clinical_variable
- 63 64 636 637 I-clinical_variable
D 64 65 637 638 I-clinical_variable
score 66 71 639 644 I-clinical_variable
of 72 74 645 647 O
20 75 77 648 650 O
, 77 78 650 651 O
and/or 79 85 652 658 O
any 86 89 659 662 O
other 90 95 663 668 O
current 96 103 669 676 O
Axis 104 108 677 681 B-chronic_disease
I 109 110 682 683 I-chronic_disease
psychiatric 111 122 684 695 I-chronic_disease
disorder 123 131 696 704 I-chronic_disease
as 132 134 705 707 O
defined 135 142 708 715 O
by 143 145 716 718 O
DSM 146 149 719 722 O
- 149 150 722 723 O
V 150 151 723 724 O
supported 152 161 725 734 O
by 162 164 735 737 O
the 165 168 738 741 O
MINI 169 173 742 746 O
that 174 178 747 751 O
in 179 181 752 754 O
the 182 185 755 758 O
investigator 186 198 759 771 O
's 198 200 771 773 O
judgment 201 209 774 782 O
are 210 213 783 786 O
unstable 214 222 787 795 O
, 222 223 795 796 O
would 224 229 797 802 O
be 230 232 803 805 O
disrupted 233 242 806 815 O
by 243 245 816 818 O
study 246 251 819 824 O
medication 252 262 825 835 O
, 262 263 835 836 O
or 264 266 837 839 O
are 267 270 840 843 O
likely 271 277 844 850 O
to 278 280 851 853 O
require 281 288 854 861 O
specialized 289 300 862 873 O
pharmacotherapy 301 316 874 889 B-treatment
or 317 319 890 892 O
psychotherapy 320 333 893 906 B-treatment
during 334 340 907 913 O
the 341 344 914 917 O
study 345 350 918 923 O
period 351 357 924 930 O

Pregnancy 0 9 931 940 B-pregnancy

Unstable 0 8 941 949 B-chronic_disease
physical 9 17 950 958 I-chronic_disease
disorders 18 27 959 968 I-chronic_disease
which 28 33 969 974 O
might 34 39 975 980 O
make 40 44 981 985 O
participation 45 58 986 999 O
hazardous 59 68 1000 1009 O
such 69 73 1010 1014 O
as 74 76 1015 1017 O
uncontrolled 77 89 1018 1030 B-chronic_disease
hypertension 90 102 1031 1043 I-chronic_disease
, 102 103 1043 1044 O
acute 104 109 1045 1050 B-chronic_disease
hepatitis 110 119 1051 1060 I-chronic_disease
, 119 120 1060 1061 O
uncontrolled 121 133 1062 1074 B-chronic_disease
diabetes 134 142 1075 1083 I-chronic_disease

Used 0 4 1084 1088 O
cocaine 5 12 1089 1096 O
at 13 15 1097 1099 O
least 16 21 1100 1105 O
four 22 26 1106 1110 B-lower_bound
days 27 31 1111 1115 I-lower_bound
in 32 34 1116 1118 O
the 35 38 1119 1122 O
past 39 43 1123 1127 O
month 44 49 1128 1133 O

failure 0 7 1134 1141 O
in 8 10 1142 1144 O
sexually 11 19 1145 1153 O
active 20 26 1154 1160 O
female 27 33 1161 1167 B-gender
patients 34 42 1168 1176 I-gender
to 43 45 1177 1179 O
use 46 49 1180 1183 B-contraception_consent
adequate 50 58 1184 1192 I-contraception_consent
contraceptive 59 72 1193 1206 I-contraception_consent
methods 73 80 1207 1214 I-contraception_consent

EKG 0 3 0 3 O
evidence 4 12 4 12 O
at 13 15 13 15 O
baseline 16 24 16 24 O
screening 25 34 25 34 O
of 35 37 35 37 O
any 38 41 38 41 O
clinically 42 52 42 52 O
significant 53 64 53 64 O
conduction 65 75 65 75 O
abnormalities 76 89 76 89 O
including 90 99 90 99 O
a 100 101 100 101 O
Bazlett 102 109 102 109 B-clinical_variable
's 109 111 109 111 I-clinical_variable
QTc 112 115 112 115 I-clinical_variable
( 116 117 116 117 I-clinical_variable
corrected 117 126 117 126 I-clinical_variable
QT 127 129 127 129 I-clinical_variable
interval 130 138 130 138 I-clinical_variable
) 138 139 138 139 I-clinical_variable
of 140 142 140 142 O
> 143 144 143 144 O
470 144 147 144 147 B-lower_bound
msec 148 152 148 152 I-lower_bound

Having 0 6 153 159 O
any 7 10 160 163 O
other 11 16 164 169 O
current 17 24 170 177 O
Axis 25 29 178 182 B-chronic_disease
I 30 31 183 184 I-chronic_disease
psychiatric 32 43 185 196 I-chronic_disease
disorders 44 53 197 206 I-chronic_disease
or 54 56 207 209 O
medical 57 64 210 217 O
conditions 65 75 218 228 O
requiring 76 85 229 238 O
treatment 86 95 239 248 O
or 96 98 249 251 O
medication 99 109 252 262 O

Must 0 4 263 267 O
be 5 7 268 270 O
able 8 12 271 275 B-language_fluency
to 13 15 276 278 I-language_fluency
read 16 20 279 283 I-language_fluency
English 21 28 284 291 I-language_fluency
and 29 32 292 295 I-language_fluency
complete 33 41 296 304 I-language_fluency
study 42 47 305 310 I-language_fluency
evaluations 48 59 311 322 I-language_fluency

Must 0 4 323 327 O
meet 5 9 328 332 O
Diagnostic 10 20 333 343 B-clinical_variable
and 21 24 344 347 I-clinical_variable
Statistical 25 36 348 359 I-clinical_variable
Manual 37 43 360 366 I-clinical_variable
of 44 46 367 369 I-clinical_variable
Mental 47 53 370 376 I-clinical_variable
Disorders 54 63 377 386 I-clinical_variable
- 63 64 386 387 I-clinical_variable
V 64 65 387 388 I-clinical_variable
( 66 67 389 390 I-clinical_variable
DSM- 67 71 390 394 I-clinical_variable
V 72 73 395 396 I-clinical_variable
) 73 74 396 397 I-clinical_variable
criteria 75 83 398 406 I-clinical_variable
for 84 87 407 410 O
moderate 88 96 411 419 O
to 97 99 420 422 O
severe 100 106 423 429 B-chronic_disease
Alcohol 107 114 430 437 I-chronic_disease
Use 115 118 438 441 I-chronic_disease
Disorder 119 127 442 450 I-chronic_disease
( 128 129 451 452 I-chronic_disease
AUD 129 132 452 455 I-chronic_disease
) 132 133 455 456 I-chronic_disease

pregnant 0 8 457 465 B-pregnancy

0 0 1 0 1 B-lower_bound
- 1 2 1 2 O
1 2 3 2 3 B-upper_bound
+ 3 4 3 4 O
HER2 5 9 5 9 B-cancer
expression 10 20 10 20 O
by 21 23 21 23 O
immunohistochemistry 24 44 24 44 B-treatment
( 45 46 45 46 I-treatment
IHC 46 49 46 49 I-treatment
) 49 50 49 50 I-treatment

Dilated 0 7 51 58 B-chronic_disease
cardiomyopathy 8 22 59 73 I-chronic_disease

Fluorescence 0 12 74 86 B-treatment
in 13 15 87 89 I-treatment
situ 16 20 90 94 I-treatment
hybridization 21 34 95 108 I-treatment
( 35 36 109 110 I-treatment
FISH 36 40 110 114 I-treatment
) 40 41 114 115 I-treatment
negative 42 50 116 124 O

Glycosylated 0 12 125 137 B-clinical_variable
hemoglobin 13 23 138 148 I-clinical_variable
measurement 24 35 149 160 I-clinical_variable
( 36 37 161 162 I-clinical_variable
HbA1c 37 42 162 167 I-clinical_variable
) 42 43 167 168 I-clinical_variable
< 44 45 169 170 O
5.7 46 49 171 174 B-upper_bound
% 49 50 174 175 I-upper_bound

Hemoglobin 0 10 176 186 B-clinical_variable
( 11 12 187 188 I-clinical_variable
Hgb 12 15 188 191 I-clinical_variable
) 15 16 191 192 I-clinical_variable
> 17 18 193 194 O
= 18 19 194 195 O
10 20 22 196 198 B-lower_bound
g 23 24 199 200 I-lower_bound
/ 24 25 200 201 I-lower_bound
dl 25 27 201 203 I-lower_bound

History 0 7 204 211 O
of 8 10 212 214 O
allergic 11 19 215 223 O
reactions 20 29 224 233 O
attributed 30 40 234 244 O
to 41 43 245 247 O
compounds 44 53 248 257 O
of 54 56 258 260 O
similar 57 64 261 268 O
chemical 65 73 269 277 O
or 74 76 278 280 O
biologic 77 85 281 289 O
composition 86 97 290 301 O
to 98 100 302 304 O
WOKVAC 101 107 305 311 B-allergy_name

History 0 7 312 319 O
of 8 10 320 322 O
autoimmunity 11 23 323 335 O
that 24 28 336 340 O
has 29 32 341 344 O
not 33 36 345 348 O
been 37 41 349 353 O
controlled 42 52 354 364 O
with 53 57 365 369 O
treatment 58 67 370 379 B-treatment
in 68 70 380 382 O
the 71 74 383 386 O
last 75 79 387 391 B-upper_bound
12 80 82 392 394 I-upper_bound
months 83 89 395 401 I-upper_bound

Known 0 5 402 407 O
history 6 13 408 415 O
of 14 16 416 418 O
human 17 22 419 424 B-chronic_disease
immunodeficiency 23 39 425 441 I-chronic_disease
virus 40 45 442 447 I-chronic_disease
( 46 47 448 449 I-chronic_disease
HIV 47 50 449 452 I-chronic_disease
) 50 51 452 453 I-chronic_disease
infection 52 61 454 463 I-chronic_disease

Left 0 4 464 468 B-clinical_variable
ventricular 5 16 469 480 I-clinical_variable
ejection 17 25 481 489 I-clinical_variable
fraction 26 34 490 498 I-clinical_variable
( 35 36 499 500 I-clinical_variable
LVEF 36 40 500 504 I-clinical_variable
) 40 41 504 505 I-clinical_variable
results 42 49 506 513 O
must 50 54 514 518 O
be 55 57 519 521 O
> 58 59 522 523 O
= 59 60 523 524 O
lower 61 66 525 530 B-clinical_variable
limit 67 72 531 536 I-clinical_variable
of 73 75 537 539 I-clinical_variable
normal 76 82 540 546 I-clinical_variable
( 83 84 547 548 I-clinical_variable
LLN 84 87 548 551 I-clinical_variable
) 87 88 551 552 I-clinical_variable
for 89 92 553 556 O
institution 93 104 557 568 O
performing 105 115 569 579 O
based 116 121 580 585 O
on 122 124 586 588 O
results 125 132 589 596 O
from 133 137 597 601 O
the 138 141 602 605 O
multi 142 147 606 611 O
- 147 148 611 612 O
gated 148 153 612 617 O
acquisition 154 165 618 629 O
( 166 167 630 631 O
MUGA 167 171 631 635 O
) 171 172 635 636 O
or 173 175 637 639 O
echocardiogram 176 190 640 654 B-treatment
( 191 192 655 656 I-treatment
ECHO 192 196 656 660 I-treatment
) 196 197 660 661 I-treatment
done 198 202 662 666 O
at 203 205 667 669 O
baseline 206 214 670 678 O

Lymphocyte 0 10 679 689 B-clinical_variable
count 11 16 690 695 I-clinical_variable
> 17 18 696 697 O
= 18 19 697 698 O
800 20 23 699 702 B-lower_bound
/ 23 24 702 703 I-lower_bound
mm^3 24 28 703 707 I-lower_bound

New 0 3 708 711 O
York 4 8 712 716 O
Heart 9 14 717 722 O
Association 15 26 723 734 O
functional 27 37 735 745 O
class 38 43 746 751 O
III 44 47 752 755 O
- 47 48 755 756 O
IV 48 50 756 758 O
heart 51 56 759 764 B-chronic_disease
failure 57 64 765 772 I-chronic_disease
on 65 67 773 775 O
active 68 74 776 782 B-treatment
treatment 75 84 783 792 I-treatment

Patients 0 8 793 801 O
must 9 13 802 806 O
be 14 16 807 809 O
at 17 19 810 812 O
least 20 25 813 818 O
28 26 28 819 821 B-lower_bound
days 29 33 822 826 I-lower_bound
post 34 38 827 831 B-treatment
cytotoxic 39 48 832 841 I-treatment
chemotherapy 49 61 842 854 I-treatment
, 61 62 854 855 O
radiotherapy 63 75 856 868 B-treatment
, 75 76 868 869 O
monoclonal 77 87 870 880 B-treatment
antibody 88 96 881 889 I-treatment
and/or 97 103 890 896 O
other 104 109 897 902 O
biologic 110 118 903 911 B-treatment
therapy 119 126 912 919 I-treatment
, 126 127 919 920 O
prior 128 133 921 926 O
to 134 136 927 929 O
enrollment 137 147 930 940 O

Patients 0 8 941 949 O
must 9 13 950 954 O
be 14 16 955 957 O
at 17 19 958 960 O
least 20 25 961 966 O
28 26 28 967 969 B-lower_bound
days 29 33 970 974 I-lower_bound
post 34 38 975 979 O
systemic 39 47 980 988 O
steroids 48 56 989 997 O
prior 57 62 998 1003 O
to 63 65 1004 1006 O
enrollment 66 76 1007 1017 O

Patients 0 8 1018 1026 O
must 9 13 1027 1031 O
have 14 18 1032 1036 O
Eastern 19 26 1037 1044 B-clinical_variable
Cooperative 27 38 1045 1056 I-clinical_variable
Oncology 39 47 1057 1065 I-clinical_variable
Group 48 53 1066 1071 I-clinical_variable
( 54 55 1072 1073 I-clinical_variable
ECOG 55 59 1073 1077 I-clinical_variable
) 59 60 1077 1078 I-clinical_variable
performance 61 72 1079 1090 I-clinical_variable
status 73 79 1091 1097 I-clinical_variable
score 80 85 1098 1103 I-clinical_variable
of 86 88 1104 1106 O
= 89 90 1107 1108 O
< 90 91 1108 1109 O
2 92 93 1110 1111 B-upper_bound

Patients 0 8 1112 1120 O
must 9 13 1121 1125 O
have 14 18 1126 1130 O
recovered 19 28 1131 1140 O
from 29 33 1141 1145 O
major 34 39 1146 1151 B-chronic_disease
infections 40 50 1152 1162 I-chronic_disease
and/or 51 57 1163 1169 O
surgical 58 66 1170 1178 B-treatment
procedures 67 77 1179 1189 I-treatment

Patients 0 8 1190 1198 O
who 9 12 1199 1202 O
are 13 16 1203 1206 O
having 17 23 1207 1213 O
sex 24 27 1214 1217 O
that 28 32 1218 1222 O
can 33 36 1223 1226 O
lead 37 41 1227 1231 O
to 42 44 1232 1234 O
pregnancy 45 54 1235 1244 B-pregnancy
must 55 59 1245 1249 O
agree 60 65 1250 1255 B-contraception_consent
to 66 68 1256 1258 I-contraception_consent
use 69 72 1259 1262 I-contraception_consent
adequate 73 81 1263 1271 I-contraception_consent
contraception 82 95 1272 1285 I-contraception_consent
( 96 97 1286 1287 I-contraception_consent
hormonal 97 105 1287 1295 I-contraception_consent
, 105 106 1295 1296 I-contraception_consent
barrier 107 114 1297 1304 I-contraception_consent
method 115 121 1305 1311 I-contraception_consent
of 122 124 1312 1314 I-contraception_consent
birth 125 130 1315 1320 I-contraception_consent
control 131 138 1321 1328 I-contraception_consent
, 138 139 1328 1329 I-contraception_consent
or 140 142 1330 1332 I-contraception_consent
abstinence 143 153 1333 1343 I-contraception_consent
) 153 154 1343 1344 I-contraception_consent
for 155 158 1345 1348 O
the 159 162 1349 1352 O
duration 163 171 1353 1361 O
of 172 174 1362 1364 O
study 175 180 1365 1370 O
participation 181 194 1371 1384 O

Patients 0 8 1385 1393 O
with 9 13 1394 1398 O
any 14 17 1399 1402 O
contraindication 18 34 1403 1419 O
or 35 37 1420 1422 O
known 38 43 1423 1428 O
hypersensitivity 44 60 1429 1445 O
to 61 63 1446 1448 O
receiving 64 73 1449 1458 O
sargramostatin 74 88 1459 1473 B-allergy_name
( 89 90 1474 1475 O
recombinant 90 101 1475 1486 B-allergy_name
human 102 107 1487 1492 I-allergy_name
granulocyte 108 119 1493 1504 I-allergy_name
macrophage 120 130 1505 1515 I-allergy_name
colony 131 137 1516 1522 I-allergy_name
stimulating 138 149 1523 1534 I-allergy_name
factor 150 156 1535 1541 I-allergy_name
[ 157 158 1542 1543 I-allergy_name
rhuGM 158 163 1543 1548 I-allergy_name
- 163 164 1548 1549 I-allergy_name
CSF 164 167 1549 1552 I-allergy_name
] 167 168 1552 1553 I-allergy_name
) 168 169 1553 1554 O
or 170 172 1555 1557 O
other 173 178 1558 1563 O
yeast 179 184 1564 1569 O
based 185 190 1570 1575 O
products 191 199 1576 1584 O

Patients 0 8 1585 1593 O
with 9 13 1594 1598 O
non 14 17 1599 1602 B-cancer
- 17 18 1602 1603 I-cancer
metastatic 18 28 1603 1613 I-cancer
, 28 29 1613 1614 O
node 30 34 1615 1619 B-cancer
positive 35 43 1620 1628 I-cancer
, 43 44 1628 1629 O
HER2 45 49 1630 1634 B-cancer
negative 50 58 1635 1643 I-cancer
breast 59 65 1644 1650 I-cancer
cancer 66 72 1651 1657 I-cancer
, 72 73 1657 1658 O
confirmed 74 83 1659 1668 O
by 84 86 1669 1671 O
pathology 87 96 1672 1681 O
report 97 103 1682 1688 O
, 103 104 1688 1689 O
who 105 108 1690 1693 O
are 109 112 1694 1697 O
in 113 115 1698 1700 O
remission 116 125 1701 1710 O
and 126 129 1711 1714 O
defined 130 137 1715 1722 O
as 138 140 1723 1725 O
having 141 147 1726 1732 O
no 148 150 1733 1735 O
evidence 151 159 1736 1744 O
of 160 162 1745 1747 O
disease 163 170 1748 1755 O
( 171 172 1756 1757 O
NED 172 175 1757 1760 O
) 175 176 1760 1761 O

Platelet 0 8 1762 1770 B-clinical_variable
count 9 14 1771 1776 I-clinical_variable
> 15 16 1777 1778 O
= 16 17 1778 1779 O
75,000 18 24 1780 1786 B-lower_bound
/ 24 25 1786 1787 I-lower_bound
mm^3 25 29 1787 1791 I-lower_bound

Pregnant 0 8 1792 1800 B-pregnancy
women 9 14 1801 1806 B-gender

Symptomatic 0 11 1807 1818 B-chronic_disease
restrictive 12 23 1819 1830 I-chronic_disease
cardiomyopathy 24 38 1831 1845 I-chronic_disease

Unstable 0 8 1846 1854 B-chronic_disease
angina 9 15 1855 1861 I-chronic_disease
within 16 22 1862 1868 O
4 23 24 1869 1870 B-upper_bound
months 25 31 1871 1877 I-upper_bound
prior 32 37 1878 1883 I-upper_bound
to 38 40 1884 1886 O
enrollment 41 51 1887 1897 O

Willing 0 7 1898 1905 O
to 8 10 1906 1908 O
not 11 14 1909 1912 O
undergo 15 22 1913 1920 O
any 23 26 1921 1924 O
elective 27 35 1925 1933 B-treatment
surgical 36 44 1934 1942 I-treatment
procedure 45 54 1943 1952 I-treatment
with 55 59 1953 1957 I-treatment
general 60 67 1958 1965 I-treatment
anesthesia 68 78 1966 1976 I-treatment
or 79 81 1977 1979 O
conscious 82 91 1980 1989 B-treatment
sedation 92 100 1990 1998 I-treatment
through 101 108 1999 2006 O
the 109 112 2007 2010 O
1 113 114 2011 2012 B-upper_bound
month 115 120 2013 2018 I-upper_bound
post 121 125 2019 2023 B-treatment
- 125 126 2023 2024 I-treatment
vaccination 126 137 2024 2035 I-treatment
visit 138 143 2036 2041 O

creatinine 0 10 2042 2052 B-clinical_variable
clearance 11 20 2053 2062 I-clinical_variable
> 21 22 2063 2064 O
60 23 25 2065 2067 B-lower_bound
ml 26 28 2068 2070 I-lower_bound
/ 28 29 2070 2071 I-lower_bound
min 29 32 2071 2074 I-lower_bound

patients 0 8 2075 2083 O
on 9 11 2084 2086 O
bisphosphonates 12 27 2087 2102 B-treatment
, 27 28 2102 2103 O
denosumab 29 38 2104 2113 B-treatment
, 38 39 2113 2114 O
and/or 40 46 2115 2121 O
endocrine 47 56 2122 2131 B-treatment
therapy 57 64 2132 2139 I-treatment
and 65 68 2140 2143 O
may 69 72 2144 2147 O
continue 73 81 2148 2156 O
throughout 82 92 2157 2167 O
duration 93 101 2168 2176 O
of 102 104 2177 2179 O
study 105 110 2180 2185 O

A 0 1 0 1 O
QT 2 4 2 4 B-clinical_variable
interval 5 13 5 13 I-clinical_variable
corrected 14 23 14 23 O
for 24 27 24 27 O
heart 28 33 28 33 O
rate 34 38 34 38 O
using 39 44 39 44 O
the 45 48 45 48 O
Bazett 49 55 49 55 B-clinical_variable
's 55 57 55 57 I-clinical_variable
formula 58 65 58 65 I-clinical_variable
QTcB 66 70 66 70 I-clinical_variable
> 71 72 71 72 O
= 72 73 72 73 O
480 74 77 74 77 B-lower_bound
msec 78 82 78 82 I-lower_bound
on 83 85 83 85 O
screening 86 95 86 95 O
electrocardiography 96 115 96 115 B-clinical_variable
( 116 117 116 117 I-clinical_variable
ECG 117 120 117 120 I-clinical_variable
) 120 121 120 121 I-clinical_variable

A 0 1 122 123 O
history 2 9 124 131 O
of 10 12 132 134 O
glucose-6 13 22 135 144 B-chronic_disease
- 22 23 144 145 I-chronic_disease
phosphate 23 32 145 154 I-chronic_disease
dehydrogenase 33 46 155 168 I-chronic_disease
( 47 48 169 170 I-chronic_disease
G6PD 48 52 170 174 I-chronic_disease
) 52 53 174 175 I-chronic_disease
deficiency 54 64 176 186 I-chronic_disease

Able 0 4 187 191 O
to 5 7 192 194 O
swallow 8 15 195 202 O
and 16 19 203 206 O
retain 20 26 207 213 O
oral 27 31 214 218 B-treatment
medication 32 42 219 229 I-treatment
and 43 46 230 233 O
must 47 51 234 238 O
not 52 55 239 242 O
have 56 60 243 247 O
any 61 64 248 251 O
clinically 65 75 252 262 O
significant 76 87 263 274 O
gastrointestinal 88 104 275 291 B-chronic_disease
abnormalities 105 118 292 305 I-chronic_disease
that 119 123 306 310 O
may 124 127 311 314 O
alter 128 133 315 320 O
absorption 134 144 321 331 O
such 145 149 332 336 O
as 150 152 337 339 O
malabsorption 153 166 340 353 B-chronic_disease
syndrome 167 175 354 362 I-chronic_disease
or 176 178 363 365 O
major 179 184 366 371 B-treatment
resection 185 194 372 381 I-treatment
of 195 197 382 384 O
the 198 201 385 388 O
stomach 202 209 389 396 O
or 210 212 397 399 O
bowels 213 219 400 406 O

Abnormal 0 8 407 415 B-clinical_variable
cardiac 9 16 416 423 I-clinical_variable
valve 17 22 424 429 I-clinical_variable
morphology 23 33 430 440 I-clinical_variable
( 34 35 441 442 O
> 35 36 442 443 O
= 36 37 443 444 O
grade 38 43 445 450 B-lower_bound
2 44 45 451 452 I-lower_bound
) 45 46 452 453 O
documented 47 57 454 464 O
by 58 60 465 467 O
echocardiogram 61 75 468 482 B-treatment
( 76 77 483 484 O
subjects 77 85 484 492 O
with 86 90 493 497 O
grade 91 96 498 503 O
1 97 98 504 505 O
abnormalities 99 112 506 519 O
[ 113 114 520 521 O
i.e. 114 118 521 525 O
, 118 119 525 526 O
mild 120 124 527 531 O
regurgitation 125 138 532 545 B-chronic_disease
/ 138 139 545 546 O
stenosis 139 147 546 554 B-chronic_disease
] 147 148 554 555 O
can 149 152 556 559 O
be 153 155 560 562 O
entered 156 163 563 570 O
on 164 166 571 573 O
study 167 172 574 579 O
) 172 173 579 580 O
; 173 174 580 581 O
subjects 175 183 582 590 O
with 184 188 591 595 O
moderate 189 197 596 604 O
valvular 198 206 605 613 O
thickening 207 217 614 624 O
should 218 224 625 631 O
not 225 228 632 635 O
be 229 231 636 638 O
entered 232 239 639 646 O
on 240 242 647 649 O
study 243 248 650 655 O

Absolute 0 8 656 664 O
neutrophil 9 19 665 675 B-clinical_variable
count 20 25 676 681 I-clinical_variable
> 26 27 682 683 O
= 27 28 683 684 O
1 29 30 685 686 B-lower_bound
x 31 32 687 688 I-lower_bound
10 33 35 689 691 I-lower_bound
^ 35 36 691 692 I-lower_bound
9 36 37 692 693 I-lower_bound
/ 37 38 693 694 I-lower_bound
L 38 39 694 695 I-lower_bound

Antibiotics 0 11 696 707 B-treatment
: 11 12 707 708 O
clarithromycin 13 27 709 723 B-treatment
, 27 28 723 724 O
telithromycin 29 42 725 738 B-treatment
, 42 43 738 739 O
troleandomycin 44 58 740 754 B-treatment

Antibiotics 0 11 755 766 B-treatment
: 11 12 766 767 O
rifamycin 13 22 768 777 B-treatment
class 23 28 778 783 O
agents 29 35 784 790 O
( 36 37 791 792 O
e.g. 37 41 792 796 O
, 41 42 796 797 O
rifampin 43 51 798 806 B-treatment
, 51 52 806 807 O
rifabutin 53 62 808 817 B-treatment
, 62 63 817 818 O
rifapentine 64 75 819 830 B-treatment
) 75 76 830 831 O

Anticoagulants 0 14 832 846 B-treatment
or 15 17 847 849 O
antiplatelet 18 30 850 862 B-treatment
agents 31 37 863 869 I-treatment
except 38 44 870 876 O
for 45 48 877 880 O
low 49 52 881 884 O
- 52 53 884 885 O
dose 53 57 885 889 O
, 57 58 889 890 O
81 59 61 891 893 O
mg 62 64 894 896 O
aspirin 65 72 897 904 B-treatment

Anticonvulsants 0 15 905 920 B-treatment
: 15 16 920 921 O
carbamazepine 17 30 922 935 B-treatment
, 30 31 935 936 O
oxcarbazepine 32 45 937 950 B-treatment
, 45 46 950 951 O
phenobarbital 47 60 952 965 B-treatment
, 60 61 965 966 O
phenytoin 62 71 967 976 B-treatment
, 71 72 976 977 O
s 73 74 978 979 O
- 74 75 979 980 O
mephenytoin 75 86 980 991 B-treatment

Antidepressants 0 15 992 1007 B-treatment
: 15 16 1007 1008 O
nefazodone 17 27 1009 1019 B-treatment

Antifungals 0 11 1020 1031 B-treatment
: 11 12 1031 1032 O
itraconazole 13 25 1033 1045 B-treatment
, 25 26 1045 1046 O
ketoconazole 27 39 1047 1059 B-treatment
, 39 40 1059 1060 O
posaconazole 41 53 1061 1073 B-treatment
, 53 54 1073 1074 O
voriconazole 55 67 1075 1087 B-treatment

Antiretroviral 0 14 1088 1102 B-treatment
: 14 15 1102 1103 O
ritonavir 16 25 1104 1113 B-treatment
, 25 26 1113 1114 O
saquinavir 27 37 1115 1125 B-treatment
, 37 38 1125 1126 O
atazanavir 39 49 1127 1137 B-treatment

Aspartate 0 9 1138 1147 B-clinical_variable
aminotransferase 10 26 1148 1164 I-clinical_variable
( 27 28 1165 1166 I-clinical_variable
AST 28 31 1166 1169 I-clinical_variable
) 31 32 1169 1170 I-clinical_variable
( 33 34 1171 1172 O
serum 34 39 1172 1177 B-clinical_variable
glutamic 40 48 1178 1186 I-clinical_variable
oxaloacetic 49 60 1187 1198 I-clinical_variable
transaminase 61 73 1199 1211 I-clinical_variable
[ 74 75 1212 1213 I-clinical_variable
SGOT])/alanine 75 89 1213 1227 I-clinical_variable
aminotransferase 90 106 1228 1244 I-clinical_variable
( 107 108 1245 1246 I-clinical_variable
ALT 108 111 1246 1249 I-clinical_variable
) 111 112 1249 1250 I-clinical_variable
( 113 114 1251 1252 O
serum 114 119 1252 1257 B-clinical_variable
glutamate 120 129 1258 1267 I-clinical_variable
pyruvate 130 138 1268 1276 I-clinical_variable
transaminase 139 151 1277 1289 I-clinical_variable
[ 152 153 1290 1291 I-clinical_variable
SGPT 153 157 1291 1295 I-clinical_variable
] 157 158 1295 1296 I-clinical_variable
) 158 159 1296 1297 O
= 160 161 1298 1299 O
< 161 162 1299 1300 O
2.5 163 166 1301 1304 B-upper_bound
x 167 168 1305 1306 I-upper_bound
institutional 169 182 1307 1320 I-upper_bound
upper 183 188 1321 1326 I-upper_bound
limit 189 194 1327 1332 I-upper_bound
of 195 197 1333 1335 I-upper_bound
normal 198 204 1336 1342 I-upper_bound

Because 0 7 1343 1350 O
the 8 11 1351 1354 O
composition 12 23 1355 1366 O
, 23 24 1366 1367 O
pharmacokinetics 25 41 1368 1384 O
( 42 43 1385 1386 O
PK 43 45 1386 1388 O
) 45 46 1388 1389 O
, 46 47 1389 1390 O
and 48 51 1391 1394 O
metabolism 52 62 1395 1405 O
of 63 65 1406 1408 O
many 66 70 1409 1413 O
herbal 71 77 1414 1420 B-treatment
supplements 78 89 1421 1432 I-treatment
are 90 93 1433 1436 O
unknown 94 101 1437 1444 O
, 101 102 1444 1445 O
the 103 106 1446 1449 O
concurrent 107 117 1450 1460 O
use 118 121 1461 1464 O
of 122 124 1465 1467 O
all 125 128 1468 1471 O
herbal 129 135 1472 1478 O
supplements 136 147 1479 1490 O
is 148 150 1491 1493 O
prohibited 151 161 1494 1504 O
during 162 168 1505 1511 O
the 169 172 1512 1515 O
study 173 178 1516 1521 O
( 179 180 1522 1523 O
including 180 189 1523 1532 O
, 189 190 1532 1533 O
but 191 194 1534 1537 O
not 195 198 1538 1541 O
limited 199 206 1542 1549 O
to 207 209 1550 1552 O
, 209 210 1552 1553 O
St. 211 214 1554 1557 B-treatment
John 215 219 1558 1562 I-treatment
's 219 221 1562 1564 I-treatment
wort 222 226 1565 1569 I-treatment
, 226 227 1569 1570 O
kava 228 232 1571 1575 B-treatment
, 232 233 1575 1576 O
ephedra 234 241 1577 1584 B-treatment
[ 242 243 1585 1586 I-treatment
ma 243 245 1586 1588 I-treatment
huang 246 251 1589 1594 I-treatment
] 251 252 1594 1595 I-treatment
, 252 253 1595 1596 O
ginkgo 254 260 1597 1603 B-treatment
biloba 261 267 1604 1610 I-treatment
, 267 268 1610 1611 O
dehydroepiandrosterone 269 291 1612 1634 B-treatment
[ 292 293 1635 1636 I-treatment
DHEA 293 297 1636 1640 I-treatment
] 297 298 1640 1641 I-treatment
, 298 299 1641 1642 O
yohimbe 300 307 1643 1650 B-treatment
, 307 308 1650 1651 O
saw 309 312 1652 1655 B-treatment
palmetto 313 321 1656 1664 I-treatment
, 321 322 1664 1665 O
or 323 325 1666 1668 O
ginseng 326 333 1669 1676 B-treatment
) 333 334 1676 1677 O

Concurrent 0 10 1678 1688 O
treatment 11 20 1689 1698 B-treatment
with 21 25 1699 1703 I-treatment
bisphosphonates 26 41 1704 1719 I-treatment
is 42 44 1720 1722 O
permitted 45 54 1723 1732 O
; 54 55 1732 1733 O
however 56 63 1734 1741 O
, 63 64 1741 1742 O
treatment 65 74 1743 1752 O
must 75 79 1753 1757 O
be 80 82 1758 1760 O
initiated 83 92 1761 1770 O
prior 93 98 1771 1776 O
to 99 101 1777 1779 O
the 102 105 1780 1783 O
first 106 111 1784 1789 O
dose 112 116 1790 1794 O
of 117 119 1795 1797 O
study 120 125 1798 1803 O
therapy 126 133 1804 1811 B-treatment
; 133 134 1811 1812 O
prophylactic 135 147 1813 1825 B-treatment
use 148 151 1826 1829 O
of 152 154 1830 1832 O
bisphosphonates 155 170 1833 1848 O
in 171 173 1849 1851 O
patients 174 182 1852 1860 O
without 183 190 1861 1868 O
bone 191 195 1869 1873 O
disease 196 203 1874 1881 O
is 204 206 1882 1884 O
not 207 210 1885 1888 O
permitted 211 220 1889 1898 O
, 220 221 1898 1899 O
except 222 228 1900 1906 O
for 229 232 1907 1910 O
the 233 236 1911 1914 O
treatment 237 246 1915 1924 B-treatment
of 247 249 1925 1927 I-treatment
osteoporosis 250 262 1928 1940 I-treatment

Current 0 7 1941 1948 O
use 8 11 1949 1952 O
of 12 14 1953 1955 O
a 15 16 1956 1957 O
prohibited 17 27 1958 1968 O
medication 28 38 1969 1979 B-treatment
; 38 39 1979 1980 O
the 40 43 1981 1984 O
following 44 53 1985 1994 O
medications 54 65 1995 2006 B-treatment
or 66 68 2007 2009 O
non 69 72 2010 2013 B-treatment
- 72 73 2013 2014 I-treatment
drug 73 77 2014 2018 I-treatment
therapies 78 87 2019 2028 I-treatment
are 88 91 2029 2032 O
prohibited 92 102 2033 2043 O

Due 0 3 2044 2047 O
to 4 6 2048 2050 O
the 7 10 2051 2054 O
expected 11 19 2055 2063 O
dose 20 24 2064 2068 O
- 24 25 2068 2069 O
limiting 25 33 2069 2077 O
toxicity 34 42 2078 2086 O
of 43 45 2087 2089 O
thrombocytopenia 46 62 2090 2106 B-chronic_disease
, 62 63 2106 2107 O
the 64 67 2108 2111 O
following 68 77 2112 2121 O
concomitant 78 89 2122 2133 B-treatment
medications 90 101 2134 2145 I-treatment
are 102 105 2146 2149 O
not 106 109 2150 2153 O
allowed 110 117 2154 2161 O
during 118 124 2162 2168 O
navitoclax 125 135 2169 2179 B-treatment
administration 136 150 2180 2194 O
: 150 151 2194 2195 O
clopidogrel 152 163 2196 2207 B-treatment
, 163 164 2207 2208 O
ibuprofen 165 174 2209 2218 B-treatment
, 174 175 2218 2219 O
tirofiban 176 185 2220 2229 B-treatment
, 185 186 2229 2230 O
warfarin 187 195 2231 2239 B-treatment
, 195 196 2239 2240 O
and 197 200 2241 2244 O
other 201 206 2245 2250 O
anticoagulants 207 221 2251 2265 B-treatment
, 221 222 2265 2266 O
drugs 223 228 2267 2272 B-treatment
, 228 229 2272 2273 O
or 230 232 2274 2276 O
herbal 233 239 2277 2283 B-treatment
supplements 240 251 2284 2295 I-treatment
that 252 256 2296 2300 O
affect 257 263 2301 2307 O
platelet 264 272 2308 2316 O
function 273 281 2317 2325 O
are 282 285 2326 2329 O
excluded 286 294 2330 2338 O
, 294 295 2338 2339 O
with 296 300 2340 2344 O
the 301 304 2345 2348 O
exception 305 314 2349 2358 O
of 315 317 2359 2361 O
low 318 321 2362 2365 O
- 321 322 2365 2366 O
dose 322 326 2366 2370 O
anticoagulation 327 342 2371 2386 B-treatment
medications 343 354 2387 2398 I-treatment
( 355 356 2399 2400 O
such 356 360 2400 2404 O
as 361 363 2405 2407 O
heparin 364 371 2408 2415 B-treatment
) 371 372 2415 2416 O
that 373 377 2417 2421 O
are 378 381 2422 2425 O
used 382 386 2426 2430 O
to 387 389 2431 2433 O
maintain 390 398 2434 2442 O
the 399 402 2443 2446 O
patency 403 410 2447 2454 O
of 411 413 2455 2457 O
a 414 415 2458 2459 O
central 416 423 2460 2467 B-treatment
intravenous 424 435 2468 2479 I-treatment
catheter 436 444 2480 2488 I-treatment
; 444 445 2488 2489 O
aspirin 446 453 2490 2497 B-treatment
will 454 458 2498 2502 O
not 459 462 2503 2506 O
be 463 465 2507 2509 O
allowed 466 473 2510 2517 O
within 474 480 2518 2524 O
7 481 482 2525 2526 B-upper_bound
days 483 487 2527 2531 I-upper_bound
prior 488 493 2532 2537 I-upper_bound
to 494 496 2538 2540 O
the 497 500 2541 2544 O
first 501 506 2545 2550 O
dose 507 511 2551 2555 O
of 512 514 2556 2558 O
navitoclax 515 525 2559 2569 O
or 526 528 2570 2572 O
during 529 535 2573 2579 O
navitoclax 536 546 2580 2590 O
administration 547 561 2591 2605 O
; 561 562 2605 2606 O
however 563 570 2607 2614 O
, 570 571 2614 2615 O
subjects 572 580 2616 2624 O
who 581 584 2625 2628 O
have 585 589 2629 2633 O
previously 590 600 2634 2644 O
received 601 609 2645 2653 O
aspirin 610 617 2654 2661 B-treatment
therapy 618 625 2662 2669 I-treatment
for 626 629 2670 2673 O
thrombosis 630 640 2674 2684 B-chronic_disease
prevention 641 651 2685 2695 O
may 652 655 2696 2699 O
resume 656 662 2700 2706 O
a 663 664 2707 2708 O
low 665 668 2709 2712 O
dose 669 673 2713 2717 O
( 674 675 2718 2719 O
i.e. 675 679 2719 2723 O
, 679 680 2723 2724 O
maximum 681 688 2725 2732 O
100 689 692 2733 2736 B-upper_bound
mg 693 695 2737 2739 I-upper_bound
QD 696 698 2740 2742 I-upper_bound
) 698 699 2742 2743 O
of 700 702 2744 2746 O
aspirin 703 710 2747 2754 O
if 711 713 2755 2757 O
platelet 714 722 2758 2766 B-clinical_variable
counts 723 729 2767 2773 I-clinical_variable
are 730 733 2774 2777 O
stable 734 740 2778 2784 O
( 741 742 2785 2786 O
> 742 743 2786 2787 O
= 743 744 2787 2788 O
50,000 745 751 2789 2795 B-lower_bound
/ 751 752 2795 2796 I-lower_bound
mm^3 752 756 2796 2800 I-lower_bound
) 756 757 2800 2801 O
through 758 765 2802 2809 O
6 766 767 2810 2811 B-upper_bound
weeks 768 773 2812 2817 I-upper_bound
of 774 776 2818 2820 O
navitoclax 777 787 2821 2831 O
administration 788 802 2832 2846 O
; 802 803 2846 2847 O
all 804 807 2848 2851 O
decisions 808 817 2852 2861 O
regarding 818 827 2862 2871 O
treatment 828 837 2872 2881 B-treatment
with 838 842 2882 2886 I-treatment
aspirin 843 850 2887 2894 I-treatment
therapy 851 858 2895 2902 I-treatment
will 859 863 2903 2907 O
be 864 866 2908 2910 O
determined 867 877 2911 2921 O
by 878 880 2922 2924 O
the 881 884 2925 2928 O
investigator 885 897 2929 2941 O
in 898 900 2942 2944 O
conjunction 901 912 2945 2956 O
with 913 917 2957 2961 O
the 918 921 2962 2965 O
medical 922 929 2966 2973 O
monitor 930 937 2974 2981 O

Eastern 0 7 2982 2989 B-clinical_variable
Cooperative 8 19 2990 3001 I-clinical_variable
Oncology 20 28 3002 3010 I-clinical_variable
Group 29 34 3011 3016 I-clinical_variable
( 35 36 3017 3018 I-clinical_variable
ECOG 36 40 3018 3022 I-clinical_variable
) 40 41 3022 3023 I-clinical_variable
performance 42 53 3024 3035 I-clinical_variable
status 54 60 3036 3042 I-clinical_variable
= 61 62 3043 3044 O
< 62 63 3044 3045 O
1 64 65 3046 3047 B-upper_bound
( 66 67 3048 3049 O
Karnofsky 67 76 3049 3058 B-clinical_variable
> 77 78 3059 3060 O
= 78 79 3060 3061 O
70 80 82 3062 3064 B-lower_bound
% 82 83 3064 3065 I-lower_bound
) 83 84 3065 3066 O

Hemoglobin 0 10 3067 3077 B-clinical_variable
> 11 12 3078 3079 O
= 12 13 3079 3080 O
9 14 15 3081 3082 B-lower_bound
g 16 17 3083 3084 I-lower_bound
/ 17 18 3084 3085 I-lower_bound
dl 18 20 3085 3087 I-lower_bound
( 21 22 3088 3089 O
patients 22 30 3089 3097 O
may 31 34 3098 3101 O
be 35 37 3102 3104 O
transfused 38 48 3105 3115 O
to 49 51 3116 3118 O
this 52 56 3119 3123 O
level 57 62 3124 3129 O
) 62 63 3129 3130 O

History 0 7 3131 3138 O
of 8 10 3139 3141 O
RVO 11 14 3142 3145 B-chronic_disease
or 15 17 3146 3148 O
CSR 18 21 3149 3152 B-chronic_disease
, 21 22 3152 3153 O
or 23 25 3154 3156 O
predisposing 26 38 3157 3169 O
factors 39 46 3170 3177 O
to 47 49 3178 3180 O
RVO 50 53 3181 3184 O
or 54 56 3185 3187 O
CSR 57 60 3188 3191 O
( 61 62 3192 3193 O
e.g. 62 66 3193 3197 O
, 66 67 3197 3198 O
uncontrolled 68 80 3199 3211 O
glaucoma 81 89 3212 3220 B-chronic_disease
or 90 92 3221 3223 O
ocular 93 99 3224 3230 B-chronic_disease
hypertension 100 112 3231 3243 I-chronic_disease
, 112 113 3243 3244 O
uncontrolled 114 126 3245 3257 O
systemic 127 135 3258 3266 B-chronic_disease
disease 136 143 3267 3274 I-chronic_disease
such 144 148 3275 3279 O
as 149 151 3280 3282 O
hypertension 152 164 3283 3295 O
, 164 165 3295 3296 O
diabetes 166 174 3297 3305 B-chronic_disease
mellitus 175 183 3306 3314 I-chronic_disease
, 183 184 3314 3315 O
or 185 187 3316 3318 O
history 188 195 3319 3326 O
of 196 198 3327 3329 O
hyperviscosity 199 213 3330 3344 B-chronic_disease
or 214 216 3345 3347 O
hypercoagulability 217 235 3348 3366 B-chronic_disease
syndromes 236 245 3367 3376 O
) 245 246 3376 3377 O

History 0 7 3378 3385 O
of 8 10 3386 3388 O
acute 11 16 3389 3394 B-chronic_disease
coronary 17 25 3395 3403 I-chronic_disease
syndromes 26 35 3404 3413 I-chronic_disease
( 36 37 3414 3415 O
including 37 46 3415 3424 O
myocardial 47 57 3425 3435 B-chronic_disease
infarction 58 68 3436 3446 I-chronic_disease
and 69 72 3447 3450 O
unstable 73 81 3451 3459 B-chronic_disease
angina 82 88 3460 3466 I-chronic_disease
) 88 89 3466 3467 O
, 89 90 3467 3468 O
coronary 91 99 3469 3477 B-treatment
angioplasty 100 111 3478 3489 I-treatment
, 111 112 3489 3490 O
or 113 115 3491 3493 O
stenting 116 124 3494 3502 B-treatment
within 125 131 3503 3509 O
6 132 133 3510 3511 B-upper_bound
months 134 140 3512 3518 I-upper_bound
prior 141 146 3519 3524 I-upper_bound
to 147 149 3525 3527 O
randomization 150 163 3528 3541 B-treatment

History 0 7 3542 3549 O
of 8 10 3550 3552 O
allergic 11 19 3553 3561 O
reactions 20 29 3562 3571 O
attributed 30 40 3572 3582 O
to 41 43 3583 3585 O
compounds 44 53 3586 3595 O
of 54 56 3596 3598 O
similar 57 64 3599 3606 O
chemical 65 73 3607 3615 O
or 74 76 3616 3618 O
biologic 77 85 3619 3627 O
composition 86 97 3628 3639 O
to 98 100 3640 3642 O
navitoclax 101 111 3643 3653 B-allergy_name
, 111 112 3653 3654 O
dabrafenib 113 123 3655 3665 B-allergy_name
, 123 124 3665 3666 O
or 125 127 3667 3669 O
trametinib 128 138 3670 3680 B-allergy_name
, 138 139 3680 3681 O
or 140 142 3682 3684 O
excipients 143 153 3685 3695 O
or 154 156 3696 3698 O
to 157 159 3699 3701 O
dimethyl 160 168 3702 3710 B-allergy_name
sulfoxide 169 178 3711 3720 I-allergy_name
( 179 180 3721 3722 I-allergy_name
DMSO 180 184 3722 3726 I-allergy_name
) 184 185 3726 3727 I-allergy_name

History 0 7 3728 3735 O
of 8 10 3736 3738 O
another 11 18 3739 3746 O
malignancy 19 29 3747 3757 B-cancer
; 29 30 3757 3758 O
exception 31 40 3759 3768 O
: 40 41 3768 3769 O
patients 42 50 3770 3778 O
who 51 54 3779 3782 O
have 55 59 3783 3787 O
been 60 64 3788 3792 O
disease 65 72 3793 3800 O
- 72 73 3800 3801 O
free 73 77 3801 3805 O
for 78 81 3806 3809 O
3 82 83 3810 3811 B-lower_bound
years 84 89 3812 3817 O
( 90 91 3818 3819 O
depending 91 100 3819 3828 O
upon 101 105 3829 3833 O
tumor 106 111 3834 3839 B-cancer
type 112 116 3840 3844 O
studied 117 124 3845 3852 O
or 125 127 3853 3855 O
clinical 128 136 3856 3864 O
setting 137 144 3865 3872 O
, 144 145 3872 3873 O
3 146 147 3874 3875 O
or 148 150 3876 3878 O
5 151 152 3879 3880 O
years 153 158 3881 3886 O
can 159 162 3887 3890 O
be 163 165 3891 3893 O
used 166 170 3894 3898 O
; 170 171 3898 3899 O
e.g. 172 176 3900 3904 O
, 176 177 3904 3905 O
for 178 181 3906 3909 O
advanced 182 190 3910 3918 B-cancer
melanoma 191 199 3919 3927 I-cancer
and 200 203 3928 3931 O
pancreatic 204 214 3932 3942 O
studies 215 222 3943 3950 O
3 223 224 3951 3952 O
years 225 230 3953 3958 O
is 231 233 3959 3961 O
more 234 238 3962 3966 O
appropriate 239 250 3967 3978 O
due 251 254 3979 3982 O
to 255 257 3983 3985 O
aggressiveness 258 272 3986 4000 O
of 273 275 4001 4003 O
the 276 279 4004 4007 O
disease 280 287 4008 4015 O
, 287 288 4015 4016 O
while 289 294 4017 4022 O
5 295 296 4023 4024 O
years 297 302 4025 4030 O
can 303 306 4031 4034 O
be 307 309 4035 4037 O
more 310 314 4038 4042 O
appropriate 315 326 4043 4054 O
for 327 330 4055 4058 O
prostate 331 339 4059 4067 B-cancer
or 340 342 4068 4070 O
ovarian 343 350 4071 4078 B-cancer
cancer 351 357 4079 4085 I-cancer
or 358 360 4086 4088 O
adjuvant 361 369 4089 4097 B-treatment
setting 370 377 4098 4105 I-treatment
when 378 382 4106 4110 O
life 383 387 4111 4115 O
expectancy 388 398 4116 4126 O
is 399 401 4127 4129 O
longer 402 408 4130 4136 O
) 408 409 4136 4137 O
, 409 410 4137 4138 O
or 411 413 4139 4141 O
patients 414 422 4142 4150 O
with 423 427 4151 4155 O
a 428 429 4156 4157 O
history 430 437 4158 4165 O
of 438 440 4166 4168 O
completely 441 451 4169 4179 O
resected 452 460 4180 4188 O
non 461 464 4189 4192 B-cancer
- 464 465 4192 4193 I-cancer
melanoma 465 473 4193 4201 I-cancer
skin 474 478 4202 4206 I-cancer
cancer 479 485 4207 4213 I-cancer
and/or 486 492 4214 4220 O
patients 493 501 4221 4229 O
with 502 506 4230 4234 O
indolent 507 515 4235 4243 O
secondary 516 525 4244 4253 B-cancer
malignancies 526 538 4254 4266 I-cancer
, 538 539 4266 4267 O
are 540 543 4268 4271 O
eligible 544 552 4272 4280 O
; 552 553 4280 4281 O
consult 554 561 4282 4289 O
the 562 565 4290 4293 O
CTEP 566 570 4294 4298 O
medical 571 578 4299 4306 O
monitor 579 586 4307 4314 O
if 587 589 4315 4317 O
unsure 590 596 4318 4324 O
whether 597 604 4325 4332 O
second 605 611 4333 4339 B-cancer
malignancies 612 624 4340 4352 I-cancer
meet 625 629 4353 4357 O
the 630 633 4358 4361 O
requirements 634 646 4362 4374 O
specified 647 656 4375 4384 O
above 657 662 4385 4390 O
; 662 663 4390 4391 O
exception 664 673 4392 4401 O
: 673 674 4401 4402 O
patients 675 683 4403 4411 O
with 684 688 4412 4416 O
history 689 696 4417 4424 O
of 697 699 4425 4427 O
RAS 700 703 4428 4431 O
mutation 704 712 4432 4440 O
- 712 713 4440 4441 O
positive 713 721 4441 4449 O
tumors 722 728 4450 4456 B-cancer
are 729 732 4457 4460 O
not 733 736 4461 4464 O
eligible 737 745 4465 4473 O
regardless 746 756 4474 4484 O
of 757 759 4485 4487 O
interval 760 768 4488 4496 O
from 769 773 4497 4501 O
the 774 777 4502 4505 O
current 778 785 4506 4513 O
study 786 791 4514 4519 O
; 791 792 4519 4520 O
prospective 793 804 4521 4532 O
RAS 805 808 4533 4536 O
testing 809 816 4537 4544 O
is 817 819 4545 4547 O
not 820 823 4548 4551 O
required 824 832 4552 4560 O
; 832 833 4560 4561 O
however 834 841 4562 4569 O
, 841 842 4569 4570 O
if 843 845 4571 4573 O
the 846 849 4574 4577 O
results 850 857 4578 4585 O
of 858 860 4586 4588 O
previous 861 869 4589 4597 O
RAS 870 873 4598 4601 O
testing 874 881 4602 4609 O
are 882 885 4610 4613 O
known 886 891 4614 4619 O
, 891 892 4619 4620 O
they 893 897 4621 4625 O
must 898 902 4626 4630 O
be 903 905 4631 4633 O
used 906 910 4634 4638 O
in 911 913 4639 4641 O
assessing 914 923 4642 4651 O
eligibility 924 935 4652 4663 O

History 0 7 4664 4671 O
of 8 10 4672 4674 O
interstitial 11 23 4675 4687 O
lung 24 28 4688 4692 B-chronic_disease
disease 29 36 4693 4700 I-chronic_disease
or 37 39 4701 4703 O
pneumonitis 40 51 4704 4715 B-chronic_disease

History 0 7 4716 4723 O
or 8 10 4724 4726 O
current 11 18 4727 4734 O
evidence 19 27 4735 4743 O
/ 27 28 4743 4744 O
risk 28 32 4744 4748 O
of 33 35 4749 4751 O
retinal 36 43 4752 4759 B-chronic_disease
vein 44 48 4760 4764 I-chronic_disease
occlusion 49 58 4765 4774 I-chronic_disease
( 59 60 4775 4776 I-chronic_disease
RVO 60 63 4776 4779 I-chronic_disease
) 63 64 4779 4780 I-chronic_disease
or 65 67 4781 4783 O
central 68 75 4784 4791 B-chronic_disease
serous 76 82 4792 4798 I-chronic_disease
retinopathy 83 94 4799 4810 I-chronic_disease
( 95 96 4811 4812 I-chronic_disease
CSR 96 99 4812 4815 I-chronic_disease
) 99 100 4815 4816 I-chronic_disease

History 0 7 4817 4824 O
or 8 10 4825 4827 O
evidence 11 19 4828 4836 O
of 20 22 4837 4839 O
current 23 30 4840 4847 O
> 31 32 4848 4849 O
= 32 33 4849 4850 O
class 34 39 4851 4856 B-lower_bound
II 40 42 4857 4859 I-lower_bound
congestive 43 53 4860 4870 B-chronic_disease
heart 54 59 4871 4876 I-chronic_disease
failure 60 67 4877 4884 I-chronic_disease
as 68 70 4885 4887 O
defined 71 78 4888 4895 O
by 79 81 4896 4898 O
the 82 85 4899 4902 O
New 86 89 4903 4906 B-clinical_variable
York 90 94 4907 4911 I-clinical_variable
Heart 95 100 4912 4917 I-clinical_variable
Association 101 112 4918 4929 I-clinical_variable
( 113 114 4930 4931 I-clinical_variable
NYHA 114 118 4931 4935 I-clinical_variable
) 118 119 4935 4936 I-clinical_variable
functional 120 130 4937 4947 O
classification 131 145 4948 4962 O
system 146 152 4963 4969 O

History 0 7 4970 4977 O
or 8 10 4978 4980 O
evidence 11 19 4981 4989 O
of 20 22 4990 4992 O
current 23 30 4993 5000 O
clinically 31 41 5001 5011 O
significant 42 53 5012 5023 O
uncontrolled 54 66 5024 5036 O
arrhythmias 67 78 5037 5048 B-chronic_disease
( 79 80 5049 5050 O
exception 80 89 5050 5059 O
: 89 90 5059 5060 O
patients 91 99 5061 5069 O
with 100 104 5070 5074 O
controlled 105 115 5075 5085 O
atrial 116 122 5086 5092 B-chronic_disease
fibrillation 123 135 5093 5105 I-chronic_disease
for 136 139 5106 5109 O
> 140 141 5110 5111 O
30 142 144 5112 5114 B-lower_bound
days 145 149 5115 5119 I-lower_bound
prior 150 155 5120 5125 I-lower_bound
to 156 158 5126 5128 O
randomization 159 172 5129 5142 O
are 173 176 5143 5146 O
eligible 177 185 5147 5155 O
) 185 186 5155 5156 O

Human 0 5 5157 5162 B-chronic_disease
immunodeficiency 6 22 5163 5179 I-chronic_disease
virus 23 28 5180 5185 I-chronic_disease
( 29 30 5186 5187 I-chronic_disease
HIV)-positive 30 43 5187 5200 I-chronic_disease
patients 44 52 5201 5209 O
on 53 55 5210 5212 O
combination 56 67 5213 5224 B-treatment
antiretroviral 68 82 5225 5239 I-treatment
therapy 83 90 5240 5247 I-treatment
that 91 95 5248 5252 O
predict 96 103 5253 5260 O
to 104 106 5261 5263 O
interact 107 115 5264 5272 O
with 116 120 5273 5277 O
any 121 124 5278 5281 O
of 125 127 5282 5284 O
the 128 131 5285 5288 O
study 132 137 5289 5294 B-treatment
drugs 138 143 5295 5300 I-treatment
are 144 147 5301 5304 O
ineligible 148 158 5305 5315 O
because 159 166 5316 5323 O
of 167 169 5324 5326 O
the 170 173 5327 5330 O
potential 174 183 5331 5340 O
for 184 187 5341 5344 O
pharmacokinetic 188 203 5345 5360 O
interactions 204 216 5361 5373 O
with 217 221 5374 5378 O
the 222 225 5379 5382 O
study 226 231 5383 5388 O
drugs 232 237 5389 5394 O
; 237 238 5394 5395 O
appropriate 239 250 5396 5407 O
studies 251 258 5408 5415 O
will 259 263 5416 5420 O
be 264 266 5421 5423 O
undertaken 267 277 5424 5434 O
in 278 280 5435 5437 O
patients 281 289 5438 5446 O
receiving 290 299 5447 5456 O
combination 300 311 5457 5468 O
antiretroviral 312 326 5469 5483 O
therapy 327 334 5484 5491 O
when 335 339 5492 5496 O
indicated 340 349 5497 5506 O
; 349 350 5506 5507 O
it 351 353 5508 5510 O
is 354 356 5511 5513 O
not 357 360 5514 5517 O
necessary 361 370 5518 5527 O
to 371 373 5528 5530 O
conduct 374 381 5531 5538 O
HIV 382 385 5539 5542 O
testing 386 393 5543 5550 O
at 394 396 5551 5553 O
screening 397 406 5554 5563 O
; 406 407 5563 5564 O
patients 408 416 5565 5573 O
who 417 420 5574 5577 O
are 421 424 5578 5581 O
HIV 425 428 5582 5585 O
- 428 429 5585 5586 O
positive 429 437 5586 5594 O
with 438 442 5595 5599 O
undetectable 443 455 5600 5612 O
viral 456 461 5613 5618 O
loads 462 467 5619 5624 O
, 467 468 5624 5625 O
not 469 472 5626 5629 O
on 473 475 5630 5632 O
interacting 476 487 5633 5644 B-treatment
antiretroviral 488 502 5645 5659 I-treatment
therapy 503 510 5660 5667 I-treatment
, 510 511 5667 5668 O
and 512 515 5669 5672 O
have 516 520 5673 5677 O
CD4 521 524 5678 5681 B-clinical_variable
counts 525 531 5682 5688 I-clinical_variable
above 532 537 5689 5694 O
300 538 541 5695 5698 B-lower_bound
/ 541 542 5698 5699 I-lower_bound
mm^3 542 546 5699 5703 I-lower_bound
may 547 550 5704 5707 O
be 551 553 5708 5710 O
eligible 554 562 5711 5719 O
after 563 568 5720 5725 O
discussion 569 579 5726 5736 O
with 580 584 5737 5741 O
the 585 588 5742 5745 O
principal 589 598 5746 5755 O
investigator 599 611 5756 5768 O

Hyperlipidemia 0 14 5769 5783 B-chronic_disease
: 14 15 5783 5784 O
gemfibrozil 16 27 5785 5796 B-treatment

Known 0 5 5797 5802 O
history 6 13 5803 5810 O
of 14 16 5811 5813 O
hepatitis 17 26 5814 5823 B-chronic_disease
B 27 28 5824 5825 I-chronic_disease
virus 29 34 5826 5831 I-chronic_disease
( 35 36 5832 5833 I-chronic_disease
HBV 36 39 5833 5836 I-chronic_disease
) 39 40 5836 5837 I-chronic_disease
, 40 41 5837 5838 O
or 42 44 5839 5841 O
hepatitis 45 54 5842 5851 B-chronic_disease
C 55 56 5852 5853 I-chronic_disease
virus 57 62 5854 5859 I-chronic_disease
( 63 64 5860 5861 I-chronic_disease
HCV 64 67 5861 5864 I-chronic_disease
) 67 68 5864 5865 I-chronic_disease
infection 69 78 5866 5875 O
( 79 80 5876 5877 O
patients 80 88 5877 5885 O
with 89 93 5886 5890 O
chronic 94 101 5891 5898 O
or 102 104 5899 5901 O
cleared 105 112 5902 5909 O
HBV 113 116 5910 5913 O
and 117 120 5914 5917 O
HCV 121 124 5918 5921 O
infection 125 134 5922 5931 O
are 135 138 5932 5935 O
eligible 139 147 5936 5944 O
) 147 148 5944 5945 O
; 148 149 5945 5946 O
it 150 152 5947 5949 O
is 153 155 5950 5952 O
not 156 159 5953 5956 O
necessary 160 169 5957 5966 O
to 170 172 5967 5969 O
conduct 173 180 5970 5977 O
HBV 181 184 5978 5981 O
and 185 188 5982 5985 O
HCV 189 192 5986 5989 O
testing 193 200 5990 5997 O
at 201 203 5998 6000 O
screening 204 213 6001 6010 O

Left 0 4 6011 6015 B-clinical_variable
ventricular 5 16 6016 6027 I-clinical_variable
ejection 17 25 6028 6036 I-clinical_variable
fraction 26 34 6037 6045 I-clinical_variable
> 35 36 6046 6047 O
= 36 37 6047 6048 O
institutional 38 51 6049 6062 O
lower 52 57 6063 6068 O
limit 58 63 6069 6074 O
of 64 66 6075 6077 O
normal 67 73 6078 6084 O
( 74 75 6085 6086 O
LLN 75 78 6086 6089 O
) 78 79 6089 6090 O
by 80 82 6091 6093 O
echocardiogram 83 97 6094 6108 B-treatment
( 98 99 6109 6110 I-treatment
ECHO 99 103 6110 6114 I-treatment
) 103 104 6114 6115 I-treatment

Leukocytes 0 10 6116 6126 B-clinical_variable
> 11 12 6127 6128 O
= 12 13 6128 6129 O
3,000 14 19 6130 6135 B-lower_bound
/ 19 20 6135 6136 I-lower_bound
mcL 20 23 6136 6139 I-lower_bound

Life 0 4 6140 6144 B-clinical_variable
expectancy 5 15 6145 6155 I-clinical_variable
of 16 18 6156 6158 O
greater 19 26 6159 6166 O
than 27 31 6167 6171 O
3 32 33 6172 6173 B-lower_bound
months 34 40 6174 6180 I-lower_bound

Miscellaneous 0 13 6181 6194 O
: 13 14 6194 6195 O
bosentan 15 23 6196 6204 B-treatment
, 23 24 6204 6205 O
St. 25 28 6206 6209 B-treatment
John 29 33 6210 6214 I-treatment
's 33 35 6214 6216 I-treatment
wort 36 40 6217 6221 I-treatment

Miscellaneous 0 13 6222 6235 O
: 13 14 6235 6236 O
conivaptan 15 25 6237 6247 B-treatment

Other 0 5 6248 6253 O
anti 6 10 6254 6258 B-treatment
- 10 11 6258 6259 I-treatment
cancer 11 17 6259 6265 I-treatment
therapy 18 25 6266 6273 I-treatment
while 26 31 6274 6279 O
on 32 34 6280 6282 O
study 35 40 6283 6288 O
treatment 41 50 6289 6298 B-treatment
; 50 51 6298 6299 O
( 52 53 6300 6301 O
note 53 57 6301 6305 O
: 57 58 6305 6306 O
megestrol 59 68 6307 6316 B-treatment
[ 69 70 6317 6318 I-treatment
Megace 70 76 6318 6324 I-treatment
] 76 77 6324 6325 I-treatment
if 78 80 6326 6328 O
used 81 85 6329 6333 O
as 86 88 6334 6336 O
an 89 91 6337 6339 O
appetite 92 100 6340 6348 O
stimulant 101 110 6349 6358 O
is 111 113 6359 6361 O
allowed 114 121 6362 6369 O
) 121 122 6369 6370 O

Patients 0 8 6371 6379 O
must 9 13 6380 6384 O
have 14 18 6385 6389 O
a 19 20 6390 6391 O
corrected 21 30 6392 6401 O
QT 31 33 6402 6404 B-clinical_variable
( 34 35 6405 6406 I-clinical_variable
QTc 35 38 6406 6409 I-clinical_variable
) 38 39 6409 6410 I-clinical_variable
interval 40 48 6411 6419 I-clinical_variable
of 49 51 6420 6422 O
less 52 56 6423 6427 O
than 57 61 6428 6432 O
480 62 65 6433 6436 B-upper_bound
msec 66 70 6437 6441 I-upper_bound

Patients 0 8 6442 6450 O
must 9 13 6451 6455 O
have 14 18 6456 6460 O
histologically 19 33 6461 6475 O
confirmed 34 43 6476 6485 O
, 43 44 6485 6486 O
BRAF 45 49 6487 6491 O
- 49 50 6491 6492 O
mutant 50 56 6492 6498 O
( 57 58 6499 6500 O
V600E 58 63 6500 6505 O
/ 63 64 6505 6506 O
K 64 65 6506 6507 O
) 65 66 6507 6508 O
melanoma 67 75 6509 6517 B-cancer
( 76 77 6518 6519 O
molecularly 77 88 6519 6530 O
confirmed 89 98 6531 6540 O
using 99 104 6541 6546 O
validated 105 114 6547 6556 O
, 114 115 6556 6557 O
commercially 116 128 6558 6570 O
available 129 138 6571 6580 O
assay 139 144 6581 6586 O
performed 145 154 6587 6596 O
in 155 157 6597 6599 O
a 158 159 6600 6601 O
Clinical 160 168 6602 6610 O
Laboratory 169 179 6611 6621 O
Improvement 180 191 6622 6633 O
Act 192 195 6634 6637 O
[ 196 197 6638 6639 O
CLIA]-approved 197 211 6639 6653 O
laboratory 212 222 6654 6664 O
) 222 223 6664 6665 O
that 224 228 6666 6670 O
is 229 231 6671 6673 O
metastatic 232 242 6674 6684 O
or 243 245 6685 6687 O
unresectable 246 258 6688 6700 O
and 259 262 6701 6704 O
for 263 266 6705 6708 O
which 267 272 6709 6714 O
standard 273 281 6715 6723 O
curative 282 290 6724 6732 O
measures 291 299 6733 6741 O
do 300 302 6742 6744 O
not 303 306 6745 6748 O
exist 307 312 6749 6754 O
or 313 315 6755 6757 O
are 316 319 6758 6761 O
no 320 322 6762 6764 O
longer 323 329 6765 6771 O
effective 330 339 6772 6781 O

Patients 0 8 6782 6790 O
must 9 13 6791 6795 O
have 14 18 6796 6800 O
measurable 19 29 6801 6811 O
disease 30 37 6812 6819 O
, 37 38 6819 6820 O
defined 39 46 6821 6828 O
as 47 49 6829 6831 O
at 50 52 6832 6834 O
least 53 58 6835 6840 O
one 59 62 6841 6844 B-lower_bound
lesion 63 69 6845 6851 O
that 70 74 6852 6856 O
can 75 78 6857 6860 O
be 79 81 6861 6863 O
accurately 82 92 6864 6874 O
measured 93 101 6875 6883 O
in 102 104 6884 6886 O
at 105 107 6887 6889 O
least 108 113 6890 6895 O
one 114 117 6896 6899 O
dimension 118 127 6900 6909 O
( 128 129 6910 6911 O
longest 129 136 6911 6918 O
diameter 137 145 6919 6927 O
to 146 148 6928 6930 O
be 149 151 6931 6933 O
recorded 152 160 6934 6942 O
for 161 164 6943 6946 O
non 165 168 6947 6950 O
- 168 169 6950 6951 O
nodal 169 174 6951 6956 O
lesions 175 182 6957 6964 O
and 183 186 6965 6968 O
short 187 192 6969 6974 O
axis 193 197 6975 6979 O
for 198 201 6980 6983 O
nodal 202 207 6984 6989 O
lesions 208 215 6990 6997 O
) 215 216 6997 6998 O
as 217 219 6999 7001 O
> 220 221 7002 7003 O
= 221 222 7003 7004 O
20 223 225 7005 7007 B-lower_bound
mm 226 228 7008 7010 I-lower_bound
with 229 233 7011 7015 O
conventional 234 246 7016 7028 B-clinical_variable
techniques 247 257 7029 7039 I-clinical_variable
or 258 260 7040 7042 O
as 261 263 7043 7045 O
> 264 265 7046 7047 O
= 265 266 7047 7048 O
10 267 269 7049 7051 B-lower_bound
mm 270 272 7052 7054 I-lower_bound
with 273 277 7055 7059 O
spiral 278 284 7060 7066 O
computed 285 293 7067 7075 B-treatment
tomography 294 304 7076 7086 I-treatment
( 305 306 7087 7088 I-treatment
CT 306 308 7088 7090 I-treatment
) 308 309 7090 7091 I-treatment
scan 310 314 7092 7096 I-treatment
, 314 315 7096 7097 O
magnetic 316 324 7098 7106 B-treatment
resonance 325 334 7107 7116 I-treatment
imaging 335 342 7117 7124 I-treatment
( 343 344 7125 7126 I-treatment
MRI 344 347 7126 7129 I-treatment
) 347 348 7129 7130 I-treatment
, 348 349 7130 7131 O
or 350 352 7132 7134 O
calipers 353 361 7135 7143 B-treatment
by 362 364 7144 7146 O
clinical 365 373 7147 7155 O
exam 374 378 7156 7160 O

Patients 0 8 7161 7169 O
must 9 13 7170 7174 O
not 14 17 7175 7178 O
have 18 22 7179 7183 O
received 23 31 7184 7192 O
prior 32 37 7193 7198 O
navitoclax 38 48 7199 7209 B-treatment
, 48 49 7209 7210 O
unless 50 56 7211 7217 O
the 57 60 7218 7221 O
patient 61 68 7222 7229 O
received 69 77 7230 7238 O
< 78 79 7239 7240 O
7 80 81 7241 7242 B-upper_bound
days 82 86 7243 7247 I-upper_bound
of 87 89 7248 7250 O
navitoclax 90 100 7251 7261 O
lead 101 105 7262 7266 O
- 105 106 7266 7267 O
in 106 108 7267 7269 O
on 109 111 7270 7272 O
this 112 116 7273 7277 O
or 117 119 7278 7280 O
another 120 127 7281 7288 O
study 128 133 7289 7294 O
and 134 137 7295 7298 O
had 138 141 7299 7302 O
to 142 144 7303 7305 O
stop 145 149 7306 7310 O
for 150 153 7311 7314 O
reasons 154 161 7315 7322 O
other 162 167 7323 7328 O
than 168 172 7329 7333 O
toxicity 173 181 7334 7342 O
or 182 184 7343 7345 O
disease 185 192 7346 7353 O
progression 193 204 7354 7365 O

Patients 0 8 7366 7374 O
receiving 9 18 7375 7384 O
any 19 22 7385 7388 O
medications 23 34 7389 7400 B-treatment
or 35 37 7401 7403 O
substances 38 48 7404 7414 O
that 49 53 7415 7419 O
are 54 57 7420 7423 O
strong 58 64 7424 7430 B-treatment
inhibitors 65 75 7431 7441 I-treatment
or 76 78 7442 7444 I-treatment
inducers 79 87 7445 7453 I-treatment
of 88 90 7454 7456 I-treatment
CYP3A 91 96 7457 7462 I-treatment
or 97 99 7463 7465 I-treatment
CYP2C8 100 106 7466 7472 I-treatment
are 107 110 7473 7476 O
ineligible 111 121 7477 7487 O
; 121 122 7487 7488 O
current 123 130 7489 7496 O
use 131 134 7497 7500 O
of 135 137 7501 7503 O
, 137 138 7503 7504 O
or 139 141 7505 7507 O
intended 142 150 7508 7516 O
ongoing 151 158 7517 7524 B-treatment
treatment 159 168 7525 7534 I-treatment
with 169 173 7535 7539 O
: 173 174 7539 7540 O
herbal 175 181 7541 7547 B-treatment
remedies 182 190 7548 7556 I-treatment
( 191 192 7557 7558 O
e.g. 192 196 7558 7562 O
, 196 197 7562 7563 O
St. 198 201 7564 7567 B-treatment
John 202 206 7568 7572 I-treatment
's 206 208 7572 7574 I-treatment
wort 209 213 7575 7579 I-treatment
) 213 214 7579 7580 O
, 214 215 7580 7581 O
or 216 218 7582 7584 O
strong 219 225 7585 7591 B-treatment
inhibitors 226 236 7592 7602 I-treatment
or 237 239 7603 7605 I-treatment
inducers 240 248 7606 7614 I-treatment
of 249 251 7615 7617 I-treatment
permeability 252 264 7618 7630 I-treatment
- 264 265 7630 7631 I-treatment
glycoprotein 265 277 7631 7643 I-treatment
( 278 279 7644 7645 I-treatment
Pgp 279 282 7645 7648 I-treatment
) 282 283 7648 7649 I-treatment
or 284 286 7650 7652 O
breast 287 293 7653 7659 B-treatment
cancer 294 300 7660 7666 I-treatment
resistance 301 311 7667 7677 I-treatment
protein 312 319 7678 7685 I-treatment
1 320 321 7686 7687 I-treatment
( 322 323 7688 7689 I-treatment
Bcrp1 323 328 7689 7694 I-treatment
) 328 329 7694 7695 I-treatment
should 330 336 7696 7702 O
also 337 341 7703 7707 O
be 342 344 7708 7710 O
excluded 345 353 7711 7719 O

Patients 0 8 7720 7728 O
who 9 12 7729 7732 O
are 13 16 7733 7736 O
receiving 17 26 7737 7746 O
any 27 30 7747 7750 O
other 31 36 7751 7756 O
investigational 37 52 7757 7772 B-treatment
agents 53 59 7773 7779 I-treatment
have 60 64 7780 7784 O
received 65 73 7785 7793 O
any 74 77 7794 7797 O
other 78 83 7798 7803 O
investigational 84 99 7804 7819 B-treatment
drugs 100 105 7820 7825 I-treatment
within 106 112 7826 7832 O
28 113 115 7833 7835 B-upper_bound
days 116 120 7836 7840 I-upper_bound
( 121 122 7841 7842 O
or 122 124 7842 7844 O
five 125 129 7845 7849 O
half 130 134 7850 7854 O
- 134 135 7854 7855 O
lives 135 140 7855 7860 O
, 140 141 7860 7861 O
whichever 142 151 7862 7871 O
is 152 154 7872 7874 O
shorter 155 162 7875 7882 O
; 162 163 7882 7883 O
with 164 168 7884 7888 O
a 169 170 7889 7890 O
minimum 171 178 7891 7898 O
of 179 181 7899 7901 O
14 182 184 7902 7904 B-lower_bound
days 185 189 7905 7909 I-lower_bound
from 190 194 7910 7914 O
the 195 198 7915 7918 O
last 199 203 7919 7923 O
dose 204 208 7924 7928 O
) 208 209 7928 7929 O
preceding 210 219 7930 7939 O
the 220 223 7940 7943 O
first 224 229 7944 7949 O
dose 230 234 7950 7954 O
of 235 237 7955 7957 O
study 238 243 7958 7963 O
treatment 244 253 7964 7973 B-treatment
and 254 257 7974 7977 O
during 258 264 7978 7984 O
the 265 268 7985 7988 O
study 269 274 7989 7994 O

Patients 0 8 7995 8003 O
who 9 12 8004 8007 O
have 13 17 8008 8012 O
had 18 21 8013 8016 O
immunotherapy 22 35 8017 8030 B-treatment
, 35 36 8030 8031 O
chemotherapy 37 49 8032 8044 B-treatment
or 50 52 8045 8047 O
radiotherapy 53 65 8048 8060 B-treatment
within 66 72 8061 8067 O
14 73 75 8068 8070 B-upper_bound
days 76 80 8071 8075 I-upper_bound
prior 81 86 8076 8081 I-upper_bound
to 87 89 8082 8084 O
the 90 93 8085 8088 O
first 94 99 8089 8094 O
dose 100 104 8095 8099 O
of 105 107 8100 8102 O
navitoclax 108 118 8103 8113 B-treatment
, 118 119 8113 8114 O
or 120 122 8115 8117 O
prior 123 128 8118 8123 B-treatment
systemic 129 137 8124 8132 I-treatment
anti 138 142 8133 8137 I-treatment
- 142 143 8137 8138 I-treatment
cancer 143 149 8138 8144 I-treatment
therapy 150 157 8145 8152 I-treatment
( 158 159 8153 8154 O
chemotherapy 159 171 8154 8166 O
with 172 176 8167 8171 O
delayed 177 184 8172 8179 O
toxicity 185 193 8180 8188 O
, 193 194 8188 8189 O
extensive 195 204 8190 8199 B-treatment
radiation 205 214 8200 8209 I-treatment
therapy 215 222 8210 8217 I-treatment
, 222 223 8217 8218 O
immunotherapy 224 237 8219 8232 O
, 237 238 8232 8233 O
biologic 239 247 8234 8242 B-treatment
therapy 248 255 8243 8250 I-treatment
, 255 256 8250 8251 O
or 257 259 8252 8254 O
vaccine 260 267 8255 8262 B-treatment
therapy 268 275 8263 8270 I-treatment
) 275 276 8270 8271 O
within 277 283 8272 8278 O
the 284 287 8279 8282 O
last 288 292 8283 8287 B-upper_bound
3 293 294 8288 8289 I-upper_bound
weeks 295 300 8290 8295 I-upper_bound
prior 301 306 8296 8301 I-upper_bound
to 307 309 8302 8304 O
first 310 315 8305 8310 O
dose 316 320 8311 8315 O
of 321 323 8316 8318 O
dabrafenib 324 334 8319 8329 B-treatment
and/or 335 341 8330 8336 O
trametinib 342 352 8337 8347 B-treatment
; 352 353 8347 8348 O
chemotherapy 354 366 8349 8361 B-treatment
regimens 367 375 8362 8370 I-treatment
without 376 383 8371 8378 O
delayed 384 391 8379 8386 O
toxicity 392 400 8387 8395 O
within 401 407 8396 8402 O
the 408 411 8403 8406 O
last 412 416 8407 8411 B-upper_bound
2 417 418 8412 8413 I-upper_bound
weeks 419 424 8414 8419 I-upper_bound
preceding 425 434 8420 8429 O
the 435 438 8430 8433 O
first 439 444 8434 8439 O
dose 445 449 8440 8444 O
of 450 452 8445 8447 O
study 453 458 8448 8453 O
treatment 459 468 8454 8463 B-treatment
; 468 469 8463 8464 O
biologics 470 479 8465 8474 B-treatment
will 480 484 8475 8479 O
not 485 488 8480 8483 O
be 489 491 8484 8486 O
allowed 492 499 8487 8494 O
within 500 506 8495 8501 O
30 507 509 8502 8504 B-upper_bound
days 510 514 8505 8509 I-upper_bound
prior 515 520 8510 8515 I-upper_bound
to 521 523 8516 8518 O
, 523 524 8518 8519 O
or 525 527 8520 8522 O
during 528 534 8523 8529 O
, 534 535 8529 8530 O
navitoclax 536 546 8531 8541 O
administration 547 561 8542 8556 O

Platelets 0 9 8557 8566 B-clinical_variable
> 10 11 8567 8568 O
= 11 12 8568 8569 O
100,000 13 20 8570 8577 B-lower_bound
/ 20 21 8577 8578 I-lower_bound
mcL 21 24 8578 8581 I-lower_bound

Preclinical 0 11 8582 8593 O
studies 12 19 8594 8601 O
indicate 20 28 8602 8610 O
that 29 33 8611 8615 O
navitoclax 34 44 8616 8626 B-treatment
is 45 47 8627 8629 O
metabolized 48 59 8630 8641 O
by 60 62 8642 8644 O
CYP3A4 63 69 8645 8651 B-treatment
, 69 70 8651 8652 O
is 71 73 8653 8655 O
a 74 75 8656 8657 O
moderate 76 84 8658 8666 B-treatment
inhibitor 85 94 8667 8676 I-treatment
of 95 97 8677 8679 I-treatment
CYP2C8 98 104 8680 8686 I-treatment
, 104 105 8686 8687 O
and 106 109 8688 8691 O
is 110 112 8692 8694 O
a 113 114 8695 8696 O
strong 115 121 8697 8703 B-treatment
inhibitor 122 131 8704 8713 I-treatment
of 132 134 8714 8716 I-treatment
CYP2C9 135 141 8717 8723 I-treatment
; 141 142 8723 8724 O
there 143 148 8725 8730 O
is 149 151 8731 8733 O
also 152 156 8734 8738 O
evidence 157 165 8739 8747 O
of 166 168 8748 8750 O
interactions 169 181 8751 8763 O
with 182 186 8764 8768 O
dabrafenib 187 197 8769 8779 B-treatment
; 197 198 8779 8780 O
therefore 199 208 8781 8790 O
, 208 209 8790 8791 O
caution 210 217 8792 8799 O
should 218 224 8800 8806 O
be 225 227 8807 8809 O
exercised 228 237 8810 8819 O
when 238 242 8820 8824 O
dosing 243 249 8825 8831 O
navitoclax 250 260 8832 8842 B-treatment
concurrently 261 273 8843 8855 I-treatment
with 274 278 8856 8860 I-treatment
CYP2C8 279 285 8861 8867 I-treatment
and 286 289 8868 8871 I-treatment
CYP2C9 290 296 8872 8878 I-treatment
substrates 297 307 8879 8889 I-treatment
; 307 308 8889 8890 O
common 309 315 8891 8897 O
CYP2C8 316 322 8898 8904 B-treatment
substrates 323 333 8905 8915 I-treatment
include 334 341 8916 8923 O
paclitaxel 342 352 8924 8934 B-treatment
, 352 353 8934 8935 O
statins 354 361 8936 8943 B-treatment
, 361 362 8943 8944 O
and 363 366 8945 8948 O
glitazones 367 377 8949 8959 B-treatment
, 377 378 8959 8960 O
whereas 379 386 8961 8968 O
CYP2C9 387 393 8969 8975 B-treatment
substrates 394 404 8976 8986 I-treatment
include 405 412 8987 8994 I-treatment
phenytoin 413 422 8995 9004 I-treatment
; 422 423 9004 9005 O
when 424 428 9006 9010 O
possible 429 437 9011 9019 O
, 437 438 9019 9020 O
investigators 439 452 9021 9034 O
should 453 459 9035 9041 O
switch 460 466 9042 9048 O
to 467 469 9049 9051 O
alternative 470 481 9052 9063 O
medications 482 493 9064 9075 B-treatment
or 494 496 9076 9078 O
monitor 497 504 9079 9086 O
the 505 508 9087 9090 O
patients 509 517 9091 9099 O
closely 518 525 9100 9107 O
; 525 526 9107 9108 O
CYP3A 527 532 9109 9114 B-treatment
inhibitors 533 543 9115 9125 I-treatment
such 544 548 9126 9130 I-treatment
as 549 551 9131 9133 I-treatment
ketoconazole 552 564 9134 9146 I-treatment
and 565 568 9147 9150 I-treatment
clarithromycin 569 583 9151 9165 I-treatment
are 584 587 9166 9169 O
not 588 591 9170 9173 O
allowed 592 599 9174 9181 O
7 600 601 9182 9183 B-upper_bound
days 602 606 9184 9188 I-upper_bound
prior 607 612 9189 9194 I-upper_bound
to 613 615 9195 9197 O
the 616 619 9198 9201 O
first 620 625 9202 9207 B-treatment
dose 626 630 9208 9212 I-treatment
of 631 633 9213 9215 I-treatment
navitoclax 634 644 9216 9226 I-treatment
or 645 647 9227 9229 O
during 648 654 9230 9236 O
navitoclax 655 665 9237 9247 O
administration 666 680 9248 9262 O

Pregnant 0 8 9263 9271 B-pregnancy
women 9 14 9272 9277 B-gender
are 15 18 9278 9281 O
excluded 19 27 9282 9290 O
from 28 32 9291 9295 O
this 33 37 9296 9300 O
study 38 43 9301 9306 O
because 44 51 9307 9314 O
navitoclax 52 62 9315 9325 B-treatment
, 62 63 9325 9326 O
dabrafenib 64 74 9327 9337 B-treatment
, 74 75 9337 9338 O
and 76 79 9339 9342 O
trametinib 80 90 9343 9353 B-treatment
may 91 94 9354 9357 O
have 95 99 9358 9362 O
teratogenic 100 111 9363 9374 O
or 112 114 9375 9377 O
abortifacient 115 128 9378 9391 O
effects 129 136 9392 9399 O
; 136 137 9399 9400 O
because 138 145 9401 9408 O
there 146 151 9409 9414 O
is 152 154 9415 9417 O
an 155 157 9418 9420 O
unknown 158 165 9421 9428 O
but 166 169 9429 9432 O
potential 170 179 9433 9442 O
risk 180 184 9443 9447 O
for 185 188 9448 9451 O
adverse 189 196 9452 9459 O
events 197 203 9460 9466 O
in 204 206 9467 9469 O
nursing 207 214 9470 9477 O
infants 215 222 9478 9485 O
secondary 223 232 9486 9495 O
to 233 235 9496 9498 O
treatment 236 245 9499 9508 B-treatment
of 246 248 9509 9511 O
the 249 252 9512 9515 O
mother 253 259 9516 9522 O
with 260 264 9523 9527 O
the 265 268 9528 9531 O
study 269 274 9532 9537 B-treatment
drugs 275 280 9538 9543 I-treatment
, 280 281 9543 9544 O
breastfeeding 282 295 9545 9558 O
should 296 302 9559 9565 O
be 303 305 9566 9568 O
discontinued 306 318 9569 9581 O
if 319 321 9582 9584 O
the 322 325 9585 9588 O
mother 326 332 9589 9595 O
is 333 335 9596 9598 O
treated 336 343 9599 9606 O
with 344 348 9607 9611 O
the 349 352 9612 9615 O
study 353 358 9616 9621 O
drugs 359 364 9622 9627 O

Prior 0 5 9628 9633 B-treatment
navitoclax 6 16 9634 9644 I-treatment
, 16 17 9644 9645 O
BRAF 18 22 9646 9650 B-treatment
inhibitor 23 32 9651 9660 I-treatment
, 32 33 9660 9661 O
and 34 37 9662 9665 O
MEK 38 41 9666 9669 B-treatment
inhibitor 42 51 9670 9679 I-treatment
is 52 54 9680 9682 O
prohibited 55 65 9683 9693 O
; 65 66 9693 9694 O
( 67 68 9695 9696 O
exceptions 68 78 9696 9706 O
for 79 82 9707 9710 O
Phase 83 88 9711 9716 O
I 89 90 9717 9718 O
are 91 94 9719 9722 O
described 95 104 9723 9732 O
above 105 110 9733 9738 O
) 110 111 9738 9739 O

Prior 0 5 9740 9745 B-treatment
therapy 6 13 9746 9753 I-treatment
is 14 16 9754 9756 O
allowed 17 24 9757 9764 O
; 24 25 9764 9765 O
for 26 29 9766 9769 O
patients 30 38 9770 9778 O
enrolled 39 47 9779 9787 O
in 48 50 9788 9790 O
the 51 54 9791 9794 O
Phase 55 60 9795 9800 O
I 61 62 9801 9802 O
portion 63 70 9803 9810 O
of 71 73 9811 9813 O
the 74 77 9814 9817 O
study 78 83 9818 9823 O
, 83 84 9823 9824 O
patients 85 93 9825 9833 O
may 94 97 9834 9837 O
have 98 102 9838 9842 O
received 103 111 9843 9851 O
any 112 115 9852 9855 O
number 116 122 9856 9862 O
of 123 125 9863 9865 O
prior 126 131 9866 9871 O
lines 132 137 9872 9877 O
of 138 140 9878 9880 O
therapy 141 148 9881 9888 O
including 149 158 9889 9898 O
treatment 159 168 9899 9908 B-treatment
with 169 173 9909 9913 I-treatment
a 174 175 9914 9915 I-treatment
BRAF 176 180 9916 9920 I-treatment
and/or 181 187 9921 9927 O
MEK 188 191 9928 9931 B-treatment
inhibitor 192 201 9932 9941 I-treatment
; 201 202 9941 9942 O
prior 203 208 9943 9948 B-treatment
navitoclax 209 219 9949 9959 I-treatment
use 220 223 9960 9963 O
will 224 228 9964 9968 O
not 229 232 9969 9972 O
be 233 235 9973 9975 O
allowed 236 243 9976 9983 O
, 243 244 9983 9984 O
unless 245 251 9985 9991 O
the 252 255 9992 9995 O
patient 256 263 9996 10003 O
received 264 272 10004 10012 O
< 273 274 10013 10014 O
7 275 276 10015 10016 B-upper_bound
days 277 281 10017 10021 I-upper_bound
of 282 284 10022 10024 O
navitoclax 285 295 10025 10035 O
lead 296 300 10036 10040 O
- 300 301 10040 10041 O
in 301 303 10041 10043 O
on 304 306 10044 10046 O
this 307 311 10047 10051 O
or 312 314 10052 10054 O
another 315 322 10055 10062 O
study 323 328 10063 10068 O
and 329 332 10069 10072 O
had 333 336 10073 10076 O
to 337 339 10077 10079 O
stop 340 344 10080 10084 O
for 345 348 10085 10088 O
reasons 349 356 10089 10096 O
other 357 362 10097 10102 O
than 363 367 10103 10107 O
toxicity 368 376 10108 10116 O
or 377 379 10117 10119 O
disease 380 387 10120 10127 O
progression 388 399 10128 10139 O

Prior 0 5 10140 10145 B-treatment
therapy 6 13 10146 10153 I-treatment
is 14 16 10154 10156 O
allowed 17 24 10157 10164 O
; 24 25 10164 10165 O
for 26 29 10166 10169 O
patients 30 38 10170 10178 O
enrolled 39 47 10179 10187 O
in 48 50 10188 10190 O
the 51 54 10191 10194 O
Phase 55 60 10195 10200 O
II 61 63 10201 10203 O
portion 64 71 10204 10211 O
of 72 74 10212 10214 O
the 75 78 10215 10218 O
study 79 84 10219 10224 O
, 84 85 10224 10225 O
patients 86 94 10226 10234 O
may 95 98 10235 10238 O
have 99 103 10239 10243 O
received 104 112 10244 10252 O
prior 113 118 10253 10258 B-treatment
immunotherapy 119 132 10259 10272 I-treatment
( 133 134 10273 10274 O
including 134 143 10274 10283 O
high 144 148 10284 10288 B-treatment
- 148 149 10288 10289 I-treatment
dose 149 153 10289 10293 I-treatment
IL-2 154 158 10294 10298 I-treatment
, 158 159 10298 10299 O
ipilimumab 160 170 10300 10310 B-treatment
, 170 171 10310 10311 O
nivolumab 172 181 10312 10321 B-treatment
, 181 182 10321 10322 O
and 183 186 10323 10326 O
other 187 192 10327 10332 O
anti 193 197 10333 10337 B-treatment
- 197 198 10337 10338 I-treatment
PD1 198 201 10338 10341 I-treatment
/ 201 202 10341 10342 I-treatment
PDL1 202 206 10342 10346 I-treatment
antibodies 207 217 10347 10357 I-treatment
) 217 218 10357 10358 O
or 219 221 10359 10361 O
chemotherapy 222 234 10362 10374 B-treatment
; 234 235 10374 10375 O
however 236 243 10376 10383 O
prior 244 249 10384 10389 B-treatment
navitoclax 250 260 10390 10400 I-treatment
, 260 261 10400 10401 O
BRAF 262 266 10402 10406 B-treatment
inhibitor 267 276 10407 10416 I-treatment
and/or 277 283 10417 10423 O
MEK 284 287 10424 10427 B-treatment
inhibitor 288 297 10428 10437 I-treatment
therapy 298 305 10438 10445 I-treatment
will 306 310 10446 10450 O
not 311 314 10451 10454 O
be 315 317 10455 10457 O
allowed 318 325 10458 10465 O

Prothrombin 0 11 10466 10477 B-clinical_variable
time 12 16 10478 10482 I-clinical_variable
( 17 18 10483 10484 I-clinical_variable
PT)/international 18 35 10484 10501 I-clinical_variable
normalized 36 46 10502 10512 I-clinical_variable
ratio 47 52 10513 10518 I-clinical_variable
( 53 54 10519 10520 I-clinical_variable
INR 54 57 10520 10523 I-clinical_variable
) 57 58 10523 10524 I-clinical_variable
and 59 62 10525 10528 O
partial 63 70 10529 10536 B-clinical_variable
thromboplastin 71 85 10537 10551 I-clinical_variable
time 86 90 10552 10556 I-clinical_variable
( 91 92 10557 10558 I-clinical_variable
PTT 92 95 10558 10561 I-clinical_variable
) 95 96 10561 10562 I-clinical_variable
< 97 98 10563 10564 O
1.3 99 102 10565 10568 B-upper_bound
x 103 104 10569 10570 I-upper_bound
upper 105 110 10571 10576 I-upper_bound
limit 111 116 10577 10582 I-upper_bound
of 117 119 10583 10585 I-upper_bound
normal 120 126 10586 10592 I-upper_bound
( 127 128 10593 10594 I-upper_bound
ULN 128 131 10594 10597 I-upper_bound
) 131 132 10597 10598 I-upper_bound

Serum 0 5 10599 10604 B-clinical_variable
creatinine 6 16 10605 10615 I-clinical_variable
= 17 18 10616 10617 O
< 18 19 10617 10618 O
1.5 20 23 10619 10622 B-upper_bound
mg 24 26 10623 10625 I-upper_bound
/ 26 27 10625 10626 I-upper_bound
dL 27 29 10626 10628 I-upper_bound
OR 30 32 10629 10631 O
creatinine 33 43 10632 10642 B-clinical_variable
clearance 44 53 10643 10652 I-clinical_variable
> 54 55 10653 10654 O
= 55 56 10654 10655 O
50 57 59 10656 10658 B-lower_bound
mL 60 62 10659 10661 I-lower_bound
/ 62 63 10661 10662 I-lower_bound
min/1.73 63 71 10662 10670 I-lower_bound
m^2 72 75 10671 10674 I-lower_bound

Strong 0 6 10675 10681 B-treatment
inducers 7 15 10682 10690 I-treatment
of 16 18 10691 10693 I-treatment
CYP3A 19 24 10694 10699 I-treatment
or 25 27 10700 10702 O
CYP2C8 28 34 10703 10709 B-treatment

Strong 0 6 10710 10716 B-treatment
inhibitors 7 17 10717 10727 I-treatment
of 18 20 10728 10730 I-treatment
CYP3A 21 26 10731 10736 I-treatment
or 27 29 10737 10739 I-treatment
CYP2C8 30 36 10740 10746 I-treatment

Subject 0 7 10747 10754 O
has 8 11 10755 10758 O
a 12 13 10759 10760 O
recent 14 20 10761 10767 O
history 21 28 10768 10775 O
of 29 31 10776 10778 O
non 32 35 10779 10782 B-treatment
- 35 36 10782 10783 I-treatment
chemotherapy 36 48 10783 10795 I-treatment
- 48 49 10795 10796 O
induced 49 56 10796 10803 O
thrombocytopenic 57 73 10804 10820 B-chronic_disease
- 73 74 10820 10821 O
associated 74 84 10821 10831 O
bleeding 85 93 10832 10840 O
within 94 100 10841 10847 O
1 101 102 10848 10849 B-upper_bound
year 103 107 10850 10854 I-upper_bound
prior 108 113 10855 10860 I-upper_bound
to 114 116 10861 10863 O
the 117 120 10864 10867 O
first 121 126 10868 10873 O
dose 127 131 10874 10878 O
of 132 134 10879 10881 O
study 135 140 10882 10887 O
drug 141 145 10888 10892 O

The 0 3 10893 10896 O
effects 4 11 10897 10904 O
of 12 14 10905 10907 O
navitoclax 15 25 10908 10918 B-treatment
, 25 26 10918 10919 O
dabrafenib 27 37 10920 10930 B-treatment
, 37 38 10930 10931 O
and 39 42 10932 10935 O
trametinib 43 53 10936 10946 B-treatment
on 54 56 10947 10949 O
the 57 60 10950 10953 O
developing 61 71 10954 10964 O
human 72 77 10965 10970 O
fetus 78 83 10971 10976 O
are 84 87 10977 10980 O
unknown 88 95 10981 10988 O
; 95 96 10988 10989 O
for 97 100 10990 10993 O
this 101 105 10994 10998 O
reason 106 112 10999 11005 O
, 112 113 11005 11006 O
women 114 119 11007 11012 B-gender
of 120 122 11013 11015 O
child 123 128 11016 11021 O
- 128 129 11021 11022 O
bearing 129 136 11022 11029 O
potential 137 146 11030 11039 O
and 147 150 11040 11043 O
men 151 154 11044 11047 O
with 155 159 11048 11052 O
partners 160 168 11053 11061 O
of 169 171 11062 11064 O
childbearing 172 184 11065 11077 O
potential 185 194 11078 11087 O
must 195 199 11088 11092 O
agree 200 205 11093 11098 B-contraception_consent
to 206 208 11099 11101 I-contraception_consent
use 209 212 11102 11105 I-contraception_consent
adequate 213 221 11106 11114 I-contraception_consent
contraception 222 235 11115 11128 I-contraception_consent
( 236 237 11129 11130 O
barrier 237 244 11130 11137 B-contraception_consent
method 245 251 11138 11144 I-contraception_consent
of 252 254 11145 11147 I-contraception_consent
birth 255 260 11148 11153 I-contraception_consent
control 261 268 11154 11161 I-contraception_consent
, 268 269 11161 11162 O
or 270 272 11163 11165 O
abstinence 273 283 11166 11176 B-contraception_consent
; 283 284 11176 11177 O
hormonal 285 293 11178 11186 B-contraception_consent
contraception 294 307 11187 11200 I-contraception_consent
is 308 310 11201 11203 O
not 311 314 11204 11207 O
allowed 315 322 11208 11215 O
due 323 326 11216 11219 O
to 327 329 11220 11222 O
drug 330 334 11223 11227 O
- 334 335 11227 11228 O
drug 335 339 11228 11232 O
interactions 340 352 11233 11245 O
which 353 358 11246 11251 O
can 359 362 11252 11255 O
render 363 369 11256 11262 O
hormonal 370 378 11263 11271 O
contraceptives 379 393 11272 11286 O
ineffective 394 405 11287 11298 O
) 405 406 11298 11299 O
prior 407 412 11300 11305 O
to 413 415 11306 11308 O
study 416 421 11309 11314 O
entry 422 427 11315 11320 O
, 427 428 11320 11321 O
for 429 432 11322 11325 O
the 433 436 11326 11329 O
duration 437 445 11330 11338 O
of 446 448 11339 11341 O
study 449 454 11342 11347 O
participation 455 468 11348 11361 O
, 468 469 11361 11362 O
and 470 473 11363 11366 O
for 474 477 11367 11370 O
4 478 479 11371 11372 B-upper_bound
months 480 486 11373 11379 I-upper_bound
after 487 492 11380 11385 I-upper_bound
completion 493 503 11386 11396 O
of 504 506 11397 11399 O
study 507 512 11400 11405 O
drug 513 517 11406 11410 O
administration 518 532 11411 11425 O
; 532 533 11425 11426 O
should 534 540 11427 11433 O
a 541 542 11434 11435 O
woman 543 548 11436 11441 B-gender
become 549 555 11442 11448 B-pregnancy
pregnant 556 564 11449 11457 I-pregnancy
or 565 567 11458 11460 O
suspect 568 575 11461 11468 O
she 576 579 11469 11472 O
is 580 582 11473 11475 O
pregnant 583 591 11476 11484 O
while 592 597 11485 11490 O
she 598 601 11491 11494 O
is 602 604 11495 11497 O
participating 605 618 11498 11511 O
in 619 621 11512 11514 O
this 622 626 11515 11519 O
study 627 632 11520 11525 O
, 632 633 11525 11526 O
she 634 637 11527 11530 O
should 638 644 11531 11537 O
inform 645 651 11538 11544 O
her 652 655 11545 11548 O
treating 656 664 11549 11557 O
physician 665 674 11558 11567 O
immediately 675 686 11568 11579 O

Total 0 5 11580 11585 B-clinical_variable
bilirubin 6 15 11586 11595 I-clinical_variable
= 16 17 11596 11597 O
< 17 18 11597 11598 O
1.5 19 22 11599 11602 O
x 23 24 11603 11604 O
institutional 25 38 11605 11618 O
upper 39 44 11619 11624 O
limit 45 50 11625 11630 O
of 51 53 11631 11633 O
normal 54 60 11634 11640 O
OR 61 63 11641 11643 O
> 64 65 11644 11645 O
1.5 66 69 11646 11649 O
x 70 71 11650 11651 O
institutional 72 85 11652 11665 O
upper 86 91 11666 11671 O
limit 92 97 11672 11677 O
of 98 100 11678 11680 O
normal 101 107 11681 11687 O
allowed 108 115 11688 11695 O
if 116 118 11696 11698 O
direct 119 125 11699 11705 B-clinical_variable
bilirubin 126 135 11706 11715 I-clinical_variable
is 136 138 11716 11718 O
within 139 145 11719 11725 O
normal 146 152 11726 11732 O
range 153 158 11733 11738 O

Treatment 0 9 11739 11748 B-treatment
- 9 10 11748 11749 I-treatment
refractory 10 20 11749 11759 I-treatment
hypertension 21 33 11760 11772 I-treatment
defined 34 41 11773 11780 O
as 42 44 11781 11783 O
a 45 46 11784 11785 O
blood 47 52 11786 11791 B-clinical_variable
pressure 53 61 11792 11800 I-clinical_variable
of 62 64 11801 11803 I-clinical_variable
systolic 65 73 11804 11812 I-clinical_variable
> 74 75 11813 11814 O
140 76 79 11815 11818 B-lower_bound
mmHg 80 84 11819 11823 I-lower_bound
and/or 85 91 11824 11830 O
diastolic 92 101 11831 11840 B-clinical_variable
> 102 103 11841 11842 O
90 104 106 11843 11845 B-lower_bound
mmHg 107 111 11846 11850 I-lower_bound
which 112 117 11851 11856 O
can 118 121 11857 11860 O
not 121 124 11860 11863 O
be 125 127 11864 11866 O
controlled 128 138 11867 11877 O
by 139 141 11878 11880 O
anti 142 146 11881 11885 B-treatment
- 146 147 11885 11886 I-treatment
hypertensive 147 159 11886 11898 I-treatment
therapy 160 167 11899 11906 I-treatment

Uncontrolled 0 12 11907 11919 O
intercurrent 13 25 11920 11932 B-chronic_disease
illness 26 33 11933 11940 I-chronic_disease
including 34 43 11941 11950 O
, 43 44 11950 11951 O
but 45 48 11952 11955 O
not 49 52 11956 11959 O
limited 53 60 11960 11967 O
to 61 63 11968 11970 O
, 63 64 11970 11971 O
ongoing 65 72 11972 11979 O
or 73 75 11980 11982 O
active 76 82 11983 11989 B-chronic_disease
serious 83 90 11990 11997 I-chronic_disease
infection 91 100 11998 12007 I-chronic_disease
, 100 101 12007 12008 O
symptomatic 102 113 12009 12020 O
congestive 114 124 12021 12031 B-chronic_disease
heart 125 130 12032 12037 I-chronic_disease
failure 131 138 12038 12045 I-chronic_disease
, 138 139 12045 12046 O
unstable 140 148 12047 12055 B-chronic_disease
angina 149 155 12056 12062 I-chronic_disease
pectoris 156 164 12063 12071 I-chronic_disease
, 164 165 12071 12072 O
cardiac 166 173 12073 12080 B-chronic_disease
arrhythmia 174 184 12081 12091 I-chronic_disease
, 184 185 12091 12092 O
uncontrolled 186 198 12093 12105 B-chronic_disease
diabetes 199 207 12106 12114 I-chronic_disease
, 207 208 12114 12115 O
or 209 211 12116 12118 O
psychiatric 212 223 12119 12130 B-chronic_disease
illness 224 231 12131 12138 I-chronic_disease
/ 231 232 12138 12139 O
social 232 238 12139 12145 B-chronic_disease
situations 239 249 12146 12156 I-chronic_disease
that 250 254 12157 12161 O
would 255 260 12162 12167 O
limit 261 266 12168 12173 O
compliance 267 277 12174 12184 O
with 278 282 12185 12189 O
study 283 288 12190 12195 O
requirements 289 301 12196 12208 O

Unresolved 0 10 12209 12219 O
toxicity 11 19 12220 12228 O
of 20 22 12229 12231 O
National 23 31 12232 12240 O
Cancer 32 38 12241 12247 O
Institute 39 48 12248 12257 O
Common 49 55 12258 12264 O
Terminology 56 67 12265 12276 O
Criteria 68 76 12277 12285 O
for 77 80 12286 12289 O
Adverse 81 88 12290 12297 O
Events 89 95 12298 12304 O
, 95 96 12304 12305 O
version 97 104 12306 12313 O
5.0 105 108 12314 12317 O
( 109 110 12318 12319 O
NCI 110 113 12319 12322 O
CTCAE 114 119 12323 12328 O
v. 120 122 12329 12331 O
5.0 123 126 12332 12335 O
) 126 127 12335 12336 O
grade 128 133 12337 12342 B-lower_bound
2 134 135 12343 12344 I-lower_bound
or 136 138 12345 12347 O
higher 139 145 12348 12354 O
from 146 150 12355 12359 O
previous 151 159 12360 12368 B-treatment
anti 160 164 12369 12373 I-treatment
- 164 165 12373 12374 I-treatment
cancer 165 171 12374 12380 I-treatment
therapy 172 179 12381 12388 I-treatment
, 179 180 12388 12389 O
except 181 187 12390 12396 O
alopecia 188 196 12397 12405 B-chronic_disease
or 197 199 12406 12408 O
an 200 202 12409 12411 O
endocrine 203 212 12412 12421 O
toxicity 213 221 12422 12430 O
related 222 229 12431 12438 O
to 230 232 12439 12441 O
immunotherapy 233 246 12442 12455 B-treatment
( 247 248 12456 12457 O
e.g. 248 252 12457 12461 O
thyroiditis 253 264 12462 12473 B-chronic_disease
/ 264 265 12473 12474 O
hypothyroidism 265 279 12474 12488 B-chronic_disease
, 279 280 12488 12489 O
adrenal 281 288 12490 12497 B-chronic_disease
insufficiency 289 302 12498 12511 I-chronic_disease
, 302 303 12511 12512 O
hypophysitis 304 316 12513 12525 B-chronic_disease
) 316 317 12525 12526 O
requiring 318 327 12527 12536 O
replacement 328 339 12537 12548 B-treatment
therapy 340 347 12549 12556 I-treatment
, 347 348 12556 12557 O
at 349 351 12558 12560 O
the 352 355 12561 12564 O
time 356 360 12565 12569 O
of 361 363 12570 12572 O
randomization 364 377 12573 12586 O

Visible 0 7 12587 12594 O
retinal 8 15 12595 12602 O
pathology 16 25 12603 12612 O
as 26 28 12613 12615 O
assessed 29 37 12616 12624 O
by 38 40 12625 12627 O
ophthalmic 41 51 12628 12638 O
exam 52 56 12639 12643 O
that 57 61 12644 12648 O
is 62 64 12649 12651 O
considered 65 75 12652 12662 O
a 76 77 12663 12664 O
risk 78 82 12665 12669 O
factor 83 89 12670 12676 O
for 90 93 12677 12680 O
RVO 94 97 12681 12684 B-chronic_disease
or 98 100 12685 12687 O
CSR 101 104 12688 12691 B-chronic_disease
such 105 109 12692 12696 O
as 110 112 12697 12699 O
evidence 113 121 12700 12708 O
of 122 124 12709 12711 O
new 125 128 12712 12715 O
optic 129 134 12716 12721 O
disc 135 139 12722 12726 O
cupping 140 147 12727 12734 O
, 147 148 12734 12735 O
evidence 149 157 12736 12744 O
of 158 160 12745 12747 O
new 161 164 12748 12751 O
visual 165 171 12752 12758 O
field 172 177 12759 12764 O
defects 178 185 12765 12772 O
, 185 186 12772 12773 O
and 187 190 12774 12777 O
intraocular 191 202 12778 12789 B-clinical_variable
pressure 203 211 12790 12798 I-clinical_variable
> 212 213 12799 12800 O
21 214 216 12801 12803 B-lower_bound
mmHg 217 221 12804 12808 I-lower_bound

BMI 0 3 0 3 B-bmi
equal 4 9 4 9 O
or 10 12 10 12 O
greater 13 20 13 20 O
than 21 25 21 25 O
40 26 28 26 28 B-lower_bound

pre 0 3 29 32 B-pregnancy
- 3 4 32 33 I-pregnancy
pregnancy 4 13 33 42 I-pregnancy

Able 0 4 0 4 O
to 5 7 5 7 O
make 8 12 8 12 O
one 13 16 13 16 O
initial 17 24 17 24 O
appointment 25 36 25 36 O
at 37 39 37 39 O
the 40 43 40 43 O
Army 44 48 44 48 O
Medical 49 56 49 56 O
Department 57 67 57 67 O
Center 68 74 68 74 O
and 75 78 75 78 O
School 79 85 79 85 O
at 86 88 86 88 O
Fort 89 93 89 93 O
Sam 94 97 94 97 O
Houston 98 105 98 105 O
, 105 106 105 106 O
one 107 110 107 110 O
treatment 111 120 111 120 B-treatment
visit 121 126 121 126 O
approximately 127 140 127 140 O
2 141 142 141 142 B-lower_bound
- 142 143 142 143 O
3 143 144 143 144 B-upper_bound
days 145 149 145 149 I-upper_bound
after 150 155 150 155 I-upper_bound
the 156 159 156 159 O
initial 160 167 160 167 O
visit 168 173 168 173 O
, 173 174 173 174 O
and 175 178 175 178 O
then 179 183 179 183 O
a 184 185 184 185 O
final 186 191 186 191 O
outcome 192 199 192 199 O
visit 200 205 200 205 O
approximately 206 219 206 219 O
5 220 221 220 221 B-lower_bound
- 221 222 221 222 O
7 222 223 222 223 B-upper_bound
days 224 228 224 228 I-upper_bound
after 229 234 229 234 I-upper_bound
2nd 235 238 235 238 O
visit 239 244 239 244 O

Age 0 3 245 248 B-age
18 4 6 249 251 B-lower_bound
- 6 7 251 252 O
64 7 9 252 254 B-upper_bound
years 10 15 255 260 I-upper_bound

Any 0 3 261 264 O
prior 4 9 265 270 B-treatment
physical 10 18 271 279 I-treatment
therapy 19 26 280 287 I-treatment
, 26 27 287 288 O
chiropractic 28 40 289 301 B-treatment
, 40 41 301 302 O
acupuncture 42 53 303 314 B-treatment
treatment 54 63 315 324 I-treatment
or 64 66 325 327 O
injections 67 77 328 338 B-treatment
for 78 81 339 342 O
neck 82 86 343 347 O
pain 87 91 348 352 O
within 92 98 353 359 O
the 99 102 360 363 O
past 103 107 364 368 B-upper_bound
3 108 109 369 370 I-upper_bound
months 110 116 371 377 I-upper_bound

Females 0 7 378 385 B-gender
known 8 13 386 391 O
or 14 16 392 394 O
thought 17 24 395 402 O
to 25 27 403 405 O
be 28 30 406 408 O
pregnant 31 39 409 417 B-pregnancy

History 0 7 418 425 O
of 8 10 426 428 O
any 11 14 429 432 O
systemic 15 23 433 441 B-chronic_disease
disorder 24 32 442 450 I-chronic_disease
in 33 35 451 453 O
which 36 41 454 459 O
thoracic 42 50 460 468 B-treatment
spine 51 56 469 474 I-treatment
manipulation 57 69 475 487 I-treatment
and 70 73 488 491 O
TDN 74 77 492 495 B-treatment
would 78 83 496 501 O
be 84 86 502 504 O
contraindicated 87 102 505 520 O
( 103 104 521 522 O
i.e. 104 108 522 526 O
osteoporosis 109 121 527 539 B-chronic_disease
, 121 122 539 540 O
bleeding 123 131 541 549 B-chronic_disease
disorders 132 141 550 559 I-chronic_disease
or 142 144 560 562 O
anticoagulant 145 158 563 576 B-treatment
medication 159 169 577 587 I-treatment
use 170 173 588 591 O
) 173 174 591 592 O

History 0 7 593 600 O
of 8 10 601 603 O
cervical 11 19 604 612 B-treatment
spine 20 25 613 618 I-treatment
surgery 26 33 619 626 I-treatment

Inability 0 9 627 636 B-language_fluency
to 10 12 637 639 I-language_fluency
read 13 17 640 644 I-language_fluency
and 18 21 645 648 I-language_fluency
understand 22 32 649 659 I-language_fluency
English 33 40 660 667 I-language_fluency

No 0 2 668 670 O
less 3 7 671 675 O
than 8 12 676 680 O
10 13 15 681 683 B-upper_bound
points 16 22 684 690 O
( 23 24 691 692 O
0 24 25 692 693 O
- 25 26 693 694 O
50 26 28 694 696 B-upper_bound
range 29 34 697 702 O
) 34 35 702 703 O
on 36 38 704 706 O
the 39 42 707 710 O
Neck 43 47 711 715 B-clinical_variable
Disability 48 58 716 726 I-clinical_variable
Index 59 64 727 732 I-clinical_variable

Prior 0 5 733 738 O
history 6 13 739 746 O
of 14 16 747 749 O
whiplash 17 25 750 758 B-chronic_disease
injury 26 32 759 765 I-chronic_disease
resulting 33 42 766 775 O
in 43 45 776 778 O
neck 46 50 779 783 O
pain 51 55 784 788 O
which 56 61 789 794 O
required 62 70 795 803 O
medical 71 78 804 811 B-treatment
treatment 79 88 812 821 I-treatment

Signs 0 5 822 827 O
and 6 9 828 831 O
symptoms 10 18 832 840 O
consistent 19 29 841 851 O
with 30 34 852 856 O
nerve 35 40 857 862 O
root 41 45 863 867 O
compression 46 57 868 879 O
( 58 59 880 881 O
i.e. 59 63 881 885 O
diminished 64 74 886 896 O
upper 75 80 897 902 O
extremity 81 90 903 912 O
strength 91 99 913 921 O
, 99 100 921 922 O
sensation 101 110 923 932 O
or 111 113 933 935 O
reflexes 114 122 936 944 O
) 122 123 944 945 O
, 123 124 945 946 O
cervical 125 133 947 955 B-chronic_disease
artery 134 140 956 962 I-chronic_disease
insufficiency 141 154 963 976 I-chronic_disease
( 155 156 977 978 O
i.e. 156 160 978 982 O
nystagmus 161 170 983 992 B-chronic_disease
, 170 171 992 993 O
gait 172 176 994 998 B-chronic_disease
disturbances 177 189 999 1011 I-chronic_disease
, 189 190 1011 1012 O
Horner 191 197 1013 1019 B-chronic_disease
Syndrome 198 206 1020 1028 I-chronic_disease
) 206 207 1028 1029 O
or 208 210 1030 1032 O
upper 211 216 1033 1038 B-chronic_disease
cervical 217 225 1039 1047 I-chronic_disease
ligament 226 234 1048 1056 I-chronic_disease
instability 235 246 1057 1068 I-chronic_disease
( 247 248 1069 1070 O
i.e. 248 252 1070 1074 O
Sharp 253 258 1075 1080 O
- 258 259 1080 1081 O
Purser 259 265 1081 1087 O
, 265 266 1087 1088 O
alar 267 271 1089 1093 O
ligament 272 280 1094 1102 O
, 280 281 1102 1103 O
transverse 282 292 1104 1114 O
ligament 293 301 1115 1123 O
tests 302 307 1124 1129 O
) 307 308 1129 1130 O

< 0 1 0 1 O
/=8 1 4 1 4 O
weeks 5 10 5 10 I-upper_bound
prior 11 16 11 16 I-upper_bound
to 17 19 17 19 O
screening 20 29 20 29 O

A 0 1 30 31 O
history 2 9 32 39 O
of 10 12 40 42 O
, 12 13 42 43 O
or 14 16 44 46 O
current 17 24 47 54 O
conditions 25 35 55 65 O
affecting 36 45 66 75 O
the 46 49 76 79 O
digestive 50 59 80 89 O
tract 60 65 90 95 O
, 65 66 95 96 O
such 67 71 97 101 O
as 72 74 102 104 O
ulcerative 75 85 105 115 B-chronic_disease
colitis 86 93 116 123 I-chronic_disease
, 93 94 123 124 O
indeterminate 95 108 125 138 B-chronic_disease
colitis 109 116 139 146 I-chronic_disease
, 116 117 146 147 O
fistulizing 118 129 148 159 B-chronic_disease
disease 130 137 160 167 I-chronic_disease
, 137 138 167 168 O
abdominal 139 148 169 178 B-chronic_disease
or 149 151 179 181 I-chronic_disease
perianal 152 160 182 190 I-chronic_disease
abscess 161 168 191 198 I-chronic_disease
, 168 169 198 199 O
adenomatous 170 181 200 211 B-chronic_disease
colonic 182 189 212 219 I-chronic_disease
polyps 190 196 220 226 I-chronic_disease
not 197 200 227 230 O
excised 201 208 231 238 O
, 208 209 238 239 O
colonic 210 217 240 247 B-chronic_disease
mucosal 218 225 248 255 I-chronic_disease
dysplasia 226 235 256 265 I-chronic_disease
, 235 236 265 266 O
and 237 240 267 270 O
short 241 246 271 276 B-chronic_disease
bowel 247 252 277 282 I-chronic_disease
syndrome 253 261 283 291 I-chronic_disease

Any 0 3 292 295 O
major 4 9 296 301 O
episode 10 17 302 309 O
of 18 20 310 312 O
infection 21 30 313 322 O
requiring 31 40 323 332 O
treatment 41 50 333 342 O
with 51 55 343 347 O
intravenous 56 67 348 359 B-treatment
antibiotics 68 79 360 371 I-treatment

Any 0 3 372 375 O
prior 4 9 376 381 B-treatment
treatment 10 19 382 391 I-treatment
with 20 24 392 396 I-treatment
anti 25 29 397 401 I-treatment
- 29 30 401 402 I-treatment
adhesion 30 38 402 410 I-treatment
molecules 39 48 411 420 I-treatment
( 49 50 421 422 O
e.g. 50 54 422 426 O
, 54 55 426 427 O
anti 56 60 428 432 B-treatment
- 60 61 432 433 I-treatment
mucosal 61 68 433 440 I-treatment
addressin 69 78 441 450 I-treatment
cell 79 83 451 455 I-treatment
adhesion 84 92 456 464 I-treatment
molecule 93 101 465 473 I-treatment
[ 102 103 474 475 I-treatment
anti 103 107 475 479 I-treatment
- 107 108 479 480 I-treatment
MAdCAM-1 108 116 480 488 I-treatment
] 116 117 488 489 I-treatment
) 117 118 489 490 O

Any 0 3 491 494 O
prior 4 9 495 500 B-treatment
treatment 10 19 501 510 I-treatment
with 20 24 511 515 I-treatment
ustekinumab 25 36 516 527 I-treatment
within 37 43 528 534 O
14 44 46 535 537 B-upper_bound
weeks 47 52 538 543 I-upper_bound
prior 53 58 544 549 I-upper_bound
to 59 61 550 552 O
randomization 62 75 553 566 O

Chronic 0 7 567 574 B-chronic_disease
hepatitis 8 17 575 584 I-chronic_disease
B 18 19 585 586 I-chronic_disease
or 20 22 587 589 I-chronic_disease
C 23 24 590 591 I-chronic_disease
infection 25 34 592 601 I-chronic_disease

Fistulas 0 8 602 610 B-chronic_disease
related 9 16 611 618 O
to 17 19 619 621 O
CD 20 22 622 624 B-chronic_disease

Has 0 3 625 628 O
received 4 12 629 637 O
non 13 16 638 641 O
- 16 17 641 642 O
permitted 17 26 642 651 O
inflammatory 27 39 652 664 B-treatment
bowel 40 45 665 670 I-treatment
disease 46 53 671 678 I-treatment
( 54 55 679 680 I-treatment
IBD 55 58 680 683 I-treatment
) 58 59 683 684 I-treatment
therapies 60 69 685 694 I-treatment
( 70 71 695 696 O
including 71 80 696 705 O
natalizumab 81 92 706 717 B-treatment
, 92 93 717 718 O
vedolizumab 94 105 719 730 B-treatment
, 105 106 730 731 O
and 107 110 732 735 O
efalizumab 111 121 736 746 B-treatment
, 121 122 746 747 O
as 123 125 748 750 O
stated 126 132 751 757 O
in 133 135 758 760 O
the 136 139 761 764 O
protocol 140 148 765 773 O
) 148 149 773 774 O

Ileostomy 0 9 775 784 B-treatment
or 10 12 785 787 O
colostomy 13 22 788 797 B-treatment

Intolerance 0 11 798 809 O
, 11 12 809 810 O
refractory 13 23 811 821 B-chronic_disease
disease 24 31 822 829 I-chronic_disease

Moderately 0 10 830 840 O
to 11 13 841 843 O
severely 14 22 844 852 O
active 23 29 853 859 O
CD 30 32 860 862 B-chronic_disease
as 33 35 863 865 O
determined 36 46 866 876 O
by 47 49 877 879 O
the 50 53 880 883 O
CDAI 54 58 884 888 B-treatment

Planned 0 7 889 896 O
surgery 8 15 897 904 B-treatment
for 16 19 905 908 O
CD 20 22 909 911 O

Treatment 0 9 912 921 B-treatment
with 10 14 922 926 I-treatment
antibiotics 15 26 927 938 I-treatment
as 27 29 939 941 I-treatment
adjunctive 30 40 942 952 I-treatment
therapy 41 48 953 960 I-treatment
for 49 52 961 964 O
CD 53 55 965 967 B-chronic_disease
in 56 58 968 970 O
the 59 62 971 974 O
absence 63 70 975 982 O
of 71 73 983 985 O
documented 74 84 986 996 O
infection 85 94 997 1006 B-chronic_disease

Use 0 3 1007 1010 B-contraception_consent
of 4 6 1011 1013 I-contraception_consent
effective 7 16 1014 1023 I-contraception_consent
contraception 17 30 1024 1037 I-contraception_consent
as 31 33 1038 1040 O
defined 34 41 1041 1048 O
by 42 44 1049 1051 O
the 45 48 1052 1055 O
protocol 49 57 1056 1064 O

active 0 6 1065 1071 O
or 7 9 1072 1074 O
latent 10 16 1075 1081 B-chronic_disease
tuberculosis 17 29 1082 1094 I-chronic_disease
( 30 31 1095 1096 O
participants 31 43 1096 1108 O
with 44 48 1109 1113 O
prior 49 54 1114 1119 O
history 55 62 1120 1127 O
of 63 65 1128 1130 O
Bacillus 66 74 1131 1139 B-treatment
Calmette 75 83 1140 1148 I-treatment
- 83 84 1148 1149 I-treatment
Guérin 84 90 1149 1155 I-treatment
[ 91 92 1156 1157 I-treatment
BCG 92 95 1157 1160 I-treatment
] 95 96 1160 1161 I-treatment
vaccination 97 108 1162 1173 I-treatment
must 109 113 1174 1178 O
pass 114 118 1179 1183 O
protocol 119 127 1184 1192 O
- 127 128 1192 1193 O
defined 128 135 1193 1200 O
screening 136 145 1201 1210 O
criteria 146 154 1211 1219 O
) 154 155 1219 1220 O

anti 0 4 1221 1225 B-treatment
- 4 5 1225 1226 I-treatment
TNF 5 8 1226 1229 I-treatment
therapy 9 16 1230 1237 I-treatment
within 17 23 1238 1244 O
5 24 25 1245 1246 B-upper_bound
years 26 31 1247 1252 I-upper_bound
from 32 36 1253 1257 O
screening 37 46 1258 1267 O

human 0 5 1268 1273 B-chronic_disease
immunodeficiency 6 22 1274 1290 I-chronic_disease
virus 23 28 1291 1296 I-chronic_disease
( 29 30 1297 1298 I-chronic_disease
HIV 30 33 1298 1301 I-chronic_disease
) 33 34 1301 1302 I-chronic_disease

intolerance 0 11 1303 1314 O
to 12 14 1315 1317 O
one 15 18 1318 1321 O
or 19 21 1322 1324 O
more 22 26 1325 1329 O
anti 27 31 1330 1334 B-allergy_name
- 31 32 1334 1335 I-allergy_name
TNF 32 35 1335 1338 I-allergy_name
therapies 36 45 1339 1348 I-allergy_name
are 46 49 1349 1352 O
eligible 50 58 1353 1361 O
to 59 61 1362 1364 O
participate 62 73 1365 1376 O
in 74 76 1377 1379 O
the 77 80 1380 1383 O
study 81 86 1384 1389 O
provided 87 95 1390 1398 O
they 96 100 1399 1403 O
are 101 104 1404 1407 O
intolerant 105 115 1408 1418 O
or 116 118 1419 1421 O
refractory 119 129 1422 1432 O
to 130 132 1433 1435 O
CS 133 135 1436 1438 B-allergy_name
or 136 138 1439 1441 O
IS 139 141 1442 1444 B-allergy_name
therapy 142 149 1445 1452 I-allergy_name

oral 0 4 1453 1457 B-clinical_variable
antibiotics 5 16 1458 1469 I-clinical_variable
< 17 18 1470 1471 O
/=4 18 21 1471 1474 O
weeks 22 27 1475 1480 I-upper_bound
prior 28 33 1481 1486 I-upper_bound
to 34 36 1487 1489 O
screening 37 46 1490 1499 O

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 7 8 7 8 O
85 9 11 9 11 B-upper_bound
years 12 17 12 17 I-upper_bound
of 18 20 18 20 O
age 21 24 21 24 B-age

Alcohol 0 7 25 32 O
use 8 11 33 36 O
of 12 14 37 39 O
more 15 19 40 44 O
than 20 24 45 49 O
4 25 26 50 51 B-lower_bound
drinks 27 33 52 58 I-lower_bound
per 34 37 59 62 I-lower_bound
day 38 41 63 66 I-lower_bound

Currently 0 9 67 76 O
uncontrolled 10 22 77 89 O
clinically 23 33 90 100 O
significant 34 45 101 112 O
depression 46 56 113 123 B-chronic_disease
( 57 58 124 125 O
BDI>20 58 64 125 131 B-clinical_variable
) 64 65 131 132 O

Medically 0 9 133 142 O
cleared 10 17 143 150 O
for 18 21 151 154 O
undergoing 22 32 155 165 O
anesthesia 33 43 166 176 O
and 44 47 177 180 O
DBS 48 51 181 184 B-treatment
surgery 52 59 185 192 I-treatment

Pregnancy 0 9 193 202 B-pregnancy

2 0 1 0 1 B-clinical_variable
hour 2 6 2 6 I-clinical_variable
plasma 7 13 7 13 I-clinical_variable
glucose 14 21 14 21 I-clinical_variable
< 22 23 22 23 O
140 23 26 23 26 O
mg 27 29 27 29 I-upper_bound
/ 29 30 29 30 I-upper_bound
dL 30 32 30 32 I-upper_bound
( 33 34 33 34 I-upper_bound
7.8 34 37 34 37 I-upper_bound
mmol 38 42 38 42 I-upper_bound
/ 42 43 42 43 I-upper_bound
L 43 44 43 44 I-upper_bound
) 44 45 44 45 I-upper_bound

30 0 2 46 48 O
, 2 3 48 49 O
60 4 6 50 52 O
, 6 7 52 53 O
90 8 10 54 56 O
minute 11 17 57 63 O
plasma 18 24 64 70 O
glucose 25 32 71 78 O
during 33 39 79 85 O
OGTT 40 44 86 90 B-treatment
≥ 45 46 91 92 O
200 47 50 93 96 B-lower_bound
mg 51 53 97 99 I-lower_bound
/ 53 54 99 100 I-lower_bound
dL 54 56 100 102 I-lower_bound
( 57 58 103 104 I-lower_bound
11.1 58 62 104 108 I-lower_bound
mmol 63 67 109 113 I-lower_bound
/ 67 68 113 114 I-lower_bound
L 68 69 114 115 I-lower_bound
) 69 70 115 116 I-lower_bound

Abnormal 0 8 117 125 O
Glucose 9 16 126 133 O
Tolerance 17 26 134 143 O
or 27 29 144 146 O
Diabetes 30 38 147 155 B-chronic_disease

Are 0 3 156 159 O
immunodeficient 4 19 160 175 B-chronic_disease
or 20 22 176 178 O
have 23 27 179 183 O
clinically 28 38 184 194 B-chronic_disease
significant 39 50 195 206 I-chronic_disease
chronic 51 58 207 214 I-chronic_disease
lymphopenia 59 70 215 226 I-chronic_disease

Be 0 2 227 229 O
currently 3 12 230 239 O
pregnant 13 21 240 248 B-pregnancy
or 22 24 249 251 O
lactating 25 34 252 261 O
, 34 35 261 262 O
or 36 38 263 265 O
anticipate 39 49 266 276 B-pregnancy
getting 50 57 277 284 I-pregnancy
pregnant 58 66 285 293 I-pregnancy
within 67 73 294 300 O
3 74 75 301 302 B-upper_bound
months 76 82 303 309 I-upper_bound
of 83 85 310 312 O
the 86 89 313 316 O
last 90 94 317 321 O
study 95 100 322 327 O
drug 101 105 328 332 O
administration 106 120 333 347 O

Between 0 7 348 355 O
the 8 11 356 359 O
ages 12 16 360 364 B-age
of 17 19 365 367 O
1 20 21 368 369 B-lower_bound
- 21 22 369 370 O
45 22 24 370 372 B-upper_bound
years 25 30 373 378 I-upper_bound
at 31 33 379 381 O
the 34 37 382 385 O
time 38 42 386 390 O
of 43 45 391 393 O
enrollment 46 56 394 404 O
in 57 59 405 407 O
TN01 60 64 408 412 O
and 65 68 413 416 O
age 69 72 417 420 O
≥ 73 74 421 422 O
6 75 76 423 424 B-lower_bound
at 77 79 425 427 O
time 80 84 428 432 O
of 85 87 433 435 O
randomization 88 101 436 449 O
in 102 104 450 452 O
this 105 109 453 457 O
trial 110 115 458 463 O

Fasting 0 7 464 471 B-clinical_variable
plasma 8 14 472 478 I-clinical_variable
glucose 15 22 479 486 I-clinical_variable
< 23 24 487 488 O
110 25 28 489 492 B-upper_bound
mg 29 31 493 495 I-upper_bound
/ 31 32 495 496 I-upper_bound
dL 32 34 496 498 I-upper_bound
( 35 36 499 500 I-upper_bound
6.1 36 39 500 503 I-upper_bound
mmol 40 44 504 508 I-upper_bound
/ 44 45 508 509 I-upper_bound
L 45 46 509 510 I-upper_bound
) 46 47 510 511 I-upper_bound

Have 0 4 512 516 O
a 5 6 517 518 O
positive 7 15 519 527 O
PPD 16 19 528 531 B-chronic_disease
test 20 24 532 536 O
result 25 31 537 543 O
or 32 34 544 546 O
history 35 42 547 554 O
of 43 45 555 557 O
previously 46 56 558 568 O
treated 57 64 569 576 O
TB 65 67 577 579 B-bmi
, 67 68 579 580 O
or 69 71 581 583 O
positive 72 80 584 592 O
interferon 81 91 593 603 O
- 91 92 603 604 O
gamma 92 97 604 609 O
release 98 105 610 617 O
assay 106 111 618 623 O
( 112 113 624 625 O
IGRA 113 117 625 629 O
) 117 118 629 630 O
test 119 123 631 635 O

Have 0 4 636 640 O
an 5 7 641 643 O
active 8 14 644 650 B-chronic_disease
infection 15 24 651 660 I-chronic_disease
at 25 27 661 663 O
time 28 32 664 668 O
of 33 35 669 671 O
randomization 36 49 672 685 O

Have 0 4 686 690 O
evidence 5 13 691 699 O
of 14 16 700 702 O
active 17 23 703 709 B-chronic_disease
EBV 24 27 710 713 I-chronic_disease
infection 28 37 714 723 I-chronic_disease

Have 0 4 724 728 O
serologic 5 14 729 738 O
evidence 15 23 739 747 O
of 24 26 748 750 O
current 27 34 751 758 O
or 35 37 759 761 O
past 38 42 762 766 O
HIV 43 46 767 770 B-chronic_disease
, 46 47 770 771 O
Hepatitis 48 57 772 781 B-chronic_disease
B 58 59 782 783 I-chronic_disease
( 60 61 784 785 O
positive 61 69 785 793 O
for 70 73 794 797 O
Hepatitis 74 83 798 807 O
B 84 85 808 809 O
core 86 90 810 814 O
antibody 91 99 815 823 O
or 100 102 824 826 O
surface 103 110 827 834 O
antigen 111 118 835 842 O
) 118 119 842 843 O
, 119 120 843 844 O
or 121 123 845 847 O
Hepatitis 124 133 848 857 B-chronic_disease
C 134 135 858 859 I-chronic_disease
infection 136 145 860 869 I-chronic_disease

Have 0 4 870 874 O
serological 5 16 875 886 O
evidence 17 25 887 895 O
of 26 28 896 898 O
current 29 36 899 906 O
CMV 37 40 907 910 B-chronic_disease
infection 41 50 911 920 I-chronic_disease

Insulin 0 7 921 928 B-treatment
autoantibodies 8 22 929 943 I-treatment
( 23 24 944 945 I-treatment
mIAA 24 28 945 949 I-treatment
) 28 29 949 950 I-treatment

Normal 0 6 951 957 O
glucose 7 14 958 965 O
tolerance 15 24 966 975 O
by 25 27 976 978 O
OGTT 28 32 979 983 O
confirmed 33 42 984 993 O
within 43 49 994 1000 O
7 50 51 1001 1002 B-upper_bound
weeks 52 57 1003 1008 I-upper_bound
( 58 59 1009 1010 O
no 59 61 1010 1012 O
more 62 66 1013 1017 O
than 67 71 1018 1022 O
52 72 74 1023 1025 B-upper_bound
days 75 79 1026 1030 I-upper_bound
) 79 80 1030 1031 O
of 81 83 1032 1034 O
baseline 84 92 1035 1043 O
( 93 94 1044 1045 O
visit 94 99 1045 1050 O
0 100 101 1051 1052 O
) 101 102 1052 1053 O

Require 0 7 1054 1061 O
use 8 11 1062 1065 O
of 12 14 1066 1068 O
other 15 20 1069 1074 O
immunosuppressive 21 38 1075 1092 B-treatment
agents 39 45 1093 1099 I-treatment

These 0 5 1100 1105 O
include 6 13 1106 1113 O
pre 14 17 1114 1117 O
- 17 18 1117 1118 O
existing 18 26 1118 1126 O
cardiac 27 34 1127 1134 B-chronic_disease
disease 35 42 1135 1142 I-chronic_disease
, 42 43 1142 1143 O
COPD 44 48 1144 1148 B-chronic_disease
, 48 49 1148 1149 O
neurological 50 62 1150 1162 B-chronic_disease
, 62 63 1162 1163 O
or 64 66 1164 1166 O
blood 67 72 1167 1172 B-chronic_disease
count 73 78 1173 1178 I-chronic_disease
abnormalities 79 92 1179 1192 I-chronic_disease
( 93 94 1193 1194 O
such 94 98 1194 1198 O
as 99 101 1199 1201 O
lymphopenia 102 113 1202 1213 B-cancer
, 113 114 1213 1214 O
leukopenia 115 125 1215 1225 B-cancer
, 125 126 1225 1226 O
or 127 129 1227 1229 O
thrombocytopenia 130 146 1230 1246 B-chronic_disease
) 146 147 1246 1247 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

Abnormal 0 8 18 26 O
liver 9 14 27 32 O
function 15 23 33 41 O
, 23 24 41 42 O
defined 25 32 43 50 O
as 33 35 51 53 O
≥3x 36 39 54 57 O
upper 40 45 58 63 I-lower_bound
limit 46 51 64 69 I-lower_bound
of 52 54 70 72 I-lower_bound
normal 55 61 73 79 I-lower_bound
( 62 63 80 81 I-lower_bound
ULN 63 66 81 84 I-lower_bound
) 66 67 84 85 I-lower_bound
of 68 70 86 88 O
aspartate 71 80 89 98 B-clinical_variable
aminotransferase 81 97 99 115 I-clinical_variable
( 98 99 116 117 I-clinical_variable
AST 99 102 117 120 I-clinical_variable
) 102 103 120 121 I-clinical_variable
, 103 104 121 122 O
alanine 105 112 123 130 B-clinical_variable
aminotransferase 113 129 131 147 I-clinical_variable
( 130 131 148 149 I-clinical_variable
ALT 131 134 149 152 I-clinical_variable
) 134 135 152 153 I-clinical_variable
or 136 138 154 156 O
known 139 144 157 162 O
cirrhosis 145 154 163 172 B-chronic_disease

Acute 0 5 173 178 B-chronic_disease
upper 6 11 179 184 I-chronic_disease
respiratory 12 23 185 196 I-chronic_disease
infection 24 33 197 206 I-chronic_disease
within 34 40 207 213 O
2 41 42 214 215 B-upper_bound
weeks 43 48 216 221 I-upper_bound
or 49 51 222 224 O
acute 52 57 225 230 B-chronic_disease
pulmonary 58 67 231 240 I-chronic_disease
exacerbation 68 80 241 253 I-chronic_disease
requiring 81 90 254 263 O
intravenous 91 102 264 275 B-treatment
antibiotics 103 114 276 287 I-treatment
within 115 121 288 294 O
4 122 123 295 296 B-upper_bound
weeks 124 129 297 302 I-upper_bound
of 130 132 303 305 O
Screening 133 142 306 315 O
Visit 143 148 316 321 O

Any 0 3 322 325 O
change 4 10 326 332 O
in 11 13 333 335 O
chronic 14 21 336 343 B-treatment
therapies 22 31 344 353 I-treatment
for 32 35 354 357 O
CF 36 38 358 360 B-chronic_disease
lung 39 43 361 365 I-chronic_disease
disease 44 51 366 373 I-chronic_disease
( 52 53 374 375 O
e.g. 53 57 375 379 O
, 57 58 379 380 O
Ibuprofen 59 68 381 390 B-treatment
, 68 69 390 391 O
Pulmozyme 70 79 392 401 B-treatment
® 79 80 401 402 I-treatment
, 80 81 402 403 O
hypertonic 82 92 404 414 B-treatment
saline 93 99 415 421 I-treatment
, 99 100 421 422 O
Azithromycin 101 113 423 435 B-treatment
, 113 114 435 436 O
TOBI 115 119 437 441 B-treatment
® 119 120 441 442 I-treatment
, 120 121 442 443 O
Cayston 122 129 444 451 B-treatment
® 129 130 451 452 I-treatment
) 130 131 452 453 O
within 132 138 454 460 O
4 139 140 461 462 B-upper_bound
weeks 141 146 463 468 I-upper_bound
of 147 149 469 471 O
Study 150 155 472 477 O
Day 156 159 478 481 O
1 160 161 482 483 O

Any 0 3 484 487 O
investigational 4 19 488 503 B-treatment
drug 20 24 504 508 I-treatment
or 25 27 509 511 I-treatment
device 28 34 512 518 I-treatment
within 35 41 519 525 O
30 42 44 526 528 B-upper_bound
days 45 49 529 533 I-upper_bound
of 50 52 534 536 O
Screening 53 62 537 546 O
or 63 65 547 549 O
within 66 72 550 556 O
6 73 74 557 558 B-upper_bound
half 75 79 559 563 I-upper_bound
- 79 80 563 564 I-upper_bound
lives 80 85 564 569 I-upper_bound
of 86 88 570 572 O
the 89 92 573 576 O
investigational 93 108 577 592 O
drug 109 113 593 597 O
( 114 115 598 599 O
whichever 115 124 599 608 O
is 125 127 609 611 O
longer 128 134 612 618 O
) 134 135 618 619 O

Clinically 0 10 620 630 O
significant 11 22 631 642 O
cardiac 23 30 643 650 B-chronic_disease
, 30 31 650 651 O
liver 32 37 652 657 B-chronic_disease
or 38 40 658 660 O
kidney 41 47 661 667 B-chronic_disease
disease 48 55 668 675 I-chronic_disease

Confirmed 0 9 676 685 O
diagnosis 10 19 686 695 O
of 20 22 696 698 O
CF 23 25 699 701 B-chronic_disease
based 26 31 702 707 O
on 32 34 708 710 O
the 35 38 711 714 O
following 39 48 715 724 O
criteria 49 57 725 733 O

Current 0 7 734 741 O
use 8 11 742 745 O
of 12 14 746 748 O
ivacaftor 15 24 749 758 B-treatment
( 25 26 759 760 I-treatment
Kalydeco 26 34 760 768 I-treatment
) 34 35 768 769 I-treatment
, 35 36 769 770 O
lumacaftor 37 47 771 781 B-treatment
/ 47 48 781 782 I-treatment
ivacaftor 48 57 782 791 I-treatment
combination 58 69 792 803 O
, 69 70 803 804 O
or 71 73 805 807 O
other 74 79 808 813 O
corrector 80 89 814 823 B-treatment
or 90 92 824 826 I-treatment
potentiator 93 104 827 838 I-treatment
( 105 106 839 840 I-treatment
Symdeko 106 113 840 847 I-treatment
) 113 114 847 848 I-treatment
less 115 119 849 853 O
than 120 124 854 858 O
30 125 127 859 861 B-upper_bound
days 128 132 862 866 I-upper_bound
from 133 137 867 871 O
Screening 138 147 872 881 O

FEV1 0 4 882 886 B-clinical_variable
greater 5 12 887 894 O
than 13 17 895 899 O
30 18 20 900 902 B-lower_bound
% 20 21 902 903 I-lower_bound
predicted 22 31 904 913 O
normal 32 38 914 920 O
for 39 42 921 924 O
age 43 46 925 928 B-age
, 46 47 928 929 O
gender 48 54 930 936 O
, 54 55 936 937 O
height 56 62 938 944 O
( 63 64 945 946 O
Hankinson 64 73 946 955 O
standards 74 83 956 965 O
) 83 84 965 966 O
pre 85 88 967 970 O
or 89 91 971 973 O
post 92 96 974 978 O
- 96 97 978 979 O
bronchodilator 97 111 979 993 O
at 112 114 994 996 O
Screening 115 124 997 1006 O

History 0 7 1007 1014 O
of 8 10 1015 1017 O
or 11 13 1018 1020 O
listed 14 20 1021 1027 O
for 21 24 1028 1031 O
solid 25 30 1032 1037 B-treatment
organ 31 36 1038 1043 I-treatment
or 37 39 1044 1046 O
hematological 40 53 1047 1060 B-treatment
transplantation 54 69 1061 1076 I-treatment

If 0 2 1077 1079 O
of 3 5 1080 1082 O
childbearing 6 18 1083 1095 O
potential 19 28 1096 1105 O
, 28 29 1105 1106 O
agree 30 35 1107 1112 B-contraception_consent
to 36 38 1113 1115 I-contraception_consent
use 39 42 1116 1119 I-contraception_consent
one 43 46 1120 1123 I-contraception_consent
highly 47 53 1124 1130 I-contraception_consent
effective 54 63 1131 1140 I-contraception_consent
method 64 70 1141 1147 I-contraception_consent
of 71 73 1148 1150 I-contraception_consent
contraception 74 87 1151 1164 I-contraception_consent
from 88 92 1165 1169 O
the 93 96 1170 1173 O
time 97 101 1174 1178 O
of 102 104 1179 1181 O
consent 105 112 1182 1189 O
through 113 120 1190 1197 O
the 121 124 1198 1201 O
Visit 125 130 1202 1207 O
4 131 132 1208 1209 O
study 133 138 1210 1215 O
visit 139 144 1216 1221 O
, 144 145 1221 1222 O
per 146 149 1223 1226 O
section 150 157 1227 1234 O
9.1.13 158 164 1235 1241 O
of 165 167 1242 1244 O
the 168 171 1245 1248 O
protocol 172 180 1249 1257 O

Male 0 4 1258 1262 B-gender

Negative 0 8 1263 1271 B-pregnancy
pregnancy 9 18 1272 1281 I-pregnancy
test 19 23 1282 1286 O
for 24 27 1287 1290 O
women 28 33 1291 1296 B-gender
of 34 36 1297 1299 O
child 37 42 1300 1305 O
- 42 43 1305 1306 O
bearing 43 50 1306 1313 O
potential 51 60 1314 1323 O

Oxygen 0 6 1324 1330 B-clinical_variable
saturation 7 17 1331 1341 I-clinical_variable
by 18 20 1342 1344 O
pulseoximetry 21 34 1345 1358 O
90 35 37 1359 1361 B-lower_bound
% 37 38 1361 1362 I-lower_bound
or 39 41 1363 1365 O
greater 42 49 1366 1373 O
breathing 50 59 1374 1383 O
ambient 60 67 1384 1391 O
air 68 71 1392 1395 O
or 72 74 1396 1398 O
regular 75 82 1399 1406 O
oxygen 83 89 1407 1413 O
regimen 90 97 1414 1421 O
at 98 100 1422 1424 O
screening 101 110 1425 1434 O
and 111 114 1435 1438 O
day 115 118 1439 1442 O
1 119 120 1443 1444 O

Pregnant 0 8 1445 1453 B-pregnancy
, 8 9 1453 1454 O
planned 10 17 1455 1462 B-pregnancy
pregnancy 18 27 1463 1472 I-pregnancy
or 28 30 1473 1475 O
breast 31 37 1476 1482 O
feeding 38 45 1483 1490 O

Seizure 0 7 1491 1498 B-chronic_disease
disorder 8 16 1499 1507 I-chronic_disease

Sinus 0 5 1508 1513 B-treatment
surgery 6 13 1514 1521 I-treatment
within 14 20 1522 1528 O
6 21 22 1529 1530 B-upper_bound
weeks 23 28 1531 1536 I-upper_bound
of 29 31 1537 1539 O
Screening 32 41 1540 1549 O
Visit 42 47 1550 1555 O

Subjects 0 8 1556 1564 O
on 9 11 1565 1567 O
chronic 12 19 1568 1575 B-treatment
inhaled 20 27 1576 1583 I-treatment
antibiotic 28 38 1584 1594 I-treatment
therapy 39 46 1595 1602 I-treatment
are 47 50 1603 1606 O
eligible 51 59 1607 1615 O
if 60 62 1616 1618 O
they 63 67 1619 1623 O
can 68 71 1624 1627 O
continue 72 80 1628 1636 O
their 81 86 1637 1642 O
usual 87 92 1643 1648 O
antibiotic 93 103 1649 1659 B-treatment
regimen 104 111 1660 1667 I-treatment
, 111 112 1667 1668 O
or 113 115 1669 1671 O
remain 116 122 1672 1678 O
on 123 125 1679 1681 O
their 126 131 1682 1687 O
off 132 135 1688 1691 O
- 135 136 1691 1692 O
cycle 136 141 1692 1697 O
period 142 148 1698 1704 O
, 148 149 1704 1705 O
for 150 153 1706 1709 O
the 154 157 1710 1713 O
duration 158 166 1714 1722 O
of 167 169 1723 1725 O
study 170 175 1726 1731 O
drug 176 180 1732 1736 O
exposure 181 189 1737 1745 O

Taking 0 6 1746 1752 O
pancreatic 7 17 1753 1763 B-treatment
enzyme 18 24 1764 1770 I-treatment
replacement 25 36 1771 1782 I-treatment
therapy 37 44 1783 1790 I-treatment
( 45 46 1791 1792 I-treatment
PERT 46 50 1792 1796 I-treatment
) 50 51 1796 1797 I-treatment

female 0 6 1798 1804 B-gender

Any 0 3 0 3 O
other 4 9 4 9 O
clinically 10 20 10 20 O
significant 21 32 21 32 O
medical 33 40 33 40 O
disease 41 48 41 48 O
or 49 51 49 51 O
condition 52 61 52 61 O
laboratory 62 72 62 72 O
abnormality 73 84 73 84 O
or 85 87 85 87 O
psychiatric 88 99 88 99 B-cancer
illness 100 107 100 107 I-cancer
that 108 112 108 112 O
, 112 113 112 113 O
in 114 116 114 116 O
the 117 120 117 120 O
investigator?s 121 135 121 135 O
opinion 136 143 136 143 O
, 143 144 143 144 O
may 145 148 145 148 O
interfere 149 158 149 158 O
with 159 163 159 163 O
protocol 164 172 164 172 O
adherence 173 182 173 182 O
or 183 185 183 185 O
a 186 187 186 187 O
subject?s 188 197 188 197 O
ability 198 205 198 205 O
to 206 208 206 208 O
give 209 213 209 213 O
informed 214 222 214 222 O
consent 223 230 223 230 O

Hypercalcemia 0 13 231 244 B-chronic_disease

Patients 0 8 245 253 O
must 9 13 254 258 O
be 14 16 259 261 O
aware 17 22 262 267 O
of 23 25 268 270 O
the 26 29 271 274 O
neoplastic 30 40 275 285 O
nature 41 47 286 292 O
of 48 50 293 295 O
his 51 54 296 299 O
/ 54 55 299 300 O
her 55 58 300 303 O
disease 59 66 304 311 O
and 67 70 312 315 O
willingly 71 80 316 325 O
provide 81 88 326 333 O
written 89 96 334 341 O
, 96 97 341 342 O
informed 98 106 343 351 O
consent 107 114 352 359 O
after 115 120 360 365 O
being 121 126 366 371 O
informed 127 135 372 380 O
of 136 138 381 383 O
the 139 142 384 387 O
procedure 143 152 388 397 O
to 153 155 398 400 O
be 156 158 401 403 O
followed 159 167 404 412 O
, 167 168 412 413 O
the 169 172 414 417 O
nature 173 179 418 424 O
of 180 182 425 427 O
the 183 186 428 431 O
therapy 187 194 432 439 B-treatment
, 194 195 439 440 O
alternatives 196 208 441 453 O
, 208 209 453 454 O
potential 210 219 455 464 O
benefits 220 228 465 473 O
, 228 229 473 474 O
side 230 234 475 479 O
- 234 235 479 480 O
effects 235 242 480 487 O
, 242 243 487 488 O
risks 244 249 489 494 O
, 249 250 494 495 O
and 251 254 496 499 O
discomforts 255 266 500 511 O

Patients 0 8 512 520 O
must 9 13 521 525 O
have 14 18 526 530 O
histologically 19 33 531 545 O
confirmed 34 43 546 555 O
newly 44 49 556 561 O
diagnosed 50 59 562 571 O
or 60 62 572 574 O
previously 63 73 575 585 O
untreated 74 83 586 595 O
( 84 85 596 597 O
patients 85 93 597 605 O
may 94 97 606 609 O
be 98 100 610 612 O
under 101 106 613 618 O
no 107 109 619 621 O
treatment 110 119 622 631 B-treatment

Simultaneous 0 12 632 644 O
participation 13 26 645 658 O
in 27 29 659 661 O
other 30 35 662 667 B-treatment
therapeutic 36 47 668 679 I-treatment
clinical 48 56 680 688 I-treatment
trials 57 63 689 695 I-treatment
will 64 68 696 700 O
be 69 71 701 703 O
allowed 72 79 704 711 O

have 0 4 712 716 O
received 5 13 717 725 O
two 14 17 726 729 O
cycles 18 24 730 736 O
of 25 27 737 739 O
chemotherapy 28 40 740 752 B-treatment
or 41 43 753 755 O
localized 44 53 756 765 B-treatment
radiation 54 63 766 775 I-treatment
therapy 64 71 776 783 I-treatment
before 72 78 784 790 O
going 79 84 791 796 O
on 85 87 797 799 O
this 88 92 800 804 O
study 93 98 805 810 O
) 98 99 810 811 O
non 100 103 812 815 B-cancer
- 103 104 815 816 I-cancer
Hodgkin?s 104 113 816 825 I-cancer
lymphoma 114 122 826 834 I-cancer
or 123 125 835 837 O
CLL 126 129 838 841 B-cancer

Acute 0 5 0 5 B-chronic_disease
ST 6 8 6 8 I-chronic_disease
- 8 9 8 9 I-chronic_disease
elevation 9 18 9 18 I-chronic_disease
myocardial 19 29 19 29 I-chronic_disease
infarction 30 40 30 40 I-chronic_disease

Age 0 3 41 44 B-age
< 4 5 45 46 O
18 5 7 46 48 B-upper_bound
years 8 13 49 54 I-upper_bound

Contra 0 6 55 61 B-treatment
- 6 7 61 62 I-treatment
indications 7 18 62 73 I-treatment
to 19 21 74 76 O
MRI 22 25 77 80 O
( 26 27 81 82 O
i.e. 27 31 82 86 O
ICD 32 35 87 90 B-treatment
, 35 36 90 91 O
pacemaker 37 46 92 101 B-treatment
, 46 47 101 102 O
aneurysm 48 56 103 111 B-treatment
clip 57 61 112 116 I-treatment
, 61 62 116 117 O
etc 63 66 118 121 O
) 66 67 121 122 O

Hemodynamic 0 11 123 134 B-chronic_disease
instability 12 23 135 146 I-chronic_disease

Pregnancy 0 9 147 156 B-pregnancy

Second 0 6 157 163 B-chronic_disease
or 7 9 164 166 I-chronic_disease
third 10 15 167 172 I-chronic_disease
degree 16 22 173 179 I-chronic_disease
AV 23 25 180 182 I-chronic_disease
block 26 31 183 188 I-chronic_disease

Severe 0 6 189 195 B-chronic_disease
Renal 7 12 196 201 I-chronic_disease
Disease 13 20 202 209 I-chronic_disease
( 21 22 210 211 O
GFR 22 25 211 214 B-clinical_variable
< 26 27 215 216 O
30cc 27 31 216 220 B-upper_bound
/ 31 32 220 221 I-upper_bound
min 32 35 221 224 I-upper_bound
or 36 38 225 227 O
hemodialysis 39 51 228 240 B-treatment
) 51 52 240 241 O

Severe 0 6 242 248 O
claustrophobia 7 21 249 263 B-chronic_disease

Suspected 0 9 264 273 O
coronary 10 18 274 282 B-chronic_disease
artery 19 25 283 289 I-chronic_disease
disease 26 33 290 297 I-chronic_disease

Symptoms 0 8 298 306 O
of 9 11 307 309 O
possible 12 20 310 318 O
coronary 21 29 319 327 B-chronic_disease
artery 30 36 328 334 I-chronic_disease
disease 37 44 335 342 I-chronic_disease

Any 0 3 0 3 O
line 4 8 4 8 O
of 9 11 9 11 O
prior 12 17 12 17 B-treatment
therapy 18 25 18 25 I-treatment

Calculated 0 10 26 36 B-clinical_variable
creatinine 11 21 37 47 I-clinical_variable
clearance 22 31 48 57 I-clinical_variable
must 32 36 58 62 O
be 37 39 63 65 O
> 40 41 66 67 O
= 41 42 67 68 O
30 43 45 69 71 B-lower_bound
mL 46 48 72 74 I-lower_bound
/ 48 49 74 75 I-lower_bound
minute 49 55 75 81 I-lower_bound

Eastern 0 7 82 89 B-clinical_variable
Cooperative 8 19 90 101 I-clinical_variable
Oncology 20 28 102 110 I-clinical_variable
Group 29 34 111 116 I-clinical_variable
( 35 36 117 118 I-clinical_variable
ECOG 36 40 118 122 I-clinical_variable
) 40 41 122 123 I-clinical_variable
performance 42 53 124 135 I-clinical_variable
status 54 60 136 142 I-clinical_variable
0 61 62 143 144 B-lower_bound
- 62 63 144 145 O
2 63 64 145 146 B-upper_bound

Have 0 4 147 151 O
unresectable 5 17 152 164 O
malignant 18 27 165 174 B-cancer
mesothelioma 28 40 175 187 I-cancer
( 41 42 188 189 O
any 42 45 189 192 O
histology 46 55 193 202 O
) 55 56 202 203 O

Hemoglobin 0 10 204 214 B-clinical_variable
( 11 12 215 216 I-clinical_variable
Hgb 12 15 216 219 I-clinical_variable
) 15 16 219 220 I-clinical_variable
> 17 18 221 222 O
8.5 19 22 223 226 B-lower_bound
g 23 24 227 228 I-lower_bound
/ 24 25 228 229 I-lower_bound
dL 25 27 229 231 I-lower_bound

Known 0 5 232 237 O
hypersensitivity 6 22 238 254 O
to 23 25 255 257 O
brentuximab 26 37 258 269 B-allergy_name
vedotin 38 45 270 277 I-allergy_name
components 46 56 278 288 I-allergy_name

Male 0 4 289 293 B-gender
subject 5 12 294 301 I-gender

Platelets 0 9 302 311 B-clinical_variable
> 10 11 312 313 O
100,000 12 19 314 321 B-lower_bound
/ 19 20 321 322 I-lower_bound
mm^3 20 24 322 326 I-lower_bound

Positive 0 8 327 335 B-cancer
CD30 9 13 336 340 I-cancer
+ 13 14 340 341 O
immunohistochemical 15 34 342 361 O
expression 35 45 362 372 O

Radiation 0 9 373 382 B-treatment
therapy 10 17 383 390 I-treatment
to 18 20 391 393 O
more 21 25 394 398 O
than 26 30 399 403 O
25 31 33 404 406 B-lower_bound
% 33 34 406 407 I-lower_bound
of 35 37 408 410 O
the 38 41 411 414 O
bone 42 46 415 419 O
marrow 47 53 420 426 O

Serious 0 7 427 434 B-chronic_disease
medical 8 15 435 442 I-chronic_disease
or 16 18 443 445 I-chronic_disease
psychiatric 19 30 446 457 I-chronic_disease
illness 31 38 458 465 I-chronic_disease
likely 39 45 466 472 O
to 46 48 473 475 O
interfere 49 58 476 485 O
with 59 63 486 490 O
participation 64 77 491 504 O
in 78 80 505 507 O
this 81 85 508 512 O
clinical 86 94 513 521 O
study 95 100 522 527 O

Total 0 5 528 533 O
bilirubin 6 15 534 543 B-clinical_variable
= 16 17 544 545 O
< 17 18 545 546 O
1.5 19 22 547 550 B-upper_bound
x 23 24 551 552 I-upper_bound
upper 25 30 553 558 I-upper_bound
limit 31 36 559 564 I-upper_bound
of 37 39 565 567 I-upper_bound
normal 40 46 568 574 I-upper_bound
( 47 48 575 576 I-upper_bound
ULN 48 51 576 579 I-upper_bound
) 51 52 579 580 I-upper_bound

completely 0 10 581 591 O
abstain 11 18 592 599 O
from 19 23 600 604 O
heterosexual 24 36 605 617 O
intercourse 37 48 618 629 O
during 49 55 630 636 O
the 56 59 637 640 O
entire 60 66 641 647 O
study 67 72 648 653 O
treatment 73 82 654 663 O
period 83 89 664 670 O
through 90 97 671 678 O
6 98 99 679 680 B-upper_bound
months 100 106 681 687 I-upper_bound
after 107 112 688 693 O
the 113 116 694 697 O
last 117 121 698 702 O
dose 122 126 703 707 O
of 127 129 708 710 O
brentuximab 130 141 711 722 B-treatment
vedotin 142 149 723 730 I-treatment

confirmation 0 12 731 743 O
that 13 17 744 748 O
the 18 21 749 752 O
subject 22 29 753 760 O
is 30 32 761 763 O
not 33 36 764 767 B-pregnancy
pregnant 37 45 768 776 I-pregnancy
must 46 50 777 781 O
be 51 53 782 784 O
established 54 65 785 796 O
by 66 68 797 799 O
a 69 70 800 801 O
negative 71 79 802 810 B-pregnancy
serum 80 85 811 816 I-pregnancy
beta 86 90 817 821 I-pregnancy
- 90 91 821 822 I-pregnancy
human 91 96 822 827 I-pregnancy
chorionic 97 106 828 837 I-pregnancy
gonadotropin 107 119 838 850 I-pregnancy
( 120 121 851 852 I-pregnancy
B 121 122 852 853 I-pregnancy
- 122 123 853 854 I-pregnancy
hCG 123 126 854 857 I-pregnancy
) 126 127 857 858 I-pregnancy
pregnancy 128 137 859 868 I-pregnancy
test 138 142 869 873 O
result 143 149 874 880 O
obtained 150 158 881 889 O
during 159 165 890 896 O
screening 166 175 897 906 O

cured 0 5 907 912 O
of 6 8 913 915 O
a 9 10 916 917 O
skin 11 15 918 922 B-cancer
cancer 16 22 923 929 I-cancer

even 0 4 930 934 O
if 5 7 935 937 O
surgically 8 18 938 948 O
sterilized 19 29 949 959 O
( 30 31 960 961 O
i.e. 31 35 961 965 O
, 35 36 965 966 O
status 37 43 967 973 O
postvasectomy 44 57 974 987 O
) 57 58 987 988 O
, 58 59 988 989 O
agrees 60 66 990 996 B-contraception_consent
to 67 69 997 999 I-contraception_consent
use 70 73 1000 1003 I-contraception_consent
an 74 76 1004 1006 I-contraception_consent
acceptable 77 87 1007 1017 I-contraception_consent
barrier 88 95 1018 1025 I-contraception_consent
method 96 102 1026 1032 I-contraception_consent
for 103 106 1033 1036 I-contraception_consent
contraception 107 120 1037 1050 I-contraception_consent
( 121 122 1051 1052 O
condom 122 128 1052 1058 B-contraception_consent
with 129 133 1059 1063 I-contraception_consent
a 134 135 1064 1065 I-contraception_consent
spermicidal 136 147 1066 1077 I-contraception_consent
agent 148 153 1078 1083 I-contraception_consent
) 153 154 1083 1084 O

examinations 0 12 1085 1097 O
for 13 16 1098 1101 O
assessment 17 27 1102 1112 O
of 28 30 1113 1115 O
measurable 31 41 1116 1126 O
disease 42 49 1127 1134 O
must 50 54 1135 1139 O
have 55 59 1140 1144 O
been 60 64 1145 1149 O
completed 65 74 1150 1159 O
within 75 81 1160 1166 O
28 82 84 1167 1169 B-upper_bound
days 85 89 1170 1174 I-upper_bound
prior 90 95 1175 1180 I-upper_bound
to 96 98 1181 1183 O
registration 99 111 1184 1196 O

no 0 2 1197 1199 O
prior 3 8 1200 1205 O
hematologic 9 20 1206 1217 B-cancer
malignancy 21 31 1218 1228 I-cancer
within 32 38 1229 1235 O
3 39 40 1236 1237 B-upper_bound
years 41 46 1238 1243 I-upper_bound

stage 0 5 1244 1249 B-lower_bound
I 6 7 1250 1251 I-lower_bound
- 7 8 1251 1252 O
III 8 11 1252 1255 B-upper_bound
solid 12 17 1256 1261 B-cancer
tumor 18 23 1262 1267 I-cancer

whole 0 5 1268 1273 B-treatment
pelvic 6 12 1274 1280 I-treatment
radiation 13 22 1281 1290 I-treatment
is 23 25 1291 1293 O
considered 26 36 1294 1304 O
to 37 39 1305 1307 O
be 40 42 1308 1310 O
over 43 47 1311 1315 O
25 48 50 1316 1318 B-lower_bound
% 50 51 1318 1319 I-lower_bound

willing 0 7 1320 1327 B-contraception_consent
to 8 10 1328 1330 I-contraception_consent
use 11 14 1331 1334 I-contraception_consent
an 15 17 1335 1337 I-contraception_consent
acceptable 18 28 1338 1348 I-contraception_consent
method 29 35 1349 1355 I-contraception_consent
of 36 38 1356 1358 I-contraception_consent
birth 39 44 1359 1364 I-contraception_consent
control 45 52 1365 1372 I-contraception_consent
( 53 54 1373 1374 O
i.e. 54 58 1374 1378 O
, 58 59 1378 1379 O
a 60 61 1380 1381 O
hormonal 62 70 1382 1390 B-contraception_consent
contraceptive 71 84 1391 1404 I-contraception_consent
, 84 85 1404 1405 O
intra 86 91 1406 1411 B-contraception_consent
- 91 92 1411 1412 I-contraception_consent
uterine 92 99 1412 1419 I-contraception_consent
device 100 106 1420 1426 I-contraception_consent
, 106 107 1426 1427 O
diaphragm 108 117 1428 1437 B-contraception_consent
with 118 122 1438 1442 I-contraception_consent
spermicide 123 133 1443 1453 I-contraception_consent
, 133 134 1453 1454 O
condom 135 141 1455 1461 B-contraception_consent
with 142 146 1462 1466 I-contraception_consent
spermicide 147 157 1467 1477 I-contraception_consent
, 157 158 1477 1478 O
or 159 161 1479 1481 O
abstinence 162 172 1482 1492 B-contraception_consent
) 172 173 1492 1493 O
for 174 177 1494 1497 O
the 178 181 1498 1501 O
duration 182 190 1502 1510 O
of 191 193 1511 1513 O
the 194 197 1514 1517 O
study 198 203 1518 1523 O
and 204 207 1524 1527 O
at 208 210 1528 1530 O
least 211 216 1531 1536 O
6 217 218 1537 1538 B-lower_bound
months 219 225 1539 1545 I-lower_bound
after 226 231 1546 1551 O
the 232 235 1552 1555 O
last 236 240 1556 1560 O
dose 241 245 1561 1565 O
of 246 248 1566 1568 O
brentuximab 249 260 1569 1580 B-treatment
vedotin 261 268 1581 1588 I-treatment

Currently 0 9 0 9 O
on 10 12 10 12 O
gabapentin 13 23 13 23 B-treatment

English 0 7 24 31 B-language_fluency
speaking 8 16 32 40 I-language_fluency

Histologically 0 14 41 55 O
proven 15 21 56 62 O
cancer 22 28 63 69 B-cancer
of 29 31 70 72 O
the 32 35 73 76 O
head 36 40 77 81 B-cancer
and 41 44 82 85 I-cancer
neck 45 49 86 90 I-cancer
cancer 50 56 91 97 I-cancer

History 0 7 98 105 O
of 8 10 106 108 O
seizure 11 18 109 116 B-chronic_disease
disorder 19 27 117 125 O

Planned 0 7 126 133 O
primary 8 15 134 141 O
or 16 18 142 144 O
adjuvant 19 27 145 153 B-treatment
chemoradiation 28 42 154 168 I-treatment
therapy 43 50 169 176 I-treatment

Prior 0 5 177 182 O
non 6 9 183 186 O
- 9 10 186 187 O
tolerance 10 19 187 196 O
of 20 22 197 199 O
gabapentin 23 33 200 210 B-treatment

Age 0 3 0 3 B-age
: 3 4 3 4 O
17 5 7 5 7 B-upper_bound
years 8 13 8 13 I-upper_bound
or 14 16 14 16 O
less 17 21 17 21 O
at 22 24 22 24 O
time 25 29 25 29 O
of 30 32 30 32 O
enrollment 33 43 33 43 O

Breast 0 6 44 50 O
- 6 7 50 51 O
feeding 7 14 51 58 O
females 15 22 59 66 B-gender

Children 0 8 67 75 O
with 9 13 76 80 O
severe 14 20 81 87 B-chronic_disease
renal 21 26 88 93 I-chronic_disease
impairment 27 37 94 104 I-chronic_disease
will 38 42 105 109 O
not 43 46 110 113 O
be 47 49 114 116 O
enrolled 50 58 117 125 O

Patients 0 8 126 134 O
who 9 12 135 138 O
are 13 16 139 142 O
older 17 22 143 148 O
than 23 27 149 153 O
17 28 30 154 156 B-lower_bound
years 31 36 157 162 I-lower_bound
will 37 41 163 167 O
not 42 45 168 171 O
be 46 48 172 174 O
enrolled 49 57 175 183 O

Post 0 4 184 188 O
- 4 5 188 189 O
pubertal 5 13 189 197 O
females 14 21 198 205 B-gender
who 22 25 206 209 O
are 26 29 210 213 O
pregnant 30 38 214 222 B-pregnancy

Subjects 0 8 223 231 O
must 9 13 232 236 O
have 14 18 237 241 O
a 19 20 242 243 O
documented 21 31 244 254 O
infantile 32 41 255 264 B-chronic_disease
or 42 44 265 267 I-chronic_disease
juvenile 45 53 268 276 I-chronic_disease
gangliosidosis 54 68 277 291 I-chronic_disease
disease 69 76 292 299 I-chronic_disease

Subjects 0 8 300 308 O
who 9 12 309 312 O
have 13 17 313 317 O
an 18 20 318 320 O
allergy 21 28 321 328 O
to 29 31 329 331 O
miglustat 32 41 332 341 B-allergy_name
or 42 44 342 344 O
any 45 48 345 348 O
of 49 51 349 351 O
the 52 55 352 355 O
components 56 66 356 366 O
within 67 73 367 373 O
the 74 77 374 377 O
drug 78 82 378 382 O
product 83 90 383 390 O

who 0 3 391 394 O
are 4 7 395 398 O
unwilling 8 17 399 408 O
to 18 20 409 411 O
use 21 24 412 415 O
highly 25 31 416 422 O
- 31 32 422 423 O
effective 32 41 423 432 O
methods 42 49 433 440 O
to 50 52 441 443 O
prevent 53 60 444 451 O
pregnancy 61 70 452 461 B-pregnancy

( 0 1 0 1 O
If 1 3 1 3 O
the 4 7 4 7 O
subject 8 15 8 15 O
chooses 16 23 16 23 O
not 24 27 24 27 O
to 28 30 28 30 O
have 31 35 31 35 O
the 36 39 36 39 O
treatment 40 49 40 49 B-treatment
, 49 50 49 50 O
they 51 55 51 55 O
can 56 59 56 59 O
not 59 62 59 62 O
participate 63 74 63 74 O
in 75 77 75 77 O
the 78 81 78 81 O
study 82 87 82 87 O

( 0 1 88 89 O
Subjects 1 9 89 97 O
not 10 13 98 101 O
required 14 22 102 110 O
to 23 25 111 113 O
participate 26 37 114 125 O
in 38 40 126 128 O
HRT 41 44 129 132 B-treatment
but 45 48 133 136 O
it 49 51 137 139 O
will 52 56 140 144 O
be 57 59 145 147 O
highly 60 66 148 154 O
encouraged 67 77 155 165 O
, 77 78 165 166 O
and 79 82 167 170 O
must 83 87 171 175 O
be 88 90 176 178 O
completed 91 100 179 188 O
prior 101 106 189 194 O
to 107 109 195 197 O
start 110 115 198 203 O
of 116 118 204 206 O
this 119 123 207 211 O
study 124 129 212 217 O
's 129 131 217 219 O
protocol 132 140 220 228 O

Abnormal 0 8 229 237 O
brain 9 14 238 243 B-treatment
magnetic 15 23 244 252 I-treatment
resonance 24 33 253 262 I-treatment
imaging 34 41 263 270 I-treatment
( 42 43 271 272 I-treatment
MRI 43 46 272 275 I-treatment
) 46 47 275 276 I-treatment
scan 48 52 277 281 I-treatment
, 52 53 281 282 O
including 54 63 283 292 O
severe 64 70 293 299 B-chronic_disease
atrophy 71 78 300 307 I-chronic_disease
, 78 79 307 308 O
hydrocephalus 80 93 309 322 B-chronic_disease
, 93 94 322 323 O
stroke 95 101 324 330 B-chronic_disease
, 101 102 330 331 O
structural 103 113 332 342 B-chronic_disease
lesions 114 121 343 350 I-chronic_disease
, 121 122 350 351 O
demyelinating 123 136 352 365 B-chronic_disease
lesions 137 144 366 373 I-chronic_disease
, 144 145 373 374 O
or 146 148 375 377 O
infectious 149 159 378 388 B-chronic_disease
lesions 160 167 389 396 I-chronic_disease
that 168 172 397 401 O
would 173 178 402 407 O
potentially 179 190 408 419 O
confound 191 199 420 428 O
the 200 203 429 432 O
outcome 204 211 433 440 O
or 212 214 441 443 O
safety 215 221 444 450 O
of 222 224 451 453 O
the 225 228 454 457 O
surgery 229 236 458 465 B-treatment
as 237 239 466 468 O
judged 240 246 469 475 O
by 247 249 476 478 O
the 250 253 479 482 O
study 254 259 483 488 O
neurosurgeon 260 272 489 501 O

Any 0 3 502 505 O
attempt 4 11 506 513 O
or 12 14 514 516 O
intent 15 21 517 523 O
of 22 24 524 526 O
suicide 25 32 527 534 B-chronic_disease
in 33 35 535 537 O
the 36 39 538 541 O
last 40 44 542 546 B-upper_bound
6 45 46 547 548 I-upper_bound
months 47 53 549 555 I-upper_bound

Any 0 3 556 559 O
previous 4 12 560 568 O
neurological 13 25 569 581 O
intervention 26 38 582 594 O
including 39 48 595 604 O
DBS 49 52 605 608 B-treatment
or 53 55 609 611 O
ablative 56 64 612 620 B-cancer
brain 65 70 621 626 I-cancer
lesions 71 78 627 634 I-cancer
, 78 79 634 635 O
any 80 83 636 639 O
metal 84 89 640 645 O
in 90 92 646 648 O
the 93 96 649 652 O
head 97 101 653 657 O
, 101 102 657 658 O
and 103 106 659 662 O
any 107 110 663 666 O
type 111 115 667 671 O
of 116 118 672 674 O
implanted 119 128 675 684 B-treatment
stimulator 129 139 685 695 I-treatment

Dementia 0 8 696 704 B-chronic_disease
or 9 11 705 707 O
cognitive 12 21 708 717 B-chronic_disease
dysfunction 22 33 718 729 I-chronic_disease
that 34 38 730 734 O
will 39 43 735 739 O
place 44 49 740 745 O
the 50 53 746 749 O
subject 54 61 750 757 O
at 62 64 758 760 O
risk 65 69 761 765 O
for 70 73 766 769 O
worsening 74 83 770 779 O
cognition 84 93 780 789 O
, 93 94 789 790 O
and/or 95 101 791 797 O
may 102 105 798 801 O
impact 106 112 802 808 O
the 113 116 809 812 O
ability 117 124 813 820 O
to 125 127 821 823 O
cooperate 128 137 824 833 O
with 138 142 834 838 O
tasks 143 148 839 844 O
involved 149 157 845 853 O
in 158 160 854 856 O
the 161 164 857 860 O
study 165 170 861 866 O

History 0 7 867 874 O
of 8 10 875 877 O
noncompliance 11 24 878 891 O
with 25 29 892 896 O
previous 30 38 897 905 B-treatment
medical 39 46 906 913 I-treatment
and 47 50 914 917 I-treatment
psychosocial 51 63 918 930 I-treatment
treatment 64 73 931 940 I-treatment
efforts 74 81 941 948 O

If 0 2 949 951 O
medication 3 13 952 962 B-treatment
trials 14 20 963 969 O
resulted 21 29 970 978 O
in 30 32 979 981 O
discontinuation 33 48 982 997 O
of 49 51 998 1000 O
TS 52 54 1001 1003 B-treatment
medications 55 66 1004 1015 I-treatment
, 66 67 1015 1016 O
the 68 71 1017 1020 O
subject 72 79 1021 1028 O
must 80 84 1029 1033 O
be 85 87 1034 1036 O
stabilized 88 98 1037 1047 O
for 99 102 1048 1051 O
3 103 104 1052 1053 O
months 105 111 1054 1060 O
off 112 115 1061 1064 O
TS 116 118 1065 1067 B-treatment
medicines 119 128 1068 1077 I-treatment

If 0 2 1078 1080 O
tic 3 6 1081 1084 O
is 7 9 1085 1087 O
focal 10 15 1088 1093 O
or 16 18 1094 1096 O
addressable 19 30 1097 1108 O
by 31 33 1109 1111 O
botulinum 34 43 1112 1121 B-treatment
toxin 44 49 1122 1127 I-treatment
treatment 50 59 1128 1137 I-treatment
, 59 60 1137 1138 O
the 61 64 1139 1142 O
study 65 70 1143 1148 O
neurologist 71 82 1149 1160 O
will 83 87 1161 1165 O
offer 88 93 1166 1171 O
to 94 96 1172 1174 O
administer 97 107 1175 1185 O
a 108 109 1186 1187 O
trial 110 115 1188 1193 O
of 116 118 1194 1196 O
botulinum 119 128 1197 1206 O
toxin 129 134 1207 1212 O
prior 135 140 1213 1218 O
to 141 143 1219 1221 O
consideration 144 157 1222 1235 O
of 158 160 1236 1238 O
surgical 161 169 1239 1247 B-treatment
therapy 170 177 1248 1255 I-treatment

Multiple 0 8 1256 1264 O
failed 9 15 1265 1271 O
medication 16 26 1272 1282 B-treatment
treatments 27 37 1283 1293 B-treatment
of 38 40 1294 1296 O
inadequate 41 51 1297 1307 O
dose 52 56 1308 1312 O
or 57 59 1313 1315 O
duration 60 68 1316 1324 O

Must 0 4 1325 1329 O
be 5 7 1330 1332 O
at 8 10 1333 1335 O
minimum 11 18 1336 1343 O
a 19 20 1344 1345 O
single 21 27 1346 1352 O
trial 28 33 1353 1358 O
with 34 38 1359 1363 O
an 39 41 1364 1366 O
alpha-2 42 49 1367 1374 B-treatment
adrenergic 50 60 1375 1385 I-treatment
agonist 61 68 1386 1393 I-treatment
( 69 70 1394 1395 O
0.1 70 73 1395 1398 B-lower_bound
- 73 74 1398 1399 O
0.3 74 77 1399 1402 B-upper_bound
mg 78 80 1403 1405 I-upper_bound
/ 80 81 1405 1406 I-upper_bound
day 81 84 1406 1409 I-upper_bound
) 84 85 1409 1410 O

Must 0 4 1411 1415 O
be 5 7 1416 1418 O
willing 8 15 1419 1426 O
to 16 18 1427 1429 O
keep 19 23 1430 1434 O
TS 24 26 1435 1437 O
related 27 34 1438 1445 O
medications 35 46 1446 1457 B-treatment
stable 47 53 1458 1464 O
and 54 57 1465 1468 O
unchanged 58 67 1469 1478 O
throughout 68 78 1479 1489 O
the 79 82 1490 1493 O
trial 83 88 1494 1499 O

Must 0 4 1500 1504 O
have 5 9 1505 1509 O
been 10 14 1510 1514 O
offered 15 22 1515 1522 O
habit 23 28 1523 1528 B-treatment
reversal 29 37 1529 1537 I-treatment
therapy 38 45 1538 1545 I-treatment
/ 45 46 1545 1546 O
cognitive 46 55 1546 1555 B-treatment
behavioral 56 66 1556 1566 I-treatment
intervention 67 79 1567 1579 I-treatment
therapy 80 87 1580 1587 I-treatment
( 88 89 1588 1589 O
HRT 89 92 1589 1592 B-treatment
) 92 93 1592 1593 O
if 94 96 1594 1596 O
subject 97 104 1597 1604 O
did 105 108 1605 1608 O
not 109 112 1609 1612 O
have 113 117 1613 1617 O
it 118 120 1618 1620 O
prior 121 126 1621 1626 O
to 127 129 1627 1629 O
enrollment 130 140 1630 1640 O

Must 0 4 1641 1645 O
have 5 9 1646 1650 O
been 10 14 1651 1655 O
stabilized 15 25 1656 1666 O
for 26 29 1667 1670 O
1 30 31 1671 1672 O
month 32 37 1673 1678 O
on 38 40 1679 1681 O
TS 41 43 1682 1684 B-treatment
medication 44 54 1685 1695 I-treatment
without 55 62 1696 1703 I-treatment
a 63 64 1704 1705 I-treatment
dose 65 69 1706 1710 I-treatment
change 70 76 1711 1717 I-treatment
prior 77 82 1718 1723 I-treatment
to 83 85 1724 1726 I-treatment
surgical 86 94 1727 1735 I-treatment
intervention 95 107 1736 1748 I-treatment

Presence 0 8 1749 1757 O
of 9 11 1758 1760 O
psychotic 12 21 1761 1770 B-chronic_disease
features 22 30 1771 1779 O

Severe 0 6 1780 1786 O
medical 7 14 1787 1794 O
co 15 17 1795 1797 O
- 17 18 1797 1798 O
morbidity 18 27 1798 1807 O
including 28 37 1808 1817 O
cardiovascular 38 52 1818 1832 B-chronic_disease
disorder 53 61 1833 1841 I-chronic_disease
, 61 62 1841 1842 O
lung 63 67 1843 1847 B-chronic_disease
disorder 68 76 1848 1856 I-chronic_disease
, 76 77 1856 1857 O
kidney 78 84 1858 1864 B-chronic_disease
disease 85 92 1865 1872 I-chronic_disease
, 92 93 1872 1873 O
chronic 94 101 1874 1881 O
neurological 102 114 1882 1894 B-chronic_disease
disease 115 122 1895 1902 I-chronic_disease
, 122 123 1902 1903 O
hematological 124 137 1904 1917 B-chronic_disease
disease 138 145 1918 1925 I-chronic_disease
, 145 146 1925 1926 O
or 147 149 1927 1929 O
frailty 150 157 1930 1937 O
that 158 162 1938 1942 O
impacts 163 170 1943 1950 O
tolerability 171 183 1951 1963 O
of 184 186 1964 1966 O
the 187 190 1967 1970 O
surgery 191 198 1971 1978 B-treatment
as 199 201 1979 1981 O
judged 202 208 1982 1988 O
by 209 211 1989 1991 O
the 212 215 1992 1995 O
screening 216 225 1996 2005 O
physicians 226 236 2006 2016 O

Significant 0 11 2017 2028 O
substance 12 21 2029 2038 O
abuse 22 27 2039 2044 O
or 28 30 2045 2047 O
dependence 31 41 2048 2058 O
within 42 48 2059 2065 O
the 49 52 2066 2069 O
last 53 57 2070 2074 B-upper_bound
6 58 59 2075 2076 I-upper_bound
months 60 66 2077 2083 I-upper_bound

TS 0 2 2084 2086 B-cancer
must 3 7 2087 2091 O
be 8 10 2092 2094 O
causing 11 18 2095 2102 O
incapacitation 19 33 2103 2117 O
with 34 38 2118 2122 O
severe 39 45 2123 2129 O
distress 46 54 2130 2138 O
, 54 55 2138 2139 O
self 56 60 2140 2144 O
- 60 61 2144 2145 O
injurious 61 70 2145 2154 O
behavior 71 79 2155 2163 O
, 79 80 2163 2164 O
and/or 81 87 2165 2171 O
quality 88 95 2172 2179 O
of 96 98 2180 2182 O
life 99 103 2183 2187 O
disruption 104 114 2188 2198 O

TS 0 2 2199 2201 O
must 3 7 2202 2206 O
be 8 10 2207 2209 O
medication 11 21 2210 2220 B-treatment
refractory 22 32 2221 2231 O
. 32 33 2231 2232 O
Criteria 34 42 2233 2241 O
to 43 45 2242 2244 O
determine 46 55 2245 2254 O
if 56 58 2255 2257 O
medication 59 69 2258 2268 O
refractory 70 80 2269 2279 O
is 81 83 2280 2282 O
the 84 87 2283 2286 O
exact 88 93 2287 2292 O
criteria 94 102 2293 2301 O
stated 103 109 2302 2308 O
by 110 112 2309 2311 O
Mink 113 117 2312 2316 O
et 118 120 2317 2319 O
. 120 121 2319 2320 O
al 122 124 2321 2323 O
TSA 125 128 2324 2327 O
DBS 129 132 2328 2331 O
Guidelines 133 143 2332 2342 O
published 144 153 2343 2352 O
in 154 156 2353 2355 O
2006 157 161 2356 2360 B-lower_bound
: 161 162 2360 2361 O
Subjects 163 171 2362 2370 O
must 172 176 2371 2375 O
have 177 181 2376 2380 O
been 182 186 2381 2385 O
treated 187 194 2386 2393 O
by 195 197 2394 2396 O
a 198 199 2397 2398 O
psychiatrist 200 212 2399 2411 O
or 213 215 2412 2414 O
neurologist 216 227 2415 2426 O
experienced 228 239 2427 2438 O
in 240 242 2439 2441 O
TS 243 245 2442 2444 O
with 246 250 2445 2449 O
therapeutic 251 262 2450 2461 O
doses 263 268 2462 2467 O
of 269 271 2468 2470 O
either 272 278 2471 2477 O
1 279 280 2478 2479 B-lower_bound
- 280 281 2479 2480 O
4 281 282 2480 2481 B-upper_bound
mg 283 285 2482 2484 I-upper_bound
/ 285 286 2484 2485 I-upper_bound
day 286 289 2485 2488 I-upper_bound
of 290 292 2489 2491 O
haloperidol 293 304 2492 2503 B-treatment
or 305 307 2504 2506 O
2 308 309 2507 2508 O
- 309 310 2508 2509 O
8 310 311 2509 2510 B-upper_bound
mg 312 314 2511 2513 I-upper_bound
/ 314 315 2513 2514 I-upper_bound
day 315 318 2514 2517 I-upper_bound
of 319 321 2518 2520 O
pimozide 322 330 2521 2529 B-treatment
, 330 331 2529 2530 O
risperidone 332 343 2531 2542 B-treatment
( 344 345 2543 2544 O
1 345 346 2544 2545 O
- 346 347 2545 2546 O
3 347 348 2546 2547 B-upper_bound
mg 349 351 2548 2550 I-upper_bound
/ 351 352 2550 2551 I-upper_bound
day 352 355 2551 2554 I-upper_bound
) 355 356 2554 2555 O
, 356 357 2555 2556 O
and 358 361 2557 2560 O
aripiprazole 362 374 2561 2573 B-treatment
( 375 376 2574 2575 O
2.5 376 379 2575 2578 B-lower_bound
- 379 380 2578 2579 O
5 380 381 2579 2580 B-upper_bound
mg 382 384 2581 2583 I-upper_bound
/ 384 385 2583 2584 I-upper_bound
day 385 388 2584 2587 I-upper_bound
) 388 389 2587 2588 O

The 0 3 2589 2592 O
presence 4 12 2593 2601 O
of 13 15 2602 2604 O
only 16 20 2605 2609 O
simple 21 27 2610 2616 O
motor 28 33 2617 2622 O
tics 34 38 2623 2627 O
, 38 39 2627 2628 O
a 40 41 2629 2630 O
movement 42 50 2631 2639 B-chronic_disease
disorder 51 59 2640 2648 I-chronic_disease
other 60 65 2649 2654 O
than 66 70 2655 2659 O
TS 71 73 2660 2662 B-chronic_disease
, 73 74 2662 2663 O
or 75 77 2664 2666 O
medication 78 88 2667 2677 B-treatment
related 89 96 2678 2685 O
movement 97 105 2686 2694 B-chronic_disease
disorders 106 115 2695 2704 I-chronic_disease
from 116 120 2705 2709 O
TS 121 123 2710 2712 B-treatment
medications 124 135 2713 2724 I-treatment

Those 0 5 2725 2730 O
who 6 9 2731 2734 O
improve 10 17 2735 2742 O
significantly 18 31 2743 2756 O
will 32 36 2757 2761 O
be 37 39 2762 2764 O
excluded 40 48 2765 2773 O
from 49 53 2774 2778 O
receiving 54 63 2779 2788 O
DBS 64 67 2789 2792 B-treatment
surgery 68 75 2793 2800 I-treatment
) 75 76 2800 2801 O

Untreated 0 9 2802 2811 O
or 10 12 2812 2814 O
unstable 13 21 2815 2823 O
anxiety 22 29 2824 2831 B-chronic_disease
, 29 30 2831 2832 O
depression 31 41 2833 2843 B-chronic_disease
, 41 42 2843 2844 O
bipolar 43 50 2845 2852 B-chronic_disease
disorder 51 59 2853 2861 I-chronic_disease
, 59 60 2861 2862 O
or 61 63 2863 2865 O
other 64 69 2866 2871 O
Axis 70 74 2872 2876 B-chronic_disease
I 75 76 2877 2878 I-chronic_disease
psychiatric 77 88 2879 2890 I-chronic_disease
disorder 89 97 2891 2899 I-chronic_disease

Women 0 5 2900 2905 B-gender
of 6 8 2906 2908 O
child 9 14 2909 2914 O
- 14 15 2914 2915 O
bearing 15 22 2915 2922 O
potential 23 32 2923 2932 O
who 33 36 2933 2936 O
are 37 40 2937 2940 B-pregnancy
pregnant 41 49 2941 2949 I-pregnancy
or 50 52 2950 2952 O
planning 53 61 2953 2961 B-pregnancy
pregnancy 62 71 2962 2971 I-pregnancy
( 72 73 2972 2973 O
urine 73 78 2973 2978 B-pregnancy
pregnancy 79 88 2979 2988 I-pregnancy
test 89 93 2989 2993 O
required 94 102 2994 3002 O
) 102 103 3002 3003 O

Yale 0 4 3004 3008 B-clinical_variable
Global 5 11 3009 3015 I-clinical_variable
Tic 12 15 3016 3019 I-clinical_variable
Severity 16 24 3020 3028 I-clinical_variable
Scale 25 30 3029 3034 I-clinical_variable
( 31 32 3035 3036 I-clinical_variable
YGTSS 32 37 3036 3041 I-clinical_variable
) 37 38 3041 3042 I-clinical_variable
must 39 43 3043 3047 O
be 44 46 3048 3050 O
≥35/50 47 53 3051 3057 O
for 54 57 3058 3061 O
at 58 60 3062 3064 O
least 61 66 3065 3070 O
12 67 69 3071 3073 B-lower_bound
months 70 76 3074 3080 I-lower_bound
; 76 77 3080 3081 O
Motor 78 83 3082 3087 B-clinical_variable
Tic 84 87 3088 3091 I-clinical_variable
subscore 88 96 3092 3100 I-clinical_variable
must 97 101 3101 3105 O
be 102 104 3106 3108 O
≥15 105 108 3109 3112 O

Be 0 2 0 2 O
18 3 5 3 5 B-lower_bound
years 6 11 6 11 I-lower_bound
of 12 14 12 14 O
age 15 18 15 18 B-age
or 19 21 19 21 O
older 22 27 22 27 O

Be 0 2 28 30 O
able 3 7 31 35 O
to 8 10 36 38 O
walk 11 15 39 43 O
unassisted 16 26 44 54 O
for 27 30 55 58 O
at 31 33 59 61 O
least 34 39 62 67 O
10 40 42 68 70 B-lower_bound
minutes 43 50 71 78 I-lower_bound

Have 0 4 79 83 O
tried 5 10 84 89 O
any 11 14 90 93 O
tobacco 15 22 94 101 O
, 22 23 101 102 O
alcohol 24 31 103 110 O
, 31 32 110 111 O
or 33 35 112 114 O
drugs 36 41 115 120 O
OR 42 44 121 123 O
ever 45 49 124 128 O
felt 50 54 129 133 O
out 55 58 134 137 O
of 59 61 138 140 O
control 62 69 141 148 O
with 70 74 149 153 O
any 75 78 154 157 O
food 79 83 158 162 O
in 84 86 163 165 O
past 87 91 166 170 B-upper_bound
5 92 93 171 172 I-upper_bound
years 94 99 173 178 I-upper_bound

Self 0 4 179 183 O
- 4 5 183 184 O
identify 5 13 184 192 O
as 14 16 193 195 O
women 17 22 196 201 B-gender

Women 0 5 202 207 B-gender
who 6 9 208 211 O
are 10 13 212 215 O
actively 14 22 216 224 O
using 23 28 225 230 O
opioids 29 36 231 238 B-treatment
( 37 38 239 240 O
i.e. 38 42 240 244 O
, 42 43 244 245 O
heroin 44 50 246 252 B-treatment
) 50 51 252 253 O
methamphetamines 52 68 254 270 B-treatment
and/or 69 75 271 277 O
abusing 76 83 278 285 O
prescription 84 96 286 298 O
drugs 97 102 299 304 O
not 103 106 305 308 O
prescribed 107 117 309 319 O
to 118 120 320 322 O
them 121 125 323 327 O
( 126 127 328 329 O
e.g. 127 131 329 333 O
, 131 132 333 334 O
Dilaudid 133 141 335 343 B-treatment
, 141 142 343 344 O
Oxycontin 143 152 345 354 B-treatment
) 152 153 354 355 O
or 154 156 356 358 O
alcohol 157 164 359 366 O
dependent 165 174 367 376 O
( 175 176 377 378 O
5 176 177 378 379 O
+ 177 178 379 380 O
bottles 179 186 381 388 O
/ 186 187 388 389 O
glasses 187 194 389 396 O
of 195 197 397 399 O
alcohol 198 205 400 407 O
a 206 207 408 409 O
day 208 211 410 413 O
) 211 212 413 414 O

Women 0 5 415 420 B-gender
who 6 9 421 424 O
exhibit 10 17 425 432 O
serious 18 25 433 440 B-chronic_disease
psychiatric 26 37 441 452 I-chronic_disease
symptoms 38 46 453 461 O
determined 47 57 462 472 O
by 58 60 473 475 O
CNO 61 64 476 479 O
trained 65 72 480 487 O
staff 73 78 488 493 O

Women 0 5 494 499 B-gender
who 6 9 500 503 O
have 10 14 504 508 O
been 15 19 509 513 O
suicidal 20 28 514 522 B-chronic_disease
in 29 31 523 525 O
past 32 36 526 530 B-upper_bound
3 37 38 531 532 I-upper_bound
months 39 45 533 539 I-upper_bound
, 45 46 539 540 O
are 47 50 541 544 O
currently 51 60 545 554 B-pregnancy
pregnant 61 69 555 563 I-pregnancy
, 69 70 563 564 O
or 71 73 565 567 O
are 74 77 568 571 O
denied 78 84 572 578 O
medical 85 92 579 586 O
approval 93 101 587 595 O

Currently 0 9 0 9 O
receiving 10 19 10 19 O
or 20 22 20 22 O
history 23 30 23 30 O
of 31 33 31 33 O
systemic 34 42 34 42 B-treatment
therapy 43 50 43 50 I-treatment
with 51 55 51 55 O
testosterone 56 68 56 68 B-treatment
suppressing 69 80 69 80 I-treatment
medication 81 91 81 91 I-treatment
( 92 93 92 93 O
i.e. 93 97 93 97 O
, 97 98 97 98 O
lupron 99 105 99 105 B-treatment
, 105 106 105 106 O
degarelix 107 116 107 116 B-treatment
, 116 117 116 117 O
abiraterone 118 129 118 129 B-treatment
, 129 130 129 130 O
enzalutamide 131 143 131 143 B-treatment
) 143 144 143 144 O
or 145 147 145 147 O
local 148 153 148 153 B-treatment
radiation 154 163 154 163 I-treatment
therapy 164 171 164 171 I-treatment

Gleason 0 7 172 179 B-clinical_variable
score 8 13 180 185 I-clinical_variable
= 14 15 186 187 O
8/ 16 18 188 190 B-lower_bound
> 19 20 191 192 O
8 21 22 193 194 O

Patient 0 7 195 202 O
is 8 10 203 205 O
at 11 13 206 208 O
low 14 17 209 212 O
risk 18 22 213 217 O
for 23 26 218 221 O
metastasis 27 37 222 232 B-cancer
with 38 42 233 237 O
Gleason 43 50 238 245 B-clinical_variable
score 51 56 246 251 I-clinical_variable
at 57 59 252 254 O
diagnosis 60 69 255 264 O
< 70 71 265 266 O
8 72 73 267 268 B-upper_bound

Prostate 0 8 269 277 B-cancer
carcinoma 9 18 278 287 I-cancer
patients 19 27 288 296 O
at 28 30 297 299 O
high 31 35 300 304 O
risk 36 40 305 309 O
for 41 44 310 313 O
metastasis 45 55 314 324 B-cancer

prostate 0 8 325 333 B-clinical_variable
- 8 9 333 334 I-clinical_variable
specific 9 17 334 342 I-clinical_variable
antigen 18 25 343 350 I-clinical_variable
( 26 27 351 352 I-clinical_variable
PSA 27 30 352 355 I-clinical_variable
) 30 31 355 356 I-clinical_variable
more 32 36 357 361 O
than 37 41 362 366 O
20 42 44 367 369 B-lower_bound
ng 45 47 370 372 I-lower_bound
/ 47 48 372 373 I-lower_bound
ml 48 50 373 375 I-lower_bound

A 0 1 0 1 O
known 2 7 2 7 O
diagnosis 8 17 8 17 O
of 18 20 18 20 O
cancer 21 27 21 27 B-cancer
( 28 29 28 29 O
except 29 35 29 35 O
basal 36 41 36 41 B-cancer
cell 42 46 42 46 I-cancer
cancer 47 53 47 53 I-cancer
) 53 54 53 54 O

Acute 0 5 55 60 B-clinical_variable
traumatic 6 15 61 70 I-clinical_variable
SCI 16 19 71 74 I-clinical_variable
> 20 21 75 76 O
24 22 24 77 79 B-lower_bound
hours 25 30 80 85 I-lower_bound
old 31 34 86 89 O

Advanced 0 8 90 98 O
cardiac 9 16 99 106 B-chronic_disease
, 16 17 106 107 O
pulmonary 18 27 108 117 B-chronic_disease
, 27 28 117 118 O
hepatic 29 36 119 126 B-chronic_disease
or 37 39 127 129 O
liver 40 45 130 135 B-chronic_disease
disease 46 53 136 143 I-chronic_disease

Age 0 3 144 147 B-age
greater 4 11 148 155 O
than 12 16 156 160 O
or 17 19 161 163 O
equal 20 25 164 169 O
to 26 28 170 172 O
16 29 31 173 175 B-lower_bound
years 32 37 176 181 I-lower_bound

Allergy 0 7 182 189 O
or 8 10 190 192 O
other 11 16 193 198 O
contraindication 17 33 199 215 O
to 34 36 216 218 O
norepinephrine 37 51 219 233 B-allergy_name

Central 0 7 234 241 B-chronic_disease
cord 8 12 242 246 I-chronic_disease
syndrome 13 21 247 255 I-chronic_disease
, 21 22 255 256 O
defined 23 30 257 264 O
as 31 33 265 267 O
ASIA 34 38 268 272 O
C 39 40 273 274 O
or 41 43 275 277 O
D 44 45 278 279 O
with 46 50 280 284 O
mean 51 55 285 289 O
lower 56 61 290 295 O
extremity 62 71 296 305 O
score 72 77 306 311 O
greater 78 85 312 319 O
than 86 90 320 324 O
upper 91 96 325 330 O
extremity 97 106 331 340 O
score 107 112 341 346 O

Isolated 0 8 347 355 B-chronic_disease
sensory 9 16 356 363 I-chronic_disease
deficit 17 24 364 371 I-chronic_disease
, 24 25 371 372 O
motor 26 31 373 378 O
intact 32 38 379 385 O

Known 0 5 386 391 O
uncorrected 6 17 392 403 O
severe 18 24 404 410 O
coronary 25 33 411 419 B-chronic_disease
artery 34 40 420 426 I-chronic_disease
disease 41 48 427 434 I-chronic_disease
or 49 51 435 437 O
evidence 52 60 438 446 O
of 61 63 447 449 O
active 64 70 450 456 B-chronic_disease
coronary 71 79 457 465 I-chronic_disease
ischemia 80 88 466 474 I-chronic_disease
( 89 90 475 476 O
ECG 90 93 476 479 B-treatment
changes 94 101 480 487 O
, 101 102 487 488 O
positive 103 111 489 497 O
troponin 112 120 498 506 B-treatment
) 120 121 506 507 O

Motor 0 5 508 513 O
complete 6 14 514 522 O
or 15 17 523 525 O
incomplete 18 28 526 536 O
( 29 30 537 538 O
ASIA 30 34 538 542 O
A 35 36 543 544 O
, 36 37 544 545 O
B 38 39 546 547 O
, 39 40 547 548 O
or 41 43 549 551 O
C 44 45 552 553 O
) 45 46 553 554 O
acute 47 52 555 560 B-chronic_disease
traumatic 53 62 561 570 I-chronic_disease
SCI 63 66 571 574 I-chronic_disease
involving 67 76 575 584 O
spinal 77 83 585 591 O
levels 84 90 592 598 O
between 91 98 599 606 O
C0 99 101 607 609 O
and 102 105 610 613 O
T12 106 109 614 617 O

Patients 0 8 618 626 O
who 9 12 627 630 O
have 13 17 631 635 O
a 18 19 636 637 O
history 20 27 638 645 O
of 28 30 646 648 O
substance 31 40 649 658 O
abuse 41 46 659 664 O
or 47 49 665 667 O
dependency 50 60 668 678 O
within 61 67 679 685 O
12 68 70 686 688 B-upper_bound
months 71 77 689 695 I-upper_bound
prior 78 83 696 701 I-upper_bound
to 84 86 702 704 O
the 87 90 705 708 O
study 91 96 709 714 O

Polytrauma 0 10 715 725 O
: 10 11 725 726 O
Abbreviated 12 23 727 738 B-clinical_variable
Injury 24 30 739 745 I-clinical_variable
Severity 31 39 746 754 I-clinical_variable
Score 40 45 755 760 I-clinical_variable
> 46 47 761 762 O
3 47 48 762 763 B-lower_bound
in 49 51 764 766 O
any 52 55 767 770 O
area 56 60 771 775 O
other 61 66 776 781 O
than 67 71 782 786 O
head 72 76 787 791 O

Pre 0 3 792 795 O
- 3 4 795 796 O
existing 4 12 796 804 O
and 13 16 805 808 O
active 17 23 809 815 O
major 24 29 816 821 O
psychiatric 30 41 822 833 B-chronic_disease
or 42 44 834 836 O
other 45 50 837 842 O
chronic 51 58 843 850 B-chronic_disease
neurological 59 71 851 863 I-chronic_disease
disease 72 79 864 871 I-chronic_disease

Pregnancy 0 9 872 881 B-pregnancy

Randomization 0 13 882 895 O
and 14 17 896 899 O
initiation 18 28 900 910 O
of 29 31 911 913 O
management 32 42 914 924 O
protocol 43 51 925 933 O
within 52 58 934 940 O
24 59 61 941 943 B-upper_bound
hours 62 67 944 949 I-upper_bound
of 68 70 950 952 O
injury 71 77 953 959 O

Uncontrolled 0 12 960 972 B-chronic_disease
hypertension 13 25 973 985 I-chronic_disease
, 25 26 985 986 O
defined 27 34 987 994 O
as 35 37 995 997 O
blood 38 43 998 1003 O
pressure 44 52 1004 1012 O
persistently 53 65 1013 1025 O
above 66 71 1026 1031 O
220 72 75 1032 1035 B-lower_bound
mmHg 76 80 1036 1040 I-lower_bound
systolic 81 89 1041 1049 O
or 90 92 1050 1052 O
120 93 96 1053 1056 B-lower_bound
mmHg 97 101 1057 1061 I-lower_bound
diastolic 102 111 1062 1071 B-clinical_variable
, 111 112 1071 1072 O
despite 113 120 1073 1080 O
antihypertensive 121 137 1081 1097 B-treatment
therapy 138 145 1098 1105 I-treatment

he 0 2 1106 1108 O
former 3 9 1109 1115 O
will 10 14 1116 1120 O
be 15 17 1121 1123 O
operationally 18 31 1124 1137 O
defined 32 39 1138 1145 O
using 40 45 1146 1151 O
NCI 46 49 1152 1155 B-clinical_variable
Toxicity 50 58 1156 1164 I-clinical_variable
Criteria 59 67 1165 1173 I-clinical_variable
( 68 69 1174 1175 O
Grade 69 74 1175 1180 B-lower_bound
2 75 76 1181 1182 I-lower_bound
or 77 79 1183 1185 O
higher 80 86 1186 1192 O
) 86 87 1192 1193 O

A 0 1 0 1 O
fetal 2 7 2 7 B-chronic_disease
cardiac 8 15 8 15 I-chronic_disease
arrhythmia 16 26 16 26 I-chronic_disease

A 0 1 27 28 O
permanent 2 11 29 38 O
cardiac 12 19 39 46 O
pacemaker 20 29 47 56 B-treatment

Active 0 6 57 63 O
preterm 7 14 64 71 O
labor 15 20 72 77 O
with 21 25 78 82 O
cervical 26 34 83 91 B-clinical_variable
dilation 35 43 92 100 I-clinical_variable
> 44 45 101 102 O
6 46 47 103 104 B-lower_bound
cm 48 50 105 107 I-lower_bound

Be 0 2 108 110 O
between 3 10 111 118 O
18 11 13 119 121 B-lower_bound
- 14 15 122 123 O
50 16 18 124 126 B-upper_bound
years 19 24 127 132 I-upper_bound
of 25 27 133 135 O
age 28 31 136 139 B-age

Be 0 2 140 142 O
between 3 10 143 150 O
23 11 13 151 153 B-lower_bound
to 14 16 154 156 O
34 17 19 157 159 B-upper_bound
weeks 20 25 160 165 I-upper_bound
pregnant 26 34 166 174 B-pregnancy
with 35 39 175 179 O
a 40 41 180 181 O
singleton 42 51 182 191 O
gestation 52 61 192 201 O

Contraindication 0 16 202 218 O
for 17 20 219 222 O
tocolysis 21 30 223 232 B-allergy_name
e.g. 31 35 233 237 O
premature 36 45 238 247 O
rupture 46 53 248 255 O
of 54 56 256 258 O
the 57 60 259 262 O
amniotic 61 69 263 271 O
membranes 70 79 272 281 O
allowing 80 88 282 290 O
for 89 92 291 294 O
ascending 93 102 295 304 O
intrauterine 103 115 305 317 B-chronic_disease
infection 116 125 318 327 I-chronic_disease
with 126 130 328 332 O
group 131 136 333 338 B-chronic_disease
B 137 138 339 340 I-chronic_disease
streptococcus 139 152 341 354 I-chronic_disease
or 153 155 355 357 I-chronic_disease
GBS 156 159 358 361 I-chronic_disease
( 160 161 362 363 O
beta 161 165 363 367 B-chronic_disease
hemolytic 166 175 368 377 I-chronic_disease
streptococcus 176 189 378 391 I-chronic_disease
, 189 190 391 392 O
S. 191 193 393 395 B-chronic_disease
agalactiae 194 204 396 406 I-chronic_disease
) 204 205 406 407 O
or 206 208 408 410 O
other 209 214 411 416 O
micro 215 220 417 422 O
- 220 221 422 423 O
organisms 221 230 423 432 O

Fetal 0 5 433 438 B-chronic_disease
anomaly 6 13 439 446 I-chronic_disease
incompatible 14 26 447 459 O
with 27 31 460 464 O
life 32 36 465 469 O

Frank 0 5 470 475 O
chorioamnionitis 6 22 476 492 B-chronic_disease

Hepatitis 0 9 493 502 B-chronic_disease
C 10 11 503 504 I-chronic_disease

IV 0 2 505 507 O
or 3 5 508 510 O
po 6 8 511 513 O
narcotic 9 17 514 522 B-clinical_variable
pain 18 22 523 527 I-clinical_variable
medication 23 33 528 538 I-clinical_variable
< 34 35 539 540 O
12 36 38 541 543 B-upper_bound
hours 39 44 544 549 I-upper_bound
prior 45 50 550 555 I-upper_bound
to 51 53 556 558 O
admission 54 63 559 568 O

Pregnancy 0 9 569 578 B-clinical_variable
Depression 10 20 579 589 I-clinical_variable
Scale 21 26 590 595 I-clinical_variable
score 27 32 596 601 I-clinical_variable
< 33 34 602 603 O
16 35 37 604 606 B-upper_bound

Severe 0 6 607 613 B-chronic_disease
abruption 7 16 614 623 I-chronic_disease
placenta 17 25 624 632 I-chronic_disease

Severe 0 6 633 639 B-chronic_disease
fetal 7 12 640 645 I-chronic_disease
growth 13 19 646 652 I-chronic_disease
restriction 20 31 653 664 I-chronic_disease
( 32 33 665 666 O
EFW 33 36 666 669 B-clinical_variable
< 37 38 670 671 O
5 39 40 672 673 B-upper_bound
% 40 41 673 674 I-upper_bound
) 41 42 674 675 O

Severe 0 6 676 682 B-chronic_disease
preeclampsia 7 19 683 695 I-chronic_disease

Vaginal 0 7 696 703 B-clinical_variable
bleeding 8 16 704 712 I-clinical_variable
> 17 18 713 714 O
10 19 21 715 717 B-lower_bound
cc 22 24 718 720 I-lower_bound

long 0 4 721 725 O
acting 5 11 726 732 O
oral 12 16 733 737 B-treatment
maintenance 17 28 738 749 I-treatment
opiates 29 36 750 757 I-treatment
i.e. 37 41 758 762 O
methadone 42 51 763 772 B-treatment
, 51 52 772 773 O
Suboxone 53 61 774 782 B-treatment
, 61 62 782 783 O
Subutex 63 70 784 791 B-treatment

regional 0 8 792 800 B-treatment
anesthesia 9 19 801 811 I-treatment

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Has 0 3 25 28 O
SCD 4 7 29 32 B-chronic_disease
diagnosis 8 17 33 42 O

Reports 0 7 43 50 O
pain 8 12 51 55 O
3 13 14 56 57 B-lower_bound
or 15 17 58 60 O
greater 18 25 61 68 O
in 26 28 69 71 O
the 29 32 72 75 O
previous 33 41 76 84 O
24 42 44 85 87 B-upper_bound
hours 45 50 88 93 I-upper_bound
( 51 52 94 95 O
0 52 53 95 96 B-lower_bound
- 53 54 96 97 O
10 54 56 97 99 B-upper_bound
scale 57 62 100 105 I-upper_bound
) 62 63 105 106 O

Speaks 0 6 107 113 B-language_fluency
and 7 10 114 117 I-language_fluency
reads 11 16 118 123 I-language_fluency
English 17 24 124 131 I-language_fluency

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
mcL 35 38 35 38 I-lower_bound

Aspartate 0 9 39 48 B-clinical_variable
aminotransferase 10 26 49 65 I-clinical_variable
( 27 28 66 67 I-clinical_variable
AST 28 31 67 70 I-clinical_variable
) 31 32 70 71 I-clinical_variable
( 33 34 72 73 I-clinical_variable
serum 34 39 73 78 I-clinical_variable
glutamic 40 48 79 87 I-clinical_variable
oxaloacetic 49 60 88 99 I-clinical_variable
transaminase 61 73 100 112 I-clinical_variable
[ 74 75 113 114 I-clinical_variable
SGOT])/alanine 75 89 114 128 I-clinical_variable
aminotransferase 90 106 129 145 I-clinical_variable
( 107 108 146 147 I-clinical_variable
ALT 108 111 147 150 I-clinical_variable
) 111 112 150 151 I-clinical_variable
( 113 114 152 153 I-clinical_variable
serum 114 119 153 158 I-clinical_variable
glutamate 120 129 159 168 I-clinical_variable
pyruvate 130 138 169 177 I-clinical_variable
transaminase 139 151 178 190 I-clinical_variable
[ 152 153 191 192 I-clinical_variable
SGPT 153 157 192 196 I-clinical_variable
] 157 158 196 197 I-clinical_variable
) 158 159 197 198 I-clinical_variable
= 160 161 199 200 O
< 161 162 200 201 O
2.5 163 166 202 205 B-upper_bound
x 167 168 206 207 I-upper_bound
institutional 169 182 208 221 I-upper_bound
upper 183 188 222 227 I-upper_bound
limit 189 194 228 233 I-upper_bound
of 195 197 234 236 I-upper_bound
normal 198 204 237 243 I-upper_bound

Carcinoma 0 9 244 253 B-cancer
of 10 12 254 256 O
the 13 16 257 260 O
neck 17 21 261 265 O
of 22 24 266 268 O
unknown 25 32 269 276 O
primary 33 40 277 284 O
site 41 45 285 289 O
origin 46 52 290 296 O
( 53 54 297 298 O
regardless 54 64 298 308 O
of 65 67 309 311 O
HPV 68 71 312 315 O
/ 71 72 315 316 O
p16 72 75 316 319 O
status 76 82 320 326 O
) 82 83 326 327 O

Clinical 0 8 328 336 B-clinical_variable
staged 9 15 337 343 I-clinical_variable
III 16 19 344 347 B-lower_bound
or 20 22 348 350 O
IV 23 25 351 353 B-upper_bound
HNSCC 26 31 354 359 B-cancer
that 32 36 360 364 O
is 37 39 365 367 O
not 40 43 368 371 O
amenable 44 52 372 380 O
to 53 55 381 383 O
surgical 56 64 384 392 B-treatment
resection 65 74 393 402 I-treatment

Creatinine 0 10 403 413 B-clinical_variable
within 11 17 414 420 O
normal 18 24 421 427 O
institutional 25 38 428 441 O
limits 39 45 442 448 O
OR 46 48 449 451 O
creatinine 49 59 452 462 B-clinical_variable
clearance 60 69 463 472 I-clinical_variable
> 70 71 473 474 O
= 71 72 474 475 O
60 73 75 476 478 B-lower_bound
mL 76 78 479 481 I-lower_bound
/ 78 79 481 482 I-lower_bound
min/1.73 79 87 482 490 I-lower_bound
m^2 88 91 491 494 I-lower_bound
for 92 95 495 498 O
patients 96 104 499 507 O
with 105 109 508 512 O
creatinine 110 120 513 523 B-clinical_variable
levels 121 127 524 530 I-clinical_variable
above 128 133 531 536 O
institutional 134 147 537 550 O
normal 148 154 551 557 O

Definitive 0 10 558 568 O
clinical 11 19 569 577 O
or 20 22 578 580 O
radiographic 23 35 581 593 O
evidence 36 44 594 602 O
of 45 47 603 605 O
distant 48 55 606 613 B-cancer
metastasis 56 66 614 624 I-cancer
or 67 69 625 627 O
adenopathy 70 80 628 638 B-chronic_disease
below 81 86 639 644 O
the 87 90 645 648 O
clavicles 91 100 649 658 O

Eastern 0 7 659 666 B-clinical_variable
Cooperative 8 19 667 678 I-clinical_variable
Oncology 20 28 679 687 I-clinical_variable
Group 29 34 688 693 I-clinical_variable
( 35 36 694 695 I-clinical_variable
ECOG 36 40 695 699 I-clinical_variable
) 40 41 699 700 I-clinical_variable
performance 42 53 701 712 I-clinical_variable
status 54 60 713 719 I-clinical_variable
= 61 62 720 721 O
< 62 63 721 722 O
2 64 65 723 724 B-upper_bound
( 66 67 725 726 O
Karnofsky 67 76 726 735 B-clinical_variable
> 77 78 736 737 O
= 78 79 737 738 O
60 80 82 739 741 B-lower_bound
% 82 83 741 742 I-lower_bound
) 83 84 742 743 O

HIV 0 3 744 747 B-chronic_disease
- 3 4 747 748 O
positive 4 12 748 756 O
patients 13 21 757 765 O
on 22 24 766 768 O
combination 25 36 769 780 B-treatment
antiretroviral 37 51 781 795 I-treatment
therapy 52 59 796 803 I-treatment
with 60 64 804 808 I-treatment
strong 65 71 809 815 I-treatment
inducers 72 80 816 824 I-treatment
or 81 83 825 827 O
inhibitors 84 94 828 838 B-treatment
of 95 97 839 841 I-treatment
CYP3A4 98 104 842 848 I-treatment

History 0 7 849 856 O
of 8 10 857 859 O
allergic 11 19 860 868 O
reactions 20 29 869 878 O
attributed 30 40 879 889 O
to 41 43 890 892 O
compounds 44 53 893 902 O
of 54 56 903 905 O
similar 57 64 906 913 O
chemical 65 73 914 922 O
or 74 76 923 925 O
biologic 77 85 926 934 O
composition 86 97 935 946 O
to 98 100 947 949 O
M6620 101 106 950 955 B-allergy_name
( 107 108 956 957 I-allergy_name
VX-970 108 114 957 963 I-allergy_name
) 114 115 963 964 I-allergy_name
or 116 118 965 967 O
cisplatin 119 128 968 977 B-allergy_name

Human 0 5 978 983 B-chronic_disease
immunodeficiency 6 22 984 1000 I-chronic_disease
virus 23 28 1001 1006 I-chronic_disease
( 29 30 1007 1008 I-chronic_disease
HIV)-positive 30 43 1008 1021 I-chronic_disease
patients 44 52 1022 1030 O
with 53 57 1031 1035 O
well 58 62 1036 1040 O
- 62 63 1040 1041 O
controlled 63 73 1041 1051 O
disease 74 81 1052 1059 O
, 81 82 1059 1060 O
as 83 85 1061 1063 O
determined 86 96 1064 1074 O
by 97 99 1075 1077 O
CD4 100 103 1078 1081 O
count 104 109 1082 1087 O
and 110 113 1088 1091 O
viral 114 119 1092 1097 O
load 120 124 1098 1102 O
, 124 125 1102 1103 O
who 126 129 1104 1107 O
are 130 133 1108 1111 O
on 134 136 1112 1114 O
antiretroviral 137 151 1115 1129 B-treatment
therapy 152 159 1130 1137 I-treatment
that 160 164 1138 1142 O
does 165 169 1143 1147 O
not 170 173 1148 1151 O
contain 174 181 1152 1159 O
a 182 183 1160 1161 O
strong 184 190 1162 1168 O
inducer 191 198 1169 1176 O
or 199 201 1177 1179 O
inhibitor 202 211 1180 1189 B-treatment
of 212 214 1190 1192 I-treatment
CYP3A4 215 221 1193 1199 I-treatment
are 222 225 1200 1203 O
allowed 226 233 1204 1211 O
on 234 236 1212 1214 O
trial 237 242 1215 1220 O

Leukocytes 0 10 1221 1231 B-clinical_variable
> 11 12 1232 1233 O
= 12 13 1233 1234 O
3,000 14 19 1235 1240 B-lower_bound
/ 19 20 1240 1241 I-lower_bound
mcL 20 23 1241 1244 I-lower_bound

Life 0 4 1245 1249 B-clinical_variable
expectancy 5 15 1250 1260 I-clinical_variable
of 16 18 1261 1263 O
greater 19 26 1264 1271 O
than 27 31 1272 1276 O
3 32 33 1277 1278 B-lower_bound
months 34 40 1279 1285 I-lower_bound

Myocardial 0 10 1286 1296 B-chronic_disease
infarction 11 21 1297 1307 I-chronic_disease
within 22 28 1308 1314 O
the 29 32 1315 1318 O
last 33 37 1319 1323 B-upper_bound
6 38 39 1324 1325 I-upper_bound
months 40 46 1326 1332 I-upper_bound

Ongoing 0 7 1333 1340 O
or 8 10 1341 1343 O
active 11 17 1344 1350 B-chronic_disease
infection 18 27 1351 1360 I-chronic_disease
requiring 28 37 1361 1370 O
intravenous 38 49 1371 1382 B-treatment
antibiotics 50 61 1383 1394 I-treatment
at 62 64 1395 1397 O
the 65 68 1398 1401 O
time 69 73 1402 1406 O
of 74 76 1407 1409 O
treatment 77 86 1410 1419 B-treatment
initiation 87 97 1420 1430 O

Patient 0 7 1431 1438 O
who 8 11 1439 1442 O
requires 12 20 1443 1451 O
live 21 25 1452 1456 B-treatment
vaccine 26 33 1457 1464 I-treatment
administration 34 48 1465 1479 O

Patients 0 8 1480 1488 O
must 9 13 1489 1493 O
have 14 18 1494 1498 O
histologically 19 33 1499 1513 O
or 34 36 1514 1516 O
cytologically 37 50 1517 1530 O
confirmed 51 60 1531 1540 O
head 61 65 1541 1545 B-cancer
and 66 69 1546 1549 I-cancer
neck 70 74 1550 1554 I-cancer
squamous 75 83 1555 1563 I-cancer
cell 84 88 1564 1568 I-cancer
cancer 89 95 1569 1575 I-cancer
( 96 97 1576 1577 I-cancer
HNSCC 97 102 1577 1582 I-cancer
) 102 103 1582 1583 I-cancer
including 104 113 1584 1593 O
paranasal 114 123 1594 1603 B-cancer
sinus 124 129 1604 1609 I-cancer
cancers 130 137 1610 1617 I-cancer

Patients 0 8 1618 1626 O
must 9 13 1627 1631 O
have 14 18 1632 1636 O
measurable 19 29 1637 1647 O
disease 30 37 1648 1655 O
, 37 38 1655 1656 O
defined 39 46 1657 1664 O
as 47 49 1665 1667 O
at 50 52 1668 1670 O
least 53 58 1671 1676 O
one 59 62 1677 1680 B-lower_bound
lesion 63 69 1681 1687 O
that 70 74 1688 1692 O
can 75 78 1693 1696 O
be 79 81 1697 1699 O
accurately 82 92 1700 1710 O
measured 93 101 1711 1719 O
in 102 104 1720 1722 O
at 105 107 1723 1725 O
least 108 113 1726 1731 O
one 114 117 1732 1735 O
dimension 118 127 1736 1745 O
( 128 129 1746 1747 O
longest 129 136 1747 1754 O
diameter 137 145 1755 1763 O
to 146 148 1764 1766 O
be 149 151 1767 1769 O
recorded 152 160 1770 1778 O
for 161 164 1779 1782 O
non 165 168 1783 1786 O
- 168 169 1786 1787 O
nodal 169 174 1787 1792 O
lesions 175 182 1793 1800 O
and 183 186 1801 1804 O
short 187 192 1805 1810 O
axis 193 197 1811 1815 O
for 198 201 1816 1819 O
nodal 202 207 1820 1825 O
lesions 208 215 1826 1833 O
) 215 216 1833 1834 O
as 217 219 1835 1837 O
> 220 221 1838 1839 O
= 221 222 1839 1840 O
20 223 225 1841 1843 B-lower_bound
mm 226 228 1844 1846 I-lower_bound
( 229 230 1847 1848 O
> 230 231 1848 1849 O
= 231 232 1849 1850 O
2 233 234 1851 1852 B-lower_bound
cm 235 237 1853 1855 I-lower_bound
) 237 238 1855 1856 O
with 239 243 1857 1861 O
conventional 244 256 1862 1874 O
techniques 257 267 1875 1885 O
or 268 270 1886 1888 O
as 271 273 1889 1891 O
> 274 275 1892 1893 O
= 275 276 1893 1894 O
10 277 279 1895 1897 B-lower_bound
mm 280 282 1898 1900 I-lower_bound
( 283 284 1901 1902 O
> 284 285 1902 1903 O
= 285 286 1903 1904 O
1 287 288 1905 1906 B-lower_bound
cm 289 291 1907 1909 I-lower_bound
) 291 292 1909 1910 O
with 293 297 1911 1915 O
spiral 298 304 1916 1922 B-treatment
computed 305 313 1923 1931 I-treatment
tomography 314 324 1932 1942 I-treatment
( 325 326 1943 1944 I-treatment
CT 326 328 1944 1946 I-treatment
) 328 329 1946 1947 I-treatment
scan 330 334 1948 1952 I-treatment
, 334 335 1952 1953 O
magnetic 336 344 1954 1962 B-treatment
resonance 345 354 1963 1972 I-treatment
imaging 355 362 1973 1980 I-treatment
( 363 364 1981 1982 I-treatment
MRI 364 367 1982 1985 I-treatment
) 367 368 1985 1986 I-treatment
, 368 369 1986 1987 O
or 370 372 1988 1990 O
calipers 373 381 1991 1999 B-treatment
by 382 384 2000 2002 O
clinical 385 393 2003 2011 O
exam 394 398 2012 2016 O

Patients 0 8 2017 2025 O
on 9 11 2026 2028 O
tacrolimus 12 22 2029 2039 B-treatment
or 23 25 2040 2042 O
any 26 29 2043 2046 O
other 30 35 2047 2052 O
immunosuppressants 36 54 2053 2071 B-treatment
with 55 59 2072 2076 O
significant 60 71 2077 2088 O
interaction 72 83 2089 2100 O
with 84 88 2101 2105 O
cisplatin 89 98 2106 2115 B-treatment

Patients 0 8 2116 2124 O
who 9 12 2125 2128 O
are 13 16 2129 2132 O
receiving 17 26 2133 2142 O
adjuvant 27 35 2143 2151 B-treatment
chemoradiation 36 50 2152 2166 I-treatment
after 51 56 2167 2172 O
surgical 57 65 2173 2181 B-treatment
resection 66 75 2182 2191 I-treatment
of 76 78 2192 2194 O
the 79 82 2195 2198 O
primary 83 90 2199 2206 O
site 91 95 2207 2211 O
of 96 98 2212 2214 O
disease 99 106 2215 2222 O

Patients 0 8 2223 2231 O
who 9 12 2232 2235 O
are 13 16 2236 2239 O
receiving 17 26 2240 2249 O
any 27 30 2250 2253 O
other 31 36 2254 2259 O
investigational 37 52 2260 2275 B-treatment
agents 53 59 2276 2282 I-treatment

Patients 0 8 2283 2291 O
who 9 12 2292 2295 O
have 13 17 2296 2300 O
had 18 21 2301 2304 O
chemotherapy 22 34 2305 2317 B-treatment
or 35 37 2318 2320 O
radiotherapy 38 50 2321 2333 B-treatment
within 51 57 2334 2340 O
4 58 59 2341 2342 O
weeks 60 65 2343 2348 O
( 66 67 2349 2350 O
6 67 68 2350 2351 O
weeks 69 74 2352 2357 O
for 75 78 2358 2361 O
nitrosoureas 79 91 2362 2374 B-treatment
or 92 94 2375 2377 O
mitomycin 95 104 2378 2387 B-treatment
C 105 106 2388 2389 I-treatment
) 106 107 2389 2390 O
prior 108 113 2391 2396 O
to 114 116 2397 2399 O
entering 117 125 2400 2408 O
the 126 129 2409 2412 O
study 130 135 2413 2418 O
or 136 138 2419 2421 O
those 139 144 2422 2427 O
who 145 148 2428 2431 O
have 149 153 2432 2436 O
not 154 157 2437 2440 O
recovered 158 167 2441 2450 O
from 168 172 2451 2455 O
adverse 173 180 2456 2463 O
events 181 187 2464 2470 O
due 188 191 2471 2474 O
to 192 194 2475 2477 O
agents 195 201 2478 2484 O
administered 202 214 2485 2497 O
more 215 219 2498 2502 O
than 220 224 2503 2507 O
4 225 226 2508 2509 O
weeks 227 232 2510 2515 O
earlier 233 240 2516 2523 O

Patients 0 8 2524 2532 O
with 9 13 2533 2537 O
known 14 19 2538 2543 O
brain 20 25 2544 2549 B-cancer
metastases 26 36 2550 2560 I-cancer
should 37 43 2561 2567 O
be 44 46 2568 2570 O
excluded 47 55 2571 2579 O
from 56 60 2580 2584 O
this 61 65 2585 2589 O
clinical 66 74 2590 2598 O
trial 75 80 2599 2604 O
because 81 88 2605 2612 O
of 89 91 2613 2615 O
their 92 97 2616 2621 O
poor 98 102 2622 2626 O
prognosis 103 112 2627 2636 O
and 113 116 2637 2640 O
because 117 124 2641 2648 O
they 125 129 2649 2653 O
often 130 135 2654 2659 O
develop 136 143 2660 2667 O
progressive 144 155 2668 2679 O
neurologic 156 166 2680 2690 O
dysfunction 167 178 2691 2702 O
that 179 183 2703 2707 O
would 184 189 2708 2713 O
confound 190 198 2714 2722 O
the 199 202 2723 2726 O
evaluation 203 213 2727 2737 O
of 214 216 2738 2740 O
neurologic 217 227 2741 2751 O
and 228 231 2752 2755 O
other 232 237 2756 2761 O
adverse 238 245 2762 2769 O
events 246 252 2770 2776 O

Patients 0 8 2777 2785 O
with 9 13 2786 2790 O
nasopharyngeal 14 28 2791 2805 B-cancer
carcinoma 29 38 2806 2815 I-cancer
, 38 39 2815 2816 O
skin 40 44 2817 2821 B-cancer
squamous 45 53 2822 2830 I-cancer
cell 54 58 2831 2835 I-cancer
carcinoma 59 68 2836 2845 I-cancer
( 69 70 2846 2847 I-cancer
SCC 70 73 2847 2850 I-cancer
) 73 74 2850 2851 I-cancer
, 74 75 2851 2852 O
and 76 79 2853 2856 O
salivary 80 88 2857 2865 B-cancer
gland 89 94 2866 2871 I-cancer
carcinomas 95 105 2872 2882 I-cancer

Platelets 0 9 2883 2892 B-clinical_variable
> 10 11 2893 2894 O
= 11 12 2894 2895 O
100,000 13 20 2896 2903 B-lower_bound
/ 20 21 2903 2904 I-lower_bound
mcL 21 24 2904 2907 I-lower_bound

Pregnant 0 8 2908 2916 B-pregnancy
women 9 14 2917 2922 B-gender
are 15 18 2923 2926 O
excluded 19 27 2927 2935 O
from 28 32 2936 2940 O
this 33 37 2941 2945 O
study 38 43 2946 2951 O
because 44 51 2952 2959 O
M6620 52 57 2960 2965 O
( 58 59 2966 2967 O
VX-970 59 65 2967 2973 O
) 65 66 2973 2974 O
as 67 69 2975 2977 O
a 70 71 2978 2979 O
DNA 72 75 2980 2983 O
- 75 76 2983 2984 O
damage 76 82 2984 2990 O
response 83 91 2991 2999 O
( 92 93 3000 3001 O
DDR 93 96 3001 3004 O
) 96 97 3004 3005 O
inhibitor 98 107 3006 3015 O
may 108 111 3016 3019 O
have 112 116 3020 3024 O
the 117 120 3025 3028 O
potential 121 130 3029 3038 O
for 131 134 3039 3042 O
teratogenic 135 146 3043 3054 B-treatment
or 147 149 3055 3057 O
abortifacient 150 163 3058 3071 O
effects 164 171 3072 3079 O

Prior 0 5 3080 3085 B-treatment
receipt 6 13 3086 3093 I-treatment
of 14 16 3094 3096 I-treatment
radiotherapy 17 29 3097 3109 I-treatment
that 30 34 3110 3114 O
would 35 40 3115 3120 O
result 41 47 3121 3127 O
in 48 50 3128 3130 O
overlap 51 58 3131 3138 O
of 59 61 3139 3141 O
the 62 65 3142 3145 O
new 66 69 3146 3149 O
and 70 73 3150 3153 O
old 74 77 3154 3157 O
radiation 78 87 3158 3167 B-treatment
therapy 88 95 3168 3175 I-treatment
fields 96 102 3176 3182 O

Prior 0 5 3183 3188 O
systemic 6 14 3189 3197 B-treatment
chemotherapy 15 27 3198 3210 I-treatment
for 28 31 3211 3214 O
the 32 35 3215 3218 O
current 36 43 3219 3226 O
cancer 44 50 3227 3233 B-cancer

Psychiatric 0 11 3234 3245 B-chronic_disease
illness 12 19 3246 3253 I-chronic_disease
/ 19 20 3253 3254 I-chronic_disease
social 20 26 3254 3260 I-chronic_disease
situations 27 37 3261 3271 I-chronic_disease
that 38 42 3272 3276 O
would 43 48 3277 3282 O
limit 49 54 3283 3288 O
compliance 55 65 3289 3299 O
with 66 70 3300 3304 O
study 71 76 3305 3310 O
requirements 77 89 3311 3323 O

Symptomatic 0 11 3324 3335 O
congestive 12 22 3336 3346 B-chronic_disease
heart 23 28 3347 3352 I-chronic_disease
failure 29 36 3353 3360 I-chronic_disease
( 37 38 3361 3362 O
requiring 38 47 3362 3371 O
hospital 48 56 3372 3380 O
stay 57 61 3381 3385 O
within 62 68 3386 3392 O
the 69 72 3393 3396 O
last 73 77 3397 3401 B-upper_bound
6 78 79 3402 3403 I-upper_bound
months 80 86 3404 3410 I-upper_bound
) 86 87 3410 3411 O

The 0 3 3412 3415 O
effects 4 11 3416 3423 O
of 12 14 3424 3426 O
M6620 15 20 3427 3432 B-treatment
( 21 22 3433 3434 I-treatment
VX-970 22 28 3434 3440 I-treatment
) 28 29 3440 3441 I-treatment
on 30 32 3442 3444 O
the 33 36 3445 3448 O
developing 37 47 3449 3459 O
human 48 53 3460 3465 O
fetus 54 59 3466 3471 O
are 60 63 3472 3475 O
unknown 64 71 3476 3483 O

Unstable 0 8 3484 3492 B-chronic_disease
angina 9 15 3493 3499 I-chronic_disease
pectoris 16 24 3500 3508 I-chronic_disease
, 24 25 3508 3509 O
cardiac 26 33 3510 3517 B-chronic_disease
arrhythmia 34 44 3518 3528 I-chronic_disease

Women 0 5 3529 3534 B-gender
of 6 8 3535 3537 O
childbearing 9 21 3538 3550 O
potential 22 31 3551 3560 O
who 32 35 3561 3564 O
are 36 39 3565 3568 O
sexually 40 48 3569 3577 O
active 49 55 3578 3584 O
should 56 62 3585 3591 O
be 63 65 3592 3594 O
willing 66 73 3595 3602 B-treatment
and 74 77 3603 3606 I-treatment
able 78 82 3607 3611 I-treatment
to 83 85 3612 3614 I-treatment
use 86 89 3615 3618 I-treatment
medically 90 99 3619 3628 I-treatment
acceptable 100 110 3629 3639 I-treatment
forms 111 116 3640 3645 I-treatment
of 117 119 3646 3648 I-treatment
contraception 120 133 3649 3662 I-treatment
throughout 134 144 3663 3673 O
the 145 148 3674 3677 O
treatment 149 158 3678 3687 B-treatment
phase 159 164 3688 3693 O
of 165 167 3694 3696 O
the 168 171 3697 3700 O
trial 172 177 3701 3706 O
and 178 181 3707 3710 O
for 182 185 3711 3714 O
up 186 188 3715 3717 O
to 189 191 3718 3720 O
6 192 193 3721 3722 B-upper_bound
months 194 200 3723 3729 I-upper_bound
following 201 210 3730 3739 I-upper_bound
the 211 214 3740 3743 O
last 215 219 3744 3748 O
administration 220 234 3749 3763 O
of 235 237 3764 3766 O
study 238 243 3767 3772 B-treatment
treatment 244 253 3773 3782 I-treatment

for 0 3 3783 3786 O
this 4 8 3787 3791 O
reason 9 15 3792 3798 O
and 16 19 3799 3802 O
because 20 27 3803 3810 O
DNA 28 31 3811 3814 O
- 31 32 3814 3815 O
damage 32 38 3815 3821 O
response 39 47 3822 3830 O
( 48 49 3831 3832 O
DDR 49 52 3832 3835 O
) 52 53 3835 3836 O
inhibitors 54 64 3837 3847 O
as 65 67 3848 3850 O
well 68 72 3851 3855 O
as 73 75 3856 3858 O
other 76 81 3859 3864 O
therapeutic 82 93 3865 3876 B-treatment
agents 94 100 3877 3883 I-treatment
used 101 105 3884 3888 O
in 106 108 3889 3891 O
this 109 113 3892 3896 O
trial 114 119 3897 3902 O
may 120 123 3903 3906 O
have 124 128 3907 3911 O
teratogenic 129 140 3912 3923 O
potential 141 150 3924 3933 O

men 0 3 3934 3937 B-gender
treated 4 11 3938 3945 O
or 12 14 3946 3948 O
enrolled 15 23 3949 3957 O
on 24 26 3958 3960 O
this 27 31 3961 3965 O
protocol 32 40 3966 3974 O
must 41 45 3975 3979 O
also 46 50 3980 3984 O
agree 51 56 3985 3990 B-contraception_consent
to 57 59 3991 3993 I-contraception_consent
use 60 63 3994 3997 I-contraception_consent
adequate 64 72 3998 4006 I-contraception_consent
contraception 73 86 4007 4020 I-contraception_consent
prior 87 92 4021 4026 O
to 93 95 4027 4029 O
the 96 99 4030 4033 O
study 100 105 4034 4039 O
, 105 106 4039 4040 O
for 107 110 4041 4044 O
the 111 114 4045 4048 O
duration 115 123 4049 4057 O
of 124 126 4058 4060 O
study 127 132 4061 4066 O
participation 133 146 4067 4080 O
, 146 147 4080 4081 O
and 148 151 4082 4085 O
for 152 155 4086 4089 O
6 156 157 4090 4091 B-upper_bound
months 158 164 4092 4098 I-upper_bound
after 165 170 4099 4104 O
completion 171 181 4105 4115 O
of 182 184 4116 4118 O
M6620 185 190 4119 4124 O
( 191 192 4125 4126 O
VX-970 192 198 4126 4132 O
) 198 199 4132 4133 O
administration 200 214 4134 4148 O

men 0 3 4149 4152 B-gender
who 4 7 4153 4156 O
are 8 11 4157 4160 O
sexually 12 20 4161 4169 O
active 21 27 4170 4176 O
must 28 32 4177 4181 O
be 33 35 4182 4184 O
willing 36 43 4185 4192 B-contraception_consent
and 44 47 4193 4196 I-contraception_consent
able 48 52 4197 4201 I-contraception_consent
to 53 55 4202 4204 I-contraception_consent
use 56 59 4205 4208 I-contraception_consent
medically 60 69 4209 4218 I-contraception_consent
acceptable 70 80 4219 4229 I-contraception_consent
forms 81 86 4230 4235 I-contraception_consent
of 87 89 4236 4238 I-contraception_consent
contraception 90 103 4239 4252 I-contraception_consent
throughout 104 114 4253 4263 O
the 115 118 4264 4267 O
treatment 119 128 4268 4277 B-treatment
phase 129 134 4278 4283 O
of 135 137 4284 4286 O
the 138 141 4287 4290 O
trial 142 147 4291 4296 O
and 148 151 4297 4300 O
for 152 155 4301 4304 O
6 156 157 4305 4306 B-upper_bound
months 158 164 4307 4313 I-upper_bound
after 165 170 4314 4319 O
completion 171 181 4320 4330 O
of 182 184 4331 4333 O
M6620 185 190 4334 4339 B-treatment
( 191 192 4340 4341 I-treatment
VX-970 192 198 4341 4347 I-treatment
) 198 199 4347 4348 I-treatment
administration 200 214 4349 4363 O

nasopharyngeal 0 14 4364 4378 B-cancer
carcinomas 15 25 4379 4389 I-cancer

patients 0 8 4390 4398 O
with 9 13 4399 4403 O
poorly 14 20 4404 4410 O
controlled 21 31 4411 4421 O
HIV 32 35 4422 4425 B-chronic_disease

prior 0 5 4426 4431 B-treatment
chemotherapy 6 18 4432 4444 I-treatment
for 19 22 4445 4448 O
a 23 24 4449 4450 O
different 25 34 4451 4460 O
cancer 35 41 4461 4467 B-cancer

women 0 5 4468 4473 B-gender
of 6 8 4474 4476 O
child 9 14 4477 4482 O
- 14 15 4482 4483 O
bearing 15 22 4483 4490 O
potential 23 32 4491 4500 O
and 33 36 4501 4504 O
men 37 40 4505 4508 O
must 41 45 4509 4513 O
agree 46 51 4514 4519 B-contraception_consent
to 52 54 4520 4522 I-contraception_consent
use 55 58 4523 4526 I-contraception_consent
adequate 59 67 4527 4535 I-contraception_consent
contraception 68 81 4536 4549 I-contraception_consent
( 82 83 4550 4551 O
hormonal 83 91 4551 4559 B-contraception_consent
or 92 94 4560 4562 I-contraception_consent
barrier 95 102 4563 4570 I-contraception_consent
method 103 109 4571 4577 I-contraception_consent
of 110 112 4578 4580 I-contraception_consent
birth 113 118 4581 4586 I-contraception_consent
control 119 126 4587 4594 I-contraception_consent

Acute 0 5 0 5 B-chronic_disease
liver 6 11 6 11 I-chronic_disease
injury 12 18 12 18 I-chronic_disease
( 19 20 19 20 O
liver 20 25 20 25 B-clinical_variable
aminotransferase 26 42 26 42 I-clinical_variable
concentrations 43 57 43 57 I-clinical_variable
> 58 59 58 59 O
5 59 60 59 60 B-lower_bound
times 61 66 61 66 I-lower_bound
the 67 70 67 70 I-lower_bound
upper 71 76 71 76 I-lower_bound
limit 77 82 77 82 I-lower_bound
of 83 85 83 85 I-lower_bound
normal 86 92 86 92 I-lower_bound
) 92 93 92 93 O

Acute 0 5 94 99 O
or 6 8 100 102 O
chronic 9 16 103 110 O
pain 17 21 111 115 O
requiring 22 31 116 125 O
opioid 32 38 126 132 B-treatment
treatment 39 48 133 142 I-treatment

Aged 0 4 143 147 B-age
18 5 7 148 150 B-lower_bound
- 7 8 150 151 O
80 8 10 151 153 B-upper_bound

Currently 0 9 154 163 O
prescribed 10 20 164 174 O
pharmacotherapy 21 36 175 190 B-treatment
for 37 40 191 194 O
alcohol 41 48 195 202 O
dependence 49 59 203 213 O
( 60 61 214 215 O
not 61 64 215 218 O
including 65 74 219 228 O
treatment 75 84 229 238 B-treatment
of 85 87 239 241 O
acute 88 93 242 247 O
alcohol 94 101 248 255 B-chronic_disease
withdrawal 102 112 256 266 I-chronic_disease
syndrome 113 121 267 275 I-chronic_disease
) 121 122 275 276 O

English 0 7 277 284 B-language_fluency
or 8 10 285 287 I-language_fluency
Spanish 11 18 288 295 I-language_fluency
speaking 19 27 296 304 I-language_fluency

Have 0 4 305 309 O
≥2 5 7 310 312 O
days 8 12 313 317 I-lower_bound
/ 12 13 317 318 I-lower_bound
week 13 17 318 322 I-lower_bound
of 18 20 323 325 O
heavy 21 26 326 331 O
drinking 27 35 332 340 O
( 36 37 341 342 O
> 37 38 342 343 O
4 38 39 343 344 B-lower_bound
drinks 40 46 345 351 I-lower_bound
/ 46 47 351 352 I-lower_bound
day 47 50 352 355 I-lower_bound
) 50 51 355 356 O

Non 0 3 357 360 B-language_fluency
- 3 4 360 361 I-language_fluency
English 4 11 361 368 I-language_fluency
Spanish 12 19 369 376 I-language_fluency
speaking 20 28 377 385 I-language_fluency
patients 29 37 386 394 I-language_fluency
will 38 42 395 399 O
not 43 46 400 403 O
be 47 49 404 406 O
enrolled 50 58 407 415 O
initially 59 68 416 425 O
until 69 74 426 431 O
study 75 80 432 437 O
documents 81 90 438 447 O
have 91 95 448 452 O
been 96 100 453 457 O
translated 101 111 458 468 O
, 111 112 468 469 O
back 113 117 470 474 O
translated 118 128 475 485 O
, 128 129 485 486 O
and 130 133 487 490 O
approved 134 142 491 499 O
by 143 145 500 502 O
the 146 149 503 506 O
Institutional 150 163 507 520 O
Review 164 170 521 527 O
Board 171 176 528 533 O
( 177 178 534 535 O
IRB 178 181 535 538 O
) 181 182 538 539 O

Pregnant 0 8 540 548 B-pregnancy

Previous 0 8 549 557 O
significant 9 20 558 569 O
adverse 21 28 570 577 O
reaction 29 37 578 586 O
to 38 40 587 589 O
naltrexone 41 51 590 600 B-allergy_name
or 52 54 601 603 O
diluent 55 62 604 611 B-allergy_name

not 0 3 612 615 B-contraception_consent
using 4 9 616 621 I-contraception_consent
effective 10 19 622 631 I-contraception_consent
methods 20 27 632 639 I-contraception_consent
of 28 30 640 642 I-contraception_consent
birth 31 36 643 648 I-contraception_consent
control 37 44 649 656 I-contraception_consent

Able 0 4 0 4 B-language_fluency
to 5 7 5 7 I-language_fluency
read 8 12 8 12 I-language_fluency
English 13 20 13 20 I-language_fluency
( 21 22 21 22 O
required 22 30 22 30 O
for 31 34 31 34 O
CGA 35 38 35 38 O
and 39 42 39 42 O
other 43 48 43 48 O
surveys 49 56 49 56 O
administered 57 69 57 69 O
) 69 70 69 70 O

Already 0 7 71 78 O
walking 8 15 79 86 O
or 16 18 87 89 O
engaging 19 27 90 98 O
in 28 30 99 101 O
other 31 36 102 107 O
physical 37 45 108 116 O
activity 46 54 117 125 O
> 55 56 126 127 O
120 56 59 127 130 B-lower_bound
minutes 60 67 131 138 I-lower_bound
per 68 71 139 142 I-lower_bound
week 72 76 143 147 I-lower_bound
as 77 79 148 150 O
documented 80 90 151 161 O
via 91 94 162 165 O
subject 95 102 166 173 O
self 103 107 174 178 O
- 107 108 178 179 O
report 108 114 179 185 O

Diagnosis 0 9 186 195 O
of 10 12 196 198 O
stage 13 18 199 204 B-lower_bound
II 19 21 205 207 I-lower_bound
- 21 22 207 208 O
III 22 25 208 211 B-upper_bound
colon 26 31 212 217 B-cancer
or 32 34 218 220 I-cancer
rectal 35 41 221 227 I-cancer
cancer 42 48 228 234 I-cancer
planned 49 56 235 242 O
for 57 60 243 246 O
treatment 61 70 247 256 B-treatment
with 71 75 257 261 I-treatment
adjuvant 76 84 262 270 I-treatment
chemotherapy 85 97 271 283 I-treatment
scheduled 98 107 284 293 O
as 108 110 294 296 O
part 111 115 297 301 O
of 116 118 302 304 O
standard 119 127 305 313 O
treatment 128 137 314 323 O

One 0 3 324 327 O
or 4 6 328 330 O
more 7 11 331 335 O
significant 12 23 336 347 O
medical 24 31 348 355 B-chronic_disease
conditions 32 42 356 366 I-chronic_disease
that 43 47 367 371 O
in 48 50 372 374 O
the 51 54 375 378 O
physician 55 64 379 388 O
's 64 66 388 390 O
judgment 67 75 391 399 O
preclude 76 84 400 408 O
participation 85 98 409 422 O
in 99 101 423 425 O
the 102 105 426 429 O
walking 106 113 430 437 O
intervention 114 126 438 450 O

Other 0 5 451 456 O
active 6 12 457 463 O
, 12 13 463 464 O
invasive 14 22 465 473 B-cancer
malignancy 23 33 474 484 I-cancer
requiring 34 43 485 494 O
ongoing 44 51 495 502 B-treatment
therapy 52 59 503 510 I-treatment
or 60 62 511 513 O
expected 63 71 514 522 O
to 72 74 523 525 O
require 75 82 526 533 O
systemic 83 91 534 542 B-treatment
therapy 92 99 543 550 I-treatment

≥ 0 1 551 552 O
Age 2 5 553 556 B-age
60 6 8 557 559 B-lower_bound
years 9 14 560 565 I-lower_bound
( 15 16 566 567 O
no 16 18 567 569 O
upper 19 24 570 575 O
age 25 28 576 579 B-age
limit 29 34 580 585 O
) 34 35 585 586 O

pregnant 0 8 0 8 B-pregnancy
females 9 16 9 16 B-gender

requiring 0 9 17 26 O
mechanical 10 20 27 37 B-treatment
ventilation 21 32 38 49 I-treatment
for 33 36 50 53 O
more 37 41 54 58 O
than 42 46 59 63 O
24 47 49 64 66 B-lower_bound
hours 50 55 67 72 I-lower_bound
in 56 58 73 75 O
one 59 62 76 79 O
of 63 65 80 82 O
the 66 69 83 86 O
University 70 80 87 97 O
of 81 83 98 100 O
Kentucky 84 92 101 109 O
adult 93 98 110 115 O
ICU 99 102 116 119 O
's 102 104 119 121 O

> 0 1 0 1 O
10 2 4 2 4 B-lower_bound
% 4 5 4 5 I-lower_bound
Sarcomatoid 6 17 6 17 B-cancer
or 18 20 18 20 O
desmoplastic 21 33 21 33 B-cancer
histology 34 43 34 43 I-cancer

AST 0 3 44 47 B-clinical_variable
( 4 5 48 49 O
SGOT 5 9 49 53 B-clinical_variable
) 9 10 53 54 O
or 11 13 55 57 O
ALT 14 17 58 61 B-clinical_variable
( 18 19 62 63 O
SGPT 19 23 63 67 B-clinical_variable
) 23 24 67 68 O
≤ 25 26 69 70 O
3.0 27 30 71 74 B-upper_bound
X 31 32 75 76 I-upper_bound
ULN 33 36 77 80 I-upper_bound

Absolute 0 8 81 89 B-clinical_variable
neutrophil 9 19 90 100 I-clinical_variable
count 20 25 101 106 I-clinical_variable
≥1.5 26 30 107 111 O
K 31 32 112 113 I-lower_bound
/ 32 33 113 114 I-lower_bound
mcL 33 36 114 117 I-lower_bound

Bulky 0 5 118 123 B-chronic_disease
disease 6 13 124 131 I-chronic_disease
in 14 16 132 134 O
the 17 20 135 138 O
fissure 21 28 139 146 O
preventing 29 39 147 157 O
lung 40 44 158 162 O
- 44 45 162 163 O
sparing 45 52 163 170 O
pleural 53 60 171 178 B-treatment
IMRT 61 65 179 183 I-treatment

DLCO 0 4 184 188 B-clinical_variable
> 5 6 189 190 O
40 7 9 191 193 B-lower_bound
% 9 10 193 194 I-lower_bound
predicted 11 20 195 204 O
( 21 22 205 206 O
corrected 22 31 206 215 O
for 32 35 216 219 O
Hgb 36 39 220 223 B-clinical_variable
) 39 40 223 224 O

Epithelioid 0 11 225 236 B-cancer
or 12 14 237 239 I-cancer
biphasic 15 23 240 248 I-cancer
histology 24 33 249 258 I-cancer
subtype 34 41 259 266 I-cancer

FEV1 0 4 267 271 B-clinical_variable
> 5 6 272 273 O
/= 6 8 273 275 O
35 9 11 276 278 B-lower_bound
% 11 12 278 279 I-lower_bound
( 13 14 280 281 O
corrected 14 23 281 290 O
for 24 27 291 294 O
Hgb 28 31 295 298 B-clinical_variable
) 31 32 298 299 O

For 0 3 300 303 O
patients 4 12 304 312 O
who 13 16 313 316 O
develop 17 24 317 324 O
or 25 27 325 327 O
have 28 32 328 332 O
baseline 33 41 333 341 O
clinically 42 52 342 352 O
significant 53 64 353 364 O
pleural 65 72 365 372 B-chronic_disease
effusions 73 82 373 382 I-chronic_disease
before 83 89 383 389 O
or 90 92 390 392 O
during 93 99 393 399 O
initiation 100 110 400 410 O
of 111 113 411 413 O
pemetrexed 114 124 414 424 B-treatment
therapy 125 132 425 432 I-treatment

Karnofsky 0 9 433 442 B-clinical_variable
performance 10 21 443 454 I-clinical_variable
status 22 28 455 461 I-clinical_variable
≥ 29 30 462 463 O
80 31 33 464 466 B-lower_bound
% 33 34 466 467 I-lower_bound

Men 0 3 468 471 B-gender
or 4 6 472 474 I-gender
women 7 12 475 480 I-gender
not 13 16 481 484 B-contraception_consent
using 17 22 485 490 I-contraception_consent
effective 23 32 491 500 I-contraception_consent
contraception 33 46 501 514 I-contraception_consent

No 0 2 515 517 O
acute 3 8 518 523 O
congestive 9 19 524 534 B-chronic_disease
heart 20 25 535 540 I-chronic_disease
failure 26 33 541 548 I-chronic_disease

No 0 2 549 551 O
evidence 3 11 552 560 O
of 12 14 561 563 O
metastatic 15 25 564 574 B-cancer
disease 26 33 575 582 I-cancer

Patients 0 8 583 591 O
undergoing 9 19 592 602 O
extrapleural 20 32 603 615 B-treatment
pneumonectomy 33 46 616 629 I-treatment

Patients 0 8 630 638 O
with 9 13 639 643 O
a 14 15 644 645 O
concurrent 16 26 646 656 O
active 27 33 657 663 B-cancer
malignancy 34 44 664 674 I-cancer
( 45 46 675 676 O
except 46 52 676 682 O
squamous 53 61 683 691 B-cancer
or 62 64 692 694 O
basal 65 70 695 700 B-cancer
cell 71 75 701 705 I-cancer
carcinoma 76 85 706 715 I-cancer
of 86 88 716 718 I-cancer
the 89 92 719 722 I-cancer
skin 93 97 723 727 I-cancer
) 97 98 727 728 O

Patients 0 8 729 737 O
with 9 13 738 742 O
an 14 16 743 745 O
active 17 23 746 752 B-chronic_disease
infection 24 33 753 762 I-chronic_disease
that 34 38 763 767 O
require 39 46 768 775 O
systemic 47 55 776 784 B-treatment
antibiotics 56 67 785 796 I-treatment
, 67 68 796 797 O
antiviral 69 78 798 807 B-treatment
, 78 79 807 808 O
or 80 82 809 811 O
antifungal 83 93 812 822 B-treatment
treatments 94 104 823 833 I-treatment

Patients 0 8 834 842 O
with 9 13 843 847 O
serious 14 21 848 855 O
unstable 22 30 856 864 O
medical 31 38 865 872 B-chronic_disease
illness 39 46 873 880 I-chronic_disease

Platelets 0 9 881 890 B-clinical_variable
≥100 10 14 891 895 O
K 15 16 896 897 I-lower_bound
/ 16 17 897 898 I-lower_bound
mcL 17 20 898 901 I-lower_bound

Pregnant 0 8 902 910 B-pregnancy

Presence 0 8 911 919 O
of 9 11 920 922 O
third 12 17 923 928 O
space 18 23 929 934 O
fluid 24 29 935 940 O
that 30 34 941 945 O
can 35 38 946 949 O
not 38 41 949 952 O
be 42 44 953 955 O
controlled 45 55 956 966 O
by 56 58 967 969 O
drainage 59 67 970 978 B-treatment

Prior 0 5 979 984 B-treatment
intrapleural 6 18 985 997 I-treatment
therapy 19 26 998 1005 I-treatment
( 27 28 1006 1007 O
except 28 34 1007 1013 O
pleurodesis 35 46 1014 1025 B-treatment
) 46 47 1025 1026 O
or 48 50 1027 1029 O
intrapleural 51 63 1030 1042 O
therapy 64 71 1043 1050 O
at 72 74 1051 1053 O
the 75 78 1054 1057 O
time 79 83 1058 1062 O
of 84 86 1063 1065 O
P 87 88 1066 1067 O
/ 88 89 1067 1068 O
D 89 90 1068 1069 O
( 91 92 1070 1071 O
i.e. 92 96 1071 1075 O
: 96 97 1075 1076 O
intrapleural 98 110 1077 1089 B-treatment
chemotherapy 111 123 1090 1102 I-treatment
, 123 124 1102 1103 O
photodynamic 125 137 1104 1116 B-treatment
therapy 138 145 1117 1124 I-treatment
, 145 146 1124 1125 O
intrapleural 147 159 1126 1138 B-treatment
betadine 160 168 1139 1147 I-treatment
) 168 169 1147 1148 O

Prior 0 5 1149 1154 B-treatment
nephrectomy 6 17 1155 1166 I-treatment
on 18 20 1167 1169 O
the 21 24 1170 1173 O
contralateral 25 38 1174 1187 O
side 39 43 1188 1192 O
of 44 46 1193 1195 O
MPM 47 50 1196 1199 O

Prior 0 5 1200 1205 B-treatment
thoracic 6 14 1206 1214 I-treatment
radiation 15 24 1215 1224 I-treatment
therapy 25 32 1225 1232 I-treatment
preventing 33 43 1233 1243 O
hemithoracic 44 56 1244 1256 B-treatment
pleural 57 64 1257 1264 I-treatment
IMRT 65 69 1265 1269 I-treatment

Serum 0 5 1270 1275 B-clinical_variable
total 6 11 1276 1281 I-clinical_variable
bilirubin 12 21 1282 1291 I-clinical_variable
≤ 22 23 1292 1293 O
1.5 24 27 1294 1297 B-upper_bound
X 28 29 1298 1299 I-upper_bound
ULN 30 33 1300 1303 I-upper_bound

Women 0 5 1304 1309 B-gender
of 6 8 1310 1312 O
childbearing 9 21 1313 1325 O
age 22 25 1326 1329 B-age
will 26 30 1330 1334 O
be 31 33 1335 1337 O
counseled 34 43 1338 1347 O
to 44 46 1348 1350 O
use 47 50 1351 1354 O
birth 51 56 1355 1360 O
control 57 64 1361 1368 O
while 65 70 1369 1374 O
on 71 73 1375 1377 O
this 74 78 1378 1382 O
study 79 84 1383 1388 O

Women 0 5 1389 1394 B-gender
should 6 12 1395 1401 O
not 13 16 1402 1405 O
breast 17 23 1406 1412 O
- 23 24 1412 1413 O
feed 24 28 1413 1417 O
a 29 30 1418 1419 O
baby 31 35 1420 1424 O
while 36 41 1425 1430 O
on 42 44 1431 1433 O
this 45 49 1434 1438 O
study 50 55 1439 1444 O

age 0 3 1445 1448 B-age
≥ 4 5 1449 1450 O
18 6 8 1451 1453 B-lower_bound
years 9 14 1454 1459 I-lower_bound
but 15 18 1460 1463 O
≤ 19 20 1464 1465 O
80 21 23 1466 1468 B-upper_bound
years 24 29 1469 1474 I-upper_bound
at 30 32 1475 1477 O
the 33 36 1478 1481 O
time 37 41 1482 1486 O
of 42 44 1487 1489 O
consent 45 52 1490 1497 O

at 0 2 1498 1500 O
the 3 6 1501 1504 O
participating 7 20 1505 1518 O
site 21 25 1519 1523 O
of 26 28 1524 1526 O
stage 29 34 1527 1532 B-lower_bound
I 35 36 1533 1534 I-lower_bound
- 36 37 1534 1535 O
III 37 40 1535 1538 B-upper_bound
malignant 41 50 1539 1548 B-cancer
pleural 51 58 1549 1556 I-cancer
mesothelioma 59 71 1557 1569 I-cancer

consideration 0 13 1570 1583 O
should 14 20 1584 1590 O
be 21 23 1591 1593 O
given 24 29 1594 1599 O
to 30 32 1600 1602 O
drain 33 38 1603 1608 O
the 39 42 1609 1612 O
effusion 43 51 1613 1621 O
prior 52 57 1622 1627 B-treatment
to 58 60 1628 1630 I-treatment
chemotherapy 61 73 1631 1643 I-treatment
administration 74 88 1644 1658 O

lactating 0 9 1659 1668 O
women 10 15 1669 1674 B-gender

patients 0 8 1675 1683 O
with 9 13 1684 1688 O
biphasic 14 22 1689 1697 B-cancer
histology 23 32 1698 1707 O
can 33 36 1708 1711 O
have 37 41 1712 1716 O
< 42 43 1717 1718 O
10 44 46 1719 1721 B-upper_bound
% 46 47 1721 1722 I-upper_bound
sarcomatoid 48 59 1723 1734 B-cancer

should 0 6 1735 1741 O
not 7 10 1742 1745 B-pregnancy
become 11 17 1746 1752 I-pregnancy
pregnant 18 26 1753 1761 I-pregnancy
or 27 29 1762 1764 O
father 30 36 1765 1771 O
a 37 38 1772 1773 O
baby 39 43 1774 1778 O
while 44 49 1779 1784 O
on 50 52 1785 1787 O
this 53 57 1788 1792 O
study 58 63 1793 1798 O
because 64 71 1799 1806 O
the 72 75 1807 1810 O
drugs 76 81 1811 1816 O
in 82 84 1817 1819 O
this 85 89 1820 1824 O
study 90 95 1825 1830 O

< 0 1 0 1 O
= 1 2 1 2 O
18 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

A 0 1 19 20 O
strong 2 8 21 27 B-treatment
or 9 11 28 30 I-treatment
moderate 12 20 31 39 I-treatment
CYP3A 21 26 40 45 I-treatment
inhibitor 27 36 46 55 I-treatment
or 37 39 56 58 I-treatment
inducer 40 47 59 66 I-treatment
within 48 54 67 73 O
7 55 56 74 75 B-upper_bound
days 57 61 76 80 I-upper_bound

An 0 2 81 83 O
excluded 3 11 84 92 O
antiplatelet 12 24 93 105 B-treatment
/ 24 25 105 106 O
anticoagulant 25 38 106 119 B-treatment
drug 39 43 120 124 I-treatment
or 44 46 125 127 O
a 47 48 128 129 O
herbal 49 55 130 136 B-treatment
supplement 56 66 137 147 I-treatment
that 67 71 148 152 O
affects 72 79 153 160 O
platelet 80 88 161 169 O
function 89 97 170 178 O
within 98 104 179 185 O
7 105 106 186 187 B-upper_bound
days 107 111 188 192 I-upper_bound
, 111 112 192 193 O
or 113 115 194 196 O
5 116 117 197 198 O
half 118 122 199 203 O
- 122 123 203 204 O
lives 123 128 204 209 O
, 128 129 209 210 O
whichever 130 139 211 220 O
is 140 142 221 223 O
longer 143 149 224 230 O

Aspirin 0 7 231 238 B-treatment
within 8 14 239 245 O
7 15 16 246 247 B-upper_bound
days 17 21 248 252 I-upper_bound
, 21 22 252 253 O
or 23 25 254 256 O
5 26 27 257 258 O
half 28 32 259 263 O
- 32 33 263 264 O
lives 33 38 264 269 O
, 38 39 269 270 O
whichever 40 49 271 280 O
is 50 52 281 283 O
longer 53 59 284 290 O

Eastern 0 7 291 298 B-clinical_variable
Cooperative 8 19 299 310 I-clinical_variable
Oncology 20 28 311 319 I-clinical_variable
Group 29 34 320 325 I-clinical_variable
( 35 36 326 327 I-clinical_variable
ECOG 36 40 327 331 I-clinical_variable
) 40 41 331 332 I-clinical_variable
less 42 46 333 337 O
than 47 51 338 342 O
3 52 53 343 344 B-upper_bound

Hydroxyurea 0 11 345 356 B-treatment
that 12 16 357 361 O
is 17 19 362 364 O
ongoing 20 27 365 372 O
( 28 29 373 374 O
hydroxyurea 29 40 374 385 B-treatment
is 41 43 386 388 O
permitted 44 53 389 398 O
up 54 56 399 401 O
to 57 59 402 404 O
the 60 63 405 408 O
first 64 69 409 414 O
dose 70 74 415 419 O
) 74 75 419 420 O

Inotuzumab 0 10 421 431 B-treatment
within 11 17 432 438 O
30 18 20 439 441 B-upper_bound
days 21 25 442 446 I-upper_bound
and 26 29 447 450 O
must 30 34 451 455 O
have 35 39 456 460 O
ALT 40 43 461 464 B-clinical_variable
, 43 44 464 465 O
AST 45 48 466 469 B-clinical_variable
and 49 52 470 473 O
bilirubin 53 62 474 483 B-clinical_variable
< 63 64 484 485 O
ULN 65 68 486 489 O

Karnofsky 0 9 490 499 B-clinical_variable
greater 10 17 500 507 O
than 18 22 508 512 O
or 23 25 513 515 O
equal 26 31 516 521 O
to 32 34 522 524 O
50 35 37 525 527 B-lower_bound

Lansky 0 6 528 534 B-clinical_variable
greater 7 14 535 542 O
than 15 19 543 547 O
or 20 22 548 550 O
equal 23 28 551 556 O
to 29 31 557 559 O
50 32 34 560 562 B-lower_bound

Must 0 4 563 567 O
have 5 9 568 572 O
relapsed 10 18 573 581 O
or 19 21 582 584 O
refractory 22 32 585 595 O
acute 33 38 596 601 B-cancer
lymphoblastic 39 52 602 615 I-cancer
leukemia 53 61 616 624 I-cancer
( 62 63 625 626 I-cancer
ALL 63 66 626 629 I-cancer
) 66 67 629 630 I-cancer
or 68 70 631 633 O
relapsed 71 79 634 642 O
or 80 82 643 645 O
refractory 83 93 646 656 O
lymphoblastic 94 107 657 670 B-cancer
lymphoma 108 116 671 679 I-cancer
( 117 118 680 681 I-cancer
LL 118 120 681 683 I-cancer
) 120 121 683 684 I-cancer

Participant 0 11 685 696 O
has 12 15 697 700 O
central 16 23 701 708 B-chronic_disease
nervous 24 31 709 716 I-chronic_disease
system 32 38 717 723 I-chronic_disease
( 39 40 724 725 I-chronic_disease
CNS 40 43 725 728 I-chronic_disease
) 43 44 728 729 I-chronic_disease
disease 45 52 730 737 I-chronic_disease
with 53 57 738 742 O
cranial 58 65 743 750 O
involvement 66 77 751 762 O
that 78 82 763 767 O
requires 83 91 768 776 O
radiation 92 101 777 786 B-treatment

Participants 0 12 787 799 O
on 13 15 800 802 O
venetoclax 16 26 803 813 B-treatment
at 27 29 814 816 O
screening 30 39 817 826 O
may 40 43 827 830 O
enroll 44 50 831 837 O
and 51 54 838 841 O
remain 55 61 842 848 O
on 62 64 849 851 O
venetoclax 65 75 852 862 O

Participants 0 12 863 875 O
with 13 17 876 880 O
malabsorption 18 31 881 894 B-chronic_disease
syndrome 32 40 895 903 I-chronic_disease
or 41 43 904 906 O
any 44 47 907 910 O
other 48 53 911 916 O
condition 54 63 917 926 O
that 64 68 927 931 O
precludes 69 78 932 941 O
enteral 79 86 942 949 O
administration 87 101 950 964 O

Philadelphia 0 12 965 977 B-cancer
Chromosome 13 23 978 988 I-cancer
( 24 25 989 990 I-cancer
Ph)+ 25 29 990 994 I-cancer
ALL 30 33 995 998 I-cancer
subjects 34 42 999 1007 O
on 43 45 1008 1010 O
TKIs 46 50 1011 1015 B-treatment
at 51 53 1016 1018 O
Screening 54 63 1019 1028 O
may 64 67 1029 1032 O
enroll 68 74 1033 1039 O
and 75 78 1040 1043 O
remain 79 85 1044 1050 O
on 86 88 1051 1053 O
Tyrosine 89 97 1054 1062 B-treatment
Kinase 98 104 1063 1069 I-treatment
Inhibitor 105 114 1070 1079 I-treatment
( 115 116 1080 1081 I-treatment
TKI 116 119 1081 1084 I-treatment
) 119 120 1084 1085 I-treatment
therapy 121 128 1086 1093 I-treatment
to 129 131 1094 1096 O
control 132 139 1097 1104 O
disease 140 147 1105 1112 O

Refractory 0 10 1113 1123 O
is 11 13 1124 1126 O
defined 14 21 1127 1134 O
as 22 24 1135 1137 O
persistent 25 35 1138 1148 O
disease 36 43 1149 1156 O
after 44 49 1157 1162 O
at 50 52 1163 1165 O
least 53 58 1166 1171 O
2 59 60 1172 1173 B-lower_bound
courses 61 68 1174 1181 O
of 69 71 1182 1184 O
chemotherapy 72 84 1185 1197 B-treatment

Steroid 0 7 1198 1205 B-treatment
therapy 8 15 1206 1213 I-treatment
for 16 19 1214 1217 O
anti 20 24 1218 1222 O
- 24 25 1222 1223 O
neoplastic 25 35 1223 1233 O
intent 36 42 1234 1240 O
within 43 49 1241 1247 O
5 50 51 1248 1249 B-upper_bound
days 52 56 1250 1254 I-upper_bound

greater 0 7 1255 1262 O
than 8 12 1263 1267 O
16 13 15 1268 1270 B-lower_bound
years 16 21 1271 1276 I-lower_bound
of 22 24 1277 1279 O
age 25 28 1280 1283 B-age

have 0 4 1284 1288 O
adequate 5 13 1289 1297 O
performance 14 25 1298 1309 B-clinical_variable
status 26 32 1310 1316 I-clinical_variable

less 0 4 1317 1321 O
than 5 9 1322 1326 O
or 10 12 1327 1329 O
equal 13 18 1330 1335 O
to 19 21 1336 1338 O
16 22 24 1339 1341 B-upper_bound
years 25 30 1342 1347 I-upper_bound
of 31 33 1348 1350 O
age 34 37 1351 1354 B-age

weigh 0 5 1355 1360 B-clinical_variable
greater 6 13 1361 1368 O
than 14 18 1369 1373 O
or 19 21 1374 1376 O
equal 22 27 1377 1382 O
to 28 30 1383 1385 O
20 31 33 1386 1388 B-lower_bound
kg 34 36 1389 1391 I-lower_bound

> 0 1 0 1 O
18 1 3 1 3 B-lower_bound
years 4 9 4 9 I-lower_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Claustrophobic 0 14 17 31 B-chronic_disease

Evidence 0 8 32 40 O
of 9 11 41 43 O
metastatic 12 22 44 54 B-cancer
disease 23 30 55 62 I-cancer

Female 0 6 63 69 B-gender

High 0 4 70 74 O
risk 5 9 75 79 O
for 10 13 80 83 O
surgical 14 22 84 92 B-treatment
intervention 23 35 93 105 I-treatment
because 36 43 106 113 O
of 44 46 114 116 O
comorbidities 47 60 117 130 O

Less 0 4 131 135 O
than 5 9 136 140 O
18 10 12 141 143 B-upper_bound
months 13 19 144 150 I-upper_bound
disease 20 27 151 158 O
- 27 28 158 159 O
free 28 32 159 163 O
interval 33 41 164 172 O

Lumpectomy 0 10 173 183 B-treatment
and 11 14 184 187 O
radiation 15 24 188 197 B-treatment
therapy 25 32 198 205 I-treatment
for 33 36 206 209 O
breast 37 43 210 216 B-cancer
carcinoma 44 53 217 226 I-cancer

Metallic 0 8 227 235 B-treatment
implant 9 16 236 243 I-treatment

Negative 0 8 244 252 B-pregnancy
pregnancy 9 18 253 262 I-pregnancy
test 19 23 263 267 O

No 0 2 268 270 O
evidence 3 11 271 279 O
of 12 14 280 282 O
metastatic 15 25 283 293 B-cancer
disease 26 33 294 301 I-cancer

Patient 0 7 302 309 O
is 8 10 310 312 O
fit 11 14 313 316 O
for 15 18 317 320 O
surgery 19 26 321 328 B-treatment
as 27 29 329 331 O
determined 30 40 332 342 O
by 41 43 343 345 O
preoperative 44 56 346 358 O
medical 57 64 359 366 O
clearance 65 74 367 376 O
workup 75 81 377 383 O
performed 82 91 384 393 O
by 92 94 394 396 O
an 95 97 397 399 O
independent 98 109 400 411 O
primary 110 117 412 419 O
care 118 122 420 424 O
physician 123 132 425 434 O

Received 0 8 435 443 O
treatment 9 18 444 453 B-treatment
with 19 23 454 458 I-treatment
an 24 26 459 461 I-treatment
investigational 27 42 462 477 I-treatment
drug 43 47 478 482 I-treatment
within 48 54 483 489 O
30 55 57 490 492 B-upper_bound
days 58 62 493 497 I-upper_bound
of 63 65 498 500 O
screening 66 75 501 510 O

Unable 0 6 511 517 O
to 7 9 518 520 O
undergo 10 17 521 528 O
MRI 18 21 529 532 B-treatment

A 0 1 0 1 O
family 2 8 2 8 O
history 9 16 9 16 O
of 17 19 17 19 O
schizophrenia 20 33 20 33 B-chronic_disease
or 34 36 34 36 O
schizoaffective 37 52 37 52 B-chronic_disease
disorder 53 61 53 61 I-chronic_disease
( 62 63 62 63 O
first 63 68 63 68 O
or 69 71 69 71 O
second 72 78 72 78 O
degree 79 85 79 85 O
relatives 86 95 86 95 O
) 95 96 95 96 O
, 96 97 96 97 O
or 98 100 98 100 O
bipolar 101 108 101 108 B-chronic_disease
disorder 109 117 109 117 I-chronic_disease
type 118 122 118 122 I-chronic_disease
1 123 124 123 124 I-chronic_disease
( 125 126 125 126 O
first 126 131 126 131 O
degree 132 138 132 138 O
relatives 139 148 139 148 O
) 148 149 148 149 O

Allergy 0 7 150 157 O
or 8 10 158 160 O
hypersensitivity 11 27 161 177 O
to 28 30 178 180 O
psilocybin 31 41 181 191 B-allergy_name
or 42 44 192 194 O
diphenhydramine 45 60 195 210 B-allergy_name

Are 0 3 211 214 O
not 4 7 215 218 O
participating 8 21 219 232 O
in 22 24 233 235 O
any 25 28 236 239 O
formal 29 35 240 246 B-treatment
treatment 36 45 247 256 I-treatment
for 46 49 257 260 O
alcohol 50 57 261 268 O
dependence 58 68 269 279 O
( 69 70 280 281 O
12 70 72 281 283 O
- 72 73 283 284 O
step 73 77 284 288 O
meetings 78 86 289 297 O
are 87 90 298 301 O
not 91 94 302 305 O
considered 95 105 306 316 O
treatment 106 115 317 326 O
) 115 116 326 327 O

Cocaine 0 7 328 335 B-treatment
, 7 8 335 336 O
psychostimulant 9 24 337 352 B-treatment
, 24 25 352 353 O
opioid 26 32 354 360 B-treatment
, 32 33 360 361 O
or 34 36 362 364 O
cannabis 37 45 365 373 B-treatment
dependence 46 56 374 384 O
( 57 58 385 386 O
past 58 62 386 390 B-upper_bound
12 63 65 391 393 I-upper_bound
months 66 72 394 400 I-upper_bound
) 72 73 400 401 O

Cognitive 0 9 402 411 B-chronic_disease
impairment 10 20 412 422 I-chronic_disease
( 21 22 423 424 O
Folstein 22 30 424 432 B-clinical_variable
Mini 31 35 433 437 I-clinical_variable
Mental 36 42 438 444 I-clinical_variable
State 43 48 445 450 I-clinical_variable
Exam 49 53 451 455 I-clinical_variable
score 54 59 456 461 I-clinical_variable
< 60 61 462 463 O
26 62 64 464 466 B-upper_bound
) 64 65 466 467 O

Current 0 7 468 475 O
non 8 11 476 479 O
- 11 12 479 480 O
medical 12 19 480 487 O
use 20 23 488 491 O
of 24 26 492 494 O
cocaine 27 34 495 502 O
, 34 35 502 503 O
psychostimulants 36 52 504 520 O
, 52 53 520 521 O
or 54 56 522 524 O
opioids 57 64 525 532 O
( 65 66 533 534 O
past 66 70 534 538 B-upper_bound
30 71 73 539 541 I-upper_bound
days 74 78 542 546 I-upper_bound
) 78 79 546 547 O

Exclusionary 0 12 548 560 O
psychiatric 13 24 561 572 B-chronic_disease
conditions 25 35 573 583 I-chronic_disease
( 36 37 584 585 O
schizophrenia 37 50 585 598 B-chronic_disease
, 50 51 598 599 O
schizoaffective 52 67 600 615 B-chronic_disease
disorder 68 76 616 624 I-chronic_disease
, 76 77 624 625 O
bipolar 78 85 626 633 B-chronic_disease
disorder 86 94 634 642 I-chronic_disease
, 94 95 642 643 O
current 96 103 644 651 O
major 104 109 652 657 B-chronic_disease
depressive 110 120 658 668 I-chronic_disease
episode 121 128 669 676 I-chronic_disease
, 128 129 676 677 O
current 130 137 678 685 O
post 138 142 686 690 B-chronic_disease
- 142 143 690 691 I-chronic_disease
traumatic 143 152 691 700 I-chronic_disease
stress 153 159 701 707 I-chronic_disease
disorder 160 168 708 716 I-chronic_disease
, 168 169 716 717 O
current 170 177 718 725 O
suicidality 178 189 726 737 O
or 190 192 738 740 O
history 193 200 741 748 O
of 201 203 749 751 O
medically 204 213 752 761 O
serious 214 221 762 769 O
suicide 222 229 770 777 O
attempt 230 237 778 785 O
) 237 238 785 786 O

Have 0 4 787 791 O
a 5 6 792 793 O
family 7 13 794 800 O
member 14 20 801 807 O
or 21 23 808 810 O
friend 24 30 811 817 O
who 31 34 818 821 O
can 35 38 822 825 O
pick 39 43 826 830 O
them 44 48 831 835 O
up 49 51 836 838 O
and 52 55 839 842 O
stay 56 60 843 847 O
with 61 65 848 852 O
them 66 70 853 857 O
overnight 71 80 858 867 O
after 81 86 868 873 O
the 87 90 874 877 O
psilocybin 91 101 878 888 B-treatment
administration 102 116 889 903 O
sessions 117 125 904 912 O

Have 0 4 913 917 O
at 5 7 918 920 O
least 8 13 921 926 O
4 14 15 927 928 B-lower_bound
heavy 16 21 929 934 O
drinking 22 30 935 943 O
days 31 35 944 948 O
in 36 38 949 951 O
the 39 42 952 955 O
past 43 47 956 960 B-upper_bound
30 48 50 961 963 I-upper_bound
days 51 55 964 968 I-upper_bound

High 0 4 969 973 O
risk 5 9 974 978 O
of 10 12 979 981 O
adverse 13 20 982 989 O
emotional 21 30 990 999 O
or 31 33 1000 1002 O
behavioral 34 44 1003 1013 O
reaction 45 53 1014 1022 O
based 54 59 1023 1028 O
on 60 62 1029 1031 O
investigator 63 75 1032 1044 O
's 75 77 1044 1046 O
clinical 78 86 1047 1055 O
evaluation 87 97 1056 1066 O
( 98 99 1067 1068 O
e.g. 99 103 1068 1072 O
, 103 104 1072 1073 O
evidence 105 113 1074 1082 O
of 114 116 1083 1085 O
serious 117 124 1086 1093 O
personality 125 136 1094 1105 B-chronic_disease
disorder 137 145 1106 1114 I-chronic_disease
, 145 146 1114 1115 O
antisocial 147 157 1116 1126 B-chronic_disease
behavior 158 166 1127 1135 I-chronic_disease
, 166 167 1135 1136 O
serious 168 175 1137 1144 O
current 176 183 1145 1152 O
stressors 184 193 1153 1162 B-chronic_disease
, 193 194 1162 1163 O
lack 195 199 1164 1168 O
of 200 202 1169 1171 O
meaningful 203 213 1172 1182 O
social 214 220 1183 1189 O
support 221 228 1190 1197 O
) 228 229 1197 1198 O

History 0 7 1199 1206 O
of 8 10 1207 1209 O
hallucinogen 11 23 1210 1222 B-treatment
use 24 27 1223 1226 O
disorder 28 36 1227 1235 O
, 36 37 1235 1236 O
or 38 40 1237 1239 O
any 41 44 1240 1243 O
use 45 48 1244 1247 O
in 49 51 1248 1250 O
the 52 55 1251 1254 O
past 56 60 1255 1259 B-upper_bound
1 61 62 1260 1261 I-upper_bound
year 63 67 1262 1266 I-upper_bound
, 67 68 1266 1267 O
or 69 71 1268 1270 O
> 72 73 1271 1272 O
25 73 75 1272 1274 B-lower_bound
lifetime 76 84 1275 1283 I-lower_bound
uses 85 89 1284 1288 O

Males 0 5 1289 1294 B-gender

Medical 0 7 1295 1302 O
conditions 8 18 1303 1313 O
that 19 23 1314 1318 O
would 24 29 1319 1324 O
preclude 30 38 1325 1333 O
safe 39 43 1334 1338 O
participation 44 57 1339 1352 O
in 58 60 1353 1355 O
the 61 64 1356 1359 O
trial 65 70 1360 1365 O
( 71 72 1366 1367 O
e.g. 72 76 1367 1371 O
, 76 77 1371 1372 O
seizure 78 85 1373 1380 B-chronic_disease
disorder 86 94 1381 1389 I-chronic_disease
, 94 95 1389 1390 O
significantly 96 109 1391 1404 O
impaired 110 118 1405 1413 B-chronic_disease
liver 119 124 1414 1419 I-chronic_disease
function 125 133 1420 1428 I-chronic_disease
, 133 134 1428 1429 O
coronary 135 143 1430 1438 B-chronic_disease
artery 144 150 1439 1445 I-chronic_disease
disease 151 158 1446 1453 I-chronic_disease
, 158 159 1453 1454 O
heart 160 165 1455 1460 B-chronic_disease
failure 166 173 1461 1468 I-chronic_disease
, 173 174 1468 1469 O
uncontrolled 175 187 1470 1482 B-chronic_disease
hypertension 188 200 1483 1495 I-chronic_disease
( 201 202 1496 1497 O
above 202 207 1497 1502 O
165/95 208 214 1503 1509 B-lower_bound
mmHg 215 219 1510 1514 I-lower_bound
at 220 222 1515 1517 O
screening 223 232 1518 1527 O
) 232 233 1527 1528 O
, 233 234 1528 1529 O
history 235 242 1530 1537 O
of 243 245 1538 1540 O
cerebrovascular 246 261 1541 1556 B-chronic_disease
accident 262 270 1557 1565 I-chronic_disease
, 270 271 1565 1566 O
asthma 272 278 1567 1573 B-chronic_disease
, 278 279 1573 1574 O
hyperthyroidism 280 295 1575 1590 B-chronic_disease
, 295 296 1590 1591 O
narrow 297 303 1592 1598 B-chronic_disease
- 303 304 1598 1599 I-chronic_disease
angle 304 309 1599 1604 I-chronic_disease
glaucoma 310 318 1605 1613 I-chronic_disease
, 318 319 1613 1614 O
stenosing 320 329 1615 1624 B-chronic_disease
peptic 330 336 1625 1631 I-chronic_disease
ulcer 337 342 1632 1637 I-chronic_disease
, 342 343 1637 1638 O
pyloroduodenal 344 358 1639 1653 B-chronic_disease
obstruction 359 370 1654 1665 I-chronic_disease
, 370 371 1665 1666 O
symptomatic 372 383 1667 1678 B-chronic_disease
prostatic 384 393 1679 1688 I-chronic_disease
hypertrophy 394 405 1689 1700 I-chronic_disease
, 405 406 1700 1701 O
or 407 409 1702 1704 O
bladder 410 417 1705 1712 B-chronic_disease
- 417 418 1712 1713 I-chronic_disease
neck 418 422 1713 1717 I-chronic_disease
obstruction 423 434 1718 1729 I-chronic_disease
) 434 435 1729 1730 O

Need 0 4 1731 1735 O
to 5 7 1736 1738 O
take 8 12 1739 1743 O
medication 13 23 1744 1754 B-treatment
with 24 28 1755 1759 O
significant 29 40 1760 1771 O
potential 41 50 1772 1781 O
to 51 53 1782 1784 O
interact 54 62 1785 1793 O
with 63 67 1794 1798 O
study 68 73 1799 1804 B-treatment
medications 74 85 1805 1816 I-treatment
( 86 87 1817 1818 O
e.g. 87 91 1818 1822 O
, 91 92 1822 1823 O
antidepressants 93 108 1824 1839 B-treatment
, 108 109 1839 1840 O
antipsychotics 110 124 1841 1855 B-treatment
, 124 125 1855 1856 O
psychostimulants 126 142 1857 1873 B-treatment
, 142 143 1873 1874 O
treatments 144 154 1875 1885 B-treatment
for 155 158 1886 1889 O
addictions 159 169 1890 1900 O
, 169 170 1900 1901 O
other 171 176 1902 1907 O
dopaminergic 177 189 1908 1920 B-treatment
or 190 192 1921 1923 O
serotonergic 193 205 1924 1936 B-treatment
agents 206 212 1937 1943 I-treatment
, 212 213 1943 1944 O
lithium 214 221 1945 1952 B-treatment
, 221 222 1952 1953 O
anticonvulsants 223 238 1954 1969 B-treatment
) 238 239 1969 1970 O

Pregnancy 0 9 1971 1980 B-pregnancy
or 10 12 1981 1983 O
lactation 13 22 1984 1993 O

Serious 0 7 1994 2001 O
ECG 8 11 2002 2005 B-treatment
abnormalities 12 25 2006 2019 O
( 26 27 2020 2021 O
e.g. 27 31 2021 2025 O
, 31 32 2025 2026 O
evidence 33 41 2027 2035 O
of 42 44 2036 2038 O
ischemia 45 53 2039 2047 B-chronic_disease
, 53 54 2047 2048 O
myocardial 55 65 2049 2059 B-chronic_disease
infarction 66 76 2060 2070 I-chronic_disease
) 76 77 2070 2071 O

Significant 0 11 2072 2083 O
alcohol 12 19 2084 2091 O
withdrawal 20 30 2092 2102 O
( 31 32 2103 2104 O
CIWA 32 36 2104 2108 B-clinical_variable
- 36 37 2108 2109 I-clinical_variable
Ar 37 39 2109 2111 I-clinical_variable
score 40 45 2112 2117 I-clinical_variable
greater 46 53 2118 2125 O
than 54 58 2126 2130 O
7 59 60 2131 2132 B-lower_bound
. 60 61 2132 2133 O
Patients 62 70 2134 2142 O
presenting 71 81 2143 2153 O
at 82 84 2154 2156 O
screening 85 94 2157 2166 O
in 95 97 2167 2169 O
withdrawal 98 108 2170 2180 O
may 109 112 2181 2184 O
be 113 115 2185 2187 O
referred 116 124 2188 2196 O
for 125 128 2197 2200 O
detoxification 129 143 2201 2215 O
and 144 147 2216 2219 O
reassessed 148 158 2220 2230 O
within 159 165 2231 2237 O
30 166 168 2238 2240 B-upper_bound
days 169 173 2241 2245 I-upper_bound
) 173 174 2245 2246 O

age 0 3 2247 2250 B-age
25 4 6 2251 2253 B-lower_bound
- 6 7 2253 2254 O
65 7 9 2254 2256 B-upper_bound

females 0 7 2257 2264 B-gender

with 0 4 2265 2269 O
SCID 5 9 2270 2274 B-chronic_disease
( 10 11 2275 2276 O
DSM 11 14 2276 2279 O
- 14 15 2279 2280 O
IV 15 17 2280 2282 O
) 17 18 2282 2283 O
diagnosis 19 28 2284 2293 O
of 29 31 2294 2296 O
alcohol 32 39 2297 2304 O
dependence 40 50 2305 2315 O
who 51 54 2316 2319 O

21 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Current 0 7 19 26 B-pregnancy
pregnancy 8 17 27 36 I-pregnancy
or 18 20 37 39 O
intent 21 27 40 46 O
to 28 30 47 49 O
become 31 37 50 56 B-pregnancy
pregnant 38 46 57 65 I-pregnancy
during 47 53 66 72 O
the 54 57 73 76 O
next 58 62 77 81 O
12 63 65 82 84 B-upper_bound
weeks 66 71 85 90 I-upper_bound

Daily 0 5 91 96 O
smokers 6 13 97 104 O
of 14 16 105 107 O
at 17 19 108 110 O
least 20 25 111 116 O
5 26 27 117 118 B-lower_bound
cigarettes 28 38 119 129 I-lower_bound
/ 38 39 129 130 I-lower_bound
day 39 42 130 133 I-lower_bound
who 43 46 134 137 O
are 47 50 138 141 O
classified 51 61 142 152 O
as 62 64 153 155 O
in 65 67 156 158 O
the 68 71 159 162 O
pre 72 75 163 166 O
- 75 76 166 167 O
contemplator 76 88 167 179 O
stage 89 94 180 185 O
of 95 97 186 188 O
change 98 104 189 195 O
( 105 106 196 197 O
i.e. 106 110 197 201 O
do 111 113 202 204 O
not 114 117 205 208 O
intend 118 124 209 215 O
to 125 127 216 218 O
quit 128 132 219 223 O
smoking 133 140 224 231 O
in 141 143 232 234 O
the 144 147 235 238 O
next 148 152 239 243 B-upper_bound
6 153 154 244 245 I-upper_bound
- 154 155 245 246 I-upper_bound
months 155 161 246 252 I-upper_bound
) 161 162 252 253 O

Have 0 4 254 258 B-technology_access
a 5 6 259 260 I-technology_access
cell 7 11 261 265 I-technology_access
phone 12 17 266 271 I-technology_access
with 18 22 272 276 I-technology_access
a 23 24 277 278 I-technology_access
text 25 29 279 283 I-technology_access
messaging 30 39 284 293 I-technology_access
service 40 47 294 301 I-technology_access
plan 48 52 302 306 I-technology_access

Marked 0 6 307 313 O
organic 7 14 314 321 O
impairment 15 25 322 332 O
or 26 28 333 335 O
unstable 29 37 336 344 O
medical 38 45 345 352 O
problems 46 54 353 361 O
( 55 56 362 363 O
such 56 60 363 367 O
as 61 63 368 370 O
a 64 65 371 372 O
seizure 66 73 373 380 B-chronic_disease
disorder 74 82 381 389 I-chronic_disease
) 82 83 389 390 O

Neurological 0 12 0 12 B-chronic_disease
impairment/ 13 24 13 24 I-chronic_disease
developmental 25 38 25 38 B-chronic_disease
delay 39 44 39 44 I-chronic_disease

New 0 3 45 48 O
/ 4 5 49 50 O
changes 6 13 51 58 O
in 14 16 59 61 O
anti 17 21 62 66 B-treatment
- 21 22 66 67 I-treatment
hypertensive 22 34 67 79 I-treatment
medication 35 45 80 90 I-treatment

No 0 2 91 93 B-technology_access
smart 3 8 94 99 I-technology_access
phone 9 14 100 105 I-technology_access
/ 15 16 106 107 I-technology_access
smart 17 22 108 113 I-technology_access
phone 23 28 114 119 I-technology_access
data 29 33 120 124 O
plan 34 38 125 129 O

Overweight 0 10 130 140 O
or 11 13 141 143 O
Obese 14 19 144 149 B-chronic_disease

Pregnancy 0 9 150 159 B-pregnancy

Prior 0 5 160 165 O
diagnosis 6 15 166 175 O
of 16 18 176 178 O
congenital 19 29 179 189 B-chronic_disease
heart 30 35 190 195 I-chronic_disease
disease 36 43 196 203 I-chronic_disease
or 44 46 204 206 O
cancer 47 53 207 213 B-cancer

Speaks 0 6 214 220 B-language_fluency
English 7 14 221 228 I-language_fluency

medication 0 10 229 239 O
known 11 16 240 245 O
to 17 19 246 248 O
affect 20 26 249 255 O
blood 27 32 256 261 O
pressure 33 41 262 270 O
within 42 48 271 277 O
the 49 52 278 281 O
last 53 57 282 286 B-upper_bound
6 58 59 287 288 I-upper_bound
months 60 66 289 295 I-upper_bound

Able 0 4 0 4 O
to 5 7 5 7 O
swallow 8 15 8 15 O
and 16 19 16 19 O
retain 20 26 20 26 O
oral 27 31 27 31 B-treatment
medication 32 42 32 42 I-treatment

Active 0 6 43 49 B-chronic_disease
hepatitis 7 16 50 59 I-chronic_disease
B 17 18 60 61 I-chronic_disease
infection 19 28 62 71 I-chronic_disease
, 28 29 71 72 O
active 30 36 73 79 B-chronic_disease
hepatitis 37 46 80 89 I-chronic_disease
C 47 48 90 91 I-chronic_disease
infection 49 58 92 101 I-chronic_disease

Additional 0 10 102 112 O
experimental 11 23 113 125 O
anti 24 28 126 130 B-treatment
- 28 29 130 131 I-treatment
cancer 29 35 131 137 I-treatment
treatment 36 45 138 147 I-treatment
and/or 46 52 148 154 O
standard 53 61 155 163 O
chemo- 62 68 164 170 O
, 68 69 170 171 O
immunotherapy 70 83 172 185 B-treatment
, 83 84 185 186 O
hormone 85 92 187 194 B-treatment
treatment 93 102 195 204 I-treatment
( 103 104 205 206 O
with 104 108 206 210 O
the 109 112 211 214 O
exception 113 122 215 224 O
of 123 125 225 227 O
megestrol 126 135 228 237 B-treatment
acetate 136 143 238 245 I-treatment
) 143 144 245 246 O
, 144 145 246 247 O
or 146 148 248 250 O
concurrent 149 159 251 261 B-treatment
radiotherapy 160 172 262 274 I-treatment
is 173 175 275 277 O
not 176 179 278 281 O
allowed 180 187 282 289 O
concomitantly 188 201 290 303 O
with 202 206 304 308 O
the 207 210 309 312 O
administration 211 225 313 327 O
of 226 228 328 330 O
study 229 234 331 336 O
treatment 235 244 337 346 O
( 245 246 347 348 O
with 246 250 348 352 O
the 251 254 353 356 O
exception 255 264 357 366 O
listed 265 271 367 373 O
in 272 274 374 376 O
section 275 282 377 384 O
9.0 283 286 385 388 O
) 286 287 388 389 O
89Zr 288 292 390 394 B-treatment
- 292 293 394 395 I-treatment
trastuzumab 293 304 395 406 I-treatment
use 305 308 407 410 O
as 309 311 411 413 O
imaging 312 319 414 421 O
agent 320 325 422 427 O
for 326 329 428 431 O
89Zr 330 334 432 436 O
- 334 335 436 437 O
trastuzumab 335 346 437 448 O
PET 347 350 449 452 B-clinical_variable
permitted 351 360 453 462 O
. 360 361 462 463 O
Afatinib 362 370 464 472 B-treatment
is 371 373 473 475 O
a 374 375 476 477 O
substrate 376 385 478 487 O
of 386 388 488 490 O
P 389 390 491 492 B-clinical_variable
- 390 391 492 493 I-clinical_variable
gp 391 393 493 495 I-clinical_variable
and 394 397 496 499 O
its 398 401 500 503 O
plasma 402 408 504 510 O
concentrations 409 423 511 525 O
can 424 427 526 529 O
be 428 430 530 532 O
affected 431 439 533 541 O
by 440 442 542 544 O
the 443 446 545 548 O
use 447 450 549 552 O
of 451 453 553 555 O
P 454 455 556 557 O
- 455 456 557 558 O
gp 456 458 558 560 O
inhibitors 459 469 561 571 O
( 470 471 572 573 O
data 471 475 573 577 O
on 476 478 578 580 O
file 479 483 581 585 O
) 483 484 585 586 O
and 485 488 587 590 O
it 489 491 591 593 O
is 492 494 594 596 O
also 495 499 597 601 O
likely 500 506 602 608 O
that 507 511 609 613 O
P 512 513 614 615 O
- 513 514 615 616 O
gp 514 516 616 618 O
inducers 517 525 619 627 O
could 526 531 628 633 O
also 532 536 634 638 O
influence 537 546 639 648 O
afatinib 547 555 649 657 B-treatment
plasma 556 562 658 664 I-treatment
concentrations 563 577 665 679 O

All 0 3 680 683 O
patients 4 12 684 692 O
with 13 17 693 697 O
disease 18 25 698 705 O
technically 26 37 706 717 O
amenable 38 46 718 726 O
to 47 49 727 729 O
biopsy 50 56 730 736 B-treatment
will 57 61 737 741 O
be 62 64 742 744 O
asked 65 70 745 750 O
to 71 73 751 753 O
undergo 74 81 754 761 O
a 82 83 762 763 O
biopsy 84 90 764 770 O
. 90 91 770 771 O
Patient 92 99 772 779 O
must 100 104 780 784 O
agree 105 110 785 790 O
to 111 113 791 793 O
allow 114 119 794 799 O
2 120 121 800 801 O
biopsies 122 130 802 810 B-treatment
of 131 133 811 813 O
any 134 137 814 817 O
malignant 138 147 818 827 B-cancer
lesion 148 154 828 834 I-cancer
that 155 159 835 839 O
can 160 163 840 843 O
be 164 166 844 846 O
accessed 167 175 847 855 O
by 176 178 856 858 O
endoscopy 179 188 859 868 B-treatment
or 189 191 869 871 O
with 192 196 872 876 O
the 197 200 877 880 O
aid 201 204 881 884 O
or 205 207 885 887 O
radiology 208 217 888 897 B-treatment
( 218 219 898 899 O
i.e. 219 223 899 903 O
CT 224 226 904 906 B-treatment
guided 227 233 907 913 O
) 233 234 913 914 O

Asymptomatic 0 12 915 927 O
, 12 13 927 928 O
central 14 21 929 936 B-cancer
nervous 22 29 937 944 I-cancer
system 30 36 945 951 I-cancer
metastases 37 47 952 962 I-cancer

At 0 2 963 965 O
least 3 8 966 971 O
one 9 12 972 975 B-lower_bound
measurable 13 23 976 986 O
metastatic 24 34 987 997 B-cancer
lesion 35 41 998 1004 I-cancer
according 42 51 1005 1014 O
to 52 54 1015 1017 O
RECIST 55 61 1018 1024 O
1.1 62 65 1025 1028 O
criteria 66 74 1029 1037 O
. 74 75 1037 1038 O
Ascites 76 83 1039 1046 B-chronic_disease
, 83 84 1046 1047 O
pleural 85 92 1048 1055 B-chronic_disease
effusions 93 102 1056 1065 I-chronic_disease
, 102 103 1065 1066 O
and 104 107 1067 1070 O
bone 108 112 1071 1075 B-cancer
metastases 113 123 1076 1086 I-cancer
are 124 127 1087 1090 O
not 128 131 1091 1094 O
considered 132 142 1095 1105 O
measurable 143 153 1106 1116 O
. 153 154 1116 1117 O
Minimum 155 162 1118 1125 O
indicator 163 172 1126 1135 O
lesion 173 179 1136 1142 B-clinical_variable
size 180 184 1143 1147 I-clinical_variable
= 185 186 1148 1149 O
10 187 189 1150 1152 B-lower_bound
mm 190 192 1153 1155 I-lower_bound
by 193 195 1156 1158 O
helical 196 203 1159 1166 B-treatment
CT 204 206 1167 1169 I-treatment
or 207 209 1170 1172 O
= 210 211 1173 1174 O
20 212 214 1175 1177 B-lower_bound
mm 215 217 1178 1180 I-lower_bound
by 218 220 1181 1183 O
conventional 221 233 1184 1196 O
techniques 234 244 1197 1207 O
. 244 245 1207 1208 O
Pathological 246 258 1209 1221 O
nodes 259 264 1222 1227 O
must 265 269 1228 1232 O
be 270 272 1233 1235 O
= 273 274 1236 1237 O
15 275 277 1238 1240 O
mm 278 280 1241 1243 O
by 281 283 1244 1246 O
the 284 287 1247 1250 O
short 288 293 1251 1256 O
axis 294 298 1257 1261 O
to 299 301 1262 1264 O
be 302 304 1265 1267 O
considered 305 315 1268 1278 O
measurable 316 326 1279 1289 O

Baseline 0 8 1290 1298 O
( 9 10 1299 1300 O
< 10 11 1300 1301 O
1 12 13 1302 1303 B-upper_bound
month 14 19 1304 1309 I-upper_bound
before 20 26 1310 1316 I-upper_bound
treatment 27 36 1317 1326 B-treatment
) 36 37 1326 1327 O
cardiac 38 45 1328 1335 B-clinical_variable
left 46 50 1336 1340 I-clinical_variable
ventricular 51 62 1341 1352 I-clinical_variable
function 63 71 1353 1361 I-clinical_variable
with 72 76 1362 1366 O
resting 77 84 1367 1374 B-clinical_variable
ejection 85 93 1375 1383 I-clinical_variable
fraction 94 102 1384 1392 I-clinical_variable
of 103 105 1393 1395 O
less 106 110 1396 1400 O
than 111 115 1401 1405 O
50 116 118 1406 1408 B-upper_bound
% 118 119 1408 1409 I-upper_bound
measured 120 128 1410 1418 O
by 129 131 1419 1421 O
echocardiogram 132 146 1422 1436 B-treatment

Completion 0 10 1437 1447 O
of 11 13 1448 1450 O
previous 14 22 1451 1459 B-treatment
chemotherapy 23 35 1460 1472 I-treatment
regimen 36 43 1473 1480 I-treatment
≥2 44 46 1481 1483 O
weeks 47 52 1484 1489 I-lower_bound
prior 53 58 1490 1495 I-lower_bound
to 59 61 1496 1498 O
the 62 65 1499 1502 O
start 66 71 1503 1508 O
of 72 74 1509 1511 O
study 75 80 1512 1517 B-treatment
treatment 81 90 1518 1527 I-treatment
. 90 91 1527 1528 O
Other 92 97 1529 1534 O
chemotherapy 98 110 1535 1547 O
regimens 111 119 1548 1556 O
may 120 123 1557 1560 O
have 124 128 1561 1565 O
been 129 133 1566 1570 O
administered 134 146 1571 1583 O
between 147 154 1584 1591 O
the 155 158 1592 1595 O
time 159 163 1596 1600 O
of 164 166 1601 1603 O
progression 167 178 1604 1615 O
on 179 181 1616 1618 O
prior 182 187 1619 1624 O
trastuzumab 188 199 1625 1636 B-treatment
containing 200 210 1637 1647 O
regimen 211 218 1648 1655 O
and 219 222 1656 1659 O
protocol 223 231 1660 1668 B-treatment
therapy 232 239 1669 1676 I-treatment
. 239 240 1676 1677 O
No 241 243 1678 1680 O
restriction 244 255 1681 1692 O
on 256 258 1693 1695 O
prior 259 264 1696 1701 B-treatment
chemotherapy 265 277 1702 1714 I-treatment
regimens 278 286 1715 1723 O
for 287 290 1724 1727 O
advanced 291 299 1728 1736 B-chronic_disease
stage 300 305 1737 1742 I-chronic_disease
disease 306 313 1743 1750 I-chronic_disease

Concurrent 0 10 1751 1761 O
medical 11 18 1762 1769 B-chronic_disease
conditions 19 29 1770 1780 I-chronic_disease
which 30 35 1781 1786 O
may 36 39 1787 1790 O
increase 40 48 1791 1799 O
the 49 52 1800 1803 O
risk 53 57 1804 1808 O
of 58 60 1809 1811 O
toxicity 61 69 1812 1820 O
, 69 70 1820 1821 O
including 71 80 1822 1831 O
ongoing 81 88 1832 1839 O
or 89 91 1840 1842 O
active 92 98 1843 1849 B-chronic_disease
infection 99 108 1850 1859 I-chronic_disease
, 108 109 1859 1860 O
history 110 117 1861 1868 O
of 118 120 1869 1871 O
significant 121 132 1872 1883 O
bleeding 133 141 1884 1892 B-chronic_disease
disorder 142 150 1893 1901 I-chronic_disease
unrelated 151 160 1902 1911 O
to 161 163 1912 1914 O
cancer 164 170 1915 1921 B-cancer
( 171 172 1922 1923 O
congenital 172 182 1923 1933 B-chronic_disease
bleeding 183 191 1934 1942 I-chronic_disease
disorders 192 201 1943 1952 I-chronic_disease
, 201 202 1952 1953 O
acquired 203 211 1954 1962 O
bleeding 212 220 1963 1971 O
disorders 221 230 1972 1981 O
within 231 237 1982 1988 O
one 238 241 1989 1992 B-upper_bound
year 242 246 1993 1997 I-upper_bound
) 246 247 1997 1998 O
, 247 248 1998 1999 O
HIV 249 252 2000 2003 B-chronic_disease
- 252 253 2003 2004 O
positive 253 261 2004 2012 O

Concurrent 0 10 2013 2023 B-treatment
radiotherapy 11 23 2024 2036 I-treatment
is 24 26 2037 2039 O
not 27 30 2040 2043 O
permitted 31 40 2044 2053 O
for 41 44 2054 2057 O
disease 45 52 2058 2065 O
progression 53 64 2066 2077 O
on 65 67 2078 2080 O
treatment 68 77 2081 2090 B-treatment
on 78 80 2091 2093 O
protocol 81 89 2094 2102 O
( 90 91 2103 2104 O
except 91 97 2104 2110 O
in 98 100 2111 2113 O
the 101 104 2114 2117 O
context 105 112 2118 2125 O
specified 113 122 2126 2135 O
in 123 125 2136 2138 O
section 126 133 2139 2146 O
9.0 134 137 2147 2150 O
) 137 138 2150 2151 O
, 138 139 2151 2152 O
but 140 143 2153 2156 O
might 144 149 2157 2162 O
be 150 152 2163 2165 O
allowed 153 160 2166 2173 O
for 161 164 2174 2177 O
pre 165 168 2178 2181 O
- 168 169 2181 2182 O
existing 169 177 2182 2190 O
non 178 181 2191 2194 O
- 181 182 2194 2195 O
target 182 188 2195 2201 O
lesions 189 196 2202 2209 B-chronic_disease

Consent 0 7 2210 2217 O
to 8 10 2218 2220 O
preservation 11 23 2221 2233 O
of 24 26 2234 2236 O
frozen 27 33 2237 2243 O
and 34 37 2244 2247 O
fixed 38 43 2248 2253 O
samples 44 51 2254 2261 O
of 52 54 2262 2264 O
tumor 55 60 2265 2270 B-cancer
cores 61 66 2271 2276 O
for 67 70 2277 2280 O
evaluation 71 81 2281 2291 O

HER2 0 4 2292 2296 O
overexpression 5 19 2297 2311 O
and/or 20 26 2312 2318 O
amplification 27 40 2319 2332 O
as 41 43 2333 2335 O
determined 44 54 2336 2346 O
by 55 57 2347 2349 O
immunohistochemistry 58 78 2350 2370 B-treatment
( 79 80 2371 2372 O
3 80 81 2372 2373 O
+ 81 82 2373 2374 O
) 82 83 2374 2375 O
or 84 86 2376 2378 O
FISH 87 91 2379 2383 B-clinical_variable
( 92 93 2384 2385 O
≥2.0 93 97 2385 2389 O
) 97 98 2389 2390 O

History 0 7 2391 2398 O
or 8 10 2399 2401 O
presence 11 19 2402 2410 O
of 20 22 2411 2413 O
clinically 23 33 2414 2424 O
relevant 34 42 2425 2433 O
cardiovascular 43 57 2434 2448 B-chronic_disease
abnormalities 58 71 2449 2462 I-chronic_disease
such 72 76 2463 2467 O
as 77 79 2468 2470 O
uncontrolled 80 92 2471 2483 B-chronic_disease
hypertension 93 105 2484 2496 I-chronic_disease
, 105 106 2496 2497 O
congestive 107 117 2498 2508 B-chronic_disease
heart 118 123 2509 2514 I-chronic_disease
failure 124 131 2515 2522 I-chronic_disease
NYHA 132 136 2523 2527 B-clinical_variable
classification 137 151 2528 2542 O
of 152 154 2543 2545 O
3 155 156 2546 2547 O
, 156 157 2547 2548 O
unstable 158 166 2549 2557 B-chronic_disease
angina 167 173 2558 2564 I-chronic_disease
or 174 176 2565 2567 O
poorly 177 183 2568 2574 O
controlled 184 194 2575 2585 O
arrhythmia 195 205 2586 2596 B-chronic_disease
. 205 206 2596 2597 O
Myocardial 207 217 2598 2608 B-chronic_disease
infarction 218 228 2609 2619 I-chronic_disease
within 229 235 2620 2626 O
6 236 237 2627 2628 B-upper_bound
months 238 244 2629 2635 I-upper_bound
prior 245 250 2636 2641 I-upper_bound
to 251 253 2642 2644 O
study 254 259 2645 2650 O
entry 260 265 2651 2656 O

Karnofsky 0 9 2657 2666 B-clinical_variable
performance 10 21 2667 2678 I-clinical_variable
status 22 28 2679 2685 I-clinical_variable
≥60 29 32 2686 2689 O
% 32 33 2689 2690 I-lower_bound

Known 0 5 2691 2696 O
HIV 6 9 2697 2700 B-chronic_disease
carrier 10 17 2701 2708 O

Known 0 5 2709 2714 O
or 6 8 2715 2717 O
suspected 9 18 2718 2727 O
active 19 25 2728 2734 O
drug 26 30 2735 2739 O
or 31 33 2740 2742 O
alcohol 34 41 2743 2750 O
abuse 42 47 2751 2756 O
. 47 48 2756 2757 O
Restricted 49 59 2758 2768 O
Therapies 60 69 2769 2778 B-treatment

Known 0 5 2779 2784 O
pre 6 9 2785 2788 O
- 9 10 2788 2789 O
existing 10 18 2789 2797 O
interstitial 19 31 2798 2810 B-chronic_disease
lung 32 36 2811 2815 I-chronic_disease
disease 37 44 2816 2823 I-chronic_disease

Life 0 4 2824 2828 B-clinical_variable
expectancy 5 15 2829 2839 I-clinical_variable
of 16 18 2840 2842 O
at 19 21 2843 2845 O
least 22 27 2846 2851 O
three 28 33 2852 2857 B-lower_bound
( 34 35 2858 2859 I-lower_bound
3 35 36 2859 2860 I-lower_bound
) 36 37 2860 2861 I-lower_bound
months 38 44 2862 2868 I-lower_bound

May 0 3 2869 2872 O
have 4 8 2873 2877 O
previously 9 19 2878 2888 O
received 20 28 2889 2897 O
lapatinib 29 38 2898 2907 B-treatment
as 39 41 2908 2910 O
part 42 46 2911 2915 O
of 47 49 2916 2918 O
a 50 51 2919 2920 O
regimen 52 59 2921 2928 O
in 60 62 2929 2931 O
the 63 66 2932 2935 O
perioperative 67 80 2936 2949 O
or 81 83 2950 2952 O
metastatic 84 94 2953 2963 O
setting 95 102 2964 2971 O
with 103 107 2972 2976 O
evidence 108 116 2977 2985 O
of 117 119 2986 2988 O
progression 120 131 2989 3000 O
of 132 134 3001 3003 O
disease 135 142 3004 3011 O
. 142 143 3011 3012 O
Washout 144 151 3013 3020 O
period 152 158 3021 3027 O
for 159 162 3028 3031 O
lapatinib 163 172 3032 3041 O
of 173 175 3042 3044 O
14 176 178 3045 3047 B-upper_bound
days 179 183 3048 3052 I-upper_bound

Negative 0 8 3053 3061 B-pregnancy
serum 9 14 3062 3067 I-pregnancy
HCG 15 18 3068 3071 I-pregnancy
pregnancy 19 28 3072 3081 I-pregnancy
test 29 33 3082 3086 O
for 34 37 3087 3090 O
premenopausal 38 51 3091 3104 O
women 52 57 3105 3110 B-gender
of 58 60 3111 3113 O
reproductive 61 73 3114 3126 O
capacity 74 82 3127 3135 O
and 83 86 3136 3139 O
for 87 90 3140 3143 O
women 91 96 3144 3149 O
less 97 101 3150 3154 O
than 102 106 3155 3159 O
12 107 109 3160 3162 B-upper_bound
months 110 116 3163 3169 I-upper_bound
after 117 122 3170 3175 O
menopause 123 132 3176 3185 O

Pathologically 0 14 3186 3200 O
or 15 17 3201 3203 O
cytologically 18 31 3204 3217 O
confirmed 32 41 3218 3227 O
esophagogastric 42 57 3228 3243 B-cancer
cancer 58 64 3244 3250 I-cancer

Patients 0 8 3251 3259 O
aged 9 13 3260 3264 B-age
18 14 16 3265 3267 O
years 17 22 3268 3273 O
or 23 25 3274 3276 O
older 26 31 3277 3282 O
, 31 32 3282 3283 O
as 33 35 3284 3286 O
no 36 38 3287 3289 O
dosing 39 45 3290 3296 O
or 46 48 3297 3299 O
adverse 49 56 3300 3307 O
event 57 62 3308 3313 O
data 63 67 3314 3318 O
are 68 71 3319 3322 O
currently 72 81 3323 3332 O
available 82 91 3333 3342 O
on 92 94 3343 3345 O
the 95 98 3346 3349 O
use 99 102 3350 3353 O
of 103 105 3354 3356 O
afatinib 106 114 3357 3365 B-treatment
in 115 117 3366 3368 O
patients 118 126 3369 3377 O
< 127 128 3378 3379 O
18 128 130 3379 3381 O
years 131 136 3382 3387 O
of 137 139 3388 3390 O
age 140 143 3391 3394 O

Patients 0 8 3395 3403 O
receiving 9 18 3404 3413 O
any 19 22 3414 3417 O
concurrent 23 33 3418 3428 O
anticancer 34 44 3429 3439 B-treatment
therapy 45 52 3440 3447 I-treatment
or 53 55 3448 3450 O
investigational 56 71 3451 3466 B-treatment
agents 72 78 3467 3473 I-treatment
with 79 83 3474 3478 O
the 84 87 3479 3482 O
intention 88 97 3483 3492 O
of 98 100 3493 3495 O
treating 101 109 3496 3504 O
esophagogastric 110 125 3505 3520 B-cancer
cancer 126 132 3521 3527 I-cancer
. 132 133 3527 3528 O
89Zr 134 138 3529 3533 B-treatment
- 138 139 3533 3534 I-treatment
trastuzumab 139 150 3534 3545 I-treatment
uses 151 155 3546 3550 O
as 156 158 3551 3553 O
imaging 159 166 3554 3561 O
agent 167 172 3562 3567 O
for 173 176 3568 3571 O
89Zr 177 181 3572 3576 O
- 181 182 3576 3577 O
trastuzumab 182 193 3577 3588 O
PET 194 197 3589 3592 B-treatment
permitted 198 207 3593 3602 O

Patients 0 8 3603 3611 O
who 9 12 3612 3615 O
are 13 16 3616 3619 O
unwilling 17 26 3620 3629 O
to 27 29 3630 3632 O
consent 30 37 3633 3640 O
to 38 40 3641 3643 O
mandatory 41 50 3644 3653 O
tumor 51 56 3654 3659 B-treatment
biopsy 57 63 3660 3666 I-treatment
. 63 64 3666 3667 O
Patients 65 73 3668 3676 O
with 74 78 3677 3681 O
archival 79 87 3682 3690 O
tissue 88 94 3691 3697 O
permitted 95 104 3698 3707 O
to 105 107 3708 3710 O
enroll 108 114 3711 3717 O
on 115 117 3718 3720 O
study 118 123 3721 3726 O
per 124 127 3727 3730 O
MSK 128 131 3731 3734 O
Principal 132 141 3735 3744 O
Investigator 142 154 3745 3757 O
discretion 155 165 3758 3768 O
Women 166 171 3769 3774 B-gender
who 172 175 3775 3778 O
are 176 179 3779 3782 B-pregnancy
pregnant 180 188 3783 3791 I-pregnancy
or 189 191 3792 3794 O
breast 192 198 3795 3801 O
feeding 199 206 3802 3809 O

Patients 0 8 3810 3818 O
who 9 12 3819 3822 O
have 13 17 3823 3827 O
previously 18 28 3828 3838 O
provided 29 37 3839 3847 O
samples 38 45 3848 3855 O
at 46 48 3856 3858 O
any 49 52 3859 3862 O
time 53 57 3863 3867 O
after 58 63 3868 3873 O
trastuzumab 64 75 3874 3885 B-treatment
resistance 76 86 3886 3896 O
will 87 91 3897 3901 O
be 92 94 3902 3904 O
exempt 95 101 3905 3911 O
from 102 106 3912 3916 O
biopsy 107 113 3917 3923 B-treatment
at 114 116 3924 3926 O
the 117 120 3927 3930 O
start 121 126 3931 3936 O
of 127 129 3937 3939 O
therapy 130 137 3940 3947 B-treatment

Previously 0 10 3948 3958 O
received 11 19 3959 3967 O
trastuzumab 20 31 3968 3979 B-treatment
as 32 34 3980 3982 O
part 35 39 3983 3987 O
of 40 42 3988 3990 O
a 43 44 3991 3992 O
regimen 45 52 3993 4000 O
in 53 55 4001 4003 O
the 56 59 4004 4007 O
perioperative 60 73 4008 4021 O
or 74 76 4022 4024 O
metastatic 77 87 4025 4035 B-cancer
setting 88 95 4036 4043 O
with 96 100 4044 4048 O
evidence 101 109 4049 4057 O
of 110 112 4058 4060 O
progression 113 124 4061 4072 O
9Zr 125 128 4073 4076 B-treatment
- 128 129 4076 4077 I-treatment
trastuzumab 129 140 4077 4088 I-treatment
use 141 144 4089 4092 O
as 145 147 4093 4095 O
imaging 148 155 4096 4103 O
agent 156 161 4104 4109 O
for 162 165 4110 4113 O
89Zr 166 170 4114 4118 B-treatment
- 170 171 4118 4119 I-treatment
trastuzumab 171 182 4119 4130 I-treatment
PET 183 186 4131 4134 O
permitted 187 196 4135 4144 O

Prior 0 5 4145 4150 O
disease 6 13 4151 4158 O
progression 14 25 4159 4170 O
on 26 28 4171 4173 O
docetaxel 29 38 4174 4183 B-treatment
or 39 41 4184 4186 O
paclitaxel 42 52 4187 4197 B-treatment
in 53 55 4198 4200 O
metastatic 56 66 4201 4211 B-treatment
setting 67 74 4212 4219 I-treatment

Significant 0 11 4220 4231 O
or 12 14 4232 4234 O
recent 15 21 4235 4241 O
acute 22 27 4242 4247 B-chronic_disease
gastrointestinal 28 44 4248 4264 I-chronic_disease
disorders 45 54 4265 4274 I-chronic_disease
with 55 59 4275 4279 O
diarrhea 60 68 4280 4288 B-chronic_disease
as 69 71 4289 4291 O
a 72 73 4292 4293 O
major 74 79 4294 4299 O
symptom 80 87 4300 4307 O
e.g. 88 92 4308 4312 O
, 92 93 4312 4313 O
Crohn 94 99 4314 4319 B-chronic_disease
's 99 101 4319 4321 I-chronic_disease
disease 102 109 4322 4329 I-chronic_disease
, 109 110 4329 4330 O
malabsorption 111 124 4331 4344 B-chronic_disease
, 124 125 4344 4345 O
or 126 128 4346 4348 O
CTCAEGrade 129 139 4349 4359 B-clinical_variable
> 140 141 4360 4361 O
2 141 142 4361 4362 B-lower_bound
diarrhea 143 151 4363 4371 O
of 152 154 4372 4374 O
any 155 158 4375 4378 O
etiology 159 167 4379 4387 O

The 0 3 4388 4391 O
use 4 7 4392 4395 O
of 8 10 4396 4398 O
potent 11 17 4399 4405 O
P 18 19 4406 4407 B-treatment
- 19 20 4407 4408 I-treatment
gp 20 22 4408 4410 I-treatment
inhibitors 23 33 4411 4421 I-treatment
( 34 35 4422 4423 O
including 35 44 4423 4432 O
cyclosporine 45 57 4433 4445 B-treatment
, 57 58 4445 4446 O
erythromycin 59 71 4447 4459 B-treatment
, 71 72 4459 4460 O
ketoconazole 73 85 4461 4473 B-treatment
, 85 86 4473 4474 O
itraconazole 87 99 4475 4487 B-treatment
, 99 100 4487 4488 O
quinidine 101 110 4489 4498 B-treatment
, 110 111 4498 4499 O
Phenobarbital 112 125 4500 4513 B-treatment
salt 126 130 4514 4518 I-treatment
with 131 135 4519 4523 I-treatment
quinidine 136 145 4524 4533 I-treatment
, 145 146 4533 4534 O
ritonavir 147 156 4535 4544 B-treatment
, 156 157 4544 4545 O
valspodar 158 167 4546 4555 B-treatment
, 167 168 4555 4556 O
verapamil 169 178 4557 4566 B-treatment
) 178 179 4566 4567 O
and 180 183 4568 4571 O
potent 184 190 4572 4578 O
P 191 192 4579 4580 B-treatment
- 192 193 4580 4581 I-treatment
gp 193 195 4581 4583 I-treatment
inducers 196 204 4584 4592 I-treatment
( 205 206 4593 4594 O
including 206 215 4594 4603 O
St 216 218 4604 4606 B-treatment
John 219 223 4607 4611 I-treatment
's 223 225 4611 4613 I-treatment
wort 226 230 4614 4618 I-treatment
, 230 231 4618 4619 O
rifampicin 232 242 4620 4630 B-treatment
) 242 243 4630 4631 O
has 244 247 4632 4635 O
to 248 250 4636 4638 O
be 251 253 4639 4641 O
avoided 254 261 4642 4649 O
during 262 268 4650 4656 O
treatment 269 278 4657 4666 B-treatment
with 279 283 4667 4671 I-treatment
afatinib 284 292 4672 4680 I-treatment

Willingness 0 11 4681 4692 B-contraception_consent
to 12 14 4693 4695 I-contraception_consent
use 15 18 4696 4699 I-contraception_consent
birth 19 24 4700 4705 I-contraception_consent
control 25 32 4706 4713 I-contraception_consent
while 33 38 4714 4719 O
on 39 41 4720 4722 O
study 42 47 4723 4728 O

Acute 0 5 0 5 B-chronic_disease
coronary 6 14 6 14 I-chronic_disease
syndrome 15 23 15 23 I-chronic_disease
( 24 25 24 25 O
defined 25 32 25 32 O
by 33 35 33 35 O
the 36 39 36 39 O
ACC 40 43 40 43 O
/ 43 44 43 44 O
AHA 44 47 44 47 O
criteria 48 56 48 56 O
, 56 57 56 57 O
Braunwald 58 67 58 67 O
2000 68 72 68 72 O
) 72 73 72 73 O

Age 0 3 74 77 B-age
> 4 5 78 79 O
18 6 8 80 82 B-lower_bound
years 9 14 83 88 I-lower_bound
old 15 18 89 92 O

Chest 0 5 93 98 B-chronic_disease
pain 6 10 99 103 I-chronic_disease
with 11 15 104 108 O
a 16 17 109 110 O
non 18 21 111 114 B-chronic_disease
- 21 22 114 115 I-chronic_disease
ischemic 22 30 115 123 I-chronic_disease
etiology 31 39 124 132 I-chronic_disease
( 40 41 133 134 O
e.g. 41 45 134 138 O
,pericarditis 45 58 138 151 O
, 58 59 151 152 O
pneumonia 60 69 153 162 B-chronic_disease
, 69 70 162 163 O
esophageal 71 81 164 174 B-chronic_disease
spasm 82 87 175 180 I-chronic_disease
) 87 88 180 181 O

Contraindications 0 17 182 199 O
to 18 20 200 202 O
adenosine 21 30 203 212 B-allergy_name
or 31 33 213 215 O
Regadenoson 34 45 216 227 B-allergy_name
( 46 47 228 229 I-allergy_name
Lexiscan 47 55 229 237 I-allergy_name
) 55 56 237 238 I-allergy_name

Documented 0 10 239 249 O
obstructive 11 22 250 261 B-chronic_disease
myocardiopathy 23 37 262 276 I-chronic_disease

Heart 0 5 277 282 B-chronic_disease
failure 6 13 283 290 I-chronic_disease
( 14 15 291 292 O
NYHA 15 19 292 296 B-clinical_variable
Class 20 25 297 302 I-clinical_variable
III 26 29 303 306 B-lower_bound
or 30 32 307 309 O
IV 33 35 310 312 B-upper_bound
on 36 38 313 315 O
treatment 39 48 316 325 B-treatment
) 48 49 325 326 O

LV 0 2 327 329 B-chronic_disease
dysfunction 3 14 330 341 I-chronic_disease

No 0 2 342 344 O
obstructive 3 14 345 356 O
coronary 15 23 357 365 B-chronic_disease
artery 24 30 366 372 I-chronic_disease
disease 31 38 373 380 I-chronic_disease
performed 39 48 381 390 O
within 49 55 391 397 O
the 56 59 398 401 O
previous 60 68 402 410 B-upper_bound
24 69 71 411 413 I-upper_bound
months 72 78 414 420 I-upper_bound
( 79 80 421 422 O
< 80 81 422 423 O
50 81 83 423 425 O
% 83 84 425 426 I-upper_bound
luminal 85 92 427 434 B-chronic_disease
obstruction 93 104 435 446 I-chronic_disease
in 105 107 447 449 O
one 108 111 450 453 B-lower_bound
or 112 114 454 456 O
more 115 119 457 461 O
coronary 120 128 462 470 O
arteries 129 137 471 479 O
on 138 140 480 482 O
angiography 141 152 483 494 B-treatment
) 152 153 494 495 O

Obstructive 0 11 496 507 B-clinical_variable
CAD 12 15 508 511 I-clinical_variable
≥ 16 17 512 513 O
50 18 20 514 516 B-lower_bound
% 20 21 516 517 I-lower_bound
luminal 22 29 518 525 I-lower_bound
diameter 30 38 526 534 I-lower_bound
stenosis 39 47 535 543 O
in 48 50 544 546 O
≥ 51 52 547 548 O
1 53 54 549 550 B-lower_bound
epicardial 55 65 551 561 I-lower_bound
coronary 66 74 562 570 I-lower_bound
artery 75 81 571 577 I-lower_bound

Patients 0 8 578 586 O
with 9 13 587 591 O
concurrent 14 24 592 602 O
cardiogenic 25 36 603 614 B-chronic_disease
shock 37 42 615 620 I-chronic_disease
or 43 45 621 623 O
requiring 46 55 624 633 O
inotropic 56 65 634 643 O
or 66 68 644 646 O
intra 69 74 647 652 B-treatment
- 74 75 652 653 I-treatment
aortic 75 81 653 659 I-treatment
balloon 82 89 660 667 I-treatment
support 90 97 668 675 I-treatment

Primary 0 7 676 683 O
valvular 8 16 684 692 B-chronic_disease
heart 17 22 693 698 I-chronic_disease
disease 23 30 699 706 I-chronic_disease
clearly 31 38 707 714 O
indicating 39 49 715 725 O
the 50 53 726 729 O
need 54 58 730 734 O
for 59 62 735 738 O
valve 63 68 739 744 B-treatment
repair 69 75 745 751 I-treatment
or 76 78 752 754 O
replacement 79 90 755 766 B-treatment

Prior 0 5 767 772 O
non 6 9 773 776 B-chronic_disease
- 9 10 776 777 I-chronic_disease
cardiac 10 17 777 784 I-chronic_disease
illness 18 25 785 792 I-chronic_disease
with 26 30 793 797 O
an 31 33 798 800 O
estimated 34 43 801 810 O
life 44 48 811 815 B-clinical_variable
expectancy 49 59 816 826 I-clinical_variable
< 60 61 827 828 O
4 61 62 828 829 B-upper_bound
years 63 68 830 835 I-upper_bound

Prior 0 5 836 841 O
or 6 8 842 844 O
planned 9 16 845 852 O
percutaneous 17 29 853 865 B-clinical_variable
coronary 30 38 866 874 I-clinical_variable
intervention 39 51 875 887 I-clinical_variable
or 52 54 888 890 O
CABG 55 59 891 895 B-treatment
or 60 62 896 898 O
prior 63 68 899 904 B-chronic_disease
acute 69 74 905 910 I-chronic_disease
MI 75 77 911 913 I-chronic_disease
in 78 80 914 916 O
prior 81 86 917 922 O
30 87 89 923 925 B-upper_bound
days 90 94 926 930 I-upper_bound

Women 0 5 931 936 B-gender
and 6 9 937 940 O
men 10 13 941 944 O
with 14 18 945 949 O
intermediate 19 31 950 962 B-chronic_disease
coronary 32 40 963 971 I-chronic_disease
stenoses 41 49 972 980 I-chronic_disease
( 50 51 981 982 O
> 51 52 982 983 O
20 52 54 983 985 B-lower_bound
% 54 55 985 986 I-lower_bound
but 56 59 987 990 O
< 60 61 991 992 O
50 61 63 992 994 B-upper_bound
% 63 64 994 995 I-upper_bound
luminal 65 72 996 1003 B-clinical_variable
diameter 73 81 1004 1012 I-clinical_variable
stenosis 82 90 1013 1021 I-clinical_variable
assessed 91 99 1022 1030 O
visually 100 108 1031 1039 O
at 109 111 1040 1042 O
the 112 115 1043 1046 O
time 116 120 1047 1051 O
of 121 123 1052 1054 O
angiography 124 135 1055 1066 O
) 135 136 1066 1067 O
will 137 141 1068 1072 O
undergo 142 149 1073 1080 O
clinically 150 160 1081 1091 O
indicated 161 170 1092 1101 O
IVUS 171 175 1102 1106 O
testing 176 183 1107 1114 O
based 184 189 1115 1120 O
on 190 192 1121 1123 O
the 193 196 1124 1127 O
judgment 197 205 1128 1136 O
of 206 208 1137 1139 O
the 209 212 1140 1143 O
operator 213 221 1144 1152 O
; 221 222 1152 1153 O
those 223 228 1154 1159 O
determined 229 239 1160 1170 O
to 240 242 1171 1173 O
have 243 247 1174 1178 O
flow 248 252 1179 1183 O
FFR 253 256 1184 1187 O
or 257 259 1188 1190 O
obstructing 260 271 1191 1202 O
stenosis 272 280 1203 1211 O
will 281 285 1212 1216 O
be 286 288 1217 1219 O
excluded 289 297 1220 1228 O
from 298 302 1229 1233 O
the 303 306 1234 1237 O
overall 307 314 1238 1245 O
study 315 320 1246 1251 O

Women 0 5 1252 1257 B-gender
and 6 9 1258 1261 I-gender
men 10 13 1262 1265 I-gender
with 14 18 1266 1270 O
signs 19 24 1271 1276 O
and 25 28 1277 1280 O
symptoms 29 37 1281 1289 O
of 38 40 1290 1292 O
myocardial 41 51 1293 1303 B-chronic_disease
ischemia 52 60 1304 1312 I-chronic_disease
and 61 64 1313 1316 O
angina 65 71 1317 1323 B-chronic_disease
or 72 74 1324 1326 O
angina 75 81 1327 1333 O
equivalent 82 92 1334 1344 O
( 93 94 1345 1346 O
chest 94 99 1346 1351 B-chronic_disease
pain 100 104 1352 1356 I-chronic_disease
, 104 105 1356 1357 O
abnormal 106 114 1358 1366 O
stress 115 121 1367 1373 B-treatment
testing 122 129 1374 1381 I-treatment
, 129 130 1381 1382 O
abnormal 131 139 1383 1391 O
noninvasive 140 151 1392 1403 B-treatment
testing 152 159 1404 1411 I-treatment
) 159 160 1411 1412 O
or 161 163 1413 1415 O
microvascular 164 177 1416 1429 B-chronic_disease
angina 178 184 1430 1436 I-chronic_disease
( 185 186 1437 1438 I-chronic_disease
MVA 186 189 1438 1441 I-chronic_disease
) 189 190 1441 1442 I-chronic_disease
which 191 196 1443 1448 O
is 197 199 1449 1451 O
defined 200 207 1452 1459 O
as 208 210 1460 1462 O
angina 211 217 1463 1469 O
and 218 221 1470 1473 O
ischemic 222 230 1474 1482 O
ECG 231 234 1483 1486 B-treatment
changes 235 242 1487 1494 O
without 243 250 1495 1502 O
organic 251 258 1503 1510 O
obstructive 259 270 1511 1522 O
stenosis 271 279 1523 1531 O
or 280 282 1532 1534 O
epicardial 283 293 1535 1545 O
spasm 294 299 1546 1551 O
of 300 302 1552 1554 O
the 303 306 1555 1558 O
coronary 307 315 1559 1567 O
arteries 316 324 1568 1576 O

ejection 0 8 1577 1585 B-clinical_variable
fraction 9 17 1586 1594 I-clinical_variable
< 18 19 1595 1596 O
40 19 21 1596 1598 B-upper_bound
% 21 22 1598 1599 I-upper_bound

A 0 1 0 1 O
psychiatric 2 13 2 13 B-chronic_disease
disorder 14 22 14 22 I-chronic_disease
, 22 23 22 23 O
other 24 29 24 29 O
than 30 34 30 34 O
mild 35 39 35 39 B-chronic_disease
depression 40 50 40 50 I-chronic_disease
; 50 51 50 51 O
e.g. 52 56 52 56 O
schizophrenia 57 70 57 70 B-chronic_disease
, 70 71 70 71 O
bipolar 72 79 72 79 B-chronic_disease
disorder 80 88 80 88 I-chronic_disease
, 88 89 88 89 O
major 90 95 90 95 B-chronic_disease
depression 96 106 96 106 I-chronic_disease
, 106 107 106 107 O
panic 108 113 108 113 O
or 114 116 114 116 O
anxiety 117 124 117 124 B-chronic_disease
disorders 125 134 125 134 I-chronic_disease

Abnormal 0 8 135 143 O
lung 9 13 144 148 O
function 14 22 149 157 O
( 23 24 158 159 O
FEV1 24 28 159 163 B-clinical_variable
and 29 32 164 167 O
FVC 33 36 168 171 B-clinical_variable
< 37 38 172 173 O
80 39 41 174 176 B-upper_bound
% 41 42 176 177 I-upper_bound
predicted 43 52 178 187 O
) 52 53 187 188 O

Ages 0 4 189 193 B-age
18 5 7 194 196 B-lower_bound
- 7 8 196 197 O
70 8 10 197 199 B-upper_bound
years 11 16 200 205 I-upper_bound

Any 0 3 206 209 O
known 4 9 210 215 O
cardiac 10 17 216 223 B-chronic_disease
( 18 19 224 225 O
apart 19 24 225 230 O
from 25 29 231 235 O
treated 30 37 236 243 O
hypertension 38 50 244 256 B-chronic_disease
with 51 55 257 261 O
acceptable 56 66 262 272 O
drugs 67 72 273 278 O
, 72 73 278 279 O
see 74 77 280 283 O
below 78 83 284 289 O
) 83 84 289 290 O
, 84 85 290 291 O
pulmonary 86 95 292 301 B-chronic_disease
( 96 97 302 303 O
including 97 106 303 312 O
asthma 107 113 313 319 B-chronic_disease
) 113 114 319 320 O
, 114 115 320 321 O
renal 116 121 322 327 B-chronic_disease
, 121 122 327 328 O
neurologic 123 133 329 339 B-chronic_disease
( 134 135 340 341 O
including 135 144 341 350 O
epilepsy 145 153 351 359 B-chronic_disease
) 153 154 359 360 O
, 154 155 360 361 O
neuromuscular 156 169 362 375 B-chronic_disease
, 169 170 375 376 O
hepatic 171 178 377 384 B-chronic_disease
disease 179 186 385 392 I-chronic_disease
, 186 187 392 393 O
or 188 190 394 396 O
patients 191 199 397 405 O
with 200 204 406 410 O
diabetes 205 213 411 419 B-chronic_disease

Females 0 7 420 427 B-gender

History 0 7 428 435 O
of 8 10 436 438 O
driving 11 18 439 446 O
or 19 21 447 449 O
other 22 27 450 455 O
accidents 28 37 456 465 O
due 38 41 466 469 O
to 42 44 470 472 O
sleepiness 45 55 473 483 O
or 56 58 484 486 O
an 59 61 487 489 O
ESS 62 65 490 493 B-clinical_variable
> 66 67 494 495 O
18 68 70 496 498 B-lower_bound

Male 0 4 499 503 B-gender

More 0 4 504 508 O
than 5 9 509 513 O
10 10 12 514 516 B-lower_bound
cups 13 17 517 521 O
of 18 20 522 524 O
beverages 21 30 525 534 O
with 31 35 535 539 O
caffeine 36 44 540 548 O
( 45 46 549 550 O
coffee 46 52 550 556 O
, 52 53 556 557 O
tea 54 57 558 561 O
, 57 58 561 562 O
soda 59 63 563 567 O
/ 63 64 567 568 O
pop 64 67 568 571 O
) 67 68 571 572 O
per 69 72 573 576 O
day 73 76 577 580 O

No 0 2 581 583 O
other 3 8 584 589 O
sleep 9 14 590 595 B-chronic_disease
disorders 15 24 596 605 I-chronic_disease

Prior 0 5 606 611 B-treatment
or 6 8 612 614 I-treatment
current 9 16 615 622 I-treatment
use 17 20 623 626 I-treatment
of 21 23 627 629 I-treatment
melatonin 24 33 630 639 I-treatment

Severe 0 6 640 646 B-chronic_disease
OSA 7 10 647 650 I-chronic_disease
( 11 12 651 652 O
≥30 12 15 652 655 O
apnea 16 21 656 661 B-clinical_variable
hypopnea 22 30 662 670 I-clinical_variable
index 31 36 671 676 I-clinical_variable
) 36 37 676 677 O

Smokers 0 7 678 685 O
( 8 9 686 687 O
quit 9 13 687 691 O
≥ 14 15 692 693 O
1 16 17 694 695 B-lower_bound
year 18 22 696 700 I-lower_bound
ago 23 26 701 704 O
acceptable 27 37 705 715 O
) 37 38 715 716 O

Substantial 0 11 717 728 O
alcohol 12 19 729 736 O
( 20 21 737 738 O
> 21 22 738 739 O
3oz 22 25 739 742 B-lower_bound
/ 25 26 742 743 I-lower_bound
day 26 29 743 746 I-lower_bound
) 29 30 746 747 O
or 31 33 748 750 O
use 34 37 751 754 O
of 38 40 755 757 O
illicit 41 48 758 765 O
drugs 49 54 766 771 O

Use 0 3 772 775 O
of 4 6 776 778 O
any 7 10 779 782 O
medications 11 22 783 794 B-treatment
that 23 27 795 799 O
may 28 31 800 803 O
affect 32 38 804 810 O
sleep 39 44 811 816 O
or 45 47 817 819 O
breathing 48 57 820 829 O

Use 0 3 830 833 O
of 4 6 834 836 O
serotonin 7 16 837 846 B-treatment
reuptake 17 25 847 855 I-treatment
inhibitors 26 36 856 866 I-treatment
, 36 37 866 867 O
serotonin 38 47 868 877 B-treatment
- 47 48 877 878 I-treatment
norepinephrine 48 62 878 892 I-treatment
reuptake 63 71 893 901 I-treatment
inhibitors 72 82 902 912 I-treatment
, 82 83 912 913 O
ACE 84 87 914 917 B-treatment
inhibitors 88 98 918 928 I-treatment
or 99 101 929 931 O
any 102 105 932 935 O
drugs 106 111 936 941 O
which 112 117 942 947 O
interfere 118 127 948 957 O
with 128 132 958 962 O
the 133 136 963 966 O
renin 137 142 967 972 O
- 142 143 972 973 O
Angiotensin 143 154 973 984 O
system 155 161 985 991 O
, 161 162 991 992 O
Losartan 163 171 993 1001 B-treatment
( 172 173 1002 1003 O
or 173 175 1003 1005 O
other 176 181 1006 1011 O
Angiotensin 182 193 1012 1023 B-treatment
II 194 196 1024 1026 I-treatment
type 197 201 1027 1031 I-treatment
1 202 203 1032 1033 I-treatment
receptor 204 212 1034 1042 I-treatment
antagonists 213 224 1043 1054 I-treatment
) 224 225 1054 1055 O
, 225 226 1055 1056 O
non 227 230 1057 1060 B-treatment
- 230 231 1060 1061 I-treatment
specific 231 239 1061 1069 I-treatment
calcium 240 247 1070 1077 I-treatment
channel 248 255 1078 1085 I-treatment
blockers 256 264 1086 1094 I-treatment
( 265 266 1095 1096 O
L 266 267 1096 1097 O
channel 268 275 1098 1105 O
specific 276 284 1106 1114 O
are 285 288 1115 1118 O
acceptable 289 299 1119 1129 O
) 299 300 1129 1130 O
, 300 301 1130 1131 O
anti 302 306 1132 1136 B-treatment
- 306 307 1136 1137 I-treatment
inflammatories 307 321 1137 1151 I-treatment
, 321 322 1151 1152 O
vitamins 323 331 1153 1161 B-treatment
or 332 334 1162 1164 O
any 335 338 1165 1168 O
antioxidants 339 351 1169 1181 B-treatment

initiating 0 10 0 10 O
radiotherapy 11 23 11 23 B-treatment
for 24 27 24 27 O
HNC 28 31 28 31 B-cancer

patient 0 7 32 39 O
has 8 11 40 43 O
Karnofsky 12 21 44 53 B-clinical_variable
score 22 27 54 59 I-clinical_variable
> 28 29 60 61 O
50 30 32 62 64 B-lower_bound
( 33 34 65 66 O
ambulatory 34 44 66 76 O
& 45 46 77 78 O
capable 47 54 79 86 O
of 55 57 87 89 O
self 58 62 90 94 O
- 62 63 94 95 O
care 63 67 95 99 O
) 67 68 99 100 O

patient 0 7 101 108 O
/ 7 8 108 109 O
partner 8 15 109 116 O
can 16 19 117 120 B-language_fluency
not 19 22 120 123 I-language_fluency
read 23 27 124 128 I-language_fluency
or 28 30 129 131 I-language_fluency
communicate 31 42 132 143 I-language_fluency
using 43 48 144 149 I-language_fluency
spoken 49 55 150 156 I-language_fluency
English 56 63 157 164 I-language_fluency

patient 0 7 165 172 O
/ 7 8 172 173 O
partner 8 15 173 180 O
is 16 18 181 183 O
> 19 20 184 185 O
age 21 24 186 189 B-age
18 25 27 190 192 B-lower_bound

pregnant 0 8 193 201 B-pregnancy
women 9 14 202 207 B-gender

All 0 3 0 3 O
patients 4 12 4 12 O
undergoing 13 23 13 23 O
pelvic 24 30 24 30 B-treatment
reconstructive 31 45 31 45 I-treatment
surgery 46 53 46 53 I-treatment
/ 53 54 53 54 O
anti 54 58 54 58 B-treatment
- 58 59 58 59 I-treatment
incontinence 59 71 59 71 I-treatment
procedures 72 82 72 82 I-treatment
who 83 86 83 86 O
are 87 90 87 90 O
planned 91 98 91 98 O
to 99 101 99 101 O
be 102 104 102 104 O
discharged 105 115 105 115 O
home 116 120 116 120 O
with 121 125 121 125 O
a 126 127 126 127 O
catheter 128 136 128 136 O

Dementia 0 8 137 145 B-chronic_disease
/ 9 10 146 147 O
altered 11 18 148 155 B-chronic_disease
cognitive 19 28 156 165 I-chronic_disease
function 29 37 166 174 I-chronic_disease

Intra 0 5 175 180 B-chronic_disease
- 5 6 180 181 I-chronic_disease
operative 6 15 181 190 I-chronic_disease
bladder 16 23 191 198 I-chronic_disease
injury 24 30 199 205 I-chronic_disease
during 31 37 206 212 O
index 38 43 213 218 B-treatment
surgery 44 51 219 226 I-treatment

For 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
metastatic 18 28 18 28 B-cancer
renal 29 34 29 34 I-cancer
tumors 35 41 35 41 I-cancer
to 42 44 42 44 O
be 45 47 45 47 O
enrolled 48 56 48 56 O
, 56 57 56 57 O
a 58 59 58 59 O
histologic 60 70 60 70 O
diagnosis 71 80 71 80 O
of 81 83 81 83 O
renal 84 89 84 89 B-cancer
cell 90 94 90 94 I-cancer
carcinoma 95 104 95 104 I-cancer
must 105 109 105 109 O
exist 110 115 110 115 O
and 116 119 116 119 O
any 120 123 120 123 O
burden 124 130 124 130 O
of 131 133 131 133 O
disease 134 141 134 141 O
> 142 143 142 143 O
= 143 144 143 144 O
1 145 146 145 146 B-lower_bound
cm 147 149 147 149 I-lower_bound
by 150 152 150 152 O
CT 153 155 153 155 B-treatment
or 156 158 156 158 O
MRI 159 162 159 162 B-treatment
is 163 165 163 165 O
acceptable 166 176 166 176 O
; 176 177 176 177 O
the 178 181 178 181 O
metastatic 182 192 182 192 O
sites 193 198 193 198 O
may 199 202 199 202 O
be 203 205 203 205 O
kidney 206 212 206 212 O
, 212 213 212 213 O
intra 214 219 214 219 O
- 219 220 219 220 O
abdominal 220 229 220 229 O
( 230 231 230 231 O
such 231 235 231 235 O
as 236 238 236 238 O
liver 239 244 239 244 O
) 244 245 244 245 O
, 245 246 245 246 O
brain 247 252 247 252 O
, 252 253 252 253 O
bone 254 258 254 258 O
, 258 259 258 259 O
or 260 262 260 262 O
lymph 263 268 263 268 O
nodes 269 274 269 274 O
; 274 275 274 275 O
lung 276 280 276 280 O
lesions 281 288 281 288 O
are 289 292 289 292 O
NOT 293 296 293 296 O
eligible 297 305 297 305 O
because 306 313 306 313 O
of 314 316 314 316 O
the 317 320 317 320 O
motion 321 327 321 327 O
artifact 328 336 328 336 O
caused 337 343 337 343 O
by 344 346 344 346 O
respiration 347 358 347 358 O

For 0 3 359 362 O
patients 4 12 363 371 O
with 13 17 372 376 O
organ 18 23 377 382 O
confined 24 32 383 391 O
renal 33 38 392 397 O
tumors 39 45 398 404 B-cancer
to 46 48 405 407 O
be 49 51 408 410 O
enrolled 52 60 411 419 O
, 60 61 419 420 O
the 62 65 421 424 O
renal 66 71 425 430 B-clinical_variable
mass 72 76 431 435 I-clinical_variable
must 77 81 436 440 O
be 82 84 441 443 O
> 85 86 444 445 O
= 86 87 445 446 O
1 88 89 447 448 B-lower_bound
cm 90 92 449 451 I-lower_bound
in 93 95 452 454 I-lower_bound
diameter 96 104 455 463 I-lower_bound
on 105 107 464 466 O
computed 108 116 467 475 B-treatment
tomography 117 127 476 486 I-treatment
( 128 129 487 488 I-treatment
CT 129 131 488 490 I-treatment
) 131 132 490 491 I-treatment
or 133 135 492 494 O
magnetic 136 144 495 503 B-clinical_variable
resonance 145 154 504 513 I-clinical_variable
imaging 155 162 514 521 I-clinical_variable
( 163 164 522 523 I-clinical_variable
MRI 164 167 523 526 I-clinical_variable
) 167 168 526 527 I-clinical_variable
and 169 172 528 531 O
can 173 176 532 535 O
be 177 179 536 538 O
any 180 183 539 542 O
clinical 184 192 543 551 O
stage 193 198 552 557 O
T1a 199 202 558 561 B-lower_bound
- 202 203 561 562 O
T4 203 205 562 564 B-upper_bound
( 206 207 565 566 O
non 207 210 566 569 O
- 210 211 569 570 O
metastatic 211 221 570 580 O
) 221 222 580 581 O
; 222 223 581 582 O
a 224 225 583 584 O
histologic 226 236 585 595 O
diagnosis 237 246 596 605 O
is 247 249 606 608 O
not 250 253 609 612 O
required 254 262 613 621 O
for 263 266 622 625 O
enrollment 267 277 626 636 O
; 277 278 636 637 O
the 279 282 638 641 O
primary 283 290 642 649 O
imaging 291 298 650 657 O
site 299 303 658 662 O
would 304 309 663 668 O
be 310 312 669 671 O
kidney 313 319 672 678 O

Negative 0 8 679 687 B-pregnancy
pregnancy 9 18 688 697 I-pregnancy
test 19 23 698 702 O
if 24 26 703 705 O
female 27 33 706 712 B-gender
of 34 36 713 715 O
child 37 42 716 721 O
- 42 43 721 722 O
bearing 43 50 722 729 O
age 51 54 730 733 B-age

Patients 0 8 734 742 O
with 9 13 743 747 O
metastatic 14 24 748 758 B-cancer
disease 25 32 759 766 I-cancer
may 33 36 767 770 O
have 37 41 771 775 O
received 42 50 776 784 O
prior 51 56 785 790 B-treatment
nephrectomy 57 68 791 802 I-treatment
and/or 69 75 803 809 O
prior 76 81 810 815 B-treatment
systemic 82 90 816 824 I-treatment
therapy 91 98 825 832 I-treatment
( 99 100 833 834 O
no 100 102 834 836 O
limit 103 108 837 842 O
on 109 111 843 845 O
number 112 118 846 852 O
) 118 119 852 853 O
; 119 120 853 854 O
their 121 126 855 860 O
baseline 127 135 861 869 O
pMRI 136 140 870 874 O
would 141 146 875 880 O
be 147 149 881 883 O
performed 150 159 884 893 O
prior 160 165 894 899 O
to 166 168 900 902 O
starting 169 177 903 911 O
a 178 179 912 913 O
new 180 183 914 917 O
treatment 184 193 918 927 B-treatment

Severe 0 6 928 934 O
concurrent 7 17 935 945 B-chronic_disease
disease 18 25 946 953 I-chronic_disease
, 25 26 953 954 O
infection 27 36 955 964 B-chronic_disease
, 36 37 964 965 O
or 38 40 966 968 O
medical 41 48 969 976 O
co 49 51 977 979 O
- 51 52 979 980 O
morbidity 52 61 980 989 O
that 62 66 990 994 O
, 66 67 994 995 O
in 68 70 996 998 O
the 71 74 999 1002 O
judgment 75 83 1003 1011 O
of 84 86 1012 1014 O
the 87 90 1015 1018 O
investigator 91 103 1019 1031 O
, 103 104 1031 1032 O
would 105 110 1033 1038 O
make 111 115 1039 1043 O
the 116 119 1044 1047 O
patient 120 127 1048 1055 O
inappropriate 128 141 1056 1069 O
for 142 145 1070 1073 O
enrollment 146 156 1074 1084 O

Severe 0 6 1085 1091 B-chronic_disease
renal 7 12 1092 1097 I-chronic_disease
function 13 21 1098 1106 I-chronic_disease
impairment 22 32 1107 1117 I-chronic_disease
( 33 34 1118 1119 O
estimated 34 43 1119 1128 B-clinical_variable
glomerular 44 54 1129 1139 I-clinical_variable
filtration 55 65 1140 1150 I-clinical_variable
rate 66 70 1151 1155 I-clinical_variable
[ 71 72 1156 1157 I-clinical_variable
eGFR 72 76 1157 1161 I-clinical_variable
] 76 77 1161 1162 I-clinical_variable
< 78 79 1163 1164 O
45 80 82 1165 1167 B-upper_bound
mL 83 85 1168 1170 I-upper_bound
/ 85 86 1170 1171 I-upper_bound
min/1.73 86 94 1171 1179 I-upper_bound
m^2 95 98 1180 1183 I-upper_bound
) 98 99 1183 1184 O
would 100 105 1185 1190 O
make 106 110 1191 1195 O
the 111 114 1196 1199 O
patient 115 122 1200 1207 O
inappropriate 123 136 1208 1221 O
for 137 140 1222 1225 O
enrollment 141 151 1226 1236 O
due 152 155 1237 1240 O
to 156 158 1241 1243 O
the 159 162 1244 1247 O
increased 163 172 1248 1257 O
risk 173 177 1258 1262 O
of 178 180 1263 1265 O
nephrogenic 181 192 1266 1277 B-chronic_disease
systemic 193 201 1278 1286 I-chronic_disease
fibrosis 202 210 1287 1295 I-chronic_disease
( 211 212 1296 1297 I-chronic_disease
NSF 212 215 1297 1300 I-chronic_disease
) 215 216 1300 1301 I-chronic_disease
with 217 221 1302 1306 O
higher 222 228 1307 1313 O
dose 229 233 1314 1318 O
of 234 236 1319 1321 O
IV 237 239 1322 1324 B-treatment
gadolinium 240 250 1325 1335 I-treatment
- 250 251 1335 1336 I-treatment
based 251 256 1336 1341 I-treatment
contrast 257 265 1342 1350 I-treatment
agents 266 272 1351 1357 I-treatment
( 273 274 1358 1359 I-treatment
GBCA 274 278 1359 1363 I-treatment
) 278 279 1363 1364 I-treatment
administration 280 294 1365 1379 O

Subjects 0 8 1380 1388 O
who 9 12 1389 1392 O
are 13 16 1393 1396 O
unable 17 23 1397 1403 O
to 24 26 1404 1406 O
tolerate 27 35 1407 1415 O
or 36 38 1416 1418 O
are 39 42 1419 1422 O
not 43 46 1423 1426 O
eligible 47 55 1427 1435 O
for 56 59 1436 1439 O
MR 60 62 1440 1442 O
imaging 63 70 1443 1450 O
( 71 72 1451 1452 O
claustrophobia 72 86 1452 1466 B-chronic_disease
, 86 87 1466 1467 O
metal 88 93 1468 1473 O
implantable 94 105 1474 1485 O
devices 106 113 1486 1493 O
such 114 118 1494 1498 O
as 119 121 1499 1501 O
pacemaker 122 131 1502 1511 B-treatment
, 131 132 1511 1512 O
aneurysm 133 141 1513 1521 B-treatment
clips 142 147 1522 1527 I-treatment
, 147 148 1527 1528 O
etc 149 152 1529 1532 O
) 152 153 1532 1533 O

Subjects 0 8 1534 1542 O
with 9 13 1543 1547 O
established 14 25 1548 1559 O
allergy 26 33 1560 1567 O
to 34 36 1568 1570 O
IV 37 39 1571 1573 B-allergy_name
GBCA 40 44 1574 1578 I-allergy_name

Women 0 5 1579 1584 B-gender
who 6 9 1585 1588 O
are 10 13 1589 1592 B-pregnancy
pregnant 14 22 1593 1601 I-pregnancy

( 0 1 0 1 O
MDD 1 4 1 4 B-chronic_disease
is 5 7 5 7 O
not 8 11 8 11 O
contraindicated 12 27 12 27 O
when 28 32 28 32 O
HDRS-21≤26 33 43 33 43 B-clinical_variable
) 43 44 43 44 O

22 0 2 45 47 B-lower_bound
- 2 3 47 48 O
68 3 5 48 50 B-upper_bound
years 6 11 51 56 I-upper_bound
of 12 14 57 59 O
age 15 18 60 63 B-age

Any 0 3 64 67 O
condition 4 13 68 77 O
likely 14 20 78 84 O
to 21 23 85 87 O
be 24 26 88 90 O
associated 27 37 91 101 O
with 38 42 102 106 O
increased 43 52 107 116 B-chronic_disease
intracranial 53 65 117 129 I-chronic_disease
pressure 66 74 130 138 I-chronic_disease

Cerebral 0 8 139 147 B-chronic_disease
aneurysm 9 17 148 156 I-chronic_disease

Criteria 0 8 157 165 O
D 9 10 166 167 O
: 10 11 167 168 O
at 12 14 169 171 O
least 15 20 172 177 O
2/7 21 24 178 181 B-lower_bound
cognition 25 34 182 191 O
& 35 36 192 193 O
mood 37 41 194 198 O
symptoms 42 50 199 207 O

Criteria 0 8 208 216 O
E 9 10 217 218 O
: 10 11 218 219 O
at 12 14 220 222 O
least 15 20 223 228 O
2/6 21 24 229 232 B-lower_bound
arousal 25 32 233 240 O
& 33 34 241 242 O
reactivity 35 45 243 253 O
symptoms 46 54 254 262 O

Criterion 0 9 263 272 O
B 10 11 273 274 O
: 11 12 274 275 O
at 13 15 276 278 O
least 16 21 279 284 O
1/5 22 25 285 288 B-lower_bound
intrusion 26 35 289 298 O
symptoms 36 44 299 307 O

History 0 7 308 315 O
of 8 10 316 318 O
cerebrovascular 11 26 319 334 B-chronic_disease
accident 27 35 335 343 I-chronic_disease

Huntington 0 10 344 354 B-chronic_disease
's 10 12 354 356 I-chronic_disease
chorea 13 19 357 363 I-chronic_disease

MMSE 0 4 364 368 B-clinical_variable
≤ 5 6 369 370 O
24 7 9 371 373 B-upper_bound

Men 0 3 374 377 B-gender

Multiple 0 8 378 386 B-chronic_disease
sclerosis 9 18 387 396 I-chronic_disease

Negative 0 8 397 405 B-pregnancy
pregnancy 9 18 406 415 I-pregnancy
test 19 23 416 420 O
in 24 26 421 423 O
childbearing 27 39 424 436 O
age 40 43 437 440 B-age
women 44 49 441 446 B-gender

Parkinson 0 9 447 456 B-chronic_disease
's 9 11 456 458 I-chronic_disease
disease 12 19 459 466 I-chronic_disease

Subject 0 7 467 474 O
diagnosed 8 17 475 484 O
according 18 27 485 494 O
to 28 30 495 497 O
the 31 34 498 501 O
SCID 35 39 502 506 O
I 40 41 507 508 O
as 42 44 509 511 O
suffering 45 54 512 521 O
from 55 59 522 526 O
any 60 63 527 530 O
other 64 69 531 536 O
major 70 75 537 542 B-chronic_disease
Axis 76 80 543 547 I-chronic_disease
I 81 82 548 549 I-chronic_disease
disorder 83 91 550 558 I-chronic_disease
, 91 92 558 559 O
such 93 97 560 564 O
as 98 100 565 567 O
Psychotic 101 110 568 577 B-chronic_disease
Disorder 111 119 578 586 I-chronic_disease
, 119 120 586 587 O
Bipolar 121 128 588 595 B-chronic_disease
affective 129 138 596 605 I-chronic_disease
disorder 139 147 606 614 I-chronic_disease
, 147 148 614 615 O
OCD 149 152 616 619 B-chronic_disease

Subject 0 7 620 627 O
has 8 11 628 631 O
a 12 13 632 633 O
history 14 21 634 641 O
of 22 24 642 644 O
cranial 25 32 645 652 B-treatment
surgery 33 40 653 660 I-treatment

Subject 0 7 661 668 O
has 8 11 669 672 O
a 12 13 673 674 O
history 14 21 675 682 O
of 22 24 683 685 O
epilepsy 25 33 686 694 B-chronic_disease
or 34 36 695 697 O
seizure 37 44 698 705 B-chronic_disease

Subject 0 7 706 713 O
has 8 11 714 717 O
a 12 13 718 719 O
history 14 21 720 727 O
of 22 24 728 730 O
significant 25 36 731 742 O
head 37 41 743 747 B-chronic_disease
trauma 42 48 748 754 I-chronic_disease
with 49 53 755 759 O
loss 54 58 760 764 O
of 59 61 765 767 O
consciousness 62 75 768 781 O
for 76 79 782 785 O
longer 80 86 786 792 O
than 87 91 793 797 O
5 92 93 798 799 B-lower_bound
minutes 94 101 800 807 I-lower_bound

Subject 0 7 808 815 O
has 8 11 816 819 O
a 12 13 820 821 O
history 14 21 822 829 O
of 22 24 830 832 O
significant 25 36 833 844 O
hearing 37 44 845 852 B-chronic_disease
loss 45 49 853 857 I-chronic_disease

Subject 0 7 858 865 O
has 8 11 866 869 O
had 12 15 870 873 O
previous 16 24 874 882 O
treatment 25 34 883 892 O
with 35 39 893 897 O
TMS 40 43 898 901 B-treatment

Subject 0 7 902 909 O
has 8 11 910 913 O
metallic 12 20 914 922 O
particles 21 30 923 932 O
in 31 33 933 935 O
the 34 37 936 939 O
eye 38 41 940 943 O
or 42 44 944 946 O
head 45 49 947 951 O
( 50 51 952 953 O
exclusive 51 60 953 962 O
of 61 63 963 965 O
mouth 64 69 966 971 O
) 69 70 971 972 O
, 70 71 972 973 O
implanted 72 81 974 983 B-treatment
cardiac 82 89 984 991 I-treatment
pacemaker 90 99 992 1001 I-treatment
or 100 102 1002 1004 O
any 103 106 1005 1008 O
intra 107 112 1009 1014 B-treatment
- 112 113 1014 1015 I-treatment
cardiac 113 120 1015 1022 I-treatment
lines 121 126 1023 1028 I-treatment
, 126 127 1028 1029 O
implanted 128 137 1030 1039 B-treatment
neurostimulators 138 154 1040 1056 I-treatment
, 154 155 1056 1057 O
intra 156 161 1058 1063 B-treatment
- 161 162 1063 1064 I-treatment
cranial 162 169 1064 1071 I-treatment
implants 170 178 1072 1080 I-treatment
( 179 180 1081 1082 O
e.g. 180 184 1082 1086 O
, 184 185 1086 1087 O
aneurysm 186 194 1088 1096 B-treatment
clips 195 200 1097 1102 I-treatment
, 200 201 1102 1103 O
shunts 202 208 1104 1110 B-treatment
, 208 209 1110 1111 O
stimulators 210 221 1112 1123 O
, 221 222 1123 1124 O
cochlear 223 231 1125 1133 B-treatment
implants 232 240 1134 1142 I-treatment
, 240 241 1142 1143 O
or 242 244 1144 1146 O
electrodes 245 255 1147 1157 B-treatment
) 255 256 1157 1158 O
or 257 259 1159 1161 O
implanted 260 269 1162 1171 B-treatment
medical 270 277 1172 1179 I-treatment
pumps 278 283 1180 1185 I-treatment

Subject 0 7 1186 1193 O
is 8 10 1194 1196 O
able 11 15 1197 1201 O
to 16 18 1202 1204 O
adhere 19 25 1205 1211 O
to 26 28 1212 1214 O
the 29 32 1215 1218 O
treatment 33 42 1219 1228 B-treatment
schedule 43 51 1229 1237 O

Subject 0 7 1238 1245 O
is 8 10 1246 1248 O
currently 11 20 1249 1258 O
on 21 23 1259 1261 O
Benzodiazepine 24 38 1262 1276 B-treatment
at 39 41 1277 1279 O
a 42 43 1280 1281 O
dose 44 48 1282 1286 O
higher 49 55 1287 1293 O
than 56 60 1294 1298 O
3 61 62 1299 1300 B-lower_bound
mg 63 65 1301 1303 I-lower_bound
of 66 68 1304 1306 O
Lorazepam 69 78 1307 1316 B-clinical_variable
or 79 81 1317 1319 O
equivalent 82 92 1320 1330 O

Subject 0 7 1331 1338 O
is 8 10 1339 1341 O
currently 11 20 1342 1351 O
participating 21 34 1352 1365 O
in 35 37 1366 1368 O
another 38 45 1369 1376 B-treatment
clinical 46 54 1377 1385 I-treatment
study 55 60 1386 1391 I-treatment
or 61 63 1392 1394 O
enrolled 64 72 1395 1403 O
in 73 75 1404 1406 O
another 76 83 1407 1414 O
clinical 84 92 1415 1423 O
study 93 98 1424 1429 O
within 99 105 1430 1436 O
30 106 108 1437 1439 B-upper_bound
days 109 113 1440 1444 I-upper_bound
prior 114 119 1445 1450 I-upper_bound
to 120 122 1451 1453 O
this 123 127 1454 1458 O
study 128 133 1459 1464 O

Subject 0 7 1465 1472 O
with 8 12 1473 1477 O
a 13 14 1478 1479 O
history 15 22 1480 1487 O
of 23 25 1488 1490 O
substance 26 35 1491 1500 O
abuse 36 41 1501 1506 O
including 42 51 1507 1516 O
alcoholism 52 62 1517 1527 O
within 63 69 1528 1534 O
the 70 73 1535 1538 O
past 74 78 1539 1543 B-upper_bound
6 79 80 1544 1545 I-upper_bound
months 81 87 1546 1552 I-upper_bound
( 88 89 1553 1554 O
except 89 95 1554 1560 O
nicotine 96 104 1561 1569 O
and 105 108 1570 1573 O
caffeine 109 117 1574 1582 O
) 117 118 1582 1583 O

Subject 0 7 1584 1591 O
with 8 12 1592 1596 O
unstable 13 21 1597 1605 O
physical 22 30 1606 1614 B-chronic_disease
disease 31 38 1615 1622 I-chronic_disease
such 39 43 1623 1627 O
as 44 46 1628 1630 O
unstable 47 55 1631 1639 O
cardiac 56 63 1640 1647 B-chronic_disease
disease 64 71 1648 1655 I-chronic_disease

Subjects 0 8 1656 1664 O
diagnosed 9 18 1665 1674 O
according 19 28 1675 1684 O
to 29 31 1685 1687 O
the 32 35 1688 1691 O
SCID 36 40 1692 1696 B-treatment
II 41 43 1697 1699 I-treatment
as 44 46 1700 1702 O
suffering 47 56 1703 1712 O
from 57 61 1713 1717 O
Severe 62 68 1718 1724 O
Personality 69 80 1725 1736 B-chronic_disease
Disorder 81 89 1737 1745 I-chronic_disease

Subjects 0 8 1746 1754 O
with 9 13 1755 1759 O
a 14 15 1760 1761 O
significant 16 27 1762 1773 O
neurological 28 40 1774 1786 B-chronic_disease
disorder 41 49 1787 1795 I-chronic_disease
or 50 52 1796 1798 O
insult 53 59 1799 1805 O

Subjects 0 8 1806 1814 O
with 9 13 1815 1819 O
an 14 16 1820 1822 O
HDRS-21 17 24 1823 1830 B-clinical_variable
score 25 30 1831 1836 I-clinical_variable
≤ 31 32 1837 1838 O
26 33 35 1839 1841 B-upper_bound
at 36 38 1842 1844 O
both 39 43 1845 1849 O
Screening 44 53 1850 1859 O
and 54 57 1860 1863 O
Baseline 58 66 1864 1872 O
visits 67 73 1873 1879 O

Subjects 0 8 1880 1888 O
with 9 13 1889 1893 O
at 14 16 1894 1896 O
least 17 22 1897 1902 O
moderate 23 31 1903 1911 O
PTSD 32 36 1912 1916 B-chronic_disease
with 37 41 1917 1921 O
a 42 43 1922 1923 O
CAPS-5 44 50 1924 1930 B-clinical_variable
score 51 56 1931 1936 I-clinical_variable
≥ 57 58 1937 1938 O
25 59 61 1939 1941 B-lower_bound
at 62 64 1942 1944 O
both 65 69 1945 1949 O
Screening 70 79 1950 1959 O
and 80 83 1960 1963 O
Baseline 84 92 1964 1972 O
visits 93 99 1973 1979 O

Transient 0 9 1980 1989 B-chronic_disease
ischemic 10 18 1990 1998 I-chronic_disease
attack 19 25 1999 2005 I-chronic_disease
within 26 32 2006 2012 O
two 33 36 2013 2016 B-upper_bound
years 37 42 2017 2022 I-upper_bound

Women 0 5 2023 2028 B-gender
of 6 8 2029 2031 O
childbearing 9 21 2032 2044 O
potential 22 31 2045 2054 O
and 32 35 2055 2058 O
not 36 39 2059 2062 B-contraception_consent
using 40 45 2063 2068 I-contraception_consent
a 46 47 2069 2070 I-contraception_consent
medically 48 57 2071 2080 I-contraception_consent
accepted 58 66 2081 2089 I-contraception_consent
form 67 71 2090 2094 I-contraception_consent
of 72 74 2095 2097 I-contraception_consent
contraception 75 88 2098 2111 I-contraception_consent
when 89 93 2112 2116 O
sexually 94 102 2117 2125 O
active 103 109 2126 2132 O

Women 0 5 2133 2138 B-gender
who 6 9 2139 2142 O
are 10 13 2143 2146 O
breast 14 20 2147 2153 O
- 20 21 2153 2154 O
feeding 21 28 2154 2161 O

women 0 5 2162 2167 B-gender

> 0 1 0 1 O
200 2 5 2 5 B-lower_bound
mg 6 8 6 8 I-lower_bound
of 9 11 9 11 O
monoclonal 12 22 12 22 B-chronic_disease
protein 23 30 23 30 I-chronic_disease
in 31 33 31 33 O
the 34 37 34 37 O
urine 38 43 38 43 O
on 44 46 44 46 O
screening 47 56 47 56 O
24 57 59 57 59 O
- 59 60 59 60 O
hour 60 64 60 64 O
electrophoresis 65 80 65 80 B-clinical_variable

A 0 1 81 82 O
female 2 8 83 89 B-gender
of 9 11 90 92 O
childbearing 12 24 93 105 O
potential 25 34 106 115 O
( 35 36 116 117 O
FCBP 36 40 117 121 O
) 40 41 121 122 O
is 42 44 123 125 O
a 45 46 126 127 O
sexually 47 55 128 136 O
mature 56 62 137 143 O
woman 63 68 144 149 B-gender
who 69 72 150 153 O
: 72 73 153 154 O
1 74 75 155 156 O
) 75 76 156 157 O
has 77 80 158 161 O
not 81 84 162 165 O
undergone 85 94 166 175 O
a 95 96 176 177 O
hysterectomy 97 109 178 190 B-treatment
or 110 112 191 193 O
bilateral 113 122 194 203 B-treatment
oophorectomy 123 135 204 216 I-treatment
; 135 136 216 217 O
or 137 139 218 220 O
2 140 141 221 222 O
) 141 142 222 223 O
has 143 146 224 227 O
not 147 150 228 231 O
been 151 155 232 236 O
naturally 156 165 237 246 O
postmenopausal 166 180 247 261 O
for 181 184 262 265 O
at 185 187 266 268 O
least 188 193 269 274 O
24 194 196 275 277 O
consecutive 197 208 278 289 O
months 209 215 290 296 O
( 216 217 297 298 O
i.e. 217 221 298 302 O
, 221 222 302 303 O
has 223 226 304 307 O
had 227 230 308 311 O
menses 231 237 312 318 O
at 238 240 319 321 O
any 241 244 322 325 O
time 245 249 326 330 O
in 250 252 331 333 O
the 253 256 334 337 O
preceding 257 266 338 347 O
24 267 269 348 350 O
consecutive 270 281 351 362 O
months 282 288 363 369 O
) 288 289 369 370 O

Absolute 0 8 371 379 B-language_fluency
neutrophil 9 19 380 390 I-language_fluency
count 20 25 391 396 I-language_fluency
( 26 27 397 398 I-language_fluency
ANC 27 30 398 401 I-language_fluency
) 30 31 401 402 I-language_fluency
> 32 33 403 404 O
= 33 34 404 405 O
1000 35 39 406 410 B-lower_bound
/ 39 40 410 411 I-lower_bound
uL 40 42 411 413 I-lower_bound

Anemia 0 6 414 420 B-chronic_disease
> 7 8 421 422 O
2 9 10 423 424 B-lower_bound
g 11 12 425 426 I-lower_bound
/ 12 13 426 427 I-lower_bound
dL 13 15 427 429 I-lower_bound
below 16 21 430 435 O
the 22 25 436 439 O
lower 26 31 440 445 O
limit 32 37 446 451 O
of 38 40 452 454 O
normal 41 47 455 461 O
or 48 50 462 464 O
a 51 52 465 466 O
hemoglobin 53 63 467 477 B-clinical_variable
value 64 69 478 483 I-clinical_variable
< 70 71 484 485 O
10 72 74 486 488 B-upper_bound
g 75 76 489 490 I-upper_bound
/ 76 77 490 491 I-upper_bound
dL 77 79 491 493 I-upper_bound

Aspartate 0 9 494 503 B-clinical_variable
aminotransferase 10 26 504 520 I-clinical_variable
( 27 28 521 522 I-clinical_variable
AST 28 31 522 525 I-clinical_variable
) 31 32 525 526 I-clinical_variable
and 33 36 527 530 O
alanine 37 44 531 538 B-clinical_variable
aminotransferase 45 61 539 555 I-clinical_variable
( 62 63 556 557 I-clinical_variable
ALT 63 66 557 560 I-clinical_variable
) 66 67 560 561 I-clinical_variable
< 68 69 562 563 O
3 70 71 564 565 B-upper_bound
x 72 73 566 567 I-upper_bound
the 74 77 568 571 I-upper_bound
institutional 78 91 572 585 I-upper_bound
upper 92 97 586 591 I-upper_bound
limit 98 103 592 597 I-upper_bound
of 104 106 598 600 I-upper_bound
normal 107 113 601 607 I-upper_bound

Bone 0 4 608 612 B-chronic_disease
lesions 5 12 613 620 I-chronic_disease
: 12 13 620 621 O
lytic 14 19 622 627 B-chronic_disease
lesions 20 27 628 635 I-chronic_disease
, 27 28 635 636 O
severe 29 35 637 643 O
osteopenia 36 46 644 654 B-chronic_disease
or 47 49 655 657 O
pathologic 50 60 658 668 B-chronic_disease
fractures 61 70 669 678 I-chronic_disease

Both 0 4 679 683 O
men 5 8 684 687 B-gender
and 9 12 688 691 I-gender
women 13 18 692 697 I-gender
of 19 21 698 700 O
all 22 25 701 704 O
races 26 31 705 710 O
and 32 35 711 714 O
ethnic 36 42 715 721 O
groups 43 49 722 728 O
are 50 53 729 732 O
eligible 54 62 733 741 O
for 63 66 742 745 O
this 67 71 746 750 O
study 72 77 751 756 O

Eastern 0 7 757 764 B-clinical_variable
Cooperative 8 19 765 776 I-clinical_variable
Oncology 20 28 777 785 I-clinical_variable
Group 29 34 786 791 I-clinical_variable
( 35 36 792 793 I-clinical_variable
ECOG 36 40 793 797 I-clinical_variable
) 40 41 797 798 I-clinical_variable
performance 42 53 799 810 I-clinical_variable
status 54 60 811 817 I-clinical_variable
= 61 62 818 819 O
< 62 63 819 820 O
2 64 65 821 822 B-upper_bound
( 66 67 823 824 O
Karnofsky 67 76 824 833 B-clinical_variable
> 77 78 834 835 O
= 78 79 835 836 O
60 80 82 837 839 B-lower_bound
% 82 83 839 840 I-lower_bound
) 83 84 840 841 O
is 85 87 842 844 O
required 88 96 845 853 O
for 97 100 854 857 O
eligibility 101 112 858 869 O
; 112 113 869 870 O
those 114 119 871 876 O
patients 120 128 877 885 O
with 129 133 886 890 O
lower 134 139 891 896 O
performance 140 151 897 908 O
status 152 158 909 915 O
based 159 164 916 921 O
solely 165 171 922 928 O
on 172 174 929 931 O
bone 175 179 932 936 O
pain 180 184 937 941 O
secondary 185 194 942 951 O
to 195 197 952 954 O
multiple 198 206 955 963 B-cancer
myeloma 207 214 964 971 I-cancer

Evidence 0 8 972 980 O
of 9 11 981 983 O
any 12 15 984 987 O
end 16 19 988 991 O
organ 20 25 992 997 O
damage 26 32 998 1004 O
criteria 33 41 1005 1013 O
listed 42 48 1014 1020 O
below 49 54 1021 1026 O
( 55 56 1027 1028 O
at 56 58 1028 1030 O
any 59 62 1031 1034 O
time 63 67 1035 1039 O
) 67 68 1039 1040 O
attributed 69 79 1041 1051 O
to 80 82 1052 1054 O
the 83 86 1055 1058 O
patient 87 94 1059 1066 O
's 94 96 1066 1068 O
myeloma 97 104 1069 1076 B-cancer

Females 0 7 1077 1084 B-gender
of 8 10 1085 1087 O
childbearing 11 23 1088 1100 O
potential 24 33 1101 1110 O
( 34 35 1111 1112 O
FCBP 35 39 1112 1116 O
) 39 40 1116 1117 O
must 41 45 1118 1122 O
have 46 50 1123 1127 O
a 51 52 1128 1129 O
negative 53 61 1130 1138 B-pregnancy
serum 62 67 1139 1144 I-pregnancy
or 68 70 1145 1147 O
urine 71 76 1148 1153 B-pregnancy
pregnancy 77 86 1154 1163 I-pregnancy
test 87 91 1164 1168 O
with 92 96 1169 1173 O
a 97 98 1174 1175 O
sensitivity 99 110 1176 1187 O
of 111 113 1188 1190 O
at 114 116 1191 1193 O
least 117 122 1194 1199 O
50 123 125 1200 1202 B-lower_bound
mIU 126 129 1203 1206 I-lower_bound
/ 129 130 1206 1207 I-lower_bound
mL 130 132 1207 1209 I-lower_bound
prior 133 138 1210 1215 B-treatment
to 139 141 1216 1218 I-treatment
starting 142 150 1219 1227 I-treatment
therapy 151 158 1228 1235 I-treatment
and 159 162 1236 1239 O
prior 163 168 1240 1245 O
to 169 171 1246 1248 O
beginning 172 181 1249 1258 O
another 182 189 1259 1266 O
cycle 190 195 1267 1272 O

Hypercalcemia 0 13 1273 1286 B-chronic_disease
: 13 14 1286 1287 O
serum 15 20 1288 1293 B-clinical_variable
calcium 21 28 1294 1301 I-clinical_variable
> 29 30 1302 1303 O
11.5 31 35 1304 1308 B-lower_bound
mg 36 38 1309 1311 I-lower_bound
/ 38 39 1311 1312 I-lower_bound
dL 39 41 1312 1314 I-lower_bound

Patient 0 7 1315 1322 O
must 8 12 1323 1327 O
have 13 17 1328 1332 O
relapsed 18 26 1333 1341 O
or 27 29 1342 1344 O
refractory 30 40 1345 1355 O
myeloma 41 48 1356 1363 B-cancer
that 49 53 1364 1368 O
fits 54 58 1369 1373 O
or 59 61 1374 1376 O
did 62 65 1377 1380 O
fit 66 69 1381 1384 O
International 70 83 1385 1398 O
Myeloma 84 91 1399 1406 O
Working 92 99 1407 1414 O
Group 100 105 1415 1420 O
( 106 107 1421 1422 O
IMWG 107 111 1422 1426 O
) 111 112 1426 1427 O
diagnostic 113 123 1428 1438 O
criteria 124 132 1439 1447 O
for 133 136 1448 1451 O
symptomatic 137 148 1452 1463 B-cancer
myeloma 149 156 1464 1471 I-cancer

Patients 0 8 1472 1480 O
must 9 13 1481 1485 O
agree 14 19 1486 1491 O
not 20 23 1492 1495 O
to 24 26 1496 1498 O
donate 27 33 1499 1505 O
blood 34 39 1506 1511 O
, 39 40 1511 1512 O
sperm 41 46 1513 1518 O
/ 46 47 1518 1519 O
ova 47 50 1519 1522 O
during 51 57 1523 1529 O
the 58 61 1530 1533 O
course 62 68 1534 1540 O
of 69 71 1541 1543 O
taking 72 78 1544 1550 O
protocol 79 87 1551 1559 O
therapy 88 95 1560 1567 B-treatment
and 96 99 1568 1571 O
for 100 103 1572 1575 O
at 104 106 1576 1578 O
least 107 112 1579 1584 O
4 113 114 1585 1586 B-lower_bound
weeks 115 120 1587 1592 I-lower_bound
after 121 126 1593 1598 I-lower_bound
stopping 127 135 1599 1607 O
treatment 136 145 1608 1617 B-treatment

Patients 0 8 1618 1626 O
must 9 13 1627 1631 O
be 14 16 1632 1634 O
able 17 21 1635 1639 O
to 22 24 1640 1642 O
avoid 25 30 1643 1648 O
direct 31 37 1649 1655 O
contact 38 45 1656 1663 O
with 46 50 1664 1668 O
pregnant 51 59 1669 1677 B-pregnancy
or 60 62 1678 1680 O
nursing 63 70 1681 1688 O
women 71 76 1689 1694 B-gender
, 76 77 1694 1695 O
infants 78 85 1696 1703 O
and 86 89 1704 1707 O
immunocompromised 90 107 1708 1725 O
individuals 108 119 1726 1737 O
during 120 126 1738 1744 O
the 127 130 1745 1748 O
days 131 135 1749 1753 O
of 136 138 1754 1756 O
reolysin 139 147 1757 1765 B-treatment
treatment 148 157 1766 1775 I-treatment
and 158 161 1776 1779 O
for 162 165 1780 1783 O
two 166 169 1784 1787 B-upper_bound
days 170 174 1788 1792 I-upper_bound
after 175 180 1793 1798 I-upper_bound

Patients 0 8 1799 1807 O
must 9 13 1808 1812 O
have 14 18 1813 1817 O
been 19 23 1818 1822 O
previously 24 34 1823 1833 O
treated 35 42 1834 1841 O
with 43 47 1842 1846 O
an 48 50 1847 1849 O
immunomodulatory 51 67 1850 1866 B-treatment
drug 68 72 1867 1871 I-treatment
( 73 74 1872 1873 I-treatment
IMiD 74 78 1873 1877 I-treatment
) 78 79 1877 1878 I-treatment
and 80 83 1879 1882 O
proteasome 84 94 1883 1893 B-treatment
inhibitor 95 104 1894 1903 I-treatment
, 104 105 1903 1904 O
must 106 110 1905 1909 O
be 111 113 1910 1912 O
refractory 114 124 1913 1923 O
to 125 127 1924 1926 O
carfilzomib 128 139 1927 1938 B-treatment
defined 140 147 1939 1946 O
as 148 150 1947 1949 O
progression 151 162 1950 1961 O
on 163 165 1962 1964 O
or 166 168 1965 1967 O
within 169 175 1968 1974 O
2 176 177 1975 1976 B-upper_bound
months 178 184 1977 1983 I-upper_bound
of 185 187 1984 1986 O
a 188 189 1987 1988 O
carfilzomib 190 201 1989 2000 B-treatment
- 201 202 2000 2001 I-treatment
containing 202 212 2001 2011 I-treatment
therapy 213 220 2012 2019 I-treatment
, 220 221 2019 2020 O
and 222 225 2021 2024 O
must 226 230 2025 2029 O
be 231 233 2030 2032 O
progressing 234 245 2033 2044 O

Patients 0 8 2045 2053 O
must 9 13 2054 2058 O
not 14 17 2059 2062 O
have 18 22 2063 2067 O
known 23 28 2068 2073 O
human 29 34 2074 2079 B-chronic_disease
immunodeficiency 35 51 2080 2096 I-chronic_disease
virus 52 57 2097 2102 I-chronic_disease
( 58 59 2103 2104 I-chronic_disease
HIV 59 62 2104 2107 I-chronic_disease
) 62 63 2107 2108 I-chronic_disease
infection 64 73 2109 2118 O
or 74 76 2119 2121 O
active 77 83 2122 2128 O
hepatitis 84 93 2129 2138 B-chronic_disease
B 94 95 2139 2140 I-chronic_disease
or 96 98 2141 2143 O
C 99 100 2144 2145 B-chronic_disease
infections 101 111 2146 2156 O

Patients 0 8 2157 2165 O
previously 9 19 2166 2176 O
treated 20 27 2177 2184 O
on 28 30 2185 2187 O
clinical 31 39 2188 2196 B-treatment
trial 40 45 2197 2202 I-treatment
with 46 50 2203 2207 I-treatment
reolysin 51 59 2208 2216 I-treatment

Patients 0 8 2217 2225 O
who 9 12 2226 2229 O
are 13 16 2230 2233 O
receiving 17 26 2234 2243 O
any 27 30 2244 2247 O
other 31 36 2248 2253 B-treatment
therapeutic 37 48 2254 2265 I-treatment
investigational 49 64 2266 2281 I-treatment
agents 65 71 2282 2288 I-treatment

Patients 0 8 2289 2297 O
who 9 12 2298 2301 O
have 13 17 2302 2306 O
had 18 21 2307 2310 O
chemotherapy 22 34 2311 2323 B-treatment
or 35 37 2324 2326 O
radiotherapy 38 50 2327 2339 B-treatment
within 51 57 2340 2346 O
2 58 59 2347 2348 B-upper_bound
weeks 60 65 2349 2354 I-upper_bound
prior 66 71 2355 2360 I-upper_bound
to 72 74 2361 2363 O
entering 75 83 2364 2372 O
the 84 87 2373 2376 O
study 88 93 2377 2382 O

Patients 0 8 2383 2391 O
with 9 13 2392 2396 O
a 14 15 2397 2398 O
currently 16 25 2399 2408 O
active 26 32 2409 2415 B-cancer
second 33 39 2416 2422 I-cancer
malignancy 40 50 2423 2433 I-cancer
that 51 55 2434 2438 O
, 55 56 2438 2439 O
in 57 59 2440 2442 O
the 60 63 2443 2446 O
opinion 64 71 2447 2454 O
of 72 74 2455 2457 O
the 75 78 2458 2461 O
principal 79 88 2462 2471 O
investigator 89 101 2472 2484 O
, 101 102 2484 2485 O
will 103 107 2486 2490 O
interfere 108 117 2491 2500 O
with 118 122 2501 2505 O
patient 123 130 2506 2513 O
participation 131 144 2514 2527 O
, 144 145 2527 2528 O
increase 146 154 2529 2537 O
patient 155 162 2538 2545 O
risk 163 167 2546 2550 O
, 167 168 2550 2551 O
shorten 169 176 2552 2559 O
survival 177 185 2560 2568 B-clinical_variable
to 186 188 2569 2571 O
< 189 190 2572 2573 O
1 191 192 2574 2575 B-upper_bound
year 193 197 2576 2580 I-upper_bound
, 197 198 2580 2581 O
or 199 201 2582 2584 O
confound 202 210 2585 2593 O
data 211 215 2594 2598 O
interpretation 216 230 2599 2613 O

Plasma 0 6 2614 2620 B-chronic_disease
cell 7 11 2621 2625 I-chronic_disease
dyscrasia 12 21 2626 2635 I-chronic_disease
with 22 26 2636 2640 O
polyneuropathy 27 41 2641 2655 B-chronic_disease
, 41 42 2655 2656 O
organomegaly 43 55 2657 2669 B-chronic_disease
, 55 56 2669 2670 O
endocrinopathy 57 71 2671 2685 B-chronic_disease
, 71 72 2685 2686 O
monoclonal 73 83 2687 2697 B-chronic_disease
protein 84 91 2698 2705 I-chronic_disease
( 92 93 2706 2707 I-chronic_disease
M 93 94 2707 2708 I-chronic_disease
- 94 95 2708 2709 I-chronic_disease
protein 95 102 2709 2716 I-chronic_disease
) 102 103 2716 2717 I-chronic_disease
, 103 104 2717 2718 O
and 105 108 2719 2722 O
skin 109 113 2723 2727 B-chronic_disease
changes 114 121 2728 2735 I-chronic_disease
( 122 123 2736 2737 I-chronic_disease
POEMS 123 128 2737 2742 I-chronic_disease
) 128 129 2742 2743 I-chronic_disease
syndrome 130 138 2744 2752 I-chronic_disease

Platelet 0 8 2753 2761 B-clinical_variable
count 9 14 2762 2767 I-clinical_variable
> 15 16 2768 2769 O
= 16 17 2769 2770 O
75,000 18 24 2771 2777 B-lower_bound
and 25 28 2778 2781 O
transfusion 29 40 2782 2793 B-treatment
independent 41 52 2794 2805 O

Pregnant 0 8 2806 2814 B-pregnancy
women 9 14 2815 2820 B-gender
are 15 18 2821 2824 O
excluded 19 27 2825 2833 O
from 28 32 2834 2838 O
this 33 37 2839 2843 O
study 38 43 2844 2849 O
; 43 44 2849 2850 O
breastfeeding 45 58 2851 2864 O
should 59 65 2865 2871 O
be 66 68 2872 2874 O
discontinued 69 81 2875 2887 O

Presence 0 8 2888 2896 O
of 9 11 2897 2899 O
clonal 12 18 2900 2906 B-cancer
bone 19 23 2907 2911 I-cancer
marrow 24 30 2912 2918 I-cancer
plasma 31 37 2919 2925 I-cancer
cells 38 43 2926 2931 I-cancer

Prior 0 5 2932 2937 O
autologous 6 16 2938 2948 B-treatment
and/or 17 23 2949 2955 I-treatment
allogeneic 24 34 2956 2966 I-treatment
transplant 35 45 2967 2977 I-treatment
is 46 48 2978 2980 O
permitted 49 58 2981 2990 O
although 59 67 2991 2999 O
transplant 68 78 3000 3010 O
must 79 83 3011 3015 O
have 84 88 3016 3020 O
occurred 89 97 3021 3029 O
greater 98 105 3030 3037 O
than 106 110 3038 3042 O
90 111 113 3043 3045 B-lower_bound
days 114 118 3046 3050 I-lower_bound
prior 119 124 3051 3056 I-lower_bound
to 125 127 3057 3059 O
registration 128 140 3060 3072 O

Prior 0 5 3073 3078 B-treatment
radiation 6 15 3079 3088 I-treatment
is 16 18 3089 3091 O
permitted 19 28 3092 3101 O
; 28 29 3101 3102 O
however 30 37 3103 3110 O
, 37 38 3110 3111 O
at 39 41 3112 3114 O
least 42 47 3115 3120 O
2 48 49 3121 3122 B-lower_bound
weeks 50 55 3123 3128 I-lower_bound
must 56 60 3129 3133 O
have 61 65 3134 3138 O
elapsed 66 73 3139 3146 O
since 74 79 3147 3152 O
the 80 83 3153 3156 O
completion 84 94 3157 3167 O
of 95 97 3168 3170 O
prior 98 103 3171 3176 B-treatment
radiation 104 113 3177 3186 I-treatment
therapy 114 121 3187 3194 I-treatment
and 122 125 3195 3198 O
patients 126 134 3199 3207 O
must 135 139 3208 3212 O
have 140 144 3213 3217 O
recovered 145 154 3218 3227 O
from 155 159 3228 3232 O
all 160 163 3233 3236 O
radiation 164 173 3237 3246 O
- 173 174 3246 3247 O
associated 174 184 3247 3257 O
toxicities 185 195 3258 3268 O
to 196 198 3269 3271 O
no 199 201 3272 3274 O
greater 202 209 3275 3282 O
than 210 214 3283 3287 O
grade 215 220 3288 3293 B-upper_bound
1 221 222 3294 3295 I-upper_bound
at 223 225 3296 3298 O
the 226 229 3299 3302 O
time 230 234 3303 3307 O
of 235 237 3308 3310 O
registration 238 250 3311 3323 O

Renal 0 5 3324 3329 B-chronic_disease
insufficiency 6 19 3330 3343 I-chronic_disease
: 19 20 3343 3344 O
serum 21 26 3345 3350 B-clinical_variable
creatinine 27 37 3351 3361 I-clinical_variable
> 38 39 3362 3363 O
2 40 41 3364 3365 B-lower_bound
mg 42 44 3366 3368 I-lower_bound
/ 44 45 3368 3369 I-lower_bound
dL 45 47 3369 3371 I-lower_bound

Serum 0 5 3372 3377 B-clinical_variable
immunoglobulin 6 20 3378 3392 I-clinical_variable
free 21 25 3393 3397 I-clinical_variable
light 26 31 3398 3403 I-clinical_variable
chain 32 37 3404 3409 I-clinical_variable
> 38 39 3410 3411 O
= 39 40 3411 3412 O
100 41 44 3413 3416 B-lower_bound
mg 45 47 3417 3419 I-lower_bound
/ 47 48 3419 3420 I-lower_bound
L 48 49 3420 3421 I-lower_bound
AND 50 53 3422 3425 O
abnormal 54 62 3426 3434 O
serum 63 68 3435 3440 O
immunoglobulin 69 83 3441 3455 O
kappa 84 89 3456 3461 B-clinical_variable
to 90 92 3462 3464 I-clinical_variable
lambda 93 99 3465 3471 I-clinical_variable
free 100 104 3472 3476 I-clinical_variable
light 105 110 3477 3482 I-clinical_variable
chain 111 116 3483 3488 I-clinical_variable
ratio 117 122 3489 3494 I-clinical_variable

Serum 0 5 3495 3500 B-clinical_variable
monoclonal 6 16 3501 3511 I-clinical_variable
protein 17 24 3512 3519 I-clinical_variable
> 25 26 3520 3521 O
= 26 27 3521 3522 O
500 28 31 3523 3526 B-lower_bound
mg 32 34 3527 3529 I-lower_bound
/ 34 35 3529 3530 I-lower_bound
dL 35 37 3530 3532 I-lower_bound
by 38 40 3533 3535 O
protein 41 48 3536 3543 B-treatment
electrophoresis 49 64 3544 3559 I-treatment

Total 0 5 3560 3565 B-clinical_variable
bilirubin 6 15 3566 3575 I-clinical_variable
< 16 17 3576 3577 O
1.5 18 21 3578 3581 B-upper_bound
mg 22 24 3582 3584 I-upper_bound
/ 24 25 3584 3585 I-upper_bound
dL 25 27 3585 3587 I-upper_bound

Uncontrolled 0 12 3588 3600 O
intercurrent 13 25 3601 3613 O
illness 26 33 3614 3621 O
including 34 43 3622 3631 O
, 43 44 3631 3632 O
but 45 48 3633 3636 O
not 49 52 3637 3640 O
limited 53 60 3641 3648 O
to 61 63 3649 3651 O
, 63 64 3651 3652 O
ongoing 65 72 3653 3660 O
or 73 75 3661 3663 O
active 76 82 3664 3670 B-chronic_disease
infection 83 92 3671 3680 I-chronic_disease
, 92 93 3680 3681 O
symptomatic 94 105 3682 3693 O
congestive 106 116 3694 3704 B-chronic_disease
heart 117 122 3705 3710 I-chronic_disease
failure 123 130 3711 3718 I-chronic_disease
, 130 131 3718 3719 O
unstable 132 140 3720 3728 B-chronic_disease
angina 141 147 3729 3735 I-chronic_disease
pectoris 148 156 3736 3744 I-chronic_disease
, 156 157 3744 3745 O
cardiac 158 165 3746 3753 B-chronic_disease
arrhythmia 166 176 3754 3764 I-chronic_disease

Women 0 5 3765 3770 B-gender
of 6 8 3771 3773 O
child 9 14 3774 3779 O
- 14 15 3779 3780 O
bearing 15 22 3780 3787 O
potential 23 32 3788 3797 O
and 33 36 3798 3801 O
men 37 40 3802 3805 O
must 41 45 3806 3810 O
agree 46 51 3811 3816 B-contraception_consent
to 52 54 3817 3819 I-contraception_consent
use 55 58 3820 3823 I-contraception_consent
adequate 59 67 3824 3832 I-contraception_consent
contraception 68 81 3833 3846 I-contraception_consent
( 82 83 3847 3848 O
hormonal 83 91 3848 3856 B-contraception_consent
or 92 94 3857 3859 O
barrier 95 102 3860 3867 B-contraception_consent
method 103 109 3868 3874 I-contraception_consent
of 110 112 3875 3877 I-contraception_consent
birth 113 118 3878 3883 I-contraception_consent
control 119 126 3884 3891 I-contraception_consent
; 126 127 3891 3892 O
abstinence 128 138 3893 3903 B-contraception_consent
) 138 139 3903 3904 O
starting 140 148 3905 3913 O
28 149 151 3914 3916 B-lower_bound
days 152 156 3917 3921 I-lower_bound
prior 157 162 3922 3927 I-lower_bound
to 163 165 3928 3930 O
starting 166 174 3931 3939 O
the 175 178 3940 3943 O
study 179 184 3944 3949 O
until 185 190 3950 3955 O
at 191 193 3956 3958 O
least 194 199 3959 3964 O
90 200 202 3965 3967 B-lower_bound
days 203 207 3968 3972 I-lower_bound
following 208 217 3973 3982 O
discontinuation 218 233 3983 3998 O
of 234 236 3999 4001 O
the 237 240 4002 4005 O
trial 241 246 4006 4011 O
therapy 247 254 4012 4019 B-treatment

myocardial 0 10 4020 4030 B-chronic_disease
infarction 11 21 4031 4041 I-chronic_disease
in 22 24 4042 4044 O
the 25 28 4045 4048 O
preceding 29 38 4049 4058 O
6 39 40 4059 4060 B-upper_bound
months 41 47 4061 4067 I-upper_bound

patients 0 8 4068 4076 O
may 9 12 4077 4080 O
be 13 15 4081 4083 O
receiving 16 25 4084 4093 O
concomitant 26 37 4094 4105 B-treatment
therapy 38 45 4106 4113 I-treatment
with 46 50 4114 4118 I-treatment
bisphosphonates 51 66 4119 4134 I-treatment
and 67 70 4135 4138 I-treatment
low 71 74 4139 4142 I-treatment
dose 75 79 4143 4147 I-treatment
corticosteroids 80 95 4148 4163 I-treatment
( 96 97 4164 4165 O
e.g. 97 101 4165 4169 O
, 101 102 4169 4170 O
prednisone 103 113 4171 4181 B-treatment
up 114 116 4182 4184 O
to 117 119 4185 4187 O
but 120 123 4188 4191 O
no 124 126 4192 4194 O
more 127 131 4195 4199 O
than 132 136 4200 4204 O
10 137 139 4205 4207 B-upper_bound
mg 140 142 4208 4210 I-upper_bound
by 143 145 4211 4213 O
mouth 146 151 4214 4219 O
daily 152 157 4220 4225 O
or 158 160 4226 4228 O
its 161 164 4229 4232 O
equivalent 165 175 4233 4243 O
) 175 176 4243 4244 O
for 177 180 4245 4248 O
symptom 181 188 4249 4256 O
management 189 199 4257 4267 O
and 200 203 4268 4271 O
comorbid 204 212 4272 4280 O
conditions 213 223 4281 4291 O
; 223 224 4291 4292 O
doses 225 230 4293 4298 O
of 231 233 4299 4301 O
corticosteroid 234 248 4302 4316 O
should 249 255 4317 4323 O
be 256 258 4324 4326 O
stable 259 265 4327 4333 O
for 266 269 4334 4337 O
at 270 272 4338 4340 O
least 273 278 4341 4346 O
7 279 280 4347 4348 B-lower_bound
days 281 285 4349 4353 I-lower_bound
prior 286 291 4354 4359 I-lower_bound
to 292 294 4360 4362 O
study 295 300 4363 4368 O
treatment 301 310 4369 4378 B-treatment

psychiatric 0 11 4379 4390 B-chronic_disease
illness 12 19 4391 4398 I-chronic_disease
/ 19 20 4398 4399 O
social 20 26 4399 4405 O
situations 27 37 4406 4416 O
that 38 42 4417 4421 O
would 43 48 4422 4427 O
limit 49 54 4428 4433 O
compliance 55 65 4434 4444 O
with 66 70 4445 4449 O
study 71 76 4450 4455 O
requirements 77 89 4456 4468 O

should 0 6 4469 4475 O
a 7 8 4476 4477 O
woman 9 14 4478 4483 B-gender
become 15 21 4484 4490 B-pregnancy
pregnant 22 30 4491 4499 I-pregnancy
or 31 33 4500 4502 O
suspect 34 41 4503 4510 O
she 42 45 4511 4514 O
is 46 48 4515 4517 O
pregnant 49 57 4518 4526 O
while 58 63 4527 4532 O
she 64 67 4533 4536 O
or 68 70 4537 4539 O
her 71 74 4540 4543 O
partner 75 82 4544 4551 O
is 83 85 4552 4554 O
participating 86 99 4555 4568 O
in 100 102 4569 4571 O
this 103 107 4572 4576 O
study 108 113 4577 4582 O
, 113 114 4582 4583 O
she 115 118 4584 4587 O
should 119 125 4588 4594 O
inform 126 132 4595 4601 O
her 133 136 4602 4605 O
treating 137 145 4606 4614 O
physician 146 155 4615 4624 O
immediately 156 167 4625 4636 O

1st 0 3 0 3 O
complete 4 12 4 12 O
remission 13 22 13 22 O
, 22 23 22 23 O
but 24 27 24 27 O
very 28 32 28 32 O
high 33 37 33 37 O
- 37 38 37 38 O
risk 38 42 38 42 O
features 43 51 43 51 O
( 52 53 52 53 O
i.e. 53 57 53 57 O
, 57 58 57 58 O
< 59 60 59 60 O
20 61 63 61 63 B-upper_bound
% 63 64 63 64 I-upper_bound
survival 65 73 65 73 B-clinical_variable
with 74 78 74 78 O
conventional 79 91 79 91 B-treatment
therapy 92 99 92 99 I-treatment
) 99 100 99 100 O

ALT 0 3 101 104 B-clinical_variable
( 4 5 105 106 I-clinical_variable
alanine 5 12 106 113 I-clinical_variable
aminotransferase 13 29 114 130 I-clinical_variable
, 29 30 130 131 I-clinical_variable
SCPT 31 35 132 136 I-clinical_variable
) 35 36 136 137 I-clinical_variable
≤ 37 38 138 139 O
5 39 40 140 141 B-upper_bound
x 41 42 142 143 I-upper_bound
Upper 43 48 144 149 I-upper_bound
LImit 49 54 150 155 I-upper_bound
of 55 57 156 158 I-upper_bound
Normal 58 64 159 165 I-upper_bound
( 65 66 166 167 I-upper_bound
ULN 66 69 167 170 I-upper_bound
) 69 70 170 171 I-upper_bound
for 71 74 172 175 O
age 75 78 176 179 B-age

Donor 0 5 180 185 O
must 6 10 186 190 O
be 11 13 191 193 O
18 14 16 194 196 B-lower_bound
years 17 22 197 202 I-lower_bound
or 23 25 203 205 O
older 26 31 206 211 O

Ejection 0 8 212 220 B-clinical_variable
fraction 9 17 221 229 I-clinical_variable
of 18 20 230 232 O
> 21 22 233 234 O
40 23 25 235 237 B-lower_bound
% 25 26 237 238 I-lower_bound
by 27 29 239 241 O
Multigated 30 40 242 252 B-treatment
Acquisition 41 52 253 264 I-treatment
Scan 53 57 265 269 I-treatment
( 58 59 270 271 I-treatment
MUGA 59 63 271 275 I-treatment
) 63 64 275 276 I-treatment
or 65 67 277 279 O
echocardiogram 68 82 280 294 B-treatment

Enrollment 0 10 295 305 O
in 11 13 306 308 O
any 14 17 309 312 O
other 18 23 313 318 B-treatment
clinical 24 32 319 327 I-treatment
study 33 38 328 333 I-treatment
from 39 43 334 338 O
screening 44 53 339 348 O
up 54 56 349 351 O
to 57 59 352 354 O
Day 60 63 355 358 O
100 64 67 359 362 O

Failure 0 7 363 370 O
to 8 10 371 373 O
achieve 11 18 374 381 O
Complete 19 27 382 390 O
Response 28 36 391 399 O
( 37 38 400 401 O
CR 38 40 401 403 O
) 40 41 403 404 O
following 42 51 405 414 O
initial 52 59 415 422 O
therapy 60 67 423 430 B-treatment

Glomerular 0 10 431 441 B-clinical_variable
Filtration 11 21 442 452 I-clinical_variable
Rate 22 26 453 457 I-clinical_variable
( 27 28 458 459 I-clinical_variable
GFR 28 31 459 462 I-clinical_variable
) 31 32 462 463 I-clinical_variable
≥ 33 34 464 465 O
60 35 37 466 468 B-lower_bound
ml 38 40 469 471 I-lower_bound
/ 40 41 471 472 I-lower_bound
min/1.73m2 41 51 472 482 I-lower_bound

HIV 0 3 483 486 B-chronic_disease
1 4 5 487 488 I-chronic_disease
& 6 7 489 490 I-chronic_disease
2 8 9 491 492 I-chronic_disease
antibody 10 18 493 501 O
( 19 20 502 503 O
Anti 20 24 503 507 O
- 24 25 507 508 O
HIV-1 25 30 508 513 B-chronic_disease
, 30 31 513 514 O
2 32 33 515 516 O
plus 34 38 517 521 O
O 39 40 522 523 O
) 40 41 523 524 O

HIV 0 3 525 528 B-chronic_disease
infection 4 13 529 538 O

HTLV 0 4 539 543 O
I 5 6 544 545 B-lower_bound
/ 6 7 545 546 O
II 7 9 546 548 B-upper_bound
antibody 10 18 549 557 O
( 19 20 558 559 O
Anti 20 24 559 563 O
- 24 25 563 564 O
HTLV 25 29 564 568 O
I 30 31 569 570 O
/ 31 32 570 571 O
II 32 34 571 573 O
) 34 35 573 574 O

Haploidentical 0 14 575 589 B-treatment
by 15 17 590 592 O
HLA 18 21 593 596 O
- 21 22 596 597 O
typing 22 28 597 603 O

Heart 0 5 604 609 B-chronic_disease
failure 6 13 610 617 I-chronic_disease

Hematologic 0 11 618 629 B-cancer
malignancy 12 22 630 640 I-cancer
or 23 25 641 643 O
solid 26 31 644 649 B-cancer
tumor 32 37 650 655 I-cancer

Hepatitis 0 9 656 665 B-treatment
B 10 11 666 667 I-treatment
core 12 16 668 672 I-treatment
antibody 17 25 673 681 I-treatment
( 26 27 682 683 I-treatment
Anti 27 31 683 687 I-treatment
- 31 32 687 688 I-treatment
HBc 32 35 688 691 I-treatment
) 35 36 691 692 I-treatment

Hepatitis 0 9 693 702 B-chronic_disease
B 10 11 703 704 I-chronic_disease
surface 12 19 705 712 O
antigen 20 27 713 720 O
( 28 29 721 722 O
HBsAg 29 34 722 727 O
) 34 35 727 728 O

Hepatitis 0 9 729 738 B-chronic_disease
C 10 11 739 740 I-chronic_disease
antibody 12 20 741 749 O
( 21 22 750 751 O
Anti 22 26 751 755 O
- 26 27 755 756 O
HCV 27 30 756 759 O
) 30 31 759 760 O

High 0 4 761 765 O
- 4 5 765 766 O
risk 5 9 766 770 O
refractory 10 20 771 781 O
or 21 23 782 784 O
relapsed 24 32 785 793 O
ALL 33 36 794 797 O
in 37 39 798 800 O
patients 40 48 801 809 O
for 49 52 810 813 O
whom 53 57 814 818 O
transplantation 58 73 819 834 B-treatment
is 74 76 835 837 O
deemed 77 83 838 844 O
indicated 84 93 845 854 O
( 94 95 855 856 O
relapse 95 102 856 863 O
occurring 103 112 864 873 O
< 113 114 874 875 O
30 115 117 876 878 B-upper_bound
months 118 124 879 885 I-upper_bound
from 125 129 886 890 O
diagnosis 130 139 891 900 O
, 139 140 900 901 O
patients 141 149 902 910 O
relapsing 150 159 911 920 O
after 160 165 921 926 O
previous 166 174 927 935 B-treatment
allogeneic 175 185 936 946 I-treatment
transplant 186 196 947 957 I-treatment
, 196 197 957 958 O
relapse 198 205 959 966 B-treatment
after 206 211 967 972 I-treatment
2nd 212 215 973 976 I-treatment
remission 216 225 977 986 I-treatment
, 225 226 986 987 O
primary 227 234 988 995 O
induction 235 244 996 1005 O
failure 245 252 1006 1013 O
or 253 255 1014 1016 O
hypodiploidy 256 268 1017 1029 B-cancer
) 268 269 1029 1030 O

Hodgkin 0 7 1031 1038 B-cancer
lymphoma 8 16 1039 1047 I-cancer
relapsing 17 26 1048 1057 O
after 27 32 1058 1063 O
auto 33 37 1064 1068 B-treatment
- 37 38 1068 1069 I-treatment
HSCT 38 42 1069 1073 I-treatment

If 0 2 1074 1076 O
measured 3 11 1077 1085 O
, 11 12 1085 1086 O
carbon 13 19 1087 1093 O
monoxide 20 28 1094 1102 O
diffusion 29 38 1103 1112 O
capacity 39 47 1113 1121 O
( 48 49 1122 1123 O
DLCO 49 53 1123 1127 B-clinical_variable
) 53 54 1127 1128 O
> 55 56 1129 1130 O
50 56 58 1130 1132 B-lower_bound
% 58 59 1132 1133 I-lower_bound

If 0 2 1134 1136 O
of 3 5 1137 1139 O
reproductive 6 18 1140 1152 O
potential 19 28 1153 1162 O
, 28 29 1162 1163 O
negative 30 38 1164 1172 B-pregnancy
pregnancy 39 48 1173 1182 I-pregnancy
test 49 53 1183 1187 O
and 54 57 1188 1191 O
willing 58 65 1192 1199 O
to 66 68 1200 1202 O
use 69 72 1203 1206 O
effective 73 82 1207 1216 O
birth 83 88 1217 1222 O
control 89 96 1223 1230 O
method 97 103 1231 1237 O

Is 0 2 1238 1240 O
free 3 7 1241 1245 O
from 8 12 1246 1250 O
communicable 13 25 1251 1263 O
disease 26 33 1264 1271 O
risks 34 39 1272 1277 O
associated 40 50 1278 1288 O
with 51 55 1289 1293 O
xenotransplantation 56 75 1294 1313 B-treatment

Is 0 2 1314 1316 O
free 3 7 1317 1321 O
from 8 12 1322 1326 O
risk 13 17 1327 1331 O
factors 18 25 1332 1339 O
for 26 29 1340 1343 O
, 29 30 1343 1344 O
and 31 34 1345 1348 O
clinical 35 43 1349 1357 O
evidence 44 52 1358 1366 O
of 53 55 1367 1369 O
, 55 56 1369 1370 O
infection 57 66 1371 1380 O
due 67 70 1381 1384 O
to 71 73 1385 1387 O
relevant 74 82 1388 1396 O
communicable 83 95 1397 1409 B-chronic_disease
disease 96 103 1410 1417 I-chronic_disease
agents 104 110 1418 1424 O
and 111 114 1425 1428 O
diseases 115 123 1429 1437 O

Lactating 0 9 1438 1447 O
females 10 17 1448 1455 B-gender

Life 0 4 1456 1460 B-clinical_variable
expectancy 5 15 1461 1471 I-clinical_variable
of 16 18 1472 1474 O
≥ 19 20 1475 1476 O
3 21 22 1477 1478 B-lower_bound
months 23 29 1479 1485 I-lower_bound

MPX 0 3 1486 1489 O
for 4 7 1490 1493 O
: 7 8 1493 1494 O
HepB 9 13 1495 1499 B-chronic_disease
( 14 15 1500 1501 O
HBV 15 18 1501 1504 O
- 18 19 1504 1505 O
PCR 19 22 1505 1508 O
) 22 23 1508 1509 O
, 23 24 1509 1510 O
HepC 25 29 1511 1515 B-chronic_disease
( 30 31 1516 1517 O
HCV 31 34 1517 1520 O
- 34 35 1520 1521 O
PCR 35 38 1521 1524 O
) 38 39 1524 1525 O
, 39 40 1525 1526 O
HIV 41 44 1527 1530 B-chronic_disease
( 45 46 1531 1532 O
HIV 46 49 1532 1535 O
- 49 50 1535 1536 O
PCR 50 53 1536 1539 O
) 53 54 1539 1540 O

Myelodysplastic 0 15 1541 1556 B-cancer
Syndrome 16 24 1557 1565 I-cancer
/ 24 25 1565 1566 O
Myeloproliferative 25 43 1566 1584 B-cancer
Syndrome 44 52 1585 1593 I-cancer

NAT 0 3 1594 1597 B-treatment
for 4 7 1598 1601 O
West 8 12 1602 1606 B-chronic_disease
Nile 13 17 1607 1611 I-chronic_disease
Virus 18 23 1612 1617 I-chronic_disease
( 24 25 1618 1619 O
WNV 25 28 1619 1622 B-treatment
- 28 29 1622 1623 I-treatment
PCR 29 32 1623 1626 I-treatment
) 32 33 1626 1627 O

Negative 0 8 1628 1636 O
testing 9 16 1637 1644 O
for 17 20 1645 1648 O
relevant 21 29 1649 1657 O
communicable 30 42 1658 1670 B-chronic_disease
diseases 43 51 1671 1679 I-chronic_disease

Neuroblastoma 0 13 1680 1693 B-cancer

No 0 2 1694 1696 O
evidence 3 11 1697 1705 O
of 12 14 1706 1708 O
dyspnea 15 22 1709 1716 B-chronic_disease
at 23 25 1717 1719 O
rest 26 30 1720 1724 O

No 0 2 1725 1727 O
severe 3 9 1728 1734 O
peripheral 10 20 1735 1745 B-chronic_disease
neuropathy 21 31 1746 1756 I-chronic_disease

No 0 2 1757 1759 O
supplemental 3 15 1760 1772 B-treatment
oxygen 16 22 1773 1779 I-treatment
requirement 23 34 1780 1791 O

Non 0 3 1792 1795 B-cancer
- 3 4 1795 1796 I-cancer
Hodgkin 4 11 1796 1803 I-cancer
lymphoma 12 20 1804 1812 I-cancer
relapsing 21 30 1813 1822 O
after 31 36 1823 1828 B-treatment
auto 37 41 1829 1833 I-treatment
- 41 42 1833 1834 I-treatment
HSCT 42 46 1834 1838 I-treatment

Osteosarcoma 0 12 1839 1851 B-cancer

Patient 0 7 1852 1859 O
must 8 12 1860 1864 O
have 13 17 1865 1869 O
fully 18 23 1870 1875 O
recovered 24 33 1876 1885 O
from 34 38 1886 1890 O
acute 39 44 1891 1896 O
toxic 45 50 1897 1902 O
effects 51 58 1903 1910 O
of 59 61 1911 1913 O
all 62 65 1914 1917 O
prior 66 71 1918 1923 B-treatment
chemotherapy 72 84 1924 1936 I-treatment
, 84 85 1936 1937 O
immunotherapy 86 99 1938 1951 B-treatment
, 99 100 1951 1952 O
or 101 103 1953 1955 O
radiotherapy 104 116 1956 1968 B-treatment
prior 117 122 1969 1974 O
to 123 125 1975 1977 O
entering 126 134 1978 1986 O
this 135 139 1987 1991 O
study 140 145 1992 1997 O

Patients 0 8 1998 2006 O
with 9 13 2007 2011 O
hematologic 14 25 2012 2023 B-cancer
malignancy 26 36 2024 2034 I-cancer
must 37 41 2035 2039 O
have 42 46 2040 2044 O
no 47 49 2045 2047 O
HLA 50 53 2048 2051 B-cancer
identical 54 63 2052 2061 O
sibling 64 71 2062 2069 O
or 72 74 2070 2072 O
suitable 75 83 2073 2081 O
unrelated 84 93 2082 2091 O
donor 94 99 2092 2097 O
OR 100 102 2098 2100 O
time 103 107 2101 2105 O
needed 108 114 2106 2112 O
to 115 117 2113 2115 O
find 118 122 2116 2120 O
an 123 125 2121 2123 O
acceptable 126 136 2124 2134 O
unrelated 137 146 2135 2144 O
donor 147 152 2145 2150 O
match 153 158 2151 2156 O

Patients 0 8 2157 2165 O
with 9 13 2166 2170 O
more 14 18 2171 2175 O
than 19 23 2176 2180 O
one 24 27 2181 2184 B-lower_bound
malignancy 28 38 2185 2195 B-cancer
( 39 40 2196 2197 O
hematologic 40 51 2197 2208 B-chronic_disease
or 52 54 2209 2211 O
solid 55 60 2212 2217 B-cancer
tumor 61 66 2218 2223 I-cancer
) 66 67 2223 2224 O

Patients 0 8 2225 2233 O
with 9 13 2234 2238 O
seizure 14 21 2239 2246 B-chronic_disease
disorders 22 31 2247 2256 I-chronic_disease
may 32 35 2257 2260 O
be 36 38 2261 2263 O
enrolled 39 47 2264 2272 O
if 48 50 2273 2275 O
seizures 51 59 2276 2284 B-chronic_disease
are 60 63 2285 2288 O
well 64 68 2289 2293 O
controlled 69 79 2294 2304 O
on 80 82 2305 2307 O
anticonvulsant 83 97 2308 2322 B-treatment
therapy 98 105 2323 2330 I-treatment

Patients 0 8 2331 2339 O
with 9 13 2340 2344 O
solid 14 19 2345 2350 B-cancer
tumor 20 25 2351 2356 I-cancer
must 26 30 2357 2361 O
have 31 35 2362 2366 O
failed 36 42 2367 2373 O
or 43 45 2374 2376 O
have 46 50 2377 2381 O
been 51 55 2382 2386 O
ineligible 56 66 2387 2397 O
to 67 69 2398 2400 O
receive 70 77 2401 2408 O
auto 78 82 2409 2413 B-treatment
- 82 83 2413 2414 I-treatment
HSCT 83 87 2414 2418 I-treatment
or 88 90 2419 2421 O
if 91 93 2422 2424 O
auto 94 98 2425 2429 O
- 98 99 2429 2430 O
HSCT 99 103 2430 2434 O
would 104 109 2435 2440 O
not 110 113 2441 2444 O
offer 114 119 2445 2450 O
> 120 121 2451 2452 O
20 122 124 2453 2455 B-lower_bound
% 124 125 2455 2456 I-lower_bound
chance 126 132 2457 2463 O
of 133 135 2464 2466 O
cure 136 140 2467 2471 O

Pregnant 0 8 2472 2480 B-pregnancy

Pregnant 0 8 2481 2489 B-pregnancy
females 9 16 2490 2497 B-gender

Primary 0 7 2498 2505 O
refractory 8 18 2506 2516 O
or 19 21 2517 2519 O
relapsed 22 30 2520 2528 O
non 31 34 2529 2532 B-cancer
- 34 35 2532 2533 I-cancer
Hodgkin 35 42 2533 2540 I-cancer
lymphoma 43 51 2541 2549 I-cancer
unable 52 58 2550 2556 O
to 59 61 2557 2559 O
achieve 62 69 2560 2567 O
2nd 70 73 2568 2571 O
remission 74 83 2572 2581 O
or 84 86 2582 2584 O
VGPR 87 91 2585 2589 O
and 92 95 2590 2593 O
therefore 96 105 2594 2603 O
ineligible 106 116 2604 2614 O
to 117 119 2615 2617 O
receive 120 127 2618 2625 O
auto 128 132 2626 2630 B-treatment
- 132 133 2630 2631 I-treatment
HSCT 133 137 2631 2635 I-treatment

Prior 0 5 2636 2641 B-treatment
organ 6 11 2642 2647 I-treatment
allograft 12 21 2648 2657 I-treatment

RPR 0 3 2658 2661 O
( 4 5 2662 2663 O
Syphilis 5 13 2663 2671 B-chronic_disease
TP 14 16 2672 2674 O
) 16 17 2674 2675 O

Relapsed 0 8 2676 2684 O
Hodgkin 9 16 2685 2692 B-cancer
lymphoma 17 25 2693 2701 I-cancer
unable 26 32 2702 2708 O
to 33 35 2709 2711 O
achieve 36 43 2712 2719 O
2nd 44 47 2720 2723 O
remission 48 57 2724 2733 O
or 58 60 2734 2736 O
Very 61 65 2737 2741 O
Good 66 70 2742 2746 O
Partial 71 78 2747 2754 O
Response 79 87 2755 2763 O
( 88 89 2764 2765 O
VGPR 89 93 2765 2769 O
) 93 94 2769 2770 O
and 95 98 2771 2774 O
therefore 99 108 2775 2784 O
ineligible 109 119 2785 2795 O
to 120 122 2796 2798 O
receive 123 130 2799 2806 O
autologous 131 141 2807 2817 B-treatment
hematopoietic 142 155 2818 2831 I-treatment
stem 156 160 2832 2836 I-treatment
cell 161 165 2837 2841 I-treatment
transplant 166 176 2842 2852 I-treatment
( 177 178 2853 2854 I-treatment
auto 178 182 2854 2858 I-treatment
- 182 183 2858 2859 I-treatment
HSCT 183 187 2859 2863 I-treatment
) 187 188 2863 2864 I-treatment

Relapsed 0 8 2865 2873 O
or 9 11 2874 2876 O
primary 12 19 2877 2884 B-cancer
refractory 20 30 2885 2895 I-cancer
metastatic 31 41 2896 2906 I-cancer

Relapsed 0 8 2907 2915 O
or 9 11 2916 2918 O
primary 12 19 2919 2926 B-treatment
therapy 20 27 2927 2934 I-treatment
- 27 28 2934 2935 O
refractory 28 38 2935 2945 O
AML 39 42 2946 2949 B-cancer
with 43 47 2950 2954 O
bone 48 52 2955 2959 B-clinical_variable
marrow 53 59 2960 2966 I-clinical_variable
blast 60 65 2967 2972 I-clinical_variable
< 66 67 2973 2974 O
20 68 70 2975 2977 B-upper_bound
% 70 71 2977 2978 I-upper_bound

Relapsed 0 8 2979 2987 O
with 9 13 2988 2992 O
pulmonary 14 23 2993 3002 B-cancer
or 24 26 3003 3005 O
bone 27 31 3006 3010 B-cancer
metastases 32 42 3011 3021 I-cancer
and 43 46 3022 3025 O
did 47 50 3026 3029 O
not 51 54 3030 3033 O
achieve 55 62 3034 3041 O
a 63 64 3042 3043 O
CR 65 67 3044 3046 O
with 68 72 3047 3051 O
surgery 73 80 3052 3059 B-treatment
and/or 81 87 3060 3066 O
chemotherapy 88 100 3067 3079 B-treatment

Significant 0 11 3080 3091 O
serious 12 19 3092 3099 O
intercurrent 20 32 3100 3112 B-chronic_disease
illness 33 40 3113 3120 I-chronic_disease
unrelated 41 50 3121 3130 O
to 51 53 3131 3133 O
cancer 54 60 3134 3140 B-cancer
or 61 63 3141 3143 O
its 64 67 3144 3147 O
treatment 68 77 3148 3157 B-treatment
not 78 81 3158 3161 O
covered 82 89 3162 3169 O
by 90 92 3170 3172 O
other 93 98 3173 3178 O
exclusion 99 108 3179 3188 O
criteria 109 117 3189 3197 O
expected 118 126 3198 3206 O
to 127 129 3207 3209 O
significantly 130 143 3210 3223 O
increase 144 152 3224 3232 O
the 153 156 3233 3236 O
risk 157 161 3237 3241 O
of 162 164 3242 3244 O
HSCT 165 169 3245 3249 B-clinical_variable

Soft 0 4 3250 3254 B-cancer
tissue 5 11 3255 3261 I-cancer
sarcomas 12 20 3262 3270 I-cancer
( 21 22 3271 3272 O
Rhabdomyosarcoma 22 38 3272 3288 B-cancer
, 38 39 3288 3289 O
Ewing 40 45 3290 3295 B-cancer
sarcoma 46 53 3296 3303 I-cancer
, 53 54 3303 3304 O
Primitive 55 64 3305 3314 B-cancer
Neuroectodermal 65 80 3315 3330 I-cancer
Tumor 81 86 3331 3336 I-cancer
or 87 89 3337 3339 O
other 90 95 3340 3345 O
high 96 100 3346 3350 O
- 100 101 3350 3351 O
risk 101 105 3351 3355 O
extracranial 106 118 3356 3368 B-cancer
solid 119 124 3369 3374 I-cancer
tumors 125 131 3375 3381 I-cancer
) 131 132 3381 3382 O

Study 0 5 3383 3388 O
enrollment 6 16 3389 3399 O
no 17 19 3400 3402 O
earlier 20 27 3403 3410 O
than 28 32 3411 3415 O
3 33 34 3416 3417 B-upper_bound
months 35 41 3418 3424 I-upper_bound
after 42 47 3425 3430 I-upper_bound
preceding 48 57 3431 3440 B-treatment
HSCT 58 62 3441 3445 I-treatment

T. 0 2 3446 3448 B-treatment
Cruzi 3 8 3449 3454 I-treatment
- 9 10 3455 3456 I-treatment
EIA 11 14 3457 3460 I-treatment
( 15 16 3461 3462 I-treatment
Chagas 16 22 3462 3468 I-treatment
) 22 23 3468 3469 I-treatment

Total 0 5 3470 3475 B-clinical_variable
bilirubin 6 15 3476 3485 I-clinical_variable
< 16 17 3486 3487 O
3 18 19 3488 3489 B-upper_bound
mg 20 22 3490 3492 I-upper_bound
/ 22 23 3492 3493 I-upper_bound
dL 23 25 3493 3495 I-upper_bound

Uncontrolled 0 12 3496 3508 B-chronic_disease
, 12 13 3508 3509 O
Serious 14 21 3510 3517 O
Active 22 28 3518 3524 B-chronic_disease
Infection 29 38 3525 3534 I-chronic_disease

active 0 6 3535 3541 O
Central 7 14 3542 3549 B-chronic_disease
Nervous 15 22 3550 3557 I-chronic_disease
System 23 29 3558 3564 I-chronic_disease
( 30 31 3565 3566 I-chronic_disease
CNS 31 34 3566 3569 I-chronic_disease
) 34 35 3569 3570 I-chronic_disease
infection 36 45 3571 3580 I-chronic_disease

signs 0 5 3581 3586 O
of 6 8 3587 3589 O
leukoencephalopathy 9 28 3590 3609 B-chronic_disease

uncontrolled 0 12 3610 3622 O
cardiac 13 20 3623 3630 B-chronic_disease
rhythm 21 27 3631 3637 I-chronic_disease
disturbance 28 39 3638 3649 I-chronic_disease

Age 0 3 0 3 B-age
above 4 9 4 9 O
or 10 12 10 12 O
equal 13 18 13 18 O
to 19 21 19 21 O
18 22 24 22 24 B-lower_bound
years 25 30 25 30 I-lower_bound

Anticoagulant 0 13 31 44 B-treatment
medication 14 24 45 55 I-treatment
of 25 27 56 58 O
any 28 31 59 62 O
kind 32 36 63 67 O
; 36 37 67 68 O
especially 38 48 69 79 O
Ascal 49 54 80 85 B-treatment
® 54 55 85 86 I-treatment
(and 55 59 86 90 O
derivates 60 69 91 100 O
) 69 70 100 101 O
, 70 71 101 102 O
coumarines 72 82 103 113 B-treatment
( 83 84 114 115 O
Sintrom 84 91 115 122 B-treatment
® 91 92 122 123 I-treatment
and 93 96 124 127 O
Marcoumar 97 106 128 137 B-treatment
® 106 107 137 138 I-treatment
) 107 108 138 139 O
, 108 109 139 140 O
all 110 113 141 144 O
heparin 114 121 145 152 B-treatment
and 122 125 153 156 O
heparin 126 133 157 164 O
- 133 134 164 165 O
like 134 138 165 169 O
formulations 139 151 170 182 O

Biopsy 0 6 183 189 B-treatment
proven 7 13 190 196 O
MLS 14 17 197 200 B-chronic_disease
( 18 19 201 202 O
including 19 28 202 211 O
the 29 32 212 215 O
reciprocal 33 43 216 226 B-treatment
chromosomal 44 55 227 238 I-treatment
translocation 56 69 239 252 I-treatment
t(12;16)(q13;p11 70 86 253 269 O
) 86 87 269 270 O
; 87 88 270 271 O
A 89 90 272 273 O
the 91 94 274 277 O
primary 95 102 278 285 B-cancer
sarcoma 103 110 286 293 I-cancer
in 111 113 294 296 O
case 114 118 297 301 O
of 119 121 302 304 O
non 122 125 305 308 B-cancer
- 125 126 308 309 I-cancer
metastatic 126 136 309 319 I-cancer
disease 137 144 320 327 I-cancer
for 145 148 328 331 O
management 149 159 332 342 O
is 160 162 343 345 O
with 163 167 346 350 O
curative 168 176 351 359 O
intent 177 183 360 366 O
( 184 185 367 368 O
regimen 185 192 368 375 O
to 193 195 376 378 O
be 196 198 379 381 O
chosen 199 205 382 388 O
= 206 207 389 390 O
18 208 210 391 393 O
x 211 212 394 395 O
2 213 214 396 397 O
GY 215 217 398 400 O
) 217 218 400 401 O
B 219 220 402 403 O
in 221 223 404 406 O
case 224 228 407 411 O
of 229 231 412 414 O
oligometastatic 232 247 415 430 B-cancer
patients 248 256 431 439 O
, 256 257 439 440 O
the 258 261 441 444 O
metastasis 262 272 445 455 O
may 273 276 456 459 O
also 277 281 460 464 O
be 282 284 465 467 O
irradiated 285 295 468 478 O
to 296 298 479 481 O
a 299 300 482 483 O
dose 301 305 484 488 O
of 306 308 489 491 O
36 309 311 492 494 B-treatment
GY 312 314 495 497 I-treatment
in 315 317 498 500 O
order 318 323 501 506 O
to 324 326 507 509 O
postpone 327 335 510 518 O
the 336 339 519 522 O
time 340 344 523 527 O
interval 345 353 528 536 O
to 354 356 537 539 O
next 357 361 540 544 O
systemic 362 370 545 553 B-treatment
chemotherapy 371 383 554 566 I-treatment
. 383 384 566 567 O
These 385 390 568 573 O
patients 391 399 574 582 O
are 400 403 583 586 O
usually 404 411 587 594 O
not 412 415 595 598 O
operated 416 424 599 607 O
upon 425 429 608 612 O
and 430 433 613 616 O
the 434 437 617 620 O
total 438 443 621 626 O
dose 444 448 627 631 O
may 449 452 632 635 O
also 453 457 636 640 O
be 458 460 641 643 O
reached 461 468 644 651 O
in 469 471 652 654 O
12 472 474 655 657 O
times 475 480 658 663 O
3 481 482 664 665 O
Gy 483 485 666 668 O
, 485 486 668 669 O
for 487 490 670 673 O
convenience 491 502 674 685 O
purposes 503 511 686 694 O
( 512 513 695 696 O
see 513 516 696 699 O
paragraph 517 526 700 709 O
10 527 529 710 712 O
for 530 533 713 716 O
radiobiological 534 549 717 732 O
considerations 550 564 733 747 O
) 564 565 747 748 O

ECOG 0 4 749 753 B-clinical_variable
( 5 6 754 755 I-clinical_variable
Eastern 6 13 755 762 I-clinical_variable
Cooperative 14 25 763 774 I-clinical_variable
Oncology 26 34 775 783 I-clinical_variable
Group 35 40 784 789 I-clinical_variable
) 40 41 789 790 I-clinical_variable

PS 0 2 791 793 B-clinical_variable
( 3 4 794 795 I-clinical_variable
Performance 4 15 795 806 I-clinical_variable
Status 16 22 807 813 I-clinical_variable
) 22 23 813 814 I-clinical_variable
0 24 25 815 816 B-lower_bound
- 25 26 816 817 O
2 26 27 817 818 B-upper_bound

Patients 0 8 819 827 O
must 9 13 828 832 O
be 14 16 833 835 O
able 17 21 836 840 O
( 22 23 841 842 O
physically 23 33 842 852 O
, 33 34 852 853 O
mentally 35 43 854 862 O
and 44 47 863 866 O
socially 48 56 867 875 O
) 56 57 875 876 O
to 58 60 877 879 O
complete 61 69 880 888 O
a 70 71 889 890 O
series 72 78 891 897 O
of 79 81 898 900 O
RT 82 84 901 903 O
, 84 85 903 904 O
followed 86 94 905 913 O
by 95 97 914 916 O
an 98 100 917 919 O
observation 101 112 920 931 B-clinical_variable
period 113 119 932 938 I-clinical_variable
of 120 122 939 941 O
4 123 124 942 943 B-lower_bound
- 124 125 943 944 O
6 125 126 944 945 B-upper_bound
weeks 127 132 946 951 I-upper_bound
and 133 136 952 955 O
undergo 137 144 956 963 O
surgery 145 152 964 971 B-treatment

Pregnancy 0 9 972 981 B-pregnancy

Prior 0 5 982 987 B-treatment
radiotherapy 6 18 988 1000 I-treatment
to 19 21 1001 1003 I-treatment
the 22 25 1004 1007 I-treatment
target 26 32 1008 1014 I-treatment
area 33 37 1015 1019 I-treatment

patients 0 8 1020 1028 O
on 9 11 1029 1031 O
anticoagulant 12 25 1032 1045 B-treatment
medication 26 36 1046 1056 I-treatment
as 37 39 1057 1059 O
described 40 49 1060 1069 O
above 50 55 1070 1075 O
may 56 59 1076 1079 O
take 60 64 1080 1084 O
part 65 69 1085 1089 O
in 70 72 1090 1092 O
the 73 76 1093 1096 O
dose 77 81 1097 1101 O
reduction 82 91 1102 1111 O
part 92 96 1112 1116 O
of 97 99 1117 1119 O
the 100 103 1120 1123 O
study 104 109 1124 1129 O
, 109 110 1129 1130 O
but 111 114 1131 1134 O
the 115 118 1135 1138 O
repeat 119 125 1139 1145 O
biopsies 126 134 1146 1154 O
may 135 138 1155 1158 O
not 139 142 1159 1162 O
be 143 145 1163 1165 O
taken 146 151 1166 1171 O

18 0 2 0 2 O
years 3 8 3 8 O
of 9 11 9 11 O
age 12 15 12 15 B-age

Mini 0 4 16 20 B-treatment
- 4 5 20 21 I-treatment
Mental 5 11 21 27 I-treatment
State 12 17 28 33 I-treatment
Examination 18 29 34 45 I-treatment
( 30 31 46 47 I-treatment
MMSE 31 35 47 51 I-treatment
: 35 36 51 52 I-treatment
[ 37 38 53 54 I-treatment
45 38 40 54 56 I-treatment
] 40 41 56 57 I-treatment
) 41 42 57 58 I-treatment

current 0 7 59 66 O
diagnosis 8 17 67 76 O
of 18 20 77 79 O
dementia 21 29 80 88 B-chronic_disease

current 0 7 89 96 O
diagnosis 8 17 97 106 O
of 18 20 107 109 O
mental 21 27 110 116 B-chronic_disease
retardation 28 39 117 128 I-chronic_disease
or 40 42 129 131 O
autistic 43 51 132 140 B-chronic_disease
disorder 52 60 141 149 I-chronic_disease

current 0 7 150 157 O
smoker 8 14 158 164 O
( 15 16 165 166 O
i.e. 16 20 166 170 O
, 20 21 170 171 O
at 22 24 172 174 O
least 25 30 175 180 O
5 31 32 181 182 B-lower_bound
cigarettes 33 43 183 193 O
/ 43 44 193 194 O
day 44 47 194 197 O
when 48 52 198 202 O
not 53 56 203 206 O
hospitalized 57 69 207 219 O
) 69 70 219 220 O

medical 0 7 221 228 O
contraindication 8 24 229 245 O
for 25 28 246 249 O
the 29 32 250 253 O
use 33 36 254 257 O
of 37 39 258 260 O
nicotine 40 48 261 269 B-treatment
replacement 49 60 270 281 I-treatment
therapy 61 68 282 289 I-treatment
( 69 70 290 291 I-treatment
NRT 70 73 291 294 I-treatment
) 73 74 294 295 I-treatment

no 0 2 296 298 B-technology_access
access 3 9 299 305 I-technology_access
to 10 12 306 308 I-technology_access
a 13 14 309 310 I-technology_access
telephone 15 24 311 320 I-technology_access
or 25 27 321 323 I-technology_access
inability 28 37 324 333 I-technology_access
to 38 40 334 336 I-technology_access
communicate 41 52 337 348 I-technology_access
by 53 55 349 351 I-technology_access
telephone 56 65 352 361 I-technology_access

patient 0 7 362 369 O
's 7 9 369 371 O
inability 10 19 372 381 O
to 20 22 382 384 O
provide 23 30 385 392 O
consent 31 38 393 400 O
for 39 42 401 404 O
study 43 48 405 410 O
participation 49 62 411 424 O
due 63 66 425 428 O
to 67 69 429 431 O
his 70 73 432 435 O
/ 73 74 435 436 O
her 74 77 436 439 O
inability 78 87 440 449 O
to 88 90 450 452 O
demonstrate 91 102 453 464 O
an 103 105 465 467 O
understanding 106 119 468 481 O
of 120 122 482 484 O
study 123 128 485 490 O
procedures 129 139 491 501 O
as 140 142 502 504 O
contained 143 152 505 514 O
in 153 155 515 517 O
the 156 159 518 521 O
statement 160 169 522 531 O
of 170 172 532 534 O
informed 173 181 535 543 O
consent 182 189 544 551 O
, 189 190 551 552 O
after 191 196 553 558 O
no 197 199 559 561 O
more 200 204 562 566 O
than 205 209 567 571 O
two 210 213 572 575 B-lower_bound
explanations 214 226 576 588 O

pregnancy 0 9 589 598 B-pregnancy
, 9 10 598 599 O
breastfeeding 11 24 600 613 O
, 24 25 613 614 O
or 26 28 615 617 O
plans 29 34 618 623 B-pregnancy
to 35 37 624 626 I-pregnancy
become 38 44 627 633 I-pregnancy
pregnant 45 53 634 642 I-pregnancy
within 54 60 643 649 O
6 61 62 650 651 B-upper_bound
months 63 69 652 658 I-upper_bound

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

Able 0 4 18 22 B-language_fluency
to 5 7 23 25 I-language_fluency
understand 8 18 26 36 I-language_fluency
English 19 26 37 44 I-language_fluency

Access 0 6 45 51 B-technology_access
to 7 9 52 54 I-technology_access
a 10 11 55 56 I-technology_access
telephone 12 21 57 66 I-technology_access

Currently 0 9 67 76 B-pregnancy
pregnant 10 18 77 85 I-pregnancy

Currently 0 9 86 95 O
using 10 15 96 101 O
chantix 16 23 102 109 B-treatment
or 24 26 110 112 O
wellbutrin 27 37 113 123 B-treatment

Diagnosed 0 9 124 133 O
with 10 14 134 138 O
an 15 17 139 141 O
unstable 18 26 142 150 B-chronic_disease
heart 27 32 151 156 I-chronic_disease
condition 33 42 157 166 I-chronic_disease

For 0 3 167 170 O
the 4 7 171 174 O
past 8 12 175 179 B-upper_bound
12 13 15 180 182 I-upper_bound
months 16 22 183 189 I-upper_bound
, 22 23 189 190 O
has 24 27 191 194 O
smoked 28 34 195 201 O
5 35 36 202 203 B-lower_bound
or 37 39 204 206 O
more 40 44 207 211 O
cigarettes 45 55 212 222 O
a 56 57 223 224 O
day 58 61 225 228 O

Not 0 3 229 232 O
currently 4 13 233 242 O
using 14 19 243 248 O
chantix 20 27 249 256 B-treatment
or 28 30 257 259 O
wellbutrin 31 41 260 270 B-treatment

Planning 0 8 271 279 O
to 9 11 280 282 O
quit 12 16 283 287 O
smoking 17 24 288 295 O
cigarettes 25 35 296 306 O
in 36 38 307 309 O
the 39 42 310 313 O
next 43 47 314 318 B-upper_bound
30 48 50 319 321 I-upper_bound
days 51 55 322 326 I-upper_bound

Willing 0 7 327 334 O
and 8 11 335 338 O
able 12 16 339 343 O
to 17 19 344 346 O
use 20 23 347 350 O
NRT 24 27 351 354 B-treatment
in 28 30 355 357 O
the 31 34 358 361 O
form 35 39 362 366 O
of 40 42 367 369 O
gum 43 46 370 373 O

planning 0 8 374 382 B-pregnancy
to 9 11 383 385 I-pregnancy
become 12 18 386 392 I-pregnancy
pregnant 19 27 393 401 I-pregnancy
in 28 30 402 404 O
the 31 34 405 408 O
next 35 39 409 413 B-upper_bound
12 40 42 414 416 I-upper_bound
months 43 49 417 423 I-upper_bound

4 0 1 0 1 B-upper_bound
priapism 2 10 2 10 B-chronic_disease
episodes 11 19 11 19 O
that 20 24 20 24 O
require 25 32 25 32 O
a 33 34 33 34 O
visit 35 40 35 40 O
to 41 43 41 43 O
a 44 45 44 45 O
medical 46 53 46 53 O
facility 54 62 54 62 O
( 63 64 63 64 O
without 64 71 64 71 O
inpatient 72 81 72 81 O
admission 82 91 82 91 O
) 91 92 91 92 O
are 93 96 93 96 O
sufficient 97 107 97 107 O
to 108 110 108 110 O
meet 111 115 111 115 O
criterion 116 125 116 125 O

Advanced 0 8 126 134 O
liver 9 14 135 140 B-chronic_disease
disease 15 22 141 148 I-chronic_disease

Any 0 3 149 152 O
contraindications 4 21 153 170 O
to 22 24 171 173 O
the 25 28 174 177 O
use 29 32 178 181 O
of 33 35 182 184 O
plerixafor 36 46 185 195 B-allergy_name
during 47 53 196 202 O
the 54 57 203 206 O
mobilization 58 70 207 219 O
of 71 73 220 222 O
hematopoietic 74 87 223 236 O
stem 88 92 237 241 O
cells 93 98 242 247 O

Any 0 3 248 251 O
history 4 11 252 259 O
of 12 14 260 262 O
severe 15 21 263 269 B-chronic_disease
cerebral 22 30 270 278 I-chronic_disease
vasculopathy 31 43 279 291 I-chronic_disease

Any 0 3 292 295 O
prior 4 9 296 301 O
or 10 12 302 304 O
current 13 20 305 312 O
malignancy 21 31 313 323 B-cancer
or 32 34 324 326 O
immunodeficiency 35 51 327 343 B-chronic_disease
disorder 52 60 344 352 I-chronic_disease

Baseline 0 8 353 361 B-clinical_variable
prothrombin 9 20 362 373 I-clinical_variable
time 21 25 374 378 I-clinical_variable
or 26 28 379 381 O
partial 29 36 382 389 B-clinical_variable
thromboplastin 37 51 390 404 I-clinical_variable
time 52 56 405 409 I-clinical_variable
> 57 58 410 411 O
1.5× 58 62 411 415 B-lower_bound
ULN 63 66 416 419 I-lower_bound

Be 0 2 420 422 O
≥12 3 6 423 426 O
and 7 10 427 430 O
≤50 11 14 431 434 O
of 15 17 435 437 O
age 18 21 438 441 B-age
at 22 24 442 444 O
time 25 29 445 449 O
of 30 32 450 452 O
consent 33 40 453 460 O

Clinically 0 10 461 471 O
significant 11 22 472 483 O
and 23 26 484 487 O
active 27 33 488 494 O
bacterial 34 43 495 504 B-chronic_disease
, 43 44 504 505 O
viral 45 50 506 511 B-chronic_disease
, 50 51 511 512 O
fungal 52 58 513 519 B-chronic_disease
, 58 59 519 520 O
or 60 62 521 523 O
parasitic 63 72 524 533 B-chronic_disease
infection 73 82 534 543 I-chronic_disease

Diagnosis 0 9 544 553 O
of 10 12 554 556 O
sickle 13 19 557 563 B-chronic_disease
cell 20 24 564 568 I-chronic_disease
disease 25 32 569 576 I-chronic_disease
( 33 34 577 578 I-chronic_disease
SCD 34 37 578 581 I-chronic_disease
) 37 38 581 582 I-chronic_disease
, 38 39 582 583 O
with 40 44 584 588 O
either 45 51 589 595 O
βS 52 54 596 598 O
/ 54 55 598 599 O
βS 55 57 599 601 O
or 58 60 602 604 O
βS 61 63 605 607 O
/ 63 64 607 608 O
β0 64 66 608 610 O
or 67 69 611 613 O
βS 70 72 614 616 O
/ 72 73 616 617 O
β+ 73 75 617 619 O
genotype 76 84 620 628 O

Diagnosis 0 9 629 638 O
of 10 12 639 641 O
significant 13 24 642 653 O
psychiatric 25 36 654 665 B-chronic_disease
disorder 37 45 666 674 I-chronic_disease
of 46 48 675 677 O
the 49 52 678 681 O
subject 53 60 682 689 O
that 61 65 690 694 O
, 65 66 694 695 O
in 67 69 696 698 O
the 70 73 699 702 O
Investigator 74 86 703 715 O
's 86 88 715 717 O
judgment 89 97 718 726 O
, 97 98 726 727 O
could 99 104 728 733 O
seriously 105 114 734 743 O
impede 115 121 744 750 O
the 122 125 751 754 O
ability 126 133 755 762 O
to 134 136 763 765 O
participate 137 148 766 777 O
in 149 151 778 780 O
the 152 155 781 784 O
study 156 161 785 790 O

For 0 3 791 794 O
the 4 7 795 798 O
purposes 8 16 799 807 O
of 17 19 808 810 O
this 20 24 811 815 O
study 25 30 816 821 O
, 30 31 821 822 O
a 32 33 823 824 O
severe 34 40 825 831 O
VOE 41 44 832 835 B-chronic_disease
is 45 47 836 838 O
defined 48 55 839 846 O
as 56 58 847 849 O
an 59 61 850 852 O
event 62 67 853 858 O
with 68 72 859 863 O
no 73 75 864 866 O
medically 76 85 867 876 O
determined 86 96 877 887 O
cause 97 102 888 893 O
other 103 108 894 899 O
than 109 113 900 904 O
a 114 115 905 906 O
vaso 116 120 907 911 O
- 120 121 911 912 O
occlusion 121 130 912 921 O
, 130 131 921 922 O
requiring 132 141 923 932 O
a 142 143 933 934 O
≥ 144 145 935 936 O
24 146 148 937 939 B-lower_bound
- 148 149 939 940 I-lower_bound
hour 149 153 940 944 I-lower_bound
hospital 154 162 945 953 O
or 163 165 954 956 O
Emergency 166 175 957 966 O
Room 176 180 967 971 O
( 181 182 972 973 O
ER 182 184 973 975 O
) 184 185 975 976 O
observation 186 197 977 988 O
unit 198 202 989 993 O
visit 203 208 994 999 O
or 209 211 1000 1002 O
at 212 214 1003 1005 O
least 215 220 1006 1011 O
2 221 222 1012 1013 O
visits 223 229 1014 1020 O
to 230 232 1021 1023 O
a 233 234 1024 1025 O
day 235 238 1026 1029 O
unit 239 243 1030 1034 O
or 244 246 1035 1037 O
ER 247 249 1038 1040 O
over 250 254 1041 1045 O
72 255 257 1046 1048 B-lower_bound
hours 258 263 1049 1054 I-lower_bound
with 264 268 1055 1059 O
both 269 273 1060 1064 O
visits 274 280 1065 1071 O
requiring 281 290 1072 1081 O
intravenous 291 302 1082 1093 B-treatment
treatment 303 312 1094 1103 I-treatment

Have 0 4 1104 1108 O
been 5 9 1109 1113 O
treated 10 17 1114 1121 O
and 18 21 1122 1125 O
followed 22 30 1126 1134 O
for 31 34 1135 1138 O
at 35 37 1139 1141 O
least 38 43 1142 1147 O
the 44 47 1148 1151 O
past 48 52 1152 1156 B-upper_bound
24 53 55 1157 1159 I-upper_bound
months 56 62 1160 1166 I-upper_bound
prior 63 68 1167 1172 I-upper_bound
to 69 71 1173 1175 O
Informed 72 80 1176 1184 O
Consent 81 88 1185 1192 O
in 89 91 1193 1195 O
medical 92 99 1196 1203 O
center(s 100 108 1204 1212 O
) 108 109 1212 1213 O
that 110 114 1214 1218 O
maintained 115 125 1219 1229 O
detailed 126 134 1230 1238 O
records 135 142 1239 1246 O
on 143 145 1247 1249 O
SCD 146 149 1250 1253 B-treatment
history 150 157 1254 1261 O

Have 0 4 1262 1266 O
either 5 11 1267 1273 O
experienced 12 23 1274 1285 O
hydroxyurea 24 35 1286 1297 B-treatment
( 36 37 1298 1299 I-treatment
HU 37 39 1299 1301 I-treatment
) 39 40 1301 1302 I-treatment
failure 41 48 1303 1310 O
at 49 51 1311 1313 O
any 52 55 1314 1317 O
point 56 61 1318 1323 O
in 62 64 1324 1326 O
the 65 68 1327 1330 O
past 69 73 1331 1335 O
or 74 76 1336 1338 O
must 77 81 1339 1343 O
have 82 86 1344 1348 O
intolerance 87 98 1349 1360 O
to 99 101 1361 1363 O
HU 102 104 1364 1366 O
( 105 106 1367 1368 O
defined 106 113 1368 1375 O
as 114 116 1376 1378 O
patient 117 124 1379 1386 O
being 125 130 1387 1392 O
unable 131 137 1393 1399 O
to 138 140 1400 1402 O
continue 141 149 1403 1411 O
to 150 152 1412 1414 O
take 153 157 1415 1419 O
HU 158 160 1420 1422 O
per 161 164 1423 1426 O
PI 165 167 1427 1429 O
judgement 168 177 1430 1439 O
) 177 178 1439 1440 O

Have 0 4 1441 1445 O
severe 5 11 1446 1452 O
SCD 12 15 1453 1456 B-chronic_disease

Immediate 0 9 1457 1466 O
family 10 16 1467 1473 O
member 17 23 1474 1480 O
with 24 28 1481 1485 O
a 29 30 1486 1487 O
known 31 36 1488 1493 O
or 37 39 1494 1496 O
suspected 40 49 1497 1506 O
Familial 50 58 1507 1515 B-chronic_disease
Cancer 59 65 1516 1522 I-chronic_disease
Syndrome 66 74 1523 1531 I-chronic_disease

In 0 2 1532 1534 O
subjects 3 11 1535 1543 O
< 12 13 1544 1545 O
18 13 15 1545 1547 B-upper_bound
years 16 21 1548 1553 I-upper_bound
of 22 24 1554 1556 O
age 25 28 1557 1560 B-age
, 28 29 1560 1561 O
these 30 35 1562 1567 O
MRI 36 39 1568 1571 B-treatment
findings 40 48 1572 1580 O
are 49 52 1581 1584 O
exclusionary 53 65 1585 1597 O
, 65 66 1597 1598 O
unless 67 73 1599 1605 O
in 74 76 1606 1608 O
the 77 80 1609 1612 O
opinion 81 88 1613 1620 O
of 89 91 1621 1623 O
the 92 95 1624 1627 O
Investigator 96 108 1628 1640 O
, 108 109 1640 1641 O
a 110 111 1642 1643 O
liver 112 117 1644 1649 B-treatment
biopsy 118 124 1650 1656 I-treatment
could 125 130 1657 1662 O
provide 131 138 1663 1670 O
additional 139 149 1671 1681 O
data 150 154 1682 1686 O
to 155 157 1687 1689 O
confirm 158 165 1690 1697 O
eligibility 166 177 1698 1709 O
and 178 181 1710 1713 O
would 182 187 1714 1719 O
be 188 190 1720 1722 O
safe 191 195 1723 1727 O
to 196 198 1728 1730 O
perform 199 206 1731 1738 O

Inadequate 0 10 1739 1749 O
bone 11 15 1750 1754 O
marrow 16 22 1755 1761 O
function 23 31 1762 1770 O
, 31 32 1770 1771 O
as 33 35 1772 1774 O
defined 36 43 1775 1782 O
by 44 46 1783 1785 O
an 47 49 1786 1788 O
absolute 50 58 1789 1797 B-clinical_variable
neutrophil 59 69 1798 1808 I-clinical_variable
count 70 75 1809 1814 I-clinical_variable
of 76 78 1815 1817 O
< 79 80 1818 1819 O
1000/µL 81 88 1820 1827 B-upper_bound
( 89 90 1828 1829 O
< 90 91 1829 1830 O
500/µL 92 98 1831 1837 B-upper_bound
for 99 102 1838 1841 O
subjects 103 111 1842 1850 O
on 112 114 1851 1853 O
HU 115 117 1854 1856 B-treatment
treatment 118 127 1857 1866 I-treatment
) 127 128 1866 1867 O
or 129 131 1868 1870 O
a 132 133 1871 1872 O
platelet 134 142 1873 1881 B-clinical_variable
count 143 148 1882 1887 I-clinical_variable
< 149 150 1888 1889 O
120,000/µL 151 161 1890 1900 B-upper_bound
( 162 163 1901 1902 O
without 163 170 1902 1909 O
hypersplenism 171 184 1910 1923 B-chronic_disease
) 184 185 1923 1924 O

Karnofsky 0 9 1925 1934 B-clinical_variable
performance 10 21 1935 1946 I-clinical_variable
status 22 28 1947 1953 I-clinical_variable
of 29 31 1954 1956 O
≥ 32 33 1957 1958 O
60 34 36 1959 1961 B-lower_bound
( 37 38 1962 1963 O
≥16 38 41 1963 1966 O
years 42 47 1967 1972 I-lower_bound
of 48 50 1973 1975 O
age 51 54 1976 1979 B-age
) 54 55 1979 1980 O

MRI 0 3 1981 1984 B-treatment
findings 4 12 1985 1993 O
suggestive 13 23 1994 2004 O
of 24 26 2005 2007 O
active 27 33 2008 2014 O
hepatitis 34 43 2015 2024 B-chronic_disease
, 43 44 2024 2025 O
significant 45 56 2026 2037 O
fibrosis 57 65 2038 2046 B-chronic_disease
, 65 66 2046 2047 O
inconclusive 67 79 2048 2060 O
evidence 80 88 2061 2069 O
of 89 91 2070 2072 O
cirrhosis 92 101 2073 2082 B-chronic_disease
, 101 102 2082 2083 O
or 103 105 2084 2086 O
liver 106 111 2087 2092 B-clinical_variable
iron 112 116 2093 2097 I-clinical_variable
concentration 117 130 2098 2111 I-clinical_variable
≥15 131 134 2112 2115 O
mg 135 137 2116 2118 I-lower_bound
/ 137 138 2118 2119 I-lower_bound
g 138 139 2119 2120 I-lower_bound
require 140 147 2121 2128 O
follow 148 154 2129 2135 O
- 154 155 2135 2136 O
up 155 157 2136 2138 O
liver 158 163 2139 2144 B-treatment
biopsy 164 170 2145 2151 I-treatment
in 171 173 2152 2154 O
subjects 174 182 2155 2163 O
≥18 183 186 2164 2167 O
years 187 192 2168 2173 I-lower_bound
of 193 195 2174 2176 O
age 196 199 2177 2180 B-age

Magnetic 0 8 2181 2189 B-treatment
Resonance 9 18 2190 2199 I-treatment
Imaging 19 26 2200 2207 I-treatment
( 27 28 2208 2209 I-treatment
MRI 28 31 2209 2212 I-treatment
) 31 32 2212 2213 I-treatment
of 33 35 2214 2216 O
the 36 39 2217 2220 O
liver 40 45 2221 2226 O
demonstrating 46 59 2227 2240 O
clear 60 65 2241 2246 O
evidence 66 74 2247 2255 O
of 75 77 2256 2258 O
cirrhosis 78 87 2259 2268 B-chronic_disease

Participation 0 13 2269 2282 O
in 14 16 2283 2285 O
another 17 24 2286 2293 B-treatment
clinical 25 33 2294 2302 I-treatment
study 34 39 2303 2308 I-treatment
with 40 44 2309 2313 I-treatment
an 45 47 2314 2316 I-treatment
investigational 48 63 2317 2332 I-treatment
drug 64 68 2333 2337 I-treatment
within 69 75 2338 2344 O
30 76 78 2345 2347 B-upper_bound
days 79 83 2348 2352 I-upper_bound
of 84 86 2353 2355 O
Screening 87 96 2356 2365 O

Patients 0 8 2366 2374 O
needing 9 16 2375 2382 O
curative 17 25 2383 2391 B-treatment
anticoagulation 26 41 2392 2407 I-treatment
therapy 42 49 2408 2415 I-treatment
during 50 56 2416 2422 O
the 57 60 2423 2426 O
period 61 67 2427 2433 O
of 68 70 2434 2436 O
conditioning 71 83 2437 2449 O
through 84 91 2450 2457 O
platelet 92 100 2458 2466 B-treatment
engraftment 101 112 2467 2478 I-treatment

Persistent 0 10 2479 2489 O
aspartate 11 20 2490 2499 B-clinical_variable
transaminase 21 33 2500 2512 I-clinical_variable

Positive 0 8 2513 2521 O
for 9 12 2522 2525 O
presence 13 21 2526 2534 O
of 22 24 2535 2537 O
human 25 30 2538 2543 B-chronic_disease
immunodeficiency 31 47 2544 2560 I-chronic_disease
virus 48 53 2561 2566 I-chronic_disease
type 54 58 2567 2571 I-chronic_disease
1 59 60 2572 2573 I-chronic_disease
or 61 63 2574 2576 I-chronic_disease
2 64 65 2577 2578 I-chronic_disease
( 66 67 2579 2580 O
HIV-1 67 72 2580 2585 B-chronic_disease
and 73 76 2586 2589 O
HIV-2 77 82 2590 2595 B-chronic_disease
) 82 83 2595 2596 O
, 83 84 2596 2597 O
hepatitis 85 94 2598 2607 B-chronic_disease
B 95 96 2608 2609 I-chronic_disease
virus 97 102 2610 2615 I-chronic_disease
( 103 104 2616 2617 I-chronic_disease
HBV 104 107 2617 2620 I-chronic_disease
) 107 108 2620 2621 I-chronic_disease
, 108 109 2621 2622 O
or 110 112 2623 2625 O
hepatitis 113 122 2626 2635 B-chronic_disease
C 123 124 2636 2637 I-chronic_disease
( 125 126 2638 2639 I-chronic_disease
HCV 126 129 2639 2642 I-chronic_disease
) 129 130 2642 2643 I-chronic_disease

Pregnancy 0 9 2644 2653 B-pregnancy

Prior 0 5 2654 2659 O
receipt 6 13 2660 2667 O
of 14 16 2668 2670 O
an 17 19 2671 2673 O
allogeneic 20 30 2674 2684 B-treatment
transplant 31 41 2685 2695 I-treatment

Prior 0 5 2696 2701 O
receipt 6 13 2702 2709 O
of 14 16 2710 2712 O
gene 17 21 2713 2717 B-treatment
therapy 22 29 2718 2725 I-treatment

Unable 0 6 2726 2732 O
to 7 9 2733 2735 O
receive 10 17 2736 2743 O
RBC 18 21 2744 2747 B-treatment
transfusion 22 33 2748 2759 I-treatment

a 0 1 2760 2761 O
Lansky 2 8 2762 2768 B-clinical_variable
performance 9 20 2769 2780 I-clinical_variable
status 21 27 2781 2787 I-clinical_variable
of 28 30 2788 2790 O
≥60 31 34 2791 2794 O
( 35 36 2795 2796 O
< 36 37 2796 2797 O
16 37 39 2797 2799 B-upper_bound
years 40 45 2800 2805 I-upper_bound
of 46 48 2806 2808 O
age 49 52 2809 2812 B-age
) 52 53 2812 2813 O

abnormal 0 8 2814 2822 B-clinical_variable
transcranial 9 21 2823 2835 I-clinical_variable
Doppler 22 29 2836 2843 I-clinical_variable
[ 30 31 2844 2845 O
≥200 31 35 2845 2849 O
cm 36 38 2850 2852 I-lower_bound
/ 38 39 2852 2853 I-lower_bound
sec 39 42 2853 2856 I-lower_bound
] 42 43 2856 2857 O
needing 44 51 2858 2865 O
chronic 52 59 2866 2873 B-treatment
transfusion 60 71 2874 2885 I-treatment

absence 0 7 2886 2893 O
of 8 10 2894 2896 O
adequate 11 19 2897 2905 B-contraception_consent
contraception 20 33 2906 2919 I-contraception_consent
for 34 37 2920 2923 O
fertile 38 45 2924 2931 O
subjects 46 54 2932 2940 O

any 0 3 2941 2944 O
contraindications 4 21 2945 2962 O
to 22 24 2963 2965 O
the 25 28 2966 2969 O
use 29 32 2970 2973 O
of 33 35 2974 2976 O
busulfan 36 44 2977 2985 B-treatment
and 45 48 2986 2989 O
any 49 52 2990 2993 O
other 53 58 2994 2999 O
medicinal 59 68 3000 3009 B-treatment
products 69 77 3010 3018 I-treatment
required 78 86 3019 3027 O
during 87 93 3028 3034 O
the 94 97 3035 3038 O
myeloablative 98 111 3039 3052 B-treatment
conditioning 112 124 3053 3065 I-treatment
, 124 125 3065 3066 O
including 126 135 3067 3076 O
hypersensitivity 136 152 3077 3093 O
to 153 155 3094 3096 O
the 156 159 3097 3100 O
active 160 166 3101 3107 O
substances 167 177 3108 3118 O
or 178 180 3119 3121 O
to 181 183 3122 3124 O
any 184 187 3125 3128 O
of 188 190 3129 3131 O
the 191 194 3132 3135 O
excipients 195 205 3136 3146 O

breastfeeding 0 13 3147 3160 O
in 14 16 3161 3163 O
a 17 18 3164 3165 O
postpartum 19 29 3166 3176 O
female 30 36 3177 3183 B-gender

direct 0 6 3184 3190 B-clinical_variable
bilirubin 7 16 3191 3200 I-clinical_variable
value 17 22 3201 3206 I-clinical_variable
> 23 24 3207 3208 O
3× 24 26 3208 3210 B-lower_bound
the 27 30 3211 3214 I-lower_bound
upper 31 36 3215 3220 I-lower_bound
limit 37 42 3221 3226 I-lower_bound
of 43 45 3227 3229 I-lower_bound
normal 46 52 3230 3236 I-lower_bound
( 53 54 3237 3238 I-lower_bound
ULN 54 57 3238 3241 I-lower_bound
) 57 58 3241 3242 I-lower_bound

in 0 2 3243 3245 O
the 3 6 3246 3249 O
setting 7 14 3250 3257 O
of 15 17 3258 3260 O
appropriate 18 29 3261 3272 O
supportive 30 40 3273 3283 O
care 41 45 3284 3288 O
measures 46 54 3289 3297 O
for 55 58 3298 3301 O
SCD 59 62 3302 3305 B-chronic_disease
( 63 64 3306 3307 O
e.g. 64 68 3307 3311 O
,pain 68 73 3311 3316 O
management 74 84 3317 3327 O
plan 85 89 3328 3332 O
) 89 90 3332 3333 O
have 91 95 3334 3338 O
experienced 96 107 3339 3350 O
at 108 110 3351 3353 O
least 111 116 3354 3359 O
4 117 118 3360 3361 B-lower_bound
severe 119 125 3362 3368 O
VOEs 126 130 3369 3373 B-chronic_disease
in 131 133 3374 3376 O
the 134 137 3377 3380 O
24 138 140 3381 3383 B-upper_bound
months 141 147 3384 3390 I-upper_bound
prior 148 153 3391 3396 I-upper_bound
to 154 156 3397 3399 O
informed 157 165 3400 3408 O
consent 166 173 3409 3416 O

occlusion 0 9 3417 3426 B-chronic_disease
or 10 12 3427 3429 O
stenosis 13 21 3430 3438 B-chronic_disease
in 22 24 3439 3441 O
the 25 28 3442 3445 O
polygon 29 36 3446 3453 O
of 37 39 3454 3456 O
Willis 40 46 3457 3463 O

overt 0 5 3464 3469 O
or 6 8 3470 3472 O
hemorrhagic 9 20 3473 3484 B-chronic_disease
stroke 21 27 3485 3491 I-chronic_disease

patients 0 8 3492 3500 O
on 9 11 3501 3503 O
prophylactic 12 24 3504 3516 O
doses 25 30 3517 3522 O
of 31 33 3523 3525 O
anticoagulants 34 48 3526 3540 B-treatment

presence 0 8 3541 3549 O
of 9 11 3550 3552 O
Moyamoya 12 20 3553 3561 B-chronic_disease
disease 21 28 3562 3569 I-chronic_disease

previously 0 10 3570 3580 O
treated 11 18 3581 3588 O
, 18 19 3588 3589 O
non 20 23 3590 3593 O
- 23 24 3593 3594 O
life 24 28 3594 3598 O
threatening 29 40 3599 3610 O
, 40 41 3610 3611 O
cured 42 47 3612 3617 O
tumors 48 54 3618 3624 B-cancer
such 55 59 3625 3629 O
as 60 62 3630 3632 O
squamous 63 71 3633 3641 B-cancer
cell 72 76 3642 3646 I-cancer
carcinoma 77 86 3647 3656 I-cancer
of 87 89 3657 3659 O
the 90 93 3660 3663 O
skin 94 98 3664 3668 O

priapism 0 8 3669 3677 B-chronic_disease
does 9 13 3678 3682 O
not 14 17 3683 3686 O
require 18 25 3687 3694 O
hospital 26 34 3695 3703 O
admission 35 44 3704 3713 O
but 45 48 3714 3717 O
does 49 53 3718 3722 O
require 54 61 3723 3730 O
a 62 63 3731 3732 O
medical 64 71 3733 3740 O
facility 72 80 3741 3749 O
visit 81 86 3750 3755 O

suspected 0 9 3756 3765 O
of 10 12 3766 3768 O
arising 13 20 3769 3776 O
from 21 25 3777 3781 O
liver 26 31 3782 3787 B-chronic_disease
disease 32 39 3788 3795 I-chronic_disease

HIV 0 3 0 3 B-chronic_disease
or 4 6 4 6 O
AIDS 7 11 7 11 B-chronic_disease
related 12 19 12 19 O
illness 20 27 20 27 B-chronic_disease

at 0 2 28 30 O
least 3 8 31 36 O
one 9 12 37 40 B-lower_bound
- 12 13 40 41 I-lower_bound
year 13 17 41 45 I-lower_bound
post 18 22 46 50 O
injury 23 29 51 57 O

cardiovascular 0 14 58 72 B-chronic_disease
, 14 15 72 73 O
respiratory 16 27 74 85 B-chronic_disease
, 27 28 85 86 O
bladder 29 36 87 94 B-chronic_disease
or 37 39 95 97 O
renal 40 45 98 103 B-chronic_disease
disease 46 53 104 111 I-chronic_disease
unrelated 54 63 112 121 O
to 64 66 122 124 O
SCI 67 70 125 128 O

dysautonomia 0 12 129 141 B-chronic_disease
that 13 17 142 146 O
would 18 23 147 152 O
contraindicate 24 38 153 167 O
standing 39 47 168 176 O

hypovolemia 0 11 177 188 B-chronic_disease

must 0 4 189 193 O
be 5 7 194 196 O
at 8 10 197 199 O
least 11 16 200 205 O
18 17 19 206 208 B-lower_bound
years 20 25 209 214 I-lower_bound
of 26 28 215 217 O
age 29 32 218 221 B-age

must 0 4 222 226 O
not 5 8 227 230 O
have 9 13 231 235 O
received 14 22 236 244 O
botox 23 28 245 250 O
injections 29 39 251 261 O
in 40 42 262 264 O
the 43 46 265 268 O
prior 47 52 269 274 B-upper_bound
six 53 56 275 278 I-upper_bound
months 57 63 279 285 I-upper_bound

no 0 2 286 288 O
clinically 3 13 289 299 O
significant 14 25 300 311 O
depression 26 36 312 322 B-chronic_disease

no 0 2 323 325 O
current 3 10 326 333 O
anti 11 15 334 338 B-treatment
- 15 16 338 339 I-treatment
spasticity 16 26 339 349 I-treatment
medication 27 37 350 360 I-treatment
regimen 38 45 361 368 I-treatment

no 0 2 369 371 O
painful 3 10 372 379 O
musculoskeletal 11 26 380 395 B-chronic_disease
dysfunction 27 38 396 407 I-chronic_disease
, 38 39 407 408 O
unhealed 40 48 409 417 O
fracture 49 57 418 426 O
, 57 58 426 427 O
contracture 59 70 428 439 O
, 70 71 439 440 O
pressure 72 80 441 449 O
sore 81 85 450 454 O

pressure 0 8 455 463 B-chronic_disease
sore 9 13 464 468 I-chronic_disease
that 14 18 469 473 O
might 19 24 474 479 O
interfere 25 34 480 489 O
with 35 39 490 494 O
training 40 48 495 503 O

severe 0 6 504 510 B-chronic_disease
anemia 7 13 511 517 I-chronic_disease
( 14 15 518 519 O
Hgb<8 15 20 519 524 B-clinical_variable
g 21 22 525 526 I-upper_bound
/ 22 23 526 527 I-upper_bound
dL 23 25 527 529 I-upper_bound
) 25 26 529 530 O

stable 0 6 531 537 O
medical 7 14 538 545 O
condition 15 24 546 555 O
without 25 32 556 563 O
cardiopulmonary 33 48 564 579 B-chronic_disease
disease 49 56 580 587 I-chronic_disease

urinary 0 7 588 595 B-chronic_disease
tract 8 13 596 601 I-chronic_disease
infection 14 23 602 611 I-chronic_disease
that 24 28 612 616 O
might 29 34 617 622 O
interfere 35 44 623 632 O
with 45 49 633 637 O
stand 50 55 638 643 O
or 56 58 644 646 O
step 59 63 647 651 O
training 64 72 652 660 O

Cardiac 0 7 0 7 B-chronic_disease

Creatinine 0 10 8 18 B-clinical_variable
clearance 11 20 19 28 I-clinical_variable
or 21 23 29 31 O
glomerular 24 34 32 42 B-clinical_variable
filtration 35 45 43 53 I-clinical_variable
rate 46 50 54 58 I-clinical_variable
( 51 52 59 60 I-clinical_variable
GFR 52 55 60 63 I-clinical_variable
) 55 56 63 64 I-clinical_variable
> 57 58 65 66 O
60 59 61 67 69 B-lower_bound
mL 62 64 70 72 I-lower_bound
/ 64 65 72 73 I-lower_bound
min/1.73m^2 65 76 73 84 I-lower_bound

Less 0 4 85 89 O
than 5 9 90 94 O
30 10 12 95 97 B-upper_bound
years 13 18 98 103 I-upper_bound
of 19 21 104 106 O
age 22 25 107 110 B-age
at 26 28 111 113 O
diagnosis 29 38 114 123 O
of 39 41 124 126 O
neuroblastoma 42 55 127 140 B-cancer

Minimum 0 7 141 148 O
frozen 8 14 149 155 O
peripheral 15 25 156 166 B-clinical_variable
blood 26 31 167 172 I-clinical_variable
stem 32 36 173 177 I-clinical_variable
cells 37 42 178 183 I-clinical_variable
( 43 44 184 185 I-clinical_variable
PBSCs 44 49 185 190 I-clinical_variable
) 49 50 190 191 I-clinical_variable
of 51 53 192 194 O
2 54 55 195 196 O
x 56 57 197 198 O
10 58 60 199 201 O
^ 60 61 201 202 O
6 61 62 202 203 O
CD34 63 67 204 208 O
cells 68 73 209 214 O
/ 73 74 214 215 O
kg 74 76 215 217 O
for 77 80 218 221 O
transplant 81 91 222 232 O
are 92 95 233 236 O
mandatory 96 105 237 246 O
and 106 109 247 250 O
2 110 111 251 252 O
x 112 113 253 254 O
10 114 116 255 257 O
^ 116 117 257 258 O
6 117 118 258 259 O
CD34 119 123 260 264 O
cells 124 129 265 270 O
/ 129 130 270 271 O
kg 130 132 271 273 O
for 133 136 274 277 O
back 137 141 278 282 O
- 141 142 282 283 O
up 142 144 283 285 O
are 145 148 286 289 O
strongly 149 157 290 298 O
recommended 158 169 299 310 O
( 170 171 311 312 O
thus 171 175 312 316 O
, 175 176 316 317 O
PBSC 177 181 318 322 O
of 182 184 323 325 O
4 185 186 326 327 O
x 187 188 328 329 O
106 189 192 330 333 O
CD34 193 197 334 338 O
cells 198 203 339 344 O
/ 203 204 344 345 O
kg 204 206 345 347 O
is 207 209 348 350 O
encouraged 210 220 351 361 O
) 220 221 361 362 O

No 0 2 363 365 O
evidence 3 11 366 374 O
of 12 14 375 377 O
disease 15 22 378 385 O
progression 23 34 386 397 O
: 34 35 397 398 O
defined 36 43 399 406 O
as 44 46 407 409 O
increase 47 55 410 418 O
in 56 58 419 421 O
tumor 59 64 422 427 O
size 65 69 428 432 O
of 70 72 433 435 O
> 73 74 436 437 O
25 74 76 437 439 B-lower_bound
% 76 77 439 440 I-lower_bound
or 78 80 441 443 O
new 81 84 444 447 O
lesions 85 92 448 455 O

Patients 0 8 456 464 O
who 9 12 465 468 O
are 13 16 469 472 O
delayed 17 24 473 480 O
in 25 27 481 483 O
consolidation 28 41 484 497 O
chemotherapy 42 54 498 510 B-treatment
beyond 55 61 511 517 O
8 62 63 518 519 B-lower_bound
weeks 64 69 520 525 I-lower_bound

Patients 0 8 526 534 O
with 9 13 535 539 O
progressive 14 25 540 551 B-chronic_disease
disease 26 33 552 559 I-chronic_disease
should 34 40 560 566 O
consider 41 49 567 575 O
participating 50 63 576 589 O
in 64 66 590 592 O
phase 67 72 593 598 O
I 73 74 599 600 O
studies 75 82 601 608 O
since 83 88 609 614 O
consolidation 89 102 615 628 B-treatment
therapy 103 110 629 636 I-treatment
using 111 116 637 642 O
the 117 120 643 646 O
regimen 121 128 647 654 O
outlined 129 137 655 663 O
in 138 140 664 666 O
this 141 145 667 671 O
document 146 154 672 680 O
have 155 159 681 685 O
not 160 163 686 689 O
been 164 168 690 694 O
determined 169 179 695 705 O
to 180 182 706 708 O
be 183 185 709 711 O
useful 186 192 712 718 O

Recovery 0 8 719 727 O
from 9 13 728 732 O
last 14 18 733 737 O
induction 19 28 738 747 O
course 29 35 748 754 O
of 36 38 755 757 O
chemotherapy 39 51 758 770 B-treatment

absolute 0 8 771 779 B-clinical_variable
neutrophil 9 19 780 790 I-clinical_variable
count 20 25 791 796 I-clinical_variable
> 26 27 797 798 O
500 28 31 799 802 B-lower_bound
and 32 35 803 806 O
platelet 36 44 807 815 B-clinical_variable
> 45 46 816 817 O
20,000 47 53 818 824 B-lower_bound

aspartate 0 9 825 834 B-clinical_variable
aminotransferase 10 26 835 851 I-clinical_variable
( 27 28 852 853 I-clinical_variable
AST 28 31 853 856 I-clinical_variable
) 31 32 856 857 I-clinical_variable
< 33 34 858 859 O
3 35 36 860 861 B-upper_bound
x 37 38 862 863 I-upper_bound
upper 39 44 864 869 I-upper_bound
limit 45 50 870 875 I-upper_bound
of 51 53 876 878 I-upper_bound
institutional 54 67 879 892 I-upper_bound
normal 68 74 893 899 I-upper_bound

shortening 0 10 900 910 B-clinical_variable
fraction 11 19 911 919 I-clinical_variable
≥ 20 21 920 921 O
27 22 24 922 924 B-lower_bound
% 24 25 924 925 I-lower_bound
or 26 28 926 928 O
ejection 29 37 929 937 B-clinical_variable
fraction 38 46 938 946 I-clinical_variable
≥ 47 48 947 948 O
50 49 51 949 951 B-lower_bound
% 51 52 951 952 I-lower_bound
, 52 53 952 953 O
no 54 56 954 956 O
clinical 57 65 957 965 O
congestive 66 76 966 976 B-chronic_disease
heart 77 82 977 982 I-chronic_disease
failure 83 90 983 990 I-chronic_disease

Patients 0 8 0 8 O
age 9 12 9 12 B-age
> 13 14 13 14 O
18 14 16 14 16 B-lower_bound
years 17 22 17 22 I-lower_bound
that 23 27 23 27 O
are 28 31 28 31 O
scheduled 32 41 32 41 O
for 42 45 42 45 O
endoscopic 46 56 46 56 B-treatment
resection 57 66 57 66 I-treatment
of 67 69 67 69 O
large 70 75 70 75 B-chronic_disease
colo 76 80 76 80 I-chronic_disease
- 80 81 80 81 I-chronic_disease
rectal 81 87 81 87 I-chronic_disease
lesions 88 95 88 95 I-chronic_disease
who 96 99 96 99 O
consent 100 107 100 107 O
to 108 110 108 110 O
this 111 115 111 115 O
study 116 121 116 121 O

Patients 0 8 122 130 O
with 9 13 131 135 O
lesions 14 21 136 143 O
showing 22 29 144 151 O
adenoma 30 37 152 159 B-cancer
invasion 38 46 160 168 O
into 47 51 169 173 O
the 52 55 174 177 O
muscularis 56 66 178 188 O
propria 67 74 189 196 O
on 75 77 197 199 O
EUS 78 81 200 203 B-treatment

Patients 0 8 204 212 O
without 9 16 213 220 O
at 17 19 221 223 O
least 20 25 224 229 O
one 26 29 230 233 B-lower_bound
colo 30 34 234 238 B-clinical_variable
- 34 35 238 239 I-clinical_variable
rectal 35 41 239 245 I-clinical_variable
lesions 42 49 246 253 I-clinical_variable
≥ 50 51 254 255 O
20 52 54 256 258 B-lower_bound
mm 54 56 258 260 I-lower_bound

Greater 0 7 0 7 O
than 8 12 8 12 O
three 13 18 13 18 B-lower_bound
years 19 24 19 24 I-lower_bound
post 25 29 25 29 O
- 29 30 29 30 O
activation 30 40 30 40 O
of 41 43 41 43 O
CI 44 46 44 46 B-treatment

Less 0 4 47 51 O
than 5 9 52 56 O
18 10 12 57 59 B-upper_bound
years 13 18 60 65 I-upper_bound
of 19 21 66 68 O
age 22 25 69 72 B-age

Prior 0 5 73 78 O
Aural 6 11 79 84 B-treatment
Rehabilitation 12 26 85 99 I-treatment
with 27 31 100 104 O
cochlear 32 40 105 113 B-treatment
implant 41 48 114 121 I-treatment

Sentence 0 8 122 130 B-clinical_variable
recognition 9 20 131 142 I-clinical_variable
scores 21 27 143 149 I-clinical_variable
( 28 29 150 151 I-clinical_variable
CasperSent 29 39 151 161 I-clinical_variable
) 39 40 161 162 I-clinical_variable
between 41 48 163 170 O
10 49 51 171 173 B-lower_bound
% 51 52 173 174 I-lower_bound
and 53 56 175 178 O
85 57 59 179 181 B-upper_bound
% 59 60 181 182 I-upper_bound

Any 0 3 0 3 O
major 4 9 4 9 O
congenital 10 20 10 20 B-chronic_disease
anomalies 21 30 21 30 I-chronic_disease

Bleeding 0 8 31 39 O
from 9 13 40 44 O
placenta 14 22 45 53 B-chronic_disease
previa 23 29 54 60 I-chronic_disease

Cord 0 4 61 65 B-chronic_disease
prolapse 5 13 66 74 I-chronic_disease

Meconium 0 8 75 83 B-chronic_disease

Premature 0 9 84 93 O
infants 10 17 94 101 O
between 18 25 102 109 O
28 26 28 110 112 B-lower_bound
and 29 32 113 116 O
34 33 35 117 119 B-upper_bound
6/7 36 39 120 123 I-upper_bound
weeks 40 45 124 129 I-upper_bound

Suspected 0 9 130 139 B-chronic_disease
placental 10 19 140 149 I-chronic_disease
abruption 20 29 150 159 I-chronic_disease

Terminal 0 8 160 168 B-chronic_disease
bradycardia 9 20 169 180 I-chronic_disease

A 0 1 0 1 O
score 2 7 2 7 O
of 8 10 8 10 O
16 11 13 11 13 B-lower_bound
or 14 16 14 16 O
greater 17 24 17 24 O
on 25 27 25 27 O
the 28 31 28 31 O
Hamilton 32 40 32 40 B-clinical_variable
Depression 41 51 41 51 I-clinical_variable
Rating 52 58 52 58 I-clinical_variable
Scale 59 64 59 64 I-clinical_variable
-32 65 68 65 68 I-clinical_variable
items 69 74 69 74 I-clinical_variable
( 75 76 75 76 I-clinical_variable
HAM 76 79 76 79 I-clinical_variable
- 79 80 79 80 I-clinical_variable
D- 80 82 80 82 I-clinical_variable
32 83 85 83 85 I-clinical_variable
) 85 86 85 86 I-clinical_variable

Any 0 3 87 90 O
investigational 4 19 91 106 B-treatment
psychotropic 20 32 107 119 I-treatment
drug 33 37 120 124 I-treatment
within 38 44 125 131 O
the 45 48 132 135 O
last 49 53 136 140 O
year 54 58 141 145 O

Any 0 3 146 149 O
unstable 4 12 150 158 O
concomitant 13 24 159 170 O
form 25 29 171 175 O
of 30 32 176 178 O
psychotherapy 33 46 179 192 B-treatment
( 47 48 193 194 O
depression 48 58 194 204 B-chronic_disease
- 58 59 204 205 O
focused 59 66 205 212 O
) 66 67 212 213 O

Clinical 0 8 214 222 B-clinical_variable
Global 9 15 223 229 I-clinical_variable
Impression 16 26 230 240 I-clinical_variable
Improvement 27 38 241 252 I-clinical_variable
( 39 40 253 254 I-clinical_variable
CGI 40 43 254 257 I-clinical_variable
) 43 44 257 258 I-clinical_variable
scores 45 51 259 265 I-clinical_variable
≤ 52 53 266 267 O
3 54 55 268 269 B-upper_bound
( 56 57 270 271 O
i.e. 57 61 271 275 O
minimally 62 71 276 285 O
improved 72 80 286 294 O
or 81 83 295 297 O
less 84 88 298 302 O
) 88 89 302 303 O
from 90 94 304 308 O
the 95 98 309 312 O
screen 99 105 313 319 O
to 106 108 320 322 O
the 109 112 323 326 O
baseline 113 121 327 335 O
visit 122 127 336 341 O

Color 0 5 342 347 O
- 5 6 347 348 O
blindness 6 15 348 357 O
for 16 19 358 361 O
blue 20 24 362 366 O
or 25 27 367 369 O
green 28 33 370 375 O
( 34 35 376 377 O
see 35 38 377 380 O
fMRI 39 43 381 385 B-treatment
task 44 48 386 390 I-treatment
) 48 49 390 391 O

Concomitant 0 11 392 403 O
use 12 15 404 407 O
of 16 18 408 410 O
trazodone 19 28 411 420 B-treatment
( 29 30 421 422 O
up 30 32 422 424 O
to 33 35 425 427 O
200 36 39 428 431 B-upper_bound
mg 40 42 432 434 I-upper_bound
daily 43 48 435 440 O
) 48 49 440 441 O

Continuing 0 10 442 452 O
to 11 13 453 455 O
meet 14 18 456 460 O
criteria 19 27 461 469 O
for 28 31 470 473 O
current 32 39 474 481 O
MDD 40 43 482 485 B-chronic_disease
at 44 46 486 488 O
baseline 47 55 489 497 O

Currently 0 9 498 507 O
taking 10 16 508 514 O
any 17 20 515 518 O
exclusionary 21 33 519 531 B-treatment
medications 34 45 532 543 I-treatment

Gabapentin 0 10 544 554 B-treatment
and 11 14 555 558 O
pregabalin 15 25 559 569 B-treatment
are 26 29 570 573 O
allowed 30 37 574 581 O

History 0 7 582 589 O
of 8 10 590 592 O
hepatic 11 18 593 600 B-chronic_disease
impairment 19 29 601 611 I-chronic_disease
or 30 32 612 614 O
congestive 33 43 615 625 B-chronic_disease
heart 44 49 626 631 I-chronic_disease
failure 50 57 632 639 I-chronic_disease

History 0 7 640 647 O
of 8 10 648 650 O
inadequate 11 21 651 661 O
response 22 30 662 670 O
/ 30 31 670 671 O
poor 31 35 671 675 O
tolerability 36 48 676 688 O
to 49 51 689 691 O
bupropio 52 60 692 700 B-allergy_name

Men 0 3 701 704 B-gender

Monoamine 0 9 705 714 B-treatment
oxidase 10 17 715 722 I-treatment
inhibitors 18 28 723 733 I-treatment

Only 0 4 734 738 O
one 5 8 739 742 O
failed 9 15 743 749 O
one 16 19 750 753 O
prior 20 25 754 759 O
antidepressant 26 40 760 774 B-treatment
in 41 43 775 777 O
the 44 47 778 781 O
current 48 55 782 789 O
episode 56 63 790 797 O

Patients 0 8 798 806 O
must 9 13 807 811 O
have 14 18 812 816 O
either 19 25 817 823 O
no 26 28 824 826 O
antidepressant 29 43 827 841 B-treatment
treatment 44 53 842 851 I-treatment
or 54 56 852 854 O
stable 57 63 855 861 O
( 64 65 862 863 O
for 65 68 863 866 O
at 69 71 867 869 O
least 72 77 870 875 O
4 78 79 876 877 B-lower_bound
weeks 80 85 878 883 I-lower_bound
prior 86 91 884 889 I-lower_bound
to 92 94 890 892 O
screening 95 104 893 902 O
) 104 105 902 903 O

Pregnant 0 8 904 912 B-pregnancy
women 9 14 913 918 B-gender

Receiving 0 9 919 928 O
or 10 12 929 931 O
have 13 17 932 936 O
received 18 26 937 945 O
during 27 33 946 952 O
the 34 37 953 956 O
index 38 43 957 962 O
episode 44 51 963 970 O
VNS 52 55 971 974 B-treatment
, 55 56 974 975 O
ECT 57 60 976 979 B-treatment
or 61 63 980 982 O
rTMS 64 68 983 987 B-treatment

Serious 0 7 988 995 B-chronic_disease
suicide 8 15 996 1003 I-chronic_disease

Subjects 0 8 1004 1012 O
who 9 12 1013 1016 O
have 13 17 1017 1021 O
not 18 21 1022 1025 O
responded 22 31 1026 1035 O
to 32 34 1036 1038 O
two 35 38 1039 1042 O
or 39 41 1043 1045 O
more 42 46 1046 1050 O
antidepressant 47 61 1051 1065 B-treatment
trials 62 68 1066 1072 O
of 69 71 1073 1075 O
adequate 72 80 1076 1084 O
doses 81 86 1085 1090 O
( 87 88 1091 1092 O
e.g. 88 92 1092 1096 O
, 92 93 1096 1097 O
fluoxetine 94 104 1098 1108 B-treatment
40 105 107 1109 1111 B-lower_bound
mg 108 110 1112 1114 I-lower_bound
/ 110 111 1114 1115 I-lower_bound
day 111 114 1115 1118 I-lower_bound
or 115 117 1119 1121 O
higher 118 124 1122 1128 O
) 124 125 1128 1129 O

Subjects 0 8 1130 1138 O
with 9 13 1139 1143 O
medical 14 21 1144 1151 O
contraindications 22 39 1152 1169 O
to 40 42 1170 1172 O
bupropion 43 52 1173 1182 B-treatment
( 53 54 1183 1184 O
e.g. 54 58 1184 1188 O
, 58 59 1188 1189 O
history 60 67 1190 1197 O
of 68 70 1198 1200 O
seizures 71 79 1201 1209 B-chronic_disease
, 79 80 1209 1210 O
uncontrolled 81 93 1211 1223 O
electrolyte 94 105 1224 1235 B-chronic_disease
imbalance 106 115 1236 1245 I-chronic_disease
due 116 119 1246 1249 I-chronic_disease
to 120 122 1250 1252 I-chronic_disease
eating 123 129 1253 1259 I-chronic_disease
disorders 130 139 1260 1269 I-chronic_disease
, 139 140 1269 1270 O
etc 141 144 1271 1274 O
. 144 145 1274 1275 O
) 145 146 1275 1276 O
unless 147 153 1277 1283 O
stable 154 160 1284 1290 O
for 161 164 1291 1294 O
8 165 166 1295 1296 B-upper_bound
weeks 167 172 1297 1302 I-upper_bound
prior 173 178 1303 1308 I-upper_bound
to 179 181 1309 1311 O
screening 182 191 1312 1321 O
and 192 195 1322 1325 O
there 196 201 1326 1331 O
will 202 206 1332 1336 O
be 207 209 1337 1339 O
no 210 212 1340 1342 O
changes 213 220 1343 1350 O
during 221 227 1351 1357 O
participation 228 241 1358 1371 O
in 242 244 1372 1374 O
the 245 248 1375 1378 O
study 249 254 1379 1384 O

Subjects 0 8 1385 1393 O
with 9 13 1394 1398 O
secondary 14 23 1399 1408 O
anxiety 24 31 1409 1416 B-chronic_disease
disorders 32 41 1417 1426 I-chronic_disease
, 41 42 1426 1427 O
like 43 47 1428 1432 O
panic 48 53 1433 1438 B-chronic_disease
, 53 54 1438 1439 O
GAD 55 58 1440 1443 B-chronic_disease
or 59 61 1444 1446 O
simple 62 68 1447 1453 B-chronic_disease
phobia 69 75 1454 1460 I-chronic_disease
will 76 80 1461 1465 O
be 81 83 1466 1468 O
allowed 84 91 1469 1476 O
, 91 92 1476 1477 O
in 93 95 1478 1480 O
order 96 101 1481 1486 O
to 102 104 1487 1489 O
make 105 109 1490 1494 O
the 110 113 1495 1498 O
population 114 124 1499 1509 O
studied 125 132 1510 1517 O
more 133 137 1518 1522 O
representative 138 152 1523 1537 O
of 153 155 1538 1540 O
the 156 159 1541 1544 O
general 160 167 1545 1552 O
population 168 178 1553 1563 O
of 179 181 1564 1566 O
MDD 182 185 1567 1570 B-chronic_disease

aged 0 4 1571 1575 B-age
18 5 7 1576 1578 B-lower_bound
to 8 10 1579 1581 O
60 11 13 1582 1584 B-upper_bound
years 14 19 1585 1590 I-upper_bound
old 20 23 1591 1594 O

antipsychotics 0 14 1595 1609 B-treatment
, 14 15 1609 1610 O
anticonvulsants 16 31 1611 1626 B-treatment
, 31 32 1626 1627 O
stimulants 33 43 1628 1638 B-treatment
, 43 44 1638 1639 O
dopaminergic 45 57 1640 1652 B-treatment
agents 58 64 1653 1659 I-treatment

any 0 3 1660 1663 O
history 4 11 1664 1671 O
of 12 14 1672 1674 O
seizure 15 22 1675 1682 B-chronic_disease
disorder 23 31 1683 1691 I-chronic_disease

bipolar 0 7 1692 1699 B-chronic_disease
disorder 8 16 1700 1708 I-chronic_disease

current 0 7 1709 1716 O
primary 8 15 1717 1724 O
diagnoses 16 25 1725 1734 O
of 26 28 1735 1737 O
panic 29 34 1738 1743 B-chronic_disease
disorder 35 43 1744 1752 I-chronic_disease
, 43 44 1752 1753 O
social 45 51 1754 1760 B-chronic_disease
phobia 52 58 1761 1767 I-chronic_disease
, 58 59 1767 1768 O
PTSD 60 64 1769 1773 B-chronic_disease
, 64 65 1773 1774 O
GAD 66 69 1775 1778 B-chronic_disease
, 69 70 1778 1779 O
or 71 73 1780 1782 O
OCD 74 77 1783 1786 B-chronic_disease

currently 0 9 1787 1796 O
taking 10 16 1797 1803 O
an 17 19 1804 1806 O
antidepressant 20 34 1807 1821 B-treatment
as 35 37 1822 1824 O
defined 38 45 1825 1832 O
by 46 48 1833 1835 O
the 49 52 1836 1839 O
MGH 53 56 1840 1843 O
- 56 57 1843 1844 O
ATRQ 57 61 1844 1848 O
, 61 62 1848 1849 O
in 63 65 1850 1852 O
the 66 69 1853 1856 O
current 70 77 1857 1864 O
episode 78 85 1865 1872 O
and 86 89 1873 1876 O
are 90 93 1877 1880 O
willing 94 101 1881 1888 O
to 102 104 1889 1891 O
take 105 109 1892 1896 O
bupropion 110 119 1897 1906 B-treatment
or 120 122 1907 1909 O
placebo 123 130 1910 1917 B-treatment
as 131 133 1918 1920 O
augmentation 134 146 1921 1933 O
, 146 147 1933 1934 O
since 148 153 1935 1940 O
we 154 156 1941 1943 O
are 157 160 1944 1947 O
using 161 166 1948 1953 O
subjects 167 175 1954 1962 O
as 176 178 1963 1965 O
their 179 184 1966 1971 O
own 185 188 1972 1975 O
controls 189 197 1976 1984 O
and 198 201 1985 1988 O
we 202 204 1989 1991 O
are 205 208 1992 1995 O
comparing 209 218 1996 2005 O
changes 219 226 2006 2013 O
within 227 233 2014 2020 O
subjects 234 242 2021 2029 O

history 0 7 2030 2037 O
of 8 10 2038 2040 O
eating 11 17 2041 2047 B-chronic_disease
disorder 18 26 2048 2056 I-chronic_disease
unless 27 33 2057 2063 O
if 34 36 2064 2066 O
in 37 39 2067 2069 O
remission 40 49 2070 2079 O
for 50 53 2080 2083 O
≥5 54 56 2084 2086 O
years 57 62 2087 2092 I-lower_bound
prior 63 68 2093 2098 I-lower_bound
to 69 71 2099 2101 O
screening 72 81 2102 2111 O
and 82 85 2112 2115 O
presenting 86 96 2116 2126 O
no 97 99 2127 2129 O
current 100 107 2130 2137 O
electrolyte 108 119 2138 2149 O
abnormalities 120 133 2150 2163 O

mood 0 4 2164 2168 B-chronic_disease
congruent 5 14 2169 2178 I-chronic_disease
or 15 17 2179 2181 O
mood 18 22 2182 2186 B-chronic_disease
incongruent 23 34 2187 2198 I-chronic_disease
psychotic 35 44 2199 2208 I-chronic_disease
features 45 53 2209 2217 O

organic 0 7 2218 2225 B-chronic_disease
mental 8 14 2226 2232 I-chronic_disease
disorders 15 24 2233 2242 I-chronic_disease

potential 0 9 2243 2252 O
augmenting 10 20 2253 2263 B-treatment
agents 21 27 2264 2270 I-treatment
( 28 29 2271 2272 O
e.g. 29 33 2272 2276 O
, 33 34 2276 2277 O
T3 35 37 2278 2280 B-treatment
, 37 38 2280 2281 O
SAMe 39 43 2282 2286 B-treatment
, 43 44 2286 2287 O
St. 45 48 2288 2291 B-treatment
John 49 53 2292 2296 I-treatment
's 53 55 2296 2298 I-treatment
Wort 56 60 2299 2303 I-treatment
, 60 61 2303 2304 O
lithium 62 69 2305 2312 B-treatment
, 69 70 2312 2313 O
) 70 71 2313 2314 O

psychotic 0 9 2315 2324 B-chronic_disease
disorders 10 19 2325 2334 I-chronic_disease

severe 0 6 2335 2341 O
borderline 7 17 2342 2352 B-chronic_disease
or 18 20 2353 2355 O
antisocial 21 31 2356 2366 B-chronic_disease
personality 32 43 2367 2378 I-chronic_disease
disorder 44 52 2379 2387 I-chronic_disease

women 0 5 2388 2393 B-gender

women 0 5 2394 2399 B-gender
of 6 8 2400 2402 O
child 9 14 2403 2408 O
bearing 15 22 2409 2416 O
potential 23 32 2417 2426 O
not 33 36 2427 2430 B-contraception_consent
using 37 42 2431 2436 I-contraception_consent
a 43 44 2437 2438 I-contraception_consent
medically 45 54 2439 2448 I-contraception_consent
accepted 55 63 2449 2457 I-contraception_consent
means 64 69 2458 2463 I-contraception_consent
of 70 72 2464 2466 I-contraception_consent
contraception 73 86 2467 2480 I-contraception_consent

Active 0 6 0 6 O
psychiatric 7 18 7 18 B-chronic_disease
disorder 19 27 19 27 I-chronic_disease

Active 0 6 28 34 B-chronic_disease
, 6 7 34 35 I-chronic_disease
uncontrolled 8 20 36 48 I-chronic_disease
infection 21 30 49 58 I-chronic_disease

Age 0 3 59 62 B-age
≥ 4 5 63 64 O
18 6 8 65 67 B-lower_bound
years 9 14 68 73 I-lower_bound

BSA 0 3 74 77 B-clinical_variable
< 4 5 78 79 O
1.4 6 9 80 83 B-upper_bound
m² 10 12 84 86 I-upper_bound

Coagulopathy 0 12 87 99 B-chronic_disease

Intolerant 0 10 100 110 O
of 11 13 111 113 O
anticoagulation 14 29 114 129 B-treatment
therapy 30 37 130 137 I-treatment

Listed 0 6 138 144 O
for 7 10 145 148 O
cardiac 11 18 149 156 B-treatment
transplant 19 29 157 167 I-treatment
as 30 32 168 170 O
a 33 34 171 172 O
status 35 41 173 179 O
1A 42 44 180 182 O
or 45 47 183 185 O
1B 48 50 186 188 O

NYHA 0 4 189 193 B-clinical_variable
Class 5 10 194 199 B-chronic_disease
IV 11 13 200 202 I-chronic_disease
heart 14 19 203 208 I-chronic_disease
failure 20 27 209 216 I-chronic_disease

Patients 0 8 217 225 O
refusing 9 17 226 234 O
blood 18 23 235 240 B-treatment
transfusion 24 35 241 252 I-treatment

Patients 0 8 253 261 O
with 9 13 262 266 O
an 14 16 267 269 O
unacceptable 17 29 270 282 O
risk 30 34 283 287 O
for 35 38 288 291 O
successful 39 49 292 302 O
LVAD 50 54 303 307 B-treatment
implantation 55 67 308 320 I-treatment
and 68 71 321 324 O
maintenance 72 83 325 336 O

Pregnancy 0 9 337 346 B-pregnancy

Presence 0 8 347 355 O
of 9 11 356 358 O
condition 12 21 359 368 O
other 22 27 369 374 O
than 28 32 375 379 O
heart 33 38 380 385 B-chronic_disease
failure 39 46 386 393 I-chronic_disease
that 47 51 394 398 O
would 52 57 399 404 O
limit 58 63 405 410 O
survival 64 72 411 419 O
to 73 75 420 422 O
less 76 80 423 427 O
than 81 85 428 432 O
3 86 87 433 434 B-upper_bound
years 88 93 435 440 I-upper_bound

Severe 0 6 441 447 B-chronic_disease
right 7 12 448 453 I-chronic_disease
ventricular 13 24 454 465 I-chronic_disease
failure 25 32 466 473 I-chronic_disease

irreversible 0 12 474 486 B-chronic_disease
cognitive 13 22 487 496 I-chronic_disease
dysfunction 23 34 497 508 I-chronic_disease

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Advanced 0 8 25 33 O
rheumatoid 9 19 34 44 B-chronic_disease
arthritis 20 29 45 54 I-chronic_disease
, 29 30 54 55 O
post 31 35 56 60 B-chronic_disease
- 35 36 60 61 I-chronic_disease
traumatic 36 45 61 70 I-chronic_disease
, 45 46 70 71 O
or 47 49 72 74 O
degenerative 50 62 75 87 B-chronic_disease
arthritis 63 72 88 97 I-chronic_disease
with 73 77 98 102 O
incapacitating 78 92 103 117 O
pain 93 97 118 122 O

Ankylosed 0 9 123 132 B-chronic_disease
joints 10 16 133 139 O
, 16 17 139 140 O
especially 18 28 141 151 O
cases 29 34 152 157 O
of 35 37 158 160 O
bilateral 38 47 161 170 O
ankylosis 48 57 171 180 B-chronic_disease
from 58 62 181 185 O
causes 63 69 186 192 O
other 70 75 193 198 O
than 76 80 199 203 O
active 81 87 204 210 O
sepsis 88 94 211 217 B-chronic_disease

Instability 0 11 218 229 O
or 12 14 230 232 O
loss 15 19 233 237 O
of 20 22 238 240 O
motion 23 29 241 247 O
when 30 34 248 252 O
the 35 38 253 256 O
degree 39 45 257 263 O
of 46 48 264 266 O
joint 49 54 267 272 O
or 55 57 273 275 O
soft 58 62 276 280 O
tissue 63 69 281 287 O
damage 70 76 288 294 O
precludes 77 86 295 304 O
reliable 87 95 305 313 O
osteosynthesis 96 110 314 328 B-chronic_disease

Patient 0 7 329 336 O
has 8 11 337 340 O
a 12 13 341 342 O
current 14 21 343 350 O
major 22 27 351 356 B-chronic_disease
infection 28 37 357 366 I-chronic_disease
distant 38 45 367 374 O
from 46 50 375 379 O
the 51 54 380 383 O
operative 55 64 384 393 O
site 65 69 394 398 O

Patient 0 7 399 406 O
has 8 11 407 410 O
a 12 13 411 412 O
currently 14 23 413 422 O
active 24 30 423 429 O
or 31 33 430 432 O
history 34 41 433 440 O
of 42 44 441 443 O
repeated 45 53 444 452 O
local 54 59 453 458 O
infection 60 69 459 468 B-chronic_disease
at 70 72 469 471 O
the 73 76 472 475 O
surgical 77 85 476 484 O
site 86 90 485 489 O

Patient 0 7 490 497 O
has 8 11 498 501 O
a 12 13 502 503 O
history 14 21 504 511 O
of 22 24 512 514 O
prior 25 30 515 520 O
sepsis 31 37 521 527 B-chronic_disease

Patient 0 7 528 535 O
has 8 11 536 539 O
significant 12 23 540 551 O
ipsilateral 24 35 552 563 B-chronic_disease
hand 36 40 564 568 I-chronic_disease
dysfunction 41 52 569 580 I-chronic_disease

Patient 0 7 581 588 O
information 8 19 589 600 O
available 20 29 601 610 O
for 30 33 611 614 O
each 34 38 615 619 O
retrospective 39 52 620 633 O
patient 53 60 634 641 O
must 61 65 642 646 O
, 65 66 646 647 O
at 67 69 648 650 O
minimum 70 77 651 658 O
, 77 78 658 659 O
include 79 86 660 667 O
preoperative 87 99 668 680 O
demographic 100 111 681 692 O
information 112 123 693 704 O
, 123 124 704 705 O
preoperative 125 137 706 718 O
physical 138 146 719 727 O
exam 147 151 728 732 O
information 152 163 733 744 O
, 163 164 744 745 O
the 165 168 746 749 O
index 169 174 750 755 O
surgery 175 182 756 763 B-treatment
operative 183 192 764 773 O
report 193 199 774 780 O
, 199 200 780 781 O
and 201 204 782 785 O
details 205 212 786 793 O
of 213 215 794 796 O
the 216 219 797 800 O
devices 220 227 801 808 O
implanted 228 237 809 818 O

Patient 0 7 819 826 O
is 8 10 827 829 O
a 11 12 830 831 O
candidate 13 22 832 841 O
for 23 26 842 845 O
primary 27 34 846 853 B-treatment
or 35 37 854 856 I-treatment
revision 38 46 857 865 I-treatment
total 47 52 866 871 I-treatment
elbow 53 58 872 877 I-treatment
arthroplasty 59 71 878 890 I-treatment

Patient 0 7 891 898 O
is 8 10 899 901 O
known 11 16 902 907 B-pregnancy
to 17 19 908 910 I-pregnancy
be 20 22 911 913 I-pregnancy
pregnant 23 31 914 922 I-pregnancy

Patient 0 7 923 930 O
is 8 10 931 933 O
mentally 11 19 934 942 B-chronic_disease
incompetent 20 31 943 954 I-chronic_disease
or 32 34 955 957 O
unable 35 41 958 964 O
to 42 44 965 967 O
understand 45 55 968 978 O
what 56 60 979 983 O
participation 61 74 984 997 O
in 75 77 998 1000 O
the 78 81 1001 1004 O
study 82 87 1005 1010 O
entails 88 95 1011 1018 O

Patient 0 7 1019 1026 O
must 8 12 1027 1031 O
have 13 17 1032 1036 O
undergone 18 27 1037 1046 O
a 28 29 1047 1048 O
total 30 35 1049 1054 B-treatment
elbow 36 41 1055 1060 I-treatment
replacement 42 53 1061 1072 I-treatment
with 54 58 1073 1077 O
the 59 62 1078 1081 O
Nexel 63 68 1082 1087 B-treatment
system 69 75 1088 1094 O
between 76 83 1095 1102 O
July 84 88 1103 1107 B-lower_bound
2013 89 93 1108 1112 I-lower_bound
and 94 97 1113 1116 O
the 98 101 1117 1120 O
date 102 106 1121 1125 O
of 107 109 1126 1128 O
the 110 113 1129 1132 O
site 114 118 1133 1137 O
initiation 119 129 1138 1148 O
visit 130 135 1149 1154 O

Patient 0 7 1155 1162 O
suffers 8 15 1163 1170 O
from 16 20 1171 1175 O
paralysis 21 30 1176 1185 B-chronic_disease
or 31 33 1186 1188 O
dysfunctional 34 47 1189 1202 B-chronic_disease
neuropathy 48 58 1203 1213 I-chronic_disease
at 59 61 1214 1216 I-chronic_disease
the 62 65 1217 1220 I-chronic_disease
elbow 66 71 1221 1226 I-chronic_disease
joint 72 77 1227 1232 I-chronic_disease

ANC 0 3 0 3 B-clinical_variable
≥ 4 5 4 5 O
1,500 6 11 6 11 B-lower_bound
/ 11 12 11 12 I-lower_bound
mm³ 12 15 12 15 I-lower_bound

AST 0 3 16 19 B-clinical_variable
≤ 4 5 20 21 O
3 6 7 22 23 B-upper_bound
times 8 13 24 29 I-upper_bound
ULN 14 17 30 33 B-clinical_variable
( 18 19 34 35 O
5 19 20 35 36 B-upper_bound
times 21 26 37 42 I-upper_bound
ULN 27 30 43 46 O
if 31 33 47 49 O
direct 34 40 50 56 O
liver 41 46 57 62 O
involvement 47 58 63 74 O
by 59 61 75 77 O
lymphoma 62 70 78 86 B-cancer
) 70 71 86 87 O

Able 0 4 88 92 O
to 5 7 93 95 O
receive 8 15 96 103 O
concurrent 16 26 104 114 O
prophylactic 27 39 115 127 B-treatment
anticoagulation 40 55 128 143 I-treatment
therapy 56 63 144 151 I-treatment
( 64 65 152 153 O
e.g. 65 69 153 157 O
, 69 70 157 158 O
low 71 74 159 162 O
- 74 75 162 163 O
dose 75 79 163 167 O
aspirin 80 87 168 175 B-treatment
[ 88 89 176 177 O
81 89 91 177 179 O
mg 92 94 180 182 O
] 94 95 182 183 O
daily 96 101 184 189 O
or 102 104 190 192 O
an 105 107 193 195 O
alternative 108 119 196 207 O
prophylaxis 120 131 208 219 B-treatment
[ 132 133 220 221 O
e.g. 133 137 221 225 O
, 137 138 225 226 O
warfarin 139 147 227 235 B-treatment
or 148 150 236 238 O
low 151 154 239 242 B-treatment
molecular 155 164 243 252 I-treatment
weight 165 171 253 259 I-treatment
heparin 172 179 260 267 I-treatment
] 179 180 267 268 O
) 180 181 268 269 O

Alkaline 0 8 270 278 B-clinical_variable
phosphatase 9 20 279 290 I-clinical_variable
≤ 21 22 291 292 O
3 23 24 293 294 B-upper_bound
times 25 30 295 300 I-upper_bound
ULN 31 34 301 304 B-clinical_variable
( 35 36 305 306 O
5 36 37 306 307 B-upper_bound
times 38 43 308 313 I-upper_bound
ULN 44 47 314 317 O
if 48 50 318 320 O
direct 51 57 321 327 O
liver 58 63 328 333 O
involvement 64 75 334 345 O
by 76 78 346 348 O
lymphoma 79 87 349 357 B-cancer
) 87 88 357 358 O

CD20 0 4 359 363 B-cancer
- 4 5 363 364 I-cancer
positive 5 13 364 372 I-cancer
disease 14 21 373 380 I-cancer

Cardiac 0 7 381 388 B-chronic_disease
arrhythmia 8 18 389 399 I-chronic_disease

Creatinine 0 10 400 410 B-clinical_variable
≤ 11 12 411 412 O
2 13 14 413 414 B-upper_bound
times 15 20 415 420 I-upper_bound
ULN 21 24 421 424 I-upper_bound

ECOG 0 4 425 429 B-clinical_variable
performance 5 16 430 441 I-clinical_variable
status 17 23 442 448 I-clinical_variable
0 24 25 449 450 B-lower_bound
- 25 26 450 451 O
2 26 27 451 452 B-upper_bound

Ejection 0 8 453 461 B-clinical_variable
fraction 9 17 462 470 I-clinical_variable
≥ 18 19 471 472 O
45 20 22 473 475 B-lower_bound
% 22 23 475 476 I-lower_bound
by 24 26 477 479 O
MUGA 27 31 480 484 B-treatment
or 32 34 485 487 O
ECHO 35 39 488 492 B-treatment

Fertile 0 7 493 500 O
female 8 14 501 507 B-gender
patients 15 23 508 516 I-gender
must 24 28 517 521 B-contraception_consent
use 29 32 522 525 I-contraception_consent
effective 33 42 526 535 I-contraception_consent
double 43 49 536 542 I-contraception_consent
- 49 50 542 543 I-contraception_consent
method 50 56 543 549 I-contraception_consent
contraception 57 70 550 563 I-contraception_consent
for 71 74 564 567 O
≥ 75 76 568 569 O
28 77 79 570 572 B-lower_bound
days 80 84 573 577 I-lower_bound
before 85 91 578 584 O
, 91 92 584 585 O
during 93 99 586 592 O
, 99 100 592 593 O
and 101 104 594 597 O
for 105 108 598 601 O
≥ 109 110 602 603 O
28 111 113 604 606 O
days 114 118 607 611 O
after 119 124 612 617 O
completion 125 135 618 628 O
of 136 138 629 631 O
study 139 144 632 637 O
therapy 145 152 638 645 B-treatment

Fertile 0 7 646 653 O
male 8 12 654 658 B-gender
patients 13 21 659 667 I-gender
must 22 26 668 672 O
use 27 30 673 676 B-contraception_consent
effective 31 40 677 686 I-contraception_consent
contraception 41 54 687 700 I-contraception_consent
during 55 61 701 707 O
and 62 65 708 711 O
for 66 69 712 715 O
≥ 70 71 716 717 O
28 72 74 718 720 B-lower_bound
days 75 79 721 725 I-lower_bound
after 80 85 726 731 O
completion 86 96 732 742 O
of 97 99 743 745 O
study 100 105 746 751 O
therapy 106 113 752 759 B-treatment
, 113 114 759 760 O
even 115 119 761 765 O
if 120 122 766 768 O
they 123 127 769 773 O
have 128 132 774 778 O
had 133 136 779 782 O
a 137 138 783 784 O
successful 139 149 785 795 O
vasectomy 150 159 796 805 B-treatment

Histologically 0 14 806 820 O
confirmed 15 24 821 830 O
diffuse 25 32 831 838 B-cancer
large 33 38 839 844 I-cancer
cell 39 43 845 849 I-cancer
or 44 46 850 852 O
grade 47 52 853 858 B-cancer
3A 53 55 859 861 I-cancer
/ 55 56 861 862 I-cancer
B 56 57 862 863 I-cancer
follicular 58 68 864 874 I-cancer
lymphoma 69 77 875 883 I-cancer

Measurable 0 10 884 894 B-clinical_variable
disease 11 18 895 902 I-clinical_variable
, 18 19 902 903 O
defined 20 27 904 911 O
as 28 30 912 914 O
≥ 31 32 915 916 O
1 33 34 917 918 B-lower_bound
lesion 35 41 919 925 I-lower_bound
≥ 42 43 926 927 O
1.5 44 47 928 931 B-lower_bound
cm 48 50 932 934 I-lower_bound
in 51 53 935 937 O
one 54 57 938 941 O
diameter 58 66 942 950 O
, 66 67 950 951 O
as 68 70 952 954 O
detected 71 79 955 963 O
by 80 82 964 966 O
CT 83 85 967 969 B-treatment
scan 86 90 970 974 I-treatment
or 91 93 975 977 O
PET 94 97 978 981 B-treatment
- 97 98 981 982 I-treatment
CT 98 100 982 984 I-treatment
scan 101 105 985 989 I-treatment
( 106 107 990 991 O
PET 107 110 991 994 B-treatment
/ 110 111 994 995 I-treatment
CT 111 113 995 997 I-treatment
fusion 114 120 998 1004 I-treatment
) 120 121 1004 1005 O

Negative 0 8 1006 1014 B-pregnancy
pregnancy 9 18 1015 1024 I-pregnancy
test 19 23 1025 1029 O

No 0 2 1030 1032 O
CNS 3 6 1033 1036 B-cancer
lymphoma 7 15 1037 1045 I-cancer
or 16 18 1046 1048 O
cerebrospinal 19 32 1049 1062 B-chronic_disease
fluid 33 38 1063 1068 I-chronic_disease
involvement 39 50 1069 1080 O
with 51 55 1081 1085 O
malignant 56 65 1086 1095 B-cancer
lymphoma 66 74 1096 1104 I-cancer
cells 75 80 1105 1110 I-cancer

No 0 2 1111 1113 O
blood 3 8 1114 1119 O
, 8 9 1119 1120 O
sperm 10 15 1121 1126 O
, 15 16 1126 1127 O
or 17 19 1128 1130 O
semen 20 25 1131 1136 O
donation 26 34 1137 1145 O
during 35 41 1146 1152 O
and 42 45 1153 1156 O
for 46 49 1157 1160 O
≥ 50 51 1161 1162 O
28 52 54 1163 1165 B-lower_bound
days 55 59 1166 1170 I-lower_bound
after 60 65 1171 1176 O
completion 66 76 1177 1187 O
of 77 79 1188 1190 O
study 80 85 1191 1196 O
therapy 86 93 1197 1204 B-treatment

No 0 2 1205 1207 O
comorbid 3 11 1208 1216 O
systemic 12 20 1217 1225 B-chronic_disease
illness 21 28 1226 1233 I-chronic_disease
or 29 31 1234 1236 O
other 32 37 1237 1242 O
severe 38 44 1243 1249 O
concurrent 45 55 1250 1260 O
disease 56 63 1261 1268 O
that 64 68 1269 1273 O
, 68 69 1273 1274 O
in 70 72 1275 1277 O
the 73 76 1278 1281 O
judgment 77 85 1282 1290 O
of 86 88 1291 1293 O
the 89 92 1294 1297 O
investigator 93 105 1298 1310 O
, 105 106 1310 1311 O
would 107 112 1312 1317 O
preclude 113 121 1318 1326 O
study 122 127 1327 1332 O
entry 128 133 1333 1338 O
or 134 136 1339 1341 O
significantly 137 150 1342 1355 O
interfere 151 160 1356 1365 O
with 161 165 1366 1370 O
the 166 169 1371 1374 O
proper 170 176 1375 1381 O
assessment 177 187 1382 1392 O
of 188 190 1393 1395 O
safety 191 197 1396 1402 O
and 198 201 1403 1406 O
toxicity 202 210 1407 1415 O
of 211 213 1416 1418 O
the 214 217 1419 1422 O
prescribed 218 228 1423 1433 O
study 229 234 1434 1439 O
regimen 235 242 1440 1447 O

No 0 2 1448 1450 O
concurrent 3 13 1451 1461 O
erythroid 14 23 1462 1471 B-treatment
- 23 24 1471 1472 I-treatment
stimulating 24 35 1472 1483 I-treatment
agents 36 42 1484 1490 I-treatment
( 43 44 1491 1492 O
e.g. 44 48 1492 1496 O
, 48 49 1496 1497 O
Procrit 50 57 1498 1505 B-treatment
, 57 58 1505 1506 O
Aranesp 59 66 1507 1514 B-treatment
) 66 67 1514 1515 O

No 0 2 1516 1518 O
concurrent 3 13 1519 1529 O
radiotherapy 14 26 1530 1542 B-treatment
, 26 27 1542 1543 O
chemotherapy 28 40 1544 1556 B-treatment
, 40 41 1556 1557 O
or 42 44 1558 1560 O
immunotherapy 45 58 1561 1574 B-treatment
for 59 62 1575 1578 O
another 63 70 1579 1586 O
active 71 77 1587 1593 O
malignancy 78 88 1594 1604 B-cancer

No 0 2 1605 1607 O
congestive 3 13 1608 1618 B-chronic_disease
heart 14 19 1619 1624 I-chronic_disease
failure 20 27 1625 1632 I-chronic_disease
requiring 28 37 1633 1642 O
ongoing 38 45 1643 1650 O
maintenance 46 57 1651 1662 O
therapy 58 65 1663 1670 B-treatment
for 66 69 1671 1674 O
life 70 74 1675 1679 O
- 74 75 1679 1680 O
threatening 75 86 1680 1691 O
ventricular 87 98 1692 1703 B-chronic_disease
arrhythmias 99 110 1704 1715 I-chronic_disease

No 0 2 1716 1718 O
history 3 10 1719 1726 O
of 11 13 1727 1729 O
life 14 18 1730 1734 O
threatening 19 30 1735 1746 O
or 31 33 1747 1749 O
recurrent 34 43 1750 1759 O
thrombosis 44 54 1760 1770 B-chronic_disease
/ 54 55 1770 1771 O
embolism 55 63 1771 1779 B-chronic_disease
( 64 65 1780 1781 O
unless 65 71 1781 1787 O
on 72 74 1788 1790 O
anticoagulation 75 90 1791 1806 B-treatment
therapy 91 98 1807 1814 I-treatment
during 99 105 1815 1821 O
study 106 111 1822 1827 O
treatment 112 121 1828 1837 B-treatment
) 121 122 1837 1838 O

No 0 2 1839 1841 O
known 3 8 1842 1847 O
HIV 9 12 1848 1851 B-chronic_disease
positivity 13 23 1852 1862 O

No 0 2 1863 1865 O
myocardial 3 13 1866 1876 B-chronic_disease
infarction 14 24 1877 1887 I-chronic_disease
within 25 31 1888 1894 O
the 32 35 1895 1898 O
past 36 40 1899 1903 B-upper_bound
6 41 42 1904 1905 I-upper_bound
months 43 49 1906 1912 I-upper_bound

No 0 2 1913 1915 O
other 3 8 1916 1921 O
active 9 15 1922 1928 B-cancer
malignancy 16 26 1929 1939 I-cancer
, 26 27 1939 1940 O
except 28 34 1941 1947 O
localized 35 44 1948 1957 O
nonmelanotic 45 57 1958 1970 B-cancer
skin 58 62 1971 1975 I-cancer
cancer 63 69 1976 1982 I-cancer
or 70 72 1983 1985 O
any 73 76 1986 1989 O
cancer 77 83 1990 1996 O
that 84 88 1997 2001 O
, 88 89 2001 2002 O
in 90 92 2003 2005 O
the 93 96 2006 2009 O
judgment 97 105 2010 2018 O
of 106 108 2019 2021 O
the 109 112 2022 2025 O
investigator 113 125 2026 2038 O
, 125 126 2038 2039 O
has 127 130 2040 2043 O
been 131 135 2044 2048 O
treated 136 143 2049 2056 O
with 144 148 2057 2061 O
curative 149 157 2062 2070 O
intent 158 164 2071 2077 O
and 165 168 2078 2081 O
will 169 173 2082 2086 O
not 174 177 2087 2090 O
interfere 178 187 2091 2100 O
with 188 192 2101 2105 O
the 193 196 2106 2109 O
study 197 202 2110 2115 O
treatment 203 212 2116 2125 O
plan 213 217 2126 2130 O
and 218 221 2131 2134 O
response 222 230 2135 2143 O
assessment 231 241 2144 2154 O

No 0 2 2155 2157 O
other 3 8 2158 2163 O
concurrent 9 19 2164 2174 O
treatment 20 29 2175 2184 B-treatment
for 30 33 2185 2188 O
lymphoma 34 42 2189 2197 B-cancer

No 0 2 2198 2200 O
post 3 7 2201 2205 B-chronic_disease
- 7 8 2205 2206 I-chronic_disease
transplant 8 18 2206 2216 I-chronic_disease
lymphoproliferative 19 38 2217 2236 I-chronic_disease
disorder 39 47 2237 2245 I-chronic_disease
( 48 49 2246 2247 I-chronic_disease
PTLD 49 53 2247 2251 I-chronic_disease
) 53 54 2251 2252 I-chronic_disease

No 0 2 2253 2255 O
prior 3 8 2256 2261 O
radiotherapy 9 21 2262 2274 B-treatment
to 22 24 2275 2277 O
≥ 25 26 2278 2279 O
25 27 29 2280 2282 B-lower_bound
% 29 30 2282 2283 I-lower_bound
of 31 33 2284 2286 O
the 34 37 2287 2290 O
bone 38 42 2291 2295 B-clinical_variable
marrow 43 49 2296 2302 I-clinical_variable

Not 0 3 2303 2306 O
immunocompromised 4 21 2307 2324 B-chronic_disease

Not 0 3 2325 2328 B-pregnancy
pregnant 4 12 2329 2337 I-pregnancy
or 13 15 2338 2340 O
nursing 16 23 2341 2348 O

Ongoing 0 7 2349 2356 O
or 8 10 2357 2359 O
active 11 17 2360 2366 O
infection 18 27 2367 2376 B-chronic_disease

Platelet 0 8 2377 2385 B-clinical_variable
count 9 14 2386 2391 I-clinical_variable
≥ 15 16 2392 2393 O
100,000 17 24 2394 2401 B-lower_bound
/ 24 25 2401 2402 I-lower_bound
mm³ 25 28 2402 2405 I-lower_bound

Psychiatric 0 11 2406 2417 B-chronic_disease
illness 12 19 2418 2425 I-chronic_disease
/ 19 20 2425 2426 I-chronic_disease
social 20 26 2426 2432 I-chronic_disease
situation 27 36 2433 2442 I-chronic_disease
that 37 41 2443 2447 O
would 42 47 2448 2453 O
preclude 48 56 2454 2462 O
compliance 57 67 2463 2473 O
with 68 72 2474 2478 O
study 73 78 2479 2484 O
requirements 79 91 2485 2497 O

Stage 0 5 2498 2503 B-lower_bound
II 6 8 2504 2506 I-lower_bound
, 8 9 2506 2507 O
III 10 13 2508 2511 O
, 13 14 2511 2512 O
or 15 17 2513 2515 O
IV 18 20 2516 2518 B-upper_bound
disease 21 28 2519 2526 O

Symptomatic 0 11 2527 2538 B-chronic_disease
congestive 12 22 2539 2549 I-chronic_disease
heart 23 28 2550 2555 I-chronic_disease
failure 29 36 2556 2563 I-chronic_disease

Total 0 5 2564 2569 B-clinical_variable
bilirubin 6 15 2570 2579 I-clinical_variable
≤ 16 17 2580 2581 O
1.5 18 21 2582 2585 B-upper_bound
times 22 27 2586 2591 I-upper_bound
upper 28 33 2592 2597 B-clinical_variable
limit 34 39 2598 2603 I-clinical_variable
of 40 42 2604 2606 I-clinical_variable
normal 43 49 2607 2613 I-clinical_variable
( 50 51 2614 2615 I-clinical_variable
ULN 51 54 2615 2618 I-clinical_variable
) 54 55 2618 2619 I-clinical_variable
OR 56 58 2620 2622 O
direct 59 65 2623 2629 B-clinical_variable
bilirubin 66 75 2630 2639 I-clinical_variable
normal 76 82 2640 2646 I-clinical_variable

Unstable 0 8 2647 2655 O
angina 9 15 2656 2662 B-chronic_disease
pectoris 16 24 2663 2671 I-chronic_disease

Altered 0 7 0 7 O
anatomy 8 15 8 15 O
that 16 20 16 20 O
might 21 26 21 26 O
limit 27 32 27 32 O
elbow 33 38 33 38 O
motion 39 45 39 45 O
, 45 46 45 46 O
independent 47 58 47 58 O
of 59 61 59 61 O
the 62 65 62 65 O
condition 66 75 66 75 O
being 76 81 76 81 O
treated 82 89 82 89 O
, 89 90 89 90 O
such 91 95 91 95 O
as 96 98 96 98 O
dysplasia 99 108 99 108 B-treatment
, 108 109 108 109 O
malunion 110 118 110 118 B-chronic_disease
, 118 119 118 119 O
osteonecrosis 120 133 120 133 B-chronic_disease
, 133 134 133 134 O
and 135 138 135 138 O
congenital 139 149 139 149 B-chronic_disease
deformity 150 159 150 159 I-chronic_disease

Contraindication 0 16 160 176 O
to 17 19 177 179 O
use 20 23 180 183 O
of 24 26 184 186 O
CPM 27 30 187 190 B-treatment
or 31 33 191 193 O
regional 34 42 194 202 B-treatment
brachial 43 51 203 211 I-treatment
plexus 52 58 212 218 I-treatment
block 59 64 219 224 I-treatment
, 64 65 224 225 O
such 66 70 226 230 O
as 71 73 231 233 O
bleeding 74 82 234 242 B-chronic_disease
diathesis 83 92 243 252 I-chronic_disease
, 92 93 252 253 O
use 94 97 254 257 O
of 98 100 258 260 O
anticoagulants 101 115 261 275 B-treatment
or 116 118 276 278 O
severe 119 125 279 285 O
restriction 126 137 286 297 O
in 138 140 298 300 O
shoulder 141 149 301 309 O
range 150 155 310 315 O
of 156 158 316 318 O
movement 159 167 319 327 O

Current 0 7 328 335 O
or 8 10 336 338 O
prior 11 16 339 344 O
septic 17 23 345 351 B-chronic_disease
arthritis 24 33 352 361 I-chronic_disease

Intra 0 5 362 367 B-chronic_disease
- 5 6 367 368 I-chronic_disease
operative 6 15 368 377 I-chronic_disease
or 16 18 378 380 I-chronic_disease
postoperative 19 32 381 394 I-chronic_disease
complication 33 45 395 407 I-chronic_disease
that 46 50 408 412 O
could 51 56 413 418 O
affect 57 63 419 425 O
outcome 64 71 426 433 O

Not 0 3 434 437 O
possible 4 12 438 446 O
to 13 15 447 449 O
have 16 20 450 454 O
postoperative 21 34 455 468 O
physical 35 43 469 477 B-treatment
therapy 44 51 478 485 I-treatment
appointment 52 63 486 497 O

Pre 0 3 498 501 O
- 3 4 501 502 O
existing 4 12 502 510 O
factors 13 20 511 518 O
that 21 25 519 523 O
might 26 31 524 529 O
limit 32 37 530 535 O
ability 38 45 536 543 O
to 46 48 544 546 O
completely 49 59 547 557 O
participate 60 71 558 569 O
in 72 74 570 572 O
rehabilitations 75 90 573 588 O
such 91 95 589 593 O
as 96 98 594 596 O
neuromuscular 99 112 597 610 B-chronic_disease
or 113 115 611 613 O
psychosocial 116 128 614 626 B-chronic_disease
condition 129 138 627 636 I-chronic_disease

Progressive 0 11 637 648 O
or 12 14 649 651 O
recalcitrant 15 27 652 664 B-chronic_disease
neuropathy 28 38 665 675 I-chronic_disease
or 39 41 676 678 O
neuritis 42 50 679 687 B-chronic_disease
, 50 51 687 688 O
except 52 58 689 695 O
for 59 62 696 699 O
isolated 63 71 700 708 O
intermittent 72 84 709 721 O
ulnar 85 90 722 727 B-chronic_disease
neuritis 91 99 728 736 I-chronic_disease

Progressive 0 11 737 748 O
or 12 14 749 751 O
recurrent 15 24 752 761 O
contracture 25 36 762 773 O
due 37 40 774 777 O
to 41 43 778 780 O
inflammatory 44 56 781 793 B-chronic_disease
disease 57 64 794 801 I-chronic_disease
such 65 69 802 806 O
as 70 72 807 809 O
rheumatoid 73 83 810 820 B-chronic_disease
arthritis 84 93 821 830 I-chronic_disease
, 93 94 830 831 O
juvenile 95 103 832 840 B-chronic_disease
idiopathic 104 114 841 851 I-chronic_disease
arthritis 115 124 852 861 I-chronic_disease
or 125 127 862 864 O
chondrolysis 128 140 865 877 B-chronic_disease

Surgery 0 7 878 885 B-treatment
to 8 10 886 888 O
be 11 13 889 891 O
performed 14 23 892 901 O
will 24 28 902 906 O
be 29 31 907 909 O
arthroscopic 32 44 910 922 B-treatment
capsulectomy 45 57 923 935 I-treatment
or 58 60 936 938 O
osteocapsular 61 74 939 952 B-treatment
arthroplasty 75 87 953 965 I-treatment
with 88 92 966 970 I-treatment
removal 93 100 971 978 I-treatment
of 101 103 979 981 I-treatment
heterotopic 104 115 982 993 I-treatment
ossification 116 128 994 1006 I-treatment
as 129 131 1007 1009 O
necessary 132 141 1010 1019 O

The 0 3 1020 1023 O
contracture 4 15 1024 1035 O
must 16 20 1036 1040 O
have 21 25 1041 1045 O
been 26 30 1046 1050 O
present 31 38 1051 1058 O
for 39 42 1059 1062 O
at 43 45 1063 1065 O
least 46 51 1066 1071 O
six 52 55 1072 1075 B-lower_bound
months 56 62 1076 1082 I-lower_bound
and 63 66 1083 1086 O
failed 67 73 1087 1093 O
to 74 76 1094 1096 O
respond 77 84 1097 1104 O
to 85 87 1105 1107 O
non 88 91 1108 1111 B-treatment
- 91 92 1111 1112 I-treatment
surgical 92 100 1112 1120 I-treatment
treatment 101 110 1121 1130 I-treatment

Women 0 5 1131 1136 B-gender
that 6 10 1137 1141 O
know 11 15 1142 1146 O
they 16 20 1147 1151 O
are 21 24 1152 1155 B-pregnancy
pregnant 25 33 1156 1164 I-pregnancy
or 34 36 1165 1167 O
breastfeeding 37 50 1168 1181 O

A 0 1 0 1 O
known 2 7 2 7 O
history 8 15 8 15 O
of 16 18 16 18 O
HIV 19 22 19 22 B-chronic_disease
seropositivity 23 37 23 37 O

Age 0 3 38 41 B-age
≥3 4 6 42 44 O
and 7 10 45 48 O
≤21 11 14 49 52 O
years 15 20 53 58 I-upper_bound

Astrocytoma 0 11 59 70 B-cancer
, 11 12 70 71 O
Low 13 16 72 75 O
Grade 17 22 76 81 O
( 23 24 82 83 O
Fibrillary 24 34 83 93 B-cancer
astrocytoma 35 46 94 105 I-cancer
, 46 47 105 106 O
WHO 48 51 107 110 O
Grade 52 57 111 116 O
2 58 59 117 118 O
) 59 60 118 119 O
- 61 62 120 121 O
10065886 63 71 122 130 O

Astrocytoma 0 11 131 142 B-cancer
, 11 12 142 143 O
Low 13 16 144 147 O
Grade 17 22 148 153 O
( 23 24 154 155 O
Low 24 27 155 158 B-cancer
- 27 28 158 159 I-cancer
grade 28 33 159 164 I-cancer
Astrocytoma 34 45 165 176 I-cancer
, 45 46 176 177 O
NOS 47 50 178 181 O
, 50 51 181 182 O
WHO 52 55 183 186 O
Grade 56 61 187 192 O
2 62 63 193 194 O
) 63 64 194 195 O
- 65 66 196 197 O
10003571 67 75 198 206 O

Because 0 7 207 214 O
no 8 10 215 217 O
dosing 11 17 218 224 O
or 18 20 225 227 O
adverse 21 28 228 235 O
event 29 34 236 241 O
data 35 39 242 246 O
are 40 43 247 250 O
currently 44 53 251 260 O
available 54 63 261 270 O
on 64 66 271 273 O
the 67 70 274 277 O
use 71 74 278 281 O
of 75 77 282 284 O
everolimus 78 88 285 295 B-treatment
in 89 91 296 298 O
patients 92 100 299 307 O
<3 101 103 308 310 O
years 104 109 311 316 I-upper_bound
of 110 112 317 319 O
age 113 116 320 323 B-age
, 116 117 323 324 O

Close 0 5 325 330 O
contact 6 13 331 338 O
with 14 18 339 343 O
those 19 24 344 349 O
who 25 28 350 353 O
have 29 33 354 358 O
received 34 42 359 367 O
attenuated 43 53 368 378 O
live 54 58 379 383 B-treatment
vaccines 59 67 384 392 I-treatment
should 68 74 393 399 O
be 75 77 400 402 O
avoided 78 85 403 410 O
during 86 92 411 417 O
treatment 93 102 418 427 B-treatment
with 103 107 428 432 O
everolimus 108 118 433 443 B-treatment

Female 0 6 444 450 B-gender
patients 7 15 451 459 I-gender
of 16 18 460 462 O
child 19 24 463 468 O
bearing 25 32 469 476 O
potential 33 42 477 486 O
must 43 47 487 491 O
not 48 51 492 495 O
be 52 54 496 498 O
breastfeeding 55 68 499 512 O
or 69 71 513 515 O
pregnant 72 80 516 524 B-pregnancy
as 81 83 525 527 O
evidenced 84 93 528 537 O
by 94 96 538 540 O
a 97 98 541 542 O
negative 99 107 543 551 B-pregnancy
pregnancy 108 117 552 561 I-pregnancy
test 118 122 562 566 O

HIV 0 3 567 570 B-chronic_disease
- 3 4 570 571 O
positive 4 12 571 579 O
patients 13 21 580 588 O
on 22 24 589 591 O
combination 25 36 592 603 B-treatment
antiretroviral 37 51 604 618 I-treatment
therapy 52 59 619 626 I-treatment

Hepatitis 0 9 627 636 B-chronic_disease
B 10 11 637 638 I-chronic_disease
/ 11 12 638 639 I-chronic_disease
C 12 13 639 640 I-chronic_disease
blood 14 19 641 646 O
test 20 24 647 651 O
must 25 29 652 656 O
be 30 32 657 659 O
done 33 37 660 664 O
at 38 40 665 667 O
screening 41 50 668 677 O
for 51 54 678 681 O
all 55 58 682 685 O
patients 59 67 686 694 O

INR 0 3 695 698 B-clinical_variable
≤1.5 4 8 699 703 O
. 8 9 703 704 O
( 10 11 705 706 O
Anticoagulation 11 26 706 721 B-treatment
is 27 29 722 724 O
allowed 30 37 725 732 O
if 38 40 733 735 O
target 41 47 736 742 O
INR 48 51 743 746 O
≤ 52 53 747 748 O
1.5 54 57 749 752 O
on 58 60 753 755 O
a 61 62 756 757 O
stable 63 69 758 764 O
dose 70 74 765 769 O
of 75 77 770 772 O
warfarin 78 86 773 781 B-treatment
or 87 89 782 784 O
on 90 92 785 787 O
a 93 94 788 789 O
stable 95 101 790 796 O
dose 102 106 797 801 O
of 107 109 802 804 O
LMW 110 113 805 808 B-treatment
heparin 114 121 809 816 I-treatment
for 122 125 817 820 O
> 126 127 821 822 O
2 127 128 822 823 B-lower_bound
weeks 129 134 824 829 I-lower_bound
at 135 137 830 832 O
time 138 142 833 837 O
of 143 145 838 840 O
randomization 146 159 841 854 O
) 159 160 854 855 O

Impairment 0 10 856 866 O
of 11 13 867 869 O
gastrointestinal 14 30 870 886 O
function 31 39 887 895 O
or 40 42 896 898 O
gastrointestinal 43 59 899 915 B-chronic_disease
disease 60 67 916 923 I-chronic_disease
that 68 72 924 928 O
may 73 76 929 932 O
significantly 77 90 933 946 O
alter 91 96 947 952 O
the 97 100 953 956 O
absorption 101 111 957 967 O
of 112 114 968 970 O
everolimus 115 125 971 981 B-treatment
( 126 127 982 983 O
e.g. 127 131 983 987 O
, 131 132 987 988 O
ulcerative 133 143 989 999 B-chronic_disease
disease 144 151 1000 1007 I-chronic_disease
, 151 152 1007 1008 O
uncontrolled 153 165 1009 1021 O
nausea 166 172 1022 1028 B-chronic_disease
, 172 173 1028 1029 O
vomiting 174 182 1030 1038 B-chronic_disease
, 182 183 1038 1039 O
diarrhea 184 192 1040 1048 B-chronic_disease
, 192 193 1048 1049 O
malabsorption 194 207 1050 1063 B-chronic_disease
syndrome 208 216 1064 1072 I-chronic_disease
or 217 219 1073 1075 O
small 220 225 1076 1081 B-treatment
bowel 226 231 1082 1087 I-treatment
resection 232 241 1088 1097 I-treatment

Lansky 0 6 1098 1104 B-clinical_variable
Performance 7 18 1105 1116 I-clinical_variable
score 19 24 1117 1122 I-clinical_variable
( 25 26 1123 1124 O
if 26 28 1124 1126 O
≤ 29 30 1127 1128 O
16 31 33 1129 1131 B-upper_bound
years 34 39 1132 1137 I-upper_bound
of 40 42 1138 1140 O
age 43 46 1141 1144 B-age
) 46 47 1144 1145 O
of 48 50 1146 1148 O
≥50 51 54 1149 1152 O
by 55 57 1153 1155 O
the 58 61 1156 1159 O
time 62 66 1160 1164 O
of 67 69 1165 1167 O
registration 70 82 1168 1180 O

Life 0 4 1181 1185 B-clinical_variable
expectancy 5 15 1186 1196 I-clinical_variable
of 16 18 1197 1199 O
greater 19 26 1200 1207 O
than 27 31 1208 1212 O
8 32 33 1213 1214 B-lower_bound
weeks 34 39 1215 1220 I-lower_bound

Patient 0 7 1221 1228 O
must 8 12 1229 1233 O
have 13 17 1234 1238 O
a 18 19 1239 1240 O
Karnofsky 20 29 1241 1250 B-clinical_variable
( 30 31 1251 1252 O
if 31 33 1252 1254 O
≥ 34 35 1255 1256 O
16 36 38 1257 1259 B-lower_bound
years 39 44 1260 1265 I-lower_bound
of 45 47 1266 1268 O
age 48 51 1269 1272 B-age
) 51 52 1272 1273 O

Patients 0 8 1274 1282 O
may 9 12 1283 1286 O
have 13 17 1287 1291 O
had 18 21 1292 1295 O
treatment 22 31 1296 1305 B-treatment
( 32 33 1306 1307 O
chemotherapy 33 45 1307 1319 B-treatment
and/or 46 52 1320 1326 O
radiotherapy 53 65 1327 1339 B-treatment
) 65 66 1339 1340 O
for 67 70 1341 1344 O
any 71 74 1345 1348 O
number 75 81 1349 1355 O
of 82 84 1356 1358 O
relapses 85 93 1359 1367 O
prior 94 99 1368 1373 O
to 100 102 1374 1376 O
this 103 107 1377 1381 O
recurrence 108 118 1382 1392 O

Patients 0 8 1393 1401 O
may 9 12 1402 1405 O
not 13 16 1406 1409 O
have 17 21 1410 1414 O
therapy 22 29 1415 1422 B-treatment
for 30 33 1423 1426 O
this 34 38 1427 1431 O
recurrence 39 49 1432 1442 O
( 50 51 1443 1444 O
including 51 60 1444 1453 O
radiation 61 70 1454 1463 B-treatment
) 70 71 1463 1464 O

Patients 0 8 1465 1473 O
must 9 13 1474 1478 O
have 14 18 1479 1483 O
adequate 19 27 1484 1492 O
bone 28 32 1493 1497 O
marrow 33 39 1498 1504 O
function 40 48 1505 1513 O
( 49 50 1514 1515 O
ANC 50 53 1515 1518 B-clinical_variable
≥ 54 55 1519 1520 O
1,000 56 61 1521 1526 B-lower_bound
/ 61 62 1526 1527 I-lower_bound
mm3 62 65 1527 1530 I-lower_bound
, 65 66 1530 1531 O
platelet 67 75 1532 1540 B-clinical_variable
count 76 81 1541 1546 I-clinical_variable
of 82 84 1547 1549 O
≥ 85 86 1550 1551 O
100,000 87 94 1552 1559 B-lower_bound
/ 94 95 1559 1560 I-lower_bound
mm3 95 98 1560 1563 I-lower_bound
, 98 99 1563 1564 O
and 100 103 1565 1568 O
hemoglobin 104 114 1569 1579 B-clinical_variable
≥ 115 116 1580 1581 O
9 117 118 1582 1583 B-lower_bound
gm 119 121 1584 1586 I-lower_bound
/ 121 122 1586 1587 I-lower_bound
dL 122 124 1587 1589 I-lower_bound
) 124 125 1589 1590 O
before 126 132 1591 1597 O
starting 133 141 1598 1606 O
therapy 142 149 1607 1614 B-treatment

Patients 0 8 1615 1623 O
must 9 13 1624 1628 O
have 14 18 1629 1633 O
adequate 19 27 1634 1642 O
liver 28 33 1643 1648 O
function 34 42 1649 1657 O
( 43 44 1658 1659 O
SGPT 44 48 1659 1663 B-clinical_variable
/ 48 49 1663 1664 I-clinical_variable
ALT 49 52 1664 1667 I-clinical_variable
≤ 53 54 1668 1669 O
2.5 55 58 1670 1673 B-upper_bound
times 59 64 1674 1679 I-upper_bound
ULN 65 68 1680 1683 I-upper_bound
and 69 72 1684 1687 O
bilirubin 73 82 1688 1697 B-clinical_variable
≤ 83 84 1698 1699 O
1.5 85 88 1700 1703 B-upper_bound
times 89 94 1704 1709 I-upper_bound
ULN 95 98 1710 1713 I-upper_bound
) 98 99 1713 1714 O
before 100 106 1715 1721 O
starting 107 115 1722 1730 O
therapy 116 123 1731 1738 B-treatment

Patients 0 8 1739 1747 O
must 9 13 1748 1752 O
have 14 18 1753 1757 O
adequate 19 27 1758 1766 O
renal 28 33 1767 1772 O
function 34 42 1773 1781 O
( 43 44 1782 1783 O
serum 44 49 1783 1788 B-clinical_variable
creatinine 50 60 1789 1799 I-clinical_variable
≤ 61 62 1800 1801 O
1.5 63 66 1802 1805 B-upper_bound
times 67 72 1806 1811 I-upper_bound
institutional 73 86 1812 1825 I-upper_bound
ULN 87 90 1826 1829 I-upper_bound
for 91 94 1830 1833 O
age 95 98 1834 1837 B-age
or 99 101 1838 1840 O
GFR 102 105 1841 1844 B-clinical_variable
≥ 106 107 1845 1846 O
70 108 110 1847 1849 B-lower_bound
ml 111 113 1850 1852 I-lower_bound
/ 113 114 1852 1853 I-lower_bound
min/1.73 114 122 1853 1861 I-lower_bound
m2 123 125 1862 1864 I-lower_bound
) 125 126 1864 1865 O
before 127 133 1866 1872 O
starting 134 142 1873 1881 O
therapy 143 150 1882 1889 B-treatment

Patients 0 8 1890 1898 O
must 9 13 1899 1903 O
have 14 18 1904 1908 O
cholesterol 19 30 1909 1920 B-clinical_variable
level 31 36 1921 1926 I-clinical_variable
< 37 38 1927 1928 O
350 38 41 1928 1931 B-upper_bound
mg 42 44 1932 1934 I-upper_bound
/ 44 45 1934 1935 I-upper_bound
dL 45 47 1935 1937 I-upper_bound
and 48 51 1938 1941 O
triglycerides 52 65 1942 1955 B-clinical_variable
< 66 67 1956 1957 O
400 68 71 1958 1961 B-upper_bound
mg 72 74 1962 1964 I-upper_bound
/ 74 75 1964 1965 I-upper_bound
dL 75 77 1965 1967 I-upper_bound
before 78 84 1968 1974 O
starting 85 93 1975 1983 O
therapy 94 101 1984 1991 B-treatment

Patients 0 8 1992 2000 O
must 9 13 2001 2005 O
have 14 18 2006 2010 O
measurable 19 29 2011 2021 O
disease 30 37 2022 2029 O
, 37 38 2029 2030 O
defined 39 46 2031 2038 O
as 47 49 2039 2041 O
at 50 52 2042 2044 O
least 53 58 2045 2050 O
one 59 62 2051 2054 B-lower_bound
lesion 63 69 2055 2061 B-clinical_variable
that 70 74 2062 2066 O
can 75 78 2067 2070 O
be 79 81 2071 2073 O
accurately 82 92 2074 2084 O
measured 93 101 2085 2093 O
in 102 104 2094 2096 O
at 105 107 2097 2099 O
least 108 113 2100 2105 O
two 114 117 2106 2109 B-lower_bound
dimensions 118 128 2110 2120 O
on 129 131 2121 2123 O
MRI 132 135 2124 2127 B-treatment

Patients 0 8 2128 2136 O
must 9 13 2137 2141 O
have 14 18 2142 2146 O
normal 19 25 2147 2153 O
pulmonary 26 35 2154 2163 O
function 36 44 2164 2172 O
testing 45 52 2173 2180 O
for 53 56 2181 2184 O
age 57 60 2185 2188 B-age
based 61 66 2189 2194 O
on 67 69 2195 2197 O
pulse 70 75 2198 2203 B-treatment
oximetry 76 84 2204 2212 I-treatment

Patients 0 8 2213 2221 O
must 9 13 2222 2226 O
have 14 18 2227 2231 O
radiographic 19 31 2232 2244 O
progressive 32 43 2245 2256 O
or 44 46 2257 2259 O
recurrent 47 56 2260 2269 O
confirmed 57 66 2270 2279 O
WHO 67 70 2280 2283 O
grade 71 76 2284 2289 B-lower_bound
I 77 78 2290 2291 I-lower_bound
or 79 81 2292 2294 O
II 82 84 2295 2297 B-upper_bound
astrocytomas 85 97 2298 2310 B-clinical_variable
, 97 98 2310 2311 O
that 99 103 2312 2316 O
was 104 107 2317 2320 O
confirmed 108 117 2321 2330 O
histologically 118 132 2331 2345 O

Patients 0 8 2346 2354 O
must 9 13 2355 2359 O
have 14 18 2360 2364 O
received 19 27 2365 2373 O
their 28 33 2374 2379 O
last 34 38 2380 2384 O
dose 39 43 2385 2389 O
of 44 46 2390 2392 O
myelosuppressive 47 63 2393 2409 B-treatment
anticancer 64 74 2410 2420 I-treatment
chemotherapy 75 87 2421 2433 I-treatment
at 88 90 2434 2436 O
least 91 96 2437 2442 O
three 97 102 2443 2448 B-lower_bound
( 103 104 2449 2450 I-lower_bound
3 104 105 2450 2451 I-lower_bound
) 105 106 2451 2452 I-lower_bound
weeks 107 112 2453 2458 I-lower_bound
prior 113 118 2459 2464 I-lower_bound
to 119 121 2465 2467 O
study 122 127 2468 2473 O
registration 128 140 2474 2486 O
or 141 143 2487 2489 O
at 144 146 2490 2492 O
least 147 152 2493 2498 O
six 153 156 2499 2502 B-lower_bound
( 157 158 2503 2504 I-lower_bound
6)weeks 158 165 2504 2511 I-lower_bound
of 166 168 2512 2514 O
nitrosourea 169 180 2515 2526 B-treatment

Patients 0 8 2527 2535 O
must 9 13 2536 2540 O
have 14 18 2541 2545 O
received 19 27 2546 2554 O
their 28 33 2555 2560 O
last 34 38 2561 2565 O
dose 39 43 2566 2570 O
of 44 46 2571 2573 O
other 47 52 2574 2579 O
investigational 53 68 2580 2595 O
or 69 71 2596 2598 O
biological 72 82 2599 2609 B-clinical_variable
agent 83 88 2610 2615 I-clinical_variable
> 89 90 2616 2617 O
7 91 92 2618 2619 B-upper_bound
days 93 97 2620 2624 I-upper_bound
prior 98 103 2625 2630 I-upper_bound
to 104 106 2631 2633 O
study 107 112 2634 2639 O
entry 113 118 2640 2645 O

Patients 0 8 2646 2654 O
must 9 13 2655 2659 O
have 14 18 2660 2664 O
received 19 27 2665 2673 O
their 28 33 2674 2679 O
last 34 38 2680 2684 O
fraction 39 47 2685 2693 O
of 48 50 2694 2696 O
craniospinal 51 63 2697 2709 B-treatment
or 64 66 2710 2712 O
focal 67 72 2713 2718 B-treatment
radiation 73 82 2719 2728 I-treatment
to 83 85 2729 2731 O
primary 86 93 2732 2739 B-cancer
tumor 94 99 2740 2745 I-cancer
or 100 102 2746 2748 O
other 103 108 2749 2754 O
sites 109 114 2755 2760 O
> 115 116 2761 2762 O
12 116 118 2762 2764 B-lower_bound
weeks 119 124 2765 2770 I-lower_bound
( 125 126 2771 2772 I-lower_bound
3 126 127 2772 2773 I-lower_bound
months 128 134 2774 2780 I-lower_bound
) 134 135 2780 2781 I-lower_bound
prior 136 141 2782 2787 I-lower_bound
to 142 144 2788 2790 O
registration 145 157 2791 2803 O

Patients 0 8 2804 2812 O
receiving 9 18 2813 2822 O
any 19 22 2823 2826 O
other 23 28 2827 2832 O
concurrent 29 39 2833 2843 O
anticancer 40 50 2844 2854 B-treatment
or 51 53 2855 2857 O
investigational 54 69 2858 2873 B-treatment
therapy 70 77 2874 2881 I-treatment

Patients 0 8 2882 2890 O
receiving 9 18 2891 2900 O
chronic 19 26 2901 2908 B-treatment
, 26 27 2908 2909 O
systemic 28 36 2910 2918 B-treatment
treatment 37 46 2919 2928 I-treatment
with 47 51 2929 2933 O
corticosteroids 52 67 2934 2949 B-treatment
or 68 70 2950 2952 O
another 71 78 2953 2960 O
immunosuppressive 79 96 2961 2978 B-treatment
agent 97 102 2979 2984 I-treatment

Patients 0 8 2985 2993 O
receiving 9 18 2994 3003 O
concomitant 19 30 3004 3015 B-treatment
medication 31 41 3016 3026 I-treatment
that 42 46 3027 3031 O
may 47 50 3032 3035 O
interfere 51 60 3036 3045 O
with 61 65 3046 3050 O
study 66 71 3051 3056 O
outcome 72 79 3057 3064 O

Patients 0 8 3065 3073 O
should 9 15 3074 3080 O
not 16 19 3081 3084 O
receive 20 27 3085 3092 O
immunization 28 40 3093 3105 B-treatment
with 41 45 3106 3110 I-treatment
attenuated 46 56 3111 3121 I-treatment
live 57 61 3122 3126 I-treatment
vaccines 62 70 3127 3135 I-treatment
within 71 77 3136 3142 O
one 78 81 3143 3146 B-upper_bound
week 82 86 3147 3151 I-upper_bound
of 87 89 3152 3154 O
study 90 95 3155 3160 O
entry 96 101 3161 3166 O
or 102 104 3167 3169 O
during 105 111 3170 3176 O
study 112 117 3177 3182 O
period 118 124 3183 3189 O

Patients 0 8 3190 3198 O
who 9 12 3199 3202 O
do 13 15 3203 3205 O
not 16 19 3206 3209 O
have 20 24 3210 3214 O
measurable 25 35 3215 3225 O
disease 36 43 3226 3233 O
on 44 46 3234 3236 O
MRI 47 50 3237 3240 B-treatment

Patients 0 8 3241 3249 O
who 9 12 3250 3253 O
have 13 17 3254 3258 O
been 18 22 3259 3263 O
previously 23 33 3264 3274 O
treated 34 41 3275 3282 O
with 42 46 3283 3287 O
an 47 49 3288 3290 O
mTOR 50 54 3291 3295 B-treatment
inhibitor 55 64 3296 3305 I-treatment

Patients 0 8 3306 3314 O
who 9 12 3315 3318 O
test 13 17 3319 3323 O
positive 18 26 3324 3332 O
for 27 30 3333 3336 O
Hepatitis 31 40 3337 3346 B-chronic_disease
C 41 42 3347 3348 I-chronic_disease
antibodies 43 53 3349 3359 O
and 54 57 3360 3363 O
the 58 61 3364 3367 O
Hepatitis 62 71 3368 3377 B-chronic_disease
B 72 73 3378 3379 I-chronic_disease
antigen 74 81 3380 3387 O

Patients 0 8 3388 3396 O
with 9 13 3397 3401 O
a 14 15 3402 3403 O
known 16 21 3404 3409 O
hypersensitivity 22 38 3410 3426 O
to 39 41 3427 3429 O
everolimus 42 52 3430 3440 B-allergy_name
or 53 55 3441 3443 O
other 56 61 3444 3449 O
rapamycins 62 72 3450 3460 B-allergy_name
( 73 74 3461 3462 O
e.g. 74 78 3462 3466 O
sirolimus 79 88 3467 3476 B-allergy_name
, 88 89 3476 3477 O
temsirolimus 90 102 3478 3490 B-allergy_name
) 102 103 3490 3491 O

Patients 0 8 3492 3500 O
with 9 13 3501 3505 O
any 14 17 3506 3509 O
clinically 18 28 3510 3520 O
significant 29 40 3521 3532 O
unrelated 41 50 3533 3542 O
systemic 51 59 3543 3551 O
illness 60 67 3552 3559 O
that 68 72 3560 3564 O
would 73 78 3565 3570 O
compromise 79 89 3571 3581 O
the 90 93 3582 3585 O
patient 94 101 3586 3593 O
's 101 103 3593 3595 O
ability 104 111 3596 3603 O
to 112 114 3604 3606 O
tolerate 115 123 3607 3615 O
protocol 124 132 3616 3624 O
therapy 133 140 3625 3632 B-treatment

Patients 0 8 3633 3641 O
with 9 13 3642 3646 O
inability 14 23 3647 3656 O
to 24 26 3657 3659 O
return 27 33 3660 3666 O
for 34 37 3667 3670 O
follow 38 44 3671 3677 O
- 44 45 3677 3678 O
up 45 47 3678 3680 O
visits 48 54 3681 3687 O
to 55 57 3688 3690 O
assess 58 64 3691 3697 O
toxicity 65 73 3698 3706 O
to 74 76 3707 3709 O
therapy 77 84 3710 3717 B-treatment

Patients 0 8 3718 3726 O
with 9 13 3727 3731 O
primary 14 21 3732 3739 O
spinal 22 28 3740 3746 O
cord 29 33 3747 3751 O
tumors 34 40 3752 3758 B-cancer

Pilocytic 0 9 3759 3768 B-cancer
Astrocytoma 10 21 3769 3780 I-cancer
- 22 23 3781 3782 O
90600112 24 32 3783 3791 O

Progressive 0 11 3792 3803 O
or 12 14 3804 3806 O
recurrent 15 24 3807 3816 O
disease 25 32 3817 3824 O
should 33 39 3825 3831 O
be 40 42 3832 3834 O
based 43 48 3835 3840 O
on 49 51 3841 3843 O
MRI 52 55 3844 3847 B-treatment
according 56 65 3848 3857 O
to 66 68 3858 3860 O
the 69 72 3861 3864 O
definition 73 83 3865 3875 O
below 84 89 3876 3881 O

Topical 0 7 3882 3889 B-treatment
or 8 10 3890 3892 O
inhaled 11 18 3893 3900 B-treatment
corticosteroids 19 34 3901 3916 I-treatment

Uncontrolled 0 12 3917 3929 O
intercurrent 13 25 3930 3942 B-chronic_disease
illness 26 33 3943 3950 I-chronic_disease
including 34 43 3951 3960 O
, 43 44 3960 3961 O
but 45 48 3962 3965 O
not 49 52 3966 3969 O
limited 53 60 3970 3977 O
to 61 63 3978 3980 O
, 63 64 3980 3981 O
ongoing 65 72 3982 3989 O
or 73 75 3990 3992 O
active 76 82 3993 3999 B-chronic_disease
infection 83 92 4000 4009 I-chronic_disease
, 92 93 4009 4010 O
symptomatic 94 105 4011 4022 O
congestive 106 116 4023 4033 B-chronic_disease
heart 117 122 4034 4039 I-chronic_disease
failure 123 130 4040 4047 I-chronic_disease
, 130 131 4047 4048 O
unstable 132 140 4049 4057 B-chronic_disease
angina 141 147 4058 4064 I-chronic_disease
pectoris 148 156 4065 4073 I-chronic_disease
, 156 157 4073 4074 O
cardiac 158 165 4075 4082 B-chronic_disease
arrhythmia 166 176 4083 4093 I-chronic_disease
, 176 177 4093 4094 O
or 178 180 4095 4097 O
psychiatric 181 192 4098 4109 B-chronic_disease
illness 193 200 4110 4117 I-chronic_disease
/ 200 201 4117 4118 O
social 201 207 4118 4124 B-chronic_disease
situations 208 218 4125 4135 I-chronic_disease
that 219 223 4136 4140 O
would 224 229 4141 4146 O
limit 230 235 4147 4152 O
compliance 236 246 4153 4163 O
with 247 251 4164 4168 O
study 252 257 4169 4174 O
requirements 258 270 4175 4187 O

the 0 3 4188 4191 O
patient 4 11 4192 4199 O
can 12 15 4200 4203 O
only 16 20 4204 4208 O
be 21 23 4209 4211 O
included 24 32 4212 4220 O
after 33 38 4221 4226 O
initiation 39 49 4227 4237 O
of 50 52 4238 4240 O
appropriate 53 64 4241 4252 O
lipid 65 70 4253 4258 B-treatment
lowering 71 79 4259 4267 I-treatment
medication 80 90 4268 4278 I-treatment
and 91 94 4279 4282 O
documentation 95 108 4283 4296 O
of 109 111 4297 4299 O
cholesterol 112 123 4300 4311 B-clinical_variable
< 124 125 4312 4313 O
350mg 126 131 4314 4319 B-upper_bound
/ 131 132 4319 4320 I-upper_bound
dL 132 134 4320 4322 I-upper_bound
and 135 138 4323 4326 O
triglycerides 139 152 4327 4340 B-clinical_variable
< 153 154 4341 4342 O
400mg 155 160 4343 4348 B-upper_bound
/ 160 161 4348 4349 I-upper_bound
dl 161 163 4349 4351 I-upper_bound
before 164 170 4352 4358 O
start 171 176 4359 4364 O
of 177 179 4365 4367 O
therapy 180 187 4368 4375 B-treatment

women 0 5 4376 4381 B-gender
of 6 8 4382 4384 O
child 9 14 4385 4390 O
- 14 15 4390 4391 O
bearing 15 22 4391 4398 O
potential 23 32 4399 4408 O
and 33 36 4409 4412 O
men 37 40 4413 4416 O
must 41 45 4417 4421 O
agree 46 51 4422 4427 B-contraception_consent
to 52 54 4428 4430 I-contraception_consent
use 55 58 4431 4434 I-contraception_consent
adequate 59 67 4435 4443 I-contraception_consent
contraception 68 81 4444 4457 I-contraception_consent
( 82 83 4458 4459 O
hormonal 83 91 4459 4467 O
or 92 94 4468 4470 O
barrier 95 102 4471 4478 O
method 103 109 4479 4485 O
of 110 112 4486 4488 O
birth 113 118 4489 4494 O
control 119 126 4495 4502 O
; 126 127 4502 4503 O
abstinence 128 138 4504 4514 O
) 138 139 4514 4515 O
prior 140 145 4516 4521 O
to 146 148 4522 4524 O
study 149 154 4525 4530 O
entry 155 160 4531 4536 O
and 161 164 4537 4540 O
for 165 168 4541 4544 O
the 169 172 4545 4548 O
duration 173 181 4549 4557 O
of 182 184 4558 4560 O
study 185 190 4561 4566 O
participation 191 204 4567 4580 O

Adequately 0 10 0 10 O
treated 11 18 11 18 O
non 19 22 19 22 B-cancer
- 22 23 22 23 I-cancer
melanoma 23 31 23 31 I-cancer
skin 32 36 32 36 I-cancer
cancer 37 43 37 43 I-cancer
or 44 46 44 46 O
lentigo 47 54 47 54 B-cancer
maligna 55 62 55 62 I-cancer
without 63 70 63 70 O
evidence 71 79 71 79 O
of 80 82 80 82 O
disease 83 90 83 90 O

Anticancer 0 10 91 101 B-treatment
therapy 11 18 102 109 I-treatment
including 19 28 110 119 O
chemotherapy 29 41 120 132 B-treatment
, 41 42 132 133 O
immunotherapy 43 56 134 147 B-treatment
, 56 57 147 148 O
radiotherapy 58 70 149 161 B-treatment
, 70 71 161 162 O
hormonal 72 80 163 171 B-treatment
or 81 83 172 174 I-treatment
any 84 87 175 178 I-treatment
investigational 88 103 179 194 I-treatment
therapy 104 111 195 202 I-treatment
within 112 118 203 209 O
14 119 121 210 212 B-upper_bound
days 122 126 213 217 I-upper_bound
or 127 129 218 220 O
5 130 131 221 222 O
half 132 136 223 227 O
- 136 137 227 228 O
lives 137 142 228 233 O
prior 143 148 234 239 O
to 149 151 240 242 O
first 152 157 243 248 O
dose 158 162 249 253 O
of 163 165 254 256 O
study 166 171 257 262 O
drug 172 176 263 267 O

Any 0 3 268 271 O
life 4 8 272 276 B-chronic_disease
- 8 9 276 277 I-chronic_disease
threatening 9 20 277 288 I-chronic_disease
illness 21 28 289 296 I-chronic_disease
, 28 29 296 297 O
medical 30 37 298 305 B-chronic_disease
condition 38 47 306 315 I-chronic_disease
, 47 48 315 316 O
or 49 51 317 319 O
organ 52 57 320 325 B-chronic_disease
system 58 64 326 332 I-chronic_disease
dysfunction 65 76 333 344 I-chronic_disease
that 77 81 345 349 O
, 81 82 349 350 O
in 83 85 351 353 O
the 86 89 354 357 O
investigator 90 102 358 370 O
's 102 104 370 372 O
opinion 105 112 373 380 O
, 112 113 380 381 O
could 114 119 382 387 O
compromise 120 130 388 398 O
the 131 134 399 402 O
subject 135 142 403 410 O
's 142 144 410 412 O
safety 145 151 413 419 O
or 152 154 420 422 O
put 155 158 423 426 O
the 159 162 427 430 O
study 163 168 431 436 O
outcomes 169 177 437 445 O
at 178 180 446 448 O
undue 181 186 449 454 O
risk 187 191 455 459 O

Bilirubin 0 9 460 469 B-clinical_variable
= 10 11 470 471 O
< 11 12 471 472 O
1.5 13 16 473 476 B-upper_bound
x 17 18 477 478 I-upper_bound
ULN 19 22 479 482 I-upper_bound
( 23 24 483 484 O
unless 24 30 484 490 O
bilirubin 31 40 491 500 O
rise 41 45 501 505 O
is 46 48 506 508 O
due 49 52 509 512 O
to 53 55 513 515 O
Gilbert 56 63 516 523 B-chronic_disease
's 63 65 523 525 I-chronic_disease
syndrome 66 74 526 534 I-chronic_disease
or 75 77 535 537 O
of 78 80 538 540 O
non 81 84 541 544 O
- 84 85 544 545 O
hepatic 85 92 545 552 O
origin 93 99 553 559 O
) 99 100 559 560 O

Concomitant 0 11 561 572 O
use 12 15 573 576 O
of 16 18 577 579 O
warfarin 19 27 580 588 B-treatment
or 28 30 589 591 O
other 31 36 592 597 O
vitamin 37 44 598 605 B-treatment
K 45 46 606 607 I-treatment
antagonists 47 58 608 619 I-treatment

Concurrent 0 10 620 630 O
systemic 11 19 631 639 B-treatment
immunosuppressant 20 37 640 657 I-treatment
therapy 38 45 658 665 I-treatment

Currently 0 9 666 675 O
active 10 16 676 682 O
, 16 17 682 683 O
clinically 18 28 684 694 O
significant 29 40 695 706 O
cardiovascular 41 55 707 721 B-chronic_disease
disease 56 63 722 729 I-chronic_disease
, 63 64 729 730 O
such 65 69 731 735 O
as 70 72 736 738 O
uncontrolled 73 85 739 751 O
arrhythmia 86 96 752 762 B-chronic_disease
or 97 99 763 765 O
class 100 105 766 771 O
3 106 107 772 773 O
or 108 110 774 776 O
4 111 112 777 778 O
congestive 113 123 779 789 B-chronic_disease
heart 124 129 790 795 I-chronic_disease
failure 130 137 796 803 I-chronic_disease
as 138 140 804 806 O
defined 141 148 807 814 O
by 149 151 815 817 O
the 152 155 818 821 O
New 156 159 822 825 B-clinical_variable
York 160 164 826 830 I-clinical_variable
Heart 165 170 831 836 I-clinical_variable
Association 171 182 837 848 I-clinical_variable
Functional 183 193 849 859 O
Classification 194 208 860 874 O
; 208 209 874 875 O
or 210 212 876 878 O
a 213 214 879 880 O
history 215 222 881 888 O
of 223 225 889 891 O
myocardial 226 236 892 902 B-chronic_disease
infarction 237 247 903 913 I-chronic_disease
, 247 248 913 914 O
unstable 249 257 915 923 B-chronic_disease
angina 258 264 924 930 I-chronic_disease
, 264 265 930 931 O
or 266 268 932 934 O
acute 269 274 935 940 B-chronic_disease
coronary 275 283 941 949 I-chronic_disease
syndrome 284 292 950 958 I-chronic_disease
within 293 299 959 965 O
6 300 301 966 967 B-upper_bound
months 302 308 968 974 I-upper_bound
prior 309 314 975 980 I-upper_bound
to 315 317 981 983 O
enrollment 318 328 984 994 O

Estimated 0 9 995 1004 B-clinical_variable
creatinine 10 20 1005 1015 I-clinical_variable
clearance 21 30 1016 1025 I-clinical_variable
> 31 32 1026 1027 O
= 32 33 1027 1028 O
30 34 36 1029 1031 B-lower_bound
ml 37 39 1032 1034 I-lower_bound
/ 39 40 1034 1035 I-lower_bound
min 40 43 1035 1038 I-lower_bound
( 44 45 1039 1040 O
Cockcroft 45 54 1040 1049 O
- 54 55 1049 1050 O
Gault 55 60 1050 1055 O
) 60 61 1055 1056 O

Female 0 6 1057 1063 B-gender
subjects 7 15 1064 1072 I-gender
who 16 19 1073 1076 O
are 20 23 1077 1080 O
of 24 26 1081 1083 O
non 27 30 1084 1087 O
- 30 31 1087 1088 O
reproductive 31 43 1088 1100 O
potential 44 53 1101 1110 O
( 54 55 1111 1112 O
ie 55 57 1112 1114 O
, 57 58 1114 1115 O
post 59 63 1116 1120 O
- 63 64 1120 1121 O
menopausal 64 74 1121 1131 O
by 75 77 1132 1134 O
history 78 85 1135 1142 O
- 86 87 1143 1144 O
no 88 90 1145 1147 O
menses 91 97 1148 1154 O
for 98 101 1155 1158 O
> 102 103 1159 1160 O
= 103 104 1160 1161 O
1 105 106 1162 1163 B-lower_bound
year 107 111 1164 1168 I-lower_bound
; 111 112 1168 1169 O
OR 113 115 1170 1172 O
history 116 123 1173 1180 O
of 124 126 1181 1183 O
hysterectomy 127 139 1184 1196 B-contraception_consent
; 139 140 1196 1197 O
OR 141 143 1198 1200 O
history 144 151 1201 1208 O
of 152 154 1209 1211 O
bilateral 155 164 1212 1221 B-contraception_consent
tubal 165 170 1222 1227 I-contraception_consent
ligation 171 179 1228 1236 I-contraception_consent
; 179 180 1236 1237 O
OR 181 183 1238 1240 O
history 184 191 1241 1248 O
of 192 194 1249 1251 O
bilateral 195 204 1252 1261 B-contraception_consent
oophorectomy 205 217 1262 1274 I-contraception_consent
) 217 218 1274 1275 O
; 218 219 1275 1276 O
or 220 222 1277 1279 O
, 222 223 1279 1280 O
female 224 230 1281 1287 B-gender
subjects 231 239 1288 1296 I-gender
of 240 242 1297 1299 O
childbearing 243 255 1300 1312 O
potential 256 265 1313 1322 O
must 266 270 1323 1327 O
have 271 275 1328 1332 O
a 276 277 1333 1334 O
negative 278 286 1335 1343 B-pregnancy
serum 287 292 1344 1349 I-pregnancy
pregnancy 293 302 1350 1359 I-pregnancy
test 303 307 1360 1364 O
upon 308 312 1365 1369 O
study 313 318 1370 1375 O
entry 319 324 1376 1381 O

For 0 3 1382 1385 O
the 4 7 1386 1389 O
dose 8 12 1390 1394 O
escalation 13 23 1395 1405 O
cohorts 24 31 1406 1413 O
, 31 32 1413 1414 O
any 33 36 1415 1418 O
prior 37 42 1419 1424 B-treatment
number 43 49 1425 1431 I-treatment
of 50 52 1432 1434 I-treatment
MDS 53 56 1435 1438 I-treatment
therapies 57 66 1439 1448 I-treatment
, 66 67 1448 1449 O
including 68 77 1450 1459 O
hypomethylating 78 93 1460 1475 B-treatment
agents 94 100 1476 1482 I-treatment

History 0 7 1483 1490 O
of 8 10 1491 1493 O
other 11 16 1494 1499 O
malignancies 17 29 1500 1512 B-cancer

History 0 7 1513 1520 O
of 8 10 1521 1523 O
stroke 11 17 1524 1530 B-chronic_disease
or 18 20 1531 1533 O
intracranial 21 33 1534 1546 B-chronic_disease
hemorrhage 34 44 1547 1557 I-chronic_disease
within 45 51 1558 1564 O
6 52 53 1565 1566 B-upper_bound
months 54 60 1567 1573 I-upper_bound
prior 61 66 1574 1579 I-upper_bound
to 67 69 1580 1582 O
enrollment 70 80 1583 1593 O

Karnofsky 0 9 1594 1603 B-clinical_variable
performance 10 21 1604 1615 I-clinical_variable
status 22 28 1616 1622 I-clinical_variable
( 29 30 1623 1624 I-clinical_variable
KPS 30 33 1624 1627 I-clinical_variable
) 33 34 1627 1628 I-clinical_variable
performance 35 46 1629 1640 I-clinical_variable
status 47 53 1641 1647 I-clinical_variable
of 54 56 1648 1650 O
60 57 59 1651 1653 B-lower_bound
% 59 60 1653 1654 I-lower_bound
or 61 63 1655 1657 O
greater 64 71 1658 1665 O

Known 0 5 1666 1671 O
bleeding 6 14 1672 1680 B-chronic_disease
disorders 15 24 1681 1690 I-chronic_disease
, 24 25 1690 1691 O
active 26 32 1692 1698 O
bleeding 33 41 1699 1707 O
disorders 42 51 1708 1717 O
or 52 54 1718 1720 O
clinical 55 63 1721 1729 O
signs 64 69 1730 1735 O
of 70 72 1736 1738 O
bleeding 73 81 1739 1747 O
( 82 83 1748 1749 O
grade 83 88 1749 1754 B-clinical_variable
> 89 90 1755 1756 O
= 90 91 1756 1757 O
2 92 93 1758 1759 B-lower_bound
) 93 94 1759 1760 O

Known 0 5 1761 1766 O
history 6 13 1767 1774 O
of 14 16 1775 1777 O
human 17 22 1778 1783 B-chronic_disease
immunodeficiency 23 39 1784 1800 I-chronic_disease
virus 40 45 1801 1806 I-chronic_disease
( 46 47 1807 1808 I-chronic_disease
HIV 47 50 1808 1811 I-chronic_disease
) 50 51 1811 1812 I-chronic_disease
or 52 54 1813 1815 O
active 55 61 1816 1822 O
with 62 66 1823 1827 O
hepatitis 67 76 1828 1837 B-chronic_disease
C 77 78 1838 1839 I-chronic_disease
virus 79 84 1840 1845 I-chronic_disease
( 85 86 1846 1847 I-chronic_disease
HCV 86 89 1847 1850 I-chronic_disease
) 89 90 1850 1851 I-chronic_disease
or 91 93 1852 1854 O
hepatitis 94 103 1855 1864 B-chronic_disease
B 104 105 1865 1866 I-chronic_disease
virus 106 111 1867 1872 I-chronic_disease
( 112 113 1873 1874 I-chronic_disease
HBV 113 116 1874 1877 I-chronic_disease
) 116 117 1877 1878 I-chronic_disease

Low 0 3 1879 1882 O
- 3 4 1882 1883 O
risk 4 8 1883 1887 O
prostate 9 17 1888 1896 B-cancer
cancer 18 24 1897 1903 I-cancer
after 25 30 1904 1909 B-treatment
curative 31 39 1910 1918 I-treatment
surgery 40 47 1919 1926 I-treatment

Major 0 5 1927 1932 B-treatment
surgery 6 13 1933 1940 I-treatment
within 14 20 1941 1947 O
4 21 22 1948 1949 B-upper_bound
weeks 23 28 1950 1955 I-upper_bound
of 29 31 1956 1958 O
first 32 37 1959 1964 O
dose 38 42 1965 1969 O
of 43 45 1970 1972 O
study 46 51 1973 1978 B-treatment
drug 52 56 1979 1983 I-treatment

Male 0 4 1984 1988 B-gender

Malignancy 0 10 1989 1999 B-cancer
treated 11 18 2000 2007 O
with 19 23 2008 2012 O
curative 24 32 2013 2021 B-treatment
intent 33 39 2022 2028 I-treatment
and 40 43 2029 2032 O
with 44 48 2033 2037 O
no 49 51 2038 2040 O
known 52 57 2041 2046 O
active 58 64 2047 2053 O
disease 65 72 2054 2061 O
present 73 80 2062 2069 O
for 81 84 2070 2073 O
> 85 86 2074 2075 O
= 86 87 2075 2076 O
1 88 89 2077 2078 B-lower_bound
years 90 95 2079 2084 I-lower_bound
before 96 102 2085 2091 I-lower_bound
the 103 106 2092 2095 O
first 107 112 2096 2101 O
dose 113 117 2102 2106 O
of 118 120 2107 2109 O
study 121 126 2110 2115 B-treatment
drug 127 131 2116 2120 I-treatment
and 132 135 2121 2124 O
felt 136 140 2125 2129 O
to 141 143 2130 2132 O
be 144 146 2133 2135 O
at 147 149 2136 2138 O
low 150 153 2139 2142 O
risk 154 158 2143 2147 O
for 159 162 2148 2151 O
recurrence 163 173 2152 2162 O
by 174 176 2163 2165 O
treating 177 185 2166 2174 O
physician 186 195 2175 2184 O

Pathologically 0 14 2185 2199 O
confirmed 15 24 2200 2209 O
diagnosis 25 34 2210 2219 O
of 35 37 2220 2222 O
myelodysplastic 38 53 2223 2238 B-cancer
syndrome 54 62 2239 2247 I-cancer

Prior 0 5 2248 2253 B-treatment
bone 6 10 2254 2258 I-treatment
marrow 11 17 2259 2265 I-treatment
transplant 18 28 2266 2276 I-treatment
within 29 35 2277 2283 O
3 36 37 2284 2285 B-upper_bound
months 38 44 2286 2292 I-upper_bound
or 45 47 2293 2295 O
with 48 52 2296 2300 O
acute 53 58 2301 2306 B-chronic_disease
graft 59 64 2307 2312 I-chronic_disease
versus 65 71 2313 2319 I-chronic_disease
host 72 76 2320 2324 I-chronic_disease
disease 77 84 2325 2332 I-chronic_disease
( 85 86 2333 2334 I-chronic_disease
GVHD 86 90 2334 2338 I-chronic_disease
) 90 91 2338 2339 I-chronic_disease

Prior 0 5 2340 2345 B-treatment
treatment 6 15 2346 2355 I-treatment
with 16 20 2356 2360 I-treatment
a 21 22 2361 2362 I-treatment
Bruton 23 29 2363 2369 I-treatment
's 29 31 2369 2371 I-treatment
tyrosine 32 40 2372 2380 I-treatment
kinase 41 47 2381 2387 I-treatment
( 48 49 2388 2389 I-treatment
BTK 49 52 2389 2392 I-treatment
) 52 53 2392 2393 I-treatment
inhibitor 54 63 2394 2403 I-treatment

Prothrombin 0 11 2404 2415 B-clinical_variable
time 12 16 2416 2420 I-clinical_variable
( 17 18 2421 2422 I-clinical_variable
PT)/international 18 35 2422 2439 I-clinical_variable
normalized 36 46 2440 2450 I-clinical_variable
ratio 47 52 2451 2456 I-clinical_variable
( 53 54 2457 2458 I-clinical_variable
INR 54 57 2458 2461 I-clinical_variable
) 57 58 2461 2462 I-clinical_variable
< 59 60 2463 2464 O
1.5 61 64 2465 2468 B-upper_bound
x 65 66 2469 2470 I-upper_bound
ULN 67 70 2471 2474 I-upper_bound
and 71 74 2475 2478 O
partial 75 82 2479 2486 B-clinical_variable
thromboplastin 83 97 2487 2501 I-clinical_variable
time 98 102 2502 2506 I-clinical_variable
( 103 104 2507 2508 I-clinical_variable
PTT 104 107 2508 2511 I-clinical_variable
) 107 108 2511 2512 I-clinical_variable
( 109 110 2513 2514 O
activated 110 119 2514 2523 B-clinical_variable
[ 120 121 2524 2525 I-clinical_variable
a]PTT 121 126 2525 2530 I-clinical_variable
) 126 127 2530 2531 O
< 128 129 2532 2533 O
1.5 130 133 2534 2537 O
x 134 135 2538 2539 O
ULN 136 139 2540 2543 O

Recent 0 6 2544 2550 O
infection 7 16 2551 2560 B-chronic_disease
requiring 17 26 2561 2570 O
intravenous 27 38 2571 2582 B-treatment
systemic 39 47 2583 2591 I-treatment
treatment 48 57 2592 2601 I-treatment

Requires 0 8 2602 2610 O
treatment 9 18 2611 2620 B-treatment
with 19 23 2621 2625 I-treatment
a 24 25 2626 2627 I-treatment
strong 26 32 2628 2634 I-treatment
cytochrome 33 43 2635 2645 I-treatment
P450 44 48 2646 2650 I-treatment
( 49 50 2651 2652 I-treatment
CYP 50 53 2652 2655 I-treatment
) 53 54 2655 2656 I-treatment
family 55 61 2657 2663 I-treatment
3 62 63 2664 2665 I-treatment
, 63 64 2665 2666 O
subfamily 65 74 2667 2676 B-treatment
A 75 76 2677 2678 I-treatment
, 76 77 2678 2679 O
polypeptide 78 89 2680 2691 B-treatment
4/5 90 93 2692 2695 I-treatment
( 94 95 2696 2697 I-treatment
3A4/5 95 100 2697 2702 I-treatment
) 100 101 2702 2703 I-treatment
inhibitor 102 111 2704 2713 I-treatment

Revised 0 7 2714 2721 B-clinical_variable
international 8 21 2722 2735 I-clinical_variable
prognostic 22 32 2736 2746 I-clinical_variable
scoring 33 40 2747 2754 I-clinical_variable
system 41 47 2755 2761 I-clinical_variable
( 48 49 2762 2763 I-clinical_variable
IPSS 49 53 2763 2767 I-clinical_variable
- 53 54 2767 2768 I-clinical_variable
R 54 55 2768 2769 I-clinical_variable
) 55 56 2769 2770 I-clinical_variable
intermediate 57 69 2771 2783 O
, 69 70 2783 2784 O
high 71 75 2785 2789 O
or 76 78 2790 2792 O
very 79 83 2793 2797 O
high 84 88 2798 2802 O

Serum 0 5 2803 2808 B-clinical_variable
aspartate 6 15 2809 2818 I-clinical_variable
transaminase 16 28 2819 2831 I-clinical_variable
( 29 30 2832 2833 I-clinical_variable
AST 30 33 2833 2836 I-clinical_variable
) 33 34 2836 2837 I-clinical_variable
and 35 38 2838 2841 I-clinical_variable
alanine 39 46 2842 2849 I-clinical_variable
transaminase 47 59 2850 2862 I-clinical_variable
( 60 61 2863 2864 I-clinical_variable
ALT 61 64 2864 2867 I-clinical_variable
) 64 65 2867 2868 I-clinical_variable
= 66 67 2869 2870 O
< 67 68 2870 2871 O
3.0 69 72 2872 2875 B-upper_bound
x 73 74 2876 2877 I-upper_bound
upper 75 80 2878 2883 I-upper_bound
limit 81 86 2884 2889 I-upper_bound
of 87 89 2890 2892 I-upper_bound
normal 90 96 2893 2899 I-upper_bound
( 97 98 2900 2901 I-upper_bound
ULN 98 101 2901 2904 I-upper_bound
) 101 102 2904 2905 I-upper_bound

Unable 0 6 2906 2912 O
to 7 9 2913 2915 O
swallow 10 17 2916 2923 O
capsules 18 26 2924 2932 O
or 27 29 2933 2935 O
malabsorption 30 43 2936 2949 B-chronic_disease
syndrome 44 52 2950 2958 I-chronic_disease
, 52 53 2958 2959 O
disease 54 61 2960 2967 O
significantly 62 75 2968 2981 O
affecting 76 85 2982 2991 O
gastrointestinal 86 102 2992 3008 O
function 103 111 3009 3017 O
, 111 112 3017 3018 O
or 113 115 3019 3021 O
resection 116 125 3022 3031 O
of 126 128 3032 3034 O
the 129 132 3035 3038 O
stomach 133 140 3039 3046 O
or 141 143 3047 3049 O
small 144 149 3050 3055 O
bowel 150 155 3056 3061 O
, 155 156 3061 3062 O
symptomatic 157 168 3063 3074 O
inflammatory 169 181 3075 3087 B-chronic_disease
bowel 182 187 3088 3093 I-chronic_disease
disease 188 195 3094 3101 I-chronic_disease
or 196 198 3102 3104 O
ulcerative 199 209 3105 3115 B-chronic_disease
colitis 210 217 3116 3123 I-chronic_disease
, 217 218 3123 3124 O
or 219 221 3125 3127 O
partial 222 229 3128 3135 O
or 230 232 3136 3138 O
complete 233 241 3139 3147 O
bowel 242 247 3148 3153 B-chronic_disease
obstruction 248 259 3154 3165 I-chronic_disease

Unresolved 0 10 3166 3176 O
toxicities 11 21 3177 3187 O
from 22 26 3188 3192 O
prior 27 32 3193 3198 B-treatment
anti 33 37 3199 3203 I-treatment
- 37 38 3203 3204 I-treatment
cancer 38 44 3204 3210 I-treatment
therapy 45 52 3211 3218 I-treatment
, 52 53 3218 3219 O
defined 54 61 3220 3227 O
as 62 64 3228 3230 O
having 65 71 3231 3237 O
not 72 75 3238 3241 O
resolved 76 84 3242 3250 O
to 85 87 3251 3253 O
Common 88 94 3254 3260 B-clinical_variable
Terminology 95 106 3261 3272 I-clinical_variable
Criteria 107 115 3273 3281 I-clinical_variable
for 116 119 3282 3285 I-clinical_variable
Adverse 120 127 3286 3293 I-clinical_variable
Event 128 133 3294 3299 I-clinical_variable
( 134 135 3300 3301 I-clinical_variable
CTCAE 135 140 3301 3306 I-clinical_variable
, 140 141 3306 3307 I-clinical_variable
version 142 149 3308 3315 I-clinical_variable
4.03 150 154 3316 3320 I-clinical_variable
) 154 155 3320 3321 I-clinical_variable
, 155 156 3321 3322 I-clinical_variable
grade 157 162 3323 3328 I-clinical_variable
= 163 164 3329 3330 O
< 164 165 3330 3331 O
1 166 167 3332 3333 B-upper_bound
, 167 168 3333 3334 O
or 169 171 3335 3337 O
to 172 174 3338 3340 O
the 175 178 3341 3344 O
levels 179 185 3345 3351 O
dictated 186 194 3352 3360 O
in 195 197 3361 3363 O
the 198 201 3364 3367 O
inclusion 202 211 3368 3377 O
/ 211 212 3377 3378 O
exclusion 212 221 3378 3387 O
criteria 222 230 3388 3396 O

Vaccinated 0 10 3397 3407 O
with 11 15 3408 3412 O
live 16 20 3413 3417 B-treatment
, 20 21 3417 3418 O
attenuated 22 32 3419 3429 B-treatment
vaccines 33 41 3430 3438 I-treatment
within 42 48 3439 3445 O
4 49 50 3446 3447 B-upper_bound
weeks 51 56 3448 3453 I-upper_bound
of 57 59 3454 3456 O
first 60 65 3457 3462 O
dose 66 70 3463 3467 O
of 71 73 3468 3470 O
study 74 79 3471 3476 B-treatment
drug 80 84 3477 3481 I-treatment

female 0 6 3482 3488 B-gender
subjects 7 15 3489 3497 I-gender

for 0 3 3498 3501 O
the 4 7 3502 3505 O
dose 8 12 3506 3510 O
expansion 13 22 3511 3520 O
cohort 23 29 3521 3527 O
, 29 30 3527 3528 O
subjects 31 39 3529 3537 O
must 40 44 3538 3542 O
be 45 47 3543 3545 O
azacitidine 48 59 3546 3557 B-treatment
naïve 60 65 3558 3563 O
, 65 66 3563 3564 O
but 67 70 3565 3568 O
otherwise 71 80 3569 3578 O
any 81 84 3579 3582 O
prior 85 90 3583 3588 B-treatment
number 91 97 3589 3595 I-treatment
of 98 100 3596 3598 I-treatment
MDS 101 104 3599 3602 I-treatment
therapies 105 114 3603 3612 I-treatment

pregnant 0 8 3613 3621 B-pregnancy

transfusion 0 11 3622 3633 B-treatment
- 11 12 3633 3634 O
dependent 12 21 3634 3643 O
patients 22 30 3644 3652 O
are 31 34 3653 3656 O
eligible 35 43 3657 3665 O
and 44 47 3666 3669 O
platelet 48 56 3670 3678 B-clinical_variable
counts 57 63 3679 3685 I-clinical_variable
should 64 70 3686 3692 O
be 71 73 3693 3695 O
maintained 74 84 3696 3706 O
greater 85 92 3707 3714 O
than 93 97 3715 3719 O
10,000 98 104 3720 3726 B-lower_bound
/ 104 105 3726 3727 I-lower_bound
mm^3 105 109 3727 3731 I-lower_bound

who 0 3 3732 3735 O
agree 4 9 3736 3741 B-contraception_consent
to 10 12 3742 3744 I-contraception_consent
use 13 16 3745 3748 I-contraception_consent
highly 17 23 3749 3755 I-contraception_consent
effective 24 33 3756 3765 I-contraception_consent
methods 34 41 3766 3773 I-contraception_consent
of 42 44 3774 3776 I-contraception_consent
birth 45 50 3777 3782 I-contraception_consent
control 51 58 3783 3790 I-contraception_consent
during 59 65 3791 3797 O
the 66 69 3798 3801 O
period 70 76 3802 3808 O
of 77 79 3809 3811 O
therapy 80 87 3812 3819 B-treatment
and 88 91 3820 3823 O
for 92 95 3824 3827 O
30 96 98 3828 3830 B-upper_bound
days 99 103 3831 3835 I-upper_bound
after 104 109 3836 3841 I-upper_bound
the 110 113 3842 3845 O
last 114 118 3846 3850 O
dose 119 123 3851 3855 O
of 124 126 3856 3858 O
study 127 132 3859 3864 B-treatment
drug 133 137 3865 3869 I-treatment

40 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Basal 0 5 25 30 B-chronic_disease
joint 6 11 31 36 I-chronic_disease
arthritis 12 21 37 46 I-chronic_disease
of 22 24 47 49 I-chronic_disease
Eaton 25 30 50 55 I-chronic_disease
stage 31 36 56 61 I-chronic_disease
3 37 38 62 63 I-chronic_disease

Diabetes 0 8 64 72 B-chronic_disease
Mellitus 9 17 73 81 I-chronic_disease

English 0 7 82 89 B-language_fluency
fluency 8 15 90 97 I-language_fluency
and 16 19 98 101 I-language_fluency
literacy 20 28 102 110 I-language_fluency

Patients 0 8 111 119 O
on 9 11 120 122 O
Coumadin 12 20 123 131 B-treatment
/ 20 21 131 132 O
Steroids 21 29 132 140 B-treatment
/ 29 30 140 141 O
NSAIDs 30 36 141 147 B-treatment
/ 36 37 147 148 O
Tylenol 37 44 148 155 B-treatment

Post 0 4 156 160 B-chronic_disease
- 4 5 160 161 I-chronic_disease
traumatic 5 14 161 170 I-chronic_disease
osteoarthritis 15 29 171 185 I-chronic_disease

Pregnant 0 8 186 194 B-pregnancy
or 9 11 195 197 O
lactating 12 21 198 207 O
women 22 27 208 213 B-gender

Radiographic 0 12 214 226 B-treatment
evidence 13 21 227 235 I-treatment
of 22 24 236 238 I-treatment
Eaton 25 30 239 244 I-treatment
stage 31 36 245 250 I-treatment
1 37 38 251 252 I-treatment
and 39 42 253 256 I-treatment
2 43 44 257 258 I-treatment
only 45 49 259 263 O

Rheumatoid 0 10 264 274 B-chronic_disease
Arthritis 11 20 275 284 I-chronic_disease
or 21 23 285 287 O
other 24 29 288 293 O
inflammatory 30 42 294 306 B-chronic_disease
disorder 43 51 307 315 I-chronic_disease
diagnoses 52 61 316 325 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
greater 19 26 19 26 O

< 0 1 27 28 O
18 2 4 29 31 B-upper_bound
years 5 10 32 37 I-upper_bound
of 11 13 38 40 O
age 14 17 41 44 B-age

Able 0 4 45 49 O
and 5 8 50 53 O
willing 9 16 54 61 O
to 17 19 62 64 O
return 20 26 65 71 O
for 27 30 72 75 O
scheduled 31 40 76 85 O
study 41 46 86 91 O
visits 47 53 92 98 O
over 54 58 99 103 O
2 59 60 104 105 B-lower_bound
years 61 66 106 111 I-lower_bound
post 67 71 112 116 O
- 71 72 116 117 O
operatively 72 83 117 128 O
( 84 85 129 130 O
following 85 94 130 139 O
research 95 103 140 148 O
related 104 111 149 156 O
surgery 112 119 157 164 O
) 119 120 164 165 O

Enterocutaneous 0 15 166 181 B-chronic_disease
fistula 16 23 182 189 I-chronic_disease

Have 0 4 190 194 O
a 5 6 195 196 O
BMI 7 10 197 200 B-bmi
< 11 12 201 202 O
or 13 15 203 205 O
equal 16 21 206 211 O
to 22 24 212 214 O
40 25 27 215 217 B-upper_bound

Have 0 4 218 222 O
a 5 6 223 224 O
BMI 7 10 225 228 B-bmi
> 11 12 229 230 O
40 12 14 230 232 B-lower_bound

Have 0 4 233 237 O
a 5 6 238 239 O
hernia 7 13 240 246 B-clinical_variable
estimated 14 23 247 256 O
to 24 26 257 259 O
be 27 29 260 262 O
< 30 31 263 264 O
200 31 34 264 267 B-upper_bound
cm2 35 38 268 271 I-upper_bound

Have 0 4 272 276 O
a 5 6 277 278 O
known 7 12 279 284 O
active 13 19 285 291 O
malignancy 20 30 292 302 B-cancer
present 31 38 303 310 O
and/or 39 45 311 317 O
had 46 49 318 321 O
chemotherapy 50 62 322 334 B-treatment
12 63 65 335 337 B-lower_bound
weeks 66 71 338 343 I-lower_bound
prior 72 77 344 349 I-lower_bound
to 78 80 350 352 O
screening 81 90 353 362 O
or 91 93 363 365 O
planned 94 101 366 373 O
chemotherapy 102 114 374 386 O
within 115 121 387 393 O
12 122 124 394 396 O
weeks 125 130 397 402 O
of 131 133 403 405 O
enrollment 134 144 406 416 O
with 145 149 417 421 O
exception 150 159 422 431 O
of 160 162 432 434 O
BCC 163 166 435 438 B-cancer
or 167 169 439 441 O
SCC 170 173 442 445 B-cancer

Have 0 4 446 450 O
a 5 6 451 452 O
known 7 12 453 458 O
collagen 13 21 459 467 B-chronic_disease
metabolism 22 32 468 478 I-chronic_disease
disorder 33 41 479 487 I-chronic_disease
or 42 44 488 490 O
any 45 48 491 494 O
medical 49 56 495 502 B-chronic_disease
condition 57 66 503 512 I-chronic_disease
that 67 71 513 517 O
could 72 77 518 523 O
interfere 78 87 524 533 O
with 88 92 534 538 O
normal 93 99 539 545 O
tissue 100 106 546 552 O
healing 107 114 553 560 O
process 115 122 561 568 O
as 123 125 569 571 O
determined 126 136 572 582 O
by 137 139 583 585 O
the 140 143 586 589 O
Investigator 144 156 590 602 O

Have 0 4 603 607 O
a 5 6 608 609 O
life 7 11 610 614 B-clinical_variable
expectancy 12 22 615 625 I-clinical_variable
greater 23 30 626 633 O
than 31 35 634 638 O
1 36 37 639 640 B-lower_bound
year 38 42 641 645 I-lower_bound
in 43 45 646 648 O
the 46 49 649 652 O
opinion 50 57 653 660 O
of 58 60 661 663 O
the 61 64 664 667 O
Investigator 65 77 668 680 O

Have 0 4 681 685 O
a 5 6 686 687 O
life 7 11 688 692 B-clinical_variable
expectancy 12 22 693 703 I-clinical_variable
less 23 27 704 708 O
than 28 32 709 713 O
1 33 34 714 715 B-upper_bound
year 35 39 716 720 I-upper_bound

Have 0 4 721 725 O
a 5 6 726 727 O
pre 7 10 728 731 B-clinical_variable
- 10 11 731 732 I-clinical_variable
operative 11 20 732 741 I-clinical_variable
estimated 21 30 742 751 I-clinical_variable
hernia 31 37 752 758 I-clinical_variable
defect 38 44 759 765 I-clinical_variable
of 45 47 766 768 O
200 48 51 769 772 B-lower_bound
cm2 52 55 773 776 I-lower_bound
OR 56 58 777 779 O
multiple 59 67 780 788 B-clinical_variable
hernia 68 74 789 795 I-clinical_variable
defects 75 82 796 803 I-clinical_variable
whose 83 88 804 809 O
combined 89 97 810 818 O
area 98 102 819 823 O
is 103 105 824 826 O
≥ 106 107 827 828 O
an 108 110 829 831 O
estimated 111 120 832 841 O
200 121 124 842 845 O
cm2 125 128 846 849 O

Have 0 4 850 854 O
active 5 11 855 861 O
necrotizing 12 23 862 873 B-chronic_disease
fasciitis 24 33 874 883 I-chronic_disease
or 34 36 884 886 O
any 37 40 887 890 O
other 41 46 891 896 O
known 47 52 897 902 O
active 53 59 903 909 O
local 60 65 910 915 O
or 66 68 916 918 O
systemic 69 77 919 927 B-chronic_disease
infection 78 87 928 937 I-chronic_disease

Have 0 4 938 942 O
known 5 10 943 948 O
moderate 11 19 949 957 O
to 20 22 958 960 O
severe 23 29 961 967 O
cirrhosis 30 39 968 977 B-chronic_disease
which 40 45 978 983 O
in 46 48 984 986 O
the 49 52 987 990 O
opinion 53 60 991 998 O
of 61 63 999 1001 O
the 64 67 1002 1005 O
Investigator 68 80 1006 1018 O
would 81 86 1019 1024 O
impact 87 93 1025 1031 O
the 94 97 1032 1035 O
outcome 98 105 1036 1043 O
of 106 108 1044 1046 O
this 109 113 1047 1051 O
trial 114 119 1052 1057 O

Known 0 5 1058 1063 O
tobacco 6 13 1064 1071 O
use 14 17 1072 1075 O
within 18 24 1076 1082 O
the 25 28 1083 1086 O
past 29 33 1087 1091 B-upper_bound
6 34 35 1092 1093 I-upper_bound
weeks 36 41 1094 1099 I-upper_bound
or 42 44 1100 1102 O
positive 45 53 1103 1111 O
serum 54 59 1112 1117 O
cotinine 60 68 1118 1126 O
test 69 73 1127 1131 O
at 74 76 1132 1134 O
time 77 81 1135 1139 O
of 82 84 1140 1142 O
admission 85 94 1143 1152 O

Participation 0 13 1153 1166 O
in 14 16 1167 1169 O
an 17 19 1170 1172 O
investigational 20 35 1173 1188 B-treatment
drug 36 40 1189 1193 I-treatment
or 41 43 1194 1196 I-treatment
device 44 50 1197 1203 I-treatment
study 51 56 1204 1209 O
that 57 61 1210 1214 O
would 62 67 1215 1220 O
impact 68 74 1221 1227 O
the 75 78 1228 1231 O
safety 79 85 1232 1238 O
or 86 88 1239 1241 O
scientific 89 99 1242 1252 O
integrity 100 109 1253 1262 O
of 110 112 1263 1265 O
this 113 117 1266 1270 O
study 118 123 1271 1276 O
( 124 125 1277 1278 O
in 125 127 1278 1280 O
the 128 131 1281 1284 O
opinion 132 139 1285 1292 O
of 140 142 1293 1295 O
the 143 146 1296 1299 O
Investigator 147 159 1300 1312 O
and 160 163 1313 1316 O
with 164 168 1317 1321 O
the 169 172 1322 1325 O
approval 173 181 1326 1334 O
of 182 184 1335 1337 O
the 185 188 1338 1341 O
Sponsor 189 196 1342 1349 O
) 196 197 1349 1350 O
within 198 204 1351 1357 O
the 205 208 1358 1361 O
past 209 213 1362 1366 B-upper_bound
6 214 215 1367 1368 I-upper_bound
weeks 216 221 1369 1374 I-upper_bound
prior 222 227 1375 1380 I-upper_bound
to 228 230 1381 1383 O
enrollment 231 241 1384 1394 O
into 242 246 1395 1399 O
this 247 251 1400 1404 O
trial 252 257 1405 1410 O

Planned 0 7 1411 1418 O
use 8 11 1419 1422 O
of 12 14 1423 1425 O
external 15 23 1426 1434 O
VAC 24 27 1435 1438 B-treatment
dressing 28 36 1439 1447 O
intra 37 42 1448 1453 O
- 42 43 1453 1454 O
operatively 43 54 1454 1465 O

Pregnancy 0 9 1466 1475 B-pregnancy

Received 0 8 1476 1484 O
high 9 13 1485 1489 O
dose 14 18 1490 1494 O
steroids 19 27 1495 1503 B-treatment
( 28 29 1504 1505 O
> 29 30 1505 1506 O
/=100 30 35 1506 1511 O
mg 35 37 1511 1513 I-lower_bound
of 38 40 1514 1516 O
prednisone 41 51 1517 1527 B-treatment
) 51 52 1527 1528 O
within 53 59 1529 1535 O
the 60 63 1536 1539 O
past 64 68 1540 1544 B-lower_bound
6 69 70 1545 1546 I-lower_bound
weeks 71 76 1547 1552 I-lower_bound

Subject 0 7 1553 1560 O
is 8 10 1561 1563 O
determined 11 21 1564 1574 O
to 22 24 1575 1577 O
have 25 29 1578 1582 O
an 30 32 1583 1585 O
American 33 41 1586 1594 B-clinical_variable
Society 42 49 1595 1602 I-clinical_variable
of 50 52 1603 1605 I-clinical_variable
Anesthesiologists'(ASA 53 75 1606 1628 I-clinical_variable
) 75 76 1628 1629 I-clinical_variable
physical 77 85 1630 1638 I-clinical_variable
class 86 91 1639 1644 I-clinical_variable
of 92 94 1645 1647 O
4 95 96 1648 1649 B-lower_bound
, 96 97 1649 1650 O
5 98 99 1651 1652 O
, 99 100 1652 1653 O
or 101 103 1654 1656 O
6 104 105 1657 1658 B-upper_bound

Uncontrolled 0 12 1659 1671 B-chronic_disease
diabetes 13 21 1672 1680 I-chronic_disease
( 22 23 1681 1682 O
i.e. 23 27 1682 1686 O
known 28 33 1687 1692 O
HbA1C 34 39 1693 1698 B-clinical_variable
value 40 45 1699 1704 I-clinical_variable
> 46 47 1705 1706 O
7 48 49 1707 1708 B-lower_bound
% 49 50 1708 1709 I-lower_bound
within 51 57 1710 1716 O
the 58 61 1717 1720 O
last 62 66 1721 1725 B-upper_bound
6 67 68 1726 1727 I-upper_bound
weeks 69 74 1728 1733 I-upper_bound
) 74 75 1733 1734 O

Ventral 0 7 1735 1742 B-chronic_disease
hernia 8 14 1743 1749 I-chronic_disease
repairs 15 22 1750 1757 O
involving 23 32 1758 1767 O
active 33 39 1768 1774 B-chronic_disease
infection 40 49 1775 1784 I-chronic_disease

< 0 1 0 1 O
18 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

history 0 7 18 25 O
of 8 10 26 28 O
Raynaud 11 18 29 36 B-chronic_disease
's 18 20 36 38 I-chronic_disease

known 0 5 39 44 O
severe 6 12 45 51 B-chronic_disease
peripheral 13 23 52 62 I-chronic_disease
artery 24 30 63 69 I-chronic_disease
disease 31 38 70 77 I-chronic_disease

less 0 4 78 82 O
than 5 9 83 87 O
5 10 11 88 89 B-upper_bound
metabolic 12 21 90 99 O
equivalents 22 33 100 111 O
( 34 35 112 113 O
METs 35 39 113 117 O
) 39 40 117 118 O

poor 0 4 119 123 O
perfusion 5 14 124 133 O
to 15 17 134 136 O
fingers 18 25 137 144 O
( 26 27 145 146 O
as 27 29 146 148 O
defined 30 37 149 156 O
as 38 40 157 159 O
a 41 42 160 161 O
perfusion 43 52 162 171 B-clinical_variable
index 53 58 172 177 I-clinical_variable
less 59 63 178 182 O
than 64 68 183 187 O
0.5%- 69 74 188 193 B-upper_bound
www.Masimo.com 75 89 194 208 O
) 89 90 208 209 O

pregnancy 0 9 210 219 B-pregnancy

For 0 3 0 3 O
at 4 6 4 6 O
least 7 12 7 12 O
2 13 14 13 14 B-upper_bound
months 15 21 15 21 I-lower_bound
before 22 28 22 28 O
the 29 32 29 32 O
Screening 33 42 33 42 O
Visit 43 48 43 48 O
, 48 49 48 49 O
the 50 53 50 53 O
patient 54 61 54 61 O
has 62 65 62 65 O
had 66 69 66 69 O
2 70 71 70 71 O
or 72 74 72 74 O
fewer 75 80 75 80 O
defecations 81 92 81 92 O
( 93 94 93 94 O
with 94 98 94 98 O
each 99 103 99 103 O
defecation 104 114 104 114 O
occurring 115 124 115 124 O
in 125 127 125 127 O
the 128 131 128 131 O
absence 132 139 132 139 O
of 140 142 140 142 O
any 143 146 143 146 O
laxative 147 155 147 155 B-treatment
, 155 156 155 156 O
suppository 157 168 157 168 B-treatment
, 168 169 168 169 O
or 170 172 170 172 O
enema 173 178 173 178 B-treatment
use 179 182 179 182 O
during 183 189 183 189 O
the 190 193 190 193 O
preceding 194 203 194 203 B-upper_bound
24 204 206 204 206 I-upper_bound
hours 207 212 207 212 I-upper_bound
) 212 213 212 213 O
in 214 216 214 216 O
the 217 220 217 220 O
toilet 221 227 221 227 O
per 228 231 228 231 O
week 232 236 232 236 O

History 0 7 237 244 O
of 8 10 245 247 O
painful 11 18 248 255 O
or 19 21 256 258 O
hard 22 26 259 263 B-chronic_disease
bowel 27 32 264 269 I-chronic_disease
movements 33 42 270 279 I-chronic_disease
( 43 44 280 281 I-chronic_disease
BMs 44 47 281 284 I-chronic_disease
) 47 48 284 285 I-chronic_disease

Patient 0 7 286 293 O
or 8 10 294 296 O
parent 11 17 297 303 O
/ 17 18 303 304 O
guardian 18 26 304 312 O
/ 26 27 312 313 O
LAR 27 30 313 316 O
or 31 33 317 319 O
caregiver 34 43 320 329 O
is 44 46 330 332 O
compliant 47 56 333 342 O
with 57 61 343 347 O
eDiary 62 68 348 354 O
by 69 71 355 357 O
completing 72 82 358 368 O
both 83 87 369 373 O
the 88 91 374 377 O
morning 92 99 378 385 O
and 100 103 386 389 O
evening 104 111 390 397 O
assessments 112 123 398 409 O
for 124 127 410 413 O
10 128 130 414 416 B-lower_bound
out 131 134 417 420 O
of 135 137 421 423 O
the 138 141 424 427 O
14 142 144 428 430 B-upper_bound
days 145 149 431 435 I-upper_bound
immediately 150 161 436 447 O
preceding 162 171 448 457 O
the 172 175 458 461 O
Randomization 176 189 462 475 O
Visit 190 195 476 481 O

Patient 0 7 482 489 O
reports 8 15 490 497 O
having 16 22 498 504 O
more 23 27 505 509 O
than 28 32 510 514 O
1 33 34 515 516 B-lower_bound
loose 35 40 517 522 O
, 40 41 522 523 O
mushy 42 47 524 529 O
stool 48 53 530 535 O
( 54 55 536 537 O
eDiary 55 61 537 543 O
- 61 62 543 544 O
recorded 62 70 544 552 O
stool 71 76 553 558 O
consistency 77 88 559 570 O
of 89 91 571 573 O
6 92 93 574 575 O
on 94 96 576 578 O
the 97 100 579 582 O
Pediatric 101 110 583 592 B-clinical_variable
Bristol 111 118 593 600 I-clinical_variable
Stool 119 124 601 606 I-clinical_variable
Form 125 129 607 611 I-clinical_variable
Scale 130 135 612 617 I-clinical_variable
[ 136 137 618 619 I-clinical_variable
p 137 138 619 620 I-clinical_variable
- 138 139 620 621 I-clinical_variable
BSFS 139 143 621 625 I-clinical_variable
] 143 144 625 626 I-clinical_variable
) 144 145 626 627 I-clinical_variable
or 146 148 628 630 O
any 149 152 631 634 O
watery 153 159 635 641 O
stool 160 165 642 647 O
( 166 167 648 649 O
eDiary 167 173 649 655 O
- 173 174 655 656 O
recorded 174 182 656 664 O
stool 183 188 665 670 O
consistency 189 200 671 682 O
of 201 203 683 685 O
7 204 205 686 687 O
on 206 208 688 690 O
the 209 212 691 694 O
p 213 214 695 696 O
- 214 215 696 697 O
BSFS 215 219 697 701 O
) 219 220 701 702 O
with 221 225 703 707 O
any 226 229 708 711 O
SBM 230 233 712 715 O
that 234 238 716 720 O
occurred 239 247 721 729 O
in 248 250 730 732 O
the 251 254 733 736 O
absence 255 262 737 744 O
of 263 265 745 747 O
laxative 266 274 748 756 B-treatment
use 275 278 757 760 O
on 279 281 761 763 O
the 282 285 764 767 O
calendar 286 294 768 776 O
day 295 298 777 780 O
of 299 301 781 783 O
the 302 305 784 787 O
BM 306 308 788 790 O
or 309 311 791 793 O
the 312 315 794 797 O
calendar 316 324 798 806 O
day 325 328 807 810 O
before 329 335 811 817 O
the 336 339 818 821 O
BM 340 342 822 824 O
during 343 349 825 831 O
the 350 353 832 835 O
14 354 356 836 838 B-upper_bound
days 357 361 839 843 I-upper_bound
before 362 368 844 850 O
the 369 372 851 854 O
randomization 373 386 855 868 O
day 387 390 869 872 O
and 391 394 873 876 O
up 395 397 877 879 O
to 398 400 880 882 O
the 401 404 883 886 O
randomization 405 418 887 900 O

at 0 2 901 903 O
least 3 8 904 909 O
once 9 13 910 914 O
per 14 17 915 918 O
week 18 22 919 923 O
for 23 26 924 927 O
at 27 29 928 930 O
least 30 35 931 936 O
2 36 37 937 938 B-lower_bound
months 38 44 939 945 I-lower_bound
before 45 51 946 952 O
Screening 52 61 953 962 O
Visit 62 67 963 968 O
, 67 68 968 969 O
the 69 72 970 973 O
patient 73 80 974 981 O
experienced 81 92 982 993 O
abdominal 93 102 994 1003 O
discomfort 103 113 1004 1014 O
( 114 115 1015 1016 O
an 115 117 1016 1018 O
uncomfortable 118 131 1019 1032 O
sensation 132 141 1033 1042 O
not 142 145 1043 1046 O
described 146 155 1047 1056 O
as 156 158 1057 1059 O
pain 159 163 1060 1064 O
) 163 164 1064 1065 O

meets 0 5 1066 1071 O
Rome 6 10 1072 1076 B-treatment
III 11 14 1077 1080 I-treatment
criteria 15 23 1081 1089 I-treatment
for 24 27 1090 1093 O
child 28 33 1094 1099 O
/ 33 34 1099 1100 O
adolescent 34 44 1100 1110 O
IBS 45 48 1111 1114 B-chronic_disease

pain 0 4 1115 1119 O
associated 5 15 1120 1130 O
with 16 20 1131 1135 O
2 21 22 1136 1137 B-lower_bound
or 23 25 1138 1140 O
more 26 30 1141 1145 O
of 31 33 1146 1148 O
the 34 37 1149 1152 O
following 38 47 1153 1162 O
at 48 50 1163 1165 O
least 51 56 1166 1171 O
25 57 59 1172 1174 B-lower_bound
% 59 60 1174 1175 I-lower_bound
of 61 63 1176 1178 O
the 64 67 1179 1182 O
time 68 72 1183 1187 O

required 0 8 1188 1196 O
manual 9 15 1197 1203 O
disimpaction 16 28 1204 1216 O
anytime 29 36 1217 1224 O
prior 37 42 1225 1230 O
to 43 45 1231 1233 O
randomization 46 59 1234 1247 O
or 60 62 1248 1250 O
disimpaction 63 75 1251 1263 O
during 76 82 1264 1270 O
in 83 85 1271 1273 O
- 85 86 1273 1274 O
patient 86 93 1274 1281 O
hospitalization 94 109 1282 1297 O
within 110 116 1298 1304 O
one 117 120 1305 1308 B-upper_bound
year 121 125 1309 1313 I-upper_bound
prior 126 131 1314 1319 I-upper_bound
to 132 134 1320 1322 O
randomization 135 148 1323 1336 O

unable 0 6 1337 1343 O
to 7 9 1344 1346 O
tolerate 10 18 1347 1355 O
the 19 22 1356 1359 O
placebo 23 30 1360 1367 B-treatment
during 31 37 1368 1374 O
rhe 38 41 1375 1378 O
Screening 42 51 1379 1388 O
Period 52 58 1389 1395 O

weighs 0 6 1396 1402 B-clinical_variable
at 7 9 1403 1405 O
least 10 15 1406 1411 O
18 16 18 1412 1414 B-lower_bound
kg 19 21 1415 1417 I-lower_bound
( 22 23 1418 1419 I-lower_bound
39.7 23 27 1419 1423 I-lower_bound
lbs 28 31 1424 1427 I-lower_bound
) 31 32 1427 1428 I-lower_bound

willing 0 7 1429 1436 O
to 8 10 1437 1439 O
discontinue 11 22 1440 1451 O
any 23 26 1452 1455 O
laxatives 27 36 1456 1465 B-treatment
used 37 41 1466 1470 O
before 42 48 1471 1477 O
the 49 52 1478 1481 O
Pretreatment 53 65 1482 1494 O
Visit 66 71 1495 1500 O
in 72 74 1501 1503 O
favor 75 80 1504 1509 O
of 81 83 1510 1512 O
the 84 87 1513 1516 O
protocol 88 96 1517 1525 O
- 96 97 1525 1526 O
permitted 97 106 1526 1535 O
rescue 107 113 1536 1542 O
medicine 114 122 1543 1551 O

Changes 0 7 0 7 O
in 8 10 8 10 O
systemic 11 19 11 19 B-treatment
chemotherapy 20 32 20 32 I-treatment
, 32 33 32 33 O
hormonal 34 42 34 42 B-treatment
therapy 43 50 43 50 I-treatment
or 51 53 51 53 O
the 54 57 54 57 O
use 58 61 58 61 O
of 62 64 62 64 O
bisphosphonates 65 80 65 80 B-treatment
for 81 84 81 84 O
4 85 86 85 86 O
weeks 87 92 87 92 O
before 93 99 93 99 O
and 100 103 100 103 O
after 104 109 104 109 O
the 110 113 110 113 O
delivery 114 122 114 122 O
of 123 125 123 125 O
radiotherapy 126 138 126 138 B-treatment
are 139 142 139 142 O
allowed 143 150 143 150 O
, 150 151 150 151 O
but 152 155 152 155 O
recording 156 165 156 165 O
and 166 169 166 169 O
accounting 170 180 170 180 O
for 181 184 181 184 O
this 185 189 185 189 O
in 190 192 190 192 O
the 193 196 193 196 O
statistical 197 208 197 208 O
analysis 209 217 209 217 O
is 218 220 218 220 O
required 221 229 221 229 O

Eastern 0 7 230 237 B-clinical_variable
Cooperative 8 19 238 249 I-clinical_variable
Oncology 20 28 250 258 I-clinical_variable
Group 29 34 259 264 I-clinical_variable
( 35 36 265 266 I-clinical_variable
ECOG 36 40 266 270 I-clinical_variable
) 40 41 270 271 I-clinical_variable
performance 42 53 272 283 I-clinical_variable
status 54 60 284 290 I-clinical_variable
of 61 63 291 293 O
0 64 65 294 295 B-lower_bound
- 66 67 296 297 O
3 68 69 298 299 B-upper_bound

Metastases 0 10 300 310 B-cancer
to 11 13 311 313 O
the 14 17 314 317 O
skull 18 23 318 323 B-cancer
, 23 24 323 324 O
hands 25 30 325 330 B-cancer
, 30 31 330 331 O
feet 32 36 332 336 B-cancer
are 37 40 337 340 O
not 41 44 341 344 O
eligible 45 53 345 353 O
treatment 54 63 354 363 B-treatment
sites 64 69 364 369 O

Negative 0 8 370 378 B-pregnancy
pregnancy 9 18 379 388 I-pregnancy
test 19 23 389 393 O
at 24 26 394 396 O
study 27 32 397 402 O
registration 33 45 403 415 O

Pain 0 4 416 420 B-clinical_variable
score 5 10 421 426 I-clinical_variable
of 11 13 427 429 O
at 14 16 430 432 O
least 17 22 433 438 O
5 23 24 439 440 O
on 25 27 441 443 O
a 28 29 444 445 O
scale 30 35 446 451 O
of 36 38 452 454 O
0 39 40 455 456 B-lower_bound
- 41 42 457 458 O
10 43 45 459 461 B-upper_bound
within 46 52 462 468 O
a 53 54 469 470 O
week 55 59 471 475 O
of 60 62 476 478 O
enrollment 63 73 479 489 O
OR 74 76 490 492 B-clinical_variable
pain 77 81 493 497 I-clinical_variable
score 82 87 498 503 I-clinical_variable
< 88 89 504 505 O
5 90 91 506 507 O
with 92 96 508 512 O
> 97 98 513 514 O
= 98 99 514 515 O
60 100 102 516 518 B-lower_bound
mg 103 105 519 521 I-lower_bound
of 106 108 522 524 O
morphine 109 117 525 533 B-treatment
( 118 119 534 535 O
or 119 121 535 537 O
equivalent 122 132 538 548 O
) 132 133 548 549 O
per 134 137 550 553 O
day 138 141 554 557 O

Previous 0 8 558 566 O
radiotherapy 9 21 567 579 B-treatment
or 22 24 580 582 O
palliative 25 35 583 593 B-treatment
surgery 36 43 594 601 I-treatment
to 44 46 602 604 O
the 47 50 605 608 O
painful 51 58 609 616 O
site 59 63 617 621 O

Radiographic 0 12 622 634 O
evidence 13 21 635 643 O
of 22 24 644 646 O
bone 25 29 647 651 B-cancer
metastases 30 40 652 662 I-cancer
within 41 47 663 669 O
8 48 49 670 671 B-upper_bound
weeks 50 55 672 677 I-upper_bound
of 56 58 678 680 O
study 59 64 681 686 O

Spinal 0 6 687 693 O
cord 7 11 694 698 O
or 12 14 699 701 O
cauda 15 20 702 707 B-chronic_disease
equine 21 27 708 714 I-chronic_disease
compression 28 39 715 726 I-chronic_disease
/ 39 40 726 727 I-chronic_disease
effacement 40 50 727 737 I-chronic_disease
in 51 53 738 740 O
vertebral 54 63 741 750 B-cancer
metastases 64 74 751 761 I-cancer
with 75 79 762 766 O
neurological 80 92 767 779 O
symptoms 93 101 780 788 O
other 102 107 789 794 O
than 108 112 795 799 O
just 113 117 800 804 O
pain 118 122 805 809 O

Up 0 2 810 812 O
to 3 5 813 815 O
5 6 7 816 817 O
consecutive 8 19 818 829 O
cervical 20 28 830 838 B-cancer
, 28 29 838 839 O
thoracic 30 38 840 848 B-cancer
or 39 41 849 851 O
lumbar 42 48 852 858 O
vertebral 49 58 859 868 O
bodies 59 65 869 875 O

for 0 3 876 879 O
patients 4 12 880 888 O
with 13 17 889 893 O
painful 18 25 894 901 O
metastases 26 36 902 912 B-cancer
that 37 41 913 917 O
are 42 45 918 921 O
contiguous 46 56 922 932 O
but 57 60 933 936 O
do 61 63 937 939 O
not 64 67 940 943 O
fit 68 71 944 947 O
into 72 76 948 952 O
the 77 80 953 956 O
definition 81 91 957 967 O
of 92 94 968 970 O
a 95 96 971 972 O
site 97 101 973 977 O
listed 102 108 978 984 O
above 109 114 985 990 O

multiple 0 8 991 999 O
sites 9 14 1000 1005 O
eligible 15 23 1006 1014 O
if 24 26 1015 1017 O
they 27 31 1018 1022 O
can 32 35 1023 1026 O
be 36 38 1027 1029 O
included 39 47 1030 1038 O
in 48 50 1039 1041 O
no 51 53 1042 1044 O
greater 54 61 1045 1052 O
than 62 66 1053 1057 O
3 67 68 1058 1059 B-upper_bound
treatment 69 78 1060 1069 O
sites 79 84 1070 1075 O

the 0 3 1076 1079 O
patient 4 11 1080 1087 O
must 12 16 1088 1092 O
have 17 21 1093 1097 O
pain 22 26 1098 1102 O
which 27 32 1103 1108 O
appears 33 40 1109 1116 O
to 41 43 1117 1119 O
be 44 46 1120 1122 O
related 47 54 1123 1130 O
to 55 57 1131 1133 O
the 58 61 1134 1137 O
radiographically 62 78 1138 1154 O
documented 79 89 1155 1165 O
metastasis 90 100 1166 1176 B-cancer
in 101 103 1177 1179 O
the 104 107 1180 1183 O
opinion 108 115 1184 1191 O
of 116 118 1192 1194 O
the 119 122 1195 1198 O
treating 123 131 1199 1207 O
physician 132 141 1208 1217 O
, 141 142 1217 1218 O
and 143 146 1219 1222 O
the 147 150 1223 1226 O
decision 151 159 1227 1235 O
has 160 163 1236 1239 O
been 164 168 1240 1244 O
made 169 173 1245 1249 O
by 174 176 1250 1252 O
the 177 180 1253 1256 O
responsible 181 192 1257 1268 O
clinician 193 202 1269 1278 O
that 203 207 1279 1283 O
a 208 209 1284 1285 O
course 210 216 1286 1292 O
of 217 219 1293 1295 O
palliative 220 230 1296 1306 O
external 231 239 1307 1315 B-treatment
beam 240 244 1316 1320 I-treatment
radiation 245 254 1321 1330 I-treatment
therapy 255 262 1331 1338 I-treatment
is 263 265 1339 1341 O
appropriate 266 277 1342 1353 O
treatment 278 287 1354 1363 O

those 0 5 1364 1369 O
patients 6 14 1370 1378 O
will 15 19 1379 1383 O
still 20 25 1384 1389 O
be 26 28 1390 1392 O
eligible 29 37 1393 1401 O
but 38 41 1402 1405 O
will 42 46 1406 1410 O
be 47 49 1411 1413 O
considered 50 60 1414 1424 O
to 61 63 1425 1427 O
have 64 68 1428 1432 O
two 69 72 1433 1436 O
treatment 73 82 1437 1446 B-treatment
sites 83 88 1447 1452 O
; 88 89 1452 1453 O
for 90 93 1454 1457 O
example 94 101 1458 1465 O
, 101 102 1465 1466 O
a 103 104 1467 1468 O
patient 105 112 1469 1476 O
with 113 117 1477 1481 O
a 118 119 1482 1483 O
lesion 120 126 1484 1490 O
of 127 129 1491 1493 O
T4 130 132 1494 1496 B-cancer
, 132 133 1496 1497 O
T7 134 136 1498 1500 B-cancer
and 137 140 1501 1504 O
T9 141 143 1505 1507 B-cancer
would 144 149 1508 1513 O
be 150 152 1514 1516 O
eligible 153 161 1517 1525 O
but 162 165 1526 1529 O
would 166 171 1530 1535 O
be 172 174 1536 1538 O
considered 175 185 1539 1549 O
as 186 188 1550 1552 O
two 189 192 1553 1556 O
treatment 193 202 1557 1566 O
sites 203 208 1567 1572 O
since 209 214 1573 1578 O
more 215 219 1579 1583 O
than 220 224 1584 1588 O
five 225 229 1589 1593 B-lower_bound
consecutive 230 241 1594 1605 O
vertebral 242 251 1606 1615 O
bodies 252 258 1616 1622 O
would 259 264 1623 1628 O
be 265 267 1629 1631 O
treated 268 275 1632 1639 O

Abnormal 0 8 0 8 B-clinical_variable
serum 9 14 9 14 I-clinical_variable
thyroid 15 22 15 22 I-clinical_variable
- 22 23 22 23 I-clinical_variable
stimulating 23 34 23 34 I-clinical_variable
hormone(TSH 35 46 35 46 I-clinical_variable
) 46 47 46 47 I-clinical_variable
HbA1c 48 53 48 53 B-clinical_variable
> 54 55 54 55 O
8.5 55 58 55 58 B-lower_bound
% 58 59 58 59 I-lower_bound
( 60 61 60 61 O
> 61 62 61 62 O
69 62 64 62 64 B-lower_bound
mmol 65 69 65 69 I-lower_bound
/ 69 70 69 70 I-lower_bound
mol 70 73 70 73 I-lower_bound
) 73 74 73 74 O

Absence 0 7 75 82 O
of 8 10 83 85 O
medically 11 20 86 95 O
approved 21 29 96 104 O
contraception 30 43 105 118 O
in 44 46 119 121 O
females 47 54 122 129 B-gender
of 55 57 130 132 O
childbearing 58 70 133 145 O
potential[exempli 71 88 146 163 O
gratia 89 95 164 170 O
( 96 97 171 172 O
e.g. 97 101 172 176 O
) 101 102 176 177 O
, 102 103 177 178 O
hysterectomy 104 116 179 191 O
, 116 117 191 192 O
oral 118 122 193 197 O
contraceptive 123 136 198 211 O
medications 137 148 212 223 O
, 148 149 223 224 O
intrauterine 149 161 224 236 O
device 162 168 237 243 O
combined 169 177 244 252 O
with 178 182 253 257 O
a 183 184 258 259 O
barrier 185 192 260 267 O
method 193 199 268 274 O
, 199 200 274 275 O
two 201 204 276 279 O
( 205 206 280 281 O
2 206 207 281 282 O
) 207 208 282 283 O
combined 209 217 284 292 O
barrier 218 225 293 300 O
methods 226 233 301 308 O
such 234 238 309 313 O
as 239 241 314 316 O
diaphragm 242 251 317 326 O
and 252 255 327 330 O
condom 256 262 331 337 O
or 263 265 338 340 O
spermicide 266 276 341 351 O
, 276 277 351 352 O
or 278 280 353 355 O
condom 281 287 356 362 O
and 288 291 363 366 O
spermicide 292 302 367 377 O
; 302 303 377 378 O
bilateral 304 313 379 388 O
tubal 314 319 389 394 O
ligation 320 328 395 403 O
and 329 332 404 407 O
vasectomy 333 342 408 417 O
are 343 346 418 421 O
acceptable 347 357 422 432 O
contraceptive 358 371 433 446 O
methods 372 379 447 454 O
when 380 384 455 459 O
combined 385 393 460 468 O
with 394 398 469 473 O
another 399 406 474 481 O
single 407 413 482 488 O
method 414 420 489 495 O
from 421 425 496 500 O
above 426 431 501 506 O
] 431 432 506 507 O

Administration 0 14 508 522 O
of 15 17 523 525 O
Prototype 18 27 526 535 B-treatment
2 28 29 536 537 I-treatment
( 30 31 538 539 I-treatment
GSP2 31 35 539 543 I-treatment
) 35 36 543 544 I-treatment
, 36 37 544 545 O
Prototype 38 47 546 555 B-treatment
3 48 49 556 557 I-treatment
( 50 51 558 559 I-treatment
GSP3 51 55 559 563 I-treatment
) 55 56 563 564 I-treatment
, 56 57 564 565 O
Gelesis100,or 58 71 566 579 B-treatment
Gelesis200 72 82 580 590 B-treatment
in 83 85 591 593 O
a 86 87 594 595 O
previous 88 96 596 604 O
study 97 102 605 610 O

Angina 0 6 611 617 B-chronic_disease
, 6 7 617 618 O
coronary 8 16 619 627 B-treatment
bypass 17 23 628 634 I-treatment
, 23 24 634 635 O
or 25 27 636 638 O
myocardial 28 38 639 649 B-chronic_disease
infarction 39 49 650 660 I-chronic_disease
within 50 56 661 667 O
six(6)months 57 69 668 680 B-upper_bound
prior 70 75 681 686 I-upper_bound
to 76 78 687 689 O
Screening 79 88 690 699 O
Visit 89 94 700 705 O

Antidiabetic 0 12 706 718 B-treatment
medications 13 24 719 730 I-treatment
within 25 31 731 737 O
one 32 35 738 741 B-upper_bound
( 36 37 742 743 I-upper_bound
1 37 38 743 744 I-upper_bound
) 38 39 744 745 I-upper_bound
month 40 45 746 751 I-upper_bound
prior 46 51 752 757 I-upper_bound
to 52 54 758 760 O
Screening 55 64 761 770 O
Visit 65 70 771 776 O
[ 71 72 777 778 O
except 72 78 778 784 O
stable 79 85 785 791 O
doses 86 91 792 797 O
of 92 94 798 800 O
metformin 95 104 801 810 B-treatment
and 105 108 811 814 O
DPP-4 109 114 815 820 B-treatment
inhibitors 115 125 821 831 I-treatment
for 126 129 832 835 O
at 130 132 836 838 O
least 133 138 839 844 O
one 139 142 845 848 O
( 143 144 849 850 O
1 144 145 850 851 O
) 145 146 851 852 O
month 147 152 853 858 O
in 153 155 859 861 O
subjects 156 164 862 870 O
with 165 169 871 875 O
Type 170 174 876 880 B-chronic_disease
2 175 176 881 882 I-chronic_disease
Diabetes 177 185 883 891 I-chronic_disease
] 185 186 891 892 O

Any 0 3 893 896 O
other 4 9 897 902 O
medication 10 20 903 913 O
known 21 26 914 919 O
to 27 29 920 922 O
cause 30 35 923 928 O
weight 36 42 929 935 O
loss 43 47 936 940 O
or 48 50 941 943 O
weight 51 57 944 950 O
gain 58 62 951 955 O
within 63 69 956 962 O
one 70 73 963 966 B-upper_bound
( 74 75 967 968 I-upper_bound
1 75 76 968 969 I-upper_bound
) 76 77 969 970 I-upper_bound
month 78 83 971 976 I-upper_bound
prior 84 89 977 982 I-upper_bound
to 90 92 983 985 O
Screening 93 102 986 995 O
Visit 103 108 996 1001 O

Blood 0 5 1002 1007 B-treatment
transfusion 6 17 1008 1019 I-treatment
within 18 24 1020 1026 O
three 25 30 1027 1032 O
( 31 32 1033 1034 B-upper_bound
3 32 33 1034 1035 I-upper_bound
) 33 34 1035 1036 I-upper_bound
months 35 41 1037 1043 I-upper_bound
prior 42 47 1044 1049 I-upper_bound
to 48 50 1050 1052 O
Screening 51 60 1053 1062 O
Visit 61 66 1063 1068 O

Body 0 4 1069 1073 B-clinical_variable
Mass 5 9 1074 1078 I-clinical_variable
Index 10 15 1079 1084 I-clinical_variable
( 16 17 1085 1086 I-clinical_variable
BMI 17 20 1086 1089 I-clinical_variable
) 20 21 1089 1090 I-clinical_variable
≥27 22 25 1091 1094 O
and 26 29 1095 1098 O
≤40 30 33 1099 1102 O
kilogram 34 42 1103 1111 I-upper_bound
( 43 44 1112 1113 I-upper_bound
kg)/meter 44 53 1113 1122 I-upper_bound
( 54 55 1123 1124 I-upper_bound
M)2 55 58 1124 1127 I-upper_bound

Change 0 6 1128 1134 O
in 7 9 1135 1137 O
medications 10 21 1138 1149 O
treating 22 30 1150 1158 O
dyslipidemia 31 43 1159 1171 B-chronic_disease
within 44 50 1172 1178 O
one 51 54 1179 1182 B-upper_bound
( 55 56 1183 1184 I-upper_bound
1 56 57 1184 1185 I-upper_bound
) 57 58 1185 1186 I-upper_bound
month 59 64 1187 1192 I-upper_bound
prior 65 70 1193 1198 I-upper_bound
to 71 73 1199 1201 O
Screening 74 83 1202 1211 O
Visit 84 89 1212 1217 O

Change 0 6 1218 1224 O
in 7 9 1225 1227 O
medications 10 21 1228 1239 B-treatment
treating 22 30 1240 1248 O
hypertension 31 43 1249 1261 B-chronic_disease
within 44 50 1262 1268 O
one 51 54 1269 1272 B-upper_bound
( 55 56 1273 1274 I-upper_bound
1 56 57 1274 1275 I-upper_bound
) 57 58 1275 1276 I-upper_bound
month 59 64 1277 1282 I-upper_bound
prior 65 70 1283 1288 I-upper_bound
to 71 73 1289 1291 O
Screening 74 83 1292 1301 O
Visit 84 89 1302 1307 O

Diabetic 0 8 1308 1316 B-chronic_disease
subjects 9 17 1317 1325 O

Fasting 0 7 1326 1333 B-clinical_variable
serum 8 13 1334 1339 I-clinical_variable
insulin 14 21 1340 1347 I-clinical_variable
< 22 23 1348 1349 O
24 23 25 1349 1351 B-upper_bound
microunit 26 35 1352 1361 I-upper_bound
( 36 37 1362 1363 I-upper_bound
µU)/milliliter 37 51 1363 1377 I-upper_bound
( 52 53 1378 1379 I-upper_bound
mL)at 53 58 1379 1384 I-upper_bound
both 59 63 1385 1389 O
Screening 64 73 1390 1399 O
Visits 74 80 1400 1406 O
in 81 83 1407 1409 O
normoglycemic 84 97 1410 1423 O
subjects 98 106 1424 1432 O
Ability 107 114 1433 1440 O
to 115 117 1441 1443 O
follow 118 124 1444 1450 O
verbal 125 131 1451 1457 O
and 132 135 1458 1461 O
written 136 143 1462 1469 O
instructions 144 156 1470 1482 O
Consent 157 164 1483 1490 O
obtained 165 173 1491 1499 O
via 174 177 1500 1503 O
signed 178 184 1504 1510 O
ICF 185 188 1511 1514 O

History 0 7 1515 1522 O
of 8 10 1523 1525 O
abdominal 11 20 1526 1535 B-treatment
radiation 21 30 1536 1545 I-treatment
treatment 31 40 1546 1555 I-treatment

History 0 7 1556 1563 O
of 8 10 1564 1566 O
cancer 11 17 1567 1573 B-cancer
within 18 24 1574 1580 O
the 25 28 1581 1584 O
past 29 33 1585 1589 B-upper_bound
five(5 34 40 1590 1596 I-upper_bound
) 40 41 1596 1597 I-upper_bound
years 42 47 1598 1603 I-upper_bound

History 0 7 1604 1611 O
of 8 10 1612 1614 O
eating 11 17 1615 1621 B-chronic_disease
disorders 18 27 1622 1631 I-chronic_disease
including 28 37 1632 1641 O
binge 38 43 1642 1647 O
eating 44 50 1648 1654 O
( 51 52 1655 1656 O
except 52 58 1656 1662 O
for 59 62 1663 1666 O
mild 63 67 1667 1671 O
binge 68 73 1672 1677 O
eating)or 74 83 1678 1687 O
emesis 84 90 1688 1694 B-clinical_variable
≥2 91 93 1695 1697 O
/ 93 94 1697 1698 I-lower_bound
week 94 98 1698 1702 I-lower_bound
from 99 103 1703 1707 O
any 104 107 1708 1711 O
cause 108 113 1712 1717 O
Weight 114 120 1718 1724 B-clinical_variable
change 121 127 1725 1731 I-clinical_variable
> 128 129 1732 1733 O
3 129 130 1733 1734 B-lower_bound
% 130 131 1734 1735 I-lower_bound
within 132 138 1736 1742 O
three(3 139 146 1743 1750 O
) 146 147 1750 1751 O
months 148 154 1752 1758 O
prior 155 160 1759 1764 O
to 161 163 1765 1767 O
and 164 167 1768 1771 O
during 168 174 1772 1778 O
the 175 178 1779 1782 O
Screening 179 188 1783 1792 O
period 189 195 1793 1799 O

History 0 7 1800 1807 O
of 8 10 1808 1810 O
gastric 11 18 1811 1818 B-treatment
bypass 19 25 1819 1825 I-treatment
or 26 28 1826 1828 O
any 29 32 1829 1832 O
other 33 38 1833 1838 O
gastric 39 46 1839 1846 B-treatment
surgery 47 54 1847 1854 I-treatment

History 0 7 1855 1862 O
of 8 10 1863 1865 O
gastric 11 18 1866 1873 B-chronic_disease
or 19 21 1874 1876 I-chronic_disease
duodenal 22 30 1877 1885 I-chronic_disease
ulcer 31 36 1886 1891 I-chronic_disease

History 0 7 1892 1899 O
of 8 10 1900 1902 O
hepatitis 11 20 1903 1912 B-chronic_disease
B 21 22 1913 1914 I-chronic_disease
or 23 25 1915 1917 I-chronic_disease
C 26 27 1918 1919 I-chronic_disease
History 28 35 1920 1927 B-chronic_disease
of 36 38 1928 1930 I-chronic_disease
human 39 44 1931 1936 I-chronic_disease
immunodeficiency 45 61 1937 1953 I-chronic_disease
virus(HIV 62 71 1954 1963 I-chronic_disease
) 71 72 1963 1964 I-chronic_disease

History 0 7 1965 1972 O
of 8 10 1973 1975 O
intestinal 11 21 1976 1986 B-chronic_disease
obstruction 22 33 1987 1998 I-chronic_disease
or 34 36 1999 2001 O
high 37 41 2002 2006 O
risk 42 46 2007 2011 O
of 47 49 2012 2014 O
intestinal 50 60 2015 2025 O
obstruction 61 72 2026 2037 O
, 72 73 2037 2038 O
including 73 82 2038 2047 O
suspected 83 92 2048 2057 O
small 93 98 2058 2063 B-chronic_disease
bowel 99 104 2064 2069 I-chronic_disease
adhesions 105 114 2070 2079 O

History 0 7 2080 2087 O
of 8 10 2088 2090 O
intestinal 11 21 2091 2101 B-chronic_disease
stricture 22 31 2102 2111 I-chronic_disease
( 32 33 2112 2113 O
e.g. 33 37 2113 2117 O
, 37 38 2117 2118 O
Crohn 39 44 2119 2124 B-chronic_disease
's 44 46 2124 2126 I-chronic_disease
disease 47 54 2127 2134 I-chronic_disease
) 54 55 2134 2135 O

History 0 7 2136 2143 O
of 8 10 2144 2146 O
pancreatitis 11 23 2147 2159 B-chronic_disease
within 24 30 2160 2166 O
the 31 34 2167 2170 O
past 35 39 2171 2175 B-upper_bound
12 40 42 2176 2178 I-upper_bound
months 43 49 2179 2185 I-upper_bound

History 0 7 2186 2193 O
of 8 10 2194 2196 O
small 11 16 2197 2202 B-chronic_disease
bowel 17 22 2203 2208 I-chronic_disease
resection 23 32 2209 2218 I-chronic_disease
( 33 34 2219 2220 O
except 34 40 2220 2226 O
if 41 43 2227 2229 O
related 44 51 2230 2237 O
to 52 54 2238 2240 O
appendectomy 55 67 2241 2253 B-treatment
) 67 68 2253 2254 O

Known 0 5 2255 2260 O
Type 6 10 2261 2265 B-chronic_disease
1 11 12 2266 2267 I-chronic_disease
Diabetes 13 21 2268 2276 I-chronic_disease

Male 0 4 2277 2281 B-gender

Non 0 3 2282 2285 O
- 3 4 2285 2286 O
diabetic 4 12 2286 2294 B-chronic_disease
subjects 13 21 2295 2303 O

Normoglycemic 0 13 2304 2317 B-clinical_variable
subjects 14 22 2318 2326 O
with 23 27 2327 2331 O
FPG 28 31 2332 2335 B-clinical_variable
≥90 32 35 2336 2339 O
milligram 36 45 2340 2349 I-lower_bound
( 46 47 2350 2351 I-lower_bound
mg)/deciliter 47 60 2351 2364 I-lower_bound
( 61 62 2365 2366 I-lower_bound
dL 62 64 2366 2368 I-lower_bound
) 64 65 2368 2369 I-lower_bound
and 66 69 2370 2373 O
< 70 71 2374 2375 O
100 71 74 2375 2378 B-upper_bound
mg 75 77 2379 2381 I-upper_bound
/ 77 78 2381 2382 I-upper_bound
dL 78 80 2382 2384 I-upper_bound
[ 81 82 2385 2386 O
≥5.0millimole 82 95 2386 2399 O
( 96 97 2400 2401 I-lower_bound
mmol)/liter 97 108 2401 2412 I-lower_bound
( 109 110 2413 2414 I-lower_bound
L 110 111 2414 2415 I-lower_bound
) 111 112 2415 2416 I-lower_bound
and 113 116 2417 2420 O
< 117 118 2421 2422 O
5.6 118 121 2422 2425 B-upper_bound
mmol 122 126 2426 2430 I-upper_bound
/ 126 127 2430 2431 I-upper_bound
L 127 128 2431 2432 I-upper_bound
] 128 129 2432 2433 O
at 130 132 2434 2436 O
both 133 137 2437 2441 O
Screening 138 147 2442 2451 O
Visits 148 154 2452 2458 O
with 155 159 2459 2463 O
HbA1c 160 165 2464 2469 B-clinical_variable
< 166 167 2470 2471 O
5.7 167 170 2471 2474 B-upper_bound
% 170 171 2474 2475 I-upper_bound
( 172 173 2476 2477 O
< 173 174 2477 2478 O
39 174 176 2478 2480 B-upper_bound
mmol 177 181 2481 2485 I-upper_bound
/ 181 182 2485 2486 I-upper_bound
mol 182 185 2486 2489 I-upper_bound
) 185 186 2489 2490 O

Positive 0 8 2491 2499 O
test 9 13 2500 2504 O
for 14 17 2505 2508 O
drugs 18 23 2509 2514 O
of 24 26 2515 2517 O
abuse 27 32 2518 2523 O
in 33 35 2524 2526 O
the 36 39 2527 2530 O
urine 40 45 2531 2536 O
Any 46 49 2537 2540 O
relevant 50 58 2541 2549 O
biochemical 59 70 2550 2561 O
abnormality 71 82 2562 2573 O
interfering 83 94 2574 2585 O
with 95 99 2586 2590 O
the 100 103 2591 2594 O
assessments 104 115 2595 2606 O
of 116 118 2607 2609 O
Gelesis200 119 129 2610 2620 B-treatment
Anti 130 134 2621 2625 I-treatment
- 134 135 2625 2626 I-treatment
obesity 135 142 2626 2633 I-treatment
medications 143 154 2634 2645 I-treatment
( 155 156 2646 2647 O
including 156 165 2647 2656 O
herbal 166 172 2657 2663 O
preparations 173 185 2664 2676 O
) 185 186 2676 2677 O
within 187 193 2678 2684 O
one(1 194 199 2685 2690 B-upper_bound
) 199 200 2690 2691 I-upper_bound
month 201 206 2692 2697 I-upper_bound
prior 207 212 2698 2703 I-upper_bound
to 213 215 2704 2706 O
Screening 216 225 2707 2716 O
Visit 226 231 2717 2722 O

Prediabetic 0 11 2723 2734 O
subjects 12 20 2735 2743 O
with 21 25 2744 2748 O
FPG≥100 26 33 2749 2756 B-clinical_variable
mg 34 36 2757 2759 I-lower_bound
/ 36 37 2759 2760 I-lower_bound
dL 37 39 2760 2762 I-lower_bound
and 40 43 2763 2766 O
< 44 45 2767 2768 O
126mg 45 50 2768 2773 B-upper_bound
/ 50 51 2773 2774 I-upper_bound
dL 51 53 2774 2776 I-upper_bound
[ 54 55 2777 2778 O
≥5.6 55 59 2778 2782 O
millimole 60 69 2783 2792 I-lower_bound
( 70 71 2793 2794 I-lower_bound
mmol)/liter 71 82 2794 2805 I-lower_bound
( 83 84 2806 2807 I-lower_bound
L 84 85 2807 2808 I-lower_bound
) 85 86 2808 2809 I-lower_bound
and 87 90 2810 2813 O
< 91 92 2814 2815 O
7.0mmol 92 99 2815 2822 B-upper_bound
/ 99 100 2822 2823 I-upper_bound
L 100 101 2823 2824 I-upper_bound
] 101 102 2824 2825 O
at 103 105 2826 2828 O
both 106 110 2829 2833 O
Screening 111 120 2834 2843 O
Visits 121 127 2844 2850 O
with 128 132 2851 2855 O
HbA1c 133 138 2856 2861 B-clinical_variable
≤6.4%[≤46 139 148 2862 2871 O
mmol 149 153 2872 2876 I-upper_bound
/ 153 154 2876 2877 I-upper_bound
mole 154 158 2877 2881 I-upper_bound
( 159 160 2882 2883 I-upper_bound
mol 160 163 2883 2886 I-upper_bound
) 163 164 2886 2887 I-upper_bound
] 164 165 2887 2888 O

Pregnancy 0 9 2889 2898 B-pregnancy

Serum 0 5 2899 2904 B-clinical_variable
low 6 9 2905 2908 I-clinical_variable
- 9 10 2908 2909 I-clinical_variable
density 10 17 2909 2916 I-clinical_variable
lipoprotein 18 29 2917 2928 I-clinical_variable
( 30 31 2929 2930 I-clinical_variable
LDL 31 34 2930 2933 I-clinical_variable
) 34 35 2933 2934 I-clinical_variable
cholesterol≥160mg 36 53 2935 2952 I-clinical_variable
/ 53 54 2952 2953 I-lower_bound
dL 54 56 2953 2955 I-lower_bound
( 57 58 2956 2957 O
≥4.15mmol 58 67 2957 2966 O
/ 67 68 2966 2967 I-lower_bound
L 68 69 2967 2968 I-lower_bound
) 69 70 2968 2969 O

Serum 0 5 2970 2975 B-clinical_variable
triglycerides 6 19 2976 2989 I-clinical_variable
≥350 20 24 2990 2994 O
mg 25 27 2995 2997 I-lower_bound
/ 27 28 2997 2998 I-lower_bound
dL 28 30 2998 3000 I-lower_bound
( 31 32 3001 3002 O
≥3.96mmol 32 41 3002 3011 O
/ 41 42 3011 3012 I-lower_bound
L 42 43 3012 3013 I-lower_bound
) 43 44 3013 3014 O

Smoking 0 7 3015 3022 O
cessation 8 17 3023 3032 O
within 18 24 3033 3039 O
six(6 25 30 3040 3045 B-upper_bound
) 30 31 3045 3046 I-upper_bound
months 32 38 3047 3053 I-upper_bound
prior 39 44 3054 3059 I-upper_bound
to 45 47 3060 3062 O
Screening 48 57 3063 3072 O
Visit 58 63 3073 3078 O
or 64 66 3079 3081 O
considering 67 78 3082 3093 O
smoking 79 86 3094 3101 O
cessation 87 96 3102 3111 O
during 97 103 3112 3118 O
the 104 107 3119 3122 O
study 108 113 3123 3128 O

Supine 0 6 3129 3135 B-clinical_variable
systolic 7 15 3136 3144 I-clinical_variable
blood 16 21 3145 3150 I-clinical_variable
pressure 22 30 3151 3159 I-clinical_variable
( 31 32 3160 3161 I-clinical_variable
SBP 32 35 3161 3164 I-clinical_variable
) 35 36 3164 3165 I-clinical_variable
> 37 38 3166 3167 O
160 38 41 3167 3170 B-lower_bound
millimeters 42 53 3171 3182 I-lower_bound
of 54 56 3183 3185 I-lower_bound
mercury 57 64 3186 3193 I-lower_bound
( 65 66 3194 3195 I-lower_bound
mmHg)and 66 74 3195 3203 I-lower_bound
/ 74 75 3203 3204 O
or 75 77 3204 3206 O
supine 78 84 3207 3213 B-clinical_variable
diastolic 85 94 3214 3223 I-clinical_variable
blood 95 100 3224 3229 I-clinical_variable
pressure(DBP 101 113 3230 3242 I-clinical_variable
) 113 114 3242 3243 I-clinical_variable
> 115 116 3244 3245 O
95mmHg 116 122 3245 3251 B-lower_bound

Systemic 0 8 3252 3260 B-treatment
corticosteroids 9 24 3261 3276 I-treatment
within 25 31 3277 3283 O
one 32 35 3284 3287 B-upper_bound
( 36 37 3288 3289 I-upper_bound
1 37 38 3289 3290 I-upper_bound
) 38 39 3290 3291 I-upper_bound
month 40 45 3292 3297 I-upper_bound
prior 46 51 3298 3303 I-upper_bound
to 52 54 3304 3306 O
Screening 55 64 3307 3316 O
Visit 65 70 3317 3322 O

Thyroid 0 7 3323 3330 O
hormones 8 16 3331 3339 O
or 17 19 3340 3342 O
preparations 20 32 3343 3355 O
within 33 39 3356 3362 O
one 40 43 3363 3366 B-upper_bound
( 44 45 3367 3368 I-upper_bound
1 45 46 3368 3369 I-upper_bound
) 46 47 3369 3370 I-upper_bound
month 48 53 3371 3376 I-upper_bound
prior 54 59 3377 3382 I-upper_bound
to 60 62 3383 3385 O
Screening 63 72 3386 3395 O
Visit 73 78 3396 3401 O
[ 79 80 3402 3403 O
except 80 86 3403 3409 O
stable 87 93 3410 3416 O
dose 94 98 3417 3421 O
of 99 101 3422 3424 O
replacement 102 113 3425 3436 B-treatment
therapy 114 121 3437 3444 I-treatment
for 122 125 3445 3448 O
at 126 128 3449 3451 O
least 129 134 3452 3457 O
two(2 135 140 3458 3463 B-lower_bound
) 140 141 3463 3464 I-lower_bound
months 142 148 3465 3471 I-lower_bound
] 148 149 3471 3472 O

Untreated 0 9 3473 3482 O
subjects 10 18 3483 3491 O
with 19 23 3492 3496 O
FPG 24 27 3497 3500 B-clinical_variable
≤200 28 32 3501 3505 O
mg 33 35 3506 3508 I-upper_bound
/ 35 36 3508 3509 I-upper_bound
dL 36 38 3509 3511 I-upper_bound
( 39 40 3512 3513 O
≤11.2 40 45 3513 3518 O
mmol 46 50 3519 3523 I-upper_bound
/ 50 51 3523 3524 I-upper_bound
L)at 51 55 3524 3528 I-upper_bound
both 56 60 3529 3533 O
Screening 61 70 3534 3543 O
Visits 71 77 3544 3550 O
and 78 81 3551 3554 O
either 82 88 3555 3561 O
FPG 89 92 3562 3565 O
≥126 93 97 3566 3570 O
mg 98 100 3571 3573 O
/ 100 101 3573 3574 O
dL 101 103 3574 3576 O
( 104 105 3577 3578 O
≥7.0 105 109 3578 3582 O
mmol 110 114 3583 3587 O
/ 114 115 3587 3588 O
L 115 116 3588 3589 O
) 116 117 3589 3590 O
at 118 120 3591 3593 O
both 121 125 3594 3598 O
Screening 126 135 3599 3608 O
Visits 136 142 3609 3615 O
or 143 145 3616 3618 O
FPG 146 149 3619 3622 O
< 150 151 3623 3624 O
126 151 154 3624 3627 O
mg 155 157 3628 3630 O
/ 157 158 3630 3631 O
dL 158 160 3631 3633 O
( 161 162 3634 3635 O
< 162 163 3635 3636 O
7.0 163 166 3636 3639 O
mmol 167 171 3640 3644 O
/ 171 172 3644 3645 O
L 172 173 3645 3646 O
) 173 174 3646 3647 O
at 175 177 3648 3650 O
one 178 181 3651 3654 O
( 182 183 3655 3656 O
1 183 184 3656 3657 O
) 184 185 3657 3658 O
or 186 188 3659 3661 O
both 189 193 3662 3666 O
Screening 194 203 3667 3676 O
Visits 204 210 3677 3683 O
with 211 215 3684 3688 O
HbA1c 216 221 3689 3694 B-clinical_variable
≥6.5 222 226 3695 3699 O
% 226 227 3699 3700 I-lower_bound
( 228 229 3701 3702 O
≥48 229 232 3702 3705 O
mmol 233 237 3706 3710 I-lower_bound
/ 237 238 3710 3711 I-lower_bound
mol 238 241 3711 3714 I-lower_bound
) 241 242 3714 3715 O

adequately 0 10 3716 3726 O
- 10 11 3726 3727 O
treated 11 18 3727 3734 O
localized 19 28 3735 3744 O
basal 29 34 3745 3750 B-cancer
cell 35 39 3751 3755 I-cancer
skin 40 44 3756 3760 I-cancer
cancer 45 51 3761 3767 I-cancer
or 52 54 3768 3770 O
in 55 57 3771 3773 O
situuterine 58 69 3774 3785 O
cervical 70 78 3786 3794 B-cancer
cancer 79 85 3795 3801 I-cancer

female 0 6 3802 3808 B-gender

if 0 2 3809 3811 O
only 3 7 3812 3816 O
one 8 11 3817 3820 O
( 12 13 3821 3822 O
1)value 13 20 3822 3829 O
is 21 23 3830 3832 O
within 24 30 3833 3839 O
this 31 35 3840 3844 O
range 36 41 3845 3850 O
, 41 42 3850 3851 O
the 43 46 3852 3855 O
other 47 52 3856 3861 O
value 53 58 3862 3867 O
should 59 65 3868 3874 O
not 66 69 3875 3878 O
be 70 72 3879 3881 O
≥126mg 73 79 3882 3888 O
/ 79 80 3888 3889 I-lower_bound
dL 80 82 3889 3891 I-lower_bound
( 83 84 3892 3893 O
≥7.0mmol 84 92 3893 3901 O
/ 92 93 3901 3902 I-lower_bound
L 93 94 3902 3903 I-lower_bound
) 94 95 3903 3904 O
and 96 99 3905 3908 O
HbA1c 100 105 3909 3914 B-clinical_variable
should 106 112 3915 3921 O
be 113 115 3922 3924 O
≥5.7 116 120 3925 3929 O
% 120 121 3929 3930 I-lower_bound
( 122 123 3931 3932 O
≥39 123 126 3932 3935 O
mmol 127 131 3936 3940 I-lower_bound
/ 131 132 3940 3941 I-lower_bound
mol 132 135 3941 3944 I-lower_bound
) 135 136 3944 3945 O
and 137 140 3946 3949 O
≤6.4%(≤46 141 150 3950 3959 O
mmol 151 155 3960 3964 I-upper_bound
/ 155 156 3964 3965 I-upper_bound
mol 156 159 3965 3968 I-upper_bound
) 159 160 3968 3969 O

positive 0 8 3970 3978 B-pregnancy
serum 9 14 3979 3984 I-pregnancy
or 15 17 3985 3987 I-pregnancy
urine 18 23 3988 3993 I-pregnancy
pregnancy 24 33 3994 4003 I-pregnancy
test(s 34 40 4004 4010 O
) 40 41 4010 4011 O
in 42 44 4012 4014 O
females 45 52 4015 4022 B-gender
of 53 55 4023 4025 O
childbearing 56 68 4026 4038 O
potential 69 78 4039 4048 O

Hemoglobin 0 10 0 10 B-clinical_variable
> 11 12 11 12 O
10 13 15 13 15 B-lower_bound
g 16 17 16 17 I-lower_bound
/ 17 18 17 18 I-lower_bound
dL 18 20 18 20 I-lower_bound
serum 21 26 21 26 B-clinical_variable
creatinine 27 37 27 37 I-clinical_variable
< 38 39 38 39 O
1.5 40 43 40 43 B-upper_bound
times 44 49 44 49 I-upper_bound
the 50 53 50 53 I-upper_bound
upper 54 59 54 59 I-upper_bound
limit 60 65 60 65 I-upper_bound
of 66 68 66 68 I-upper_bound
normal 69 75 69 75 I-upper_bound

Patient 0 7 76 83 O
must 8 12 84 88 O
be 13 15 89 91 O
> 16 17 92 93 O
18 17 19 93 95 B-lower_bound
years 20 25 96 101 I-lower_bound
of 26 28 102 104 O
age 29 32 105 108 B-age

Patients 0 8 109 117 O
must 9 13 118 122 O
be 14 16 123 125 O
surgical 17 25 126 134 O
candidates 26 36 135 145 O
with 37 41 146 150 O
adequate 42 50 151 159 O
hematologic 51 62 160 171 B-chronic_disease
, 62 63 171 172 O
renal 64 69 173 178 B-chronic_disease
, 69 70 178 179 O
hepatic 71 78 180 187 B-chronic_disease
and 79 82 188 191 O
pulmonary 83 92 192 201 B-chronic_disease
function 93 101 202 210 I-chronic_disease

Patients 0 8 211 219 O
must 9 13 220 224 O
have 14 18 225 229 O
an 19 21 230 232 O
ECOG 22 26 233 237 B-clinical_variable
Performance 27 38 238 249 I-clinical_variable
Status 39 45 250 256 I-clinical_variable
of 46 48 257 259 O
0 49 50 260 261 B-lower_bound
- 50 51 261 262 O
1 51 52 262 263 B-upper_bound

Patients 0 8 264 272 O
must 9 13 273 277 O
have 14 18 278 282 O
bilirubin 19 28 283 292 B-clinical_variable
< 29 30 293 294 O
1.5 31 34 295 298 B-upper_bound
× 35 36 299 300 I-upper_bound
normal 37 43 301 307 I-upper_bound

Patients 0 8 308 316 O
with 9 13 317 321 O
AJCC 14 18 322 326 O
7th 19 22 327 330 O
edition 23 30 331 338 O
clinical 31 39 339 347 O
stage 40 45 348 353 B-cancer
IIB 46 49 354 357 I-cancer
- 49 50 357 358 O
IIIC 50 54 358 362 B-cancer

Patients 0 8 363 371 O
with 9 13 372 376 O
a 14 15 377 378 O
histologic 16 26 379 389 O
diagnosis 27 36 390 399 O
of 37 39 400 402 O
adenocarcinoma 40 54 403 417 B-cancer
of 55 57 418 420 O
the 58 61 421 424 O
esophagus 62 71 425 434 O
located 72 79 435 442 O
distal 80 86 443 449 O
to 87 89 450 452 O
the 90 93 453 456 O
carina 94 100 457 463 O

Patients 0 8 464 472 O
with 9 13 473 477 O
primary 14 21 478 485 B-clinical_variable
tumors 22 28 486 492 I-clinical_variable
exceeding 29 38 493 502 O
8 39 40 503 504 B-lower_bound
cm 41 43 505 507 I-lower_bound
in 44 46 508 510 I-lower_bound
length 47 53 511 517 I-lower_bound
or 54 56 518 520 O
5 57 58 521 522 B-lower_bound
cm 59 61 523 525 I-lower_bound
in 62 64 526 528 I-lower_bound
width 65 70 529 534 I-lower_bound
( 71 72 535 536 O
length 73 79 537 543 O
should 80 86 544 550 O
be 87 89 551 553 O
measured 90 98 554 562 O
by 99 101 563 565 O
endoscopic 102 112 566 576 B-treatment
findings 113 121 577 585 I-treatment
, 121 122 585 586 O
width 123 128 587 592 O
should 129 135 593 599 O
be 136 138 600 602 O
measured 139 147 603 611 O
by 148 150 612 614 O
diagnostic 151 161 615 625 O
CT 162 164 626 628 B-treatment
or 165 167 629 631 O
CT 168 170 632 634 B-treatment
portion 171 178 635 642 I-treatment
of 179 181 643 645 I-treatment
PET 182 185 646 649 I-treatment
/ 185 186 649 650 I-treatment
CT 186 188 650 652 I-treatment
) 188 189 652 653 O

Patients 0 8 654 662 O
with 9 13 663 667 O
primary 14 21 668 675 O
tumors 22 28 676 682 B-cancer
located 29 36 683 690 O
at 37 39 691 693 O
or 40 42 694 696 O
above 43 48 697 702 O
the 49 52 703 706 O
carina 53 59 707 713 O

Pregnant 0 8 714 722 B-pregnancy
women 9 14 723 728 B-gender
, 14 15 728 729 O
women 16 21 730 735 B-pregnancy
planning 22 30 736 744 I-pregnancy
to 31 33 745 747 I-pregnancy
become 34 40 748 754 I-pregnancy
pregnant 41 49 755 763 I-pregnancy
and 50 53 764 767 O
women 54 59 768 773 O
that 60 64 774 778 O
are 65 68 779 782 O
nursing 69 76 783 790 O

Prior 0 5 791 796 O
or 6 8 797 799 O
simultaneous 9 21 800 812 O
malignancies 22 34 813 825 B-cancer
within 35 41 826 832 O
the 42 45 833 836 O
past 46 50 837 841 B-upper_bound
two 51 54 842 845 I-upper_bound
years 55 60 846 851 I-upper_bound
( 61 62 852 853 O
other 62 67 853 858 O
than 68 72 859 863 O
cutaneous 73 82 864 873 B-cancer
squamous 83 91 874 882 I-cancer
or 92 94 883 885 O
basal 95 100 886 891 B-cancer
cell 101 105 892 896 I-cancer
carcinoma 106 115 897 906 I-cancer
, 115 116 906 907 O
melanoma 117 125 908 916 B-cancer
in 126 128 917 919 I-cancer
situ 129 133 920 924 I-cancer
or 134 136 925 927 O
thyroid 137 144 928 935 B-cancer
carcinoma 145 154 936 945 I-cancer
) 154 155 945 946 O

WBC 0 3 947 950 B-clinical_variable
> 4 5 951 952 O
3000 6 10 953 957 B-lower_bound
/ 10 11 957 958 I-lower_bound
mm3 11 14 958 961 I-lower_bound

Women 0 5 962 967 B-gender
of 6 8 968 970 O
child 9 14 971 976 O
- 14 15 976 977 O
bearing 15 22 977 984 O
potential 23 32 985 994 O
as 33 35 995 997 O
long 36 40 998 1002 O
as 41 43 1003 1005 O
she 44 47 1006 1009 O
agrees 48 54 1010 1016 B-contraception_consent
to 55 57 1017 1019 I-contraception_consent
use 58 61 1020 1023 I-contraception_consent
a 62 63 1024 1025 I-contraception_consent
recognized 64 74 1026 1036 I-contraception_consent
method 75 81 1037 1043 I-contraception_consent
of 82 84 1044 1046 I-contraception_consent
birth 85 90 1047 1052 I-contraception_consent
control 91 98 1053 1060 I-contraception_consent
( 99 100 1061 1062 O
e.g. 100 104 1062 1066 O
oral 105 109 1067 1071 B-contraception_consent
contraceptive 110 123 1072 1085 I-contraception_consent
, 123 124 1085 1086 O
IUD 125 128 1087 1090 B-contraception_consent
, 128 129 1090 1091 O
condoms 130 137 1092 1099 B-contraception_consent
or 138 140 1100 1102 O
other 141 146 1103 1108 O
barrier 147 154 1109 1116 O
methods 155 162 1117 1124 O
etc 163 166 1125 1128 O
. 166 167 1128 1129 O
) 167 168 1129 1130 O
. 168 169 1130 1131 O
Hysterectomy 170 182 1132 1144 B-treatment
or 183 185 1145 1147 O
menopause 186 195 1148 1157 O
must 196 200 1158 1162 O
be 201 203 1163 1165 O
clinically 204 214 1166 1176 O
documented 215 225 1177 1187 O

platelets 0 9 1188 1197 B-clinical_variable
> 10 11 1198 1199 O
100,000 12 19 1200 1207 B-lower_bound
mm3 20 23 1208 1211 I-lower_bound

serum 0 5 1212 1217 B-clinical_variable
AST 6 9 1218 1221 I-clinical_variable
and 10 13 1222 1225 O
ALT 14 17 1226 1229 B-clinical_variable
< 18 19 1230 1231 O
2 20 21 1232 1233 B-upper_bound
times 22 27 1234 1239 I-upper_bound
the 28 31 1240 1243 I-upper_bound
upper 32 37 1244 1249 I-upper_bound
limit 38 43 1250 1255 I-upper_bound
of 44 46 1256 1258 I-upper_bound
normal 47 53 1259 1265 I-upper_bound

At 0 2 0 2 O
least 3 8 3 8 O
three 9 14 9 14 B-lower_bound
episodes 15 23 15 23 O
of 24 26 24 26 O
mild 27 31 27 31 O
- 31 32 31 32 O
to 32 34 32 34 O
- 34 35 34 35 O
moderate 35 43 35 43 O
CDI 44 47 44 47 B-clinical_variable
and 48 51 48 51 O
failure 52 59 52 59 O
of 60 62 60 62 O
a 63 64 63 64 O
6 65 66 65 66 B-lower_bound
- 66 67 66 67 O
8 67 68 67 68 B-upper_bound
week 69 73 69 73 I-upper_bound
taper 74 79 74 79 O
with 80 84 80 84 O
vancomycin 85 95 85 95 B-treatment
with 96 100 96 100 O
or 101 103 101 103 O
without 104 111 104 111 O
an 112 114 112 114 O
alternative 115 126 115 126 O
antibiotic 127 137 127 137 B-treatment
( 138 139 138 139 O
e.g. 139 143 139 143 O
, 143 144 143 144 O
rifaximin 145 154 145 154 B-treatment
, 154 155 154 155 O
nitazoxanide 156 168 156 168 B-treatment
, 168 169 168 169 O
fidaxomicin 170 181 170 181 B-treatment
) 181 182 181 182 O

At 0 2 183 185 O
least 3 8 186 191 O
two 9 12 192 195 B-lower_bound
episodes 13 21 196 204 O
of 22 24 205 207 O
severe 25 31 208 214 O
CDI 32 35 215 218 B-chronic_disease
resulting 36 45 219 228 O
in 46 48 229 231 O
hospitalization 49 64 232 247 O
and 65 68 248 251 O
associated 69 79 252 262 O
with 80 84 263 267 O
significant 85 96 268 279 O
morbidity 97 106 280 289 O

Moderate 0 8 290 298 O
CDI 9 12 299 302 O
not 13 16 303 306 O
responding 17 27 307 317 O
to 28 30 318 320 O
standard 31 39 321 329 O
therapy 40 47 330 337 B-treatment
( 48 49 338 339 O
vancomycin 49 59 339 349 B-treatment
) 59 60 349 350 O
for 61 64 351 354 O
at 65 67 355 357 O
least 68 73 358 363 O
a 74 75 364 365 O
week 76 80 366 370 O

Severe 0 6 371 377 O
C. 7 9 378 380 B-chronic_disease
difficile 10 19 381 390 I-chronic_disease
infection 20 29 391 400 I-chronic_disease
with 30 34 401 405 O
toxic 35 40 406 411 B-chronic_disease
megacolon 41 50 412 421 I-chronic_disease
, 50 51 421 422 O
not 52 55 423 426 O
responding 56 66 427 437 O
to 67 69 438 440 O
standard 70 78 441 449 B-treatment
therapy 79 86 450 457 I-treatment
or 87 89 458 460 O
the 90 93 461 464 O
use 94 97 465 468 O
of 98 100 469 471 O
IVIg 101 105 472 476 B-treatment

Subject 0 7 477 484 O
has 8 11 485 488 O
recurrent 12 21 489 498 O
or 22 24 499 501 O
relapsing 25 34 502 511 O
CDI 35 38 512 515 B-chronic_disease

Subject 0 7 516 523 O
is 8 10 524 526 O
at 11 13 527 529 O
least 14 19 530 535 O
18 20 22 536 538 B-lower_bound
years 23 28 539 544 I-lower_bound
old 29 32 545 548 O

Subject 0 7 549 556 O
is 8 10 557 559 O
pregnant 11 19 560 568 B-pregnancy

BMI 0 3 0 3 B-bmi
> 4 5 4 5 O
18 6 8 6 8 B-lower_bound
kg 9 11 9 11 I-lower_bound
/ 11 12 11 12 I-lower_bound
m2 12 14 12 14 I-lower_bound
and 15 18 15 18 O
normal 19 25 19 25 O
testosterone 26 38 26 38 B-clinical_variable
and 39 42 39 42 O
prolactin 43 52 43 52 B-clinical_variable
levels 53 59 53 59 I-clinical_variable

Mitral 0 6 60 66 B-chronic_disease
valve 7 12 67 72 I-chronic_disease
prolapse 13 21 73 81 I-chronic_disease
with 22 26 82 86 O
ballooning 27 37 87 97 O
of 38 40 98 100 O
the 41 44 101 104 O
mitral 45 51 105 111 O
valve 52 57 112 117 O
will 58 62 118 122 O
be 63 65 123 125 O
cause 66 71 126 131 O
for 72 75 132 135 O
exclusion 76 85 136 145 O
of 86 88 146 148 O
the 89 92 149 152 O
patient 93 100 153 160 O
from 101 105 161 165 O
intravenous 106 117 166 177 O
GnRH 118 122 178 182 B-treatment
treatment 123 132 183 192 I-treatment

Subjects 0 8 193 201 O
will 9 13 202 206 O
be 14 16 207 209 O
otherwise 17 26 210 219 O
healthy 27 34 220 227 O
women 35 40 228 233 B-gender
and 41 44 234 237 O
female 45 51 238 244 B-gender
minors 52 58 245 251 O

Subjects 0 8 252 260 O
will 9 13 261 265 O
have 14 18 266 270 O
normal 19 25 271 277 O
complete 26 34 278 286 B-clinical_variable
blood 35 40 287 292 I-clinical_variable
count 41 46 293 298 I-clinical_variable
( 47 48 299 300 O
hemoglobin 48 58 300 310 B-clinical_variable
greater 59 66 311 318 O
than 67 71 319 323 O
or 72 74 324 326 O
equal 75 80 327 332 O
to 81 83 333 335 O
11.5gm 84 90 336 342 B-lower_bound
/ 90 91 342 343 I-lower_bound
dl 91 93 343 345 I-lower_bound
) 93 94 345 346 O
and 95 98 347 350 O
thyroid 99 106 351 358 O
function 107 115 359 367 O
tests 116 121 368 373 O
and 122 125 374 377 O
a 126 127 378 379 O
negative 128 136 380 388 B-pregnancy
pregnancy 137 146 389 398 I-pregnancy
test 147 151 399 403 O

Women 0 5 404 409 B-gender
and 6 9 410 413 O
minors 10 16 414 420 O
with 17 21 421 425 O
GnRH 22 26 426 430 B-chronic_disease
deficiency 27 37 431 441 I-chronic_disease
or 38 40 442 444 O
idiopathic 41 51 445 455 B-chronic_disease
hypogonadotropic 52 68 456 472 I-chronic_disease
hypogonadism 69 81 473 485 I-chronic_disease
( 82 83 486 487 I-chronic_disease
IHH 83 86 487 490 I-chronic_disease
) 86 87 490 491 I-chronic_disease
will 88 92 492 496 O
have 93 97 497 501 O
a 98 99 502 503 O
history 100 107 504 511 O
of 108 110 512 514 O
primary 111 118 515 522 B-chronic_disease
amenorrhea 119 129 523 533 I-chronic_disease

Women 0 5 534 539 B-gender
and 6 9 540 543 O
minors 10 16 544 550 O
with 17 21 551 555 O
acquired 22 30 556 564 O
hypogonadotropic 31 47 565 581 B-chronic_disease
hypogonadism 48 60 582 594 I-chronic_disease
will 61 65 595 599 O
have 66 70 600 604 O
a 71 72 605 606 O
history 73 80 607 614 O
of 81 83 615 617 O
hypothalamic 84 96 618 630 B-cancer
or 97 99 631 633 O
pituitary 100 109 634 643 B-cancer
tumor 110 115 644 649 I-cancer
treated 116 123 650 657 O
with 124 128 658 662 O
surgery 129 136 663 670 B-treatment
alone 137 142 671 676 O
or 143 145 677 679 O
in 146 148 680 682 O
combination 149 160 683 694 O
with 161 165 695 699 O
radiotherapy 166 178 700 712 B-treatment
or 179 181 713 715 O
a 182 183 716 717 O
history 184 191 718 725 O
of 192 194 726 728 O
hypothalamic 195 207 729 741 B-treatment
irradiation 208 219 742 753 I-treatment
as 220 222 754 756 O
adjunctive 223 233 757 767 B-treatment
therapy 234 241 768 775 I-treatment
for 242 245 776 779 O
leukemia 246 254 780 788 B-cancer
or 255 257 789 791 O
craniofacial 258 270 792 804 B-cancer
neoplasms 271 280 805 814 I-cancer

Women 0 5 815 820 B-gender
and 6 9 821 824 O
minors 10 16 825 831 O
with 17 21 832 836 O
hypothalamic 22 34 837 849 B-chronic_disease
amenorrhea 35 45 850 860 I-chronic_disease
will 46 50 861 865 O
have 51 55 866 870 O
a 56 57 871 872 O
history 58 65 873 880 O
of 66 68 881 883 O
secondary 69 78 884 893 B-chronic_disease
amenorrhea 79 89 894 904 I-chronic_disease
of 90 92 905 907 O
at 93 95 908 910 O
least 96 101 911 916 O
six 102 105 917 920 B-lower_bound
months 106 112 921 927 I-lower_bound
duration 113 121 928 936 O
with 122 126 937 941 O
low 127 130 942 945 O
or 131 133 946 948 O
normal 134 140 949 955 O
gonadotropins 141 154 956 969 B-treatment
or 155 157 970 972 O
a 158 159 973 974 O
history 160 167 975 982 O
of 168 170 983 985 O
primary 171 178 986 993 B-chronic_disease
amenorrhea 179 189 994 1004 I-chronic_disease
in 190 192 1005 1007 O
the 193 196 1008 1011 O
presence 197 205 1012 1020 O
of 206 208 1021 1023 O
pulsatile 209 218 1024 1033 O
patterns 219 227 1034 1042 O
of 228 230 1043 1045 O
LH 231 233 1046 1048 O
or 234 236 1049 1051 O
FAS 237 240 1052 1055 O
on 241 243 1056 1058 O
baseline 244 252 1059 1067 O
frequent 253 261 1068 1076 O
sampling 262 270 1077 1085 O
studies 271 278 1086 1093 O

a 0 1 1094 1095 O
deficient 2 11 1096 1105 O
pattern 12 19 1106 1113 O
of 20 22 1114 1116 O
luteinizing 23 34 1117 1128 B-clinical_variable
hormone 35 42 1129 1136 I-clinical_variable
( 43 44 1137 1138 I-clinical_variable
LH 44 46 1138 1140 I-clinical_variable
) 46 47 1140 1141 I-clinical_variable
and/or 48 54 1142 1148 O
free 55 59 1149 1153 B-clinical_variable
alpha 60 65 1154 1159 I-clinical_variable
subunit 66 73 1160 1167 I-clinical_variable
( 74 75 1168 1169 I-clinical_variable
FAS 75 78 1169 1172 I-clinical_variable
) 78 79 1172 1173 I-clinical_variable
secretion 80 89 1174 1183 O
on 90 92 1184 1186 O
baseline 93 101 1187 1195 O
sampling 102 110 1196 1204 O
and 111 114 1205 1208 O
a 115 116 1209 1210 O
normal 117 123 1211 1217 O
cranial 124 131 1218 1225 B-treatment
CT 132 134 1226 1228 I-treatment
or 135 137 1229 1231 O
MRI 138 141 1232 1235 B-treatment

a 0 1 1236 1237 O
minimum 2 9 1238 1245 O
of 10 12 1246 1248 O
2 13 14 1249 1250 B-lower_bound
years 15 20 1251 1256 I-lower_bound
since 21 26 1257 1262 O
irradiation 27 38 1263 1274 B-treatment
and 39 42 1275 1278 O
no 43 45 1279 1281 O
gonadal 46 53 1282 1289 B-treatment
radiation 54 63 1290 1299 I-treatment

between 0 7 1300 1307 O
the 8 11 1308 1311 O
ages 12 16 1312 1316 B-age
of 17 19 1317 1319 O
16 20 22 1320 1322 B-lower_bound
and 23 26 1323 1326 O
45 27 29 1327 1329 B-upper_bound
years 30 35 1330 1335 I-upper_bound

normoprolactinemic 0 18 1336 1354 O
on 19 21 1355 1357 O
dopamine 22 30 1358 1366 B-treatment
agonists 31 39 1367 1375 I-treatment
if 40 42 1376 1378 O
needed 43 49 1379 1385 O

patients 0 8 1386 1394 O
will 9 13 1395 1399 O
be 14 16 1400 1402 O
euthyroid 17 26 1403 1412 B-chronic_disease
on 27 29 1413 1415 O
thyroid 30 37 1416 1423 B-treatment
replacement 38 49 1424 1435 I-treatment
if 50 52 1436 1438 O
needed 53 59 1439 1445 O

receiving 0 9 1446 1455 O
physiologic 10 21 1456 1467 B-treatment
glucocorticoid 22 36 1468 1482 I-treatment
replacement 37 48 1483 1494 I-treatment
if 49 51 1495 1497 O
needed 52 58 1498 1504 O

who 0 3 1505 1508 O
have 4 8 1509 1513 O
not 9 12 1514 1517 O
been 13 17 1518 1522 O
on 18 20 1523 1525 O
gonadal 21 28 1526 1533 B-treatment
steroid 29 36 1534 1541 I-treatment
preparations 37 49 1542 1554 O
for 50 53 1555 1558 O
at 54 56 1559 1561 O
least 57 62 1562 1567 O
1 63 64 1568 1569 B-lower_bound
month 65 70 1570 1575 I-lower_bound

Additional 0 10 0 10 O
fracture 11 19 11 19 O
, 19 20 19 20 O
dislocations 21 33 21 33 O
or 34 36 34 36 O
soft 37 41 37 41 O
tissue 42 48 42 48 O
injuries 49 57 49 57 O
to 58 60 58 60 O
the 61 64 61 64 O
study 65 70 65 70 O
limb 71 75 71 75 O
that 76 80 76 80 O
would 81 86 81 86 O
compromise 87 97 87 97 O
the 98 101 98 101 O
ability 102 109 102 109 O
to 110 112 110 112 O
weight 113 119 113 119 O
bear 120 124 120 124 O
as 125 127 125 127 O
tolerated 128 137 128 137 O
and 138 141 138 141 O
initiate 142 150 142 150 O
PT 151 153 151 153 O
within 154 160 154 160 O
28 161 163 161 163 B-upper_bound
days 164 168 164 168 I-upper_bound
of 169 171 169 171 O
definitive 172 182 172 182 B-treatment
fixation 183 191 183 191 I-treatment

Adults 0 6 192 198 O
ages 7 11 199 203 B-age
18 12 14 204 206 B-lower_bound
- 14 15 206 207 O
55 15 17 207 209 B-upper_bound
inclusive 18 27 210 219 O

Any 0 3 220 223 O
fractures 4 13 224 233 O
, 13 14 233 234 O
dislocations 15 27 235 247 O
or 28 30 248 250 O
soft 31 35 251 255 O
tissue 36 42 256 262 O
injuries 43 51 263 271 O
to 52 54 272 274 O
the 55 58 275 278 O
contralateral 59 72 279 292 O
limb 73 77 293 297 O
or 78 80 298 300 O
pelvis 81 87 301 307 O
that 88 92 308 312 O
would 93 98 313 318 O
compromise 99 109 319 329 O
the 110 113 330 333 O
ability 114 121 334 341 O
to 122 124 342 344 O
weight 125 131 345 351 O
bear 132 136 352 356 O
as 137 139 357 359 O
tolerated 140 149 360 369 O
and 150 153 370 373 O
initiate 154 162 374 382 O
PT 163 165 383 385 O
within 166 172 386 392 O
28 173 175 393 395 B-upper_bound
days 176 180 396 400 I-upper_bound
of 181 183 401 403 O
definitive 184 194 404 414 O
fixation 195 203 415 423 O

Current 0 7 424 431 O
diagnosis 8 17 432 441 O
of 18 20 442 444 O
acidosis 21 29 445 453 B-chronic_disease

Current 0 7 454 461 O
diagnosis 8 17 462 471 O
of 18 20 472 474 O
cancer 21 27 475 481 B-cancer

Current 0 7 482 489 O
tumor 8 13 490 495 B-cancer
( 14 15 496 497 O
malignant 15 24 497 506 O
or 25 27 507 509 O
benign 28 34 510 516 O
) 34 35 516 517 O
distal 36 42 518 524 O
to 43 45 525 527 O
study 46 51 528 533 O
injury 52 58 534 540 O
and 59 62 541 544 O
future 63 69 545 551 O
tourniquet 70 80 552 562 O
placement 81 90 563 572 O

Diagnosis 0 9 573 582 O
of 10 12 583 585 O
severe 13 19 586 592 B-chronic_disease
hypertension 20 32 593 605 I-chronic_disease
( 33 34 606 607 O
blood 34 39 607 612 O
pressure 40 48 613 621 O
of 49 51 622 624 O
180/110 52 59 625 632 O
) 59 60 632 633 O

Diagnosis 0 9 634 643 O
of 10 12 644 646 O
sickle 13 19 647 653 B-chronic_disease
cell 20 24 654 658 I-chronic_disease
anemia 25 31 659 665 I-chronic_disease

Extremities 0 11 666 677 O
with 12 16 678 682 O
dialysis 17 25 683 691 B-treatment
access 26 32 692 698 I-treatment

History 0 7 699 706 O
of 8 10 707 709 O
Peripheral 11 21 710 720 B-chronic_disease
Artery 22 28 721 727 I-chronic_disease
Disease 29 36 728 735 I-chronic_disease
and/or 37 43 736 742 I-chronic_disease
Peripheral 44 54 743 753 I-chronic_disease
Vascular 55 63 754 762 I-chronic_disease
Disease 64 71 763 770 I-chronic_disease
( 72 73 771 772 I-chronic_disease
PAD 73 76 772 775 I-chronic_disease
/ 76 77 775 776 I-chronic_disease
PVD 77 80 776 779 I-chronic_disease
) 80 81 779 780 I-chronic_disease

History 0 7 781 788 O
of 8 10 789 791 O
lymphotomies 11 23 792 804 B-cancer

Impaired 0 8 805 813 B-chronic_disease
circulation 9 20 814 825 I-chronic_disease

Injuries 0 8 826 834 O
to 9 11 835 837 O
other 12 17 838 843 O
body 18 22 844 848 O
systems 23 30 849 856 O
( 31 32 857 858 O
or 32 34 858 860 O
other 35 40 861 866 O
medical 41 48 867 874 O
conditions 49 59 875 885 O
) 59 60 885 886 O
that 61 65 887 891 O
would 66 71 892 897 O
preclude 72 80 898 906 O
the 81 84 907 910 O
ability 85 92 911 918 O
to 93 95 919 921 O
weight 96 102 922 928 O
bear 103 107 929 933 O
as 108 110 934 936 O
tolerated 111 120 937 946 O
and 121 124 947 950 O
initiate 125 133 951 959 O
PT 134 136 960 962 O
within 137 143 963 969 O
28 144 146 970 972 B-upper_bound
days 147 151 973 977 I-upper_bound
of 152 154 978 980 O
definitive 155 165 981 991 B-treatment
fixation 166 174 992 1000 I-treatment

Morbidly 0 8 1001 1009 O
obese 9 14 1010 1015 O
( 15 16 1016 1017 O
BMI 16 19 1017 1020 B-bmi
> 20 21 1021 1022 O
40 22 24 1023 1025 B-lower_bound
) 24 25 1025 1026 O

Open 0 4 1027 1031 O
diaphyseal 5 15 1032 1042 B-chronic_disease
femur 16 21 1043 1048 I-chronic_disease
fracture 22 30 1049 1057 I-chronic_disease

Patient 0 7 1058 1065 O
is 8 10 1066 1068 O
pregnant 11 19 1069 1077 B-pregnancy

Patient 0 7 1078 1085 O
received 8 16 1086 1094 O
BFR 17 20 1095 1098 B-treatment
between 21 28 1099 1106 O
date 29 33 1107 1111 O
of 34 36 1112 1114 O
injury 37 43 1115 1121 O
and 44 47 1122 1125 O
start 48 53 1126 1131 O
of 54 56 1132 1134 O
Physical 57 65 1135 1143 B-treatment
Therap 66 72 1144 1150 I-treatment

Skin 0 4 1151 1155 B-treatment
grafts 5 11 1156 1162 I-treatment
in 12 14 1163 1165 O
which 15 20 1166 1171 O
all 21 24 1172 1175 O
bleeding 25 33 1176 1184 O
points 34 40 1185 1191 O
must 41 45 1192 1196 O
be 46 48 1197 1199 O
readily 49 56 1200 1207 O
distinguished 57 70 1208 1221 O

Unable 0 6 1222 1228 B-language_fluency
to 7 9 1229 1231 I-language_fluency
speak 10 15 1232 1237 I-language_fluency
either 16 22 1238 1244 I-language_fluency
English 23 30 1245 1252 I-language_fluency
or 31 33 1253 1255 I-language_fluency
Spanish 34 41 1256 1263 I-language_fluency

Use 0 3 1264 1267 O
of 4 6 1268 1270 O
blood 7 12 1271 1276 O
flow 13 17 1277 1281 O
restriction 18 29 1282 1293 O
( 30 31 1294 1295 O
BFR 31 34 1295 1298 O
) 34 35 1298 1299 O
at 36 38 1300 1302 O
any 39 42 1303 1306 O
time 43 47 1307 1311 O
between 48 55 1312 1319 O
treatment 56 65 1320 1329 O
and 66 69 1330 1333 O
the 70 73 1334 1337 O
start 74 79 1338 1343 O
of 80 82 1344 1346 O
physical 83 91 1347 1355 B-treatment
therapy 92 99 1356 1363 I-treatment
for 100 103 1364 1367 O
the 104 107 1368 1371 O
study 108 113 1372 1377 O

have 0 4 1378 1382 O
document 5 13 1383 1391 O
psychiatric 14 25 1392 1403 B-chronic_disease
disorders 26 35 1404 1413 I-chronic_disease

severe 0 6 1414 1420 B-chronic_disease
traumatic 7 16 1421 1430 I-chronic_disease
brain 17 22 1431 1436 I-chronic_disease
injury 23 29 1437 1443 I-chronic_disease

skin 0 4 1444 1448 B-treatment
graft 5 10 1449 1454 I-treatment

vascular 0 8 1455 1463 B-treatment
reconstruction 9 23 1464 1478 I-treatment

Acute 0 5 0 5 B-chronic_disease
coronary 6 14 6 14 I-chronic_disease
syndrome 15 23 15 23 I-chronic_disease

Advanced 0 8 24 32 B-chronic_disease
Parkinson 9 18 33 42 I-chronic_disease
's 18 20 42 44 I-chronic_disease

Eligibility 0 11 45 56 O
for 12 15 57 60 O
TAVR 16 20 61 65 B-treatment

Stroke 0 6 66 72 B-chronic_disease
with 7 11 73 77 O
neurological 12 24 78 90 B-chronic_disease
deficit 25 32 91 98 I-chronic_disease

Sustained 0 9 99 108 O
ventricular 10 21 109 120 B-chronic_disease
arrhythmia 22 32 121 131 I-chronic_disease

Active 0 6 0 6 O
suicidal 7 15 7 15 B-chronic_disease
or 16 18 16 18 O
homicidal 19 28 19 28 B-chronic_disease
ideation 29 37 29 37 I-chronic_disease

Current 0 7 38 45 O
CBT 8 11 46 49 B-treatment
and/or 12 18 50 56 O
formal 19 25 57 63 O
mindfulness 26 37 64 75 O
/ 37 38 75 76 O
meditation 38 48 76 86 O
training 49 57 87 95 O

Current 0 7 96 103 O
or 8 10 104 106 O
past 11 15 107 111 O
manic 16 21 112 117 B-chronic_disease
/ 21 22 117 118 I-chronic_disease
hypomanic 22 31 118 127 I-chronic_disease
episode 32 39 128 135 I-chronic_disease
or 40 42 136 138 O
psychotic 43 52 139 148 B-chronic_disease
symptoms 53 61 149 157 I-chronic_disease

Current 0 7 158 165 O
use 8 11 166 169 O
of 12 14 170 172 O
psychotropic 15 27 173 185 B-treatment
medications 28 39 186 197 I-treatment
, 39 40 197 198 O
except 41 47 199 205 O
antidepressants 48 63 206 221 B-treatment
taken 64 69 222 227 O
at 70 72 228 230 O
a 73 74 231 232 O
stable 75 81 233 239 O
dose 82 86 240 244 O
for 87 90 245 248 O
2 91 92 249 250 O
weeks 93 98 251 256 O
, 98 99 256 257 O
to 100 102 258 260 O
maximize 103 111 261 269 O
generalizability 112 128 270 286 O
of 129 131 287 289 O
sample 132 138 290 296 O

Fluent 0 6 297 303 B-language_fluency
in 7 9 304 306 I-language_fluency
English 10 17 307 314 I-language_fluency
, 17 18 314 315 O
and 19 22 316 319 O
willing 23 30 320 327 O
to 31 33 328 330 O
provide 34 41 331 338 O
informed 42 50 339 347 O
consent 51 58 348 355 O

For 0 3 356 359 O
healthy 4 11 360 367 O
controls 12 20 368 376 O
only 21 25 377 381 O
: 25 26 381 382 O
no 27 29 383 385 O
current 30 37 386 393 O
or 38 40 394 396 O
lifetime 41 49 397 405 O
history 50 57 406 413 O
of 58 60 414 416 O
psychiatric 61 72 417 428 B-chronic_disease
disorders 73 82 429 438 I-chronic_disease
, 82 83 438 439 O
and 84 87 440 443 O
score 88 93 444 449 O
of 94 96 450 452 O
below 97 102 453 458 O
1 103 104 459 460 B-upper_bound
SD 105 107 461 463 I-upper_bound
of 108 110 464 466 I-upper_bound
mean 111 115 467 471 I-upper_bound
on 116 118 472 474 O
the 119 122 475 478 O
SCS 123 126 479 482 B-clinical_variable
- 126 127 482 483 I-clinical_variable
R 127 128 483 484 I-clinical_variable

For 0 3 485 488 O
patients 4 12 489 497 O
: 12 13 497 498 O
treatment 14 23 499 508 O
- 23 24 508 509 O
seeking 24 31 509 516 O
individuals 32 43 517 528 O
presenting 44 54 529 539 O
with 55 59 540 544 O
at 60 62 545 547 O
least 63 68 548 553 O
moderate 69 77 554 562 O
levels 78 84 563 569 O
of 85 87 570 572 O
social 88 94 573 579 O
anxiety 95 102 580 587 O
/ 102 103 587 588 O
body 103 107 588 592 O
dysmorphic 108 118 593 603 O
symptoms 119 127 604 612 O
, 127 128 612 613 O
and 129 132 614 617 O
a 133 134 618 619 O
score 135 140 620 625 O
of 141 143 626 628 O
at 144 146 629 631 O
least 147 152 632 637 O
1 153 154 638 639 O
SD 155 157 640 642 O
above 158 163 643 648 O
the 164 167 649 652 O
mean 168 172 653 657 O
on 173 175 658 660 O
the 176 179 661 664 O
public 180 186 665 671 O
self 187 191 672 676 O
- 191 192 676 677 O
consciousness 192 205 677 690 O
scale 206 211 691 696 O
of 212 214 697 699 O
the 215 218 700 703 O
Self 219 223 704 708 B-clinical_variable
- 223 224 708 709 I-clinical_variable
Consciousness 224 237 709 722 I-clinical_variable
Scale- 238 244 723 729 I-clinical_variable
Revised 245 252 730 737 I-clinical_variable

History 0 7 738 745 O
of 8 10 746 748 O
head 11 15 749 753 O
injury 16 22 754 760 O
, 22 23 760 761 O
neurological 24 36 762 774 B-chronic_disease
disorder 37 45 775 783 I-chronic_disease
, 45 46 783 784 O
or 47 49 785 787 O
neurosurgical 50 63 788 801 B-chronic_disease
procedure 64 73 802 811 I-chronic_disease

History 0 7 812 819 O
of 8 10 820 822 O
more 11 15 823 827 O
than 16 20 828 832 O
10 21 23 833 835 B-lower_bound
sessions 24 32 836 844 O
of 33 35 845 847 O
CBT 36 39 848 851 B-treatment
and 40 43 852 855 O
formal 44 50 856 862 O
mindfulness 51 62 863 874 O
/ 62 63 874 875 O
meditation 63 73 875 885 O
training 74 82 886 894 O

Men 0 3 895 898 B-gender

women 0 5 899 904 B-gender

AST 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGOT)/ALT 5 14 5 14 I-clinical_variable
( 15 16 15 16 I-clinical_variable
SGPT 16 20 16 20 I-clinical_variable
): 20 22 20 22 I-clinical_variable
= 23 24 23 24 O
< 24 25 24 25 O
3 26 27 26 27 B-upper_bound
x 28 29 28 29 I-upper_bound
ULN 30 33 30 33 I-upper_bound
( 34 35 34 35 O
within 35 41 35 41 O
2 42 43 42 43 B-upper_bound
weeks 44 49 44 49 I-upper_bound
prior 50 55 50 55 I-upper_bound
to 56 58 56 58 O
enrollment 59 69 59 69 O
) 69 70 69 70 O
( 71 72 71 72 O
participants 72 84 72 84 O
may 85 88 85 88 O
receive 89 96 89 96 O
GCSF 97 101 97 101 O
and 102 105 102 105 O
transfusions 106 118 106 118 O
to 119 121 119 121 O
meet 122 126 122 126 O
these 127 132 127 132 O
parameters 133 143 133 143 O
) 143 144 143 144 O

AST 0 3 145 148 B-clinical_variable
( 4 5 149 150 I-clinical_variable
serum 5 10 150 155 I-clinical_variable
glutamic 11 19 156 164 I-clinical_variable
oxaloacetic 20 31 165 176 I-clinical_variable
transaminase 32 44 177 189 I-clinical_variable
[ 45 46 190 191 I-clinical_variable
SGOT])/ALT 46 56 191 201 I-clinical_variable
( 57 58 202 203 I-clinical_variable
serum 58 63 203 208 I-clinical_variable
glutamate 64 73 209 218 I-clinical_variable
pyruvate 74 82 219 227 I-clinical_variable
transaminase 83 95 228 240 I-clinical_variable
[ 96 97 241 242 I-clinical_variable
SGPT 97 101 242 246 I-clinical_variable
] 101 102 246 247 I-clinical_variable
) 102 103 247 248 O
= 104 105 249 250 O
< 105 106 250 251 O
3 107 108 252 253 B-upper_bound
x 109 110 254 255 I-upper_bound
ULN 111 114 256 259 I-upper_bound
( 115 116 260 261 O
within 116 122 261 267 O
2 123 124 268 269 B-upper_bound
weeks 125 130 270 275 I-upper_bound
prior 131 136 276 281 I-upper_bound
to 137 139 282 284 O
enrollment 140 150 285 295 O
) 150 151 295 296 O

Absolute 0 8 297 305 B-clinical_variable
neutrophil 9 19 306 316 I-clinical_variable
count 20 25 317 322 I-clinical_variable
> 26 27 323 324 O
= 27 28 324 325 O
1,000 29 34 326 331 B-lower_bound
/ 34 35 331 332 I-lower_bound
mm^3 35 39 332 336 I-lower_bound
( 40 41 337 338 O
within 41 47 338 344 O
2 48 49 345 346 B-upper_bound
weeks 50 55 347 352 I-upper_bound
prior 56 61 353 358 I-upper_bound
to 62 64 359 361 O
enrollment 65 75 362 372 O
) 75 76 372 373 O

CD4 0 3 374 377 B-clinical_variable
cell 4 8 378 382 I-clinical_variable
count 9 14 383 388 I-clinical_variable
of 15 17 389 391 O
at 18 20 392 394 O
least 21 26 395 400 O
100 27 30 401 404 B-upper_bound
cells 31 36 405 410 I-upper_bound
/ 36 37 410 411 I-upper_bound
mm^3 37 41 411 415 I-upper_bound

Creatinine 0 10 416 426 B-clinical_variable
< 11 12 427 428 O
1.5 13 16 429 432 B-upper_bound
UNL 17 20 433 436 I-upper_bound
or 21 23 437 439 O
creatinine 24 34 440 450 B-clinical_variable
clearance 35 44 451 460 I-clinical_variable
( 45 46 461 462 I-clinical_variable
CrCl 46 50 462 466 I-clinical_variable
) 50 51 466 467 I-clinical_variable
> 52 53 468 469 O
50 54 56 470 472 B-lower_bound
ml 57 59 473 475 I-lower_bound
/ 59 60 475 476 I-lower_bound
min 60 63 476 479 I-lower_bound
( 64 65 480 481 O
within 65 71 481 487 O
2 72 73 488 489 B-upper_bound
weeks 74 79 490 495 I-upper_bound
prior 80 85 496 501 I-upper_bound
to 86 88 502 504 O
enrollment 89 99 505 515 O
) 99 100 515 516 O

Creatinine 0 10 517 527 B-clinical_variable
: 10 11 527 528 O
< 12 13 529 530 O
1.5 14 17 531 534 B-upper_bound
x 18 19 535 536 I-upper_bound
upper 20 25 537 542 I-upper_bound
normal 26 32 543 549 I-upper_bound
limit 33 38 550 555 I-upper_bound
( 39 40 556 557 I-upper_bound
UNL 40 43 557 560 I-upper_bound
) 43 44 560 561 I-upper_bound
or 45 47 562 564 O
CrCl 48 52 565 569 B-clinical_variable
> 53 54 570 571 O
50ml 55 59 572 576 B-lower_bound
/ 59 60 576 577 I-lower_bound
min 60 63 577 580 I-lower_bound
( 64 65 581 582 O
within 65 71 582 588 O
2 72 73 589 590 B-upper_bound
weeks 74 79 591 596 I-upper_bound
prior 80 85 597 602 I-upper_bound
to 86 88 603 605 O
enrollment 89 99 606 616 O
) 99 100 616 617 O
( 101 102 618 619 O
participants 102 114 619 631 O
may 115 118 632 635 O
receive 119 126 636 643 O
GCSF 127 131 644 648 O
and 132 135 649 652 O
transfusions 136 148 653 665 O
to 149 151 666 668 O
meet 152 156 669 673 O
these 157 162 674 679 O
parameters 163 173 680 690 O
) 173 174 690 691 O

Eastern 0 7 692 699 B-clinical_variable
Cooperative 8 19 700 711 I-clinical_variable
Oncology 20 28 712 720 I-clinical_variable
Group 29 34 721 726 I-clinical_variable
( 35 36 727 728 I-clinical_variable
ECOG 36 40 728 732 I-clinical_variable
) 40 41 732 733 I-clinical_variable
performance 42 53 734 745 I-clinical_variable
status 54 60 746 752 I-clinical_variable
= 61 62 753 754 O
< 62 63 754 755 O
1 64 65 756 757 B-upper_bound
( 66 67 758 759 O
Karnofsky 67 76 759 768 B-clinical_variable
> 77 78 769 770 O
= 78 79 770 771 O
70 80 82 772 774 B-lower_bound
% 82 83 774 775 I-lower_bound
) 83 84 775 776 O

For 0 3 777 780 O
Stratum 4 11 781 788 O
1 12 13 789 790 O
: 13 14 790 791 O
CD4 15 18 792 795 B-clinical_variable
+ 18 19 795 796 I-clinical_variable
cell 20 24 797 801 I-clinical_variable
count 25 30 802 807 I-clinical_variable
greater 31 38 808 815 O
than 39 43 816 820 O
200 44 47 821 824 B-lower_bound
cells 48 53 825 830 I-lower_bound
/ 53 54 830 831 I-lower_bound
mm^3 54 58 831 835 I-lower_bound
obtained 59 67 836 844 O
within 68 74 845 851 O
2 75 76 852 853 B-upper_bound
weeks 77 82 854 859 I-upper_bound
prior 83 88 860 865 I-upper_bound
to 89 91 866 868 O
enrollment 92 102 869 879 O
at 103 105 880 882 O
any 106 109 883 886 O
United 110 116 887 893 O
States 117 123 894 900 O
( 124 125 901 902 O
U.S. 125 129 902 906 O
) 129 130 906 907 O
laboratory 131 141 908 918 O
that 142 146 919 923 O
has 147 150 924 927 O
a 151 152 928 929 O
clinical 153 161 930 938 O
laboratory 162 172 939 949 O
improvement 173 184 950 961 O
amendments 185 195 962 972 O
( 196 197 973 974 O
CLIA 197 201 974 978 O
) 201 202 978 979 O
certification 203 216 980 993 O
or 217 219 994 996 O
its 220 223 997 1000 O
equivalent 224 234 1001 1011 O

For 0 3 1012 1015 O
Stratum 4 11 1016 1023 O
2 12 13 1024 1025 O
: 13 14 1025 1026 O
CD4 15 18 1027 1030 B-clinical_variable
cell 19 23 1031 1035 I-clinical_variable
count 24 29 1036 1041 I-clinical_variable
between 30 37 1042 1049 O
100 38 41 1050 1053 B-lower_bound
- 41 42 1053 1054 O
200 42 45 1054 1057 B-upper_bound
cells 46 51 1058 1063 I-upper_bound
/ 51 52 1063 1064 I-upper_bound
mm^3 52 56 1064 1068 I-upper_bound
obtained 57 65 1069 1077 O
within 66 72 1078 1084 O
2 73 74 1085 1086 B-upper_bound
weeks 75 80 1087 1092 I-upper_bound
prior 81 86 1093 1098 I-upper_bound
to 87 89 1099 1101 O
enrollment 90 100 1102 1112 O
at 101 103 1113 1115 O
any 104 107 1116 1119 O
U.S. 108 112 1120 1124 O
laboratory 113 123 1125 1135 O
that 124 128 1136 1140 O
has 129 132 1141 1144 O
a 133 134 1145 1146 O
clinical 135 143 1147 1155 O
laboratory 144 154 1156 1166 O
improvement 155 166 1167 1178 O
amendments 167 177 1179 1189 O
( 178 179 1190 1191 O
CLIA 179 183 1191 1195 O
) 183 184 1195 1196 O
certification 185 198 1197 1210 O
or 199 201 1211 1213 O
its 202 205 1214 1217 O
equivalent 206 216 1218 1228 O

For 0 3 1229 1232 O
participants 4 16 1233 1245 O
in 17 19 1246 1248 O
the 20 23 1249 1252 O
24 24 26 1253 1255 O
participant 27 38 1256 1267 O
solid 39 44 1268 1273 B-cancer
tumor 45 50 1274 1279 I-cancer
cohort 51 57 1280 1286 O
, 57 58 1286 1287 O
only 59 63 1288 1292 O
those 64 69 1293 1298 O
histologies 70 81 1299 1310 O
not 82 85 1311 1314 O
known 86 91 1315 1320 O
to 92 94 1321 1323 O
respond 95 102 1324 1331 O
to 103 105 1332 1334 O
single 106 112 1335 1341 O
agent 113 118 1342 1347 O
nivolumab 119 128 1348 1357 B-treatment
( 129 130 1358 1359 O
such 130 134 1359 1363 O
as 135 137 1364 1366 O
pancreas 138 146 1367 1375 B-cancer
, 146 147 1375 1376 O
prostate 148 156 1377 1385 B-cancer
, 156 157 1385 1386 O
and 158 161 1387 1390 O
microsatellite 162 176 1391 1405 B-cancer
stable 177 183 1406 1412 I-cancer
[ 184 185 1413 1414 I-cancer
MSS 185 188 1414 1417 I-cancer
] 188 189 1417 1418 I-cancer
colorectal 190 200 1419 1429 I-cancer
cancer 201 207 1430 1436 I-cancer
) 207 208 1436 1437 O

HIV 0 3 1438 1441 B-chronic_disease
viral 4 9 1442 1447 O
load 10 14 1448 1452 O
should 15 21 1453 1459 O
be 22 24 1460 1462 O
well 25 29 1463 1467 O
suppressed 30 40 1468 1478 O
, 40 41 1478 1479 O
defined 42 49 1480 1487 O
as 50 52 1488 1490 O
below 53 58 1491 1496 O
the 59 62 1497 1500 O
limit 63 68 1501 1506 O
of 69 71 1507 1509 O
detection 72 81 1510 1519 O
of 82 84 1520 1522 O
the 85 88 1523 1526 O
local 89 94 1527 1532 O
assay 95 100 1533 1538 O
or 101 103 1539 1541 O
below 104 109 1542 1547 O
75 110 112 1548 1550 B-upper_bound
copies 113 119 1551 1557 I-upper_bound
/ 119 120 1557 1558 I-upper_bound
mL 120 122 1558 1560 I-upper_bound
by 123 125 1561 1563 O
Food 126 130 1564 1568 O
and 131 134 1569 1572 O
Drug 135 139 1573 1577 O
Administration 140 154 1578 1592 O
( 155 156 1593 1594 O
FDA)-approved 156 169 1594 1607 O
assays 170 176 1608 1614 O
, 176 177 1614 1615 O
within 178 184 1616 1622 O
4 185 186 1623 1624 B-upper_bound
weeks 187 192 1625 1630 I-upper_bound
prior 193 198 1631 1636 I-upper_bound
to 199 201 1637 1639 O
registration 202 214 1640 1652 O

HIV-1 0 5 1653 1658 B-chronic_disease
infection 6 15 1659 1668 I-chronic_disease
, 15 16 1668 1669 O
as 17 19 1670 1672 O
documented 20 30 1673 1683 O
by 31 33 1684 1686 O
any 34 37 1687 1690 O
federally 38 47 1691 1700 O
approved 48 56 1701 1709 O
, 56 57 1709 1710 O
licensed 58 66 1711 1719 O
HIV 67 70 1720 1723 B-treatment
rapid 71 76 1724 1729 I-treatment
test 77 81 1730 1734 I-treatment
performed 82 91 1735 1744 O
in 92 94 1745 1747 O
conjunction 95 106 1748 1759 O
with 107 111 1760 1764 O
screening 112 121 1765 1774 O
( 122 123 1775 1776 O
or 123 125 1776 1778 O
enzyme 126 132 1779 1785 B-treatment
linked 133 139 1786 1792 I-treatment
immunosorbent 140 153 1793 1806 I-treatment
assay 154 159 1807 1812 I-treatment
[ 160 161 1813 1814 I-treatment
ELISA 161 166 1814 1819 I-treatment
] 166 167 1819 1820 I-treatment
, 167 168 1820 1821 O
test 169 173 1822 1826 O
kit 174 177 1827 1830 O
, 177 178 1830 1831 O
and 179 182 1832 1835 O
confirmed 183 192 1836 1845 O
by 193 195 1846 1848 O
Western 196 203 1849 1856 O
blot 204 208 1857 1861 O
or 209 211 1862 1864 O
other 212 217 1865 1870 O
approved 218 226 1871 1879 O
test 227 231 1880 1884 O
) 231 232 1884 1885 O
; 232 233 1885 1886 O
alternatively 234 247 1887 1900 O
, 247 248 1900 1901 O
this 249 253 1902 1906 O
documentation 254 267 1907 1920 O
may 268 271 1921 1924 O
include 272 279 1925 1932 O
a 280 281 1933 1934 O
record 282 288 1935 1941 O
demonstrating 289 302 1942 1955 O
that 303 307 1956 1960 O
another 308 315 1961 1968 O
physician 316 325 1969 1978 O
has 326 329 1979 1982 O
documented 330 340 1983 1993 O
the 341 344 1994 1997 O
participant 345 356 1998 2009 O
's 356 358 2009 2011 O
HIV 359 362 2012 2015 O
status 363 369 2016 2022 O

Hemoglobin 0 10 2023 2033 B-clinical_variable
> 11 12 2034 2035 O
= 12 13 2035 2036 O
9 14 15 2037 2038 B-lower_bound
g 16 17 2039 2040 I-lower_bound
/ 17 18 2040 2041 I-lower_bound
dL 18 20 2041 2043 I-lower_bound
( 21 22 2044 2045 O
within 22 28 2045 2051 O
2 29 30 2052 2053 B-upper_bound
weeks 31 36 2054 2059 I-upper_bound
prior 37 42 2060 2065 I-upper_bound
to 43 45 2066 2068 O
enrollment 46 56 2069 2079 O
) 56 57 2079 2080 O

History 0 7 2081 2088 O
of 8 10 2089 2091 O
allergic 11 19 2092 2100 O
reactions 20 29 2101 2110 O
attributed 30 40 2111 2121 O
to 41 43 2122 2124 O
compounds 44 53 2125 2134 O
of 54 56 2135 2137 O
similar 57 64 2138 2145 O
chemical 65 73 2146 2154 O
or 74 76 2155 2157 O
biologic 77 85 2158 2166 O
composition 86 97 2167 2178 O
to 98 100 2179 2181 O
ipilimumab 101 111 2182 2192 B-allergy_name
, 111 112 2192 2193 O
nivolumab 113 122 2194 2203 B-allergy_name
, 122 123 2203 2204 O
or 124 126 2205 2207 O
other 127 132 2208 2213 O
agents 133 139 2214 2220 O
used 140 144 2221 2225 O
in 145 147 2226 2228 O
study 148 153 2229 2234 O
, 153 154 2234 2235 O
or 155 157 2236 2238 O
history 158 165 2239 2246 O
of 166 168 2247 2249 O
severe 169 175 2250 2256 O
hypersensitivity 176 192 2257 2273 O
reaction 193 201 2274 2282 O
to 202 204 2283 2285 O
any 205 208 2286 2289 O
monoclonal 209 219 2290 2300 B-allergy_name
antibody 220 228 2301 2309 I-allergy_name

Leukocyte 0 9 2310 2319 B-clinical_variable
count 10 15 2320 2325 I-clinical_variable
: 15 16 2325 2326 O
no 17 19 2327 2329 O
lower 20 25 2330 2335 O
limit 26 31 2336 2341 O
( 32 33 2342 2343 O
within 33 39 2343 2349 O
2 40 41 2350 2351 B-upper_bound
weeks 42 47 2352 2357 I-upper_bound
prior 48 53 2358 2363 I-upper_bound
to 54 56 2364 2366 O
enrollment 57 67 2367 2377 O
) 67 68 2377 2378 O
( 69 70 2379 2380 O
participants 70 82 2380 2392 O
may 83 86 2393 2396 O
receive 87 94 2397 2404 O
granulocyte 95 106 2405 2416 O
colony 107 113 2417 2423 I-clinical_variable
stimulating 114 125 2424 2435 I-clinical_variable
factor 126 132 2436 2442 I-clinical_variable
[ 133 134 2443 2444 I-clinical_variable
GCSF 134 138 2444 2448 I-clinical_variable
] 138 139 2448 2449 I-clinical_variable
and 140 143 2450 2453 O
transfusions 144 156 2454 2466 O
to 157 159 2467 2469 O
meet 160 164 2470 2474 O
these 165 170 2475 2480 O
parameters 171 181 2481 2491 O
) 181 182 2491 2492 O

Leukocytes 0 10 2493 2503 B-upper_bound
> 11 12 2504 2505 O
= 12 13 2505 2506 O
2,000 14 19 2507 2512 B-lower_bound
/ 19 20 2512 2513 I-lower_bound
mm^3 20 24 2513 2517 I-lower_bound
( 25 26 2518 2519 O
within 26 32 2519 2525 O
2 33 34 2526 2527 B-upper_bound
weeks 35 40 2528 2533 I-upper_bound
prior 41 46 2534 2539 I-upper_bound
to 47 49 2540 2542 O
enrollment 50 60 2543 2553 O
) 60 61 2553 2554 O

Participants 0 12 2555 2567 O
MUST 13 17 2568 2572 O
receive 18 25 2573 2580 O
appropriate 26 37 2581 2592 O
care 38 42 2593 2597 O
and 43 46 2598 2601 O
treatment 47 56 2602 2611 B-treatment
for 57 60 2612 2615 O
HIV 61 64 2616 2619 B-chronic_disease
infection 65 74 2620 2629 I-chronic_disease
, 74 75 2629 2630 O
including 76 85 2631 2640 O
antiretroviral 86 100 2641 2655 B-treatment
medications 101 112 2656 2667 I-treatment
when 113 117 2668 2672 O
clinically 118 128 2673 2683 O
indicated 129 138 2684 2693 O
, 138 139 2693 2694 O
and 140 143 2695 2698 O
should 144 150 2699 2705 O
be 151 153 2706 2708 O
under 154 159 2709 2714 O
the 160 163 2715 2718 O
care 164 168 2719 2723 O
of 169 171 2724 2726 O
a 172 173 2727 2728 O
physician 174 183 2729 2738 O
experienced 184 195 2739 2750 O
in 196 198 2751 2753 O
HIV 199 202 2754 2757 O
management 203 213 2758 2768 O

Participants 0 12 2769 2781 O
must 13 17 2782 2786 O
have 18 22 2787 2791 O
histologically 23 37 2792 2806 O
confirmed 38 47 2807 2816 O
solid 48 53 2817 2822 B-cancer
tumor 54 59 2823 2828 I-cancer
malignancy 60 70 2829 2839 I-cancer
that 71 75 2840 2844 O
is 76 78 2845 2847 O
metastatic 79 89 2848 2858 B-cancer
or 90 92 2859 2861 O
unresectable 93 105 2862 2874 O
and 106 109 2875 2878 O
for 110 113 2879 2882 O
which 114 119 2883 2888 O
standard 120 128 2889 2897 O
curative 129 137 2898 2906 O
or 138 140 2907 2909 O
palliative 141 151 2910 2920 O
measures 152 160 2921 2929 O
do 161 163 2930 2932 O
not 164 167 2933 2936 O
exist 168 173 2937 2942 O
or 174 176 2943 2945 O
are 177 180 2946 2949 O
no 181 183 2950 2952 O
longer 184 190 2953 2959 O
effective 191 200 2960 2969 O

Participants 0 12 2970 2982 O
must 13 17 2983 2987 O
have 18 22 2988 2992 O
measurable 23 33 2993 3003 O
disease 34 41 3004 3011 O
, 41 42 3011 3012 O
defined 43 50 3013 3020 O
as 51 53 3021 3023 O
at 54 56 3024 3026 O
least 57 62 3027 3032 O
one 63 66 3033 3036 B-lower_bound
lesion 67 73 3037 3043 O
that 74 78 3044 3048 O
can 79 82 3049 3052 O
be 83 85 3053 3055 O
accurately 86 96 3056 3066 O
measured 97 105 3067 3075 O
in 106 108 3076 3078 O
at 109 111 3079 3081 O
least 112 117 3082 3087 O
one 118 121 3088 3091 O
dimension 122 131 3092 3101 B-clinical_variable
( 132 133 3102 3103 O
longest 133 140 3103 3110 O
diameter 141 149 3111 3119 B-clinical_variable
to 150 152 3120 3122 O
be 153 155 3123 3125 O
recorded 156 164 3126 3134 O
for 165 168 3135 3138 O
non 169 172 3139 3142 O
- 172 173 3142 3143 O
nodal 173 178 3143 3148 B-clinical_variable
lesions 179 186 3149 3156 I-clinical_variable
and 187 190 3157 3160 O
short 191 196 3161 3166 O
axis 197 201 3167 3171 O
for 202 205 3172 3175 O
nodal 206 211 3176 3181 O
lesions 212 219 3182 3189 O
) 219 220 3189 3190 O
as 221 223 3191 3193 O
> 224 225 3194 3195 O
= 225 226 3195 3196 O
20 227 229 3197 3199 B-lower_bound
mm 230 232 3200 3202 I-lower_bound
with 233 237 3203 3207 O
conventional 238 250 3208 3220 O
techniques 251 261 3221 3231 O
or 262 264 3232 3234 O
as 265 267 3235 3237 O
> 268 269 3238 3239 O
= 269 270 3239 3240 O
10 271 273 3241 3243 B-lower_bound
mm 274 276 3244 3246 I-lower_bound
with 277 281 3247 3251 O
spiral 282 288 3252 3258 B-treatment
computed 289 297 3259 3267 I-treatment
tomography 298 308 3268 3278 I-treatment
( 309 310 3279 3280 I-treatment
CT 310 312 3280 3282 I-treatment
) 312 313 3282 3283 I-treatment
scan 314 318 3284 3288 I-treatment
, 318 319 3288 3289 O
magnetic 320 328 3290 3298 B-treatment
resonance 329 338 3299 3308 I-treatment
imaging 339 346 3309 3316 I-treatment
( 347 348 3317 3318 I-treatment
MRI 348 351 3318 3321 I-treatment
) 351 352 3321 3322 I-treatment
, 352 353 3322 3323 O
or 354 356 3324 3326 O
calipers 357 365 3327 3335 B-treatment
by 366 368 3336 3338 O
clinical 369 377 3339 3347 O
exam 378 382 3348 3352 O

Participants 0 12 3353 3365 O
who 13 16 3366 3369 O
have 17 21 3370 3374 O
hepatitis 22 31 3375 3384 B-chronic_disease
C 32 33 3385 3386 I-chronic_disease
( 34 35 3387 3388 O
both 35 39 3388 3392 O
reactive 40 48 3393 3401 O
anti 49 53 3402 3406 O
- 53 54 3406 3407 O
hepatitis 54 63 3407 3416 B-chronic_disease
C 64 65 3417 3418 I-chronic_disease
virus 66 71 3419 3424 I-chronic_disease
[ 72 73 3425 3426 I-chronic_disease
HCV 73 76 3426 3429 I-chronic_disease
] 76 77 3429 3430 I-chronic_disease
antibody 78 86 3431 3439 O
and 87 90 3440 3443 O
detectable 91 101 3444 3454 O
HCV 102 105 3455 3458 O
ribonucleic 106 117 3459 3470 O
acid 118 122 3471 3475 O
[ 123 124 3476 3477 O
RNA 124 127 3477 3480 O
] 127 128 3480 3481 O
) 128 129 3481 3482 O
and 130 133 3483 3486 O
hepatitis 134 143 3487 3496 B-chronic_disease
B 144 145 3497 3498 I-chronic_disease
( 146 147 3499 3500 O
hepatitis 147 156 3500 3509 O
B 157 158 3510 3511 O
surface 159 166 3512 3519 O
antigen 167 174 3520 3527 O
[ 175 176 3528 3529 O
HBsAg 176 181 3529 3534 O
] 181 182 3534 3535 O
positive 183 191 3536 3544 O
and 192 195 3545 3548 O
anti 196 200 3549 3553 O
- 200 201 3553 3554 O
hepatitis 201 210 3554 3563 O
B 211 212 3564 3565 O
core 213 217 3566 3570 O
[ 218 219 3571 3572 O
HBc]-total 219 229 3572 3582 O
positive 230 238 3583 3591 O
) 238 239 3591 3592 O
, 239 240 3592 3593 O
may 241 244 3594 3597 O
be 245 247 3598 3600 O
enrolled 248 256 3601 3609 O
, 256 257 3609 3610 O
provided 258 266 3611 3619 O
total 267 272 3620 3625 B-clinical_variable
bilirubin 273 282 3626 3635 I-clinical_variable
is 283 285 3636 3638 O
= 286 287 3639 3640 O
< 287 288 3640 3641 O
1.5 289 292 3642 3645 B-upper_bound
x 293 294 3646 3647 I-upper_bound
institutional 295 308 3648 3661 I-upper_bound
ULN 309 312 3662 3665 I-upper_bound
, 312 313 3665 3666 O
and 314 317 3667 3670 O
AST 318 321 3671 3674 B-clinical_variable
( 322 323 3675 3676 I-clinical_variable
SGOT 323 327 3676 3680 I-clinical_variable
) 327 328 3680 3681 I-clinical_variable
and 329 332 3682 3685 O
ALT 333 336 3686 3689 B-clinical_variable
( 337 338 3690 3691 I-clinical_variable
SGPT 338 342 3691 3695 I-clinical_variable
) 342 343 3695 3696 I-clinical_variable
must 344 348 3697 3701 O
be 349 351 3702 3704 O
= 352 353 3705 3706 O
< 353 354 3706 3707 O
3 355 356 3708 3709 B-upper_bound
X 357 358 3710 3711 I-upper_bound
institutional 359 372 3712 3725 I-upper_bound
upper 373 378 3726 3731 I-upper_bound
limit 379 384 3732 3737 I-upper_bound
of 385 387 3738 3740 I-upper_bound
normal 388 394 3741 3747 I-upper_bound
, 394 395 3747 3748 O
and 396 399 3749 3752 O
hepatitis 400 409 3753 3762 B-clinical_variable
B 410 411 3763 3764 I-clinical_variable
virus 412 417 3765 3770 I-clinical_variable
( 418 419 3771 3772 I-clinical_variable
HBV 419 422 3772 3775 I-clinical_variable
) 422 423 3775 3776 I-clinical_variable
deoxyribonucleic 424 440 3777 3793 I-clinical_variable
acid 441 445 3794 3798 I-clinical_variable
( 446 447 3799 3800 I-clinical_variable
DNA 447 450 3800 3803 I-clinical_variable
) 450 451 3803 3804 I-clinical_variable
< 452 453 3805 3806 O
100 454 457 3807 3810 B-upper_bound
IU 458 460 3811 3813 I-upper_bound
/ 460 461 3813 3814 I-upper_bound
mL 461 463 3814 3816 I-upper_bound
( 464 465 3817 3818 O
if 465 467 3818 3820 O
hepatitis 468 477 3821 3830 O
B 478 479 3831 3832 O
positive 480 488 3833 3841 O
) 488 489 3841 3842 O
within 490 496 3843 3849 O
2 497 498 3850 3851 B-upper_bound
weeks 499 504 3852 3857 I-upper_bound
prior 505 510 3858 3863 I-upper_bound
to 511 513 3864 3866 O
enrollment 514 524 3867 3877 O

Participants 0 12 3878 3890 O
who 13 16 3891 3894 O
have 17 21 3895 3899 O
received 22 30 3900 3908 O
any 31 34 3909 3912 O
other 35 40 3913 3918 O
investigational 41 56 3919 3934 B-treatment
agents 57 63 3935 3941 I-treatment
within 64 70 3942 3948 O
the 71 74 3949 3952 O
4 75 76 3953 3954 B-upper_bound
weeks 77 82 3955 3960 I-upper_bound
prior 83 88 3961 3966 I-upper_bound
to 89 91 3967 3969 O
enrollment 92 102 3970 3980 O
; 102 103 3980 3981 O
concurrent 104 114 3982 3992 B-treatment
radiation 115 124 3993 4002 I-treatment
therapy 125 132 4003 4010 I-treatment

Participants 0 12 4011 4023 O
with 13 17 4024 4028 O
clinical 18 26 4029 4037 O
or 27 29 4038 4040 O
radiographic 30 42 4041 4053 O
evidence 43 51 4054 4062 O
of 52 54 4063 4065 O
pancreatitis 55 67 4066 4078 B-chronic_disease

Platelets 0 9 4079 4088 B-clinical_variable
> 10 11 4089 4090 O
= 11 12 4090 4091 O
75,000 13 19 4092 4098 B-lower_bound
/ 19 20 4098 4099 I-lower_bound
mm^3 20 24 4099 4103 I-lower_bound
( 25 26 4104 4105 O
within 26 32 4105 4111 O
2 33 34 4112 4113 B-upper_bound
weeks 35 40 4114 4119 I-upper_bound
prior 41 46 4120 4125 I-upper_bound
to 47 49 4126 4128 O
enrollment 50 60 4129 4139 O
) 60 61 4139 4140 O

Platelets 0 9 4141 4150 B-clinical_variable
: 9 10 4150 4151 O
> 11 12 4152 4153 O
= 12 13 4153 4154 O
75,000 14 20 4155 4161 B-lower_bound
/ 20 21 4161 4162 I-lower_bound
mm^3 21 25 4162 4166 I-lower_bound
, 25 26 4166 4167 O
unless 27 33 4168 4174 O
decreased 34 43 4175 4184 O
due 44 47 4185 4188 O
to 48 50 4189 4191 O
bone 51 55 4192 4196 O
marrow 56 62 4197 4203 O
involvement 63 74 4204 4215 O
with 75 79 4216 4220 O
lymphoma 80 88 4221 4229 B-cancer
( 89 90 4230 4231 O
within 90 96 4231 4237 O
2 97 98 4238 4239 B-upper_bound
weeks 99 104 4240 4245 I-upper_bound
prior 105 110 4246 4251 I-upper_bound
to 111 113 4252 4254 O
enrollment 114 124 4255 4265 O
) 124 125 4265 4266 O
( 126 127 4267 4268 O
participants 127 139 4268 4280 O
may 140 143 4281 4284 O
receive 144 151 4285 4292 O
GCSF 152 156 4293 4297 B-clinical_variable
and 157 160 4298 4301 O
transfusions 161 173 4302 4314 O
to 174 176 4315 4317 O
meet 177 181 4318 4322 O
these 182 187 4323 4328 O
parameters 188 198 4329 4339 O
) 198 199 4339 4340 O

Prior 0 5 4341 4346 B-treatment
therapy 6 13 4347 4354 I-treatment
for 14 17 4355 4358 O
metastatic 18 28 4359 4369 B-cancer
disease 29 36 4370 4377 I-cancer

Repeat 0 6 4378 4384 O
imaging 7 14 4385 4392 O
demonstrates 15 27 4393 4405 O
no 28 30 4406 4408 O
new 31 34 4409 4412 O
sites 35 40 4413 4418 O
of 41 43 4419 4421 O
bone 44 48 4422 4426 B-cancer
metastases 49 59 4427 4437 I-cancer

Serum 0 5 4438 4443 B-clinical_variable
albumin 6 13 4444 4451 I-clinical_variable
> 14 15 4452 4453 O
= 15 16 4453 4454 O
2.8 17 20 4455 4458 B-lower_bound
g 21 22 4459 4460 I-lower_bound
/ 22 23 4460 4461 I-lower_bound
dL 23 25 4461 4463 I-lower_bound
( 26 27 4464 4465 O
within 27 33 4465 4471 O
2 34 35 4472 4473 B-upper_bound
weeks 36 41 4474 4479 I-upper_bound
prior 42 47 4480 4485 I-upper_bound
to 48 50 4486 4488 O
enrollment 51 61 4489 4499 O
) 61 62 4499 4500 O

Serum 0 5 4501 4506 B-clinical_variable
lipase 6 12 4507 4513 I-clinical_variable
and 13 16 4514 4517 I-clinical_variable
amylase 17 24 4518 4525 I-clinical_variable
< 25 26 4526 4527 O
1.5 27 30 4528 4531 B-upper_bound
x 31 32 4532 4533 I-upper_bound
ULN 33 36 4534 4537 I-upper_bound
( 37 38 4538 4539 O
within 38 44 4539 4545 O
2 45 46 4546 4547 B-upper_bound
weeks 47 52 4548 4553 I-upper_bound
prior 53 58 4554 4559 I-upper_bound
to 59 61 4560 4562 O
enrollment 62 72 4563 4573 O
) 72 73 4573 4574 O

Serum 0 5 4575 4580 B-clinical_variable
lipase 6 12 4581 4587 I-clinical_variable
and 13 16 4588 4591 I-clinical_variable
amylase 17 24 4592 4599 I-clinical_variable
< 25 26 4600 4601 O
1.5 27 30 4602 4605 B-upper_bound
x 31 32 4606 4607 I-upper_bound
ULN 33 36 4608 4611 I-upper_bound
( 37 38 4612 4613 O
within 38 44 4613 4619 O
2 45 46 4620 4621 B-upper_bound
weeks 47 52 4622 4627 I-upper_bound
prior 53 58 4628 4633 I-upper_bound
to 59 61 4634 4636 O
enrollment 62 72 4637 4647 O
) 72 73 4647 4648 O
( 74 75 4649 4650 O
participants 75 87 4650 4662 O
may 88 91 4663 4666 O
receive 92 99 4667 4674 O
GCSF 100 104 4675 4679 B-treatment
and 105 108 4680 4683 O
transfusions 109 121 4684 4696 O
to 122 124 4697 4699 O
meet 125 129 4700 4704 O
these 130 135 4705 4710 O
parameters 136 146 4711 4721 O
) 146 147 4721 4722 O

Solid 0 5 4723 4728 B-cancer
Tumor 6 11 4729 4734 I-cancer
Expansion 12 21 4735 4744 O
Cohort 22 28 4745 4751 O
: 28 29 4751 4752 O
CD4 30 33 4753 4756 B-clinical_variable
+ 33 34 4756 4757 I-clinical_variable
cell 35 39 4758 4762 I-clinical_variable
count 40 45 4763 4768 I-clinical_variable
greater 46 53 4769 4776 O
than 54 58 4777 4781 O
200 59 62 4782 4785 B-lower_bound
cells 63 68 4786 4791 I-lower_bound
/ 68 69 4791 4792 I-lower_bound
mm^3 69 73 4792 4796 I-lower_bound
obtained 74 82 4797 4805 O
within 83 89 4806 4812 O
2 90 91 4813 4814 B-upper_bound
weeks 92 97 4815 4820 I-upper_bound
prior 98 103 4821 4826 I-upper_bound
to 104 106 4827 4829 O
enrollment 107 117 4830 4840 O
at 118 120 4841 4843 O
any 121 124 4844 4847 O
U.S. 125 129 4848 4852 O
laboratory 130 140 4853 4863 O
that 141 145 4864 4868 O
has 146 149 4869 4872 O
a 150 151 4873 4874 O
clinical 152 160 4875 4883 O
laboratory 161 171 4884 4894 O
improvement 172 183 4895 4906 O
amendments 184 194 4907 4917 O
( 195 196 4918 4919 O
CLIA 196 200 4919 4923 O
) 200 201 4923 4924 O
certification 202 215 4925 4938 O
or 216 218 4939 4941 O
its 219 222 4942 4945 O
equivalent 223 233 4946 4956 O

The 0 3 4957 4960 O
effects 4 11 4961 4968 O
of 12 14 4969 4971 O
nivolumab 15 24 4972 4981 B-treatment
and 25 28 4982 4985 O
ipilimumab 29 39 4986 4996 B-treatment
on 40 42 4997 4999 O
the 43 46 5000 5003 O
developing 47 57 5004 5014 O
human 58 63 5015 5020 O
fetus 64 69 5021 5026 O
are 70 73 5027 5030 O
unknown 74 81 5031 5038 O
; 81 82 5038 5039 O
for 83 86 5040 5043 O
this 87 91 5044 5048 O
reason 92 98 5049 5055 O
and 99 102 5056 5059 O
because 103 110 5060 5067 O
other 111 116 5068 5073 O
therapeutic 117 128 5074 5085 B-treatment
agents 129 135 5086 5092 I-treatment
used 136 140 5093 5097 O
in 141 143 5098 5100 O
this 144 148 5101 5105 O
trial 149 154 5106 5111 O
are 155 158 5112 5115 O
known 159 164 5116 5121 O
to 165 167 5122 5124 O
be 168 170 5125 5127 O
teratogenic 171 182 5128 5139 B-treatment
, 182 183 5139 5140 O
women 184 189 5141 5146 B-gender
of 190 192 5147 5149 O
childbearing 193 205 5150 5162 O
potential 206 215 5163 5172 O
( 216 217 5173 5174 O
WOCBP 217 222 5174 5179 O
) 222 223 5179 5180 O
and 224 227 5181 5184 O
men 228 231 5185 5188 O
must 232 236 5189 5193 O
agree 237 242 5194 5199 B-contraception_consent
to 243 245 5200 5202 I-contraception_consent
use 246 249 5203 5206 I-contraception_consent
adequate 250 258 5207 5215 I-contraception_consent
contraception 259 272 5216 5229 I-contraception_consent
( 273 274 5230 5231 O
hormonal 274 282 5231 5239 B-contraception_consent
or 283 285 5240 5242 I-contraception_consent
barrier 286 293 5243 5250 I-contraception_consent
method 294 300 5251 5257 I-contraception_consent
of 301 303 5258 5260 I-contraception_consent
birth 304 309 5261 5266 I-contraception_consent
control 310 317 5267 5274 I-contraception_consent
; 317 318 5274 5275 O
abstinence 319 329 5276 5286 B-contraception_consent
) 329 330 5286 5287 O
prior 331 336 5288 5293 O
to 337 339 5294 5296 O
study 340 345 5297 5302 O
entry 346 351 5303 5308 O
and 352 355 5309 5312 O
for 356 359 5313 5316 O
the 360 363 5317 5320 O
duration 364 372 5321 5329 O
of 373 375 5330 5332 O
study 376 381 5333 5338 O
participation 382 395 5339 5352 O
; 395 396 5352 5353 O
WOCBP 397 402 5354 5359 O
should 403 409 5360 5366 O
use 410 413 5367 5370 O
an 414 416 5371 5373 O
adequate 417 425 5374 5382 O
method 426 432 5383 5389 O
to 433 435 5390 5392 O
avoid 436 441 5393 5398 O
pregnancy 442 451 5399 5408 B-pregnancy
for 452 455 5409 5412 O
6 456 457 5413 5414 B-upper_bound
months 458 464 5415 5421 I-upper_bound
after 465 470 5422 5427 I-upper_bound
the 471 474 5428 5431 O
last 475 479 5432 5436 O
dose 480 484 5437 5441 O
of 485 487 5442 5444 O
investigational 488 503 5445 5460 B-treatment
drug 504 508 5461 5465 I-treatment

The 0 3 5466 5469 O
lesion 4 10 5470 5476 O
being 11 16 5477 5482 O
considered 17 27 5483 5493 O
for 28 31 5494 5497 O
palliative 32 42 5498 5508 B-treatment
radiation 43 52 5509 5518 I-treatment
is 53 55 5519 5521 O
not 56 59 5522 5525 O
a 60 61 5526 5527 O
target 62 68 5528 5534 O
lesion 69 75 5535 5541 O

Total 0 5 5542 5547 B-clinical_variable
bilirubin 6 15 5548 5557 I-clinical_variable
= 16 17 5558 5559 O
< 17 18 5559 5560 O
1.5 19 22 5561 5564 B-upper_bound
x 23 24 5565 5566 I-upper_bound
institutional 25 38 5567 5580 I-upper_bound
upper 39 44 5581 5586 I-upper_bound
limit 45 50 5587 5592 I-upper_bound
of 51 53 5593 5595 I-upper_bound
normal 54 60 5596 5602 I-upper_bound
( 61 62 5603 5604 I-upper_bound
ULN 62 65 5604 5607 I-upper_bound
) 65 66 5607 5608 I-upper_bound
= 67 68 5609 5610 O
< 68 69 5610 5611 O
3 70 71 5612 5613 B-upper_bound
x 72 73 5614 5615 I-upper_bound
ULN 74 77 5616 5619 I-upper_bound
for 78 81 5620 5623 O
subjects 82 90 5624 5632 O
with 91 95 5633 5637 O
Gilbert 96 103 5638 5645 B-chronic_disease
's 103 105 5645 5647 I-chronic_disease
disease 106 113 5648 5655 I-chronic_disease
or 114 116 5656 5658 O
with 117 121 5659 5663 O
atazanavir- 122 133 5664 5675 B-treatment
or 134 136 5676 5678 O
indinavir 137 146 5679 5688 B-treatment
- 146 147 5688 5689 O
induced 147 154 5689 5696 O
unconjugated 155 167 5697 5709 O
hyperbilirubinemia 168 186 5710 5728 B-chronic_disease
without 187 194 5729 5736 O
aspartate 195 204 5737 5746 O
aminotransferase 205 221 5747 5763 O
( 222 223 5764 5765 O
AST 223 226 5765 5768 O
) 226 227 5768 5769 O
or 228 230 5770 5772 O
alanine 231 238 5773 5780 O
aminotransferase 239 255 5781 5797 O
( 256 257 5798 5799 O
ALT 257 260 5799 5802 O
) 260 261 5802 5803 O
elevation 262 271 5804 5813 O
and 272 275 5814 5817 O
must 276 280 5818 5822 O
have 281 285 5823 5827 O
a 286 287 5828 5829 O
total 288 293 5830 5835 B-clinical_variable
bilirubin 294 303 5836 5845 I-clinical_variable
less 304 308 5846 5850 O
than 309 313 5851 5855 O
3.0 314 317 5856 5859 B-upper_bound
mg 318 320 5860 5862 I-upper_bound
/ 320 321 5862 5863 I-upper_bound
dL 321 323 5863 5865 I-upper_bound
( 324 325 5866 5867 O
within 325 331 5867 5873 O
2 332 333 5874 5875 B-upper_bound
weeks 334 339 5876 5881 I-upper_bound
prior 340 345 5882 5887 I-upper_bound
to 346 348 5888 5890 O
enrollment 349 359 5891 5901 O
) 359 360 5901 5902 O

Total 0 5 5903 5908 B-clinical_variable
bilirubin 6 15 5909 5918 I-clinical_variable
: 15 16 5918 5919 O
= 17 18 5920 5921 O
< 18 19 5921 5922 O
1.5 19 22 5922 5925 B-upper_bound
x 23 24 5926 5927 I-upper_bound
institutional 25 38 5928 5941 I-upper_bound
upper 39 44 5942 5947 I-upper_bound
limit 45 50 5948 5953 I-upper_bound
of 51 53 5954 5956 I-upper_bound
normal 54 60 5957 5963 I-upper_bound
( 61 62 5964 5965 I-upper_bound
ULN 62 65 5965 5968 I-upper_bound
) 65 66 5968 5969 I-upper_bound
, 66 67 5969 5970 O
or 68 70 5971 5973 O
= 71 72 5974 5975 O
< 72 73 5975 5976 O
3 74 75 5977 5978 B-upper_bound
x 76 77 5979 5980 I-upper_bound
ULN 78 81 5981 5984 I-upper_bound
for 82 85 5985 5988 O
participants 86 98 5989 6001 O
with 99 103 6002 6006 O
Gilbert 104 111 6007 6014 B-chronic_disease
's 111 113 6014 6016 I-chronic_disease
disease 114 121 6017 6024 I-chronic_disease
or 122 124 6025 6027 O
with 125 129 6028 6032 O
atazanavir- 130 141 6033 6044 B-treatment
or 142 144 6045 6047 O
indinavir 145 154 6048 6057 B-treatment
- 154 155 6057 6058 O
induced 155 162 6058 6065 O
unconjugated 163 175 6066 6078 B-treatment
hyperbilirubinemia 176 194 6079 6097 I-treatment
without 195 202 6098 6105 O
AST 203 206 6106 6109 B-clinical_variable
or 207 209 6110 6112 O
ALT 210 213 6113 6116 B-clinical_variable
elevation 214 223 6117 6126 O
, 223 224 6126 6127 O
and 225 228 6128 6131 O
must 229 233 6132 6136 O
have 234 238 6137 6141 O
a 239 240 6142 6143 O
total 241 246 6144 6149 B-clinical_variable
bilirubin 247 256 6150 6159 I-clinical_variable
less 257 261 6160 6164 O
than 262 266 6165 6169 O
3.0 267 270 6170 6173 B-upper_bound
mg 271 273 6174 6176 I-upper_bound
/ 273 274 6176 6177 I-upper_bound
dL 274 276 6177 6179 I-upper_bound
) 276 277 6179 6180 O
( 278 279 6181 6182 O
within 279 285 6182 6188 O
2 286 287 6189 6190 B-upper_bound
weeks 288 293 6191 6196 I-upper_bound
prior 294 299 6197 6202 I-upper_bound
to 300 302 6203 6205 O
enrollment 303 313 6206 6216 O
) 313 314 6216 6217 O
( 315 316 6218 6219 O
participants 316 328 6219 6231 O
may 329 332 6232 6235 O
receive 333 340 6236 6243 O
GCSF 341 345 6244 6248 O
and 346 349 6249 6252 O
transfusions 350 362 6253 6265 O
to 363 365 6266 6268 O
meet 366 370 6269 6273 O
these 371 376 6274 6279 O
parameters 377 387 6280 6290 O
) 387 388 6290 6291 O

Uncontrolled 0 12 6292 6304 O
intercurrent 13 25 6305 6317 O
illness 26 33 6318 6325 O
including 34 43 6326 6335 O
, 43 44 6335 6336 O
but 45 48 6337 6340 O
not 49 52 6341 6344 O
limited 53 60 6345 6352 O
to 61 63 6353 6355 O
, 63 64 6355 6356 O
ongoing 65 72 6357 6364 O
or 73 75 6365 6367 O
active 76 82 6368 6374 B-chronic_disease
infection 83 92 6375 6384 I-chronic_disease
, 92 93 6384 6385 O
symptomatic 94 105 6386 6397 O
congestive 106 116 6398 6408 B-chronic_disease
heart 117 122 6409 6414 I-chronic_disease
failure 123 130 6415 6422 I-chronic_disease
, 130 131 6422 6423 O
unstable 132 140 6424 6432 B-chronic_disease
angina 141 147 6433 6439 I-chronic_disease
pectoris 148 156 6440 6448 O
, 156 157 6448 6449 O
cardiac 158 165 6450 6457 B-chronic_disease
arrhythmia 166 176 6458 6468 I-chronic_disease
, 176 177 6468 6469 O
or 178 180 6470 6472 O
psychiatric 181 192 6473 6484 O
illness 193 200 6485 6492 I-chronic_disease
/ 200 201 6492 6493 O
social 201 207 6493 6499 O
situations 208 218 6500 6510 O
that 219 223 6511 6515 O
would 224 229 6516 6521 O
limit 230 235 6522 6527 O
compliance 236 246 6528 6538 O
with 247 251 6539 6543 O
study 252 257 6544 6549 O
requirements 258 270 6550 6562 O

WOCBP 0 5 6563 6568 O
receiving 6 15 6569 6578 O
nivolumab 16 25 6579 6588 B-treatment
will 26 30 6589 6593 O
be 31 33 6594 6596 O
instructed 34 44 6597 6607 O
to 45 47 6608 6610 O
adhere 48 54 6611 6617 B-contraception_consent
to 55 57 6618 6620 I-contraception_consent
contraception 58 71 6621 6634 I-contraception_consent
for 72 75 6635 6638 O
a 76 77 6639 6640 O
period 78 84 6641 6647 O
of 85 87 6648 6650 O
6 88 89 6651 6652 B-upper_bound
months 90 96 6653 6659 I-upper_bound
after 97 102 6660 6665 I-upper_bound
the 103 106 6666 6669 O
last 107 111 6670 6674 O
dose 112 116 6675 6679 O
of 117 119 6680 6682 O
investigational 120 135 6683 6698 O
product 136 143 6699 6706 O

a 0 1 6707 6708 O
brief 2 7 6709 6714 O
course 8 14 6715 6721 O
of 15 17 6722 6724 O
corticosteroids 18 33 6725 6740 B-treatment
for 34 37 6741 6744 I-treatment
prophylaxis 38 49 6745 6756 I-treatment
( 50 51 6757 6758 O
e.g. 51 55 6758 6762 O
, 55 56 6762 6763 O
contrast 57 65 6764 6772 O
dye 66 69 6773 6776 B-allergy_name
allergy 70 77 6777 6784 I-allergy_name
) 77 78 6784 6785 O
or 79 81 6786 6788 O
for 82 85 6789 6792 O
treatment 86 95 6793 6802 B-treatment
of 96 98 6803 6805 O
non 99 102 6806 6809 O
- 102 103 6809 6810 O
autoimmune 103 113 6810 6820 O
conditions 114 124 6821 6831 O
( 125 126 6832 6833 O
e.g. 126 130 6833 6837 O
, 130 131 6837 6838 O
delayed 132 139 6839 6846 O
- 139 140 6846 6847 O
type 140 144 6847 6851 O
hypersensitivity 145 161 6852 6868 O
reaction 162 170 6869 6877 O
caused 171 177 6878 6884 O
by 178 180 6885 6887 O
contact 181 188 6888 6895 B-clinical_variable
allergen 189 197 6896 6904 I-clinical_variable
) 197 198 6904 6905 O

anabolic 0 8 6906 6914 B-treatment
steroids 9 17 6915 6923 I-treatment

delayed 0 7 6924 6931 O
- 7 8 6931 6932 O
type 8 12 6932 6936 O
hypersensitivity 13 29 6937 6953 O
reaction 30 38 6954 6962 O
caused 39 45 6963 6969 O
by 46 48 6970 6972 O
contact 49 56 6973 6980 B-allergy_name
allergen 57 65 6981 6989 I-allergy_name

for 0 3 6990 6993 O
participants 4 16 6994 7006 O
with 17 21 7007 7011 O
Kaposi 22 28 7012 7018 B-cancer
sarcoma 29 36 7019 7026 I-cancer
, 36 37 7026 7027 O
the 38 41 7028 7031 O
following 42 51 7032 7041 O
apply 52 57 7042 7047 O
: 57 58 7047 7048 O
at 59 61 7049 7051 O
least 62 67 7052 7057 O
five 68 72 7058 7062 B-lower_bound
measurable 73 83 7063 7073 O
cutaneous 84 93 7074 7083 O
KS 94 96 7084 7086 O
lesions 97 104 7087 7094 O
or 105 107 7095 7097 O
any 108 111 7098 7101 O
number 112 118 7102 7108 O
of 119 121 7109 7111 O
lesions 122 129 7112 7119 O
with 130 134 7120 7124 O
systemic 135 143 7125 7133 O
unresectable 144 156 7134 7146 O
disease 157 164 7147 7154 O
with 165 169 7155 7159 O
no 170 172 7160 7162 O
previous 173 181 7163 7171 B-treatment
local 182 187 7172 7177 I-treatment
radiation 188 197 7178 7187 I-treatment
, 197 198 7187 7188 O
surgical 199 207 7189 7197 B-treatment
, 207 208 7197 7198 O
or 209 211 7199 7201 O
intralesional 212 225 7202 7215 B-treatment
cytotoxic 226 235 7216 7225 I-treatment
therapy 236 243 7226 7233 I-treatment
that 244 248 7234 7238 O
would 249 254 7239 7244 O
prevent 255 262 7245 7252 O
response 263 271 7253 7261 O
assessment 272 282 7262 7272 O

men 0 3 7273 7276 B-gender
receiving 4 13 7277 7286 O
nivolumab 14 23 7287 7296 B-treatment
and 24 27 7297 7300 O
who 28 31 7301 7304 O
are 32 35 7305 7308 O
sexually 36 44 7309 7317 O
active 45 51 7318 7324 O
with 52 56 7325 7329 O
WOCBP 57 62 7330 7335 O
will 63 67 7336 7340 O
be 68 70 7341 7343 O
instructed 71 81 7344 7354 O
to 82 84 7355 7357 O
adhere 85 91 7358 7364 B-contraception_consent
to 92 94 7365 7367 I-contraception_consent
contraception 95 108 7368 7381 I-contraception_consent
for 109 112 7382 7385 O
a 113 114 7386 7387 O
period 115 121 7388 7394 O
of 122 124 7395 7397 O
31 125 127 7398 7400 B-upper_bound
weeks 128 133 7401 7406 I-upper_bound
after 134 139 7407 7412 I-upper_bound
the 140 143 7413 7416 O
last 144 148 7417 7421 O
dose 149 153 7422 7426 O
of 154 156 7427 7429 O
investigational 157 172 7430 7445 B-treatment
product 173 180 7446 7453 I-treatment

men 0 3 7454 7457 B-gender
who 4 7 7458 7461 O
are 8 11 7462 7465 O
sexually 12 20 7466 7474 O
active 21 27 7475 7481 O
with 28 32 7482 7486 O
WOCBP 33 38 7487 7492 O
must 39 43 7493 7497 O
use 44 47 7498 7501 B-contraception_consent
any 48 51 7502 7505 I-contraception_consent
contraceptive 52 65 7506 7519 I-contraception_consent
method 66 72 7520 7526 I-contraception_consent
with 73 77 7527 7531 O
a 78 79 7532 7533 O
failure 80 87 7534 7541 B-clinical_variable
rate 88 92 7542 7546 I-clinical_variable
of 93 95 7547 7549 O
less 96 100 7550 7554 O
than 101 105 7555 7559 O
1 106 107 7560 7561 B-upper_bound
% 107 108 7561 7562 I-upper_bound
per 109 112 7563 7566 I-upper_bound
year 113 117 7567 7571 I-upper_bound

palliative 0 10 7572 7582 B-treatment
( 11 12 7583 7584 I-treatment
limited 12 19 7584 7591 I-treatment
- 19 20 7591 7592 I-treatment
field 20 25 7592 7597 I-treatment
) 25 26 7597 7598 I-treatment
radiation 27 36 7599 7608 I-treatment
therapy 37 44 7609 7616 I-treatment

participants 0 12 7617 7629 O
will 13 17 7630 7634 O
be 18 20 7635 7637 O
eligible 21 29 7638 7646 O
regardless 30 40 7647 7657 O
of 41 43 7658 7660 O
antiretroviral 44 58 7661 7675 B-treatment
medication 59 69 7676 7686 I-treatment
( 70 71 7687 7688 O
including 71 80 7688 7697 O
no 81 83 7698 7700 O
antiretroviral 84 98 7701 7715 O
medication 99 109 7716 7726 O
) 109 110 7726 7727 O
provided 111 119 7728 7736 O
there 120 125 7737 7742 O
is 126 128 7743 7745 O
no 129 131 7746 7748 O
intention 132 141 7749 7758 O
to 142 144 7759 7761 O
initiate 145 153 7762 7770 O
therapy 154 161 7771 7778 B-treatment
or 162 164 7779 7781 O
the 165 168 7782 7785 O
regimen 169 176 7786 7793 B-treatment
has 177 180 7794 7797 O
been 181 185 7798 7802 O
stable 186 192 7803 7809 O
for 193 196 7810 7813 O
at 197 199 7814 7816 O
least 200 205 7817 7822 O
4 206 207 7823 7824 B-lower_bound
weeks 208 213 7825 7830 I-lower_bound
with 214 218 7831 7835 O
no 219 221 7836 7838 O
intention 222 231 7839 7848 O
to 232 234 7849 7851 O
change 235 241 7852 7858 O
the 242 245 7859 7862 O
regimen 246 253 7863 7870 O
within 254 260 7871 7877 O
12 261 263 7878 7880 B-upper_bound
weeks 264 269 7881 7886 I-upper_bound
following 270 279 7887 7896 O
enrollment 280 290 7897 7907 O

participants 0 12 7908 7920 O
with 13 17 7921 7925 O
uncontrolled 18 30 7926 7938 O
Kaposi 31 37 7939 7945 B-cancer
sarcoma 38 45 7946 7953 I-cancer
are 46 49 7954 7957 O
permitted 50 59 7958 7967 O
( 60 61 7968 7969 O
KS 61 63 7969 7971 B-cancer
must 64 68 7972 7976 O
be 69 71 7977 7979 O
increasing 72 82 7980 7990 O
despite 83 90 7991 7998 O
HAART 91 96 7999 8004 B-treatment
and 97 100 8005 8008 O
HIV 101 104 8009 8012 B-treatment
suppression 105 116 8013 8024 I-treatment
for 117 120 8025 8028 O
greater 121 128 8029 8036 O
than 129 133 8037 8041 O
or 134 136 8042 8044 O
equal 137 142 8045 8050 O
to 143 145 8051 8053 O
2 146 147 8054 8055 B-lower_bound
months 148 154 8056 8062 I-lower_bound
, 154 155 8062 8063 O
or 156 158 8064 8066 O
stable 159 165 8067 8073 O
KS 166 168 8074 8076 O
despite 169 176 8077 8084 O
HAART 177 182 8085 8090 O
for 183 186 8091 8094 O
greater 187 194 8095 8102 O
than 195 199 8103 8107 O
or 200 202 8108 8110 O
equal 203 208 8111 8116 O
to 209 211 8117 8119 O
3 212 213 8120 8121 B-lower_bound
months 214 220 8122 8128 I-lower_bound

radiotherapy 0 12 8129 8141 B-treatment
must 13 17 8142 8146 O
be 18 20 8147 8149 O
completed 21 30 8150 8159 O
at 31 33 8160 8162 O
least 34 39 8163 8168 O
4 40 41 8169 8170 B-lower_bound
weeks 42 47 8171 8176 I-lower_bound
prior 48 53 8177 8182 I-lower_bound
to 54 56 8183 8185 O
registration 57 69 8186 8198 O

scans 0 5 8199 8204 O
must 6 10 8205 8209 O
have 11 15 8210 8214 O
been 16 20 8215 8219 O
performed 21 30 8220 8229 O
within 31 37 8230 8236 O
4 38 39 8237 8238 B-upper_bound
weeks 40 45 8239 8244 I-upper_bound
prior 46 51 8245 8250 I-upper_bound
to 52 54 8251 8253 O
registration 55 67 8254 8266 O

the 0 3 8267 8270 O
referring 4 13 8271 8280 O
physician 14 23 8281 8290 O
's 23 25 8290 8292 O
written 26 33 8293 8300 O
record 34 40 8301 8307 O
that 41 45 8308 8312 O
HIV 46 49 8313 8316 B-chronic_disease
infection 50 59 8317 8326 I-chronic_disease
was 60 63 8327 8330 O
documented 64 74 8331 8341 O
, 74 75 8341 8342 O
with 76 80 8343 8347 O
supporting 81 91 8348 8358 O
information 92 103 8359 8370 O
on 104 106 8371 8373 O
the 107 110 8374 8377 O
participant 111 122 8378 8389 O
's 122 124 8389 8391 O
relevant 125 133 8392 8400 O
medical 134 141 8401 8408 O
history 142 149 8409 8416 O
and/or 150 156 8417 8423 O
current 157 164 8424 8431 O
management 165 175 8432 8442 O
of 176 178 8443 8445 O
HIV 179 182 8446 8449 O
infection 183 192 8450 8459 O

the 0 3 8460 8463 O
result 4 10 8464 8470 O
must 11 15 8471 8475 O
be 16 18 8476 8478 O
obtained 19 27 8479 8487 O
within 28 34 8488 8494 O
12 35 37 8495 8497 O
weeks 38 43 8498 8503 O
prior 44 49 8504 8509 O
to 50 52 8510 8512 O
enrollment 53 63 8513 8523 O
; 63 64 8523 8524 O
PPD 65 68 8525 8528 B-chronic_disease
positive 69 77 8529 8537 O
( 78 79 8538 8539 O
or 79 81 8539 8541 O
Quantiferon 82 93 8542 8553 O
assay 94 99 8554 8559 O
positive 100 108 8560 8568 O
) 108 109 8568 8569 O
participants 110 122 8570 8582 O
are 123 126 8583 8586 O
permitted 127 136 8587 8596 O
if 137 139 8597 8599 O
prophylaxis 140 151 8600 8611 B-treatment
has 152 155 8612 8615 O
been 156 160 8616 8620 O
completed 161 170 8621 8630 O
prior 171 176 8631 8636 O
to 177 179 8637 8639 O
enrollment 180 190 8640 8650 O

use 0 3 8651 8654 O
of 4 6 8655 8657 O
anabolic 7 15 8658 8666 B-treatment
steroids 16 24 8667 8675 I-treatment

women 0 5 8676 8681 B-gender
must 6 10 8682 8686 O
not 11 14 8687 8690 O
be 15 17 8691 8693 O
breastfeeding 18 31 8694 8707 O

women 0 5 8708 8713 B-gender
of 6 8 8714 8716 O
childbearing 9 21 8717 8729 O
potential 22 31 8730 8739 O
must 32 36 8740 8744 O
have 37 41 8745 8749 O
a 42 43 8750 8751 O
negative 44 52 8752 8760 B-pregnancy
serum 53 58 8761 8766 I-pregnancy
or 59 61 8767 8769 I-pregnancy
urine 62 67 8770 8775 I-pregnancy
pregnancy 68 77 8776 8785 I-pregnancy
test 78 82 8786 8790 O
( 83 84 8791 8792 O
minimum 84 91 8792 8799 O
sensitivity 92 103 8800 8811 O
25 104 106 8812 8814 B-lower_bound
IU 107 109 8815 8817 I-lower_bound
/ 109 110 8817 8818 I-lower_bound
L 110 111 8818 8819 I-lower_bound
or 112 114 8820 8822 O
equivalent 115 125 8823 8833 O
units 126 131 8834 8839 O
of 132 134 8840 8842 O
human 135 140 8843 8848 O
chorionic 141 150 8849 8858 O
gonadotropic 151 163 8859 8871 O
[ 164 165 8872 8873 O
HCG 165 168 8873 8876 B-clinical_variable
] 168 169 8876 8877 O
) 169 170 8877 8878 O
within 171 177 8879 8885 O
72 178 180 8886 8888 B-upper_bound
hours 181 186 8889 8894 I-upper_bound
prior 187 192 8895 8900 I-upper_bound
enrollment 193 203 8901 8911 O
and 204 207 8912 8915 O
the 208 211 8916 8919 O
start 212 217 8920 8925 O
of 218 220 8926 8928 O
nivolumab 221 230 8929 8938 B-treatment

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
including 17 26 17 26 O
tuberculosis 27 39 27 39 B-chronic_disease
, 39 40 39 40 O
hepatitis 41 50 41 50 B-chronic_disease
B 51 52 51 52 I-chronic_disease
, 52 53 52 53 O
hepatitis 54 63 54 63 B-chronic_disease
C 64 65 64 65 I-chronic_disease
, 65 66 65 66 O
or 67 69 67 69 O
human 70 75 70 75 B-chronic_disease
immunodeficiency 76 92 76 92 I-chronic_disease
virus 93 98 93 98 I-chronic_disease
( 99 100 99 100 I-chronic_disease
HIV 100 103 100 103 I-chronic_disease
) 103 104 103 104 I-chronic_disease

Active 0 6 105 111 O
or 7 9 112 114 O
prior 10 15 115 120 O
documented 16 26 121 131 O
autoimmune 27 37 132 142 B-chronic_disease
or 38 40 143 145 O
inflammatory 41 53 146 158 B-chronic_disease
disorders 54 63 159 168 I-chronic_disease
. 63 64 168 169 O
The 65 68 170 173 O
following 69 78 174 183 O
are 79 82 184 187 O
exceptions 83 93 188 198 O
to 94 96 199 201 O
this 97 101 202 206 O
criterion 102 111 207 216 O
: 111 112 216 217 O
• 113 114 218 219 O
Patients 115 123 220 228 O
with 124 128 229 233 O
vitiligo 129 137 234 242 B-chronic_disease
or 138 140 243 245 O
alopecia 141 149 246 254 B-chronic_disease
• 150 151 255 256 O
Patients 152 160 257 265 O
with 161 165 266 270 O
hypothyroidism 166 180 271 285 B-chronic_disease
( 181 182 286 287 O
eg 182 184 287 289 O
, 184 185 289 290 O
following 186 195 291 300 O
Hashimoto 196 205 301 310 B-chronic_disease
syndrome 206 214 311 319 I-chronic_disease
) 214 215 319 320 O
stable 216 222 321 327 O
on 223 225 328 330 O
hormone 226 233 331 338 B-treatment
replacement 234 245 339 350 I-treatment
• 246 247 351 352 O
Any 248 251 353 356 O
chronic 252 259 357 364 O
skin 260 264 365 369 O
condition 265 274 370 379 O
that 275 279 380 384 O
does 280 284 385 389 O
not 285 288 390 393 O
require 289 296 394 401 O
systemic 297 305 402 410 B-treatment
therapy 306 313 411 418 I-treatment
• 314 315 419 420 O
Patients 316 324 421 429 O
without 325 332 430 437 O
active 333 339 438 444 O
disease 340 347 445 452 O
in 348 350 453 455 O
the 351 354 456 459 O
last 355 359 460 464 B-upper_bound
3 360 361 465 466 I-upper_bound
years 362 367 467 472 I-upper_bound
may 368 371 473 476 O
be 372 374 477 479 O
included 375 383 480 488 O
but 384 387 489 492 O
only 388 392 493 497 O
after 393 398 498 503 O
consultation 399 411 504 516 O
with 412 416 517 521 O
AstraZeneca 417 428 522 533 O
• 429 430 534 535 O
Patients 431 439 536 544 O
with 440 444 545 549 O
celiac 445 451 550 556 B-chronic_disease
disease 452 459 557 564 I-chronic_disease
controlled 460 470 565 575 O
by 471 473 576 578 O
diet 474 478 579 583 O
alone 479 484 584 589 O
may 485 488 590 593 O
be 489 491 594 596 O
included 492 500 597 605 O
but 501 504 606 609 O
only 505 509 610 614 O
after 510 515 615 620 O
consultation 516 528 621 633 O
with 529 533 634 638 O
AstraZeneca 534 545 639 650 O

Brain 0 5 651 656 B-cancer
metastases 6 16 657 667 I-cancer
or 17 19 668 670 O
spinal 20 26 671 677 B-chronic_disease
cord 27 31 678 682 I-chronic_disease
compression 32 43 683 694 I-chronic_disease
unless 44 50 695 701 O
the 51 54 702 705 O
patient 55 62 706 713 O
's 62 64 713 715 O
condition 65 74 716 725 O
is 75 77 726 728 O
stable 78 84 729 735 O
and 85 88 736 739 O
off 89 92 740 743 O
steroids 93 101 744 752 B-treatment
for 102 105 753 756 O
at 106 108 757 759 O
least 109 114 760 765 O
14 115 117 766 768 B-lower_bound
days 118 122 769 773 I-lower_bound
prior 123 128 774 779 I-lower_bound
to 129 131 780 782 O
the 132 135 783 786 O
start 136 141 787 792 O
of 142 144 793 795 O
study 145 150 796 801 B-treatment
treatment 151 160 802 811 I-treatment
. 160 161 811 812 O
Patients 162 170 813 821 O
with 171 175 822 826 O
suspected 176 185 827 836 O
or 186 188 837 839 O
known 189 194 840 845 O
brain 195 200 846 851 B-cancer
metastases 201 211 852 862 I-cancer
at 212 214 863 865 O
screening 215 224 866 875 O
should 225 231 876 882 O
have 232 236 883 887 O
an 237 239 888 890 O
MRI 240 243 891 894 B-treatment
( 244 245 895 896 O
preferred)/CT 245 258 896 909 O
, 258 259 909 910 O
preferably 260 270 911 921 O
with 271 275 922 926 O
IV 276 278 927 929 O
contrast 279 287 930 938 O
to 288 290 939 941 O
access 291 297 942 948 O
baseline 298 306 949 957 O
disease 307 314 958 965 O
status 315 321 966 972 O

Creatinine 0 10 973 983 B-clinical_variable
clearance 11 20 984 993 I-clinical_variable
( 21 22 994 995 O
calculated 22 32 995 1005 O
or 33 35 1006 1008 O
measured 36 44 1009 1017 O
) 44 45 1017 1018 O
< 46 47 1019 1020 O
60 47 49 1020 1022 B-upper_bound
mL 50 52 1023 1025 I-upper_bound
/ 52 53 1025 1026 I-upper_bound
min 53 56 1026 1029 I-upper_bound
calculated 57 67 1030 1040 O
by 68 70 1041 1043 O
Cockcroft 71 80 1044 1053 O
- 80 81 1053 1054 O
Gault 81 86 1054 1059 O
equation 87 95 1060 1068 O
( 96 97 1069 1070 O
using 97 102 1070 1075 O
actual 103 109 1076 1082 O
body 110 114 1083 1087 O
weight 115 121 1088 1094 O
) 121 122 1094 1095 O
or 123 125 1096 1098 O
by 126 128 1099 1101 O
measured 129 137 1102 1110 O
24 138 140 1111 1113 B-lower_bound
- 140 141 1113 1114 O
hour 141 145 1114 1118 O
urine 146 151 1119 1124 O
collection 152 162 1125 1135 O
for 163 166 1136 1139 O
determination 167 180 1140 1153 O
• 181 182 1154 1155 O
Common 183 189 1156 1162 B-clinical_variable
Terminology 190 201 1163 1174 I-clinical_variable
Criteria 202 210 1175 1183 I-clinical_variable
for 211 214 1184 1187 I-clinical_variable
Adverse 215 222 1188 1195 I-clinical_variable
Events 223 229 1196 1202 I-clinical_variable
( 230 231 1203 1204 I-clinical_variable
CTCAE 231 236 1204 1209 I-clinical_variable
) 236 237 1209 1210 I-clinical_variable
Grade 238 243 1211 1216 I-clinical_variable
≥2 244 246 1217 1219 O
audiometric 247 258 1220 1231 O
hearing 259 266 1232 1239 B-chronic_disease
loss 267 271 1240 1244 I-chronic_disease
• 272 273 1245 1246 O
CTCAE 274 279 1247 1252 B-clinical_variable
Grade 280 285 1253 1258 I-clinical_variable
≥2 286 288 1259 1261 O
peripheral 289 299 1262 1272 B-chronic_disease
neuropathy 300 310 1273 1283 I-chronic_disease
• 311 312 1284 1285 O
New 313 316 1286 1289 O
York 317 321 1290 1294 O
Heart 322 327 1295 1300 O
Association 328 339 1301 1312 O
≥Class 340 346 1313 1319 O
III 347 350 1320 1323 I-lower_bound
heart 351 356 1324 1329 B-chronic_disease
failure 357 364 1330 1337 I-chronic_disease

Current 0 7 1338 1345 O
or 8 10 1346 1348 O
prior 11 16 1349 1354 O
use 17 20 1355 1358 O
of 21 23 1359 1361 O
immunosuppressive 24 41 1362 1379 B-treatment
medication 42 52 1380 1390 I-treatment
within 53 59 1391 1397 O
14 60 62 1398 1400 B-upper_bound
days 63 67 1401 1405 I-upper_bound
before 68 74 1406 1412 O
the 75 78 1413 1416 O
first 79 84 1417 1422 O
dose 85 89 1423 1427 O
of 90 92 1428 1430 O
investigational 93 108 1431 1446 B-treatment
product 109 116 1447 1454 I-treatment
( 117 118 1455 1456 I-treatment
IP 118 120 1456 1458 I-treatment
) 120 121 1458 1459 I-treatment
. 121 122 1459 1460 O
The 123 126 1461 1464 O
following 127 136 1465 1474 O
are 137 140 1475 1478 O
exceptions 141 151 1479 1489 O
to 152 154 1490 1492 O
this 155 159 1493 1497 O
criterion 160 169 1498 1507 O
: 169 170 1507 1508 O
• 171 172 1509 1510 O
Intranasal 173 183 1511 1521 B-treatment
, 183 184 1521 1522 O
inhaled 185 192 1523 1530 B-treatment
, 192 193 1530 1531 O
topical 194 201 1532 1539 B-treatment
steroids 202 210 1540 1548 I-treatment
, 210 211 1548 1549 O
or 212 214 1550 1552 O
local 215 220 1553 1558 B-treatment
steroid 221 228 1559 1566 I-treatment
injections 229 239 1567 1577 I-treatment
( 240 241 1578 1579 O
eg 241 243 1579 1581 O
, 243 244 1581 1582 O
intra 245 250 1583 1588 B-treatment
articular 251 260 1589 1598 I-treatment
injection 261 270 1599 1608 I-treatment
) 270 271 1608 1609 O
• 272 273 1610 1611 O
Systemic 274 282 1612 1620 B-treatment
corticosteroids 283 298 1621 1636 I-treatment
at 299 301 1637 1639 O
physiologic 302 313 1640 1651 B-treatment
doses 314 319 1652 1657 I-treatment
not 320 323 1658 1661 O
to 324 326 1662 1664 O
exceed 327 333 1665 1671 O
10 334 336 1672 1674 B-upper_bound
mg 337 339 1675 1677 I-upper_bound
/ 339 340 1677 1678 O
day 340 343 1678 1681 O
of 344 346 1682 1684 O
prednisone 347 357 1685 1695 B-treatment
or 358 360 1696 1698 O
its 361 364 1699 1702 O
equivalent 365 375 1703 1713 O
• 376 377 1714 1715 O
Steroids 378 386 1716 1724 B-treatment
as 387 389 1725 1727 O
premedication 390 403 1728 1741 O
for 404 407 1742 1745 O
hypersensitivity 408 424 1746 1762 O
reactions 425 434 1763 1772 O
( 435 436 1773 1774 O
eg 436 438 1774 1776 O
, 438 439 1776 1777 O
CT 440 442 1778 1780 B-treatment
scan 443 447 1781 1785 I-treatment
premedication 448 461 1786 1799 I-treatment
) 461 462 1799 1800 O

History 0 7 1801 1808 O
of 8 10 1809 1811 O
allogenic 11 20 1812 1821 B-treatment
organ 21 26 1822 1827 I-treatment
transplantation 27 42 1828 1843 I-treatment
that 43 47 1844 1848 O
requires 48 56 1849 1857 O
use 57 60 1858 1861 O
of 61 63 1862 1864 O
immunosuppressive 64 81 1865 1882 B-treatment
agents 82 88 1883 1889 I-treatment

Patients 0 8 1890 1898 O
eligible 9 17 1899 1907 O
or 18 20 1908 1910 O
ineligible 21 31 1911 1921 O
for 32 35 1922 1925 O
cisplatin 36 45 1926 1935 B-treatment
- 45 46 1935 1936 I-treatment
based 46 51 1936 1941 I-treatment
chemotherapy 52 64 1942 1954 I-treatment

Patients 0 8 1955 1963 O
with 9 13 1964 1968 O
histologically 14 28 1969 1983 O
or 29 31 1984 1986 O
cytologically 32 45 1987 2000 O
documented 46 56 2001 2011 O
, 56 57 2011 2012 O
unresectable 58 70 2013 2025 O
, 70 71 2025 2026 O
Stage 72 77 2027 2032 B-cancer
IV 78 80 2033 2035 I-cancer
transitional 81 93 2036 2048 I-cancer
cell 94 98 2049 2053 I-cancer
carcinoma 99 108 2054 2063 I-cancer
of 109 111 2064 2066 I-cancer
the 112 115 2067 2070 I-cancer
urothelium 116 126 2071 2081 I-cancer
who 127 130 2082 2085 O
have 131 135 2086 2090 O
not 136 139 2091 2094 O
been 140 144 2095 2099 O
previously 145 155 2100 2110 O
treated 156 163 2111 2118 O
with 164 168 2119 2123 O
first 169 174 2124 2129 B-treatment
- 174 175 2129 2130 I-treatment
line 175 179 2130 2134 I-treatment
chemotherapy 180 192 2135 2147 I-treatment

Prior 0 5 2148 2153 O
exposure 6 14 2154 2162 O
to 15 17 2163 2165 O
immune 18 24 2166 2172 B-treatment
- 24 25 2172 2173 I-treatment
mediated 25 33 2173 2181 I-treatment
therapy 34 41 2182 2189 I-treatment
, 41 42 2189 2190 O
including 43 52 2191 2200 O
but 53 56 2201 2204 O
not 57 60 2205 2208 O
limited 61 68 2209 2216 O
to 69 71 2217 2219 O
, 71 72 2219 2220 O
other 73 78 2221 2226 O
anti 79 83 2227 2231 B-treatment
cytotoxic 84 93 2232 2241 I-treatment
T 94 95 2242 2243 I-treatment
- 95 96 2243 2244 I-treatment
lymphocyte 96 106 2244 2254 I-treatment
- 106 107 2254 2255 I-treatment
associated 107 117 2255 2265 I-treatment
protein 118 125 2266 2273 I-treatment
4 126 127 2274 2275 I-treatment
( 128 129 2276 2277 I-treatment
CTLA 129 133 2277 2281 I-treatment
4 134 135 2282 2283 I-treatment
) 135 136 2283 2284 I-treatment
, 136 137 2284 2285 O
anti 138 142 2286 2290 B-treatment
- 142 143 2290 2291 I-treatment
PD-1 143 147 2291 2295 I-treatment
, 147 148 2295 2296 O
anti 149 153 2297 2301 B-treatment
- 153 154 2301 2302 I-treatment
PD 154 156 2302 2304 I-treatment
- 156 157 2304 2305 I-treatment
L1 157 159 2305 2307 I-treatment
, 159 160 2307 2308 O
or 161 163 2309 2311 O
anti 164 168 2312 2316 B-treatment
- 168 169 2316 2317 I-treatment
PD 169 171 2317 2319 I-treatment
- 171 172 2319 2320 I-treatment
L2 172 174 2320 2322 I-treatment
antibodies 175 185 2323 2333 I-treatment
, 185 186 2333 2334 O
including 187 196 2335 2344 O
therapeutic 197 208 2345 2356 B-treatment
anticancer 209 219 2357 2367 I-treatment
vaccines 220 228 2368 2376 I-treatment
. 228 229 2376 2377 O
Prior 230 235 2378 2383 O
local 236 241 2384 2389 O
intervesical 242 254 2390 2402 B-treatment
chemotherapy 255 267 2403 2415 I-treatment
or 268 270 2416 2418 O
immunotherapy 271 284 2419 2432 B-treatment
is 285 287 2433 2435 O
allowed 288 295 2436 2443 O
if 296 298 2444 2446 O
completed 299 308 2447 2456 O
at 309 311 2457 2459 O
least 312 317 2460 2465 O
28 318 320 2466 2468 B-lower_bound
days 321 325 2469 2473 I-lower_bound
prior 326 331 2474 2479 I-lower_bound
to 332 334 2480 2482 O
the 335 338 2483 2486 O
initiation 339 349 2487 2497 O
of 350 352 2498 2500 O
study 353 358 2501 2506 O
treatment 359 368 2507 2516 O

Receipt 0 7 2517 2524 O
of 8 10 2525 2527 O
live 11 15 2528 2532 B-treatment
attenuated 16 26 2533 2543 I-treatment
vaccine 27 34 2544 2551 I-treatment
within 35 41 2552 2558 O
30 42 44 2559 2561 B-upper_bound
days 45 49 2562 2566 I-upper_bound
prior 50 55 2567 2572 I-upper_bound
to 56 58 2573 2575 O
the 59 62 2576 2579 O
first 63 68 2580 2585 O
dose 69 73 2586 2590 O
of 74 76 2591 2593 O
IP 77 79 2594 2596 B-treatment
. 79 80 2596 2597 O
Note 81 85 2598 2602 O
: 85 86 2602 2603 O
Patients 87 95 2604 2612 O
, 95 96 2612 2613 O
if 97 99 2614 2616 O
enrolled 100 108 2617 2625 O
, 108 109 2625 2626 O
should 110 116 2627 2633 O
not 117 120 2634 2637 O
receive 121 128 2638 2645 O
live 129 133 2646 2650 O
vaccine 134 141 2651 2658 O
during 142 148 2659 2665 O
the 149 152 2666 2669 O
study 153 158 2670 2675 O
and 159 162 2676 2679 O
up 163 165 2680 2682 O
to 166 168 2683 2685 O
30 169 171 2686 2688 O
days 172 176 2689 2693 O
after 177 182 2694 2699 O
the 183 186 2700 2703 O
last 187 191 2704 2708 O
dose 192 196 2709 2713 O
of 197 199 2714 2716 O
IP 200 202 2717 2719 O

Tumor 0 5 2720 2725 B-cancer
PD 6 8 2726 2728 I-cancer
- 8 9 2728 2729 I-cancer
L1 9 11 2729 2731 I-cancer
status 12 18 2732 2738 O
, 18 19 2738 2739 O
with 20 24 2740 2744 O
Immunohistochemical 25 44 2745 2764 B-treatment
( 45 46 2765 2766 I-treatment
IHC 46 49 2766 2769 I-treatment
) 49 50 2769 2770 I-treatment
assay 51 56 2771 2776 I-treatment
confirmed 57 66 2777 2786 O
by 67 69 2787 2789 O
a 70 71 2790 2791 O
reference 72 81 2792 2801 O
laboratory 82 92 2802 2812 O
, 92 93 2812 2813 O
must 94 98 2814 2818 O
be 99 101 2819 2821 O
known 102 107 2822 2827 O
prior 108 113 2828 2833 O
to 114 116 2834 2836 O
randomization 117 130 2837 2850 O

Able 0 4 0 4 O
to 5 7 5 7 O
take 8 12 8 12 O
enteral 13 20 13 20 B-treatment
medication 21 31 21 31 I-treatment

All 0 3 32 35 O
age 4 7 36 39 B-age
groups 8 14 40 46 O
, 14 15 46 47 O
including 16 25 48 57 O
adults 26 32 58 64 O

Diagnosis 0 9 65 74 O
of 10 12 75 77 O
FA 13 15 78 80 B-chronic_disease
proven 16 22 81 87 O
by 23 25 88 90 O
DEB 26 29 91 94 B-treatment
test 30 34 95 99 I-treatment
or 35 37 100 102 O
molecular 38 47 103 112 B-treatment
testing 48 55 113 120 I-treatment

Patients 0 8 121 129 O
receiving 9 18 130 139 O
cyclosporine 19 31 140 152 B-treatment
or 32 34 153 155 O
digoxin 35 42 156 163 B-treatment
therapy 43 50 164 171 I-treatment
or 51 53 172 174 O
are 54 57 175 178 O
unable 58 64 179 185 O
to 65 67 186 188 O
discontinue 68 79 189 200 O
either 80 86 201 207 O
treatment 87 96 208 217 B-treatment
due 97 100 218 221 O
to 101 103 222 224 O
medical 104 111 225 232 O
reasons 112 119 233 240 O

Patients 0 8 241 249 O
who 9 12 250 253 O
are 13 16 254 257 O
pregnant 17 25 258 266 B-pregnancy
or 26 28 267 269 O
breastfeeding 29 42 270 283 O
or 43 45 284 286 O
are 46 49 287 290 O
at 50 52 291 293 O
risk 53 57 294 298 O
of 58 60 299 301 O
pregnancy 61 70 302 311 B-pregnancy
and 71 74 312 315 O
are 75 78 316 319 O
unable 79 85 320 326 B-contraception_consent
to 86 88 327 329 I-contraception_consent
use 89 92 330 333 I-contraception_consent
acceptable 93 103 334 344 I-contraception_consent
methods 104 111 345 352 I-contraception_consent
of 112 114 353 355 I-contraception_consent
birth 115 120 356 361 I-contraception_consent
control 121 128 362 369 I-contraception_consent
during 129 135 370 376 O
the 136 139 377 380 O
length 140 146 381 387 O
of 147 149 388 390 O
the 150 153 391 394 O
study 154 159 395 400 O

Patients 0 8 401 409 O
who 9 12 410 413 O
have 13 17 414 418 O
received 18 26 419 427 O
quercetin 27 36 428 437 B-treatment
supplementation 37 52 438 453 I-treatment
or 53 55 454 456 O
other 56 61 457 462 O
antioxidants 62 74 463 475 B-treatment
within 75 81 476 482 O
the 82 85 483 486 O
last 86 90 487 491 O
30 91 93 492 494 B-upper_bound
days 94 98 495 499 I-upper_bound

Patients 0 8 500 508 O
with 9 13 509 513 O
morphological 14 27 514 527 O
evidence 28 36 528 536 O
of 37 39 537 539 O
myelodysplasia 40 54 540 554 B-cancer
or 55 57 555 557 O
leukemia 58 66 558 566 B-cancer

Renal 0 5 567 572 B-chronic_disease
failure 6 13 573 580 I-chronic_disease
requiring 14 23 581 590 O
dialysis 24 32 591 599 B-treatment

Total 0 5 600 605 B-clinical_variable
bilirubin 6 15 606 615 I-clinical_variable
> 16 17 616 617 O
3 18 19 618 619 B-lower_bound
mg 20 22 620 622 I-lower_bound
/ 22 23 622 623 I-lower_bound
dl 23 25 623 625 I-lower_bound
and/or 26 32 626 632 O
SGPT 33 37 633 637 B-clinical_variable
> 38 39 638 639 O
200 39 42 639 642 B-lower_bound
at 43 45 643 645 O
time 46 50 646 650 O
of 51 53 651 653 O
enrollment 54 64 654 664 O

Baseline 0 8 0 8 B-clinical_variable
Barthel 9 16 9 16 I-clinical_variable
Index 17 22 17 22 I-clinical_variable
Functional 23 33 23 33 I-clinical_variable
Score 34 39 34 39 I-clinical_variable
> 40 41 40 41 O
70 42 44 42 44 B-lower_bound
, 44 45 44 45 O
functional 46 56 46 56 O
at 57 59 57 59 O
home 60 64 60 64 O

Cardiac 0 7 65 72 B-chronic_disease
arrest 8 14 73 79 I-chronic_disease
as 15 17 80 82 O
cause 18 23 83 88 O
for 24 27 89 92 O
respiratory 28 39 93 104 B-chronic_disease
failure 40 47 105 112 I-chronic_disease

Elevated 0 8 113 121 O
intracranial 9 21 122 134 B-cancer
pressure 22 30 135 143 I-cancer

MV 0 2 144 146 B-clinical_variable
> 3 4 147 148 O
24 5 7 149 151 B-lower_bound
, 7 8 151 152 O
< 9 10 153 154 O
96 11 13 155 157 B-upper_bound
hours 14 19 158 163 I-upper_bound

Pregnancy 0 9 164 173 B-pregnancy

Rapidly 0 7 174 181 O
changing 8 16 182 190 O
neurological 17 29 191 203 B-chronic_disease
conditions 30 40 204 214 I-chronic_disease

Severe 0 6 215 221 O
chronic 7 14 222 229 B-chronic_disease
pain 15 19 230 234 I-chronic_disease
syndrome 20 28 235 243 I-chronic_disease
on 29 31 244 246 O
admission 32 41 247 256 O

Terminal 0 8 257 265 B-chronic_disease
condition 9 18 266 275 I-chronic_disease

Traumatic 0 9 276 285 B-chronic_disease
brain 10 15 286 291 I-chronic_disease
injury 16 22 292 298 I-chronic_disease
, 22 23 298 299 O
multiple 24 32 300 308 B-chronic_disease
limb 33 37 309 313 I-chronic_disease
fractures 38 47 314 323 I-chronic_disease
, 47 48 323 324 O
pelvic 49 55 325 331 B-chronic_disease
fractures 56 65 332 341 I-chronic_disease

life 0 4 342 346 B-clinical_variable
expectancy 5 15 347 357 I-clinical_variable
< 16 17 358 359 O
6 18 19 360 361 B-upper_bound
months 20 26 362 368 I-upper_bound

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
Crohn 15 20 15 20 B-chronic_disease
's 20 22 20 22 I-chronic_disease
disease 23 30 23 30 I-chronic_disease
or 31 33 31 33 O
Inflammatory 34 46 34 46 B-chronic_disease
Bowel 47 52 47 52 I-chronic_disease
Disease 53 60 53 60 I-chronic_disease

A 0 1 61 62 O
diagnosis 2 11 63 72 O
of 12 14 73 75 O
UC 15 17 76 78 B-chronic_disease
made 18 22 79 83 O
by 23 25 84 86 O
standard 26 34 87 95 O
clinical 35 43 96 104 O
, 43 44 104 105 O
radiological 45 57 106 118 O
, 57 58 118 119 O
endoscopic 59 69 120 130 O
and 70 73 131 134 O
histological 74 86 135 147 O
criteria 87 95 148 156 O

A 0 1 157 158 O
negative 2 10 159 167 B-pregnancy
pregnancy 11 20 168 177 I-pregnancy
test 21 25 178 182 O
in 26 28 183 185 O
the 29 32 186 189 O
2 33 34 190 191 O
weeks 35 40 192 197 O
prior 41 46 198 203 O
to 47 49 204 206 O
anticipated 50 61 207 218 O
commencement 62 74 219 231 O
of 75 77 232 234 O
the 78 81 235 238 O
study 82 87 239 244 O
drug 88 92 245 249 O
, 92 93 249 250 O
in 94 96 251 253 O
female 97 103 254 260 B-gender
subjects 104 112 261 269 O
of 113 115 270 272 O
child 116 121 273 278 O
- 121 122 278 279 O
bearing 122 129 279 286 O
age 130 133 287 290 B-age

Abnormal 0 8 291 299 O
thyroid 9 16 300 307 B-chronic_disease
function 17 25 308 316 O
tests 26 31 317 322 O

Age 0 3 323 326 B-age
18 4 6 327 329 B-lower_bound
- 6 7 329 330 O
70 7 9 330 332 B-upper_bound
years 10 15 333 338 I-upper_bound

Allergy 0 7 339 346 O
to 8 10 347 349 O
any 11 14 350 353 O
component 15 24 354 363 B-allergy_name
of 25 27 364 366 I-allergy_name
the 28 31 367 370 I-allergy_name
study 32 37 371 376 I-allergy_name
drug 38 42 377 381 I-allergy_name

Corticosteroid 0 14 382 396 B-treatment
dependency 15 25 397 407 O
( 26 27 408 409 O
inability 27 36 409 418 O
to 37 39 419 421 O
taper 40 45 422 427 O
oral 46 50 428 432 B-treatment
corticosteroids 51 66 433 448 I-treatment
without 67 74 449 456 O
a 75 76 457 458 O
recurrence 77 87 459 469 O
of 88 90 470 472 O
disease 91 98 473 480 O
activity 99 107 481 489 O
) 107 108 489 490 O
is 109 111 491 493 O
also 112 116 494 498 O
included 117 125 499 507 O
in 126 128 508 510 O
this 129 133 511 515 O
category 134 142 516 524 O

Creatinine 0 10 525 535 B-clinical_variable
≥ 11 12 536 537 O
1.5x 13 17 538 542 B-lower_bound
institutional 18 31 543 556 I-lower_bound
upper 32 37 557 562 I-lower_bound
limit 38 43 563 568 I-lower_bound
of 44 46 569 571 I-lower_bound
normal 47 53 572 578 I-lower_bound
( 54 55 579 580 I-lower_bound
ULN 55 58 580 583 I-lower_bound
) 58 59 583 584 I-lower_bound

Failure 0 7 585 592 O
to 8 10 593 595 O
tolerate 11 19 596 604 O
or 20 22 605 607 O
failure 23 30 608 615 O
to 31 33 616 618 O
respond 34 41 619 626 O
to 42 44 627 629 O
at 45 47 630 632 O
least 48 53 633 638 O
one 54 57 639 642 B-lower_bound
conventional 58 70 643 655 B-treatment
therapy 71 78 656 663 I-treatment
with 79 83 664 668 O
the 84 87 669 672 O
intention 88 97 673 682 O
of 98 100 683 685 O
inducing 101 109 686 694 O
or 110 112 695 697 O
maintaining 113 124 698 709 O
remission 125 134 710 719 O
( 135 136 720 721 O
examples 136 144 721 729 O
include 145 152 730 737 O
oral 153 157 738 742 B-treatment
corticosteroids 158 173 743 758 I-treatment
, 173 174 758 759 O
oral 175 179 760 764 B-treatment
5 180 181 765 766 I-treatment
- 181 182 766 767 I-treatment
aminosalicylates 182 198 767 783 I-treatment
, 198 199 783 784 O
azathioprine 200 212 785 797 B-treatment
and/or 213 219 798 804 O
6 220 221 805 806 B-treatment
- 221 222 806 807 I-treatment
mercaptopurine 222 236 807 821 I-treatment
, 236 237 821 822 O
or 238 240 823 825 O
a 241 242 826 827 O
tumor 243 248 828 833 B-treatment
necrosis 249 257 834 842 I-treatment
factor 258 264 843 849 I-treatment
( 265 266 850 851 I-treatment
TNF 266 269 851 854 I-treatment
) 269 270 854 855 I-treatment
antagonist 271 281 856 866 I-treatment

First 0 5 867 872 O
dose 6 10 873 877 O
of 11 13 878 880 O
an 14 16 881 883 O
anti 17 21 884 888 B-treatment
- 21 22 888 889 I-treatment
TNF 22 25 889 892 I-treatment
medication 26 36 893 903 I-treatment
within 37 43 904 910 O
4 44 45 911 912 B-upper_bound
weeks 46 51 913 918 I-upper_bound
of 52 54 919 921 O
anticipated 55 66 922 933 O
study 67 72 934 939 O
commencement 73 85 940 952 O
, 85 86 952 953 O
or 87 89 954 956 O
a 90 91 957 958 O
subsequent 92 102 959 969 O
dose 103 107 970 974 O
within 108 114 975 981 O
2 115 116 982 983 B-upper_bound
weeks 117 122 984 989 I-upper_bound
of 123 125 990 992 O
commencement 126 138 993 1005 O
; 138 139 1005 1006 O
or 140 142 1007 1009 O
ciclosporin 143 154 1010 1021 B-treatment
or 155 157 1022 1024 O
tacrolimus 158 168 1025 1035 B-treatment
within 169 175 1036 1042 O
2 176 177 1043 1044 O
weeks 178 183 1045 1050 O
of 184 186 1051 1053 O
anticipated 187 198 1054 1065 O
study 199 204 1066 1071 O
commencement 205 217 1072 1084 O

History 0 7 1085 1092 O
of 8 10 1093 1095 O
colorectal 11 21 1096 1106 B-cancer
cancer 22 28 1107 1113 I-cancer
or 29 31 1114 1116 O
dysplasia 32 41 1117 1126 B-chronic_disease

Ileostomy 0 9 1127 1136 B-treatment
, 9 10 1136 1137 O
proctocolectomy 11 26 1138 1153 B-treatment
or 27 29 1154 1156 O
subtotal 30 38 1157 1165 B-treatment
colectomy 39 48 1166 1175 I-treatment
with 49 53 1176 1180 O
ileorectal 54 64 1181 1191 B-treatment
anastomosis 65 76 1192 1203 I-treatment

Malignancy 0 10 1204 1214 B-cancer
within 11 17 1215 1221 O
the 18 21 1222 1225 O
last 22 26 1226 1230 B-upper_bound
5 27 28 1231 1232 I-upper_bound
years 29 34 1233 1238 I-upper_bound

Men 0 3 1239 1242 B-gender
and 4 7 1243 1246 O
women 8 13 1247 1252 B-gender
of 14 16 1253 1255 O
reproductive 17 29 1256 1268 O
potential 30 39 1269 1278 O
must 40 44 1279 1283 O
agree 45 50 1284 1289 B-contraception_consent
to 51 53 1290 1292 I-contraception_consent
use 54 57 1293 1296 I-contraception_consent
an 58 60 1297 1299 I-contraception_consent
acceptable 61 71 1300 1310 I-contraception_consent
method 72 78 1311 1317 I-contraception_consent
of 79 81 1318 1320 I-contraception_consent
birth 82 87 1321 1326 I-contraception_consent
control 88 95 1327 1334 I-contraception_consent
during 96 102 1335 1341 O
treatment 103 112 1342 1351 B-treatment
and 113 116 1352 1355 O
for 117 120 1356 1359 O
six 121 124 1360 1363 B-upper_bound
months 125 131 1364 1370 I-upper_bound
after 132 137 1371 1376 I-upper_bound
completion 138 148 1377 1387 O
of 149 151 1388 1390 O
treatment 152 161 1391 1400 O

Moderate 0 8 1401 1409 B-chronic_disease
to 9 11 1410 1412 I-chronic_disease
severe 12 18 1413 1419 I-chronic_disease
UC 19 21 1420 1422 I-chronic_disease
with 22 26 1423 1427 O
a 27 28 1428 1429 O
Mayo 29 33 1430 1434 B-clinical_variable
score 34 39 1435 1440 I-clinical_variable
of 40 42 1441 1443 O
6 43 44 1444 1445 B-lower_bound
- 44 45 1445 1446 O
12 45 47 1446 1448 B-upper_bound

Positive 0 8 1449 1457 O
screening 9 18 1458 1467 O
test 19 23 1468 1472 O
for 24 27 1473 1476 O
tuberculosis 28 40 1477 1489 B-chronic_disease
( 41 42 1490 1491 I-chronic_disease
TB 42 44 1491 1493 I-chronic_disease
) 44 45 1493 1494 I-chronic_disease

Positive 0 8 1495 1503 O
serology 9 17 1504 1512 B-treatment
for 18 21 1513 1516 O
HIV 22 25 1517 1520 B-chronic_disease
, 25 26 1520 1521 O
hepatitis 27 36 1522 1531 B-chronic_disease
B 37 38 1532 1533 I-chronic_disease
virus 39 44 1534 1539 I-chronic_disease
( 45 46 1540 1541 I-chronic_disease
HBV 46 49 1541 1544 I-chronic_disease
) 49 50 1544 1545 I-chronic_disease
or 51 53 1546 1548 O
HCV 54 57 1549 1552 B-chronic_disease

Positive 0 8 1553 1561 O
stool 9 14 1562 1567 O
test 15 19 1568 1572 O
for 20 23 1573 1576 O
Clostridium 24 35 1577 1588 B-chronic_disease
difficile 36 45 1589 1598 I-chronic_disease

Pregnant 0 8 1599 1607 B-pregnancy
or 9 11 1608 1610 O
lactating 12 21 1611 1620 O
women 22 27 1621 1626 B-gender

Prior 0 5 1627 1632 O
exposure 6 14 1633 1641 O
to 15 17 1642 1644 O
IL-2 18 22 1645 1649 B-treatment

Received 0 8 1650 1658 O
another 9 16 1659 1666 O
investigational 17 32 1667 1682 B-treatment
new 33 36 1683 1686 I-treatment
drug 37 41 1687 1691 I-treatment
( 42 43 1692 1693 I-treatment
IND 43 46 1693 1696 I-treatment
) 46 47 1696 1697 I-treatment
within 48 54 1698 1704 O
5 55 56 1705 1706 B-upper_bound
half 57 61 1707 1711 I-upper_bound
- 61 62 1711 1712 I-upper_bound
lives 62 67 1712 1717 I-upper_bound
of 68 70 1718 1720 O
that 71 75 1721 1725 O
agent 76 81 1726 1731 O
before 82 88 1732 1738 O
the 89 92 1739 1742 O
planned 93 100 1743 1750 O
commencement 101 113 1751 1763 O
of 114 116 1764 1766 O
SC 117 119 1767 1769 O
IL-2 120 124 1770 1774 O

Requirement 0 11 1775 1786 O
for 12 15 1787 1790 O
immediate 16 25 1791 1800 O
surgical 26 34 1801 1809 B-treatment
, 34 35 1809 1810 O
endoscopic 36 46 1811 1821 B-treatment
or 47 49 1822 1824 O
radiological 50 62 1825 1837 B-treatment
intervention 63 75 1838 1850 O
for 76 79 1851 1854 O
toxic 80 85 1855 1860 B-chronic_disease
megacolon 86 95 1861 1870 I-chronic_disease
, 95 96 1870 1871 O
massive 97 104 1872 1879 B-chronic_disease
hemorrhage 105 115 1880 1890 I-chronic_disease
, 115 116 1890 1891 O
perforation 117 128 1892 1903 B-chronic_disease
, 128 129 1903 1904 O
sepsis 130 136 1905 1911 B-chronic_disease
, 136 137 1911 1912 O
or 138 140 1913 1915 O
intra 141 146 1916 1921 B-chronic_disease
- 146 147 1921 1922 I-chronic_disease
abdominal 147 156 1922 1931 I-chronic_disease
or 157 159 1932 1934 I-chronic_disease
perianal 160 168 1935 1943 I-chronic_disease
abscess 169 176 1944 1951 I-chronic_disease

Stable 0 6 1952 1958 O
doses 7 12 1959 1964 O
of 13 15 1965 1967 O
concomitant 16 27 1968 1979 B-treatment
medications 28 39 1980 1991 I-treatment

Total 0 5 1992 1997 B-clinical_variable
bilirubin 6 15 1998 2007 I-clinical_variable
> 16 17 2008 2009 O
2.0 18 21 2010 2013 B-lower_bound
mg 22 24 2014 2016 I-lower_bound
/ 24 25 2016 2017 I-lower_bound
dL 25 27 2017 2019 I-lower_bound
, 27 28 2019 2020 O
ALT 29 32 2021 2024 B-clinical_variable
> 33 34 2025 2026 O
2x 35 37 2027 2029 B-lower_bound
institutional 38 51 2030 2043 I-lower_bound
ULN 52 55 2044 2047 I-lower_bound
, 55 56 2047 2048 O
GGT 57 60 2049 2052 B-clinical_variable
> 61 62 2053 2054 O
2x 63 65 2055 2057 O
institutional 66 79 2058 2071 O
ULN 80 83 2072 2075 O
. 83 84 2075 2076 O
Elevated 85 93 2077 2085 O
unconjugated 94 106 2086 2098 O
bilirubin 107 116 2099 2108 O
related 117 124 2109 2116 O
to 125 127 2117 2119 O
Gilbert 128 135 2120 2127 B-chronic_disease
's 135 137 2127 2129 I-chronic_disease
syndrome 138 146 2130 2138 I-chronic_disease
is 147 149 2139 2141 O
allowed 150 157 2142 2149 O

Uncontrolled 0 12 2150 2162 O
cardiac 13 20 2163 2170 O
angina 21 27 2171 2177 B-chronic_disease
or 28 30 2178 2180 O
symptomatic 31 42 2181 2192 O
congestive 43 53 2193 2203 B-chronic_disease
cardiac 54 61 2204 2211 I-chronic_disease
failure 62 69 2212 2219 I-chronic_disease
( 70 71 2220 2221 O
NYHA 71 75 2221 2225 B-clinical_variable
Class 76 81 2226 2231 B-lower_bound
III 82 85 2232 2235 I-lower_bound
or 86 88 2236 2238 O
IV 89 91 2239 2241 B-upper_bound
) 91 92 2241 2242 O

Unspecified 0 11 2243 2254 O
( 12 13 2255 2256 O
IBD 13 16 2256 2259 B-chronic_disease
- 16 17 2259 2260 I-chronic_disease
U 17 18 2260 2261 I-chronic_disease
, 18 19 2261 2262 O
a 20 21 2263 2264 O
diagnostic 22 32 2265 2275 O
classification 33 47 2276 2290 O
formerly 48 56 2291 2299 O
termed 57 63 2300 2306 O
indeterminate 64 77 2307 2320 B-chronic_disease
colitis 78 85 2321 2328 I-chronic_disease

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

All 0 3 15 18 O
histology 4 13 19 28 O
of 14 16 29 31 O
renal 17 22 32 37 B-cancer
cancers 23 30 38 45 I-cancer
are 31 34 46 49 O
included 35 43 50 58 O
including 44 53 59 68 O
oncocytoma 54 64 69 79 B-cancer

Biopsy 0 6 80 86 O
proven 7 13 87 93 O
Renal 14 19 94 99 B-cancer
neoplasm 20 28 100 108 I-cancer

Growth 0 6 109 115 O
of 7 9 116 118 O
renal 10 15 119 124 B-clinical_variable
mass 16 20 125 129 I-clinical_variable
> 21 22 130 131 O
4 22 23 131 132 B-lower_bound
mm 23 25 132 134 I-lower_bound
in 26 28 135 137 O
radiographic 29 41 138 150 B-clinical_variable
scans 42 47 151 156 I-clinical_variable
or 48 50 157 159 O
> 51 52 160 161 O
2 52 53 161 162 B-lower_bound
mm 53 55 162 164 I-lower_bound
in 56 58 165 167 O
two 59 62 168 171 O
different 63 72 172 181 O
scans 73 78 182 187 O
must 79 83 188 192 O
be 84 86 193 195 O
demonstrated 87 99 196 208 O
within 100 106 209 215 O
a 107 108 216 217 O
one 109 112 218 221 B-upper_bound
year 113 117 222 226 I-upper_bound
period 118 124 227 233 O

No 0 2 234 236 O
clinical 3 11 237 245 O
evidence 12 20 246 254 O
of 21 23 255 257 O
metastatic 24 34 258 268 B-cancer
disease 35 42 269 276 I-cancer

Renal 0 5 277 282 B-clinical_variable
mass 6 10 283 287 I-clinical_variable
≤ 11 12 288 289 O
3 13 14 290 291 B-upper_bound
cm 14 16 291 293 I-upper_bound

Subjects 0 8 294 302 O
may 9 12 303 306 O
not 13 16 307 310 O
have 17 21 311 315 O
received 22 30 316 324 O
any 31 34 325 328 O
treatment 35 44 329 338 B-treatment
for 45 48 339 342 I-treatment
the 49 52 343 346 I-treatment
renal 53 58 347 352 I-treatment
mass 59 63 353 357 I-treatment
before 64 70 358 364 O
such 71 75 365 369 O
as 76 78 370 372 O
RFA 79 82 373 376 B-treatment
or 83 85 377 379 O
cryoablation 86 98 380 392 B-treatment

Subjects 0 8 393 401 O
must 9 13 402 406 B-pregnancy
not 14 17 407 410 I-pregnancy
be 18 20 411 413 I-pregnancy
pregnant 21 29 414 422 I-pregnancy
during 30 36 423 429 O
the 37 40 430 433 O
course 41 47 434 440 O
of 48 50 441 443 O
SABR 51 55 444 448 O

Subjects 0 8 449 457 O
must 9 13 458 462 O
not 14 17 463 466 O
have 18 22 467 471 O
received 23 31 472 480 O
previous 32 40 481 489 O
abdominal 41 50 490 499 B-treatment
radiation 51 60 500 509 I-treatment

Patients 0 8 0 8 O
< 9 10 9 10 O
30 10 12 10 12 B-upper_bound
years 13 18 13 18 I-upper_bound
old 19 22 19 22 O
with 23 27 23 27 O
an 28 30 28 30 O
extracoelomic 31 44 31 44 O
solid 45 50 45 50 B-cancer
tumor 51 56 51 56 I-cancer
requiring 57 66 57 66 O
SLN 67 70 67 70 B-treatment
biopsy 71 77 71 77 I-treatment

Patients 0 8 78 86 O
who 9 12 87 90 O
are 13 16 91 94 O
cleared 17 24 95 102 O
for 25 28 103 106 O
surgery 29 36 107 114 B-treatment

Patients 0 8 115 123 O
with 9 13 124 128 O
extensive 14 23 129 138 O
prior 24 29 139 144 B-treatment
surgery 30 37 145 152 I-treatment
at 38 40 153 155 O
the 41 44 156 159 O
primary 45 52 160 167 O
site 53 57 168 172 O
or 58 60 173 175 O
nodal 61 66 176 181 O
basin 67 72 182 187 O
expected 73 81 188 196 O
to 82 84 197 199 O
affect 85 91 200 206 O
the 92 95 207 210 O
lymphatic 96 105 211 220 B-treatment
drainage 106 114 221 229 I-treatment

Women 0 5 230 235 B-gender
of 6 8 236 238 O
childbearing 9 21 239 251 O
potential 22 31 252 261 O
must 32 36 262 266 O
have 37 41 267 271 O
a 42 43 272 273 O
negative 44 52 274 282 B-pregnancy
pregnancy 53 62 283 292 I-pregnancy
test 63 67 293 297 O
( 68 69 298 299 O
urine 69 74 299 304 O
or 75 77 305 307 O
blood 78 83 308 313 O
) 83 84 313 314 O
pre 85 88 315 318 O
- 88 89 318 319 O
operatively 89 100 319 330 O
as 101 103 331 333 O
per 104 107 334 337 O
the 108 111 338 341 O
standard 112 120 342 350 O
hospital 121 129 351 359 O
policy 130 136 360 366 O

Women 0 5 367 372 B-gender
who 6 9 373 376 O
are 10 13 377 380 B-pregnancy
pregnant 14 22 381 389 I-pregnancy
or 23 25 390 392 O
breast 26 32 393 399 O
- 32 33 399 400 O
feeding 33 40 400 407 O

Access 0 6 0 6 B-technology_access
to 7 9 7 9 I-technology_access
a 10 11 10 11 I-technology_access
computer 12 20 12 20 I-technology_access
and 21 24 21 24 O
are 25 28 25 28 O
able 29 33 29 33 O
to 34 36 34 36 O
enter 37 42 37 42 O
information 43 54 43 54 O
into 55 59 55 59 O
the 60 63 60 63 O
computer 64 72 64 72 O

Age 0 3 73 76 B-age
18 4 6 77 79 B-lower_bound
to 7 9 80 82 O
70 10 12 83 85 B-upper_bound
years 13 18 86 91 I-upper_bound

BMI 0 3 92 95 B-bmi
of 4 6 96 98 O
27 7 9 99 101 B-lower_bound
kg 10 12 102 104 I-lower_bound
/ 12 13 104 105 I-lower_bound
m2 13 15 105 107 I-lower_bound
with 16 20 108 112 O
comorbidities 21 34 113 126 B-chronic_disease
or 35 37 127 129 O
30 38 40 130 132 B-lower_bound
kg 41 43 133 135 I-lower_bound
/ 43 44 135 136 I-lower_bound
m2 44 46 136 138 I-lower_bound
and 47 50 139 142 O
above 51 56 143 148 O

Currently 0 9 149 158 O
undergoing 10 20 159 169 O
cancer 21 27 170 176 B-treatment
treatment 28 37 177 186 I-treatment

Fluoxetine 0 10 187 197 B-treatment

MAO 0 3 198 201 B-treatment
inhibitors 4 14 202 212 I-treatment

Oral 0 4 213 217 B-chronic_disease
Corticosteroids 5 20 218 233 I-chronic_disease

Perceived 0 9 234 243 B-clinical_variable
Stress 10 16 244 250 I-clinical_variable
Scale 17 22 251 256 I-clinical_variable
( 23 24 257 258 I-clinical_variable
PSS 24 27 258 261 I-clinical_variable
) 27 28 261 262 I-clinical_variable
score 29 34 263 268 I-clinical_variable
of 35 37 269 271 O
≥ 38 39 272 273 O
20 40 42 274 276 B-lower_bound
at 43 45 277 279 O
screening 46 55 280 289 O

Pregnant 0 8 290 298 B-pregnancy
women 9 14 299 304 B-gender

SSRI 0 4 305 309 B-treatment
's 4 6 309 311 I-treatment

Started 0 7 312 319 O
within 8 14 320 326 O
the 15 18 327 330 O
last 19 23 331 335 B-upper_bound
14 24 26 336 338 I-upper_bound
days 27 31 339 343 I-upper_bound
or 32 34 344 346 O
plan 35 39 347 351 O
to 40 42 352 354 O
start 43 48 355 360 O
taking 49 55 361 367 O

Taking 0 6 368 374 O
chronic 7 14 375 382 O
anti 15 19 383 387 B-treatment
- 19 20 387 388 I-treatment
anxiety 20 27 388 395 I-treatment

Tricyclic 0 9 396 405 B-treatment
antidepressants 10 25 406 421 I-treatment

anti 0 4 422 426 B-treatment
- 4 5 426 427 I-treatment
insomnia 5 13 427 435 I-treatment
medication 14 24 436 446 I-treatment
on 25 27 447 449 O
a 28 29 450 451 O
regular 30 37 452 459 O
basis 38 43 460 465 O

anti 0 4 466 470 B-treatment
- 4 5 470 471 I-treatment
obesity 5 12 471 478 I-treatment
( 13 14 479 480 O
other 14 19 480 485 O
than 20 24 486 490 O
phentermine 25 36 491 502 B-treatment
) 36 37 502 503 O

unwilling 0 9 504 513 O
to 10 12 514 516 O
stop 13 17 517 521 O
taking 18 24 522 528 O
these 25 30 529 534 O
classes 31 38 535 542 O
of 39 41 543 545 O
medications 42 53 546 557 O
for 54 57 558 561 O
the 58 61 562 565 O
duration 62 70 566 574 O
of 71 73 575 577 O
the 74 77 578 581 O
12 78 80 582 584 B-upper_bound
week 81 85 585 589 I-upper_bound
trial 86 91 590 595 O

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 6 7 6 7 O
90 7 9 7 9 B-upper_bound
years 10 15 10 15 I-upper_bound

Cancer 0 6 16 22 B-cancer
diagnosis 7 16 23 32 O

Meeting 0 7 33 40 O
medium 8 14 41 47 O
to 15 17 48 50 O
high 18 22 51 55 O
risk 23 27 56 60 O
for 28 31 61 64 O
death 32 37 65 70 O
at 38 40 71 73 O
1 41 42 74 75 O
year 43 47 76 80 O
using 48 53 81 86 O
the 54 57 87 90 O
CARING 58 64 91 97 O
criteria 65 73 98 106 O
( 74 75 107 108 O
although 75 83 108 116 O
excluding 84 93 117 126 O
patients 94 102 127 135 O
with 103 107 136 140 O
cancer 108 114 141 147 B-cancer
diagnosis 115 124 148 157 O
) 124 125 157 158 O

Pregnant 0 8 159 167 B-pregnancy

Self 0 4 168 172 O
- 4 5 172 173 O
identify 5 13 173 181 O
as 14 16 182 184 O
Latino 17 23 185 191 B-ethnicity

Liver 0 5 0 5 B-clinical_variable
mass 6 10 6 10 I-clinical_variable
( 11 12 11 12 O
> 12 13 12 13 O
= 13 14 13 14 O
1 15 16 15 16 B-lower_bound
cm 17 19 17 19 I-lower_bound
) 19 20 19 20 O
with 21 25 21 25 O
arterial 26 34 26 34 O
phase 35 40 35 40 O
contrast 41 49 41 49 O
enhancement 50 61 50 61 O
and 62 65 62 65 O
early 66 71 66 71 O
washout 72 79 72 79 O
on 80 82 80 82 O
subsequent 83 93 83 93 O
phases 94 100 94 100 O
by 101 103 101 103 O
CT 104 106 104 106 O

Liver 0 5 107 112 B-clinical_variable
mass 6 10 113 117 I-clinical_variable
( 11 12 118 119 O
≥ 12 13 119 120 O
1 14 15 121 122 B-lower_bound
cm 16 18 123 125 I-lower_bound
) 18 19 125 126 O
that 20 24 127 131 O
has 25 28 132 135 O
suggestive 29 39 136 146 O
imaging 40 47 147 154 O
findings 48 56 155 163 O
of 57 59 164 166 O
a 60 61 167 168 O
benign 62 68 169 175 B-cancer
liver 69 74 176 181 I-cancer
mass 75 79 182 186 I-cancer
( 80 81 187 188 O
adenoma 81 88 188 195 B-cancer
, 88 89 195 196 O
hemangioma 90 100 197 207 B-cancer
, 100 101 207 208 O
focal 102 107 209 214 B-cancer
nodular 108 115 215 222 I-cancer
hyperplasia 116 127 223 234 I-cancer
) 127 128 234 235 O

Liver 0 5 236 241 B-clinical_variable
mass 6 10 242 246 I-clinical_variable
( 11 12 247 248 O
≥ 12 13 248 249 O
1 14 15 250 251 B-lower_bound
cm 16 18 252 254 I-lower_bound
) 18 19 254 255 O
that 20 24 256 260 O
is 25 27 261 263 O
a 28 29 264 265 O
non 30 33 266 269 B-cancer
- 33 34 269 270 I-cancer
HCC 34 37 270 273 I-cancer
primary 38 45 274 281 I-cancer
malignancy 46 56 282 292 I-cancer
( 57 58 293 294 O
cholangiocarcinoma 58 76 294 312 B-cancer
) 76 77 312 313 O

Liver 0 5 314 319 B-clinical_variable
mass 6 10 320 324 I-clinical_variable
( 11 12 325 326 O
≥ 12 13 326 327 O
1 14 15 328 329 B-lower_bound
cm 16 18 330 332 I-lower_bound
) 18 19 332 333 O
that 20 24 334 338 O
is 25 27 339 341 O
biopsy 28 34 342 348 B-treatment
proven 35 41 349 355 O
metastatic 42 52 356 366 B-cancer
disease 53 60 367 374 I-cancer
( 61 62 375 376 O
metastatic 62 72 376 386 O
colorectal 73 83 387 397 B-cancer
cancer 84 90 398 404 I-cancer
, 90 91 404 405 O
metastatic 92 102 406 416 O
pancreatic 103 113 417 427 B-cancer
cancer 114 120 428 434 I-cancer
) 120 121 434 435 O

Patients 0 8 436 444 O
with 9 13 445 449 O
a 14 15 450 451 O
known 16 21 452 457 O
infiltrative 22 34 458 470 O
variant 35 42 471 478 O
of 43 45 479 481 O
HCC 46 49 482 485 B-cancer

Patients 0 8 486 494 O
with 9 13 495 499 O
a 14 15 500 501 O
known 16 21 502 507 O
prior 22 27 508 513 O
malignancy 28 38 514 524 B-cancer
who 39 42 525 528 O
have 43 47 529 533 O
received 48 56 534 542 O
systemic 57 65 543 551 B-treatment
chemotherapy 66 78 552 564 I-treatment
within 79 85 565 571 O
five 86 90 572 576 B-upper_bound
years 91 96 577 582 I-upper_bound

Patients 0 8 583 591 O
with 9 13 592 596 O
poorly 14 20 597 603 O
controlled 21 31 604 614 O
diabetes 32 40 615 623 B-chronic_disease
mellitus 41 49 624 632 I-chronic_disease
( 50 51 633 634 O
fasting 51 58 634 641 B-clinical_variable
blood 59 64 642 647 I-clinical_variable
glucose 65 72 648 655 I-clinical_variable
level 73 78 656 661 I-clinical_variable
> 79 80 662 663 O
200 81 84 664 667 B-lower_bound
mg 85 87 668 670 I-lower_bound
/ 87 88 670 671 I-lower_bound
dL 88 90 671 673 I-lower_bound
) 90 91 673 674 O

Pregnant 0 8 675 683 B-pregnancy

Suggestive 0 10 684 694 O
imaging 11 18 695 702 O
findings 19 27 703 711 O
plus 28 32 712 716 O
alpha 33 38 717 722 B-clinical_variable
- 38 39 722 723 I-clinical_variable
feto 39 43 723 727 I-clinical_variable
protein 44 51 728 735 I-clinical_variable
( 52 53 736 737 I-clinical_variable
AFP 53 56 737 740 I-clinical_variable
) 56 57 740 741 I-clinical_variable
> 58 59 742 743 O
200 60 63 744 747 B-lower_bound
mg 64 66 748 750 I-lower_bound
/ 66 67 750 751 I-lower_bound
dL 67 69 751 753 I-lower_bound

Tumor 0 5 754 759 B-cancer
confirmed 6 15 760 769 O
by 16 18 770 772 O
arteriography 19 32 773 786 O

basal 0 5 787 792 B-cancer
cell 6 10 793 797 I-cancer
carcinoma 11 20 798 807 I-cancer
of 21 23 808 810 I-cancer
the 24 27 811 814 I-cancer
skin 28 32 815 819 I-cancer

carcinoma 0 9 820 829 B-cancer
in 10 12 830 832 I-cancer
situ 13 17 833 837 I-cancer
of 18 20 838 840 I-cancer
the 21 24 841 844 I-cancer
cervix 25 31 845 851 I-cancer

patients 0 8 852 860 O
with 9 13 861 865 O
liver 14 19 866 871 B-cancer
mass(es 20 27 872 879 I-cancer
) 27 28 879 880 I-cancer
proven 29 35 881 887 O
to 36 38 888 890 O
be 39 41 891 893 O
metastatic 42 52 894 904 B-cancer
disease 53 60 905 912 I-cancer

prior 0 5 913 918 O
HCC 6 9 919 922 B-cancer

22 0 2 0 2 B-lower_bound
to 3 5 3 5 O
70 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O

Females 0 7 19 26 B-gender

Skin 0 4 27 31 B-treatment
- 4 5 31 32 I-treatment
sparing 5 12 32 39 I-treatment
or 13 15 40 42 I-treatment
nipple 16 22 43 49 I-treatment
- 22 23 49 50 I-treatment
sparing 23 30 50 57 I-treatment
mastectomy 31 41 58 68 I-treatment
with 42 46 69 73 O
or 47 49 74 76 O
without 50 57 77 84 O
sentinel 58 66 85 93 B-treatment
lymph 67 72 94 99 I-treatment
node 73 77 100 104 I-treatment
biopsy 78 84 105 111 I-treatment

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥ 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
mc 34 36 34 36 I-lower_bound

Active 0 6 37 43 O
congestive 7 17 44 54 B-chronic_disease
heart 18 23 55 60 I-chronic_disease
failure 24 31 61 68 I-chronic_disease
( 32 33 69 70 O
New 33 36 70 73 B-clinical_variable
York 37 41 74 78 I-clinical_variable
heart 42 47 79 84 I-clinical_variable
Association 48 59 85 96 I-clinical_variable
Class 60 65 97 102 B-lower_bound
III 66 69 103 106 I-lower_bound
or 70 72 107 109 O
IV 73 75 110 112 B-upper_bound
) 75 76 112 113 O
, 76 77 113 114 O
symptomatic 78 89 115 126 O
ischemia 90 98 127 135 B-chronic_disease
, 98 99 135 136 O
or 100 102 137 139 O
conduction 103 113 140 150 O
abnormalities 114 127 151 164 O
uncontrolled 128 140 165 177 O
by 141 143 178 180 O
conventional 144 156 181 193 O
intervention 157 169 194 206 O
or 170 172 207 209 O
myocardial 173 183 210 220 B-chronic_disease
infarction 184 194 221 231 I-chronic_disease
within 195 201 232 238 O
four 202 206 239 243 B-upper_bound
months 207 213 244 250 I-upper_bound
prior 214 219 251 256 I-upper_bound
to 220 222 257 259 O
enrollment 223 233 260 270 O

Adequate 0 8 271 279 O
cardiac 9 16 280 287 O
function 17 25 288 296 O
left 26 30 297 301 B-clinical_variable
ventricular 31 42 302 313 I-clinical_variable
ejection 43 51 314 322 I-clinical_variable
fraction 52 60 323 331 I-clinical_variable
( 61 62 332 333 I-clinical_variable
LVEF 62 66 333 337 I-clinical_variable
) 66 67 337 338 I-clinical_variable
> 68 69 339 340 O
50 70 72 341 343 B-lower_bound
% 72 73 343 344 I-lower_bound
as 74 76 345 347 O
assessed 77 85 348 356 O
by 86 88 357 359 O
echocardiogram 89 103 360 374 B-treatment
or 104 106 375 377 O
MUGA 107 111 378 382 B-treatment
( 112 113 383 384 I-treatment
Multi 113 118 384 389 I-treatment
Gated 119 124 390 395 I-treatment
Acquisition 125 136 396 407 I-treatment
Scan 137 141 408 412 I-treatment
) 141 142 412 413 I-treatment

Age 0 3 414 417 B-age
≥ 4 5 418 419 O
60 6 8 420 422 B-lower_bound
( 9 10 423 424 O
1 10 11 424 425 O
point 12 17 426 431 O

Alanine 0 7 432 439 B-clinical_variable
aminotransferase 8 24 440 456 I-clinical_variable
( 25 26 457 458 I-clinical_variable
ALT 26 29 458 461 I-clinical_variable
) 29 30 461 462 I-clinical_variable
( 31 32 463 464 O
serum 32 37 464 469 B-clinical_variable
glutamate 38 47 470 479 I-clinical_variable
pyruvate 48 56 480 488 I-clinical_variable
transaminase 57 69 489 501 I-clinical_variable
[ 70 71 502 503 I-clinical_variable
SGPT 71 75 503 507 I-clinical_variable
] 75 76 507 508 I-clinical_variable
) 76 77 508 509 O
≤ 78 79 510 511 O
2.5 80 83 512 515 B-upper_bound
X 84 85 516 517 I-upper_bound
institutional 86 99 518 531 I-upper_bound
upper 100 105 532 537 I-upper_bound
limit 106 111 538 543 I-upper_bound
of 112 114 544 546 I-upper_bound
normal 115 121 547 553 I-upper_bound

Ann 0 3 554 557 B-clinical_variable
Arbor 4 9 558 563 I-clinical_variable
stage 10 15 564 569 I-clinical_variable
III 16 19 570 573 B-lower_bound
or 20 22 574 576 O
IV 23 25 577 579 B-upper_bound
( 26 27 580 581 O
1 27 28 581 582 O
point 29 34 583 588 O
) 34 35 588 589 O

Aspartate 0 9 590 599 B-clinical_variable
aminotransferase 10 26 600 616 I-clinical_variable
( 27 28 617 618 I-clinical_variable
AST 28 31 618 621 I-clinical_variable
) 31 32 621 622 I-clinical_variable
( 33 34 623 624 O
serum 34 39 624 629 B-clinical_variable
glutamic 40 48 630 638 I-clinical_variable
oxaloacetic 49 60 639 650 I-clinical_variable
transaminase 61 73 651 663 I-clinical_variable
[ 74 75 664 665 I-clinical_variable
SGOT 75 79 665 669 I-clinical_variable
] 79 80 669 670 I-clinical_variable
) 80 81 670 671 I-clinical_variable
≤ 82 83 672 673 O
2.5 84 87 674 677 B-upper_bound
X 88 89 678 679 I-upper_bound
institutional 90 103 680 693 I-upper_bound
upper 104 109 694 699 I-upper_bound
limit 110 115 700 705 I-upper_bound
of 116 118 706 708 I-upper_bound
normal 119 125 709 715 I-upper_bound

Creatinine 0 10 716 726 B-clinical_variable
clearance 11 20 727 736 I-clinical_variable
≥ 21 22 737 738 O
45 23 25 739 741 B-lower_bound
mL 26 28 742 744 I-lower_bound
/ 28 29 744 745 I-lower_bound
min 29 32 745 748 I-lower_bound
calculated 33 43 749 759 O
by 44 46 760 762 O
Cockcroft 47 56 763 772 O
- 56 57 772 773 O
Gault 57 62 773 778 O

ECOG 0 4 779 783 B-clinical_variable
performance 5 16 784 795 I-clinical_variable
status 17 23 796 802 I-clinical_variable
≥ 24 25 803 804 O
2 26 27 805 806 B-lower_bound
( 28 29 807 808 O
1 29 30 808 809 O
point 31 36 810 815 O
) 36 37 815 816 O

Eastern 0 7 817 824 B-clinical_variable
Cooperative 8 19 825 836 I-clinical_variable
Oncology 20 28 837 845 I-clinical_variable
Group 29 34 846 851 I-clinical_variable
( 35 36 852 853 I-clinical_variable
ECOG 36 40 853 857 I-clinical_variable
) 40 41 857 858 I-clinical_variable
performance 42 53 859 870 I-clinical_variable
status 54 60 871 877 I-clinical_variable
≤ 61 62 878 879 O
2 63 64 880 881 B-upper_bound
; 64 65 881 882 O
performance 66 77 883 894 O
status 78 84 895 901 O
of 85 87 902 904 O
3 88 89 905 906 B-upper_bound
will 90 94 907 911 O
be 95 97 912 914 O
accepted 98 106 915 923 O
if 107 109 924 926 O
impairment 110 120 927 937 O
is 121 123 938 940 O
caused 124 130 941 947 O
by 131 133 948 950 O
DLBCL 134 139 951 956 O
complications 140 153 957 970 O
and 154 157 971 974 O
improvement 158 169 975 986 O
is 170 172 987 989 O
expected 173 181 990 998 O
once 182 186 999 1003 O
therapy 187 194 1004 1011 B-treatment
is 195 197 1012 1014 O
initiated 198 207 1015 1024 O

Hemoglobin 0 10 1025 1035 B-clinical_variable
≥ 11 12 1036 1037 O
7.0 13 16 1038 1041 B-lower_bound
g 17 18 1042 1043 I-lower_bound
/ 18 19 1043 1044 I-lower_bound
dl 19 21 1044 1046 I-lower_bound

History 0 7 1047 1054 O
of 8 10 1055 1057 O
allergic 11 19 1058 1066 O
reactions 20 29 1067 1076 O
attributed 30 40 1077 1087 O
to 41 43 1088 1090 O
compounds 44 53 1091 1100 O
of 54 56 1101 1103 O
similar 57 64 1104 1111 O
chemical 65 73 1112 1120 O
or 74 76 1121 1123 O
biologic 77 85 1124 1132 O
composition 86 97 1133 1144 O
to 98 100 1145 1147 O
carfilzomib 101 112 1148 1159 B-allergy_name
or 113 115 1160 1162 O
other 116 121 1163 1168 O
agents 122 128 1169 1175 O
( 129 130 1176 1177 O
R 130 131 1177 1178 B-allergy_name
- 131 132 1178 1179 I-allergy_name
CHOP 132 136 1179 1183 I-allergy_name
) 136 137 1183 1184 O
used 138 142 1185 1189 O
in 143 145 1190 1192 O
this 146 150 1193 1197 O
study 151 156 1198 1203 O

Human 0 5 1204 1209 B-chronic_disease
immunodeficiency 6 22 1210 1226 I-chronic_disease
virus 23 28 1227 1232 I-chronic_disease
( 29 30 1233 1234 I-chronic_disease
HIV)-positive 30 43 1234 1247 I-chronic_disease
patients 44 52 1248 1256 O
on 53 55 1257 1259 O
combination 56 67 1260 1271 B-treatment
antiretroviral 68 82 1272 1286 I-treatment
therapy 83 90 1287 1294 I-treatment
are 91 94 1295 1298 O
ineligible 95 105 1299 1309 O

Known 0 5 1310 1315 O
central 6 13 1316 1323 B-chronic_disease
nervous 14 21 1324 1331 I-chronic_disease
system 22 28 1332 1338 I-chronic_disease
( 29 30 1339 1340 I-chronic_disease
CNS 30 33 1340 1343 I-chronic_disease
) 33 34 1343 1344 I-chronic_disease
involvement 35 46 1345 1356 O
by 47 49 1357 1359 O
lymphoma 50 58 1360 1368 B-cancer

Lactate 0 7 1369 1376 B-clinical_variable
dehydrogenase 8 21 1377 1390 I-clinical_variable
( 22 23 1391 1392 I-clinical_variable
LDH 23 26 1392 1395 I-clinical_variable
) 26 27 1395 1396 I-clinical_variable
> 28 29 1397 1398 O
upper 30 35 1399 1404 B-lower_bound
limit 36 41 1405 1410 I-lower_bound
of 42 44 1411 1413 I-lower_bound
normal 45 51 1414 1420 I-lower_bound
( 52 53 1421 1422 I-lower_bound
1 53 54 1422 1423 I-lower_bound
point 55 60 1424 1429 I-lower_bound
) 60 61 1429 1430 I-lower_bound

Other 0 5 1431 1436 O
malignancies 6 18 1437 1449 B-cancer
within 19 25 1450 1456 O
the 26 29 1457 1460 O
past 30 34 1461 1465 B-upper_bound
3 35 36 1466 1467 I-upper_bound
years 37 42 1468 1473 I-upper_bound
except 43 49 1474 1480 O
for 50 53 1481 1484 O
adequately 54 64 1485 1495 O
treated 65 72 1496 1503 O
carcinoma 73 82 1504 1513 B-cancer
of 83 85 1514 1516 I-cancer
the 86 89 1517 1520 I-cancer
cervix 90 96 1521 1527 I-cancer
or 97 99 1528 1530 O
basal 100 105 1531 1536 B-cancer
or 106 108 1537 1539 O
squamous 109 117 1540 1548 B-cancer
cell 118 122 1549 1553 I-cancer
carcinomas 123 133 1554 1564 I-cancer
of 134 136 1565 1567 I-cancer
the 137 140 1568 1571 I-cancer
skin 141 145 1572 1576 I-cancer
, 145 146 1576 1577 O
or 147 149 1578 1580 O
low 150 153 1581 1584 O
- 153 154 1584 1585 O
risk 154 158 1585 1589 O
prostate 159 167 1590 1598 B-cancer
cancer 168 174 1599 1605 I-cancer
after 175 180 1606 1611 O
curative 181 189 1612 1620 B-treatment
therapy 190 197 1621 1628 I-treatment

Patients 0 8 1629 1637 O
may 9 12 1638 1641 O
have 13 17 1642 1646 O
received 18 26 1647 1655 O
brief 27 32 1656 1661 O
( 33 34 1662 1663 O
< 34 35 1663 1664 O
15 35 37 1664 1666 B-upper_bound
days 38 42 1667 1671 I-upper_bound
) 42 43 1671 1672 O
treatment 44 53 1673 1682 B-treatment
with 54 58 1683 1687 I-treatment
glucocorticoids 59 74 1688 1703 I-treatment
and/or 75 81 1704 1710 O
1 82 83 1711 1712 B-treatment
cycle 84 89 1713 1718 I-treatment
of 90 92 1719 1721 I-treatment
chemotherapy 93 105 1722 1734 I-treatment
such 106 110 1735 1739 O
as 111 113 1740 1742 O
R 114 115 1743 1744 B-treatment
- 115 116 1744 1745 I-treatment
CHOP 116 120 1745 1749 I-treatment
[ 121 122 1750 1751 O
or 122 124 1751 1753 O
some 125 129 1754 1758 O
component(s 130 141 1759 1770 O
) 141 142 1770 1771 O
thereof 143 150 1772 1779 O
] 150 151 1779 1780 O
for 152 155 1781 1784 O
the 156 159 1785 1788 O
diagnosis 160 169 1789 1798 O
of 170 172 1799 1801 O
B 173 174 1802 1803 B-cancer
- 174 175 1803 1804 I-cancer
cell 175 179 1804 1808 I-cancer
lymphoma 180 188 1809 1817 I-cancer
provided 189 197 1818 1826 O
they 198 202 1827 1831 O
had 203 206 1832 1835 O
all 207 210 1836 1839 O
necessary 211 220 1840 1849 O
staging 221 228 1850 1857 O
tests 229 234 1858 1863 O
performed 235 244 1864 1873 O
prior 245 250 1874 1879 O
to 251 253 1880 1882 O
R 254 255 1883 1884 O
- 255 256 1884 1885 O
CHOP 256 260 1885 1889 O
including 261 270 1890 1899 O
CT 271 273 1900 1902 B-treatment
and/or 274 280 1903 1909 O
PET 281 284 1910 1913 B-treatment
/ 284 285 1913 1914 I-treatment
CT 285 287 1914 1916 I-treatment
scans 288 293 1917 1922 I-treatment
, 293 294 1922 1923 O
echocardiogram 295 309 1924 1938 B-treatment
and 310 313 1939 1942 O
bone 314 318 1943 1947 B-treatment
marrow 319 325 1948 1954 I-treatment
biopsy 326 332 1955 1961 I-treatment
. 332 333 1961 1962 O
Treatment 334 343 1963 1972 B-treatment
must 344 348 1973 1977 O
occur 349 354 1978 1983 O
within 355 361 1984 1990 O
60 362 364 1991 1993 B-upper_bound
days 365 369 1994 1998 I-upper_bound
prior 370 375 1999 2004 I-upper_bound
to 376 378 2005 2007 O
enrollment 379 389 2008 2018 O

Patients 0 8 2019 2027 O
must 9 13 2028 2032 O
have 14 18 2033 2037 O
histologically 19 33 2038 2052 O
confirmed 34 43 2053 2062 O
diffuse 44 51 2063 2070 B-cancer
large 52 57 2071 2076 I-cancer
B 58 59 2077 2078 I-cancer
- 59 60 2078 2079 I-cancer
cell 60 64 2079 2083 I-cancer
lymphoma 65 73 2084 2092 I-cancer
( 74 75 2093 2094 I-cancer
DLBCL 75 80 2094 2099 I-cancer
) 80 81 2099 2100 I-cancer
; 81 82 2100 2101 O
patients 83 91 2102 2110 O
with 92 96 2111 2115 O
previously 97 107 2116 2126 O
diagnosed 108 117 2127 2136 O
indolent 118 126 2137 2145 B-cancer
lymphoma 127 135 2146 2154 I-cancer
( 136 137 2155 2156 O
follicular 137 147 2156 2166 B-cancer
lymphoma 148 156 2167 2175 I-cancer
and 157 160 2176 2179 O
marginal 161 169 2180 2188 B-cancer
zone 170 174 2189 2193 I-cancer
lymphoma 175 183 2194 2202 I-cancer
but 184 187 2203 2206 O
not 188 191 2207 2210 O
small 192 197 2211 2216 B-cancer
lymphocytic 198 209 2217 2228 I-cancer
lymphoma 210 218 2229 2237 I-cancer
) 218 219 2237 2238 O
who 220 223 2239 2242 O
have 224 228 2243 2247 O
transformed 229 240 2248 2259 O
to 241 243 2260 2262 O
DLBCL 244 249 2263 2268 O
are 250 253 2269 2272 O
eligible 254 262 2273 2281 O
only 263 267 2282 2286 O
if 268 270 2287 2289 O
they 271 275 2290 2294 O
have 276 280 2295 2299 O
not 281 284 2300 2303 O
previously 285 295 2304 2314 O
been 296 300 2315 2319 O
treated 301 308 2320 2327 O
for 309 312 2328 2331 O
indolent 313 321 2332 2340 O
lymphoma 322 330 2341 2349 O
. 330 331 2349 2350 O
For 332 335 2351 2354 O
the 336 339 2355 2358 O
Phase 340 345 2359 2364 O
II 346 348 2365 2367 O
study 349 354 2368 2373 O
, 354 355 2373 2374 O
patients 356 364 2375 2383 O
must 365 369 2384 2388 O
have 370 374 2389 2393 O
non 375 378 2394 2397 O
- 378 379 2397 2398 O
GC 379 381 2398 2400 O
DLBCL 382 387 2401 2406 O
as 388 390 2407 2409 O
determined 391 401 2410 2420 O
by 402 404 2421 2423 O
Hans 405 409 2424 2428 O
Algorithm 410 419 2429 2438 O

Patients 0 8 2439 2447 O
who 9 12 2448 2451 O
are 13 16 2452 2455 O
receiving 17 26 2456 2465 O
any 27 30 2466 2469 O
other 31 36 2470 2475 O
investigational 37 52 2476 2491 B-treatment
agents 53 59 2492 2498 I-treatment

Patients 0 8 2499 2507 O
who 9 12 2508 2511 O
are 13 16 2512 2515 O
reported 17 25 2516 2524 O
to 26 28 2525 2527 O
be 29 31 2528 2530 O
of 32 34 2531 2533 O
direct 35 41 2534 2540 O
Asian 42 47 2541 2546 B-ethnicity
- 47 48 2546 2547 I-ethnicity
Pacific 48 55 2547 2554 I-ethnicity
( 56 57 2555 2556 I-ethnicity
China 57 62 2556 2561 I-ethnicity
, 62 63 2561 2562 I-ethnicity
Japan 64 69 2563 2568 I-ethnicity
, 69 70 2568 2569 I-ethnicity
Taiwan 71 77 2570 2576 I-ethnicity
, 77 78 2576 2577 I-ethnicity
Singapore 79 88 2578 2587 I-ethnicity
, 88 89 2587 2588 I-ethnicity
Republic 90 98 2589 2597 I-ethnicity
of 99 101 2598 2600 I-ethnicity
Korea 102 107 2601 2606 I-ethnicity
, 107 108 2606 2607 I-ethnicity
and 109 112 2608 2611 I-ethnicity
Thailand 113 121 2612 2620 I-ethnicity
) 121 122 2620 2621 I-ethnicity
ancestry 123 131 2622 2630 I-ethnicity

Patients 0 8 2631 2639 O
who 9 12 2640 2643 O
have 13 17 2644 2648 O
had 18 21 2649 2652 O
major 22 27 2653 2658 O
surgical 28 36 2659 2667 O
procedures 37 47 2668 2678 O
or 48 50 2679 2681 O
significant 51 62 2682 2693 O
traumatic 63 72 2694 2703 B-chronic_disease
injury 73 79 2704 2710 I-chronic_disease
within 80 86 2711 2717 O
28 87 89 2718 2720 B-upper_bound
days 90 94 2721 2725 I-upper_bound
prior 95 100 2726 2731 I-upper_bound
to 101 103 2732 2734 O
study 104 109 2735 2740 O
treatment 110 119 2741 2750 B-treatment

Patients 0 8 2751 2759 O
who 9 12 2760 2763 O
have 13 17 2764 2768 O
not 18 21 2769 2772 O
recovered 22 31 2773 2782 O
from 32 36 2783 2787 O
adverse 37 44 2788 2795 O
events 45 51 2796 2802 O
due 52 55 2803 2806 O
to 56 58 2807 2809 O
agents 59 65 2810 2816 O
administered 66 78 2817 2829 O
more 79 83 2830 2834 O
than 84 88 2835 2839 O
4 89 90 2840 2841 B-lower_bound
weeks 91 96 2842 2847 I-lower_bound
earlier 97 104 2848 2855 I-lower_bound

Patients 0 8 2856 2864 O
with 9 13 2865 2869 O
uncontrolled 14 26 2870 2882 O
intercurrent 27 39 2883 2895 O
illness 40 47 2896 2903 O
including 48 57 2904 2913 O
, 57 58 2913 2914 O
but 59 62 2915 2918 O
not 63 66 2919 2922 O
limited 67 74 2923 2930 O
to 75 77 2931 2933 O
ongoing 78 85 2934 2941 O
or 86 88 2942 2944 O
active 89 95 2945 2951 B-chronic_disease
infection 96 105 2952 2961 I-chronic_disease
, 105 106 2961 2962 O
or 107 109 2963 2965 O
psychiatric 110 121 2966 2977 B-chronic_disease
illness 122 129 2978 2985 I-chronic_disease
/ 129 130 2985 2986 O
social 130 136 2986 2992 O
situations 137 147 2993 3003 O
that 148 152 3004 3008 O
would 153 158 3009 3014 O
limit 159 164 3015 3020 O
compliance 165 175 3021 3031 O
with 176 180 3032 3036 O
study 181 186 3037 3042 O
requirements 187 199 3043 3055 O

Platelet 0 8 3056 3064 B-clinical_variable
count 9 14 3065 3070 I-clinical_variable
≥ 15 16 3071 3072 O
100,000 17 24 3073 3080 B-lower_bound
/ 24 25 3080 3081 I-lower_bound
mcL 25 28 3081 3084 I-lower_bound

Pregnant 0 8 3085 3093 B-pregnancy

The 0 3 3094 3097 O
effects 4 11 3098 3105 O
of 12 14 3106 3108 O
Carfilzomib 15 26 3109 3120 B-treatment
on 27 29 3121 3123 O
the 30 33 3124 3127 O
developing 34 44 3128 3138 O
human 45 50 3139 3144 O
fetus 51 56 3145 3150 O
are 57 60 3151 3154 O
unknown 61 68 3155 3162 O
. 68 69 3162 3163 O
For 70 73 3164 3167 O
this 74 78 3168 3172 O
reason 79 85 3173 3179 O
and 86 89 3180 3183 O
because 90 97 3184 3191 O
chemotherapeutic 98 114 3192 3208 B-treatment
agents 115 121 3209 3215 I-treatment
used 122 126 3216 3220 O
in 127 129 3221 3223 O
this 130 134 3224 3228 O
study 135 140 3229 3234 O
are 141 144 3235 3238 O
known 145 150 3239 3244 O
to 151 153 3245 3247 O
be 154 156 3248 3250 O
teratogenic 157 168 3251 3262 O
, 168 169 3262 3263 O
women 170 175 3264 3269 B-gender
of 176 178 3270 3272 O
child 179 184 3273 3278 O
- 184 185 3278 3279 O
bearing 185 192 3279 3286 O
potential 193 202 3287 3296 O
and 203 206 3297 3300 O
men 207 210 3301 3304 O
must 211 215 3305 3309 O
agree 216 221 3310 3315 B-contraception_consent
to 222 224 3316 3318 I-contraception_consent
use 225 228 3319 3322 I-contraception_consent
adequate 229 237 3323 3331 I-contraception_consent
contraception 238 251 3332 3345 I-contraception_consent
( 252 253 3346 3347 O
double 253 259 3347 3353 B-contraception_consent
barrier 260 267 3354 3361 I-contraception_consent
method 268 274 3362 3368 I-contraception_consent
of 275 277 3369 3371 I-contraception_consent
birth 278 283 3372 3377 I-contraception_consent
control 284 291 3378 3385 I-contraception_consent
or 292 294 3386 3388 O
abstinence 295 305 3389 3399 B-contraception_consent
) 305 306 3399 3400 O
2 307 308 3401 3402 B-upper_bound
weeks 309 314 3403 3408 I-upper_bound
prior 315 320 3409 3414 I-upper_bound
to 321 323 3415 3417 O
initiation 324 334 3418 3428 O
of 335 337 3429 3431 O
treatment 338 347 3432 3441 B-treatment
, 347 348 3441 3442 O
for 349 352 3443 3446 O
the 353 356 3447 3450 O
duration 357 365 3451 3459 O
of 366 368 3460 3462 O
study 369 374 3463 3468 O
participation 375 388 3469 3482 O
and 389 392 3483 3486 O
for 393 396 3487 3490 O
3 397 398 3491 3492 B-upper_bound
months 399 405 3493 3499 I-upper_bound
after 406 411 3500 3505 I-upper_bound
completing 412 422 3506 3516 O
treatment 423 432 3517 3526 O
. 432 433 3526 3527 O
Should 434 440 3528 3534 O
a 441 442 3535 3536 O
woman 443 448 3537 3542 B-gender
become 449 455 3543 3549 B-pregnancy
pregnant 456 464 3550 3558 I-pregnancy
or 465 467 3559 3561 O
suspect 468 475 3562 3569 O
that 476 480 3570 3574 O
she 481 484 3575 3578 O
is 485 487 3579 3581 O
pregnant 488 496 3582 3590 O
while 497 502 3591 3596 O
she 503 506 3597 3600 O
or 507 509 3601 3603 O
her 510 513 3604 3607 O
partner 514 521 3608 3615 O
is 522 524 3616 3618 O
participating 525 538 3619 3632 O
in 539 541 3633 3635 O
this 542 546 3636 3640 O
study 547 552 3641 3646 O
, 552 553 3646 3647 O
she 554 557 3648 3651 O
should 558 564 3652 3658 O
inform 565 571 3659 3665 O
the 572 575 3666 3669 O
treating 576 584 3670 3678 O
physician 585 594 3679 3688 O
immediately 595 606 3689 3700 O
. 606 607 3700 3701 O
Men 608 611 3702 3705 B-gender
must 612 616 3706 3710 O
agree 617 622 3711 3716 O
to 623 625 3717 3719 O
refrain 626 633 3720 3727 O
from 634 638 3728 3732 O
sperm 639 644 3733 3738 O
donation 645 653 3739 3747 O
for 654 657 3748 3751 O
at 658 660 3752 3754 O
least 661 666 3755 3760 O
90 667 669 3761 3763 B-lower_bound
days 670 674 3764 3768 I-lower_bound
after 675 680 3769 3774 I-lower_bound
the 681 684 3775 3778 O
last 685 689 3779 3783 O
dose 690 694 3784 3788 O
of 695 697 3789 3791 O
carfilzomib 698 709 3792 3803 B-treatment

Total 0 5 3804 3809 B-clinical_variable
bilirubin 6 15 3810 3819 I-clinical_variable
within 16 22 3820 3826 O
normal 23 29 3827 3833 O
institutional 30 43 3834 3847 O
limits 44 50 3848 3854 O
unless 51 57 3855 3861 O
due 58 61 3862 3865 O
to 62 64 3866 3868 O
Gilbert 65 72 3869 3876 B-chronic_disease
's 72 74 3876 3878 I-chronic_disease
disease 75 82 3879 3886 I-chronic_disease

breastfeeding 0 13 3887 3900 O
women 14 19 3901 3906 B-gender
are 20 23 3907 3910 O
excluded 24 32 3911 3919 O
from 33 37 3920 3924 O
this 38 42 3925 3929 O
study 43 48 3930 3935 O
; 48 49 3935 3936 O
breastfeeding 50 63 3937 3950 O
should 64 70 3951 3957 O
be 71 73 3958 3960 O
discontinued 74 86 3961 3973 O
if 87 89 3974 3976 O
the 90 93 3977 3980 O
mother 94 100 3981 3987 O
is 101 103 3988 3990 O
treated 104 111 3991 3998 O
with 112 116 3999 4003 O
carfilzomib 117 128 4004 4015 B-treatment

≥ 0 1 4016 4017 O
2 2 3 4018 4019 B-lower_bound
extranodal 4 14 4020 4030 B-cancer
sites 15 20 4031 4036 I-cancer
( 21 22 4037 4038 O
1 22 23 4038 4039 O
point 24 29 4040 4045 O
) 29 30 4045 4046 O

BMI 0 3 0 3 B-bmi
between 4 11 4 11 O
18 12 14 12 14 B-lower_bound
and 15 18 15 18 O
60 19 21 19 21 B-upper_bound
kg 22 24 22 24 I-upper_bound
/ 24 25 24 25 I-upper_bound
m2 25 27 25 27 I-upper_bound
, 27 28 27 28 O
inclusive 29 38 29 38 O

Baseline 0 8 39 47 O
UFC 9 12 48 51 B-clinical_variable
1.3 13 16 52 55 B-lower_bound
to 17 19 56 58 O
10 20 22 59 61 B-upper_bound
× 23 24 62 63 I-upper_bound
upper 25 30 64 69 I-upper_bound
limit 31 36 70 75 I-upper_bound
of 37 39 76 78 I-upper_bound
normal 40 46 79 85 I-upper_bound
( 47 48 86 87 I-upper_bound
ULN 48 51 87 90 I-upper_bound
) 51 52 90 91 I-upper_bound

Candidates 0 10 92 102 O
for 11 14 103 106 O
surgical 15 23 107 115 B-treatment
treatment 24 33 116 125 I-treatment
of 34 36 126 128 O
Cushing 37 44 129 136 B-chronic_disease
's 44 46 136 138 I-chronic_disease
syndrome 47 55 139 147 I-chronic_disease
, 55 56 147 148 O
unless 57 63 149 155 O
surgery 64 71 156 163 O
is 72 74 164 166 O
not 75 78 167 170 O
anticipated 79 90 171 182 O
to 91 93 183 185 O
occur 94 99 186 191 O
during 100 106 192 198 O
the 107 110 199 202 O
study 111 116 203 208 O

Pseudo 0 6 209 215 B-chronic_disease
- 6 7 215 216 I-chronic_disease
Cushing 7 14 216 223 I-chronic_disease
's 14 16 223 225 I-chronic_disease
syndrome 17 25 226 234 I-chronic_disease

Radiotherapy 0 12 235 247 B-treatment
of 13 15 248 250 O
the 16 19 251 254 O
pituitary 20 29 255 264 O
within 30 36 265 271 O
6 37 38 272 273 B-upper_bound
months 39 45 274 280 I-upper_bound

current 0 7 281 288 O
iatrogenic 8 18 289 299 B-chronic_disease
Cushing 19 26 300 307 I-chronic_disease
's 26 28 307 309 I-chronic_disease
syndrome 29 37 310 318 I-chronic_disease

cyclic 0 6 319 325 B-chronic_disease
Cushing 7 14 326 333 I-chronic_disease
's 14 16 333 335 I-chronic_disease
syndrome 17 25 336 344 I-chronic_disease

Adult 0 5 0 5 O
patients 6 14 6 14 O
( 15 16 15 16 O
18 16 18 16 18 B-lower_bound
and 19 22 19 22 O
over 23 27 23 27 O
) 27 28 27 28 O

pregnant 0 8 29 37 B-pregnancy
women 9 14 38 43 B-gender

who 0 3 44 47 O
speak 4 9 48 53 B-language_fluency
English 10 17 54 61 I-language_fluency
, 17 18 61 62 I-language_fluency
Spanish 19 26 63 70 I-language_fluency
or 27 29 71 73 I-language_fluency
Creole 30 36 74 80 I-language_fluency

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
cells/µL 35 43 35 43 I-lower_bound

Active 0 6 44 50 O
heart 7 12 51 56 B-chronic_disease
disease 13 20 57 64 I-chronic_disease
including 21 30 65 74 O
myocardial 31 41 75 85 B-chronic_disease
infarction 42 52 86 96 I-chronic_disease
within 53 59 97 103 O
previous 60 68 104 112 B-upper_bound
3 69 70 113 114 I-upper_bound
months 71 77 115 121 I-upper_bound
, 77 78 121 122 O
symptomatic 79 90 123 134 B-chronic_disease
coronary 91 99 135 143 I-chronic_disease
artery 100 106 144 150 I-chronic_disease
disease 107 114 151 158 I-chronic_disease
or 115 117 159 161 O
heart 118 123 162 167 B-chronic_disease
block 124 129 168 173 I-chronic_disease
, 129 130 173 174 O
or 131 133 175 177 O
uncontrolled 134 146 178 190 O
congestive 147 157 191 201 B-chronic_disease
heart 158 163 202 207 I-chronic_disease
failure 164 171 208 215 I-chronic_disease

Aspartate 0 9 216 225 B-clinical_variable
aminotransferase 10 26 226 242 I-clinical_variable
( 27 28 243 244 I-clinical_variable
AST)/alanine 28 40 244 256 I-clinical_variable
aminotransferase 41 57 257 273 I-clinical_variable
( 58 59 274 275 I-clinical_variable
ALT 59 62 275 278 I-clinical_variable
) 62 63 278 279 I-clinical_variable
= 64 65 280 281 O
< 65 66 281 282 O
2.5 67 70 283 286 B-upper_bound
x 71 72 287 288 I-upper_bound
ULN 73 76 289 292 I-upper_bound
; 76 77 292 293 O
AST 78 81 294 297 O
/ 81 82 297 298 O
ALT 82 85 298 301 O
= 86 87 302 303 O
< 87 88 303 304 O
5 89 90 305 306 O
x 91 92 307 308 O
ULN 93 96 309 312 O
if 97 99 313 315 O
liver 100 105 316 321 B-cancer
metastasis 106 116 322 332 I-cancer
is 117 119 333 335 O
present 120 127 336 343 O

Eastern 0 7 344 351 B-clinical_variable
Cooperative 8 19 352 363 I-clinical_variable
Oncology 20 28 364 372 I-clinical_variable
Group 29 34 373 378 I-clinical_variable
( 35 36 379 380 I-clinical_variable
ECOG 36 40 380 384 I-clinical_variable
) 40 41 384 385 I-clinical_variable
performance 42 53 386 397 I-clinical_variable
status 54 60 398 404 I-clinical_variable
= 61 62 405 406 O
< 62 63 406 407 O
2 64 65 408 409 B-upper_bound

Leukocytes 0 10 410 420 B-clinical_variable
> 11 12 421 422 O
= 12 13 422 423 O
3,000 14 19 424 429 B-lower_bound
cells/µL 20 28 430 438 I-lower_bound

Life 0 4 439 443 B-clinical_variable
expectancy 5 15 444 454 I-clinical_variable
of 16 18 455 457 O
greater 19 26 458 465 O
than 27 31 466 470 O
3 32 33 471 472 B-lower_bound
months 34 40 473 479 I-lower_bound
by 41 43 480 482 O
physician 44 53 483 492 O
assessment 54 64 493 503 O

Negative 0 8 504 512 O
serum 9 14 513 518 O
beta 15 19 519 523 O
- 19 20 523 524 O
human 20 25 524 529 O
chorionic 26 35 530 539 O
gonadotropin 36 48 540 552 O
( 49 50 553 554 O
HCG 50 53 554 557 O
) 53 54 557 558 O
test 55 59 559 563 O
( 60 61 564 565 O
female 61 67 565 571 B-gender
patient 68 75 572 579 I-gender
of 76 78 580 582 O
childbearing 79 91 583 595 O
potential 92 101 596 605 O
only 102 106 606 610 O
) 106 107 610 611 O

Patients 0 8 612 620 O
may 9 12 621 624 O
be 13 15 625 627 O
enrolled 16 24 628 636 O
with 25 29 637 641 O
a 30 31 642 643 O
history 32 39 644 651 O
of 40 42 652 654 O
treated 43 50 655 662 O
brain 51 56 663 668 B-cancer
metastases 57 67 669 679 I-cancer
that 68 72 680 684 O
are 73 76 685 688 O
clinically 77 87 689 699 O
stable 88 94 700 706 O
for 95 98 707 710 O
> 99 100 711 712 O
= 100 101 712 713 O
4 102 103 714 715 B-lower_bound
weeks 104 109 716 721 I-lower_bound
prior 110 115 722 727 I-lower_bound
to 116 118 728 730 O
start 119 124 731 736 O
of 125 127 737 739 O
study 128 133 740 745 O
treatment 134 143 746 755 B-treatment

Patients 0 8 756 764 O
may 9 12 765 768 O
not 13 16 769 772 O
be 17 19 773 775 O
receiving 20 29 776 785 O
any 30 33 786 789 O
other 34 39 790 795 O
investigational 40 55 796 811 B-treatment
agents 56 62 812 818 I-treatment
; 62 63 818 819 O
use 64 67 820 823 O
of 68 70 824 826 O
over 71 75 827 831 B-treatment
- 75 76 831 832 I-treatment
the 76 79 832 835 I-treatment
- 79 80 835 836 I-treatment
counter 80 87 836 843 I-treatment
herbal 88 94 844 850 I-treatment
medications 95 106 851 862 I-treatment

Patients 0 8 863 871 O
must 9 13 872 876 O
have 14 18 877 881 O
histologically 19 33 882 896 O
or 34 36 897 899 O
cytologically 37 50 900 913 O
confirmed 51 60 914 923 O
( 61 62 924 925 O
at 62 64 925 927 O
original 65 73 928 936 O
diagnosis 74 83 937 946 O
or 84 86 947 949 O
subsequent 87 97 950 960 O
recurrence 98 108 961 971 O
or 109 111 972 974 O
progression 112 123 975 986 O
) 123 124 986 987 O
solid 125 130 988 993 B-cancer
tumor 131 136 994 999 I-cancer
that 137 141 1000 1004 O
is 142 144 1005 1007 O
metastatic 145 155 1008 1018 O
, 155 156 1018 1019 O
unresectable 157 169 1020 1032 O
, 169 170 1032 1033 O
progressive 171 182 1034 1045 O
, 182 183 1045 1046 O
or 184 186 1047 1049 O
recurrent 187 196 1050 1059 O
, 196 197 1059 1060 O
and 198 201 1061 1064 O
for 202 205 1065 1068 O
which 206 211 1069 1074 O
standard 212 220 1075 1083 O
curative 221 229 1084 1092 O
or 230 232 1093 1095 O
palliative 233 243 1096 1106 O
measures 244 252 1107 1115 O
do 253 255 1116 1118 O
not 256 259 1119 1122 O
exist 260 265 1123 1128 O
or 266 268 1129 1131 O
are 269 272 1132 1135 O
no 273 275 1136 1138 O
longer 276 282 1139 1145 O
effective 283 292 1146 1155 O

Patients 0 8 1156 1164 O
must 9 13 1165 1169 O
not 14 17 1170 1173 O
have 18 22 1174 1178 O
received 23 31 1179 1187 O
prior 32 37 1188 1193 B-treatment
chemotherapy 38 50 1194 1206 I-treatment
or 51 53 1207 1209 O
radiation 54 63 1210 1219 B-treatment
for 64 67 1220 1223 O
< 68 69 1224 1225 O
4 70 71 1226 1227 B-upper_bound
weeks 72 77 1228 1233 I-upper_bound
prior 78 83 1234 1239 I-upper_bound
to 84 86 1240 1242 O
start 87 92 1243 1248 O
of 93 95 1249 1251 O
study 96 101 1252 1257 O
treatment 102 111 1258 1267 B-treatment

Patients 0 8 1268 1276 O
with 9 13 1277 1281 O
a 14 15 1282 1283 O
history 16 23 1284 1291 O
of 24 26 1292 1294 O
noninfectious 27 40 1295 1308 O
pneumonitis 41 52 1309 1320 B-chronic_disease
will 53 57 1321 1325 O
be 58 60 1326 1328 O
excluded 61 69 1329 1337 O
during 70 76 1338 1344 O
the 77 80 1345 1348 O
dose 81 85 1349 1353 O
- 85 86 1353 1354 O
escalation 86 96 1354 1364 O
phase 97 102 1365 1370 O
of 103 105 1371 1373 O
the 106 109 1374 1377 O
trial 110 115 1378 1383 O

Patients 0 8 1384 1392 O
with 9 13 1393 1397 O
uncontrolled 14 26 1398 1410 O
undercurrent 27 39 1411 1423 O
illness 40 47 1424 1431 O
including 48 57 1432 1441 O
, 57 58 1441 1442 O
but 59 62 1443 1446 O
not 63 66 1447 1450 O
limited 67 74 1451 1458 O
to 75 77 1459 1461 O
, 77 78 1461 1462 O
ongoing 79 86 1463 1470 O
or 87 89 1471 1473 O
active 90 96 1474 1480 B-chronic_disease
infection 97 106 1481 1490 I-chronic_disease
, 106 107 1490 1491 O
or 108 110 1492 1494 O
psychiatric 111 122 1495 1506 B-chronic_disease
illness 123 130 1507 1514 I-chronic_disease
/ 130 131 1514 1515 I-chronic_disease
social 131 137 1515 1521 I-chronic_disease
situations 138 148 1522 1532 I-chronic_disease
that 149 153 1533 1537 O
would 154 159 1538 1543 O
limit 160 165 1544 1549 O
compliance 166 176 1550 1560 O
with 177 181 1561 1565 O
study 182 187 1566 1571 O
requirements 188 200 1572 1584 O

Platelets 0 9 1585 1594 B-clinical_variable
> 10 11 1595 1596 O
= 11 12 1596 1597 O
100 13 16 1598 1601 B-lower_bound
, 16 17 1601 1602 I-lower_bound
000 18 21 1603 1606 I-lower_bound
cells/µL 22 30 1607 1615 I-lower_bound

Prothrombin 0 11 1616 1627 B-clinical_variable
time 12 16 1628 1632 I-clinical_variable
( 17 18 1633 1634 I-clinical_variable
PT)/international 18 35 1634 1651 I-clinical_variable
normalized 36 46 1652 1662 I-clinical_variable
ratio 47 52 1663 1668 I-clinical_variable
( 53 54 1669 1670 I-clinical_variable
INR)/ 54 59 1670 1675 I-clinical_variable
activated 60 69 1676 1685 B-clinical_variable
partial 70 77 1686 1693 I-clinical_variable
thromboplastin 78 92 1694 1708 I-clinical_variable
time 93 97 1709 1713 I-clinical_variable
( 98 99 1714 1715 I-clinical_variable
aPTT 99 103 1715 1719 I-clinical_variable
) 103 104 1719 1720 I-clinical_variable
= 105 106 1721 1722 O
< 106 107 1722 1723 O
1.5 108 111 1724 1727 B-upper_bound
x 112 113 1728 1729 I-upper_bound
ULN 114 117 1730 1733 I-upper_bound

Serum 0 5 1734 1739 B-clinical_variable
creatinine 6 16 1740 1750 I-clinical_variable
= 17 18 1751 1752 O
< 18 19 1752 1753 O
1.5 20 23 1754 1757 B-upper_bound
mg 24 26 1758 1760 I-upper_bound
/ 26 27 1760 1761 I-upper_bound
dL 27 29 1761 1763 I-upper_bound
or 30 32 1764 1766 O
a 33 34 1767 1768 O
measured 35 43 1769 1777 O
creatinine 44 54 1778 1788 B-clinical_variable
clearance 55 64 1789 1798 I-clinical_variable
> 65 66 1799 1800 O
= 66 67 1800 1801 O
50 68 70 1802 1804 B-lower_bound
mL 71 73 1805 1807 I-lower_bound
/ 73 74 1807 1808 I-lower_bound
min 74 77 1808 1811 I-lower_bound

Total 0 5 1812 1817 B-clinical_variable
bilirubin 6 15 1818 1827 I-clinical_variable
= 16 17 1828 1829 O
< 17 18 1829 1830 O
1.5 19 22 1831 1834 B-upper_bound
times 23 28 1835 1840 I-upper_bound
the 29 32 1841 1844 I-upper_bound
upper 33 38 1845 1850 I-upper_bound
limit 39 44 1851 1856 I-upper_bound
of 45 47 1857 1859 I-upper_bound
normal 48 54 1860 1866 I-upper_bound
( 55 56 1867 1868 I-upper_bound
ULN 56 59 1868 1871 I-upper_bound
) 59 60 1871 1872 I-upper_bound

Women 0 5 1873 1878 B-gender
of 6 8 1879 1881 O
child 9 14 1882 1887 O
- 14 15 1887 1888 O
bearing 15 22 1888 1895 O
potential 23 32 1896 1905 O
and 33 36 1906 1909 O
men 37 40 1910 1913 O
must 41 45 1914 1918 O
agree 46 51 1919 1924 B-contraception_consent
to 52 54 1925 1927 I-contraception_consent
use 55 58 1928 1931 I-contraception_consent
adequate 59 67 1932 1940 I-contraception_consent
contraception 68 81 1941 1954 I-contraception_consent
( 82 83 1955 1956 O
hormonal 83 91 1956 1964 B-contraception_consent
or 92 94 1965 1967 O
barrier 95 102 1968 1975 B-contraception_consent
method 103 109 1976 1982 I-contraception_consent
of 110 112 1983 1985 I-contraception_consent
birth 113 118 1986 1991 I-contraception_consent
control 119 126 1992 1999 I-contraception_consent
or 127 129 2000 2002 O
abstinence 130 140 2003 2013 B-contraception_consent
) 140 141 2013 2014 O
prior 142 147 2015 2020 O
to 148 150 2021 2023 O
study 151 156 2024 2029 O
entry 157 162 2030 2035 O
and 163 166 2036 2039 O
for 167 170 2040 2043 O
six 171 174 2044 2047 B-upper_bound
months 175 181 2048 2054 I-upper_bound
following 182 191 2055 2064 O
duration 192 200 2065 2073 O
of 201 203 2074 2076 O
study 204 209 2077 2082 O
participation 210 223 2083 2096 O

any 0 3 2097 2100 O
prior 4 9 2101 2106 B-treatment
radiation 10 19 2107 2116 I-treatment
therapy 20 27 2117 2124 I-treatment
must 28 32 2125 2129 O
have 33 37 2130 2134 O
been 38 42 2135 2139 O
administered 43 55 2140 2152 O
> 56 57 2153 2154 O
= 57 58 2154 2155 O
4 59 60 2156 2157 B-lower_bound
weeks 61 66 2158 2163 I-lower_bound
prior 67 72 2164 2169 I-lower_bound
to 73 75 2170 2172 O
start 76 81 2173 2178 O
of 82 84 2179 2181 O
study 85 90 2182 2187 B-treatment
treatment 91 100 2188 2197 I-treatment

the 0 3 2198 2201 O
patient 4 11 2202 2209 O
must 12 16 2210 2214 O
be 17 19 2215 2217 O
recovered 20 29 2218 2227 O
from 30 34 2228 2232 O
the 35 38 2233 2236 O
acute 39 44 2237 2242 O
toxic 45 50 2243 2248 O
effects 51 58 2249 2256 O
of 59 61 2257 2259 O
the 62 65 2260 2263 O
treatment 66 75 2264 2273 B-treatment
prior 76 81 2274 2279 O
to 82 84 2280 2282 O
start 85 90 2283 2288 O
of 91 93 2289 2291 O
study 94 99 2292 2297 B-treatment
treatment 100 109 2298 2307 I-treatment

EMTs 0 4 0 4 O
who 5 8 5 8 O
expect 9 15 9 15 O
to 16 18 16 18 O
leave 19 24 19 24 O
the 25 28 25 28 O
job 29 32 29 32 O
in 33 35 33 35 O
less 36 40 36 40 O
than 41 45 41 45 O
1 46 47 46 47 B-upper_bound
year 48 52 48 52 I-upper_bound

over 0 4 53 57 O
the 5 8 58 61 O
age 9 12 62 65 B-age
of 13 15 66 68 O
18 16 18 69 71 B-lower_bound
years 19 24 72 77 I-lower_bound

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
or 7 9 7 9 O
older 10 15 10 15 O

Age 0 3 16 19 B-age
less 4 8 20 24 O
than 9 13 25 29 O
18 14 16 30 32 B-upper_bound
yrs 17 20 33 36 I-upper_bound

Allergy 0 7 37 44 O
to 8 10 45 47 O
local 11 16 48 53 B-allergy_name
anesthetics 17 28 54 65 I-allergy_name

Conversion 0 10 66 76 O
from 11 15 77 81 O
laparoscopic 16 28 82 94 B-treatment
to 29 31 95 97 O
open 32 36 98 102 B-treatment
surgery 37 44 103 110 I-treatment

History 0 7 111 118 O
of 8 10 119 121 O
Chronic 11 18 122 129 O
pain 19 23 130 134 O
or 24 26 135 137 O
ongoing 27 34 138 145 O
treatment 35 44 146 155 B-treatment
for 45 48 156 159 O
chronic 49 56 160 167 O
pain 57 61 168 172 O

with 0 4 173 177 O
unilateral 5 15 178 188 O
or 16 18 189 191 O
bilateral 19 28 192 201 B-chronic_disease
inguinal 29 37 202 210 I-chronic_disease
herna 38 43 211 216 I-chronic_disease
for 44 47 217 220 O
laparoscopic 48 60 221 233 O
repair 61 67 234 240 O

Be 0 2 0 2 O
> 3 4 3 4 O
18 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound
old 14 17 14 17 O

Be 0 2 18 20 O
suspected 3 12 21 30 O
by 13 15 31 33 O
the 16 19 34 37 O
referring 20 29 38 47 O
medical 30 37 48 55 O
provider 38 46 56 64 O
to 47 49 65 67 O
have 50 54 68 72 O
a 55 56 73 74 O
first 57 62 75 80 O
episode 63 70 81 88 O
of 71 73 89 91 O
acute 74 79 92 97 B-chronic_disease
DVT 80 83 98 101 I-chronic_disease
of 84 86 102 104 O
the 87 90 105 108 O
lower 91 96 109 114 O
extremities 97 108 115 126 O

Long 0 4 127 131 O
term 5 9 132 136 O
anticoagulation 10 25 137 152 B-treatment
will 26 30 153 157 O
be 31 33 158 160 O
required 34 42 161 169 O
for 43 46 170 173 O
another 47 54 174 181 O
diagnosis 55 64 182 191 O
( 65 66 192 193 O
e.g. 66 70 193 197 O
atrial 71 77 198 204 B-chronic_disease
fibrillation 78 90 205 217 I-chronic_disease
) 90 91 217 218 O

Pregnancy 0 9 219 228 B-pregnancy
confirmed 10 19 229 238 O
by 20 22 239 241 O
an 23 25 242 244 O
objective 26 35 245 254 O
test 36 40 255 259 O

Previous 0 8 260 268 O
venous 9 15 269 275 O
ultrasound 16 26 276 286 O
has 27 30 287 290 O
been 31 35 291 295 O
performed 36 45 296 305 O
during 46 52 306 312 O
the 53 56 313 316 O
same 57 61 317 321 O
pregnancy 62 71 322 331 B-pregnancy

The 0 3 332 335 O
patient 4 11 336 343 O
has 12 15 344 347 O
a 16 17 348 349 O
prior 18 23 350 355 O
history 24 31 356 363 O
of 32 34 364 366 O
DVT 35 38 367 370 B-chronic_disease
in 39 41 371 373 O
the 42 45 374 377 O
ipsilateral 46 57 378 389 O
leg 58 61 390 393 O

The 0 3 394 397 O
patient 4 11 398 405 O
is 12 14 406 408 O
suspected 15 24 409 418 O
by 25 27 419 421 O
the 28 31 422 425 O
referring 32 41 426 435 O
clinician 42 51 436 445 O
to 52 54 446 448 O
have 55 59 449 453 O
symptomatic 60 71 454 465 B-chronic_disease
pulmonary 72 81 466 475 I-chronic_disease
embolism 82 90 476 484 I-chronic_disease

Therapeutic 0 11 485 496 O
doses 12 17 497 502 O
of 18 20 503 505 O
an 21 23 506 508 O
anticoagulant 24 37 509 522 B-treatment
have 38 42 523 527 O
been 43 47 528 532 O
received 48 56 533 541 O
for 57 60 542 545 O
more 61 65 546 550 O
than 66 70 551 555 O
24 71 73 556 558 B-lower_bound
hours 74 79 559 564 I-lower_bound
before 80 86 565 571 O
enrollment 87 97 572 582 O

Age 0 3 0 3 B-age
≥18 4 7 4 7 O
years 8 13 8 13 I-lower_bound

CrCl 0 4 14 18 B-clinical_variable
= 5 6 19 20 O
( 7 8 21 22 O
140 8 11 22 25 B-lower_bound
- 12 13 26 27 O
age 14 17 28 31 B-age
in 18 20 32 34 O
years 21 26 35 40 O
) 26 27 40 41 O
x 28 29 42 43 O
weight 30 36 44 50 B-clinical_variable
in 37 39 51 53 O
kg 40 42 54 56 O
x 43 44 57 58 O
0.85 45 49 59 63 O
72 50 52 64 66 O
x 53 54 67 68 O
serum 55 60 69 74 B-clinical_variable
creatinine 61 71 75 85 I-clinical_variable
in 72 74 86 88 O
mg 75 77 89 91 O
/ 77 78 91 92 O
dL 78 80 92 94 O
Male 81 85 95 99 B-gender
CrCl 86 90 100 104 O
= 91 92 105 106 O
( 93 94 107 108 O
140 94 97 108 111 O
- 98 99 112 113 O
age 100 103 114 117 O
in 104 106 118 120 O
years 107 112 121 126 O
) 112 113 126 127 O
x 114 115 128 129 O
weight 116 122 130 136 O
in 123 125 137 139 O
kg 126 128 140 142 O
x 129 130 143 144 O
1.00 131 135 145 149 O
72 136 138 150 152 O
x 139 140 153 154 O
serum 141 146 155 160 O
creatinine 147 157 161 171 O
in 158 160 172 174 O
mg 161 163 175 177 O
/ 163 164 177 178 O
dL 164 166 178 180 O

Female 0 6 181 187 B-gender

History 0 7 188 195 O
of 8 10 196 198 O
severe 11 17 199 205 O
hypersensitivity 18 34 206 222 O
reaction 35 43 223 231 O
to 44 46 232 234 O
any 47 50 235 238 O
monoclonal 51 61 239 249 B-allergy_name
antibody 62 70 250 258 I-allergy_name

Inhaled 0 7 259 266 B-treatment
or 8 10 267 269 O
topical 11 18 270 277 B-treatment
steroids 19 27 278 286 I-treatment
and 28 31 287 290 O
adrenal 32 39 291 298 B-clinical_variable
replacement 40 51 299 310 I-clinical_variable
doses 52 57 311 316 I-clinical_variable
< 58 59 317 318 O
10 59 61 318 320 B-upper_bound
mg 62 64 321 323 I-upper_bound
daily 65 70 324 329 I-upper_bound
prednisone 71 81 330 340 O
equivalents 82 93 341 352 O

Patients 0 8 353 361 O
who 9 12 362 365 O
have 13 17 366 370 O
disease 18 25 371 378 O
relapse 26 33 379 386 O
, 33 34 386 387 O
active 35 41 388 394 O
GVHD 42 46 395 399 B-chronic_disease
or 47 49 400 402 O
history 50 57 403 410 O
of 58 60 411 413 O
more 61 65 414 418 O
than 66 70 419 423 O
Stage 71 76 424 429 B-lower_bound
1 77 78 430 431 I-lower_bound
skin 79 83 432 436 B-chronic_disease
acute 84 89 437 442 I-chronic_disease
GVHD 90 94 443 447 I-chronic_disease
, 94 95 447 448 O
history 96 103 449 456 O
of 104 106 457 459 O
cGVHD 107 112 460 465 B-chronic_disease

Patients 0 8 466 474 O
who 9 12 475 478 O
have 13 17 479 483 O
had 18 21 484 487 O
chemotherapy 22 34 488 500 B-treatment
or 35 37 501 503 O
radiotherapy 38 50 504 516 B-treatment
within 51 57 517 523 O
4 58 59 524 525 O
weeks 60 65 526 531 O
( 66 67 532 533 O
6 67 68 533 534 O
weeks 69 74 535 540 O
for 75 78 541 544 O
nitrosoureas 79 91 545 557 O
or 92 94 558 560 O
mitomycin 95 104 561 570 B-treatment
C 105 106 571 572 I-treatment
) 106 107 572 573 O
prior 108 113 574 579 O
to 114 116 580 582 O
entering 117 125 583 591 O
the 126 129 592 595 O
study 130 135 596 601 O
or 136 138 602 604 O
those 139 144 605 610 O
who 145 148 611 614 O
have 149 153 615 619 O
not 154 157 620 623 O
recovered 158 167 624 633 O
from 168 172 634 638 O
adverse 173 180 639 646 O
events 181 187 647 653 O
( 188 189 654 655 O
AEs 189 192 655 658 O
) 192 193 658 659 O
due 194 197 660 663 O
to 198 200 664 666 O
agents 201 207 667 673 O
administered 208 220 674 686 O
more 221 225 687 691 O
than 226 230 692 696 O
4 231 232 697 698 O
weeks 233 238 699 704 O
earlier 239 246 705 712 O

Patients 0 8 713 721 O
who 9 12 722 725 O
have 13 17 726 730 O
had 18 21 731 734 O
evidence 22 30 735 743 O
of 31 33 744 746 O
active 34 40 747 753 O
or 41 43 754 756 O
acute 44 49 757 762 B-chronic_disease
diverticulitis 50 64 763 777 I-chronic_disease
, 64 65 777 778 O
intra 66 71 779 784 B-chronic_disease
- 71 72 784 785 I-chronic_disease
abdominal 72 81 785 794 I-chronic_disease
abscess 82 89 795 802 I-chronic_disease
, 89 90 802 803 O
GI 91 93 804 806 B-chronic_disease
obstruction 94 105 807 818 I-chronic_disease
and 106 109 819 822 O
abdominal 110 119 823 832 B-cancer
carcinomatosis 120 134 833 847 I-cancer
which 135 140 848 853 O
are 141 144 854 857 O
known 145 150 858 863 O
risk 151 155 864 868 O
factors 156 163 869 876 O
for 164 167 877 880 O
bowel 168 173 881 886 O
perforation 174 185 887 898 O
should 186 192 899 905 O
be 193 195 906 908 O
evaluated 196 205 909 918 O
for 206 209 919 922 O
the 210 213 923 926 O
potential 214 223 927 936 O
need 224 228 937 941 O
for 229 232 942 945 O
additional 233 243 946 956 O
treatment 244 253 957 966 B-treatment
before 254 260 967 973 O
coming 261 267 974 980 O
on 268 270 981 983 O
study 271 276 984 989 O

Patients 0 8 990 998 O
with 9 13 999 1003 O
active 14 20 1004 1010 B-chronic_disease
autoimmune 21 31 1011 1021 I-chronic_disease
disease 32 39 1022 1029 I-chronic_disease
or 40 42 1030 1032 O
history 43 50 1033 1040 O
of 51 53 1041 1043 O
autoimmune 54 64 1044 1054 O
disease 65 72 1055 1062 O
that 73 77 1063 1067 O
might 78 83 1068 1073 O
recur 84 89 1074 1079 O
, 89 90 1079 1080 O
which 91 96 1081 1086 O
may 97 100 1087 1090 O
affect 101 107 1091 1097 O
vital 108 113 1098 1103 O
organ 114 119 1104 1109 O
function 120 128 1110 1118 O
or 129 131 1119 1121 O
require 132 139 1122 1129 O
immune 140 146 1130 1136 B-treatment
suppressive 147 158 1137 1148 I-treatment
treatment 159 168 1149 1158 I-treatment
including 169 178 1159 1168 O
systemic 179 187 1169 1177 B-treatment
corticosteroids 188 203 1178 1193 I-treatment

Patients 0 8 1194 1202 O
with 9 13 1203 1207 O
active 14 20 1208 1214 B-chronic_disease
infection 21 30 1215 1224 I-chronic_disease
, 30 31 1224 1225 O
un 32 34 1226 1228 O
- 34 35 1228 1229 O
resolving 35 44 1229 1238 O
more 45 49 1239 1243 O
than 50 54 1244 1248 O
grade 55 60 1249 1254 B-lower_bound
2 61 62 1255 1256 I-lower_bound
transplant 63 73 1257 1267 O
- 73 74 1267 1268 O
related 74 81 1268 1275 O
toxicities 82 92 1276 1286 O

Patients 0 8 1287 1295 O
with 9 13 1296 1300 O
hematologic 14 25 1301 1312 B-cancer
malignancies 26 38 1313 1325 I-cancer
status 39 45 1326 1332 O
post 46 50 1333 1337 B-treatment
allogeneic 51 61 1338 1348 I-treatment
SCT 62 65 1349 1352 I-treatment
without 66 73 1353 1360 O
evidence 74 82 1361 1369 O
of 83 85 1370 1372 O
disease 86 93 1373 1380 O
relapse 94 101 1381 1388 O
, 101 102 1388 1389 O
active 103 109 1390 1396 O
GVHD 110 114 1397 1401 B-chronic_disease
or 115 117 1402 1404 O
history 118 125 1405 1412 O
of 126 128 1413 1415 O
more 129 133 1416 1420 O
than 134 138 1421 1425 O
Stage 139 144 1426 1431 B-lower_bound
I 145 146 1432 1433 I-lower_bound
skin 147 151 1434 1438 B-chronic_disease
acute 152 157 1439 1444 I-chronic_disease
GVHD 158 162 1445 1449 I-chronic_disease

Patients 0 8 1450 1458 O
with 9 13 1459 1463 O
high 14 18 1464 1468 O
risk 19 23 1469 1473 O
myeloid 24 31 1474 1481 B-cancer
or 32 34 1482 1484 O
lymphoid 35 43 1485 1493 B-cancer
malignancies 44 56 1494 1506 I-cancer
at 57 59 1507 1509 O
stem 60 64 1510 1514 B-treatment
cell 65 69 1515 1519 I-treatment
transplant 70 80 1520 1530 I-treatment
following 81 90 1531 1540 O
ASBMT 91 96 1541 1546 O
criteria 97 105 1547 1555 O
( 106 107 1556 1557 O
http://www.asbmt.org/displaycommon.cfm?an=1&subarticlenbr=35 107 167 1557 1617 O
, 167 168 1617 1618 O
under 169 174 1619 1624 O
disease 175 182 1625 1632 O
classification 183 197 1633 1647 O
) 197 198 1647 1648 O
, 198 199 1648 1649 O
including 200 209 1650 1659 O
but 210 213 1660 1663 O
not 214 217 1664 1667 O
limited 218 225 1668 1675 O
to 226 228 1676 1678 O
conditions 229 239 1679 1689 O
listed 240 246 1690 1696 O

Patients 0 8 1697 1705 O
with 9 13 1706 1710 O
rheumatoid 14 24 1711 1721 B-chronic_disease
arthritis 25 34 1722 1731 I-chronic_disease
and 35 38 1732 1735 O
other 39 44 1736 1741 O
arthropathies 45 58 1742 1755 B-chronic_disease
, 58 59 1755 1756 O
Sjögren 60 67 1757 1764 B-chronic_disease
's 67 69 1764 1766 I-chronic_disease
syndrome 70 78 1767 1775 I-chronic_disease
and 79 82 1776 1779 O
psoriasis 83 92 1780 1789 B-chronic_disease
controlled 93 103 1790 1800 O
with 104 108 1801 1805 O
topical 109 116 1806 1813 B-treatment
medication 117 127 1814 1824 I-treatment
and 128 131 1825 1828 O
patients 132 140 1829 1837 O
with 141 145 1838 1842 O
positive 146 154 1843 1851 O
serology 155 163 1852 1860 B-treatment
, 163 164 1860 1861 O
such 165 169 1862 1866 O
as 170 172 1867 1869 O
antinuclear 173 184 1870 1881 B-treatment
antibodies 185 195 1882 1892 I-treatment
( 196 197 1893 1894 I-treatment
ANA 197 200 1894 1897 I-treatment
) 200 201 1897 1898 I-treatment
, 201 202 1898 1899 O
anti 203 207 1900 1904 B-treatment
- 207 208 1904 1905 I-treatment
thyroid 208 215 1905 1912 I-treatment
antibodies 216 226 1913 1923 I-treatment
should 227 233 1924 1930 O
be 234 236 1931 1933 O
evaluated 237 246 1934 1943 O
for 247 250 1944 1947 O
the 251 254 1948 1951 O
presence 255 263 1952 1960 O
of 264 266 1961 1963 O
target 267 273 1964 1970 O
organ 274 279 1971 1976 O
involvement 280 291 1977 1988 O
and 292 295 1989 1992 O
potential 296 305 1993 2002 O
need 306 310 2003 2007 O
for 311 314 2008 2011 O
systemic 315 323 2012 2020 B-treatment
treatment 324 333 2021 2030 I-treatment

Patients 0 8 2031 2039 O
with 9 13 2040 2044 O
vitiligo 14 22 2045 2053 B-chronic_disease
, 22 23 2053 2054 O
endocrine 24 33 2055 2064 B-chronic_disease
deficiencies 34 46 2065 2077 I-chronic_disease
including 47 56 2078 2087 O
thyroiditis 57 68 2088 2099 B-chronic_disease
managed 69 76 2100 2107 O
with 77 81 2108 2112 O
replacement 82 93 2113 2124 O
hormones 94 102 2125 2133 O
including 103 112 2134 2143 O
physiologic 113 124 2144 2155 O
corticosteroids 125 140 2156 2171 B-treatment

Refractory 0 10 2172 2182 B-cancer
acute 11 16 2183 2188 I-cancer
myelogenous 17 28 2189 2200 I-cancer
or 29 31 2201 2203 I-cancer
lymphoid 32 40 2204 2212 I-cancer
leukemia 41 49 2213 2221 I-cancer
Relapsed 50 58 2222 2230 B-cancer
acute 59 64 2231 2236 I-cancer
myelogenous 65 76 2237 2248 I-cancer
or 77 79 2249 2251 I-cancer
lymphoid 80 88 2252 2260 I-cancer
leukemia 89 97 2261 2269 I-cancer
Myelodysplastic 98 113 2270 2285 B-cancer
syndromes 114 123 2286 2295 I-cancer
with 124 128 2296 2300 O
5 129 130 2301 2302 O
% 130 131 2302 2303 O
or 132 134 2304 2306 O
more 135 139 2307 2311 O
blasts 140 146 2312 2318 O
Chronic 147 154 2319 2326 B-cancer
myelogenous 155 166 2327 2338 I-cancer
leukemia 167 175 2339 2347 I-cancer
in 176 178 2348 2350 O
chronic 179 186 2351 2358 O
phase 187 192 2359 2364 O
3 193 194 2365 2366 B-lower_bound
or 195 197 2367 2369 O
more 198 202 2370 2374 O
, 202 203 2374 2375 O
blast 204 209 2376 2381 O
phase 210 215 2382 2387 O
presently 216 225 2388 2397 O
, 225 226 2397 2398 O
or 227 229 2399 2401 O
second 230 236 2402 2408 O
accelerated 237 248 2409 2420 O
phase 249 254 2421 2426 O
, 254 255 2426 2427 O
Recurrent 256 265 2428 2437 B-cancer
or 266 268 2438 2440 I-cancer
refractory 269 279 2441 2451 I-cancer
malignant 280 289 2452 2461 I-cancer
lymphoma 290 298 2462 2470 I-cancer
or 299 301 2471 2473 O
Hodgkin 302 309 2474 2481 B-cancer
's 309 311 2481 2483 I-cancer
disease 312 319 2484 2491 I-cancer
with 320 324 2492 2496 O
less 325 329 2497 2501 O
than 330 334 2502 2506 O
a 335 336 2507 2508 O
partial 337 344 2509 2516 O
response 345 353 2517 2525 O
at 354 356 2526 2528 O
transplant 357 367 2529 2539 B-treatment
High 368 372 2540 2544 O
risk 373 377 2545 2549 O
chronic 378 385 2550 2557 B-cancer
lymphocytic 386 397 2558 2569 I-cancer
leukemia 398 406 2570 2578 I-cancer
defined 407 414 2579 2586 O
as 415 417 2587 2589 O
no 418 420 2590 2592 O
response 421 429 2593 2601 O
or 430 432 2602 2604 O
stable 433 439 2605 2611 O
disease 440 447 2612 2619 O
to 448 450 2620 2622 O
the 451 454 2623 2626 O
most 455 459 2627 2631 O
recent 460 466 2632 2638 O
treatment 467 476 2639 2648 B-treatment
regimen 477 484 2649 2656 I-treatment

Serum 0 5 2657 2662 B-clinical_variable
creatinine 6 16 2663 2673 I-clinical_variable
≤1.5× 17 22 2674 2679 O
ULN 23 26 2680 2683 I-upper_bound
OR 27 29 2684 2686 O

Uncontrolled 0 12 2687 2699 O
intercurrent 13 25 2700 2712 B-chronic_disease
illness 26 33 2713 2720 I-chronic_disease
including 34 43 2721 2730 O
, 43 44 2730 2731 O
but 45 48 2732 2735 O
not 49 52 2736 2739 O
limited 53 60 2740 2747 O
to 61 63 2748 2750 O
, 63 64 2750 2751 O
ongoing 65 72 2752 2759 O
or 73 75 2760 2762 O
active 76 82 2763 2769 B-chronic_disease
infection 83 92 2770 2779 I-chronic_disease
, 92 93 2779 2780 O
symptomatic 94 105 2781 2792 O
congestive 106 116 2793 2803 B-chronic_disease
heart 117 122 2804 2809 I-chronic_disease
failure 123 130 2810 2817 I-chronic_disease
, 130 131 2817 2818 O
unstable 132 140 2819 2827 B-chronic_disease
angina 141 147 2828 2834 I-chronic_disease
pectoris 148 156 2835 2843 I-chronic_disease
, 156 157 2843 2844 O
cardiac 158 165 2845 2852 B-chronic_disease
arrhythmia 166 176 2853 2863 I-chronic_disease
, 176 177 2863 2864 O
or 178 180 2865 2867 O
psychiatric 181 192 2868 2879 B-chronic_disease
illness 193 200 2880 2887 I-chronic_disease
/ 200 201 2887 2888 I-chronic_disease
social 201 207 2888 2894 I-chronic_disease
situations 208 218 2895 2905 I-chronic_disease
that 219 223 2906 2910 O
would 224 229 2911 2916 O
limit 230 235 2917 2922 O
compliance 236 246 2923 2933 O
with 247 251 2934 2938 O
study 252 257 2939 2944 O
requirements 258 270 2945 2957 O

WOCBP 0 5 2958 2963 O
receiving 6 15 2964 2973 O
nivolumab 16 25 2974 2983 B-treatment
will 26 30 2984 2988 O
be 31 33 2989 2991 O
instructed 34 44 2992 3002 O
to 45 47 3003 3005 O
adhere 48 54 3006 3012 B-contraception_consent
to 55 57 3013 3015 I-contraception_consent
contraception 58 71 3016 3029 I-contraception_consent
for 72 75 3030 3033 O
a 76 77 3034 3035 O
period 78 84 3036 3042 O
of 85 87 3043 3045 O
23 88 90 3046 3048 O
weeks 91 96 3049 3054 O
( 97 98 3055 3056 O
30 98 100 3056 3058 O
days 101 105 3059 3063 O
plus 106 110 3064 3068 O
the 111 114 3069 3072 O
time 115 119 3073 3077 O
required 120 128 3078 3086 O
for 129 132 3087 3090 O
nivolumab 133 142 3091 3100 O
to 143 145 3101 3103 O
undergo 146 153 3104 3111 O
five 154 158 3112 3116 O
half 159 163 3117 3121 O
- 163 164 3121 3122 O
lives 164 169 3122 3127 O
) 169 170 3127 3128 O
after 171 176 3129 3134 O
the 177 180 3135 3138 O
last 181 185 3139 3143 O
dose 186 190 3144 3148 O
of 191 193 3149 3151 O
investigational 194 209 3152 3167 O
product 210 217 3168 3175 O

WOCBP 0 5 3176 3181 O
should 6 12 3182 3188 O
use 13 16 3189 3192 O
an 17 19 3193 3195 O
adequate 20 28 3196 3204 O
method 29 35 3205 3211 O
to 36 38 3212 3214 O
avoid 39 44 3215 3220 O
pregnancy 45 54 3221 3230 B-pregnancy
for 55 58 3231 3234 O
23 59 61 3235 3237 O
weeks 62 67 3238 3243 O
) 67 68 3243 3244 O
after 69 74 3245 3250 O
the 75 78 3251 3254 O
last 79 83 3255 3259 O
dose 84 88 3260 3264 O
of 89 91 3265 3267 O
investigational 92 107 3268 3283 O
drug 108 112 3284 3288 O
Nivolumab 113 122 3289 3298 B-treatment

Women 0 5 3299 3304 B-gender
must 6 10 3305 3309 O
not 11 14 3310 3313 O
be 15 17 3314 3316 O
breastfeeding 18 31 3317 3330 O

Women 0 5 3331 3336 B-gender
of 6 8 3337 3339 O
childbearing 9 21 3340 3352 O
potential 22 31 3353 3362 O
( 32 33 3363 3364 O
WOCBP 33 38 3364 3369 O
) 38 39 3369 3370 O
is 40 42 3371 3373 O
defined 43 50 3374 3381 O
as 51 53 3382 3384 O
any 54 57 3385 3388 O
female 58 64 3389 3395 B-gender
who 65 68 3396 3399 O
has 69 72 3400 3403 O
experienced 73 84 3404 3415 O
menarche 85 93 3416 3424 O
and 94 97 3425 3428 O
who 98 101 3429 3432 O
has 102 105 3433 3436 O
not 106 109 3437 3440 O
undergone 110 119 3441 3450 O
surgical 120 128 3451 3459 O
sterilization 129 142 3460 3473 O
( 143 144 3474 3475 O
hysterectomy 144 156 3475 3487 B-treatment
or 157 159 3488 3490 O
bilateral 160 169 3491 3500 B-treatment
oophorectomy 170 182 3501 3513 I-treatment
) 182 183 3513 3514 O
or 184 186 3515 3517 O
who 187 190 3518 3521 O
is 191 193 3522 3524 O
not 194 197 3525 3528 O
postmenopausal 198 212 3529 3543 O

Women 0 5 3544 3549 B-gender
of 6 8 3550 3552 O
childbearing 9 21 3553 3565 O
potential 22 31 3566 3575 O
must 32 36 3576 3580 O
have 37 41 3581 3585 O
a 42 43 3586 3587 O
negative 44 52 3588 3596 B-pregnancy
serum 53 58 3597 3602 I-pregnancy
or 59 61 3603 3605 I-pregnancy
urine 62 67 3606 3611 I-pregnancy
pregnancy 68 77 3612 3621 I-pregnancy
test 78 82 3622 3626 O
( 83 84 3627 3628 O
minimum 84 91 3628 3635 O
sensitivity 92 103 3636 3647 O
25 104 106 3648 3650 B-lower_bound
IU 107 109 3651 3653 I-lower_bound
/ 109 110 3653 3654 I-lower_bound
L 110 111 3654 3655 I-lower_bound
or 112 114 3656 3658 O
equivalent 115 125 3659 3669 O
units 126 131 3670 3675 O
of 132 134 3676 3678 O
HCG 135 138 3679 3682 B-clinical_variable
) 138 139 3682 3683 O
within 140 146 3684 3690 O
24 147 149 3691 3693 B-upper_bound
hours 150 155 3694 3699 I-upper_bound
prior 156 161 3700 3705 I-upper_bound
to 162 164 3706 3708 O
the 165 168 3709 3712 O
start 169 174 3713 3718 O
of 175 177 3719 3721 O
nivolumab 178 187 3722 3731 B-treatment

Women 0 5 3732 3737 B-gender
who 6 9 3738 3741 O
are 10 13 3742 3745 O
not 14 17 3746 3749 O
of 18 20 3750 3752 O
childbearing 21 33 3753 3765 O
potential 34 43 3766 3775 O
( 44 45 3776 3777 O
i.e. 45 49 3777 3781 O
, 49 50 3781 3782 O
who 51 54 3783 3786 O
are 55 58 3787 3790 O
postmenopausal 59 73 3791 3805 O
or 74 76 3806 3808 O
surgically 77 87 3809 3819 O
sterile 88 95 3820 3827 O
as 96 98 3828 3830 O
well 99 103 3831 3835 O
as 104 106 3836 3838 O
azoospermic 107 118 3839 3850 O
men 119 122 3851 3854 O
) 122 123 3854 3855 O
do 124 126 3856 3858 O
not 127 130 3859 3862 O
require 131 138 3863 3870 O
contraception 139 152 3871 3884 O

absolute 0 8 3885 3893 B-clinical_variable
neutrophil 9 19 3894 3904 I-clinical_variable
count 20 25 3905 3910 I-clinical_variable
≥1,000 26 32 3911 3917 O
/ 32 33 3917 3918 I-lower_bound
mcL 33 36 3918 3921 I-lower_bound

creatinine 0 10 3922 3932 B-clinical_variable
clearance 11 20 3933 3942 I-clinical_variable
( 21 22 3943 3944 I-clinical_variable
CrCl 22 26 3944 3948 I-clinical_variable
) 26 27 3948 3949 I-clinical_variable
≥40 28 31 3950 3953 O
mL 32 34 3954 3956 I-lower_bound
/ 34 35 3956 3957 I-lower_bound
min 35 38 3957 3960 I-lower_bound

leukocytes 0 10 3961 3971 B-clinical_variable
≥2000 11 16 3972 3977 O
/ 16 17 3977 3978 I-lower_bound
mcL 17 20 3978 3981 I-lower_bound

patients 0 8 3982 3990 O
with 9 13 3991 3995 O
Gilbert 14 21 3996 4003 B-chronic_disease
Syndrome 22 30 4004 4012 I-chronic_disease

patients 0 8 4013 4021 O
with 9 13 4022 4026 O
a 14 15 4027 4028 O
history 16 23 4029 4036 O
of 24 26 4037 4039 O
immune 27 33 4040 4046 B-chronic_disease
related 34 41 4047 4054 I-chronic_disease
neurologic 42 52 4055 4065 I-chronic_disease
disease 53 60 4066 4073 I-chronic_disease
, 60 61 4073 4074 O
multiple 62 70 4075 4083 B-chronic_disease
sclerosis 71 80 4084 4093 I-chronic_disease
, 80 81 4093 4094 O
autoimmune 82 92 4095 4105 B-chronic_disease
( 93 94 4106 4107 I-chronic_disease
demyelinating 94 107 4107 4120 I-chronic_disease
) 107 108 4120 4121 I-chronic_disease
neuropathy 109 119 4122 4132 I-chronic_disease
, 119 120 4132 4133 O
Guillain 121 129 4134 4142 B-chronic_disease
- 129 130 4142 4143 I-chronic_disease
Barre 130 135 4143 4148 I-chronic_disease
syndrome 136 144 4149 4157 I-chronic_disease
, 144 145 4157 4158 O
myasthenia 146 156 4159 4169 B-chronic_disease
gravis 157 163 4170 4176 I-chronic_disease
; 163 164 4176 4177 O
systemic 165 173 4178 4186 B-chronic_disease
autoimmune 174 184 4187 4197 I-chronic_disease
disease 185 192 4198 4205 I-chronic_disease
such 193 197 4206 4210 O
as 198 200 4211 4213 O
SLE 201 204 4214 4217 B-chronic_disease
, 204 205 4217 4218 O
connective 206 216 4219 4229 B-chronic_disease
tissue 217 223 4230 4236 I-chronic_disease
diseases 224 232 4237 4245 I-chronic_disease
, 232 233 4245 4246 O
scleroderma 234 245 4247 4258 B-chronic_disease
, 245 246 4258 4259 O
inflammatory 247 259 4260 4272 B-chronic_disease
bowel 260 265 4273 4278 I-chronic_disease
disease 266 273 4279 4286 I-chronic_disease
( 274 275 4287 4288 I-chronic_disease
IBD 275 278 4288 4291 I-chronic_disease
) 278 279 4291 4292 I-chronic_disease
, 279 280 4292 4293 O
Crohn 281 286 4294 4299 B-chronic_disease
's 286 288 4299 4301 I-chronic_disease
, 288 289 4301 4302 O
ulcerative 290 300 4303 4313 B-chronic_disease
colitis 301 308 4314 4321 I-chronic_disease
, 308 309 4321 4322 O
hepatitis 310 319 4323 4332 B-chronic_disease
; 319 320 4332 4333 O
and 321 324 4334 4337 O
patients 325 333 4338 4346 O
with 334 338 4347 4351 O
a 339 340 4352 4353 O
history 341 348 4354 4361 O
of 349 351 4362 4364 O
toxic 352 357 4365 4370 B-chronic_disease
epidermal 358 367 4371 4380 I-chronic_disease
necrolysis 368 378 4381 4391 I-chronic_disease
( 379 380 4392 4393 I-chronic_disease
TEN 380 383 4393 4396 I-chronic_disease
) 383 384 4396 4397 I-chronic_disease
, 384 385 4397 4398 O
Stevens 386 393 4399 4406 B-chronic_disease
- 393 394 4406 4407 I-chronic_disease
Johnson 394 401 4407 4414 I-chronic_disease
syndrome 402 410 4415 4423 I-chronic_disease
, 410 411 4423 4424 O
or 412 414 4425 4427 O
phospholipid 415 427 4428 4440 B-chronic_disease
syndrome 428 436 4441 4449 I-chronic_disease

recovery 0 8 4450 4458 O
to 9 11 4459 4461 O
the 12 15 4462 4465 O
baseline 16 24 4466 4474 O
count(in 25 33 4475 4483 O
the 34 37 4484 4487 O
absence 38 45 4488 4495 O
of 46 48 4496 4498 O
transfusion)Hgb 49 64 4499 4514 O
> 65 66 4515 4516 O
9.0g 66 70 4516 4520 B-lower_bound
/ 70 71 4520 4521 I-lower_bound
dL 71 73 4521 4523 I-lower_bound

total 0 5 4524 4529 B-clinical_variable
bilirubin 6 15 4530 4539 I-clinical_variable
≤1.5× 16 21 4540 4545 O
institutional 22 35 4546 4559 I-upper_bound
upper 36 41 4560 4565 I-upper_bound
limit 42 47 4566 4571 I-upper_bound
of 48 50 4572 4574 I-upper_bound
normal 51 57 4575 4581 I-upper_bound
( 58 59 4582 4583 I-upper_bound
ULN 59 62 4583 4586 I-upper_bound
) 62 63 4586 4587 I-upper_bound

A 0 1 0 1 O
second 2 8 2 8 O
post 9 13 9 13 B-treatment
- 13 14 13 14 I-treatment
treatment 14 23 14 23 I-treatment
biopsy 24 30 24 30 I-treatment
will 31 35 31 35 O
be 36 38 36 38 O
offered 39 46 39 46 O
but 47 50 47 50 O
will 51 55 51 55 O
not 56 59 56 59 O
be 60 62 60 62 O
mandated 63 71 63 71 O

ALT 0 3 72 75 B-clinical_variable
( 4 5 76 77 I-clinical_variable
SGPT 5 9 77 81 I-clinical_variable
) 9 10 81 82 I-clinical_variable
≤ 11 12 83 84 O
2.5 13 16 85 88 B-upper_bound
X 17 18 89 90 I-upper_bound
institutional 19 32 91 104 I-upper_bound
upper 33 38 105 110 I-upper_bound
limit 39 44 111 116 I-upper_bound
of 45 47 117 119 I-upper_bound
normal 48 54 120 126 I-upper_bound

AST 0 3 127 130 B-clinical_variable
( 4 5 131 132 I-clinical_variable
SGOT 5 9 132 136 I-clinical_variable
) 9 10 136 137 I-clinical_variable
≤ 11 12 138 139 O
2.5 13 16 140 143 B-upper_bound
X 17 18 144 145 I-upper_bound
institutional 19 32 146 159 I-upper_bound
upper 33 38 160 165 I-upper_bound
limit 39 44 166 171 I-upper_bound
of 45 47 172 174 I-upper_bound
normal 48 54 175 181 I-upper_bound

ECOG 0 4 182 186 B-clinical_variable
Performance 5 16 187 198 I-clinical_variable
Status 17 23 199 205 I-clinical_variable
0 24 25 206 207 B-lower_bound
- 25 26 207 208 O
1 26 27 208 209 B-upper_bound

Hemoglobin 0 10 210 220 B-clinical_variable
≥ 11 12 221 222 O
10.0 13 17 223 227 B-lower_bound
g 18 19 228 229 I-lower_bound
/ 19 20 229 230 I-lower_bound
dl 20 22 230 232 I-lower_bound

History 0 7 233 240 O
of 8 10 241 243 O
allergic 11 19 244 252 O
reactions 20 29 253 262 O
attributed 30 40 263 273 O
to 41 43 274 276 O
compounds 44 53 277 286 B-allergy_name
of 54 56 287 289 I-allergy_name
similar 57 64 290 297 I-allergy_name
chemical 65 73 298 306 I-allergy_name
or 74 76 307 309 I-allergy_name
biologic 77 85 310 318 I-allergy_name
composition 86 97 319 330 I-allergy_name
to 98 100 331 333 I-allergy_name
nab 101 104 334 337 I-allergy_name
- 104 105 337 338 I-allergy_name
paclitaxel 105 115 338 348 I-allergy_name
, 115 116 348 349 O
carboplatin 117 128 350 361 B-allergy_name
, 128 129 361 362 O
pembrolizumab 130 143 363 376 B-allergy_name
, 143 144 376 377 O
or 145 147 378 380 O
other 148 153 381 386 B-allergy_name
agents 154 160 387 393 I-allergy_name
used 161 165 394 398 O
in 166 168 399 401 O
this 169 173 402 406 O
study 174 179 407 412 O

Patients 0 8 413 421 O
active 9 15 422 428 B-chronic_disease
infection 16 25 429 438 I-chronic_disease
requiring 26 35 439 448 O
intravenous 36 47 449 460 O
systemic 48 56 461 469 B-treatment
therapy 57 64 470 477 I-treatment

Patients 0 8 478 486 O
who 9 12 487 490 O
have 13 17 491 495 O
participated 18 30 496 508 O
in 31 33 509 511 O
MK-3475 34 41 512 519 B-treatment
Merck 42 47 520 525 I-treatment
studies 48 55 526 533 I-treatment

Patients 0 8 534 542 O
who 9 12 543 546 O
have 13 17 547 551 O
received 18 26 552 560 O
a 27 28 561 562 O
live 29 33 563 567 B-treatment
vaccine 34 41 568 575 I-treatment
within 42 48 576 582 O
30 49 51 583 585 B-upper_bound
days 52 56 586 590 I-upper_bound
prior 57 62 591 596 I-upper_bound
to 63 65 597 599 O
the 66 69 600 603 O
first 70 75 604 609 O
dose 76 80 610 614 O
of 81 83 615 617 O
pembrolizumab 84 97 618 631 B-treatment

Patients 0 8 632 640 O
who 9 12 641 644 O
have 13 17 645 649 O
received 18 26 650 658 O
chemotherapy 27 39 659 671 B-treatment
, 39 40 671 672 O
small 41 46 673 678 B-treatment
molecule 47 55 679 687 I-treatment
targeted 56 64 688 696 I-treatment
therapy 65 72 697 704 I-treatment
or 73 75 705 707 O
radiation 76 85 708 717 B-treatment
within 86 92 718 724 O
the 93 96 725 728 O
2 97 98 729 730 B-upper_bound
weeks 99 104 731 736 I-upper_bound
of 105 107 737 739 O
first 108 113 740 745 O
dose 114 118 746 750 O
of 119 121 751 753 O
study 122 127 754 759 B-treatment
drugs 128 133 760 765 I-treatment

Patients 0 8 766 774 O
who 9 12 775 778 O
have 13 17 779 783 O
received 18 26 784 792 O
monoclonal 27 37 793 803 B-treatment
anti 38 42 804 808 I-treatment
- 42 43 808 809 I-treatment
cancer 43 49 809 815 I-treatment
antibody 50 58 816 824 I-treatment
within 59 65 825 831 O
4 66 67 832 833 B-upper_bound
weeks 68 73 834 839 I-upper_bound
of 74 76 840 842 O
first 77 82 843 848 O
dose 83 87 849 853 O
of 88 90 854 856 O
study 91 96 857 862 O
drugs 97 102 863 868 O

Patients 0 8 869 877 O
with 9 13 878 882 O
a 14 15 883 884 O
known 16 21 885 890 O
additional 22 32 891 901 O
malignancy 33 43 902 912 B-cancer
that 44 48 913 917 O
is 49 51 918 920 O
progressing 52 63 921 932 O
or 64 66 933 935 O
requires 67 75 936 944 O
active 76 82 945 951 B-treatment
treatment 83 92 952 961 I-treatment
( 93 94 962 963 O
within 94 100 963 969 O
the 101 104 970 973 O
last 105 109 974 978 B-upper_bound
5 110 111 979 980 I-upper_bound
years 112 117 981 986 I-upper_bound
) 117 118 986 987 O

Patients 0 8 988 996 O
with 9 13 997 1001 O
carcinomatous 14 27 1002 1015 B-cancer
meningitis 28 38 1016 1026 I-cancer

Patients 0 8 1027 1035 O
with 9 13 1036 1040 O
chronic 14 21 1041 1048 B-chronic_disease
autoimmune 22 32 1049 1059 I-chronic_disease
disease 33 40 1060 1067 I-chronic_disease

Patients 0 8 1068 1076 O
with 9 13 1077 1081 O
conditions 14 24 1082 1092 O
requiring 25 34 1093 1102 O
immunosuppressive 35 52 1103 1120 B-treatment
medications 53 64 1121 1132 I-treatment
or 65 67 1133 1135 O
chronic 68 75 1136 1143 B-chronic_disease
infections 76 86 1144 1154 I-chronic_disease
( 87 88 1155 1156 O
including 88 97 1156 1165 O
HIV 98 101 1166 1169 B-chronic_disease
infection 102 111 1170 1179 I-chronic_disease
, 111 112 1179 1180 O
hepatitis 113 122 1181 1190 B-chronic_disease
B 123 124 1191 1192 I-chronic_disease
and 125 128 1193 1196 I-chronic_disease
C 129 130 1197 1198 I-chronic_disease
) 130 131 1198 1199 O

Patients 0 8 1200 1208 O
with 9 13 1209 1213 O
evidence 14 22 1214 1222 O
of 23 25 1223 1225 O
active 26 32 1226 1232 O
, 32 33 1232 1233 O
non 34 37 1234 1237 O
- 37 38 1237 1238 O
infectious 38 48 1238 1248 O
pneumonia 49 58 1249 1258 B-chronic_disease

Patients 0 8 1259 1267 O
with 9 13 1268 1272 O
prior 14 19 1273 1278 B-treatment
therapy 20 27 1279 1286 I-treatment
with 28 32 1287 1291 O
antibodies 33 43 1292 1302 B-treatment
that 44 48 1303 1307 I-treatment
modulate 49 57 1308 1316 I-treatment
T 58 59 1317 1318 I-treatment
- 59 60 1318 1319 I-treatment
cell 60 64 1319 1323 I-treatment
function 65 73 1324 1332 I-treatment
( 74 75 1333 1334 O
e.g. 75 79 1334 1338 O
, 79 80 1338 1339 O
anti 81 85 1340 1344 B-treatment
- 85 86 1344 1345 I-treatment
PD-1 86 90 1345 1349 I-treatment
, 90 91 1349 1350 O
anti 92 96 1351 1355 B-treatment
- 96 97 1355 1356 I-treatment
PD 97 99 1356 1358 I-treatment
- 99 100 1358 1359 I-treatment
L1 100 102 1359 1361 I-treatment
) 102 103 1361 1362 O

Platelet 0 8 1363 1371 B-clinical_variable
count 9 14 1372 1377 I-clinical_variable
≥ 15 16 1378 1379 O
100,000 17 24 1380 1387 B-lower_bound
/ 24 25 1387 1388 I-lower_bound
μL 25 27 1388 1390 I-lower_bound

Serum 0 5 1391 1396 B-clinical_variable
creatinine 6 16 1397 1407 I-clinical_variable
≤ 17 18 1408 1409 O
1.5 19 22 1410 1413 B-upper_bound
normal 23 29 1414 1420 I-upper_bound
institutional 30 43 1421 1434 I-upper_bound
limits 44 50 1435 1441 I-upper_bound

Subjects 0 8 1442 1450 O
must 9 13 1451 1455 O
have 14 18 1456 1460 O
received 19 27 1461 1469 O
no 28 30 1470 1472 O
more 31 35 1473 1477 O
than 36 40 1478 1482 O
2 41 42 1483 1484 B-upper_bound
prior 43 48 1485 1490 I-upper_bound
therapies 49 58 1491 1500 B-treatment
for 59 62 1501 1504 O
this 63 67 1505 1509 O
disease 68 75 1510 1517 O

Subjects 0 8 1518 1526 O
with 9 13 1527 1531 O
radiographically 14 30 1532 1548 O
stable 31 37 1549 1555 O
treated 38 45 1556 1563 O
brain 46 51 1564 1569 B-cancer
metastases 52 62 1570 1580 I-cancer

Subjects 0 8 1581 1589 O
with 9 13 1590 1594 O
uncontrolled 14 26 1595 1607 O
intercurrent 27 39 1608 1620 B-chronic_disease
illness 40 47 1621 1628 I-chronic_disease
including 48 57 1629 1638 O
, 57 58 1638 1639 O
but 59 62 1640 1643 O
not 63 66 1644 1647 O
limited 67 74 1648 1655 O
to 75 77 1656 1658 O
ongoing 78 85 1659 1666 O
or 86 88 1667 1669 O
active 89 95 1670 1676 B-chronic_disease
infection 96 105 1677 1686 I-chronic_disease
, 105 106 1686 1687 O
symptomatic 107 118 1688 1699 O
congestive 119 129 1700 1710 B-chronic_disease
heart 130 135 1711 1716 I-chronic_disease
failure 136 143 1717 1724 I-chronic_disease
, 143 144 1724 1725 O
unstable 145 153 1726 1734 B-chronic_disease
angina 154 160 1735 1741 I-chronic_disease
pectoris 161 169 1742 1750 I-chronic_disease
, 169 170 1750 1751 O
cardiac 171 178 1752 1759 B-chronic_disease
arrhythmia 179 189 1760 1770 I-chronic_disease
, 189 190 1770 1771 O
or 191 193 1772 1774 O
psychiatric 194 205 1775 1786 B-chronic_disease
illness 206 213 1787 1794 I-chronic_disease
/ 213 214 1794 1795 I-chronic_disease
social 214 220 1795 1801 I-chronic_disease
situations 221 231 1802 1812 I-chronic_disease
that 232 236 1813 1817 O
would 237 242 1818 1823 O
limit 243 248 1824 1829 O
compliance 249 259 1830 1840 O
with 260 264 1841 1845 O
study 265 270 1846 1851 O
requirements 271 283 1852 1864 O

Total 0 5 1865 1870 B-clinical_variable
bilirubin 6 15 1871 1880 I-clinical_variable
within 16 22 1881 1887 O
normal 23 29 1888 1894 O
institutional 30 43 1895 1908 O
limits 44 50 1909 1915 O

basal 0 5 1916 1921 B-cancer
cell 6 10 1922 1926 I-cancer
carcinoma 11 20 1927 1936 I-cancer
of 21 23 1937 1939 O
the 24 27 1940 1943 O
skin 28 32 1944 1948 O

must 0 4 1949 1953 O
not 5 8 1954 1957 O
have 9 13 1958 1962 O
been 14 18 1963 1967 O
on 19 21 1968 1970 O
steroid 22 29 1971 1978 B-treatment
therapy 30 37 1979 1986 I-treatment
for 38 41 1987 1990 O
at 42 44 1991 1993 O
least 45 50 1994 1999 O
4 51 52 2000 2001 B-lower_bound
weeks 53 58 2002 2007 I-lower_bound

willing 0 7 2008 2015 O
to 8 10 2016 2018 O
undergo 11 18 2019 2026 O
a 19 20 2027 2028 O
preliminary 21 32 2029 2040 O
biopsy 33 39 2041 2047 O
of 40 42 2048 2050 O
a 43 44 2051 2052 O
metastatic 45 55 2053 2063 B-cancer
focus 56 61 2064 2069 O
for 62 65 2070 2073 O
research 66 74 2074 2082 O
purposes 75 83 2083 2091 O

Pts 0 3 0 3 B-chronic_disease
undergoing 4 14 4 14 O
colectomy 15 24 15 24 B-treatment

Pts 0 3 25 28 O
undergoing 4 14 29 39 O
sleeve 15 21 40 46 B-treatment
gastrectomy 22 33 47 58 I-treatment

Active 0 6 0 6 O
systemic 7 15 7 15 B-chronic_disease
viral 16 21 16 21 I-chronic_disease
, 21 22 21 22 O
bacterial 23 32 23 32 B-chronic_disease
or 33 35 33 35 O
fungal 36 42 36 42 B-chronic_disease
infection 43 52 43 52 I-chronic_disease
requiring 53 62 53 62 O
treatment 63 72 63 72 B-treatment

Adults 0 6 73 79 O
greater 7 14 80 87 O
than 15 19 88 92 O
or 20 22 93 95 O
equal 23 28 96 101 O
to 29 31 102 104 O
18 32 34 105 107 B-lower_bound

Age 0 3 108 111 B-age
greater 4 11 112 119 O
than 12 16 120 124 O
or 17 19 125 127 O
equal 20 25 128 133 O
to 26 28 134 136 O
18 29 31 137 139 B-lower_bound
years 32 37 140 145 I-lower_bound

Baseline 0 8 146 154 O
LVEF 9 13 155 159 B-clinical_variable
by 14 16 160 162 O
2D 17 19 163 165 B-treatment
Echocardiogram 20 34 166 180 I-treatment
greater 35 42 181 188 O
than 43 47 189 193 O
or 48 50 194 196 O
equal 51 56 197 202 O
to 57 59 203 205 O
53 60 62 206 208 B-lower_bound
% 62 63 208 209 I-lower_bound

Chemistry 0 9 210 219 O
parameters 10 20 220 230 O
: 20 21 230 231 O
Creatinine 22 32 232 242 B-clinical_variable
less 33 37 243 247 O
than 38 42 248 252 O
1.5 43 46 253 256 B-upper_bound
mg 47 49 257 259 I-upper_bound
/ 49 50 259 260 I-upper_bound
dL 50 52 260 262 I-upper_bound
, 52 53 262 263 O
SGOT 54 58 264 268 B-clinical_variable
and 59 62 269 272 O
SGPT 63 67 273 277 B-clinical_variable
less 68 72 278 282 O
than 73 77 283 287 O
or 78 80 288 290 O
equal 81 86 291 296 O
to 87 89 297 299 O
3X 90 92 300 302 B-upper_bound
the 93 96 303 306 I-upper_bound
upper 97 102 307 312 I-upper_bound
limits 103 109 313 319 I-upper_bound
of 110 112 320 322 I-upper_bound
normal 113 119 323 329 I-upper_bound
and 120 123 330 333 O
total 124 129 334 339 B-clinical_variable
bilirubin 130 139 340 349 I-clinical_variable
less 140 144 350 354 O
than 145 149 355 359 O
or 150 152 360 362 O
equal 153 158 363 368 O
to 159 161 369 371 O
1.5 162 165 372 375 B-upper_bound
mg 166 168 376 378 I-upper_bound
/ 168 169 378 379 I-upper_bound
dl 169 171 379 381 I-upper_bound
, 171 172 381 382 O
Alk 173 176 383 386 B-clinical_variable
PO4 177 180 387 390 I-clinical_variable
less 181 185 391 395 O
than 186 190 396 400 O
or 191 193 401 403 O
equal 194 199 404 409 O
to 200 202 410 412 O
3X 203 205 413 415 O
the 206 209 416 419 O
upper 210 215 420 425 O
limits 216 222 426 432 O
of 223 225 433 435 O
normal 226 232 436 442 O
( 233 234 443 444 O
except 234 240 444 450 O
for 241 244 451 454 O
patients 245 253 455 463 O
with 254 258 464 468 O
documented 259 269 469 479 O
metastatic 270 280 480 490 B-cancer
disease 281 288 491 498 I-cancer
to 289 291 499 501 O
bone 292 296 502 506 O
and/or 297 303 507 513 O
liver 304 309 514 519 O
) 309 310 519 520 O

Chemistry 0 9 521 530 O
parameters 10 20 531 541 O
: 20 21 541 542 O
Creatinine 22 32 543 553 B-clinical_variable
less 33 37 554 558 O
than 38 42 559 563 O
mg 43 45 564 566 O
/ 45 46 566 567 O
dL 46 48 567 569 O
, 48 49 569 570 O
SGOT 50 54 571 575 B-clinical_variable
and 55 58 576 579 O
SGPT 59 63 580 584 B-clinical_variable
less 64 68 585 589 O
than 69 73 590 594 O
or 74 76 595 597 O
equal 77 82 598 603 O
to 83 85 604 606 O
3X 86 88 607 609 B-upper_bound
ULN 89 92 610 613 I-upper_bound
, 92 93 613 614 O
total 94 99 615 620 O
bilirubin 100 109 621 630 B-clinical_variable
less 110 114 631 635 O
than 115 119 636 640 O
or 120 122 641 643 O
equal 123 128 644 649 O
to 129 131 650 652 O
1.5X 132 136 653 657 B-upper_bound
ULN 137 140 658 661 I-upper_bound
and 141 144 662 665 O
Alk 145 148 666 669 B-clinical_variable
PO4 149 152 670 673 I-clinical_variable
less 153 157 674 678 O
than 158 162 679 683 O
or 163 165 684 686 O
equal 166 171 687 692 O
to 172 174 693 695 O
3X 175 177 696 698 O
ULN 178 181 699 702 O
( 182 183 703 704 O
except 183 189 704 710 O
for 190 193 711 714 O
patients 194 202 715 723 O
with 203 207 724 728 O
documented 208 218 729 739 O
metastatic 219 229 740 750 B-cancer
disease 230 237 751 758 I-cancer
to 238 240 759 761 O
bone 241 245 762 766 O
and/or 246 252 767 773 O
liver 253 258 774 779 O
) 258 259 779 780 O

Clinically 0 10 781 791 O
significant 11 22 792 803 O
cardiac 23 30 804 811 B-chronic_disease
dysfunction 31 42 812 823 I-chronic_disease
defined 43 50 824 831 O
as 51 53 832 834 O
a 54 55 835 836 O
history 56 63 837 844 O
of 64 66 845 847 O
> 67 68 848 849 O
= 68 69 849 850 O
NYHA 70 74 851 855 B-clinical_variable
Class 75 80 856 861 I-clinical_variable
II 81 83 862 864 I-clinical_variable
symptoms 84 92 865 873 O
, 92 93 873 874 O
angina 94 100 875 881 B-chronic_disease
, 100 101 881 882 O
congestive 102 112 883 893 B-chronic_disease
heart 113 118 894 899 I-chronic_disease
failure 119 126 900 907 I-chronic_disease
, 126 127 907 908 O
myocardial 128 138 909 919 B-chronic_disease
infarction 139 149 920 930 I-chronic_disease
, 149 150 930 931 O
arrhythmias 151 162 932 943 B-chronic_disease
or 163 165 944 946 O
cardiac 166 173 947 954 O
dysfunction 174 185 955 966 O
requiring 186 195 967 976 O
treatment 196 205 977 986 B-treatment
or 206 208 987 989 O
discontinuation 209 224 990 1005 O
of 225 227 1006 1008 O
chemotherapy 228 240 1009 1021 B-treatment

Cumulative 0 10 1022 1032 O
doxorubicin 11 22 1033 1044 B-treatment
dose 23 27 1045 1049 O
> 28 29 1050 1051 O
= 29 30 1051 1052 O
400mg 31 36 1053 1058 B-lower_bound
/ 36 37 1058 1059 I-lower_bound
m^2 37 40 1059 1062 I-lower_bound
( 41 42 1063 1064 O
> 42 43 1064 1065 O
450 43 46 1065 1068 B-lower_bound
mg 47 49 1069 1071 I-lower_bound
/ 49 50 1071 1072 I-lower_bound
m^2 50 53 1072 1075 I-lower_bound
for 54 57 1076 1079 O
malignant 58 67 1080 1089 B-cancer
soft 68 72 1090 1094 I-cancer
tissue 73 79 1095 1101 I-cancer
and 80 83 1102 1105 O
bone 84 88 1106 1110 B-cancer
tumor 89 94 1111 1116 I-cancer
patients 95 103 1117 1125 O
) 103 104 1125 1126 O
or 105 107 1127 1129 O
cumulative 108 118 1130 1140 O
epirubicin 119 129 1141 1151 B-treatment
dose 130 134 1152 1156 O
> 135 136 1157 1158 O
= 136 137 1158 1159 O
800mg 138 143 1160 1165 B-lower_bound
/ 143 144 1165 1166 I-lower_bound
m^2 144 147 1166 1169 I-lower_bound

Greater 0 7 1170 1177 O
than 8 12 1178 1182 O
or 13 15 1183 1185 O
equal 16 21 1186 1191 O
to 22 24 1192 1194 O
1 25 26 1195 1196 B-lower_bound
week 27 31 1197 1201 I-lower_bound
since 32 37 1202 1207 O
receipt 38 45 1208 1215 O
of 46 48 1216 1218 O
standard 49 57 1219 1227 B-treatment
or 58 60 1228 1230 O
investigational 61 76 1231 1246 B-treatment
HER2- 77 82 1247 1252 I-treatment
directed 83 91 1253 1261 I-treatment
therapy 92 99 1262 1269 I-treatment
for 100 103 1270 1273 O
metastatic 104 114 1274 1284 B-cancer
or 115 117 1285 1287 O
recurrent 118 127 1288 1297 O
disease 128 135 1298 1305 O

Greater 0 7 1306 1313 O
than 8 12 1314 1318 O
or 13 15 1319 1321 O
equal 16 21 1322 1327 O
to 22 24 1328 1330 O
1 25 26 1331 1332 B-lower_bound
week 27 31 1333 1337 I-lower_bound
since 32 37 1338 1343 O
standard 38 46 1344 1352 O
or 47 49 1353 1355 O
investigational 50 65 1356 1371 B-treatment
treatment 66 75 1372 1381 I-treatment
for 76 79 1382 1385 O
metastatic 80 90 1386 1396 B-cancer
disease 91 98 1397 1404 I-cancer

Greater 0 7 1405 1412 O
than 8 12 1413 1417 O
or 13 15 1418 1420 O
equal 16 21 1421 1426 O
to 22 24 1427 1429 O
6 25 26 1430 1431 B-lower_bound
weeks 27 32 1432 1437 I-lower_bound
s 33 34 1438 1439 O
/ 34 35 1439 1440 O
p 35 36 1440 1441 O
primary 37 44 1442 1449 O
surgery 45 52 1450 1457 B-treatment
with 53 57 1458 1462 I-treatment
curative 58 66 1463 1471 I-treatment
intent 67 73 1472 1478 I-treatment

Hematologic 0 11 1479 1490 O
parameters 12 22 1491 1501 O
: 22 23 1501 1502 O
ANC 24 27 1503 1506 B-clinical_variable
> 28 29 1507 1508 O
= 29 30 1508 1509 O
1000 31 35 1510 1514 B-lower_bound
cells 36 41 1515 1520 I-lower_bound
/ 41 42 1520 1521 I-lower_bound
mm^3 42 46 1521 1525 I-lower_bound
, 46 47 1525 1526 O
ALC 48 51 1527 1530 B-clinical_variable
> 52 53 1531 1532 O
= 53 54 1532 1533 O
300 55 58 1534 1537 B-lower_bound
cells 59 64 1538 1543 I-lower_bound
/ 64 65 1543 1544 I-lower_bound
mm^3 65 69 1544 1548 I-lower_bound
, 69 70 1548 1549 O
Hemoglobin 71 81 1550 1560 B-clinical_variable
> 82 83 1561 1562 O
= 83 84 1562 1563 O
9.0 85 88 1564 1567 B-lower_bound
gm 89 91 1568 1570 I-lower_bound
/ 91 92 1570 1571 I-lower_bound
dL 92 94 1571 1573 I-lower_bound
, 94 95 1573 1574 O
WBC 96 99 1575 1578 B-clinical_variable
> 100 101 1579 1580 O
= 101 102 1580 1581 O
2,500 103 108 1582 1587 B-lower_bound
cells 109 114 1588 1593 I-lower_bound
/ 114 115 1593 1594 I-lower_bound
mm^3 115 119 1594 1598 I-lower_bound
, 119 120 1598 1599 O
platelet 121 129 1600 1608 B-clinical_variable
count 130 135 1609 1614 I-clinical_variable
> 136 137 1615 1616 O
= 137 138 1616 1617 O
75,000 139 145 1618 1624 B-lower_bound
/ 145 146 1624 1625 I-lower_bound
mm^3 146 150 1625 1629 I-lower_bound
, 150 151 1629 1630 O
PT 152 154 1631 1633 B-clinical_variable
/ 154 155 1633 1634 O
PTT 155 158 1634 1637 B-clinical_variable
less 159 163 1638 1642 O
than 164 168 1643 1647 O
or 169 171 1648 1650 O
equla 172 177 1651 1656 O
to1.5X 178 184 1657 1663 B-upper_bound
the 185 188 1664 1667 I-upper_bound
upper 189 194 1668 1673 I-upper_bound
limits 195 201 1674 1680 I-upper_bound
of 202 204 1681 1683 I-upper_bound
normal 205 211 1684 1690 I-upper_bound

Hematologic 0 11 1691 1702 O
parameters 12 22 1703 1713 O
: 22 23 1713 1714 O
ANC 24 27 1715 1718 B-clinical_variable
> 28 29 1719 1720 O
= 29 30 1720 1721 O
1000 31 35 1722 1726 B-lower_bound
cells 36 41 1727 1732 I-lower_bound
/ 41 42 1732 1733 I-lower_bound
mm^3 42 46 1733 1737 I-lower_bound
, 46 47 1737 1738 O
ALC 48 51 1739 1742 B-clinical_variable
> 52 53 1743 1744 O
= 53 54 1744 1745 O
300 55 58 1746 1749 B-lower_bound
cells 59 64 1750 1755 I-lower_bound
/ 64 65 1755 1756 I-lower_bound
mm^3 65 69 1756 1760 I-lower_bound
, 69 70 1760 1761 O
absolute 71 79 1762 1770 B-clinical_variable
Hemoglobin 80 90 1771 1781 I-clinical_variable
> 91 92 1782 1783 O
= 92 93 1783 1784 O
9.0 93 96 1784 1787 B-lower_bound
gm 97 99 1788 1790 I-lower_bound
/ 99 100 1790 1791 I-lower_bound
dL 100 102 1791 1793 I-lower_bound
, 102 103 1793 1794 O
WBC 104 107 1795 1798 B-clinical_variable
> 108 109 1799 1800 O
= 109 110 1800 1801 O
2500 110 114 1801 1805 B-lower_bound
cells 115 120 1806 1811 I-lower_bound
/ 120 121 1811 1812 I-lower_bound
mm3 121 124 1812 1815 I-lower_bound
, 124 125 1815 1816 O
platelet 126 134 1817 1825 B-clinical_variable
count 135 140 1826 1831 I-clinical_variable
> 141 142 1832 1833 O
= 142 143 1833 1834 O
75,000 143 149 1834 1840 B-lower_bound
/ 149 150 1840 1841 I-lower_bound
mm^3 150 154 1841 1845 I-lower_bound
, 154 155 1845 1846 O
PT 156 158 1847 1849 B-clinical_variable
/ 158 159 1849 1850 I-clinical_variable
PTT 159 162 1850 1853 I-clinical_variable
1.5X 163 167 1854 1858 O
the 168 171 1859 1862 O
upper 172 177 1863 1868 O
limits 178 184 1869 1875 O
of 185 187 1876 1878 O
normal 188 194 1879 1885 O

History 0 7 1886 1893 O
of 8 10 1894 1896 O
changes 11 18 1897 1904 O
in 19 21 1905 1907 O
baseline 22 30 1908 1916 O
LVEF 31 35 1917 1921 B-clinical_variable
that 36 40 1922 1926 O
occurred 41 49 1927 1935 O
during 50 56 1936 1942 O
prior 57 62 1943 1948 B-treatment
treatment 63 72 1949 1958 I-treatment
with 73 77 1959 1963 O
anti 78 82 1964 1968 B-treatment
- 82 83 1968 1969 I-treatment
HER2 83 87 1969 1973 I-treatment
treatment 88 97 1974 1983 I-treatment

May 0 3 1984 1987 O
or 4 6 1988 1990 O
may 7 10 1991 1994 O
not 11 14 1995 1998 O
have 15 19 1999 2003 O
received 20 28 2004 2012 O
adjuvant 29 37 2013 2021 B-treatment
radiotherapy 38 50 2022 2034 I-treatment
or 51 53 2035 2037 O
chemotherapy 54 66 2038 2050 B-treatment
based 67 72 2051 2056 O
on 73 75 2057 2059 O
pathologic 76 86 2060 2070 O
risk 87 91 2071 2075 O
per 92 95 2076 2079 O
NCCN 96 100 2080 2084 O
guidelines 101 111 2085 2095 O

May 0 3 2096 2099 O
or 4 6 2100 2102 O
may 7 10 2103 2106 O
not 11 14 2107 2110 O
have 15 19 2111 2115 O
received 20 28 2116 2124 O
neoadjuvant 29 40 2125 2136 B-treatment
cisplatin 41 50 2137 2146 O
- 50 51 2146 2147 O
based 51 56 2147 2152 O
combination 57 68 2153 2164 O
chemotherapy 69 81 2165 2177 B-treatment
per 82 85 2178 2181 O
NCCN 86 90 2182 2186 O
guidelines 91 101 2187 2197 O

Naive 0 5 2198 2203 O
to 6 8 2204 2206 O
trastuzumab 9 20 2207 2218 B-treatment
( 21 22 2219 2220 I-treatment
Herceptin(TM 22 34 2220 2232 I-treatment
) 34 35 2232 2233 I-treatment
) 35 36 2233 2234 O
, 36 37 2234 2235 O
pertuzumab 38 48 2236 2246 B-treatment
( 49 50 2247 2248 I-treatment
Perjeta(TM 50 60 2248 2258 I-treatment
) 60 61 2258 2259 I-treatment
) 61 62 2259 2260 O
and 63 66 2261 2264 O
lapatinib 67 76 2265 2274 B-treatment
( 77 78 2275 2276 I-treatment
Tykerb(TM 78 87 2276 2285 I-treatment
) 87 88 2285 2286 I-treatment
) 88 89 2286 2287 O
, 89 90 2287 2288 O
ado 91 94 2289 2292 B-treatment
- 94 95 2292 2293 I-treatment
trastuzumab 95 106 2293 2304 I-treatment
emtansine 107 116 2305 2314 I-treatment
( 117 118 2315 2316 I-treatment
Kadcyla(TM 118 128 2316 2326 I-treatment
) 128 129 2326 2327 I-treatment
) 129 130 2327 2328 O
or 131 133 2329 2331 O
other 134 139 2332 2337 O
HER2 140 144 2338 2342 B-treatment
- 144 145 2342 2343 I-treatment
directed 145 153 2343 2351 I-treatment
therapies 154 163 2352 2361 I-treatment

Negative 0 8 2362 2370 O
serology 9 17 2371 2379 O
for 18 21 2380 2383 O
anti 22 26 2384 2388 O
- 26 27 2388 2389 O
HIV-1/2 27 34 2389 2396 B-chronic_disease
and 35 38 2397 2400 O
anti 39 43 2401 2405 O
- 43 44 2405 2406 O
HTLV 44 48 2406 2410 B-chronic_disease
1/2 49 52 2411 2414 O

Negative 0 8 2415 2423 O
serology 9 17 2424 2432 B-treatment
for 18 21 2433 2436 O
hepatitis 22 31 2437 2446 B-chronic_disease
B 32 33 2447 2448 I-chronic_disease
and 34 37 2449 2452 I-chronic_disease
C 38 39 2453 2454 I-chronic_disease
unless 40 46 2455 2461 O
the 47 50 2462 2465 O
result 51 57 2466 2472 O
is 58 60 2473 2475 O
consistent 61 71 2476 2486 O
with 72 76 2487 2491 O
prior 77 82 2492 2497 B-treatment
vaccination 83 94 2498 2509 I-treatment
or 95 97 2510 2512 O
prior 98 103 2513 2518 O
infection 104 113 2519 2528 B-chronic_disease
with 114 118 2529 2533 O
full 119 123 2534 2538 O
recovery 124 132 2539 2547 O

Negative 0 8 2548 2556 B-clinical_variable
serum 9 14 2557 2562 I-clinical_variable
beta 15 19 2563 2567 I-clinical_variable
HCG 20 23 2568 2571 I-clinical_variable
if 24 26 2572 2574 O
female 27 33 2575 2581 B-gender
and 34 37 2582 2585 O
of 38 40 2586 2588 O
childbearing 41 53 2589 2601 O
potential 54 63 2602 2611 O

Negative 0 8 2612 2620 B-pregnancy
serum 9 14 2621 2626 I-pregnancy
beta 15 19 2627 2631 I-pregnancy
HCG 20 23 2632 2635 I-pregnancy
if 24 26 2636 2638 O
of 27 29 2639 2641 O
childbearing 30 42 2642 2654 O
potential 43 52 2655 2664 O

Patients 0 8 2665 2673 O
with 9 13 2674 2678 O
active 14 20 2679 2685 O
CNS 21 24 2686 2689 B-cancer
metastases 25 35 2690 2700 I-cancer
or 36 38 2701 2703 O
leptomeningeal 39 53 2704 2718 B-cancer
involvement 54 65 2719 2730 O
by 66 68 2731 2733 O
tumor 69 74 2734 2739 B-cancer
( 75 76 2740 2741 O
patients 76 84 2741 2749 O
with 85 89 2750 2754 O
a 90 91 2755 2756 O
history 92 99 2757 2764 O
of 100 102 2765 2767 O
brain 103 108 2768 2773 B-cancer
metastases 109 119 2774 2784 I-cancer
who 120 123 2785 2788 O
have 124 128 2789 2793 O
been 129 133 2794 2798 O
successfully 134 146 2799 2811 O
treated 147 154 2812 2819 O
for 155 158 2820 2823 O
brain 159 164 2824 2829 B-chronic_disease
metastasis 165 175 2830 2840 I-chronic_disease
by 176 178 2841 2843 O
surgery 179 186 2844 2851 B-treatment
or 187 189 2852 2854 O
radiation 190 199 2855 2864 B-treatment
and 200 203 2865 2868 O
who 204 207 2869 2872 O
have 208 212 2873 2877 O
not 213 216 2878 2881 O
had 217 220 2882 2885 O
any 221 224 2886 2889 O
evidence 225 233 2890 2898 O
of 234 236 2899 2901 O
the 237 240 2902 2905 O
new 241 244 2906 2909 O
or 245 247 2910 2912 O
progressive 248 259 2913 2924 O
CNS 260 263 2925 2928 B-chronic_disease
disease 264 271 2929 2936 I-chronic_disease
fot 272 275 2937 2940 O
more 276 280 2941 2945 O
than 281 285 2946 2950 O
12 286 288 2951 2953 B-lower_bound
months 289 295 2954 2960 I-lower_bound
are 296 299 2961 2964 O
eligible 300 308 2965 2973 O
) 308 309 2973 2974 O

Patients 0 8 2975 2983 O
with 9 13 2984 2988 O
breast 14 20 2989 2995 B-cancer
cancer 21 27 2996 3002 I-cancer
that 28 32 3003 3007 O
is 33 35 3008 3010 O
known 36 41 3011 3016 O
to 42 44 3017 3019 O
be 45 47 3020 3022 O
HER2 48 52 3023 3027 O
1 53 54 3028 3029 O
+ 54 55 3029 3030 O
or 56 58 3031 3033 O
2 59 60 3034 3035 O
+ 60 61 3035 3036 O
by 62 64 3037 3039 O
IHC 65 68 3040 3043 B-treatment
or 69 71 3044 3046 O
with 72 76 3047 3051 O
a 77 78 3052 3053 O
Vysis 79 84 3054 3059 B-clinical_variable
FISH 85 89 3060 3064 I-clinical_variable
result 90 96 3065 3071 O
of 97 99 3072 3074 O
1.8 100 103 3075 3078 B-lower_bound
- 104 105 3079 3080 O
less 106 110 3081 3085 O
than 111 115 3086 3090 O
2.2 116 119 3091 3094 B-upper_bound

Patients 0 8 3095 3103 O
with 9 13 3104 3108 O
breast 14 20 3109 3115 B-cancer
cancer 21 27 3116 3122 I-cancer
, 27 28 3122 3123 O
gastric 29 36 3124 3131 B-cancer
, 36 37 3131 3132 O
gastroesophageal 38 54 3133 3149 B-cancer
junction 55 63 3150 3158 I-cancer
or 64 66 3159 3161 O
other 67 72 3162 3167 O
cancers 73 80 3168 3175 B-cancer
with 81 85 3176 3180 O
1 86 87 3181 3182 O
+ 87 88 3182 3183 O
to 89 91 3184 3186 O
3 92 93 3187 3188 O
+ 93 94 3188 3189 O
HER2 95 99 3190 3194 B-clinical_variable
/ 99 100 3194 3195 O
neu 100 103 3195 3198 O
expression 104 114 3199 3209 O
by 115 117 3210 3212 O
IHC 118 121 3213 3216 O
or 122 124 3217 3219 O
a 125 126 3220 3221 O
Vysis 127 132 3222 3227 B-clinical_variable
FISH 133 137 3228 3232 I-clinical_variable
result 138 144 3233 3239 I-clinical_variable
> 145 146 3240 3241 O
2.2 147 150 3242 3245 B-lower_bound

Patients 0 8 3246 3254 O
with 9 13 3255 3259 O
inadequate 14 24 3260 3270 O
bilateral 25 34 3271 3280 B-chronic_disease
peripheral 35 45 3281 3291 I-chronic_disease
venous 46 52 3292 3298 I-chronic_disease
or 53 55 3299 3301 O
central 56 63 3302 3309 O
venous 64 70 3310 3316 O
catheter 71 79 3317 3325 O
access 80 86 3326 3332 O
for 87 90 3333 3336 O
the 91 94 3337 3340 O
required 95 103 3341 3349 O
apheresis 104 113 3350 3359 B-treatment
to 114 116 3360 3362 O
allow 117 122 3363 3368 O
generation 123 133 3369 3379 O
of 134 136 3380 3382 O
the 137 140 3383 3386 O
autologous 141 151 3387 3397 B-treatment
AdHER2 152 158 3398 3404 I-treatment
DC 159 161 3405 3407 I-treatment
vaccine 162 169 3408 3415 I-treatment
product 170 177 3416 3423 O

Patients 0 8 3424 3432 O
with 9 13 3433 3437 O
ovarian 14 21 3438 3445 B-cancer
, 21 22 3445 3446 O
cervical 23 31 3447 3455 B-cancer
, 31 32 3455 3456 O
colon 33 38 3457 3462 B-cancer
, 38 39 3462 3463 O
gastric 40 47 3464 3471 B-cancer
/ 47 48 3471 3472 O
gastroesophageal 48 64 3472 3488 B-cancer
junction 65 73 3489 3497 I-cancer
, 73 74 3497 3498 O
non 75 78 3499 3502 B-cancer
- 78 79 3502 3503 I-cancer
small 79 84 3503 3508 I-cancer
cell 85 89 3509 3513 I-cancer
lung 90 94 3514 3518 I-cancer
, 94 95 3518 3519 O
renal 96 101 3520 3525 B-cancer
cell 102 106 3526 3530 I-cancer
, 106 107 3530 3531 O
bladder 108 115 3532 3539 B-cancer
, 115 116 3539 3540 O
malignant 117 126 3541 3550 B-cancer
soft 127 131 3551 3555 I-cancer
tissue 132 138 3556 3562 I-cancer
and 139 142 3563 3566 O
bone 143 147 3567 3571 B-cancer
tumor 148 153 3572 3577 I-cancer
prostate 154 162 3578 3586 I-cancer
cancer 163 169 3587 3593 I-cancer
or 170 172 3594 3596 O
other 173 178 3597 3602 O
solid 179 184 3603 3608 B-cancer
tumors 185 191 3609 3615 I-cancer
that 192 196 3616 3620 O
is 197 199 3621 3623 O
known 200 205 3624 3629 O
to 206 208 3630 3632 O
be 209 211 3633 3635 O
HER2 212 216 3636 3640 O
1 217 218 3641 3642 O
+ 218 219 3642 3643 O
, 219 220 3643 3644 O
2 221 222 3645 3646 O
+ 222 223 3646 3647 O
or 224 226 3648 3650 O
3 227 228 3651 3652 O
+ 228 229 3652 3653 O
by 230 232 3654 3656 O
IHC 233 236 3657 3660 B-clinical_variable
OR 237 239 3661 3663 O
have 240 244 3664 3668 O
a 245 246 3669 3670 O
Vysis 247 252 3671 3676 B-clinical_variable
FISH 253 257 3677 3681 I-clinical_variable
result 258 264 3682 3688 O
greater 265 272 3689 3696 O
than 273 277 3697 3701 O
or 278 280 3702 3704 O
equal 281 286 3705 3710 O
to 287 289 3711 3713 O
1.8 290 293 3714 3717 B-lower_bound

Performance 0 11 3718 3729 B-clinical_variable
Status 12 18 3730 3736 I-clinical_variable
: 18 19 3736 3737 O
ECOG 20 24 3738 3742 B-clinical_variable
0 25 26 3743 3744 B-lower_bound
- 26 27 3744 3745 O
1 27 28 3745 3746 B-upper_bound

Perormance 0 10 3747 3757 B-clinical_variable
Status 11 17 3758 3764 I-clinical_variable
: 17 18 3764 3765 O
ECOG 19 23 3766 3770 B-clinical_variable
0 24 25 3771 3772 B-lower_bound
- 25 26 3772 3773 O
1 26 27 3773 3774 B-upper_bound

Pregnant 0 8 3775 3783 B-pregnancy
women 9 14 3784 3789 B-gender
are 15 18 3790 3793 O
excluded 19 27 3794 3802 O
from 28 32 3803 3807 O
this 33 37 3808 3812 O
study 38 43 3813 3818 O
because 44 51 3819 3826 O
AdHER 52 57 3827 3832 B-treatment
DC 58 60 3833 3835 I-treatment
vaccine 61 68 3836 3843 I-treatment
may 69 72 3844 3847 O
have 73 77 3848 3852 O
the 78 81 3853 3856 O
potential 82 91 3857 3866 O
for 92 95 3867 3870 O
teratogenic 96 107 3871 3882 B-treatment
or 108 110 3883 3885 O
abortifacient 111 124 3886 3899 O
effects 125 132 3900 3907 O

Recurrent 0 9 3908 3917 O
or 10 12 3918 3920 O
progressive 13 24 3921 3932 B-chronic_disease
disease 25 32 3933 3940 I-chronic_disease
on 33 35 3941 3943 O
prior 36 41 3944 3949 O
standard 42 50 3950 3958 O
therapies 51 60 3959 3968 B-treatment
with 61 65 3969 3973 O
known 66 71 3974 3979 O
clinical 72 80 3980 3988 O
benefit 81 88 3989 3996 O
with 89 93 3997 4001 O
the 94 97 4002 4005 O
exception 98 107 4006 4015 O
of 108 110 4016 4018 O
adjuvant 111 119 4019 4027 O
bladder 120 127 4028 4035 B-cancer
cancer 128 134 4036 4042 I-cancer
population 135 145 4043 4053 O

Recurrent 0 9 4054 4063 O
or 10 12 4064 4066 O
progressive 13 24 4067 4078 O
metastatic 25 35 4079 4089 B-cancer
disease 36 43 4090 4097 I-cancer
after 44 49 4098 4103 O
standard 50 58 4104 4112 O
of 59 61 4113 4115 O
care 62 66 4116 4120 O
HER2 67 71 4121 4125 B-clinical_variable
- 71 72 4125 4126 O
targeted 72 80 4126 4134 B-treatment
therapies 81 90 4135 4144 I-treatment

Stable 0 6 4145 4151 O
, 6 7 4151 4152 O
concurrent 8 18 4153 4163 O
use 19 22 4164 4167 O
of 23 25 4168 4170 O
tamoxifen 26 35 4171 4180 B-treatment
or 36 38 4181 4183 O
aromatase 39 48 4184 4193 B-treatment
inhibitors 49 59 4194 4204 I-treatment
for 60 63 4205 4208 O
hormone 64 71 4209 4216 B-cancer
receptor 72 80 4217 4225 I-cancer
positive 81 89 4226 4234 I-cancer
breast 90 96 4235 4241 I-cancer
cancer 97 103 4242 4248 I-cancer

Stable 0 6 4249 4255 O
, 6 7 4255 4256 O
concurrent 8 18 4257 4267 O
use 19 22 4268 4271 O
of 23 25 4272 4274 O
tamoxifen 26 35 4275 4284 B-treatment
or 36 38 4285 4287 O
aromatase 39 48 4288 4297 B-treatment
inhibitors 49 59 4298 4308 I-treatment
for 60 63 4309 4312 O
hormone 64 71 4313 4320 O
receptor 72 80 4321 4329 O
positive 81 89 4330 4338 O
breast 90 96 4339 4345 B-cancer
cancer 97 103 4346 4352 I-cancer
are 104 107 4353 4356 O
allowed 108 115 4357 4364 O

Status 0 6 4365 4371 O
- 6 7 4371 4372 O
post 7 11 4372 4376 O
primary 12 19 4377 4384 O
cystectomy 20 30 4385 4395 B-treatment
with 31 35 4396 4400 O
curative 36 44 4401 4409 O
intent 45 51 4410 4416 O

Tumor 0 5 4417 4422 B-cancer
stage 6 11 4423 4428 B-cancer
T3a 12 15 4429 4432 I-cancer
, 15 16 4432 4433 O
T3b 17 20 4434 4437 B-cancer
, 20 21 4437 4438 O
T4a 22 25 4439 4442 B-cancer
, 25 26 4442 4443 O
T4b 27 30 4444 4447 B-cancer
and 31 34 4448 4451 O
any 35 38 4452 4455 O
node 39 43 4456 4460 O
positive 44 52 4461 4469 O
disease 53 60 4470 4477 O
regardless 61 71 4478 4488 O
of 72 74 4489 4491 O
tumor 75 80 4492 4497 B-cancer
stage 81 86 4498 4503 O

Tumors 0 6 4504 4510 B-cancer
that 7 11 4511 4515 O
are 12 15 4516 4519 O
HER2 16 20 4520 4524 B-clinical_variable
1 21 22 4525 4526 B-lower_bound
+ 22 23 4526 4527 O
, 23 24 4527 4528 O
2 25 26 4529 4530 O
+ 26 27 4530 4531 O
or 28 30 4532 4534 O
3 31 32 4535 4536 B-upper_bound
+ 32 33 4536 4537 O
by 34 36 4538 4540 O
IHC 37 40 4541 4544 B-clinical_variable
or 41 43 4545 4547 O
have 44 48 4548 4552 O
a 49 50 4553 4554 O
Vysis 51 56 4555 4560 B-clinical_variable
FISH 57 61 4561 4565 I-clinical_variable
result 62 68 4566 4572 I-clinical_variable
greater 69 76 4573 4580 O
than 77 81 4581 4585 O
1.8 82 85 4586 4589 B-lower_bound

Use 0 3 4590 4593 O
of 4 6 4594 4596 O
any 7 10 4597 4600 O
standard 11 19 4601 4609 O
chemotherapy 20 32 4610 4622 B-treatment
or 33 35 4623 4625 O
other 36 41 4626 4631 O
investigational 42 57 4632 4647 B-treatment
agent(s 58 65 4648 4655 I-treatment
) 65 66 4655 4656 I-treatment
within 67 73 4657 4663 O
1 74 75 4664 4665 B-upper_bound
week 76 80 4666 4670 I-upper_bound
of 81 83 4671 4673 O
study 84 89 4674 4679 O
enrollment 90 100 4680 4690 O

Use 0 3 4691 4694 O
of 4 6 4695 4697 O
systemic 7 15 4698 4706 B-treatment
corticosteroid 16 30 4707 4721 I-treatment
therapy 31 38 4722 4729 I-treatment
within 39 45 4730 4736 O
2 46 47 4737 4738 B-upper_bound
weeks 48 53 4739 4744 I-upper_bound
of 54 56 4745 4747 O
study 57 62 4748 4753 O
enrollment 63 73 4754 4764 O
, 73 74 4764 4765 O
including 75 84 4766 4775 O
patients 85 93 4776 4784 O
receiving 94 103 4785 4794 O
replacement 104 115 4795 4806 B-treatment
corticosteroid 116 130 4807 4821 I-treatment
therapy 131 138 4822 4829 I-treatment

Willingness 0 11 4830 4841 O
of 12 14 4842 4844 O
female 15 21 4845 4851 B-gender
and 22 25 4852 4855 I-gender
male 26 30 4856 4860 I-gender
subjects 31 39 4861 4869 I-gender
to 40 42 4870 4872 O
use 43 46 4873 4876 B-contraception_consent
effective 47 56 4877 4886 I-contraception_consent
contraception 57 70 4887 4900 I-contraception_consent
e.g. 71 75 4901 4905 O
oral 76 80 4906 4910 B-contraception_consent
contraceptives 81 95 4911 4925 I-contraception_consent
, 95 96 4925 4926 O
barrier 97 104 4927 4934 B-contraception_consent
device 105 111 4935 4941 I-contraception_consent
, 111 112 4941 4942 O
intrauterine 113 125 4943 4955 B-contraception_consent
device 126 132 4956 4962 I-contraception_consent
, 132 133 4962 4963 O
or 134 136 4964 4966 O
condoms 137 144 4967 4974 B-contraception_consent
, 144 145 4974 4975 O
during 146 152 4976 4982 O
the 153 156 4983 4986 O
study 157 162 4987 4992 O
and 163 166 4993 4996 O
for 167 170 4997 5000 O
three 171 176 5001 5006 B-upper_bound
months 177 183 5007 5013 I-upper_bound
following 184 193 5014 5023 O
the 194 197 5024 5027 O
last 198 202 5028 5032 O
dose 203 207 5033 5037 O
of 208 210 5038 5040 O
study 211 216 5041 5046 B-treatment
vaccine 217 224 5047 5054 I-treatment

Willingness 0 11 5055 5066 O
of 12 14 5067 5069 O
female 15 21 5070 5076 B-gender
subjects 22 30 5077 5085 I-gender
to 31 33 5086 5088 O
use 34 37 5089 5092 B-contraception_consent
effective 38 47 5093 5102 I-contraception_consent
contraception 48 61 5103 5116 I-contraception_consent

with 0 4 5117 5121 O
HER2 5 9 5122 5126 B-cancer
+ 9 10 5126 5127 O
bladder 11 18 5128 5135 B-cancer
cancer 19 25 5136 5142 I-cancer
in 26 28 5143 5145 O
the 29 32 5146 5149 O
adjuvant 33 41 5150 5158 O
setting 42 49 5159 5166 O
( 50 51 5167 5168 O
adjuvant 51 59 5168 5176 O
bladder 60 67 5177 5184 O
cancer 68 74 5185 5191 O
patients 75 83 5192 5200 O
) 83 84 5200 5201 O

with 0 4 5202 5206 O
malignant 5 14 5207 5216 O
soft 15 19 5217 5221 O
tissue 20 26 5222 5228 O
and 27 30 5229 5232 O
bone 31 35 5233 5237 B-cancer
tumors 36 42 5238 5244 I-cancer
and 43 46 5245 5248 O
recurrent 47 56 5249 5258 O
or 57 59 5259 5261 O
progressive 60 71 5262 5273 O
, 71 72 5273 5274 O
metastatic 73 83 5275 5285 B-cancer
solid 84 89 5286 5291 B-cancer
tumors 90 96 5292 5298 I-cancer
who 97 100 5299 5302 O
have 101 105 5303 5307 O
progressed 106 116 5308 5318 O
on 117 119 5319 5321 O
standard 120 128 5322 5330 B-treatment
therapies 129 138 5331 5340 I-treatment
with 139 143 5341 5345 O
known 144 149 5346 5351 O
benefit 150 157 5352 5359 O
but 158 161 5360 5363 O
for 162 165 5364 5367 O
whom 166 170 5368 5372 O
anti 171 175 5373 5377 B-treatment
- 175 176 5377 5378 I-treatment
HER2 176 180 5378 5382 I-treatment
therapy 181 188 5383 5390 I-treatment
is 189 191 5391 5393 O
not 192 195 5394 5397 O
clinically 196 206 5398 5408 O
indicated 207 216 5409 5418 O

Cancer 0 6 0 6 B-cancer
should 7 13 7 13 O
be 14 16 14 16 O
judged 17 23 17 23 O
to 24 26 24 26 O
be 27 29 27 29 O
stage 30 35 30 35 B-lower_bound
1 36 37 36 37 I-lower_bound
to 38 40 38 40 O
3 41 42 41 42 B-upper_bound
based 43 48 43 48 O
on 49 51 49 51 O
preoperative 52 64 52 64 O
staging 65 72 65 72 O

Patient 0 7 73 80 O
must 8 12 81 85 O
have 13 17 86 90 O
biopsy 18 24 91 97 B-treatment
proven 25 31 98 104 O
colon 32 37 105 110 B-cancer
or 38 40 111 113 O
rectal 41 47 114 120 B-cancer
cancer 48 54 121 127 I-cancer

Patients 0 8 128 136 O
must 9 13 137 141 O
be 14 16 142 144 O
age 17 20 145 148 B-age
18 21 23 149 151 B-lower_bound
to 24 26 152 154 O
85 27 29 155 157 B-upper_bound
years 30 35 158 163 I-upper_bound

Patients 0 8 164 172 O
undergoing 9 19 173 183 O
emergency 20 29 184 193 B-treatment
surgery 30 37 194 201 I-treatment
for 38 41 202 205 O
cancer 42 48 206 212 B-cancer
are 49 52 213 216 O
not 53 56 217 220 O
eligible 57 65 221 229 O

Patients 0 8 230 238 O
who 9 12 239 242 O
are 13 16 243 246 O
immunosuppressed 17 33 247 263 O
or 34 36 264 266 O
taking 37 43 267 273 O
immunosuppressive 44 61 274 291 B-treatment
medications 62 73 292 303 I-treatment
( 74 75 304 305 O
steroids 75 83 305 313 B-treatment
or 84 86 314 316 O
chemotherapeutic 87 103 317 333 B-treatment
agents 104 110 334 340 I-treatment
) 110 111 340 341 O
are 112 115 342 345 O
not 116 119 346 349 O
eligible 120 128 350 358 O

Patients 0 8 359 367 O
who 9 12 368 371 O
are 13 16 372 375 O
taking 17 23 376 382 O
part 24 28 383 387 O
in 29 31 388 390 O
other 32 37 391 396 O
neoadjuvant 38 49 397 408 B-treatment
and 50 53 409 412 O
early 54 59 413 418 O
adjuvant 60 68 419 427 B-treatment
chemotherapy 69 81 428 440 I-treatment
trials 82 88 441 447 O
are 89 92 448 451 O
not 93 96 452 455 O
eligible 97 105 456 464 O

Patients 0 8 465 473 O
with 9 13 474 478 O
Crohn 14 19 479 484 B-chronic_disease
's 19 21 484 486 I-chronic_disease
disease 22 29 487 494 I-chronic_disease
or 30 32 495 497 O
ulcerative 33 43 498 508 B-chronic_disease
colitis 44 51 509 516 I-chronic_disease
are 52 55 517 520 O
not 56 59 521 524 O
eligible 60 68 525 533 O

Patients 0 8 534 542 O
with 9 13 543 547 O
cancer 14 20 548 554 B-cancer
judged 21 27 555 561 O
to 28 30 562 564 O
be 31 33 565 567 O
stage 34 39 568 573 O
4 40 41 574 575 O
are 42 45 576 579 O
not 46 49 580 583 O
eligible 50 58 584 592 O

Patients 0 8 593 601 O
with 9 13 602 606 O
other 14 19 607 612 O
malignancies 20 32 613 625 B-cancer
are 33 36 626 629 O
not 37 40 630 633 O
eligible 41 49 634 642 O

Any 0 3 0 3 O
positive 4 12 4 12 O
test 13 17 13 17 O
for 18 21 18 21 O
hepatitis 22 31 22 31 B-chronic_disease
B 32 33 32 33 I-chronic_disease
virus 34 39 34 39 I-chronic_disease
or 40 42 40 42 O
hepatitis 43 52 43 52 B-chronic_disease
C 53 54 53 54 I-chronic_disease
virus 55 60 55 60 I-chronic_disease
or 61 63 61 63 O
human 64 69 64 69 B-chronic_disease
immunodeficiency 70 86 70 86 I-chronic_disease
virus 87 92 87 92 I-chronic_disease
( 93 94 93 94 I-chronic_disease
HIV 94 97 94 97 I-chronic_disease
) 97 98 97 98 I-chronic_disease
indicating 99 109 99 109 O
acute 110 115 110 115 B-chronic_disease
or 116 118 116 118 I-chronic_disease
chronic 119 126 119 126 I-chronic_disease
infection 127 136 127 136 I-chronic_disease

Eastern 0 7 137 144 B-clinical_variable
Cooperative 8 19 145 156 I-clinical_variable
Oncology 20 28 157 165 I-clinical_variable
Group 29 34 166 171 I-clinical_variable
( 35 36 172 173 I-clinical_variable
ECOG 36 40 173 177 I-clinical_variable
) 40 41 177 178 I-clinical_variable
Performance 42 53 179 190 I-clinical_variable
Status 54 60 191 197 I-clinical_variable
of 61 63 198 200 O
≤ 64 65 201 202 O
1 66 67 203 204 B-upper_bound

Measurable 0 10 205 215 O
disease 11 18 216 223 O
by 19 21 224 226 O
CT 22 24 227 229 B-treatment
or 25 27 230 232 O
MRI 28 31 233 236 B-treatment
per 32 35 237 240 O
response 36 44 241 249 O
evaluation 45 55 250 260 O
criteria 56 64 261 269 O
in 65 67 270 272 O
solid 68 73 273 278 B-cancer
tumors 74 80 279 285 I-cancer
version 81 88 286 293 O
1.1 89 92 294 297 O
( 93 94 298 299 O
RECIST 94 100 299 305 O
1.1 101 104 306 309 O
) 104 105 309 310 O
criteria 106 114 311 319 O

Subjects 0 8 320 328 O
with 9 13 329 333 O
an 14 16 334 336 O
active 17 23 337 343 O
, 23 24 343 344 O
known 25 30 345 350 O
or 31 33 351 353 O
suspected 34 43 354 363 O
autoimmune 44 54 364 374 B-chronic_disease
disease 55 62 375 382 I-chronic_disease

Subjects 0 8 383 391 O
with 9 13 392 396 O
untreated 14 23 397 406 O
Central 24 31 407 414 B-cancer
nervous 32 39 415 422 I-cancer
system 40 46 423 429 I-cancer
( 47 48 430 431 I-cancer
CNS 48 51 431 434 I-cancer
) 51 52 434 435 I-cancer
metastases 53 63 436 446 I-cancer

recurrent 0 9 447 456 O
NSCLC 10 15 457 462 B-cancer
squamous 16 24 463 471 I-cancer
or 25 27 472 474 O
non 28 31 475 478 B-cancer
- 31 32 478 479 I-cancer
squamous 32 40 479 487 I-cancer
histology 41 50 488 497 O

with 0 4 498 502 O
no 5 7 503 505 O
prior 8 13 506 511 B-treatment
systemic 14 22 512 520 I-treatment
anticancer 23 33 521 531 I-treatment
therapy 34 41 532 539 I-treatment

Age 0 3 0 3 B-age
≥18 4 7 4 7 O
yrs 8 11 8 11 I-lower_bound

Allergy 0 7 12 19 O
to 8 10 20 22 O
phenylephrine 11 24 23 36 B-allergy_name
or 25 27 37 39 O
ephedrine 28 37 40 49 B-allergy_name
, 37 38 49 50 O
or 39 41 51 53 O
any 42 45 54 57 O
other 46 51 58 63 O
standardized 52 64 64 76 O
medication 65 75 77 87 O

Any 0 3 88 91 O
other 4 9 92 97 O
physical 10 18 98 106 O
or 19 21 107 109 O
psychiatric 22 33 110 121 B-chronic_disease
condition 34 43 122 131 I-chronic_disease
which 44 49 132 137 O
may 50 53 138 141 O
impair 54 60 142 148 O
their 61 66 149 154 O
ability 67 74 155 162 O
to 75 77 163 165 O
cooperate 78 87 166 175 O
with 88 92 176 180 O
study 93 98 181 186 O
data 99 103 187 191 O
collection 104 114 192 202 O

CD 0 2 203 205 B-chronic_disease
under 3 8 206 211 O
spinal 9 15 212 218 B-treatment
anesthesia 16 26 219 229 I-treatment

English 0 7 230 237 B-language_fluency
speaking 8 16 238 246 I-language_fluency

Height 0 6 247 253 B-clinical_variable
< 7 8 254 255 O
5'0 9 12 256 259 B-upper_bound

Non 0 3 260 263 O
- 3 4 263 264 O
laboring 4 12 264 272 O
women 13 18 273 278 B-gender

Patients 0 8 279 287 O
on 9 11 288 290 O
Monoamine 12 21 291 300 B-treatment
Oxidase 22 29 301 308 I-treatment
Inhibitors 30 40 309 319 I-treatment
or 41 43 320 322 O
Tricyclic 44 53 323 332 B-treatment
Antidepressants 54 69 333 348 I-treatment

Pre 0 3 349 352 B-chronic_disease
- 3 4 352 353 I-chronic_disease
eclampsia 4 13 353 362 I-chronic_disease
( 14 15 363 364 O
mild 15 19 364 368 O
, 19 20 368 369 O
or 21 23 370 372 O
severe 24 30 373 379 O
) 30 31 379 380 O

Severe 0 6 381 387 O
Cardiac 7 14 388 395 B-chronic_disease
disease 15 22 396 403 I-chronic_disease
in 23 25 404 406 O
pregnancy 26 35 407 416 B-pregnancy
with 36 40 417 421 O
marked 41 47 422 428 O
functional 48 58 429 439 O
limitations 59 70 440 451 O
( 71 72 452 453 O
NYHA 72 76 453 457 O
Class 77 82 458 463 O
III 83 86 464 467 O
and 87 90 468 471 O
IV 91 93 472 474 O
) 93 94 474 475 O

Subject 0 7 476 483 O
enrollment 8 18 484 494 O
in 19 21 495 497 O
another 22 29 498 505 O
study 30 35 506 511 O
involving 36 45 512 521 O
a 46 47 522 523 O
study 48 53 524 529 O
medication 54 64 530 540 O
within 65 71 541 547 O
30 72 74 548 550 B-upper_bound
days 75 79 551 555 I-upper_bound
of 80 82 556 558 O
CD 83 85 559 561 O

Overweight 0 10 0 10 O
/ 10 11 10 11 O
obese 11 16 11 16 B-chronic_disease
adults 17 23 17 23 O

Amblyopia 0 9 0 9 B-chronic_disease

Aniridia 0 8 10 18 B-chronic_disease

Capsular 0 8 19 27 O
bag 9 12 28 31 O
tearing 13 20 32 39 O
beyond 21 27 40 46 O
the 28 31 47 50 O
point 32 37 51 56 O
where 38 43 57 62 O
the 44 47 63 66 O
surgeon 48 55 67 74 O
thinks 56 62 75 81 O
it 63 65 82 84 O
is 66 68 85 87 O
in 69 71 88 90 O
the 72 75 91 94 O
best 76 80 95 99 O
interest 81 89 100 108 O
of 90 92 109 111 O
the 93 96 112 115 O
patient 97 104 116 123 O
to 105 107 124 126 O
have 108 112 127 131 O
a 113 114 132 133 O
capsular 115 123 134 142 B-treatment
ring 124 128 143 147 I-treatment
implanted 129 138 148 157 I-treatment

Cataracts 0 9 158 167 B-chronic_disease
due 10 13 168 171 O
to 14 16 172 174 O
rubella 17 24 175 182 B-chronic_disease

Congenital 0 10 183 193 B-chronic_disease
cataracts 11 20 194 203 I-chronic_disease

Corneal 0 7 204 211 B-chronic_disease
disease 8 15 212 219 I-chronic_disease

Diabetes 0 8 220 228 B-chronic_disease

Flat 0 4 229 233 B-chronic_disease
anterior 5 13 234 242 I-chronic_disease
chamber 14 21 243 250 I-chronic_disease

Iris 0 4 251 255 B-chronic_disease
atrophy 5 12 256 263 I-chronic_disease

Iritis 0 6 264 270 B-chronic_disease

Microphthalmia 0 14 271 285 B-chronic_disease

Ocular 0 6 286 292 B-chronic_disease
inflammation 7 19 293 305 I-chronic_disease

Optic 0 5 306 311 B-chronic_disease
atrophy 6 13 312 319 I-chronic_disease

Preoperative 0 12 320 332 B-clinical_variable
intraocular 13 24 333 344 I-clinical_variable
pressure 25 33 345 353 I-clinical_variable
over 34 38 354 358 O
21 39 41 359 361 B-lower_bound
mm 42 44 362 364 I-lower_bound
Hg 45 47 365 367 I-lower_bound

Preoperative 0 12 368 380 O
ocular 13 19 381 387 B-chronic_disease
infection 20 29 388 397 I-chronic_disease

Retinal 0 7 398 405 B-chronic_disease
degeneration 8 20 406 418 I-chronic_disease

Retinal 0 7 419 426 B-chronic_disease
detachment 8 18 427 437 I-chronic_disease

Significant 0 11 438 449 O
zonular 12 19 450 457 B-treatment
didlysis 20 28 458 466 I-treatment
during 29 35 467 473 O
surgery 36 43 474 481 B-treatment

Vitritis 0 8 482 490 B-chronic_disease

patient 0 7 491 498 O
has 8 11 499 502 O
observed 12 20 503 511 O
or 21 23 512 514 O
suspected 24 33 515 524 O
weakened 34 42 525 533 O
, 42 43 533 534 O
torn 44 48 535 539 O
, 48 49 539 540 O
missing 50 57 541 548 O
or 58 60 549 551 O
otherwise 61 70 552 561 O
compromised 71 82 562 573 O
zonules 83 90 574 581 O
( 91 92 582 583 O
torn 92 96 583 587 O
or 97 99 588 590 O
missing 100 107 591 598 O
estimated 108 117 599 608 O
not 118 121 609 612 O
to 122 124 613 615 O
exceed 125 131 616 622 O
one 132 135 623 626 O
- 135 136 626 627 O
third 136 141 627 632 O
of 142 144 633 635 O
the 145 148 636 639 O
capsular 149 157 640 648 O
bag 158 161 649 652 O
diameter 162 170 653 661 O
) 170 171 661 662 O
due 172 175 663 666 O
to 176 178 667 669 O
Pseudoexfoliation 179 196 670 687 B-chronic_disease
Syndrome 197 205 688 696 I-chronic_disease
, 205 206 696 697 O
Marfans 207 214 698 705 B-chronic_disease
Syndrome 215 223 706 714 I-chronic_disease
, 223 224 714 715 O
trauma 225 231 716 722 B-chronic_disease
or 232 234 723 725 O
other 235 240 726 731 O
zonular 241 248 732 739 O
compromising 249 261 740 752 O
condition 262 271 753 762 O

patient 0 7 763 770 O
is 8 10 771 773 O
at 11 13 774 776 O
least 14 19 777 782 O
21 20 22 783 785 B-lower_bound
years 23 28 786 791 I-lower_bound
old 29 32 792 795 O

patient 0 7 796 803 O
requires 8 16 804 812 O
cataract 17 25 813 821 B-treatment
surgery 26 33 822 829 I-treatment
with 34 38 830 834 I-treatment
IOL 39 42 835 838 I-treatment
implantation 43 55 839 851 I-treatment

uveitis 0 7 852 859 B-chronic_disease

ALT 0 3 0 3 B-clinical_variable
or 4 6 4 6 O
AST 7 10 7 10 B-clinical_variable
< 11 12 11 12 O
3 13 14 13 14 B-upper_bound
x 15 16 15 16 I-upper_bound
upper 17 22 17 22 I-upper_bound
limit 23 28 23 28 I-upper_bound
of 29 31 29 31 I-upper_bound
normal 32 38 32 38 I-upper_bound

Abdominal 0 9 39 48 B-treatment
/ 9 10 48 49 I-treatment
pelvic 10 16 49 55 I-treatment
CT 17 19 56 58 I-treatment
scan 20 24 59 63 I-treatment
with 25 29 64 68 O
IV 30 32 69 71 O
contrast 33 41 72 80 O
within 42 48 81 87 O
21 49 51 88 90 B-upper_bound
days 52 56 91 95 I-upper_bound
prior 57 62 96 101 I-upper_bound
to 63 65 102 104 O
study 66 71 105 110 O
entry 72 77 111 116 O

Abdominal 0 9 117 126 O
/ 9 10 126 127 O
pelvic 10 16 127 133 O
MR 17 19 134 136 B-clinical_variable
prior 20 25 137 142 B-treatment
to 26 28 143 145 I-treatment
radiation 29 38 146 155 I-treatment
with 39 43 156 160 O
perfusion 44 53 161 170 O
and 54 57 171 174 O
diffusion- 58 68 175 185 O
weighted 69 77 186 194 O
sequences 78 87 195 204 O
and 88 91 205 208 O
MR 92 94 209 211 O
and 95 98 212 215 O
CT 99 101 216 218 B-clinical_variable
sim 102 105 219 222 O
for 106 109 223 226 O
radiation 110 119 227 236 O
planning 120 128 237 245 O
Pet 129 132 246 249 B-treatment
scan 133 137 250 254 I-treatment
within 138 144 255 261 O
21 145 147 262 264 B-upper_bound
days 148 152 265 269 I-upper_bound
prior 153 158 270 275 I-upper_bound
to 159 161 276 278 O
study 162 167 279 284 O
entry 168 173 285 290 O
, 173 174 290 291 O
Functional 175 185 292 302 O
renal 186 191 303 308 O
study 192 197 309 314 O

Ability 0 7 315 322 O
to 8 10 323 325 O
swallow 11 18 326 333 O
oral 19 23 334 338 B-treatment
medications 24 35 339 350 I-treatment

Absolute 0 8 351 359 B-clinical_variable
neutrophil 9 19 360 370 I-clinical_variable
count 20 25 371 376 I-clinical_variable
( 26 27 377 378 I-clinical_variable
ANC 27 30 378 381 I-clinical_variable
) 30 31 381 382 I-clinical_variable
≥ 32 33 383 384 O
1,500 34 39 385 390 B-lower_bound
cells 40 45 391 396 I-lower_bound
/ 45 46 396 397 I-lower_bound
mm3 46 49 397 400 I-lower_bound

Acute 0 5 401 406 O
bacterial 6 15 407 416 B-chronic_disease
or 16 18 417 419 O
fungal 19 25 420 426 B-chronic_disease
infection 26 35 427 436 I-chronic_disease
requiring 36 45 437 446 O
intravenous 46 57 447 458 B-treatment
antibiotics 58 69 459 470 I-treatment
at 70 72 471 473 O
the 73 76 474 477 O
time 77 81 478 482 O
of 82 84 483 485 O
registration 85 97 486 498 O

Age 0 3 499 502 B-age
≥ 4 5 503 504 O
18 6 8 505 507 B-lower_bound

Alkaline 0 8 508 516 B-clinical_variable
phosphatase 9 20 517 528 I-clinical_variable
< 21 22 529 530 O
3 23 24 531 532 B-upper_bound
x 25 26 533 534 I-upper_bound
upper 27 32 535 540 I-upper_bound
limit 33 38 541 546 I-upper_bound
of 39 41 547 549 I-upper_bound
normal 42 48 550 556 I-upper_bound

Any 0 3 557 560 O
major 4 9 561 566 B-clinical_variable
surgery 10 17 567 574 I-clinical_variable
within 18 24 575 581 O
28 25 27 582 584 B-upper_bound
days 28 32 585 589 I-upper_bound
prior 33 38 590 595 I-upper_bound
to 39 41 596 598 O
study 42 47 599 604 O
entry 48 53 605 610 O

Any 0 3 611 614 O
unresolved 4 14 615 625 O
bowel 15 20 626 631 B-chronic_disease
or 21 23 632 634 O
bile 24 28 635 639 B-chronic_disease
duct 29 33 640 644 I-chronic_disease
obstruction 34 45 645 656 I-chronic_disease

Chest 0 5 657 662 B-treatment
CT 6 8 663 665 I-treatment
scan 9 13 666 670 I-treatment
, 13 14 670 671 O
or 15 17 672 674 O
X 18 19 675 676 B-treatment
- 19 20 676 677 I-treatment
ray 20 23 677 680 I-treatment
within 24 30 681 687 O
21 31 33 688 690 B-upper_bound
days 34 38 691 695 I-upper_bound
prior 39 44 696 701 I-upper_bound
to 45 47 702 704 O
study 48 53 705 710 O
entry 54 59 711 716 O

Chronic 0 7 717 724 B-chronic_disease
obstructive 8 19 725 736 I-chronic_disease
pulmonary 20 29 737 746 I-chronic_disease
disease 30 37 747 754 I-chronic_disease
exacerbation 38 50 755 767 B-treatment
or 51 53 768 770 O
other 54 59 771 776 O
respiratory 60 71 777 788 B-chronic_disease
illness 72 79 789 796 I-chronic_disease
requiring 80 89 797 806 O
hospitalization 90 105 807 822 O
or 106 108 823 825 O
precluding 109 119 826 836 O
study 120 125 837 842 O
therapy 126 133 843 850 B-treatment
within 134 140 851 857 O
30 141 143 858 860 B-upper_bound
days 144 148 861 865 I-upper_bound
before 149 155 866 872 O
registration 156 168 873 885 O

Distant 0 7 886 893 B-cancer
metastatic 8 18 894 904 I-cancer
disease 19 26 905 912 I-cancer
, 26 27 912 913 O
second 28 34 914 920 B-cancer
malignancy 35 45 921 931 I-cancer
or 46 48 932 934 O
peritoneal 49 59 935 945 B-chronic_disease
seeding 60 67 946 953 I-chronic_disease

Fasting 0 7 954 961 B-clinical_variable
blood 8 13 962 967 I-clinical_variable
glucose 14 21 968 975 I-clinical_variable
< 22 23 976 977 O
160 24 27 978 981 B-upper_bound
mg 28 30 982 984 I-upper_bound
/ 30 31 984 985 I-upper_bound
dl 31 33 985 987 I-upper_bound

Hemoglobin 0 10 988 998 B-clinical_variable
≥ 11 12 999 1000 O
8.0 13 16 1001 1004 B-lower_bound
g 17 18 1005 1006 I-lower_bound
/ 18 19 1006 1007 I-lower_bound
dl 19 21 1007 1009 I-lower_bound
( 22 23 1010 1011 O
Note 23 27 1011 1015 O
: 27 28 1015 1016 O
The 29 32 1017 1020 O
use 33 36 1021 1024 O
of 37 39 1025 1027 O
transfusion 40 51 1028 1039 B-treatment
or 52 54 1040 1042 O
other 55 60 1043 1048 O
intervention 61 73 1049 1061 O
to 74 76 1062 1064 O
achieve 77 84 1065 1072 O
Hgb 85 88 1073 1076 B-clinical_variable
≥ 89 90 1077 1078 O
8.0 91 94 1079 1082 O
g 95 96 1083 1084 O
/ 96 97 1084 1085 O
dl 97 99 1085 1087 O
is 100 102 1088 1090 O
acceptable 103 113 1091 1101 O
. 113 114 1101 1102 O
) 114 115 1102 1103 O

History 0 7 1104 1111 O
/ 7 8 1111 1112 O
physical 8 16 1112 1120 O
examination 17 28 1121 1132 O
, 28 29 1132 1133 O
including 30 39 1134 1143 O
collection 40 50 1144 1154 O
of 51 53 1155 1157 O
weight 54 60 1158 1164 O
and 61 64 1165 1168 O
vital 65 70 1169 1174 O
signs 71 76 1175 1180 O
, 76 77 1180 1181 O
within 78 84 1182 1188 O
28 85 87 1189 1191 B-upper_bound
days 88 92 1192 1196 I-upper_bound
prior 93 98 1197 1202 I-upper_bound
to 99 101 1203 1205 O
study 102 107 1206 1211 O
entry 108 113 1212 1217 O

Inability 0 9 1218 1227 O
to 10 12 1228 1230 O
undergo 13 20 1231 1238 O
an 21 23 1239 1241 O
MR 24 26 1242 1244 B-treatment
of 27 29 1245 1247 O
the 30 33 1248 1251 O
abdomen 34 41 1252 1259 O
/ 41 42 1259 1260 O
pelvis 42 48 1260 1266 O

Major 0 5 1267 1272 B-treatment
resection 6 15 1273 1282 I-treatment
of 16 18 1283 1285 I-treatment
the 19 22 1286 1289 I-treatment
stomach 23 30 1290 1297 I-treatment
or 31 33 1298 1300 I-treatment
small 34 39 1301 1306 I-treatment
bowel 40 45 1307 1312 I-treatment
that 46 50 1313 1317 O
could 51 56 1318 1323 O
affect 57 63 1324 1330 O
the 64 67 1331 1334 O
absorption 68 78 1335 1345 O
of 79 81 1346 1348 O
capecitabine 82 94 1349 1361 B-treatment

Negative 0 8 1362 1370 B-pregnancy
serum 9 14 1371 1376 I-pregnancy
pregnancy 15 24 1377 1386 I-pregnancy
test 25 29 1387 1391 O
( 30 31 1392 1393 O
if 31 33 1393 1395 O
applicable 34 44 1396 1406 O
) 44 45 1406 1407 O
within 46 52 1408 1414 O
14 53 55 1415 1417 B-upper_bound
days 56 60 1418 1422 I-upper_bound
prior 61 66 1423 1428 I-upper_bound
to 67 69 1429 1431 O
study 70 75 1432 1437 O
entry 76 81 1438 1443 O

Participation 0 13 1444 1457 O
in 14 16 1458 1460 O
another 17 24 1461 1468 O
clinical 25 33 1469 1477 O
treatment 34 43 1478 1487 B-treatment
trial 44 49 1488 1493 O
while 50 55 1494 1499 O
on 56 58 1500 1502 O
study 59 64 1503 1508 O

Pathologically 0 14 1509 1523 O
confirmed 15 24 1524 1533 O
( 25 26 1534 1535 O
histologic 26 36 1535 1545 O
or 37 39 1546 1548 O
cytologic 40 49 1549 1558 O
) 49 50 1558 1559 O
, 50 51 1559 1560 O
locally 52 59 1561 1568 B-cancer
advanced 60 68 1569 1577 I-cancer
, 68 69 1577 1578 O
adenocarcinoma 70 84 1579 1593 B-cancer
of 85 87 1594 1596 O
the 88 91 1597 1600 O
pancreas 92 100 1601 1609 O
; 100 101 1609 1610 O
patients 102 110 1611 1619 O
must 111 115 1620 1624 O
have 116 120 1625 1629 O
unresectable 121 133 1630 1642 O
disease 134 141 1643 1650 O
based 142 147 1651 1656 O
on 148 150 1657 1659 O
institutional 151 164 1660 1673 O
standardized 165 177 1674 1686 O
criteria 178 186 1687 1695 O
of 187 189 1696 1698 O
unresectability 190 205 1699 1714 O
or 206 208 1715 1717 O
medical 209 216 1718 1725 O
inoperability 217 230 1726 1739 O

Patients 0 8 1740 1748 O
must 9 13 1749 1753 O
have 14 18 1754 1758 O
had 19 22 1759 1762 O
at 23 25 1763 1765 O
least 26 31 1766 1771 O
4 32 33 1772 1773 B-lower_bound
months 34 40 1774 1780 I-lower_bound
of 41 43 1781 1783 O
prior 44 49 1784 1789 B-treatment
systemic 50 58 1790 1798 I-treatment
chemotherapy 59 71 1799 1811 I-treatment

Patients 0 8 1812 1820 O
with 9 13 1821 1825 O
and 14 17 1826 1829 O
without 18 25 1830 1837 O
regional 26 34 1838 1846 O
adenopathy 35 45 1847 1857 B-chronic_disease
are 46 49 1858 1861 O
eligible 50 58 1862 1870 O

Platelets 0 9 1871 1880 B-clinical_variable
≥ 10 11 1881 1882 O
100,000 12 19 1883 1890 B-lower_bound
cells 20 25 1891 1896 I-lower_bound
/ 25 26 1896 1897 I-lower_bound
mm3 26 29 1897 1900 I-lower_bound

Pregnancy 0 9 1901 1910 B-pregnancy
or 10 12 1911 1913 O
women 13 18 1914 1919 B-gender
of 19 21 1920 1922 O
childbearing 22 34 1923 1935 O
potential 35 44 1936 1945 O
and 45 48 1946 1949 O
men 49 52 1950 1953 O
who 53 56 1954 1957 O
are 57 60 1958 1961 O
sexually 61 69 1962 1970 O
active 70 76 1971 1977 O
and 77 80 1978 1981 O
not 81 84 1982 1985 B-contraception_consent
willing 85 92 1986 1993 I-contraception_consent
/ 92 93 1993 1994 I-contraception_consent
able 93 97 1994 1998 I-contraception_consent
to 98 100 1999 2001 I-contraception_consent
use 101 104 2002 2005 I-contraception_consent
medically 105 114 2006 2015 I-contraception_consent
acceptable 115 125 2016 2026 I-contraception_consent
forms 126 131 2027 2032 I-contraception_consent
of 132 134 2033 2035 I-contraception_consent
contraception 135 148 2036 2049 I-contraception_consent
during 149 155 2050 2056 O
the 156 159 2057 2060 O
course 160 166 2061 2067 O
of 167 169 2068 2070 O
the 170 173 2071 2074 O
study 174 179 2075 2080 O
and 180 183 2081 2084 O
for 184 187 2085 2088 O
women 188 193 2089 2094 O
, 193 194 2094 2095 O
for 195 198 2096 2099 O
3 199 200 2100 2101 B-upper_bound
months 201 207 2102 2108 I-upper_bound
after 208 213 2109 2114 I-upper_bound
the 214 217 2115 2118 O
last 218 222 2119 2123 O
study 223 228 2124 2129 B-treatment
drug 229 233 2130 2134 I-treatment
administration 234 248 2135 2149 O

Prior 0 5 2150 2155 O
allergic 6 14 2156 2164 O
reaction 15 23 2165 2173 O
to 24 26 2174 2176 O
capecitabine 27 39 2177 2189 B-allergy_name
or 40 42 2190 2192 O
gemcitabine 43 54 2193 2204 B-allergy_name

Prior 0 5 2205 2210 B-treatment
radiotherapy 6 18 2211 2223 I-treatment
to 19 21 2224 2226 O
the 22 25 2227 2230 O
region 26 32 2231 2237 O
of 33 35 2238 2240 O
the 36 39 2241 2244 O
study 40 45 2245 2250 O
cancer 46 52 2251 2257 B-cancer
that 53 57 2258 2262 O
would 58 63 2263 2268 O
result 64 70 2269 2275 O
in 71 73 2276 2278 O
overlap 74 81 2279 2286 O
of 82 84 2287 2289 O
radiation 85 94 2290 2299 B-treatment
therapy 95 102 2300 2307 I-treatment
fields 103 109 2308 2314 O

Serum 0 5 2315 2320 B-clinical_variable
creatinine 6 16 2321 2331 I-clinical_variable
≤ 17 18 2332 2333 O
1.5 19 22 2334 2337 B-upper_bound
mg 23 25 2338 2340 I-upper_bound
/ 25 26 2340 2341 I-upper_bound
dl 26 28 2341 2343 I-upper_bound

Total 0 5 2344 2349 B-clinical_variable
bilirubin 6 15 2350 2359 I-clinical_variable
< 16 17 2360 2361 O
3.0 18 21 2362 2365 B-upper_bound
mg 22 24 2366 2368 I-upper_bound
/ 24 25 2368 2369 I-upper_bound
dL 25 27 2369 2371 I-upper_bound

Transmural 0 10 2372 2382 B-chronic_disease
myocardial 11 21 2383 2393 I-chronic_disease
infarction 22 32 2394 2404 I-chronic_disease
within 33 39 2405 2411 O
3 40 41 2412 2413 B-upper_bound
months 42 48 2414 2420 I-upper_bound
prior 49 54 2421 2426 I-upper_bound
to 55 57 2427 2429 O
study 58 63 2430 2435 O
entry 64 69 2436 2441 O

Uncontrolled 0 12 2442 2454 O
malabsorption 13 26 2455 2468 B-chronic_disease
syndrome 27 35 2469 2477 I-chronic_disease
significantly 36 49 2478 2491 O
affecting 50 59 2492 2501 O
gastrointestinal 60 76 2502 2518 O
function 77 85 2519 2527 O

Unstable 0 8 2528 2536 B-chronic_disease
angina 9 15 2537 2543 I-chronic_disease
and/or 16 22 2544 2550 O
congestive 23 33 2551 2561 B-chronic_disease
heart 34 39 2562 2567 I-chronic_disease
failure 40 47 2568 2575 I-chronic_disease
requiring 48 57 2576 2585 O
hospitalization 58 73 2586 2601 O
within 74 80 2602 2608 O
the 81 84 2609 2612 O
last 85 89 2613 2617 B-upper_bound
6 90 91 2618 2619 I-upper_bound
months 92 98 2620 2626 I-upper_bound

Women 0 5 2627 2632 B-gender
of 6 8 2633 2635 O
childbearing 9 21 2636 2648 O
potential 22 31 2649 2658 O
and 32 35 2659 2662 O
male 36 40 2663 2667 B-gender
participants 41 53 2668 2680 I-gender
who 54 57 2681 2684 O
are 58 61 2685 2688 O
sexually 62 70 2689 2697 O
active 71 77 2698 2704 O
must 78 82 2705 2709 O
practice 83 91 2710 2718 O
adequate 92 100 2719 2727 O
contraception 101 114 2728 2741 O

Zubrod 0 6 2742 2748 B-clinical_variable
performance 7 18 2749 2760 I-clinical_variable
status 19 25 2761 2767 I-clinical_variable
0 26 27 2768 2769 B-lower_bound
- 27 28 2769 2770 O
1 28 29 2770 2771 B-upper_bound
within 30 36 2772 2778 O
1 37 38 2779 2780 B-upper_bound
week 39 43 2781 2785 I-upper_bound
of 44 46 2786 2788 O
study 47 52 2789 2794 O
entry 53 58 2795 2800 O

ALT 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGPT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
≤ 11 12 11 12 O
2.5 13 16 13 16 B-upper_bound
x 17 18 17 18 I-upper_bound
institutional 19 32 19 32 I-upper_bound
upper 33 38 33 38 I-upper_bound
limit 39 44 39 44 I-upper_bound
of 45 47 45 47 I-upper_bound
normal 48 54 48 54 I-upper_bound
( 55 56 55 56 I-upper_bound
ULN 56 59 56 59 I-upper_bound
) 59 60 59 60 I-upper_bound
≤ 61 62 61 62 O
5 63 64 63 64 B-upper_bound
x 65 66 65 66 I-upper_bound
IULN 67 71 67 71 I-upper_bound
for 72 75 72 75 O
patients 76 84 76 84 O
with 85 89 85 89 O
liver 90 95 90 95 B-cancer
metastases 96 106 96 106 I-cancer

AST 0 3 107 110 B-clinical_variable
( 4 5 111 112 I-clinical_variable
SGOT 5 9 112 116 I-clinical_variable
) 9 10 116 117 I-clinical_variable
≤ 11 12 118 119 O
2.5 13 16 120 123 B-upper_bound
x 17 18 124 125 I-upper_bound
institutional 19 32 126 139 I-upper_bound
upper 33 38 140 145 I-upper_bound
limit 39 44 146 151 I-upper_bound
of 45 47 152 154 I-upper_bound
normal 48 54 155 161 I-upper_bound
( 55 56 162 163 O
IULN 56 60 163 167 B-clinical_variable
) 60 61 167 168 O
≤ 62 63 169 170 O
5 64 65 171 172 B-upper_bound
x 66 67 173 174 I-upper_bound
IULN 68 72 175 179 I-upper_bound
for 73 76 180 183 O
patients 77 85 184 192 O
with 86 90 193 197 O
liver 91 96 198 203 B-cancer
metastases 97 107 204 214 I-cancer

AST 0 3 215 218 B-clinical_variable
/ 3 4 218 219 I-clinical_variable
ALT 4 7 219 222 I-clinical_variable
≤ 8 9 223 224 O
2.5 10 13 225 228 B-upper_bound
x 14 15 229 230 O
the 16 19 231 234 O
IULN 20 24 235 239 O

Absolute 0 8 240 248 B-clinical_variable
neutrophil 9 19 249 259 I-clinical_variable
count 20 25 260 265 I-clinical_variable
( 26 27 266 267 I-clinical_variable
ANC 27 30 267 270 I-clinical_variable
) 30 31 270 271 I-clinical_variable
≥ 32 33 272 273 O
1500 34 38 274 278 B-lower_bound
, 38 39 278 279 O
platelets 40 49 280 289 B-clinical_variable
≥ 50 51 290 291 O
100,000 52 59 292 299 B-lower_bound
, 59 60 299 300 O
unless 61 67 301 307 O
due 68 71 308 311 O
to 72 74 312 314 O
direct 75 81 315 321 O
bone 82 86 322 326 B-chronic_disease
marrow 87 93 327 333 I-chronic_disease
involvement 94 105 334 345 I-chronic_disease
of 106 108 346 348 I-chronic_disease
disease 109 116 349 356 I-chronic_disease

Age 0 3 357 360 B-age
18 4 6 361 363 B-lower_bound
years 7 12 364 369 I-lower_bound
or 13 15 370 372 O
greater 16 23 373 380 O

Age 0 3 381 384 B-age
> 4 5 385 386 O
18 5 7 386 388 B-lower_bound
years 8 13 389 394 I-lower_bound

All 0 3 395 398 O
patients 4 12 399 407 O
must 13 17 408 412 O
have 18 22 413 417 O
measurable 23 33 418 428 O
disease 34 41 429 436 O
documented 42 52 437 447 O
by 53 55 448 450 O
CT 56 58 451 453 B-treatment
, 58 59 453 454 O
MRI 60 63 455 458 B-treatment
, 63 64 458 459 O
or 65 67 460 462 O
non 68 71 463 466 O
- 71 72 466 467 O
measurable 72 82 467 477 O
disease 83 90 478 485 O
documented 91 101 486 496 O
by 102 104 497 499 O
Physical 105 113 500 508 O
Exam 114 118 509 513 O
within 119 125 514 520 O
28 126 128 521 523 B-upper_bound
days 129 133 524 528 I-upper_bound
prior 134 139 529 534 I-upper_bound
to 140 142 535 537 O
registration 143 155 538 550 O

Baseline 0 8 551 559 B-treatment
( 9 10 560 561 I-treatment
pre 10 13 561 564 I-treatment
- 13 14 564 565 I-treatment
treatment 14 23 565 574 I-treatment
) 23 24 574 575 I-treatment
EKG 25 28 576 579 I-treatment
with 29 33 580 584 O
any 34 37 585 588 O
of 38 40 589 591 O
the 41 44 592 595 O
following 45 54 596 605 O
changes 55 62 606 613 O
consistent 63 73 614 624 O
with 74 78 625 629 O
cardiac 79 86 630 637 B-chronic_disease
ischemia 87 95 638 646 I-chronic_disease

Baseline 0 8 647 655 O
( 9 10 656 657 O
pre 10 13 657 660 B-treatment
- 13 14 660 661 I-treatment
treatment 14 23 661 670 I-treatment
) 23 24 670 671 O
serum 25 30 672 677 B-clinical_variable
troponin 31 39 678 686 I-clinical_variable
T 40 41 687 688 I-clinical_variable
( 42 43 689 690 I-clinical_variable
TnT 43 46 690 693 I-clinical_variable
) 46 47 693 694 I-clinical_variable
≥ 48 49 695 696 O
0.03 50 54 697 701 B-lower_bound
ng 55 57 702 704 I-lower_bound
/ 57 58 704 705 I-lower_bound
mL 58 60 705 707 I-lower_bound

Baseline 0 8 708 716 O
fasting 9 16 717 724 O
triglycerides 17 30 725 738 B-clinical_variable
> 31 32 739 740 O
2.5 33 36 741 744 B-lower_bound
institutional 37 50 745 758 I-lower_bound
upper 51 56 759 764 I-lower_bound
limit 57 62 765 770 I-lower_bound
of 63 65 771 773 I-lower_bound
normal 66 72 774 780 I-lower_bound
( 73 74 781 782 I-lower_bound
IULN 74 78 782 786 I-lower_bound
) 78 79 786 787 I-lower_bound
or 80 82 788 790 O
hypertriglyceridemia 83 103 791 811 B-chronic_disease
requiring 104 113 812 821 O
medication 114 124 822 832 B-treatment

Concomitant 0 11 833 844 O
use 12 15 845 848 O
of 16 18 849 851 O
the 19 22 852 855 O
following 23 32 856 865 O
drugs 33 38 866 871 O
( 39 40 872 873 O
see 40 43 873 876 O
Concomitant 44 55 877 888 O
Medications 56 67 889 900 O
, 67 68 900 901 O
Section 69 76 902 909 O
3.3 77 80 910 913 O
): 80 82 913 915 O
antioxidants 83 95 916 928 B-treatment
; 95 96 928 929 O
herbal 97 103 930 936 B-treatment
or 104 106 937 939 I-treatment
other 107 112 940 945 I-treatment
alternative 113 124 946 957 I-treatment
therapy 125 132 958 965 I-treatment
medications 133 144 966 977 I-treatment
; 144 145 977 978 O
vitamin 146 153 979 986 B-treatment
supplements 154 165 987 998 I-treatment
( 166 167 999 1000 O
especially 167 177 1000 1010 O
vitamins 178 186 1011 1019 B-treatment
A 187 188 1020 1021 I-treatment
, 188 189 1021 1022 I-treatment
C 190 191 1023 1024 I-treatment
, 191 192 1024 1025 I-treatment
and 193 196 1026 1029 I-treatment
E 197 198 1030 1031 I-treatment
) 198 199 1031 1032 O
other 200 205 1033 1038 O
than 206 210 1039 1043 O
a 211 212 1044 1045 O
standard 213 221 1046 1054 O
dose 222 226 1055 1059 O
multivitamin 227 239 1060 1072 B-treatment
, 239 240 1072 1073 O
acetaminophen 241 254 1074 1087 B-treatment
, 254 255 1087 1088 O
cyclosporine 256 268 1089 1101 B-treatment
A 269 270 1102 1103 I-treatment
or 271 273 1104 1106 O
analogue 274 282 1107 1115 O
; 282 283 1115 1116 O
verapamil 284 293 1117 1126 B-treatment
; 293 294 1126 1127 O
tamoxifen 295 304 1128 1137 B-treatment
or 305 307 1138 1140 O
analogue 308 316 1141 1149 O
, 316 317 1149 1150 O
ketoconazole 318 330 1151 1163 B-treatment
, 330 331 1163 1164 O
chlorpromazine 332 346 1165 1179 B-treatment
; 346 347 1179 1180 O
RU486 348 353 1181 1186 B-treatment
; 353 354 1186 1187 O
indomethacin 355 367 1188 1200 B-treatment
; 367 368 1200 1201 O
or 369 371 1202 1204 O
sulfinpyrazone 372 386 1205 1219 B-treatment
, 386 387 1219 1220 O
tetracycline 388 400 1221 1233 B-treatment
, 400 401 1233 1234 O
nalidixic 402 411 1235 1244 B-treatment
acid 412 416 1245 1249 I-treatment
, 416 417 1249 1250 O
nitrofurantoin 418 432 1251 1265 B-treatment
, 432 433 1265 1266 O
phenytoin 434 443 1267 1276 B-treatment
, 443 444 1276 1277 O
sulfonamides 445 457 1278 1290 B-treatment
, 457 458 1290 1291 O
lithium 459 466 1292 1299 B-treatment
, 466 467 1299 1300 O
ceftriaxone 468 479 1301 1312 B-treatment
, 479 480 1312 1313 O
and 481 484 1314 1317 O
amiodarone 485 495 1318 1328 B-treatment

ECOG 0 4 1329 1333 B-clinical_variable
performance 5 16 1334 1345 I-clinical_variable
status 17 23 1346 1352 I-clinical_variable
of 24 26 1353 1355 O
0 27 28 1356 1357 B-lower_bound
- 29 30 1358 1359 O
2 31 32 1360 1361 B-upper_bound

ECOG 0 4 1362 1366 B-clinical_variable
performance 5 16 1367 1378 I-clinical_variable
status 17 23 1379 1385 I-clinical_variable
of 24 26 1386 1388 O
0 27 28 1389 1390 B-lower_bound
- 29 30 1391 1392 O
2 31 32 1393 1394 B-upper_bound
and 33 36 1395 1398 O
estimated 37 46 1399 1408 O
survival 47 55 1409 1417 O
of 56 58 1418 1420 O
at 59 61 1421 1423 O
least 62 67 1424 1429 O
3 68 69 1430 1431 B-upper_bound
months 70 76 1432 1438 I-upper_bound

Effects 0 7 1439 1446 O
of 8 10 1447 1449 O
fenretinide 11 22 1450 1461 B-treatment
and 23 26 1462 1465 O
safingol 27 35 1466 1474 B-treatment
on 36 38 1475 1477 O
the 39 42 1478 1481 O
developing 43 53 1482 1492 O
human 54 59 1493 1498 O
fetus 60 65 1499 1504 O
are 66 69 1505 1508 O
unknown 70 77 1509 1516 O

For 0 3 1517 1520 O
women 4 9 1521 1526 B-gender
of 10 12 1527 1529 O
child 13 18 1530 1535 O
- 18 19 1535 1536 O
bearing 19 26 1536 1543 O
potential 27 36 1544 1553 O
, 36 37 1553 1554 O
a 38 39 1555 1556 O
negative 40 48 1557 1565 B-pregnancy
serum 49 54 1566 1571 I-pregnancy
pregnancy 55 64 1572 1581 I-pregnancy
test 65 69 1582 1586 O
is 70 72 1587 1589 O
required 73 81 1590 1598 O
within 82 88 1599 1605 O
72 89 91 1606 1608 B-upper_bound
hours 92 97 1609 1614 I-upper_bound
prior 98 103 1615 1620 I-upper_bound
to 104 106 1621 1623 O
receiving 107 116 1624 1633 O
study 117 122 1634 1639 B-treatment
drug 123 127 1640 1644 I-treatment
each 128 132 1645 1649 O
cycle 133 138 1650 1655 O

For 0 3 1656 1659 O
women 4 9 1660 1665 B-gender
of 10 12 1666 1668 O
child 13 18 1669 1674 O
- 18 19 1674 1675 O
bearing 19 26 1675 1682 O
potential 27 36 1683 1692 O
, 36 37 1692 1693 O
a 38 39 1694 1695 O
negative 40 48 1696 1704 B-pregnancy
serum 49 54 1705 1710 I-pregnancy
pregnancy 55 64 1711 1720 I-pregnancy
test 65 69 1721 1725 O
is 70 72 1726 1728 O
required 73 81 1729 1737 O
within 82 88 1738 1744 O
72hours 89 96 1745 1752 B-upper_bound
prior 97 102 1753 1758 I-upper_bound
to 103 105 1759 1761 O
receiving 106 115 1762 1771 O
study 116 121 1772 1777 O
drug 122 126 1778 1782 O
each 127 131 1783 1787 O
cycle 132 137 1788 1793 O

Hemoglobin 0 10 1794 1804 B-clinical_variable
≥ 11 12 1805 1806 O
8.0 13 16 1807 1810 B-lower_bound
gm 17 19 1811 1813 I-lower_bound
/ 19 20 1813 1814 I-lower_bound
dL 20 22 1814 1816 I-lower_bound
; 22 23 1816 1817 O
transfusion 24 35 1818 1829 B-treatment
permitted 36 45 1830 1839 O
to 46 48 1840 1842 O
achieve 49 56 1843 1850 O
this 57 61 1851 1855 O
level 62 67 1856 1861 O

Karnofsky 0 9 1862 1871 B-clinical_variable
> 10 11 1872 1873 O
60 12 14 1874 1876 B-lower_bound
% 14 15 1876 1877 I-lower_bound

Known 0 5 1878 1883 O
allergy 6 13 1884 1891 O
to 14 16 1892 1894 O
egg 17 20 1895 1898 B-allergy_name
products 21 29 1899 1907 I-allergy_name
or 30 32 1908 1910 O
soy 33 36 1911 1914 B-allergy_name
bean 37 41 1915 1919 I-allergy_name
oil 42 45 1920 1923 I-allergy_name

Known 0 5 1924 1929 O
history 6 13 1930 1937 O
of 14 16 1938 1940 O
allergic 17 25 1941 1949 O
reactions 26 35 1950 1959 O
attributed 36 46 1960 1970 O
to 47 49 1971 1973 O
compounds 50 59 1974 1983 B-allergy_name
of 60 62 1984 1986 I-allergy_name
similar 63 70 1987 1994 I-allergy_name
chemical 71 79 1995 2003 I-allergy_name
or 80 82 2004 2006 I-allergy_name
biologic 83 91 2007 2015 I-allergy_name
composition 92 103 2016 2027 I-allergy_name
to 104 106 2028 2030 I-allergy_name
fenretinide 107 118 2031 2042 I-allergy_name
, 118 119 2042 2043 O
such 120 124 2044 2048 O
as 125 127 2049 2051 O
13 128 130 2052 2054 B-allergy_name
- 130 131 2054 2055 I-allergy_name
cis 131 134 2055 2058 I-allergy_name
- 134 135 2058 2059 I-allergy_name
retinoic 135 143 2059 2067 I-allergy_name
acid 144 148 2068 2072 I-allergy_name
, 148 149 2072 2073 O
retinol 150 157 2074 2081 B-allergy_name
, 157 158 2081 2082 O
or 159 161 2083 2085 O
all 162 165 2086 2089 B-allergy_name
- 165 166 2089 2090 I-allergy_name
trans 166 171 2090 2095 I-allergy_name
- 171 172 2095 2096 I-allergy_name
retinoic 172 180 2096 2104 I-allergy_name
acid 181 185 2105 2109 I-allergy_name

Life 0 4 2110 2114 B-clinical_variable
expectancy 5 15 2115 2125 I-clinical_variable
of 16 18 2126 2128 O
greater 19 26 2129 2136 O
than 27 31 2137 2141 O
3 32 33 2142 2143 B-lower_bound
months 34 40 2144 2150 I-lower_bound

Major 0 5 2151 2156 B-treatment
surgery 6 13 2157 2164 I-treatment
in 14 16 2165 2167 O
the 17 20 2168 2171 O
last 21 25 2172 2176 B-upper_bound
three 26 31 2177 2182 I-upper_bound
weeks 32 37 2183 2188 I-upper_bound
due 38 41 2189 2192 O
to 42 44 2193 2195 O
unknown 45 52 2196 2203 O
effects 53 60 2204 2211 O
of 61 63 2212 2214 O
fenretinide 64 75 2215 2226 B-treatment
and 76 79 2227 2230 O
safingol 80 88 2231 2239 B-treatment
on 89 91 2240 2242 O
wound 92 97 2243 2248 O
healing 98 105 2249 2256 O

Patients 0 8 2257 2265 O
known 9 14 2266 2271 O
to 15 17 2272 2274 O
be 18 20 2275 2277 O
HIV 21 24 2278 2281 B-chronic_disease
- 24 25 2281 2282 O
positive 25 33 2282 2290 O
receiving 34 43 2291 2300 O
anti 44 48 2301 2305 B-treatment
- 48 49 2305 2306 I-treatment
retroviral 49 59 2306 2316 I-treatment
therapy 60 67 2317 2324 I-treatment
are 68 71 2325 2328 O
excluded 72 80 2329 2337 O
from 81 85 2338 2342 O
the 86 89 2343 2346 O
study 90 95 2347 2352 O
because 96 103 2353 2360 O
of 104 106 2361 2363 O
possible 107 115 2364 2372 O
pharmacokinetic 116 131 2373 2388 O
interactions 132 144 2389 2401 O

Patients 0 8 2402 2410 O
must 9 13 2411 2415 O
have 14 18 2416 2420 O
histologically 19 33 2421 2435 O
or 34 36 2436 2438 O
cytologically 37 50 2439 2452 O
confirmed 51 60 2453 2462 O
malignancy 61 71 2463 2473 B-cancer
that 72 76 2474 2478 O
is 77 79 2479 2481 O
metastatic 80 90 2482 2492 O
or 91 93 2493 2495 O
unresectable 94 106 2496 2508 O
and 107 110 2509 2512 O
for 111 114 2513 2516 O
which 115 120 2517 2522 O
standard 121 129 2523 2531 O
curative 130 138 2532 2540 B-treatment
or 139 141 2541 2543 O
palliative 142 152 2544 2554 B-treatment
measures 153 161 2555 2563 I-treatment
do 162 164 2564 2566 O
not 165 168 2567 2570 O
exist 169 174 2571 2576 O
or 175 177 2577 2579 O
are 178 181 2580 2583 O
no 182 184 2584 2586 O
longer 185 191 2587 2593 O
effective 192 201 2594 2603 O

Patients 0 8 2604 2612 O
must 9 13 2613 2617 O
have 14 18 2618 2622 O
histologically 19 33 2623 2637 O
or 34 36 2638 2640 O
cytologically 37 50 2641 2654 O
confirmed 51 60 2655 2664 O
non 61 64 2665 2668 B-cancer
- 64 65 2668 2669 I-cancer
Hodgkin 65 72 2669 2676 I-cancer
's 72 74 2676 2678 I-cancer
lymphoma 75 83 2679 2687 I-cancer
for 84 87 2688 2691 O
which 88 93 2692 2697 O
standard 94 102 2698 2706 B-treatment
therapies 103 112 2707 2716 I-treatment
do 113 115 2717 2719 O
not 116 119 2720 2723 O
exist 120 125 2724 2729 O
or 126 128 2730 2732 O
are 129 132 2733 2736 O
no 133 135 2737 2739 O
longer 136 142 2740 2746 O
effective 143 152 2747 2756 O

Patients 0 8 2757 2765 O
must 9 13 2766 2770 O
have 14 18 2771 2775 O
recovered 19 28 2776 2785 O
from 29 33 2786 2790 O
toxicities 34 44 2791 2801 O
of 45 47 2802 2804 O
prior 48 53 2805 2810 B-treatment
therapy 54 61 2811 2818 I-treatment

Patients 0 8 2819 2827 O
requiring 9 18 2828 2837 O
medication 19 29 2838 2848 B-treatment
for 30 33 2849 2852 O
other 34 39 2853 2858 O
dyslipidemias 40 53 2859 2872 B-chronic_disease
( 54 55 2873 2874 O
i.e. 55 59 2874 2878 O
, 59 60 2878 2879 O
elevated 61 69 2880 2888 O
LDL 70 73 2889 2892 B-clinical_variable
cholesterol 74 85 2893 2904 I-clinical_variable
) 85 86 2904 2905 O

Patients 0 8 2906 2914 O
who 9 12 2915 2918 O
have 13 17 2919 2923 O
received 18 26 2924 2932 O
prior 27 32 2933 2938 B-treatment
treatment 33 42 2939 2948 I-treatment
with 43 47 2949 2953 O
oral 48 52 2954 2958 B-treatment
or 53 55 2959 2961 I-treatment
intravenous 56 67 2962 2973 I-treatment
fenretinide 68 79 2974 2985 I-treatment
as 80 82 2986 2988 O
a 83 84 2989 2990 O
single 85 91 2991 2997 O
agent 92 97 2998 3003 O
are 98 101 3004 3007 O
eligible 102 110 3008 3016 O
, 110 111 3016 3017 O
provided 112 120 3018 3026 O
they 121 125 3027 3031 O
did 126 129 3032 3035 O
not 130 133 3036 3039 O
experience 134 144 3040 3050 O
severe 145 151 3051 3057 O
toxicity 152 160 3058 3066 O
related 161 168 3067 3074 O
to 169 171 3075 3077 O
fenretinide 172 183 3078 3089 O

Patients 0 8 3090 3098 O
with 9 13 3099 3103 O
an 14 16 3104 3106 O
identified 17 27 3107 3117 O
familial 28 36 3118 3126 B-chronic_disease
hyperlipidemia 37 51 3127 3141 I-chronic_disease
disorder 52 60 3142 3150 I-chronic_disease

Patients 0 8 3151 3159 O
with 9 13 3160 3164 O
esophageal 14 24 3165 3175 B-cancer
cancer 25 31 3176 3182 I-cancer
with 32 36 3183 3187 O
unresected 37 47 3188 3198 O
or 48 50 3199 3201 O
recurrent 51 60 3202 3211 O
primary 61 68 3212 3219 B-cancer
tumors 69 75 3220 3226 I-cancer
in 76 78 3227 3229 O
the 79 82 3230 3233 O
esophagus 83 92 3234 3243 O
are 93 96 3244 3247 O
only 97 101 3248 3252 O
permitted 102 111 3253 3262 O
after 112 117 3263 3268 O
discussion 118 128 3269 3279 O
of 129 131 3280 3282 O
patient 132 139 3283 3290 O
with 140 144 3291 3295 O
Study 145 150 3296 3301 O
Chair 151 156 3302 3307 O
due 157 160 3308 3311 O
to 161 163 3312 3314 O
concern 164 171 3315 3322 O
of 172 174 3323 3325 O
tumor 175 180 3326 3331 B-treatment
necrosis 181 189 3332 3340 I-treatment
and 190 193 3341 3344 O
esophageal 194 204 3345 3355 B-treatment
perforation 205 216 3356 3367 I-treatment

Patients 0 8 3368 3376 O
with 9 13 3377 3381 O
previously 14 24 3382 3392 O
untreated 25 34 3393 3402 O
brain 35 40 3403 3408 B-cancer
metastases 41 51 3409 3419 I-cancer
( 52 53 3420 3421 O
including 53 62 3421 3430 O
parenchymal 63 74 3431 3442 B-chronic_disease
, 74 75 3442 3443 O
meningeal 76 85 3444 3453 B-chronic_disease
or 86 88 3454 3456 O
dural 89 94 3457 3462 B-chronic_disease
- 94 95 3462 3463 I-chronic_disease
based 95 100 3463 3468 I-chronic_disease
CNS 101 104 3469 3472 I-chronic_disease
lesions 105 112 3473 3480 I-chronic_disease
) 112 113 3480 3481 O

Poorly 0 6 3482 3488 O
- 6 7 3488 3489 O
controlled 7 17 3489 3499 O
diabetes 18 26 3500 3508 B-chronic_disease
mellitus 27 35 3509 3517 I-chronic_disease
, 35 36 3517 3518 O
as 37 39 3519 3521 O
defined 40 47 3522 3529 O
as 48 50 3530 3532 O
fasting 51 58 3533 3540 B-clinical_variable
serum 59 64 3541 3546 I-clinical_variable
glucose 65 72 3547 3554 I-clinical_variable
concentration 73 86 3555 3568 I-clinical_variable
over 87 91 3569 3573 O
200 92 95 3574 3577 B-lower_bound
mg 96 98 3578 3580 I-lower_bound
/ 98 99 3580 3581 I-lower_bound
dl 99 101 3581 3583 I-lower_bound
or 102 104 3584 3586 O
a 105 106 3587 3588 O
hemoglobin 107 117 3589 3599 B-clinical_variable
A1C 118 121 3600 3603 I-clinical_variable
over 122 126 3604 3608 O
7.5 127 130 3609 3612 B-lower_bound
% 130 131 3612 3613 I-lower_bound

Pregnant 0 8 3614 3622 B-pregnancy
women 9 14 3623 3628 B-gender
are 15 18 3629 3632 O
excluded 19 27 3633 3641 O
from 28 32 3642 3646 O
this 33 37 3647 3651 O
study 38 43 3652 3657 O
because 44 51 3658 3665 O
the 52 55 3666 3669 O
effects 56 63 3670 3677 O
of 64 66 3678 3680 O
fenretinide 67 78 3681 3692 B-treatment
and 79 82 3693 3696 O
safingol 83 91 3697 3705 B-treatment
on 92 94 3706 3708 O
the 95 98 3709 3712 O
developing 99 109 3713 3723 O
human 110 115 3724 3729 O
fetus 116 121 3730 3735 O
are 122 125 3736 3739 O
unknown 126 133 3740 3747 O

Radiation 0 9 3748 3757 B-treatment
therapy 10 17 3758 3765 I-treatment
, 17 18 3765 3766 O
chemotherapy 19 31 3767 3779 B-treatment
, 31 32 3779 3780 O
and 33 36 3781 3784 O
other 37 42 3785 3790 O
investigational 43 58 3791 3806 O
agents 59 65 3807 3813 O
within 66 72 3814 3820 O
3weeks 73 79 3821 3827 B-upper_bound
( 80 81 3828 3829 O
6 81 82 3829 3830 B-upper_bound
weeks 83 88 3831 3836 I-upper_bound
for 89 92 3837 3840 O
nitrosourea 93 104 3841 3852 B-treatment
or 105 107 3853 3855 O
mitomycin 108 117 3856 3865 B-treatment
C 118 119 3866 3867 I-treatment
) 119 120 3867 3868 O
prior 121 126 3869 3874 O
to 127 129 3875 3877 O
starting 130 138 3878 3886 O
fenretinide 139 150 3887 3898 B-treatment
+ 151 152 3899 3900 O
safingol 153 161 3901 3909 B-treatment

Serum 0 5 3910 3915 B-clinical_variable
creatinine 6 16 3916 3926 I-clinical_variable
≤ 17 18 3927 3928 O
1.5 19 22 3929 3932 B-upper_bound
x 23 24 3933 3934 I-upper_bound
the 25 28 3935 3938 I-upper_bound
upper 29 34 3939 3944 I-upper_bound
limits 35 41 3945 3951 I-upper_bound
of 42 44 3952 3954 I-upper_bound
institutional 45 58 3955 3968 I-upper_bound
normal 59 65 3969 3975 I-upper_bound
( 66 67 3976 3977 I-upper_bound
IULN 67 71 3977 3981 I-upper_bound
) 71 72 3981 3982 I-upper_bound

Should 0 6 3983 3989 O
a 7 8 3990 3991 O
woman 9 14 3992 3997 B-gender
become 15 21 3998 4004 O
pregnant 22 30 4005 4013 B-pregnancy
or 31 33 4014 4016 O
suspect 34 41 4017 4024 O
she 42 45 4025 4028 O
is 46 48 4029 4031 O
pregnant 49 57 4032 4040 O
while 58 63 4041 4046 O
participating 64 77 4047 4060 O
in 78 80 4061 4063 O
this 81 85 4064 4068 O
study 86 91 4069 4074 O
, 91 92 4074 4075 O
she 93 96 4076 4079 O
should 97 103 4080 4086 O
inform 104 110 4087 4093 O
her 111 114 4094 4097 O
treating 115 123 4098 4106 O
physician 124 133 4107 4116 O
immediately 134 145 4117 4128 O

Should 0 6 4129 4135 O
a 7 8 4136 4137 O
woman 9 14 4138 4143 B-gender
become 15 21 4144 4150 B-pregnancy
pregnant 22 30 4151 4159 I-pregnancy
or 31 33 4160 4162 O
suspect 34 41 4163 4170 O
she 42 45 4171 4174 O
is 46 48 4175 4177 O
pregnant 49 57 4178 4186 O
while 58 63 4187 4192 O
she 64 67 4193 4196 O
or 68 70 4197 4199 O
her 71 74 4200 4203 O
partner 75 82 4204 4211 O
is 83 85 4212 4214 O
participating 86 99 4215 4228 O
in 100 102 4229 4231 O
this 103 107 4232 4236 O
study 108 113 4237 4242 O
, 113 114 4242 4243 O
she 115 118 4244 4247 O
should 119 125 4248 4254 O
inform 126 132 4255 4261 O
her 133 136 4262 4265 O
treating 137 145 4266 4274 O
physician 146 155 4275 4284 O
immediately 156 167 4285 4296 O

The 0 3 4297 4300 O
effects 4 11 4301 4308 O
of 12 14 4309 4311 O
fenretinide 15 26 4312 4323 B-treatment
and 27 30 4324 4327 O
safingol 31 39 4328 4336 B-treatment
on 40 42 4337 4339 O
the 43 46 4340 4343 O
developing 47 57 4344 4354 O
human 58 63 4355 4360 O
fetus 64 69 4361 4366 O
are 70 73 4367 4370 O
unknown 74 81 4371 4378 O

Total 0 5 4379 4384 B-clinical_variable
bilirubin 6 15 4385 4394 I-clinical_variable
≤ 16 17 4395 4396 O
1.5 18 21 4397 4400 B-upper_bound
x 22 23 4401 4402 I-upper_bound
the 24 27 4403 4406 I-upper_bound
IULN 28 32 4407 4411 I-upper_bound

Uncontrolled 0 12 4412 4424 O
intercurrent 13 25 4425 4437 O
illnesses 26 35 4438 4447 O
including 36 45 4448 4457 O
, 45 46 4457 4458 O
but 47 50 4459 4462 O
not 51 54 4463 4466 O
limited 55 62 4467 4474 O
to 63 65 4475 4477 O
, 65 66 4477 4478 O
ongoing 67 74 4479 4486 O
or 75 77 4487 4489 O
active 78 84 4490 4496 O
systemic 85 93 4497 4505 B-chronic_disease
infection 94 103 4506 4515 I-chronic_disease
, 103 104 4515 4516 O
symptomatic 105 116 4517 4528 B-chronic_disease
congestive 117 127 4529 4539 I-chronic_disease
heart 128 133 4540 4545 I-chronic_disease
failure 134 141 4546 4553 I-chronic_disease
, 141 142 4553 4554 O
unstable 143 151 4555 4563 B-chronic_disease
angina 152 158 4564 4570 I-chronic_disease
pectoris 159 167 4571 4579 I-chronic_disease
, 167 168 4579 4580 O
cardiac 169 176 4581 4588 B-chronic_disease
arrhythmia 177 187 4589 4599 I-chronic_disease
, 187 188 4599 4600 O
coagulation 189 200 4601 4612 B-chronic_disease
disorders 201 210 4613 4622 I-chronic_disease

absolute 0 8 4623 4631 B-clinical_variable
neutrophil 9 19 4632 4642 I-clinical_variable
count 20 25 4643 4648 I-clinical_variable
≥ 26 27 4649 4650 O
1,500 28 33 4651 4656 B-lower_bound
/ 33 34 4656 4657 I-lower_bound
μL 34 36 4657 4659 I-lower_bound

creatinine 0 10 4660 4670 B-clinical_variable
clearance 11 20 4671 4680 I-clinical_variable
≥ 21 22 4681 4682 O
60 23 25 4683 4685 B-lower_bound
mL 26 28 4686 4688 I-lower_bound
/ 28 29 4688 4689 I-lower_bound
min/1.73 29 37 4689 4697 I-lower_bound
m2 38 40 4698 4700 I-lower_bound
for 41 44 4701 4704 O
patients 45 53 4705 4713 O
with 54 58 4714 4718 O
creatinine 59 69 4719 4729 O
levels 70 76 4730 4736 O
above 77 82 4737 4742 O
institutional 83 96 4743 4756 O
normal 97 103 4757 4763 O

creatinine 0 10 4764 4774 B-clinical_variable
within 11 17 4775 4781 O
institutional 18 31 4782 4795 O
normal 32 38 4796 4802 O
limits 39 45 4803 4809 O
( 46 47 4810 4811 O
WNL 47 50 4811 4814 O
) 50 51 4814 4815 O

lymphoma 0 8 4816 4824 B-cancer
patients 9 17 4825 4833 O
must 18 22 4834 4838 O
have 23 27 4839 4843 O
no 28 30 4844 4846 O
marrow 31 37 4847 4853 O
involvement 38 49 4854 4865 O
as 50 52 4866 4868 O
documented 53 63 4869 4879 O
by 64 66 4880 4882 O
routine 67 74 4883 4890 O
marrow 75 81 4891 4897 B-treatment
aspiration 82 92 4898 4908 I-treatment
and 93 96 4909 4912 O
biopsy 97 103 4913 4919 B-treatment
performed 104 113 4920 4929 O
within 114 120 4930 4936 O
30 121 123 4937 4939 B-upper_bound
days 124 128 4940 4944 I-upper_bound
of 129 131 4945 4947 O
study 132 137 4948 4953 O
entry 138 143 4954 4959 O

other 0 5 4960 4965 O
major 6 11 4966 4971 B-chronic_disease
medical 12 19 4972 4979 I-chronic_disease
illnesses 20 29 4980 4989 I-chronic_disease
of 30 32 4990 4992 O
the 33 36 4993 4996 O
cardiovascular 37 51 4997 5011 O
or 52 54 5012 5014 O
respiratory 55 66 5015 5026 O
systems 67 74 5027 5034 O
or 75 77 5035 5037 O
psychiatric 78 89 5038 5049 B-chronic_disease
illness 90 97 5050 5057 I-chronic_disease
/ 97 98 5057 5058 O
social 98 104 5058 5064 B-chronic_disease
situations 105 115 5065 5075 I-chronic_disease
that 116 120 5076 5080 O
would 121 126 5081 5086 O
limit 127 132 5087 5092 O
compliance 133 143 5093 5103 O
with 144 148 5104 5108 O
study 149 154 5109 5114 O
requirements 155 167 5115 5127 O

patients 0 8 5128 5136 O
with 9 13 5137 5141 O
previously 14 24 5142 5152 O
treated 25 32 5153 5160 O
( 33 34 5161 5162 O
surgery 34 41 5162 5169 B-treatment
, 41 42 5169 5170 O
radiation 43 52 5171 5180 B-treatment
or 53 55 5181 5183 O
both 56 60 5184 5188 O
) 60 61 5188 5189 O
, 61 62 5189 5190 O
clinically 63 73 5191 5201 O
inactive 74 82 5202 5210 O
brain 83 88 5211 5216 B-cancer
metastases 89 99 5217 5227 I-cancer
, 99 100 5227 5228 O
who 101 104 5229 5232 O
have 105 109 5233 5237 O
not 110 113 5238 5241 O
received 114 122 5242 5250 O
corticosteroid 123 137 5251 5265 B-treatment
therapy 138 145 5266 5273 I-treatment
within 146 152 5274 5280 O
three 153 158 5281 5286 B-upper_bound
weeks 159 164 5287 5292 I-upper_bound
of 165 167 5293 5295 O
starting 168 176 5296 5304 O
protocol 177 185 5305 5313 B-treatment
therapy 186 193 5314 5321 I-treatment

platelets 0 9 5322 5331 B-clinical_variable
≥ 10 11 5332 5333 O
100,000 12 19 5334 5341 B-lower_bound
/ 19 20 5341 5342 I-lower_bound
μL 20 22 5342 5344 I-lower_bound

significant 0 11 5345 5356 O
ST 12 14 5357 5359 B-clinical_variable
depression 15 25 5360 5370 I-clinical_variable
( 26 27 5371 5372 O
ST 27 29 5372 5374 O
depression 30 40 5375 5385 O
of 41 43 5386 5388 O
≥2 44 46 5389 5391 O
mm 47 49 5392 5394 I-lower_bound
, 49 50 5394 5395 O
measured 51 59 5396 5404 O
from 60 64 5405 5409 O
isoelectric 65 76 5410 5421 O
line 77 81 5422 5426 O
to 82 84 5427 5429 O
the 85 88 5430 5433 O
ST 89 91 5434 5436 O
segment 92 99 5437 5444 O
at 100 102 5445 5447 O
a 103 104 5448 5449 O
point 105 110 5450 5455 O
60 111 113 5456 5458 O
msec 114 118 5459 5463 O
from 119 123 5464 5468 O
the 124 127 5469 5472 O
end 128 131 5473 5476 O
of 132 134 5477 5479 O
the 135 138 5480 5483 O
QRS 139 142 5484 5487 O
complex 143 150 5488 5495 O
) 150 151 5495 5496 O

significant 0 11 5497 5508 O
ST 12 14 5509 5511 B-clinical_variable
elevation 15 24 5512 5521 I-clinical_variable
( 25 26 5522 5523 O
> 26 27 5523 5524 O
1 28 29 5525 5526 B-lower_bound
mm 29 31 5526 5528 I-lower_bound
in 32 34 5529 5531 O
limb 35 39 5532 5536 B-clinical_variable
lead 40 44 5537 5541 I-clinical_variable
or 45 47 5542 5544 O
2 48 49 5545 5546 B-lower_bound
mm 50 52 5547 5549 I-lower_bound
in 53 55 5550 5552 O
precordial 56 66 5553 5563 B-clinical_variable
lead 67 71 5564 5568 I-clinical_variable
measured 72 80 5569 5577 O
at 81 83 5578 5580 O
a 84 85 5581 5582 O
point 86 91 5583 5588 O
0.04 92 96 5589 5593 O
sec 97 100 5594 5597 O
( 101 102 5598 5599 O
1 102 103 5599 5600 O
mm 104 106 5601 5603 O
) 106 107 5603 5604 O
after 108 113 5605 5610 O
the 114 117 5611 5614 O
J 118 119 5615 5616 O
- 119 120 5616 5617 O
point 120 125 5617 5622 O
[ 126 127 5623 5624 O
the 127 130 5624 5627 O
end 131 134 5628 5631 O
of 135 137 5632 5634 O
the 138 141 5635 5638 O
QRS 142 145 5639 5642 O
complex 146 153 5643 5650 O
] 153 154 5650 5651 O
and 155 158 5652 5655 O
compared 159 167 5656 5664 O
to 168 170 5665 5667 O
baseline 171 179 5668 5676 O
[ 180 181 5677 5678 O
line 181 185 5678 5682 O
drawn 186 191 5683 5688 O
from 192 196 5689 5693 O
P 197 198 5694 5695 O
start 199 204 5696 5701 O
to 205 207 5702 5704 O
T 208 209 5705 5706 O
end 210 213 5707 5710 O
] 213 214 5710 5711 O
) 214 215 5711 5712 O

total 0 5 5713 5718 O
bilirubin 6 15 5719 5728 B-clinical_variable
≤ 16 17 5729 5730 O
1.5 18 21 5731 5734 B-upper_bound
x 22 23 5735 5736 I-upper_bound
institutional 24 37 5737 5750 B-clinical_variable
upper 38 43 5751 5756 I-clinical_variable
limit 44 49 5757 5762 I-clinical_variable
of 50 52 5763 5765 I-clinical_variable
normal 53 59 5766 5772 I-clinical_variable
( 60 61 5773 5774 I-clinical_variable
IULN 61 65 5774 5778 I-clinical_variable
) 65 66 5778 5779 I-clinical_variable

women 0 5 5780 5785 B-gender
of 6 8 5786 5788 O
child 9 14 5789 5794 O
- 14 15 5794 5795 O
bearing 15 22 5795 5802 O
potential 23 32 5803 5812 O
and 33 36 5813 5816 O
men 37 40 5817 5820 O
must 41 45 5821 5825 O
agree 46 51 5826 5831 B-contraception_consent
to 52 54 5832 5834 I-contraception_consent
use 55 58 5835 5838 I-contraception_consent
adequate 59 67 5839 5847 I-contraception_consent
contraception 68 81 5848 5861 I-contraception_consent
( 82 83 5862 5863 O
hormonal 83 91 5863 5871 O
or 92 94 5872 5874 O
barrier 95 102 5875 5882 O
method 103 109 5883 5889 O
of 110 112 5890 5892 O
birth 113 118 5893 5898 O
control 119 126 5899 5906 O
) 126 127 5906 5907 O
prior 128 133 5908 5913 O
to 134 136 5914 5916 O
study 137 142 5917 5922 O
entry 143 148 5923 5928 O
, 148 149 5928 5929 O
for 150 153 5930 5933 O
the 154 157 5934 5937 O
duration 158 166 5938 5946 O
of 167 169 5947 5949 O
study 170 175 5950 5955 O
, 175 176 5955 5956 O
and 177 180 5957 5960 O
for 181 184 5961 5964 O
two 185 188 5965 5968 B-lower_bound
months 189 195 5969 5975 I-lower_bound
after 196 201 5976 5981 O
study 202 207 5982 5987 O
participation 208 221 5988 6001 O

women 0 5 6002 6007 B-gender
of 6 8 6008 6010 O
child 9 14 6011 6016 O
- 14 15 6016 6017 O
bearing 15 22 6017 6024 O
potential 23 32 6025 6034 O
and 33 36 6035 6038 O
men 37 40 6039 6042 O
must 41 45 6043 6047 O
agree 46 51 6048 6053 B-contraception_consent
to 52 54 6054 6056 I-contraception_consent
use 55 58 6057 6060 I-contraception_consent
adequate 59 67 6061 6069 I-contraception_consent
contraception 68 81 6070 6083 I-contraception_consent
( 82 83 6084 6085 O
hormonal 83 91 6085 6093 B-contraception_consent
or 92 94 6094 6096 I-contraception_consent
barrier 95 102 6097 6104 I-contraception_consent
method 103 109 6105 6111 I-contraception_consent
of 110 112 6112 6114 I-contraception_consent
birth 113 118 6115 6120 I-contraception_consent
control 119 126 6121 6128 I-contraception_consent
; 126 127 6128 6129 O
abstinence 128 138 6130 6140 B-contraception_consent
) 138 139 6140 6141 O
prior 140 145 6142 6147 O
to 146 148 6148 6150 O
study 149 154 6151 6156 O
entry 155 160 6157 6162 O
and 161 164 6163 6166 O
for 165 168 6167 6170 O
the 169 172 6171 6174 O
duration 173 181 6175 6183 O
of 182 184 6184 6186 O
study 185 190 6187 6192 O
participation 191 204 6193 6206 O

≤ 0 1 6207 6208 O
5 2 3 6209 6210 B-upper_bound
x 4 5 6211 6212 I-upper_bound
IULN 6 10 6213 6217 I-upper_bound
for 11 14 6218 6221 O
patients 15 23 6222 6230 O
with 24 28 6231 6235 O
liver 29 34 6236 6241 B-cancer
metastases 35 45 6242 6252 I-cancer

Ancillary 0 9 0 9 B-treatment
cPoP 10 14 10 14 I-treatment
Part 15 19 15 19 O
: 19 20 19 20 O
any 21 24 21 24 O
tumor 25 30 25 30 B-cancer
with 31 35 31 35 O
at 36 38 36 38 O
least 39 44 39 44 O
2 45 46 45 46 B-lower_bound
( 47 48 47 48 B-cancer
sub)cutaneous 48 61 48 61 I-cancer
tumor 62 67 62 67 I-cancer
/ 67 68 67 68 O
metastases 68 78 68 78 B-cancer
at 79 81 79 81 O
least 82 87 82 87 O
2 88 89 88 89 B-lower_bound
cm 90 92 90 92 I-lower_bound
apart 93 98 93 98 O
which 99 104 99 104 O
are 105 108 105 108 O
RT 109 111 109 111 O
naïve 112 117 112 117 O
with 118 122 118 122 O
an 123 125 123 125 O
indication 126 136 126 136 O
for 137 140 137 140 O
high 141 145 141 145 O
dose 146 150 146 150 O
palliative 151 161 151 161 B-treatment
RT 162 164 162 164 I-treatment

Bone 0 4 165 169 B-chronic_disease
marrow 5 11 170 176 I-chronic_disease
impairment 12 22 177 187 I-chronic_disease
as 23 25 188 190 O
evidenced 26 35 191 200 O
by 36 38 201 203 O
hemoglobin 39 49 204 214 B-clinical_variable
< 50 51 215 216 O
10.0 51 55 216 220 B-upper_bound
g 56 57 221 222 I-upper_bound
/ 57 58 222 223 I-upper_bound
dL 58 60 223 225 I-upper_bound
, 60 61 225 226 O
neutrophil 62 72 227 237 B-clinical_variable
count 73 78 238 243 I-clinical_variable
< 79 80 244 245 O
1.0 80 83 245 248 B-upper_bound
× 84 85 249 250 I-upper_bound
109 86 89 251 254 I-upper_bound
/ 89 90 254 255 I-upper_bound
L 90 91 255 256 I-upper_bound
, 91 92 256 257 O
platelets 93 102 258 267 B-clinical_variable
< 103 104 268 269 O
100 104 107 269 272 B-upper_bound
× 108 109 273 274 I-upper_bound
109 110 113 275 278 I-upper_bound
/ 113 114 278 279 I-upper_bound
L 114 115 279 280 I-upper_bound

Eastern 0 7 281 288 B-clinical_variable
Cooperative 8 19 289 300 I-clinical_variable
Oncology 20 28 301 309 I-clinical_variable
Group 29 34 310 315 I-clinical_variable
performance 35 46 316 327 I-clinical_variable
status 47 53 328 334 I-clinical_variable
( 54 55 335 336 I-clinical_variable
ECOG 55 59 336 340 I-clinical_variable
PS 60 62 341 343 I-clinical_variable
) 62 63 343 344 I-clinical_variable
≤ 64 65 345 346 O
1 66 67 347 348 B-upper_bound

Extensive 0 9 349 358 O
prior 10 15 359 364 B-treatment
RT 16 18 365 367 I-treatment
on 19 21 368 370 O
≥30 22 25 371 374 O
% 25 26 374 375 I-lower_bound
of 27 29 376 378 O
bone 30 34 379 383 B-clinical_variable
marrow 35 41 384 390 I-clinical_variable
reserve 42 49 391 398 O
as 50 52 399 401 O
judged 53 59 402 408 O
by 60 62 409 411 O
the 63 66 412 415 O
investigator 67 79 416 428 O
or 80 82 429 431 O
prior 83 88 432 437 B-treatment
bone 89 93 438 442 I-treatment
marrow 94 100 443 449 I-treatment
/ 100 101 449 450 O
stem 101 105 450 454 B-treatment
cell 106 110 455 459 I-treatment
transplantation 111 126 460 475 I-treatment
within 127 133 476 482 O
5 134 135 483 484 B-upper_bound
years 136 141 485 490 I-upper_bound
before 142 148 491 497 I-upper_bound
trial 149 154 498 503 O
start 155 160 504 509 O

Female 0 6 510 516 B-gender
subjects 7 15 517 525 I-gender
of 16 18 526 528 O
childbearing 19 31 529 541 O
potential 32 41 542 551 O
and 42 45 552 555 O
male 46 50 556 560 O
subjects 51 59 561 569 O
with 60 64 570 574 O
female 65 71 575 581 B-gender
partners 72 80 582 590 I-gender
of 81 83 591 593 O
childbearing 84 96 594 606 O
potential 97 106 607 616 O
must 107 111 617 621 O
be 112 114 622 624 O
willing 115 122 625 632 O
to 123 125 633 635 O
avoid 126 131 636 641 O
pregnancy 132 141 642 651 B-pregnancy

History 0 7 652 659 O
of 8 10 660 662 O
any 11 14 663 666 O
other 15 20 667 672 O
significant 21 32 673 684 O
medical 33 40 685 692 O
disease 41 48 693 700 O
such 49 53 701 705 O
as 54 56 706 708 O
major 57 62 709 714 B-treatment
gastric 63 70 715 722 I-treatment
or 71 73 723 725 O
small 74 79 726 731 B-treatment
bowel 80 85 732 737 I-treatment
surgery 86 93 738 745 I-treatment
, 93 94 745 746 O
recent 95 101 747 753 O
drainage 102 110 754 762 B-treatment
of 111 113 763 765 I-treatment
significant 114 125 766 777 I-treatment
volumes 126 133 778 785 I-treatment
of 134 136 786 788 I-treatment
ascites 137 144 789 796 I-treatment
or 145 147 797 799 O
pleural 148 155 800 807 B-chronic_disease
effusion 156 164 808 816 I-chronic_disease
( 165 166 817 818 O
as 166 168 818 820 O
per 169 172 821 824 O
Investigator 173 185 825 837 O
's 185 187 837 839 O
judgement 188 197 840 849 O
) 197 198 849 850 O
or 199 201 851 853 O
a 202 203 854 855 O
psychiatric 204 215 856 867 O
condition 216 225 868 877 O
that 226 230 878 882 O
might 231 236 883 888 O
impair 237 243 889 895 O
the 244 247 896 899 O
subject 248 255 900 907 O
's 255 257 907 909 O
well 258 262 910 914 O
- 262 263 914 915 O
being 263 268 915 920 O
or 269 271 921 923 O
preclude 272 280 924 932 O
full 281 285 933 937 O
participation 286 299 938 951 O
in 300 302 952 954 O
the 303 306 955 958 O
trial 307 312 959 964 O

History 0 7 965 972 O
of 8 10 973 975 O
difficulty 11 21 976 986 O
swallowing 22 32 987 997 O
, 32 33 997 998 O
malabsorption 34 47 999 1012 O
or 48 50 1013 1015 O
other 51 56 1016 1021 O
chronic 57 64 1022 1029 O
gastrointestinal 65 81 1030 1046 B-chronic_disease
disease 82 89 1047 1054 I-chronic_disease
or 90 92 1055 1057 O
conditions 93 103 1058 1068 O
that 104 108 1069 1073 O
may 109 112 1074 1077 O
hamper 113 119 1078 1084 O
compliance 120 130 1085 1095 O
and/or 131 137 1096 1102 O
absorption 138 148 1103 1113 O
of 149 151 1114 1116 O
the 152 155 1117 1120 O
IMP 156 159 1121 1124 B-treatment

History 0 7 1125 1132 O
of 8 10 1133 1135 O
difficulty 11 21 1136 1146 O
swallowing 22 32 1147 1157 O
, 32 33 1157 1158 O
malabsorption 34 47 1159 1172 B-chronic_disease
or 48 50 1173 1175 O
other 51 56 1176 1181 O
chronic 57 64 1182 1189 O
gastrointestinal 65 81 1190 1206 B-chronic_disease
disease 82 89 1207 1214 I-chronic_disease
or 90 92 1215 1217 O
conditions 93 103 1218 1228 O
that 104 108 1229 1233 O
may 109 112 1234 1237 O
hamper 113 119 1238 1244 O
compliance 120 130 1245 1255 O
and/or 131 137 1256 1262 O
absorption 138 148 1263 1273 O
of 149 151 1274 1276 O
the 152 155 1277 1280 O
IMP 156 159 1281 1284 B-treatment
, 159 160 1284 1285 O
use 161 164 1286 1289 O
of 165 167 1290 1292 O
percutaneous 168 180 1293 1305 B-treatment
endoscopic 181 191 1306 1316 I-treatment
gastrostomy 192 203 1317 1328 I-treatment
( 204 205 1329 1330 I-treatment
PEG 205 208 1330 1333 I-treatment
) 208 209 1333 1334 I-treatment
tubes 210 215 1335 1340 I-treatment

Life 0 4 1341 1345 B-clinical_variable
expectancy 5 15 1346 1356 I-clinical_variable
of 16 18 1357 1359 O
≥ 19 20 1360 1361 O
3 21 22 1362 1363 B-lower_bound
months 23 29 1364 1370 I-lower_bound
( 30 31 1371 1372 O
Phase 31 36 1372 1377 B-clinical_variable
Ia 37 39 1378 1380 I-clinical_variable
, 39 40 1380 1381 I-clinical_variable
Arm 41 44 1382 1385 I-clinical_variable
A 45 46 1386 1387 I-clinical_variable
) 46 47 1387 1388 O
or 48 50 1389 1391 O
≥ 51 52 1392 1393 O
6 53 54 1394 1395 B-lower_bound
months 55 61 1396 1402 I-lower_bound
( 62 63 1403 1404 O
Phase 63 68 1404 1409 B-clinical_variable
Ia 69 71 1410 1412 I-clinical_variable
, 71 72 1412 1413 I-clinical_variable
Arm 73 76 1414 1417 I-clinical_variable
B 77 78 1418 1419 I-clinical_variable
and 79 82 1420 1423 I-clinical_variable
Phase 83 88 1424 1429 I-clinical_variable
Ib 89 91 1430 1432 I-clinical_variable
) 91 92 1432 1433 O

Liver 0 5 1434 1439 O
function 6 14 1440 1448 O
abnormality 15 26 1449 1460 O
as 27 29 1461 1463 O
defined 30 37 1464 1471 O
by 38 40 1472 1474 O
total 41 46 1475 1480 B-clinical_variable
bilirubin 47 56 1481 1490 I-clinical_variable
> 57 58 1491 1492 O
1.5 58 61 1492 1495 B-lower_bound
× 62 63 1496 1497 I-lower_bound
ULN 64 67 1498 1501 I-lower_bound
or 68 70 1502 1504 O
aspartate 71 80 1505 1514 B-clinical_variable
aminotransferase 81 97 1515 1531 I-clinical_variable
( 98 99 1532 1533 I-clinical_variable
AST)/alanine 99 111 1533 1545 I-clinical_variable
aminotransferase 112 128 1546 1562 I-clinical_variable
( 129 130 1563 1564 I-clinical_variable
ALT 130 133 1564 1567 I-clinical_variable
) 133 134 1567 1568 I-clinical_variable
> 135 136 1569 1570 O
2.5 136 139 1570 1573 B-lower_bound
× 140 141 1574 1575 I-lower_bound
ULN 142 145 1576 1579 I-lower_bound
( 146 147 1580 1581 O
except 147 153 1581 1587 O
for 154 157 1588 1591 O
subjects 158 166 1592 1600 O
with 167 171 1601 1605 O
liver 172 177 1606 1611 O
involvement 178 189 1612 1623 O
, 189 190 1623 1624 O
who 191 194 1625 1628 O
can 195 198 1629 1632 O
have 199 203 1633 1637 O
AST 204 207 1638 1641 B-clinical_variable
/ 207 208 1641 1642 I-clinical_variable
ALT 208 211 1642 1645 I-clinical_variable
> 212 213 1646 1647 O
5 213 214 1647 1648 O
× 215 216 1649 1650 O
ULN 217 220 1651 1654 O
) 220 221 1654 1655 O

Measurable 0 10 1656 1666 O
or 11 13 1667 1669 O
evaluable 14 23 1670 1679 O
disease 24 31 1680 1687 O
by 32 34 1688 1690 O
RECIST 35 41 1691 1697 O
v1.1 42 46 1698 1702 O
( 47 48 1703 1704 O
not 48 51 1704 1707 O
required 52 60 1708 1716 O
for 61 64 1717 1720 O
ancillary 65 74 1721 1730 B-treatment
cPoP 75 79 1731 1735 I-treatment
part 80 84 1736 1740 O
of 85 87 1741 1743 O
the 88 91 1744 1747 O
study 92 97 1748 1753 O
) 97 98 1753 1754 O

Phase 0 5 1755 1760 O
Ia 6 8 1761 1763 O
part 9 13 1764 1768 O
: 13 14 1768 1769 O
advanced 15 23 1770 1778 O
solid 24 29 1779 1784 B-cancer
tumors 30 36 1785 1791 I-cancer
or 37 39 1792 1794 O
metastases 40 50 1795 1805 B-cancer
including 51 60 1806 1815 O
lymphoma 61 69 1816 1824 B-cancer
localized 70 79 1825 1834 O
in 80 82 1835 1837 O
the 83 86 1838 1841 O
head 87 91 1842 1846 O
and 92 95 1847 1850 O
neck 96 100 1851 1855 O
region 101 107 1856 1862 O
or 108 110 1863 1865 O
thorax 111 117 1866 1872 O
with 118 122 1873 1877 O
an 123 125 1878 1880 O
indication 126 136 1881 1891 O
for 137 140 1892 1895 O
fractionated 141 153 1896 1908 O
palliative 154 164 1909 1919 O
RT 165 167 1920 1922 B-treatment
( 168 169 1923 1924 O
Arm 169 172 1924 1927 O
A 173 174 1928 1929 O
) 174 175 1929 1930 O
; 175 176 1930 1931 O
or 177 179 1932 1934 O
treatment 180 189 1935 1944 B-treatment
- 189 190 1944 1945 O
naïve 190 195 1945 1950 O
SCCHN 196 201 1951 1956 B-cancer
eligible 202 210 1957 1965 O
for 211 214 1966 1969 O
fractionated 215 227 1970 1982 O
curatively 228 238 1983 1993 O
intended 239 247 1994 2002 O
RT 248 250 2003 2005 O
with 251 255 2006 2010 O
concurrent 256 266 2011 2021 O
cisplatin 267 276 2022 2031 B-treatment
( 277 278 2032 2033 O
Arm 278 281 2033 2036 O
B 282 283 2037 2038 O
) 283 284 2038 2039 O

Phase 0 5 2040 2045 O
Ib 6 8 2046 2048 O
part 9 13 2049 2053 O
: 13 14 2053 2054 O
treatment 15 24 2055 2064 B-treatment
- 24 25 2064 2065 O
naïve 25 30 2065 2070 O
Stage 31 36 2071 2076 O
III 37 40 2077 2080 O
A 41 42 2081 2082 O
/ 42 43 2082 2083 O
B 43 44 2083 2084 O
NSCLC 45 50 2085 2090 B-cancer
not 51 54 2091 2094 O
eligible 55 63 2095 2103 O
for 64 67 2104 2107 O
surgical 68 76 2108 2116 B-treatment
resection 77 86 2117 2126 I-treatment
or 87 89 2127 2129 O
concurrent 90 100 2130 2140 O
chemoradiation 101 115 2141 2155 B-treatment
( 116 117 2156 2157 O
Arm 117 120 2157 2160 O
A 121 122 2161 2162 O
expansion 123 132 2163 2172 O
cohort 133 139 2173 2179 O
) 139 140 2179 2180 O
or 141 143 2181 2183 O
treatment 144 153 2184 2193 O
- 153 154 2193 2194 O
naïve 154 159 2194 2199 O
SCCHN 160 165 2200 2205 B-cancer
eligible 166 174 2206 2214 O
for 175 178 2215 2218 O
fractionated 179 191 2219 2231 O
curatively 192 202 2232 2242 O
intended 203 211 2243 2251 O
RT 212 214 2252 2254 O
with 215 219 2255 2259 O
concurrent 220 230 2260 2270 O
cisplatin 231 240 2271 2280 B-treatment
( 241 242 2281 2282 O
Arm 242 245 2282 2285 O
B 246 247 2286 2287 O
expansion 248 257 2288 2297 O
cohort 258 264 2298 2304 O
) 264 265 2304 2305 O

Prior 0 5 2306 2311 B-treatment
RT 6 8 2312 2314 I-treatment
to 9 11 2315 2317 O
the 12 15 2318 2321 O
same 16 20 2322 2326 O
region 21 27 2327 2333 O
within 28 34 2334 2340 O
12 35 37 2341 2343 B-upper_bound
months 38 44 2344 2350 I-upper_bound
( 45 46 2351 2352 O
Phase 46 51 2352 2357 O
Ia 52 54 2358 2360 O
, 54 55 2360 2361 O
Arm 56 59 2362 2365 O
A 60 61 2366 2367 O
; 61 62 2367 2368 O
subjects 63 71 2369 2377 O
with 72 76 2378 2382 O
tumors 77 83 2383 2389 B-cancer
localized 84 93 2390 2399 O
in 94 96 2400 2402 O
the 97 100 2403 2406 O
head 101 105 2407 2411 O
and 106 109 2412 2415 O
neck 110 114 2416 2420 O
region 115 121 2421 2427 O
or 122 124 2428 2430 O
thorax 125 131 2431 2437 O
) 131 132 2437 2438 O
or 133 135 2439 2441 O
at 136 138 2442 2444 O
any 139 142 2445 2448 O
time 143 147 2449 2453 O
previously 148 158 2454 2464 O
( 159 160 2465 2466 O
Phase 160 165 2466 2471 O
Ia 166 168 2472 2474 O
, 168 169 2474 2475 O
Arm 170 173 2476 2479 O
B 174 175 2480 2481 O
; 175 176 2481 2482 O
treatment 177 186 2483 2492 B-treatment
- 186 187 2492 2493 O
naïve 187 192 2493 2498 O
subjects 193 201 2499 2507 O
with 202 206 2508 2512 O
SCCHN 207 212 2513 2518 B-cancer
and 213 216 2519 2522 O
Phase 217 222 2523 2528 O
Ib 223 225 2529 2531 O
; 225 226 2531 2532 O
treatment 227 236 2533 2542 O
- 236 237 2542 2543 O
naïve 237 242 2543 2548 O
subjects 243 251 2549 2557 O
with 252 256 2558 2562 O
Stage 257 262 2563 2568 B-cancer
III 263 266 2569 2572 I-cancer
A 267 268 2573 2574 I-cancer
/ 268 269 2574 2575 I-cancer
B 269 270 2575 2576 I-cancer
NSCLC 271 276 2577 2582 I-cancer
or 277 279 2583 2585 O
SCCHN 280 285 2586 2591 O
) 285 286 2591 2592 O

Renal 0 5 2593 2598 B-chronic_disease
impairment 6 16 2599 2609 I-chronic_disease
as 17 19 2610 2612 O
evidenced 20 29 2613 2622 O
by 30 32 2623 2625 O
serum 33 38 2626 2631 B-clinical_variable
creatinine 39 49 2632 2642 I-clinical_variable
> 50 51 2643 2644 O
1.5 51 54 2644 2647 B-lower_bound
× 55 56 2648 2649 I-lower_bound
upper 57 62 2650 2655 I-lower_bound
limit 63 68 2656 2661 I-lower_bound
of 69 71 2662 2664 I-lower_bound
normal 72 78 2665 2671 I-lower_bound
( 79 80 2672 2673 I-lower_bound
ULN 80 83 2673 2676 I-lower_bound
) 83 84 2676 2677 I-lower_bound

Significant 0 11 2678 2689 O
cardiac 12 19 2690 2697 B-chronic_disease
conduction 20 30 2698 2708 I-chronic_disease
abnormalities 31 44 2709 2722 I-chronic_disease
, 44 45 2722 2723 O
including 46 55 2724 2733 O
a 56 57 2734 2735 O
history 58 65 2736 2743 O
of 66 68 2744 2746 O
long 69 73 2747 2751 B-chronic_disease
QTc 74 77 2752 2755 I-chronic_disease
syndrome 78 86 2756 2764 I-chronic_disease
and/or 87 93 2765 2771 O
pacemaker 94 103 2772 2781 O
, 103 104 2781 2782 O
or 105 107 2783 2785 O
impaired 108 116 2786 2794 B-chronic_disease
cardiovascular 117 131 2795 2809 I-chronic_disease
function 132 140 2810 2818 I-chronic_disease
such 141 145 2819 2823 O
as 146 148 2824 2826 O
New 149 152 2827 2830 B-clinical_variable
York 153 157 2831 2835 I-clinical_variable
Heart 158 163 2836 2841 I-clinical_variable
Association 164 175 2842 2853 I-clinical_variable
classification 176 190 2854 2868 I-clinical_variable
score 191 196 2869 2874 I-clinical_variable
> 197 198 2875 2876 O
2 198 199 2876 2877 B-lower_bound

Subjects 0 8 2878 2886 O
currently 9 18 2887 2896 O
receiving 19 28 2897 2906 O
( 29 30 2907 2908 O
or 30 32 2908 2910 O
unable 33 39 2911 2917 O
to 40 42 2918 2920 O
stop 43 47 2921 2925 O
using 48 53 2926 2931 O
prior 54 59 2932 2937 O
to 60 62 2938 2940 O
receiving 63 72 2941 2950 O
the 73 76 2951 2954 O
first 77 82 2955 2960 O
dose 83 87 2961 2965 O
of 88 90 2966 2968 O
study 91 96 2969 2974 B-treatment
drug 97 101 2975 2979 I-treatment
) 101 102 2979 2980 O
medications 103 114 2981 2992 B-treatment
or 115 117 2993 2995 O
herbal 118 124 2996 3002 B-treatment
supplements 125 136 3003 3014 I-treatment
known 137 142 3015 3020 O
to 143 145 3021 3023 O
be 146 148 3024 3026 O
potent 149 155 3027 3033 B-treatment
inhibitors 156 166 3034 3044 I-treatment
of 167 169 3045 3047 I-treatment
CYP3A 170 175 3048 3053 I-treatment
or 176 178 3054 3056 O
CYP2C19 179 186 3057 3064 B-treatment
must 187 191 3065 3069 O
stop 192 196 3070 3074 O
at 197 199 3075 3077 O
least 200 205 3078 3083 O
1 206 207 3084 3085 B-lower_bound
week 208 212 3086 3090 I-lower_bound
prior 213 218 3091 3096 I-lower_bound
to 219 221 3097 3099 O
taking 222 228 3100 3106 O
MSC2490484A. 229 241 3107 3119 B-treatment
Subjects 242 250 3120 3128 O
receiving 251 260 3129 3138 O
potent 261 267 3139 3145 B-treatment
inducers 268 276 3146 3154 I-treatment
of 277 279 3155 3157 I-treatment
CYP3A 280 285 3158 3163 I-treatment
or 286 288 3164 3166 O
CYP2C19 289 296 3167 3174 O
must 297 301 3175 3179 O
stop 302 306 3180 3184 O
at 307 309 3185 3187 O
least 310 315 3188 3193 O
3 316 317 3194 3195 B-lower_bound
weeks 318 323 3196 3201 I-lower_bound
prior 324 329 3202 3207 I-lower_bound
to 330 332 3208 3210 O
taking 333 339 3211 3217 O
MSC2490484A. 340 352 3218 3230 O
Those 353 358 3231 3236 O
receiving 359 368 3237 3246 O
drugs 369 374 3247 3252 O
mainly 375 381 3253 3259 O
metabolized 382 393 3260 3271 O
by 394 396 3272 3274 O
CYP3A 397 402 3275 3280 O
with 403 407 3281 3285 O
a 408 409 3286 3287 O
narrow 410 416 3288 3294 O
therapeutic 417 428 3295 3306 O
index 429 434 3307 3312 O
as 435 437 3313 3315 O
judged 438 444 3316 3322 O
by 445 447 3323 3325 O
the 448 451 3326 3329 O
Investigator 452 464 3330 3342 O
( 465 466 3343 3344 O
and 466 469 3344 3347 O
after 470 475 3348 3353 O
optional 476 484 3354 3362 O
consultation 485 497 3363 3375 O
with 498 502 3376 3380 O
the 503 506 3381 3384 O
Sponsor 507 514 3385 3392 O
) 514 515 3392 3393 O
must 516 520 3394 3398 O
stop 521 525 3399 3403 O
at 526 528 3404 3406 O
least 529 534 3407 3412 O
one 535 538 3413 3416 B-lower_bound
day 539 542 3417 3420 I-lower_bound
prior 543 548 3421 3426 I-lower_bound
to 549 551 3427 3429 O
taking 552 558 3430 3436 O
MSC2490484A 559 570 3437 3448 O

Subjects 0 8 3449 3457 O
currently 9 18 3458 3467 O
receiving 19 28 3468 3477 O
( 29 30 3478 3479 O
or 30 32 3479 3481 O
unable 33 39 3482 3488 O
to 40 42 3489 3491 O
stop 43 47 3492 3496 O
using 48 53 3497 3502 O
prior 54 59 3503 3508 O
to 60 62 3509 3511 O
receiving 63 72 3512 3521 O
the 73 76 3522 3525 O
first 77 82 3526 3531 O
dose 83 87 3532 3536 O
of 88 90 3537 3539 O
trial 91 96 3540 3545 O
drug 97 101 3546 3550 O
) 101 102 3550 3551 O
medications 103 114 3552 3563 B-treatment
or 115 117 3564 3566 O
herbal 118 124 3567 3573 B-treatment
supplements 125 136 3574 3585 I-treatment
known 137 142 3586 3591 O
to 143 145 3592 3594 O
be 146 148 3595 3597 O
potent 149 155 3598 3604 O
inhibitors 156 166 3605 3615 O
of 167 169 3616 3618 O
cytochrome 170 180 3619 3629 B-treatment
P450 181 185 3630 3634 I-treatment
( 186 187 3635 3636 B-treatment
CYP)3A 187 193 3636 3642 I-treatment
or 194 196 3643 3645 O
CYP2C19 197 204 3646 3653 B-treatment
( 205 206 3654 3655 O
must 206 210 3655 3659 O
stop 211 215 3660 3664 O
at 216 218 3665 3667 O
least 219 224 3668 3673 O
1 225 226 3674 3675 B-lower_bound
week 227 231 3676 3680 I-lower_bound
prior 232 237 3681 3686 I-lower_bound
) 237 238 3686 3687 O
, 238 239 3687 3688 O
potent 240 246 3689 3695 O
inducers 247 255 3696 3704 O
of 256 258 3705 3707 O
CYP3A 259 264 3708 3713 B-treatment
or 265 267 3714 3716 O
CYP2C19 268 275 3717 3724 O
( 276 277 3725 3726 O
must 277 281 3726 3730 O
stop 282 286 3731 3735 O
at 287 289 3736 3738 O
least 290 295 3739 3744 O
3 296 297 3745 3746 B-lower_bound
weeks 298 303 3747 3752 I-lower_bound
prior 304 309 3753 3758 I-lower_bound
) 309 310 3758 3759 O
, 310 311 3759 3760 O
or 312 314 3761 3763 O
drugs 315 320 3764 3769 O
mainly 321 327 3770 3776 O
metabolized 328 339 3777 3788 O
by 340 342 3789 3791 O
CYP3A 343 348 3792 3797 B-treatment
with 349 353 3798 3802 I-treatment
a 354 355 3803 3804 I-treatment
narrow 356 362 3805 3811 I-treatment
therapeutic 363 374 3812 3823 I-treatment
index 375 380 3824 3829 I-treatment
( 381 382 3830 3831 O
must 382 386 3831 3835 O
stop 387 391 3836 3840 O
at 392 394 3841 3843 O
least 395 400 3844 3849 O
one 401 404 3850 3853 B-lower_bound
day 405 408 3854 3857 I-lower_bound
prior 409 414 3858 3863 I-lower_bound
) 414 415 3863 3864 O

Subjects 0 8 3865 3873 O
currently 9 18 3874 3883 O
receiving 19 28 3884 3893 O
H2 29 31 3894 3896 B-treatment
- 31 32 3896 3897 I-treatment
blocker 32 39 3897 3904 I-treatment
or 40 42 3905 3907 O
proton 43 49 3908 3914 B-treatment
pump 50 54 3915 3919 I-treatment
inhibitors 55 65 3920 3930 I-treatment
( 66 67 3931 3932 O
or 67 69 3932 3934 O
unable 70 76 3935 3941 O
to 77 79 3942 3944 O
stop 80 84 3945 3949 O
at 85 87 3950 3952 O
least 88 93 3953 3958 O
5 94 95 3959 3960 B-lower_bound
days 96 100 3961 3965 I-lower_bound
prior 101 106 3966 3971 I-lower_bound
to 107 109 3972 3974 O
the 110 113 3975 3978 O
first 114 119 3979 3984 B-treatment
treatment 120 129 3985 3994 I-treatment
) 129 130 3994 3995 O

Subjects 0 8 3996 4004 O
where 9 14 4005 4010 O
more 15 19 4011 4015 O
than 20 24 4016 4020 O
10 25 27 4021 4023 B-lower_bound
% 27 28 4023 4024 I-lower_bound
of 29 31 4025 4027 O
the 32 35 4028 4031 O
total 36 41 4032 4037 B-clinical_variable
esophagus 42 51 4038 4047 I-clinical_variable
volume 52 58 4048 4054 I-clinical_variable
receives 59 67 4055 4063 O
more 68 72 4064 4068 O
than 73 77 4069 4073 O
50 78 80 4074 4076 B-lower_bound
% 80 81 4076 4077 I-lower_bound
of 82 84 4078 4080 O
the 85 88 4081 4084 O
prescribed 89 99 4085 4095 O
RT 100 102 4096 4098 O
dose 103 107 4099 4103 O

Willing 0 7 4104 4111 O
to 8 10 4112 4114 O
have 11 15 4115 4119 O
tumor 16 21 4120 4125 B-cancer
biopsies 22 30 4126 4134 B-treatment
collected 31 40 4135 4144 O
in 41 43 4145 4147 O
Ancillary 44 53 4148 4157 O
cPoP 54 58 4158 4162 O

Histologically 0 14 0 14 O
confirmed 15 24 15 24 O
lymphoma 25 33 25 33 B-cancer
( 34 35 34 35 O
WHO 35 38 35 38 O
classification 39 53 39 53 O
) 53 54 53 54 O
, 54 55 54 55 O
or 56 58 56 58 O
confirmed 59 68 59 68 O
MM 69 71 69 71 B-cancer
( 72 73 72 73 I-cancer
IMWG 73 77 73 77 I-cancer
) 77 78 77 78 I-cancer
, 78 79 78 79 O
that 80 84 80 84 O
is 85 87 85 87 O
relapsed 88 96 88 96 O
and/or 97 103 97 103 O
refractory 104 114 104 114 O

History 0 7 115 122 O
of 8 10 123 125 O
chronic 11 18 126 133 B-chronic_disease
pancreatitis 19 31 134 146 I-chronic_disease

Known 0 5 147 152 O
history 6 13 153 160 O
of 14 16 161 163 O
chronic 17 24 164 171 B-chronic_disease
liver 25 30 172 177 I-chronic_disease
disease 31 38 178 185 I-chronic_disease

Prior 0 5 186 191 B-treatment
treatment 6 15 192 201 I-treatment
with 16 20 202 206 I-treatment
Mcl-1 21 26 207 212 I-treatment
inhibitor 27 36 213 222 I-treatment

Women 0 5 0 5 B-gender
undergoing 6 16 6 16 O
cesarean 17 25 17 25 B-treatment
delivery 26 34 26 34 I-treatment
after 35 40 35 40 O
labor 41 46 41 46 O
at 47 49 47 49 O
Barnes 50 56 50 56 O
- 56 57 56 57 O
Jewish 57 63 57 63 O
Hospital 64 72 64 72 O

known 0 5 73 78 O
or 6 8 79 81 O
suspected 9 18 82 91 O
allergy 19 26 92 99 O
to 27 29 100 102 O
iodine 30 36 103 109 B-allergy_name
or 37 39 110 112 O
shellfish 40 49 113 122 B-allergy_name

women 0 5 123 128 B-gender
with 6 10 129 133 O
active 11 17 134 140 O
herpes 18 24 141 147 B-chronic_disease
simplex 25 32 148 155 I-chronic_disease
virus 33 38 156 161 I-chronic_disease
infection 39 48 162 171 I-chronic_disease

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,000 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
uL 41 43 41 43 I-lower_bound

Additional 0 10 44 54 O
exclusion 11 20 55 64 O
criteria 21 29 65 73 O
for 30 33 74 77 O
exploratory 34 45 78 89 O
cohort 46 52 90 96 O
ONLY 53 57 97 101 O
: 57 58 101 102 O
Known 59 64 103 108 O
pulmonary 65 74 109 118 B-chronic_disease
hypertension 75 87 119 131 I-chronic_disease

Any 0 3 132 135 O
condition 4 13 136 145 O
which 14 19 146 151 O
in 20 22 152 154 O
the 23 26 155 158 O
Investigator 27 39 159 171 O
's 39 41 171 173 O
opinion 42 49 174 181 O
deems 50 55 182 187 O
the 56 59 188 191 O
patient 60 67 192 199 O
an 68 70 200 202 O
unsuitable 71 81 203 213 O
candidate 82 91 214 223 O
to 92 94 224 226 O
receive 95 102 227 234 O
study 103 108 235 240 B-treatment
drug 109 113 241 245 I-treatment
( 114 115 246 247 O
i.e. 115 119 247 251 O
, 119 120 251 252 O
any 121 124 253 256 O
significant 125 136 257 268 O
medical 137 144 269 276 O
illness 145 152 277 284 O
or 153 155 285 287 O
abnormal 156 164 288 296 O
laboratory 165 175 297 307 O
finding 176 183 308 315 O
that 184 188 316 320 O
would 189 194 321 326 O
, 194 195 326 327 O
in 196 198 328 330 O
the 199 202 331 334 O
investigator 203 215 335 347 O
's 215 217 347 349 O
judgment 218 226 350 358 O
, 226 227 358 359 O
increase 228 236 360 368 O
the 237 240 369 372 O
patient 241 248 373 380 O
's 248 250 380 382 O
risk 251 255 383 387 O
by 256 258 388 390 O
participating 259 272 391 404 O
in 273 275 405 407 O
this 276 280 408 412 O
study 281 286 413 418 O
) 286 287 418 419 O

Any 0 3 420 423 O
human 4 9 424 429 B-clinical_variable
leukocyte 10 19 430 439 I-clinical_variable
antigen 20 27 440 447 I-clinical_variable
( 28 29 448 449 I-clinical_variable
HLA 29 32 449 452 I-clinical_variable
) 32 33 452 453 I-clinical_variable
type 34 38 454 458 O
; 38 39 458 459 O
( 40 41 460 461 O
historic 41 49 461 469 O
HLA 50 53 470 473 O
typing 54 60 474 480 O
is 61 63 481 483 O
permitted 64 73 484 493 O
) 73 74 493 494 O

Chemotherapy 0 12 495 507 B-treatment
, 12 13 507 508 O
radiation 14 23 509 518 B-treatment
therapy 24 31 519 526 I-treatment
, 31 32 526 527 O
or 33 35 528 530 O
immunotherapy 36 49 531 544 B-treatment
within 50 56 545 551 O
4 57 58 552 553 B-upper_bound
weeks 59 64 554 559 I-upper_bound
prior 65 70 560 565 I-upper_bound
to 71 73 566 568 O
first 74 79 569 574 O
dosing 80 86 575 581 O
of 87 89 582 584 O
study 90 95 585 590 B-treatment
drug 96 100 591 595 I-treatment
( 101 102 596 597 O
6 102 103 597 598 B-upper_bound
weeks 104 109 599 604 I-upper_bound
for 110 113 605 608 O
nitrosoureas 114 126 609 621 B-treatment
) 126 127 621 622 O

Concomitant 0 11 623 634 O
systemic 12 20 635 643 B-treatment
treatment 21 30 644 653 I-treatment
with 31 35 654 658 O
chronic 36 43 659 666 O
use 44 47 667 670 O
( 48 49 671 672 O
based 49 54 672 677 O
on 55 57 678 680 O
the 58 61 681 684 O
investigator 62 74 685 697 O
's 74 76 697 699 O
judgment 77 85 700 708 O
) 85 86 708 709 O
of 87 89 710 712 O
corticosteroids 90 105 713 728 B-treatment
, 105 106 728 729 O
anti 107 111 730 734 B-treatment
- 111 112 734 735 I-treatment
histamine 112 121 735 744 I-treatment
or 122 124 745 747 O
non 125 128 748 751 B-treatment
- 128 129 751 752 I-treatment
steroidal 129 138 752 761 I-treatment
anti 139 143 762 766 I-treatment
- 143 144 766 767 I-treatment
inflammatory 144 156 767 779 I-treatment
drugs 157 162 780 785 I-treatment
, 162 163 785 786 O
and 164 167 787 790 O
other 168 173 791 796 B-treatment
platelet 174 182 797 805 I-treatment
inhibitory 183 193 806 816 I-treatment
agents 194 200 817 823 I-treatment

Eligible 0 8 824 832 O
patients 9 17 833 841 O
will 18 22 842 846 O
be 23 25 847 849 O
women 26 31 850 855 O
with 32 36 856 860 O
epithelial 37 47 861 871 B-cancer
ovarian 48 55 872 879 I-cancer
, 55 56 879 880 O
fallopian 57 66 881 890 B-cancer
tube 67 71 891 895 I-cancer
, 71 72 895 896 O
or 73 75 897 899 O
primary 76 83 900 907 O
peritoneal 84 94 908 918 B-cancer
carcinoma 95 104 919 928 I-cancer
after 105 110 929 934 O
chemotherapy 111 123 935 947 B-treatment
with 124 128 948 952 O
no 129 131 953 955 O
evidence 132 140 956 964 O
of 141 143 965 967 O
disease 144 151 968 975 O
or 152 154 976 978 O
minimal 155 162 979 986 B-cancer
residual 163 171 987 995 I-cancer
disease 172 179 996 1003 I-cancer
for 180 183 1004 1007 O
primary 184 191 1008 1015 O
or 192 194 1016 1018 O
recurrent 195 204 1019 1028 O
disease 205 212 1029 1036 O
; 212 213 1036 1037 O
this 214 218 1038 1042 O
may 219 222 1043 1046 O
or 223 225 1047 1049 O
may 226 229 1050 1053 O
not 230 233 1054 1057 O
be 234 236 1058 1060 O
measurable 237 247 1061 1071 O
; 247 248 1071 1072 O
these 249 254 1073 1078 O
patients 255 263 1079 1087 O
would 264 269 1088 1093 O
normally 270 278 1094 1102 O
enter 279 284 1103 1108 O
a 285 286 1109 1110 O
period 287 293 1111 1117 O
of 294 296 1118 1120 O
observation 297 308 1121 1132 O
after 309 314 1133 1138 O
standard 315 323 1139 1147 O
management 324 334 1148 1158 O

Evidence 0 8 1159 1167 O
of 9 11 1168 1170 O
current 12 19 1171 1178 O
drug 20 24 1179 1183 O
or 25 27 1184 1186 O
alcohol 28 35 1187 1194 O
abuse 36 41 1195 1200 O
or 42 44 1201 1203 O
psychiatric 45 56 1204 1215 B-chronic_disease
impairment 57 67 1216 1226 I-chronic_disease
, 67 68 1226 1227 O
which 69 74 1228 1233 O
in 75 77 1234 1236 O
the 78 81 1237 1240 O
Investigator 82 94 1241 1253 O
's 94 96 1253 1255 O
opinion 97 104 1256 1263 O
will 105 109 1264 1268 O
prevent 110 117 1269 1276 O
completion 118 128 1277 1287 O
of 129 131 1288 1290 O
the 132 135 1291 1294 O
protocol 136 144 1295 1303 O
therapy 145 152 1304 1311 B-treatment
or 153 155 1312 1314 O
follow 156 162 1315 1321 O
- 162 163 1321 1322 O
up 163 165 1322 1324 O

Have 0 4 1325 1329 O
an 5 7 1330 1332 O
Eastern 8 15 1333 1340 B-clinical_variable
Cooperative 16 27 1341 1352 I-clinical_variable
Oncology 28 36 1353 1361 I-clinical_variable
Group 37 42 1362 1367 I-clinical_variable
( 43 44 1368 1369 I-clinical_variable
ECOG 44 48 1369 1373 I-clinical_variable
) 48 49 1373 1374 I-clinical_variable
performance 50 61 1375 1386 I-clinical_variable
status 62 68 1387 1393 I-clinical_variable
of 69 71 1394 1396 O
= 72 73 1397 1398 O
< 73 74 1398 1399 O
2 75 76 1400 1401 B-upper_bound

Have 0 4 1402 1406 O
been 5 9 1407 1411 O
informed 10 18 1412 1420 O
of 19 21 1421 1423 O
other 22 27 1424 1429 O
treatment 28 37 1430 1439 B-treatment
options 38 45 1440 1447 O

Hemoglobin 0 10 1448 1458 B-clinical_variable
( 11 12 1459 1460 I-clinical_variable
Hgb 12 15 1460 1463 I-clinical_variable
) 15 16 1463 1464 I-clinical_variable
> 17 18 1465 1466 O
= 18 19 1466 1467 O
8 20 21 1468 1469 B-lower_bound
g 22 23 1470 1471 I-lower_bound
/ 23 24 1471 1472 I-lower_bound
dL 24 26 1472 1474 I-lower_bound

History 0 7 1475 1482 O
of 8 10 1483 1485 O
severe 11 17 1486 1492 O
autoimmune 18 28 1493 1503 B-chronic_disease
disorders 29 38 1504 1513 I-chronic_disease
requiring 39 48 1514 1523 O
use 49 52 1524 1527 O
of 53 55 1528 1530 O
steroids 56 64 1531 1539 B-treatment
or 65 67 1540 1542 O
other 68 73 1543 1548 O
immunosuppressives 74 92 1549 1567 B-treatment

Known 0 5 1568 1573 O
hepatitis 6 15 1574 1583 B-chronic_disease
B 16 17 1584 1585 I-chronic_disease
, 17 18 1585 1586 O
hepatitis 19 28 1587 1596 B-chronic_disease
C 29 30 1597 1598 I-chronic_disease
, 30 31 1598 1599 O
or 32 34 1600 1602 O
human 35 40 1603 1608 B-treatment
immunodeficiency 41 57 1609 1625 I-treatment
virus 58 63 1626 1631 I-treatment
( 64 65 1632 1633 I-treatment
HIV 65 68 1633 1636 I-treatment
) 68 69 1636 1637 I-treatment

Life 0 4 1638 1642 B-clinical_variable
expectancy 5 15 1643 1653 I-clinical_variable
> 16 17 1654 1655 O
6 18 19 1656 1657 B-lower_bound
months 20 26 1658 1664 I-lower_bound

Mental 0 6 1665 1671 B-chronic_disease
impairment 7 17 1672 1682 I-chronic_disease
that 18 22 1683 1687 O
may 23 26 1688 1691 O
compromise 27 37 1692 1702 O
the 38 41 1703 1706 O
ability 42 49 1707 1714 O
to 50 52 1715 1717 O
give 53 57 1718 1722 O
informed 58 66 1723 1731 O
consent 67 74 1732 1739 O
and 75 78 1740 1743 O
comply 79 85 1744 1750 O
with 86 90 1751 1755 O
the 91 94 1756 1759 O
requirements 95 107 1760 1772 O
of 108 110 1773 1775 O
the 111 114 1776 1779 O
study 115 120 1780 1785 O

Metastatic 0 10 1786 1796 B-cancer
disease 11 18 1797 1804 I-cancer
to 19 21 1805 1807 O
the 22 25 1808 1811 O
central 26 33 1812 1819 O
nervous 34 41 1820 1827 O
system 42 48 1828 1834 O
for 49 52 1835 1838 O
which 53 58 1839 1844 O
other 59 64 1845 1850 O
therapeutic 65 76 1851 1862 O
options 77 84 1863 1870 O
, 84 85 1870 1871 O
including 86 95 1872 1881 O
radiotherapy 96 108 1882 1894 B-treatment
, 108 109 1894 1895 O
may 110 113 1896 1899 O
be 114 116 1900 1902 O
available 117 126 1903 1912 O

Other 0 5 1913 1918 O
serious 6 13 1919 1926 B-chronic_disease
illnesses 14 23 1927 1936 I-chronic_disease
( 24 25 1937 1938 O
e.g. 25 29 1938 1942 O
, 29 30 1942 1943 O
serious 31 38 1944 1951 B-chronic_disease
infections 39 49 1952 1962 I-chronic_disease
requiring 50 59 1963 1972 O
antibiotics 60 71 1973 1984 B-treatment
, 71 72 1984 1985 O
bleeding 73 81 1986 1994 B-chronic_disease
disorders 82 91 1995 2004 I-chronic_disease
) 91 92 2004 2005 O

Participation 0 13 2006 2019 O
in 14 16 2020 2022 O
any 17 20 2023 2026 B-treatment
other 21 26 2027 2032 I-treatment
clinical 27 35 2033 2041 I-treatment
trial 36 41 2042 2047 I-treatment
involving 42 51 2048 2057 I-treatment
another 52 59 2058 2065 I-treatment
investigational 60 75 2066 2081 I-treatment
agent 76 81 2082 2087 I-treatment
within 82 88 2088 2094 O
4 89 90 2095 2096 B-upper_bound
weeks 91 96 2097 2102 I-upper_bound
prior 97 102 2103 2108 I-upper_bound
to 103 105 2109 2111 O
first 106 111 2112 2117 O
dosing 112 118 2118 2124 O
of 119 121 2125 2127 O
study 122 127 2128 2133 O
drug 128 132 2134 2138 O

Patients 0 8 2139 2147 O
may 9 12 2148 2151 O
have 13 17 2152 2156 O
received 18 26 2157 2165 O
previous 27 35 2166 2174 B-treatment
NY 36 38 2175 2177 I-treatment
- 38 39 2177 2178 I-treatment
ESO-1 39 44 2178 2183 I-treatment
vaccine 45 52 2184 2191 I-treatment
therapy 53 60 2192 2199 I-treatment
; 60 61 2199 2200 O
patients 62 70 2201 2209 O
who 71 74 2210 2213 O
received 75 83 2214 2222 O
maintenance 84 95 2223 2234 O
paclitaxel 96 106 2235 2245 B-treatment
or 107 109 2246 2248 O
bevacizumab 110 121 2249 2260 B-treatment
are 122 125 2261 2264 O
eligible 126 134 2265 2273 O
for 135 138 2274 2277 O
enrollment 139 149 2278 2288 O
provided 150 158 2289 2297 O
they 159 163 2298 2302 O
have 164 168 2303 2307 O
discontinued 169 181 2308 2320 O
therapy 182 189 2321 2328 O
( 190 191 2329 2330 O
at 191 193 2330 2332 O
least 194 199 2333 2338 O
4 200 201 2339 2340 B-lower_bound
weeks 202 207 2341 2346 I-lower_bound
for 208 211 2347 2350 I-lower_bound
prior 212 217 2351 2356 I-lower_bound
taxane 218 224 2357 2363 B-treatment
or 225 227 2364 2366 O
prior 228 233 2367 2372 O
bevacizumab 234 245 2373 2384 O
) 245 246 2384 2385 O
prior 247 252 2386 2391 O
to 253 255 2392 2394 O
randomization 256 269 2395 2408 O
and 270 273 2409 2412 O
recovered 274 283 2413 2422 O
from 284 288 2423 2427 O
toxicities 289 299 2428 2438 O
to 300 302 2439 2441 O
less 303 307 2442 2446 O
than 308 312 2447 2451 O
grade 313 318 2452 2457 B-upper_bound
2 319 320 2458 2459 I-upper_bound

Patients 0 8 2460 2468 O
of 9 11 2469 2471 O
child 12 17 2472 2477 O
- 17 18 2477 2478 O
bearing 18 25 2478 2485 O
potential 26 35 2486 2495 O
must 36 40 2496 2500 O
agree 41 46 2501 2506 B-contraception_consent
to 47 49 2507 2509 I-contraception_consent
use 50 53 2510 2513 I-contraception_consent
acceptable 54 64 2514 2524 I-contraception_consent
contraceptive 65 78 2525 2538 I-contraception_consent
methods 79 86 2539 2546 I-contraception_consent
( 87 88 2547 2548 O
e.g. 88 92 2548 2552 O
, 92 93 2552 2553 O
double 94 100 2554 2560 B-contraception_consent
barrier 101 108 2561 2568 I-contraception_consent
) 108 109 2568 2569 O
during 110 116 2570 2576 O
treatment 117 126 2577 2586 B-treatment

Platelets 0 9 2587 2596 B-clinical_variable
( 10 11 2597 2598 I-clinical_variable
PLT 11 14 2598 2601 I-clinical_variable
) 14 15 2601 2602 I-clinical_variable
> 16 17 2603 2604 O
= 17 18 2604 2605 O
100,000 19 26 2606 2613 B-lower_bound
/ 26 27 2613 2614 I-lower_bound
uL 27 29 2614 2616 I-lower_bound

Pregnant 0 8 2617 2625 B-pregnancy

Serum 0 5 2626 2631 B-clinical_variable
aspartate 6 15 2632 2641 I-clinical_variable
aminotransferase 16 32 2642 2658 I-clinical_variable
( 33 34 2659 2660 I-clinical_variable
serum 34 39 2660 2665 I-clinical_variable
glutamic 40 48 2666 2674 I-clinical_variable
oxaloacetic 49 60 2675 2686 I-clinical_variable
transaminase 61 73 2687 2699 I-clinical_variable
[ 74 75 2700 2701 I-clinical_variable
SGOT]/AST 75 84 2701 2710 I-clinical_variable
) 84 85 2710 2711 I-clinical_variable
or 86 88 2712 2714 O
serum 89 94 2715 2720 B-clinical_variable
alanine 95 102 2721 2728 I-clinical_variable
aminotransferase 103 119 2729 2745 I-clinical_variable
( 120 121 2746 2747 I-clinical_variable
serum 121 126 2747 2752 I-clinical_variable
glutamate 127 136 2753 2762 I-clinical_variable
pyruvate 137 145 2763 2771 I-clinical_variable
transaminase 146 158 2772 2784 I-clinical_variable
[ 159 160 2785 2786 I-clinical_variable
SGPT]/ALT 160 169 2786 2795 I-clinical_variable
) 169 170 2795 2796 I-clinical_variable
= 171 172 2797 2798 O
< 172 173 2798 2799 O
3 174 175 2800 2801 B-upper_bound
x 176 177 2802 2803 I-upper_bound
ULN 178 181 2804 2807 I-upper_bound

Serum 0 5 2808 2813 B-clinical_variable
creatinine 6 16 2814 2824 I-clinical_variable
= 17 18 2825 2826 O
< 18 19 2826 2827 O
2 20 21 2828 2829 B-upper_bound
x 22 23 2830 2831 I-upper_bound
ULN 24 27 2832 2835 I-upper_bound

Subjects 0 8 2836 2844 O
being 9 14 2845 2850 O
treated 15 22 2851 2858 O
with 23 27 2859 2863 O
a 28 29 2864 2865 O
monoamine 30 39 2866 2875 B-treatment
oxidase 40 47 2876 2883 I-treatment
inhibitor 48 57 2884 2893 I-treatment
( 58 59 2894 2895 I-treatment
MAOI 59 63 2895 2899 I-treatment
) 63 64 2899 2900 I-treatment
, 64 65 2900 2901 O
or 66 68 2902 2904 O
drug 69 73 2905 2909 O
which 74 79 2910 2915 O
has 80 83 2916 2919 O
significant 84 95 2920 2931 O
MAOI 96 100 2932 2936 O
activity 101 109 2937 2945 O
( 110 111 2946 2947 O
e.g. 111 115 2947 2951 O
, 115 116 2951 2952 O
Meperidine 117 127 2953 2963 B-treatment
, 127 128 2963 2964 O
linezolid 129 138 2965 2974 B-treatment
, 138 139 2974 2975 O
methylene 140 149 2976 2985 B-treatment
blue 150 154 2986 2990 I-treatment
) 154 155 2990 2991 O
within 156 162 2992 2998 O
3 163 164 2999 3000 B-upper_bound
weeks 165 170 3001 3006 I-upper_bound
prior 171 176 3007 3012 I-upper_bound
to 177 179 3013 3015 O
screening 180 189 3016 3025 O

Subjects 0 8 3026 3034 O
who 9 12 3035 3038 O
are 13 16 3039 3042 O
currently 17 26 3043 3052 O
receiving 27 36 3053 3062 O
therapy 37 44 3063 3070 B-treatment
with 45 49 3071 3075 I-treatment
a 50 51 3076 3077 I-treatment
potent 52 58 3078 3084 I-treatment
cytochrome 59 69 3085 3095 I-treatment
P450 70 74 3096 3100 I-treatment
, 74 75 3100 3101 O
family 76 82 3102 3108 B-treatment
3 83 84 3109 3110 I-treatment
, 84 85 3110 3111 O
subfamily 86 95 3112 3121 B-treatment
A 96 97 3122 3123 I-treatment
, 97 98 3123 3124 O
polypeptide 99 110 3125 3136 B-treatment
4 111 112 3137 3138 I-treatment
( 113 114 3139 3140 I-treatment
CYP3A4 114 120 3140 3146 I-treatment
) 120 121 3146 3147 I-treatment
inducer 122 129 3148 3155 I-treatment
or 130 132 3156 3158 O
inhibitor 133 142 3159 3168 O
( 143 144 3169 3170 O
e.g. 144 148 3170 3174 O
clarithromycin 149 163 3175 3189 B-treatment
, 163 164 3189 3190 O
telithromycin 165 178 3191 3204 B-treatment
, 178 179 3204 3205 O
nefazodone 180 190 3206 3216 B-treatment
, 190 191 3216 3217 O
itraconazole 192 204 3218 3230 B-treatment
, 204 205 3230 3231 O
ketoconazole 206 218 3232 3244 B-treatment
, 218 219 3244 3245 O
atazanavir 220 230 3246 3256 B-treatment
) 230 231 3256 3257 O

The 0 3 3258 3261 O
ability 4 11 3262 3269 O
to 12 14 3270 3272 O
swallow 15 22 3273 3280 O
and 23 26 3281 3284 O
retain 27 33 3285 3291 O
oral 34 38 3292 3296 O
medication 39 49 3297 3307 B-treatment

Total 0 5 3308 3313 B-clinical_variable
bilirubin 6 15 3314 3323 I-clinical_variable
= 16 17 3324 3325 O
< 17 18 3325 3326 O
1.5 19 22 3327 3330 B-upper_bound
x 23 24 3331 3332 I-upper_bound
upper 25 30 3333 3338 I-upper_bound
limit 31 36 3339 3344 I-upper_bound
of 37 39 3345 3347 I-upper_bound
normal 40 46 3348 3354 I-upper_bound
( 47 48 3355 3356 I-upper_bound
ULN 48 51 3356 3359 I-upper_bound
) 51 52 3359 3360 I-upper_bound

Tumor 0 5 3361 3366 B-cancer
expression 6 16 3367 3377 O
of 17 19 3378 3380 O
NY 20 22 3381 3383 O
- 22 23 3383 3384 O
ESO-1 23 28 3384 3389 O
or 29 31 3390 3392 O
LAGE-1 32 38 3393 3399 O
by 39 41 3400 3402 O
immunohistochemistry 42 62 3403 3423 B-treatment
( 63 64 3424 3425 I-treatment
IHC 64 67 3425 3428 I-treatment
) 67 68 3428 3429 I-treatment
and/or 69 75 3430 3436 O
reverse 76 83 3437 3444 O
transcriptase 84 97 3445 3458 O
polymerase 98 108 3459 3469 O
chain 109 114 3470 3475 O
reaction 115 123 3476 3484 O
( 124 125 3485 3486 O
RTPCR 125 130 3486 3491 O
) 130 131 3491 3492 O

Use 0 3 3493 3496 O
of 4 6 3497 3499 O
UDP 7 10 3500 3503 B-treatment
glucuronosyltransferase 11 34 3504 3527 I-treatment
1 35 36 3528 3529 O
family 37 43 3530 3536 O
, 43 44 3536 3537 O
polypeptide 45 56 3538 3549 B-treatment
A9 57 59 3550 3552 I-treatment
( 60 61 3553 3554 I-treatment
UGT1A9 61 67 3554 3560 I-treatment
) 67 68 3560 3561 I-treatment
inhibitor 69 78 3562 3571 I-treatment
including 79 88 3572 3581 O
: 88 89 3581 3582 O
diclofenac 90 100 3583 3593 B-treatment
, 100 101 3593 3594 O
imipramine 102 112 3595 3605 B-treatment
, 112 113 3605 3606 O
and 114 117 3607 3610 O
ketoconazole 118 130 3611 3623 B-treatment

nursing 0 7 3624 3631 O
female 8 14 3632 3638 B-gender
patients 15 23 3639 3647 I-gender

Appendix 0 8 0 8 O
removed 9 16 9 16 O
at 17 19 17 19 O
time 20 24 20 24 O
of 25 27 25 27 O
laparoscopy 28 39 28 39 B-treatment
for 40 43 40 43 O
treatment 44 53 44 53 O
of 54 56 54 56 O
endometriosis 57 70 57 70 B-chronic_disease
and/or 71 77 71 77 O
pelvic 78 84 78 84 O
pain 85 89 85 89 O

Chronic 0 7 90 97 B-chronic_disease
pelvic 8 14 98 104 I-chronic_disease
pain 15 19 105 109 I-chronic_disease
and/or 20 26 110 116 O
diagnosis 27 36 117 126 O
of 37 39 127 129 O
endometriosis 40 53 130 143 B-chronic_disease

English 0 7 144 151 B-language_fluency
Speaking 8 16 152 160 I-language_fluency

Non 0 3 161 164 B-language_fluency
- 3 4 164 165 I-language_fluency
English 4 11 165 172 I-language_fluency
speaking 12 20 173 181 I-language_fluency

Previous 0 8 182 190 B-treatment
appendectomy 9 21 191 203 I-treatment

Women 0 5 204 209 B-gender

age 0 3 210 213 B-age
18 4 6 214 216 B-lower_bound
- 6 7 216 217 O
51 7 9 217 219 B-upper_bound
years 10 15 220 225 I-upper_bound
of 16 18 226 228 O
age 19 22 229 232 O

Active 0 6 0 6 O
or 7 9 7 9 O
suspected 10 19 10 19 O
neoplasia 20 29 20 29 B-chronic_disease

Cardiomegaly 0 12 30 42 B-chronic_disease
/ 12 13 42 43 O
valvulopathy 13 25 43 55 B-chronic_disease

Hepatic 0 7 56 63 B-chronic_disease
insufficiency 8 21 64 77 I-chronic_disease

History 0 7 78 85 O
of 8 10 86 88 O
allergy 11 18 89 96 O
to 19 21 97 99 O
IGF-1 22 27 100 105 B-allergy_name

Intracranial 0 12 106 118 B-chronic_disease
hypertension 13 25 119 131 I-chronic_disease

Language 0 8 132 140 B-language_fluency
delay 9 14 141 146 I-language_fluency
( 15 16 147 148 I-language_fluency
lack 16 20 148 152 I-language_fluency
of 21 23 153 155 I-language_fluency
fluent 24 30 156 162 I-language_fluency
phrase 31 37 163 169 I-language_fluency
speech 38 44 170 176 I-language_fluency
) 44 45 176 177 I-language_fluency
reflected 46 55 178 187 O
by 56 58 188 190 O
use 59 62 191 194 O
of 63 65 195 197 O
ADOS 66 70 198 202 O
Module 71 77 203 209 O
1 78 79 210 211 O
or 80 82 212 214 O
2 83 84 215 216 O

Meet 0 4 217 221 O
DSM-5 5 10 222 227 O
criteria 11 19 228 236 O
for 20 23 237 240 O
Autism 24 30 241 247 B-chronic_disease
Spectrum 31 39 248 256 I-chronic_disease
Disorder 40 48 257 265 I-chronic_disease
confirmed 49 58 266 275 O
by 59 61 276 278 O
the 62 65 279 282 O
Autism 66 72 283 289 O
Diagnostic 73 83 290 300 O
Interview 84 93 301 310 O
- 93 94 310 311 O
Revised 94 101 311 318 O
( 102 103 319 320 O
ADI 103 106 320 323 O
- 106 107 323 324 O
R 107 108 324 325 O
) 108 109 325 326 O

Must 0 4 327 331 O
be 5 7 332 334 O
on 8 10 335 337 O
stable 11 17 338 344 O
medication 18 28 345 355 B-treatment
regimens 29 37 356 364 I-treatment
for 38 41 365 368 O
at 42 44 369 371 O
least 45 50 372 377 O
three 51 56 378 383 B-lower_bound
months 57 63 384 390 I-lower_bound
prior 64 69 391 396 I-lower_bound
to 70 72 397 399 O
enrollment 73 83 400 410 O
, 83 84 410 411 O
assuming 85 93 412 420 O
the 94 97 421 424 O
concomitant 98 109 425 436 O
medication 110 120 437 447 O
is 121 123 448 450 O
safe 124 128 451 455 O
for 129 132 456 459 O
use 133 136 460 463 O
with 137 141 464 468 O
IGF-1 142 147 469 474 B-treatment

Patients 0 8 475 483 O
with 9 13 484 488 O
comorbid 14 22 489 497 O
conditions 23 33 498 508 O
deemed 34 40 509 515 O
too 41 44 516 519 O
medically 45 54 520 529 O
compromised 55 66 530 541 O
to 67 69 542 544 O
tolerate 70 78 545 553 O
the 79 82 554 557 O
risk 83 87 558 562 O
of 88 90 563 565 O
experimental 91 103 566 578 O
treatment 104 113 579 588 B-treatment
with 114 118 589 593 I-treatment
IGF-1 119 124 594 599 I-treatment

Renal 0 5 600 605 B-chronic_disease
insufficiency 6 19 606 619 I-chronic_disease

between 0 7 620 627 O
the 8 11 628 631 O
ages 12 16 632 636 B-age
of 17 19 637 639 O
5 20 21 640 641 B-lower_bound
- 21 22 641 642 O
12 22 24 642 644 B-upper_bound
years 25 30 645 650 I-upper_bound
of 31 33 651 653 O
age 34 37 654 657 O

Active 0 6 0 6 O
central 7 14 7 14 O
nervous 15 22 15 22 O
system 23 29 23 29 O
( 30 31 30 31 O
CNS 31 34 31 34 O
) 34 35 34 35 O
or 36 38 36 38 O
extramedullary 39 53 39 53 B-cancer
disease 54 61 54 61 I-cancer

Bilirubin 0 9 62 71 B-clinical_variable
less 10 14 72 76 O
than 15 19 77 81 O
or 20 22 82 84 O
equal 23 28 85 90 O
to 29 31 91 93 O
3.0 32 35 94 97 B-upper_bound
mg 36 38 98 100 I-upper_bound
/ 38 39 100 101 I-upper_bound
dL 39 41 101 103 I-upper_bound

Creatinine 0 10 104 114 B-clinical_variable
clearance 11 20 115 124 I-clinical_variable
> 21 22 125 126 O
= 22 23 126 127 O
30 24 26 128 130 B-lower_bound
ml 27 29 131 133 I-lower_bound
/ 29 30 133 134 I-lower_bound
minute 30 36 134 140 I-lower_bound

Known 0 5 141 146 O
to 6 8 147 149 O
be 9 11 150 152 O
human 12 17 153 158 B-chronic_disease
immunodeficiency 18 34 159 175 I-chronic_disease
virus 35 40 176 181 I-chronic_disease
positive 41 49 182 190 I-chronic_disease
( 50 51 191 192 I-chronic_disease
HIV+ 51 55 192 196 I-chronic_disease
) 55 56 196 197 I-chronic_disease

Monoclonal 0 10 198 208 B-treatment
antibodies 11 21 209 219 I-treatment
therapy 22 29 220 227 I-treatment
within 30 36 228 234 O
2 37 38 235 236 B-upper_bound
weeks 39 44 237 242 I-upper_bound
before 45 51 243 249 I-upper_bound
study 52 57 250 255 O
entry 58 63 256 261 O

No 0 2 262 264 O
active 3 9 265 271 O
or 10 12 272 274 O
co 13 15 275 277 O
- 15 16 277 278 O
existing 16 24 278 286 O
malignancy 25 35 287 297 B-cancer

Patients 0 8 298 306 O
with 9 13 307 311 O
B 14 15 312 313 B-cancer
- 15 16 313 314 I-cancer
lineage 16 23 314 321 I-cancer
ALL 24 27 322 325 I-cancer
in 28 30 326 328 O
hematologic 31 42 329 340 O
complete 43 51 341 349 O
remission 52 61 350 359 O
( 62 63 360 361 O
CR 63 65 361 363 O
) 65 66 363 364 O
with 67 71 365 369 O
molecular 72 81 370 379 O
failure 82 89 380 387 O
( 90 91 388 389 O
i.e. 91 95 389 393 O
, 95 96 393 394 O
had 97 100 395 398 O
never 101 106 399 404 O
achieved 107 115 405 413 O
an 116 118 414 416 O
MRD 119 122 417 420 B-cancer
- 122 123 420 421 O
negativity 123 133 421 431 O
status 134 140 432 438 O
before 141 147 439 445 O
blinatumomab 148 160 446 458 B-treatment
) 160 161 458 459 O
or 162 164 460 462 O
had 165 168 463 466 O
a 169 170 467 468 O
molecular 171 180 469 478 O
relapse 181 188 479 486 O
( 189 190 487 488 O
i.e. 190 194 488 492 O
, 194 195 492 493 O
became 196 202 494 500 O
MRD 203 206 501 504 O
positive 207 215 505 513 O
after 216 221 514 519 O
having 222 228 520 526 O
been 229 233 527 531 O
MRD 234 237 532 535 O
negative 238 246 536 544 O
) 246 247 544 545 O
starting 248 256 546 554 O
at 257 259 555 557 O
any 260 263 558 561 O
time 264 268 562 566 O
point 269 274 567 572 O
after 275 280 573 578 O
3 281 282 579 580 B-upper_bound
months 283 289 581 587 I-upper_bound
of 290 292 588 590 O
frontline 293 302 591 600 B-treatment
therapy 303 310 601 608 I-treatment
; 310 311 608 609 O
molecular 312 321 610 619 B-chronic_disease
disease 322 329 620 627 I-chronic_disease
or 330 332 628 630 I-chronic_disease
minimal 333 340 631 638 I-chronic_disease
residual 341 349 639 647 I-chronic_disease
disease 350 357 648 655 I-chronic_disease
is 358 360 656 658 O
defined 361 368 659 666 O
by 369 371 667 669 O
a 372 373 670 671 O
value 374 379 672 677 O
of 380 382 678 680 O
at 383 385 681 683 O
least 386 391 684 689 O
of 392 394 690 692 O
1 395 396 693 694 B-lower_bound
x 397 398 695 696 I-lower_bound
10 399 401 697 699 I-lower_bound
- 401 402 699 700 I-lower_bound
4 402 403 700 701 I-lower_bound
( 404 405 702 703 I-lower_bound
0.01 405 409 703 707 I-lower_bound
% 409 410 707 708 I-lower_bound
) 410 411 708 709 I-lower_bound
by 412 414 710 712 O
multicolor 415 425 713 723 O
flow 426 430 724 728 O
cytometry 431 440 729 738 O
and/or 441 447 739 745 O
by 448 450 746 748 O
next 451 455 749 753 O
generation 456 466 754 764 O
sequencing 467 477 765 775 O
( 478 479 776 777 O
NGS 479 482 777 780 O
) 482 483 780 781 O

Patients 0 8 782 790 O
with 9 13 791 795 O
B 14 15 796 797 B-cancer
- 15 16 797 798 I-cancer
lineage 16 23 798 805 I-cancer
acute 24 29 806 811 I-cancer
lymphocytic 30 41 812 823 I-cancer
leukemia 42 50 824 832 I-cancer
( 51 52 833 834 I-cancer
ALL 52 55 834 837 I-cancer
) 55 56 837 838 I-cancer
in 57 59 839 841 O
hematologic 60 71 842 853 B-treatment
complete 72 80 854 862 I-treatment
remission 81 90 863 872 I-treatment
( 91 92 873 874 I-treatment
CR 92 94 874 876 I-treatment
) 94 95 876 877 I-treatment
with 96 100 878 882 O
molecular 101 110 883 892 B-chronic_disease
failure 111 118 893 900 I-chronic_disease
( 119 120 901 902 O
i.e. 120 124 902 906 O
, 124 125 906 907 O
had 126 129 908 911 O
never 130 135 912 917 O
achieved 136 144 918 926 O
an 145 147 927 929 O
MRD 148 151 930 933 O
- 151 152 933 934 O
negativity 152 162 934 944 O
status 163 169 945 951 O
before 170 176 952 958 O
blinatumomab 177 189 959 971 B-treatment
) 189 190 971 972 O
or 191 193 973 975 O
had 194 197 976 979 O
a 198 199 980 981 O
molecular 200 209 982 991 O
relapse 210 217 992 999 O
( 218 219 1000 1001 O
i.e. 219 223 1001 1005 O
, 223 224 1005 1006 O
became 225 231 1007 1013 O
MRD 232 235 1014 1017 O
positive 236 244 1018 1026 O
after 245 250 1027 1032 O
having 251 257 1033 1039 O
been 258 262 1040 1044 O
MRD 263 266 1045 1048 O
negative 267 275 1049 1057 O
) 275 276 1057 1058 O
starting 277 285 1059 1067 O
at 286 288 1068 1070 O
any 289 292 1071 1074 O
time 293 297 1075 1079 O
point 298 303 1080 1085 O
after 304 309 1086 1091 B-upper_bound
3 310 311 1092 1093 I-upper_bound
months 312 318 1094 1100 I-upper_bound
of 319 321 1101 1103 O
frontline 322 331 1104 1113 B-treatment
therapy 332 339 1114 1121 I-treatment
; 339 340 1121 1122 O
molecular 341 350 1123 1132 B-chronic_disease
disease 351 358 1133 1140 I-chronic_disease
or 359 361 1141 1143 O
minimal 362 369 1144 1151 B-cancer
residual 370 378 1152 1160 I-cancer
disease 379 386 1161 1168 I-cancer
is 387 389 1169 1171 O
defined 390 397 1172 1179 O
by 398 400 1180 1182 O
a 401 402 1183 1184 O
value 403 408 1185 1190 O
of 409 411 1191 1193 O
at 412 414 1194 1196 O
least 415 420 1197 1202 O
of 421 423 1203 1205 O
1 424 425 1206 1207 B-lower_bound
x 426 427 1208 1209 I-lower_bound
10 428 430 1210 1212 I-lower_bound
^ 430 431 1212 1213 I-lower_bound
-4 431 433 1213 1215 I-lower_bound
( 434 435 1216 1217 O
0.01 435 439 1217 1221 O
% 439 440 1221 1222 O
) 440 441 1222 1223 O
by 442 444 1224 1226 O
multicolor 445 455 1227 1237 O
flow 456 460 1238 1242 O
cytometry 461 470 1243 1252 O
and/or 471 477 1253 1259 O
by 478 480 1260 1262 O
next 481 485 1263 1267 O
generation 486 496 1268 1278 O
sequencing 497 507 1279 1289 O
( 508 509 1290 1291 O
NGS 509 512 1291 1294 O
) 512 513 1294 1295 O

Patients 0 8 1296 1304 O
with 9 13 1305 1309 O
Philadelphia 14 26 1310 1322 B-cancer
chromosome 27 37 1323 1333 I-cancer
positive 38 46 1334 1342 I-cancer
( 47 48 1343 1344 I-cancer
Ph+ 48 51 1344 1347 I-cancer
) 51 52 1347 1348 I-cancer
ALL 53 56 1349 1352 I-cancer
can 57 60 1353 1356 O
be 61 63 1357 1359 O
enrolled 64 72 1360 1368 O
in 73 75 1369 1371 O
CR1 76 79 1372 1375 O
or 80 82 1376 1378 O
CR2 83 86 1379 1382 O
and 87 90 1383 1386 O
beyond 91 97 1387 1393 O
; 97 98 1393 1394 O
a 99 100 1395 1396 O
tyrosine 101 109 1397 1405 B-treatment
kinase 110 116 1406 1412 I-treatment
inhibitor 117 126 1413 1422 I-treatment
( 127 128 1423 1424 I-treatment
TKI 128 131 1424 1427 I-treatment
) 131 132 1427 1428 I-treatment
will 133 137 1429 1433 O
be 138 140 1434 1436 O
added 141 146 1437 1442 O
at 147 149 1443 1445 O
the 150 153 1446 1449 O
discretion 154 164 1450 1460 O
of 165 167 1461 1463 O
the 168 171 1464 1467 O
treating 172 180 1468 1476 O
physician 181 190 1477 1486 O
; 190 191 1486 1487 O
MRD 192 195 1488 1491 B-clinical_variable
for 196 199 1492 1495 O
these 200 205 1496 1501 O
patients 206 214 1502 1510 O
will 215 219 1511 1515 O
be 220 222 1516 1518 O
defined 223 230 1519 1526 O
by 231 233 1527 1529 O
PCR 234 237 1530 1533 O
of 238 240 1534 1536 O
0.1 241 244 1537 1540 B-lower_bound
% 244 245 1540 1541 I-lower_bound
and 246 249 1542 1545 O
above 250 255 1546 1551 O
( 256 257 1552 1553 O
International 257 270 1553 1566 O
Scale 271 276 1567 1572 O
) 276 277 1572 1573 O

Performance 0 11 1574 1585 B-clinical_variable
status 12 18 1586 1592 I-clinical_variable
of 19 21 1593 1595 O
0 22 23 1596 1597 B-lower_bound
, 23 24 1597 1598 O
1 25 26 1599 1600 O
, 26 27 1600 1601 O
or 28 30 1602 1604 O
2 31 32 1605 1606 B-upper_bound

Pregnant 0 8 1607 1615 B-pregnancy

Radiotherapy 0 12 1616 1628 B-treatment
and 13 16 1629 1632 I-treatment
cancer 17 23 1633 1639 I-treatment
chemotherapy 24 36 1640 1652 I-treatment
( 37 38 1653 1654 O
except 38 44 1654 1660 O
for 45 48 1661 1664 O
intrathecal 49 60 1665 1676 O
prophylaxis 61 72 1677 1688 O
and/or 73 79 1689 1695 O
low 80 83 1696 1699 O
- 83 84 1699 1700 O
dose 84 88 1700 1704 O
maintenance 89 100 1705 1716 B-treatment
therapy 101 108 1717 1724 I-treatment
such 109 113 1725 1729 I-treatment
as 114 116 1730 1732 I-treatment
vinca 117 122 1733 1738 I-treatment
alkaloids 123 132 1739 1748 I-treatment
, 132 133 1748 1749 O
mercaptopurine 134 148 1750 1764 B-treatment
, 148 149 1764 1765 O
methotrexate 150 162 1766 1778 B-treatment
, 162 163 1778 1779 O
steroids 164 172 1780 1788 B-treatment
) 172 173 1788 1789 O
or 174 176 1790 1792 O
any 177 180 1793 1796 O
investigational 181 196 1797 1812 B-treatment
drug 197 201 1813 1817 I-treatment
within 202 208 1818 1824 O
2 209 210 1825 1826 B-upper_bound
weeks 211 216 1827 1832 I-upper_bound
before 217 223 1833 1839 O
study 224 229 1840 1845 O
entry 230 235 1846 1851 O

life 0 4 1852 1856 B-clinical_variable
expectancy 5 15 1857 1867 I-clinical_variable
less 16 20 1868 1872 O
than 21 25 1873 1877 O
12 26 28 1878 1880 B-upper_bound
months 29 35 1881 1887 I-upper_bound

nursing 0 7 1888 1895 O
women 8 13 1896 1901 B-gender

AST 0 3 0 3 B-clinical_variable
and 4 7 4 7 I-clinical_variable
ALT 8 11 8 11 I-clinical_variable
are 12 15 12 15 O
each 16 20 16 20 O
≤5 21 23 21 23 O
× 24 25 24 25 I-upper_bound
the 26 29 26 29 I-upper_bound
ULN 30 33 30 33 I-upper_bound

Absolute 0 8 34 42 B-clinical_variable
neutrophil 9 19 43 53 I-clinical_variable
count 20 25 54 59 I-clinical_variable
( 26 27 60 61 I-clinical_variable
ANC 27 30 61 64 I-clinical_variable
) 30 31 64 65 I-clinical_variable
≥1,500 32 38 66 72 O
/ 38 39 72 73 I-lower_bound
mm3 39 42 73 76 I-lower_bound

Active 0 6 77 83 B-chronic_disease
bacterial 7 16 84 93 I-chronic_disease
, 16 17 93 94 O
viral 18 23 95 100 B-chronic_disease
, 23 24 100 101 O
or 25 27 102 104 O
fungal 28 34 105 111 B-chronic_disease
infection 35 44 112 121 I-chronic_disease
requiring 45 54 122 131 O
systemic 55 63 132 140 B-treatment
therapy 64 71 141 148 I-treatment

Alanine 0 7 149 156 B-clinical_variable
aminotransferase 8 24 157 173 I-clinical_variable
( 25 26 174 175 I-clinical_variable
ALT 26 29 175 178 I-clinical_variable
[ 30 31 179 180 I-clinical_variable
SGPT 31 35 180 184 I-clinical_variable
] 35 36 184 185 I-clinical_variable
) 36 37 185 186 I-clinical_variable
≤2.5 38 42 187 191 O
× 43 44 192 193 I-upper_bound
the 45 48 194 197 I-upper_bound
ULN 49 52 198 201 I-upper_bound

Any 0 3 202 205 O
cytotoxic 4 13 206 215 B-treatment
chemotherapy 14 26 216 228 I-treatment
within 27 33 229 235 O
21 34 36 236 238 B-upper_bound
days 37 41 239 243 I-upper_bound
prior 42 47 244 249 I-upper_bound
to 48 50 250 252 O
initiation 51 61 253 263 O
of 62 64 264 266 O
study 65 70 267 272 B-treatment
drug 71 75 273 277 I-treatment

Any 0 3 278 281 O
immunomodulatory 4 20 282 298 B-treatment
drug 21 25 299 303 I-treatment
therapy 26 33 304 311 I-treatment
, 33 34 311 312 O
anti 35 39 313 317 B-treatment
- 39 40 317 318 I-treatment
neoplastic 40 50 318 328 I-treatment
hormonal 51 59 329 337 I-treatment
therapy 60 67 338 345 I-treatment
( 68 69 346 347 O
unless 69 75 347 353 O
dose 76 80 354 358 O
has 81 84 359 362 O
been 85 89 363 367 O
stable 90 96 368 374 O
for 97 100 375 378 O
3 101 102 379 380 B-upper_bound
months 103 109 381 387 I-upper_bound
prior 110 115 388 393 I-upper_bound
to 116 118 394 396 O
Baseline 119 127 397 405 O
and 128 131 406 409 O
will 132 136 410 414 O
remain 137 143 415 421 O
stable 144 150 422 428 O
during 151 157 429 435 O
the 158 161 436 439 O
trial 162 167 440 445 O
) 167 168 445 446 O

Aspartate 0 9 447 456 B-clinical_variable
aminotransferase 10 26 457 473 I-clinical_variable
( 27 28 474 475 I-clinical_variable
AST 28 31 475 478 I-clinical_variable
[ 32 33 479 480 I-clinical_variable
SGOT 33 37 480 484 I-clinical_variable
] 37 38 484 485 I-clinical_variable
) 38 39 485 486 I-clinical_variable
≤2.5 40 44 487 491 O
× 45 46 492 493 I-upper_bound
the 47 50 494 497 I-upper_bound
ULN 51 54 498 501 I-upper_bound

Clinically 0 10 502 512 O
significant 11 22 513 524 O
hearing 23 30 525 532 B-chronic_disease
impairment 31 41 533 543 I-chronic_disease
, 41 42 543 544 O
as 43 45 545 547 O
judged 46 52 548 554 O
by 53 55 555 557 O
the 56 59 558 561 O
Principal 60 69 562 571 O
Investigator 70 82 572 584 O

Eastern 0 7 585 592 B-clinical_variable
Collaborative 8 21 593 606 I-clinical_variable
Oncology 22 30 607 615 I-clinical_variable
Group 31 36 616 621 I-clinical_variable
( 37 38 622 623 I-clinical_variable
ECOG 38 42 623 627 I-clinical_variable
) 42 43 627 628 I-clinical_variable
Performance 44 55 629 640 I-clinical_variable
Status 56 62 641 647 I-clinical_variable
of 63 65 648 650 O
0 66 67 651 652 B-lower_bound
- 67 68 652 653 O
1 68 69 653 654 B-upper_bound
( 70 71 655 656 O
Appendix 71 79 656 664 O
1 80 81 665 666 O
) 81 82 666 667 O

Evaluable 0 9 668 677 O
disease 10 17 678 685 O
, 17 18 685 686 O
either 19 25 687 693 O
measurable 26 36 694 704 O
on 37 39 705 707 O
physical 40 48 708 716 B-treatment
examination 49 60 717 728 I-treatment

Known 0 5 729 734 O
human 6 11 735 740 B-chronic_disease
immunodeficiency 12 28 741 757 I-chronic_disease
virus 29 34 758 763 I-chronic_disease
or 35 37 764 766 O
acquired 38 46 767 775 B-chronic_disease
immunodeficiency 47 63 776 792 I-chronic_disease
syndrome 64 72 793 801 I-chronic_disease
related 73 80 802 809 O
illness 81 88 810 817 O

Life 0 4 818 822 B-clinical_variable
expectancy 5 15 823 833 I-clinical_variable
< 16 17 834 835 O
12 17 19 835 837 B-upper_bound
weeks 20 25 838 843 I-upper_bound

Major 0 5 844 849 B-treatment
surgery 6 13 850 857 I-treatment
within 14 20 858 864 O
28 21 23 865 867 B-upper_bound
days 24 28 868 872 I-upper_bound
prior 29 34 873 878 I-upper_bound
to 35 37 879 881 O
initiation 38 48 882 892 O
of 49 51 893 895 O
study 52 57 896 901 B-treatment
drug 58 62 902 906 I-treatment

Negative 0 8 907 915 O
serum 9 14 916 921 O
β 15 16 922 923 O
hCG 17 20 924 927 O
( 21 22 928 929 O
human 22 27 929 934 O
chorionic 28 37 935 944 O
gonadotropin 38 50 945 957 O
) 50 51 957 958 O
test 52 56 959 963 O
in 57 59 964 966 O
women 60 65 967 972 B-gender
of 66 68 973 975 O
childbearing 69 81 976 988 O
potential 82 91 989 998 O
( 92 93 999 1000 O
defined 93 100 1000 1007 O
as 101 103 1008 1010 O
women 104 109 1011 1016 O
≤50 110 113 1017 1020 O
years 114 119 1021 1026 O
of 120 122 1027 1029 O
age 123 126 1030 1033 B-age
, 126 127 1033 1034 O
or 128 130 1035 1037 O
> 131 132 1038 1039 O
50 132 134 1039 1041 O
years 135 140 1042 1047 O
of 141 143 1048 1050 O
age 144 147 1051 1054 O
with 148 152 1055 1059 O
a 153 154 1060 1061 O
history 155 162 1062 1069 O
of 163 165 1070 1072 O
amenorrhea 166 176 1073 1083 B-chronic_disease
for 177 180 1084 1087 O
≤12 181 184 1088 1091 O
months 185 191 1092 1098 I-upper_bound
prior 192 197 1099 1104 I-upper_bound
to 198 200 1105 1107 O
study 201 206 1108 1113 O
entry 207 212 1114 1119 O
) 212 213 1119 1120 O

Pathologically 0 14 1121 1135 O
confirmed 15 24 1136 1145 O
advanced 25 33 1146 1154 O
solid 34 39 1155 1160 B-cancer
tumor 40 45 1161 1166 I-cancer
for 46 49 1167 1170 O
which 50 55 1171 1176 O
standard 56 64 1177 1185 B-treatment
therapy 65 72 1186 1193 I-treatment
proven 73 79 1194 1200 O
to 80 82 1201 1203 O
provide 83 90 1204 1211 O
clinical 91 99 1212 1220 O
benefit 100 107 1221 1228 O
does 108 112 1229 1233 O
not 113 116 1234 1237 O
exist 117 122 1238 1243 O
or 123 125 1244 1246 O
is 126 128 1247 1249 O
no 129 131 1250 1252 O
longer 132 138 1253 1259 O
effective 139 148 1260 1269 O

Platelets 0 9 1270 1279 B-clinical_variable
≥100,000 10 18 1280 1288 O
/ 18 19 1288 1289 I-lower_bound
mm3 19 22 1289 1292 I-lower_bound

Presence 0 8 1293 1301 O
of 9 11 1302 1304 O
an 12 14 1305 1307 O
acute 15 20 1308 1313 O
or 21 23 1314 1316 O
chronic 24 31 1317 1324 O
toxicity 32 40 1325 1333 O
of 41 43 1334 1336 O
prior 44 49 1337 1342 B-treatment
chemotherapy 50 62 1343 1355 I-treatment
, 62 63 1355 1356 O
with 64 68 1357 1361 O
the 69 72 1362 1365 O
exception 73 82 1366 1375 O
of 83 85 1376 1378 O
alopecia 86 94 1379 1387 B-chronic_disease
, 94 95 1387 1388 O
that 96 100 1389 1393 O
has 101 104 1394 1397 O
not 105 108 1398 1401 O
resolved 109 117 1402 1410 O
to 118 120 1411 1413 O
≤Grade 121 127 1414 1420 O
1 128 129 1421 1422 I-upper_bound
, 129 130 1422 1423 O
as 131 133 1424 1426 O
determined 134 144 1427 1437 O
by 145 147 1438 1440 O
National 148 156 1441 1449 O
Cancer 157 163 1450 1456 O
Institute 164 173 1457 1466 O
Common 174 180 1467 1473 O
Toxicity 181 189 1474 1482 O
Criteria 190 198 1483 1491 O
for 199 202 1492 1495 O
Adverse 203 210 1496 1503 O
Effects 211 218 1504 1511 O
( 219 220 1512 1513 O
CTCAE 220 225 1513 1518 O
) 225 226 1518 1519 O
v 227 228 1520 1521 O
4.0 229 232 1522 1525 O
( 233 234 1526 1527 O
http://evs.nci.nih.gov/ftp1/CTCAE/About.html 234 278 1527 1571 O
) 278 279 1571 1572 O

Previous 0 8 1573 1581 O
malignancy 9 19 1582 1592 B-chronic_disease

Radiotherapy 0 12 1593 1605 B-treatment
within 13 19 1606 1612 O
28 20 22 1613 1615 B-upper_bound
days 23 27 1616 1620 I-upper_bound
prior 28 33 1621 1626 I-upper_bound
to 34 36 1627 1629 O
baseline 37 45 1630 1638 O

Receipt 0 7 1639 1646 O
of 8 10 1647 1649 O
more 11 15 1650 1654 O
than 16 20 1655 1659 O
3 21 22 1660 1661 B-lower_bound
prior 23 28 1662 1667 B-treatment
regimens 29 37 1668 1676 I-treatment
of 38 40 1677 1679 I-treatment
cytotoxic 41 50 1680 1689 I-treatment
chemotherapy 51 63 1690 1702 I-treatment
for 64 67 1703 1706 O
metastatic 68 78 1707 1717 B-cancer
disease 79 86 1718 1725 I-cancer
unless 87 93 1726 1732 O
prior 94 99 1733 1738 O
approval 100 108 1739 1747 O
is 109 111 1748 1750 O
granted 112 119 1751 1758 O
by 120 122 1759 1761 O
the 123 126 1762 1765 O
Sponsor 127 134 1766 1773 O

Receipt 0 7 1774 1781 O
of 8 10 1782 1784 O
radiotherapy 11 23 1785 1797 B-treatment
to 24 26 1798 1800 O
> 27 28 1801 1802 O
25 28 30 1802 1804 B-lower_bound
% 31 32 1805 1806 I-lower_bound
of 33 35 1807 1809 O
bone 36 40 1810 1814 O
marrow 41 47 1815 1821 O

Serum 0 5 1822 1827 B-clinical_variable
albumin 6 13 1828 1835 I-clinical_variable
≥3.0 14 18 1836 1840 O
gm 19 21 1841 1843 I-lower_bound
/ 21 22 1843 1844 I-lower_bound
dL 22 24 1844 1846 I-lower_bound

Serum 0 5 1847 1852 B-clinical_variable
creatinine 6 16 1853 1863 I-clinical_variable
≤1.5 17 21 1864 1868 O
mg 22 24 1869 1871 I-upper_bound
/ 24 25 1871 1872 I-upper_bound
dL 25 27 1872 1874 I-upper_bound

Severe 0 6 1875 1881 O
liver 7 12 1882 1887 B-chronic_disease
dysfunction 13 24 1888 1899 I-chronic_disease
( 25 26 1900 1901 O
Child 26 31 1901 1906 O
- 31 32 1906 1907 O
Pugh 32 36 1907 1911 O
Class 37 42 1912 1917 O
B 43 44 1918 1919 O
or 45 47 1920 1922 O
C 48 49 1923 1924 O
) 49 50 1924 1925 O

Subjects 0 8 1926 1934 O
with 9 13 1935 1939 O
a 14 15 1940 1941 O
history 16 23 1942 1949 O
of 24 26 1950 1952 O
esophageal 27 37 1953 1963 O
bleeding 38 46 1964 1972 O
have 47 51 1973 1977 O
varices 52 59 1978 1985 O
that 60 64 1986 1990 O
have 65 69 1991 1995 O
been 70 74 1996 2000 O
sclerosed 75 84 2001 2010 O
or 85 87 2011 2013 O
banded 88 94 2014 2020 O
and 95 98 2021 2024 O
no 99 101 2025 2027 O
bleeding 102 110 2028 2036 O
episodes 111 119 2037 2045 O
have 120 124 2046 2050 O
occurred 125 133 2051 2059 O
during 134 140 2060 2066 O
the 141 144 2067 2070 O
prior 145 150 2071 2076 B-upper_bound
6 151 152 2077 2078 I-upper_bound
months 153 159 2079 2085 I-upper_bound

Subjects 0 8 2086 2094 O
with 9 13 2095 2099 O
primary 14 21 2100 2107 O
liver 22 27 2108 2113 B-cancer
cancer 28 34 2114 2120 I-cancer
or 35 37 2121 2123 O
hepatic 38 45 2124 2131 B-cancer
metastasis 46 56 2132 2142 I-cancer

Total 0 5 2143 2148 B-clinical_variable
bilirubin 6 15 2149 2158 I-clinical_variable
is 16 18 2159 2161 O
no 19 21 2162 2164 O
higher 22 28 2165 2171 O
than 29 33 2172 2176 O
the 34 37 2177 2180 O
ULN 38 41 2181 2184 O

Total 0 5 2185 2190 B-clinical_variable
bilirubin 6 15 2191 2200 I-clinical_variable
≤1.5 16 20 2201 2205 O
× 21 22 2206 2207 I-upper_bound
the 23 26 2208 2211 I-upper_bound
upper 27 32 2212 2217 I-upper_bound
limit 33 38 2218 2223 I-upper_bound
of 39 41 2224 2226 I-upper_bound
normal 42 48 2227 2233 I-upper_bound
( 49 50 2234 2235 I-upper_bound
ULN 50 53 2235 2238 I-upper_bound
) 53 54 2238 2239 I-upper_bound

Uncontrolled 0 12 2240 2252 O
congestive 13 23 2253 2263 B-chronic_disease
heart 24 29 2264 2269 I-chronic_disease
failure 30 37 2270 2277 I-chronic_disease
( 38 39 2278 2279 O
New 39 42 2279 2282 B-clinical_variable
York 43 47 2283 2287 I-clinical_variable
Heart 48 53 2288 2293 I-clinical_variable
Association 54 65 2294 2305 I-clinical_variable
Classification 66 80 2306 2320 I-clinical_variable
3 81 82 2321 2322 B-lower_bound
or 83 85 2323 2325 O
4 86 87 2326 2327 B-upper_bound
) 87 88 2327 2328 O
, 88 89 2328 2329 O
angina 90 96 2330 2336 O
, 96 97 2336 2337 O
myocardial 98 108 2338 2348 B-chronic_disease
infarction 109 119 2349 2359 I-chronic_disease
, 119 120 2359 2360 O
cerebrovascular 121 136 2361 2376 B-chronic_disease
accident 137 145 2377 2385 I-chronic_disease
, 145 146 2385 2386 O
coronary 147 155 2387 2395 B-treatment
/ 155 156 2395 2396 I-treatment
peripheral 156 166 2396 2406 I-treatment
artery 167 173 2407 2413 I-treatment
bypass 174 180 2414 2420 I-treatment
graft 181 186 2421 2426 I-treatment
surgery 187 194 2427 2434 I-treatment
, 194 195 2434 2435 O
transient 196 205 2436 2445 B-chronic_disease
ischemic 206 214 2446 2454 I-chronic_disease
attack 215 221 2455 2461 I-chronic_disease
, 221 222 2461 2462 O
or 223 225 2463 2465 O
pulmonary 226 235 2466 2475 B-chronic_disease
embolism 236 244 2476 2484 I-chronic_disease
within 245 251 2485 2491 O
3 252 253 2492 2493 B-upper_bound
months 254 260 2494 2500 I-upper_bound
prior 261 266 2501 2506 I-upper_bound
to 267 269 2507 2509 O
initiation 270 280 2510 2520 O
of 281 283 2521 2523 O
study 284 289 2524 2529 B-treatment
drug 290 294 2530 2534 I-treatment

Unstable 0 8 2535 2543 O
cardiac 9 16 2544 2551 B-chronic_disease
dysrhythmias 17 29 2552 2564 I-chronic_disease
or 30 32 2565 2567 O
persistent 33 43 2568 2578 O
prolongation 44 56 2579 2591 O
of 57 59 2592 2594 O
the 60 63 2595 2598 O
corrected 64 73 2599 2608 B-clinical_variable
QT 74 76 2609 2611 I-clinical_variable
interval 77 85 2612 2620 I-clinical_variable
( 86 87 2621 2622 I-clinical_variable
QTc 87 90 2622 2625 I-clinical_variable
) 90 91 2625 2626 I-clinical_variable
( 92 93 2627 2628 I-clinical_variable
Fridericia 93 103 2628 2638 I-clinical_variable
) 103 104 2638 2639 I-clinical_variable
to 105 107 2640 2642 O
> 108 109 2643 2644 O
450 109 112 2644 2647 B-lower_bound
msec 113 117 2648 2652 I-lower_bound
for 118 121 2653 2656 O
males 122 127 2657 2662 B-gender
or 128 130 2663 2665 O
> 131 132 2666 2667 O
470 132 135 2667 2670 B-lower_bound
msec 136 140 2671 2675 I-lower_bound
for 141 144 2676 2679 O
females 145 152 2680 2687 B-gender

corticosteroids 0 15 2688 2703 B-treatment
> 16 17 2704 2705 O
20 17 19 2705 2707 B-lower_bound
mg 20 22 2708 2710 I-lower_bound
/ 22 23 2710 2711 I-lower_bound
day 23 26 2711 2714 I-lower_bound
prednisone 27 37 2715 2725 B-treatment
or 38 40 2726 2728 O
equivalent 41 51 2729 2739 O
, 51 52 2739 2740 O
or 53 55 2741 2743 O
growth 56 62 2744 2750 B-treatment
factor 63 69 2751 2757 I-treatment
treatment 70 79 2758 2767 I-treatment
( 80 81 2768 2769 O
e.g. 81 85 2769 2773 O
, 85 86 2773 2774 O
erythropoietin 87 101 2775 2789 B-treatment
) 101 102 2789 2790 O
within 103 109 2791 2797 O
14 110 112 2798 2800 B-upper_bound
days 113 117 2801 2805 I-upper_bound
prior 118 123 2806 2811 I-upper_bound
to 124 126 2812 2814 O
initiation 127 137 2815 2825 O
of 138 140 2826 2828 O
study 141 146 2829 2834 B-treatment
drug 147 151 2835 2839 I-treatment

imaging 0 7 2840 2847 O
by 8 10 2848 2850 O
Response 11 19 2851 2859 O
Evaluation 20 30 2860 2870 O
Criteria 31 39 2871 2879 O
in 40 42 2880 2882 O
Solid 43 48 2883 2888 B-cancer
Tumors 49 55 2889 2895 I-cancer
( 56 57 2896 2897 O
RECIST 57 63 2897 2903 O
v1.1 64 68 2904 2908 O
, 68 69 2908 2909 O
Appendix 70 78 2910 2918 O
2 79 80 2919 2920 O
) 80 81 2920 2921 O

immunosuppressive 0 17 2922 2939 B-treatment
therapy 18 25 2940 2947 I-treatment

informative 0 11 2948 2959 O
tumor 12 17 2960 2965 B-cancer
marker(s 18 26 2966 2974 O
) 26 27 2974 2975 O

measured 0 8 2976 2984 B-clinical_variable
creatinine 9 19 2985 2995 I-clinical_variable
clearance 20 29 2996 3005 I-clinical_variable
≥60 30 33 3006 3009 O
mL 34 36 3010 3012 I-lower_bound
/ 36 37 3012 3013 I-lower_bound
min 37 40 3013 3016 I-lower_bound

non 0 3 3017 3020 B-cancer
- 3 4 3020 3021 I-cancer
squamous 4 12 3021 3029 I-cancer
- 12 13 3029 3030 I-cancer
cell 13 17 3030 3034 I-cancer
carcinoma 18 27 3035 3044 I-cancer
of 28 30 3045 3047 I-cancer
skin 31 35 3048 3052 I-cancer
or 36 38 3053 3055 O
carcinoma 39 48 3056 3065 B-cancer
in 49 51 3066 3068 I-cancer
- 51 52 3068 3069 I-cancer
situ 52 56 3069 3073 I-cancer
of 57 59 3074 3076 I-cancer
the 60 63 3077 3080 I-cancer
uterine 64 71 3081 3088 I-cancer
cervix 72 78 3089 3095 I-cancer
, 78 79 3095 3096 O
unless 80 86 3097 3103 O
the 87 90 3104 3107 O
tumor 91 96 3108 3113 B-cancer
was 97 100 3114 3117 O
treated 101 108 3118 3125 O
with 109 113 3126 3130 O
curative 114 122 3131 3139 B-treatment
intent 123 129 3140 3146 I-treatment
more 130 134 3147 3151 O
than 135 139 3152 3156 O
2 140 141 3157 3158 B-lower_bound
years 142 147 3159 3164 I-lower_bound
prior 148 153 3165 3170 I-lower_bound
to 154 156 3171 3173 O
study 157 162 3174 3179 O
entry 163 168 3180 3185 O

Aged 0 4 0 4 B-age
50 5 7 5 7 B-lower_bound
- 7 8 7 8 O
90 8 10 8 10 B-upper_bound
years 11 16 11 16 I-upper_bound
old 17 20 17 20 O

Capable 0 7 21 28 O
of 8 10 29 31 O
following 11 20 32 41 O
directions 21 31 42 52 O
. 31 32 52 53 O
iPD 33 36 54 57 O
subjects 37 45 58 66 O
: 45 46 66 67 O
UK 47 49 68 70 O
Brain 50 55 71 76 O
Bank 56 60 77 81 O
criteria 61 69 82 90 O
, 69 70 90 91 O
i.e. 71 75 92 96 O
, 75 76 96 97 O
bradykinesia 77 89 98 110 B-chronic_disease

Contraindications 0 17 111 128 O
to 18 20 129 131 O
MRI 21 24 132 135 B-treatment
scans 25 30 136 141 I-treatment
( 31 32 142 143 O
eg 32 34 143 145 O
, 34 35 145 146 O
claustrophobia 36 50 147 161 B-chronic_disease
, 50 51 161 162 O
metal 52 57 163 168 O
in 58 60 169 171 O
body 61 65 172 176 O
) 65 66 176 177 O

Control 0 7 178 185 O
subjects 8 16 186 194 O
: 16 17 194 195 O
Will 18 22 196 200 O
be 23 25 201 203 O
matched 26 33 204 211 O
for 34 37 212 215 O
age 38 41 216 219 B-age
and 42 45 220 223 O
gender 46 52 224 230 O
to 53 55 231 233 O
iPD 56 59 234 237 B-chronic_disease
and 60 63 238 241 O
parkinsonism 64 76 242 254 B-chronic_disease
groups 77 83 255 261 O

Idiopathic 0 10 262 272 O
PD 11 13 273 275 B-chronic_disease
subjects 14 22 276 284 O
: 22 23 284 285 O
Same 24 28 286 290 O
as 29 31 291 293 O
above 32 37 294 299 O
and 38 41 300 303 O
deep 42 46 304 308 O
brain 47 52 309 314 O
stimulation 53 64 315 326 O
electrodes 65 75 327 337 O

Inability 0 9 338 347 O
to 10 12 348 350 O
stand 13 18 351 356 O
or 19 21 357 359 O
walk 22 26 360 364 O
for 27 30 365 368 O
2 31 32 369 370 B-upper_bound
min 33 36 371 374 I-upper_bound
without 37 44 375 382 O
an 45 47 383 385 O
assistive 48 57 386 395 O
device 58 64 396 402 O

No 0 2 403 405 O
musculoskeletal 3 18 406 421 B-chronic_disease
or 19 21 422 424 O
peripheral 22 32 425 435 B-chronic_disease
or 33 35 436 438 O
central 36 43 439 446 B-chronic_disease
nervous 44 51 447 454 I-chronic_disease
system 52 58 455 461 I-chronic_disease
disorders 59 68 462 471 I-chronic_disease
( 69 70 472 473 O
other 70 75 473 478 O
than 76 80 479 483 O
idiopathic 81 91 484 494 B-chronic_disease
Parkinson 92 101 495 504 I-chronic_disease
disease 102 109 505 512 I-chronic_disease
( 110 111 513 514 I-chronic_disease
iPD 111 114 514 517 I-chronic_disease
) 114 115 517 518 I-chronic_disease
or 116 118 519 521 O
parkinsonism 119 131 522 534 B-chronic_disease
) 131 132 534 535 O
that 133 137 536 540 O
could 138 143 541 546 O
significantly 144 157 547 560 O
affect 158 164 561 567 O
balance 165 172 568 575 O
or 173 175 576 578 O
gait 176 180 579 583 O

Parkinsonism 0 12 584 596 B-chronic_disease
subjects 13 21 597 605 O
: 21 22 605 606 O
Gait 23 27 607 611 O
characterized 28 41 612 625 O
by 42 44 626 628 O
slow 45 49 629 633 O
short 50 55 634 639 O
steps 56 61 640 645 O
, 61 62 645 646 O
shuffling 63 72 647 656 O
gait 73 77 657 661 O
and 78 81 662 665 O
may 82 85 666 669 O
be 86 88 670 672 O
wide 89 93 673 677 O
- 93 94 677 678 O
based 94 99 678 683 O
, 99 100 683 684 O
with 101 105 685 689 O
FoG 106 109 690 693 O
, 109 110 693 694 O
postural 111 119 695 703 B-chronic_disease
instability 120 131 704 715 I-chronic_disease

Parkinsonism 0 12 716 728 B-chronic_disease
subjects 13 21 729 737 O
: 21 22 737 738 O
iPD 23 26 739 742 B-chronic_disease
and 27 30 743 746 I-chronic_disease
Parkinson 31 40 747 756 I-chronic_disease
plus 41 45 757 761 I-chronic_disease
syndromes 46 55 762 771 I-chronic_disease
such 56 60 772 776 O
as 61 63 777 779 O
Progressive 64 75 780 791 B-chronic_disease
Supranuclear 76 88 792 804 I-chronic_disease
Palsy 89 94 805 810 I-chronic_disease
, 94 95 810 811 O
Multiple 96 104 812 820 B-chronic_disease
System 105 111 821 827 I-chronic_disease
Atrophy 112 119 828 835 I-chronic_disease
, 119 120 835 836 O
Corticobasal 121 133 837 849 B-chronic_disease
Syndrome 134 142 850 858 I-chronic_disease
, 142 143 858 859 O
or 144 146 860 862 O
Cerebellar 147 157 863 873 B-chronic_disease
Ataxia 158 164 874 880 I-chronic_disease

Recent 0 6 881 887 O
changes 7 14 888 895 O
in 15 17 896 898 O
medication 18 28 899 909 B-treatment

Significant 0 11 910 921 O
tremor 12 18 922 928 B-chronic_disease
that 19 23 929 933 O
would 24 29 934 939 O
interfere 30 39 940 949 O
withMRI 40 47 950 957 O
scan 48 52 958 962 I-treatment

Unilateral 0 10 963 973 O
onset 11 16 974 979 O
, 16 17 979 980 O
response 18 26 981 989 O
to 27 29 990 992 O
levodopa 30 38 993 1001 B-treatment

at 0 2 1002 1004 O
least 3 8 1005 1010 O
one 9 12 1011 1014 O
of 13 15 1015 1017 O
the 16 19 1018 1021 O
following 20 29 1022 1031 O
: 29 30 1031 1032 O
rest 31 35 1033 1037 B-chronic_disease
tremor 36 42 1038 1044 I-chronic_disease
, 42 43 1044 1045 O
muscular 44 52 1046 1054 B-chronic_disease
rigidity 53 61 1055 1063 I-chronic_disease
, 61 62 1063 1064 O
and 63 66 1065 1068 O
postural 67 75 1069 1077 B-chronic_disease
instability 76 87 1078 1089 I-chronic_disease
not 88 91 1090 1093 O
cause 92 97 1094 1099 O
by 98 100 1100 1102 O
visual 101 107 1103 1109 B-chronic_disease
, 107 108 1109 1110 O
vestibular 109 119 1111 1121 B-chronic_disease
, 119 120 1121 1122 O
cerebellar 121 131 1123 1133 B-chronic_disease
or 132 134 1134 1136 O
proprioceptive 135 149 1137 1151 B-chronic_disease
dysfunction 150 161 1152 1163 I-chronic_disease

participating 0 13 1164 1177 O
in 14 16 1178 1180 O
a 17 18 1181 1182 O
vigorous 19 27 1183 1191 O
exercise 28 36 1192 1200 O
program 37 44 1201 1208 O
more 45 49 1209 1213 O
than 50 54 1214 1218 O
2 55 56 1219 1220 B-lower_bound
x 57 58 1221 1222 I-lower_bound
/ 58 59 1222 1223 I-lower_bound
week 59 63 1223 1227 I-lower_bound

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1200 27 31 27 31 B-lower_bound
/ 31 32 31 32 I-lower_bound
mm3 32 35 32 35 I-lower_bound

Adjuvant 0 8 36 44 B-treatment
chemotherapy 9 21 45 57 I-treatment

Adjuvant 0 8 58 66 B-treatment
immunotherapy/ 9 23 67 81 I-treatment
biologics 24 33 82 91 B-treatment

Age 0 3 92 95 B-age
≥21 4 7 96 99 O
years 8 13 100 105 I-lower_bound

Bilirubin 0 9 106 115 B-clinical_variable
< 10 11 116 117 O
2 11 12 117 118 B-upper_bound
x 13 14 119 120 I-upper_bound
upper 15 20 121 126 I-upper_bound
limit 21 26 127 132 I-upper_bound
of 27 29 133 135 I-upper_bound
normal 30 36 136 142 I-upper_bound
( 37 38 143 144 I-upper_bound
ULN 38 41 144 147 I-upper_bound
) 41 42 147 148 I-upper_bound

Calculated 0 10 149 159 B-clinical_variable
creatinine 11 21 160 170 I-clinical_variable
clearance 22 31 171 180 I-clinical_variable
( 32 33 181 182 I-clinical_variable
CRCL 33 37 182 186 I-clinical_variable
) 37 38 186 187 I-clinical_variable
≥40 39 42 188 191 O
mL 43 45 192 194 I-lower_bound
/ 45 46 194 195 I-lower_bound
min 46 49 195 198 I-lower_bound

Central 0 7 199 206 B-cancer
nervous 8 15 207 214 I-cancer
system 16 22 215 221 I-cancer
metastasis 23 33 222 232 I-cancer

Eastern 0 7 233 240 B-clinical_variable
Cooperative 8 19 241 252 I-clinical_variable
Oncology 20 28 253 261 I-clinical_variable
Group 29 34 262 267 I-clinical_variable
Performance 35 46 268 279 I-clinical_variable
Scale 47 52 280 285 I-clinical_variable
( 53 54 286 287 I-clinical_variable
ECOG 54 58 287 291 I-clinical_variable
- 58 59 291 292 I-clinical_variable
PS 59 61 292 294 I-clinical_variable
) 61 62 294 295 I-clinical_variable
≤2 63 65 296 298 O

Glomerular 0 10 299 309 B-clinical_variable
Filtration 11 21 310 320 I-clinical_variable
Rate 22 26 321 325 I-clinical_variable
( 27 28 326 327 I-clinical_variable
GFR 28 31 327 330 I-clinical_variable
) 31 32 330 331 I-clinical_variable
is 33 35 332 334 O
calculated 36 46 335 345 O
based 47 52 346 351 O
on 53 55 352 354 O
Cockcroft 56 65 355 364 O
- 65 66 364 365 O
Gault 66 71 365 370 O
method 72 78 371 377 O

HIV 0 3 378 381 B-chronic_disease
Positive 4 12 382 390 O

Human 0 5 391 396 B-chronic_disease
Immunodeficiency 6 22 397 413 I-chronic_disease
Virus 23 28 414 419 I-chronic_disease
( 29 30 420 421 I-chronic_disease
HIV 30 33 421 424 I-chronic_disease
) 33 34 424 425 I-chronic_disease
negative 35 43 426 434 O

Investigational 0 15 435 450 B-treatment
therapy 16 23 451 458 I-treatment
less 24 28 459 463 O
than 29 33 464 468 O
one 34 37 469 472 B-upper_bound
month 38 43 473 478 I-upper_bound
prior 44 49 479 484 I-upper_bound
to 50 52 485 487 O
study 53 58 488 493 O
entry 59 64 494 499 O

Known 0 5 500 505 O
history 6 13 506 513 O
of 14 16 514 516 O
hepatitis 17 26 517 526 B-chronic_disease
C 27 28 527 528 I-chronic_disease

Life 0 4 529 533 B-clinical_variable
expectancy 5 15 534 544 I-clinical_variable
> 16 17 545 546 O
6 17 18 546 547 B-lower_bound
months 19 25 548 554 I-lower_bound

Localised 0 9 555 564 O
palliative 10 20 565 575 B-treatment
radiotherapy 21 33 576 588 I-treatment
Prior 34 39 589 594 O
chemotherapy 40 52 595 607 B-treatment
must 53 57 608 612 O
be 58 60 613 615 O
> 61 62 616 617 O
6 63 64 618 619 B-lower_bound
months 65 71 620 626 I-lower_bound
before 72 78 627 633 O
screening 79 88 634 643 O

Male 0 4 644 648 B-gender

Metastatic 0 10 649 659 B-cancer
or 11 13 660 662 O
locally 14 21 663 670 O
recurrent 22 31 671 680 O
EBV 32 35 681 684 B-chronic_disease
- 35 36 684 685 I-chronic_disease
positive 36 44 685 693 I-chronic_disease

Positive 0 8 694 702 O
hepatitis 9 18 703 712 B-chronic_disease
B 19 20 713 714 I-chronic_disease
surface 21 28 715 722 O
antigen 29 36 723 730 O
( 37 38 731 732 O
HBsAg 38 43 732 737 O
) 43 44 737 738 O
results 45 52 739 746 O

Pre 0 3 747 750 O
- 3 4 750 751 O
existing 4 12 751 759 O
peripheral 13 23 760 770 B-chronic_disease
neuropathy 24 34 771 781 I-chronic_disease
( 35 36 782 783 O
National 36 44 783 791 B-clinical_variable
Cancer 45 51 792 798 I-clinical_variable
Institute 52 61 799 808 I-clinical_variable
Common 62 68 809 815 I-clinical_variable
Terminology 69 80 816 827 I-clinical_variable
Criteria 81 89 828 836 I-clinical_variable
for 90 93 837 840 I-clinical_variable
Adverse 94 101 841 848 I-clinical_variable
Events 102 108 849 855 I-clinical_variable
[ 109 110 856 857 I-clinical_variable
NCI 110 113 857 860 I-clinical_variable
CTCAE 114 119 861 866 I-clinical_variable
] 119 120 866 867 I-clinical_variable
≥2 121 123 868 870 O
) 123 124 870 871 O

Pregnant 0 8 872 880 B-pregnancy

Previous 0 8 881 889 O
or 9 11 890 892 O
concurrent 12 22 893 903 O
cancer 23 29 904 910 B-cancer
that 30 34 911 915 O
is 35 37 916 918 O
distinct 38 46 919 927 O
in 47 49 928 930 O
primary 50 57 931 938 O
site 58 62 939 943 O
or 63 65 944 946 O
histology 66 75 947 956 O
from 76 80 957 961 O
the 81 84 962 965 O
cancer 85 91 966 972 O
being 92 97 973 978 O
evaluated 98 107 979 988 O
in 108 110 989 991 O
this 111 115 992 996 O
study 116 121 997 1002 O

Prior 0 5 1003 1008 B-treatment
chemo 6 11 1009 1014 I-treatment
- 11 12 1014 1015 I-treatment
radiotherapy 12 24 1015 1027 I-treatment
with 25 29 1028 1032 I-treatment
curative 30 38 1033 1041 I-treatment
intent 39 45 1042 1048 I-treatment

Prior 0 5 1049 1054 B-treatment
chemotherapy 6 18 1055 1067 I-treatment
for 19 22 1068 1071 O
metastatic 23 33 1072 1082 B-cancer
or 34 36 1083 1085 O
locally 37 44 1086 1093 B-chronic_disease
recurrent 45 54 1094 1103 I-chronic_disease
disease 55 62 1104 1111 I-chronic_disease

Prior 0 5 1112 1117 B-treatment
immunotherapy 6 19 1118 1131 I-treatment
for 20 23 1132 1135 O
metastatic 24 34 1136 1146 O
or 35 37 1147 1149 O
locally 38 45 1150 1157 O
recurrent 46 55 1158 1167 O
disease 56 63 1168 1175 O

Prior 0 5 1176 1181 B-treatment
radiotherapy 6 18 1182 1194 I-treatment
with 19 23 1195 1199 I-treatment
curative 24 32 1200 1208 I-treatment
intent 33 39 1209 1215 I-treatment

Refuse 0 6 1216 1222 B-contraception_consent
of 7 9 1223 1225 I-contraception_consent
use 10 13 1226 1229 I-contraception_consent
of 14 16 1230 1232 I-contraception_consent
contraception 17 30 1233 1246 I-contraception_consent
during 31 37 1247 1253 O
trial 38 43 1254 1259 O
( 44 45 1260 1261 O
both 45 49 1261 1265 O
male 50 54 1266 1270 B-gender
and 55 58 1271 1274 I-gender
female 59 65 1275 1281 I-gender
patients 66 74 1282 1290 I-gender
) 74 75 1290 1291 O

Severe 0 6 1292 1298 B-chronic_disease
concomitant 7 18 1299 1310 I-chronic_disease
illness 19 26 1311 1318 I-chronic_disease

Severe 0 6 1319 1325 B-chronic_disease
intercurrent 7 19 1326 1338 I-chronic_disease
infections 20 30 1339 1349 I-chronic_disease

Status 0 6 1350 1356 O
of 7 9 1357 1359 O
HIV 10 13 1360 1363 B-chronic_disease
must 14 18 1364 1368 O
be 19 21 1369 1371 O
confirmed 22 31 1372 1381 O
via 32 35 1382 1385 O
a 36 37 1386 1387 O
HIV 38 41 1388 1391 O
antibody 42 50 1392 1400 O
test 51 55 1401 1405 O
or 56 58 1406 1408 O
other 59 64 1409 1414 O
confirmatory 65 77 1415 1427 O
tests 78 83 1428 1433 O
available 84 93 1434 1443 O
within 94 100 1444 1450 O
12 101 103 1451 1453 B-upper_bound
months 104 110 1454 1460 I-upper_bound
before 111 117 1461 1467 I-upper_bound
screening 118 127 1468 1477 O
or 128 130 1478 1480 O
at 131 133 1481 1483 O
screening 134 143 1484 1493 O

Subjects 0 8 1494 1502 O
will 9 13 1503 1507 O
be 14 16 1508 1510 O
enrolled 17 25 1511 1519 O
based 26 31 1520 1525 O
on 32 34 1526 1528 O
confirmed 35 44 1529 1538 O
histology 45 54 1539 1548 O
diagnosis 55 64 1549 1558 O
of 65 67 1559 1561 O
the 68 71 1562 1565 O
NPC 72 75 1566 1569 B-cancer

active 0 6 1570 1576 O
angina 7 13 1577 1583 B-chronic_disease
pectoris 14 22 1584 1592 I-chronic_disease

active 0 6 1593 1599 O
congestive 7 17 1600 1610 B-chronic_disease
cardiac 18 25 1611 1618 I-chronic_disease
failure 26 33 1619 1626 I-chronic_disease
( 34 35 1627 1628 I-chronic_disease
CCF 35 38 1628 1631 I-chronic_disease
) 38 39 1631 1632 I-chronic_disease

alanine 0 7 1633 1640 B-clinical_variable
aminotransferase 8 24 1641 1657 I-clinical_variable
( 25 26 1658 1659 I-clinical_variable
ALT 26 29 1659 1662 I-clinical_variable
) 29 30 1662 1663 I-clinical_variable
<3 31 33 1664 1666 O
x 34 35 1667 1668 I-upper_bound
ULN 36 39 1669 1672 I-upper_bound

any 0 3 1673 1676 O
cancer 4 10 1677 1683 B-cancer
curatively 11 21 1684 1694 O
treated 22 29 1695 1702 O
> 30 31 1703 1704 O
3 31 32 1704 1705 B-lower_bound
years 33 38 1706 1711 I-lower_bound
prior 39 44 1712 1717 I-lower_bound
to 45 47 1718 1720 O
study 48 53 1721 1726 O
entry 54 59 1727 1732 O

aspartate 0 9 1733 1742 B-clinical_variable
aminotransferase 10 26 1743 1759 I-clinical_variable
( 27 28 1760 1761 I-clinical_variable
AST 28 31 1761 1764 I-clinical_variable
) 31 32 1764 1765 I-clinical_variable

cervical 0 8 1766 1774 B-cancer
carcinoma 9 18 1775 1784 I-cancer
in 19 21 1785 1787 I-cancer
situ 22 26 1788 1792 I-cancer

chronic 0 7 1793 1800 B-chronic_disease
obstructive 8 19 1801 1812 I-chronic_disease
pulmonary 20 29 1813 1822 I-chronic_disease
disease 30 37 1823 1830 I-chronic_disease
( 38 39 1831 1832 I-chronic_disease
COPD 39 43 1832 1836 I-chronic_disease
) 43 44 1836 1837 I-chronic_disease

female 0 6 1838 1844 B-gender

hemoglobin 0 10 1845 1855 B-clinical_variable
( 11 12 1856 1857 I-clinical_variable
Hb 12 14 1857 1859 I-clinical_variable
) 14 15 1859 1860 I-clinical_variable
≥10 16 19 1861 1864 O
g 20 21 1865 1866 I-lower_bound
/ 21 22 1866 1867 I-lower_bound
dL 22 24 1867 1869 I-lower_bound
and 25 28 1870 1873 O
platelets 29 38 1874 1883 B-clinical_variable
≥100,000 39 47 1884 1892 O
/ 47 48 1892 1893 I-lower_bound
mm3 48 51 1893 1896 I-lower_bound

ischemic 0 8 1897 1905 B-chronic_disease
heart 9 14 1906 1911 I-chronic_disease
disease 15 22 1912 1919 I-chronic_disease
( 23 24 1920 1921 I-chronic_disease
IHD 24 27 1921 1924 I-chronic_disease
) 27 28 1924 1925 I-chronic_disease

lactating 0 9 1926 1935 O
females 10 17 1936 1943 B-gender

superficial 0 11 1944 1955 B-cancer
bladder 12 19 1956 1963 I-cancer
tumors 20 26 1964 1970 I-cancer
[ 27 28 1971 1972 I-cancer
Ta 28 30 1972 1974 I-cancer
, 30 31 1974 1975 I-cancer
Tis 32 35 1976 1979 I-cancer
and 36 39 1980 1983 I-cancer
T1 40 42 1984 1986 I-cancer
] 42 43 1986 1987 I-cancer

treated 0 7 1988 1995 O
basal 8 13 1996 2001 B-cancer
cell 14 18 2002 2006 I-cancer
carcinoma 19 28 2007 2016 I-cancer

uncontrolled 0 12 2017 2029 O
arrhythmia 13 23 2030 2040 B-chronic_disease

uncontrolled 0 12 2041 2053 O
hypertension 13 25 2054 2066 B-chronic_disease

undifferentiated 0 16 2067 2083 O
NPC 17 20 2084 2087 B-cancer
* 20 21 2087 2088 O
who 22 25 2089 2092 O
do 26 28 2093 2095 O
not 29 32 2096 2099 O
have 33 37 2100 2104 O
curative 38 46 2105 2113 O
options 47 54 2114 2121 O
such 55 59 2122 2126 O
as 60 62 2127 2129 O
chemo 63 68 2130 2135 B-treatment
- 68 69 2135 2136 I-treatment
radiation 69 78 2136 2145 I-treatment
or 79 81 2146 2148 O
surgery 82 89 2149 2156 B-treatment

40 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
old 9 12 9 12 O
or 13 15 13 15 O
older 16 21 16 21 O

History 0 7 22 29 O
of 8 10 30 32 O
serious 11 18 33 40 O
neurologic 19 29 41 51 B-chronic_disease
disease 30 37 52 59 I-chronic_disease

Hypersensitivity 0 16 60 76 O
to 17 19 77 79 O
atomoxetine 20 31 80 91 B-allergy_name

Impaired 0 8 92 100 B-chronic_disease
renal 9 14 101 106 I-chronic_disease
function 15 23 107 115 I-chronic_disease
( 24 25 116 117 O
serum 25 30 117 122 B-clinical_variable
creatinine 31 41 123 133 I-clinical_variable
equal 42 47 134 139 O
or 48 50 140 142 O
more 51 55 143 147 O
than 56 60 148 152 O
1.6 61 64 153 156 B-lower_bound
mg 65 67 157 159 I-lower_bound
/ 67 68 159 160 I-lower_bound
dl 68 70 160 162 I-lower_bound
) 70 71 162 163 O

Myocardial 0 10 164 174 B-chronic_disease
infarction 11 21 175 185 I-chronic_disease
within 22 28 186 192 O
6 29 30 193 194 B-upper_bound
months 31 37 195 201 I-upper_bound
prior 38 43 202 207 I-upper_bound
to 44 46 208 210 O
enrollment 47 57 211 221 O

Narrow 0 6 222 228 B-chronic_disease
- 6 7 228 229 I-chronic_disease
angle 7 12 229 234 I-chronic_disease
glaucoma 13 21 235 243 I-chronic_disease

Previous 0 8 244 252 O
history 9 16 253 260 O
( 17 18 261 262 O
within 18 24 262 268 O
14 25 27 269 271 B-upper_bound
days 28 32 272 276 I-upper_bound
prior 33 38 277 282 I-upper_bound
to 39 41 283 285 O
enrollment 42 52 286 296 O
) 52 53 296 297 O

Use 0 3 298 301 O
of 4 6 302 304 O
other 7 12 305 310 O
norepinephrine 13 27 311 325 O
transporter 28 39 326 337 O
inhibitors 40 50 338 348 O
such 51 55 349 353 O
as 56 58 354 356 O
Wellbutrin 59 69 357 367 B-treatment
( 70 71 368 369 I-treatment
Bupropion 71 80 369 378 I-treatment
) 80 81 378 379 I-treatment
, 81 82 379 380 O
Cymbalta 83 91 381 389 B-treatment
( 92 93 390 391 I-treatment
Duloxetine 93 103 391 401 I-treatment
) 103 104 401 402 I-treatment
, 104 105 402 403 O
Effexor 106 113 404 411 B-treatment
( 114 115 412 413 I-treatment
venlafaxine 115 126 413 424 I-treatment
) 126 127 424 425 I-treatment
, 127 128 425 426 O
Pristiq 129 136 427 434 B-treatment
( 137 138 435 436 I-treatment
desvenlafaxine 138 152 436 450 I-treatment
) 152 153 450 451 I-treatment
, 153 154 451 452 O
Savella 155 162 453 460 B-treatment
( 163 164 461 462 I-treatment
milnacipran 164 175 462 473 I-treatment
) 175 176 473 474 I-treatment

cerebral 0 8 475 483 B-chronic_disease
hemorrhage 9 19 484 494 I-chronic_disease

current 0 7 495 502 O
use 8 11 503 506 O
of 12 14 507 509 O
monoamine 15 24 510 519 B-treatment
oxidase 25 32 520 527 I-treatment
inhibitors 33 43 528 538 I-treatment

urticaria 0 9 539 548 B-chronic_disease

any 0 3 0 3 O
serious 4 11 4 11 O
systemic 12 20 12 20 B-chronic_disease
disease 21 28 21 28 I-chronic_disease
that 29 33 29 33 O
might 34 39 34 39 O
influence 40 49 40 49 O
survival 50 58 50 58 O

autonomic 0 9 59 68 B-chronic_disease
dysfunction 10 21 69 80 I-chronic_disease

clinical 0 8 81 89 O
evidence 9 17 90 98 O
of 18 20 99 101 O
congestive 21 31 102 112 B-chronic_disease
heart 32 37 113 118 I-chronic_disease
failure 38 45 119 126 I-chronic_disease

ejection 0 8 127 135 B-clinical_variable
fraction 9 17 136 144 I-clinical_variable
below 18 23 145 150 O
35 24 26 151 153 B-upper_bound
% 26 27 153 154 I-upper_bound

myocardial 0 10 155 165 B-chronic_disease
infarction 11 21 166 176 I-chronic_disease
or 22 24 177 179 O
cerebrovascular 25 40 180 195 B-chronic_disease
accident 41 49 196 204 I-chronic_disease
within 50 56 205 211 O
the 57 60 212 215 O
past 61 65 216 220 B-upper_bound
six 66 69 221 224 I-upper_bound
months 70 76 225 231 I-upper_bound

peripheral 0 10 232 242 B-chronic_disease
neuropathy 11 21 243 253 I-chronic_disease

pregnancy 0 9 254 263 B-pregnancy

severe 0 6 264 270 O
anemia 7 13 271 277 B-chronic_disease
with 14 18 278 282 O
hgb 19 22 283 286 B-clinical_variable
level 23 28 287 292 I-clinical_variable
< 29 30 293 294 O
8 30 31 294 295 B-upper_bound
g 32 33 296 297 I-upper_bound
/ 33 34 297 298 I-upper_bound
dL 34 36 298 300 I-upper_bound

surgery 0 7 301 308 B-treatment
within 8 14 309 315 O
the 15 18 316 319 O
past 19 23 320 324 B-upper_bound
3 24 25 325 326 I-upper_bound
months 26 32 327 333 I-upper_bound

Chronic 0 7 0 7 O
stage 8 13 8 13 O
stroke 14 20 14 20 B-chronic_disease
recovery 21 29 21 29 O
( 30 31 30 31 O
8 31 32 31 32 B-lower_bound
+ 32 33 32 33 I-lower_bound
months 34 40 34 40 I-lower_bound
post 41 45 41 45 O
) 45 46 45 46 O

STROKE 0 6 47 53 B-chronic_disease
SURVIVORS 7 16 54 63 O

a 0 1 64 65 O
Fugl 2 6 66 70 B-clinical_variable
- 6 7 70 71 I-clinical_variable
Meyer 7 12 71 76 I-clinical_variable
score 13 18 77 82 I-clinical_variable
( 19 20 83 84 O
between 20 27 84 91 O
15 28 30 92 94 B-lower_bound
- 30 31 94 95 O
50 31 33 95 97 B-upper_bound
) 33 34 97 98 O
to 35 37 99 101 O
evaluate 38 46 102 110 O
arm 47 50 111 114 O
motor 51 56 115 120 O
impairment 57 67 121 131 O
level 68 73 132 137 O

age 0 3 138 141 B-age
> 4 5 142 143 O
18 5 7 143 145 B-lower_bound

aphasia 0 7 146 153 B-chronic_disease
, 7 8 153 154 O
cognitive 9 18 155 164 B-chronic_disease
impairment 19 29 165 175 I-chronic_disease
or 30 32 176 178 O
affective 33 42 179 188 O
dysfunction 43 54 189 200 O
that 55 59 201 205 O
would 60 65 206 211 O
influence 66 75 212 221 O
the 76 79 222 225 O
ability 80 87 226 233 O
to 88 90 234 236 O
perform 91 98 237 244 O
the 99 102 245 248 O
experiment 103 113 249 259 O

bilateral 0 9 260 269 B-chronic_disease
paresis 10 17 270 277 I-chronic_disease

diffuse 0 7 278 285 O
/ 7 8 285 286 O
multiple 8 16 286 294 O
lesion 17 23 295 301 O
sites 24 29 302 307 O
or 30 32 308 310 O
multiple 33 41 311 319 B-chronic_disease
stroke 42 48 320 326 I-chronic_disease
events 49 55 327 333 O

healthy 0 7 334 341 O
individuals 8 19 342 353 O
with 20 24 354 358 O
no 25 27 359 361 O
history 28 35 362 369 O
of 36 38 370 372 O
stroke 39 45 373 379 B-chronic_disease
or 46 48 380 382 O
neural 49 55 383 389 O
injury 56 62 390 396 O

hemispatial 0 11 397 408 B-chronic_disease
neglect 12 19 409 416 I-chronic_disease
or 20 22 417 419 O
visual 23 29 420 426 B-chronic_disease
field 30 35 427 432 I-chronic_disease
cut 36 39 433 436 I-chronic_disease
that 40 44 437 441 O
would 45 50 442 447 O
prevent 51 58 448 455 O
subjects 59 67 456 464 O
from 68 72 465 469 O
seeing 73 79 470 476 O
the 80 83 477 480 O
targets 84 91 481 488 O

severe 0 6 489 495 O
sensory 7 14 496 503 B-chronic_disease
deficits 15 23 504 512 I-chronic_disease
in 24 26 513 515 I-chronic_disease
the 27 30 516 519 I-chronic_disease
limb 31 35 520 524 I-chronic_disease

severe 0 6 525 531 O
spasticity 7 17 532 542 B-chronic_disease
( 18 19 543 544 O
Modified 19 27 544 552 B-clinical_variable
Ashworth 28 36 553 561 I-clinical_variable
of 37 39 562 564 O
4 40 41 565 566 O
) 41 42 566 567 O
preventing 43 53 568 578 O
movement 54 62 579 587 O

strokes 0 7 588 595 B-chronic_disease
caused 8 14 596 602 O
by 15 17 603 605 O
an 18 20 606 608 O
ischemic 21 29 609 617 B-chronic_disease
infarct 30 37 618 625 I-chronic_disease
in 38 40 626 628 O
the 41 44 629 632 O
middle 45 51 633 639 O
cerebral 52 60 640 648 O
artery 61 67 649 655 O

Patients 0 8 0 8 O
with 9 13 9 13 O
liver 14 19 14 19 B-chronic_disease
disease 20 27 20 27 I-chronic_disease
as 28 30 28 30 O
tested 31 37 31 37 O
by 38 40 38 40 O
LFTs 41 45 41 45 O

less 0 4 46 50 O
than 5 9 51 55 O
or 10 12 56 58 O
equal 13 18 59 64 O
to 19 21 65 67 O
30 22 24 68 70 B-upper_bound
weeks 25 30 71 76 I-upper_bound
gestation 31 40 77 86 O
or 41 43 87 89 O
less 44 48 90 94 O
than 49 53 95 99 O
1500 54 58 100 104 B-upper_bound
g 59 60 105 106 I-upper_bound
at 61 63 107 109 O
birth 64 69 110 115 O

≤ 0 1 116 117 O
500 2 5 118 121 B-upper_bound
grams 6 11 122 127 I-upper_bound
birthweight 12 23 128 139 B-clinical_variable

Aneurysm 0 8 0 8 B-chronic_disease
located 9 16 9 16 O
at 17 19 17 19 O
basilar 20 27 20 27 O
apex 28 32 28 32 O

At 0 2 33 35 O
least 3 8 36 41 O
one 9 12 42 45 B-lower_bound
documented 13 23 46 56 O
, 23 24 56 57 O
intradural 25 35 58 68 B-cancer
, 35 36 68 69 O
intracranial 37 49 70 82 B-chronic_disease
aneurysm 50 58 83 91 I-chronic_disease
, 58 59 91 92 O
ruptured 60 68 93 101 B-chronic_disease
within 69 75 102 108 O
last 76 80 109 113 B-upper_bound
30 81 83 114 116 I-upper_bound
days 84 88 117 121 I-upper_bound

Patients 0 8 122 130 O
at 9 11 131 133 O
least 12 17 134 139 O
18 18 20 140 142 B-lower_bound
years 21 26 143 148 I-lower_bound
of 27 29 149 151 O
age 30 33 152 155 B-age

Patients 0 8 156 164 O
with 9 13 165 169 O
AVM 14 17 170 173 B-chronic_disease
- 17 18 173 174 I-chronic_disease
associated 18 28 174 184 I-chronic_disease
aneurysms 29 38 185 194 I-chronic_disease

The 0 3 195 198 O
patient 4 11 199 206 O
and 12 15 207 210 O
aneurysm 16 24 211 219 B-chronic_disease
are 25 28 220 223 O
considered 29 39 224 234 O
appropriate 40 51 235 246 O
for 52 55 247 250 O
either 56 62 251 257 O
surgical 63 71 258 266 B-treatment
or 72 74 267 269 O
endovascular 75 87 270 282 B-treatment
treatment 88 97 283 292 I-treatment
by 98 100 293 295 O
the 101 104 296 299 O
treating 105 113 300 308 O
team 114 118 309 313 O

Creatinine 0 10 0 10 B-clinical_variable
clearance 11 20 11 20 I-clinical_variable
rate 21 25 21 25 I-clinical_variable
< 26 27 26 27 O
30ml 28 32 28 32 B-upper_bound
/ 32 33 32 33 I-upper_bound
min 33 36 33 36 I-upper_bound

Diagnosed 0 9 37 46 O
as 10 12 47 49 O
respiratory 13 24 50 61 B-chronic_disease
or 25 27 62 64 I-chronic_disease
circulatory 28 39 65 76 I-chronic_disease
instability 40 51 77 88 I-chronic_disease

PAgR 0 4 89 93 B-clinical_variable
is 5 7 94 96 O
more 8 12 97 101 O
than 13 17 102 106 O
46 18 20 107 109 B-lower_bound
% 20 21 109 110 I-lower_bound
and 22 25 111 114 O
the 26 29 115 118 O
percentage 30 40 119 129 O
of 41 43 130 132 O
inhibition 44 54 133 143 O
of 55 57 144 146 O
ADP 58 61 147 150 B-clinical_variable
- 61 62 150 151 I-clinical_variable
induced 62 69 151 158 I-clinical_variable
platelet 70 78 159 167 I-clinical_variable
aggregation 79 90 168 179 O
measured 91 99 180 188 O
by 100 102 189 191 O
thrombelastogram 103 119 192 208 B-treatment
is 120 122 209 211 O
not 123 126 212 215 O
more 127 131 216 220 O
than 132 136 221 225 O
30 137 139 226 228 B-lower_bound
% 139 140 228 229 I-lower_bound

Platelet 0 8 230 238 B-clinical_variable
count 9 14 239 244 I-clinical_variable
< 15 16 245 246 O
100g 16 20 246 250 B-upper_bound
/ 20 21 250 251 I-upper_bound
L 21 22 251 252 I-upper_bound

The 0 3 253 256 O
platelet 4 12 257 265 B-clinical_variable
aggregation 13 24 266 277 I-clinical_variable
rate 25 29 278 282 I-clinical_variable
( 30 31 283 284 I-clinical_variable
PAgR 31 35 284 288 I-clinical_variable
) 35 36 288 289 I-clinical_variable
measured 37 45 290 298 I-clinical_variable
with 46 50 299 303 I-clinical_variable
light 51 56 304 309 I-clinical_variable
transmission 57 69 310 322 I-clinical_variable
aggregometry 70 82 323 335 I-clinical_variable
( 83 84 336 337 I-clinical_variable
LTA 84 87 337 340 I-clinical_variable
) 87 88 340 341 I-clinical_variable
is 89 91 342 344 O
decreased 92 101 345 354 O
no 102 104 355 357 O
more 105 109 358 362 O
than 110 114 363 367 O
10 115 117 368 370 B-upper_bound
% 117 118 370 371 I-upper_bound
from 119 123 372 376 O
baseline 124 132 377 385 O
level 133 138 386 391 O

cardiac 0 7 392 399 B-chronic_disease
shock 8 13 400 405 I-chronic_disease

severe 0 6 406 412 B-chronic_disease
congestive 7 17 413 423 I-chronic_disease
heart 18 23 424 429 I-chronic_disease
failure 24 31 430 437 I-chronic_disease
NYHA 32 36 438 442 I-chronic_disease
II 37 39 443 445 I-chronic_disease
- 39 40 445 446 I-chronic_disease
IV 40 42 446 448 I-chronic_disease

A 0 1 0 1 O
positive 2 10 2 10 B-pregnancy
urine 11 16 11 16 I-pregnancy
pregnancy 17 26 17 26 I-pregnancy
test 27 31 27 31 O
in 32 34 32 34 O
the 35 38 35 38 O
MCRU 39 43 39 43 O
prior 44 49 44 49 O
to 50 52 50 52 O
the 53 56 53 56 O
study 57 62 57 62 O

Asians 0 6 63 69 B-ethnicity
will 7 11 70 74 O
not 12 15 75 78 O
be 16 18 79 81 O
included 19 27 82 90 O
in 28 30 91 93 O
the 31 34 94 97 O
study 35 40 98 103 O
as 41 43 104 106 O
the 44 47 107 110 O
CES1 48 52 111 115 O
SNP 53 56 116 119 O
G143E 57 62 120 125 O
is 63 65 126 128 O
absent 66 72 129 135 O
in 73 75 136 138 O
this 76 80 139 143 O
population 81 91 144 154 O

No 0 2 155 157 O
subjects 3 11 158 166 O
weighing 12 20 167 175 O
under 21 26 176 181 O
50 27 29 182 184 B-upper_bound
kg 30 32 185 187 I-upper_bound
will 33 37 188 192 O
be 38 40 193 195 O
selected 41 49 196 204 O

Subject 0 7 205 212 O
with 8 12 213 217 O
a 13 14 218 219 O
history 15 22 220 227 O
of 23 25 228 230 O
angioedema 26 36 231 241 B-chronic_disease

Subjects 0 8 242 250 O
hypersensitive 9 23 251 265 O
to 24 26 266 268 O
enalapril 27 36 269 278 B-allergy_name

between 0 7 279 286 O
the 8 11 287 290 O
ages 12 16 291 295 B-age
of 17 19 296 298 O
18 20 22 299 301 B-lower_bound
- 22 23 301 302 O
55 23 25 302 304 B-upper_bound
years 26 31 305 310 I-upper_bound

habitual 0 8 311 319 O
consumption 9 20 320 331 O
of 21 23 332 334 O
large 24 29 335 340 O
quantities 30 40 341 351 O
of 41 43 352 354 O
ethanol 44 51 355 362 B-treatment
( 52 53 363 364 O
> 53 54 364 365 O
3 54 55 365 366 B-lower_bound
drinks 56 62 367 373 I-lower_bound
/ 62 63 373 374 I-lower_bound
day 63 66 374 377 I-lower_bound
) 66 67 377 378 O

Biopsy 0 6 0 6 B-treatment
proven 7 13 7 13 O
T2 14 16 14 16 B-cancer
malignant 17 26 17 26 I-cancer
melanoma 27 35 27 35 I-cancer

Eastern 0 7 36 43 B-clinical_variable
Cooperative 8 19 44 55 I-clinical_variable
Oncology 20 28 56 64 I-clinical_variable
Group 29 34 65 70 I-clinical_variable
( 35 36 71 72 I-clinical_variable
ECOG 36 40 72 76 I-clinical_variable
) 40 41 76 77 I-clinical_variable
score 42 47 78 83 I-clinical_variable
of 48 50 84 86 O
0 51 52 87 88 B-lower_bound
- 52 53 88 89 O
2 53 54 89 90 B-upper_bound

Melanoma 0 8 91 99 B-cancer
located 9 16 100 107 O
on 17 19 108 110 O
face 20 24 111 115 O
or 25 27 116 118 O
digits 28 34 119 125 O

Unable 0 6 126 132 O
to 7 9 133 135 O
tolerate 10 18 136 144 O
general 19 26 145 152 B-treatment
anesthesia 27 37 153 163 I-treatment

aged 0 4 0 4 B-age
3 5 6 5 6 B-lower_bound
- 6 7 6 7 O
5 7 8 7 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O
in 19 21 19 21 O
our 22 25 22 25 O
partnering 26 36 26 36 O
Head 37 41 37 41 O
Start 42 47 42 47 O
agency 48 54 48 54 O

A 0 1 0 1 O
QT 2 4 2 4 O
interval 5 13 5 13 O
corrected 14 23 14 23 O
for 24 27 24 27 O
heart 28 33 28 33 O
rate 34 38 34 38 O
using 39 44 39 44 O
the 45 48 45 48 O
Bazett 49 55 49 55 B-clinical_variable
's 55 57 55 57 I-clinical_variable
formula 58 65 58 65 I-clinical_variable
( 66 67 66 67 I-clinical_variable
QTcB 67 71 67 71 I-clinical_variable
) 71 72 71 72 I-clinical_variable
> 73 74 73 74 O
= 74 75 74 75 O
480 76 79 76 79 B-lower_bound
msec 80 84 80 84 I-lower_bound

A 0 1 85 86 O
metastatic 2 12 87 97 B-cancer
lesion 13 19 98 104 I-cancer
that 20 24 105 109 O
is 25 27 110 112 O
not 28 31 113 116 O
radioiodine 32 43 117 128 B-treatment
- 43 44 128 129 O
avid 44 48 129 133 O
on 49 51 134 136 O
a 52 53 137 138 O
diagnostic 54 64 139 149 O
radioiodine 65 76 150 161 O
scan 77 81 162 166 O
performed 82 91 167 176 O
prior 92 97 177 182 O
to 98 100 183 185 O
enrollment 101 111 186 196 O
in 112 114 197 199 O
the 115 118 200 203 O
current 119 126 204 211 O
study 127 132 212 217 O

A 0 1 218 219 O
radioiodine 2 13 220 231 B-treatment
- 13 14 231 232 O
avid 14 18 232 236 O
metastatic 19 29 237 247 B-cancer
lesion 30 36 248 254 I-cancer
which 37 42 255 260 O
remained 43 51 261 269 O
stable 52 58 270 276 O
in 59 61 277 279 O
size 62 66 280 284 O
or 67 69 285 287 O
progressed 70 80 288 298 O
despite 81 88 299 306 O
radioiodine 89 100 307 318 B-treatment
treatment 101 110 319 328 I-treatment
6 111 112 329 330 B-lower_bound
months 113 119 331 337 I-lower_bound
or 120 122 338 340 O
more 123 127 341 345 O
prior 128 133 346 351 O
to 134 136 352 354 O
entry 137 142 355 360 O
in 143 145 361 363 O
the 146 149 364 367 O
study 150 155 368 373 O
; 155 156 373 374 O
there 157 162 375 380 O
are 163 166 381 384 O
no 167 169 385 387 O
size 170 174 388 392 O
limitations 175 186 393 404 O
for 187 190 405 408 O
the 191 194 409 412 O
index 195 200 413 418 O
lesion 201 207 419 425 O
used 208 212 426 430 O
to 213 215 431 433 O
satisfy 216 223 434 441 O
this 224 228 442 446 O
entry 229 234 447 452 O
criterion 235 244 453 462 O

Able 0 4 463 467 O
to 5 7 468 470 O
swallow 8 15 471 478 O
and 16 19 479 482 O
retain 20 26 483 489 O
orally 27 33 490 496 B-treatment
- 33 34 496 497 I-treatment
administered 34 46 497 509 I-treatment
medication 47 57 510 520 I-treatment
and 58 61 521 524 O
does 62 66 525 529 O
not 67 70 530 533 O
have 71 75 534 538 O
any 76 79 539 542 O
clinically 80 90 543 553 O
significant 91 102 554 565 O
gastrointestinal 103 119 566 582 O
abnormalities 120 133 583 596 O
that 134 138 597 601 O
may 139 142 602 605 O
alter 143 148 606 611 O
absorption 149 159 612 622 O
such 160 164 623 627 O
as 165 167 628 630 O
malabsorption 168 181 631 644 B-chronic_disease
syndrome 182 190 645 653 I-chronic_disease
or 191 193 654 656 O
major 194 199 657 662 B-treatment
resection 200 209 663 672 I-treatment
of 210 212 673 675 I-treatment
the 213 216 676 679 I-treatment
stomach 217 224 680 687 I-treatment
or 225 227 688 690 O
bowels 228 234 691 697 B-treatment

Absolute 0 8 698 706 B-clinical_variable
neutrophil 9 19 707 717 I-clinical_variable
count 20 25 718 723 I-clinical_variable
( 26 27 724 725 I-clinical_variable
ANC 27 30 725 728 I-clinical_variable
) 30 31 728 729 I-clinical_variable
> 32 33 730 731 O
= 33 34 731 732 O
1.5 35 38 733 736 B-lower_bound
x 39 40 737 738 I-lower_bound
10 41 43 739 741 I-lower_bound
^ 43 44 741 742 I-lower_bound
9 44 45 742 743 I-lower_bound
/ 45 46 743 744 I-lower_bound
L 46 47 744 745 I-lower_bound

Albumin 0 7 746 753 B-clinical_variable
> 8 9 754 755 O
= 9 10 755 756 O
2.5 11 14 757 760 B-lower_bound
g 15 16 761 762 I-lower_bound
/ 16 17 762 763 I-lower_bound
dL 17 19 763 765 I-lower_bound

All 0 3 766 769 O
prior 4 9 770 775 O
treatment 10 19 776 785 B-treatment
- 19 20 785 786 O
related 20 27 786 793 O
toxicities 28 38 794 804 O
must 39 43 805 809 O
be 44 46 810 812 O
Common 47 53 813 819 B-clinical_variable
Terminology 54 65 820 831 I-clinical_variable
Criteria 66 74 832 840 I-clinical_variable
for 75 78 841 844 I-clinical_variable
Adverse 79 86 845 852 I-clinical_variable
Events 87 93 853 859 I-clinical_variable
version 94 101 860 867 I-clinical_variable
4.0 102 105 868 871 I-clinical_variable
( 106 107 872 873 I-clinical_variable
CTCAE 107 112 873 878 I-clinical_variable
v 113 114 879 880 I-clinical_variable
4.0 115 118 881 884 I-clinical_variable
) 118 119 884 885 I-clinical_variable
grade 120 125 886 891 I-clinical_variable
= 126 127 892 893 O
< 127 128 893 894 O
1 129 130 895 896 B-upper_bound

Animal 0 6 897 903 O
reproductive 7 19 904 916 O
studies 20 27 917 924 O
have 28 32 925 929 O
not 33 36 930 933 O
been 37 41 934 938 O
conducted 42 51 939 948 O
with 52 56 949 953 O
trametinib 57 67 954 964 B-treatment

Aspartate 0 9 965 974 B-clinical_variable
aminotransferase 10 26 975 991 I-clinical_variable
( 27 28 992 993 I-clinical_variable
AST 28 31 993 996 I-clinical_variable
) 31 32 996 997 I-clinical_variable
and 33 36 998 1001 O
alanine 37 44 1002 1009 B-clinical_variable
aminotransferase 45 61 1010 1026 I-clinical_variable
( 62 63 1027 1028 I-clinical_variable
ALT 63 66 1028 1031 I-clinical_variable
) 66 67 1031 1032 I-clinical_variable
= 68 69 1033 1034 O
< 69 70 1034 1035 O
2.5 71 74 1036 1039 B-upper_bound
x 75 76 1040 1041 I-upper_bound
institutional 77 90 1042 1055 I-upper_bound
ULN 91 94 1056 1059 I-upper_bound

Availability 0 12 1060 1072 O
of 13 15 1073 1075 O
archival 16 24 1076 1084 O
tumor 25 30 1085 1090 B-cancer
tissue 31 37 1091 1097 O
from 38 42 1098 1102 O
the 43 46 1103 1106 O
thyroid 47 54 1107 1114 B-cancer
cancer 55 61 1115 1121 I-cancer
primary 62 69 1122 1129 O
or 70 72 1130 1132 O
metastasis 73 83 1133 1143 B-cancer
( 84 85 1144 1145 O
a 85 86 1145 1146 O
tissue 87 93 1147 1153 O
block 94 99 1154 1159 O
or 100 102 1160 1162 O
a 103 104 1163 1164 O
minimum 105 112 1165 1172 O
of 113 115 1173 1175 O
30 116 118 1176 1178 O
unstained 119 128 1179 1188 O
slides 129 135 1189 1195 O
would 136 141 1196 1201 O
be 142 144 1202 1204 O
required 145 153 1205 1213 O
; 153 154 1213 1214 O
patients 155 163 1215 1223 O
with 164 168 1224 1228 O
less 169 173 1229 1233 O
archival 174 182 1234 1242 O
tissue 183 189 1243 1249 O
available 190 199 1250 1259 O
may 200 203 1260 1263 O
still 204 209 1264 1269 O
be 210 212 1270 1272 O
eligible 213 221 1273 1281 O
for 222 225 1282 1285 O
the 226 229 1286 1289 O
study 230 235 1290 1295 O
after 236 241 1296 1301 O
discussion 242 252 1302 1312 O
with 253 257 1313 1317 O
the 258 261 1318 1321 O
MSK 262 265 1322 1325 O
principal 266 275 1326 1335 O
investigator 276 288 1336 1348 O
) 288 289 1348 1349 O

COHORT 0 6 1350 1356 O
A 7 8 1357 1358 O
: 8 9 1358 1359 O
Confirmation 10 22 1360 1372 O
in 23 25 1373 1375 O
a 26 27 1376 1377 O
Clinical 28 36 1378 1386 O
Laboratory 37 47 1387 1397 O
Improvement 48 59 1398 1409 O
Amendments 60 70 1410 1420 O
( 71 72 1421 1422 O
CLIA 72 76 1422 1426 O
) 76 77 1426 1427 O
certified 78 87 1428 1437 O
laboratory 88 98 1438 1448 O
that 99 103 1449 1453 O
one 104 107 1454 1457 O
of 108 110 1458 1460 O
the 111 114 1461 1464 O
patient 115 122 1465 1472 O
's 122 124 1472 1474 O
thyroid 125 132 1475 1482 B-cancer
tumors 133 139 1483 1489 I-cancer
( 140 141 1490 1491 O
primary 141 148 1491 1498 B-cancer
tumor 149 154 1499 1504 I-cancer
, 154 155 1504 1505 O
recurrent 156 165 1506 1515 O
tumor 166 171 1516 1521 O
, 171 172 1521 1522 O
or 173 175 1523 1525 O
metastasis 176 186 1526 1536 B-cancer
) 186 187 1536 1537 O
has 188 191 1538 1541 O
an 192 194 1542 1544 O
neuroblastoma 195 208 1545 1558 B-cancer
RAS 209 212 1559 1562 O
viral 213 218 1563 1568 O
( 219 220 1569 1570 O
v 220 221 1570 1571 O
- 221 222 1571 1572 O
ras 222 225 1572 1575 O
) 225 226 1575 1576 O
oncogene 227 235 1577 1585 O
homolog 236 243 1586 1593 O
( 244 245 1594 1595 O
NRAS 245 249 1595 1599 O
) 249 250 1599 1600 O
or 251 253 1601 1603 O
Kirsten 254 261 1604 1611 O
rat 262 265 1612 1615 O
sarcoma 266 273 1616 1623 B-cancer
viral 274 279 1624 1629 O
oncogene 280 288 1630 1638 O
homolog 289 296 1639 1646 O
( 297 298 1647 1648 O
KRAS 298 302 1648 1652 O
) 302 303 1652 1653 O
or 304 306 1654 1656 O
Harvey 307 313 1657 1663 O
rat 314 317 1664 1667 O
sarcoma 318 325 1668 1675 O
viral 326 331 1676 1681 O
oncogene 332 340 1682 1690 O
homolog 341 348 1691 1698 O
( 349 350 1699 1700 O
HRAS 350 354 1700 1704 O
) 354 355 1704 1705 O
mutation 356 364 1706 1714 O
at 365 367 1715 1717 O
G12 368 371 1718 1721 O
, 371 372 1721 1722 O
G13 373 376 1723 1726 O
, 376 377 1726 1727 O
or 378 380 1728 1730 O
Q61 381 384 1731 1734 O
; 384 385 1734 1735 O
this 386 390 1736 1740 O
group 391 396 1741 1746 O
of 397 399 1747 1749 O
patients 400 408 1750 1758 O
will 409 413 1759 1763 O
also 414 418 1764 1768 O
be 419 421 1769 1771 O
referred 422 430 1772 1780 O
to 431 433 1781 1783 O
as 434 436 1784 1786 O
RAS 437 440 1787 1790 O
MUT 441 444 1791 1794 O

COHORT 0 6 1795 1801 O
A 7 8 1802 1803 O
: 8 9 1803 1804 O
Patients 10 18 1805 1813 O
must 19 23 1814 1818 O
have 24 28 1819 1823 O
progressive 29 40 1824 1835 B-chronic_disease
disease 41 48 1836 1843 I-chronic_disease
, 48 49 1843 1844 O
defined 50 57 1845 1852 O
as 58 60 1853 1855 O
the 61 64 1856 1859 O
presence 65 73 1860 1868 O
of 74 76 1869 1871 O
new 77 80 1872 1875 O
or 81 83 1876 1878 O
growing 84 91 1879 1886 O
lesion(s 92 100 1887 1895 O
) 100 101 1895 1896 O
on 102 104 1897 1899 O
radiologic 105 115 1900 1910 B-treatment
imaging 116 123 1911 1918 I-treatment
within 124 130 1919 1925 O
14 131 133 1926 1928 B-upper_bound
months 134 140 1929 1935 I-upper_bound
of 141 143 1936 1938 O
study 144 149 1939 1944 O
enrollment 150 160 1945 1955 O
and/or 161 167 1956 1962 O
new 168 171 1963 1966 O
/ 171 172 1966 1967 O
worsening 172 181 1967 1976 O
disease 182 189 1977 1984 O
related 190 197 1985 1992 O
symptoms 198 206 1993 2001 O
within 207 213 2002 2008 O
14 214 216 2009 2011 O
months 217 223 2012 2018 O
of 224 226 2019 2021 O
study 227 232 2022 2027 O
enrollment 233 243 2028 2038 O

Concurrent 0 10 2039 2049 B-treatment
treatment 11 20 2050 2059 I-treatment
with 21 25 2060 2064 O
bisphosphonates 26 41 2065 2080 B-treatment

Creatinine 0 10 2081 2091 B-clinical_variable
= 11 12 2092 2093 O
< 12 13 2093 2094 O
1.5 14 17 2095 2098 B-upper_bound
mg 18 20 2099 2101 I-upper_bound
/ 20 21 2101 2102 I-upper_bound
dL 21 23 2102 2104 I-upper_bound
OR 24 26 2105 2107 O
calculated 27 37 2108 2118 B-clinical_variable
creatinine 38 48 2119 2129 I-clinical_variable
clearance 49 58 2130 2139 I-clinical_variable
( 59 60 2140 2141 O
Cockcroft 60 69 2141 2150 O
- 69 70 2150 2151 O
Gault 70 75 2151 2156 O
formula 76 83 2157 2164 O
) 83 84 2164 2165 O
> 85 86 2166 2167 O
= 86 87 2167 2168 O
50 88 90 2169 2171 B-lower_bound
mL 91 93 2172 2174 I-lower_bound
/ 93 94 2174 2175 I-lower_bound
min 94 97 2175 2178 I-lower_bound
OR 98 100 2179 2181 O
24 101 103 2182 2184 O
- 103 104 2184 2185 O
hour 104 108 2185 2189 O
urine 109 114 2190 2195 O
creatinine 115 125 2196 2206 O
clearance 126 135 2207 2216 O
> 136 137 2217 2218 O
= 137 138 2218 2219 O
50 139 141 2220 2222 O
mL 142 144 2223 2225 O
/ 144 145 2225 2226 O
min 145 148 2226 2229 O

Current 0 7 2230 2237 O
use 8 11 2238 2241 O
of 12 14 2242 2244 O
a 15 16 2245 2246 O
prohibited 17 27 2247 2257 B-treatment
medication 28 38 2258 2268 I-treatment

Eastern 0 7 2269 2276 B-clinical_variable
Cooperative 8 19 2277 2288 I-clinical_variable
Oncology 20 28 2289 2297 I-clinical_variable
Group 29 34 2298 2303 I-clinical_variable
( 35 36 2304 2305 I-clinical_variable
ECOG 36 40 2305 2309 I-clinical_variable
) 40 41 2309 2310 I-clinical_variable
performance 42 53 2311 2322 I-clinical_variable
status 54 60 2323 2329 I-clinical_variable
= 61 62 2330 2331 O
< 62 63 2331 2332 O
2 64 65 2333 2334 B-upper_bound
( 66 67 2335 2336 O
Karnofsky 67 76 2336 2345 B-clinical_variable
> 77 78 2346 2347 O
= 78 79 2347 2348 O
60 80 82 2349 2351 B-lower_bound
% 82 83 2351 2352 I-lower_bound
) 83 84 2352 2353 O

HIV 0 3 2354 2357 B-chronic_disease
- 3 4 2357 2358 O
positive 4 12 2358 2366 O
patients 13 21 2367 2375 O
on 22 24 2376 2378 O
combination 25 36 2379 2390 B-treatment
antiretroviral 37 51 2391 2405 I-treatment
therapy 52 59 2406 2413 I-treatment
are 60 63 2414 2417 O
ineligible 64 74 2418 2428 O
because 75 82 2429 2436 O
of 83 85 2437 2439 O
the 86 89 2440 2443 O
potential 90 99 2444 2453 O
for 100 103 2454 2457 O
pharmacokinetic 104 119 2458 2473 B-treatment
interactions 120 132 2474 2486 I-treatment
with 133 137 2487 2491 I-treatment
trametinib 138 148 2492 2502 I-treatment

Have 0 4 2503 2507 O
a 5 6 2508 2509 O
known 7 12 2510 2515 O
immediate 13 22 2516 2525 O
or 23 25 2526 2528 O
delayed 26 33 2529 2536 O
hypersensitivity 34 50 2537 2553 O
reaction 51 59 2554 2562 O
or 60 62 2563 2565 O
idiosyncrasy 63 75 2566 2578 O
to 76 78 2579 2581 O
drugs 79 84 2582 2587 O
chemically 85 95 2588 2598 O
related 96 103 2599 2606 O
to 104 106 2607 2609 O
trametinib 107 117 2610 2620 B-allergy_name
, 117 118 2620 2621 O
or 119 121 2622 2624 O
excipients 122 132 2625 2635 B-allergy_name
or 133 135 2636 2638 O
to 136 138 2639 2641 O
dimethyl 139 147 2642 2650 B-allergy_name
sulfoxide 148 157 2651 2660 I-allergy_name
( 158 159 2661 2662 I-allergy_name
DMSO 159 163 2662 2666 I-allergy_name
) 163 164 2666 2667 I-allergy_name
or 165 167 2668 2670 O
to 168 170 2671 2673 O
thyrotropin 171 182 2674 2685 B-allergy_name
alpha 183 188 2686 2691 I-allergy_name
( 189 190 2692 2693 I-allergy_name
Thyrogen 190 198 2693 2701 I-allergy_name
) 198 199 2701 2702 I-allergy_name

Hemoglobin 0 10 2703 2713 B-clinical_variable
> 11 12 2714 2715 O
= 12 13 2715 2716 O
9 14 15 2717 2718 B-lower_bound
g 16 17 2719 2720 I-lower_bound
/ 17 18 2720 2721 I-lower_bound
dL 18 20 2721 2723 I-lower_bound

History 0 7 2724 2731 O
of 8 10 2732 2734 O
acute 11 16 2735 2740 B-chronic_disease
coronary 17 25 2741 2749 I-chronic_disease
syndromes 26 35 2750 2759 I-chronic_disease
( 36 37 2760 2761 O
including 37 46 2761 2770 O
myocardial 47 57 2771 2781 B-chronic_disease
infarction 58 68 2782 2792 I-chronic_disease
and 69 72 2793 2796 O
unstable 73 81 2797 2805 B-chronic_disease
angina 82 88 2806 2812 I-chronic_disease
) 88 89 2812 2813 O
, 89 90 2813 2814 O
coronary 91 99 2815 2823 B-treatment
angioplasty 100 111 2824 2835 I-treatment
, 111 112 2835 2836 O
or 113 115 2837 2839 O
stenting 116 124 2840 2848 B-treatment
within 125 131 2849 2855 O
6 132 133 2856 2857 B-upper_bound
months 134 140 2858 2864 I-upper_bound
prior 141 146 2865 2870 I-upper_bound
to 147 149 2871 2873 O
randomization 150 163 2874 2887 O

History 0 7 2888 2895 O
of 8 10 2896 2898 O
another 11 18 2899 2906 O
malignancy 19 29 2907 2917 B-cancer

History 0 7 2918 2925 O
of 8 10 2926 2928 O
interstitial 11 23 2929 2941 B-chronic_disease
lung 24 28 2942 2946 I-chronic_disease
disease 29 36 2947 2954 I-chronic_disease
or 37 39 2955 2957 O
pneumonitis 40 51 2958 2969 B-chronic_disease

History 0 7 2970 2977 O
or 8 10 2978 2980 O
evidence 11 19 2981 2989 O
of 20 22 2990 2992 O
cardiovascular 23 37 2993 3007 B-chronic_disease
risk 38 42 3008 3012 I-chronic_disease

History 0 7 3013 3020 O
or 8 10 3021 3023 O
evidence 11 19 3024 3032 O
of 20 22 3033 3035 O
current 23 30 3036 3043 O
> 31 32 3044 3045 O
= 32 33 3045 3046 O
class 34 39 3047 3052 O
II 40 42 3053 3055 O
congestive 43 53 3056 3066 B-chronic_disease
heart 54 59 3067 3072 I-chronic_disease
failure 60 67 3073 3080 I-chronic_disease
as 68 70 3081 3083 O
defined 71 78 3084 3091 O
by 79 81 3092 3094 O
the 82 85 3095 3098 O
New 86 89 3099 3102 B-clinical_variable
York 90 94 3103 3107 I-clinical_variable
Heart 95 100 3108 3113 I-clinical_variable
Association 101 112 3114 3125 I-clinical_variable
( 113 114 3126 3127 I-clinical_variable
NYHA 114 118 3127 3131 I-clinical_variable
) 118 119 3131 3132 I-clinical_variable
functional 120 130 3133 3143 O
classification 131 145 3144 3158 O
system 146 152 3159 3165 O

History 0 7 3166 3173 O
or 8 10 3174 3176 O
evidence 11 19 3177 3185 O
of 20 22 3186 3188 O
current 23 30 3189 3196 O
clinically 31 41 3197 3207 O
significant 42 53 3208 3219 O
uncontrolled 54 66 3220 3232 O
arrhythmias 67 78 3233 3244 B-chronic_disease

Known 0 5 3245 3250 O
cardiac 6 13 3251 3258 B-cancer
metastases 14 24 3259 3269 I-cancer

Known 0 5 3270 3275 O
human 6 11 3276 3281 B-chronic_disease
immunodeficiency 12 28 3282 3298 I-chronic_disease
virus 29 34 3299 3304 I-chronic_disease
( 35 36 3305 3306 I-chronic_disease
HIV 36 39 3306 3309 I-chronic_disease
) 39 40 3309 3310 I-chronic_disease
, 40 41 3310 3311 O
hepatitis 42 51 3312 3321 B-chronic_disease
B 52 53 3322 3323 I-chronic_disease
virus 54 59 3324 3329 I-chronic_disease
( 60 61 3330 3331 I-chronic_disease
HBV 61 64 3331 3334 I-chronic_disease
) 64 65 3334 3335 I-chronic_disease
, 65 66 3335 3336 O
or 67 69 3337 3339 O
hepatitis 70 79 3340 3349 B-chronic_disease
C 80 81 3350 3351 I-chronic_disease
virus 82 87 3352 3357 I-chronic_disease
( 88 89 3358 3359 I-chronic_disease
HCV 89 92 3359 3362 I-chronic_disease
) 92 93 3362 3363 I-chronic_disease
infection 94 103 3364 3373 O

Left 0 4 3374 3378 B-clinical_variable
ventricular 5 16 3379 3390 I-clinical_variable
ejection 17 25 3391 3399 I-clinical_variable
fraction 26 34 3400 3408 I-clinical_variable
( 35 36 3409 3410 I-clinical_variable
LVEF 36 40 3410 3414 I-clinical_variable
) 40 41 3414 3415 I-clinical_variable
< 42 43 3416 3417 O
LLN 44 47 3418 3421 O

Left 0 4 3422 3426 B-clinical_variable
ventricular 5 16 3427 3438 I-clinical_variable
ejection 17 25 3439 3447 I-clinical_variable
fraction 26 34 3448 3456 I-clinical_variable
> 35 36 3457 3458 O
= 36 37 3458 3459 O
institutional 38 51 3460 3473 O
lower 52 57 3474 3479 O
limit 58 63 3480 3485 O
of 64 66 3486 3488 O
normal 67 73 3489 3495 O
( 74 75 3496 3497 O
LLN 75 78 3497 3500 O
) 78 79 3500 3501 O
by 80 82 3502 3504 O
echocardiogram 83 97 3505 3519 B-treatment
( 98 99 3520 3521 I-treatment
ECHO 99 103 3521 3525 I-treatment
) 103 104 3525 3526 I-treatment
or 105 107 3527 3529 O
multi 108 113 3530 3535 B-treatment
gated 114 119 3536 3541 I-treatment
acquisition 120 131 3542 3553 I-treatment
scan 132 136 3554 3558 I-treatment
( 137 138 3559 3560 I-treatment
MUGA 138 142 3560 3564 I-treatment
) 142 143 3564 3565 I-treatment

Life 0 4 3566 3570 B-clinical_variable
expectancy 5 15 3571 3581 I-clinical_variable
of 16 18 3582 3584 O
greater 19 26 3585 3592 O
than 27 31 3593 3597 O
3 32 33 3598 3599 B-lower_bound
months 34 40 3600 3606 I-lower_bound

No 0 2 3607 3609 O
chemotherapy 3 15 3610 3622 B-treatment
or 16 18 3623 3625 O
targeted 19 27 3626 3634 B-treatment
therapy 28 35 3635 3642 I-treatment
( 36 37 3643 3644 O
e.g. 37 41 3644 3648 O
, 41 42 3648 3649 O
tyrosine 43 51 3650 3658 B-treatment
kinase 52 58 3659 3665 I-treatment
inhibitor 59 68 3666 3675 I-treatment
) 68 69 3675 3676 O
is 70 72 3677 3679 O
allowed 73 80 3680 3687 O
< 81 82 3688 3689 O
4 83 84 3690 3691 B-upper_bound
weeks 85 90 3692 3697 I-upper_bound
prior 91 96 3698 3703 I-upper_bound
to 97 99 3704 3706 O
the 100 103 3707 3710 O
initiation 104 114 3711 3721 O
of 115 117 3722 3724 O
therapy 118 125 3725 3732 O
on 126 128 3733 3735 O
this 129 133 3736 3740 O
protocol 134 142 3741 3749 O

No 0 2 3750 3752 O
external 3 11 3753 3761 B-treatment
beam 12 16 3762 3766 I-treatment
radiation 17 26 3767 3776 I-treatment
therapy 27 34 3777 3784 I-treatment
< 35 36 3785 3786 O
4 37 38 3787 3788 B-upper_bound
weeks 39 44 3789 3794 I-upper_bound
prior 45 50 3795 3800 I-upper_bound
to 51 53 3801 3803 O
initiation 54 64 3804 3814 O
of 65 67 3815 3817 O
therapy 68 75 3818 3825 O
on 76 78 3826 3828 O
this 79 83 3829 3833 O
protocol 84 92 3834 3842 O

No 0 2 3843 3845 O
prior 3 8 3846 3851 B-treatment
RAI 9 12 3852 3855 I-treatment
therapy 13 20 3856 3863 I-treatment
is 21 23 3864 3866 O
allowed 24 31 3867 3874 O
< 32 33 3875 3876 O
6 34 35 3877 3878 B-upper_bound
months 36 42 3879 3885 I-upper_bound
prior 43 48 3886 3891 I-upper_bound
to 49 51 3892 3894 O
initiation 52 62 3895 3905 O
of 63 65 3906 3908 O
therapy 66 73 3909 3916 O
on 74 76 3917 3919 O
this 77 81 3920 3924 O
protocol 82 90 3925 3933 O

No 0 2 3934 3936 O
recent 3 9 3937 3943 O
treatment 10 19 3944 3953 B-treatment
for 20 23 3954 3957 O
thyroid 24 31 3958 3965 B-cancer
cancer 32 38 3966 3972 I-cancer

Other 0 5 3973 3978 B-treatment
anti 6 10 3979 3983 I-treatment
- 10 11 3983 3984 I-treatment
cancer 11 17 3984 3990 I-treatment
therapy 18 25 3991 3998 O
while 26 31 3999 4004 O
on 32 34 4005 4007 O
study 35 40 4008 4013 O

Patients 0 8 4014 4022 O
must 9 13 4023 4027 O
agree 14 19 4028 4033 O
to 20 22 4034 4036 O
undergo 23 30 4037 4044 O
two 31 34 4045 4048 O
separate 35 43 4049 4057 O
biopsies 44 52 4058 4066 B-treatment
of 53 55 4067 4069 O
a 56 57 4070 4071 O
malignant 58 67 4072 4081 O
lesion 68 74 4082 4088 O

Patients 0 8 4089 4097 O
must 9 13 4098 4102 O
have 14 18 4103 4107 O
histologically 19 33 4108 4122 O
or 34 36 4123 4125 O
cytologically 37 50 4126 4139 O
confirmed 51 60 4140 4149 O
thyroid 61 68 4150 4157 B-cancer
carcinoma 69 78 4158 4167 I-cancer
of 79 81 4168 4170 O
follicular 82 92 4171 4181 O
origin 93 99 4182 4188 O
( 100 101 4189 4190 O
including 101 110 4190 4199 O
papillary 111 120 4200 4209 O
, 120 121 4209 4210 O
follicular 122 132 4211 4221 O
, 132 133 4221 4222 O
or 134 136 4223 4225 O
poorly 137 143 4226 4232 O
differentiated 144 158 4233 4247 O
subtypes 159 167 4248 4256 O
and 168 171 4257 4260 O
their 172 177 4261 4266 O
respective 178 188 4267 4277 O
variants 189 197 4278 4286 O
) 197 198 4286 4287 O
; 198 199 4287 4288 O
confirmation 200 212 4289 4301 O
of 213 215 4302 4304 O
thyroid 216 223 4305 4312 O
carcinoma 224 233 4313 4322 O
will 234 238 4323 4327 O
be 239 241 4328 4330 O
done 242 246 4331 4335 O
at 247 249 4336 4338 O
Memorial 250 258 4339 4347 O
Sloan 259 264 4348 4353 O
- 264 265 4353 4354 O
Kettering 265 274 4354 4363 O
( 275 276 4364 4365 O
MSK 276 279 4365 4368 O
) 279 280 4368 4369 O

Patients 0 8 4370 4378 O
must 9 13 4379 4383 O
have 14 18 4384 4388 O
measurable 19 29 4389 4399 O
disease 30 37 4400 4407 O
, 37 38 4407 4408 O
defined 39 46 4409 4416 O
as 47 49 4417 4419 O
at 50 52 4420 4422 O
least 53 58 4423 4428 O
one 59 62 4429 4432 B-lower_bound
lesion 63 69 4433 4439 O
that 70 74 4440 4444 O
can 75 78 4445 4448 O
be 79 81 4449 4451 O
accurately 82 92 4452 4462 O
measured 93 101 4463 4471 O
in 102 104 4472 4474 O
at 105 107 4475 4477 O
least 108 113 4478 4483 O
one 114 117 4484 4487 O
dimension 118 127 4488 4497 O
( 128 129 4498 4499 O
longest 129 136 4499 4506 O
diameter 137 145 4507 4515 O
to 146 148 4516 4518 O
be 149 151 4519 4521 O
recorded 152 160 4522 4530 O
for 161 164 4531 4534 O
non 165 168 4535 4538 O
- 168 169 4538 4539 O
nodal 169 174 4539 4544 O
lesions 175 182 4545 4552 O
and 183 186 4553 4556 O
short 187 192 4557 4562 O
axis 193 197 4563 4567 O
for 198 201 4568 4571 O
nodal 202 207 4572 4577 O
lesions 208 215 4578 4585 O
) 215 216 4585 4586 O
as 217 219 4587 4589 O
> 220 221 4590 4591 O
= 221 222 4591 4592 O
20 223 225 4593 4595 B-lower_bound
mm 226 228 4596 4598 I-lower_bound
with 229 233 4599 4603 O
conventional 234 246 4604 4616 B-treatment
techniques 247 257 4617 4627 I-treatment
or 258 260 4628 4630 O
as 261 263 4631 4633 O
> 264 265 4634 4635 O
= 265 266 4635 4636 O
10 267 269 4637 4639 B-lower_bound
mm 270 272 4640 4642 I-lower_bound
with 273 277 4643 4647 O
spiral 278 284 4648 4654 B-treatment
CT 285 287 4655 4657 I-treatment
scan 288 292 4658 4662 I-treatment
, 292 293 4662 4663 O
magnetic 294 302 4664 4672 B-treatment
resonance 303 312 4673 4682 I-treatment
imaging 313 320 4683 4690 I-treatment
( 321 322 4691 4692 I-treatment
MRI 322 325 4692 4695 I-treatment
) 325 326 4695 4696 I-treatment
, 326 327 4696 4697 O
or 328 330 4698 4700 O
calipers 331 339 4701 4709 B-treatment
by 340 342 4710 4712 O
clinical 343 351 4713 4721 O
exam 352 356 4722 4726 O

Patients 0 8 4727 4735 O
unable 9 15 4736 4742 O
to 16 18 4743 4745 O
follow 19 25 4746 4752 O
a 26 27 4753 4754 O
low 28 31 4755 4758 O
iodine 32 38 4759 4765 O
diet 39 43 4766 4770 O
or 44 46 4771 4773 O
requiring 47 56 4774 4783 O
medication 57 67 4784 4794 B-treatment
with 68 72 4795 4799 O
high 73 77 4800 4804 O
content 78 85 4805 4812 O
in 86 88 4813 4815 O
iodide 89 95 4816 4822 O
( 96 97 4823 4824 O
amiodarone 97 107 4824 4834 B-treatment
) 107 108 4834 4835 O

Patients 0 8 4836 4844 O
who 9 12 4845 4848 O
received 13 21 4849 4857 O
iodinated 22 31 4858 4867 B-treatment
intravenous 32 43 4868 4879 I-treatment
contrast 44 52 4880 4888 I-treatment
as 53 55 4889 4891 O
part 56 60 4892 4896 O
of 61 63 4897 4899 O
a 64 65 4900 4901 O
radiographic 66 78 4902 4914 B-treatment
procedure 79 88 4915 4924 I-treatment
within 89 95 4925 4931 O
3 96 97 4932 4933 B-upper_bound
months 98 104 4934 4940 I-upper_bound
of 105 107 4941 4943 O
study 108 113 4944 4949 O
registration 114 126 4950 4962 O

Patients 0 8 4963 4971 O
with 9 13 4972 4976 O
intra 14 19 4977 4982 B-treatment
- 19 20 4982 4983 I-treatment
cardiac 20 27 4983 4990 I-treatment
defibrillators 28 42 4991 5005 I-treatment

Platelets 0 9 5006 5015 B-clinical_variable
> 10 11 5016 5017 O
= 11 12 5017 5018 O
100 13 16 5019 5022 B-lower_bound
x 17 18 5023 5024 I-lower_bound
10 19 21 5025 5027 I-lower_bound
^ 21 22 5027 5028 I-lower_bound
9 22 23 5028 5029 I-lower_bound
/ 23 24 5029 5030 I-lower_bound
L 24 25 5030 5031 I-lower_bound

Prothrombin 0 11 5032 5043 B-clinical_variable
time 12 16 5044 5048 I-clinical_variable
( 17 18 5049 5050 I-clinical_variable
PT)/international 18 35 5050 5067 I-clinical_variable
normalized 36 46 5068 5078 I-clinical_variable
ratio 47 52 5079 5084 I-clinical_variable
( 53 54 5085 5086 I-clinical_variable
INR 54 57 5086 5089 I-clinical_variable
) 57 58 5089 5090 I-clinical_variable
and 59 62 5091 5094 O
partial 63 70 5095 5102 B-clinical_variable
thromboplastin 71 85 5103 5117 I-clinical_variable
time 86 90 5118 5122 I-clinical_variable
( 91 92 5123 5124 I-clinical_variable
PTT 92 95 5124 5127 I-clinical_variable
) 95 96 5127 5128 I-clinical_variable
= 97 98 5129 5130 O
< 98 99 5130 5131 O
1.5 100 103 5132 5135 B-upper_bound
x 104 105 5136 5137 I-upper_bound
institutional 106 119 5138 5151 I-upper_bound
ULN 120 123 5152 5155 I-upper_bound

RAI 0 3 5156 5159 B-treatment
- 3 4 5159 5160 O
refractory 4 14 5160 5170 O
disease 15 22 5171 5178 O
on 23 25 5179 5181 O
structural 26 36 5182 5192 O
imaging 37 44 5193 5200 O

Symptomatic 0 11 5201 5212 O
or 12 14 5213 5215 O
untreated 15 24 5216 5225 O
leptomeningeal 25 39 5226 5240 B-cancer
or 40 42 5241 5243 O
brain 43 48 5244 5249 B-cancer
metastases 49 59 5250 5260 I-cancer
or 60 62 5261 5263 O
spinal 63 69 5264 5270 B-chronic_disease
cord 70 74 5271 5275 I-chronic_disease
compression 75 86 5276 5287 I-chronic_disease

The 0 3 5288 5291 O
goal 4 8 5292 5296 O
will 9 13 5297 5301 O
be 14 16 5302 5304 O
to 17 19 5305 5307 O
have 20 24 5308 5312 O
a 25 26 5313 5314 O
minimum 27 34 5315 5322 O
of 35 37 5323 5325 O
6 38 39 5326 5327 B-lower_bound
patients 40 48 5328 5336 O
from 49 53 5337 5341 O
Cohort 54 60 5342 5348 O
A 61 62 5349 5350 O
and 63 66 5351 5354 O
3 67 68 5355 5356 O
patients 69 77 5357 5365 O
from 78 82 5366 5370 O
Cohort 83 89 5371 5377 O
B 90 91 5378 5379 O
attempt 92 99 5380 5387 O
to 100 102 5388 5390 O
have 103 107 5391 5395 O
one 108 111 5396 5399 O
or 112 114 5400 5402 O
both 115 119 5403 5407 O
of 120 122 5408 5410 O
these 123 128 5411 5416 O
research 129 137 5417 5425 B-treatment
biopsies 138 146 5426 5434 I-treatment
done 147 151 5435 5439 O
( 152 153 5440 5441 O
for 153 156 5441 5444 O
a 157 158 5445 5446 O
total 159 164 5447 5452 O
of 165 167 5453 5455 O
9 168 169 5456 5457 O
patients 170 178 5458 5466 O
total 179 184 5467 5472 O
) 184 185 5472 5473 O
; 185 186 5473 5474 O
accrual 187 194 5475 5482 O
may 195 198 5483 5486 O
be 199 201 5487 5489 O
limited 202 209 5490 5497 O
only 210 214 5498 5502 O
to 215 217 5503 5505 O
subjects 218 226 5506 5514 O
for 227 230 5515 5518 O
whom 231 235 5519 5523 O
tumor 236 241 5524 5529 B-cancer
is 242 244 5530 5532 O
accessible 245 255 5533 5543 O
for 256 259 5544 5547 O
biopsy 260 266 5548 5554 B-treatment
and 267 270 5555 5558 O
attempt 271 278 5559 5566 O
at 279 281 5567 5569 O
biopsy 282 288 5570 5576 O
is 289 291 5577 5579 O
considered 292 302 5580 5590 O
safe 303 307 5591 5595 O
if 308 310 5596 5598 O
continued 311 320 5599 5608 O
enrollment 321 331 5609 5619 O
of 332 334 5620 5622 O
those 335 340 5623 5628 O
who 341 344 5629 5632 O
are 345 348 5633 5636 O
not 349 352 5637 5640 O
candidates 353 363 5641 5651 O
for 364 367 5652 5655 O
biopsy 368 374 5656 5662 O
make 375 379 5663 5667 O
it 380 382 5668 5670 O
impossible 383 393 5671 5681 O
to 394 396 5682 5684 O
reach 397 402 5685 5690 O
the 403 406 5691 5694 O
accrual 407 414 5695 5702 O
goals 415 420 5703 5708 O
for 421 424 5709 5712 O
research 425 433 5713 5721 O
biopsies 434 442 5722 5730 O
described 443 452 5731 5740 O
above 453 458 5741 5746 O
( 459 460 5747 5748 O
e.g. 460 464 5748 5752 O
, 464 465 5752 5753 O
if 466 468 5754 5756 O
19 469 471 5757 5759 O
[ 472 473 5760 5761 O
of 473 475 5761 5763 O
25 476 478 5764 5766 O
] 478 479 5766 5767 O
patients 480 488 5768 5776 O
are 489 492 5777 5780 O
accrued 493 500 5781 5788 O
to 501 503 5789 5791 O
Cohort 504 510 5792 5798 O
A 511 512 5799 5800 O
without 513 520 5801 5808 O
any 521 524 5809 5812 O
biopsies 525 533 5813 5821 O
having 534 540 5822 5828 O
been 541 545 5829 5833 O
obtained 546 554 5834 5842 O
within 555 561 5843 5849 O
the 562 565 5850 5853 O
cohort 566 572 5854 5860 O
, 572 573 5860 5861 O
then 574 578 5862 5866 O
all 579 582 5867 5870 O
further 583 590 5871 5878 O
subjects 591 599 5879 5887 O
who 600 603 5888 5891 O
are 604 607 5892 5895 O
registered 608 618 5896 5906 O
to 619 621 5907 5909 O
that 622 626 5910 5914 O
cohort 627 633 5915 5921 O
must 634 638 5922 5926 O
qualify 639 646 5927 5934 O
for 647 650 5935 5938 O
attempted 651 660 5939 5948 O
research 661 669 5949 5957 B-treatment
biopsy 670 676 5958 5964 I-treatment
in 677 679 5965 5967 O
order 680 685 5968 5973 O
to 686 688 5974 5976 O
be 689 691 5977 5979 O
enrolled 692 700 5980 5988 O
into 701 705 5989 5993 O
the 706 709 5994 5997 O
study 710 715 5998 6003 O

The 0 3 6004 6007 O
presence 4 12 6008 6016 O
of 13 15 6017 6019 O
at 16 18 6020 6022 O
least 19 24 6023 6028 O
one 25 28 6029 6032 B-lower_bound
fluorodeoxyglucose 29 47 6033 6051 B-treatment
( 48 49 6052 6053 I-treatment
FDG 49 52 6053 6056 I-treatment
) 52 53 6056 6057 I-treatment
avid 54 58 6058 6062 O
lesion 59 65 6063 6069 O

Total 0 5 6070 6075 B-clinical_variable
bilirubin 6 15 6076 6085 I-clinical_variable
= 16 17 6086 6087 O
< 17 18 6087 6088 O
1.5 19 22 6089 6092 B-upper_bound
x 23 24 6093 6094 I-upper_bound
institutional 25 38 6095 6108 I-upper_bound
upper 39 44 6109 6114 I-upper_bound
limit 45 50 6115 6120 I-upper_bound
of 51 53 6121 6123 I-upper_bound
normal 54 60 6124 6130 I-upper_bound
( 61 62 6131 6132 I-upper_bound
ULN 62 65 6132 6135 I-upper_bound
) 65 66 6135 6136 I-upper_bound

Treatment 0 9 6137 6146 B-treatment
- 9 10 6146 6147 I-treatment
refractory 10 20 6147 6157 I-treatment
hypertension 21 33 6158 6170 I-treatment
defined 34 41 6171 6178 O
as 42 44 6179 6181 O
a 45 46 6182 6183 O
blood 47 52 6184 6189 B-clinical_variable
pressure 53 61 6190 6198 I-clinical_variable
of 62 64 6199 6201 I-clinical_variable
systolic 65 73 6202 6210 I-clinical_variable
> 74 75 6211 6212 O
140 76 79 6213 6216 B-lower_bound
mmHg 80 84 6217 6221 I-lower_bound
and/or 85 91 6222 6228 O
diastolic 92 101 6229 6238 B-clinical_variable
> 102 103 6239 6240 O
90 104 106 6241 6243 B-lower_bound
mmHg 107 111 6244 6248 I-lower_bound
which 112 117 6249 6254 O
can 118 121 6255 6258 O
not 121 124 6258 6261 O
be 125 127 6262 6264 O
controlled 128 138 6265 6275 O
by 139 141 6276 6278 O
anti 142 146 6279 6283 B-treatment
- 146 147 6283 6284 I-treatment
hypertensive 147 159 6284 6296 I-treatment
therapy 160 167 6297 6304 I-treatment

Uncontrolled 0 12 6305 6317 O
intercurrent 13 25 6318 6330 B-chronic_disease
illness 26 33 6331 6338 I-chronic_disease
including 34 43 6339 6348 O
, 43 44 6348 6349 O
but 45 48 6350 6353 O
not 49 52 6354 6357 O
limited 53 60 6358 6365 O
to 61 63 6366 6368 O
, 63 64 6368 6369 O
ongoing 65 72 6370 6377 O
or 73 75 6378 6380 O
active 76 82 6381 6387 B-chronic_disease
infection 83 92 6388 6397 I-chronic_disease
, 92 93 6397 6398 O
symptomatic 94 105 6399 6410 O
congestive 106 116 6411 6421 B-chronic_disease
heart 117 122 6422 6427 I-chronic_disease
failure 123 130 6428 6435 I-chronic_disease
, 130 131 6435 6436 O
unstable 132 140 6437 6445 O
angina 141 147 6446 6452 B-chronic_disease
pectoris 148 156 6453 6461 I-chronic_disease
, 156 157 6461 6462 O
cardiac 158 165 6463 6470 O
arrhythmia 166 176 6471 6481 B-chronic_disease
, 176 177 6481 6482 O
or 178 180 6483 6485 O
psychiatric 181 192 6486 6497 B-chronic_disease
illness 193 200 6498 6505 I-chronic_disease
/ 200 201 6505 6506 O
social 201 207 6506 6512 O
situations 208 218 6513 6523 O
that 219 223 6524 6528 O
would 224 229 6529 6534 O
limit 230 235 6535 6540 O
compliance 236 246 6541 6551 O
with 247 251 6552 6556 O
study 252 257 6557 6562 O
requirements 258 270 6563 6575 O

Use 0 3 6576 6579 O
of 4 6 6580 6582 O
other 7 12 6583 6588 B-treatment
investigational 13 28 6589 6604 I-treatment
drugs 29 34 6605 6610 I-treatment
within 35 41 6611 6617 O
28 42 44 6618 6620 B-upper_bound
days 45 49 6621 6625 I-upper_bound
( 50 51 6626 6627 O
or 51 53 6627 6629 O
five 54 58 6630 6634 B-upper_bound
half 59 63 6635 6639 I-upper_bound
- 63 64 6639 6640 I-upper_bound
lives 64 69 6640 6645 I-upper_bound
, 69 70 6645 6646 O
whichever 71 80 6647 6656 O
is 81 83 6657 6659 O
shorter 84 91 6660 6667 O
; 91 92 6667 6668 O
with 93 97 6669 6673 O
a 98 99 6674 6675 O
minimum 100 107 6676 6683 O
of 108 110 6684 6686 O
14 111 113 6687 6689 B-lower_bound
days 114 118 6690 6694 I-lower_bound
from 119 123 6695 6699 O
the 124 127 6700 6703 O
last 128 132 6704 6708 O
dose 133 137 6709 6713 O
) 137 138 6713 6714 O
preceding 139 148 6715 6724 O
the 149 152 6725 6728 O
first 153 158 6729 6734 O
dose 159 163 6735 6739 O
of 164 166 6740 6742 O
trametinib 167 177 6743 6753 B-treatment
and 178 181 6754 6757 O
during 182 188 6758 6764 O
the 189 192 6765 6768 O
study 193 198 6769 6774 O

alopecia 0 8 6775 6783 B-chronic_disease

chronic 0 7 6784 6791 O
or 8 10 6792 6794 O
cleared 11 18 6795 6802 O
HBV 19 22 6803 6806 B-chronic_disease
and 23 26 6807 6810 O
HCV 27 30 6811 6814 B-chronic_disease
infection 31 40 6815 6824 B-chronic_disease

grade 0 5 6825 6830 O
2 6 7 6831 6832 O
prior 8 13 6833 6838 B-treatment
treatment 14 23 6839 6848 I-treatment
related 24 31 6849 6856 O
toxicities 32 42 6857 6867 O
may 43 46 6868 6871 O
be 47 49 6872 6874 O
allowed 50 57 6875 6882 O
after 58 63 6883 6888 O
discussion 64 74 6889 6899 O
with 75 79 6900 6904 O
the 80 83 6905 6908 O
principal 84 93 6909 6918 O
investigator 94 106 6919 6931 O

megestrol 0 9 6932 6941 B-treatment
[ 10 11 6942 6943 I-treatment
Megace 11 17 6943 6949 I-treatment
] 17 18 6949 6950 I-treatment
if 19 21 6951 6953 O
used 22 26 6954 6958 O
as 27 29 6959 6961 O
an 30 32 6962 6964 O
appetite 33 41 6965 6973 O
stimulant 42 51 6974 6983 O

men 0 3 6984 6987 B-gender
treated 4 11 6988 6995 O
or 12 14 6996 6998 O
enrolled 15 23 6999 7007 O
on 24 26 7008 7010 O
this 27 31 7011 7015 O
protocol 32 40 7016 7024 O
must 41 45 7025 7029 O
also 46 50 7030 7034 O
agree 51 56 7035 7040 B-contraception_consent
to 57 59 7041 7043 I-contraception_consent
use 60 63 7044 7047 I-contraception_consent
adequate 64 72 7048 7056 I-contraception_consent
contraception 73 86 7057 7070 I-contraception_consent
prior 87 92 7071 7076 O
to 93 95 7077 7079 O
the 96 99 7080 7083 O
study 100 105 7084 7089 O
, 105 106 7089 7090 O
for 107 110 7091 7094 O
the 111 114 7095 7098 O
duration 115 123 7099 7107 O
of 124 126 7108 7110 O
study 127 132 7111 7116 O
participation 133 146 7117 7130 O
, 146 147 7130 7131 O
and 148 151 7132 7135 O
4 152 153 7136 7137 B-upper_bound
months 154 160 7138 7144 I-upper_bound
after 161 166 7145 7150 I-upper_bound
completion 167 177 7151 7161 O
of 178 180 7162 7164 O
trametinib 181 191 7165 7175 B-treatment
administration 192 206 7176 7190 O

palliative 0 10 7191 7201 B-treatment
radiation 11 20 7202 7211 I-treatment
therapy 21 28 7212 7219 I-treatment
to 29 31 7220 7222 O
non 32 35 7223 7226 O
- 35 36 7226 7227 O
target 36 42 7227 7233 O
lesions 43 50 7234 7241 O

patients 0 8 7242 7250 O
who 9 12 7251 7254 O
have 13 17 7255 7259 O
been 18 22 7260 7264 O
disease 23 30 7265 7272 O
- 30 31 7272 7273 O
free 31 35 7273 7277 O
for 36 39 7278 7281 O
3 40 41 7282 7283 B-upper_bound
years 42 47 7284 7289 I-upper_bound

patients 0 8 7290 7298 O
with 9 13 7299 7303 O
a 14 15 7304 7305 O
history 16 23 7306 7313 O
of 24 26 7314 7316 O
completely 27 37 7317 7327 O
resected 38 46 7328 7336 O
non 47 50 7337 7340 B-cancer
- 50 51 7340 7341 I-cancer
melanoma 51 59 7341 7349 I-cancer
skin 60 64 7350 7354 I-cancer
cancer 65 71 7355 7361 I-cancer

patients 0 8 7362 7370 O
with 9 13 7371 7375 O
controlled 14 24 7376 7386 O
atrial 25 31 7387 7393 B-clinical_variable
fibrillation 32 44 7394 7406 I-clinical_variable
for 45 48 7407 7410 O
> 49 50 7411 7412 O
30 51 53 7413 7415 B-lower_bound
days 54 58 7416 7420 I-lower_bound
prior 59 64 7421 7426 I-lower_bound
to 65 67 7427 7429 O
randomization 68 81 7430 7443 B-treatment

patients 0 8 7444 7452 O
with 9 13 7453 7457 O
indolent 14 22 7458 7466 O
secondary 23 32 7467 7476 B-cancer
malignancies 33 45 7477 7489 I-cancer

pregnant 0 8 7490 7498 B-pregnancy
women 9 14 7499 7504 B-gender

prophylactic 0 12 7505 7517 O
use 13 16 7518 7521 O
of 17 19 7522 7524 O
bisphosphonates 20 35 7525 7540 B-treatment
in 36 38 7541 7543 O
patients 39 47 7544 7552 O
without 48 55 7553 7560 O
bone 56 60 7561 7565 B-chronic_disease
disease 61 68 7566 7573 I-chronic_disease

subjects 0 8 7574 7582 O
who 9 12 7583 7586 O
would 13 18 7587 7592 O
have 19 23 7593 7597 O
been 24 28 7598 7602 O
excluded 29 37 7603 7611 O
from 38 42 7612 7616 O
having 43 49 7617 7623 O
biopsies 50 58 7624 7632 B-treatment
done 59 63 7633 7637 O
due 64 67 7638 7641 O
to 68 70 7642 7644 O
the 71 74 7645 7648 O
above 75 80 7649 7654 O
reasons 81 88 7655 7662 O

these 0 5 7663 7668 O
potential 6 15 7669 7678 O
risks 16 21 7679 7684 O
may 22 25 7685 7688 O
also 26 30 7689 7693 O
apply 31 36 7694 7699 O
to 37 39 7700 7702 O
RAI 40 43 7703 7706 B-treatment
and 44 47 7707 7710 O
thyrogen 48 56 7711 7719 B-treatment

thyroid 0 7 7720 7727 B-clinical_variable
- 7 8 7727 7728 I-clinical_variable
stimulating 8 19 7728 7739 I-clinical_variable
hormone 20 27 7740 7747 I-clinical_variable
[ 28 29 7748 7749 I-clinical_variable
TSH 29 32 7749 7752 I-clinical_variable
] 32 33 7752 7753 I-clinical_variable
suppressive 34 45 7754 7765 B-treatment
therapy 46 53 7766 7773 I-treatment

treatment 0 9 7774 7783 B-treatment
of 10 12 7784 7786 O
osteoporosis 13 25 7787 7799 B-chronic_disease

women 0 5 7800 7805 B-gender
of 6 8 7806 7808 O
child 9 14 7809 7814 O
- 14 15 7814 7815 O
bearing 15 22 7815 7822 O
potential 23 32 7823 7832 O
and 33 36 7833 7836 O
men 37 40 7837 7840 O
must 41 45 7841 7845 O
agree 46 51 7846 7851 B-contraception_consent
to 52 54 7852 7854 I-contraception_consent
use 55 58 7855 7858 I-contraception_consent
adequate 59 67 7859 7867 I-contraception_consent
contraception 68 81 7868 7881 I-contraception_consent
( 82 83 7882 7883 O
hormonal 83 91 7883 7891 B-contraception_consent
or 92 94 7892 7894 O
barrier 95 102 7895 7902 B-contraception_consent
method 103 109 7903 7909 I-contraception_consent
of 110 112 7910 7912 I-contraception_consent
birth 113 118 7913 7918 I-contraception_consent
control 119 126 7919 7926 I-contraception_consent
; 126 127 7926 7927 O
abstinence 128 138 7928 7938 B-contraception_consent
) 138 139 7938 7939 O
prior 140 145 7940 7945 O
to 146 148 7946 7948 O
study 149 154 7949 7954 O
entry 155 160 7955 7960 O
and 161 164 7961 7964 O
for 165 168 7965 7968 O
the 169 172 7969 7972 O
duration 173 181 7973 7981 O
of 182 184 7982 7984 O
study 185 190 7985 7990 O
participation 191 204 7991 8004 O

women 0 5 8005 8010 B-gender
of 6 8 8011 8013 O
child 9 14 8014 8019 O
- 14 15 8019 8020 O
bearing 15 22 8020 8027 O
potential 23 32 8028 8037 O
must 33 37 8038 8042 O
have 38 42 8043 8047 O
a 43 44 8048 8049 O
negative 45 53 8050 8058 B-pregnancy
pregnancy 54 63 8059 8068 I-pregnancy
test 64 68 8069 8073 O
within 69 75 8074 8080 O
2 76 77 8081 8082 B-upper_bound
weeks 78 83 8083 8088 I-upper_bound
prior 84 89 8089 8094 I-upper_bound
study 90 95 8095 8100 O
registration 96 108 8101 8113 O

CNC 0 3 0 3 B-clinical_variable
word 4 8 4 8 O
recognition 9 20 9 20 O
equal 21 26 21 26 O
to 27 29 27 29 O
or 30 32 30 32 O
better 33 39 33 39 O
than 40 44 40 44 O
that 45 49 45 49 O
in 50 52 50 52 O
the 53 56 53 56 O
ear 57 60 57 60 O
to 61 63 61 63 O
be 64 66 64 66 O
implanted 67 76 67 76 O
but 77 80 77 80 O
not 81 84 81 84 O
more 85 89 85 89 O
than 90 94 90 94 O
80 95 97 95 97 B-lower_bound
% 97 98 97 98 I-lower_bound
correct 99 106 99 106 O

Moderately 0 10 107 117 O
severe 11 17 118 124 O
to 18 20 125 127 O
profound 21 29 128 136 O
mid 30 33 137 140 O
to 34 36 141 143 O
high 37 41 144 148 O
frequency 42 51 149 158 O
hearing 52 59 159 166 B-chronic_disease
loss 60 64 167 171 I-chronic_disease
in 65 67 172 174 O
the 68 71 175 178 O
contralateral 72 85 179 192 O
ear 86 89 193 196 O

Normal 0 6 197 203 O
to 7 9 204 206 O
moderate 10 18 207 215 O
hearing 19 26 216 223 B-chronic_disease
loss 27 31 224 228 I-chronic_disease
in 32 34 229 231 O
the 35 38 232 235 O
low 39 42 236 239 O
frequencies 43 54 240 251 O
with 55 59 252 256 O
severe 60 66 257 263 O
to 67 69 264 266 O
profound 70 78 267 275 O
mid 79 82 276 279 O
to 83 85 280 282 O
high 86 90 283 287 O
frequency 91 100 288 297 O
hearing 101 108 298 305 O
loss 109 113 306 310 O
in 114 116 311 313 O
the 117 120 314 317 O
ear 121 124 318 321 O
to 125 127 322 324 O
be 128 130 325 327 O
implanted 131 140 328 337 O

duration 0 8 338 346 O
of 9 11 347 349 O
sever 12 17 350 355 O
to 18 20 356 358 O
profound 21 29 359 367 O
hearing 30 37 368 375 B-chronic_disease
loss 38 42 376 380 I-chronic_disease
of 43 45 381 383 O
30 46 48 384 386 B-lower_bound
years 49 54 387 392 I-lower_bound
or 55 57 393 395 O
greater 58 65 396 403 O

non 0 3 404 407 B-language_fluency
- 3 4 407 408 I-language_fluency
native 4 10 408 414 I-language_fluency
English 11 18 415 422 I-language_fluency
speaker 19 26 423 430 I-language_fluency

Ability 0 7 0 7 O
to 8 10 8 10 O
obtain 11 17 11 17 O
medication 18 28 18 28 O
within 29 35 29 35 O
36 36 38 36 38 B-upper_bound
hours 39 44 39 44 I-upper_bound
of 45 47 45 47 O
presentation 48 60 48 60 O

Clinically 0 10 61 71 O
manifested 11 21 72 82 O
by 22 24 83 85 O
no 25 27 86 88 O
attempt 28 35 89 96 O
at 36 38 97 99 O
securing 39 47 100 108 O
aneurysm 48 56 109 117 B-chronic_disease

Expected 0 8 118 126 O
mortality 9 18 127 136 O
within 19 25 137 143 O
72 26 28 144 146 B-upper_bound
hours 29 34 147 152 I-upper_bound
as 35 37 153 155 O
determined 38 48 156 166 O
by 49 51 167 169 O
PI 52 54 170 172 O

Fisher 0 6 173 179 B-chronic_disease
grade 7 12 180 185 I-chronic_disease
3 13 14 186 187 I-chronic_disease
hemorrhage 15 25 188 198 I-chronic_disease
( 26 27 199 200 O
thick 27 32 200 205 O
subarachnoid 33 45 206 218 O
clot 46 50 219 223 O
) 50 51 223 224 O
on 52 54 225 227 O
initial 55 62 228 235 O
computed 63 71 236 244 B-treatment
tomography 72 82 245 255 I-treatment
( 83 84 256 257 I-treatment
CT 84 86 257 259 I-treatment
) 86 87 259 260 I-treatment
scan 88 92 261 265 I-treatment

History 0 7 266 273 O
of 8 10 274 276 O
dementia 11 19 277 285 B-chronic_disease

History 0 7 286 293 O
of 8 10 294 296 O
severe 11 17 297 303 O
hepatic 18 25 304 311 B-chronic_disease
impairment 26 36 312 322 I-chronic_disease
( 37 38 323 324 O
Child 38 43 324 329 B-clinical_variable
- 43 44 329 330 I-clinical_variable
Pugh 44 48 330 334 I-clinical_variable
score 49 54 335 340 I-clinical_variable
of 55 57 341 343 O
10 58 60 344 346 B-lower_bound
- 60 61 346 347 O
15 61 63 347 349 B-upper_bound
) 63 64 349 350 O

Hunt 0 4 351 355 B-clinical_variable
and 5 8 356 359 I-clinical_variable
Hess 9 13 360 364 I-clinical_variable
grade 14 19 365 370 B-lower_bound
1 20 21 371 372 I-lower_bound
- 21 22 372 373 O
5 22 23 373 374 B-upper_bound
at 24 26 375 377 O
time 27 31 378 382 O
of 32 34 383 385 O
randomization 35 48 386 399 O

Pre 0 3 400 403 O
- 3 4 403 404 O
existing 4 12 404 412 O
disability 13 23 413 423 O
with 24 28 424 428 O
modified 29 37 429 437 B-clinical_variable
Rankin 38 44 438 444 I-clinical_variable
Scale 45 50 445 450 I-clinical_variable
( 51 52 451 452 I-clinical_variable
mRS 52 55 452 455 I-clinical_variable
) 55 56 455 456 I-clinical_variable
score 57 62 457 462 I-clinical_variable
≥2 63 65 463 465 O

Presence 0 8 466 474 O
of 9 11 475 477 O
a 12 13 478 479 O
cerebral 14 22 480 488 B-chronic_disease
aneurysm 23 31 489 497 I-chronic_disease
on 32 34 498 500 O
computed 35 43 501 509 O
tomographic 44 55 510 521 O
angiography 56 67 522 533 O
( 68 69 534 535 O
CTA 69 72 535 538 O
) 72 73 538 539 O
or 74 76 540 542 O
Angiogram 77 86 543 552 O
for 87 90 553 556 O
which 91 96 557 562 O
clipping 97 105 563 571 O
or 106 108 572 574 O
coiling 109 116 575 582 O
is 117 119 583 585 O
possible 120 128 586 594 O

Renal 0 5 595 600 B-chronic_disease
disease 6 13 601 608 I-chronic_disease
as 14 16 609 611 O
defined 17 24 612 619 O
by 25 27 620 622 O
creatinine 28 38 623 633 B-clinical_variable
clearance 39 48 634 643 I-clinical_variable
less 49 53 644 648 O
than 54 58 649 653 O
9 59 60 654 655 B-upper_bound
milliliters 61 72 656 667 I-upper_bound
/ 72 73 667 668 I-upper_bound
min 73 76 668 671 I-upper_bound

current 0 7 0 7 B-pregnancy
pregnancy 8 17 8 17 I-pregnancy

current 0 7 18 25 O
use 8 11 26 29 O
of 12 14 30 32 O
hypnotics 15 24 33 42 B-treatment
or 25 27 43 45 O
clonidine 28 37 46 55 B-treatment

diabetic 0 8 56 64 B-chronic_disease
patients 9 17 65 73 O
who 18 21 74 77 O
are 22 25 78 81 O
insulin 26 33 82 89 O
dependent 34 43 90 99 O
( 44 45 100 101 O
or 45 47 101 103 O
have 48 52 104 108 O
HbA1c>9.0 53 62 109 118 B-clinical_variable
% 62 63 118 119 I-lower_bound
) 63 64 119 120 O

pre 0 3 121 124 O
- 3 4 124 125 O
hypertension 4 16 125 137 B-chronic_disease
or 17 19 138 140 O
stage 20 25 141 146 O
one 26 29 147 150 O
hypertension 30 42 151 163 O
( 43 44 164 165 O
BP 44 46 165 167 B-clinical_variable
≥120/80 47 54 168 175 O
and 55 58 176 179 O
< 59 60 180 181 O
160/100 60 67 181 188 B-upper_bound
) 67 68 188 189 O

renal 0 5 190 195 B-chronic_disease
/ 5 6 195 196 I-chronic_disease
electrolyte 6 17 196 207 I-chronic_disease
disorders 18 27 208 217 I-chronic_disease
and 28 31 218 221 O
any 32 35 222 225 O
other 36 41 226 231 O
condition 42 51 232 241 O
that 52 56 242 246 O
the 57 60 247 250 O
study 61 66 251 256 O
screening 67 76 257 266 O
physician 77 86 267 276 O
considers 87 96 277 286 O
would 97 102 287 292 O
significantly 103 116 293 306 O
impede 117 123 307 313 O
participation 124 137 314 327 O
in 138 140 328 330 O
the 141 144 331 334 O
study 145 150 335 340 O

significant 0 11 341 352 O
active 12 18 353 359 O
or 19 21 360 362 O
uncontrolled 22 34 363 375 O
sleep 35 40 376 381 B-chronic_disease
disorders 41 50 382 391 I-chronic_disease

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

Speaks 0 6 18 24 B-language_fluency
English 7 14 25 32 I-language_fluency

Any 0 3 0 3 O
major 4 9 4 9 O
surgery 10 17 10 17 B-treatment

Diagnosis 0 9 18 27 O
of 10 12 28 30 O
Non 13 16 31 34 B-cancer
- 16 17 34 35 I-cancer
Hodgkin 17 24 35 42 I-cancer
's 24 26 42 44 I-cancer
Lymphoma 27 35 45 53 I-cancer
including 36 45 54 63 O
Diffuse 46 53 64 71 B-cancer
Large 54 59 72 77 I-cancer
B 60 61 78 79 I-cancer
- 61 62 79 80 I-cancer
cell 62 66 80 84 I-cancer
Lymphoma 67 75 85 93 I-cancer
, 75 76 93 94 O
Follicular 77 87 95 105 B-cancer
, 87 88 105 106 O
Mantle 89 95 107 113 B-cancer
Cell 96 100 114 118 I-cancer
Lymphoma 101 109 119 127 I-cancer
and 110 113 128 131 O
Marginal 114 122 132 140 B-cancer
Zone 123 127 141 145 I-cancer
Lymphoma 128 136 146 154 I-cancer

Evidence 0 8 155 163 O
of 9 11 164 166 O
hepatitis 12 21 167 176 B-chronic_disease
B 22 23 177 178 I-chronic_disease
virus 24 29 179 184 I-chronic_disease
, 29 30 184 185 O
hepatitis 31 40 186 195 B-chronic_disease
C 41 42 196 197 I-chronic_disease
virus 43 48 198 203 I-chronic_disease

Prior 0 5 204 209 B-treatment
Allogeneic 6 16 210 220 I-treatment
hematologic 17 28 221 232 I-treatment
stem 29 33 233 237 I-treatment
cell 34 38 238 242 I-treatment
transplant 39 49 243 253 I-treatment

Prior 0 5 254 259 B-treatment
therapy 6 13 260 267 I-treatment
with 14 18 268 272 O
a 19 20 273 274 O
PI3 21 24 275 278 B-treatment
K 24 25 278 279 I-treatment
delta 26 31 280 285 I-treatment
inhibitor 32 41 286 295 I-treatment

chemotherapy 0 12 296 308 B-treatment

Age 0 3 0 3 B-age
20 4 6 4 6 B-lower_bound
- 6 7 6 7 O
50 7 9 7 9 B-upper_bound

ISI 0 3 10 13 B-clinical_variable
cutoff 4 10 14 20 I-clinical_variable
score 11 16 21 26 I-clinical_variable
of 17 19 27 29 O
10 20 22 30 32 B-lower_bound
or 23 25 33 35 O
higher 26 32 36 42 O

Major 0 5 43 48 B-chronic_disease
psychiatric 6 17 49 60 I-chronic_disease
diagnosis 18 27 61 70 I-chronic_disease
with 28 32 71 75 O
comorbid 33 41 76 84 O
sleep 42 47 85 90 B-chronic_disease
problems 48 56 91 99 I-chronic_disease

Meet 0 4 100 104 O
diagnostic 5 15 105 115 O
criteria 16 24 116 124 O
for 25 28 125 128 O
IBS 29 32 129 132 B-chronic_disease

Pregnancy 0 9 133 142 B-pregnancy
( 10 11 143 144 O
self 11 15 144 148 O
- 15 16 148 149 O
reported 16 24 149 157 O
) 24 25 157 158 O

Stable 0 6 159 165 O
medication 7 17 166 176 O
for 18 21 177 180 O
IBS 22 25 181 184 B-chronic_disease
for 26 29 185 188 O
at 30 32 189 191 O
least 33 38 192 197 O
1 39 40 198 199 B-lower_bound
month 41 46 200 205 I-lower_bound

Stable 0 6 206 212 O
medication 7 17 213 223 O
for 18 21 224 227 O
sleep 22 27 228 233 O
for 28 31 234 237 O
at 32 34 238 240 O
least 35 40 241 246 O
1 41 42 247 248 B-lower_bound
month 43 48 249 254 I-lower_bound

other 0 5 255 260 O
neurological 6 18 261 273 B-chronic_disease
disorder 19 27 274 282 I-chronic_disease

Cooperative 0 11 0 11 O
, 11 12 11 12 O
patient 13 20 13 20 O
scheduled 21 30 21 30 O
for 31 34 31 34 O
amputation 35 45 35 45 B-treatment
, 45 46 45 46 O
with 47 51 47 51 O
time 52 56 52 56 O
and 57 60 57 60 O
availability 61 73 61 73 O
to 74 76 74 76 O
do 77 79 77 79 O
fMRI 80 84 80 84 O
prior 85 90 85 90 O
to 91 93 91 93 O
their 94 99 94 99 O
operative 100 109 100 109 O
date 110 114 110 114 O

Cooperative 0 11 115 126 O
, 11 12 126 127 O
with 13 17 128 132 O
time 18 22 133 137 O
and 23 26 138 141 O
availability 27 39 142 154 O
to 40 42 155 157 O
do 43 45 158 160 O
an 46 48 161 163 O
fMRI 49 53 164 168 B-treatment

Subjects 0 8 169 177 O
age 9 12 178 181 B-age
18 13 15 182 184 B-lower_bound
years 16 21 185 190 I-lower_bound
or 22 24 191 193 O
older 25 30 194 199 O

Subjects 0 8 200 208 O
age 9 12 209 212 B-age
18 13 15 213 215 B-lower_bound
years 16 21 216 221 I-lower_bound
to 22 24 222 224 O
30 25 27 225 227 B-upper_bound

Subjects 0 8 228 236 O
who 9 12 237 240 O
opt 13 16 241 244 O
for 17 20 245 248 O
fMRI 21 25 249 253 B-treatment
portion 26 33 254 261 O
of 34 36 262 264 O
the 37 40 265 268 O
study 41 46 269 274 O
are 47 50 275 278 O
willing 51 58 279 286 O
and/or 59 65 287 293 O
able 66 70 294 298 O
to 71 73 299 301 O
tolerate 74 82 302 310 O
fMRI 83 87 311 315 O

Willing 0 7 316 323 O
and 8 11 324 327 O
able 12 16 328 332 O
to 17 19 333 335 O
tolerate 20 28 336 344 O
fMRI 29 33 345 349 B-treatment

Willing 0 7 350 357 O
to 8 10 358 360 O
perform 11 18 361 368 O
mirror 19 25 369 375 B-treatment
therapy 26 33 376 383 I-treatment
for 34 37 384 387 O
14 38 40 388 390 O
days 41 45 391 395 O
prior 46 51 396 401 O
and 52 55 402 405 O
post 56 60 406 410 O
- 60 61 410 411 O
operative 61 70 411 420 O
procedure 71 80 421 430 O

inability 0 9 431 440 O
to 10 12 441 443 O
cooperate 13 22 444 453 O
with 23 27 454 458 O
physical 28 36 459 467 B-treatment
therapy 37 44 468 475 I-treatment

patients 0 8 476 484 O
with 9 13 485 489 O
claustrophobia 14 28 490 504 B-chronic_disease
will 29 33 505 509 O
be 34 36 510 512 O
excluded 37 45 513 521 O
from 46 50 522 526 O
participating 51 64 527 540 O
in 65 67 541 543 O
the 68 71 544 547 O
fMRI 72 76 548 552 O
portion 77 84 553 560 O
of 85 87 561 563 O
this 88 92 564 568 O
study 93 98 569 574 O

possessing 0 10 575 585 O
a 11 12 586 587 O
contraindication 13 29 588 604 O
to 30 32 605 607 O
mirror 33 39 608 614 B-treatment
therapy 40 47 615 622 I-treatment
for 48 51 623 626 O
example 52 59 627 634 O
blindness 60 69 635 644 B-chronic_disease
or 70 72 645 647 O
inability 73 82 648 657 O
to 83 85 658 660 O
position 86 94 661 669 O
properly 95 103 670 678 O
for 104 107 679 682 O
the 108 111 683 686 O
therapy 112 119 687 694 O

primary 0 7 695 702 B-chronic_disease
central 8 15 703 710 I-chronic_disease
nervous 16 23 711 718 I-chronic_disease
disease 24 31 719 726 I-chronic_disease
such 32 36 727 731 O
as 37 39 732 734 O
status 40 46 735 741 O
post 47 51 742 746 O
cerebral 52 60 747 755 O
vascular 61 69 756 764 O
accident 70 78 765 773 O
with 79 83 774 778 O
persistent 84 94 779 789 O
deficit 95 102 790 797 O
, 102 103 797 798 O
Alzheimer 104 113 799 808 B-chronic_disease
's 113 115 808 810 I-chronic_disease
disease 116 123 811 818 I-chronic_disease
or 124 126 819 821 O
Multiple 127 135 822 830 B-chronic_disease
Sclerosis 136 145 831 840 I-chronic_disease

scheduled 0 9 841 850 O
for 10 13 851 854 O
elective 14 22 855 863 B-treatment
amputation 23 33 864 874 I-treatment

non 0 3 0 3 B-language_fluency
- 3 4 3 4 I-language_fluency
English 4 11 4 11 I-language_fluency
speakers 12 20 12 20 I-language_fluency

over 0 4 21 25 O
18 5 7 26 28 B-lower_bound
years 8 13 29 34 I-lower_bound
of 14 16 35 37 O
age 17 20 38 41 B-age

planned 0 7 42 49 B-pregnancy
pregnancy 8 17 50 59 I-pregnancy
during 18 24 60 66 O
the 25 28 67 70 O
follow 29 35 71 77 O
- 35 36 77 78 O
up 36 38 78 80 O
period 39 45 81 87 O
( 46 47 88 89 O
since 47 52 89 94 O
exposure 53 61 95 103 O
to 62 64 104 106 O
an 65 67 107 109 O
insecticide 68 79 110 121 O
is 80 82 122 124 O
involved 83 91 125 133 O
) 91 92 133 134 O

pregnancy 0 9 135 144 B-pregnancy

sensitivity 0 11 145 156 O
to 12 14 157 159 O
insecticides 15 27 160 172 B-allergy_name

spending 0 8 173 181 O
an 9 11 182 184 O
average 12 19 185 192 O
of 20 22 193 195 O
10 23 25 196 198 B-lower_bound
or 26 28 199 201 O
more 29 33 202 206 O
hours 34 39 207 212 O
of 40 42 213 215 O
outdoor 43 50 216 223 O
work 51 55 224 228 O
per 56 59 229 232 O
week 60 64 233 237 O
during 65 71 238 244 O
peak 72 76 245 249 O
tick 77 81 250 254 O
season 82 88 255 261 O

Allergy 0 7 0 7 O
to 8 10 8 10 O
lidocaine 11 20 11 20 B-allergy_name
or 21 23 21 23 O
oxymetazoline 24 37 24 37 B-allergy_name
hydrochloride 38 51 38 51 I-allergy_name

Any 0 3 52 55 O
unstable 4 12 56 64 O
cardiac 13 20 65 72 O
condition 21 30 73 82 O
( 31 32 83 84 O
other 32 37 84 89 O
than 38 42 90 94 O
well 43 47 95 99 O
controlled 48 58 100 110 O
hypertension 59 71 111 123 O
) 71 72 123 124 O
or 73 75 125 127 O
pulmonary 76 85 128 137 B-chronic_disease
problems 86 94 138 146 I-chronic_disease

Claustrophobia 0 14 147 161 B-chronic_disease

Concurrent 0 10 162 172 B-chronic_disease
sleep 11 16 173 178 I-chronic_disease
disorders 17 26 179 188 I-chronic_disease
( 27 28 189 190 O
insomnia 28 36 190 198 B-chronic_disease
, 36 37 198 199 O
narcolepsy 38 48 200 210 B-chronic_disease
, 48 49 210 211 O
central 50 57 212 219 B-chronic_disease
sleep 58 63 220 225 I-chronic_disease
apnea 64 69 226 231 I-chronic_disease
or 70 72 232 234 O
parasomnia 73 83 235 245 B-chronic_disease
) 83 84 245 246 O

Patients 0 8 247 255 O
with 9 13 256 260 O
Obstructive 14 25 261 272 B-chronic_disease
Sleep 26 31 273 278 I-chronic_disease
Apnea 32 37 279 284 I-chronic_disease

Periodontal 0 11 285 296 B-chronic_disease
disease 12 19 297 304 I-chronic_disease
and/or 20 26 305 311 O
insufficient 27 39 312 324 O
number 40 46 325 331 O
of 47 49 332 334 O
teeth 50 55 335 340 O

Pregnancy 0 9 341 350 B-pregnancy

18 0 2 0 2 B-lower_bound
year 3 7 3 7 I-lower_bound
of 8 10 8 10 O
age 11 14 11 14 B-age
or 15 17 15 17 O
older 18 23 18 23 O

Age18 0 5 24 29 B-age

Diagnosed 0 9 30 39 O
with 10 14 40 44 O
any 15 18 45 48 O
other 19 24 49 54 O
invasive 25 33 55 63 B-cancer
malignancy 34 44 64 74 I-cancer
currently 45 54 75 84 O
, 54 55 84 85 O
in 56 58 86 88 O
the 59 62 89 92 O
last 63 67 93 97 B-upper_bound
five 68 72 98 102 I-upper_bound
years 73 78 103 108 I-upper_bound
or 79 81 109 111 O
expected 82 90 112 120 O
to 91 93 121 123 O
undergo 94 101 124 131 O
active 102 108 132 138 B-treatment
treatment 109 118 139 148 I-treatment
with 119 123 149 153 O
either 124 130 154 160 O
cytotoxic 131 140 161 170 B-treatment
chemotherapy 141 153 171 183 I-treatment
or 154 156 184 186 O
radiation 157 166 187 196 B-treatment
during 167 173 197 203 O
the 174 177 204 207 O
6 178 179 208 209 O
week 180 184 210 214 O
caloric 185 192 215 222 O
restriction 193 204 223 234 O
period 205 211 235 241 O

Inability 0 9 242 251 O
to 10 12 252 254 O
communicate 13 24 255 266 B-language_fluency
in 25 27 267 269 I-language_fluency
English 28 35 270 277 I-language_fluency

Newly 0 5 278 283 O
diagnosed 6 15 284 293 O
with 16 20 294 298 O
Endometrial 21 32 299 310 B-cancer
Cancer 33 39 311 317 I-cancer

Scheduled 0 9 318 327 O
for 10 13 328 331 O
definitive 14 24 332 342 O
surgical 25 33 343 351 B-treatment
intervention 34 46 352 364 I-treatment
( 47 48 365 366 O
hysterectomy 48 60 366 378 B-treatment
, 60 61 378 379 O
bilateral 62 71 380 389 B-treatment
salpingoopherectomy 72 91 390 409 I-treatment
with 92 96 410 414 I-treatment
or 97 99 415 417 I-treatment
without 100 107 418 425 I-treatment
lymphadenectomy 108 123 426 441 I-treatment
) 123 124 441 442 O
in 125 127 443 445 O
the 128 131 446 449 O
following 132 141 450 459 O
2 142 143 460 461 B-lower_bound
- 143 144 461 462 O
3 144 145 462 463 B-upper_bound
weeks 146 151 464 469 I-upper_bound
as 152 154 470 472 O
part 155 159 473 477 O
of 160 162 478 480 O
the 163 166 481 484 O
standard 167 175 485 493 O
of 176 178 494 496 O
care 179 183 497 501 O

life 0 4 502 506 B-clinical_variable
expectancy 5 15 507 517 I-clinical_variable
of 16 18 518 520 O
at 19 21 521 523 O
least 22 27 524 529 O
1 28 29 530 531 B-lower_bound
year 30 34 532 536 I-lower_bound

uncontrolled 0 12 537 549 O
serious 13 20 550 557 O
medical 21 28 558 565 B-chronic_disease
or 29 31 566 568 O
psychiatric 32 43 569 580 B-chronic_disease
conditions 44 54 581 591 I-chronic_disease
that 55 59 592 596 O
would 60 65 597 602 O
affect 66 72 603 609 O
their 73 78 610 615 O
ability 79 86 616 623 O
to 87 89 624 626 O
participate 90 101 627 638 O
in 102 104 639 641 O
an 105 107 642 644 O
intervention 108 120 645 657 O
study 121 126 658 663 O
, 126 127 663 664 O
( 128 129 665 666 O
e.g. 129 133 666 670 O
, 133 134 670 671 O
severe 135 141 672 678 O
/ 141 142 678 679 O
uncontrolled 142 154 679 691 O
diabetes 155 163 692 700 B-chronic_disease
mellitus 164 172 701 709 I-chronic_disease
, 172 173 709 710 O
severe 174 180 711 717 O
cardiac 181 188 718 725 B-chronic_disease
and/or 189 195 726 732 O
pulmonary 196 205 733 742 B-chronic_disease
disease 206 213 743 750 I-chronic_disease
and/or 214 220 751 757 O
depression 221 231 758 768 B-chronic_disease
) 231 232 768 769 O

Active 0 6 0 6 O
uncontrolled 7 19 7 19 O
infection 20 29 20 29 B-chronic_disease
or 30 32 30 32 O
severe 33 39 33 39 O
systemic 40 48 40 48 O
infection 49 58 49 58 O
( 59 60 59 60 O
enrollment 60 70 60 70 O
is 71 73 71 73 O
possible 74 82 74 82 O
after 83 88 83 88 O
control 89 96 89 96 O
of 97 99 97 99 O
infection 100 109 100 109 O
) 109 110 109 110 O

Adequate 0 8 111 119 O
organ 9 14 120 125 O
function 15 23 126 134 O
within 24 30 135 141 O
14 31 33 142 144 B-upper_bound
days 34 38 145 149 I-upper_bound
of 39 41 150 152 O
study 42 47 153 158 O
registration 48 60 159 171 O

Any 0 3 172 175 O
history 4 11 176 183 O
of 12 14 184 186 O
epilepsy 15 23 187 195 B-chronic_disease
or 24 26 196 198 O
a 27 28 199 200 O
seizure 29 36 201 208 B-chronic_disease
disorder 37 45 209 217 I-chronic_disease
or 46 48 218 220 O
any 49 52 221 224 O
known 53 58 225 230 O
prior 59 64 231 236 O
seizures 65 73 237 245 B-chronic_disease

Confirmation 0 12 246 258 O
that 13 17 259 263 O
the 18 21 264 267 O
subject 22 29 268 275 O
is 30 32 276 278 O
not 33 36 279 282 B-pregnancy
pregnant 37 45 283 291 I-pregnancy
must 46 50 292 296 O
be 51 53 297 299 O
established 54 65 300 311 O
by 66 68 312 314 O
a 69 70 315 316 O
negative 71 79 317 325 B-pregnancy
serum 80 85 326 331 I-pregnancy
beta 86 90 332 336 I-pregnancy
- 90 91 336 337 I-pregnancy
human 91 96 337 342 I-pregnancy
chorionic 97 106 343 352 I-pregnancy
gonadotropin 107 119 353 365 I-pregnancy
( 120 121 366 367 I-pregnancy
beta 121 125 367 371 I-pregnancy
- 125 126 371 372 I-pregnancy
hCG 126 129 372 375 I-pregnancy
) 129 130 375 376 I-pregnancy
pregnancy 131 140 377 386 I-pregnancy
test 141 145 387 391 O
result 146 152 392 398 O
obtained 153 161 399 407 O
during 162 168 408 414 O
screening 169 178 415 424 O

Confirmed 0 9 425 434 O
histologic 10 20 435 445 O
diagnosis 21 30 446 455 O
on 31 33 456 458 O
bone 34 38 459 463 B-treatment
marrow 39 45 464 470 I-treatment
biopsy 46 52 471 477 I-treatment
and 53 56 478 481 O
aspirate 57 65 482 490 O
within 66 72 491 497 O
28 73 75 498 500 B-upper_bound
days 76 80 501 505 I-upper_bound
of 81 83 506 508 O
trial 84 89 509 514 O
entry 90 95 515 520 O
prior 96 101 521 526 O
to 102 104 527 529 O
starting 105 113 530 538 O
cycle 114 119 539 544 O
1 120 121 545 546 O

Diagnosis 0 9 547 556 O
of 10 12 557 559 O
MDS 13 16 560 563 B-cancer
/ 16 17 563 564 O
CMML 17 21 564 568 B-cancer
that 22 26 569 573 O
is 27 29 574 576 O
refractory 30 40 577 587 O
to 41 43 588 590 O
or 44 46 591 593 O
intolerant 47 57 594 604 O
to 58 60 605 607 O
standard 61 69 608 616 B-treatment
therapy 70 77 617 624 I-treatment
and 78 81 625 628 O
is 82 84 629 631 O
no 85 87 632 634 O
longer 88 94 635 641 O
likely 95 101 642 648 O
to 102 104 649 651 O
respond 105 112 652 659 O
to 113 115 660 662 O
such 116 120 663 667 O
therapy 121 128 668 675 O
( 129 130 676 677 O
at 130 132 677 679 O
least 133 138 680 685 O
one 139 142 686 689 O
line 143 147 690 694 O
of 148 150 695 697 O
therapy 151 158 698 705 O
) 158 159 705 706 O

ECOG 0 4 707 711 B-clinical_variable
performance 5 16 712 723 I-clinical_variable
status 17 23 724 730 I-clinical_variable
of 24 26 731 733 O
0 27 28 734 735 B-lower_bound
, 28 29 735 736 O
1 30 31 737 738 O
or 32 34 739 741 O
2 35 36 742 743 B-upper_bound

Grade 0 5 744 749 B-chronic_disease
3 6 7 750 751 I-chronic_disease
peripheral 8 18 752 762 I-chronic_disease
neuropathy 19 29 763 773 I-chronic_disease
within 30 36 774 780 O
14 37 39 781 783 B-upper_bound
days 40 44 784 788 I-upper_bound
before 45 51 789 795 O
enrollment 52 62 796 806 O

Intrathecal 0 11 807 818 B-treatment
methotrexate 12 24 819 831 I-treatment
is 25 27 832 834 O
allowed 28 35 835 842 O
prior 36 41 843 848 O
to 42 44 849 851 O
and 45 48 852 855 O
during 49 55 856 862 O
treatment 56 65 863 872 O
per 66 69 873 876 O
investigator 70 82 877 889 O
discretion 83 93 890 900 O

Known 0 5 901 906 O
immediate 6 15 907 916 O
or 16 18 917 919 O
delayed 19 26 920 927 O
hypersensitivity 27 43 928 944 O
reaction 44 52 945 953 O
or 53 55 954 956 O
idiosyncrasy 56 68 957 969 O
to 69 71 970 972 O
drugs 72 77 973 978 O
chemically 78 88 979 989 O
related 89 96 990 997 O
to 97 99 998 1000 O
IGF 100 103 1001 1004 B-allergy_name
or 104 106 1005 1007 O
methotrexate 107 119 1008 1020 B-allergy_name

Male 0 4 1021 1025 B-gender
and 5 8 1026 1029 I-gender
female 9 15 1030 1036 I-gender
patients 16 24 1037 1045 I-gender
with 25 29 1046 1050 O
reproductive 30 42 1051 1063 O
potential 43 52 1064 1073 O
must 53 57 1074 1078 O
use 58 61 1079 1082 B-contraception_consent
an 62 64 1083 1085 I-contraception_consent
approved 65 73 1086 1094 I-contraception_consent
contraceptive 74 87 1095 1108 I-contraception_consent
method 88 94 1109 1115 I-contraception_consent
if 95 97 1116 1118 O
appropriate 98 109 1119 1130 O

Negative 0 8 1131 1139 B-pregnancy
serum 9 14 1140 1145 I-pregnancy
pregnancy 15 24 1146 1155 I-pregnancy
test 25 29 1156 1160 O
in 30 32 1161 1163 O
females 33 40 1164 1171 B-gender

Patients 0 8 1172 1180 O
with 9 13 1181 1185 O
active 14 20 1186 1192 B-chronic_disease
extramedullary 21 35 1193 1207 I-chronic_disease
disease 36 43 1208 1215 I-chronic_disease

Platelets 0 9 1216 1225 B-clinical_variable
> 10 11 1226 1227 O
10 12 14 1228 1230 B-lower_bound
x 15 16 1231 1232 I-lower_bound
10 17 19 1233 1235 I-lower_bound
^ 19 20 1235 1236 I-lower_bound
9 20 21 1236 1237 I-lower_bound
/ 21 22 1237 1238 I-lower_bound
L 22 23 1238 1239 I-lower_bound

Pregnancy 0 9 1240 1249 B-pregnancy
testing 10 17 1250 1257 O
is 18 20 1258 1260 O
not 21 24 1261 1264 O
required 25 33 1265 1273 O
for 34 37 1274 1277 O
post 38 42 1278 1282 O
- 42 43 1282 1283 O
menopausal 43 53 1283 1293 O
or 54 56 1294 1296 O
surgically 57 67 1297 1307 O
sterilized 68 78 1308 1318 O
women 79 84 1319 1324 B-gender

Pregnant 0 8 1325 1333 B-pregnancy
or 9 11 1334 1336 O
breastfeeding 12 25 1337 1350 O

Prior 0 5 1351 1356 B-treatment
systemic 6 14 1357 1365 I-treatment
chemotherapy 15 27 1366 1378 I-treatment
, 27 28 1378 1379 O
immunotherapy 29 42 1380 1393 B-treatment
, 42 43 1393 1394 O
or 44 46 1395 1397 O
biological 47 57 1398 1408 B-treatment
therapy 58 65 1409 1416 I-treatment
, 65 66 1416 1417 O
radiation 67 76 1418 1427 B-treatment
therapy 77 84 1428 1435 I-treatment
and/or 85 91 1436 1442 O
surgery 92 99 1443 1450 B-treatment
are 100 103 1451 1454 O
allowed 104 111 1455 1462 O

Prior 0 5 1463 1468 O
to 6 8 1469 1471 O
study 9 14 1472 1477 O
entry 15 20 1478 1483 O
, 20 21 1483 1484 O
any 22 25 1485 1488 O
ECG 26 29 1489 1492 B-clinical_variable
abnormality 30 41 1493 1504 I-clinical_variable
at 42 44 1505 1507 O
screening 45 54 1508 1517 O
has 55 58 1518 1521 O
to 59 61 1522 1524 O
be 62 64 1525 1527 O
documented 65 75 1528 1538 O
by 76 78 1539 1541 O
the 79 82 1542 1545 O
investigator 83 95 1546 1558 O
as 96 98 1559 1561 O
not 99 102 1562 1565 O
medically 103 112 1566 1575 O
relevant 113 121 1576 1584 O

Serious 0 7 1585 1592 O
concomitant 8 19 1593 1604 O
systemic 20 28 1605 1613 B-chronic_disease
disorders 29 38 1614 1623 I-chronic_disease
( 39 40 1624 1625 O
e.g. 40 44 1625 1629 O
, 44 45 1629 1630 O
active 46 52 1631 1637 B-chronic_disease
uncontrolled 53 65 1638 1650 I-chronic_disease
infection 66 75 1651 1660 I-chronic_disease
or 76 78 1661 1663 O
uncontrolled 79 91 1664 1676 B-chronic_disease
diabetes 92 100 1677 1685 I-chronic_disease
) 100 101 1685 1686 O
or 102 104 1687 1689 O
psychiatric 105 116 1690 1701 B-chronic_disease
disorders 117 126 1702 1711 I-chronic_disease
that 127 131 1712 1716 O
, 131 132 1716 1717 O
in 133 135 1718 1720 O
the 136 139 1721 1724 O
opinion 140 147 1725 1732 O
of 148 150 1733 1735 O
the 151 154 1736 1739 O
investigator 155 167 1740 1752 O
, 167 168 1752 1753 O
would 169 174 1754 1759 O
compromise 175 185 1760 1770 O
the 186 189 1771 1774 O
safety 190 196 1775 1781 O
of 197 199 1782 1784 O
the 200 203 1785 1788 O
patient 204 211 1789 1796 O
or 212 214 1797 1799 O
compromise 215 225 1800 1810 O
the 226 229 1811 1814 O
patient 230 237 1815 1822 O
's 237 239 1822 1824 O
ability 240 247 1825 1832 O
to 248 250 1833 1835 O
complete 251 259 1836 1844 O
the 260 263 1845 1848 O
study 264 269 1849 1854 O

Uncontrolled 0 12 1855 1867 B-chronic_disease
diabetes 13 21 1868 1876 I-chronic_disease
mellitus 22 30 1877 1885 I-chronic_disease
defined 31 38 1886 1893 O
as 39 41 1894 1896 O
a 42 43 1897 1898 O
Hemoglobin 44 54 1899 1909 B-clinical_variable
A1C≥ 55 59 1910 1914 I-clinical_variable
10 60 62 1915 1917 B-lower_bound
% 62 63 1917 1918 I-lower_bound
in 64 66 1919 1921 O
patients 67 75 1922 1930 O
with 76 80 1931 1935 O
a 81 82 1936 1937 O
prior 83 88 1938 1943 O
history 89 96 1944 1951 O
of 97 99 1952 1954 O
diabetes 100 108 1955 1963 O
, 108 109 1963 1964 O
prior 110 115 1965 1970 O
to 116 118 1971 1973 O
study 119 124 1974 1979 O
enrollment 125 135 1980 1990 O

methotrexate 0 12 1991 2003 B-treatment
is 13 15 2004 2006 O
Pregnancy 16 25 2007 2016 B-pregnancy
Category 26 34 2017 2025 O
X 35 36 2026 2027 O
- 37 38 2028 2029 O
has 39 42 2030 2033 O
been 43 47 2034 2038 O
reported 48 56 2039 2047 O
to 57 59 2048 2050 O
cause 60 65 2051 2056 O
fetal 66 71 2057 2062 O
death 72 77 2063 2068 O
and/or 78 84 2069 2075 O
congenital 85 95 2076 2086 O
abnormalities 96 109 2087 2100 O

prior 0 5 2101 2106 B-treatment
use 6 9 2107 2110 I-treatment
of 10 12 2111 2113 I-treatment
systemic 13 21 2114 2122 I-treatment
methotrexate 22 34 2123 2135 I-treatment
> 35 36 2136 2137 O
1 37 38 2138 2139 B-lower_bound
month 39 44 2140 2145 I-lower_bound
prior 45 50 2146 2151 I-lower_bound
to 51 53 2152 2154 O
study 54 59 2155 2160 O
entry 60 65 2161 2166 O
is 66 68 2167 2169 O
allowed 69 76 2170 2177 O

A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
variceal 13 21 13 21 B-chronic_disease
bleeding 22 30 22 30 I-chronic_disease
where 31 36 31 36 O
the 37 40 37 40 O
varices 41 48 41 48 O
have 49 53 49 53 O
not 54 57 54 57 O
been 58 62 58 62 O
eradicated 63 73 63 73 O
or 74 76 74 76 O
decompressed 77 89 77 89 O
by 90 92 90 92 O
shunt 93 98 93 98 O
placement 99 108 99 108 O

A 0 1 109 110 O
life 2 6 111 115 B-clinical_variable
expectancy 7 17 116 126 I-clinical_variable
of 18 20 127 129 O
at 21 23 130 132 O
least 24 29 133 138 O
6 30 31 139 140 B-lower_bound
months 32 38 141 147 I-lower_bound
with 39 43 148 152 O
a 44 45 153 154 O
Karnofsky 46 55 155 164 B-clinical_variable
performance 56 67 165 176 I-clinical_variable
status 68 74 177 183 I-clinical_variable
of 75 77 184 186 O
at 78 80 187 189 O
least 81 86 190 195 O
70 87 89 196 198 B-lower_bound

Cirrhotic 0 9 199 208 B-clinical_variable
status 10 16 209 215 I-clinical_variable
of 17 19 216 218 I-clinical_variable
Child 20 25 219 224 I-clinical_variable
- 25 26 224 225 I-clinical_variable
Pugh 26 30 225 229 I-clinical_variable
class 31 36 230 235 I-clinical_variable
A 37 38 236 237 I-clinical_variable
or 39 41 238 240 I-clinical_variable
B 42 43 241 242 I-clinical_variable

Extensive 0 9 243 252 O
liver 10 15 253 258 B-cancer
tumor 16 21 259 264 I-cancer
burden 22 28 265 271 I-cancer
, 28 29 271 272 O
defined 30 37 273 280 O
as 38 40 281 283 O
more 41 45 284 288 O
than 46 50 289 293 O
75 51 53 294 296 B-lower_bound
% 53 54 296 297 I-lower_bound
of 55 57 298 300 O
the 58 61 301 304 O
liver 62 67 305 310 O

History 0 7 311 318 O
of 8 10 319 321 O
an 11 13 322 324 O
active 14 20 325 331 O
connective 21 31 332 342 B-chronic_disease
tissue 32 38 343 349 I-chronic_disease
disorder 39 47 350 358 I-chronic_disease

Male 0 4 359 363 B-gender

Must 0 4 364 368 O
be 5 7 369 371 O
aware 8 13 372 377 O
of 14 16 378 380 O
the 17 20 381 384 O
neoplastic 21 31 385 395 O
nature 32 38 396 402 O
of 39 41 403 405 O
his 42 45 406 409 O
/ 45 46 409 410 O
her 46 49 410 413 O
disease 50 57 414 421 O
and 58 61 422 425 O
willingly 62 71 426 435 O
provide 72 79 436 443 O
written 80 87 444 451 O
, 87 88 451 452 O
informed 89 97 453 461 O
consent 98 105 462 469 O
after 106 111 470 475 O
being 112 117 476 481 O
informed 118 126 482 490 O
of 127 129 491 493 O
the 130 133 494 497 O
procedure 134 143 498 507 O
to 144 146 508 510 O
be 147 149 511 513 O
followed 150 158 514 522 O
, 158 159 522 523 O
the 160 163 524 527 O
experimental 164 176 528 540 O
nature 177 183 541 547 O
of 184 186 548 550 O
the 187 190 551 554 O
therapy 191 198 555 562 B-treatment
, 198 199 562 563 O
alternatives 200 212 564 576 O
, 212 213 576 577 O
potential 214 223 578 587 O
benefits 224 232 588 596 O
, 232 233 596 597 O
side 234 238 598 602 O
- 238 239 602 603 O
effects 239 246 603 610 O
, 246 247 610 611 O
risks 248 253 612 617 O
and 254 257 618 621 O
discomforts 258 269 622 633 O

Myocardial 0 10 634 644 B-chronic_disease
infarction 11 21 645 655 I-chronic_disease
more 22 26 656 660 O
than 27 31 661 665 O
6 32 33 666 667 B-lower_bound
months 34 40 668 674 I-lower_bound
prior 41 46 675 680 I-lower_bound
to 47 49 681 683 O
study 50 55 684 689 O
entry 56 61 690 695 O

No 0 2 696 698 O
prior 3 8 699 704 O
radiotherapy 9 21 705 717 B-treatment
to 22 24 718 720 O
the 25 28 721 724 O
upper 29 34 725 730 O
abdomen 35 42 731 738 O

Other 0 5 739 744 O
baseline 6 14 745 753 O
labs 15 19 754 758 O
must 20 24 759 763 O
meet 25 29 764 768 O
the 30 33 769 772 O
following 34 43 773 782 O
criteria 44 52 783 791 O
: 52 53 791 792 O
total 54 59 793 798 O
bilirubin 60 69 799 808 B-clinical_variable
< 70 71 809 810 O
3mg 72 75 811 814 B-upper_bound
/ 75 76 814 815 I-upper_bound
dl 76 78 815 817 I-upper_bound
, 78 79 817 818 O
albumin 80 87 819 826 B-clinical_variable
> 87 88 826 827 O
2.5mg 89 94 828 833 B-lower_bound
/ 94 95 833 834 I-lower_bound
dl 95 97 834 836 I-lower_bound
, 97 98 836 837 O
and 99 102 838 841 O
liver 103 108 842 847 B-clinical_variable
enzymes 109 116 848 855 I-clinical_variable
less 117 121 856 860 O
than 122 126 861 865 O
three 127 132 866 871 B-upper_bound
times 133 138 872 877 I-upper_bound
the 139 142 878 881 I-upper_bound
upper 143 148 882 887 I-upper_bound
limit 149 154 888 893 I-upper_bound
of 155 157 894 896 I-upper_bound
normal 158 164 897 903 I-upper_bound
. 164 165 903 904 O
Creatinine 166 176 905 915 B-clinical_variable
must 177 181 916 920 O
also 182 186 921 925 O
be 187 189 926 928 O
< 190 191 929 930 O
1.8mg 192 197 931 936 B-upper_bound
/ 197 198 936 937 I-upper_bound
dl 198 200 937 939 I-upper_bound
or 201 203 940 942 O
a 204 205 943 944 O
creatinine 206 216 945 955 B-clinical_variable
clearance 217 226 956 965 I-clinical_variable
> 227 228 966 967 O
50ml 229 233 968 972 B-upper_bound
/ 233 234 972 973 I-upper_bound
min 234 237 973 976 I-upper_bound

Patient 0 7 977 984 O
's 7 9 984 986 O
will 10 14 987 991 O
have 15 19 992 996 O
no 20 22 997 999 O
evidence 23 31 1000 1008 O
of 32 34 1009 1011 O
gross 35 40 1012 1017 B-chronic_disease
vascular 41 49 1018 1026 I-chronic_disease
invasion 50 58 1027 1035 I-chronic_disease

Patients 0 8 1036 1044 O
can 9 12 1045 1048 O
have 13 17 1049 1053 O
extra 18 23 1054 1059 B-chronic_disease
- 23 24 1059 1060 I-chronic_disease
hepatic 24 31 1060 1067 I-chronic_disease
disease 32 39 1068 1075 I-chronic_disease
, 39 40 1075 1076 O
provided 41 49 1077 1085 O
the 50 53 1086 1089 O
hepatic 54 61 1090 1097 O
disease 62 69 1098 1105 O
is 70 72 1106 1108 O
the 73 76 1109 1112 O
highest 77 84 1113 1120 O
burden 85 91 1121 1127 O
, 91 92 1127 1128 O
the 93 96 1129 1132 O
extra 97 102 1133 1138 O
- 102 103 1138 1139 O
hepatic 103 110 1139 1146 O
disease 111 118 1147 1154 O
is 119 121 1155 1157 O
low 122 125 1158 1161 O
burden 126 132 1162 1168 O
and 133 136 1169 1172 O
potentially 137 148 1173 1184 O
treatable 149 158 1185 1194 O
with 159 163 1195 1199 O
surgery 164 171 1200 1207 B-treatment
, 171 172 1207 1208 O
ablative 173 181 1209 1217 B-treatment
radiation 182 191 1218 1227 I-treatment
therapy 192 199 1228 1235 I-treatment
, 199 200 1235 1236 O
or 201 203 1237 1239 O
US 204 206 1240 1242 O
Food 207 211 1243 1247 O
and 212 215 1248 1251 O
Drug 216 220 1252 1256 O
Administration 221 235 1257 1271 O
- 235 236 1271 1272 O
approved 236 244 1272 1280 O
first- 245 251 1281 1287 O
or 252 254 1288 1290 O
second 255 261 1291 1297 B-treatment
- 261 262 1297 1298 I-treatment
line 262 266 1298 1302 I-treatment
systemic 267 275 1303 1311 I-treatment
therapy 276 283 1312 1319 I-treatment
regimens 284 292 1320 1328 I-treatment

Patients 0 8 1329 1337 O
who 9 12 1338 1341 O
are 13 16 1342 1345 O
being 17 22 1346 1351 O
therapeutically 23 38 1352 1367 O
anticoagulated 39 53 1368 1382 O
with 54 58 1383 1387 O
an 59 61 1388 1390 O
agent 62 67 1391 1396 O
such 68 72 1397 1401 O
as 73 75 1402 1404 O
Coumadin 76 84 1405 1413 B-treatment
or 85 87 1414 1416 O
heparin 88 95 1417 1424 B-treatment
will 96 100 1425 1429 O
be 101 103 1430 1432 O
allowed 104 111 1433 1440 O
to 112 114 1441 1443 O
participate 115 126 1444 1455 O
provided 127 135 1456 1464 O
that 136 140 1465 1469 O
no 141 143 1470 1472 O
prior 144 149 1473 1478 O
evidence 150 158 1479 1487 O
of 159 161 1488 1490 O
underlying 162 172 1491 1501 O
abnormality 173 184 1502 1513 O
in 185 187 1514 1516 O
these 188 193 1517 1522 O
parameters 194 204 1523 1533 O
exists 205 211 1534 1540 O

Patients 0 8 1541 1549 O
will 9 13 1550 1554 O
have 14 18 1555 1559 O
no 19 21 1560 1562 O
more 22 26 1563 1567 O
than 27 31 1568 1572 O
3 32 33 1573 1574 B-upper_bound
distinct 34 42 1575 1583 O
lesions 43 50 1584 1591 B-clinical_variable
, 50 51 1591 1592 O
all 52 55 1593 1596 O
being 56 61 1597 1602 O
≤ 62 63 1603 1604 O
3 64 65 1605 1606 B-upper_bound
cm 65 67 1606 1608 I-upper_bound
in 68 70 1609 1611 I-upper_bound
greatest 71 79 1612 1620 I-upper_bound
dimension 80 89 1621 1630 I-upper_bound
, 89 90 1630 1631 O
OR 91 93 1632 1634 O
1 94 95 1635 1636 O
lesion 96 102 1637 1643 O
≤ 103 104 1644 1645 O
6 105 106 1646 1647 B-upper_bound
cm 106 108 1647 1649 I-upper_bound
in 109 111 1650 1652 I-upper_bound
greatest 112 120 1653 1661 I-upper_bound
dimension 121 130 1662 1671 I-upper_bound

Patients 0 8 1672 1680 O
with 9 13 1681 1685 O
hepatocellular 14 28 1686 1700 B-cancer
carcinoma 29 38 1701 1710 I-cancer
will 39 43 1711 1715 O
be 44 46 1716 1718 O
excluded 47 55 1719 1727 O
from 56 60 1728 1732 O
this 61 65 1733 1737 O
study 66 71 1738 1743 O

Patients 0 8 1744 1752 O
with 9 13 1753 1757 O
primary 14 21 1758 1765 B-cancer
tumor 22 27 1766 1771 I-cancer
histology 28 37 1772 1781 O
of 38 40 1782 1784 O
lymphoma 41 49 1785 1793 B-cancer
, 49 50 1793 1794 O
leukemia 51 59 1795 1803 B-cancer
, 59 60 1803 1804 O
or 61 63 1805 1807 O
germ 64 68 1808 1812 B-cancer
cell 69 73 1813 1817 I-cancer
tumor 74 79 1818 1823 I-cancer

Platelet 0 8 1824 1832 B-clinical_variable
count 9 14 1833 1838 I-clinical_variable
≥ 15 16 1839 1840 O
60 17 19 1841 1843 B-lower_bound
x 20 21 1844 1845 I-lower_bound
109 22 25 1846 1849 I-lower_bound
/ 25 26 1849 1850 I-lower_bound
L 26 27 1850 1851 I-lower_bound
, 27 28 1851 1852 O
Hemoglobin 29 39 1853 1863 B-clinical_variable
≥ 40 41 1864 1865 O
8.5 42 45 1866 1869 B-lower_bound
g 46 47 1870 1871 I-lower_bound
/ 47 48 1871 1872 I-lower_bound
dL 48 50 1872 1874 I-lower_bound
, 50 51 1874 1875 O
WBC 52 55 1876 1879 B-clinical_variable
≥ 56 57 1880 1881 O
2000 58 62 1882 1886 B-lower_bound
/ 62 63 1886 1887 I-lower_bound
μL 63 65 1887 1889 I-lower_bound
International 66 79 1890 1903 B-clinical_variable
normalized 80 90 1904 1914 I-clinical_variable
ratio 91 96 1915 1920 I-clinical_variable
( 97 98 1921 1922 I-clinical_variable
INR 98 101 1922 1925 I-clinical_variable
) 101 102 1925 1926 I-clinical_variable
must 103 107 1927 1931 O
be 108 110 1932 1934 O
≤ 111 112 1935 1936 O
2.3 113 116 1937 1940 B-upper_bound

Portal 0 6 1941 1947 B-chronic_disease
vein 7 11 1948 1952 I-chronic_disease
occlusion 12 21 1953 1962 I-chronic_disease

Pregnant 0 8 1963 1971 B-pregnancy

Previous 0 8 1972 1980 B-treatment
systemic 9 17 1981 1989 I-treatment
chemotherapy 18 30 1990 2002 I-treatment
or 31 33 2003 2005 O
non 34 37 2006 2009 B-treatment
- 37 38 2009 2010 I-treatment
radiation 38 47 2010 2019 I-treatment
local 48 53 2020 2025 I-treatment
therapy 54 61 2026 2033 I-treatment
( 62 63 2034 2035 O
such 63 67 2035 2039 O
as 68 70 2040 2042 O
surgery 71 78 2043 2050 B-treatment
, 78 79 2050 2051 O
hepatic 80 87 2052 2059 B-treatment
arterial 88 96 2060 2068 I-treatment
therapy 97 104 2069 2076 I-treatment
, 104 105 2076 2077 O
chemoembolization 106 123 2078 2095 B-treatment
, 123 124 2095 2096 O
radiofrequency 125 139 2097 2111 B-treatment
ablation 140 148 2112 2120 I-treatment
, 148 149 2120 2121 O
percutaneous 150 162 2122 2134 B-treatment
ethanol 163 170 2135 2142 I-treatment
injection 171 180 2143 2152 I-treatment
or 181 183 2153 2155 O
cryoablation 184 196 2156 2168 B-treatment
) 196 197 2168 2169 O
is 198 200 2170 2172 O
allowed 201 208 2173 2180 O
. 208 209 2180 2181 O
The 210 213 2182 2185 O
lesion 214 220 2186 2192 O
must 221 225 2193 2197 O
however 226 233 2198 2205 O
have 234 238 2206 2210 O
shown 239 244 2211 2216 O
criteria 245 253 2217 2225 O
of 254 256 2226 2228 O
progression 257 268 2229 2240 O
based 269 274 2241 2246 O
on 275 277 2247 2249 O
RECIST 278 284 2250 2256 O
. 284 285 2256 2257 O
Local 286 291 2258 2263 B-treatment
therapy 292 299 2264 2271 I-treatment
must 300 304 2272 2276 O
be 305 307 2277 2279 O
completed 308 317 2280 2289 O
at 318 320 2290 2292 O
least 321 326 2293 2298 O
4 327 328 2299 2300 B-lower_bound
weeks 329 334 2301 2306 I-lower_bound
prior 335 340 2307 2312 I-lower_bound
to 341 343 2313 2315 O
the 344 347 2316 2319 O
baseline 348 356 2320 2328 O
scan 357 361 2329 2333 O
. 361 362 2333 2334 O
This 363 367 2335 2339 O
is 368 370 2340 2342 O
to 371 373 2343 2345 O
create 374 380 2346 2352 O
a 381 382 2353 2354 O
safer 383 388 2355 2360 O
treatment 389 398 2361 2370 B-treatment
environment 399 410 2371 2382 O
and 411 414 2383 2386 O
to 415 417 2387 2389 O
help 418 422 2390 2394 O
determine 423 432 2395 2404 O
the 433 436 2405 2408 O
effect 437 443 2409 2415 O
of 444 446 2416 2418 O
treatment 447 456 2419 2428 O
by 457 459 2429 2431 O
SBRT 460 464 2432 2436 B-treatment
alone 465 470 2437 2442 O
. 470 471 2442 2443 O
Patients 472 480 2444 2452 O
will 481 485 2453 2457 O
be 486 488 2458 2460 O
allowed 489 496 2461 2468 O
to 497 499 2469 2471 O
go 500 502 2472 2474 O
onto 503 507 2475 2479 O
appropriate 508 519 2480 2491 O
systemic 520 528 2492 2500 B-treatment
therapy 529 536 2501 2508 I-treatment
, 536 537 2508 2509 O
as 538 540 2510 2512 O
determined 541 551 2513 2523 O
by 552 554 2524 2526 O
their 555 560 2527 2532 O
medical 561 568 2533 2540 O
oncologist 569 579 2541 2551 O
, 579 580 2551 2552 O
2 581 582 2553 2554 B-lower_bound
weeks 583 588 2555 2560 I-lower_bound
following 589 598 2561 2570 O
delivery 599 607 2571 2579 O
of 608 610 2580 2582 O
SBRT 611 615 2583 2587 O

Renal 0 5 2588 2593 B-chronic_disease
failure 6 13 2594 2601 I-chronic_disease
requiring 14 23 2602 2611 O
hemo- 24 29 2612 2617 B-treatment
or 30 32 2618 2620 I-treatment
peritoneal 33 43 2621 2631 I-treatment
dialysis 44 52 2632 2640 I-treatment

Substance 0 9 2641 2650 O
abuse 10 15 2651 2656 O
, 15 16 2656 2657 O
medical 17 24 2658 2665 B-chronic_disease
, 24 25 2665 2666 O
psychological 26 39 2667 2680 B-chronic_disease
or 40 42 2681 2683 O
social 43 49 2684 2690 B-chronic_disease
conditions 50 60 2691 2701 I-chronic_disease
that 61 65 2702 2706 O
may 66 69 2707 2710 O
interfere 70 79 2711 2720 O
with 80 84 2721 2725 O
the 85 88 2726 2729 O
patient 89 96 2730 2737 O
's 96 98 2737 2739 O
participation 99 112 2740 2753 O
in 113 115 2754 2756 O
the 116 119 2757 2760 O
study 120 125 2761 2766 O
or 126 128 2767 2769 O
evaluation 129 139 2770 2780 O
of 140 142 2781 2783 O
the 143 146 2784 2787 O
study 147 152 2788 2793 O
results 153 160 2794 2801 O

The 0 3 2802 2805 O
target 4 10 2806 2812 O
lesion(s 11 19 2813 2821 O
) 19 20 2821 2822 O
can 21 24 2823 2826 O
be 25 27 2827 2829 O
accurately 28 38 2830 2840 O
measured 39 47 2841 2849 O
in 48 50 2850 2852 O
at 51 53 2853 2855 O
least 54 59 2856 2861 O
one 60 63 2862 2865 B-lower_bound
dimension 64 73 2866 2875 O
according 74 83 2876 2885 O
to 84 86 2886 2888 O
RECIST 87 93 2889 2895 O
and 94 97 2896 2899 O
must 98 102 2900 2904 O
have 103 107 2905 2909 O
a 108 109 2910 2911 O
maximum 110 117 2912 2919 B-clinical_variable
tumor 118 123 2920 2925 I-clinical_variable
volume 124 130 2926 2932 I-clinical_variable
of 131 133 2933 2935 O
≤ 134 135 2936 2937 O
100 136 139 2938 2941 B-upper_bound
cm3 140 143 2942 2945 I-upper_bound

Uncontrolled 0 12 2946 2958 O
inter 13 18 2959 2964 B-chronic_disease
- 18 19 2964 2965 I-chronic_disease
current 19 26 2965 2972 I-chronic_disease
illness 27 34 2973 2980 I-chronic_disease
including 35 44 2981 2990 O
, 44 45 2990 2991 O
but 46 49 2992 2995 O
not 50 53 2996 2999 O
limited 54 61 3000 3007 O
to 62 64 3008 3010 O
ongoing 65 72 3011 3018 O
or 73 75 3019 3021 O
active 76 82 3022 3028 B-chronic_disease
infection 83 92 3029 3038 I-chronic_disease
( 93 94 3039 3040 O
> 94 95 3040 3041 O
grade 96 101 3042 3047 B-lower_bound
2 102 103 3048 3049 I-lower_bound
National 104 112 3050 3058 O
Cancer 113 119 3059 3065 O
Institute 120 129 3066 3075 O
[ 130 131 3076 3077 O
NCI]-Common 131 142 3077 3088 O
Terminology 143 154 3089 3100 I-clinical_variable
Criteria 155 163 3101 3109 I-clinical_variable
for 164 167 3110 3113 I-clinical_variable
Adverse 168 175 3114 3121 I-clinical_variable
Events 176 182 3122 3128 I-clinical_variable
[ 183 184 3129 3130 I-clinical_variable
CTCAE 184 189 3130 3135 I-clinical_variable
] 189 190 3135 3136 I-clinical_variable
version 191 198 3137 3144 O
4.0 199 202 3145 3148 O
) 202 203 3148 3149 O
, 203 204 3149 3150 O
congestive 205 215 3151 3161 B-chronic_disease
heart 216 221 3162 3167 I-chronic_disease
failure 222 229 3168 3175 I-chronic_disease
( 230 231 3176 3177 O
> 231 232 3177 3178 O
New 233 236 3179 3182 B-clinical_variable
York 237 241 3183 3187 I-clinical_variable
Heart 242 247 3188 3193 I-clinical_variable
Association 248 259 3194 3205 I-clinical_variable
( 260 261 3206 3207 I-clinical_variable
NYHA 261 265 3207 3211 I-clinical_variable
) 265 266 3211 3212 I-clinical_variable
class 267 272 3213 3218 B-lower_bound
2 273 274 3219 3220 I-lower_bound
) 274 275 3220 3221 O
, 275 276 3221 3222 O
active 277 283 3223 3229 O
coronary 284 292 3230 3238 B-chronic_disease
artery 293 299 3239 3245 I-chronic_disease
disease 300 307 3246 3253 I-chronic_disease
( 308 309 3254 3255 I-chronic_disease
CAD 309 312 3255 3258 I-chronic_disease
) 312 313 3258 3259 I-chronic_disease
, 313 314 3259 3260 O
cardiac 315 322 3261 3268 B-chronic_disease
arrhythmias 323 334 3269 3280 I-chronic_disease
requiring 335 344 3281 3290 O
anti 345 349 3291 3295 B-treatment
- 349 350 3295 3296 I-treatment
arrhythmic 350 360 3296 3306 I-treatment
therapy 361 368 3307 3314 I-treatment
other 369 374 3315 3320 O
than 375 379 3321 3325 O
beta 380 384 3326 3330 B-treatment
blockers 385 393 3331 3339 I-treatment
or 394 396 3340 3342 O
digoxin 397 404 3343 3350 B-treatment
) 404 405 3350 3351 O
, 405 406 3351 3352 O
uncontrolled 407 419 3353 3365 B-chronic_disease
hypertension 420 432 3366 3378 I-chronic_disease
and 433 436 3379 3382 O
any 437 440 3383 3386 O
condition 441 450 3387 3396 O
which 451 456 3397 3402 O
could 457 462 3403 3408 O
jeopardize 463 473 3409 3419 O
the 474 477 3420 3423 O
safety 478 484 3424 3430 O
of 485 487 3431 3433 O
the 488 491 3434 3437 O
patient 492 499 3438 3445 O
and 500 503 3446 3449 O
his 504 507 3450 3453 O
/ 507 508 3453 3454 O
her 508 511 3454 3457 O
compliance 512 522 3458 3468 O
in 523 525 3469 3471 O
the 526 529 3472 3475 O
study 530 535 3476 3481 O

female 0 6 3482 3488 B-gender

patients 0 8 3489 3497 O
≥ 9 10 3498 3499 O
18 11 13 3500 3502 B-lower_bound
years 14 19 3503 3508 I-lower_bound
of 20 22 3509 3511 O
age 23 26 3512 3515 B-age

Acute 0 5 0 5 B-cancer
leukemia 6 14 6 14 I-cancer
in 15 17 15 17 O
first 18 23 18 23 O
remission 24 33 24 33 O
at 34 36 34 36 O
high 37 41 37 41 O
- 41 42 41 42 O
risk 42 46 42 46 O
for 47 50 47 50 O
recurrence 51 61 51 61 O

Age 0 3 62 65 B-age
≥ 4 5 66 67 O
18 6 8 68 70 B-lower_bound
years 9 14 71 76 I-lower_bound

Aplastic 0 8 77 85 B-chronic_disease
anemia 9 15 86 92 I-chronic_disease

Chronic 0 7 93 100 B-chronic_disease
lymphocytic 8 19 101 112 I-chronic_disease
leukemia 20 28 113 121 I-chronic_disease
, 28 29 121 122 O
relapsed 30 38 123 131 O
or 39 41 132 134 O
with 42 46 135 139 O
poor 47 51 140 144 O
prognostic 52 62 145 155 O
features 63 71 156 164 O

Chronic 0 7 165 172 B-cancer
myelogenous 8 19 173 184 I-cancer
leukemia 20 28 185 193 I-cancer
in 29 31 194 196 O
chronic 32 39 197 204 O

Chronic 0 7 205 212 B-chronic_disease
myeloproliferative 8 26 213 231 I-chronic_disease
disease 27 34 232 239 I-chronic_disease

Evidence 0 8 240 248 O
of 9 11 249 251 O
chronic 12 19 252 259 B-chronic_disease
active 20 26 260 266 I-chronic_disease
hepatitis 27 36 267 276 I-chronic_disease
or 37 39 277 279 O
cirrhosis 40 49 280 289 B-chronic_disease

Hemoglobinopathies 0 18 290 308 B-chronic_disease

Karnofsky 0 9 309 318 B-clinical_variable
( 10 11 319 320 I-clinical_variable
KPS 11 14 320 323 I-clinical_variable
) 14 15 323 324 I-clinical_variable
Performance 16 27 325 336 O
status 28 34 337 343 O
of 35 37 344 346 O
> 38 39 347 348 O
= 39 40 348 349 O
70 41 43 350 352 B-lower_bound
% 43 44 352 353 I-lower_bound

Life 0 4 354 358 B-clinical_variable
expectancy 5 15 359 369 I-clinical_variable
is 16 18 370 372 O
severely 19 27 373 381 O
limited 28 35 382 389 O
by 36 38 390 392 O
concomitant 39 50 393 404 O
illness 51 58 405 412 O
or 59 61 413 415 O
uncontrolled 62 74 416 428 O
infection 75 84 429 438 O

Multiple 0 8 439 447 B-cancer
myeloma 9 16 448 455 I-cancer

Myelodysplastic 0 15 456 471 B-cancer
syndrome 16 24 472 480 I-cancer

Other 0 5 481 486 O
hematological 6 19 487 500 B-chronic_disease
disorder 20 28 501 509 I-chronic_disease
in 29 31 510 512 O
need 32 36 513 517 O
of 37 39 518 520 O
allogeneic 40 50 521 531 B-treatment
transplant 51 61 532 542 I-treatment

Pregnant 0 8 543 551 B-pregnancy

Previously 0 10 552 562 O
Relapsed 11 19 563 571 O
or 20 22 572 574 O
refractory 23 33 575 585 O
acute 34 39 586 591 B-cancer
leukemia 40 48 592 600 I-cancer
( 49 50 601 602 I-cancer
myeloid 50 57 602 609 I-cancer
or 58 60 610 612 I-cancer
lymphoid 61 69 613 621 I-cancer
) 69 70 621 622 I-cancer

Recurrent 0 9 623 632 O
or 10 12 633 635 O
refractory 13 23 636 646 O
malignant 24 33 647 656 B-cancer
lymphoma 34 42 657 665 I-cancer
or 43 45 666 668 O
Hodgkin 46 53 669 676 B-cancer
lymphoma 54 62 677 685 I-cancer

Severely 0 8 686 694 O
decreased 9 18 695 704 O
Left 19 23 705 709 B-clinical_variable
Ventricular 24 35 710 721 I-clinical_variable
Ejection 36 44 722 730 I-clinical_variable
Fraction 45 53 731 739 I-clinical_variable
( 54 55 740 741 I-clinical_variable
LVEF 55 59 741 745 I-clinical_variable
) 59 60 745 746 I-clinical_variable

Uncontrolled 0 12 747 759 O
HIV 13 16 760 763 B-chronic_disease
disease 17 24 764 771 I-chronic_disease

accelerated 0 11 772 783 O
phase 12 17 784 789 O
or 18 20 790 792 O
blast 21 26 793 798 B-cancer
- 26 27 798 799 I-cancer
crisis 27 33 799 805 I-cancer

blastoid 0 8 806 814 B-cancer
dendritic 9 18 815 824 I-cancer
cell 19 23 825 829 I-cancer
neoplasm 24 32 830 838 I-cancer

autoimmune 0 10 0 10 B-chronic_disease
, 10 11 10 11 O
vascular 12 20 12 20 B-chronic_disease
or 21 23 21 23 O
neuromuscular 24 37 24 37 B-chronic_disease
disease 38 45 38 45 I-chronic_disease
that 46 50 46 50 O
could 51 56 51 56 O
alter 57 62 57 62 O
skeletal 63 71 63 71 O
muscle 72 78 72 78 O

contraindications 0 17 79 96 O
for 18 21 97 100 O
use 22 25 101 104 O
of 26 28 105 107 O
neuromuscular 29 42 108 121 B-allergy_name
electrical 43 53 122 132 I-allergy_name
stimulation 54 65 133 144 I-allergy_name
, 65 66 144 145 O
including 67 76 146 155 O
an 77 79 156 158 O
implanted 80 89 159 168 B-allergy_name
cardiac 90 97 169 176 I-allergy_name
defibrillator 98 111 177 190 I-allergy_name
or 112 114 191 193 O
pacemaker 115 124 194 203 B-allergy_name
, 124 125 203 204 O
lower 126 131 205 210 B-allergy_name
extremity 132 141 211 220 I-allergy_name
blood 142 147 221 226 I-allergy_name
clot 148 152 227 231 I-allergy_name
or 153 155 232 234 O
coagulopathy 156 168 235 247 B-allergy_name

metastatic 0 10 248 258 B-cancer
disease 11 18 259 266 I-cancer
, 18 19 266 267 O
a 20 21 268 269 O
prior 22 27 270 275 O
history 28 35 276 283 O
of 36 38 284 286 O
cancer 39 45 287 293 B-cancer
, 45 46 293 294 O
excluding 47 56 295 304 O
non 57 60 305 308 B-cancer
- 60 61 308 309 I-cancer
melanoma 61 69 309 317 I-cancer
skin 70 74 318 322 I-cancer
cancer 75 81 323 329 I-cancer
, 81 82 329 330 O
or 83 85 331 333 O
prior 86 91 334 339 O
receipt 92 99 340 347 O
of 100 102 348 350 O
chemotherapy 103 115 351 363 B-treatment

pregnancy 0 9 364 373 B-pregnancy

prior 0 5 374 379 B-treatment
knee 6 10 380 384 I-treatment
or 11 13 385 387 I-treatment
hip 14 17 388 391 I-treatment
replacement 18 29 392 403 I-treatment

receiving 0 9 404 413 O
neoadjuvant 10 21 414 425 B-treatment
or 22 24 426 428 O
adjuvant 25 33 429 437 B-treatment
chemotherapy 34 46 438 450 I-treatment
with 47 51 451 455 O
or 52 54 456 458 O
without 55 62 459 466 O
radiation 63 72 467 476 B-treatment

stage 0 5 477 482 B-cancer
I 6 7 483 484 I-cancer
, 7 8 484 485 I-cancer
II 9 11 486 488 I-cancer
or 12 14 489 491 I-cancer
III 15 18 492 495 I-cancer
breast 19 25 496 502 I-cancer
cancer 26 32 503 509 I-cancer

A 0 1 0 1 O
creatinine 2 12 2 12 B-clinical_variable
level 13 18 13 18 I-clinical_variable
of 19 21 19 21 O
less 22 26 22 26 O
than 27 31 27 31 O
1 32 33 32 33 B-upper_bound
1/2 34 37 34 37 I-upper_bound
times 38 43 38 43 I-upper_bound
the 44 47 44 47 I-upper_bound
upper 48 53 48 53 I-upper_bound
limit 54 59 54 59 I-upper_bound
of 60 62 60 62 I-upper_bound
normal 63 69 63 69 I-upper_bound
for 70 73 70 73 O
the 74 77 74 77 O
local 78 83 78 83 O
lab 84 87 84 87 O
test 88 92 88 92 O
, 92 93 92 93 O
or 94 96 94 96 O
, 96 97 96 97 O
a 98 99 98 99 O
creatinine 100 110 100 110 B-clinical_variable
clearance 111 120 111 120 I-clinical_variable
of 121 123 121 123 O
at 124 126 124 126 O
least 127 132 127 132 O
60 133 135 133 135 B-lower_bound
mL/(min*1.73m2 136 150 136 150 I-lower_bound
) 150 151 150 151 I-lower_bound

Commit 0 6 152 158 B-contraception_consent
to 7 9 159 161 I-contraception_consent
using 10 15 162 167 I-contraception_consent
birth 16 21 168 173 I-contraception_consent
control 22 29 174 181 I-contraception_consent
during 30 36 182 188 O
the 37 40 189 192 O
study 41 46 193 198 O
( 47 48 199 200 O
all 48 51 200 203 O
participants 52 64 204 216 O
) 64 65 216 217 O

Glucose-6 0 9 218 227 B-chronic_disease
- 9 10 227 228 I-chronic_disease
phosphate 10 19 228 237 I-chronic_disease
dehydrogenase 20 33 238 251 I-chronic_disease
( 34 35 252 253 I-chronic_disease
G6PD 35 39 253 257 I-chronic_disease
) 39 40 257 258 I-chronic_disease
deficiency 41 51 259 269 I-chronic_disease

HIV 0 3 270 273 B-chronic_disease
positive 4 12 274 282 O
individuals 13 24 283 294 O
undergoing 25 35 295 305 O
therapy 36 43 306 313 B-treatment
due 44 47 314 317 O
to 48 50 318 320 O
known 51 56 321 326 O
drug 57 61 327 331 O
: 61 62 331 332 O
drug 62 66 332 336 O
interaction 67 78 337 348 O
between 79 86 349 356 O
antiretroviral 87 101 357 371 B-treatment
drugs 102 107 372 377 I-treatment
and 108 111 378 381 O
high 112 116 382 386 O
- 116 117 386 387 O
dose 117 121 387 391 O
ascorbate 122 131 392 401 B-treatment
therapy 132 139 402 409 I-treatment

If 0 2 410 412 O
all 3 6 413 416 O
of 7 9 417 419 O
the 10 13 420 423 O
above 14 19 424 429 O
are 20 23 430 433 O
met 24 27 434 437 O
, 27 28 437 438 O
the 29 32 439 442 O
potential 33 42 443 452 O
participant 43 54 453 464 O
will 55 59 465 469 O
receive 60 67 470 477 O
a 68 69 478 479 O
15 70 72 480 482 O
gram 73 77 483 487 O
challenge 78 87 488 497 O
dose 88 92 498 502 O
of 93 95 503 505 O
ascorbate 96 105 506 515 B-treatment
via 106 109 516 519 I-treatment
intravenous 110 121 520 531 I-treatment
infusion 122 130 532 540 I-treatment
. 130 131 540 541 O
This 132 136 542 546 O
is 137 139 547 549 O
the 140 143 550 553 O
final 144 149 554 559 O
screening 150 159 560 569 O
procedure 160 169 570 579 O

Metastatic 0 10 580 590 B-chronic_disease
or 11 13 591 593 I-chronic_disease
node 14 18 594 598 I-chronic_disease
positive 19 27 599 607 I-chronic_disease
disease 28 35 608 615 I-chronic_disease

Other 0 5 616 621 O
therapy 6 13 622 629 B-treatment
( 14 15 630 631 O
including 15 24 631 640 O
radiation 25 34 641 650 B-treatment
) 34 35 650 651 O
within 36 42 652 658 O
the 43 46 659 662 O
past 47 51 663 667 B-upper_bound
4 52 53 668 669 I-upper_bound
weeks 54 59 670 675 I-upper_bound

Pathologic 0 10 676 686 O
diagnosis 11 20 687 696 O
( 21 22 697 698 O
cell 22 26 698 702 O
samples 27 34 703 710 O
, 34 35 710 711 O
biopsy 36 42 712 718 O
, 42 43 718 719 O
brushing 44 52 720 728 O
, 52 53 728 729 O
surgical 54 62 730 738 O
sample 63 69 739 745 O
) 69 70 745 746 O
of 71 73 747 749 O
adenocarcinoma 74 88 750 764 B-cancer
of 89 91 765 767 O
the 92 95 768 771 O
pancreas 96 104 772 780 O

Patients 0 8 781 789 O
actively 9 17 790 798 O
receiving 18 27 799 808 O
insulin 28 35 809 816 B-treatment

Prior 0 5 817 822 O
chemotherapy 6 18 823 835 B-treatment
to 19 21 836 838 O
treat 22 27 839 844 O
the 28 31 845 848 O
metastatic 32 42 849 859 B-cancer
disease 43 50 860 867 I-cancer

Side 0 4 868 872 O
effects 5 12 873 880 O
from 13 17 881 885 O
prior 18 23 886 891 B-treatment
therapies 24 33 892 901 I-treatment
that 34 38 902 906 O
are 39 42 907 910 O
still 43 48 911 916 O
deemed 49 55 917 923 O
moderate 56 64 924 932 O
to 65 67 933 935 O
severe 68 74 936 942 O
by 75 77 943 945 O
a 78 79 946 947 O
physician 80 89 948 957 O

The 0 3 958 961 O
patient 4 11 962 969 O
must 12 16 970 974 O
have 17 21 975 979 O
failed 22 28 980 986 O
initial 29 36 987 994 B-treatment
therapy 37 44 995 1002 I-treatment
or 45 47 1003 1005 O
be 48 50 1006 1008 O
ineligible 51 61 1009 1019 O
for 62 65 1020 1023 O
definitive 66 76 1024 1034 O
curative 77 85 1035 1043 B-treatment
therapy 86 93 1044 1051 I-treatment
( 94 95 1052 1053 O
e.g. 95 99 1053 1057 O
, 99 100 1057 1058 O
surgical 101 109 1059 1067 B-treatment
excision 110 118 1068 1076 I-treatment
, 118 119 1076 1077 O
radiation 120 129 1078 1087 B-treatment
therapy 130 137 1088 1095 I-treatment
) 137 138 1095 1096 O

Uncontrolled 0 12 1097 1109 O
, 12 13 1109 1110 O
intercurrent 14 26 1111 1123 B-chronic_disease
illness 27 34 1124 1131 I-chronic_disease

methadone 0 9 1132 1141 B-treatment

< 0 1 0 1 O
45 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

< 0 1 17 18 O
45 1 3 18 20 B-upper_bound
years 4 9 21 26 I-upper_bound
of 10 12 27 29 O
age 13 16 30 33 B-age
who 17 20 34 37 O
are 21 24 38 41 O
at 25 27 42 44 O
least 28 33 45 50 O
6 34 35 51 52 B-lower_bound
months 36 42 53 59 I-lower_bound
after 43 48 60 65 O
initial 49 56 66 73 O
hematopoietic 57 70 74 87 B-treatment
stem 71 75 88 92 I-treatment
cell 76 80 93 97 I-treatment
transplant 81 91 98 108 I-treatment
( 92 93 109 110 I-treatment
HSCT 93 97 110 114 I-treatment
) 97 98 114 115 I-treatment

Diagnosis 0 9 116 125 O
of 10 12 126 128 O
acute 13 18 129 134 B-cancer
lymphoblastic 19 32 135 148 I-cancer
leukemia 33 41 149 157 I-cancer
( 42 43 158 159 I-cancer
ALL 43 46 159 162 I-cancer
) 46 47 162 163 I-cancer
, 47 48 163 164 O
acute 49 54 165 170 B-cancer
myeloid 55 62 171 178 I-cancer
leukemia 63 71 179 187 I-cancer
( 72 73 188 189 I-cancer
AML 73 76 189 192 I-cancer
) 76 77 192 193 I-cancer
or 78 80 194 196 O
myelodysplastic 81 96 197 212 B-cancer
syndrome 97 105 213 221 I-cancer
( 106 107 222 223 I-cancer
MDS 107 110 223 226 I-cancer
) 110 111 226 227 I-cancer
and 112 115 228 231 O
current 116 123 232 239 O
in 124 126 240 242 O
complete 127 135 243 251 O
remission 136 145 252 261 O

Karnofsky 0 9 262 271 B-clinical_variable
performance 10 21 272 283 I-clinical_variable
status 22 28 284 290 I-clinical_variable
> 29 30 291 292 O
70 30 32 292 294 B-lower_bound
% 32 33 294 295 I-lower_bound

Women 0 5 296 301 B-gender
of 6 8 302 304 O
childbearing 9 21 305 317 O
age 22 25 318 321 B-age
must 26 30 322 326 O
have 31 35 327 331 O
a 36 37 332 333 O
negative 38 46 334 342 B-pregnancy
pregnancy 47 56 343 352 I-pregnancy
test 57 61 353 357 O

active 0 6 358 364 O
uncontrolled 7 19 365 377 O
infection 20 29 378 387 O
within 30 36 388 394 O
one 37 40 395 398 B-upper_bound
week 41 45 399 403 I-upper_bound
of 46 48 404 406 O
study 49 54 407 412 O
enrollment 55 65 413 423 O

all 0 3 424 427 O
sexually 4 12 428 436 O
active 13 19 437 443 O
participants 20 32 444 456 O
must 33 37 457 461 O
agree 38 43 462 467 B-contraception_consent
to 44 46 468 470 I-contraception_consent
use 47 50 471 474 I-contraception_consent
effective 51 60 475 484 I-contraception_consent
contraception 61 74 485 498 I-contraception_consent
during 75 81 499 505 O
study 82 87 506 511 O
treatment 88 97 512 521 O

cardiac 0 7 522 529 B-chronic_disease
: 7 8 529 530 O
left 9 13 531 535 B-clinical_variable
ventricular 14 25 536 547 I-clinical_variable
ejection 26 34 548 556 I-clinical_variable
fraction 35 43 557 565 I-clinical_variable
> 44 45 566 567 O
45 45 47 567 569 B-lower_bound
% 47 48 569 570 I-lower_bound
by 49 51 571 573 O
echocardiogram 52 66 574 588 B-treatment
( 67 68 589 590 I-treatment
ECHO 68 72 590 594 I-treatment
/ 72 73 594 595 I-treatment
MUGA 73 77 595 599 I-treatment
) 77 78 599 600 I-treatment

eligible 0 8 601 609 O
for 9 12 610 613 O
TBI 13 16 614 617 B-treatment
containing 17 27 618 628 I-treatment
preparative 28 39 629 640 I-treatment
regimen 40 47 641 648 I-treatment

have 0 4 649 653 O
received 5 13 654 662 O
sufficient 14 24 663 673 O
radiation 25 34 674 683 B-treatment
treatment 35 44 684 693 O
to 45 47 694 696 O
be 48 50 697 699 O
ineligible 51 61 700 710 O
for 62 65 711 714 O
total 66 71 715 720 B-treatment
body 72 76 721 725 I-treatment
irradiation 77 88 726 737 I-treatment
( 89 90 738 739 I-treatment
TBI 90 93 739 742 I-treatment
) 93 94 742 743 I-treatment
containing 95 105 744 754 O
preparative 106 117 755 766 O
therapy 118 125 767 774 O

hepatic 0 7 775 782 O
: 7 8 782 783 O
no 9 11 784 786 O
clinical 12 20 787 795 O
evidence 21 29 796 804 O
of 30 32 805 807 O
hepatic 33 40 808 815 B-chronic_disease
failure 41 48 816 823 I-chronic_disease
( 49 50 824 825 O
e.g. 50 54 825 829 O
, 54 55 829 830 O
coagulopathy 56 68 831 843 B-chronic_disease
, 68 69 843 844 O
ascites 70 77 845 852 B-chronic_disease
) 77 78 852 853 O

lactating 0 9 854 863 O
female 10 16 864 870 B-gender

pregnant 0 8 871 879 B-pregnancy

renal 0 5 880 885 O
: 5 6 885 886 O
creatinine 7 17 887 897 B-clinical_variable
clearance 18 27 898 907 I-clinical_variable
> 28 29 908 909 O
40 29 31 909 911 B-lower_bound
mL 32 34 912 914 I-lower_bound
/ 34 35 914 915 I-lower_bound
min/1.73m^2 35 46 915 926 I-lower_bound

English 0 7 0 7 B-language_fluency
as 8 10 8 10 I-language_fluency
a 11 12 11 12 I-language_fluency
primary 13 20 13 20 I-language_fluency
language 21 29 21 29 I-language_fluency

a 0 1 30 31 O
current 2 9 32 39 O
diagnosis 10 19 40 49 O
of 20 22 50 52 O
Major 23 28 53 58 B-chronic_disease
Depressive 29 39 59 69 I-chronic_disease
Disorder 40 48 70 78 I-chronic_disease

currently 0 9 79 88 O
taking 10 16 89 95 O
steroids 17 25 96 104 B-treatment
or 26 28 105 107 O
benzodiazepines 29 44 108 123 B-treatment

diagnosis 0 9 124 133 O
of 10 12 134 136 O
Multiple 13 21 137 145 B-chronic_disease
Sclerosis 22 31 146 155 I-chronic_disease

history 0 7 156 163 O
of 8 10 164 166 O
significant 11 22 167 178 O
psychiatric 23 34 179 190 B-chronic_disease
illness 35 42 191 198 I-chronic_disease
( 43 44 199 200 O
bipolar 44 51 200 207 B-chronic_disease
disorder 52 60 208 216 I-chronic_disease
, 60 61 216 217 O
schizophrenia 62 75 218 231 B-chronic_disease
, 75 76 231 232 O
or 77 79 233 235 O
psychosis 80 89 236 245 B-chronic_disease
) 89 90 245 246 O

most 0 4 247 251 O
recent 5 11 252 258 O
exacerbation 12 24 259 271 O
within 25 31 272 278 O
one 32 35 279 282 B-upper_bound
month 36 41 283 288 I-upper_bound

A 0 1 0 1 O
previous 2 10 2 10 O
concussion 11 21 11 21 B-chronic_disease
within 22 28 22 28 O
the 29 32 29 32 O
last 33 37 33 37 B-upper_bound
12 38 40 38 40 I-upper_bound
months 41 47 41 47 I-upper_bound

Greater 0 7 48 55 O
than 8 12 56 60 O
24 13 15 61 63 B-lower_bound
hours 16 21 64 69 I-lower_bound
have 22 26 70 74 O
elapsed 27 34 75 82 O
since 35 40 83 88 O
the 41 44 89 92 O
concussion 45 55 93 103 O
occurred 56 64 104 112 O

Less 0 4 113 117 O
than 5 9 118 122 O
18 10 12 123 125 B-upper_bound
years 13 18 126 131 I-upper_bound
old 19 22 132 135 O

The 0 3 136 139 O
student 4 11 140 147 O
- 11 12 147 148 O
athlete 12 19 148 155 O
has 20 23 156 159 O
already 24 31 160 167 O
participated 32 44 168 180 O
in 45 47 181 183 O
the 48 51 184 187 O
study 52 57 188 193 O
during 58 64 194 200 O
which 65 70 201 206 O
he 71 73 207 209 O
/ 73 74 209 210 O
she 74 77 210 213 O
took 78 82 214 218 O
Riboflavin 83 93 219 229 B-treatment

over 0 4 230 234 O
the 5 8 235 238 O
age 9 12 239 242 B-age
of 13 15 243 245 O
18 16 18 246 248 B-lower_bound
years 19 24 249 254 I-lower_bound
old 25 28 255 258 O

who 0 3 259 262 O
are 4 7 263 266 O
diagnosed 8 17 267 276 O
with 18 22 277 281 O
a 23 24 282 283 O
sports 25 31 284 290 B-chronic_disease
related 32 39 291 298 I-chronic_disease
concussion 40 50 299 309 I-chronic_disease

Any 0 3 0 3 O
pregnant 4 12 4 12 B-pregnancy
woman 13 18 13 18 B-gender

regardless 0 10 19 29 O
of 11 13 30 32 O
age 14 17 33 36 B-age

with 0 4 37 41 O
a 5 6 42 43 O
prenatal 7 15 44 52 O
diagnosis 16 25 53 62 O
of 26 28 63 65 O
HLHS 29 33 66 70 B-chronic_disease

Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to 26 28 26 28 O
18 29 31 29 31 B-lower_bound
years 32 37 32 37 I-lower_bound

Current 0 7 38 45 O
treatment 8 17 46 55 B-treatment
with 18 22 56 60 O
tyrosine 23 31 61 69 B-treatment
kinase 32 38 70 76 I-treatment
inhibitors 39 49 77 87 I-treatment

Diagnosis 0 9 88 97 O
of 10 12 98 100 O
colorectal 13 23 101 111 B-cancer
or 24 26 112 114 O
head 27 31 115 119 B-cancer
and 32 35 120 123 I-cancer
neck 36 40 124 128 I-cancer
cancer 41 47 129 135 I-cancer

Patients 0 8 136 144 O
who 9 12 145 148 O
are 13 16 149 152 O
pregnant 17 25 153 161 B-pregnancy

Prior 0 5 162 167 B-treatment
cetuximab 6 15 168 177 I-treatment
treatment 16 25 178 187 I-treatment
within 26 32 188 194 O
the 33 36 195 198 O
6 37 38 199 200 B-upper_bound
months 39 45 201 207 I-upper_bound
of 46 48 208 210 O
study 49 54 211 216 O
initiation 55 65 217 227 O

Receipt 0 7 228 235 O
of 8 10 236 238 O
at 11 13 239 241 O
least 14 19 242 247 O
one 20 23 248 251 B-lower_bound
dose 24 28 252 256 O
of 29 31 257 259 O
cetuximab 32 41 260 269 B-treatment
during 42 48 270 276 O
the 49 52 277 280 O
study 53 58 281 286 O
time 59 63 287 291 O
period 64 70 292 298 O

Active 0 6 0 6 O
or 7 9 7 9 O
untreated 10 19 10 19 O
central 20 27 20 27 B-cancer
nervous 28 35 28 35 I-cancer
system 36 42 36 42 I-cancer
( 43 44 43 44 I-cancer
CNS 44 47 44 47 I-cancer
) 47 48 47 48 I-cancer
metastases 49 59 49 59 I-cancer
as 60 62 60 62 O
determined 63 73 63 73 O
by 74 76 74 76 O
computed 77 85 77 85 B-treatment
tomography 86 96 86 96 I-treatment
( 97 98 97 98 I-treatment
CT 98 100 98 100 I-treatment
) 100 101 100 101 I-treatment
or 102 104 102 104 O
magnetic 105 113 105 113 B-treatment
resonance 114 123 114 123 I-treatment
imaging 124 131 124 131 I-treatment
evaluation 132 142 132 142 O
during 143 149 143 149 O
screening 150 159 150 159 O
( 160 161 160 161 O
within 161 167 161 167 O
28 168 170 168 170 B-upper_bound
days 171 175 171 175 I-upper_bound
before 176 182 176 182 I-upper_bound
C1D1 183 187 183 187 O
) 187 188 187 188 O
and 189 192 189 192 O
prior 193 198 193 198 O
radiographic 199 211 199 211 O
assessments 212 223 212 223 O

Allergy 0 7 224 231 O
or 8 10 232 234 O
hypersensitivity 11 27 235 251 O
to 28 30 252 254 O
components 31 41 255 265 O
of 42 44 266 268 O
the 45 48 269 272 O
emactuzumab 49 60 273 284 B-allergy_name
formulation 61 72 285 296 O
or 73 75 297 299 O
to 76 78 300 302 O
components 79 89 303 313 O
of 90 92 314 316 O
the 93 96 317 320 O
atezolizumab 97 109 321 333 B-allergy_name
formulation 110 121 334 345 O

Any 0 3 346 349 O
approved 4 12 350 358 O
anti 13 17 359 363 B-treatment
- 17 18 363 364 I-treatment
cancer 18 24 364 370 I-treatment
therapy 25 32 371 378 I-treatment
, 32 33 378 379 O
including 34 43 380 389 O
chemotherapy 44 56 390 402 B-treatment
or 57 59 403 405 O
hormonal 60 68 406 414 B-treatment
therapy 69 76 415 422 I-treatment
, 76 77 422 423 O
within 78 84 424 430 O
3 85 86 431 432 B-upper_bound
weeks 87 92 433 438 I-upper_bound
prior 93 98 439 444 I-upper_bound
to 99 101 445 447 O
initiation 102 112 448 458 O
of 113 115 459 461 O
study 116 121 462 467 O
treatment 122 131 468 477 O
, 131 132 477 478 O
with 133 137 479 483 O
the 138 141 484 487 O
exceptions 142 152 488 498 O
provided 153 161 499 507 O
in 162 164 508 510 O
the 165 168 511 514 O
protocol 169 177 515 523 O

Eastern 0 7 524 531 B-clinical_variable
Cooperative 8 19 532 543 I-clinical_variable
Oncology 20 28 544 552 I-clinical_variable
Group 29 34 553 558 I-clinical_variable
performance 35 46 559 570 I-clinical_variable
status 47 53 571 577 I-clinical_variable
0 54 55 578 579 B-lower_bound
or 56 58 580 582 O
1 59 60 583 584 B-upper_bound

Evidence 0 8 585 593 O
of 9 11 594 596 O
significant 12 23 597 608 O
, 23 24 608 609 O
uncontrolled 25 37 610 622 O
concomitant 38 49 623 634 B-chronic_disease
diseases 50 58 635 643 I-chronic_disease
, 58 59 643 644 O
which 60 65 645 650 O
could 66 71 651 656 O
affect 72 78 657 663 O
compliance 79 89 664 674 O
with 90 94 675 679 O
the 95 98 680 683 O
protocol 99 107 684 692 O
or 108 110 693 695 O
interpretation 111 125 696 710 O
of 126 128 711 713 O
results 129 136 714 721 O
, 136 137 721 722 O
including 138 147 723 732 O
significant 148 159 733 744 O
cardiovascular 160 174 745 759 B-chronic_disease
disease 175 182 760 767 I-chronic_disease
( 183 184 768 769 O
such 184 188 769 773 O
as 189 191 774 776 O
New 192 195 777 780 B-chronic_disease
York 196 200 781 785 I-chronic_disease
Heart 201 206 786 791 I-chronic_disease
Association 207 218 792 803 I-chronic_disease
Class 219 224 804 809 I-chronic_disease
III 225 228 810 813 I-chronic_disease
or 229 231 814 816 I-chronic_disease
IV 232 234 817 819 I-chronic_disease
cardiac 235 242 820 827 I-chronic_disease
disease 243 250 828 835 I-chronic_disease
, 250 251 835 836 O
myocardial 252 262 837 847 B-chronic_disease
infarction 263 273 848 858 I-chronic_disease
within 274 280 859 865 O
the 281 284 866 869 O
last 285 289 870 874 B-upper_bound
6 290 291 875 876 I-upper_bound
months 292 298 877 883 I-upper_bound
, 298 299 883 884 O
unstable 300 308 885 893 O
arrhythmias 309 320 894 905 B-chronic_disease
, 320 321 905 906 O
or 322 324 907 909 O
unstable 325 333 910 918 B-chronic_disease
angina 334 340 919 925 I-chronic_disease
) 340 341 925 926 O
or 342 344 927 929 O
pulmonary 345 354 930 939 B-chronic_disease
disease 355 362 940 947 I-chronic_disease
( 363 364 948 949 O
including 364 373 949 958 O
obstructive 374 385 959 970 B-chronic_disease
pulmonary 386 395 971 980 I-chronic_disease
disease 396 403 981 988 I-chronic_disease
and 404 407 989 992 O
history 408 415 993 1000 O
of 416 418 1001 1003 O
symptomatic 419 430 1004 1015 O
bronchospasm 431 443 1016 1028 B-chronic_disease
) 443 444 1028 1029 O

History 0 7 1030 1037 O
of 8 10 1038 1040 O
human 11 16 1041 1046 B-chronic_disease
immunodeficiency 17 33 1047 1063 I-chronic_disease
virus 34 39 1064 1069 I-chronic_disease
( 40 41 1070 1071 I-chronic_disease
HIV 41 44 1071 1074 I-chronic_disease
) 44 45 1074 1075 I-chronic_disease

History 0 7 1076 1083 O
of 8 10 1084 1086 O
or 11 13 1087 1089 O
active 14 20 1090 1096 B-chronic_disease
autoimmune 21 31 1097 1107 I-chronic_disease
disease 32 39 1108 1115 I-chronic_disease

Leptomeningeal 0 14 1116 1130 B-cancer
disease 15 22 1131 1138 I-cancer

Life 0 4 1139 1143 B-clinical_variable
expectancy 5 15 1144 1154 I-clinical_variable
of 16 18 1155 1157 O
greater 19 26 1158 1165 O
than 27 31 1166 1170 O
or 32 34 1171 1173 O
equal 35 40 1174 1179 O
to 41 43 1180 1182 O
( 44 45 1183 1184 O
> 45 46 1184 1185 O
=) 46 48 1185 1187 O
16 49 51 1188 1190 B-lower_bound
weeks 52 57 1191 1196 I-lower_bound

Negative 0 8 1197 1205 B-pregnancy
serum 9 14 1206 1211 I-pregnancy
pregnancy 15 24 1212 1221 I-pregnancy
test 25 29 1222 1226 O
within 30 36 1227 1233 O
7 37 38 1234 1235 B-upper_bound
days 39 43 1236 1240 I-upper_bound
prior 44 49 1241 1246 I-upper_bound
to 50 52 1247 1249 O
study 53 58 1250 1255 O
treatment 59 68 1256 1265 B-treatment
in 69 71 1266 1268 O
premenopausal 72 85 1269 1282 O
women 86 91 1283 1288 B-gender
and 92 95 1289 1292 O
women 96 101 1293 1298 O
less 102 106 1299 1303 O
than 107 111 1304 1308 O
or 112 114 1309 1311 O
equal 115 120 1312 1317 O
to 121 123 1318 1320 O
( 124 125 1321 1322 O
< 125 126 1322 1323 O
=) 126 128 1323 1325 O
12 129 131 1326 1328 B-upper_bound
months 132 138 1329 1335 I-upper_bound
post 139 143 1336 1340 O
- 143 144 1340 1341 O
menopause 144 153 1341 1350 O

Participant 0 11 1351 1362 O
has 12 15 1363 1366 O
had 16 19 1367 1370 O
pulmonary 20 29 1371 1380 B-chronic_disease
embolism 30 38 1381 1389 I-chronic_disease
or 39 41 1390 1392 O
any 42 45 1393 1396 O
other 46 51 1397 1402 O
thrombo 52 59 1403 1410 B-chronic_disease
- 59 60 1410 1411 I-chronic_disease
embolic 60 67 1411 1418 I-chronic_disease
event 68 73 1419 1424 O
within 74 80 1425 1431 O
6 81 82 1432 1433 B-upper_bound
months 83 89 1434 1440 I-upper_bound
prior 90 95 1441 1446 I-upper_bound
to 96 98 1447 1449 O
study 99 104 1450 1455 O
entry 105 110 1456 1461 O

Participants 0 12 1462 1474 O
has 13 16 1475 1478 O
a 17 18 1479 1480 O
history 19 26 1481 1488 O
of 27 29 1489 1491 O
hematological 30 43 1492 1505 B-cancer
malignancy 44 54 1506 1516 I-cancer
within 55 61 1517 1523 O
the 62 65 1524 1527 O
last 66 70 1528 1532 B-upper_bound
5 71 72 1533 1534 I-upper_bound
years 73 78 1535 1540 I-upper_bound
prior 79 84 1541 1546 I-upper_bound
to 85 87 1547 1549 O
study 88 93 1550 1555 O
entry 94 99 1556 1561 O

Participants 0 12 1562 1574 O
must 13 17 1575 1579 O
have 18 22 1580 1584 O
histologically 23 37 1585 1599 O
confirmed 38 47 1600 1609 O
diagnosis 48 57 1610 1619 O
of 58 60 1620 1622 O
locally 61 68 1623 1630 O
advanced 69 77 1631 1639 O
and/or 78 84 1640 1646 O
metastatic 85 95 1647 1657 B-cancer
triple 96 102 1658 1664 I-cancer
negative 103 111 1665 1673 I-cancer
breast 112 118 1674 1680 I-cancer
cancer 119 125 1681 1687 I-cancer
, 125 126 1687 1688 O
ovarian 127 134 1689 1696 B-cancer
cancer 135 141 1697 1703 I-cancer
, 141 142 1703 1704 O
bladder 143 150 1705 1712 B-cancer
cancer 151 157 1713 1719 I-cancer
, 157 158 1719 1720 O
gastric 159 166 1721 1728 B-cancer
cancer 167 173 1729 1735 I-cancer
, 173 174 1735 1736 O
or 175 177 1737 1739 O
soft 178 182 1740 1744 B-cancer
tissue 183 189 1745 1751 I-cancer
sarcoma 190 197 1752 1759 I-cancer

Participants 0 12 1760 1772 O
with 13 17 1773 1777 O
active 18 24 1778 1784 O
hepatitis 25 34 1785 1794 B-chronic_disease
B 35 36 1795 1796 I-chronic_disease
, 36 37 1796 1797 O
active 38 44 1798 1804 O
hepatitis 45 54 1805 1814 B-chronic_disease
C 55 56 1815 1816 I-chronic_disease
, 56 57 1816 1817 O
or 58 60 1818 1820 O
active 61 67 1821 1827 B-chronic_disease
tuberculosis 68 80 1828 1840 I-chronic_disease

Participants 0 12 1841 1853 O
with 13 17 1854 1858 O
metastases 18 28 1859 1869 B-cancer
to 29 31 1870 1872 O
the 32 35 1873 1876 O
brain 36 41 1877 1882 O
stem 42 46 1883 1887 O
, 46 47 1887 1888 O
midbrain 48 56 1889 1897 O
, 56 57 1897 1898 O
pons 58 62 1899 1903 O
, 62 63 1903 1904 O
medulla 64 71 1905 1912 O
, 71 72 1912 1913 O
or 73 75 1914 1916 O
within 76 82 1917 1923 O
10 83 85 1924 1926 B-upper_bound
millimeter 86 96 1927 1937 I-upper_bound
( 97 98 1938 1939 I-upper_bound
mm 98 100 1939 1941 I-upper_bound
) 100 101 1941 1942 I-upper_bound
of 102 104 1943 1945 O
the 105 108 1946 1949 O
optic 109 114 1950 1955 O
apparatus 115 124 1956 1965 O
( 125 126 1966 1967 O
optic 126 131 1967 1972 O
nerves 132 138 1973 1979 O
and 139 142 1980 1983 O
chiasm 143 149 1984 1990 O
) 149 150 1990 1991 O

Postmenopausal 0 14 1992 2006 B-clinical_variable
state 15 20 2007 2012 O
is 21 23 2013 2015 O
defined 24 31 2016 2023 O
as 32 34 2024 2026 O
amenorrhea 35 45 2027 2037 B-clinical_variable
for 46 49 2038 2041 O
greater 50 57 2042 2049 O
than 58 62 2050 2054 O
( 63 64 2055 2056 O
> 64 65 2056 2057 O
) 65 66 2057 2058 O
12 67 69 2059 2061 B-lower_bound
months 70 76 2062 2068 I-lower_bound

Pregnant 0 8 2069 2077 B-pregnancy

Prior 0 5 2078 2083 B-treatment
corticosteroids 6 21 2084 2099 I-treatment
as 22 24 2100 2102 O
anti 25 29 2103 2107 B-treatment
- 29 30 2107 2108 I-treatment
cancer 30 36 2108 2114 I-treatment
therapy 37 44 2115 2122 I-treatment
within 45 51 2123 2129 O
a 52 53 2130 2131 O
minimum 54 61 2132 2139 O
of 62 64 2140 2142 O
14 65 67 2143 2145 B-lower_bound
days 68 72 2146 2150 I-lower_bound
of 73 75 2151 2153 O
first 76 81 2154 2159 O
receipt 82 89 2160 2167 O
of 90 92 2168 2170 O
study 93 98 2171 2176 B-treatment
drug 99 103 2177 2181 I-treatment

Prior 0 5 2182 2187 O
toxicities 6 16 2188 2198 O
from 17 21 2199 2203 O
chemotherapy 22 34 2204 2216 B-treatment
, 34 35 2216 2217 O
radiotherapy 36 48 2218 2230 B-treatment
, 48 49 2230 2231 O
and 50 53 2232 2235 O
other 54 59 2236 2241 O
anti 60 64 2242 2246 B-treatment
- 64 65 2246 2247 I-treatment
cancer 65 71 2247 2253 I-treatment
therapies 72 81 2254 2263 I-treatment
, 81 82 2263 2264 O
including 83 92 2265 2274 O
immunotherapy 93 106 2275 2288 B-treatment
that 107 111 2289 2293 O
have 112 116 2294 2298 O
not 117 120 2299 2302 O
regressed 121 130 2303 2312 O
to 131 133 2313 2315 O
Grade 134 139 2316 2321 O
< 140 141 2322 2323 O
= 141 142 2323 2324 O
1 142 143 2324 2325 B-upper_bound
severity 144 152 2326 2334 O
( 153 154 2335 2336 O
Common 154 160 2336 2342 O
Terminology 161 172 2343 2354 O
Criteria 173 181 2355 2363 O
for 182 185 2364 2367 O
Adverse 186 193 2368 2375 O
Events 194 200 2376 2382 O
[ 201 202 2383 2384 O
CTCAE 202 207 2384 2389 O
] 207 208 2389 2390 O
v4.03 209 214 2391 2396 O
, 214 215 2396 2397 O
or 216 218 2398 2400 O
later 219 224 2401 2406 O
versions 225 233 2407 2415 O
) 233 234 2415 2416 O

Treatment 0 9 2417 2426 B-treatment
with 10 14 2427 2431 O
systemic 15 23 2432 2440 O
immunosuppressive 24 41 2441 2458 B-treatment
medications 42 53 2459 2470 I-treatment

lactating 0 9 2471 2480 O
women 10 15 2481 2486 B-gender

Location 0 8 0 8 O
of 9 11 9 11 O
buccal 12 18 12 18 O
alveolar 19 27 19 27 O
crest 28 33 28 33 O
has 34 37 34 37 O
to 38 40 38 40 O
be 41 43 41 43 O
generally 44 53 44 53 O
within 54 60 54 60 O
4 61 62 61 62 B-upper_bound
mm 63 65 63 65 I-upper_bound
from 66 70 66 70 O
the 71 74 71 74 O
free 75 79 75 79 O
gingival 80 88 80 88 O
margin 89 95 89 95 O
, 95 96 95 96 O
verified 97 105 97 105 O
after 106 111 106 111 O
the 112 115 112 115 O
extraction 116 126 116 126 B-treatment
, 126 127 126 127 O
before 128 134 128 134 O
randomization; 135 149 135 149 B-treatment
and 150 153 150 153 O
fenestration 154 166 154 166 B-treatment

The 0 3 167 170 O
reasons 4 11 171 178 O
for 12 15 179 182 O
extraction 16 26 183 193 O
will 27 31 194 198 O
include 32 39 199 206 O
poor 40 44 207 211 O
endodontic 45 55 212 222 B-treatment
prognosis 56 65 223 232 I-treatment

allergy 0 7 233 240 O
to 8 10 241 243 O
antibiotics 11 22 244 255 O
contained 23 32 256 265 O
in 33 35 266 268 O
the 36 39 269 272 O
ADM 40 43 273 276 B-allergy_name
( 44 45 277 278 O
Gentimicin 45 55 278 288 B-allergy_name
, 55 56 288 289 O
Cefoxitin 57 66 290 299 B-allergy_name
, 66 67 299 300 O
Lincomcin 68 77 301 310 B-allergy_name
, 77 78 310 311 O
polymixin 79 88 312 321 B-allergy_name
B 89 90 322 323 I-allergy_name
and 91 94 324 327 O
Vancomycin 95 105 328 338 B-allergy_name
) 105 106 338 339 O
will 107 111 340 344 O
not 112 115 345 348 O
be 116 118 349 351 O
included 119 127 352 360 O
in 128 130 361 363 O
the 131 134 364 367 O
immediate 135 144 368 377 O
implant 145 152 378 385 O
combined 153 161 386 394 O
with 162 166 395 399 O
ADM 167 170 400 403 O
group 171 176 404 409 O

are 0 3 410 413 O
pregnant 4 12 414 422 B-pregnancy

currently 0 9 423 432 O
smoke 10 15 433 438 O
exceeding 16 25 439 448 O
10 26 28 449 451 B-lower_bound
cigarettes/ 29 40 452 463 I-lower_bound
day 41 44 464 467 I-lower_bound

level 0 5 468 473 O
of 6 8 474 476 O
radiographic 9 21 477 489 B-clinical_variable
bone 22 26 490 494 I-clinical_variable
level 27 32 495 500 I-clinical_variable
has 33 36 501 504 O
the 37 40 505 508 O
distance 41 49 509 517 O
from 50 54 518 522 O
CEJ 55 58 523 526 O
to 59 61 527 529 O
interproximal 62 75 530 543 O
crest 76 81 544 549 O
up 82 84 550 552 O
to 85 87 553 555 O
4 88 89 556 557 B-upper_bound
mm 90 92 558 560 I-upper_bound

patients 0 8 561 569 O
who 9 12 570 573 O
are 13 16 574 577 O
in 17 19 578 580 O
need 20 24 581 585 O
of 25 27 586 588 O
a 28 29 589 590 O
tooth 30 35 591 596 B-treatment
extraction 36 46 597 607 I-treatment
at 47 49 608 610 O
the 50 53 611 614 O
maxillary 54 63 615 624 O
premolar 64 72 625 633 O
, 72 73 633 634 O
canine 74 80 635 641 O
and 81 84 642 645 O
incisor 85 92 646 653 O
region 93 99 654 660 O
, 99 100 660 661 O
and 101 104 662 665 O
subsequent 105 115 666 676 O
single 116 122 677 683 B-treatment
implant 123 130 684 691 I-treatment
placement 131 140 692 701 I-treatment

severe 0 6 702 708 O
parafunctional 7 21 709 723 B-chronic_disease
habits 22 28 724 730 I-chronic_disease
, 28 29 730 731 O
malocclusion 30 42 732 744 B-chronic_disease
or 43 45 745 747 O
intent 46 52 748 754 O
of 53 55 755 757 O
orthodontic 56 67 758 769 B-treatment
therapy 68 75 770 777 I-treatment
in 76 78 778 780 O
the 79 82 781 784 O
future 83 89 785 791 O

the 0 3 792 795 O
eligible 4 12 796 804 O
tooth 13 18 805 810 O
has 19 22 811 814 O
esthetically 23 35 815 827 O
acceptable 36 46 828 838 O
buccal 47 53 839 845 O
gingival 54 62 846 854 O
margin 63 69 855 861 O
position 70 78 862 870 O
prior 79 84 871 876 O
to 85 87 877 879 O
surgery 88 95 880 887 B-treatment

unrestorable 0 12 888 900 O
teeth 13 18 901 906 O
( 19 20 907 908 O
extensive 20 29 908 917 O
caries 30 36 918 924 O
, 36 37 924 925 O
traumatic 38 47 926 935 O
fractures 48 57 936 945 O
, 57 58 945 946 O
fractures 59 68 947 956 O
of 69 71 957 959 O
endodontically 72 86 960 974 O
treated 87 94 975 982 O
teeth 95 100 983 988 O
, 100 101 988 989 O
root 102 106 990 994 O
perforation 107 118 995 1006 O
, 118 119 1006 1007 O
root 120 124 1008 1012 O
resorption 125 135 1013 1023 O
with 136 140 1024 1028 O
or 141 143 1029 1031 O
without 144 151 1032 1039 O
radiographic 152 164 1040 1052 O
periapical 165 175 1053 1063 O
lesion 176 182 1064 1070 O
up 183 185 1071 1073 O
to 186 188 1074 1076 O
3 189 190 1077 1078 B-upper_bound
mm 191 193 1079 1081 I-upper_bound
in 194 196 1082 1084 O
diameter 197 205 1085 1093 O
) 205 206 1093 1094 O

up 0 2 1095 1097 O
to 3 5 1098 1100 O
3 6 7 1101 1102 B-upper_bound
mm 7 9 1102 1104 I-upper_bound
in 10 12 1105 1107 I-upper_bound
diameter 13 21 1108 1116 I-upper_bound
at 22 24 1117 1119 O
the 25 28 1120 1123 O
apical 29 35 1124 1130 O
part 36 40 1131 1135 O
of 41 43 1136 1138 O
the 44 47 1139 1142 O
root 48 52 1143 1147 O
and 53 56 1148 1151 O
affecting 57 66 1152 1161 O
less 67 71 1162 1166 O
than 72 76 1167 1171 O
30 77 79 1172 1174 B-upper_bound
% 79 80 1174 1175 I-upper_bound
of 81 83 1176 1178 O
the 84 87 1179 1182 O
buccal 88 94 1183 1189 O
socket 95 101 1190 1196 O
wall 102 106 1197 1201 O

Are 0 3 0 3 B-pregnancy
pregnant 4 12 4 12 I-pregnancy

Be 0 2 13 15 O
in 3 5 16 18 O
first 6 11 19 24 O
relapse 12 19 25 32 O
( 20 21 33 34 O
within 21 27 34 40 O
24 28 30 41 43 B-upper_bound
months 31 37 44 50 I-upper_bound
of 38 40 51 53 O
CR 41 43 54 56 B-treatment
) 43 44 56 57 O
or 45 47 58 60 O
have 48 52 61 65 O
failed 53 59 66 72 O
induction 60 69 73 82 B-treatment
therapy 70 77 83 90 I-treatment
* 77 78 90 91 O
( 79 80 92 93 O
no 80 82 93 95 O
CR 83 85 96 98 O
or 86 88 99 101 O
CRi 89 92 102 105 B-treatment
after 93 98 106 111 O
treatment 99 108 112 121 B-treatment
with 109 113 122 126 I-treatment
an 114 116 127 129 I-treatment
intensive 117 126 130 139 I-treatment
regimen 127 134 140 147 I-treatment
( 135 136 148 149 O
eg 136 138 149 151 O
, 138 139 151 152 O
anthracycline 140 153 153 166 B-treatment
/ 153 154 166 167 O
cytarabine 154 164 167 177 B-treatment
± 165 166 178 179 O
etoposide 167 176 180 189 B-treatment
, 176 177 189 190 O
gemtuzumab 178 188 191 201 O
ozogamicin 189 199 202 212 O
, 199 200 212 213 O
or 201 203 214 216 O
cladribine 204 214 217 227 O
) 214 215 227 228 O

Be 0 2 229 231 O
nonfertile 3 13 232 242 O
or 14 16 243 245 O
agree 17 22 246 251 B-contraception_consent
to 23 25 252 254 I-contraception_consent
use 26 29 255 258 I-contraception_consent
an 30 32 259 261 I-contraception_consent
adequate 33 41 262 270 I-contraception_consent
method 42 48 271 277 I-contraception_consent
of 49 51 278 280 I-contraception_consent
contraception 52 65 281 294 I-contraception_consent
. 65 66 294 295 O
Sexually 67 75 296 304 O
active 76 82 305 311 O
patients 83 91 312 320 O
and 92 95 321 324 O
their 96 101 325 330 O
partners 102 110 331 339 O
must 111 115 340 344 O
use 116 119 345 348 B-contraception_consent
an 120 122 349 351 I-contraception_consent
effective 123 132 352 361 I-contraception_consent
method 133 139 362 368 I-contraception_consent
of 140 142 369 371 I-contraception_consent
contraception 143 156 372 385 I-contraception_consent
associated 157 167 386 396 O
with 168 172 397 401 O
a 173 174 402 403 O
low 175 178 404 407 O
failure 179 186 408 415 O
rate 187 191 416 420 O
prior 192 197 421 426 O
to 198 200 427 429 O
study 201 206 430 435 O
entry 207 212 436 441 O
, 212 213 441 442 O
for 214 217 443 446 O
the 218 221 447 450 O
duration 222 230 451 459 O
of 231 233 460 462 O
study 234 239 463 468 O
participation 240 253 469 482 O
, 253 254 482 483 O
and 255 258 484 487 O
for 259 262 488 491 O
at 263 265 492 494 O
least 266 271 495 500 O
3 272 273 501 502 B-lower_bound
months 274 280 503 509 I-lower_bound
( 281 282 510 511 O
males 282 287 511 516 B-gender
) 287 288 516 517 O
and 289 292 518 521 O
6 293 294 522 523 B-lower_bound
months 295 301 524 530 I-lower_bound
( 302 303 531 532 O
females 303 310 532 539 B-gender
) 310 311 539 540 O
after 312 317 541 546 O
the 318 321 547 550 O
last 322 326 551 555 O
dose 327 331 556 560 O
of 332 334 561 563 O
study 335 340 564 569 B-treatment
drug 341 345 570 574 I-treatment

Demonstrate 0 11 575 586 O
MCL-1 12 17 587 592 B-clinical_variable
dependence 18 28 593 603 O
of 29 31 604 606 O
≥40 32 35 607 610 O
% 35 36 610 611 I-lower_bound
by 37 39 612 614 O
mitochondrial 40 53 615 628 O
profiling 54 63 629 638 O
in 64 66 639 641 O
bone 67 71 642 646 O
marrow 72 78 647 653 O

Diagnosed 0 9 654 663 O
with 10 14 664 668 O
acute 15 20 669 674 B-cancer
promyelocytic 21 34 675 688 I-cancer
leukemia 35 43 689 697 I-cancer
( 44 45 698 699 I-cancer
APL 45 48 699 702 I-cancer
, 48 49 702 703 I-cancer
M3 50 52 704 706 I-cancer
) 52 53 706 707 I-cancer

Have 0 4 708 712 O
a 5 6 713 714 O
left 7 11 715 719 B-clinical_variable
ventricular 12 23 720 731 I-clinical_variable
ejection 24 32 732 740 I-clinical_variable
fraction 33 41 741 749 I-clinical_variable
( 42 43 750 751 I-clinical_variable
LVEF 43 47 751 755 I-clinical_variable
) 47 48 755 756 I-clinical_variable
> 49 50 757 758 O
45 50 52 758 760 B-lower_bound
% 52 53 760 761 I-lower_bound
by 54 56 762 764 O
echocardiogram 57 71 765 779 B-treatment
( 72 73 780 781 I-treatment
ECHO 73 77 781 785 I-treatment
) 77 78 785 786 I-treatment
or 79 81 787 789 O
multigated 82 92 790 800 B-treatment
acquisition 93 104 801 812 I-treatment
( 105 106 813 814 I-treatment
MUGA 106 110 814 818 I-treatment
) 110 111 818 819 I-treatment
scan 112 116 820 824 I-treatment

Have 0 4 825 829 O
a 5 6 830 831 O
peripheral 7 17 832 842 B-clinical_variable
blast 18 23 843 848 I-clinical_variable
count 24 29 849 854 I-clinical_variable
of 30 32 855 857 O
> 33 34 858 859 O
30,000 34 40 859 865 B-lower_bound
/ 40 41 865 866 I-lower_bound
mm3 41 44 866 869 I-lower_bound
( 45 46 870 871 O
may 46 49 871 874 O
use 50 53 875 878 O
hydroxyurea 54 65 879 890 B-treatment
as 66 68 891 893 O
in 69 71 894 896 O
# 72 73 897 898 O
5 73 74 898 899 O
above 75 80 900 905 O
) 80 81 905 906 O

Have 0 4 907 911 O
a 5 6 912 913 O
serum 7 12 914 919 B-clinical_variable
creatinine 13 23 920 930 I-clinical_variable
level 24 29 931 936 I-clinical_variable
≤1.8 30 34 937 941 O
mg 35 37 942 944 I-upper_bound
/ 37 38 944 945 I-upper_bound
dL 38 40 945 947 I-upper_bound

Have 0 4 948 952 O
a 5 6 953 954 O
total 7 12 955 960 B-clinical_variable
bilirubin 13 22 961 970 I-clinical_variable
level 23 28 971 976 O
≤2.0 29 33 977 981 B-upper_bound
mg 34 36 982 984 I-upper_bound
/ 36 37 984 985 I-upper_bound
dL 37 39 985 987 I-upper_bound
( 40 41 988 989 O
unless 41 47 989 995 O
secondary 48 57 996 1005 O
to 58 60 1006 1008 O
Gilbert 61 68 1009 1016 B-chronic_disease
syndrome 69 77 1017 1025 I-chronic_disease
, 77 78 1025 1026 O
hemolysis 79 88 1027 1036 B-chronic_disease
, 88 89 1036 1037 O
or 90 92 1038 1040 O
leukemia 93 101 1041 1049 B-cancer
) 101 102 1049 1050 O

Have 0 4 1051 1055 O
active 5 11 1056 1062 O
central 12 19 1063 1070 B-cancer
nervous 20 27 1071 1078 I-cancer
system 28 34 1079 1085 I-cancer
( 35 36 1086 1087 I-cancer
CNS 36 39 1087 1090 I-cancer
) 39 40 1090 1091 I-cancer
leukemia 41 49 1092 1100 I-cancer

Have 0 4 1101 1105 O
an 5 7 1106 1108 O
Eastern 8 15 1109 1116 B-clinical_variable
Cooperative 16 27 1117 1128 I-clinical_variable
Oncology 28 36 1129 1137 I-clinical_variable
Group 37 42 1138 1143 I-clinical_variable
( 43 44 1144 1145 I-clinical_variable
ECOG 44 48 1145 1149 I-clinical_variable
) 48 49 1149 1150 I-clinical_variable
performance 50 61 1151 1162 I-clinical_variable
status 62 68 1163 1169 I-clinical_variable
( 69 70 1170 1171 I-clinical_variable
PS 70 72 1171 1173 I-clinical_variable
) 72 73 1173 1174 I-clinical_variable
≤2 74 76 1175 1177 O

Have 0 4 1178 1182 O
an 5 7 1183 1185 O
active 8 14 1186 1192 O
, 14 15 1192 1193 O
uncontrolled 16 28 1194 1206 O
infection 29 38 1207 1216 B-chronic_disease

Have 0 4 1217 1221 O
an 5 7 1222 1224 O
alanine 8 15 1225 1232 B-clinical_variable
aminotransferase 16 32 1233 1249 I-clinical_variable
( 33 34 1250 1251 I-clinical_variable
ALT)/aspartate 34 48 1251 1265 I-clinical_variable
aminotransferase 49 65 1266 1282 I-clinical_variable
( 66 67 1283 1284 I-clinical_variable
AST 67 70 1284 1287 I-clinical_variable
) 70 71 1287 1288 I-clinical_variable
level 72 77 1289 1294 I-clinical_variable
≤5 78 80 1295 1297 O
times 81 86 1298 1303 I-upper_bound
upper 87 92 1304 1309 I-upper_bound
limit 93 98 1310 1315 I-upper_bound
of 99 101 1316 1318 I-upper_bound
normal 102 108 1319 1325 I-upper_bound
( 109 110 1326 1327 I-upper_bound
ULN 110 113 1327 1330 I-upper_bound
) 113 114 1330 1331 I-upper_bound

Have 0 4 1332 1336 O
an 5 7 1337 1339 O
established 8 19 1340 1351 O
, 19 20 1351 1352 O
pathologically 21 35 1353 1367 O
confirmed 36 45 1368 1377 O
diagnoses 46 55 1378 1387 O
of 56 58 1388 1390 O
AML 59 62 1391 1394 B-clinical_variable
by 63 65 1395 1397 O
World 66 71 1398 1403 O
Health 72 78 1404 1410 O
Organization 79 91 1411 1423 O
( 92 93 1424 1425 O
WHO 93 96 1425 1428 O
) 96 97 1428 1429 O
criteria 98 106 1430 1438 O
excluding 107 116 1439 1448 O
acute 117 122 1449 1454 B-cancer
promyelocytic 123 136 1455 1468 I-cancer
leukemia 137 145 1469 1477 I-cancer
( 146 147 1478 1479 I-cancer
APL 147 150 1479 1482 I-cancer
- 150 151 1482 1483 I-cancer
M3 151 153 1483 1485 I-cancer
) 153 154 1485 1486 I-cancer
with 155 159 1487 1491 O
a 160 161 1492 1493 O
bone 162 166 1494 1498 O
marrow 167 173 1499 1505 O
of 174 176 1506 1508 O
> 177 178 1509 1510 O
5 178 179 1510 1511 B-lower_bound
% 179 180 1511 1512 I-lower_bound
blasts 181 187 1513 1519 O
based 188 193 1520 1525 O
on 194 196 1526 1528 O
histology 197 206 1529 1538 O
or 207 209 1539 1541 O
flow 210 214 1542 1546 O
cytometry 215 224 1547 1556 O

Have 0 4 1557 1561 O
clinically 5 15 1562 1572 O
significant 16 27 1573 1584 O
graft 28 33 1585 1590 B-chronic_disease
versus 34 40 1591 1597 I-chronic_disease
host 41 45 1598 1602 I-chronic_disease
disease 46 53 1603 1610 I-chronic_disease
( 54 55 1611 1612 I-chronic_disease
GVHD 55 59 1612 1616 I-chronic_disease
) 59 60 1616 1617 I-chronic_disease
, 60 61 1617 1618 O
or 62 64 1619 1621 O
GVHD 65 69 1622 1626 O
requiring 70 79 1627 1636 O
initiation 80 90 1637 1647 O
or 91 93 1648 1650 O
escalation 94 104 1651 1661 O
of 105 107 1662 1664 O
treatment 108 117 1665 1674 B-treatment
within 118 124 1675 1681 O
the 125 128 1682 1685 O
last 129 133 1686 1690 B-upper_bound
21 134 136 1691 1693 I-upper_bound
days 137 141 1694 1698 I-upper_bound

Have 0 4 1699 1703 O
evidence 5 13 1704 1712 O
of 14 16 1713 1715 O
uncontrolled 17 29 1716 1728 O
disseminated 30 42 1729 1741 B-chronic_disease
intravascular 43 56 1742 1755 I-chronic_disease
coagulation 57 68 1756 1767 I-chronic_disease

Have 0 4 1768 1772 O
mental 5 11 1773 1779 B-chronic_disease
deficits 12 20 1780 1788 I-chronic_disease
and/or 21 27 1789 1795 O
psychiatric 28 39 1796 1807 B-chronic_disease
history 40 47 1808 1815 O
that 48 52 1816 1820 O
may 53 56 1821 1824 O
compromise 57 67 1825 1835 O
the 68 71 1836 1839 O
ability 72 79 1840 1847 O
to 80 82 1848 1850 O
give 83 87 1851 1855 O
written 88 95 1856 1863 O
informed 96 104 1864 1872 O
consent 105 112 1873 1880 O
or 113 115 1881 1883 O
to 116 118 1884 1886 O
comply 119 125 1887 1893 O
with 126 130 1894 1898 O
the 131 134 1899 1902 O
study 135 140 1903 1908 O
protocol 141 149 1909 1917 O

Have 0 4 1918 1922 O
other 5 10 1923 1928 O
active 11 17 1929 1935 O
malignancies 18 30 1936 1948 B-cancer
or 31 33 1949 1951 O
diagnosed 34 43 1952 1961 O
with 44 48 1962 1966 O
other 49 54 1967 1972 O
malignancies 55 67 1973 1985 O
within 68 74 1986 1992 O
the 75 78 1993 1996 O
last 79 83 1997 2001 B-upper_bound
6 84 85 2002 2003 I-upper_bound
months 86 92 2004 2010 I-upper_bound
, 92 93 2010 2011 O
except 94 100 2012 2018 O
nonmelanoma 101 112 2019 2030 B-cancer
skin 113 117 2031 2035 I-cancer
cancer 118 124 2036 2042 I-cancer
or 125 127 2043 2045 O
cervical 128 136 2046 2054 B-cancer
intraepithelial 137 152 2055 2070 I-cancer
neoplasia 153 162 2071 2080 I-cancer

Have 0 4 2081 2085 O
received 5 13 2086 2094 O
any 14 17 2095 2098 O
live 18 22 2099 2103 B-treatment
vaccine 23 30 2104 2111 I-treatment
within 31 37 2112 2118 O
14 38 40 2119 2121 B-upper_bound
days 41 45 2122 2126 I-upper_bound
prior 46 51 2127 2132 I-upper_bound
to 52 54 2133 2135 O
first 55 60 2136 2141 O
study 61 66 2142 2147 B-treatment
drug 67 71 2148 2152 I-treatment
administration 72 86 2153 2167 O

Received 0 8 2168 2176 O
> 9 10 2177 2178 O
360 10 13 2178 2181 B-lower_bound
mg 14 16 2182 2184 I-lower_bound
/ 16 17 2184 2185 I-lower_bound
m2 17 19 2185 2187 I-lower_bound
equivalents 20 31 2188 2199 O
of 32 34 2200 2202 O
daunorubicin 35 47 2203 2215 B-treatment

Received 0 8 2216 2224 O
a 9 10 2225 2226 O
hematopoietic 11 24 2227 2240 B-treatment
stem 25 29 2241 2245 I-treatment
cell 30 34 2246 2250 I-treatment
transplant 35 45 2251 2261 I-treatment
within 46 52 2262 2268 O
the 53 56 2269 2272 O
previous 57 65 2273 2281 B-upper_bound
2 66 67 2282 2283 I-upper_bound
months 68 74 2284 2290 I-upper_bound

Received 0 8 2291 2299 O
antileukemic 9 21 2300 2312 B-treatment
therapy 22 29 2313 2320 I-treatment
within 30 36 2321 2327 O
the 37 40 2328 2331 O
last 41 45 2332 2336 B-upper_bound
3 46 47 2337 2338 I-upper_bound
weeks 48 53 2339 2344 I-upper_bound
( 54 55 2345 2346 O
with 55 59 2346 2350 O
the 60 63 2351 2354 O
exception 64 73 2355 2364 O
of 74 76 2365 2367 O
hydroxyurea 77 88 2368 2379 B-treatment
or 89 91 2380 2382 O
if 92 94 2383 2385 O
the 95 98 2386 2389 O
patient 99 106 2390 2397 O
has 107 110 2398 2401 O
definite 111 119 2402 2410 O
refractory 120 130 2411 2421 O
disease 131 138 2422 2429 O
) 138 139 2429 2430 O
. 139 140 2430 2431 O
Refractory 141 151 2432 2442 O
patients 152 160 2443 2451 O
who 161 164 2452 2455 O
received 165 173 2456 2464 O
therapy 174 181 2465 2472 O
within 182 188 2473 2479 O
the 189 192 2480 2483 O
last 193 197 2484 2488 O
3 198 199 2489 2490 O
weeks 200 205 2491 2496 O
may 206 209 2497 2500 O
be 210 212 2501 2503 O
eligible 213 221 2504 2512 O
with 222 226 2513 2517 O
prior 227 232 2518 2523 O
approval 233 241 2524 2532 O
of 242 244 2533 2535 O
the 245 248 2536 2539 O
Medical 249 256 2540 2547 O
Monitor 257 264 2548 2555 O

Received 0 8 2556 2564 O
any 9 12 2565 2568 O
previous 13 21 2569 2577 O
treatment 22 31 2578 2587 B-treatment
with 32 36 2588 2592 I-treatment
alvocidib 37 46 2593 2602 I-treatment
or 47 49 2603 2605 O
any 50 53 2606 2609 O
other 54 59 2610 2615 O
CDK 60 63 2616 2619 B-treatment
inhibitor 64 73 2620 2629 I-treatment

Received 0 8 2630 2638 O
more 9 13 2639 2643 O
than 14 18 2644 2648 O
2 19 20 2649 2650 B-lower_bound
cycles 21 27 2651 2657 I-lower_bound
of 28 30 2658 2660 O
induction 31 40 2661 2670 B-treatment
therapy 41 48 2671 2678 I-treatment
for 49 52 2679 2682 O
AML 53 56 2683 2686 B-cancer
. 56 57 2686 2687 O
Investigational 58 73 2688 2703 B-treatment
agents 74 80 2704 2710 I-treatment
as 81 83 2711 2713 O
part 84 88 2714 2718 O
of 89 91 2719 2721 O
front 92 97 2722 2727 B-treatment
- 97 98 2727 2728 I-treatment
line 98 102 2728 2732 I-treatment
therapy 103 110 2733 2740 I-treatment
for 111 114 2741 2744 O
AML 115 118 2745 2748 O
may 119 122 2749 2752 O
by 123 125 2753 2755 O
acceptable 126 136 2756 2766 O
following 137 146 2767 2776 O
discussion 147 157 2777 2787 O
with 158 162 2788 2792 O
the 163 166 2793 2796 O
Medical 167 174 2797 2804 O
Monitor 175 182 2805 2812 O
. 182 183 2812 2813 O
Hydroxyurea 184 195 2814 2825 B-treatment
is 196 198 2826 2828 O
permitted 199 208 2829 2838 O
( 209 210 2839 2840 O
see 210 213 2840 2843 O
# 214 215 2844 2845 O
5 215 216 2845 2846 O
below 217 222 2847 2852 O
) 222 223 2852 2853 O

Require 0 7 2854 2861 O
concomitant 8 19 2862 2873 B-treatment
chemotherapy 20 32 2874 2886 I-treatment
, 32 33 2886 2887 O
radiation 34 43 2888 2897 B-treatment
therapy 44 51 2898 2905 I-treatment
, 51 52 2905 2906 O
or 53 55 2907 2909 O
immunotherapy 56 69 2910 2923 B-treatment
. 69 70 2923 2924 O
Hydroxyurea 71 82 2925 2936 B-treatment
is 83 85 2937 2939 O
allowed 86 93 2940 2947 O
up 94 96 2948 2950 O
to 97 99 2951 2953 O
the 100 103 2954 2957 O
evening 104 111 2958 2965 O
before 112 118 2966 2972 O
starting 119 127 2973 2981 O
( 128 129 2982 2983 O
but 129 132 2983 2986 O
not 133 136 2987 2990 O
within 137 143 2991 2997 O
12 144 146 2998 3000 B-upper_bound
hours 147 152 3001 3006 I-upper_bound
) 152 153 3006 3007 O
of 154 156 3008 3010 O
starting 157 165 3011 3019 O
treatment 166 175 3020 3029 B-treatment
on 176 178 3030 3032 O
either 179 185 3033 3039 O
arm 186 189 3040 3043 O

between 0 7 3044 3051 O
the 8 11 3052 3055 O
ages 12 16 3056 3060 B-age
of 17 19 3061 3063 O
≥18 20 23 3064 3067 O
and 24 27 3068 3071 O
≤65 28 31 3072 3075 O
years 32 37 3076 3081 I-upper_bound

A 0 1 0 1 O
minimum 2 9 2 9 O
of 10 12 10 12 O
1 13 14 13 14 B-upper_bound
measurable 15 25 15 25 O
Target 26 32 26 32 O
Lesion 33 39 33 39 O
that 40 44 40 44 O
can 45 48 45 48 O
be 49 51 49 51 O
accurately 52 62 52 62 O
measured 63 71 63 71 O
by 72 74 72 74 O
calipers 75 83 75 83 O
, 83 84 83 84 O
computed 85 93 85 93 B-treatment
tomography 94 104 94 104 I-treatment
( 105 106 105 106 I-treatment
CT 106 108 106 108 I-treatment
) 108 109 108 109 I-treatment
or 110 112 110 112 O
magnetic 113 121 113 121 B-treatment
resonance 122 131 122 131 I-treatment
imaging 132 139 132 139 I-treatment
( 140 141 140 141 I-treatment
MRI 141 144 141 144 I-treatment
) 144 145 144 145 I-treatment

Age 0 3 146 149 B-age
18 4 6 150 152 B-lower_bound
years 7 12 153 158 I-lower_bound
or 13 15 159 161 O
older 16 21 162 167 O

At 0 2 168 170 O
least 3 8 171 176 O
1 9 10 177 178 B-lower_bound
Injectable 11 21 179 189 O
Lesion 22 28 190 196 O
( 29 30 197 198 O
i.e. 30 34 198 202 O
, 34 35 202 203 O
cutaneous 36 45 204 213 O
, 45 46 213 214 O
subcutaneous 47 59 215 227 O
, 59 60 227 228 O
soft 61 65 229 233 O
tissue 66 72 234 240 O
, 72 73 240 241 O
superficial 74 85 242 253 O
nodal 86 91 254 259 O
or 92 94 260 262 O
palpable 95 103 263 271 O
nodal 104 109 272 277 O
lesion 110 116 278 284 O
with 117 121 285 289 O
longest 122 129 290 297 O
diameter 130 138 298 306 O
at 139 141 307 309 O
least 142 147 310 315 O
5 148 149 316 317 B-lower_bound
mm 150 152 318 320 I-lower_bound
that 153 157 321 325 O
is 158 160 326 328 O
suitable 161 169 329 337 O
for 170 173 338 341 O
injection 174 183 342 351 O
with 184 188 352 356 O
PV-10 189 194 357 362 B-treatment
) 194 195 362 363 O

Clinically 0 10 364 374 O
significant 11 22 375 386 O
acute 23 28 387 392 B-chronic_disease
or 29 31 393 395 O
unstable 32 40 396 404 B-chronic_disease
cardiovascular 41 55 405 419 I-chronic_disease
, 55 56 419 420 O
cerebrovascular 57 72 421 436 B-chronic_disease
( 73 74 437 438 I-chronic_disease
stroke 74 80 438 444 I-chronic_disease
) 80 81 444 445 I-chronic_disease
, 81 82 445 446 O
renal 83 88 447 452 B-chronic_disease
, 88 89 452 453 O
gastrointestinal 90 106 454 470 B-chronic_disease
, 106 107 470 471 O
pulmonary 108 117 472 481 B-chronic_disease
, 117 118 481 482 O
immunological 119 132 483 496 B-chronic_disease
, 132 133 496 497 O
endocrine 134 143 498 507 B-chronic_disease
, 143 144 507 508 O
or 145 147 509 511 O
central 148 155 512 519 B-chronic_disease
nervous 156 163 520 527 I-chronic_disease
system 164 170 528 534 I-chronic_disease
disorders 171 180 535 544 I-chronic_disease

Evidence 0 8 545 553 O
of 9 11 554 556 O
clinically 12 22 557 567 O
significant 23 34 568 579 O
immunosuppression 35 52 580 597 B-treatment

Female 0 6 598 604 B-gender
subjects 7 15 605 613 I-gender
of 16 18 614 616 O
childbearing 19 31 617 629 O
potential 32 41 630 639 O
( 42 43 640 641 O
defined 43 50 641 648 O
as 51 53 649 651 O
having 54 60 652 658 O
a 61 62 659 660 O
menstrual 63 72 661 670 O
cycle 73 78 671 676 O
within 79 85 677 683 O
the 86 89 684 687 O
past 90 94 688 692 B-upper_bound
12 95 97 693 695 I-upper_bound
months 98 104 696 702 I-upper_bound
and 105 108 703 706 O
not 109 112 707 710 O
having 113 119 711 717 O
had 120 123 718 721 O
a 124 125 722 723 O
surgical 126 134 724 732 B-treatment
procedure 135 144 733 742 I-treatment
to 145 147 743 745 O
accomplish 148 158 746 756 O
sterilization 159 172 757 770 B-treatment
) 172 173 770 771 O
who 174 177 772 775 O
are 178 181 776 779 O
not 182 185 780 783 B-contraception_consent
using 186 191 784 789 I-contraception_consent
highly 192 198 790 796 I-contraception_consent
effective 199 208 797 806 I-contraception_consent
contraception 209 222 807 820 I-contraception_consent
( 223 224 821 822 O
e.g. 224 228 822 826 O
, 228 229 826 827 O
oral 230 234 828 832 B-contraception_consent
contraceptives 235 249 833 847 I-contraception_consent
, 249 250 847 848 O
intrauterine 251 263 849 861 B-contraception_consent
devices 264 271 862 869 I-contraception_consent
, 271 272 869 870 O
double 273 279 871 877 B-contraception_consent
barrier 280 287 878 885 I-contraception_consent
methods 288 295 886 893 I-contraception_consent
such 296 300 894 898 O
as 301 303 899 901 O
condoms 304 311 902 909 B-contraception_consent
and 312 315 910 913 O
diaphragms 316 326 914 924 B-contraception_consent
, 326 327 924 925 O
abstinence 328 338 926 936 B-contraception_consent
or 339 341 937 939 O
equivalent 342 352 940 950 O
measures 353 361 951 959 O
) 361 362 959 960 O

Female 0 6 961 967 B-gender
subjects 7 15 968 976 I-gender
who 16 19 977 980 O
are 20 23 981 984 B-pregnancy
pregnant 24 32 985 993 I-pregnancy

Female 0 6 994 1000 B-gender
subjects 7 15 1001 1009 I-gender
who 16 19 1010 1013 O
have 20 24 1014 1018 O
positive 25 33 1019 1027 O
serum 34 39 1028 1033 O
pregnancy 40 49 1034 1043 B-pregnancy
test 50 54 1044 1048 O
taken 55 60 1049 1054 O
within 61 67 1055 1061 O
14 68 70 1062 1064 B-upper_bound
days 71 75 1065 1069 I-upper_bound
of 76 78 1070 1072 O
initiation 79 89 1073 1083 O
of 90 92 1084 1086 O
study 93 98 1087 1092 B-treatment
treatment 99 108 1093 1102 I-treatment

Histologically 0 14 1103 1117 O
or 15 17 1118 1120 O
cytologically 18 31 1121 1134 O
confirmed 32 41 1135 1144 O
diagnosis 42 51 1145 1154 O
of 52 54 1155 1157 O
melanoma 55 63 1158 1166 B-cancer

History 0 7 1167 1174 O
or 8 10 1175 1177 O
evidence 11 19 1178 1186 O
of 20 22 1187 1189 O
symptomatic 23 34 1190 1201 O
autoimmune 35 45 1202 1212 O
pneumonitis 46 57 1213 1224 B-chronic_disease
, 57 58 1224 1225 O
glomerulonephritis 59 77 1226 1244 B-chronic_disease
, 77 78 1244 1245 O
vasculitis 79 89 1246 1256 B-chronic_disease
, 89 90 1256 1257 O
or 91 93 1258 1260 O
other 94 99 1261 1266 O
systemic 100 108 1267 1275 B-chronic_disease
autoimmune 109 119 1276 1286 I-chronic_disease
disease 120 127 1287 1294 I-chronic_disease

Impaired 0 8 1295 1303 O
wound 9 14 1304 1309 O
healing 15 22 1310 1317 O
or 23 25 1318 1320 O
other 26 31 1321 1326 O
extremity 32 41 1327 1336 O
complications 42 55 1337 1350 O
due 56 59 1351 1354 O
to 60 62 1355 1357 O
severe 63 69 1358 1364 O
or 70 72 1365 1367 O
uncontrolled 73 85 1368 1380 B-chronic_disease
diabetes 86 94 1381 1389 I-chronic_disease
mellitus 95 103 1390 1398 I-chronic_disease
in 104 106 1399 1401 O
subjects 107 115 1402 1410 O
whose 116 121 1411 1416 O
Injectable 122 132 1417 1427 O
Lesions 133 140 1428 1435 O
are 141 144 1436 1439 O
located 145 152 1440 1447 O
in 153 155 1448 1450 O
an 156 158 1451 1453 O
extremity 159 168 1454 1463 O

Male 0 4 1464 1468 B-gender
subjects 5 13 1469 1477 I-gender
who 14 17 1478 1481 O
are 18 21 1482 1485 O
unwilling 22 31 1486 1495 B-contraception_consent
to 32 34 1496 1498 I-contraception_consent
use 35 38 1499 1502 I-contraception_consent
acceptable 39 49 1503 1513 I-contraception_consent
method 50 56 1514 1520 I-contraception_consent
of 57 59 1521 1523 I-contraception_consent
effective 60 69 1524 1533 I-contraception_consent
contraception 70 83 1534 1547 I-contraception_consent

Malignancy 0 10 1548 1558 B-cancer
other 11 16 1559 1564 O
than 17 21 1565 1569 O
melanoma 22 30 1570 1578 B-cancer
within 31 37 1579 1585 O
2 38 39 1586 1587 B-upper_bound
years 40 45 1588 1593 I-upper_bound
of 46 48 1594 1596 O
enrollment 49 59 1597 1607 O

Other 0 5 1608 1613 O
prior 6 11 1614 1619 B-treatment
cancer 12 18 1620 1626 I-treatment
therapy 19 26 1627 1634 I-treatment
or 27 29 1635 1637 O
anti 30 34 1638 1642 B-treatment
- 34 35 1642 1643 I-treatment
cancer 35 41 1643 1649 I-treatment
vaccine 42 49 1650 1657 I-treatment
within 50 56 1658 1664 O
the 57 60 1665 1668 O
lesser 61 67 1669 1675 O
of 68 70 1676 1678 O
4 71 72 1679 1680 B-upper_bound
weeks 73 78 1681 1686 I-upper_bound
or 79 81 1687 1689 O
5 82 83 1690 1691 B-upper_bound
half 84 88 1692 1696 I-upper_bound
- 88 89 1696 1697 I-upper_bound
lives 89 94 1697 1702 I-upper_bound
before 95 101 1703 1709 I-upper_bound
initial 102 109 1710 1717 B-treatment
study 110 115 1718 1723 I-treatment
treatment 116 125 1724 1733 I-treatment

Performance 0 11 1734 1745 B-clinical_variable
Status 12 18 1746 1752 I-clinical_variable
: 18 19 1752 1753 I-clinical_variable
Eastern 20 27 1754 1761 I-clinical_variable
Cooperative 28 39 1762 1773 I-clinical_variable
Oncology 40 48 1774 1782 I-clinical_variable
Group 49 54 1783 1788 I-clinical_variable
( 55 56 1789 1790 I-clinical_variable
ECOG 56 60 1790 1794 I-clinical_variable
) 60 61 1794 1795 I-clinical_variable
0 62 63 1796 1797 B-lower_bound
- 63 64 1797 1798 O
1 64 65 1798 1799 B-upper_bound

Prior 0 5 1800 1805 B-treatment
treatment 6 15 1806 1815 I-treatment
with 16 20 1816 1820 I-treatment
PV-10 21 26 1821 1826 I-treatment
or 27 29 1827 1829 O
any 30 33 1830 1833 O
checkpoint 34 44 1834 1844 O
inhibitor 45 54 1845 1854 O

Severe 0 6 1855 1861 O
peripheral 7 17 1862 1872 B-chronic_disease
vascular 18 26 1873 1881 I-chronic_disease
disease 27 34 1882 1889 I-chronic_disease
( 35 36 1890 1891 O
i.e. 36 40 1891 1895 O
, 40 41 1895 1896 O
severe 42 48 1897 1903 O
claudication 49 61 1904 1916 B-clinical_variable
[ 62 63 1917 1918 O
pain 63 67 1918 1922 O
occurring 68 77 1923 1932 O
after 78 83 1933 1938 O
less 84 88 1939 1943 O
than 89 93 1944 1948 O
200 94 97 1949 1952 B-upper_bound
meters 98 104 1953 1959 I-upper_bound
of 105 107 1960 1962 O
walking 108 115 1963 1970 O
] 115 116 1970 1971 O
, 116 117 1971 1972 O
rest 118 122 1973 1977 O
pain 123 127 1978 1982 O
, 127 128 1982 1983 O
ischemic 129 137 1984 1992 B-chronic_disease
ulceration 138 148 1993 2003 I-chronic_disease
or 149 151 2004 2006 O
gangrene 152 160 2007 2015 O
) 160 161 2015 2016 O
in 162 164 2017 2019 O
subjects 165 173 2020 2028 O
whose 174 179 2029 2034 O
Injectable 180 190 2035 2045 O
Lesions 191 198 2046 2053 O
are 199 202 2054 2057 O
located 203 210 2058 2065 O
in 211 213 2066 2068 O
an 214 216 2069 2071 O
extremity 217 226 2072 2081 O

Significant 0 11 2082 2093 O
concurrent 12 22 2094 2104 O
or 23 25 2105 2107 O
intercurrent 26 38 2108 2120 B-chronic_disease
illness 39 46 2121 2128 I-chronic_disease
, 46 47 2128 2129 O
psychiatric 48 59 2130 2141 B-chronic_disease
disorders 60 69 2142 2151 I-chronic_disease
, 69 70 2151 2152 O
or 71 73 2153 2155 O
alcohol 74 81 2156 2163 O
or 82 84 2164 2166 O
chemical 85 93 2167 2175 O
dependence 94 104 2176 2186 O
that 105 109 2187 2191 O
would 110 115 2192 2197 O
, 115 116 2197 2198 O
in 117 119 2199 2201 O
the 120 123 2202 2205 O
opinion 124 131 2206 2213 O
of 132 134 2214 2216 O
the 135 138 2217 2220 O
Investigator 139 151 2221 2233 O
, 151 152 2233 2234 O
compromise 153 163 2235 2245 O
the 164 167 2246 2249 O
subject 168 175 2250 2257 O
's 175 177 2257 2259 O
safety 178 184 2260 2266 O
or 185 187 2267 2269 O
compliance 188 198 2270 2280 O
or 199 201 2281 2283 O
interfere 202 211 2284 2293 O
with 212 216 2294 2298 O
interpretation 217 231 2299 2313 O
of 232 234 2314 2316 O
study 235 240 2317 2322 O
results 241 248 2323 2330 O

Stage 0 5 2331 2336 B-cancer
IV 6 8 2337 2339 I-cancer
or 9 11 2340 2342 I-cancer
Stage 12 17 2343 2348 I-cancer
III 18 21 2349 2352 I-cancer
( 22 23 2353 2354 I-cancer
unresectable 23 35 2354 2366 I-cancer
, 35 36 2366 2367 I-cancer
in 37 39 2368 2370 I-cancer
- 39 40 2370 2371 I-cancer
transit 40 47 2371 2378 I-cancer
or 48 50 2379 2381 I-cancer
satellite 51 60 2382 2391 I-cancer
) 60 61 2391 2392 I-cancer
melanoma 62 70 2393 2401 I-cancer

Subjects 0 8 2402 2410 O
with 9 13 2411 2415 O
> 14 15 2416 2417 O
1 16 17 2418 2419 B-lower_bound
cm 18 20 2420 2422 I-lower_bound
or 21 23 2423 2425 O
> 24 25 2426 2427 O
3 26 27 2428 2429 B-lower_bound
in 28 30 2430 2432 O
number 31 37 2433 2439 O
treated 38 45 2440 2447 O
brain 46 51 2448 2453 B-cancer
metastases 52 62 2454 2464 I-cancer

Subjects 0 8 2465 2473 O
with 9 13 2474 2478 O
≤ 14 15 2479 2480 O
3 16 17 2481 2482 B-upper_bound
brain 18 23 2483 2488 B-clinical_variable
metastases 24 34 2489 2499 I-clinical_variable
and 35 38 2500 2503 O
each 39 43 2504 2508 O
≤ 44 45 2509 2510 O
1 46 47 2511 2512 B-upper_bound
cm 48 50 2513 2515 I-upper_bound
size 51 55 2516 2520 O
that 56 60 2521 2525 O
were 61 65 2526 2530 O
treated 66 73 2531 2538 O
with 74 78 2539 2543 O
either 79 85 2544 2550 O
surgical 86 94 2551 2559 B-treatment
resection 95 104 2560 2569 I-treatment
and/or 105 111 2570 2576 O
radiation 112 121 2577 2586 B-treatment
therapy 122 129 2587 2594 I-treatment

Thyroid 0 7 2595 2602 O
function 8 16 2603 2611 O
abnormality 17 28 2612 2623 O
≤ 29 30 2624 2625 O
Common 31 37 2626 2632 B-clinical_variable
Toxicity 38 46 2633 2641 I-clinical_variable
Criteria 47 55 2642 2650 I-clinical_variable
for 56 59 2651 2654 I-clinical_variable
Adverse 60 67 2655 2662 I-clinical_variable
Effects 68 75 2663 2670 I-clinical_variable
( 76 77 2671 2672 I-clinical_variable
CTCAE 77 82 2672 2677 I-clinical_variable
) 82 83 2677 2678 I-clinical_variable
Grade 84 89 2679 2684 I-clinical_variable
2 90 91 2685 2686 B-upper_bound

Uncontrolled 0 12 2687 2699 O
thyroid 13 20 2700 2707 B-chronic_disease
disease 21 28 2708 2715 I-chronic_disease
or 29 31 2716 2718 O
cystic 32 38 2719 2725 B-chronic_disease
fibrosis 39 47 2726 2734 I-chronic_disease

Untreated 0 9 2735 2744 O
or 10 12 2745 2747 O
clinically 13 23 2748 2758 O
active 24 30 2759 2765 O
melanoma 31 39 2766 2774 O
brain 40 45 2775 2780 B-cancer
metastases 46 56 2781 2791 I-cancer

absolute 0 8 2792 2800 B-clinical_variable
neutrophil 9 19 2801 2811 I-clinical_variable
count 20 25 2812 2817 I-clinical_variable
( 26 27 2818 2819 I-clinical_variable
ANC 27 30 2819 2822 I-clinical_variable
) 30 31 2822 2823 I-clinical_variable
≥ 32 33 2824 2825 O
1.5 34 37 2826 2829 B-lower_bound
x 38 39 2830 2831 I-lower_bound
109 40 43 2832 2835 I-lower_bound
/ 43 44 2835 2836 I-lower_bound
L 44 45 2836 2837 I-lower_bound
and 46 49 2838 2841 O
platelet 50 58 2842 2850 B-clinical_variable
count 59 64 2851 2856 I-clinical_variable
≥100 65 69 2857 2861 O
x 70 71 2862 2863 I-lower_bound
109 72 75 2864 2867 I-lower_bound
/ 75 76 2867 2868 I-lower_bound
L 76 77 2868 2869 I-lower_bound

adequately 0 10 2870 2880 O
treated 11 18 2881 2888 O
( 19 20 2889 2890 O
i.e. 20 24 2890 2894 O
, 24 25 2894 2895 O
with 26 30 2896 2900 O
curative 31 39 2901 2909 B-treatment
intent 40 46 2910 2916 I-treatment
) 46 47 2916 2917 O
basal 48 53 2918 2923 B-cancer
or 54 56 2924 2926 O
squamous 57 65 2927 2935 B-cancer
cell 66 70 2936 2940 I-cancer
carcinoma 71 80 2941 2950 I-cancer
, 80 81 2950 2951 O
in 82 84 2952 2954 B-cancer
situ 85 89 2955 2959 I-cancer
carcinoma 90 99 2960 2969 I-cancer
of 100 102 2970 2972 I-cancer
the 103 106 2973 2976 I-cancer
cervix 107 113 2977 2983 I-cancer
, 113 114 2983 2984 O
in 115 117 2985 2987 B-cancer
situ 118 122 2988 2992 I-cancer
ductal 123 129 2993 2999 I-cancer
adenocarcinoma 130 144 3000 3014 I-cancer
of 145 147 3015 3017 I-cancer
the 148 151 3018 3021 I-cancer
breast 152 158 3022 3028 I-cancer
, 158 159 3028 3029 O
in 160 162 3030 3032 B-cancer
situ 163 167 3033 3037 I-cancer
prostate 168 176 3038 3046 I-cancer
cancer 177 183 3047 3053 I-cancer
, 183 184 3053 3054 O
or 185 187 3055 3057 O
limited 188 195 3058 3065 O
stage 196 201 3066 3071 O
bladder 202 209 3072 3079 B-cancer
cancer 210 216 3080 3086 I-cancer

aspartate 0 9 3087 3096 B-clinical_variable
transaminase 10 22 3097 3109 I-clinical_variable
( 23 24 3110 3111 I-clinical_variable
AST 24 27 3111 3114 I-clinical_variable
) 27 28 3114 3115 I-clinical_variable
, 28 29 3115 3116 O
alanine 30 37 3117 3124 B-clinical_variable
transaminase 38 50 3125 3137 I-clinical_variable
( 51 52 3138 3139 I-clinical_variable
ALT 52 55 3139 3142 I-clinical_variable
) 55 56 3142 3143 I-clinical_variable
and 57 60 3144 3147 O
alkaline 61 69 3148 3156 B-clinical_variable
phosphatase 70 81 3157 3168 I-clinical_variable
( 82 83 3169 3170 I-clinical_variable
ALP 83 86 3170 3173 I-clinical_variable
) 86 87 3173 3174 I-clinical_variable
≤ 88 89 3175 3176 O
5 90 91 3177 3178 B-upper_bound
times 92 97 3179 3184 I-upper_bound
the 98 101 3185 3188 I-upper_bound
upper 102 107 3189 3194 I-upper_bound
limit 108 113 3195 3200 I-upper_bound
of 114 116 3201 3203 I-upper_bound
normal 117 123 3204 3210 I-upper_bound
( 124 125 3211 3212 I-upper_bound
ULN 125 128 3212 3215 I-upper_bound
) 128 129 3215 3216 I-upper_bound

at 0 2 3217 3219 O
least 3 8 3220 3225 O
one 9 12 3226 3229 B-lower_bound
cutaneous 13 22 3230 3239 B-clinical_variable
lesion 23 29 3240 3246 I-clinical_variable
( 30 31 3247 3248 O
each 31 35 3248 3252 O
lesion 36 42 3253 3259 O
≥ 43 44 3260 3261 O
10 45 47 3262 3264 B-lower_bound
mm 48 50 3265 3267 I-lower_bound
longest 51 58 3268 3275 O
diameteror 59 69 3276 3286 O
up 70 72 3287 3289 O
to 73 75 3290 3292 O
5 76 77 3293 3294 B-upper_bound
lesions 78 85 3295 3302 I-upper_bound
in 86 88 3303 3305 O
aggregate 89 98 3306 3315 O
having 99 105 3316 3322 O
a 106 107 3323 3324 O
sum 108 111 3325 3328 O
of 112 114 3329 3331 O
longest 115 122 3332 3339 B-clinical_variable
diameters 123 132 3340 3349 I-clinical_variable
≥ 133 134 3350 3351 O
10 135 137 3352 3354 O
mm 138 140 3355 3357 O
) 140 141 3357 3358 O

at 0 2 3359 3361 O
least 3 8 3362 3367 O
one 9 12 3368 3371 B-lower_bound
nodal 13 18 3372 3377 O
lesion 19 25 3378 3384 B-clinical_variable
( 26 27 3385 3386 O
each 27 31 3386 3390 O
lesion 32 38 3391 3397 O
≥ 39 40 3398 3399 O
15 41 43 3400 3402 B-lower_bound
mm 44 46 3403 3405 I-lower_bound
in 47 49 3406 3408 O
short 50 55 3409 3414 O
axis 56 60 3415 3419 O
diameter 61 69 3420 3428 O
by 70 72 3429 3431 O
CT 73 75 3432 3434 B-treatment
or 76 78 3435 3437 O
MRI 79 82 3438 3441 B-treatment
) 82 83 3441 3442 O

at 0 2 3443 3445 O
least 3 8 3446 3451 O
one 9 12 3452 3455 B-lower_bound
subcutaneous 13 25 3456 3468 O
or 26 28 3469 3471 O
soft 29 33 3472 3476 O
tissue 34 40 3477 3483 O
lesion 41 47 3484 3490 B-clinical_variable
( 48 49 3491 3492 O
each 49 53 3492 3496 O
lesion 54 60 3497 3503 O
≥ 61 62 3504 3505 O
10 63 65 3506 3508 B-lower_bound
mm 66 68 3509 3511 I-lower_bound
in 69 71 3512 3514 O
longest 72 79 3515 3522 O
diameter 80 88 3523 3531 O
by 89 91 3532 3534 O
CT 92 94 3535 3537 B-treatment
or 95 97 3538 3540 O
MRI 98 101 3541 3544 B-treatment
) 101 102 3544 3545 O

at 0 2 3546 3548 O
least 3 8 3549 3554 O
one 9 12 3555 3558 B-lower_bound
visceral 13 21 3559 3567 O
lesion 22 28 3568 3574 O
( 29 30 3575 3576 O
each 30 34 3576 3580 O
lesion 35 41 3581 3587 O
≥ 42 43 3588 3589 O
10 44 46 3590 3592 B-lower_bound
mm 47 49 3593 3595 I-lower_bound
in 50 52 3596 3598 O
longest 53 60 3599 3606 O
diameter 61 69 3607 3615 B-clinical_variable
by 70 72 3616 3618 O
CT 73 75 3619 3621 B-treatment
or 76 78 3622 3624 O
MRI 79 82 3625 3628 B-treatment
) 82 83 3628 3629 O

estimated 0 9 3630 3639 B-clinical_variable
glomerular 10 20 3640 3650 I-clinical_variable
filtration 21 31 3651 3661 I-clinical_variable
rate 32 36 3662 3666 I-clinical_variable
( 37 38 3667 3668 I-clinical_variable
eGFR 38 42 3668 3672 I-clinical_variable
) 42 43 3672 3673 I-clinical_variable
≥ 44 45 3674 3675 O
30 46 48 3676 3678 B-lower_bound
mL 49 51 3679 3681 I-lower_bound
/ 51 52 3681 3682 I-lower_bound
min/1.73 52 60 3682 3690 I-lower_bound
m2 61 63 3691 3693 I-lower_bound

female 0 6 3694 3700 B-gender

male 0 4 3701 3705 B-gender

the 0 3 3706 3709 O
subject 4 11 3710 3717 O
is 12 14 3718 3720 O
not 15 18 3721 3724 O
taking 19 25 3725 3731 O
prednisone 26 36 3732 3742 B-treatment
at 37 39 3743 3745 O
> 40 41 3746 3747 O
10 41 43 3747 3749 B-lower_bound
mg 44 46 3750 3752 I-lower_bound
or 47 49 3753 3755 O
equivalent 50 60 3756 3766 O
daily 61 66 3767 3772 O

there 0 5 3773 3778 O
is 6 8 3779 3781 O
no 9 11 3782 3784 O
evidence 12 20 3785 3793 O
of 21 23 3794 3796 O
progressive 24 35 3797 3808 O
CNS 36 39 3809 3812 B-chronic_disease
disease 40 47 3813 3820 I-chronic_disease
on 48 50 3821 3823 O
brain 51 56 3824 3829 B-treatment
imaging 57 64 3830 3837 I-treatment
at 65 67 3838 3840 O
least 68 73 3841 3846 O
90 74 76 3847 3849 B-lower_bound
days 77 81 3850 3854 I-lower_bound
after 82 87 3855 3860 I-lower_bound
treatment 88 97 3861 3870 B-treatment
with 98 102 3871 3875 I-treatment
surgery 103 110 3876 3883 I-treatment
and/or 111 117 3884 3890 O
radiation 118 127 3891 3900 B-treatment
therapy 128 135 3901 3908 I-treatment

there 0 5 3909 3914 O
is 6 8 3915 3917 O
no 9 11 3918 3920 O
evidence 12 20 3921 3929 O
of 21 23 3930 3932 O
progressive 24 35 3933 3944 O
central 36 43 3945 3952 B-chronic_disease
nervous 44 51 3953 3960 I-chronic_disease
system 52 58 3961 3967 I-chronic_disease
( 59 60 3968 3969 I-chronic_disease
CNS 60 63 3969 3972 I-chronic_disease
) 63 64 3972 3973 I-chronic_disease
disease 65 72 3974 3981 I-chronic_disease
on 73 75 3982 3984 O
brain 76 81 3985 3990 B-treatment
imaging 82 89 3991 3998 I-treatment
at 90 92 3999 4001 O
least 93 98 4002 4007 O
30 99 101 4008 4010 B-lower_bound
days 102 106 4011 4015 I-lower_bound
after 107 112 4016 4021 I-lower_bound
definitive 113 123 4022 4032 B-treatment
treatment 124 133 4033 4042 I-treatment

total 0 5 4043 4048 B-clinical_variable
bilirubin 6 15 4049 4058 I-clinical_variable
≤ 16 17 4059 4060 O
3 18 19 4061 4062 B-upper_bound
times 20 25 4063 4068 I-upper_bound
the 26 29 4069 4072 I-upper_bound
upper 30 35 4073 4078 I-upper_bound
limit 36 41 4079 4084 I-upper_bound
of 42 44 4085 4087 I-upper_bound
normal 45 51 4088 4094 I-upper_bound
( 52 53 4095 4096 I-upper_bound
ULN 53 56 4096 4099 I-upper_bound
) 56 57 4099 4100 I-upper_bound

who 0 3 4101 4104 O
have 4 8 4105 4109 O
failed 9 15 4110 4116 O
to 16 18 4117 4119 O
achieve 19 26 4120 4127 O
a 27 28 4128 4129 O
complete 29 37 4130 4138 O
or 38 40 4139 4141 O
partial 41 48 4142 4149 O
response 49 57 4150 4158 O
within 58 64 4159 4165 O
24 65 67 4166 4168 B-upper_bound
weeks 68 73 4169 4174 I-upper_bound
following 74 83 4175 4184 O
initiation 84 94 4185 4195 O
of 95 97 4196 4198 O
checkpoint 98 108 4199 4209 B-treatment
inhibition 109 119 4210 4220 I-treatment

who 0 3 4221 4224 O
progressed 4 14 4225 4235 O
after 15 20 4236 4241 O
more 21 25 4242 4246 O
than 26 30 4247 4251 O
12 31 33 4252 4254 B-lower_bound
weeks 34 39 4255 4260 I-lower_bound
of 40 42 4261 4263 O
checkpoint 43 53 4264 4274 O
inhibition 54 64 4275 4285 O
are 65 68 4286 4289 O
eligible 69 77 4290 4298 O
for 78 81 4299 4302 O
study 82 87 4303 4308 O
participation 88 101 4309 4322 O
in 102 104 4323 4325 O
the 105 108 4326 4329 O
Phase 109 114 4330 4335 O
1b 115 117 4336 4338 O
Expansion 118 127 4339 4348 O
Cohort 128 134 4349 4355 O
1 135 136 4356 4357 O
without 137 144 4358 4365 O
washout 145 152 4366 4373 O
period 153 159 4374 4380 O
for 160 163 4381 4384 O
checkpoint 164 174 4385 4395 O
inhibition 175 185 4396 4406 O

Chronic 0 7 0 7 B-chronic_disease
medical 8 15 8 15 I-chronic_disease
condition 16 25 16 25 I-chronic_disease
( 26 27 26 27 O
e.g. 27 31 27 31 O
self 32 36 32 36 O
reported 37 45 37 45 O
hypertension 46 58 46 58 B-chronic_disease
, 58 59 58 59 O
or 60 62 60 62 O
diabetes 63 71 63 71 B-chronic_disease
, 71 72 71 72 O
or 73 75 73 75 O
chronic 76 83 76 83 B-chronic_disease
obstructive 84 95 84 95 I-chronic_disease
pulmonary 96 105 96 105 I-chronic_disease
disease 106 113 106 113 I-chronic_disease
or 114 116 114 116 O
heart 117 122 117 122 B-chronic_disease
disease 123 130 123 130 I-chronic_disease
) 130 131 130 131 O

Greater 0 7 132 139 O
than 8 12 140 144 O
moderate 13 21 145 153 B-chronic_disease
valvular 22 30 154 162 I-chronic_disease
disease 31 38 163 170 I-chronic_disease
or 39 41 171 173 O
congenital 42 52 174 184 B-chronic_disease
heart 53 58 185 190 I-chronic_disease
disease 59 66 191 198 I-chronic_disease

Left 0 4 199 203 B-clinical_variable
ventricular 5 16 204 215 I-clinical_variable
ejection 17 25 216 224 I-clinical_variable
fraction 26 34 225 233 I-clinical_variable
≥50 35 38 234 237 O
% 38 39 237 238 I-lower_bound

matched 0 7 239 246 O
to 8 10 247 249 O
the 11 14 250 253 O
age 15 18 254 257 B-age
and 19 22 258 261 O
sex 23 26 262 265 O
of 27 29 266 268 O
HFpEF 30 35 269 274 O
patients 36 44 275 283 O

Patients 0 8 0 8 O
with 9 13 9 13 O
collagen 14 22 14 22 B-chronic_disease
vascular 23 31 23 31 I-chronic_disease
, 31 32 31 32 O
autoimmune 33 43 33 43 B-chronic_disease
or 44 46 44 46 O
immunodeficiency 47 63 47 63 B-chronic_disease
disease 64 71 64 71 I-chronic_disease

Pregnant 0 8 72 80 B-pregnancy

Who 0 3 81 84 O
are 4 7 85 88 O
21 8 10 89 91 B-lower_bound
years 11 16 92 97 I-lower_bound
of 17 19 98 100 O
age 20 23 101 104 B-age
or 24 26 105 107 O
older 27 32 108 113 O

Who 0 3 114 117 O
have 4 8 118 122 O
a 9 10 123 124 O
corneal 11 18 125 132 B-clinical_variable
thickness 19 28 133 142 I-clinical_variable
of 29 31 143 145 O
450 32 35 146 149 B-lower_bound
microns 36 43 150 157 O
or 44 46 158 160 O
greater 47 54 161 168 O
at 55 57 169 171 O
the 58 61 172 175 O
proposed 62 70 176 184 O
incision 71 79 185 193 O
site 80 84 194 198 O

Who 0 3 199 202 O
have 4 8 203 207 O
corneal 9 16 208 215 B-treatment
transplantation 17 32 216 231 I-treatment
as 33 35 232 234 O
the 36 39 235 238 O
only 40 44 239 243 O
remaining 45 54 244 253 O
option 55 61 254 260 O
to 62 64 261 263 O
improve 65 72 264 271 O
their 73 78 272 277 O
functional 79 89 278 288 O
vision 90 96 289 295 O

amiodarone 0 10 296 306 B-treatment
HCL 11 14 307 310 I-treatment
( 15 16 311 312 I-treatment
Cordarone 16 25 312 321 I-treatment
) 25 26 321 322 I-treatment

corneal 0 7 323 330 B-chronic_disease
dystrophy 8 17 331 340 I-chronic_disease

isotretinoin 0 12 341 353 B-treatment
( 13 14 354 355 I-treatment
Accutane 14 22 355 363 I-treatment
) 22 23 363 364 I-treatment

recurrent 0 9 365 374 B-chronic_disease
corneal 10 17 375 382 I-chronic_disease
erosion 18 25 383 390 I-chronic_disease
syndrome 26 34 391 399 I-chronic_disease

who 0 3 400 403 O
have 4 8 404 408 O
a 9 10 409 410 O
corneal 11 18 411 418 B-clinical_variable
thickness 19 28 419 428 I-clinical_variable
of 29 31 429 431 O
449 32 35 432 435 B-upper_bound
microns 36 43 436 443 I-upper_bound
or 44 46 444 446 O
less 47 51 447 451 O
at 52 54 452 454 O
the 55 58 455 458 O
proposed 59 67 459 467 O
incision 68 76 468 476 O
site 77 81 477 481 O

ferromagnetic 0 13 0 13 B-treatment
implants 14 22 14 22 I-treatment
such 23 27 23 27 O
as 28 30 28 30 O
aneurysm 31 39 31 39 B-treatment
clips 40 45 40 45 I-treatment
, 45 46 45 46 O
surgical 47 55 47 55 B-treatment
clips 56 61 56 61 I-treatment
, 61 62 61 62 O
prostheses 63 73 63 73 B-treatment
, 73 74 73 74 O
artificial 75 85 75 85 B-treatment
hearts 86 92 86 92 I-treatment
, 92 93 92 93 O
valves 94 100 94 100 B-treatment
with 101 105 101 105 I-treatment
steel 106 111 106 111 I-treatment
parts 112 117 112 117 I-treatment
, 117 118 117 118 O
metal 119 124 119 124 B-treatment
fragments 125 134 125 134 I-treatment
, 134 135 134 135 O
shrapnel 136 144 136 144 B-treatment
, 144 145 144 145 O
tattoos 146 153 146 153 O
near 154 158 154 158 O
the 159 162 159 162 O
eye 163 166 163 166 O
, 166 167 166 167 O
or 168 170 168 170 O
steel 171 176 171 176 B-treatment
implants 177 185 177 185 I-treatment

pre 0 3 186 189 O
- 3 4 189 190 O
existing 4 12 190 198 O
medical 13 20 199 206 O
conditions 21 31 207 217 O
including 32 41 218 227 O
a 42 43 228 229 O
likelihood 44 54 230 240 O
of 55 57 241 243 O
developing 58 68 244 254 O
seizures 69 77 255 263 B-chronic_disease
or 78 80 264 266 O
claustrophobic 81 95 267 281 B-chronic_disease
reactions 96 105 282 291 I-chronic_disease
, 105 106 291 292 O
and 107 110 293 296 O
any 111 114 297 300 O
greater 115 122 301 308 O
than 123 127 309 313 O
normal 128 134 314 320 O
potential 135 144 321 330 O
for 145 148 331 334 O
cardiac 149 156 335 342 B-chronic_disease
arrest 157 163 343 349 I-chronic_disease

Ability 0 7 0 7 O
to 8 10 8 10 O
swallow 11 18 11 18 O
and 19 22 19 22 O
retain 23 29 23 29 O
oral 30 34 30 34 O
medication 35 45 35 45 B-treatment

Absolute 0 8 46 54 B-clinical_variable
neutrophil 9 19 55 65 I-clinical_variable
count 20 25 66 71 I-clinical_variable
( 26 27 72 73 I-clinical_variable
ANC 27 30 73 76 I-clinical_variable
) 30 31 76 77 I-clinical_variable
> 32 33 78 79 O
= 33 34 79 80 O
1.5 35 38 81 84 B-lower_bound
x 39 40 85 86 I-lower_bound
10 41 43 87 89 I-lower_bound
^ 43 44 89 90 I-lower_bound
9 44 45 90 91 I-lower_bound
/ 45 46 91 92 I-lower_bound
L 46 47 92 93 I-lower_bound

Alanine 0 7 94 101 B-clinical_variable
aminotransferase 8 24 102 118 I-clinical_variable
( 25 26 119 120 I-clinical_variable
ALT 26 29 120 123 I-clinical_variable
) 29 30 123 124 I-clinical_variable
and 31 34 125 128 O
aspartate 35 44 129 138 B-clinical_variable
aminotransferase 45 61 139 155 I-clinical_variable
( 62 63 156 157 I-clinical_variable
AST 63 66 157 160 I-clinical_variable
) 66 67 160 161 I-clinical_variable
= 68 69 162 163 O
< 69 70 163 164 O
ULN 71 74 165 168 O

Any 0 3 169 172 O
condition 4 13 173 182 O
which 14 19 183 188 O
in 20 22 189 191 O
the 23 26 192 195 O
investigator 27 39 196 208 O
's 39 41 208 210 O
opinion 42 49 211 218 O
deems 50 55 219 224 O
the 56 59 225 228 O
subject 60 67 229 236 O
an 68 70 237 239 O
unsuitable 71 81 240 250 O
candidate 82 91 251 260 O
to 92 94 261 263 O
receive 95 102 264 271 O
study 103 108 272 277 B-treatment
drug 109 113 278 282 I-treatment

Biopsy 0 6 283 289 B-treatment
/ 6 7 289 290 O
pathology 7 16 290 299 O
- 16 17 299 300 O
proven 17 23 300 306 O
clear 24 29 307 312 B-cancer
cell 30 34 313 317 I-cancer
renal 35 40 318 323 I-cancer
cell 41 45 324 328 I-cancer
carcinoma 46 55 329 338 I-cancer
( 56 57 339 340 I-cancer
CCRCC 57 62 340 345 I-cancer
) 62 63 345 346 I-cancer
with 64 68 347 351 O
metastases 69 79 352 362 B-cancer

Concurrent 0 10 363 373 O
use 11 14 374 377 O
of 15 17 378 380 O
another 18 25 381 388 O
anti 26 30 389 393 B-treatment
- 30 31 393 394 I-treatment
cancer 31 37 394 400 I-treatment
drug 38 42 401 405 I-treatment
including 43 52 406 415 O
an 53 55 416 418 O
investigational 56 71 419 434 O
anti 72 76 435 439 B-treatment
- 76 77 439 440 I-treatment
cancer 77 83 440 446 I-treatment
agent 84 89 447 452 I-treatment

Coronary 0 8 453 461 B-treatment
angioplasty 9 20 462 473 I-treatment
or 21 23 474 476 O
stenting 24 32 477 485 B-treatment

Coronary 0 8 486 494 B-treatment
artery 9 15 495 501 I-treatment
bypass 16 22 502 508 I-treatment
grafting 23 31 509 517 I-treatment
( 32 33 518 519 I-treatment
CABG 33 37 519 523 I-treatment
) 37 38 523 524 I-treatment

Corrected 0 9 525 534 B-clinical_variable
QT 10 12 535 537 I-clinical_variable
interval 13 21 538 546 I-clinical_variable
( 22 23 547 548 I-clinical_variable
QTc 23 26 548 551 I-clinical_variable
) 26 27 551 552 I-clinical_variable
> 28 29 553 554 O
480 30 33 555 558 B-lower_bound
msec 34 38 559 563 I-lower_bound

Evidence 0 8 564 572 O
of 9 11 573 575 O
active 12 18 576 582 B-chronic_disease
bleeding 19 27 583 591 I-chronic_disease
or 28 30 592 594 O
bleeding 31 39 595 603 B-chronic_disease
disorder 40 48 604 612 I-chronic_disease

Have 0 4 613 617 O
an 5 7 618 620 O
Eastern 8 15 621 628 B-clinical_variable
Cooperative 16 27 629 640 I-clinical_variable
Oncology 28 36 641 649 I-clinical_variable
Group 37 42 650 655 I-clinical_variable
( 43 44 656 657 I-clinical_variable
ECOG 44 48 657 661 I-clinical_variable
) 48 49 661 662 I-clinical_variable
performance 50 61 663 674 I-clinical_variable
status 62 68 675 681 I-clinical_variable
= 69 70 682 683 O
< 70 71 683 684 O
1 72 73 685 686 B-upper_bound

Hemoglobin 0 10 687 697 B-clinical_variable
> 11 12 698 699 O
= 12 13 699 700 O
10 14 16 701 703 B-lower_bound
gm 17 19 704 706 I-lower_bound
/ 19 20 706 707 I-lower_bound
dL 20 22 707 709 I-lower_bound

History 0 7 710 717 O
of 8 10 718 720 O
any 11 14 721 724 O
of 15 17 725 727 O
the 18 21 728 731 O
following 22 31 732 741 O
cardio 32 38 742 748 B-chronic_disease
- 38 39 748 749 I-chronic_disease
vascular 39 47 749 757 I-chronic_disease
condition 48 57 758 767 I-chronic_disease

History 0 7 768 775 O
of 8 10 776 778 O
cerebrovascular 11 26 779 794 B-chronic_disease
accidents 27 36 795 804 I-chronic_disease
including 37 46 805 814 O
transient 47 56 815 824 B-chronic_disease
ischemic 57 65 825 833 I-chronic_disease
attacks 66 73 834 841 I-chronic_disease
( 74 75 842 843 I-chronic_disease
TIA 75 78 843 846 I-chronic_disease
) 78 79 846 847 I-chronic_disease

History 0 7 848 855 O
of 8 10 856 858 O
deep 11 15 859 863 B-chronic_disease
vein 16 20 864 868 I-chronic_disease
thrombosis 21 31 869 879 I-chronic_disease
( 32 33 880 881 I-chronic_disease
DVT 33 36 881 884 I-chronic_disease
) 36 37 884 885 I-chronic_disease

History 0 7 886 893 O
of 8 10 894 896 O
symptomatic 11 22 897 908 O
chronic 23 30 909 916 B-chronic_disease
congestive 31 41 917 927 I-chronic_disease
heart 42 47 928 933 I-chronic_disease
failure 48 55 934 941 I-chronic_disease
( 56 57 942 943 I-chronic_disease
CHF 57 60 943 946 I-chronic_disease
) 60 61 946 947 I-chronic_disease

International 0 13 948 961 B-clinical_variable
normalization 14 27 962 975 I-clinical_variable
ratio 28 33 976 981 I-clinical_variable
( 34 35 982 983 I-clinical_variable
INR 35 38 983 986 I-clinical_variable
) 38 39 986 987 I-clinical_variable
and 40 43 988 991 O
activated 44 53 992 1001 B-clinical_variable
partial 54 61 1002 1009 I-clinical_variable
thromboplastin 62 76 1010 1024 I-clinical_variable
time 77 81 1025 1029 I-clinical_variable
( 82 83 1030 1031 I-clinical_variable
aPTT 83 87 1031 1035 I-clinical_variable
) 87 88 1035 1036 I-clinical_variable
< 89 90 1037 1038 O
1.2 91 94 1039 1042 B-upper_bound
x 95 96 1043 1044 I-upper_bound
ULN 97 100 1045 1048 I-upper_bound

Major 0 5 1049 1054 B-treatment
surgery 6 13 1055 1062 I-treatment
within 14 20 1063 1069 O
28 21 23 1070 1072 B-upper_bound
days 24 28 1073 1077 I-upper_bound
prior 29 34 1078 1083 I-upper_bound
to 35 37 1084 1086 O
treatment 38 47 1087 1096 B-treatment
or 48 50 1097 1099 O
major 51 56 1100 1105 B-treatment
surgery 57 64 1106 1113 I-treatment
planned 65 72 1114 1121 O
during 73 79 1122 1128 O
the 80 83 1129 1132 O
next 84 88 1133 1137 B-upper_bound
6 89 90 1138 1139 I-upper_bound
months 91 97 1140 1146 I-upper_bound

Myocardial 0 10 1147 1157 B-chronic_disease
infarction 11 21 1158 1168 I-chronic_disease
( 22 23 1169 1170 I-chronic_disease
MI 23 25 1170 1172 I-chronic_disease
) 25 26 1172 1173 I-chronic_disease

Normal 0 6 1174 1180 B-clinical_variable
cardiac 7 14 1181 1188 I-clinical_variable
ejection 15 23 1189 1197 I-clinical_variable
fraction 24 32 1198 1206 I-clinical_variable
( 33 34 1207 1208 O
> 34 35 1208 1209 O
50 36 38 1210 1212 B-lower_bound
% 38 39 1212 1213 I-lower_bound
) 39 40 1213 1214 O
by 41 43 1215 1217 O
multi 44 49 1218 1223 B-treatment
gated 50 55 1224 1229 I-treatment
acquisition 56 67 1230 1241 I-treatment
scan 68 72 1242 1246 I-treatment
( 73 74 1247 1248 I-treatment
MUGA 74 78 1248 1252 I-treatment
) 78 79 1252 1253 I-treatment
or 80 82 1254 1256 O
echocardiogram 83 97 1257 1271 B-treatment

Platelets 0 9 1272 1281 B-clinical_variable
> 10 11 1282 1283 O
= 11 12 1283 1284 O
100 13 16 1285 1288 B-lower_bound
x 17 18 1289 1290 I-lower_bound
10 19 21 1291 1293 I-lower_bound
^ 21 22 1293 1294 I-lower_bound
9 22 23 1294 1295 I-lower_bound
/ 23 24 1295 1296 I-lower_bound
L 24 25 1296 1297 I-lower_bound

Pregnant 0 8 1298 1306 B-pregnancy

Prior 0 5 1307 1312 B-treatment
VEGF 6 10 1313 1317 I-treatment
targeted 11 19 1318 1326 I-treatment
therapies 20 29 1327 1336 I-treatment
for 30 33 1337 1340 O
renal 34 39 1341 1346 B-cancer
cell 40 44 1347 1351 I-cancer
carcinoma 45 54 1352 1361 I-cancer
( 55 56 1362 1363 I-cancer
RCC 56 59 1363 1366 I-cancer
) 59 60 1366 1367 I-cancer
including 61 70 1368 1377 O
adjuvant 71 79 1378 1386 B-treatment
or 80 82 1387 1389 O
neoadjuvant 83 94 1390 1401 B-treatment
treatments 95 105 1402 1412 I-treatment

Received 0 8 1413 1421 O
an 9 11 1422 1424 O
investigational 12 27 1425 1440 B-treatment
agent 28 33 1441 1446 I-treatment
within 34 40 1447 1453 O
30 41 43 1454 1456 B-upper_bound
days 44 48 1457 1461 I-upper_bound
prior 49 54 1462 1467 I-upper_bound
to 55 57 1468 1470 O
enrollment 58 68 1471 1481 O

Subjects 0 8 1482 1490 O
currently 9 18 1491 1500 O
on 19 21 1501 1503 O
anti 22 26 1504 1508 B-treatment
- 26 27 1508 1509 I-treatment
coagulation 27 38 1509 1520 I-treatment
therapy 39 46 1521 1528 I-treatment

Subjects 0 8 1529 1537 O
diagnosed 9 18 1538 1547 O
with 19 23 1548 1552 O
another 24 31 1553 1560 O
cancer 32 38 1561 1567 B-cancer
in 39 41 1568 1570 O
the 42 45 1571 1574 O
past 46 50 1575 1579 B-upper_bound
3 51 52 1580 1581 I-upper_bound
years 53 58 1582 1587 I-upper_bound

Subjects 0 8 1588 1596 O
of 9 11 1597 1599 O
child 12 17 1600 1605 O
- 17 18 1605 1606 O
bearing 18 25 1606 1613 O
potential 26 35 1614 1623 O
must 36 40 1624 1628 O
agree 41 46 1629 1634 B-contraception_consent
to 47 49 1635 1637 I-contraception_consent
use 50 53 1638 1641 I-contraception_consent
adequate 54 62 1642 1650 I-contraception_consent
contraceptive 63 76 1651 1664 I-contraception_consent
methods 77 84 1665 1672 I-contraception_consent
( 85 86 1673 1674 O
e.g. 86 90 1674 1678 O
, 90 91 1678 1679 O
hormonal 92 100 1680 1688 B-contraception_consent
or 101 103 1689 1691 O
barrier 104 111 1692 1699 B-contraception_consent
method 112 118 1700 1706 I-contraception_consent
of 119 121 1707 1709 I-contraception_consent
birth 122 127 1710 1715 I-contraception_consent
control 128 135 1716 1723 I-contraception_consent
; 135 136 1723 1724 O
abstinence 137 147 1725 1735 B-contraception_consent
) 147 148 1735 1736 O
prior 149 154 1737 1742 O
to 155 157 1743 1745 O
study 158 163 1746 1751 O
entry 164 169 1752 1757 O
and 170 173 1758 1761 O
for 174 177 1762 1765 O
the 178 181 1766 1769 O
duration 182 190 1770 1778 O
of 191 193 1779 1781 O
study 194 199 1782 1787 O
participation 200 213 1788 1801 O

Subjects 0 8 1802 1810 O
should 9 15 1811 1817 O
not 16 19 1818 1821 O
have 20 24 1822 1826 O
packed 25 31 1827 1833 B-clinical_variable
red 32 35 1834 1837 I-clinical_variable
blood 36 41 1838 1843 I-clinical_variable
cells 42 47 1844 1849 I-clinical_variable
( 48 49 1850 1851 I-clinical_variable
PRBC 49 53 1851 1855 I-clinical_variable
) 53 54 1855 1856 I-clinical_variable
or 55 57 1857 1859 O
platelet 58 66 1860 1868 B-clinical_variable
transfusion 67 78 1869 1880 I-clinical_variable
within 79 85 1881 1887 O
14 86 88 1888 1890 B-upper_bound
days 89 93 1891 1895 I-upper_bound
of 94 96 1896 1898 O
the 97 100 1899 1902 O
screening 101 110 1903 1912 O

Subjects 0 8 1913 1921 O
with 9 13 1922 1926 O
known 14 19 1927 1932 O
brain 20 25 1933 1938 B-cancer
metastases 26 36 1939 1949 I-cancer

Symptomatic 0 11 1950 1961 O
peripheral 12 22 1962 1972 B-chronic_disease
arterial 23 31 1973 1981 I-chronic_disease
disease 32 39 1982 1989 I-chronic_disease
( 40 41 1990 1991 I-chronic_disease
PAD 41 44 1991 1994 I-chronic_disease
) 44 45 1994 1995 I-chronic_disease

Total 0 5 1996 2001 B-clinical_variable
bilirubin 6 15 2002 2011 I-clinical_variable
= 16 17 2012 2013 O
< 17 18 2013 2014 O
upper 19 24 2015 2020 B-upper_bound
limit 25 30 2021 2026 I-upper_bound
of 31 33 2027 2029 I-upper_bound
normal 34 40 2030 2036 I-upper_bound
( 41 42 2037 2038 I-upper_bound
ULN 42 45 2038 2041 I-upper_bound
) 45 46 2041 2042 I-upper_bound

Unable 0 6 2043 2049 O
to 7 9 2050 2052 O
discontinue 10 21 2053 2064 O
the 22 25 2065 2068 O
use 26 29 2069 2072 O
of 30 32 2073 2075 O
prohibited 33 43 2076 2086 O
medications 44 55 2087 2098 B-treatment

Uncontrolled 0 12 2099 2111 O
hypertension 13 25 2112 2124 B-chronic_disease
( 26 27 2125 2126 O
systolic 27 35 2126 2134 B-clinical_variable
blood 36 41 2135 2140 I-clinical_variable
pressure 42 50 2141 2149 I-clinical_variable
[ 51 52 2150 2151 I-clinical_variable
BP 52 54 2151 2153 I-clinical_variable
] 54 55 2153 2154 I-clinical_variable
> 56 57 2155 2156 O
150 58 61 2157 2160 B-lower_bound
mm 62 64 2161 2163 I-lower_bound
Hg 65 67 2164 2166 I-lower_bound
or 68 70 2167 2169 O
diastolic 71 80 2170 2179 B-clinical_variable
BP 81 83 2180 2182 I-clinical_variable
of 84 86 2183 2185 O
> 87 88 2186 2187 O
90 89 91 2188 2190 B-lower_bound
mm 92 94 2191 2193 I-lower_bound
Hg 95 97 2194 2196 I-lower_bound
) 97 98 2196 2197 O

Uncontrolled 0 12 2198 2210 O
intercurrent 13 25 2211 2223 O
illness 26 33 2224 2231 O
including 34 43 2232 2241 O
, 43 44 2241 2242 O
but 45 48 2243 2246 O
not 49 52 2247 2250 O
limited 53 60 2251 2258 O
to 61 63 2259 2261 O
, 63 64 2261 2262 O
ongoing 65 72 2263 2270 O
or 73 75 2271 2273 O
active 76 82 2274 2280 B-chronic_disease
infection 83 92 2281 2290 I-chronic_disease
, 92 93 2290 2291 O
symptomatic 94 105 2292 2303 O
or 106 108 2304 2306 O
psychiatric 109 120 2307 2318 B-chronic_disease
illness 121 128 2319 2326 I-chronic_disease
/ 128 129 2326 2327 I-chronic_disease
social 129 135 2327 2333 I-chronic_disease
situations 136 146 2334 2344 I-chronic_disease
that 147 151 2345 2349 O
would 152 157 2350 2355 O
limit 158 163 2356 2361 O
compliance 164 174 2362 2372 O
with 175 179 2373 2377 O
study 180 185 2378 2383 O
requirements 186 198 2384 2396 O

Unstable 0 8 2397 2405 B-chronic_disease
angina 9 15 2406 2412 I-chronic_disease

basal 0 5 2413 2418 B-cancer
cell 6 10 2419 2423 I-cancer
carcinoma 11 20 2424 2433 I-cancer
or 21 23 2434 2436 O
squamous 24 32 2437 2445 B-cancer
cell 33 37 2446 2450 I-cancer
carcinoma 38 47 2451 2460 I-cancer
, 47 48 2460 2461 O
of 49 51 2462 2464 O
skin 52 56 2465 2469 O
which 57 62 2470 2475 O
were 63 67 2476 2480 O
completely 68 78 2481 2491 O
cured 79 84 2492 2497 O
by 85 87 2498 2500 O
resection 88 97 2501 2510 B-treatment

nursing 0 7 2511 2518 O
female 8 14 2519 2525 B-gender
subjects 15 23 2526 2534 I-gender

one 0 3 2535 2538 O
prior 4 9 2539 2544 B-treatment
therapy 10 17 2545 2552 I-treatment
with 18 22 2553 2557 I-treatment
high 23 27 2558 2562 I-treatment
dose 28 32 2563 2567 I-treatment
IL-2 33 37 2568 2572 I-treatment
or 38 40 2573 2575 I-treatment
anti 41 45 2576 2580 I-treatment
- 45 46 2580 2581 I-treatment
programmed 46 56 2581 2591 I-treatment
cell 57 61 2592 2596 I-treatment
death 62 67 2597 2602 I-treatment
( 68 69 2603 2604 I-treatment
PD)-1 69 74 2604 2609 I-treatment
compound 75 83 2610 2618 I-treatment
alone 84 89 2619 2624 I-treatment
or 90 92 2625 2627 O
in 93 95 2628 2630 O
combination 96 107 2631 2642 B-treatment
with 108 112 2643 2647 I-treatment
cytotoxic 113 122 2648 2657 I-treatment
T 123 124 2658 2659 I-treatment
- 124 125 2659 2660 I-treatment
lymphocyte 125 135 2660 2670 I-treatment
- 135 136 2670 2671 I-treatment
associated 136 146 2671 2681 I-treatment
protein 147 154 2682 2689 I-treatment
4 155 156 2690 2691 I-treatment
( 157 158 2692 2693 I-treatment
CTLA-4 158 164 2693 2699 I-treatment
) 164 165 2699 2700 I-treatment
targeting 166 175 2701 2710 I-treatment
drug 176 180 2711 2715 I-treatment

pulmonary 0 9 2716 2725 B-chronic_disease
embolism 10 18 2726 2734 I-chronic_disease
( 19 20 2735 2736 I-chronic_disease
PE 20 22 2736 2738 I-chronic_disease
) 22 23 2738 2739 I-chronic_disease
in 24 26 2740 2742 O
the 27 30 2743 2746 O
past 31 35 2747 2751 B-upper_bound
6 36 37 2752 2753 I-upper_bound
months 38 44 2754 2760 I-upper_bound

the 0 3 2761 2764 O
3 4 5 2765 2766 O
values 6 12 2767 2773 O
have 13 17 2774 2778 O
to 18 20 2779 2781 O
be 21 23 2782 2784 O
below 24 29 2785 2790 O
150/90 30 36 2791 2797 B-upper_bound
mm 37 39 2798 2800 I-upper_bound
Hg 40 42 2801 2803 I-upper_bound
for 43 46 2804 2807 O
eligibility 47 58 2808 2819 O
and 59 62 2820 2823 O
can 63 66 2824 2827 O
only 67 71 2828 2832 O
be 72 74 2833 2835 O
obtained 75 83 2836 2844 O
after 84 89 2845 2850 O
2 90 91 2851 2852 B-upper_bound
days 92 96 2853 2857 I-upper_bound
of 97 99 2858 2860 O
the 100 103 2861 2864 O
last 104 108 2865 2869 O
change 109 115 2870 2876 O
in 116 118 2877 2879 O
anti 119 123 2880 2884 B-treatment
- 123 124 2884 2885 I-treatment
hypertensive 124 136 2885 2897 I-treatment
medication 137 147 2898 2908 I-treatment

use 0 3 2909 2912 O
of 4 6 2913 2915 O
clonidine 7 16 2916 2925 B-treatment
is 17 19 2926 2928 O
not 20 23 2929 2932 O
permissible 24 35 2933 2944 O
for 36 39 2945 2948 O
adjusting 40 49 2949 2958 O
the 50 53 2959 2962 O
BP 54 56 2963 2965 B-clinical_variable
during 57 63 2966 2972 O
this 64 68 2973 2977 O
period 69 75 2978 2984 O

Any 0 3 0 3 O
PCI 4 7 4 7 B-clinical_variable
within 8 14 8 14 O
30 15 17 15 17 B-upper_bound
days 18 22 18 22 I-upper_bound
prior 23 28 23 28 I-upper_bound
to 29 31 29 31 O
the 32 35 32 35 O
index 36 41 36 41 B-treatment
procedure 42 51 42 51 I-treatment
or 52 54 52 54 O
planned 55 62 55 62 O
3 63 64 63 64 B-upper_bound
months 65 71 65 71 I-upper_bound
post 72 76 72 76 O
the 77 80 77 80 O
index 81 86 81 86 O
procedure 87 96 87 96 O

Chronic 0 7 97 104 O
functional 8 18 105 115 B-chronic_disease
tricuspid 19 28 116 125 I-chronic_disease
regurgitation 29 42 126 139 I-chronic_disease
( 43 44 140 141 I-chronic_disease
FTR 44 47 141 144 I-chronic_disease
) 47 48 144 145 I-chronic_disease
with 49 53 146 150 O
a 54 55 151 152 O
minimum 56 63 153 160 O
of 64 66 161 163 O
moderate 67 75 164 172 O
tricuspid 76 85 173 182 O
regurgitation 86 99 183 196 O

Chronic 0 7 197 204 O
oral 8 12 205 209 B-treatment
steroid 13 20 210 217 I-treatment
use 21 24 218 221 O
( 25 26 222 223 O
≥6 26 28 223 225 O
months 29 35 226 232 I-lower_bound
) 35 36 232 233 O

LVEF 0 4 234 238 B-clinical_variable
≥35 5 8 239 242 O
% 8 9 242 243 I-lower_bound

Life 0 4 244 248 B-clinical_variable
expectancy 5 15 249 259 I-clinical_variable
of 16 18 260 262 O
less 19 23 263 267 O
than 24 28 268 272 O
12 29 31 273 275 B-upper_bound
- 31 32 275 276 I-upper_bound
months 32 38 276 282 I-upper_bound

MI 0 2 283 285 B-chronic_disease
or 3 5 286 288 O
known 6 11 289 294 O
unstable 12 20 295 303 B-chronic_disease
angina 21 27 304 310 I-chronic_disease
within 28 34 311 317 O
the 35 38 318 321 O
30 39 41 322 324 B-upper_bound
- 41 42 324 325 I-upper_bound
days 42 46 325 329 I-upper_bound
prior 47 52 330 335 I-upper_bound
to 53 55 336 338 O
the 56 59 339 342 O
index 60 65 343 348 O
procedure 66 75 349 358 O

NYHA 0 4 359 363 B-chronic_disease
II 5 7 364 366 I-chronic_disease
- 8 9 367 368 I-chronic_disease
IV 10 12 369 371 I-chronic_disease

Pregnant 0 8 372 380 B-pregnancy

Previous 0 8 381 389 O
tricuspid 9 18 390 399 B-treatment
valve 19 24 400 405 I-treatment
repair 25 31 406 412 I-treatment
or 32 34 413 415 I-treatment
replacement 35 46 416 427 I-treatment

Severe 0 6 428 434 O
coronary 7 15 435 443 B-chronic_disease
artery 16 22 444 450 I-chronic_disease
disease 23 30 451 458 I-chronic_disease

Severe 0 6 459 465 O
uncontrolled 7 19 466 478 O
hypertension 20 32 479 491 B-chronic_disease
( 33 34 492 493 O
SBP 34 37 493 496 B-clinical_variable
≥ 38 39 497 498 O
180 40 43 499 502 B-lower_bound
mmHg 44 48 503 507 I-lower_bound
and/or 49 55 508 514 O
DBP 56 59 515 518 B-clinical_variable
≥ 60 61 519 520 O
110 62 65 521 524 B-lower_bound
mmHg 66 70 525 529 I-lower_bound
) 70 71 529 530 O

Tricuspid 0 9 531 540 B-clinical_variable
valve 10 15 541 546 I-clinical_variable
annular 16 23 547 554 I-clinical_variable
diameter 24 32 555 563 I-clinical_variable
≥ 33 34 564 565 O
40 35 37 566 568 B-lower_bound
mm 38 40 569 571 I-lower_bound
( 41 42 572 573 O
or 42 44 573 575 O
21 45 47 576 578 B-lower_bound
mm 48 50 579 581 I-lower_bound
/ 50 51 581 582 I-lower_bound
m2 51 53 582 584 I-lower_bound
( 54 55 585 586 O
Superscript 55 66 586 597 O
) 66 67 597 598 O
) 67 68 598 599 O
and 69 72 600 603 O
≤55 73 76 604 607 O
mm 77 79 608 610 I-upper_bound
( 80 81 611 612 O
or 81 83 612 614 O
29 84 86 615 617 B-upper_bound
mm 87 89 618 620 I-upper_bound
/ 89 90 620 621 I-upper_bound
m2 90 92 621 623 I-upper_bound
( 93 94 624 625 O
Superscript 94 105 625 636 O
) 105 106 636 637 O

lactating 0 9 638 647 O
female 10 16 648 654 B-gender

≥18 0 3 655 658 O
and 4 7 659 662 O
≤85 8 11 663 666 O
years 12 17 667 672 I-upper_bound
old 18 21 673 676 O

Age 0 3 0 3 B-age
> 4 5 4 5 O
18 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound

Age 0 3 14 17 B-age
≥ 4 5 18 19 O
18 6 8 20 22 B-lower_bound
years 9 14 23 28 I-lower_bound

Available 0 9 29 38 O
autologous 10 20 39 49 B-treatment
transduced 21 31 50 60 I-treatment
T 32 33 61 62 I-treatment
cell 34 38 63 67 I-treatment
product 39 46 68 75 I-treatment

Child 0 5 76 81 B-clinical_variable
- 5 6 81 82 I-clinical_variable
Pugh 6 10 82 86 I-clinical_variable
- 10 11 86 87 I-clinical_variable
Turcotte 11 19 87 95 I-clinical_variable
score 20 25 96 101 I-clinical_variable
< 26 27 102 103 O
8 28 29 104 105 B-upper_bound

Child 0 5 106 111 B-clinical_variable
- 5 6 111 112 I-clinical_variable
Pugh 6 10 112 116 I-clinical_variable
- 10 11 116 117 I-clinical_variable
Turcotte 11 19 117 125 I-clinical_variable
score 20 25 126 131 I-clinical_variable
< 26 27 132 133 O
7 27 28 133 134 B-upper_bound

Heart 0 5 135 140 B-chronic_disease
failure 6 13 141 148 I-chronic_disease
of 14 16 149 151 O
Class 17 22 152 157 B-lower_bound
III 23 26 158 161 I-lower_bound
- 26 27 161 162 O
IV 27 29 162 164 B-upper_bound
and 30 33 165 168 O
/ 34 35 169 170 O
or 36 38 171 173 O
C 39 40 174 175 O
- 40 41 175 176 O
D 41 42 176 177 O
per 43 46 178 181 O
NYHA 47 51 182 186 O
Criteria 52 60 187 195 O

Hepatic 0 7 196 203 B-chronic_disease
encephalopathy 8 22 204 218 I-chronic_disease

Hgb 0 3 219 222 B-clinical_variable
≥7.0 4 8 223 227 O
g 9 10 228 229 I-lower_bound
/ 10 11 229 230 I-lower_bound
dl 11 13 230 232 I-lower_bound

INR 0 3 233 236 B-clinical_variable
≤1.7 4 8 237 241 O

Karnofsky 0 9 242 251 B-clinical_variable
score 10 15 252 257 I-clinical_variable
> 16 17 258 259 O
60 17 19 259 261 B-lower_bound
% 19 20 261 262 I-lower_bound

Life 0 4 263 267 B-clinical_variable
expectancy 5 15 268 278 I-clinical_variable
of 16 18 279 281 O
≥ 19 20 282 283 O
12 21 23 284 286 B-lower_bound
weeks 24 29 287 292 I-lower_bound

Pregnancy 0 9 293 302 B-pregnancy

Pulse 0 5 303 308 B-clinical_variable
oximetry 6 14 309 317 I-clinical_variable
> 15 16 318 319 O
90 16 18 319 321 B-lower_bound
% 18 19 321 322 I-lower_bound
on 20 22 323 325 O
room 23 27 326 330 O
air 28 31 331 334 O

Sexually 0 8 335 343 O
active 9 15 344 350 O
patients 16 24 351 359 O
must 25 29 360 364 O
be 30 32 365 367 O
willing 33 40 368 375 B-contraception_consent
to 41 43 376 378 I-contraception_consent
utilize 44 51 379 386 I-contraception_consent
one 52 55 387 390 I-contraception_consent
of 56 58 391 393 I-contraception_consent
the 59 62 394 397 I-contraception_consent
more 63 67 398 402 I-contraception_consent
effective 68 77 403 412 I-contraception_consent
birth 78 83 413 418 I-contraception_consent
control 84 91 419 426 I-contraception_consent
methods 92 99 427 434 I-contraception_consent
for 100 103 435 438 O
3 104 105 439 440 B-upper_bound
months 106 112 441 447 I-upper_bound
after 113 118 448 453 O
the 119 122 454 457 O
T 123 124 458 459 B-treatment
- 124 125 459 460 I-treatment
cell 125 129 460 464 I-treatment
infusion 130 138 465 473 I-treatment

Systemic 0 8 474 482 B-clinical_variable
steroid 9 16 483 490 I-clinical_variable
treatment 17 26 491 500 I-clinical_variable
( 27 28 501 502 O
greater 28 35 502 509 O
than 36 40 510 514 O
or 41 43 515 517 O
equal 44 49 518 523 O
to 50 52 524 526 O
0.5 53 56 527 530 B-lower_bound
mg 57 59 531 533 I-lower_bound
prednisone 60 70 534 544 B-treatment
equivalent 71 81 545 555 O
/ 81 82 555 556 O
kg 82 84 556 558 O
/ 84 85 558 559 O
day 85 88 559 562 O
) 88 89 562 563 O

absolute 0 8 564 572 B-clinical_variable
neutrophil 9 19 573 583 I-clinical_variable
count 20 25 584 589 I-clinical_variable
> 26 27 590 591 O
500 28 31 592 595 B-lower_bound
/ 31 32 595 596 I-lower_bound
microliter 32 42 596 606 I-lower_bound

creatinine 0 10 607 617 B-clinical_variable
clearance 11 20 618 627 I-clinical_variable
( 21 22 628 629 O
as 22 24 629 631 O
estimated 25 34 632 641 O
by 35 37 642 644 O
Cockcroft 38 47 645 654 O
Gault 48 53 655 660 O
) 53 54 660 661 O
≥ 55 56 662 663 O
60 57 59 664 666 B-lower_bound
ml 60 62 667 669 I-lower_bound
/ 62 63 669 670 I-lower_bound
min 63 66 670 673 I-lower_bound

platelet 0 8 674 682 B-clinical_variable
count 9 14 683 688 I-clinical_variable
> 15 16 689 690 O
20,000 17 23 691 697 B-lower_bound
/ 23 24 697 698 I-lower_bound
microliter 24 34 698 708 I-lower_bound

serum 0 5 709 714 B-clinical_variable
AST 6 9 715 718 I-clinical_variable
< 9 10 718 719 O
5 11 12 720 721 B-upper_bound
times 13 18 722 727 I-upper_bound
ULN 19 22 728 731 I-upper_bound

total 0 5 732 737 B-clinical_variable
bilirubin 6 15 738 747 I-clinical_variable
< 16 17 748 749 O
3 18 19 750 751 B-upper_bound
times 20 25 752 757 I-upper_bound
ULN 26 29 758 761 I-upper_bound
for 30 33 762 765 O
age 34 37 766 769 B-age

60 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O

Age 0 3 19 22 B-age
less 4 8 23 27 O
than 9 13 28 32 O
60 14 16 33 35 B-upper_bound

Patients 0 8 36 44 O
having 9 15 45 51 O
combined 16 24 52 60 O
general 25 32 61 68 B-treatment
anesthesia 33 43 69 79 I-treatment
and 44 47 80 83 O
epidural 48 56 84 92 B-treatment
anesthesia 57 67 93 103 I-treatment

Patients 0 8 104 112 O
scheduled 9 18 113 122 O
for 19 22 123 126 O
cardiovascular 23 37 127 141 B-treatment
surgery 38 45 142 149 I-treatment

Patients 0 8 150 158 O
who 9 12 159 162 O
will 13 17 163 167 O
receive 18 25 168 175 O
rapid 26 31 176 181 O
sequence 32 40 182 190 O
induction 41 50 191 200 O
with 51 55 201 205 O
succinylcholine 56 71 206 221 B-treatment

Patients 0 8 222 230 O
with 9 13 231 235 O
a 14 15 236 237 O
pre 16 19 238 241 O
- 19 20 241 242 O
induction 20 29 242 251 O
mean 30 34 252 256 B-clinical_variable
arterial 35 43 257 265 I-clinical_variable
blood 44 49 266 271 I-clinical_variable
pressure 50 58 272 280 I-clinical_variable
( 59 60 281 282 I-clinical_variable
MAP 60 63 282 285 I-clinical_variable
) 63 64 285 286 I-clinical_variable
less 65 69 287 291 O
than 70 74 292 296 O
50 75 77 297 299 B-upper_bound
or 78 80 300 302 O
greater 81 88 303 310 O
than 89 93 311 315 O
150 94 97 316 319 B-lower_bound

Patients 0 8 320 328 O
with 9 13 329 333 O
weight 14 20 334 340 B-clinical_variable
greater 21 28 341 348 O
than 29 33 349 353 O
125 34 37 354 357 B-lower_bound
kg 38 40 358 360 I-lower_bound

Surgeries 0 9 361 370 O
with 10 14 371 375 O
general 15 22 376 383 B-treatment
anesthesia 23 33 384 394 I-treatment
alone 34 39 395 400 O
or 40 42 401 403 O
if 43 45 404 406 O
combined 46 54 407 415 O
with 55 59 416 420 O
peripheral 60 70 421 431 B-treatment
nerve 71 76 432 437 I-treatment
blocks 77 83 438 444 I-treatment

Any 0 3 0 3 O
patient 4 11 4 11 O
that 12 16 12 16 O
is 17 19 17 19 O
not 20 23 20 23 O
a 24 25 24 25 O
suitable 26 34 26 34 O
candidate 35 44 35 44 O
for 45 48 45 48 O
LASIK 49 54 49 54 B-treatment
will 55 59 55 59 O
not 60 63 60 63 O
be 64 66 64 66 O
included 67 75 67 75 O

Subjects 0 8 76 84 O
who 9 12 85 88 O
are 13 16 89 92 O
deemed 17 23 93 99 O
suitable 24 32 100 108 O
candidates 33 43 109 119 O
for 44 47 120 123 O
bilateral 48 57 124 133 B-treatment
LASIK 58 63 134 139 I-treatment
will 64 68 140 144 O
be 69 71 145 147 O
considered 72 82 148 158 O
eligible 83 91 159 167 O
for 92 95 168 171 O
participation 96 109 172 185 O
in 110 112 186 188 O
this 113 117 189 193 O
study 118 123 194 199 O

Adequate 0 8 0 8 O
hepatic 9 16 9 16 B-clinical_variable
function 17 25 17 25 I-clinical_variable
( 26 27 26 27 O
> 27 28 27 28 O
= 28 29 28 29 O
1.5 30 33 30 33 B-lower_bound
x 34 35 34 35 I-lower_bound
upper 36 41 36 41 I-lower_bound
limit 42 47 42 47 I-lower_bound
of 48 50 48 50 I-lower_bound
normal 51 57 51 57 I-lower_bound
[ 58 59 58 59 I-lower_bound
ULN 59 62 59 62 I-lower_bound
] 62 63 62 63 I-lower_bound

Any 0 3 64 67 O
unstable 4 12 68 76 O
, 12 13 76 77 O
serious 14 21 78 85 O
co 22 24 86 88 O
- 24 25 88 89 O
existing 25 33 89 97 O
medical 34 41 98 105 O
conditions 42 52 106 116 O
including 53 62 117 126 O
but 63 66 127 130 O
not 67 70 131 134 O
limited 71 78 135 142 O
to 79 81 143 145 O
myocardial 82 92 146 156 B-chronic_disease
infarction 93 103 157 167 I-chronic_disease
, 103 104 167 168 O
coronary 105 113 169 177 B-treatment
bypass 114 120 178 184 I-treatment
surgery 121 128 185 192 I-treatment
, 128 129 192 193 O
unstable 130 138 194 202 B-chronic_disease
angina 139 145 203 209 I-chronic_disease
, 145 146 209 210 O
cardiac 147 154 211 218 B-chronic_disease
arrhythmias 155 166 219 230 I-chronic_disease
, 166 167 230 231 O
clinically 168 178 232 242 O
evident 179 186 243 250 O
congestive 187 197 251 261 B-chronic_disease
heart 198 203 262 267 I-chronic_disease
failure 204 211 268 275 I-chronic_disease
, 211 212 275 276 O
or 213 215 277 279 O
cerebrovascular 216 231 280 295 B-chronic_disease
accident 232 240 296 304 I-chronic_disease
within 241 247 305 311 O
twelve 248 254 312 318 B-upper_bound
( 255 256 319 320 I-upper_bound
12 256 258 320 322 I-upper_bound
) 258 259 322 323 I-upper_bound
months 260 266 324 330 I-upper_bound
prior 267 272 331 336 I-upper_bound
to 273 275 337 339 O
screening 276 285 340 349 O

Current 0 7 350 357 O
use 8 11 358 361 O
of 12 14 362 364 O
exogenous 15 24 365 374 B-treatment
testosterone 25 37 375 387 I-treatment

Eastern 0 7 388 395 B-clinical_variable
Cooperative 8 19 396 407 I-clinical_variable
Oncology 20 28 408 416 I-clinical_variable
Group 29 34 417 422 I-clinical_variable
( 35 36 423 424 I-clinical_variable
ECOG 36 40 424 428 I-clinical_variable
) 40 41 428 429 I-clinical_variable
performance 42 53 430 441 I-clinical_variable
status 54 60 442 448 I-clinical_variable
= 61 62 449 450 O
< 62 63 450 451 O
2 64 65 452 453 B-upper_bound

History 0 7 454 461 O
of 8 10 462 464 O
loss 11 15 465 469 O
of 16 18 470 472 O
consciousness 19 32 473 486 O
or 33 35 487 489 O
transient 36 45 490 499 B-chronic_disease
ischemic 46 54 500 508 I-chronic_disease
attack 55 61 509 515 I-chronic_disease
within 62 68 516 522 O
twelve 69 75 523 529 B-upper_bound
( 76 77 530 531 I-upper_bound
12 77 79 531 533 I-upper_bound
) 79 80 533 534 I-upper_bound
months 81 87 535 541 I-upper_bound
of 88 90 542 544 O
enrollment 91 101 545 555 O

History 0 7 556 563 O
of 8 10 564 566 O
seizure 11 18 567 574 B-chronic_disease
or 19 21 575 577 O
any 22 25 578 581 O
condition 26 35 582 591 O
that 36 40 592 596 O
may 41 44 597 600 O
predispose 45 55 601 611 O
to 56 58 612 614 O
seizure 59 66 615 622 O
( 67 68 623 624 O
e.g. 68 72 624 628 O
, 72 73 628 629 O
prior 74 79 630 635 O
cortical 80 88 636 644 B-chronic_disease
stroke 89 95 645 651 I-chronic_disease
or 96 98 652 654 O
significant 99 110 655 666 O
brain 111 116 667 672 B-chronic_disease
trauma 117 123 673 679 I-chronic_disease
) 123 124 679 680 O

History 0 7 681 688 O
of 8 10 689 691 O
unprovoked 11 21 692 702 O
deep 22 26 703 707 B-chronic_disease
vein 27 31 708 712 I-chronic_disease
thrombosis 32 42 713 723 I-chronic_disease
/ 42 43 723 724 I-chronic_disease
pulmonary 43 52 724 733 I-chronic_disease
embolism 53 61 734 742 I-chronic_disease
( 62 63 743 744 I-chronic_disease
DVT 63 66 744 747 I-chronic_disease
/ 66 67 747 748 I-chronic_disease
PE 67 69 748 750 I-chronic_disease
) 69 70 750 751 I-chronic_disease
in 71 73 752 754 O
past 74 78 755 759 O
twelve 79 85 760 766 O
( 86 87 767 768 O
12 87 89 768 770 O
) 89 90 770 771 O
months 91 97 772 778 O

Men 0 3 779 782 B-gender
must 4 8 783 787 O
use 9 12 788 791 B-contraception_consent
adequate 13 21 792 800 I-contraception_consent
methods 22 29 801 808 I-contraception_consent
of 30 32 809 811 I-contraception_consent
contraception 33 46 812 825 I-contraception_consent
during 47 53 826 832 O
and 54 57 833 836 O
at 58 60 837 839 O
least 61 66 840 845 O
3 67 68 846 847 B-lower_bound
months 69 75 848 854 I-lower_bound
after 76 81 855 860 O
treatment 82 91 861 870 O
if 92 94 871 873 O
engaging 95 103 874 882 O
in 104 106 883 885 O
sexual 107 113 886 892 O
activity 114 122 893 901 O
with 123 127 902 906 O
a 128 129 907 908 O
female 130 136 909 915 B-gender
of 137 139 916 918 O
child 140 145 919 924 O
bearing 146 153 925 932 O
age 154 157 933 936 B-age

Metastatic 0 10 937 947 B-cancer
RCC 11 14 948 951 I-cancer

No 0 2 952 954 O
evidence 3 11 955 963 O
of 12 14 964 966 O
metastatic 15 25 967 977 B-cancer
disease 26 33 978 985 I-cancer
on 34 36 986 988 O
baseline 37 45 989 997 O
imaging 46 53 998 1005 O
( 54 55 1006 1007 O
chest 55 60 1007 1012 O
x 61 62 1013 1014 O
- 62 63 1014 1015 O
ray 63 66 1015 1018 O
[ 67 68 1019 1020 O
CXR 68 71 1020 1023 O
] 71 72 1023 1024 O
or 73 75 1025 1027 O
chest 76 81 1028 1033 O
CT 82 84 1034 1036 O
, 84 85 1036 1037 O
abdominal 86 95 1038 1047 O
CT 96 98 1048 1050 O
or 99 101 1051 1053 O
MRI 102 105 1054 1057 O
) 105 106 1057 1058 O

Pregnant 0 8 1059 1067 B-pregnancy
women 9 14 1068 1073 B-gender
or 15 17 1074 1076 O
women 18 23 1077 1082 O
who 24 27 1083 1086 O
are 28 31 1087 1090 O
of 32 34 1091 1093 O
child 35 40 1094 1099 O
bearing 41 48 1100 1107 O
age 49 52 1108 1111 B-age
who 53 56 1112 1115 O
are 57 60 1116 1119 O
not 61 64 1120 1123 B-contraception_consent
willing 65 72 1124 1131 I-contraception_consent
to 73 75 1132 1134 I-contraception_consent
use 76 79 1135 1138 I-contraception_consent
two 80 83 1139 1142 I-contraception_consent
( 84 85 1143 1144 I-contraception_consent
2 85 86 1144 1145 I-contraception_consent
) 86 87 1145 1146 I-contraception_consent
forms 88 93 1147 1152 I-contraception_consent
of 94 96 1153 1155 I-contraception_consent
contraception 97 110 1156 1169 I-contraception_consent
during 111 117 1170 1176 O
treatment 118 127 1177 1186 B-treatment
with 128 132 1187 1191 I-treatment
enzalutamide 133 145 1192 1204 I-treatment
and 146 149 1205 1208 O
for 150 153 1209 1212 O
six 154 157 1213 1216 B-upper_bound
( 158 159 1217 1218 I-upper_bound
6 159 160 1218 1219 I-upper_bound
) 160 161 1219 1220 I-upper_bound
months 162 168 1221 1227 I-upper_bound
after 169 174 1228 1233 O
treatment 175 184 1234 1243 O

Prior 0 5 1244 1249 O
use 6 9 1250 1253 O
of 10 12 1254 1256 O
androgen 13 21 1257 1265 B-treatment
deprivation 22 33 1266 1277 I-treatment
including 34 43 1278 1287 O
enzalutamide 44 56 1288 1300 B-treatment

Retroperitoneal 0 15 1301 1316 B-chronic_disease
/ 15 16 1316 1317 I-chronic_disease
hilar 16 21 1317 1322 I-chronic_disease
adenopathy 22 32 1323 1333 I-chronic_disease
concerning 33 43 1334 1344 O
for 44 47 1345 1348 O
locally 48 55 1349 1356 O
advanced 56 64 1357 1365 O
disease 65 72 1366 1373 O

Tumor 0 5 1374 1379 B-cancer
with 6 10 1380 1384 O
androgen 11 19 1385 1393 B-clinical_variable
receptor 20 28 1394 1402 I-clinical_variable
( 29 30 1403 1404 I-clinical_variable
AR 30 32 1404 1406 I-clinical_variable
) 32 33 1406 1407 I-clinical_variable
expressed 34 43 1408 1417 O
> 44 45 1418 1419 O
= 45 46 1419 1420 O
4580 47 51 1421 1425 B-lower_bound
copies 52 58 1426 1432 I-lower_bound
/ 58 59 1432 1433 I-lower_bound
ug 59 61 1433 1435 I-lower_bound
ribonucleic 62 73 1436 1447 O
acid 74 78 1448 1452 O
( 79 80 1453 1454 O
RNA 80 83 1454 1457 O
) 83 84 1457 1458 O

patient 0 7 1459 1466 O
's 7 9 1466 1468 O
with 10 14 1469 1473 O
Gilbert 15 22 1474 1481 B-chronic_disease
's 22 24 1481 1483 I-chronic_disease
disease 25 32 1484 1491 I-chronic_disease
are 33 36 1492 1495 O
not 37 40 1496 1499 O
excluded 41 49 1500 1508 O

( 0 1 0 1 O
either 1 7 1 7 O
the 8 11 8 11 O
influenza 12 21 12 21 B-chronic_disease
virus 22 27 22 27 I-chronic_disease
, 27 28 27 28 O
pneumococcal 29 41 29 41 B-treatment
or 42 44 42 44 O
meningococcal 45 58 45 58 B-treatment
vaccine 59 66 59 66 I-treatment
) 66 67 66 67 O

( 0 1 68 69 O
mild 1 5 69 73 O
illness 6 13 74 81 O
, 13 14 81 82 O
such 15 19 83 87 O
as 20 22 88 90 O
diarrhea 23 31 91 99 B-chronic_disease
or 32 34 100 102 O
mild 35 39 103 107 B-chronic_disease
respiratory 40 51 108 119 I-chronic_disease
infection 52 61 120 129 I-chronic_disease
with 62 66 130 134 O
or 67 69 135 137 O
without 70 77 138 145 O
fever 78 83 146 151 O
, 83 84 151 152 O
and 85 88 153 156 O
local 89 94 157 162 O
infections 95 105 163 173 O
do 106 108 174 176 O
not 109 112 177 180 O
apply 113 118 181 186 O
) 118 119 186 187 O

18 0 2 188 190 B-lower_bound
- 2 3 190 191 O
80 3 5 191 193 B-upper_bound
years 6 11 194 199 I-upper_bound
of 12 14 200 202 O
age 15 18 203 206 B-age

Any 0 3 207 210 O
clinically 4 14 211 221 O
significant 15 26 222 233 O
abnormality 27 38 234 245 O
on 39 41 246 248 O
medical 42 49 249 256 O
history 50 57 257 264 O
or 58 60 265 267 O
physical 61 69 268 276 O
examination 70 81 277 288 O
including 82 91 289 298 O
history 92 99 299 306 O
of 100 102 307 309 O
immunodeficiency 103 119 310 326 B-chronic_disease
or 120 122 327 329 O
autoimmune 123 133 330 340 B-chronic_disease
disease 134 141 341 348 I-chronic_disease

Any 0 3 349 352 O
clinically 4 14 353 363 O
significant 15 26 364 375 O
acute 27 32 376 381 O
or 33 35 382 384 O
chronic 36 43 385 392 O
medical 44 51 393 400 O
condition 52 61 401 410 O
requiring 62 71 411 420 O
care 72 76 421 425 O
of 77 79 426 428 O
a 80 81 429 430 O
physician 82 91 431 440 O
( 92 93 441 442 O
e.g. 93 97 442 446 O
, 97 98 446 447 O
diabetes 99 107 448 456 B-chronic_disease
, 107 108 456 457 O
coronary 109 117 458 466 B-chronic_disease
artery 118 124 467 473 I-chronic_disease
disease 125 132 474 481 I-chronic_disease
, 132 133 481 482 O
rheumatologic 134 147 483 496 B-chronic_disease
illness 148 155 497 504 I-chronic_disease
, 155 156 504 505 O
malignancy 157 167 506 516 B-cancer
, 167 168 516 517 O
substance 169 178 518 527 O
abuse 179 184 528 533 O
) 184 185 533 534 O
that 186 190 535 539 O
, 190 191 539 540 O
in 192 194 541 543 O
the 195 198 544 547 O
opinion 199 206 548 555 O
of 207 209 556 558 O
the 210 213 559 562 O
investigator 214 226 563 575 O
, 226 227 575 576 O
would 228 233 577 582 O
preclude 234 242 583 591 O
participation 243 256 592 605 O

Confirmed 0 9 606 615 O
HIV 10 13 616 619 B-chronic_disease
infection 14 23 620 629 I-chronic_disease
, 23 24 629 630 O
positive 25 33 631 639 O
for 34 37 640 643 O
hepatitis 38 47 644 653 B-chronic_disease
B 48 49 654 655 I-chronic_disease
surface 50 57 656 663 I-chronic_disease
antigen 58 65 664 671 I-chronic_disease
or 66 68 672 674 O
positive 69 77 675 683 O
for 78 81 684 687 O
hepatitis 82 91 688 697 B-chronic_disease
C 92 93 698 699 I-chronic_disease
antibodies 94 104 700 710 I-chronic_disease

Currently 0 9 711 720 O
taking 10 16 721 727 O
systemic 17 25 728 736 B-treatment
steroids 26 34 737 745 I-treatment
or 35 37 746 748 O
other 38 43 749 754 O
immunomodulatory 44 60 755 771 B-treatment
medications 61 72 772 783 I-treatment
including 73 82 784 793 O
anticancer 83 93 794 804 B-treatment
medications 94 105 805 816 I-treatment
and 106 109 817 820 O
antiviral 110 119 821 830 B-treatment
medications 120 131 831 842 I-treatment

Documented 0 10 843 853 O
previous 11 19 854 862 O
infection 20 29 863 872 O
with 30 34 873 877 O
dengue 35 41 878 884 B-chronic_disease
, 41 42 884 885 O
zika 43 47 886 890 B-chronic_disease
or 48 50 891 893 O
chikungunya 51 62 894 905 B-chronic_disease
virus 63 68 906 911 I-chronic_disease
or 69 71 912 914 O
no 72 74 915 917 O
history 75 82 918 925 O
of 83 85 926 928 O
dengue 86 92 929 935 O
, 92 93 935 936 O
zika 94 98 937 941 O
or 99 101 942 944 O
chikungunya 102 113 945 956 B-chronic_disease
infection 114 123 957 966 I-chronic_disease

Egg 0 3 967 970 B-allergy_name
allergy 4 11 971 978 O

Female 0 6 979 985 B-gender

For 0 3 986 989 O
Flumist 4 11 990 997 B-treatment
participants 12 24 998 1010 O
: 24 25 1010 1011 O
Close 26 31 1012 1017 O
contact 32 39 1018 1025 O
with 40 44 1026 1030 O
person 45 51 1031 1037 O
with 52 56 1038 1042 O
severely 57 65 1043 1051 B-chronic_disease
compromised 66 77 1052 1063 I-chronic_disease
immune 78 84 1064 1070 I-chronic_disease
system 85 91 1071 1077 I-chronic_disease
requiring 92 101 1078 1087 O
isolation 102 111 1088 1097 O

For 0 3 1098 1101 O
Flumist 4 11 1102 1109 B-treatment
participants 12 24 1110 1122 O
: 24 25 1122 1123 O
Current 26 33 1124 1131 O
illness 34 41 1132 1139 O
that 42 46 1140 1144 O
limits 47 53 1145 1151 O
delivery 54 62 1152 1160 O
to 63 65 1161 1163 O
nasal 66 71 1164 1169 O
airway 72 78 1170 1176 O

History 0 7 1177 1184 O
of 8 10 1185 1187 O
Guillain 11 19 1188 1196 B-chronic_disease
- 19 20 1196 1197 I-chronic_disease
Barre 20 25 1197 1202 I-chronic_disease
syndrome 26 34 1203 1211 I-chronic_disease

History 0 7 1212 1219 O
of 8 10 1220 1222 O
seizure 11 18 1223 1230 B-chronic_disease
disorder 19 27 1231 1239 I-chronic_disease
for 28 31 1240 1243 O
Flumist 32 39 1244 1251 O
group 40 45 1252 1257 O
participants 46 58 1258 1270 O
only 59 63 1271 1275 O

Is 0 2 1276 1278 O
pregnant 3 11 1279 1287 B-pregnancy

Male 0 4 1288 1292 B-gender

Participation 0 13 1293 1306 O
in 14 16 1307 1309 O
another 17 24 1310 1317 O
clinical 25 33 1318 1326 O
study 34 39 1327 1332 O
of 40 42 1333 1335 O
an 43 45 1336 1338 O
investigational 46 61 1339 1354 O
product 62 69 1355 1362 O
currently 70 79 1363 1372 O
or 80 82 1373 1375 O
within 83 89 1376 1382 O
the 90 93 1383 1386 O
past 94 98 1387 1391 B-upper_bound
90 99 101 1392 1394 I-upper_bound
days 102 106 1395 1399 I-upper_bound
, 106 107 1399 1400 O
or 108 110 1401 1403 O
expected 111 119 1404 1412 O
participation 120 133 1413 1426 O
during 134 140 1427 1433 O
this 141 145 1434 1438 O
study 146 151 1439 1444 O

Prior 0 5 1445 1450 O
allergic 6 14 1451 1459 O
reaction 15 23 1460 1468 O
to 24 26 1469 1471 O
commercial 27 37 1472 1482 B-allergy_name
vaccination 38 49 1483 1494 I-allergy_name

Received 0 8 1495 1503 O
the 9 12 1504 1507 O
influenza 13 22 1508 1517 B-treatment
vaccine 23 30 1518 1525 I-treatment
less 31 35 1526 1530 O
than 36 40 1531 1535 O
1 41 42 1536 1537 B-upper_bound
month 43 48 1538 1543 I-upper_bound
ago 49 52 1544 1547 O
and/or 53 59 1548 1554 O
received 60 68 1555 1563 O
the 69 72 1564 1567 O
pneumococcal 73 85 1568 1580 B-treatment
and 86 89 1581 1584 O
meningococcal 90 103 1585 1598 B-treatment
vaccine 104 111 1599 1606 I-treatment
less 112 116 1607 1611 O
than 117 121 1612 1616 O
4 122 123 1617 1618 B-upper_bound
years 124 129 1619 1624 I-upper_bound
ago 130 133 1625 1628 O

Unable 0 6 1629 1635 O
to 7 9 1636 1638 O
continue 10 18 1639 1647 O
participation 19 32 1648 1661 O
for 33 36 1662 1665 O
12 37 39 1666 1668 B-upper_bound
weeks 40 45 1669 1674 I-upper_bound

Willing 0 7 1675 1682 O
to 8 10 1683 1685 O
receive 11 18 1686 1693 O
a 19 20 1694 1695 O
single 21 27 1696 1702 O
dose 28 32 1703 1707 O
of 33 35 1708 1710 O
an 36 38 1711 1713 O
FDA 39 42 1714 1717 B-treatment
- 42 43 1717 1718 I-treatment
approved 43 51 1718 1726 I-treatment
vaccine 52 59 1727 1734 I-treatment

Females 0 7 0 7 B-gender
who 8 11 8 11 O
are 12 15 12 15 O
pregnant 16 24 16 24 B-pregnancy

History 0 7 25 32 O
of 8 10 33 35 O
confounding 11 22 36 47 O
skin 23 27 48 52 O
conditions 28 38 53 63 O
, 38 39 63 64 O
eg 40 42 65 67 O
, 42 43 67 68 O
psoriasis 44 53 69 78 B-chronic_disease
, 53 54 78 79 O
rosacea 55 62 80 87 B-chronic_disease
, 62 63 87 88 O
erythroderma 64 76 89 101 B-chronic_disease
, 76 77 101 102 O
or 78 80 103 105 O
ichthyosis 81 91 106 116 B-chronic_disease
( 92 93 117 118 O
other 93 98 118 123 O
than 99 103 124 128 O
ichthyosis 104 114 129 139 B-chronic_disease
vulgaris 115 123 140 148 I-chronic_disease
) 123 124 148 149 O

Male 0 4 150 154 B-gender

Nonimmunocompromized 0 20 155 175 O
male 21 25 176 180 B-gender
or 26 28 181 183 I-gender
female 29 35 184 190 I-gender
who 36 39 191 194 O
failed 40 46 195 201 O
to 47 49 202 204 O
respond 50 57 205 212 O
adequately 58 68 213 223 O
to 69 71 224 226 O
other 72 77 227 232 O
topical 78 85 233 240 B-treatment
prescription 86 98 241 253 I-treatment
treatment 99 108 254 263 I-treatment
for 109 112 264 267 O
AD 113 115 268 270 B-chronic_disease
or 116 118 271 273 O
for 119 122 274 277 O
whom 123 127 278 282 O
those 128 133 283 288 O
treatments 134 144 289 299 B-treatment
are 145 148 300 303 O
not 149 152 304 307 O
advisable 153 162 308 317 O

subjects 0 8 318 326 O
less 9 13 327 331 O
than 14 18 332 336 O
age 19 22 337 340 B-age
of 23 25 341 343 O
consent 26 33 344 351 O
must 34 38 352 356 O
sign 39 43 357 361 O
an 44 46 362 364 O
assent 47 53 365 371 O
for 54 57 372 375 O
the 58 61 376 379 O
study 62 67 380 385 O
and 68 71 386 389 O
a 72 73 390 391 O
parent 74 80 392 398 O
or 81 83 399 401 O
a 84 85 402 403 O
legal 86 91 404 409 O
guardian 92 100 410 418 O
must 101 105 419 423 O
sign 106 110 424 428 O
the 111 114 429 432 O
informed 115 123 433 441 O
consent 124 131 442 449 O

who 0 3 450 453 O
wish 4 8 454 458 O
to 9 11 459 461 O
become 12 18 462 468 B-pregnancy
pregnant 19 27 469 477 I-pregnancy
during 28 34 478 484 O
the 35 38 485 488 O
study 39 44 489 494 O
period 45 51 495 501 O

diagnosis 0 9 0 9 O
of 10 12 10 12 O
ankle 13 18 13 18 B-chronic_disease
OA 19 21 19 21 I-chronic_disease
or 22 24 22 24 I-chronic_disease
PTTD 25 29 25 29 I-chronic_disease
[ 30 31 30 31 O
non 31 34 31 34 O
- 34 35 34 35 O
control 35 42 35 42 O
subjects 43 51 43 51 O
only 52 56 52 56 O
] 56 57 56 57 O

lack 0 4 58 62 O
of 5 7 63 65 O
a 8 9 66 67 O
telephone 10 19 68 77 B-technology_access
number 20 26 78 84 I-technology_access
or 27 29 85 87 O
stable 30 36 88 94 O
mailing 37 44 95 102 O
address 45 52 103 110 O

recent 0 6 111 117 O
( 7 8 118 119 O
< 8 9 119 120 O
1 9 10 120 121 B-upper_bound
year 11 15 122 126 I-upper_bound
) 15 16 126 127 O
surgical 17 25 128 136 B-treatment
, 25 26 136 137 O
neurological 27 39 138 150 B-chronic_disease
, 39 40 150 151 O
metabolic 41 50 152 161 O
or 51 53 162 164 O
lower 54 59 165 170 B-chronic_disease
limb 60 64 171 175 I-chronic_disease
musculoskeletal 65 80 176 191 I-chronic_disease
problem 81 88 192 199 O
that 89 93 200 204 O
might 94 99 205 210 O
impair 100 106 211 217 O
the 107 110 218 221 O
ambulation 111 121 222 232 O
measures 122 130 233 241 O
in 131 133 242 244 O
the 134 137 245 248 O
study 138 143 249 254 O
, 143 144 254 255 O
such 145 149 256 260 O
as 150 152 261 263 O
severe 153 159 264 270 O
knee 160 164 271 275 O
or 165 167 276 278 O
hip 168 171 279 282 B-chronic_disease
osteoarthritis 172 186 283 297 I-chronic_disease

rheumatoid 0 10 298 308 B-chronic_disease
arthritis 11 20 309 318 I-chronic_disease
or 21 23 319 321 O
other 24 29 322 327 O
inflammatory 30 42 328 340 B-chronic_disease
disease 43 50 341 348 I-chronic_disease

0 0 1 0 1 B-lower_bound
- 1 2 1 2 O
21 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Adequate 0 8 18 26 O
liver 9 14 27 32 O
function 15 23 33 41 O
defined 24 31 42 49 O
as 32 34 50 52 O
total 35 40 53 58 B-clinical_variable
bilirubin 41 50 59 68 I-clinical_variable
≤ 51 52 69 70 O
1.5 53 56 71 74 B-upper_bound
x 57 58 75 76 I-upper_bound
upper 59 64 77 82 I-upper_bound
limit 65 70 83 88 I-upper_bound
of 71 73 89 91 I-upper_bound
normal 74 80 92 98 I-upper_bound
( 81 82 99 100 I-upper_bound
ULN 82 85 100 103 I-upper_bound
) 85 86 103 104 I-upper_bound
for 87 90 105 108 O
age 91 94 109 112 B-age

Age 0 3 113 116 B-age
< 4 5 117 118 O
22 6 8 119 121 B-upper_bound
years 9 14 122 127 I-upper_bound
( 15 16 128 129 O
eligible 16 24 129 137 O
until 25 30 138 143 O
22nd 31 35 144 148 O
birthday 36 44 149 157 O
) 44 45 157 158 O

Creatinine 0 10 159 169 B-clinical_variable
clearance 11 20 170 179 I-clinical_variable
or 21 23 180 182 O
radioisotope 24 36 183 195 B-clinical_variable
GFR 37 40 196 199 I-clinical_variable
≥ 41 42 200 201 O
70 43 45 202 204 B-lower_bound
mL 46 48 205 207 I-lower_bound
/ 48 49 207 208 I-lower_bound
min/1.732 49 58 208 217 I-lower_bound

Female 0 6 218 224 B-gender
participants 7 19 225 237 I-gender
who 20 23 238 241 O
are 24 27 242 245 O
breast 28 34 246 252 O
feeding 35 42 253 260 O
must 43 47 261 265 O
agree 48 53 266 271 O
to 54 56 272 274 O
stop 57 61 275 279 O
breast 62 68 280 286 O
feeding 69 76 287 294 O

Female 0 6 295 301 B-gender
participants 7 19 302 314 I-gender
≥ 20 21 315 316 O
10 22 24 317 319 B-lower_bound
years 25 30 320 325 I-lower_bound
of 31 33 326 328 O
age 34 37 329 332 B-age
or 38 40 333 335 O
post 41 45 336 340 O
- 45 46 340 341 O
menarchal 46 55 341 350 O
must 56 60 351 355 O
have 61 65 356 360 O
a 66 67 361 362 O
negative 68 76 363 371 B-pregnancy
serum 77 82 372 377 I-pregnancy
or 83 85 378 380 O
urine 86 91 381 386 B-pregnancy
pregnancy 92 101 387 396 I-pregnancy
test 102 106 397 401 O
within 107 113 402 408 O
24 114 116 409 411 B-upper_bound
hours 117 122 412 417 I-upper_bound
prior 123 128 418 423 I-upper_bound
to 129 131 424 426 O
beginning 132 141 427 436 O
treatment 142 151 437 446 B-treatment

Females 0 7 447 454 B-gender
of 8 10 455 457 O
child 11 16 458 463 O
- 16 17 463 464 O
bearing 17 24 464 471 O
potential 25 34 472 481 O
can 35 38 482 485 O
not 38 41 485 488 O
be 42 44 489 491 O
pregnant 45 53 492 500 B-pregnancy
or 54 56 501 503 O
breast 57 63 504 510 O
- 63 64 510 511 O
feeding 64 71 511 518 O

High 0 4 519 523 O
- 4 5 523 524 O
risk 5 9 524 528 O
: 9 10 528 529 O
Embryonal 11 20 530 539 B-cancer
, 20 21 539 540 O
botryoid 22 30 541 549 B-cancer
, 30 31 549 550 O
spindle 32 39 551 558 B-cancer
cell 40 44 559 563 I-cancer
, 44 45 563 564 O
alveolar 46 54 565 573 B-cancer
, 54 55 573 574 O
undifferentiated 56 72 575 591 B-cancer
, 72 73 591 592 O
or 74 76 593 595 O
anaplastic 77 87 596 606 B-cancer
RMS 88 91 607 610 I-cancer
with 92 96 611 615 O
metastatic 97 107 616 626 B-cancer
disease 108 115 627 634 I-cancer
at 116 118 635 637 O
diagnosis 119 128 638 647 O
( 129 130 648 649 O
stage 130 135 649 654 O
4 136 137 655 656 O
) 137 138 656 657 O

History 0 7 658 665 O
of 8 10 666 668 O
allergy 11 18 669 676 O
to 19 21 677 679 O
Optison(TM 22 32 680 690 B-allergy_name
) 32 33 690 691 I-allergy_name
contrast 34 42 692 700 I-allergy_name
agent 43 48 701 706 I-allergy_name
or 49 51 707 709 O
blood 52 57 710 715 B-allergy_name
products 58 66 716 724 I-allergy_name

Initiation 0 10 725 735 O
of 11 13 736 738 O
chemotherapy 14 26 739 751 B-treatment
is 27 29 752 754 O
planned 30 37 755 762 O
within 38 44 763 769 O
6 45 46 770 771 B-upper_bound
weeks 47 52 772 777 I-upper_bound
( 53 54 778 779 I-upper_bound
42 54 56 779 781 I-upper_bound
days 57 61 782 786 I-upper_bound
) 61 62 786 787 I-upper_bound
of 63 65 788 790 O
the 66 69 791 794 O
definitive 70 80 795 805 O
biopsy 81 87 806 812 B-treatment
or 88 90 813 815 O
surgical 91 99 816 824 B-treatment
resection 100 109 825 834 I-treatment

Low 0 3 835 838 O
- 3 4 838 839 O
risk 4 8 839 843 O
: 8 9 843 844 O
Embryonal 10 19 845 854 B-cancer
, 19 20 854 855 O
botryoid 21 29 856 864 B-cancer
, 29 30 864 865 O
spindle 31 38 866 873 B-cancer
cell 39 43 874 878 I-cancer
tumors 44 50 879 885 I-cancer
only 51 55 886 890 O
( 56 57 891 892 O
Subset 57 63 892 898 O
1 64 65 899 900 O
: 65 66 900 901 O
Stage 67 72 902 907 O
1 73 74 908 909 O
, 74 75 909 910 O
Group 76 81 911 916 O
I 82 83 917 918 O
; 83 84 918 919 O
Stage 85 90 920 925 O
1 91 92 926 927 O
Group 93 98 928 933 O
I 99 100 934 935 O
; 100 101 935 936 O
Stage 102 107 937 942 O
1 108 109 943 944 O
Group 110 115 945 950 O
III 116 119 951 954 O
orbital 120 127 955 962 O
only 128 132 963 967 O
; 132 133 967 968 O
Stage 134 139 969 974 O
2 140 141 975 976 O
Group 142 147 977 982 O
I 148 149 983 984 O
; 149 150 984 985 O
Stage 151 156 986 991 O
2 157 158 992 993 O
Group 159 164 994 999 O
II 165 167 1000 1002 O
) 167 168 1002 1003 O
( 169 170 1004 1005 O
Subset 170 176 1005 1011 O
2 177 178 1012 1013 O
: 178 179 1013 1014 O
Stage 180 185 1015 1020 O
1 186 187 1021 1022 O
Group 188 193 1023 1028 O
III 194 197 1029 1032 O
non 198 201 1033 1036 O
orbit 202 207 1037 1042 O
; 207 208 1042 1043 O
Stage 209 214 1044 1049 O
3 215 216 1050 1051 O
Group 217 222 1052 1057 O
I 223 224 1058 1059 O
, 224 225 1059 1060 O
II 226 228 1061 1063 O
) 228 229 1063 1064 O

Newly 0 5 1065 1070 O
diagnosed 6 15 1071 1080 O
participants 16 28 1081 1093 O
with 29 33 1094 1098 O
localized 34 43 1099 1108 O
rhabdomyosarcoma 44 60 1109 1125 B-cancer
( 61 62 1126 1127 I-cancer
RMS 62 65 1127 1130 I-cancer
) 65 66 1130 1131 I-cancer

Newly 0 5 1132 1137 O
diagnosis 6 15 1138 1147 O
or 16 18 1148 1150 O
suspected 19 28 1151 1160 O
diagnosis 29 38 1161 1170 O
of 39 41 1171 1173 O
previously 42 52 1174 1184 O
untreated 53 62 1185 1194 O
participants 63 75 1195 1207 O
with 76 80 1208 1212 O
rhabdomyosarcoma 81 97 1213 1229 B-cancer
( 98 99 1230 1231 I-cancer
RMS 99 102 1231 1234 I-cancer
) 102 103 1234 1235 I-cancer

No 0 2 1236 1238 O
evidence 3 11 1239 1247 O
of 12 14 1248 1250 O
active 15 21 1251 1257 B-chronic_disease
, 21 22 1257 1258 O
uncontrolled 23 35 1259 1271 B-chronic_disease
infection 36 45 1272 1281 I-chronic_disease

Participant 0 11 1282 1293 O
has 12 15 1294 1297 O
received 16 24 1298 1306 O
no 25 27 1307 1309 O
prior 28 33 1310 1315 B-treatment
radiotherapy 34 46 1316 1328 I-treatment
or 47 49 1329 1331 O
chemotherapy 50 62 1332 1344 B-treatment
for 63 66 1345 1348 I-treatment
rhabdomyosarcoma 67 83 1349 1365 I-treatment
( 84 85 1366 1367 O
excluding 85 94 1367 1376 O
steroids 95 103 1377 1385 B-treatment
) 103 104 1385 1386 O
unless 105 111 1387 1393 O
an 112 114 1394 1396 O
emergency 115 124 1397 1406 O
situation 125 134 1407 1416 O
requires 135 143 1417 1425 O
local 144 149 1426 1431 O
tumor 150 155 1432 1437 B-cancer
treatment 156 165 1438 1447 B-treatment

Participants 0 12 1448 1460 O
treated 13 20 1461 1468 O
on 21 23 1469 1471 O
this 24 28 1472 1476 O
protocol 29 37 1477 1485 O
in 38 40 1486 1488 O
the 41 44 1489 1492 O
low 45 48 1493 1496 O
or 49 51 1497 1499 O
intermediate 52 64 1500 1512 O
risk 65 69 1513 1517 O
arm 70 73 1518 1521 O
who 74 77 1522 1525 O
experience 78 88 1526 1536 O
disease 89 96 1537 1544 O
progression 97 108 1545 1556 O
prior 109 114 1557 1562 B-upper_bound
to 115 117 1563 1565 I-upper_bound
week 118 122 1566 1570 I-upper_bound
13 123 125 1571 1573 I-upper_bound
will 126 130 1574 1578 O
transfer 131 139 1579 1587 O
to 140 142 1588 1590 O
the 143 146 1591 1594 O
high 147 151 1595 1599 O
risk 152 156 1600 1604 O
arm 157 160 1605 1608 O
and 161 164 1609 1612 O
proceed 165 172 1613 1620 O
with 173 177 1621 1625 O
high 178 182 1626 1630 O
risk 183 187 1631 1635 O
chemotherapy 188 200 1636 1648 B-treatment
starting 201 209 1649 1657 O
at 210 212 1658 1660 O
week 213 217 1661 1665 O
1 218 219 1666 1667 O
of 220 222 1668 1670 O
the 223 226 1671 1674 O
protocol 227 235 1675 1683 O

Participants 0 12 1684 1696 O
with 13 17 1697 1701 O
biliary 18 25 1702 1709 O
or 26 28 1710 1712 O
hepatic 29 36 1713 1720 O
primaries 37 46 1721 1730 O
with 47 51 1731 1735 O
bilirubin 52 61 1736 1745 B-clinical_variable
values 62 68 1746 1752 O
greater 69 76 1753 1760 O
than 77 81 1761 1765 O
1.5 82 85 1766 1769 B-upper_bound
x 86 87 1770 1771 I-upper_bound
ULN 88 91 1772 1775 I-upper_bound
may 92 95 1776 1779 O
be 96 98 1780 1782 O
enrolled 99 107 1783 1791 O
on 108 110 1792 1794 O
study 111 116 1795 1800 O
if 117 119 1801 1803 O
all 120 123 1804 1807 O
other 124 129 1808 1813 O
eligibility 130 141 1814 1825 O
criteria 142 150 1826 1834 O
are 151 154 1835 1838 O
met 155 158 1839 1842 O

Participants 0 12 1843 1855 O
with 13 17 1856 1860 O
urinary 18 25 1861 1868 O
tract 26 31 1869 1874 O
obstruction 32 43 1875 1886 O
by 44 46 1887 1889 O
tumor 47 52 1890 1895 B-cancer
must 53 57 1896 1900 O
meet 58 62 1901 1905 O
the 63 66 1906 1909 O
renal 67 72 1910 1915 O
function 73 81 1916 1924 O
criteria 82 90 1925 1933 O
listed 91 97 1934 1940 O
above 98 103 1941 1946 O
AND 104 107 1947 1950 O
must 108 112 1951 1955 O
have 113 117 1956 1960 O
unimpeded 118 127 1961 1970 O
urinary 128 135 1971 1978 O
flow 136 140 1979 1983 O
established 141 152 1984 1995 O
via 153 156 1996 1999 O
decompression 157 170 2000 2013 O
of 171 173 2014 2016 O
the 174 177 2017 2020 O
obstructed 178 188 2021 2031 O
portion 189 196 2032 2039 O
of 197 199 2040 2042 O
the 200 203 2043 2046 O
urinary 204 211 2047 2054 O
tract 212 217 2055 2060 O

Patients 0 8 2061 2069 O
requiring 9 18 2070 2079 O
emergency 19 28 2080 2089 O
radiation 29 38 2090 2099 B-treatment
therapy 39 46 2100 2107 I-treatment
are 47 50 2108 2111 O
eligible 51 59 2112 2120 O
for 60 63 2121 2124 O
enrollment 64 74 2125 2135 O
on 75 77 2136 2138 O
this 78 82 2139 2143 O
study 83 88 2144 2149 O

Performance 0 11 2150 2161 O
level 12 17 2162 2167 O
corresponding 18 31 2168 2181 O
to 32 34 2182 2184 O
ECOG 35 39 2185 2189 B-clinical_variable
score 40 45 2190 2195 I-clinical_variable
of 46 48 2196 2198 O
0 49 50 2199 2200 B-lower_bound
, 50 51 2200 2201 O
1 52 53 2202 2203 O
, 53 54 2203 2204 O
or 55 57 2205 2207 O
2 58 59 2208 2209 B-lower_bound

Peripheral 0 10 2210 2220 B-clinical_variable
absolute 11 19 2221 2229 I-clinical_variable
neutrophil 20 30 2230 2240 I-clinical_variable
count 31 36 2241 2246 I-clinical_variable
( 37 38 2247 2248 I-clinical_variable
ANC 38 41 2248 2251 I-clinical_variable
) 41 42 2251 2252 I-clinical_variable
≥ 43 44 2253 2254 O
750 45 48 2255 2258 B-lower_bound
/ 48 49 2258 2259 I-lower_bound
μL 49 51 2259 2261 I-lower_bound

Platelet 0 8 2262 2270 B-clinical_variable
count 9 14 2271 2276 I-clinical_variable
≥ 15 16 2277 2278 O
75,000 17 23 2279 2285 B-lower_bound
/ 23 24 2285 2286 I-lower_bound
μL 24 26 2286 2288 I-lower_bound
( 27 28 2289 2290 O
transfusion 28 39 2290 2301 O
independent 40 51 2302 2313 O
) 51 52 2313 2314 O

Prior 0 5 2315 2320 B-treatment
biopsy 6 12 2321 2327 I-treatment
, 12 13 2327 2328 O
surgical 14 22 2329 2337 B-treatment
resection 23 32 2338 2347 I-treatment
and 33 36 2348 2351 O
lymph 37 42 2352 2357 O
node 43 47 2358 2362 O
sampling 48 56 2363 2371 O
is 57 59 2372 2374 O
allowed 60 67 2375 2382 O

Serum 0 5 2383 2388 B-chronic_disease
creatinine 6 16 2389 2399 I-chronic_disease
based 17 22 2400 2405 O
on 23 25 2406 2408 O
age 26 29 2409 2412 B-age
and 30 33 2413 2416 O
gender 34 40 2417 2423 O

Sexually 0 8 2424 2432 O
active 9 15 2433 2439 O
patients 16 24 2440 2448 O
of 25 27 2449 2451 O
childbearing 28 40 2452 2464 O
potential 41 50 2465 2474 O
must 51 55 2475 2479 O
be 56 58 2480 2482 O
willing 59 66 2483 2490 B-contraception_consent
to 67 69 2491 2493 I-contraception_consent
use 70 73 2494 2497 I-contraception_consent
effective 74 83 2498 2507 I-contraception_consent
contraception 84 97 2508 2521 I-contraception_consent
during 98 104 2522 2528 O
therapy 105 112 2529 2536 B-treatment
and 113 116 2537 2540 O
for 117 120 2541 2544 O
at 121 123 2545 2547 O
least 124 129 2548 2553 O
1 130 131 2554 2555 B-lower_bound
month 132 137 2556 2561 I-lower_bound
after 138 143 2562 2567 I-lower_bound
treatment 144 153 2568 2577 B-treatment
is 154 156 2578 2580 O
completed 157 166 2581 2590 O

The 0 3 2591 2594 O
Lansky 4 10 2595 2601 B-clinical_variable
performance 11 22 2602 2613 I-clinical_variable
score 23 28 2614 2619 I-clinical_variable
should 29 35 2620 2626 O
be 36 38 2627 2629 O
used 39 43 2630 2634 O
for 44 47 2635 2638 O
participants 48 60 2639 2651 O
< 61 62 2652 2653 O
16 63 65 2654 2656 B-upper_bound
years 66 71 2657 2662 I-upper_bound

Undergoing 0 10 2663 2673 O
upfront 11 18 2674 2681 O
surgical 19 27 2682 2690 B-treatment
resection 28 37 2691 2700 I-treatment
of 38 40 2701 2703 O
the 41 44 2704 2707 O
primary 45 52 2708 2715 O
tumor 53 58 2716 2721 B-cancer

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
uL 35 37 35 37 I-lower_bound

Completion 0 10 38 48 O
of 11 13 49 51 O
preoperative 14 26 52 64 B-treatment
systemic 27 35 65 73 I-treatment
chemotherapy 36 48 74 86 I-treatment
and 49 52 87 90 O
preoperative 53 65 91 103 B-treatment
laparoscopic 66 78 104 116 I-treatment
HIPEC 79 84 117 122 I-treatment

Distant 0 7 123 130 O
metastatic 8 18 131 141 B-cancer
disease 19 26 142 149 I-cancer
not 27 30 150 153 O
limited 31 38 154 161 O
to 39 41 162 164 O
peritoneum 42 52 165 175 O
: 52 53 175 176 O
Solid 54 59 177 182 B-cancer
organ 60 65 183 188 I-cancer
metastases 66 76 189 199 I-cancer
( 77 78 200 201 O
liver 78 83 201 206 B-cancer
, 83 84 206 207 O
central 85 92 208 215 B-cancer
nervous 93 100 216 223 I-cancer
system 101 107 224 230 I-cancer
, 107 108 230 231 O
lung 109 113 232 236 B-cancer
) 113 114 236 237 O

Distant 0 7 238 245 O
metastatic 8 18 246 256 B-cancer
disease 19 26 257 264 I-cancer
of 27 29 265 267 I-cancer
peritoneum 30 40 268 278 I-cancer

Eastern 0 7 279 286 B-clinical_variable
Cooperative 8 19 287 298 I-clinical_variable
Oncology 20 28 299 307 I-clinical_variable
Group 29 34 308 313 I-clinical_variable
( 35 36 314 315 I-clinical_variable
ECOG 36 40 315 319 I-clinical_variable
) 40 41 319 320 I-clinical_variable
performance 42 53 321 332 I-clinical_variable
status 54 60 333 339 I-clinical_variable
= 61 62 340 341 O
< 62 63 341 342 O
2 64 65 343 344 B-upper_bound

Infections 0 10 345 355 O
such 11 15 356 360 O
as 16 18 361 363 O
pneumonia 19 28 364 373 B-chronic_disease
or 29 31 374 376 O
wound 32 37 377 382 B-chronic_disease
infections 38 48 383 393 I-chronic_disease
that 49 53 394 398 O
would 54 59 399 404 O
preclude 60 68 405 413 O
protocol 69 77 414 422 B-treatment
therapy 78 85 423 430 I-treatment

Leukocytes 0 10 431 441 B-clinical_variable
> 11 12 442 443 O
= 12 13 443 444 O
3,000 14 19 445 450 B-lower_bound
/ 19 20 450 451 I-lower_bound
uL 20 22 451 453 I-lower_bound

Platelets 0 9 454 463 B-clinical_variable
> 10 11 464 465 O
= 11 12 465 466 O
60,000 13 19 467 473 B-lower_bound
/ 19 20 473 474 I-lower_bound
Ul 20 22 474 476 I-lower_bound

Positive 0 8 477 485 B-cancer
peritoneal 9 19 486 496 I-cancer
cytology 20 28 497 505 I-cancer

Subjects 0 8 506 514 O
with 9 13 515 519 O
a 14 15 520 521 O
known 16 21 522 527 O
hypersensitivity 22 38 528 544 O
to 39 41 545 547 O
protocol 42 50 548 556 B-allergy_name
systemic 51 59 557 565 I-allergy_name
chemotherapy 60 72 566 578 I-allergy_name
that 73 77 579 583 O
was 78 81 584 587 O
life 82 86 588 592 O
- 86 87 592 593 O
threatening 87 98 593 604 O
, 98 99 604 605 O
required 100 108 606 614 O
hospitalization 109 124 615 630 O
or 125 127 631 633 O
prolongation 128 140 634 646 O
of 141 143 647 649 O
existing 144 152 650 658 O
hospitalization 153 168 659 674 O
, 168 169 674 675 O
or 170 172 676 678 O
resulted 173 181 679 687 O
in 182 184 688 690 O
persistent 185 195 691 701 O
or 196 198 702 704 O
significant 199 210 705 716 O
disability 211 221 717 727 O
or 222 224 728 730 O
incapacity 225 235 731 741 O

Active 0 6 0 6 B-chronic_disease
untreated 7 16 7 16 I-chronic_disease
infection 17 26 17 26 I-chronic_disease
such 27 31 27 31 O
as 32 34 32 34 O
decubitus 35 44 35 44 B-chronic_disease
ulcer 45 50 45 50 I-chronic_disease

Age 0 3 51 54 B-age
> 4 5 55 56 O
16 6 8 57 59 B-lower_bound
years 9 14 60 65 I-lower_bound

American 0 8 66 74 B-clinical_variable
Spinal 9 15 75 81 I-clinical_variable
Injury 16 22 82 88 I-clinical_variable
Impairment 23 33 89 99 I-clinical_variable
Scale 34 39 100 105 I-clinical_variable
( 40 41 106 107 I-clinical_variable
AIS 41 44 107 110 I-clinical_variable
) 44 45 110 111 I-clinical_variable
grade 46 51 112 117 O
A 52 53 118 119 O
, 53 54 119 120 O
B 55 56 121 122 O
, 56 57 122 123 O
C 58 59 124 125 O
, 59 60 125 126 O
or 61 63 127 129 O
D 64 65 130 131 O

Biceps 0 6 132 138 B-clinical_variable
/ 6 7 138 139 I-clinical_variable
brachialis 7 17 139 149 I-clinical_variable
/ 17 18 149 150 I-clinical_variable
brachioradialis 18 33 150 165 I-clinical_variable
strength 34 42 166 174 I-clinical_variable
of 43 45 175 177 O
2/5 46 49 178 181 B-lower_bound
or 50 52 182 184 O
higher 53 59 185 191 O
on 60 62 192 194 O
Manual 63 69 195 201 O
Muscle 70 76 202 208 O
Test 77 81 209 213 O

Currently 0 9 214 223 B-pregnancy
pregnant 10 18 224 232 I-pregnancy

Diagnosis 0 9 233 242 O
of 10 12 243 245 O
cervical 13 21 246 254 B-chronic_disease
level 22 27 255 260 I-chronic_disease
spinal 28 34 261 267 I-chronic_disease
cord 35 39 268 272 I-chronic_disease
injury 40 46 273 279 I-chronic_disease
, 46 47 279 280 O
either 48 54 281 287 O
complete 55 63 288 296 O
or 64 66 297 299 O
incomplete 67 77 300 310 O

Disorder 0 8 311 319 O
or 9 11 320 322 O
condition 12 21 323 332 O
that 22 26 333 337 O
require 27 34 338 345 O
MRI 35 38 346 349 B-treatment
monitoring 39 49 350 360 I-treatment

HIV 0 3 361 364 B-chronic_disease

History 0 7 365 372 O
of 8 10 373 375 O
coagulopathy 11 23 376 388 B-chronic_disease

Less 0 4 389 393 O
than 5 9 394 398 O
six 10 13 399 402 B-upper_bound
months 14 20 403 409 I-upper_bound
post 21 25 410 414 O
- 25 26 414 415 O
injury 26 32 415 421 O

Medically 0 9 422 431 O
stable 10 16 432 438 O
- 17 18 439 440 O
cleared 19 26 441 448 O
for 27 30 449 452 O
surgery 31 38 453 460 B-treatment

Other 0 5 461 466 O
neurological 6 18 467 479 B-chronic_disease
conditions 19 29 480 490 I-chronic_disease

Progressive 0 11 491 502 O
SCI 12 15 503 506 B-chronic_disease
In 16 18 507 509 O
subjects 19 27 510 518 O
who 28 31 519 522 O
are 32 35 523 526 O
undergoing 36 46 527 537 B-treatment
bilateral 47 56 538 547 I-treatment
implantation 57 69 548 560 I-treatment

at 0 2 561 563 O
least 3 8 564 569 O
two 9 12 570 573 B-lower_bound
of 13 15 574 576 O
the 16 19 577 580 O
following 20 29 581 590 O
muscles 30 37 591 598 O
: 37 38 598 599 O
left 39 43 600 604 O
/ 43 44 604 605 O
right 44 49 605 610 O
gluteus 50 57 611 618 O
maximus 58 65 619 626 O
, 65 66 626 627 O
left 67 71 628 632 O
/ 71 72 632 633 O
right 72 77 633 638 O
erector 78 85 639 646 O
spinae 86 92 647 653 O
, 92 93 653 654 O
left 94 98 655 659 O
/ 98 99 659 660 O
right 99 104 660 665 O
quadratus 105 114 666 675 O
lumborum 115 123 676 684 O

chronic 0 7 685 692 B-chronic_disease
obstructive 8 19 693 704 I-chronic_disease
pulmonary 20 29 705 714 I-chronic_disease
disease 30 37 715 722 I-chronic_disease

diabetes 0 8 723 731 B-chronic_disease
or 9 11 732 734 O
any 12 15 735 738 O
condition 16 25 739 748 O
which 26 31 749 754 O
requires 32 40 755 763 O
frequent 41 49 764 772 O
blood 50 55 773 778 O
pressure 56 64 779 787 O
monitoring 65 75 788 798 O
or 76 78 799 801 O
frequent 79 87 802 810 O
venipuncture 88 100 811 823 O

diabetes 0 8 824 832 B-chronic_disease
with 9 13 833 837 I-chronic_disease
peripheral 14 24 838 848 I-chronic_disease
nerve 25 30 849 854 I-chronic_disease
involvement 31 42 855 866 I-chronic_disease

hypertension 0 12 867 879 B-chronic_disease

multiple 0 8 880 888 B-chronic_disease
sclerosis 9 18 889 898 I-chronic_disease

neuroprosthesis 0 15 899 914 B-treatment
implantation 16 28 915 927 I-treatment
delayed 29 36 928 935 O
until 37 42 936 941 O
criteria 43 51 942 950 O
met 52 55 951 954 O

neuroprosthesis 0 15 955 970 B-treatment
implantation 16 28 971 983 I-treatment
delayed 29 36 984 991 O
until 37 42 992 997 O
no 43 45 998 1000 O
longer 46 52 1001 1007 O
pregnant 53 61 1008 1016 B-pregnancy

pneumonia 0 9 1017 1026 B-chronic_disease

severe 0 6 1027 1033 B-chronic_disease
autonomic 7 16 1034 1043 I-chronic_disease
dysreflexia 17 28 1044 1055 I-chronic_disease

severe 0 6 1056 1062 O
bradycardia 7 18 1063 1074 B-chronic_disease

severe 0 6 1075 1081 O
cardiopulmonary 7 22 1082 1097 B-chronic_disease
disease 23 30 1098 1105 I-chronic_disease

six 0 3 1106 1109 B-lower_bound
months 4 10 1110 1116 I-lower_bound
or 11 13 1117 1119 O
more 14 18 1120 1124 O
post 19 23 1125 1129 O
- 23 24 1129 1130 O
injury 24 30 1130 1136 O

subjects 0 8 1137 1145 O
should 9 15 1146 1152 O
not 16 19 1153 1156 O
have 20 24 1157 1161 O
a 25 26 1162 1163 O
history 27 34 1164 1171 O
of 35 37 1172 1174 O
autonomic 38 47 1175 1184 B-chronic_disease
dysreflexia 48 59 1185 1196 I-chronic_disease

urinary 0 7 1197 1204 B-chronic_disease
tract 8 13 1205 1210 I-chronic_disease
infection 14 23 1211 1220 I-chronic_disease

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
ataxia 15 21 15 21 B-chronic_disease
telangiectasia 22 36 22 36 I-chronic_disease

Aged 0 4 37 41 B-age
at 5 7 42 44 O
least 8 13 45 50 O
18 14 16 51 53 B-lower_bound

Bad 0 3 54 57 O
reaction 4 12 58 66 O
to 13 15 67 69 O
AZD6738 16 23 70 77 B-allergy_name

Contra 0 6 78 84 O
- 6 7 84 85 O
indicated 7 16 85 94 O
for 17 20 95 98 O
treatment 21 30 99 108 B-treatment
with 31 35 109 113 O
MEDI4736 36 44 114 122 B-allergy_name

Contra 0 6 123 129 O
- 6 7 129 130 O
indicated 7 16 130 139 O
for 17 20 140 143 O
treatment 21 30 144 153 O
with 31 35 154 158 O
carboplatin 36 47 159 170 B-allergy_name

Contra 0 6 171 177 O
- 6 7 177 178 O
indicated 7 16 178 187 O
for 17 20 188 191 O
treatment 21 30 192 201 B-treatment
with 31 35 202 206 I-treatment
olaparib 36 44 207 215 I-treatment

No 0 2 216 218 O
previous 3 11 219 227 O
treatment 12 21 228 237 B-treatment
with 22 26 238 242 O
PARP 27 31 243 247 B-treatment
inhibitor 32 41 248 257 I-treatment

Prior 0 5 258 263 O
exposure 6 14 264 272 O
to 15 17 273 275 O
an 18 20 276 278 O
ATR 21 24 279 282 B-treatment
inhibitor 25 34 283 292 I-treatment

Second 0 6 293 299 O
or 7 9 300 302 O
third 10 15 303 308 O
line 16 20 309 313 O
triple 21 27 314 320 B-cancer
negative 28 36 321 329 I-cancer
breast 37 43 330 336 I-cancer
cancer 44 50 337 343 I-cancer
( 51 52 344 345 I-cancer
TNBC 52 56 345 349 I-cancer
) 56 57 349 350 I-cancer

Second 0 6 351 357 O
or 7 9 358 360 O
thrid 10 15 361 366 O
line 16 20 367 371 O
HER2 21 25 372 376 B-cancer
negative 26 34 377 385 I-cancer
breast 35 41 386 392 I-cancer
cancer 42 48 393 399 I-cancer

The 0 3 400 403 O
presence 4 12 404 412 O
of 13 15 413 415 O
a 16 17 416 417 O
solid 18 23 418 423 B-cancer
malignant 24 33 424 433 I-cancer
tumour 34 40 434 440 I-cancer
that 41 45 441 445 O
is 46 48 446 448 O
not 49 52 449 452 O
considered 53 63 453 463 O
appropriate 64 75 464 475 O
for 76 79 476 479 O
further 80 87 480 487 O
standard 88 96 488 496 O
treatment 97 106 497 506 O

advanced 0 8 507 515 O
gastric 9 16 516 523 B-cancer
adenocarcinoma 17 31 524 538 I-cancer
( 32 33 539 540 O
including 33 42 540 549 O
GEJ 43 46 550 553 O
) 46 47 553 554 O
patients 48 56 555 563 O
with 57 61 564 568 O
ATM 62 65 569 572 B-cancer
deficient 66 75 573 582 I-cancer
tumours 76 83 583 590 I-cancer

advanced 0 8 591 599 O
gastric 9 16 600 607 B-cancer
adenocarcinoma 17 31 608 622 I-cancer
( 32 33 623 624 O
including 33 42 624 633 O
GEJ 43 46 634 637 B-cancer
) 46 47 637 638 O
patients 48 56 639 647 O
with 57 61 648 652 O
ATM 62 65 653 656 O
proficient 66 76 657 667 O
tumours 77 84 668 675 B-cancer

advanced 0 8 676 684 O
recurrent 9 18 685 694 O
or 19 21 695 697 O
metastatic 22 32 698 708 O
non 33 36 709 712 B-cancer
- 36 37 712 713 I-cancer
small 37 42 713 718 I-cancer
cell 43 47 719 723 I-cancer
lung 48 52 724 728 I-cancer
cancer 53 59 729 735 I-cancer

head 0 4 736 740 B-cancer
and 5 8 741 744 I-cancer
neck 9 13 745 749 I-cancer
squamous 14 22 750 758 I-cancer
cell 23 27 759 763 I-cancer
carcinoma 28 37 764 773 I-cancer

patients 0 8 774 782 O
must 9 13 783 787 O
have 14 18 788 792 O
a 19 20 793 794 O
tumour 21 27 795 801 B-cancer
at 28 30 802 804 O
least 31 36 805 810 O
1 37 38 811 812 B-lower_bound
cm 39 41 813 815 I-lower_bound
in 42 44 816 818 O
size 45 49 819 823 O
that 50 54 824 828 O
can 55 58 829 832 O
be 59 61 833 835 O
measured 62 70 836 844 O
using 71 76 845 850 O
a 77 78 851 852 O
CT 79 81 853 855 B-treatment
or 82 84 856 858 O
MRI 85 88 859 862 B-treatment
scan 89 93 863 867 I-treatment

second 0 6 868 874 O
line 7 11 875 879 O
lung 12 16 880 884 B-cancer
adenocarcinoma 17 31 885 899 I-cancer
with 32 36 900 904 O
ATM 37 40 905 908 B-cancer
deficient 41 50 909 918 I-cancer
tumours 51 58 919 926 I-cancer

Cystic 0 6 0 6 B-chronic_disease
fibrosis 7 15 7 15 I-chronic_disease
/ 15 16 15 16 O
bronchiectasis 16 30 16 30 B-chronic_disease
/ 30 31 30 31 O
resistant 31 40 31 40 O
infection 41 50 41 50 B-chronic_disease
patients 51 59 51 59 O
where 60 65 60 65 O
surgeon 66 73 66 73 O
will 74 78 74 78 O
need 79 83 79 83 O
to 84 86 84 86 O
remove 87 93 87 93 O
both 94 98 94 98 O
lungs 99 104 99 104 O
prior 105 110 105 110 O
to 111 113 111 113 O
implantation 114 126 114 126 B-treatment

Patient 0 7 127 134 O
with 8 12 135 139 O
specific 13 21 140 148 O
anatomy 22 29 149 156 O
that 30 34 157 161 O
require 35 42 162 169 O
full 43 47 170 174 O
cardiac 48 55 175 182 B-chronic_disease
decompression 56 69 183 196 I-chronic_disease
such 70 74 197 201 O
as 75 77 202 204 O
severe 78 84 205 211 B-chronic_disease
pulmonary 85 94 212 221 I-chronic_disease
hypertension 95 107 222 234 I-chronic_disease
or 108 110 235 237 O
large 111 116 238 243 O
heart 117 122 244 249 O
that 123 127 250 254 O
are 128 131 255 258 O
shifted 132 139 259 266 O
severely 140 148 267 275 O
into 149 153 276 280 O
the 154 157 281 284 O
left 158 162 285 289 O
chest 163 168 290 295 O

Patients 0 8 296 304 O
bridged 9 16 305 312 O
to 17 19 313 315 O
transplant 20 30 316 326 O
with 31 35 327 331 O
ECMO 36 40 332 336 B-treatment

Patients 0 8 337 345 O
who 9 12 346 349 O
the 13 16 350 353 O
surgeon 17 24 354 361 O
feels 25 30 362 367 O
would 31 36 368 373 O
be 37 39 374 376 O
better 40 46 377 383 O
served 47 53 384 390 O
with 54 58 391 395 O
CPB 59 62 396 399 B-treatment
rather 63 69 400 406 O
than 70 74 407 411 O
ECMO- 75 80 412 417 B-treatment
These 81 86 418 423 O
patients 87 95 424 432 O
will 96 100 433 437 O
be 101 103 438 440 O
entered 104 111 441 448 O
into 112 116 449 453 O
a 117 118 454 455 O
registry 119 127 456 464 O
and 128 131 465 468 O
followed 132 140 469 477 O

all 0 3 478 481 O
patients 4 12 482 490 O
requiring 13 22 491 500 O
cardiopulmonary 23 38 501 516 B-treatment
support 39 46 517 524 O
while 47 52 525 530 O
undergoing 53 63 531 541 O
lung 64 68 542 546 B-treatment
transplantation 69 84 547 562 I-treatment

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
primary 13 20 13 20 O
plasma 21 27 21 27 B-cancer
cell 28 32 28 32 I-cancer
leukemia 33 41 33 41 I-cancer

Forced 0 6 42 48 B-clinical_variable
Expiratory 7 17 49 59 I-clinical_variable
Volume 18 24 60 66 I-clinical_variable
1 25 26 67 68 I-clinical_variable
( 27 28 69 70 I-clinical_variable
FEV1 28 32 70 74 I-clinical_variable
) 32 33 74 75 I-clinical_variable
, 33 34 75 76 O
Forced 35 41 77 83 B-clinical_variable
Vital 42 47 84 89 I-clinical_variable
Capacity 48 56 90 98 I-clinical_variable
( 57 58 99 100 I-clinical_variable
FVC 58 61 100 103 I-clinical_variable
) 61 62 103 104 I-clinical_variable
and 63 66 105 108 O
diffusion 67 76 109 118 B-clinical_variable
capacity 77 85 119 127 I-clinical_variable
( 86 87 128 129 I-clinical_variable
DLCO 87 91 129 133 I-clinical_variable
) 91 92 133 134 I-clinical_variable
> 93 94 135 136 O
50 95 97 137 139 B-lower_bound
% 97 98 139 140 I-lower_bound
of 99 101 141 143 O
predicted 102 111 144 153 O

Lactate 0 7 154 161 B-clinical_variable
Dehydrogenase 8 21 162 175 I-clinical_variable
( 22 23 176 177 I-clinical_variable
LDH 23 26 177 180 I-clinical_variable
) 26 27 180 181 I-clinical_variable
≥ 28 29 182 183 O
360 30 33 184 187 B-lower_bound
U 34 35 188 189 I-lower_bound
/ 35 36 189 190 I-lower_bound
L 36 37 190 191 I-lower_bound

Multiple 0 8 192 200 B-clinical_variable
- 8 9 200 201 I-clinical_variable
gated 9 14 201 206 I-clinical_variable
Acquisition 15 26 207 218 I-clinical_variable
Scan 27 31 219 223 I-clinical_variable
( 32 33 224 225 I-clinical_variable
MUGA 33 37 225 229 I-clinical_variable
) 37 38 229 230 I-clinical_variable
scan 39 43 231 235 I-clinical_variable
≥ 44 45 236 237 O
45 46 48 238 240 B-lower_bound
% 48 49 240 241 I-lower_bound

Patients 0 8 242 250 O
must 9 13 251 255 O
be 14 16 256 258 O
at 17 19 259 261 O
least 20 25 262 267 O
18 26 28 268 270 B-lower_bound
years 29 34 271 276 I-lower_bound
of 35 37 277 279 O
age 38 41 280 283 B-age
and 42 45 284 287 O
not 46 49 288 291 O
older 50 55 292 297 O
than 56 60 298 302 O
75 61 63 303 305 B-upper_bound
years 64 69 306 311 I-upper_bound
of 70 72 312 314 O
age 73 76 315 318 O
at 77 79 319 321 O
the 80 83 322 325 O
time 84 88 326 330 O
of 89 91 331 333 O
registration 92 104 334 346 O

Patients 0 8 347 355 O
must 9 13 356 360 O
be 14 16 361 363 O
either 17 23 364 370 O
untreated 24 33 371 380 O
or 34 36 381 383 O
have 37 41 384 388 O
not 42 45 389 392 O
received 46 54 393 401 O
more 55 59 402 406 O
than 60 64 407 411 O
four 65 69 412 416 B-lower_bound
cycles 70 76 417 423 O
of 77 79 424 426 O
systemic 80 88 427 435 B-treatment
MM 89 91 436 438 I-treatment
therapy 92 99 439 446 I-treatment
( 100 101 447 448 O
e.g. 101 105 448 452 O
Revlimid 106 114 453 461 B-treatment
Dexamethasone 115 128 462 475 I-treatment
( 129 130 476 477 I-treatment
RD 130 132 477 479 I-treatment
) 132 133 479 480 I-treatment
, 133 134 480 481 O
Bortezomib 135 145 482 492 B-treatment
Revlimid 146 154 493 501 I-treatment
Dexamethasone 155 168 502 515 I-treatment
( 169 170 516 517 I-treatment
VRD 170 173 517 520 I-treatment
) 173 174 520 521 I-treatment
. 174 175 521 522 O
Prior 176 181 523 528 B-treatment
bisphosphonates 182 197 529 544 I-treatment
and 198 201 545 548 O
localized 202 211 549 558 B-treatment
radiation 212 221 559 568 I-treatment
are 222 225 569 572 O
allowed 226 233 573 580 O

Patients 0 8 581 589 O
must 9 13 590 594 O
have 14 18 595 599 O
a 19 20 600 601 O
platelet 21 29 602 610 B-clinical_variable
count 30 35 611 616 I-clinical_variable
≥ 36 37 617 618 O
50,000 38 44 619 625 B-lower_bound
/ 44 45 625 626 I-lower_bound
μL 45 47 626 628 I-lower_bound

Patients 0 8 629 637 O
must 9 13 638 642 O
have 14 18 643 647 O
adequate 19 27 648 656 O
pulmonary 28 37 657 666 B-clinical_variable
function 38 46 667 675 I-clinical_variable
studies 47 54 676 683 I-clinical_variable
> 55 56 684 685 O
50 57 59 686 688 B-lower_bound
% 59 60 688 689 I-lower_bound
of 61 63 690 692 O
predicted 64 73 693 702 O
on 74 76 703 705 O
mechanical 77 87 706 716 O
aspects 88 95 717 724 O

Patients 0 8 725 733 O
must 9 13 734 738 O
have 14 18 739 743 O
newly 19 24 744 749 O
diagnosed 25 34 750 759 O
active 35 41 760 766 B-cancer
Multiple 42 50 767 775 I-cancer
Myeloma 51 58 776 783 I-cancer
( 59 60 784 785 I-cancer
MM 60 62 785 787 I-cancer
) 62 63 787 788 I-cancer
requiring 64 73 789 798 O
treatment 74 83 799 808 O

Patients 0 8 809 817 O
must 9 13 818 822 O
not 14 17 823 826 O
have 18 22 827 831 O
prior 23 28 832 837 O
malignancy 29 39 838 848 B-cancer
, 39 40 848 849 O
except 41 47 850 856 O
for 48 51 857 860 O
adequately 52 62 861 871 O
treated 63 70 872 879 O
basal 71 76 880 885 B-cancer
cell 77 81 886 890 I-cancer
or 82 84 891 893 O
squamous 85 93 894 902 B-cancer
cell 94 98 903 907 I-cancer
skin 99 103 908 912 I-cancer
cancer 104 110 913 919 I-cancer
, 110 111 919 920 O
in 112 114 921 923 O
situ 115 119 924 928 B-cancer
cervical 120 128 929 937 I-cancer
cancer 129 135 938 944 I-cancer
, 135 136 944 945 O
or 137 139 946 948 O
other 140 145 949 954 O
cancer 146 152 955 961 O
for 153 156 962 965 O
which 157 162 966 971 O
the 163 166 972 975 O
patient 167 174 976 983 O
has 175 178 984 987 O
not 179 182 988 991 O
received 183 191 992 1000 O
treatment 192 201 1001 1010 B-treatment
for 202 205 1011 1014 O
one 206 209 1015 1018 B-upper_bound
year 210 214 1019 1023 I-upper_bound
prior 215 220 1024 1029 I-upper_bound
to 221 223 1030 1032 O
enrollment 224 234 1033 1043 O

Poorly 0 6 1044 1050 O
controlled 7 17 1051 1061 O
hypertension 18 30 1062 1074 B-chronic_disease
, 30 31 1074 1075 O
diabetes 32 40 1076 1084 B-chronic_disease
mellitus 41 49 1085 1093 I-chronic_disease
, 49 50 1093 1094 O
active 51 57 1095 1101 O
or 58 60 1102 1104 O
uncontrolled 61 73 1105 1117 O
hepatitis 74 83 1118 1127 B-chronic_disease

Pregnant 0 8 1128 1136 B-pregnancy

baseline 0 8 1137 1145 O
Alanine 9 16 1146 1153 B-clinical_variable
Aminotransferase 17 33 1154 1170 I-clinical_variable
( 34 35 1171 1172 I-clinical_variable
ALT 35 38 1172 1175 I-clinical_variable
) 38 39 1175 1176 I-clinical_variable
< 40 41 1177 1178 O
3x 42 44 1179 1181 B-upper_bound
Upper 45 50 1182 1187 I-upper_bound
Limit 51 56 1188 1193 I-upper_bound
of 57 59 1194 1196 I-upper_bound
Normal 60 66 1197 1203 I-upper_bound
( 67 68 1204 1205 I-upper_bound
ULN 68 71 1205 1208 I-upper_bound
) 71 72 1208 1209 I-upper_bound

nursing 0 7 1210 1217 O
women 8 13 1218 1223 B-gender
may 14 17 1224 1227 O
not 18 21 1228 1231 O
participate 22 33 1232 1243 O

other 0 5 1244 1249 O
serious 6 13 1250 1257 O
medical 14 21 1258 1265 O
or 22 24 1266 1268 O
psychiatric 25 36 1269 1280 B-chronic_disease
illness 37 44 1281 1288 I-chronic_disease
that 45 49 1289 1293 O
could 50 55 1294 1299 O
potentially 56 67 1300 1311 O
interfere 68 77 1312 1321 O
with 78 82 1322 1326 O
the 83 86 1327 1330 O
completion 87 97 1331 1341 O
of 98 100 1342 1344 O
treatment 101 110 1345 1354 B-treatment
according 111 120 1355 1364 O
to 121 123 1365 1367 O
this 124 128 1368 1372 O
protocol 129 137 1373 1381 O

unless 0 6 1382 1388 O
lower 7 12 1389 1394 O
levels 13 19 1395 1401 O
are 20 23 1402 1405 O
explained 24 33 1406 1415 O
by 34 36 1416 1418 O
extensive 37 46 1419 1428 O
bone 47 51 1429 1433 B-cancer
marrow 52 58 1434 1440 I-cancer
plasmacytosis 59 72 1441 1454 I-cancer

Anticoagulant 0 13 0 13 B-treatment
usage 14 19 14 19 O
such 20 24 20 24 O
as 25 27 25 27 O
heparin 28 35 28 35 B-treatment
or 36 38 36 38 O
Plavix 39 45 39 45 B-treatment

Arrhythmia 0 10 46 56 B-chronic_disease

Known 0 5 57 62 O
or 6 8 63 65 O
suspected 9 18 66 75 O
Zenker 19 25 76 82 B-chronic_disease
's 25 27 82 84 I-chronic_disease
diverticulum 28 40 85 97 I-chronic_disease
of 41 43 98 100 O
esophagus 44 53 101 110 O
, 53 54 110 111 O
esophageal 55 65 112 122 B-chronic_disease
stricture 66 75 123 132 I-chronic_disease
, 75 76 132 133 O
head 77 81 134 138 B-treatment
/ 81 82 138 139 I-treatment
neck 82 86 139 143 I-treatment
radiation 87 96 144 153 I-treatment
therapy 97 104 154 161 I-treatment
, 104 105 161 162 O
hereditary 106 116 163 173 B-chronic_disease
telangiectasis 117 131 174 188 I-chronic_disease
, 131 132 188 189 O
esophageal 133 143 190 200 B-chronic_disease
varices 144 151 201 208 I-chronic_disease
, 151 152 208 209 O
cirrhosis 153 162 210 219 B-chronic_disease

Pregnant 0 8 220 228 B-pregnancy

Prior 0 5 229 234 O
known 6 11 235 240 O
or 12 14 241 243 O
suspected 15 24 244 253 O
nasal 25 30 254 259 B-chronic_disease
obstruction 31 42 260 271 I-chronic_disease

Serum 0 5 272 277 B-clinical_variable
creatinine 6 16 278 288 I-clinical_variable
> 17 18 289 290 O
2 19 20 291 292 B-lower_bound
mg 21 23 293 295 I-lower_bound
/ 23 24 295 296 I-lower_bound
dl 24 26 296 298 I-lower_bound

White 0 5 299 304 B-clinical_variable
Blood 6 11 305 310 I-clinical_variable
Cell 12 16 311 315 I-clinical_variable
count 17 22 316 321 I-clinical_variable
< 23 24 322 323 O
5,000 25 30 324 329 B-upper_bound
/ 30 31 329 330 I-upper_bound
mm3 31 34 330 333 I-upper_bound

Willing 0 7 334 341 O
and 8 11 342 345 O
able 12 16 346 350 O
to 17 19 351 353 O
give 20 24 354 358 O
informed 25 33 359 367 O
consent 34 41 368 375 O
in 42 44 376 378 O
either 45 51 379 385 O
English 52 59 386 393 B-language_fluency
or 60 62 394 396 O
Spanish 63 70 397 404 B-language_fluency

Active 0 6 0 6 O
pressure 7 15 7 15 B-chronic_disease
ulcers 16 22 16 22 I-chronic_disease

Current 0 7 23 30 O
use 8 11 31 34 O
of 12 14 35 37 O
medications 15 26 38 49 O
for 27 30 50 53 O
psychosis 31 40 54 63 B-chronic_disease

Diagnosed 0 9 64 73 O
with 10 14 74 78 O
stroke 15 21 79 85 B-chronic_disease

Recent 0 6 86 92 O
weight 7 13 93 99 B-clinical_variable
change 14 20 100 106 I-clinical_variable
( 21 22 107 108 O
+ 22 23 108 109 O
/- 23 25 109 111 O
25 26 28 112 114 B-upper_bound
pounds 29 35 115 121 I-upper_bound
in 36 38 122 124 O
1 39 40 125 126 B-upper_bound
year 41 45 127 131 I-upper_bound
) 45 46 131 132 O

Renal 0 5 133 138 B-chronic_disease
failure 6 13 139 146 I-chronic_disease

Severe 0 6 147 153 B-chronic_disease
pulmonary 7 16 154 163 I-chronic_disease
disease 17 24 164 171 I-chronic_disease

Chronic 0 7 0 7 B-clinical_variable
Kidney 8 14 8 14 I-clinical_variable
Disease 15 22 15 22 I-clinical_variable
Epidemiology 23 35 23 35 I-clinical_variable
Collaboration 36 49 36 49 I-clinical_variable
for 50 53 50 53 I-clinical_variable
estimation 54 64 54 64 I-clinical_variable
of 65 67 65 67 I-clinical_variable
GFR 68 71 68 71 I-clinical_variable
< 72 73 72 73 O
30 74 76 74 76 B-upper_bound
ml 77 79 77 79 I-upper_bound
/ 79 80 79 80 I-upper_bound
min/1.73m2 80 90 80 90 I-upper_bound

English 0 7 91 98 B-language_fluency
- 7 8 98 99 I-language_fluency
speaking 8 16 99 107 I-language_fluency
during 17 23 108 114 O
clinical 24 32 115 123 O
encounters 33 43 124 134 O

Known 0 5 135 140 O
history 6 13 141 148 O
of 14 16 149 151 O
dementia 17 25 152 160 B-chronic_disease

Legally 0 7 161 168 O
blind 8 13 169 174 B-chronic_disease

Listed 0 6 175 181 O
for 7 10 182 185 O
kidney 11 17 186 192 B-treatment
transplant 18 28 193 203 I-treatment

Stage 0 5 204 209 B-chronic_disease
4 6 7 210 211 I-chronic_disease
or 8 10 212 214 I-chronic_disease
5 11 12 215 216 I-chronic_disease
CKD 13 16 217 220 I-chronic_disease

HbA1c 0 5 0 5 B-clinical_variable
> 6 7 6 7 O
7.0 7 10 7 10 B-lower_bound
% 10 11 10 11 I-lower_bound
and 12 15 12 15 O
< 16 17 16 17 O
10.0 17 21 17 21 B-upper_bound
% 21 22 21 22 I-upper_bound

Individuals 0 11 23 34 O
with 12 16 35 39 O
evidence 17 25 40 48 O
of 26 28 49 51 O
proliferative 29 42 52 65 B-chronic_disease
diabetic 43 51 66 74 I-chronic_disease
retinopathy 52 63 75 86 I-chronic_disease
, 63 64 86 87 O
plasma 65 71 88 94 B-clinical_variable
creatinine 72 82 95 105 I-clinical_variable
> 83 84 106 107 O
1.4 84 87 107 110 B-lower_bound
females 88 95 111 118 B-gender
or 96 98 119 121 O
> 99 100 122 123 O
1.5 100 103 123 126 B-lower_bound
males 104 109 127 132 O
, 109 110 132 133 O
or 111 113 134 136 O
24 114 116 137 139 B-clinical_variable
- 116 117 139 140 I-clinical_variable
hour 117 121 140 144 I-clinical_variable
urine 122 127 145 150 I-clinical_variable
albumin 128 135 151 158 I-clinical_variable
excretion 136 145 159 168 I-clinical_variable
> 146 147 169 170 O
300 148 151 171 174 B-lower_bound
mg 152 154 175 177 I-lower_bound
will 155 159 178 182 O
be 160 162 183 185 O
excluded 163 171 186 194 O

Only 0 4 195 199 O
subjects 5 13 200 208 O
whose 14 19 209 214 O
body 20 24 215 219 B-clinical_variable
weight 25 31 220 226 I-clinical_variable
has 32 35 227 230 O
been 36 40 231 235 O
stable 41 47 236 242 O
( 48 49 243 244 O
± 49 50 244 245 O
3 51 52 246 247 B-lower_bound
lbs 53 56 248 251 I-lower_bound
) 56 57 251 252 O
over 58 62 253 257 O
the 63 66 258 261 O
preceding 67 76 262 271 B-upper_bound
three 77 82 272 277 I-upper_bound
months 83 89 278 284 I-upper_bound

Are 0 3 0 3 O
older 4 9 4 9 O
than 10 14 10 14 O
18 15 17 15 17 B-lower_bound
years 18 23 18 23 I-lower_bound

Cancer 0 6 24 30 B-cancer
patients 7 15 31 39 O

Latex 0 5 40 45 B-allergy_name
allergic 6 14 46 54 O
patients 15 23 55 63 O

Patients 0 8 64 72 O
that 9 13 73 77 O
present 14 21 78 85 O
with 22 26 86 90 O
free 27 31 91 95 O
pulmonary 32 41 96 105 B-chronic_disease
insufficiency 42 55 106 119 I-chronic_disease

Patients 0 8 120 128 O
who 9 12 129 132 O
have 13 17 133 137 O
lesions 18 25 138 145 O
predisposing 26 38 146 158 O
to 39 41 159 161 O
chronic 42 49 162 169 O
volume 50 56 170 176 O
overload 57 65 177 185 O
( 66 67 186 187 O
i.e. 67 71 187 191 O
patients 72 80 192 200 O
with 81 85 201 205 O
significant 86 97 206 217 O
residual 98 106 218 226 O
postoperative 107 120 227 240 O
ventricular 121 132 241 252 B-chronic_disease
septal 133 139 253 259 I-chronic_disease
defects 140 147 260 267 I-chronic_disease
( 148 149 268 269 I-chronic_disease
VSD 149 152 269 272 I-chronic_disease
) 152 153 272 273 I-chronic_disease
, 153 154 273 274 O
or 155 157 275 277 O
large 158 163 278 283 O
aorto 164 169 284 289 O
- 169 170 289 290 O
pulmonary 170 179 290 299 O
collaterals 180 191 300 311 O
or 192 194 312 314 O
more 195 199 315 319 O
than 200 204 320 324 O
moderate 205 213 325 333 O
tricuspid 214 223 334 343 B-chronic_disease
insufficiency 224 237 344 357 I-chronic_disease
) 237 238 357 358 O
since 239 244 359 364 O
all 245 248 365 368 O
these 249 254 369 374 O
hemodynamic 255 266 375 386 B-chronic_disease
conditions 267 277 387 397 I-chronic_disease
can 278 281 398 401 O
influence 282 291 402 411 O
the 292 295 412 415 O
late 296 300 416 420 O
function 301 309 421 429 O
of 310 312 430 432 O
the 313 316 433 436 O
right 317 322 437 442 O
ventricle 323 332 443 452 O
and 333 336 453 456 O
potentially 337 348 457 468 O
affect 349 355 469 475 O
the 356 359 476 479 O
response 360 368 480 488 O
of 369 371 489 491 O
the 372 375 492 495 O
right 376 381 496 501 O
side 382 386 502 506 O
of 387 389 507 509 O
the 390 393 510 513 O
heart 394 399 514 519 O
in 400 402 520 522 O
changes 403 410 523 530 O
in 411 413 531 533 O
volume 414 420 534 540 O
status 421 427 541 547 O

Patients 0 8 548 556 O
who 9 12 557 560 O
have 13 17 561 565 O
significant 18 29 566 577 O
residual 30 38 578 586 O
right 39 44 587 592 B-treatment
- 44 45 592 593 I-treatment
sided 45 50 593 598 I-treatment
obstruction 51 62 599 610 I-treatment
( 63 64 611 612 O
i.e. 64 68 612 616 O
patients 69 77 617 625 O
who 78 81 626 629 O
have 82 86 630 634 O
residual 87 95 635 643 O
RVOT 96 100 644 648 B-treatment
obstruction 101 112 649 660 I-treatment
or 113 115 661 663 O
significant 116 127 664 675 O
residual 128 136 676 684 O
branch 137 143 685 691 O
pulmonary 144 153 692 701 B-chronic_disease
artery 154 160 702 708 I-chronic_disease
stenosis 161 169 709 717 I-chronic_disease
) 169 170 717 718 O
, 170 171 718 719 O
as 172 174 720 722 O
it 175 177 723 725 O
is 178 180 726 728 O
shown 181 186 729 734 O
that 187 191 735 739 O
residual 192 200 740 748 B-treatment
pulmonary 201 210 749 758 I-treatment
stenosis 211 219 759 767 O
may 220 223 768 771 O
protect 224 231 772 779 O
from 232 236 780 784 O
RV 237 239 785 787 O
dilation 240 248 788 796 O
and 249 252 797 800 O
from 253 257 801 805 O
deterioration 258 271 806 819 O
of 272 274 820 822 O
the 275 278 823 826 O
RV 279 281 827 829 O
function 282 290 830 838 O

Patients 0 8 839 847 O
with 9 13 848 852 O
diabetes 14 22 853 861 B-chronic_disease

Patients 0 8 862 870 O
with 9 13 871 875 O
renal 14 19 876 881 B-chronic_disease
failure 20 27 882 889 I-chronic_disease
and 28 31 890 893 O
renal 32 37 894 899 B-chronic_disease
insufficiency 38 51 900 913 I-chronic_disease

Patients 0 8 914 922 O
with 9 13 923 927 O
uncompensated 14 27 928 941 B-chronic_disease
heart 28 33 942 947 I-chronic_disease
failure 34 41 948 955 I-chronic_disease

Pregnant 0 8 956 964 B-pregnancy
females 9 16 965 972 B-gender

TOF 0 3 973 976 B-chronic_disease
patients 4 12 977 985 O
who 13 16 986 989 O
have 17 21 990 994 O
had 22 25 995 998 O
repair 26 32 999 1005 O
using 33 38 1006 1011 O
a 39 40 1012 1013 O
transannular 41 53 1014 1026 B-treatment
patch 54 59 1027 1032 I-treatment

patients 0 8 1033 1041 O
with 9 13 1042 1046 O
anomalous 14 23 1047 1056 B-chronic_disease
coronary 24 32 1057 1065 I-chronic_disease
crossing 33 41 1066 1074 I-chronic_disease
the 42 45 1075 1078 I-chronic_disease
right 46 51 1079 1084 I-chronic_disease
ventricular 52 63 1085 1096 I-chronic_disease
outflow 64 71 1097 1104 I-chronic_disease
tract 72 77 1105 1110 I-chronic_disease
( 78 79 1111 1112 I-chronic_disease
RVOT 79 83 1112 1116 I-chronic_disease
) 83 84 1116 1117 I-chronic_disease

pulmonary 0 9 1118 1127 B-chronic_disease
atresia 10 17 1128 1135 I-chronic_disease
and 18 21 1136 1139 O
VSD 22 25 1140 1143 B-chronic_disease

Patients 0 8 0 8 O
who 9 12 9 12 O
are 13 16 13 16 B-pregnancy
pregnant 17 25 17 25 I-pregnancy

Patients 0 8 26 34 O
will 9 13 35 39 O
be 14 16 40 42 O
excluded 17 25 43 51 O
if 26 28 52 54 O
a 29 30 55 56 O
metabolic 31 40 57 66 B-chronic_disease
, 40 41 66 67 O
mechanical 42 52 68 78 B-chronic_disease
, 52 53 78 79 O
or 54 56 80 82 O
mucosal 57 64 83 90 B-chronic_disease
inflammatory 65 77 91 103 I-chronic_disease
cause 78 83 104 109 O
has 84 87 110 113 O
been 88 92 114 118 O
defined 93 100 119 126 O
to 101 103 127 129 O
explain 104 111 130 137 O
their 112 117 138 143 O
gastrointestinal 118 134 144 160 B-chronic_disease
symptoms 135 143 161 169 I-chronic_disease

Patients 0 8 170 178 O
will 9 13 179 183 O
be 14 16 184 186 O
recruited 17 26 187 196 O
from 27 31 197 201 O
the 32 35 202 205 O
pediatric 36 45 206 215 O
GI 46 48 216 218 O
clinic 49 55 219 225 O
if 56 58 226 228 O
they 59 63 229 233 O
meet 64 68 234 238 O
Rome 69 73 239 243 O
III 74 77 244 247 O
criteria 78 86 248 256 O
for 87 90 257 260 O
childhood 91 100 261 270 O
functional 101 111 271 281 O
dyspepsia 112 121 282 291 B-chronic_disease
with 122 126 292 296 O
nausea 127 133 297 303 O
as 134 136 304 306 O
the 137 140 307 310 O
predominant 141 152 311 322 O
symptom 153 160 323 330 O

Patients 0 8 331 339 O
with 9 13 340 344 O
diabetes 14 22 345 353 B-chronic_disease
will 23 27 354 358 O
be 28 30 359 361 O
excluded 31 39 362 370 O
due 40 43 371 374 O
to 44 46 375 377 O
the 47 50 378 381 O
possibility 51 62 382 393 O
that 63 67 394 398 O
the 68 71 399 402 O
autonomic 72 81 403 412 O
dysfunction 82 93 413 424 O
results 94 101 425 432 O
from 102 106 433 437 O
a 107 108 438 439 O
peripheral 109 119 440 450 B-chronic_disease
neuropathy 120 130 451 461 I-chronic_disease

a 0 1 462 463 O
diagnosis 2 11 464 473 O
of 12 14 474 476 O
inflammatory 15 27 477 489 B-chronic_disease
bowel 28 33 490 495 I-chronic_disease
disease 34 41 496 503 I-chronic_disease
, 41 42 503 504 O
celiac 43 49 505 511 B-chronic_disease
disease 50 57 512 519 I-chronic_disease
, 57 58 519 520 O
liver 59 64 521 526 B-chronic_disease
or 65 67 527 529 I-chronic_disease
pancreatic 68 78 530 540 I-chronic_disease
disease 79 86 541 548 I-chronic_disease
, 86 87 548 549 O
hiatal 88 94 550 556 B-chronic_disease
hernia 95 101 557 563 I-chronic_disease
, 101 102 563 564 O
or 103 105 565 567 O
bowel 106 111 568 573 B-chronic_disease
obstruction 112 123 574 585 I-chronic_disease

age 0 3 586 589 B-age
range 4 9 590 595 O
of 10 12 596 598 O
10 13 15 599 601 B-lower_bound
- 15 16 601 602 O
18 16 18 602 604 B-upper_bound
years 19 24 605 610 I-upper_bound

Age 0 3 0 3 B-age
over 4 8 4 8 O
18 9 11 9 11 B-lower_bound
years 12 17 12 17 I-lower_bound

Corneal 0 7 18 25 B-chronic_disease
ulcer 8 13 26 31 I-chronic_disease
that 14 18 32 36 O
is 19 21 37 39 O
smear 22 27 40 45 O
positive 28 36 46 54 O
for 37 40 55 58 O
either 41 47 59 65 O
bacteria 48 56 66 74 O
or 57 59 75 77 O
filamentous 60 71 78 89 O
fungus 72 78 90 96 O

Evidence 0 8 97 105 O
of 9 11 106 108 O
concomitant 12 23 109 120 O
infection 24 33 121 130 O
on 34 36 131 133 O
exam 37 41 134 138 O
or 42 44 139 141 O
gram 45 49 142 146 B-treatment
stain 50 55 147 152 I-treatment
( 56 57 153 154 O
i.e. 57 61 154 158 O
herpes 62 68 159 165 B-chronic_disease
, 68 69 165 166 O
both 70 74 167 171 O
bacteria 75 83 172 180 O
and 84 87 181 184 O
acanthamoeba 88 100 185 197 O
on 101 103 198 200 O
gram 104 108 201 205 O
stain 109 114 206 211 O
) 114 115 211 212 O

History 0 7 213 220 O
of 8 10 221 223 O
corneal 11 18 224 231 B-treatment
transplantation 19 34 232 247 I-treatment
or 35 37 248 250 O
recent 38 44 251 257 B-treatment
intraocular 45 56 258 269 I-treatment
surgery 57 64 270 277 I-treatment

Impending 0 9 278 287 O
or 10 12 288 290 O
frank 13 18 291 296 B-chronic_disease
perforation 19 30 297 308 I-chronic_disease
at 31 33 309 311 O
recruitment 34 45 312 323 O

Non 0 3 324 327 B-chronic_disease
- 3 4 327 328 I-chronic_disease
infectious 4 14 328 338 I-chronic_disease
or 15 17 339 341 I-chronic_disease
autoimmune 18 28 342 352 I-chronic_disease
keratitis 29 38 353 362 I-chronic_disease

Not 0 3 363 366 O
treated 4 11 367 374 O
already 12 19 375 382 O
with 20 24 383 387 O
antimicrobial 25 38 388 401 B-treatment
medications 39 50 402 413 I-treatment
at 51 53 414 416 O
presentation 54 66 417 429 O

Participants 0 12 430 442 O
who 13 16 443 446 O
are 17 20 447 450 O
decisionally 21 33 451 463 O
and/or 34 40 464 470 O
cognitively 41 52 471 482 B-chronic_disease
impaired 53 61 483 491 I-chronic_disease

Pinhole 0 7 492 499 B-clinical_variable
visual 8 14 500 506 I-clinical_variable
acuity 15 21 507 513 I-clinical_variable
worse 22 27 514 519 O
than 28 32 520 524 O
20/200 33 39 525 531 B-lower_bound
in 40 42 532 534 O
the 43 46 535 538 O
unaffected 47 57 539 549 O
eye 58 61 550 553 O

Pinhole 0 7 554 561 B-clinical_variable
visual 8 14 562 568 I-clinical_variable
acuity 15 21 569 575 I-clinical_variable
worse 22 27 576 581 O
than 28 32 582 586 O
20/70 33 38 587 592 B-lower_bound
in 39 41 593 595 O
the 42 45 596 599 O
affected 46 54 600 608 O
eye 55 58 609 612 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
either 13 19 13 19 O
Open 20 24 20 24 B-chronic_disease
- 24 25 24 25 I-chronic_disease
Angle 25 30 25 30 I-chronic_disease
Glaucoma 31 39 31 39 I-chronic_disease
or 40 42 40 42 O
Ocular 43 49 43 49 B-chronic_disease
Hypertension 50 62 50 62 I-chronic_disease
in 63 65 63 65 O
each 66 70 66 70 O
eye 71 74 71 74 O
that 75 79 75 79 O
require 80 87 80 87 O
IOP 88 91 88 91 B-treatment
lowering 92 100 92 100 I-treatment
treatment 101 110 101 110 I-treatment

Enrollment 0 10 111 121 O
in 11 13 122 124 O
other 14 19 125 130 O
studies 20 27 131 138 O
using 28 33 139 144 O
Bimatoprost 34 45 145 156 O
SR 46 48 157 159 I-treatment

Eye 0 3 160 163 B-treatment
surgery 4 11 164 171 I-treatment
( 12 13 172 173 O
including 13 22 173 182 O
cataract 23 31 183 191 B-treatment
surgery 32 39 192 199 I-treatment
) 39 40 199 200 O
and 41 44 201 204 O
or 45 47 205 207 O
eye 48 51 208 211 B-treatment
laser 52 57 212 217 I-treatment
surgery 58 65 218 225 I-treatment
within 66 72 226 232 O
the 73 76 233 236 O
past 77 81 237 241 B-upper_bound
6 82 83 242 243 I-upper_bound
months 84 90 244 250 I-upper_bound

At 0 2 0 2 O
least 3 8 3 8 O
1 9 10 9 10 B-lower_bound
lesion 11 17 11 17 O
with 18 22 18 22 O
measurable 23 33 23 33 O
disease 34 41 34 41 O
at 42 44 42 44 O
baseline 45 53 45 53 O

Autoimmune 0 10 54 64 B-chronic_disease
disease 11 18 65 72 I-chronic_disease

Availability 0 12 73 85 O
of 13 15 86 88 O
an 16 18 89 91 O
existing 19 27 92 100 O
tumor 28 33 101 106 B-treatment
biopsy 34 40 107 113 I-treatment
sample 41 47 114 120 O
( 48 49 121 122 O
and 49 52 122 125 O
consent 53 60 126 133 O
to 61 63 134 136 O
allow 64 69 137 142 O
pre 70 73 143 146 B-treatment
- 73 74 146 147 I-treatment
treatment 74 83 147 156 I-treatment
tumor 84 89 157 162 I-treatment
biopsy 90 96 163 169 I-treatment
) 96 97 169 170 O

ECOG 0 4 171 175 B-clinical_variable
performance 5 16 176 187 I-clinical_variable
status 17 23 188 194 I-clinical_variable
between 24 31 195 202 O
0 32 33 203 204 B-lower_bound
and 34 37 205 208 O
2 38 39 209 210 B-upper_bound

Encephalitis 0 12 211 223 B-chronic_disease
, 12 13 223 224 O
meningitis 14 24 225 235 B-chronic_disease
, 24 25 235 236 O
or 26 28 237 239 O
uncontrolled 29 41 240 252 O
seizures 42 50 253 261 B-chronic_disease
in 51 53 262 264 O
the 54 57 265 268 O
year 58 62 269 273 O
prior 63 68 274 279 O
to 69 71 280 282 O
informed 72 80 283 291 O
consent 81 88 292 299 O

For 0 3 300 303 O
Dose 4 8 304 308 O
Expansion 9 18 309 318 O
: 18 19 318 319 O
all 20 23 320 323 O
of 24 26 324 326 O
the 27 30 327 330 O
above 31 36 331 336 O
in 37 39 337 339 O
escalation 40 50 340 350 O
except 51 57 351 357 O
for 58 61 358 361 O
cervical 62 70 362 370 B-cancer
, 70 71 370 371 O
ovarian 72 79 372 379 B-cancer
, 79 80 379 380 O
and 81 84 381 384 O
CRC 85 88 385 388 B-cancer

For 0 3 389 392 O
Dose 4 8 393 397 O
escalation 9 19 398 408 O
: 19 20 408 409 O
subjects 21 29 410 418 O
with 30 34 419 423 O
cervical 35 43 424 432 B-cancer
, 43 44 432 433 O
ovarian 45 52 434 441 B-cancer
, 52 53 441 442 O
bladder 54 61 443 450 B-cancer
and 62 65 451 454 O
colorectal 66 76 455 465 B-cancer
cancer 77 83 466 472 I-cancer
( 84 85 473 474 I-cancer
CRC 85 88 474 477 I-cancer
) 88 89 477 478 I-cancer
, 89 90 478 479 O
head 91 95 480 484 B-cancer
and 96 99 485 488 I-cancer
neck 100 104 489 493 I-cancer
, 104 105 493 494 O
gastric 106 113 495 502 B-cancer
and 114 117 503 506 O
hepatocellular 118 132 507 521 B-cancer
cancer 133 139 522 528 I-cancer
naive 140 145 529 534 O
to 146 148 535 537 O
immuno 149 155 538 544 B-treatment
- 155 156 544 545 I-treatment
oncology 156 164 545 553 I-treatment
agents 165 171 554 560 I-treatment
; 171 172 560 561 O
1st 173 176 562 565 B-cancer
line 177 181 566 570 I-cancer
melanoma 182 190 571 579 I-cancer
and 191 194 580 583 O
1st 195 198 584 587 O
line/2nd 199 207 588 596 O
line 208 212 597 601 O
NSCLC 213 218 602 607 B-cancer
; 218 219 607 608 O
Renal 220 225 609 614 B-cancer
Cell 226 230 615 619 I-cancer
Carcinoma 231 240 620 629 I-cancer
naive 241 246 630 635 O
to 247 249 636 638 O
IO 250 252 639 641 B-treatment
; 252 253 641 642 O
NSCLC 254 259 643 648 O
progressing 260 271 649 660 O
while 272 277 661 666 O
on 278 280 667 669 O
or 281 283 670 672 O
after 284 289 673 678 B-treatment
therapy 290 297 679 686 I-treatment
with 298 302 687 691 I-treatment
anti 303 307 692 696 I-treatment
- 307 308 696 697 I-treatment
PD1 308 311 697 700 I-treatment
/ 311 312 700 701 I-treatment
anti 312 316 701 705 I-treatment
- 316 317 705 706 I-treatment
PDL-1 317 322 706 711 I-treatment
and 323 326 712 715 O
melanoma 327 335 716 724 O
subjects 336 344 725 733 O
progressed 345 355 734 744 O
while 356 361 745 750 O
- 361 362 750 751 O
on 362 364 751 753 O
or 365 367 754 756 O
after 368 373 757 762 B-treatment
treatment 374 383 763 772 I-treatment
with 384 388 773 777 I-treatment
anti 389 393 778 782 I-treatment
- 393 394 782 783 I-treatment
PD1 394 397 783 786 I-treatment
or 398 400 787 789 I-treatment
anti 401 405 790 794 I-treatment
- 405 406 794 795 I-treatment
PDL1 406 410 795 799 I-treatment
with 411 415 800 804 I-treatment
or 416 418 805 807 I-treatment
without 419 426 808 815 I-treatment
anti 427 431 816 820 I-treatment
- 431 432 820 821 I-treatment
CTLA-4 432 438 821 827 I-treatment

Primary 0 7 828 835 B-cancer
central 8 15 836 843 I-cancer
nervous 16 23 844 851 I-cancer
system 24 30 852 858 I-cancer
( 31 32 859 860 I-cancer
CNS 32 35 860 863 I-cancer
) 35 36 863 864 I-cancer
tumors 37 43 865 871 I-cancer
or 44 46 872 874 O
solid 47 52 875 880 B-cancer
tumors 53 59 881 887 I-cancer
with 60 64 888 892 O
CNS 65 68 893 896 B-cancer
metastases 69 79 897 907 I-cancer
as 80 82 908 910 O
the 83 86 911 914 O
only 87 91 915 919 O
site 92 96 920 924 O
of 97 99 925 927 O
active 100 106 928 934 O
disease 107 114 935 942 O

Progressed 0 10 943 953 O
, 10 11 953 954 O
or 12 14 955 957 O
been 15 19 958 962 O
intolerant 20 30 963 973 O
to 31 33 974 976 O
, 33 34 976 977 O
at 35 37 978 980 O
least 38 43 981 986 O
one 44 47 987 990 B-lower_bound
standard 48 56 991 999 O
treatment 57 66 1000 1009 B-treatment
regimen 67 74 1010 1017 I-treatment
, 74 75 1017 1018 O
except 76 82 1019 1025 O
for 83 86 1026 1029 O
subjects 87 95 1030 1038 O
in 96 98 1039 1041 O
1st 99 102 1042 1045 O
line 103 107 1046 1050 O
cohorts 108 115 1051 1058 O

Uncontrolled 0 12 1059 1071 O
CNS 13 16 1072 1075 B-cancer
metastases 17 27 1076 1086 I-cancer

Barcelona 0 9 0 9 B-clinical_variable
Clinic 10 16 10 16 I-clinical_variable
Liver 17 22 17 22 I-clinical_variable
Cancer 23 29 23 29 I-clinical_variable
Stage 30 35 30 35 I-clinical_variable
A 36 37 36 37 O
, 37 38 37 38 O
B 39 40 39 40 O
or 41 43 41 43 O
C 44 45 44 45 O
( 46 47 46 47 O
for 47 50 47 50 O
patients 51 59 51 59 O
with 60 64 60 64 O
hepatocellular 65 79 65 79 B-cancer
carcinoma 80 89 80 89 I-cancer
only 90 94 90 94 O
) 94 95 94 95 O

Child 0 5 96 101 B-clinical_variable
- 5 6 101 102 I-clinical_variable
Pugh 6 10 102 106 I-clinical_variable
- 10 11 106 107 I-clinical_variable
Turcotte 11 19 107 115 I-clinical_variable
score 20 25 116 121 I-clinical_variable
< 26 27 122 123 O
7 28 29 124 125 B-upper_bound
( 30 31 126 127 O
for 31 34 127 130 O
patients 35 43 131 139 O
with 44 48 140 144 O
hepatocellular 49 63 145 159 B-cancer
carcinoma 64 73 160 169 I-cancer
only 74 78 170 174 O
) 78 79 174 175 O

Child 0 5 176 181 B-clinical_variable
- 5 6 181 182 I-clinical_variable
Pugh 6 10 182 186 I-clinical_variable
- 10 11 186 187 I-clinical_variable
Turcotte 11 19 187 195 I-clinical_variable
score 20 25 196 201 I-clinical_variable
< 26 27 202 203 O
7 27 28 203 204 B-upper_bound
( 29 30 205 206 O
for 30 33 206 209 O
patients 34 42 210 218 O
with 43 47 219 223 O
hepatocellular 48 62 224 238 B-cancer
carcinoma 63 72 239 248 I-cancer
only 73 77 249 253 O
) 77 78 253 254 O

Creatinine 0 10 255 265 B-clinical_variable
clearance 11 20 266 275 I-clinical_variable
as 21 23 276 278 O
estimated 24 33 279 288 O
by 34 36 289 291 O
Cockcroft 37 46 292 301 O
Gault 47 52 302 307 O
or 53 55 308 310 O
Schwartz 56 64 311 319 O
≥ 65 66 320 321 O
60 67 69 322 324 B-lower_bound
ml 70 72 325 327 I-lower_bound
/ 72 73 327 328 I-lower_bound
min 73 76 328 331 I-lower_bound

GPC3 0 4 332 336 O
expression 5 15 337 347 O
will 16 20 348 352 O
be 21 23 353 355 O
evaluated 24 33 356 365 O
by 34 36 366 368 O
standard 37 45 369 377 O
immunohistochemistry 46 66 378 398 B-treatment
( 67 68 399 400 I-treatment
IHC 68 71 400 403 I-treatment
) 71 72 403 404 I-treatment
. 72 73 404 405 O
A 74 75 406 407 O
tumor 76 81 408 413 B-cancer
is 82 84 414 416 O
considered 85 95 417 427 O
GPC3 96 100 428 432 O
positive 101 109 433 441 O
, 109 110 441 442 O
when 111 115 443 447 O
the 116 119 448 451 O
staining 120 128 452 460 O
is 129 131 461 463 O
Grade 132 137 464 469 O
2 138 139 470 471 B-lower_bound
( 140 141 472 473 O
> 141 142 473 474 O
25 142 144 474 476 B-lower_bound
% 144 145 476 477 I-lower_bound
positive 146 154 478 486 B-clinical_variable
tumor 155 160 487 492 I-clinical_variable
cells 161 166 493 498 I-clinical_variable
) 166 167 498 499 O
or 168 170 500 502 O
above 171 176 503 508 O
with 177 181 509 513 O
an 182 184 514 516 O
intensity 185 194 517 526 O
score 195 200 527 532 O
of 201 203 533 535 O
2 204 205 536 537 O
or 206 208 538 540 O
above 209 214 541 546 O
on 215 217 547 549 O
a 218 219 550 551 O
scale 220 225 552 557 O
of 226 228 558 560 O
0 229 230 561 562 B-lower_bound
to 231 233 563 565 O
4 234 235 566 567 B-upper_bound

Hgb 0 3 568 571 B-clinical_variable
≥7.0 4 8 572 576 O
g 9 10 577 578 I-lower_bound
/ 10 11 578 579 I-lower_bound
dl 11 13 579 581 I-lower_bound
( 14 15 582 583 O
can 15 18 583 586 O
be 19 21 587 589 O
transfused 22 32 590 600 O
) 32 33 600 601 O

INR 0 3 602 605 B-clinical_variable
≤1.7 4 8 606 610 O
( 9 10 611 612 O
for 10 13 612 615 O
patients 14 22 616 624 O
with 23 27 625 629 O
hepatocellular 28 42 630 644 B-cancer
carcinoma 43 52 645 654 I-cancer
only 53 57 655 659 O
) 57 58 659 660 O

Lansky 0 6 661 667 B-clinical_variable
or 7 9 668 670 O
Karnofsky 10 19 671 680 B-clinical_variable
score 20 25 681 686 I-clinical_variable
≥ 26 27 687 688 O
60 28 30 689 691 B-lower_bound
% 30 31 691 692 I-lower_bound

Lansky 0 6 693 699 B-clinical_variable
or 7 9 700 702 O
Karnofsky 10 19 703 712 B-clinical_variable
score 20 25 713 718 I-clinical_variable
≥60 26 29 719 722 O
% 29 30 722 723 I-lower_bound

Life 0 4 724 728 B-clinical_variable
expectancy 5 15 729 739 I-clinical_variable
of 16 18 740 742 O
≥ 19 20 743 744 O
12 21 23 745 747 B-lower_bound
weeks 24 29 748 753 I-lower_bound

Pregnancy 0 9 754 763 B-pregnancy

Recovered 0 9 764 773 O
from 10 14 774 778 O
acute 15 20 779 784 O
toxic 21 26 785 790 O
effects 27 34 791 798 O
of 35 37 799 801 O
all 38 41 802 805 O
prior 42 47 806 811 O
chemotherapy 48 60 812 824 B-treatment
and 61 64 825 828 O
investigational 65 80 829 844 B-treatment
agents 81 87 845 851 I-treatment
before 88 94 852 858 O
entering 95 103 859 867 O
this 104 108 868 872 O
study 109 114 873 878 O

Sexually 0 8 879 887 O
active 9 15 888 894 O
patients 16 24 895 903 O
must 25 29 904 908 O
be 30 32 909 911 O
willing 33 40 912 919 O
to 41 43 920 922 O
utilize 44 51 923 930 O
one 52 55 931 934 O
of 56 58 935 937 O
the 59 62 938 941 O
more 63 67 942 946 O
effective 68 77 947 956 O
birth 78 83 957 962 O
control 84 91 963 970 O
methods 92 99 971 978 O
for 100 103 979 982 O
3 104 105 983 984 B-upper_bound
months 106 112 985 991 I-upper_bound
after 113 118 992 997 O
the 119 122 998 1001 O
T 123 124 1002 1003 B-treatment
- 124 125 1003 1004 I-treatment
cell 125 129 1004 1008 I-treatment
infusion 130 138 1009 1017 I-treatment

Uncontrolled 0 12 1018 1030 B-chronic_disease
infection 13 22 1031 1040 I-chronic_disease

absolute 0 8 1041 1049 B-clinical_variable
neutrophil 9 19 1050 1060 I-clinical_variable
count 20 25 1061 1066 I-clinical_variable
> 26 27 1067 1068 O
500 28 31 1069 1072 B-lower_bound
/ 31 32 1072 1073 I-lower_bound
microliter 32 42 1073 1083 I-lower_bound

platelet 0 8 1084 1092 B-clinical_variable
count 9 14 1093 1098 I-clinical_variable
> 15 16 1099 1100 O
25,000 17 23 1101 1107 B-lower_bound
/ 23 24 1107 1108 I-lower_bound
microliter 24 34 1108 1118 I-lower_bound
( 35 36 1119 1120 O
can 36 39 1120 1123 O
be 40 42 1124 1126 O
transfused 43 53 1127 1137 O
) 53 54 1137 1138 O

pulse 0 5 1139 1144 B-clinical_variable
oximetry 6 14 1145 1153 I-clinical_variable
> 15 16 1154 1155 O
90 16 18 1155 1157 B-lower_bound
% 18 19 1157 1158 I-lower_bound
on 20 22 1159 1161 O
room 23 27 1162 1166 O
air 28 31 1167 1170 O

serum 0 5 1171 1176 B-clinical_variable
AST 6 9 1177 1180 I-clinical_variable
< 9 10 1180 1181 O
5 11 12 1182 1183 B-upper_bound
times 13 18 1184 1189 I-upper_bound
ULN 19 22 1190 1193 I-upper_bound

total 0 5 1194 1199 O
bilirubin 6 15 1200 1209 B-clinical_variable
< 16 17 1210 1211 O
3 18 19 1212 1213 B-upper_bound
times 20 25 1214 1219 I-upper_bound
ULN 26 29 1220 1223 I-upper_bound
for 30 33 1224 1227 O
age 34 37 1228 1231 B-age

( 0 1 0 1 O
inclusive 1 10 1 10 O
) 10 11 10 11 O
at 12 14 12 14 O
time 15 19 15 19 O
of 20 22 20 22 O
diagnosis 23 32 23 32 O
of 33 35 33 35 O
underlying 36 46 36 46 O
malignancy 47 57 47 57 B-cancer

Are 0 3 58 61 O
anticipated 4 15 62 73 O
to 16 18 74 76 O
be 19 21 77 79 O
able 22 26 80 84 O
to 27 29 85 87 O
comply 30 36 88 94 O
with 37 41 95 99 O
end 42 45 100 103 O
- 45 46 103 104 O
of 46 48 104 106 O
- 48 49 106 107 O
therapy 49 56 107 114 B-treatment
audiology 57 66 115 124 O
assessment 67 77 125 135 O
( 78 79 136 137 O
note 79 83 137 141 O
that 84 88 142 146 O
hearing 89 96 147 154 O
assessments 97 108 155 166 O
are 109 112 167 170 O
performed 113 122 171 180 O
per 123 126 181 184 O
routine 127 134 185 192 O
clinical 135 143 193 201 O
care 144 148 202 206 O
in 149 151 207 209 O
children 152 160 210 218 O
receiving 161 170 219 228 O
cisplatin 171 180 229 238 B-treatment
and 181 184 239 242 O
consist 185 192 243 250 O
of 193 195 251 253 O
an 196 198 254 256 O
audiogram 199 208 257 266 B-treatment
or 209 211 267 269 O
auditory 212 220 270 278 B-treatment
brainstem 221 230 279 288 I-treatment
response 231 239 289 297 I-treatment
, 239 240 297 298 O
and 241 244 299 302 O
distortion 245 255 303 313 B-treatment
- 255 256 313 314 I-treatment
product 256 263 314 321 I-treatment
otoacoustic 264 275 322 333 I-treatment
emissions 276 285 334 343 I-treatment

Are 0 3 344 347 O
between 4 11 348 355 O
1 12 13 356 357 B-lower_bound
and 14 17 358 361 O
21 18 20 362 364 B-upper_bound
years 21 26 365 370 I-upper_bound
of 27 29 371 373 O
age 30 33 374 377 B-age

Cisplatin 0 9 378 387 B-treatment
must 10 14 388 392 O
be 15 17 393 395 O
delivered 18 27 396 405 O
over 28 32 406 410 O
<3 33 35 411 413 O
day 36 39 414 417 I-upper_bound

Disseminated 0 12 418 430 B-chronic_disease
disease 13 20 431 438 I-chronic_disease
( 21 22 439 440 O
e.g. 22 26 440 444 O
lepto 27 32 445 450 B-cancer
- 32 33 450 451 I-cancer
meningeal 33 42 451 460 I-cancer
spread 43 49 461 467 O
, 49 50 467 468 O
tumor 51 56 469 474 B-cancer
metastases 57 67 475 485 I-cancer
) 67 68 485 486 O

Documented 0 10 487 497 O
hypersensitivity 11 27 498 514 O
or 28 30 515 517 O
allergy 31 38 518 525 O
to 39 41 526 528 O
previous 42 50 529 537 O
NAC 51 54 538 541 B-allergy_name
infusion 55 63 542 550 I-allergy_name

Have 0 4 551 555 O
a 5 6 556 557 O
new 7 10 558 561 O
diagnosis 11 20 562 571 O
of 21 23 572 574 O
a 24 25 575 576 O
localized 26 35 577 586 O
malignancy 36 46 587 597 B-cancer
with 47 51 598 602 O
a 52 53 603 604 O
planned 54 61 605 612 B-treatment
treatment 62 71 613 622 I-treatment
course 72 78 623 629 O
to 79 81 630 632 O
include 82 89 633 640 O
at 90 92 641 643 O
least 93 98 644 649 O
two 99 102 650 653 B-lower_bound
cycles 103 109 654 660 O
of 110 112 661 663 O
cisplatin 113 122 664 673 B-treatment

Hepatic 0 7 674 681 O
, 7 8 681 682 O
biliary 9 16 683 690 O
, 16 17 690 691 O
cardiac 18 25 692 699 O
, 25 26 699 700 O
or 27 29 701 703 O
bone 30 34 704 708 O
marrow 35 41 709 715 O
function 42 50 716 724 O
inadequate 51 61 725 735 O
for 62 65 736 739 O
chemotherapy 66 78 740 752 B-treatment
as 79 81 753 755 O
per 82 85 756 759 O
patient 86 93 760 767 O
's 93 95 767 769 O
treatment 96 105 770 779 B-treatment
regimen 106 113 780 787 I-treatment

Karnofsky 0 9 788 797 B-clinical_variable
or 10 12 798 800 I-clinical_variable
Lansky 13 19 801 807 I-clinical_variable
score 20 25 808 813 I-clinical_variable
< 26 27 814 815 O
50 27 29 815 817 B-upper_bound
% 29 30 817 818 I-upper_bound

Moderate 0 8 819 827 B-chronic_disease
or 9 11 828 830 I-chronic_disease
Severe 12 18 831 837 I-chronic_disease
Persistent 19 29 838 848 I-chronic_disease
Asthma 30 36 849 855 I-chronic_disease
as 37 39 856 858 O
defined 40 47 859 866 O
by 48 50 867 869 O
the 51 54 870 873 O
latest 55 61 874 880 O
recommendations 62 77 881 896 O
from 78 82 897 901 O
the 83 86 902 905 O
National 87 95 906 914 O
Heart 96 101 915 920 O
Lung 102 106 921 925 O
and 107 110 926 929 O
Blood 111 116 930 935 O
Institute 117 126 936 945 O
definition 127 137 946 956 O
includes 138 146 957 965 O
daily 147 152 966 971 O
asthma 153 159 972 978 B-chronic_disease
exacerbation 160 172 979 991 I-chronic_disease
with 173 177 992 996 O
need 178 182 997 1001 O
for 183 186 1002 1005 O
rescue 187 193 1006 1012 O
medication 194 204 1013 1023 B-treatment
) 204 205 1023 1024 O
or 206 208 1025 1027 O
an 209 211 1028 1030 O
overnight 212 221 1031 1040 O
hospitalization 222 237 1041 1056 B-treatment
for 238 241 1057 1060 O
asthma 242 248 1061 1067 O
exacerbation 249 261 1068 1080 O
within 262 268 1081 1087 O
the 269 272 1088 1091 O
previous 273 281 1092 1100 B-upper_bound
28 282 284 1101 1103 I-upper_bound
days 285 289 1104 1108 I-upper_bound

Most 0 4 1109 1113 O
common 5 11 1114 1120 O
but 12 15 1121 1124 O
not 16 19 1125 1128 O
exclusive 20 29 1129 1138 O
diagnoses 30 39 1139 1148 O
consist 40 47 1149 1156 O
of 48 50 1157 1159 O
hepatoblastoma 51 65 1160 1174 B-cancer
, 65 66 1174 1175 O
medulloblastoma 67 82 1176 1191 B-cancer
, 82 83 1191 1192 O
osteosarcoma 84 96 1193 1205 B-cancer

Planned 0 7 1206 1213 O
cisplatin 8 17 1214 1223 B-treatment
dose 18 22 1224 1228 O
to 23 25 1229 1231 O
be 26 28 1232 1234 O
infused 29 36 1235 1242 O
over 37 41 1243 1247 O
≤6 42 44 1248 1250 O
hours 45 50 1251 1256 I-upper_bound
for 51 54 1257 1260 O
≤2 55 57 1261 1263 O
days 58 62 1264 1268 I-upper_bound
per 63 66 1269 1272 O
cycle 67 72 1273 1278 O

Pregnancy 0 9 1279 1288 B-pregnancy
or 10 12 1289 1291 O
breast 13 19 1292 1298 O
- 19 20 1298 1299 O
feeding 20 27 1299 1306 O
mothers 28 35 1307 1314 O

Total 0 5 1315 1320 O
cumulative 6 16 1321 1331 O
dose 17 21 1332 1336 O
of 22 24 1337 1339 O
planned 25 32 1340 1347 O
cisplatin 33 42 1348 1357 B-clinical_variable
must 43 47 1358 1362 O
be 48 50 1363 1365 O
> 51 52 1366 1367 O
200 52 55 1367 1370 B-lower_bound
mg 56 58 1371 1373 I-lower_bound
/ 58 59 1373 1374 I-lower_bound
m2 59 61 1374 1376 I-lower_bound
( 62 63 1377 1378 O
or 63 65 1378 1380 O
6.67 66 70 1381 1385 B-lower_bound
mg 71 73 1386 1388 I-lower_bound
/ 73 74 1388 1389 I-lower_bound
kg 74 76 1389 1391 I-lower_bound
equivalent 77 87 1392 1402 O
for 88 91 1403 1406 O
infants 92 99 1407 1414 O
requiring 100 109 1415 1424 O
weight 110 116 1425 1431 O
- 116 117 1431 1432 O
based 117 122 1432 1437 O
dosing 123 129 1438 1444 O

no 0 2 1445 1447 O
preexisting 3 14 1448 1459 O
risk 15 19 1460 1464 O
of 20 22 1465 1467 O
serious 23 30 1468 1475 O
arrhythmia 31 41 1476 1486 B-chronic_disease
as 42 44 1487 1489 O
defined 45 52 1490 1497 O
by 53 55 1498 1500 O
( 56 57 1501 1502 O
a 57 58 1502 1503 O
) 58 59 1503 1504 O
normal 60 66 1505 1511 O
sinus 67 72 1512 1517 O
rhythm 73 79 1518 1524 O
on 80 82 1525 1527 O
electrocardiogram 83 100 1528 1545 O
and 101 104 1546 1549 O
corrected 105 114 1550 1559 B-clinical_variable
QT 115 117 1560 1562 I-clinical_variable
interval 118 126 1563 1571 I-clinical_variable
< 127 128 1572 1573 O
500 128 131 1573 1576 B-upper_bound
and 132 135 1577 1580 O
( 136 137 1581 1582 O
b 137 138 1582 1583 O
) 138 139 1583 1584 O
no 140 142 1585 1587 O
previous 143 151 1588 1596 O
history 152 159 1597 1604 O
of 160 162 1605 1607 O
congenital 163 173 1608 1618 O
arrhythmia 174 184 1619 1629 O
( 185 186 1630 1631 O
e.g. 186 190 1631 1635 O
Wolf 191 195 1636 1640 B-chronic_disease
- 195 196 1640 1641 I-chronic_disease
Parkinson 196 205 1641 1650 I-chronic_disease
- 205 206 1650 1651 I-chronic_disease
White 206 211 1651 1656 I-chronic_disease
) 211 212 1656 1657 O

Active 0 6 0 6 B-chronic_disease
vaginal 7 14 7 14 I-chronic_disease
bleeding 15 23 15 23 I-chronic_disease
requiring 24 33 24 33 O
packing 34 41 34 41 O
and 42 45 42 45 O
emergent 46 54 46 54 B-treatment
radiation 55 64 55 64 I-treatment
therapy 65 72 65 72 I-treatment

Age 0 3 73 76 B-age
≥ 4 5 77 78 O
18 6 8 79 81 B-lower_bound
years 9 14 82 87 I-lower_bound
of 15 17 88 90 O
age 18 21 91 94 B-age
( 22 23 95 96 O
no 23 25 96 98 O
upper 26 31 99 104 O
age 32 35 105 108 O
limit 36 41 109 114 O
) 41 42 114 115 O

Body 0 4 116 120 B-bmi
Mass 5 9 121 125 I-bmi
Index 10 15 126 131 I-bmi
( 16 17 132 133 I-bmi
BMI 17 20 133 136 I-bmi
) 20 21 136 137 I-bmi
> 22 23 138 139 O
35 24 26 140 142 B-lower_bound

History 0 7 143 150 O
of 8 10 151 153 O
a 11 12 154 155 O
prior 13 18 156 161 O
malignancy 19 29 162 172 B-cancer
within 30 36 173 179 O
past 37 41 180 184 B-upper_bound
5 42 43 185 186 I-upper_bound
years 44 49 187 192 I-upper_bound

Inability 0 9 193 202 O
to 10 12 203 205 O
tolerate 13 21 206 214 O
MRI 22 25 215 218 O
( 26 27 219 220 O
e.g. 27 31 220 224 O
, 31 32 224 225 O
inability 33 42 226 235 O
to 43 45 236 238 O
lie 46 49 239 242 O
flat 50 54 243 247 O
for 55 58 248 251 O
> 59 60 252 253 O
1 60 61 253 254 B-lower_bound
hour 62 66 255 259 I-lower_bound
) 66 67 259 260 O

Medical 0 7 261 268 O
conditions 8 18 269 279 O
precluding 19 29 280 290 O
radiation 30 39 291 300 B-treatment
therapy 40 47 301 308 I-treatment
or 48 50 309 311 O
curative 51 59 312 320 B-treatment
intent 60 66 321 327 I-treatment
surgery 67 74 328 335 I-treatment

Must 0 4 336 340 O
be 5 7 341 343 O
in 8 10 344 346 O
acceptable 11 21 347 357 O
health 22 28 358 364 O
to 29 31 365 367 O
undergo 32 39 368 375 O
radiation 40 49 376 385 B-treatment
therapy 50 57 386 393 I-treatment
and 58 61 394 397 O
curative 62 70 398 406 B-treatment
intent 71 77 407 413 I-treatment
surgery 78 85 414 421 I-treatment
as 86 88 422 424 O
assessed 89 97 425 433 O
by 98 100 434 436 O
UNC 101 104 437 440 O
surgeons 105 113 441 449 O
and 114 117 450 453 O
radiation 118 127 454 463 O
oncologist 128 138 464 474 O

Must 0 4 475 479 O
receive 5 12 480 487 O
their 13 18 488 493 O
neoadjuvant 19 30 494 505 B-treatment
radiation 31 40 506 515 I-treatment
therapy 41 48 516 523 I-treatment
and 49 52 524 527 O
curative 53 61 528 536 B-treatment
intent 62 68 537 543 I-treatment
surgery 69 76 544 551 I-treatment
at 77 79 552 554 O
UNC 80 83 555 558 O
Hospitals 84 93 559 568 O

Poorly 0 6 569 575 O
controlled 7 17 576 586 O
diabetes 18 26 587 595 B-chronic_disease
mellitus 27 35 596 604 I-chronic_disease

Pregnancy 0 9 605 614 B-pregnancy

Previous 0 8 615 623 O
radiation 9 18 624 633 O
exposure 19 27 634 642 O
precluding 28 38 643 653 O
radiation 39 48 654 663 B-treatment
therapy 49 56 664 671 I-treatment

Women 0 5 672 677 B-gender
of 6 8 678 680 O
childbearing 9 21 681 693 O
potential 22 31 694 703 O
must 32 36 704 708 O
have 37 41 709 713 O
a 42 43 714 715 O
negative 44 52 716 724 B-pregnancy
serum 53 58 725 730 I-pregnancy
or 59 61 731 733 I-pregnancy
urine 62 67 734 739 I-pregnancy
pregnancy 68 77 740 749 I-pregnancy
test 78 82 750 754 O
performed 83 92 755 764 O
within 93 99 765 771 O
7 100 101 772 773 B-upper_bound
days 102 106 774 778 I-upper_bound
prior 107 112 779 784 I-upper_bound
to 113 115 785 787 O
each 116 120 788 792 O
PET 121 124 793 796 O
/ 124 125 796 797 O
MRI 125 128 797 800 O

intracranial 0 12 801 813 B-chronic_disease
aneurysm 13 21 814 822 I-chronic_disease
clip 22 26 823 827 O

lactating 0 9 828 837 O
female 10 16 838 844 B-gender

AF 0 2 0 2 B-chronic_disease
with 3 7 3 7 I-chronic_disease
hydrops 8 15 8 15 I-chronic_disease

Antiarrhythmic 0 14 16 30 B-treatment
drugs 15 20 31 36 I-treatment

Any 0 3 37 40 O
maternal 4 12 41 49 B-chronic_disease
- 12 13 49 50 I-chronic_disease
fetal 13 18 50 55 I-chronic_disease
conditions 19 29 56 66 I-chronic_disease
associated 30 40 67 77 O
with 41 45 78 82 O
high 46 50 83 87 O
odds 51 55 88 92 O
of 56 58 93 95 O
premature 59 68 96 105 O
delivery 69 77 106 114 O
or 78 80 115 117 O
death 81 86 118 123 O

Gestational 0 11 124 135 B-clinical_variable
age 12 15 136 139 I-clinical_variable
> 16 17 140 141 O
12 18 20 142 144 B-lower_bound
0/7 21 24 145 148 I-lower_bound
weeks 25 30 149 154 I-lower_bound
and 31 34 155 158 O
< 35 36 159 160 O
36 36 38 160 162 B-upper_bound
0/7 39 42 163 166 I-upper_bound
weeks 43 48 167 172 I-upper_bound
at 49 51 173 175 O
time 52 56 176 180 O
of 57 59 181 183 O
enrollment 60 70 184 194 O

History 0 7 195 202 O
of 8 10 203 205 O
significant 11 22 206 217 O
maternal 23 31 218 226 B-chronic_disease
heart 32 37 227 232 I-chronic_disease
condition 38 47 233 242 I-chronic_disease

Maternal 0 8 243 251 B-clinical_variable
ionized 9 16 252 259 I-clinical_variable
serum 17 22 260 265 I-clinical_variable
calcium 23 30 266 273 I-clinical_variable
level 31 36 274 279 I-clinical_variable
of 37 39 280 282 O
< 40 41 283 284 O
1 41 42 284 285 B-upper_bound
mmol 43 47 286 290 I-upper_bound
/ 47 48 290 291 I-upper_bound
L 48 49 291 292 I-upper_bound
/ 50 51 293 294 O
< 52 53 295 296 O
4 53 54 296 297 B-upper_bound
mg 55 57 298 300 I-upper_bound
/ 57 58 300 301 I-upper_bound
dL 58 60 301 303 I-upper_bound
) 60 61 303 304 O

Maternal 0 8 305 313 O
serum 9 14 314 319 B-clinical_variable
creatinine 15 25 320 330 I-clinical_variable
level 26 31 331 336 I-clinical_variable
> 32 33 337 338 O
97.2 34 38 339 343 B-lower_bound
µmol 39 43 344 348 I-lower_bound
/ 43 44 348 349 I-lower_bound
L 44 45 349 350 I-lower_bound
( 46 47 351 352 O
> 47 48 352 353 O
1.1 48 51 353 356 B-lower_bound
mg 52 54 357 359 I-lower_bound
/ 54 55 359 360 I-lower_bound
dl 55 57 360 362 I-lower_bound
) 57 58 362 363 O

Maternal 0 8 364 372 B-clinical_variable
serum 9 14 373 378 I-clinical_variable
potassium 15 24 379 388 I-clinical_variable
level 25 30 389 394 I-clinical_variable
< 31 32 395 396 O
3.3 32 35 396 399 B-upper_bound
mmol 36 40 400 404 I-upper_bound
/ 40 41 404 405 I-upper_bound
L 41 42 405 406 I-upper_bound
/ 43 44 407 408 O
< 45 46 409 410 O
3.3 46 49 410 413 B-upper_bound
mEq 50 53 414 417 I-upper_bound
/ 53 54 417 418 I-upper_bound
L 54 55 418 419 I-upper_bound
( 56 57 420 421 O
at 57 59 421 423 O
start 60 65 424 429 O
of 66 68 430 432 O
treatment 69 78 433 442 O
) 78 79 442 443 O

Pentamidine 0 11 444 455 B-treatment

Relevant 0 8 456 464 O
preexisting 9 20 465 476 O
maternal 21 29 477 485 O
obstructive 30 41 486 497 B-chronic_disease
airway 42 48 498 504 I-chronic_disease
disease 49 56 505 512 I-chronic_disease

SVT 0 3 513 516 B-chronic_disease
with 4 8 517 521 O
fetal 9 14 522 527 O
hydrops 15 22 528 535 O
( 23 24 536 537 O
irrespective 24 36 537 549 O
of 37 39 550 552 O
duration 40 48 553 561 O
) 48 49 561 562 O

Singleton 0 9 563 572 O
Pregnancy 10 19 573 582 B-pregnancy

Systolic 0 8 583 591 B-clinical_variable
BP 9 11 592 594 I-clinical_variable
≥ 12 13 595 596 O
85 14 16 597 599 B-lower_bound
bpm 17 20 600 603 I-lower_bound

Tachycardia 0 11 604 615 B-clinical_variable
≥ 12 13 616 617 O
170 14 17 618 621 B-lower_bound
bpm 18 21 622 625 I-lower_bound
during 22 28 626 632 O
+100 29 33 633 637 O
% 33 34 637 638 O
of 35 37 639 641 O
time 38 42 642 646 O
( 43 44 647 648 O
≤ 44 45 648 649 O
30 46 48 650 652 B-upper_bound
0/7 49 52 653 656 I-upper_bound
weeks 53 58 657 662 I-upper_bound
of 59 61 663 665 O
gestation 62 71 666 675 O
) 71 72 675 676 O

Tachycardia 0 11 677 688 B-clinical_variable
≥ 12 13 689 690 O
280 14 17 691 694 B-lower_bound
bpm 18 21 695 698 I-lower_bound
( 22 23 699 700 O
irrespective 23 35 700 712 O
of 36 38 713 715 O
SVA 39 42 716 719 O
duration 43 51 720 728 O
) 51 52 728 729 O

Untreated 0 9 730 739 O
tachycardia 10 21 740 751 B-chronic_disease
at 22 24 752 754 O
time 25 29 755 759 O
of 30 32 760 762 O
enrollment 33 43 763 773 O

asthma 0 6 774 780 B-chronic_disease

cardiomyopathy 0 14 781 795 B-chronic_disease

life 0 4 796 800 B-chronic_disease
- 4 5 800 801 I-chronic_disease
threatening 5 16 801 812 I-chronic_disease
maternal 17 25 813 821 I-chronic_disease
disease 26 33 822 829 I-chronic_disease

pre 0 3 830 833 B-chronic_disease
- 3 4 833 834 I-chronic_disease
eclampsia 4 13 834 843 I-chronic_disease

severe 0 6 844 850 O
IUGR 7 11 851 855 B-chronic_disease

severe 0 6 856 862 B-chronic_disease
congenital 7 17 863 873 I-chronic_disease
fetal 18 23 874 879 I-chronic_disease
abnormalities 24 37 880 893 I-chronic_disease
( 38 39 894 895 O
T 39 40 895 896 O
13 41 43 897 899 O
or 44 46 900 902 O
18 47 49 903 905 O
; 49 50 905 906 O
surgery 51 58 907 914 B-clinical_variable
or 59 61 915 917 I-clinical_variable
death 62 67 918 923 I-clinical_variable
expected 68 76 924 932 I-clinical_variable
< 77 78 933 934 O
1 79 80 935 936 B-upper_bound
month 81 86 937 942 I-upper_bound
) 86 87 942 943 O

sick 0 4 944 948 B-chronic_disease
sinus 5 10 949 954 I-chronic_disease
syndrome 11 19 955 963 I-chronic_disease

tachycardia 0 11 964 975 B-chronic_disease

9/10 0 4 0 4 O
donors 5 11 5 11 O
where 12 17 12 17 O
all 18 21 18 21 O
the 22 25 22 25 O
HLA 26 29 26 29 B-clinical_variable
sequences 30 39 30 39 O
have 40 44 40 44 O
the 45 48 45 48 O
same 49 53 49 53 O
antigen 54 61 54 61 B-clinical_variable
/ 61 62 61 62 O
peptide 62 69 62 69 B-clinical_variable
binding 70 77 70 77 O
domains 78 85 78 85 O
in 86 88 86 88 O
key 89 92 89 92 O
exons 93 98 93 98 O
to 99 101 99 101 O
the 102 105 102 105 O
patient 106 113 106 113 O
. 113 114 113 114 O
This 115 119 115 119 O
can 120 123 120 123 O
result 124 130 124 130 O
in 131 133 131 133 O
identical 134 143 134 143 O
protein 144 151 144 151 O
sequences 152 161 152 161 O
between 162 169 162 169 O
patient 170 177 170 177 O
and 178 181 178 181 O
donor 182 187 182 187 O
. 187 188 187 188 O
Allele 189 195 189 195 B-clinical_variable
mismatches 196 206 196 206 O
in 207 209 207 209 O
p 210 211 210 211 O
and 212 215 212 215 O
g 216 217 216 217 O
groups 218 224 218 224 O
can 225 228 225 228 O
be 229 231 229 231 O
considered 232 242 232 242 O
acceptable 243 253 243 253 O
due 254 257 254 257 O
to 258 260 258 260 O
the 261 264 261 264 O
exact 265 270 265 270 O
matching 271 279 271 279 O
which 280 285 280 285 O
exists 286 292 286 292 O
in 293 295 293 295 O
the 296 299 296 299 O
binding 300 307 300 307 O
domains 308 315 308 315 O

Age 0 3 316 319 B-age
greater 4 11 320 327 O
than 12 16 328 332 O
or 17 19 333 335 O
equal 20 25 336 341 O
to 26 28 342 344 O
4 29 30 345 346 B-lower_bound
and 31 34 347 350 O
less 35 39 351 355 O
than 40 44 356 360 O
or 45 47 361 363 O
equal 48 53 364 369 O
to 54 56 370 372 O
80 57 59 373 375 B-upper_bound
years 60 65 376 381 I-upper_bound
old 66 69 382 385 I-upper_bound

Ages 0 4 386 390 B-age
4 5 6 391 392 B-lower_bound
to 7 9 393 395 O
80 10 12 396 398 B-upper_bound
( 13 14 399 400 O
both 14 18 400 404 O
inclusive 19 28 405 414 O
) 28 29 414 415 O
, 29 30 415 416 O
and 31 34 417 420 O
weight 35 41 421 427 B-clinical_variable
> 42 43 428 429 O
18 43 45 429 431 B-lower_bound
kg 45 47 431 433 I-lower_bound

Availability 0 12 434 446 O
of 13 15 447 449 O
HLA 16 19 450 453 O
identical 20 29 454 463 O
or 30 32 464 466 O
single 33 39 467 473 O
HLA 40 43 474 477 O
locus 44 49 478 483 O
mismatched 50 60 484 494 O
family 61 67 495 501 O
donor 68 73 502 507 O
or 74 76 508 510 O
10/10 77 82 511 516 O
matched 83 90 517 524 O
unrelated 91 100 525 534 O
donor 101 106 535 540 O
at 107 109 541 543 O
the 110 113 544 547 O
allelic 114 121 548 555 B-clinical_variable
level 122 127 556 561 I-clinical_variable
( 128 129 562 563 O
HLA 129 132 563 566 O
alleles 133 140 567 574 O
A 141 142 575 576 O
, 142 143 576 577 O
B 144 145 578 579 O
, 145 146 579 580 O
C 147 148 581 582 O
, 148 149 582 583 O
DR 150 152 584 586 O
, 152 153 586 587 O
and 154 157 588 591 O
DQ 158 160 592 594 O
) 160 161 594 595 O

Donors 0 6 596 602 O
with 7 11 603 607 O
HbAS 12 16 608 612 B-clinical_variable
are 17 20 613 616 O
acceptable 21 31 617 627 O

ECOG 0 4 628 632 B-clinical_variable
performance 5 16 633 644 I-clinical_variable
status 17 23 645 651 I-clinical_variable
of 24 26 652 654 O
3 27 28 655 656 B-lower_bound
or 29 31 657 659 O
more 32 36 660 664 O
( 37 38 665 666 O
See 38 41 666 669 O
Bone 42 46 670 674 O
& 47 48 675 676 O
Marrow 49 55 677 683 O
Transplant 56 66 684 694 O
Consortium 67 77 695 705 O
Supportive 78 88 706 716 O
Care 89 93 717 721 O
Guidelines 94 104 722 732 O
for 105 108 733 736 O
HSCT 109 113 737 741 B-treatment
Recipients 114 124 742 752 O
) 124 125 752 753 O

Fanconi 0 7 754 761 B-chronic_disease
s 8 9 762 763 I-chronic_disease
anemia 10 16 764 770 I-chronic_disease

Germline 0 8 771 779 O
/ 8 9 779 780 O
Inherited 9 18 780 789 O
gene 19 23 790 794 O
panel 24 29 795 800 O
in 30 32 801 803 O
patients 33 41 804 812 O
where 42 47 813 818 O
a 48 49 819 820 O
suspicion 50 59 821 830 O
for 60 63 831 834 O
a 64 65 835 836 O
familial 66 74 837 845 B-clinical_variable
bone 75 79 846 850 I-clinical_variable
marrow 80 86 851 857 I-clinical_variable
failure 87 94 858 865 I-clinical_variable
syndrome 95 103 866 874 I-clinical_variable
( 104 105 875 876 I-clinical_variable
BMFS 105 109 876 880 I-clinical_variable
) 109 110 880 881 I-clinical_variable
exists 111 117 882 888 O
, 117 118 888 889 O
hTERC 119 124 890 895 B-clinical_variable
and 125 128 896 899 O
hTERT 129 134 900 905 B-clinical_variable
, 134 135 905 906 O
GATA2 136 141 907 912 O
mutation 142 150 913 921 O
testing 151 158 922 929 O
will 159 163 930 934 O
be 164 166 935 937 O
performed 167 176 938 947 O
on 177 179 948 950 O
protocol 180 188 951 959 O
04 189 191 960 962 O
- 191 192 962 963 O
H-0012 192 198 963 969 O
or 199 201 970 972 O
performed 202 211 973 982 O
elsewhere 212 221 983 992 O
prior 222 227 993 998 O
to 228 230 999 1001 O
enrolling 231 240 1002 1011 O
on 241 243 1012 1014 O
04 244 246 1015 1017 O
- 246 247 1017 1018 O
H-0012 247 253 1018 1024 O

HIV 0 3 1025 1028 B-chronic_disease
positive 4 12 1029 1037 O
( 13 14 1038 1039 O
donors 14 20 1039 1045 O
who 21 24 1046 1049 O
are 25 28 1050 1053 O
positive 29 37 1054 1062 O
for 38 41 1063 1066 O
HBV 42 45 1067 1070 B-chronic_disease
, 45 46 1070 1071 O
HCV 47 50 1072 1075 B-chronic_disease
or 51 53 1076 1078 O
HTLV 54 58 1079 1083 B-chronic_disease
- 58 59 1083 1084 I-chronic_disease
I 59 60 1084 1085 I-chronic_disease
/ 60 61 1085 1086 I-chronic_disease
II 61 63 1086 1088 I-chronic_disease
, 63 64 1088 1089 O
T.cruzi 65 72 1090 1097 B-chronic_disease
[ 73 74 1098 1099 I-chronic_disease
Chagas 74 80 1099 1105 I-chronic_disease
] 80 81 1105 1106 I-chronic_disease
may 82 85 1107 1110 O
be 86 88 1111 1113 O
used 89 93 1114 1118 O
at 94 96 1119 1121 O
the 97 100 1122 1125 O
discretion 101 111 1126 1136 O
of 112 114 1137 1139 O
the 115 118 1140 1143 O
investigator 119 131 1144 1156 O
following 132 141 1157 1166 O
counseling 142 152 1167 1177 O
and 153 156 1178 1181 O
approval 157 165 1182 1190 O
from 166 170 1191 1195 O
the 171 174 1196 1199 O
recipient 175 184 1200 1209 O
) 184 185 1209 1210 O

Left 0 4 1211 1215 B-clinical_variable
ventricular 5 16 1216 1227 I-clinical_variable
ejection 17 25 1228 1236 I-clinical_variable
fraction 26 34 1237 1245 I-clinical_variable
< 35 36 1246 1247 O
40 36 38 1247 1249 B-upper_bound
% 38 39 1249 1250 I-upper_bound
( 40 41 1251 1252 O
evaluated 41 50 1252 1261 O
by 51 53 1262 1264 O
ECHO 54 58 1265 1269 B-treatment
) 58 59 1269 1270 O
or 60 62 1271 1273 O
< 63 64 1274 1275 O
30 64 66 1275 1277 B-upper_bound
% 66 67 1277 1278 I-upper_bound
( 68 69 1279 1280 O
evaluated 69 78 1280 1289 O
by 79 81 1290 1292 O
MUGA 82 86 1293 1297 B-treatment
) 86 87 1297 1298 O

Major 0 5 1299 1304 B-chronic_disease
anticipated 6 17 1305 1316 I-chronic_disease
illness 18 25 1317 1324 I-chronic_disease
or 26 28 1325 1327 O
organ 29 34 1328 1333 B-chronic_disease
failure 35 42 1334 1341 I-chronic_disease
incompatible 43 55 1342 1354 O
with 56 60 1355 1359 O
survival 61 69 1360 1368 O
from 70 74 1369 1373 O
PBSC 75 79 1374 1378 B-treatment
transplant 80 90 1379 1389 I-treatment

Other 0 5 1390 1395 O
malignant 6 15 1396 1405 B-cancer
diseases 16 24 1406 1414 I-cancer
liable 25 31 1415 1421 O
to 32 34 1422 1424 O
relapse 35 42 1425 1432 O
or 43 45 1433 1435 O
progress 46 54 1436 1444 O
within 55 61 1445 1451 O
5 62 63 1452 1453 B-upper_bound
years 64 69 1454 1459 I-upper_bound

Paroxysmal 0 10 1460 1470 B-chronic_disease
nocturnal 11 20 1471 1480 I-chronic_disease
hemoglobinuria 21 35 1481 1495 I-chronic_disease
( 36 37 1496 1497 I-chronic_disease
PNH 37 40 1497 1500 I-chronic_disease
) 40 41 1500 1501 I-chronic_disease
associated 42 52 1502 1512 O
with 53 57 1513 1517 O
life 58 62 1518 1522 O
- 62 63 1522 1523 O
threatening 63 74 1523 1534 O
thrombosis 75 85 1535 1545 B-chronic_disease
, 85 86 1545 1546 O
and/or 87 93 1547 1553 O
cytopenia 94 103 1554 1563 B-chronic_disease
, 103 104 1563 1564 O
and/or 105 111 1565 1571 O
transfusion 112 123 1572 1583 O
dependence 124 134 1584 1594 O
and/or 135 141 1595 1601 O
recurrent 142 151 1602 1611 O
and 152 155 1612 1615 O
debilitating 156 168 1616 1628 O
hemolytic 169 178 1629 1638 O
crisis 179 185 1639 1645 O

Patients 0 8 1646 1654 O
diagnosed 9 18 1655 1664 O
with 19 23 1665 1669 O
one 24 27 1670 1673 O
of 28 30 1674 1676 O
the 31 34 1677 1680 O
following 35 44 1681 1690 O
hematologic 45 56 1691 1702 B-chronic_disease
diseases 57 65 1703 1711 I-chronic_disease
which 66 71 1712 1717 O
are 72 75 1718 1721 O
associated 76 86 1722 1732 O
with 87 91 1733 1737 O
reasonable 92 102 1738 1748 O
longevity 103 112 1749 1758 O
, 112 113 1758 1759 O
shown 114 119 1760 1765 O
to 120 122 1766 1768 O
be 123 125 1769 1771 O
curable 126 133 1772 1779 O
by 134 136 1780 1782 O
allogeneic 137 147 1783 1793 B-treatment
BMT 148 151 1794 1797 I-treatment
but 152 155 1798 1801 O
where 156 161 1802 1807 O
concern 162 169 1808 1815 O
for 170 173 1816 1819 O
a 174 175 1820 1821 O
high 176 180 1822 1826 O
procedural 181 191 1827 1837 O
mortality 192 201 1838 1847 O
with 202 206 1848 1852 O
conventional 207 219 1853 1865 B-treatment
BMT 220 223 1866 1869 I-treatment
may 224 227 1870 1873 O
delay 228 233 1874 1879 O
or 234 236 1880 1882 O
prevent 237 244 1883 1890 O
such 245 249 1891 1895 O
treatment 250 259 1896 1905 O

Pregnant 0 8 1906 1914 B-pregnancy

Presence 0 8 1915 1923 O
of 9 11 1924 1926 O
an 12 14 1927 1929 O
active 15 21 1930 1936 B-chronic_disease
infection 22 31 1937 1946 I-chronic_disease
not 32 35 1947 1950 O
adequately 36 46 1951 1961 O
responding 47 57 1962 1972 O
to 58 60 1973 1975 O
appropriate 61 72 1976 1987 O
therapy 73 80 1988 1995 B-treatment

Refractory 0 10 1996 2006 B-chronic_disease
anemia 11 17 2007 2013 I-chronic_disease
( 18 19 2014 2015 I-chronic_disease
RA 19 21 2015 2017 I-chronic_disease
) 21 22 2017 2018 I-chronic_disease
or 23 25 2019 2021 O
RARS 26 30 2022 2026 B-chronic_disease
MDS 31 34 2027 2030 I-chronic_disease
patients 35 43 2031 2039 O
who 44 47 2040 2043 O
have 48 52 2044 2048 O
associated 53 63 2049 2059 O
transfusion 64 75 2060 2071 B-treatment
dependence 76 86 2072 2082 O
and/or 87 93 2083 2089 O
neutropenia 94 105 2090 2101 B-chronic_disease

Screening 0 9 2102 2111 O
test 10 14 2112 2116 O
positive 15 23 2117 2125 O
for 24 27 2126 2129 O
Chagas 28 34 2130 2136 B-chronic_disease
disease 35 42 2137 2144 I-chronic_disease
( 43 44 2145 2146 O
Trypanosoma 44 55 2146 2157 B-chronic_disease
cruzi 56 61 2158 2163 I-chronic_disease
/T. 62 65 2164 2167 O
cruzi 66 71 2168 2173 I-chronic_disease
/ 71 72 2173 2174 O
trypanosomiasis 72 87 2174 2189 B-chronic_disease
) 87 88 2189 2190 O
confirmed 89 98 2191 2200 O
by 99 101 2201 2203 O
the 102 105 2204 2207 O
Center 106 112 2208 2214 O
for 113 116 2215 2218 O
Disease 117 124 2219 2226 O
Control 125 132 2227 2234 O
( 133 134 2235 2236 O
CDC 134 137 2236 2239 O
) 137 138 2239 2240 O

Serum 0 5 2241 2246 B-clinical_variable
bilirubin 6 15 2247 2256 I-clinical_variable
greater 16 23 2257 2264 O
than 24 28 2265 2269 O
4 29 30 2270 2271 B-lower_bound
mg 31 33 2272 2274 I-lower_bound
/ 33 34 2274 2275 I-lower_bound
dl 34 36 2275 2277 I-lower_bound
, 36 37 2277 2278 O
transaminases 38 51 2279 2292 B-clinical_variable
greater 52 59 2293 2300 O
than 60 64 2301 2305 O
5 65 66 2306 2307 B-lower_bound
times 67 72 2308 2313 I-lower_bound
the 73 76 2314 2317 O
upper 77 82 2318 2323 B-clinical_variable
limit 83 88 2324 2329 I-clinical_variable
of 89 91 2330 2332 I-clinical_variable
normal 92 98 2333 2339 I-clinical_variable

Serum 0 5 2340 2345 B-clinical_variable
creatinine 6 16 2346 2356 I-clinical_variable
greater 17 24 2357 2364 O
than 25 29 2365 2369 O
2.5mg 30 35 2370 2375 B-lower_bound
/ 35 36 2375 2376 I-lower_bound
dl 36 38 2376 2378 I-lower_bound
or 39 41 2379 2381 O
creatinine 42 52 2382 2392 B-clinical_variable
clearance 53 62 2393 2402 I-clinical_variable
less 63 67 2403 2407 O
than 68 72 2408 2412 O
50 73 75 2413 2415 B-upper_bound
ml 76 78 2416 2418 I-upper_bound
/ 78 79 2418 2419 I-upper_bound
min 79 82 2419 2422 I-upper_bound
by 83 85 2423 2425 O
24 86 88 2426 2428 O
hr 89 91 2429 2431 O
urine 92 97 2432 2437 O
collection 98 108 2438 2448 O

Severe 0 6 2449 2455 B-chronic_disease
aplastic 7 15 2456 2464 I-chronic_disease
anemia 16 22 2465 2471 I-chronic_disease
( 23 24 2472 2473 I-chronic_disease
SAA 24 27 2473 2476 I-chronic_disease
) 27 28 2476 2477 I-chronic_disease
or 29 31 2478 2480 O
pure 32 36 2481 2485 B-chronic_disease
red 37 40 2486 2489 I-chronic_disease
cell 41 45 2490 2494 I-chronic_disease
aplasia 46 53 2495 2502 I-chronic_disease
( 54 55 2503 2504 I-chronic_disease
PRCA 55 59 2504 2508 I-chronic_disease
[ 60 61 2509 2510 O
acquired 61 69 2510 2518 O
or 70 72 2519 2521 O
congenital 73 83 2522 2532 O
] 83 84 2532 2533 O
) 84 85 2533 2534 O
associated 86 96 2535 2545 O
with 97 101 2546 2550 O
transfusion 102 113 2551 2562 O
dependence 114 124 2563 2573 O
and/or 125 131 2574 2580 O
neutropenia 132 143 2581 2592 B-treatment
in 144 146 2593 2595 O
patients 147 155 2596 2604 O
who 156 159 2605 2608 O
are 160 163 2609 2612 O
not 164 167 2613 2616 O
candidates 168 178 2617 2627 O
for 179 182 2628 2631 O
, 182 183 2631 2632 O
or 184 186 2633 2635 O
who 187 190 2636 2639 O
have 191 195 2640 2644 O
failed 196 202 2645 2651 O
immunosuppressive 203 220 2652 2669 B-treatment
therapy 221 228 2670 2677 I-treatment

Sickling 0 8 2678 2686 O
hemoglobinopathies 9 27 2687 2705 B-chronic_disease
including 28 37 2706 2715 O
HbSS 38 42 2716 2720 B-chronic_disease
or 43 45 2721 2723 O
HbSC 46 50 2724 2728 B-chronic_disease

Telomere 0 8 2729 2737 B-treatment
Length 9 15 2738 2744 I-treatment
Testing 16 23 2745 2752 I-treatment

The 0 3 2753 2756 O
procedure 4 13 2757 2766 O
will 14 18 2767 2771 O
be 19 21 2772 2774 O
explained 22 31 2775 2784 O
to 32 34 2785 2787 O
subjects 35 43 2788 2796 O
age 44 47 2797 2800 B-age
8 48 49 2801 2802 B-lower_bound
-17 50 53 2803 2806 O
years 54 59 2807 2812 I-upper_bound
with 60 64 2813 2817 O
formal 65 71 2818 2824 O
consent 72 79 2825 2832 O
being 80 85 2833 2838 O
obtained 86 94 2839 2847 O
from 95 99 2848 2852 O
parents 100 107 2853 2860 O
or 108 110 2861 2863 O
legal 111 116 2864 2869 O
guardian 117 125 2870 2878 O

Unfit 0 5 2879 2884 O
to 6 8 2885 2887 O
receive 9 16 2888 2895 O
filgrastim 17 27 2896 2906 B-treatment
( 28 29 2907 2908 I-treatment
G 29 30 2908 2909 I-treatment
- 30 31 2909 2910 I-treatment
CSF 31 34 2910 2913 I-treatment
) 34 35 2913 2914 I-treatment
or 36 38 2915 2917 O
undergo 39 46 2918 2925 O
apheresis 47 56 2926 2935 B-treatment
( 57 58 2936 2937 O
history 58 65 2937 2944 O
of 66 68 2945 2947 O
stroke 69 75 2948 2954 B-chronic_disease
, 75 76 2954 2955 O
MI 77 79 2956 2958 B-chronic_disease
, 79 80 2958 2959 O
unstable 81 89 2960 2968 B-chronic_disease
angina 90 96 2969 2975 I-chronic_disease
, 96 97 2975 2976 O
uncontrolled 98 110 2977 2989 B-chronic_disease
hypertension 111 123 2990 3002 I-chronic_disease
, 123 124 3002 3003 O
severe 125 131 3004 3010 O
heart 132 137 3011 3016 B-chronic_disease
disease 138 145 3017 3024 I-chronic_disease
or 146 148 3025 3027 O
palpable 149 157 3028 3036 B-chronic_disease
spleen 158 164 3037 3043 I-chronic_disease
) 164 165 3043 3044 O

Weight 0 6 3045 3051 B-clinical_variable
> 7 8 3052 3053 O
18 9 11 3054 3056 B-lower_bound
kg 12 14 3057 3059 I-lower_bound

separate 0 8 3060 3068 O
hematologic 9 20 3069 3080 B-cancer
malignancy 21 31 3081 3091 I-cancer
where 32 37 3092 3097 O
allogeneic 38 48 3098 3108 B-treatment
stem 49 53 3109 3113 I-treatment
cell 54 58 3114 3118 I-treatment
transplant 59 69 3119 3129 I-treatment
has 70 73 3130 3133 O
been 74 78 3134 3138 O
shown 79 84 3139 3144 O
to 85 87 3145 3147 O
be 88 90 3148 3150 O
potentially 91 102 3151 3162 O
curative 103 111 3163 3171 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Acute 0 5 25 30 B-chronic_disease
dermatitis 6 16 31 41 I-chronic_disease
outbreak 17 25 42 50 O
or 26 28 51 53 O
dermatitis 29 39 54 64 O
on 40 42 65 67 O
or 43 45 68 70 O
near 46 50 71 75 O
the 51 54 76 79 O
test 55 59 80 84 O
area 60 64 85 89 O
on 65 67 90 92 O
the 68 71 93 96 O
back 72 76 97 101 O

Conditions 0 10 102 112 O
such 11 15 113 117 O
as 16 18 118 120 O
; 18 19 120 121 O
fibromyalgia 20 32 122 134 B-chronic_disease
, 32 33 134 135 O
chronic 34 41 136 143 B-chronic_disease
fatigue 42 49 144 151 I-chronic_disease
, 49 50 151 152 O
depression 51 61 153 163 B-chronic_disease
, 61 62 163 164 O
cognitive 63 72 165 174 B-chronic_disease
impairment 73 83 175 185 I-chronic_disease
, 83 84 185 186 O
flu 85 88 187 190 B-chronic_disease
- 88 89 190 191 I-chronic_disease
like 89 93 191 195 I-chronic_disease
symptoms 94 102 196 204 I-chronic_disease
, 102 103 204 205 O
diarrhea 104 112 206 214 B-chronic_disease
and/or 113 119 215 221 O
headache 120 128 222 230 B-chronic_disease
without 129 136 231 238 O
at 137 139 239 241 O
least 140 145 242 247 O
one 146 149 248 251 O
of 150 152 252 254 O
the 153 156 255 258 O
symptoms 157 165 259 267 O
related 166 173 268 275 O
to 174 176 276 278 O
metal 177 182 279 284 O
exposure 183 191 285 293 O
listed 192 198 294 300 O
in 199 201 301 303 O
Section 202 209 304 311 O
10.1 210 214 312 316 O
under 215 220 317 322 O
physical 221 229 323 331 O
examination 230 241 332 343 O

Inability 0 9 344 353 O
to 10 12 354 356 O
become 13 19 357 363 B-pregnancy
pregnant 20 28 364 372 I-pregnancy
includes 29 37 373 381 O
all 38 41 382 385 O
male 42 46 386 390 B-gender
subjects 47 55 391 399 I-gender
and 56 59 400 403 I-gender
female 60 66 404 410 I-gender
subjects 67 75 411 419 I-gender
who 76 79 420 423 O
are 80 83 424 427 O
postmenopausal 84 98 428 442 O
for 99 102 443 446 O
at 103 105 447 449 O
least 106 111 450 455 O
1 112 113 456 457 B-lower_bound
year 114 118 458 462 I-lower_bound
, 118 119 462 463 O
or 120 122 464 466 O
surgically 123 133 467 477 O
sterile- 134 142 478 486 O
have 143 147 487 491 O
had 148 151 492 495 O
a 152 153 496 497 O
hysterectomy 154 166 498 510 B-treatment
, 166 167 510 511 O
bilateral 168 177 512 521 B-treatment
ovariectomy 178 189 522 533 I-treatment
, 189 190 533 534 O
uterine 191 198 535 542 B-treatment
ablation 199 207 543 551 I-treatment
or 208 210 552 554 O
bilateral 211 220 555 564 B-treatment
tubal 221 226 565 570 I-treatment
ligation 227 235 571 579 I-treatment

Inhaled 0 7 580 587 B-treatment
treatments 8 18 588 598 I-treatment

Participation 0 13 599 612 O
in 14 16 613 615 O
a 17 18 616 617 O
clinical 19 27 618 626 O
trial 28 33 627 632 O
of 34 36 633 635 O
an 37 39 636 638 O
investigational 40 55 639 654 B-treatment
drug 56 60 655 659 I-treatment
, 60 61 659 660 O
treatment 62 71 661 670 B-treatment
or 72 74 671 673 O
device 75 81 674 680 B-treatment
during 82 88 681 687 O
this 89 93 688 692 O
study 94 99 693 698 O
or 100 102 699 701 O
3 103 104 702 703 B-upper_bound
weeks 105 110 704 709 I-upper_bound
prior 111 116 710 715 I-upper_bound
to 117 119 716 718 O
inclusion 120 129 719 728 O
in 130 132 729 731 O
this 133 137 732 736 O
study 138 143 737 742 O

Past 0 4 743 747 O
positive 5 13 748 756 O
patch 14 19 757 762 O
test 20 24 763 767 O
result 25 31 768 774 O
within 32 38 775 781 O
the 39 42 782 785 O
past 43 47 786 790 B-upper_bound
10 48 50 791 793 I-upper_bound
years 51 56 794 799 I-upper_bound
( 57 58 800 801 O
to 58 60 801 803 O
one 61 64 804 807 O
of 65 67 808 810 O
the 68 71 811 814 O
dilution 72 80 815 823 O
series 81 87 824 830 O
metals 88 94 831 837 O
being 95 100 838 843 O
tested 101 107 844 850 O
on 108 110 851 853 O
this 111 115 854 858 O
study 116 121 859 864 O
) 121 122 864 865 O

Subject 0 7 866 873 O
must 8 12 874 878 O
agree 13 18 879 884 B-contraception_consent
to 19 21 885 887 I-contraception_consent
use 22 25 888 891 I-contraception_consent
acceptable 26 36 892 902 I-contraception_consent
contraception 37 50 903 916 I-contraception_consent
for 51 54 917 920 O
the 55 58 921 924 O
duration 59 67 925 933 O
of 68 70 934 936 O
the 71 74 937 940 O
entire 75 81 941 947 O
study 82 87 948 953 O

Topical 0 7 954 961 B-treatment
treatment 8 17 962 971 I-treatment
with 18 22 972 976 I-treatment
corticosteroids 23 38 977 992 I-treatment
or 39 41 993 995 I-treatment
other 42 47 996 1001 I-treatment
immunosuppressive 48 65 1002 1019 I-treatment
agents 66 72 1020 1026 I-treatment
on 73 75 1027 1029 O
or 76 78 1030 1032 O
near 79 83 1033 1037 O
the 84 87 1038 1041 O
test 88 92 1042 1046 O
area 93 97 1047 1051 O
during 98 104 1052 1058 O
the 105 108 1059 1062 O
14 109 111 1063 1065 B-upper_bound
days 112 116 1066 1070 I-upper_bound
prior 117 122 1071 1076 I-upper_bound
to 123 125 1077 1079 O
inclusion 126 135 1080 1089 O
in 136 138 1090 1092 O
this 139 143 1093 1097 O
study 144 149 1098 1103 O

Treatment 0 9 1104 1113 B-treatment
with 10 14 1114 1118 I-treatment
ultraviolet 15 26 1119 1130 I-treatment
( 27 28 1131 1132 I-treatment
UV 28 30 1132 1134 I-treatment
) 30 31 1134 1135 I-treatment
light 32 37 1136 1141 I-treatment
( 38 39 1142 1143 I-treatment
including 39 48 1143 1152 I-treatment
tanning 49 56 1153 1160 I-treatment
) 56 57 1160 1161 I-treatment
during 58 64 1162 1168 O
the 65 68 1169 1172 O
3 69 70 1173 1174 B-upper_bound
weeks 71 76 1175 1180 I-upper_bound
prior 77 82 1181 1186 I-upper_bound
to 83 85 1187 1189 O
inclusion 86 95 1190 1199 O
in 96 98 1200 1202 O
this 99 103 1203 1207 O
study 104 109 1208 1213 O

Unable 0 6 1214 1220 B-pregnancy
to 7 9 1221 1223 I-pregnancy
become 10 16 1224 1230 I-pregnancy
pregnant 17 25 1231 1239 I-pregnancy

intending 0 9 1240 1249 B-pregnancy
to 10 12 1250 1252 I-pregnancy
become 13 19 1253 1259 I-pregnancy
pregnant 20 28 1260 1268 I-pregnancy
during 29 35 1269 1275 O
the 36 39 1276 1279 O
course 40 46 1280 1286 O
of 47 49 1287 1289 O
the 50 53 1290 1293 O
study 54 59 1294 1299 O

other 0 5 1300 1305 O
immunosuppressive 6 23 1306 1323 B-treatment
agents 24 30 1324 1330 I-treatment
during 31 37 1331 1337 O
the 38 41 1338 1341 O
14 42 44 1342 1344 B-upper_bound
days 45 49 1345 1349 I-upper_bound
prior 50 55 1350 1355 I-upper_bound
to 56 58 1356 1358 O
inclusion 59 68 1359 1368 O
in 69 71 1369 1371 O
this 72 76 1372 1376 O
study 77 82 1377 1382 O

pregnant 0 8 1383 1391 B-pregnancy
( 9 10 1392 1393 O
as 10 12 1393 1395 O
determined 13 23 1396 1406 O
by 24 26 1407 1409 O
urine 27 32 1410 1415 O
pregnancy 33 42 1416 1425 O
test 43 47 1426 1430 O
) 47 48 1430 1431 O

strong 0 6 1432 1438 O
suspicion 7 16 1439 1448 O
of 17 19 1449 1451 O
metal 20 25 1452 1457 B-allergy_name
contact 26 33 1458 1465 O
allergy 34 41 1466 1473 O
based 42 47 1474 1479 O
on 48 50 1480 1482 O
results 51 58 1483 1490 O
of 59 61 1491 1493 O
the 62 65 1494 1497 O
Qualification 66 79 1498 1511 O
Questionnaire 80 93 1512 1525 O

willing 0 7 1526 1533 B-contraception_consent
to 8 10 1534 1536 I-contraception_consent
use 11 14 1537 1540 I-contraception_consent
an 15 17 1541 1543 I-contraception_consent
acceptable 18 28 1544 1554 I-contraception_consent
method 29 35 1555 1561 I-contraception_consent
of 36 38 1562 1564 I-contraception_consent
contraception 39 52 1565 1578 I-contraception_consent
to 53 55 1579 1581 O
prevent 56 63 1582 1589 O
pregnancy 64 73 1590 1599 B-pregnancy
if 74 76 1600 1602 O
female 77 83 1603 1609 B-gender
of 84 86 1610 1612 O
childbearing 87 99 1613 1625 O
potential 100 109 1626 1635 O

Absolute 0 8 0 8 O
lymphocyte 9 19 9 19 B-clinical_variable
count 20 25 20 25 I-clinical_variable
below 26 31 26 31 O
the 32 35 32 35 O
lower 36 41 36 41 O
limit 42 47 42 47 O
of 48 50 48 50 O
normal 51 57 51 57 O
( 58 59 58 59 O
LLN 59 62 59 62 O
) 62 63 62 63 O

Any 0 3 64 67 O
chronic 4 11 68 75 O
inflammatory 12 24 76 88 B-chronic_disease
disease 25 32 89 96 I-chronic_disease
that 33 37 97 101 O
is 38 40 102 104 O
not 41 44 105 108 O
adequately 45 55 109 119 O
controlled 56 66 120 130 O
or 67 69 131 133 O
that 70 74 134 138 O
requires 75 83 139 147 O
systemic 84 92 148 156 B-treatment
immunosuppressive 93 110 157 174 I-treatment
or 111 113 175 177 O
immunomodulatory 114 130 178 194 B-treatment
therapy 131 138 195 202 I-treatment

Any 0 3 203 206 O
condition 4 13 207 216 O
that 14 18 217 221 O
may 19 22 222 225 O
be 23 25 226 228 O
contributing 26 38 229 241 O
to 39 41 242 244 O
cognitive 42 51 245 254 B-chronic_disease
impairment 52 62 255 265 I-chronic_disease
above 63 68 266 271 O
and 69 72 272 275 O
beyond 73 79 276 282 O
that 80 84 283 287 O
caused 85 91 288 294 O
by 92 94 295 297 O
the 95 98 298 301 O
participant 99 110 302 313 O
's 110 112 313 315 O
AD 113 115 316 318 B-chronic_disease

CDR 0 3 319 322 B-clinical_variable
Memory 4 10 323 329 I-clinical_variable
Box 11 14 330 333 I-clinical_variable
score 15 20 334 339 I-clinical_variable
of 21 23 340 342 O
0.5 24 27 343 346 B-lower_bound
or 28 30 347 349 O
greater 31 38 350 357 O

CDR 0 3 358 361 B-clinical_variable
global 4 10 362 368 I-clinical_variable
score 11 16 369 374 I-clinical_variable
of 17 19 375 377 O
0.5 20 23 378 381 O

Females 0 7 382 389 B-gender
of 8 10 390 392 O
child 11 16 393 398 O
- 16 17 398 399 O
bearing 17 24 399 406 O
potential 25 34 407 416 O
must 35 39 417 421 O
use 40 43 422 425 B-contraception_consent
a 44 45 426 427 I-contraception_consent
highly 46 52 428 434 I-contraception_consent
effective 53 62 435 444 I-contraception_consent
method 63 69 445 451 I-contraception_consent
of 70 72 452 454 I-contraception_consent
contraception 73 86 455 468 I-contraception_consent
throughout 87 97 469 479 O
the 98 101 480 483 O
entire 102 108 484 490 O
study 109 114 491 496 O
period 115 121 497 503 O
and 122 125 504 507 O
for 126 129 508 511 O
28 130 132 512 514 B-upper_bound
days 133 137 515 519 I-upper_bound
after 138 143 520 525 O
study 144 149 526 531 O
drug 150 154 532 536 O
discontinuation 155 170 537 552 O

Females 0 7 553 560 B-gender
who 8 11 561 564 O
are 12 15 565 568 O
breastfeeding 16 29 569 582 O
or 30 32 583 585 O
pregnant 33 41 586 594 B-pregnancy
at 42 44 595 597 O
Screening 45 54 598 607 O
or 55 57 608 610 O
Baseline 58 66 611 619 O

Have 0 4 620 624 O
lesions 5 12 625 632 O
that 13 17 633 637 O
could 18 23 638 643 O
indicate 24 32 644 652 O
a 33 34 653 654 O
dementia 35 43 655 663 B-chronic_disease
diagnosis 44 53 664 673 I-chronic_disease
other 54 59 674 679 O
than 60 64 680 684 O
AD 65 67 685 687 B-chronic_disease
on 68 70 688 690 O
brain 71 76 691 696 B-treatment
MRI 77 80 697 700 I-treatment

Have 0 4 701 705 O
received 5 13 706 714 O
any 14 17 715 718 O
live 18 22 719 723 B-treatment
vaccine 23 30 724 731 I-treatment
/ 30 31 731 732 I-treatment
live 31 35 732 736 I-treatment
attenuated 36 46 737 747 I-treatment
vaccine 47 54 748 755 I-treatment
in 55 57 756 758 O
the 58 61 759 762 O
3 62 63 763 764 B-upper_bound
months 64 70 765 771 I-upper_bound
before 71 77 772 778 O
randomization 78 91 779 792 O

History 0 7 793 800 O
of 8 10 801 803 O
transient 11 20 804 813 B-chronic_disease
ischemic 21 29 814 822 I-chronic_disease
attacks 30 37 823 830 I-chronic_disease
or 38 40 831 833 I-chronic_disease
stroke 41 47 834 840 I-chronic_disease
within 48 54 841 847 O
12 55 57 848 850 B-upper_bound
months 58 64 851 857 I-upper_bound
of 65 67 858 860 O
Screening 68 77 861 870 O

Malignant 0 9 871 880 B-cancer
neoplasms 10 19 881 890 I-cancer
within 20 26 891 897 O
5 27 28 898 899 B-upper_bound
years 29 34 900 905 I-upper_bound
of 35 37 906 908 O
Screening 38 47 909 918 O

Participants 0 12 919 931 O
who 13 16 932 935 O
have 17 21 936 940 O
a 22 23 941 942 O
history 24 31 943 950 O
of 32 34 951 953 O
moderate 35 43 954 962 B-chronic_disease
to 44 46 963 965 I-chronic_disease
severe 47 53 966 972 I-chronic_disease
hepatic 54 61 973 980 I-chronic_disease
impairment 62 72 981 991 I-chronic_disease
( 73 74 992 993 O
eg 74 76 993 995 O
, 76 77 995 996 O
Child 78 83 997 1002 B-chronic_disease
- 83 84 1002 1003 I-chronic_disease
Pugh 84 88 1003 1007 I-chronic_disease
Class 89 94 1008 1013 I-chronic_disease
B 95 96 1014 1015 I-chronic_disease
or 97 99 1016 1018 I-chronic_disease
C 100 101 1019 1020 I-chronic_disease
) 101 102 1020 1021 O

Participants 0 12 1022 1034 O
with 13 17 1035 1039 O
a 18 19 1040 1041 O
history 20 27 1042 1049 O
of 28 30 1050 1052 O
seizures 31 39 1053 1061 B-chronic_disease
within 40 46 1062 1068 O
5 47 48 1069 1070 B-upper_bound
years 49 54 1071 1076 I-upper_bound
of 55 57 1077 1079 O
Screening 58 67 1080 1089 O

Psychiatric 0 11 1090 1101 O
diagnosis 12 21 1102 1111 O
or 22 24 1112 1114 O
symptoms 25 33 1115 1123 O
( 34 35 1124 1125 O
e.g. 35 39 1125 1129 O
, 39 40 1129 1130 O
hallucinations 41 55 1131 1145 B-chronic_disease
, 55 56 1145 1146 O
major 57 62 1147 1152 B-chronic_disease
depression 63 73 1153 1163 I-chronic_disease
, 73 74 1163 1164 O
delusions 75 84 1165 1174 B-chronic_disease
, 84 85 1174 1175 O
etc 86 89 1176 1179 O
. 89 90 1179 1180 O
) 90 91 1180 1181 O

Severe 0 6 1182 1188 B-chronic_disease
visual 7 13 1189 1195 I-chronic_disease
or 14 16 1196 1198 I-chronic_disease
hearing 17 24 1199 1206 I-chronic_disease
impairment 25 35 1207 1217 I-chronic_disease

Suicidal 0 8 1218 1226 B-chronic_disease
ideation 9 17 1227 1235 I-chronic_disease
or 18 20 1236 1238 O
any 21 24 1239 1242 O
suicidal 25 33 1243 1251 B-chronic_disease
behavior 34 42 1252 1260 I-chronic_disease
within 43 49 1261 1267 O
6 50 51 1268 1269 B-upper_bound
months 52 58 1270 1276 I-upper_bound
before 59 65 1277 1283 O
Screening 66 75 1284 1293 O

A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
serious 13 20 13 20 O
medical 21 28 21 28 O
or 29 31 29 31 O
neurological 32 44 32 44 B-chronic_disease
illness 45 52 45 52 I-chronic_disease
, 52 53 52 53 O
such 54 58 54 58 O
as 59 61 59 61 O
cardiovascular 62 76 62 76 B-chronic_disease
, 76 77 76 77 O
gastrointestinal 78 94 78 94 B-chronic_disease
, 94 95 94 95 O
hepatic 96 103 96 103 B-chronic_disease
, 103 104 103 104 O
renal 105 110 105 110 B-chronic_disease
, 110 111 110 111 O
neurologic 112 122 112 122 O
or 123 125 123 125 O
other 126 131 126 131 O
systemic 132 140 132 140 B-chronic_disease
illness 141 148 141 148 I-chronic_disease

Current 0 7 149 156 O
or 8 10 157 159 O
lifetime 11 19 160 168 O
history 20 27 169 176 O
of 28 30 177 179 O
schizophrenia 31 44 180 193 B-chronic_disease
, 44 45 193 194 O
schizoaffective 46 61 195 210 B-chronic_disease
disorder 62 70 211 219 I-chronic_disease
, 70 71 219 220 O
or 72 74 221 223 O
bulimia 75 82 224 231 B-chronic_disease
, 82 83 231 232 I-chronic_disease
based 84 89 233 238 O
on 90 92 239 241 O
the 93 96 242 245 O
SCID 97 101 246 250 B-chronic_disease

Do 0 2 251 253 O
not 3 6 254 257 O
meet 7 11 258 262 O
criteria 12 20 263 271 O
for 21 24 272 275 O
post 25 29 276 280 B-chronic_disease
traumatic 30 39 281 290 I-chronic_disease
stress 40 46 291 297 I-chronic_disease
disorder 47 55 298 306 I-chronic_disease
( 56 57 307 308 I-chronic_disease
PTSD 57 61 308 312 I-chronic_disease
) 61 62 312 313 I-chronic_disease

History 0 7 314 321 O
of 8 10 322 324 O
loss 11 15 325 329 B-clinical_variable
of 16 18 330 332 I-clinical_variable
consciousness 19 32 333 346 I-clinical_variable
greater 33 40 347 354 O
than 41 45 355 359 O
one 46 49 360 363 B-lower_bound
minute 50 56 364 370 I-lower_bound

Neurological 0 12 371 383 B-chronic_disease
disorder 13 21 384 392 I-chronic_disease
or 22 24 393 395 O
organic 25 32 396 403 B-chronic_disease
mental 33 39 404 410 I-chronic_disease
disorder 40 48 411 419 I-chronic_disease

Positive 0 8 420 428 B-pregnancy
pregnancy 9 18 429 438 I-pregnancy
test 19 23 439 443 O

Traumatic 0 9 444 453 B-chronic_disease
brain 10 15 454 459 I-chronic_disease
injury 16 22 460 466 I-chronic_disease

other 0 5 467 472 O
major 6 11 473 478 O
mental 12 18 479 485 B-chronic_disease
disorder 19 27 486 494 I-chronic_disease
as 28 30 495 497 O
determined 31 41 498 508 O
by 42 44 509 511 O
the 45 48 512 515 O
Structured 49 59 516 526 O
Clinical 60 68 527 535 O
Interview 69 78 536 545 O
for 79 82 546 549 O
Diagnostic 83 93 550 560 O
and 94 97 561 564 O
Statistical 98 109 565 576 O
Manual 110 116 577 583 O
of 117 119 584 586 O
Mental 120 126 587 593 O
Disorders-5 127 138 594 605 O
( 139 140 606 607 O
DSM-5 140 145 607 612 O
SCID 146 150 613 617 O
) 150 151 617 618 O
interview 152 161 619 628 O
for 162 165 629 632 O
PTSD 166 170 633 637 O

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
with 17 21 17 21 O
human 22 27 22 27 B-chronic_disease
immunodeficiency 28 44 28 44 I-chronic_disease
virus 45 50 45 50 I-chronic_disease
( 51 52 51 52 I-chronic_disease
HIV 52 55 52 55 I-chronic_disease
) 55 56 55 56 I-chronic_disease
, 56 57 56 57 O
hepatitis 58 67 58 67 B-chronic_disease
B 68 69 68 69 I-chronic_disease
virus 70 75 70 75 I-chronic_disease
( 76 77 76 77 I-chronic_disease
HBV 77 80 77 80 I-chronic_disease
) 80 81 80 81 I-chronic_disease
, 81 82 81 82 O
hepatitis 83 92 83 92 B-chronic_disease
C 93 94 93 94 I-chronic_disease
virus 95 100 95 100 I-chronic_disease
( 101 102 101 102 I-chronic_disease
HCV 102 105 102 105 I-chronic_disease
) 105 106 105 106 I-chronic_disease
or 107 109 107 109 O
human 110 115 110 115 B-chronic_disease
T 116 117 116 117 I-chronic_disease
- 117 118 117 118 I-chronic_disease
cell 118 122 118 122 I-chronic_disease
lymphotropic 123 135 123 135 I-chronic_disease
virus 136 141 136 141 I-chronic_disease
( 142 143 142 143 I-chronic_disease
HTLV 143 147 143 147 I-chronic_disease
) 147 148 147 148 I-chronic_disease
as 149 151 149 151 O
minimally 152 161 152 161 O
defined 162 169 162 169 O
below 170 175 170 175 O
: 175 176 175 176 O
a 177 178 177 178 O
) 178 179 178 179 O
Positive 180 188 180 188 O
serology 189 197 189 197 O
for 198 201 198 201 O
HIV 202 205 202 205 O
. 205 206 205 206 O
b 207 208 207 208 O
) 208 209 208 209 O
Active 210 216 210 216 B-chronic_disease
hepatitis 217 226 217 226 I-chronic_disease
B 227 228 227 228 I-chronic_disease
infection 229 238 229 238 I-chronic_disease
as 239 241 239 241 O
determined 242 252 242 252 O
by 253 255 253 255 O
hepatitis 256 265 256 265 O
B 266 267 266 267 O
surface 268 275 268 275 O
antigen 276 283 276 283 O
. 283 284 283 284 O
c 285 286 285 286 O
) 286 287 286 287 O
Active 288 294 288 294 B-chronic_disease
hepatitis 295 304 295 304 I-chronic_disease
C 305 306 305 306 I-chronic_disease
infection 307 316 307 316 I-chronic_disease
as 317 319 317 319 O
determined 320 330 320 330 O
by 331 333 331 333 O
hepatitis 334 343 334 343 O
C 344 345 344 345 O
RNA 346 349 346 349 O
; 349 350 349 350 O
A 351 352 351 352 O
subject 353 360 353 360 O
who 361 364 361 364 O
is 365 367 365 367 O
HCV 368 371 368 371 B-treatment
antibody 372 380 372 380 I-treatment
positive 381 389 381 389 O
will 390 394 390 394 O
be 395 397 395 397 O
screened 398 406 398 406 O
for 407 410 407 410 O
HCV 411 414 411 414 O
ribonucleic 415 426 415 426 O
acid 427 431 427 431 O
( 432 433 432 433 O
RNA 433 436 433 436 O
) 436 437 436 437 O
by 438 440 438 440 O
any 441 444 441 444 O
reverse 445 452 445 452 O
transcriptase 453 466 453 466 O
( 467 468 467 468 O
RT 468 470 468 470 O
) 470 471 470 471 O
polymerase 472 482 472 482 O
chain 483 488 483 488 O
reaction 489 497 489 497 O
( 498 499 498 499 O
PCR 499 502 499 502 O
) 502 503 502 503 O
or 504 506 504 506 O
bDNA 507 511 507 511 O
assay 512 517 512 517 O
. 517 518 517 518 O
If 519 521 519 521 O
HCV 522 525 522 525 O
antibody 526 534 526 534 O
is 535 537 535 537 O
positive 538 546 538 546 O
, 546 547 546 547 O
eligibility 548 559 548 559 O
will 560 564 560 564 O
be 565 567 565 567 O
determined 568 578 568 578 O
based 579 584 579 584 O
on 585 587 585 587 O
a 588 589 588 589 O
negative 590 598 590 598 O
screening 599 608 599 608 O
RNA 609 612 609 612 O
value 613 618 613 618 O
. 618 619 618 619 O
d 620 621 620 621 O
) 621 622 621 622 O
Positive 623 631 623 631 O
serology 632 640 632 640 O
for 641 644 641 644 O
HTLV 645 649 645 649 B-chronic_disease
1 650 651 650 651 I-chronic_disease
or 652 654 652 654 I-chronic_disease
2 655 656 655 656 I-chronic_disease

Contraceptive 0 13 657 670 O
use 14 17 671 674 O
by 18 20 675 677 O
men 21 24 678 681 B-gender
or 25 27 682 684 O
women 28 33 685 690 B-gender
should 34 40 691 697 O
be 41 43 698 700 O
consistent 44 54 701 711 O
with 55 59 712 716 O
local 60 65 717 722 O
regulations 66 77 723 734 O
regarding 78 87 735 744 O
the 88 91 745 748 O
methods 92 99 749 756 O
of 100 102 757 759 O
contraception 103 116 760 773 O
for 117 120 774 777 O
those 121 126 778 783 O
participating 127 140 784 797 O
in 141 143 798 800 O
clinical 144 152 801 809 O
studies 153 160 810 817 O
. 160 161 817 818 O
Male 162 166 819 823 B-gender
subjects 167 175 824 832 I-gender
: 175 176 832 833 O
Male 177 181 834 838 O
subjects 182 190 839 847 O
are 191 194 848 851 O
eligible 195 203 852 860 O
to 204 206 861 863 O
participate 207 218 864 875 O
if 219 221 876 878 O
they 222 226 879 883 O
agree 227 232 884 889 O
to 233 235 890 892 O
the 236 239 893 896 O
following 240 249 897 906 O
during 250 256 907 913 O
the 257 260 914 917 O
intervention 261 273 918 930 O
period 274 280 931 937 O
starting 281 289 938 946 O
at 290 292 947 949 O
the 293 296 950 953 O
first 297 302 954 959 O
dose 303 307 960 964 O
of 308 310 965 967 O
chemotherapy 311 323 968 980 B-treatment
for 324 327 981 984 O
at 328 330 985 987 O
least 331 336 988 993 O
12 337 339 994 996 B-lower_bound
months 340 346 997 1003 I-lower_bound
after 347 352 1004 1009 I-lower_bound
receiving 353 362 1010 1019 O
the 363 366 1020 1023 O
T 367 368 1024 1025 B-treatment
- 368 369 1025 1026 I-treatment
cell 369 373 1026 1030 I-treatment
infusion 374 382 1031 1039 I-treatment
, 382 383 1039 1040 O
or 384 386 1041 1043 O
4 387 388 1044 1045 O
months 389 395 1046 1052 O
after 396 401 1053 1058 O
there 402 407 1059 1064 O
is 408 410 1065 1067 O
no 411 413 1068 1070 O
evidence 414 422 1071 1079 O
of 423 425 1080 1082 O
persistence/ 426 438 1083 1095 O
gene 439 443 1096 1100 O
modified 444 452 1101 1109 O
cells 453 458 1110 1115 O
in 459 461 1116 1118 O
the 462 465 1119 1122 O
subject 466 473 1123 1130 O
's 473 475 1130 1132 O
blood 476 481 1133 1138 O
, 481 482 1138 1139 O
whichever 483 492 1140 1149 O
is 493 495 1150 1152 O
longer 496 502 1153 1159 O
. 502 503 1159 1160 O
A 504 505 1161 1162 O
) 505 506 1162 1163 O
Refrain 507 514 1164 1171 O
from 515 519 1172 1176 O
donating 520 528 1177 1185 O
sperm 529 534 1186 1191 O
Plus 535 539 1192 1196 O
either 540 546 1197 1203 O
: 546 547 1203 1204 O
B 548 549 1205 1206 O
) 549 550 1206 1207 O
Be 551 553 1208 1210 B-contraception_consent
abstinent 554 563 1211 1220 I-contraception_consent
from 564 568 1221 1225 I-contraception_consent
heterosexual 569 581 1226 1238 I-contraception_consent
or 582 584 1239 1241 I-contraception_consent
homosexual 585 595 1242 1252 I-contraception_consent
intercourse 596 607 1253 1264 I-contraception_consent
as 608 610 1265 1267 O
their 611 616 1268 1273 O
preferred 617 626 1274 1283 O
and 627 630 1284 1287 O
usual 631 636 1288 1293 O
lifestyle 637 646 1294 1303 O
( 647 648 1304 1305 O
abstinent 648 657 1305 1314 O
on 658 660 1315 1317 O
a 661 662 1318 1319 O
long 663 667 1320 1324 O
term 668 672 1325 1329 O
and 673 676 1330 1333 O
persistent 677 687 1334 1344 O
basis 688 693 1345 1350 O
) 693 694 1350 1351 O
and 695 698 1352 1355 O
agree 699 704 1356 1361 B-contraception_consent
to 705 707 1362 1364 I-contraception_consent
remain 708 714 1365 1371 I-contraception_consent
abstinent 715 724 1372 1381 I-contraception_consent
OR 725 727 1382 1384 O
C 728 729 1385 1386 O
) 729 730 1386 1387 O
Must 731 735 1388 1392 O
agree 736 741 1393 1398 B-contraception_consent
to 742 744 1399 1401 I-contraception_consent
use 745 748 1402 1405 I-contraception_consent
contraception 749 762 1406 1419 I-contraception_consent
/ 762 763 1419 1420 I-contraception_consent
barrier 763 770 1420 1427 I-contraception_consent
. 770 771 1427 1428 O
Female 772 778 1429 1435 B-gender
subjects 779 787 1436 1444 I-gender
: 787 788 1444 1445 O
A 789 790 1446 1447 O
female 791 797 1448 1454 B-gender
subject 798 805 1455 1462 I-gender
is 806 808 1463 1465 O
eligible 809 817 1466 1474 O
to 818 820 1475 1477 O
participate 821 832 1478 1489 O
if 833 835 1490 1492 O
she 836 839 1493 1496 O
is 840 842 1497 1499 O
not 843 846 1500 1503 B-pregnancy
pregnant 847 855 1504 1512 I-pregnancy
or 856 858 1513 1515 O
breastfeeding 859 872 1516 1529 O
, 872 873 1529 1530 O
and 874 877 1531 1534 O
at 878 880 1535 1537 O
least 881 886 1538 1543 O
one 887 890 1544 1547 B-lower_bound
of 891 893 1548 1550 O
the 894 897 1551 1554 O
following 898 907 1555 1564 O
conditions 908 918 1565 1575 O
applies 919 926 1576 1583 O
: 926 927 1583 1584 O
Is 928 930 1585 1587 O
not 931 934 1588 1591 O
a 935 936 1592 1593 O
woman 937 942 1594 1599 B-gender
of 943 945 1600 1602 O
childbearing 946 958 1603 1615 O
potential 959 968 1616 1625 O
( 969 970 1626 1627 O
WOCBP 970 975 1627 1632 O
) 975 976 1632 1633 O
OR 977 979 1634 1636 O
Is 980 982 1637 1639 O
a 983 984 1640 1641 O
WOCBP 985 990 1642 1647 O
who 991 994 1648 1651 O
will 995 999 1652 1656 O
agree 1000 1005 1657 1662 B-contraception_consent
to 1006 1008 1663 1665 I-contraception_consent
use 1009 1012 1666 1669 I-contraception_consent
a 1013 1014 1670 1671 I-contraception_consent
barrier 1015 1022 1672 1679 I-contraception_consent
method 1023 1029 1680 1686 I-contraception_consent
( 1030 1031 1687 1688 I-contraception_consent
male 1031 1035 1688 1692 I-contraception_consent
condom 1036 1042 1693 1699 I-contraception_consent
) 1042 1043 1699 1700 I-contraception_consent
and 1044 1047 1701 1704 I-contraception_consent
use 1048 1051 1705 1708 I-contraception_consent
a 1052 1053 1709 1710 I-contraception_consent
contraceptive 1054 1067 1711 1724 I-contraception_consent
method 1068 1074 1725 1731 I-contraception_consent
that 1075 1079 1732 1736 O
is 1080 1082 1737 1739 O
highly 1083 1089 1740 1746 O
effective 1090 1099 1747 1756 O
during 1100 1106 1757 1763 O
the 1107 1110 1764 1767 O
intervention 1111 1123 1768 1780 O
period 1124 1130 1781 1787 O
and 1131 1134 1788 1791 O
for 1135 1138 1792 1795 O
at 1139 1141 1796 1798 O
least 1142 1147 1799 1804 O
12 1148 1150 1805 1807 O
months 1151 1157 1808 1814 O
after 1158 1163 1815 1820 O
receiving 1164 1173 1821 1830 O
the 1174 1177 1831 1834 O
T 1178 1179 1835 1836 O
- 1179 1180 1836 1837 O
cell 1180 1184 1837 1841 O
infusion 1185 1193 1842 1850 O
, 1193 1194 1850 1851 O
or 1195 1197 1852 1854 O
4 1198 1199 1855 1856 O
months 1200 1206 1857 1863 O
after 1207 1212 1864 1869 O
there 1213 1218 1870 1875 O
is 1219 1221 1876 1878 O
no 1222 1224 1879 1881 O
evidence 1225 1233 1882 1890 O
of 1234 1236 1891 1893 O
persistence/ 1237 1249 1894 1906 O
gene 1250 1254 1907 1911 O
modified 1255 1263 1912 1920 O
cells 1264 1269 1921 1926 O
in 1270 1272 1927 1929 O
the 1273 1276 1930 1933 O
subject 1277 1284 1934 1941 O
's 1284 1286 1941 1943 O
blood 1287 1292 1944 1949 O
, 1292 1293 1949 1950 O
whichever 1294 1303 1951 1960 O
is 1304 1306 1961 1963 O
longer 1307 1313 1964 1970 O
. 1313 1314 1970 1971 O
WOCBP 1315 1320 1972 1977 O
should 1321 1327 1978 1984 O
also 1328 1332 1985 1989 O
agree 1333 1338 1990 1995 O
not 1339 1342 1996 1999 O
to 1343 1345 2000 2002 O
donate 1346 1352 2003 2009 O
eggs 1353 1357 2010 2014 O
( 1358 1359 2015 2016 O
ova 1359 1362 2016 2019 O
, 1362 1363 2019 2020 O
oocytes 1364 1371 2021 2028 O
) 1371 1372 2028 2029 O
for 1373 1376 2030 2033 O
the 1377 1380 2034 2037 O
purpose 1381 1388 2038 2045 O
of 1389 1391 2046 2048 O
reproduction 1392 1404 2049 2061 O
during 1405 1411 2062 2068 O
this 1412 1416 2069 2073 O
period 1417 1423 2074 2080 O
. 1423 1424 2080 2081 O
The 1425 1428 2082 2085 O
Investigator 1429 1441 2086 2098 O
should 1442 1448 2099 2105 O
evaluate 1449 1457 2106 2114 O
the 1458 1461 2115 2118 O
effectiveness 1462 1475 2119 2132 O
of 1476 1478 2133 2135 O
the 1479 1482 2136 2139 O
contraceptive 1483 1496 2140 2153 O
method 1497 1503 2154 2160 O
in 1504 1506 2161 2163 O
relationship 1507 1519 2164 2176 O
to 1520 1522 2177 2179 O
the 1523 1526 2180 2183 O
first 1527 1532 2184 2189 O
dose 1533 1537 2190 2194 O
of 1538 1540 2195 2197 O
study 1541 1546 2198 2203 O
intervention 1547 1559 2204 2216 O

Corrected 0 9 2217 2226 O
QT 10 12 2227 2229 B-clinical_variable
interval 13 21 2230 2238 I-clinical_variable
( 22 23 2239 2240 I-clinical_variable
QTc 23 26 2240 2243 I-clinical_variable
) 26 27 2243 2244 I-clinical_variable
> 28 29 2245 2246 O
450 29 32 2246 2249 B-lower_bound
milliseconds 33 45 2250 2262 I-lower_bound
( 46 47 2263 2264 I-lower_bound
msec 47 51 2264 2268 I-lower_bound
) 51 52 2268 2269 I-lower_bound
or 53 55 2270 2272 O
QTc 56 59 2273 2276 O
> 60 61 2277 2278 O
480 61 64 2278 2281 B-lower_bound
msec 65 69 2282 2286 I-lower_bound
for 70 73 2287 2290 O
subjects 74 82 2291 2299 O
with 83 87 2300 2304 O
Bundle 88 94 2305 2311 B-chronic_disease
Branch 95 101 2312 2318 I-chronic_disease
Block 102 107 2319 2324 I-chronic_disease
( 108 109 2325 2326 I-chronic_disease
BBB 109 112 2326 2329 I-chronic_disease
) 112 113 2329 2330 I-chronic_disease

Current 0 7 2331 2338 O
active 8 14 2339 2345 B-chronic_disease
liver 15 20 2346 2351 I-chronic_disease
or 21 23 2352 2354 I-chronic_disease
biliary 24 31 2355 2362 I-chronic_disease
disease 32 39 2363 2370 I-chronic_disease
( 40 41 2371 2372 O
with 41 45 2372 2376 O
the 46 49 2377 2380 O
exception 50 59 2381 2390 O
of 60 62 2391 2393 O
Gilbert 63 70 2394 2401 B-chronic_disease
's 70 72 2401 2403 I-chronic_disease
syndrome 73 81 2404 2412 I-chronic_disease
or 82 84 2413 2415 O
asymptomatic 85 97 2416 2428 B-chronic_disease
gallstones 98 108 2429 2439 I-chronic_disease
, 108 109 2439 2440 O
liver 110 115 2441 2446 B-cancer
metastases 116 126 2447 2457 I-cancer
or 127 129 2458 2460 O
otherwise 130 139 2461 2470 O
stable 140 146 2471 2477 O
chronic 147 154 2478 2485 B-chronic_disease
liver 155 160 2486 2491 I-chronic_disease
disease 161 168 2492 2499 I-chronic_disease
per 169 172 2500 2503 O
Investigator 173 185 2504 2516 O
assessment 186 196 2517 2527 O
) 196 197 2527 2528 O
. 197 198 2528 2529 O
Stable 199 205 2530 2536 O
chronic 206 213 2537 2544 O
liver 214 219 2545 2550 O
disease 220 227 2551 2558 O
should 228 234 2559 2565 O
generally 235 244 2566 2575 O
be 245 247 2576 2578 O
defined 248 255 2579 2586 O
by 256 258 2587 2589 O
the 259 262 2590 2593 O
absence 263 270 2594 2601 O
of 271 273 2602 2604 O
ascites 274 281 2605 2612 B-chronic_disease
, 281 282 2612 2613 O
encephalopathy 283 297 2614 2628 B-chronic_disease
, 297 298 2628 2629 O
coagulopathy 299 311 2630 2642 B-chronic_disease
, 311 312 2642 2643 O
hypoalbuminemia 313 328 2644 2659 B-chronic_disease
, 328 329 2659 2660 O
esophageal 330 340 2661 2671 B-chronic_disease
or 341 343 2672 2674 I-chronic_disease
gastric 344 351 2675 2682 I-chronic_disease
varices 352 359 2683 2690 I-chronic_disease
, 359 360 2690 2691 O
persistent 361 371 2692 2702 O
jaundice 372 380 2703 2711 O
or 381 383 2712 2714 O
cirrhosis 384 393 2715 2724 B-chronic_disease

Exceptions 0 10 2725 2735 O
: 10 11 2735 2736 O
adequately 12 22 2737 2747 O
treated 23 30 2748 2755 O
malignancies 31 43 2756 2768 B-cancer
not 44 47 2769 2772 O
likely 48 54 2773 2779 O
to 55 57 2780 2782 O
require 58 65 2783 2790 O
therapy 66 73 2791 2798 B-treatment
( 74 75 2799 2800 O
e.g. 75 79 2800 2804 O
, 79 80 2804 2805 O
completely 81 91 2806 2816 O
resected 92 100 2817 2825 O
non 101 104 2826 2829 B-cancer
- 104 105 2829 2830 I-cancer
melanomatous 105 117 2830 2842 I-cancer
skin 118 122 2843 2847 I-cancer
carcinoma 123 132 2848 2857 I-cancer
or 133 135 2858 2860 O
successfully 136 148 2861 2873 O
treated 149 156 2874 2881 O
in 157 159 2882 2884 B-cancer
situ 160 164 2885 2889 I-cancer
carcinoma 165 174 2890 2899 I-cancer
) 174 175 2899 2900 O

Female 0 6 2901 2907 B-gender

History 0 7 2908 2915 O
of 8 10 2916 2918 O
allergic 11 19 2919 2927 O
reactions 20 29 2928 2937 O
attributed 30 40 2938 2948 O
to 41 43 2949 2951 O
compounds 44 53 2952 2961 O
of 54 56 2962 2964 O
similar 57 64 2965 2972 O
chemical 65 73 2973 2981 O
or 74 76 2982 2984 O
biologic 77 85 2985 2993 O
composition 86 97 2994 3005 O
to 98 100 3006 3008 O
cyclophosphamide 101 117 3009 3025 B-allergy_name
, 117 118 3025 3026 O
fludarabine 119 130 3027 3038 B-allergy_name
, 130 131 3038 3039 O
or 132 134 3040 3042 O
other 135 140 3043 3048 O
agents 141 147 3049 3055 O
used 148 152 3056 3060 O
in 153 155 3061 3063 O
the 156 159 3064 3067 O
study 160 165 3068 3073 O

History 0 7 3074 3081 O
of 8 10 3082 3084 O
chronic 11 18 3085 3092 O
or 19 21 3093 3095 O
recurrent 22 31 3096 3105 O
( 32 33 3106 3107 O
within 33 39 3107 3113 O
the 40 43 3114 3117 O
last 44 48 3118 3122 O
year 49 53 3123 3127 O
prior 54 59 3128 3133 O
to 60 62 3134 3136 O
enrollment 63 73 3137 3147 O
) 73 74 3147 3148 O
severe 75 81 3149 3155 O
autoimmune 82 92 3156 3166 B-chronic_disease
or 93 95 3167 3169 O
active 96 102 3170 3176 O
immune 103 109 3177 3183 B-chronic_disease
- 109 110 3183 3184 I-chronic_disease
mediated 110 118 3184 3192 I-chronic_disease
disease 119 126 3193 3200 I-chronic_disease
requiring 127 136 3201 3210 O
steroids 137 145 3211 3219 B-treatment
or 146 148 3220 3222 O
other 149 154 3223 3228 O
immunosuppressive 155 172 3229 3246 B-treatment
treatments 173 183 3247 3257 I-treatment

Immune 0 6 3258 3264 B-treatment
therapy 7 14 3265 3272 I-treatment
( 15 16 3273 3274 O
including 16 25 3274 3283 O
monoclonal 26 36 3284 3294 B-treatment
antibody 37 45 3295 3303 I-treatment
therapy 46 53 3304 3311 I-treatment
, 53 54 3311 3312 O
checkpoint 55 65 3313 3323 O
inhibitors 66 76 3324 3334 O
) 76 77 3334 3335 O
or 78 80 3336 3338 O
biological 81 91 3339 3349 B-treatment
therapy 92 99 3350 3357 I-treatment
with 100 104 3358 3362 O
no 105 107 3363 3365 O
wash 108 112 3366 3370 O
- 112 113 3370 3371 O
out 113 116 3371 3374 O
times 117 122 3375 3380 O
required 123 131 3381 3389 O

Investigational 0 15 3390 3405 B-treatment
treatment 16 25 3406 3415 I-treatment
within 26 32 3416 3422 O
4 33 34 3423 3424 B-upper_bound
weeks 35 40 3425 3430 I-upper_bound
prior 41 46 3431 3436 I-upper_bound
to 47 49 3437 3439 O
leukapheresis 50 63 3440 3453 B-treatment
; 63 64 3453 3454 O
experimental 65 77 3455 3467 B-treatment
anti 78 82 3468 3472 I-treatment
- 82 83 3472 3473 I-treatment
cancer 83 89 3473 3479 I-treatment
vaccine 90 97 3480 3487 I-treatment
within 98 104 3488 3494 O
2 105 106 3495 3496 B-upper_bound
months 107 113 3497 3503 I-upper_bound
prior 114 119 3504 3509 I-upper_bound
to 120 122 3510 3512 O
leukapheresis 123 136 3513 3526 O
in 137 139 3527 3529 O
the 140 143 3530 3533 O
absence 144 151 3534 3541 O
of 152 154 3542 3544 O
response 155 163 3545 3553 O
or 164 166 3554 3556 O
in 167 169 3557 3559 O
the 170 173 3560 3563 O
opinion 174 181 3564 3571 O
of 182 184 3572 3574 O
the 185 188 3575 3578 O
Investigator 189 201 3579 3591 O
is 202 204 3592 3594 O
responding 205 215 3595 3605 O
to 216 218 3606 3608 O
an 219 221 3609 3611 O
experimental 222 234 3612 3624 B-treatment
vaccine 235 242 3625 3632 I-treatment
given 243 248 3633 3638 O
within 249 255 3639 3645 O
6 256 257 3646 3647 B-upper_bound
months 258 264 3648 3654 I-upper_bound
prior 265 270 3655 3660 I-upper_bound
to 271 273 3661 3663 O
leukapheresis 274 287 3664 3677 O
; 287 288 3677 3678 O
any 289 292 3679 3682 O
prior 293 298 3683 3688 B-treatment
gene 299 303 3689 3693 I-treatment
therapy 304 311 3694 3701 I-treatment
using 312 317 3702 3707 I-treatment
an 318 320 3708 3710 I-treatment
integrating 321 332 3711 3722 I-treatment
vector 333 339 3723 3729 I-treatment

Male 0 4 3730 3734 B-gender

Other 0 5 3735 3740 O
active 6 12 3741 3747 O
malignancies 13 25 3748 3760 B-cancer
besides 26 33 3761 3768 O
NSCLC 34 39 3769 3774 B-cancer
within 40 46 3775 3781 O
3 47 48 3782 3783 B-upper_bound
years 49 54 3784 3789 I-upper_bound
prior 55 60 3790 3795 I-upper_bound
to 61 63 3796 3798 O
Screening 64 73 3799 3808 O

Subject 0 7 3809 3816 O
has 8 11 3817 3820 O
Eastern 12 19 3821 3828 B-clinical_variable
Cooperative 20 31 3829 3840 I-clinical_variable
Oncology 32 40 3841 3849 I-clinical_variable
Group 41 46 3850 3855 I-clinical_variable
( 47 48 3856 3857 I-clinical_variable
ECOG 48 52 3857 3861 I-clinical_variable
) 52 53 3861 3862 I-clinical_variable
Performance 54 65 3863 3874 I-clinical_variable
Status 66 72 3875 3881 I-clinical_variable
0 73 74 3882 3883 B-lower_bound
- 74 75 3883 3884 O
1 75 76 3884 3885 B-upper_bound
10 77 79 3886 3888 O
. 79 80 3888 3889 O
Subject 81 88 3890 3897 O
has 89 92 3898 3901 O
an 93 95 3902 3904 O
anticipated 96 107 3905 3916 O
life 108 112 3917 3921 B-clinical_variable
expectancy 113 123 3922 3932 I-clinical_variable
> 124 125 3933 3934 O
3 125 126 3934 3935 B-lower_bound
months 127 133 3936 3942 I-lower_bound

Subject 0 7 3943 3950 O
has 8 11 3951 3954 O
a 12 13 3955 3956 O
diagnosis 14 23 3957 3966 O
of 24 26 3967 3969 O
histologically 27 41 3970 3984 O
or 42 44 3985 3987 O
cytologically 45 58 3988 4001 O
confirmed 59 68 4002 4011 O
advanced 69 77 4012 4020 O
non 78 81 4021 4024 B-cancer
- 81 82 4024 4025 I-cancer
small 82 87 4025 4030 I-cancer
cell 88 92 4031 4035 I-cancer
lung 93 97 4036 4040 I-cancer
cancer 98 104 4041 4047 I-cancer
( 105 106 4048 4049 O
Stage 106 111 4049 4054 B-lower_bound
IIIB 112 116 4055 4059 I-lower_bound
or 117 119 4060 4062 O
IV 120 122 4063 4065 B-upper_bound
) 122 123 4065 4066 O
or 124 126 4067 4069 O
recurrent 127 136 4070 4079 O
disease 137 144 4080 4087 O

Subject 0 7 4088 4095 O
has 8 11 4096 4099 O
active 12 18 4100 4106 O
brain 19 24 4107 4112 B-cancer
metastases 25 35 4113 4123 I-cancer
or 36 38 4124 4126 O
leptomeningeal 39 53 4127 4141 B-cancer
metastases 54 64 4142 4152 I-cancer

Subject 0 7 4153 4160 O
has 8 11 4161 4164 O
active 12 18 4165 4171 O
brain 19 24 4172 4177 B-cancer
metastases 25 35 4178 4188 I-cancer
or 36 38 4189 4191 O
leptomeningeal 39 53 4192 4206 B-cancer
metastases 54 64 4207 4217 I-cancer
. 64 65 4217 4218 O
Subjects 66 74 4219 4227 O
with 75 79 4228 4232 O
prior 80 85 4233 4238 O
history 86 93 4239 4246 O
of 94 96 4247 4249 O
brain 97 102 4250 4255 B-cancer
metastasis 103 113 4256 4266 I-cancer
who 114 117 4267 4270 O
have 118 122 4271 4275 O
undergone 123 132 4276 4285 O
local 133 138 4286 4291 B-treatment
therapy 139 146 4292 4299 I-treatment
( 147 148 4300 4301 O
i.e. 148 152 4301 4305 O
, 152 153 4305 4306 O
metastatectomy 154 168 4307 4321 B-treatment
and/or 169 175 4322 4328 O
radiation 176 185 4329 4338 B-treatment
) 185 186 4338 4339 O
and 187 190 4340 4343 O
show 191 195 4344 4348 O
no 196 198 4349 4351 O
evidence 199 207 4352 4360 O
of 208 210 4361 4363 O
local 211 216 4364 4369 O
recurrence 217 227 4370 4380 O
or 228 230 4381 4383 O
progression 231 242 4384 4395 O
over 243 247 4396 4400 O
the 248 251 4401 4404 O
past 252 256 4405 4409 B-upper_bound
3 257 258 4410 4411 I-upper_bound
months 259 265 4412 4418 I-upper_bound
prior 266 271 4419 4424 I-upper_bound
to 272 274 4425 4427 O
Screening 275 284 4428 4437 O
are 285 288 4438 4441 O
eligible 289 297 4442 4450 O

Subject 0 7 4451 4458 O
has 8 11 4459 4462 O
left 12 16 4463 4467 B-clinical_variable
ventricular 17 28 4468 4479 I-clinical_variable
ejection 29 37 4480 4488 I-clinical_variable
fraction 38 46 4489 4497 I-clinical_variable
> 47 48 4498 4499 O
= 48 49 4499 4500 O
50 49 51 4500 4502 B-lower_bound
% 51 52 4502 4503 I-lower_bound

Subject 0 7 4504 4511 O
is 8 10 4512 4514 O
> 11 12 4515 4516 O
= 12 13 4516 4517 O
18 13 15 4517 4519 B-lower_bound
years 16 21 4520 4525 I-lower_bound
of 22 24 4526 4528 O
age 25 28 4529 4532 B-age
on 29 31 4533 4535 O
the 32 35 4536 4539 O
day 36 39 4540 4543 O
of 40 42 4544 4546 O
signing 43 50 4547 4554 O
informed 51 59 4555 4563 O
consent 60 67 4564 4571 O

Subject 0 7 4572 4579 O
is 8 10 4580 4582 O
fit 11 14 4583 4586 O
for 15 18 4587 4590 O
leukapheresis 19 32 4591 4604 B-treatment
and 33 36 4605 4608 O
has 37 40 4609 4612 O
adequate 41 49 4613 4621 O
venous 50 56 4622 4628 O
access 57 63 4629 4635 O
for 64 67 4636 4639 O
the 68 71 4640 4643 O
cell 72 76 4644 4648 O
collection 77 87 4649 4659 O

Subject 0 7 4660 4667 O
is 8 10 4668 4670 O
pregnant 11 19 4671 4679 B-pregnancy
or 20 22 4680 4682 O
breastfeeding 23 36 4683 4696 O
. 36 37 4696 4697 O
Furthermore 38 49 4698 4709 O
and 50 53 4710 4713 O
prior 54 59 4714 4719 O
to 60 62 4720 4722 O
lymphodepleting 63 78 4723 4738 B-treatment
chemotherapy 79 91 4739 4751 I-treatment
, 91 92 4751 4752 O
a 93 94 4753 4754 O
subject 95 102 4755 4762 O
meeting 103 110 4763 4770 O
the 111 114 4771 4774 O
following 115 124 4775 4784 O
criteria 125 133 4785 4793 O
is 134 136 4794 4796 O
not 137 140 4797 4800 O
eligible 141 149 4801 4809 O
for 150 153 4810 4813 O
participation 154 167 4814 4827 O
in 168 170 4828 4830 O
the 171 174 4831 4834 O
study 175 180 4835 4840 O
: 180 181 4840 4841 O
1 182 183 4842 4843 O
) 183 184 4843 4844 O
Subject 185 192 4845 4852 O
has 193 196 4853 4856 O
received 197 205 4857 4865 O
: 205 206 4865 4866 O
Cytotoxic 207 216 4867 4876 B-treatment
chemotherapy 217 229 4877 4889 I-treatment
within 230 236 4890 4896 O
3 237 238 4897 4898 B-upper_bound
weeks 239 244 4899 4904 I-upper_bound
prior 245 250 4905 4910 I-upper_bound
to 251 253 4911 4913 O
lymphodepleting 254 269 4914 4929 O
chemotherapy 270 282 4930 4942 O
; 282 283 4942 4943 O
Immune 284 290 4944 4950 B-treatment
therapy 291 298 4951 4958 I-treatment
( 299 300 4959 4960 O
including 300 309 4960 4969 O
monoclonal 310 320 4970 4980 B-treatment
antibody 321 329 4981 4989 I-treatment
therapy 330 337 4990 4997 I-treatment
, 337 338 4997 4998 O
checkpoint 339 349 4999 5009 B-treatment
inhibitors 350 360 5010 5020 I-treatment
) 360 361 5020 5021 O
or 362 364 5022 5024 O
biological 365 375 5025 5035 B-treatment
therapy 376 383 5036 5043 I-treatment
within 384 390 5044 5050 O
4 391 392 5051 5052 B-upper_bound
weeks 393 398 5053 5058 I-upper_bound
prior 399 404 5059 5064 I-upper_bound
lymphodepleting 405 420 5065 5080 O
chemotherapy 421 433 5081 5093 O
; 433 434 5093 5094 O
Corticosteroids 435 450 5095 5110 B-treatment
or 451 453 5111 5113 O
any 454 457 5114 5117 O
other 458 463 5118 5123 O
immunosuppressive 464 481 5124 5141 B-treatment
therapy 482 489 5142 5149 I-treatment
within 490 496 5150 5156 O
2 497 498 5157 5158 B-upper_bound
weeks 499 504 5159 5164 I-upper_bound
prior 505 510 5165 5170 I-upper_bound
to 511 513 5171 5173 O
lymphodepleting 514 529 5174 5189 O
chemotherapy 530 542 5190 5202 O
; 542 543 5202 5203 O
Tyrosine 544 552 5204 5212 B-treatment
kinase 553 559 5213 5219 I-treatment
inhibitor 560 569 5220 5229 I-treatment
( 570 571 5230 5231 O
e.g. 571 575 5231 5235 O
erlotinib 576 585 5236 5245 B-treatment
, 585 586 5245 5246 O
gefitinib 587 596 5247 5256 B-treatment
) 596 597 5256 5257 O
and 598 601 5258 5261 O
any 602 605 5262 5265 O
other 606 611 5266 5271 O
anti 612 616 5272 5276 B-treatment
- 616 617 5276 5277 I-treatment
cancer 617 623 5277 5283 I-treatment
treatment 624 633 5284 5293 I-treatment
within 634 640 5294 5300 O
1 641 642 5301 5302 B-upper_bound
week 643 647 5303 5307 I-upper_bound
prior 648 653 5308 5313 I-upper_bound
to 654 656 5314 5316 O
lymphodepleting 657 672 5317 5332 O
chemotherapy 673 685 5333 5345 O
; 685 686 5345 5346 O
Major 687 692 5347 5352 B-treatment
surgery 693 700 5353 5360 I-treatment
within 701 707 5361 5367 O
4 708 709 5368 5369 O
weeks 710 715 5370 5375 O
prior 716 721 5376 5381 O
to 722 724 5382 5384 O
lymphodepleting 725 740 5385 5400 O
chemotherapy 741 753 5401 5413 O
; 753 754 5413 5414 O
subjects 755 763 5415 5423 O
must 764 768 5424 5428 O
have 769 773 5429 5433 O
recovered 774 783 5434 5443 O
from 784 788 5444 5448 O
any 789 792 5449 5452 O
surgical 793 801 5453 5461 O
- 801 802 5461 5462 O
related 802 809 5462 5469 O
toxicities 810 820 5470 5480 O
in 821 823 5481 5483 O
the 824 827 5484 5487 O
opinion 828 835 5488 5495 O
of 836 838 5496 5498 O
the 839 842 5499 5502 O
Investigator 843 855 5503 5515 O
; 855 856 5515 5516 O
Radiotherapy 857 869 5517 5529 B-treatment
that 870 874 5530 5534 O
involves 875 883 5535 5543 O
the 884 887 5544 5547 O
lung 888 892 5548 5552 O
or 893 895 5553 5555 O
mediastinum 896 907 5556 5567 O
within 908 914 5568 5574 O
3 915 916 5575 5576 B-upper_bound
months 917 923 5577 5583 I-upper_bound
prior 924 929 5584 5589 I-upper_bound
to 930 932 5590 5592 O
lymphodepleting 933 948 5593 5608 O
chemotherapy 949 961 5609 5621 O
; 961 962 5621 5622 O
however 963 970 5623 5630 O
, 970 971 5630 5631 O
electron 972 980 5632 5640 B-treatment
beam 981 985 5641 5645 I-treatment
radiotherapy 986 998 5646 5658 I-treatment
to 999 1001 5659 5661 O
superficial 1002 1013 5662 5673 O
structures 1014 1024 5674 5684 O
in 1025 1027 5685 5687 O
the 1028 1031 5688 5691 O
chest 1032 1037 5692 5697 O
is 1038 1040 5698 5700 O
permitted 1041 1050 5701 5710 O

Subject 0 7 5711 5718 O
must 8 12 5719 5723 O
have 13 17 5724 5728 O
adequate 18 26 5729 5737 O
organ 27 32 5738 5743 O
function 33 41 5744 5752 O
as 42 44 5753 5755 O
indicated 45 54 5756 5765 O
by 55 57 5766 5768 O
the 58 61 5769 5772 O
following 62 71 5773 5782 O
laboratory 72 82 5783 5793 O
values 83 89 5794 5800 O
: 89 90 5800 5801 O
a 91 92 5802 5803 O
) 92 93 5803 5804 O
Absolute 94 102 5805 5813 B-clinical_variable
Neutrophil 103 113 5814 5824 I-clinical_variable
count 114 119 5825 5830 I-clinical_variable
( 120 121 5831 5832 I-clinical_variable
ANC 121 124 5832 5835 I-clinical_variable
) 124 125 5835 5836 I-clinical_variable
> 126 127 5837 5838 O
= 127 128 5838 5839 O
1.0 128 131 5839 5842 B-lower_bound
x10 132 135 5843 5846 I-lower_bound
^ 135 136 5846 5847 I-lower_bound
9 136 137 5847 5848 I-lower_bound
per 138 141 5849 5852 I-lower_bound
liter 142 147 5853 5858 I-lower_bound
( 148 149 5859 5860 I-lower_bound
/L 149 151 5860 5862 I-lower_bound
) 151 152 5862 5863 I-lower_bound
( 153 154 5864 5865 O
without 154 161 5865 5872 O
G 162 163 5873 5874 O
- 163 164 5874 5875 O
CSF 164 167 5875 5878 O
support 168 175 5879 5886 O
) 175 176 5886 5887 O
; 176 177 5887 5888 O
b 178 179 5889 5890 O
) 179 180 5890 5891 O
Platelets 181 190 5892 5901 B-clinical_variable
> 191 192 5902 5903 O
= 192 193 5903 5904 O
75 194 196 5905 5907 B-lower_bound
x10 197 200 5908 5911 I-lower_bound
^ 200 201 5911 5912 I-lower_bound
9 201 202 5912 5913 I-lower_bound
/ 202 203 5913 5914 I-lower_bound
L 203 204 5914 5915 I-lower_bound
; 204 205 5915 5916 O
c 206 207 5917 5918 O
) 207 208 5918 5919 O
Hemoglobin 209 219 5920 5930 B-clinical_variable
> 220 221 5931 5932 O
80 221 223 5932 5934 B-lower_bound
grams 224 229 5935 5940 I-lower_bound
per 230 233 5941 5944 I-lower_bound
deciliter 234 243 5945 5954 I-lower_bound
( 244 245 5955 5956 I-lower_bound
g 245 246 5956 5957 I-lower_bound
/ 246 247 5957 5958 I-lower_bound
dL 247 249 5958 5960 I-lower_bound
) 249 250 5960 5961 I-lower_bound
( 251 252 5962 5963 O
without 252 259 5963 5970 O
transfusion 260 271 5971 5982 O
support 272 279 5983 5990 O
within 280 286 5991 5997 O
7 287 288 5998 5999 B-upper_bound
days 289 293 6000 6004 I-upper_bound
from 294 298 6005 6009 O
start 299 304 6010 6015 O
of 305 307 6016 6018 O
leukapheresis 308 321 6019 6032 B-treatment
) 321 322 6032 6033 O
; 322 323 6033 6034 O
d 324 325 6035 6036 O
) 325 326 6036 6037 O
Prothrombin 327 338 6038 6049 B-clinical_variable
Time 339 343 6050 6054 I-clinical_variable
or 344 346 6055 6057 I-clinical_variable
International 347 360 6058 6071 I-clinical_variable
Normalized 361 371 6072 6082 I-clinical_variable
Ratio 372 377 6083 6088 I-clinical_variable
( 378 379 6089 6090 I-clinical_variable
INR 379 382 6090 6093 I-clinical_variable
) 382 383 6093 6094 I-clinical_variable
< 384 385 6095 6096 O
= 385 386 6096 6097 O
1.5 386 389 6097 6100 B-upper_bound
times 390 395 6101 6106 I-upper_bound
upper 396 401 6107 6112 I-upper_bound
limit 402 407 6113 6118 I-upper_bound
of 408 410 6119 6121 I-upper_bound
normal 411 417 6122 6128 I-upper_bound
( 418 419 6129 6130 I-upper_bound
ULN 419 422 6130 6133 I-upper_bound
) 422 423 6133 6134 I-upper_bound
unless 424 430 6135 6141 O
receiving 431 440 6142 6151 O
therapeutic 441 452 6152 6163 B-treatment
anticoagulation 453 468 6164 6179 I-treatment
. 468 469 6179 6180 O
e 470 471 6181 6182 O
) 471 472 6182 6183 O
Partial 473 480 6184 6191 B-clinical_variable
Thromboplastin 481 495 6192 6206 I-clinical_variable
Time 496 500 6207 6211 I-clinical_variable
( 501 502 6212 6213 I-clinical_variable
PTT 502 505 6213 6216 I-clinical_variable
) 505 506 6216 6217 I-clinical_variable
< 507 508 6218 6219 O
= 508 509 6219 6220 O
1.5 509 512 6220 6223 O
times 513 518 6224 6229 O
upper 519 524 6230 6235 O
limit 525 530 6236 6241 O
of 531 533 6242 6244 O
normal 534 540 6245 6251 O
( 541 542 6252 6253 O
ULN 542 545 6253 6256 O
) 545 546 6256 6257 O
unless 547 553 6258 6264 O
receiving 554 563 6265 6274 O
therapeutic 564 575 6275 6286 O
anticoagulation 576 591 6287 6302 O
. 591 592 6302 6303 O
f 593 594 6304 6305 O
) 594 595 6305 6306 O
Calculated 596 606 6307 6317 B-clinical_variable
or 607 609 6318 6320 I-clinical_variable
measured 610 618 6321 6329 I-clinical_variable
creatinine 619 629 6330 6340 I-clinical_variable
clearance 630 639 6341 6350 I-clinical_variable
> 640 641 6351 6352 O
= 641 642 6352 6353 O
40 642 644 6353 6355 B-lower_bound
milliliters 645 656 6356 6367 I-lower_bound
per 657 660 6368 6371 I-lower_bound
minute 661 667 6372 6378 I-lower_bound
( 668 669 6379 6380 I-lower_bound
mL 669 671 6380 6382 I-lower_bound
/ 671 672 6382 6383 I-lower_bound
min 672 675 6383 6386 I-lower_bound
) 675 676 6386 6387 I-lower_bound
; 676 677 6387 6388 O
g 678 679 6389 6390 O
) 679 680 6390 6391 O
Serum 681 686 6392 6397 B-clinical_variable
total 687 692 6398 6403 I-clinical_variable
bilirubin 693 702 6404 6413 I-clinical_variable
< 703 704 6414 6415 O
= 704 705 6415 6416 O
1.5 705 708 6416 6419 B-upper_bound
times 709 714 6420 6425 I-upper_bound
ULN 715 718 6426 6429 I-upper_bound
( 719 720 6430 6431 O
unless 720 726 6431 6437 O
subject 727 734 6438 6445 O
had 735 738 6446 6449 O
documented 739 749 6450 6460 O
Gilbert 750 757 6461 6468 B-chronic_disease
's 757 759 6468 6470 I-chronic_disease
Syndrome 760 768 6471 6479 I-chronic_disease
) 768 769 6479 6480 O
; 769 770 6480 6481 O
h 771 772 6482 6483 O
) 772 773 6483 6484 O
Alanine 774 781 6485 6492 B-clinical_variable
aminotransferase 782 798 6493 6509 I-clinical_variable
( 799 800 6510 6511 I-clinical_variable
ALT)/Serum 800 810 6511 6521 I-clinical_variable
Glutamic 811 819 6522 6530 I-clinical_variable
Pyruvic 820 827 6531 6538 I-clinical_variable
Transaminase 828 840 6539 6551 I-clinical_variable
( 841 842 6552 6553 I-clinical_variable
SGPT 842 846 6553 6557 I-clinical_variable
) 846 847 6557 6558 I-clinical_variable
< 848 849 6559 6560 O
= 849 850 6560 6561 O
2.5 850 853 6561 6564 B-upper_bound
times 854 859 6565 6570 I-upper_bound
ULN 860 863 6571 6574 I-upper_bound

Subject 0 7 6575 6582 O
who 8 11 6583 6586 O
has 12 15 6587 6590 O
had 16 19 6591 6594 O
cytotoxic 20 29 6595 6604 B-treatment
chemotherapy 30 42 6605 6617 I-treatment
within 43 49 6618 6624 O
2 50 51 6625 6626 B-upper_bound
weeks 52 57 6627 6632 I-upper_bound
prior 58 63 6633 6638 I-upper_bound
to 64 66 6639 6641 O
leukapheresis 67 80 6642 6655 B-treatment

Subject 0 7 6656 6663 O
's 7 9 6663 6665 O
tumor 10 15 6666 6671 B-cancer
( 16 17 6672 6673 O
either 17 23 6673 6679 O
an 24 26 6680 6682 O
archival 27 35 6683 6691 O
specimen 36 44 6692 6700 O
or 45 47 6701 6703 O
a 48 49 6704 6705 O
fresh 50 55 6706 6711 O
biopsy 56 62 6712 6718 B-treatment
if 63 65 6719 6721 O
archival 66 74 6722 6730 O
tissue 75 81 6731 6737 O
is 82 84 6738 6740 O
unavailable 85 96 6741 6752 O
) 96 97 6752 6753 O
has 98 101 6754 6757 O
been 102 106 6758 6762 O
pathologically 107 121 6763 6777 O
reviewed 122 130 6778 6786 O
by 131 133 6787 6789 O
an 134 136 6790 6792 O
Adaptimmune- 137 149 6793 6805 O
/ 150 151 6806 6807 O
GSK 152 155 6808 6811 O
- 155 156 6811 6812 O
designated 156 166 6812 6822 O
central 167 174 6823 6830 O
laboratory 175 185 6831 6841 O
confirming 186 196 6842 6852 O
NY 197 199 6853 6855 O
- 199 200 6855 6856 O
ESO-1 200 205 6856 6861 O
and/or 206 212 6862 6868 O
LAGE-1a 213 220 6869 6876 O
expression 221 231 6877 6887 O

Subjects 0 8 6888 6896 O
must 9 13 6897 6901 O
be 14 16 6902 6904 O
in 17 19 6905 6907 O
complete 20 28 6908 6916 O
remission 29 38 6917 6926 O
from 39 43 6927 6931 O
prior 44 49 6932 6937 O
malignancy 50 60 6938 6948 B-cancer
in 61 63 6949 6951 O
order 64 69 6952 6957 O
to 70 72 6958 6960 O
be 73 75 6961 6963 O
eligible 76 84 6964 6972 O
to 85 87 6973 6975 O
enter 88 93 6976 6981 O
the 94 97 6982 6985 O
study 98 103 6986 6991 O

Subjects 0 8 6992 7000 O
with 9 13 7001 7005 O
known 14 19 7006 7011 O
epidermal 20 29 7012 7021 O
growth 30 36 7022 7028 O
factor 37 43 7029 7035 O
receptor 44 52 7036 7044 O
( 53 54 7045 7046 O
EGFR 54 58 7046 7050 O
) 58 59 7050 7051 O
mutations 60 69 7052 7061 O
or 70 72 7062 7064 O
ALK 73 76 7065 7068 B-treatment
or 77 79 7069 7071 O
ROS1 80 84 7072 7076 O
gene 85 89 7077 7081 O
rearrangements 90 104 7082 7096 O
must 105 109 7097 7101 O
have 110 114 7102 7106 O
failed 115 121 7107 7113 O
( 122 123 7114 7115 O
disease 123 130 7115 7122 O
progression 131 142 7123 7134 O
[ 143 144 7135 7136 O
PD 144 146 7136 7138 O
] 146 147 7138 7139 O
or 148 150 7140 7142 O
unacceptable 151 163 7143 7155 O
toxicity 164 172 7156 7164 O
) 172 173 7164 7165 O
prior 174 179 7166 7171 B-treatment
EGFR 180 184 7172 7176 I-treatment
or 185 187 7177 7179 O
ALK 188 191 7180 7183 O
or 192 194 7184 7186 O
ROS1 195 199 7187 7191 B-treatment
tyrosine 200 208 7192 7200 I-treatment
kinase 209 215 7201 7207 I-treatment
inhibitor 216 225 7208 7217 I-treatment
, 225 226 7217 7218 O
respectively 227 239 7219 7231 O
( 240 241 7232 7233 O
PD 241 243 7233 7235 O
or 244 246 7236 7238 O
unacceptable 247 259 7239 7251 O
toxicity 260 268 7252 7260 O
) 268 269 7260 7261 O

Subjects 0 8 7262 7270 O
with 9 13 7271 7275 O
prior 14 19 7276 7281 O
history 20 27 7282 7289 O
of 28 30 7290 7292 O
brain 31 36 7293 7298 B-cancer
metastasis 37 47 7299 7309 I-cancer
who 48 51 7310 7313 O
have 52 56 7314 7318 O
undergone 57 66 7319 7328 O
local 67 72 7329 7334 B-treatment
therapy 73 80 7335 7342 I-treatment
( 81 82 7343 7344 O
i.e. 82 86 7344 7348 O
, 86 87 7348 7349 O
metastasectomy 88 102 7350 7364 B-treatment
and/or 103 109 7365 7371 I-treatment
radiation 110 119 7372 7381 I-treatment
) 119 120 7381 7382 O
and 121 124 7383 7386 O
show 125 129 7387 7391 O
no 130 132 7392 7394 O
evidence 133 141 7395 7403 O
of 142 144 7404 7406 O
local 145 150 7407 7412 O
recurrence 151 161 7413 7423 O
or 162 164 7424 7426 O
progression 165 176 7427 7438 O
over 177 181 7439 7443 O
the 182 185 7444 7447 O
past 186 190 7448 7452 B-upper_bound
3 191 192 7453 7454 I-upper_bound
months 193 199 7455 7461 I-upper_bound
prior 200 205 7462 7467 I-upper_bound
to 206 208 7468 7470 O
Screening 209 218 7471 7480 O
are 219 222 7481 7484 O
eligible 223 231 7485 7493 O

Toxicity 0 8 7494 7502 O
from 9 13 7503 7507 O
previous 14 22 7508 7516 B-treatment
anti 23 27 7517 7521 I-treatment
- 27 28 7521 7522 I-treatment
cancer 28 34 7522 7528 I-treatment
therapy 35 42 7529 7536 I-treatment
that 43 47 7537 7541 O
has 48 51 7542 7545 O
not 52 55 7546 7549 O
recovered 56 65 7550 7559 O
to 66 68 7560 7562 O
< 69 70 7563 7564 O
= 70 71 7564 7565 O
Grade 71 76 7565 7570 B-upper_bound
1 77 78 7571 7572 I-upper_bound
prior 79 84 7573 7578 O
to 85 87 7579 7581 O
enrollment 88 98 7582 7592 O
( 99 100 7593 7594 O
except 100 106 7594 7600 O
for 107 110 7601 7604 O
non 111 114 7605 7608 O
- 114 115 7608 7609 O
clinically 115 125 7609 7619 O
significant 126 137 7620 7631 O
toxicities 138 148 7632 7642 O
, 148 149 7642 7643 O
e.g. 150 154 7644 7648 O
, 154 155 7648 7649 O
alopecia 156 164 7650 7658 B-chronic_disease
, 164 165 7658 7659 O
vitiligo 166 174 7660 7668 B-chronic_disease
) 174 175 7668 7669 O
. 175 176 7669 7670 O
Subjects 177 185 7671 7679 O
with 186 190 7680 7684 O
existing 191 199 7685 7693 O
pneumonitis 200 211 7694 7705 B-chronic_disease
as 212 214 7706 7708 O
a 215 216 7709 7710 O
result 217 223 7711 7717 O
of 224 226 7718 7720 O
radiation 227 236 7721 7730 B-treatment
are 237 240 7731 7734 O
not 241 244 7735 7738 O
excluded 245 253 7739 7747 O
; 253 254 7747 7748 O
however 255 262 7749 7756 O
, 262 263 7756 7757 O
subjects 264 272 7758 7766 O
can 273 276 7767 7770 O
not 276 279 7770 7773 O
be 280 282 7774 7776 O
oxygen 283 289 7777 7783 O
dependent 290 299 7784 7793 O

Unintended 0 10 7794 7804 B-clinical_variable
weight 11 17 7805 7811 I-clinical_variable
loss 18 22 7812 7816 I-clinical_variable
> 23 24 7817 7818 O
10 24 26 7818 7820 B-lower_bound
% 26 27 7820 7821 I-lower_bound
in 28 30 7822 7824 O
6 31 32 7825 7826 B-upper_bound
months 33 39 7827 7833 I-upper_bound
preceding 40 49 7834 7843 O
study 50 55 7844 7849 O
entry 56 61 7850 7855 O

corticosteroids 0 15 7856 7871 B-treatment
or 16 18 7872 7874 O
any 19 22 7875 7878 O
other 23 28 7879 7884 O
immunosuppressive 29 46 7885 7902 B-treatment
therapy 47 54 7903 7910 I-treatment
within 55 61 7911 7917 O
2 62 63 7918 7919 B-upper_bound
weeks 64 69 7920 7925 I-upper_bound
prior 70 75 7926 7931 I-upper_bound
to 76 78 7932 7934 O
leukapheresis 79 92 7935 7948 B-treatment

8 0 1 0 1 B-lower_bound
- 1 2 1 2 O
13.99 2 7 2 7 B-upper_bound
years 8 13 8 13 I-upper_bound
for 14 17 14 17 O
Phase 18 23 18 23 O
2 24 25 24 25 O

> 0 1 26 27 O
300 1 4 27 30 B-lower_bound
mg 5 7 31 33 I-lower_bound
/ 7 8 33 34 I-lower_bound
dL 8 10 34 36 I-lower_bound
protein 11 18 37 44 B-clinical_variable
in 19 21 45 47 O
spot 22 26 48 52 O
urinalysis 27 37 53 63 O

Age 0 3 64 67 B-age
12 4 6 68 70 B-lower_bound
- 6 7 70 71 O
65 7 9 71 73 B-upper_bound
years 10 15 74 79 I-upper_bound
for 16 19 80 83 O
Phase 20 25 84 89 O
1 26 27 90 91 O

Concomitant 0 11 92 103 B-chronic_disease
acute 12 17 104 109 I-chronic_disease
process 18 25 110 117 O
, 25 26 117 118 O
including 27 36 119 128 O
fever 37 42 129 134 B-clinical_variable
> 43 44 135 136 O
38.5 45 49 137 141 B-lower_bound
° 49 50 141 142 I-lower_bound
C 51 52 143 144 I-lower_bound
with 53 57 145 149 O
clinical 58 66 150 158 O
suspicion 67 76 159 168 B-chronic_disease
of 77 79 169 171 I-chronic_disease
infection 80 89 172 181 I-chronic_disease

Current 0 7 182 189 O
participation 8 21 190 203 O
in 22 24 204 206 O
another 25 32 207 214 B-treatment
investigational 33 48 215 230 I-treatment
drug 49 53 231 235 I-treatment
study 54 59 236 241 I-treatment

Current 0 7 242 249 O
treatment 8 17 250 259 B-treatment
with 18 22 260 264 O
chronic 23 30 265 272 B-treatment
transfusion 31 42 273 284 I-treatment

Documented 0 10 285 295 O
diagnosis 11 20 296 305 O
of 21 23 306 308 O
sickle 24 30 309 315 B-chronic_disease
cell 31 35 316 320 I-chronic_disease
disease 36 43 321 328 I-chronic_disease
( 44 45 329 330 O
SS 45 47 330 332 B-chronic_disease
or 48 50 333 335 O
S 51 52 336 337 B-chronic_disease
- 52 53 337 338 I-chronic_disease
β 53 54 338 339 I-chronic_disease
thalassemia 55 66 340 351 I-chronic_disease
genotype 67 75 352 360 I-chronic_disease
) 75 76 360 361 O

Hb 0 2 362 364 B-clinical_variable
> 3 4 365 366 O
10 5 7 367 369 B-lower_bound
g 8 9 370 371 I-lower_bound
/ 9 10 371 372 I-lower_bound
dL 10 12 372 374 I-lower_bound

Hb 0 2 375 377 B-clinical_variable
< 2 3 377 378 O
5 4 5 379 380 B-upper_bound
g 6 7 381 382 I-upper_bound
/ 7 8 382 383 I-upper_bound
dl 8 10 383 385 I-upper_bound

Increased 0 9 386 395 B-clinical_variable
ALT 10 13 396 399 I-clinical_variable
> 14 15 400 401 O
2X 16 18 402 404 B-lower_bound
ULN 19 22 405 408 I-lower_bound

Increased 0 9 409 418 O
stroke 10 16 419 425 B-chronic_disease
risk 17 21 426 430 O
as 22 24 431 433 O
assessed 25 33 434 442 O
by 34 36 443 445 O
transcranial 37 49 446 458 B-treatment
Doppler 50 57 459 466 I-treatment
or 58 60 467 469 O
magnetic 61 69 470 478 B-treatment
resonance 70 79 479 488 I-treatment
imaging 80 87 489 496 I-treatment
( 88 89 497 498 O
all 89 92 498 501 O
subjects 93 101 502 510 O
undergo 102 109 511 518 O
testing 110 117 519 526 O
) 117 118 526 527 O

Known 0 5 528 533 O
IgA 6 9 534 537 B-chronic_disease
deficiency 10 20 538 548 I-chronic_disease

Pregnancy 0 9 549 558 B-pregnancy

Prior 0 5 559 564 O
thromboses 6 16 565 575 B-chronic_disease

Serum 0 5 576 581 B-clinical_variable
creatinine 6 16 582 592 I-clinical_variable
≥1.3 17 21 593 597 O
mg 22 24 598 600 I-lower_bound
/ 24 25 600 601 I-lower_bound
dL 25 27 601 603 I-lower_bound

Vaccination 0 11 604 615 B-treatment
with 12 16 616 620 I-treatment
a 17 18 621 622 I-treatment
live 19 23 623 627 I-treatment
attenuated 24 34 628 638 I-treatment
virus 35 40 639 644 I-treatment
in 41 43 645 647 O
the 44 47 648 651 O
preceding 48 57 652 661 B-upper_bound
6 58 59 662 663 I-upper_bound
weeks 60 65 664 669 I-upper_bound

ct 0 2 670 672 B-clinical_variable
> 3 4 673 674 O
30 5 7 675 677 B-lower_bound
% 7 8 677 678 I-lower_bound

current 0 7 679 686 O
estrogen 8 16 687 695 B-treatment
use 17 20 696 699 O

known 0 5 700 705 O
allergy 6 13 706 713 O
to 14 16 714 716 O
gamma 17 22 717 722 B-allergy_name
globulin 23 31 723 731 I-allergy_name

known 0 5 732 737 O
condition 6 15 738 747 O
associated 16 26 748 758 O
with 27 31 759 763 O
renal 32 37 764 769 B-chronic_disease
dysfunction 38 49 770 781 I-chronic_disease

ALT 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
2.5 6 9 6 9 B-lower_bound
x 10 11 10 11 I-lower_bound
ULN 12 15 12 15 I-lower_bound

Age 0 3 16 19 B-age
18 4 6 20 22 B-lower_bound
- 6 7 22 23 O
55 7 9 23 25 B-upper_bound

BMI 0 3 26 29 B-bmi
18 4 6 30 32 B-lower_bound
- 6 7 32 33 O
45 7 9 33 35 B-upper_bound
kg 10 12 36 38 I-upper_bound
/ 12 13 38 39 I-upper_bound
m^2 13 16 39 42 I-upper_bound

Bleeding 0 8 43 51 B-chronic_disease
Disorders 9 18 52 61 I-chronic_disease

Creatinine 0 10 62 72 B-clinical_variable
> 11 12 73 74 O
1.5 13 16 75 78 B-lower_bound
mg 17 19 79 81 I-lower_bound
/ 19 20 81 82 I-lower_bound
dL 20 22 82 84 I-lower_bound

Current 0 7 85 92 O
or 8 10 93 95 O
recent 11 17 96 102 O
steroid 18 25 103 110 B-treatment
use 26 29 111 114 O
in 30 32 115 117 O
last 33 37 118 122 B-upper_bound
3 38 39 123 124 I-upper_bound
months 40 46 125 131 I-upper_bound

Hgb 0 3 132 135 B-clinical_variable
< 4 5 136 137 O
10 6 8 138 140 B-upper_bound
mg 9 11 141 143 I-upper_bound
/ 11 12 143 144 I-upper_bound
dL 12 14 144 146 I-upper_bound

Known 0 5 147 152 O
Neurological 6 18 153 165 B-chronic_disease
Disorders 19 28 166 175 I-chronic_disease

Malignancy 0 10 176 186 B-cancer

Pregnancy 0 9 187 196 B-pregnancy
, 9 10 196 197 O
actively 11 19 198 206 B-pregnancy
seeking 20 27 207 214 I-pregnancy
pregnancy 28 37 215 224 I-pregnancy
, 37 38 224 225 O
or 39 41 226 228 O
breastfeeding 42 55 229 242 O

Type 0 4 243 247 B-chronic_disease
2 5 6 248 249 I-chronic_disease
DM 7 9 250 252 I-chronic_disease
with 10 14 253 257 O
HbA1C 15 20 258 263 B-treatment
treated 21 28 264 271 O
with 29 33 272 276 O
metformin 34 43 277 286 B-treatment
, 43 44 286 287 O
sulfonylurea 45 57 288 300 B-treatment
, 57 58 300 301 O
insulin 59 66 302 309 B-treatment
, 66 67 309 310 O
or 68 70 311 313 O
combination 71 82 314 325 O
OR 83 85 326 328 O
age 86 89 329 332 O
- 89 90 332 333 O
matched 90 97 333 340 O
, 97 98 340 341 O
non 99 102 342 345 B-chronic_disease
- 102 103 345 346 I-chronic_disease
diabetic 103 111 346 354 I-chronic_disease
obese 112 117 355 360 I-chronic_disease
( 118 119 361 362 O
BMI 119 122 362 365 B-bmi
> 123 124 366 367 O
30 125 127 368 370 B-lower_bound
kg 128 130 371 373 I-lower_bound
/ 130 131 373 374 I-lower_bound
m^2 131 134 374 377 I-lower_bound
) 134 135 377 378 O
OR 136 138 379 381 O
age 139 142 382 385 O
- 142 143 385 386 O
matched 143 150 386 393 O
lean 151 155 394 398 O
, 155 156 398 399 O
healthy 157 164 400 407 O
control 165 172 408 415 O
subjects 173 181 416 424 O
( 182 183 425 426 O
BMI 183 186 426 429 O
< 187 188 430 431 O
25 189 191 432 434 B-upper_bound
kg 192 194 435 437 I-upper_bound
/ 194 195 437 438 I-upper_bound
m^2 195 198 438 441 I-upper_bound
) 198 199 441 442 O

Uncontrolled 0 12 443 455 B-chronic_disease
Hypertension 13 25 456 468 I-chronic_disease

Untreated 0 9 469 478 B-chronic_disease
Psychiatric 10 21 479 490 I-chronic_disease
Disorders 22 31 491 500 I-chronic_disease

Untreated 0 9 501 510 O
thyroid 10 17 511 518 B-chronic_disease
disease 18 25 519 526 I-chronic_disease

Any 0 3 0 3 O
adult 4 9 4 9 O
female 10 16 10 16 B-gender
volunteers 17 27 17 27 O
of 28 30 28 30 O
any 31 34 31 34 O
race 35 39 35 39 O
or 40 42 40 42 O
ethnic 43 49 43 49 O
background 50 60 50 60 O

Under 0 5 61 66 O
30 6 8 67 69 B-upper_bound
years 9 14 70 75 I-upper_bound
old 15 18 76 79 O
or 19 21 80 82 O
over 22 26 83 87 O
80 27 29 88 90 B-lower_bound
years 30 35 91 96 I-lower_bound
old 36 39 97 100 O

between 0 7 101 108 O
the 8 11 109 112 O
ages 12 16 113 117 B-age
of 17 19 118 120 O
30 20 22 121 123 B-lower_bound
to 23 25 124 126 O
80 26 28 127 129 B-upper_bound

pregnant 0 8 130 138 B-pregnancy
or 9 11 139 141 O
thinks 12 18 142 148 O
she 19 22 149 152 O
may 23 26 153 156 B-pregnancy
become 27 33 157 163 I-pregnancy
pregnant 34 42 164 172 I-pregnancy

presenting 0 10 173 183 O
for 11 14 184 187 O
breast 15 21 188 194 B-treatment
cancer 22 28 195 201 I-treatment
treatment 29 38 202 211 I-treatment

Any 0 3 0 3 O
current 4 11 4 11 O
, 11 12 11 12 O
serious 13 20 13 20 O
, 20 21 20 21 O
chronic 22 29 22 29 B-chronic_disease
medical 30 37 30 37 I-chronic_disease
or 38 40 38 40 O
psychiatric 41 52 41 52 B-chronic_disease
disease 53 60 53 60 I-chronic_disease
that 61 65 61 65 O
, 65 66 65 66 O
in 67 69 67 69 O
the 70 73 70 73 O
Principal 74 83 74 83 O
Investigator 84 96 84 96 O
's 96 98 96 98 O
judgment 99 107 99 107 O
, 107 108 107 108 O
may 109 112 109 112 O
interfere 113 122 113 122 O
with 123 127 123 127 O
study 128 133 128 133 O
participation 134 147 134 147 O
or 148 150 148 150 O
data 151 155 151 155 O
integrity 156 165 156 165 O

Concussion 0 10 166 176 O
will 11 15 177 181 O
be 16 18 182 184 O
diagnosed 19 28 185 194 O
by 29 31 195 197 O
board 32 37 198 203 O
- 37 38 203 204 O
certified 38 47 204 213 O
sports 48 54 214 220 O
medicine 55 63 221 229 O
physicians 64 74 230 240 O
, 74 75 240 241 O
and 76 79 242 245 O
defined 80 87 246 253 O
as 88 90 254 256 O
a 91 92 257 258 O
direct 93 99 259 265 O
or 100 102 266 268 O
indirect 103 111 269 277 O
blow 112 116 278 282 O
to 117 119 283 285 O
the 120 123 286 289 O
head 124 128 290 294 O
, 128 129 294 295 O
face 130 134 296 300 O
, 134 135 300 301 O
neck 136 140 302 306 O
, 140 141 306 307 O
or 142 144 308 310 O
elsewhere 145 154 311 320 O
that 155 159 321 325 O
manifests 160 169 326 335 O
with 170 174 336 340 O
the 175 178 341 344 O
presence 179 187 345 353 O
of 188 190 354 356 O
symptoms 191 199 357 365 O
and 200 203 366 369 O
neurological 204 216 370 382 B-chronic_disease
impairment 217 227 383 393 I-chronic_disease

Experienced 0 11 394 405 O
a 12 13 406 407 O
concussion 14 24 408 418 B-chronic_disease
within 25 31 419 425 O
the 32 35 426 429 O
last 36 40 430 434 B-upper_bound
2 41 42 435 436 I-upper_bound
weeks 43 48 437 442 I-upper_bound

History 0 7 443 450 O
of 8 10 451 453 O
neurological 11 23 454 466 B-treatment
surgery 24 31 467 474 I-treatment

Seizure 0 7 475 482 B-chronic_disease
disorder 8 16 483 491 I-chronic_disease

21 0 2 0 2 B-lower_bound
- 2 3 2 3 O
55 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Caucasian 0 9 19 28 B-ethnicity

History 0 7 29 36 O
of 8 10 37 39 O
sleep 11 16 40 45 B-chronic_disease
disorder 17 25 46 54 I-chronic_disease
or 26 28 55 57 O
regular 29 36 58 65 O
use 37 40 66 69 O
of 41 43 70 72 O
sleep 44 49 73 78 O
- 49 50 78 79 O
promoting 50 59 79 88 O
medication 60 70 89 99 O

Traveling 0 9 100 109 O
across 10 16 110 116 O
2 17 18 117 118 O
or 19 21 119 121 O
more 22 26 122 126 O
time 27 31 127 131 O
zones 32 37 132 137 O
within 38 44 138 144 O
past 45 49 145 149 B-upper_bound
3 50 51 150 151 I-upper_bound
months 52 58 152 158 I-upper_bound

Worked 0 6 159 165 O
night 7 12 166 171 O
or 13 15 172 174 O
rotating 16 24 175 183 O
shift 25 30 184 189 O
work 31 35 190 194 O
within 36 42 195 201 O
past 43 47 202 206 B-upper_bound
1 48 49 207 208 I-upper_bound
year 50 54 209 213 I-upper_bound

Non 0 3 0 3 B-language_fluency
- 3 4 3 4 I-language_fluency
English 4 11 4 11 I-language_fluency
speaking 12 20 12 20 I-language_fluency

pregnant 0 8 0 8 B-pregnancy

referred 0 8 9 17 O
for 9 12 18 21 O
90Y 13 16 22 25 O
SIRT 17 21 26 30 B-treatment
radioembolization 22 39 31 48 I-treatment
of 40 42 49 51 O
liver 43 48 52 57 B-cancer
tumor(s 49 56 58 65 I-cancer
) 56 57 65 66 I-cancer

AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
less 20 24 20 24 O
than 25 29 25 29 O
or 30 32 30 32 O
equal 33 38 33 38 O
to 39 41 39 41 O
3 42 43 42 43 B-upper_bound
X 44 45 44 45 I-upper_bound
institutional 46 59 46 59 I-upper_bound
upper 60 65 60 65 I-upper_bound
limit 66 71 66 71 I-upper_bound
of 72 74 72 74 I-upper_bound
normal 75 81 75 81 I-upper_bound
; 81 82 81 82 O
5.0 83 86 83 86 O
x 87 88 87 88 O
ULN 89 92 89 92 O
in 93 95 93 95 O
cases 96 101 96 101 O
of 102 104 102 104 O
liver 105 110 105 110 B-cancer
metastases 111 121 111 121 I-cancer

Ability 0 7 122 129 O
to 8 10 130 132 O
understand 11 21 133 143 O
and 22 25 144 147 O
the 26 29 148 151 O
willingness 30 41 152 163 O
to 42 44 164 166 O
sign 45 49 167 171 O
a 50 51 172 173 O
written 52 59 174 181 O
informed 60 68 182 190 O
consent 69 76 191 198 O
document 77 85 199 207 O
and 86 89 208 211 O
to 90 92 212 214 O
undergo 93 100 215 222 O
tumor 101 106 223 228 B-cancer
biopsies 107 115 229 237 B-treatment
in 116 118 238 240 O
the 119 122 241 244 O
expansion 123 132 245 254 O
phase 133 138 255 260 O

Absolute 0 8 261 269 B-clinical_variable
neutrophil 9 19 270 280 I-clinical_variable
count 20 25 281 286 I-clinical_variable
greater 26 33 287 294 O
than 34 38 295 299 O
1,500 39 44 300 305 B-lower_bound
/ 44 45 305 306 I-lower_bound
mcL 45 48 306 309 I-lower_bound

Adequately 0 10 310 320 O
managed 11 18 321 328 O
stage 19 24 329 334 B-lower_bound
0 25 26 335 336 I-lower_bound
( 27 28 337 338 O
carcinoma 28 37 338 347 B-cancer
in 38 40 348 350 I-cancer
situ 41 45 351 355 I-cancer
) 45 46 355 356 O
, 46 47 356 357 O
I 48 49 358 359 O
, 49 50 359 360 O
or 51 53 361 363 O
II 54 56 364 366 B-upper_bound
basal 57 62 367 372 B-cancer
cell 63 67 373 377 I-cancer
or 68 70 378 380 O
squamous 71 79 381 389 B-cancer
cell 80 84 390 394 I-cancer
carcinoma 85 94 395 404 I-cancer
from 95 99 405 409 O
which 100 105 410 415 O
the 106 109 416 419 O
patient 110 117 420 427 O
is 118 120 428 430 O
currently 121 130 431 440 O
in 131 133 441 443 O
complete 134 142 444 452 O
remission 143 152 453 462 O

Adequately 0 10 463 473 O
managed 11 18 474 481 O
stage 19 24 482 487 B-lower_bound
I 25 26 488 489 I-lower_bound
or 27 29 490 492 O
II 30 32 493 495 B-upper_bound
well 33 37 496 500 O
differentiated 38 52 501 515 O
thyroid 53 60 516 523 B-cancer
or 61 63 524 526 O
prostate 64 72 527 535 B-cancer
cancer 73 79 536 542 I-cancer
is 80 82 543 545 O
also 83 87 546 550 O
eligible 88 96 551 559 O
, 96 97 559 560 O
wherein 98 105 561 568 O
the 106 109 569 572 O
patient 110 117 573 580 O
is 118 120 581 583 O
not 121 124 584 587 O
required 125 133 588 596 O
to 134 136 597 599 O
be 137 139 600 602 O
in 140 142 603 605 O
complete 143 151 606 614 O
remission 152 161 615 624 O

Age 0 3 625 628 B-age
greater 4 11 629 636 O
than18 12 18 637 643 O
years 19 24 644 649 I-lower_bound

Any 0 3 650 653 O
other 4 9 654 659 O
cancer 10 16 660 666 B-cancer
from 17 21 667 671 O
which 22 27 672 677 O
the 28 31 678 681 O
patient 32 39 682 689 O
has 40 43 690 693 O
been 44 48 694 698 O
disease 49 56 699 706 O
- 56 57 706 707 O
free 57 61 707 711 O
for 62 65 712 715 O
three 66 71 716 721 B-upper_bound
years 72 77 722 727 I-upper_bound

ECOG 0 4 728 732 B-clinical_variable
performance 5 16 733 744 I-clinical_variable
status 17 23 745 751 I-clinical_variable
less 24 28 752 756 O
than 29 33 757 761 O
2 34 35 762 763 B-upper_bound
( 36 37 764 765 O
Phase 37 42 765 770 O
I 43 44 771 772 O
) 44 45 772 773 O
, 45 46 773 774 O
less 47 51 775 779 O
than 52 56 780 784 O
or 57 59 785 787 O
equal 60 65 788 793 O
to 66 68 794 796 O
1(Phase 69 76 797 804 B-upper_bound
II 77 79 805 807 O
) 79 80 807 808 O

HIV 0 3 809 812 B-chronic_disease
- 3 4 812 813 O
positive 4 12 813 821 O
patients 13 21 822 830 O
on 22 24 831 833 O
combination 25 36 834 845 B-treatment
antiretroviral 37 51 846 860 I-treatment
therapy 52 59 861 868 I-treatment
are 60 63 869 872 O
ineligible 64 74 873 883 O
because 75 82 884 891 O
of 83 85 892 894 O
possible 86 94 895 903 O
PK 95 97 904 906 O
interactions 98 110 907 919 O
with 111 115 920 924 O
TRC102 116 122 925 931 B-treatment

Hemoglobin 0 10 932 942 B-clinical_variable
greater 11 18 943 950 O
than 19 23 951 955 O
or 24 26 956 958 O
equal 27 32 959 964 O
to 33 35 965 967 O
10 36 38 968 970 B-lower_bound
g 39 40 971 972 I-lower_bound
/ 40 41 972 973 I-lower_bound
dL 41 43 973 975 I-lower_bound
without 44 51 976 983 O
transfusion 52 63 984 995 O
within 64 70 996 1002 O
1 71 72 1003 1004 B-upper_bound
week 73 77 1005 1009 I-upper_bound
prior 78 83 1010 1015 I-upper_bound
to 84 86 1016 1018 O
enrollment 87 97 1019 1029 O

History 0 7 1030 1037 O
of 8 10 1038 1040 O
allergic 11 19 1041 1049 O
reactions 20 29 1050 1059 O
attributed 30 40 1060 1070 O
to 41 43 1071 1073 O
compounds 44 53 1074 1083 O
of 54 56 1084 1086 O
similar 57 64 1087 1094 O
chemical 65 73 1095 1103 O
or 74 76 1104 1106 O
biologic 77 85 1107 1115 O
composition 86 97 1116 1127 O
to 98 100 1128 1130 O
TRC102 101 107 1131 1137 B-allergy_name
or 108 110 1138 1140 O
TMZ 111 114 1141 1144 B-allergy_name

Life 0 4 1145 1149 B-clinical_variable
expectancy 5 15 1150 1160 I-clinical_variable
of 16 18 1161 1163 O
greater 19 26 1164 1171 O
than 27 31 1172 1176 O
3 32 33 1177 1178 B-lower_bound
months 34 40 1179 1185 I-lower_bound

Patients 0 8 1186 1194 O
enrolling 9 18 1195 1204 O
in 19 21 1205 1207 O
the 22 25 1208 1211 O
expansion 26 35 1212 1221 O
cohorts 36 43 1222 1229 O
must 44 48 1230 1234 O
have 49 53 1235 1239 O
disease 54 61 1240 1247 O
amenable 62 70 1248 1256 O
to 71 73 1257 1259 O
biopsy 74 80 1260 1266 B-treatment
and 81 84 1267 1270 O
be 85 87 1271 1273 O
willing 88 95 1274 1281 O
to 96 98 1282 1284 O
undergo 99 106 1285 1292 O
pre 107 110 1293 1296 B-treatment
- 110 111 1296 1297 I-treatment
and 111 114 1297 1300 I-treatment
post 115 119 1301 1305 I-treatment
- 119 120 1305 1306 I-treatment
treatment 120 129 1306 1315 I-treatment
biopsies 130 138 1316 1324 I-treatment

Patients 0 8 1325 1333 O
must 9 13 1334 1338 O
be 14 16 1339 1341 O
able 17 21 1342 1346 O
to 22 24 1347 1349 O
swallow 25 32 1350 1357 O
whole 33 38 1358 1363 O
tablets 39 46 1364 1371 O
or 47 49 1372 1374 O
capsules 50 58 1375 1383 O
; 58 59 1383 1384 O
nasogastric 60 71 1385 1396 B-treatment
or 72 74 1397 1399 O
G 75 76 1400 1401 O
- 76 77 1401 1402 O
tube 77 81 1402 1406 O
administration 82 96 1407 1421 O
is 97 99 1422 1424 O
not 100 103 1425 1428 O
allowed 104 111 1429 1436 O

Patients 0 8 1437 1445 O
must 9 13 1446 1450 O
have 14 18 1451 1455 O
completed 19 28 1456 1465 O
any 29 32 1466 1469 O
chemotherapy 33 45 1470 1482 B-treatment
, 45 46 1482 1483 O
radiation 47 56 1484 1493 B-treatment
therapy 57 64 1494 1501 I-treatment
, 64 65 1501 1502 O
or 66 68 1503 1505 O
biologic 69 77 1506 1514 B-treatment
therapy 78 85 1515 1522 I-treatment
greater 86 93 1523 1530 O
than 94 98 1531 1535 O
or 99 101 1536 1538 O
equal 102 107 1539 1544 O
to 108 110 1545 1547 O
4 111 112 1548 1549 B-lower_bound
weeks 113 118 1550 1555 I-lower_bound
( 119 120 1556 1557 O
or 120 122 1557 1559 O
5 123 124 1560 1561 B-lower_bound
half 125 129 1562 1566 I-lower_bound
- 129 130 1566 1567 I-lower_bound
lives 130 135 1567 1572 I-lower_bound
, 135 136 1572 1573 O
whichever 137 146 1574 1583 O
is 147 149 1584 1586 O
shorter 150 157 1587 1594 O
) 157 158 1594 1595 O
prior 159 164 1596 1601 O
to 165 167 1602 1604 O
entering 168 176 1605 1613 O
the 177 180 1614 1617 O
study 181 186 1618 1623 O
( 187 188 1624 1625 O
6 188 189 1625 1626 B-lower_bound
weeks 190 195 1627 1632 I-lower_bound
for 196 199 1633 1636 O
nitrosoureas 200 212 1637 1649 B-treatment
or 213 215 1650 1652 O
mitomycin 216 225 1653 1662 B-treatment
C 226 227 1663 1664 I-treatment
) 227 228 1664 1665 O
. 228 229 1665 1666 O
Patients 230 238 1667 1675 O
must 239 243 1676 1680 O
be 244 246 1681 1683 O
greater 247 254 1684 1691 O
than 255 259 1692 1696 O
or 260 262 1697 1699 O
equal 263 268 1700 1705 O
to 269 271 1706 1708 O
2 272 273 1709 1710 B-lower_bound
weeks 274 279 1711 1716 I-lower_bound
since 280 285 1717 1722 O
any 286 289 1723 1726 O
prior 290 295 1727 1732 O
administration 296 310 1733 1747 O
of 311 313 1748 1750 O
a 314 315 1751 1752 O
study 316 321 1753 1758 B-treatment
drug 322 326 1759 1763 I-treatment
in 327 329 1764 1766 O
a 330 331 1767 1768 O
Phase 332 337 1769 1774 O
0 338 339 1775 1776 O
or 340 342 1777 1779 O
equivalent 343 353 1780 1790 O
study 354 359 1791 1796 O
and 360 363 1797 1800 O
greater 364 371 1801 1808 O
than 372 376 1809 1813 O
or 377 379 1814 1816 O
equal 380 385 1817 1822 O
to 386 388 1823 1825 O
1 389 390 1826 1827 B-lower_bound
week 391 395 1828 1832 I-lower_bound
from 396 400 1833 1837 O
palliative 401 411 1838 1848 B-treatment
radiation 412 421 1849 1858 I-treatment
therapy 422 429 1859 1866 I-treatment
. 429 430 1866 1867 O
Patients 431 439 1868 1876 O
must 440 444 1877 1881 O
have 445 449 1882 1886 O
recovered 450 459 1887 1896 O
to 460 462 1897 1899 O
eligibility 463 474 1900 1911 O
levels 475 481 1912 1918 O
from 482 486 1919 1923 O
prior 487 492 1924 1929 O
toxicity 493 501 1930 1938 O
or 502 504 1939 1941 O
adverse 505 512 1942 1949 O
events 513 519 1950 1956 O
. 519 520 1956 1957 O
Treatment 521 530 1958 1967 B-treatment
with 531 535 1968 1972 I-treatment
bisphosphonates 536 551 1973 1988 I-treatment
is 552 554 1989 1991 O
permitted 555 564 1992 2001 O

Patients 0 8 2002 2010 O
who 9 12 2011 2014 O
are 13 16 2015 2018 O
actively 17 25 2019 2027 O
receiving 26 35 2028 2037 O
any 36 39 2038 2041 O
other 40 45 2042 2047 O
investigational 46 61 2048 2063 B-treatment
agents 62 68 2064 2070 I-treatment

Patients 0 8 2071 2079 O
with 9 13 2080 2084 O
active 14 20 2085 2091 O
brain 21 26 2092 2097 B-cancer
metastases 27 37 2098 2108 I-cancer
or 38 40 2109 2111 O
carcinomatous 41 54 2112 2125 B-cancer
meningitis 55 65 2126 2136 I-cancer
are 66 69 2137 2140 O
excluded 70 78 2141 2149 O
from 79 83 2150 2154 O
this 84 88 2155 2159 O
clinical 89 97 2160 2168 O
trial 98 103 2169 2174 O
. 103 104 2174 2175 O
Patients 105 113 2176 2184 O
with 114 118 2185 2189 O
treated 119 126 2190 2197 O
brain 127 132 2198 2203 O
metastases 133 143 2204 2214 O
, 143 144 2214 2215 O
whose 145 150 2216 2221 O
brain 151 156 2222 2227 B-clinical_variable
metastatic 157 167 2228 2238 I-clinical_variable
disease 168 175 2239 2246 I-clinical_variable
has 176 179 2247 2250 O
remained 180 188 2251 2259 O
stable 189 195 2260 2266 O
for 196 199 2267 2270 O
greater 200 207 2271 2278 O
than 208 212 2279 2283 O
or 213 215 2284 2286 O
equal 216 221 2287 2292 O
to 222 224 2293 2295 O
4 225 226 2296 2297 B-lower_bound
weeks 227 232 2298 2303 I-lower_bound
without 233 240 2304 2311 O
requiring 241 250 2312 2321 O
steroid 251 258 2322 2329 B-treatment
and 259 262 2330 2333 O
anti 263 267 2334 2338 B-treatment
- 267 268 2338 2339 I-treatment
seizure 268 275 2339 2346 I-treatment
medications 276 287 2347 2358 I-treatment
are 288 291 2359 2362 O
eligible 292 300 2363 2371 O
to 301 303 2372 2374 O
participate 304 315 2375 2386 O

Phase 0 5 2387 2392 O
I 6 7 2393 2394 O
: 7 8 2394 2395 O
histologically 9 23 2396 2410 O
confirmed 24 33 2411 2420 O
solid 34 39 2421 2426 B-cancer
tumors 40 46 2427 2433 I-cancer
that 47 51 2434 2438 O
have 52 56 2439 2443 O
progressed 57 67 2444 2454 O
on 68 70 2455 2457 O
standard 71 79 2458 2466 O
therapy 80 87 2467 2474 B-treatment
known 88 93 2475 2480 O
to 94 96 2481 2483 O
prolong 97 104 2484 2491 O
survival 105 113 2492 2500 O
or 114 116 2501 2503 O
for 117 120 2504 2507 O
which 121 126 2508 2513 O
no 127 129 2514 2516 O
standard 130 138 2517 2525 O
treatment 139 148 2526 2535 B-treatment
options 149 156 2536 2543 O
exist 157 162 2544 2549 O

Phase 0 5 2550 2555 O
II 6 8 2556 2558 O
only 9 13 2559 2563 O
: 13 14 2563 2564 O
No 15 17 2565 2567 O
other 18 23 2568 2573 O
prior 24 29 2574 2579 O
malignancies 30 42 2580 2592 B-cancer
are 43 46 2593 2596 O
allowed 47 54 2597 2604 O

Phase 0 5 2605 2610 O
II 6 8 2611 2613 O
only 9 13 2614 2618 O
: 13 14 2618 2619 O
patients 15 23 2620 2628 O
with 24 28 2629 2633 O
colorectal 29 39 2634 2644 B-cancer
cancer 40 46 2645 2651 I-cancer
with 47 51 2652 2656 O
known 52 57 2657 2662 O
MSI 58 61 2663 2666 B-chronic_disease
- 61 62 2666 2667 I-chronic_disease
high 62 66 2667 2671 I-chronic_disease
disease 67 74 2672 2679 I-chronic_disease
who 75 78 2680 2683 O
have 79 83 2684 2688 O
not 84 87 2689 2692 O
previously 88 98 2693 2703 O
been 99 103 2704 2708 O
treated 104 111 2709 2716 O
with 112 116 2717 2721 O
immunotherapy 117 130 2722 2735 B-treatment
or 131 133 2736 2738 O
who 134 137 2739 2742 O
have 138 142 2743 2747 O
refused 143 150 2748 2755 O
treatment 151 160 2756 2765 B-treatment
with 161 165 2766 2770 I-treatment
immunotherapy 166 179 2771 2784 I-treatment

Phase 0 5 2785 2790 O
II 6 8 2791 2793 O
: 8 9 2793 2794 O
histologically 10 24 2795 2809 O
confirmed 25 34 2810 2819 O
colorectal 35 45 2820 2830 B-cancer
adenocarcinoma 46 60 2831 2845 I-cancer
post 61 65 2846 2850 O
at 66 68 2851 2853 O
least 69 74 2854 2859 O
two 75 78 2860 2863 B-lower_bound
lines 79 84 2864 2869 O
of 85 87 2870 2872 O
therapy 88 95 2873 2880 B-treatment
, 95 96 2880 2881 O
NSCLC 97 102 2882 2887 B-cancer
post 103 107 2888 2892 O
at 108 110 2893 2895 O
least 111 116 2896 2901 O
two 117 120 2902 2905 O
lines 121 126 2906 2911 O
of 127 129 2912 2914 O
therapy 130 137 2915 2922 O
, 137 138 2922 2923 O
or 139 141 2924 2926 O
granulosa 142 151 2927 2936 B-cancer
cell 152 156 2937 2941 I-cancer
ovarian 157 164 2942 2949 I-cancer
cancer 165 171 2950 2956 I-cancer
post 172 176 2957 2961 O
at 177 179 2962 2964 O
least 180 185 2965 2970 O
one 186 189 2971 2974 B-lower_bound
line 190 194 2975 2979 O
of 195 197 2980 2982 O
therapy 198 205 2983 2990 O
. 205 206 2990 2991 O
Patients 207 215 2992 3000 O
must 216 220 3001 3005 O
have 221 225 3006 3010 O
measurable 226 236 3011 3021 O
disease 237 244 3022 3029 O

Platelets 0 9 3030 3039 B-clinical_variable
greater 10 17 3040 3047 O
than 18 22 3048 3052 O
or 23 25 3053 3055 O
equal 26 31 3056 3061 O
to 32 34 3062 3064 O
100,000 35 42 3065 3072 B-lower_bound
/ 42 43 3072 3073 I-lower_bound
mcL 43 46 3073 3076 I-lower_bound

Pregnant 0 8 3077 3085 B-pregnancy
women 9 14 3086 3091 B-gender
are 15 18 3092 3095 O
excluded 19 27 3096 3104 O
from 28 32 3105 3109 O
this 33 37 3110 3114 O
study 38 43 3115 3120 O
because 44 51 3121 3128 O
the 52 55 3129 3132 O
effects 56 63 3133 3140 O
of 64 66 3141 3143 O
the 67 70 3144 3147 O
study 71 76 3148 3153 B-treatment
drugs 77 82 3154 3159 I-treatment
on 83 85 3160 3162 O
the 86 89 3163 3166 O
developing 90 100 3167 3177 O
fetus 101 106 3178 3183 O
are 107 110 3184 3187 O
unknown 111 118 3188 3195 O
. 118 119 3195 3196 O
Because 120 127 3197 3204 O
there 128 133 3205 3210 O
is 134 136 3211 3213 O
an 137 139 3214 3216 O
unknown 140 147 3217 3224 O
but 148 151 3225 3228 O
potential 152 161 3229 3238 O
risk 162 166 3239 3243 O
for 167 170 3244 3247 O
adverse 171 178 3248 3255 O
events 179 185 3256 3262 O
in 186 188 3263 3265 O
nursing 189 196 3266 3273 O
infants 197 204 3274 3281 O
secondary 205 214 3282 3291 O
to 215 217 3292 3294 O
treatment 218 227 3295 3304 B-treatment
of 228 230 3305 3307 O
the 231 234 3308 3311 O
mother 235 241 3312 3318 O
with 242 246 3319 3323 O
the 247 250 3324 3327 O
study 251 256 3328 3333 O
drugs 257 262 3334 3339 O
, 262 263 3339 3340 O
breastfeeding 264 277 3341 3354 O
should 278 284 3355 3361 O
be 285 287 3362 3364 O
discontinued 288 300 3365 3377 O
prior 301 306 3378 3383 O
to 307 309 3384 3386 O
the 310 313 3387 3390 O
first 314 319 3391 3396 O
dose 320 324 3397 3401 O
of 325 327 3402 3404 O
study 328 333 3405 3410 O
drug 334 338 3411 3415 O
and 339 342 3416 3419 O
women 343 348 3420 3425 O
should 349 355 3426 3432 O
refrain 356 363 3433 3440 O
from 364 368 3441 3445 O
nursing 369 376 3446 3453 O
throughout 377 387 3454 3464 O
the 388 391 3465 3468 O
treatment 392 401 3469 3478 O
period 402 408 3479 3485 O
and 409 412 3486 3489 O
for 413 416 3490 3493 O
3 417 418 3494 3495 O
months 419 425 3496 3502 O
following 426 435 3503 3512 O
the 436 439 3513 3516 O
last 440 444 3517 3521 O
dose 445 449 3522 3526 O
of 450 452 3527 3529 O
study 453 458 3530 3535 O
drug 459 463 3536 3540 O

Total 0 5 3541 3546 O
bilirubin 6 15 3547 3556 B-clinical_variable
less 16 20 3557 3561 O
than 21 25 3562 3566 O
or 26 28 3567 3569 O
equal 29 34 3570 3575 O
to1.5 35 40 3576 3581 O
X 41 42 3582 3583 I-upper_bound
institutional 43 56 3584 3597 I-upper_bound
ULN 57 60 3598 3601 I-upper_bound

Uncontrolled 0 12 3602 3614 O
intercurrent 13 25 3615 3627 O
illness 26 33 3628 3635 O
including 34 43 3636 3645 O
, 43 44 3645 3646 O
but 45 48 3647 3650 O
not 49 52 3651 3654 O
limited 53 60 3655 3662 O
to 61 63 3663 3665 O
, 63 64 3665 3666 O
serious 65 72 3667 3674 O
untreated 73 82 3675 3684 O
infection 83 92 3685 3694 B-chronic_disease
, 92 93 3694 3695 O
symptomatic 94 105 3696 3707 O
congestive 106 116 3708 3718 B-chronic_disease
heart 117 122 3719 3724 I-chronic_disease
failure 123 130 3725 3732 I-chronic_disease
, 130 131 3732 3733 O
unstable 132 140 3734 3742 B-chronic_disease
angina 141 147 3743 3749 I-chronic_disease
pectoris 148 156 3750 3758 I-chronic_disease
, 156 157 3758 3759 O
cardiac 158 165 3760 3767 B-chronic_disease
arrhythmia 166 176 3768 3778 I-chronic_disease
, 176 177 3778 3779 O
or 178 180 3780 3782 O
psychiatric 181 192 3783 3794 B-chronic_disease
illness 193 200 3795 3802 I-chronic_disease
/ 200 201 3802 3803 I-chronic_disease
social 201 207 3803 3809 I-chronic_disease
situations 208 218 3810 3820 I-chronic_disease
that 219 223 3821 3825 O
would 224 229 3826 3831 O
limit 230 235 3832 3837 O
compliance 236 246 3838 3848 O
with 247 251 3849 3853 O
study 252 257 3854 3859 O
requirements 258 270 3860 3872 O

creatinine 0 10 3873 3883 B-clinical_variable
clearance 11 20 3884 3893 I-clinical_variable
greater 21 28 3894 3901 O
than 29 33 3902 3906 O
or 34 36 3907 3909 O
equal 37 42 3910 3915 O
to 43 45 3916 3918 O
60 46 48 3919 3921 B-lower_bound
mL 49 51 3922 3924 I-lower_bound
/ 51 52 3924 3925 I-lower_bound
min/1.73 52 60 3925 3933 I-lower_bound
m2 61 63 3934 3936 I-lower_bound
for 64 67 3937 3940 O
patients 68 76 3941 3949 O
with 77 81 3950 3954 O
creatinine 82 92 3955 3965 B-clinical_variable
levels 93 99 3966 3972 I-clinical_variable
greater 100 107 3973 3980 O
than 108 112 3981 3985 O
1.5 113 116 3986 3989 B-lower_bound
mg 117 119 3990 3992 I-lower_bound
/ 119 120 3992 3993 I-lower_bound
dL 120 122 3993 3995 I-lower_bound

creatinine 0 10 3996 4006 B-clinical_variable
less 11 15 4007 4011 I-clinical_variable
than 16 20 4012 4016 O
or 21 23 4017 4019 O
equal 24 29 4020 4025 O
to 30 32 4026 4028 O
1.5 33 36 4029 4032 B-upper_bound
X 37 38 4033 4034 I-upper_bound
institutional 39 52 4035 4048 I-upper_bound
ULN 53 56 4049 4052 I-upper_bound

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
1500 33 37 33 37 B-lower_bound
/ 37 38 37 38 I-lower_bound
mm3 38 41 38 41 I-lower_bound

Advanced 0 8 42 50 O
or 9 11 51 53 O
metastatic 12 22 54 64 B-cancer
esophageal 23 33 65 75 I-cancer
and/or 34 40 76 82 O
gastric 41 48 83 90 B-cancer
cancer 49 55 91 97 I-cancer
( 56 57 98 99 O
15 57 59 99 101 B-lower_bound
- 59 60 101 102 O
30 60 62 102 104 B-upper_bound
enrollment 63 73 105 115 I-upper_bound
slots 74 79 116 121 I-upper_bound
) 79 80 121 122 O

All 0 3 123 126 O
tumors 4 10 127 133 B-cancer
must 11 15 134 138 O
test 16 20 139 143 O
positive 21 29 144 152 O
for 30 33 153 156 O
Rb 34 36 157 159 O
expression 37 47 160 170 O

Any 0 3 171 174 O
tumor 4 9 175 180 B-cancer
type 10 14 181 185 O
if 15 17 186 188 O
tissue 18 24 189 195 O
tests 25 30 196 201 O
positive 31 39 202 210 O
for 40 43 211 214 O
CCND1 44 49 215 220 O
amplification 50 63 221 234 O
, 63 64 234 235 O
CDK4/6 65 71 236 242 O
mutation 72 80 243 251 O
, 80 81 251 252 O
CCND2 82 87 253 258 O
amplification 88 101 259 272 O
OR 102 104 273 275 O
any 105 108 276 279 O
other 109 114 280 285 O
functional 115 125 286 296 O
alteration 126 136 297 307 O
at 137 139 308 310 O
the 140 143 311 314 O
G1 144 146 315 317 O
/ 146 147 317 318 O
S 147 148 318 319 O
checkpoint 149 159 320 330 O

Any 0 3 331 334 O
tumor 4 9 335 340 B-cancer
type 10 14 341 345 O
if 15 17 346 348 O
tissue 18 24 349 355 O
tests 25 30 356 361 O
positive 31 39 362 370 O
for 40 43 371 374 O
CCND1 44 49 375 380 O
amplification 50 63 381 394 O
, 63 64 394 395 O
CDK4/6 65 71 396 402 O
mutation 72 80 403 411 O
, 80 81 411 412 O
CCND2 82 87 413 418 O
amplification 88 101 419 432 O
OR 102 104 433 435 O
any 105 108 436 439 O
other 109 114 440 445 O
functional 115 125 446 456 O
alteration 126 136 457 467 O
at 137 139 468 470 O
the 140 143 471 474 O
G1 144 146 475 477 O
/ 146 147 477 478 O
S 147 148 478 479 O
checkpoint 149 159 480 490 O
. 159 160 490 491 O
( 161 162 492 493 O
15 162 164 493 495 O
- 164 165 495 496 O
30 165 167 496 498 O
enrollment 168 178 499 509 O
slots 179 184 510 515 O
) 184 185 515 516 O

Bilirubin 0 9 517 526 B-clinical_variable
≤ 10 11 527 528 O
1.5 12 15 529 532 B-upper_bound
x 16 17 533 534 I-upper_bound
the 18 21 535 538 I-upper_bound
upper 22 27 539 544 I-upper_bound
limit 28 33 545 550 I-upper_bound
of 34 36 551 553 I-upper_bound
normal 37 43 554 560 I-upper_bound
( 44 45 561 562 I-upper_bound
ULN 45 48 562 565 I-upper_bound
) 48 49 565 566 I-upper_bound

Cisplatin 0 9 567 576 B-cancer
- 9 10 576 577 I-cancer
refractory 10 20 577 587 I-cancer
, 20 21 587 588 O
unresectable 22 34 589 601 O
germ 35 39 602 606 B-cancer
cell 40 44 607 611 I-cancer
tumors 45 51 612 618 I-cancer
( 52 53 619 620 O
15 53 55 620 622 B-lower_bound
- 55 56 622 623 O
30 56 58 623 625 B-upper_bound
enrollment 59 69 626 636 O
slots 70 75 637 642 O
) 75 76 642 643 O

ER 0 2 644 646 B-cancer
positive 3 11 647 655 I-cancer
metastatic 12 22 656 666 I-cancer
breast 23 29 667 673 I-cancer
tumors 30 36 674 680 I-cancer
( 37 38 681 682 O
data 38 42 682 686 O
now 43 46 687 690 O
shows 47 52 691 696 O
all 53 56 697 700 O
to 57 59 701 703 O
be 60 62 704 706 O
Rb 63 65 707 709 O
positive 66 74 710 718 O
. 74 75 718 719 O
) 75 76 719 720 O

Female 0 6 721 727 B-gender
subjects 7 15 728 736 I-gender
of 16 18 737 739 O
childbearing 19 31 740 752 O
potential 32 41 753 762 O
must 42 46 763 767 O
have 47 51 768 772 O
a 52 53 773 774 O
negative 54 62 775 783 B-pregnancy
pregnancy 63 72 784 793 I-pregnancy
test 73 77 794 798 O
at 78 80 799 801 O
screening 81 90 802 811 O

Females 0 7 812 819 B-gender
of 8 10 820 822 O
childbearing 11 23 823 835 O
potential 24 33 836 845 O
are 34 37 846 849 O
defined 38 45 850 857 O
as 46 48 858 860 O
sexually 49 57 861 869 O
mature 58 64 870 876 O
women 65 70 877 882 B-gender
without 71 78 883 890 O
prior 79 84 891 896 B-treatment
hysterectomy 85 97 897 909 I-treatment
or 98 100 910 912 O
who 101 104 913 916 O
have 105 109 917 921 O
had 110 113 922 925 O
any 114 117 926 929 O
evidence 118 126 930 938 O
of 127 129 939 941 O
menses 130 136 942 948 O
in 137 139 949 951 O
the 140 143 952 955 O
past 144 148 956 960 B-upper_bound
12 149 151 961 963 I-upper_bound
months 152 158 964 970 I-upper_bound

For 0 3 971 974 O
subjects 4 12 975 983 O
with 13 17 984 988 O
liver 18 23 989 994 B-cancer
metastases 24 34 995 1005 I-cancer
: 34 35 1005 1006 O
alanine 36 43 1007 1014 B-clinical_variable
aminotransferase 44 60 1015 1031 I-clinical_variable
( 61 62 1032 1033 I-clinical_variable
ALT 62 65 1033 1036 I-clinical_variable
) 65 66 1036 1037 I-clinical_variable
and 67 70 1038 1041 O
aspartate 71 80 1042 1051 B-clinical_variable
aminotransferase 81 97 1052 1068 I-clinical_variable
≤ 98 99 1069 1070 O
5 100 101 1071 1072 B-upper_bound
x 102 103 1073 1074 I-upper_bound
ULN 104 107 1075 1078 I-upper_bound

For 0 3 1079 1082 O
subjects 4 12 1083 1091 O
without 13 20 1092 1099 O
liver 21 26 1100 1105 B-cancer
metastases 27 37 1106 1116 I-cancer
: 37 38 1116 1117 O
alanine 39 46 1118 1125 B-clinical_variable
aminotransferase 47 63 1126 1142 I-clinical_variable
( 64 65 1143 1144 I-clinical_variable
ALT 65 68 1144 1147 I-clinical_variable
) 68 69 1147 1148 I-clinical_variable
and 70 73 1149 1152 O
aspartate 74 83 1153 1162 B-clinical_variable
aminotransferase 84 100 1163 1179 I-clinical_variable
( 101 102 1180 1181 I-clinical_variable
AST 102 105 1181 1184 I-clinical_variable
) 105 106 1184 1185 I-clinical_variable
≤ 107 108 1186 1187 O
2.5 109 112 1188 1191 B-upper_bound
x 113 114 1192 1193 I-upper_bound
ULN 115 118 1194 1197 I-upper_bound

Hemoglobin 0 10 1198 1208 B-clinical_variable
> 11 12 1209 1210 O
9 13 14 1211 1212 B-lower_bound
g 15 16 1213 1214 I-lower_bound
/ 16 17 1214 1215 I-lower_bound
dL 17 19 1215 1217 I-lower_bound

Metastatic 0 10 1218 1228 B-cancer
breast 11 17 1229 1235 I-cancer
cancer 18 24 1236 1242 I-cancer
( 25 26 1243 1244 O
7 26 27 1244 1245 O
triple 28 34 1246 1252 O
negative 35 43 1253 1261 O
, 43 44 1261 1262 O
23 45 47 1263 1265 O
ER+ 48 51 1266 1269 B-clinical_variable
after 52 57 1270 1275 O
the 58 61 1276 1279 O
first 62 67 1280 1285 O
15 68 70 1286 1288 O
patients 71 79 1289 1297 O
are 80 83 1298 1301 O
enrolled 84 92 1302 1310 O
on 93 95 1311 1313 O
the 96 99 1314 1317 O
non 100 103 1318 1321 O
- 103 104 1321 1322 O
CCND1cohort 104 115 1322 1333 B-clinical_variable
; 115 116 1333 1334 O
in 117 119 1335 1337 O
addition 120 128 1338 1346 O
10 129 131 1347 1349 O
HER2 132 136 1350 1354 B-clinical_variable
+ 136 137 1354 1355 I-clinical_variable
for 138 141 1356 1359 O
combination 142 153 1360 1371 O
trastuzumab 154 165 1372 1383 B-treatment
and 166 169 1384 1387 O
PD0332991 170 179 1388 1397 B-treatment
therapy 180 187 1398 1405 I-treatment
) 187 188 1405 1406 O
up 189 191 1407 1409 O
to 192 194 1410 1412 O
55 195 197 1413 1415 B-upper_bound
total 198 203 1416 1421 O
enrollment 204 214 1422 1432 O
slots 215 220 1433 1438 O
B 221 222 1439 1440 O

Metastatic 0 10 1441 1451 B-cancer
colorectal 11 21 1452 1462 I-cancer
cancer 22 28 1463 1469 I-cancer
that 29 33 1470 1474 O
harbors 34 41 1475 1482 O
the 42 45 1483 1486 O
Kras 46 50 1487 1491 B-cancer
or 51 53 1492 1494 O
BRAF 54 58 1495 1499 B-cancer
mutation 59 67 1500 1508 I-cancer
( 68 69 1509 1510 O
15 69 71 1510 1512 O
- 71 72 1512 1513 O
30 72 74 1513 1515 O
enrollment 75 85 1516 1526 O
slots 86 91 1527 1532 O
) 91 92 1532 1533 O

Patients 0 8 1534 1542 O
with 9 13 1543 1547 O
HER2 14 18 1548 1552 B-cancer
- 18 19 1552 1553 O
overexpressing 19 33 1553 1567 O
tumors 34 40 1568 1574 B-cancer
may 41 44 1575 1578 O
receive 45 52 1579 1586 O
trastuzumab 53 64 1587 1598 B-treatment
up 65 67 1599 1601 O
to 68 70 1602 1604 O
the 71 74 1605 1608 O
date 75 79 1609 1613 O
of 80 82 1614 1616 O
starting 83 91 1617 1625 O
therapy 92 99 1626 1633 B-treatment
, 99 100 1633 1634 O
and 101 104 1635 1638 O
may 105 108 1639 1642 O
continue 109 117 1643 1651 O
to 118 120 1652 1654 O
receive 121 128 1655 1662 O
trastuzumab 129 140 1663 1674 O
while 141 146 1675 1680 O
receiving 147 156 1681 1690 O
PD0332991 157 166 1691 1700 B-treatment

Platelets 0 9 1701 1710 B-clinical_variable
> 10 11 1711 1712 O
100,000 11 18 1712 1719 B-lower_bound
/ 18 19 1719 1720 I-lower_bound
mm3 19 22 1720 1723 I-lower_bound

Serum 0 5 1724 1729 B-clinical_variable
creatinine 6 16 1730 1740 I-clinical_variable
≤ 17 18 1741 1742 O
1.5 19 22 1743 1746 B-upper_bound
x 23 24 1747 1748 I-upper_bound
UNL 25 28 1749 1752 B-clinical_variable
or 29 31 1753 1755 O
calculated 32 42 1756 1766 O
creatinine 43 53 1767 1777 B-clinical_variable
clearance 54 63 1778 1787 I-clinical_variable
≥ 64 65 1788 1789 O
60 66 68 1790 1792 B-lower_bound
mL 69 71 1793 1795 I-lower_bound
/ 71 72 1795 1796 I-lower_bound
min 72 75 1796 1799 I-lower_bound

Sexually 0 8 1800 1808 O
active 9 15 1809 1815 O
subjects 16 24 1816 1824 O
( 25 26 1825 1826 O
male 26 30 1826 1830 B-gender
and 31 34 1831 1834 I-gender
female 35 41 1835 1841 I-gender
) 41 42 1841 1842 O
must 43 47 1843 1847 O
use 48 51 1848 1851 B-contraception_consent
accepted 52 60 1852 1860 I-contraception_consent
methods 61 68 1861 1868 I-contraception_consent
of 69 71 1869 1871 I-contraception_consent
contraception 72 85 1872 1885 I-contraception_consent
during 86 92 1886 1892 O
the 93 96 1893 1896 O
course 97 103 1897 1903 O
of 104 106 1904 1906 O
the 107 110 1907 1910 O
study 111 116 1911 1916 O
and 117 120 1917 1920 O
for 121 124 1921 1924 O
3 125 126 1925 1926 B-upper_bound
months 127 133 1927 1933 I-upper_bound
after 134 139 1934 1939 O
the 140 143 1940 1943 O
last 144 148 1944 1948 O
dose 149 153 1949 1953 O
of 154 156 1954 1956 O
protocol 157 165 1957 1965 B-treatment
drug(s 166 172 1966 1972 I-treatment
) 172 173 1972 1973 I-treatment

Subjects 0 8 1974 1982 O
will 9 13 1983 1987 O
be 14 16 1988 1990 O
> 17 18 1991 1992 O
18 19 21 1993 1995 B-lower_bound
years 22 27 1996 2001 I-lower_bound
old 28 31 2002 2005 O

The 0 3 2006 2009 O
subject 4 11 2010 2017 O
has 12 15 2018 2021 O
a 16 17 2022 2023 O
baseline 18 26 2024 2032 B-clinical_variable
corrected 27 36 2033 2042 I-clinical_variable
QT 37 39 2043 2045 I-clinical_variable
interval 40 48 2046 2054 I-clinical_variable
( 49 50 2055 2056 I-clinical_variable
QTc 50 53 2056 2059 I-clinical_variable
) 53 54 2059 2060 I-clinical_variable
> 55 56 2061 2062 O
470 57 60 2063 2066 B-lower_bound
ms 61 63 2067 2069 I-lower_bound

The 0 3 2070 2073 O
subject 4 11 2074 2081 O
has 12 15 2082 2085 O
an 16 18 2086 2088 O
Eastern 19 26 2089 2096 B-clinical_variable
Cooperative 27 38 2097 2108 I-clinical_variable
Oncology 39 47 2109 2117 I-clinical_variable
Group 48 53 2118 2123 I-clinical_variable
( 54 55 2124 2125 I-clinical_variable
ECOG 55 59 2125 2129 I-clinical_variable
) 59 60 2129 2130 I-clinical_variable
performance 61 72 2131 2142 I-clinical_variable
status 73 79 2143 2149 I-clinical_variable
of 80 82 2150 2152 O
0 83 84 2153 2154 B-lower_bound
or 85 87 2155 2157 O
1 88 89 2158 2159 B-upper_bound

The 0 3 2160 2163 O
subject 4 11 2164 2171 O
has 12 15 2172 2175 O
disease 16 23 2176 2183 O
that 24 28 2184 2188 O
is 29 31 2189 2191 O
assessable 32 42 2192 2202 O
by 43 45 2203 2205 O
tumor 46 51 2206 2211 B-cancer
marker 52 58 2212 2218 I-cancer
, 58 59 2218 2219 O
physical 60 68 2220 2228 O
, 68 69 2228 2229 O
or 70 72 2230 2232 O
radiologic 73 83 2233 2243 O
means 84 89 2244 2249 O

The 0 3 2250 2253 O
subject 4 11 2254 2261 O
has 12 15 2262 2265 O
not 16 19 2266 2269 O
recovered 20 29 2270 2279 O
from 30 34 2280 2284 O
clinically 35 45 2285 2295 O
- 45 46 2295 2296 O
meaningful 46 56 2296 2306 O
toxicity 57 65 2307 2315 O
due 66 69 2316 2319 O
to 70 72 2320 2322 O
prior 73 78 2323 2328 B-treatment
therapy 79 86 2329 2336 I-treatment
( 87 88 2337 2338 O
i.e. 88 92 2338 2342 O
, 92 93 2342 2343 O
back 94 98 2344 2348 O
to 99 101 2349 2351 O
baseline 102 110 2352 2360 O
or 111 113 2361 2363 O
Grade 114 119 2364 2369 O
≤ 120 121 2370 2371 O
1 122 123 2372 2373 B-upper_bound
) 123 124 2373 2374 O

The 0 3 2375 2378 O
subject 4 11 2379 2386 O
has 12 15 2387 2390 O
received 16 24 2391 2399 O
any 25 28 2400 2403 O
other 29 34 2404 2409 O
type 35 39 2410 2414 O
of 40 42 2415 2417 O
investigational 43 58 2418 2433 B-treatment
agent 59 64 2434 2439 I-treatment
within 65 71 2440 2446 O
28 72 74 2447 2449 B-upper_bound
days 75 79 2450 2454 I-upper_bound
before 80 86 2455 2461 O
the 87 90 2462 2465 O
first 91 96 2466 2471 O
dose 97 101 2472 2476 O
of 102 104 2477 2479 O
study 105 110 2480 2485 O
treatment 111 120 2486 2495 B-treatment

The 0 3 2496 2499 O
subject 4 11 2500 2507 O
has 12 15 2508 2511 O
received 16 24 2512 2520 O
cytotoxic 25 34 2521 2530 B-treatment
chemotherapy 35 47 2531 2543 I-treatment
( 48 49 2544 2545 O
including 49 58 2545 2554 O
investigational 59 74 2555 2570 B-treatment
cytotoxic 75 84 2571 2580 I-treatment
chemotherapy 85 97 2581 2593 I-treatment
) 97 98 2593 2594 O
within 99 105 2595 2601 O
3 106 107 2602 2603 B-upper_bound
weeks 108 113 2604 2609 I-upper_bound
( 114 115 2610 2611 O
or 115 117 2611 2613 O
nitrosoureas 118 130 2614 2626 B-treatment
or 131 133 2627 2629 O
mitomycin 134 143 2630 2639 B-treatment
C 144 145 2640 2641 I-treatment
within 146 152 2642 2648 O
6 153 154 2649 2650 B-upper_bound
weeks 155 160 2651 2656 I-upper_bound
) 160 161 2656 2657 O
before 162 168 2658 2664 O
the 169 172 2665 2668 O
first 173 178 2669 2674 O
dose 179 183 2675 2679 O
of 184 186 2680 2682 O
PD 187 189 2683 2685 B-treatment
0332991 190 197 2686 2693 I-treatment

The 0 3 2694 2697 O
subject 4 11 2698 2705 O
is 12 14 2706 2708 O
known 15 20 2709 2714 O
to 21 23 2715 2717 O
be 24 26 2718 2720 O
positive 27 35 2721 2729 O
for 36 39 2730 2733 O
the 40 43 2734 2737 O
human 44 49 2738 2743 B-chronic_disease
immunodeficiency 50 66 2744 2760 I-chronic_disease
virus 67 72 2761 2766 I-chronic_disease
( 73 74 2767 2768 I-chronic_disease
HIV 74 77 2768 2771 I-chronic_disease
) 77 78 2771 2772 I-chronic_disease

The 0 3 2773 2776 O
subject 4 11 2777 2784 O
is 12 14 2785 2787 O
pregnant 15 23 2788 2796 B-pregnancy

diabetes 0 8 2797 2805 B-chronic_disease
mellitus 9 17 2806 2814 I-chronic_disease

hypertension 0 12 2815 2827 B-chronic_disease

ongoing 0 7 2828 2835 O
or 8 10 2836 2838 O
active 11 17 2839 2845 B-chronic_disease
infection 18 27 2846 2855 I-chronic_disease

symptomatic 0 11 2856 2867 O
congestive 12 22 2868 2878 B-chronic_disease
heart 23 28 2879 2884 I-chronic_disease
failure 29 36 2885 2892 I-chronic_disease
, 36 37 2892 2893 O
unstable 38 46 2894 2902 B-chronic_disease
angina 47 53 2903 2909 I-chronic_disease
pectoris 54 62 2910 2918 I-chronic_disease
, 62 63 2918 2919 O
stroke 64 70 2920 2926 B-chronic_disease
or 71 73 2927 2929 O
myocardial 74 84 2930 2940 B-chronic_disease
infarction 85 95 2941 2951 I-chronic_disease
within 96 102 2952 2958 O
3 103 104 2959 2960 B-upper_bound
months 105 111 2961 2967 I-upper_bound

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
60 6 8 6 8 B-lower_bound

Blind 0 5 9 14 B-chronic_disease
, 5 6 14 15 O
deafness 7 15 16 24 B-chronic_disease
or 16 18 25 27 O
the 19 22 28 31 O
inability 23 32 32 41 B-language_fluency
to 33 35 42 44 I-language_fluency
speak 36 41 45 50 I-language_fluency
English 42 49 51 58 I-language_fluency

Follow 0 6 59 65 O
- 6 7 65 66 O
up 7 9 66 68 O
difficulties 10 22 69 81 O
( 23 24 82 83 O
i.e. 24 28 83 87 O
active 29 35 88 94 B-chronic_disease
substance 36 45 95 104 I-chronic_disease
abuse 46 51 105 110 I-chronic_disease
, 51 52 110 111 O
psychotic 53 62 112 121 B-chronic_disease
disorder 63 71 122 130 I-chronic_disease
, 71 72 130 131 O
homelessness 73 85 132 144 O
) 85 86 144 145 O

Previous 0 8 146 154 O
cardiac 9 16 155 162 B-treatment
surgery 17 24 163 170 I-treatment
within 25 31 171 177 O
1 32 33 178 179 B-upper_bound
year 34 38 180 184 I-upper_bound
of 39 41 185 187 O
surgical 42 50 188 196 O
procedure 51 60 197 206 O

Renal 0 5 207 212 B-chronic_disease
and 6 9 213 216 O
liver 10 15 217 222 B-chronic_disease
failure 16 23 223 230 I-chronic_disease
requiring 24 33 231 240 O
dialysis 34 42 241 249 B-treatment
or 43 45 250 252 O
Child 46 51 253 258 B-clinical_variable
- 51 52 258 259 I-clinical_variable
Pugh 52 56 259 263 I-clinical_variable
score 57 62 264 269 I-clinical_variable
> 63 64 270 271 O
5 65 66 272 273 B-lower_bound

Scheduled 0 9 274 283 O
for 10 13 284 287 O
a 14 15 288 289 O
cardiac 16 23 290 297 B-treatment
surgical 24 32 298 306 I-treatment
procedure 33 42 307 316 I-treatment
with 43 47 317 321 O
planned 48 55 322 329 O
post 56 60 330 334 O
- 60 61 334 335 O
operative 61 70 335 344 O
admission 71 80 345 354 O
to 81 83 355 357 O
the 84 87 358 361 O
CSICU 88 93 362 367 B-clinical_variable
for 94 97 368 371 O
≥ 98 99 372 373 O
24 100 102 374 376 B-lower_bound
hours 103 108 377 382 I-lower_bound

Scheduled 0 9 383 392 O
for 10 13 393 396 O
a 14 15 397 398 O
second 16 22 399 405 O
surgical 23 31 406 414 B-treatment
procedure 32 41 415 424 I-treatment
during 42 48 425 431 O
hospital 49 57 432 440 O
stay 58 62 441 445 O

Acute 0 5 0 5 O
urinary 6 13 6 13 B-chronic_disease
tract 14 19 14 19 I-chronic_disease
infection 20 29 20 29 I-chronic_disease

Gleason 0 7 30 37 B-clinical_variable
Score 8 13 38 43 I-clinical_variable
≤ 14 15 44 45 O
7 16 17 46 47 B-upper_bound

If 0 2 48 50 O
the 3 6 51 54 O
standard 7 15 55 63 B-treatment
biopsy 16 22 64 70 I-treatment
cores 23 28 71 76 O
are 29 32 77 80 O
positive 33 41 81 89 O
, 41 42 89 90 O
they 43 47 91 95 O
must 48 52 96 100 O
be 53 55 101 103 O
from 56 60 104 108 O
the 61 64 109 112 O
same 65 69 113 117 O
location 70 78 118 126 O
in 79 81 127 129 O
the 82 85 130 133 O
prostate 86 94 134 142 O
as 95 97 143 145 O
MR 98 100 146 148 O
lesion 101 107 149 155 O
was 108 111 156 159 O
biopsied 112 120 160 168 O
and 121 124 169 172 O
proven 125 131 173 179 O
to 132 134 180 182 O
be 135 137 183 185 O
cancerous 138 147 186 195 O

Lower 0 5 196 201 B-chronic_disease
urinary 6 13 202 209 I-chronic_disease
tract 14 19 210 215 I-chronic_disease
symptoms 20 28 216 224 I-chronic_disease
defined 29 36 225 232 O
by 37 39 233 235 O
International 40 53 236 249 B-clinical_variable
Prostate 54 62 250 258 I-clinical_variable
symptom 63 70 259 266 I-clinical_variable
score 71 76 267 272 I-clinical_variable
( 77 78 273 274 I-clinical_variable
IPSS 78 82 274 278 I-clinical_variable
) 82 83 278 279 I-clinical_variable
> 84 85 280 281 O
20 86 88 282 284 B-lower_bound

Prior 0 5 285 290 O
MRI 6 9 291 294 O
results 10 17 295 302 O
dated 18 23 303 308 O
within 24 30 309 315 O
120 31 34 316 319 B-upper_bound
days 35 39 320 324 I-upper_bound
prior 40 45 325 330 I-upper_bound
to 46 48 331 333 O
ablation 49 57 334 342 B-treatment

Prostate 0 8 343 351 B-cancer
cancer 9 15 352 358 I-cancer
is 16 18 359 361 O
diagnosed 19 28 362 371 O
by 29 31 372 374 O
MR 32 34 375 377 B-treatment
image 35 40 378 383 I-treatment
guided 41 47 384 390 I-treatment
biopsies 48 56 391 399 I-treatment

active 0 6 400 406 B-chronic_disease
bacterial 7 16 407 416 I-chronic_disease
infection 17 26 417 426 I-chronic_disease

acute 0 5 427 432 B-chronic_disease
or 6 8 433 435 I-chronic_disease
chronic 9 16 436 443 I-chronic_disease
hepatic 17 24 444 451 I-chronic_disease
dysfunction 25 36 452 463 I-chronic_disease
as 37 39 464 466 O
evidenced 40 49 467 476 O
by 50 52 477 479 O
clinically 53 63 480 490 O
significant 64 75 491 502 O
abnormalities 76 89 503 516 O
in 90 92 517 519 O
albumin 93 100 520 527 B-clinical_variable
, 100 101 527 528 O
total 102 107 529 534 O
protein 108 115 535 542 B-clinical_variable
, 115 116 542 543 O
or 117 119 544 546 O
prothrombin 120 131 547 558 B-clinical_variable
time 132 136 559 563 I-clinical_variable
, 136 137 563 564 O
or 138 140 565 567 O
evidence 141 149 568 576 O
of 150 152 577 579 O
hepatic 153 160 580 587 O
injury 161 167 588 594 O
with 168 172 595 599 O
clinically 173 183 600 610 O
important 184 193 611 620 O
( 194 195 621 622 O
> 195 196 622 623 O
grade 197 202 624 629 B-lower_bound
1 203 204 630 631 I-lower_bound
) 204 205 631 632 O
changes 206 213 633 640 O
in 214 216 641 643 O
AST 217 220 644 647 B-clinical_variable
, 220 221 647 648 O
ALT 222 225 649 652 B-clinical_variable
, 225 226 652 653 O
ALP 227 230 654 657 B-clinical_variable
, 230 231 657 658 O
bilirubin 232 241 659 668 B-clinical_variable
, 241 242 668 669 O
or 243 245 670 672 O
GGT 246 249 673 676 B-clinical_variable
values 250 256 677 683 O

documented 0 10 684 694 O
histological 11 23 695 707 O
or 24 26 708 710 O
cytological 27 38 711 722 O
evidence 39 47 723 731 O
of 48 50 732 734 O
tumor(s 51 58 735 742 B-cancer
) 58 59 742 743 I-cancer
of 60 62 744 746 I-cancer
the 63 66 747 750 I-cancer
prostate 67 75 751 759 I-cancer

extra 0 5 760 765 B-treatment
capsular 6 14 766 774 I-treatment

mental 0 6 775 781 B-chronic_disease
illness 7 14 782 789 I-chronic_disease

metastatic 0 10 790 800 B-chronic_disease
disease 11 18 801 808 I-chronic_disease

received 0 8 809 817 O
investigational 9 24 818 833 B-treatment
therapy 25 32 834 841 I-treatment
within 33 39 842 848 O
a 40 41 849 850 O
period 42 48 851 857 O
of 49 51 858 860 O
5 52 53 861 862 B-upper_bound
half 54 58 863 867 I-upper_bound
- 58 59 867 868 I-upper_bound
lives 59 64 868 873 I-upper_bound
of 65 67 874 876 O
the 68 71 877 880 O
investigational 72 87 881 896 O
therapy 88 95 897 904 O
in 96 98 905 907 O
question 99 107 908 916 O
prior 108 113 917 922 O
to 114 116 923 925 O
the 117 120 926 929 O
day 121 124 930 933 O
of 125 127 934 936 O
dosing 128 134 937 943 O
with 135 139 944 948 O
the 140 143 949 952 O
PEGylated 144 153 953 962 O
AuroShell 154 163 963 972 O
particles 164 173 973 982 O

renal 0 5 983 988 B-chronic_disease
insufficiency 6 19 989 1002 I-chronic_disease
with 20 24 1003 1007 O
an 25 27 1008 1010 O
estimated 28 37 1011 1020 B-clinical_variable
glomerular 38 48 1021 1031 I-clinical_variable
filtration 49 59 1032 1042 I-clinical_variable
( 60 61 1043 1044 I-clinical_variable
EGF 61 64 1044 1047 I-clinical_variable
) 64 65 1047 1048 I-clinical_variable
< 66 67 1049 1050 O
= 67 68 1050 1051 O
30 69 71 1052 1054 B-upper_bound

seminal 0 7 1055 1062 B-cancer
vesicle 8 15 1063 1070 I-cancer
invasion 16 24 1071 1079 I-cancer

treatment 0 9 1080 1089 O
for 10 13 1090 1093 O
prostate 14 22 1094 1102 B-cancer
cancer 23 29 1103 1109 I-cancer

uncontrolled 0 12 1110 1122 O
coagulopathies 13 27 1123 1137 B-chronic_disease
who 28 31 1138 1141 O
are 32 35 1142 1145 O
at 36 38 1146 1148 O
increased 39 48 1149 1158 O
risk 49 53 1159 1163 O
of 54 56 1164 1166 O
bleeding 57 65 1167 1175 O

A 0 1 0 1 O
parent 2 8 2 8 O
or 9 11 9 11 O
guardian 12 20 12 20 O
must 21 25 21 25 O
be 26 28 26 28 O
available 29 38 29 38 O
for 39 42 39 42 O
giving 43 49 43 49 O
consent 50 57 50 57 O
for 58 61 58 61 O
pediatric 62 71 62 71 O
subjects 72 80 72 80 O
under 81 86 81 86 O
18 87 89 87 89 B-upper_bound
years 90 95 90 95 I-upper_bound
of 96 98 96 98 O
age 99 102 99 102 B-age

Age 0 3 103 106 B-age
greater 4 11 107 114 O
than 12 16 115 119 O
or 17 19 120 122 O
equal 20 25 123 128 O
to 26 28 129 131 O
12 29 31 132 134 B-lower_bound
years 32 37 135 140 I-lower_bound

Any 0 3 141 144 O
abnormality 4 15 145 156 O
that 16 20 157 161 O
would 21 26 162 167 O
be 27 29 168 170 O
scored 30 36 171 177 O
as 37 39 178 180 O
NCI 40 43 181 184 O
CTC 44 47 185 188 O
Grade 48 53 189 194 O
IV 54 56 195 197 O
toxicity 57 65 198 206 O
that 66 70 207 211 O
is 71 73 212 214 O
unrelated 74 83 215 224 O
to 84 86 225 227 O
HIV 87 90 228 231 B-chronic_disease
, 90 91 231 232 O
its 92 95 233 236 O
treatment 96 105 237 246 O
, 105 106 246 247 O
or 107 109 248 250 O
to 110 112 251 253 O
MCD 113 116 254 257 B-chronic_disease
that 117 121 258 262 O
would 122 127 263 268 O
preclude 128 136 269 277 O
protocol 137 145 278 286 O
treatment 146 155 287 296 O
and/or 156 162 297 303 O
observation 163 174 304 315 O
only 175 179 316 320 O

Biopsy 0 6 321 327 O
proven 7 13 328 334 O
KSHV 14 18 335 339 B-chronic_disease
- 18 19 339 340 O
associated 19 29 340 350 O
MCD 30 33 351 354 B-chronic_disease

Pregnant 0 8 355 363 B-pregnancy
women 9 14 364 369 B-gender
are 15 18 370 373 O
excluded 19 27 374 382 O
from 28 32 383 387 O
this 33 37 388 392 O
study 38 43 393 398 O
as 44 46 399 401 O
certain 47 54 402 409 O
of 55 57 410 412 O
the 58 61 413 416 O
study 62 67 417 422 O
agents 68 74 423 429 O
have 75 79 430 434 O
the 80 83 435 438 O
potential 84 93 439 448 O
for 94 97 449 452 O
teratogenic 98 109 453 464 O
effects 110 117 465 472 O

Presence 0 8 473 481 O
of 9 11 482 484 O
another 12 19 485 492 O
malignancy 20 30 493 503 B-cancer
requiring 31 40 504 513 O
current 41 48 514 521 O
treatment 49 58 522 531 B-treatment
that 59 63 532 536 O
would 64 69 537 542 O
preclude 70 78 543 551 O
the 79 82 552 555 O
use 83 86 556 559 O
of 87 89 560 562 O
all 90 93 563 566 O
of 94 96 567 569 O
the 97 100 570 573 O
study 101 106 574 579 O
treatments 107 117 580 590 B-treatment
or 118 120 591 593 O
the 121 124 594 597 O
ability 125 132 598 605 O
to 133 135 606 608 O
monitor 136 143 609 616 O
the 144 147 617 620 O
natural 148 155 621 628 O
history 156 163 629 636 O
of 164 166 637 639 O
MCD 167 170 640 643 B-chronic_disease
untreated 171 180 644 653 O

ECOG 0 4 0 4 B-clinical_variable
Performance 5 16 5 16 I-clinical_variable
Score 17 22 17 22 I-clinical_variable
must 23 27 23 27 O
be 28 30 28 30 O
≤ 31 32 31 32 O
2 33 34 33 34 B-upper_bound
within 35 41 35 41 O
two 42 45 42 45 B-upper_bound
weeks 46 51 46 51 I-upper_bound
prior 52 57 52 57 I-upper_bound
to 58 60 58 60 O
registration 61 73 61 73 O

Newly 0 5 74 79 O
diagnosed 6 15 80 89 O
, 15 16 89 90 O
untreated 17 26 91 100 O
intraocular 27 38 101 112 B-cancer
retinoblastoma 39 53 113 127 I-cancer
. 53 54 127 128 O
Participants 55 67 129 141 O
previously 68 78 142 152 O
diagnosed 79 88 153 162 O
with 89 93 163 167 O
unilateral 94 104 168 178 B-cancer
retinoblastoma 105 119 179 193 I-cancer
treated 120 127 194 201 O
surgically 128 138 202 212 O
, 138 139 212 213 O
with 140 144 214 218 O
focal 145 150 219 224 B-treatment
therapy 151 158 225 232 I-treatment
or 159 161 233 235 O
needing 162 169 236 243 O
chemotherapy 170 182 244 256 B-treatment
who 183 186 257 260 O
develop 187 194 261 268 O
asynchronous 195 207 269 281 O
involvement 208 219 282 293 O
of 220 222 294 296 O
the 223 226 297 300 O
contralateral 227 240 301 314 O
eye 241 244 315 318 O
, 244 245 318 319 O
or 246 248 320 322 O
patients 249 257 323 331 O
with 258 262 332 336 O
unilateral 263 273 337 347 O
retinoblastoma 274 288 348 362 O
treated 289 296 363 370 O
only 297 301 371 375 O
with 302 306 376 380 O
enucleation 307 318 381 392 B-treatment
or 319 321 393 395 O
focal 322 327 396 401 O
therapy 328 335 402 409 O
who 336 339 410 413 O
develop 340 347 414 421 O
asynchronous 348 360 422 434 O
involvement 361 372 435 446 O
of 373 375 447 449 O
the 376 379 450 453 O
contralateral 380 393 454 467 O
eye 394 397 468 471 O
, 397 398 471 472 O
will 399 403 473 477 O
be 404 406 478 480 O
eligible 407 415 481 489 O
for 416 419 490 493 O
study 420 425 494 499 O

Participants 0 12 500 512 O
must 13 17 513 517 O
have 18 22 518 522 O
adequate 23 31 523 531 B-chronic_disease
renal 32 37 532 537 I-chronic_disease
function 38 46 538 546 I-chronic_disease
as 47 49 547 549 O
defined 50 57 550 557 O
by 58 60 558 560 O
serum 61 66 561 566 B-clinical_variable
creatinine 67 77 567 577 I-clinical_variable
≤ 78 79 578 579 O
to 80 82 580 582 O
3X 83 85 583 585 B-upper_bound
ULN 86 89 586 589 I-upper_bound
for 90 93 590 593 O
age 94 97 594 597 B-age

Participants 0 12 598 610 O
must 13 17 611 615 O
have 18 22 616 620 O
an 23 25 621 623 O
adequate 26 34 624 632 O
liver 35 40 633 638 O
function 41 49 639 647 O
, 49 50 647 648 O
as 51 53 649 651 O
defined 54 61 652 659 O
by 62 64 660 662 O
bilirubin 65 74 663 672 B-clinical_variable
≤ 75 76 673 674 O
to 77 79 675 677 O
3X 80 82 678 680 B-upper_bound
upper 83 88 681 686 I-upper_bound
limit 89 94 687 692 I-upper_bound
of 95 97 693 695 I-upper_bound
normal 98 104 696 702 I-upper_bound
( 105 106 703 704 I-upper_bound
ULN 106 109 704 707 I-upper_bound
) 109 110 707 708 I-upper_bound
, 110 111 708 709 O
and 112 115 710 713 O
SGOT 116 120 714 718 B-clinical_variable
and 121 124 719 722 O
SGPT 125 129 723 727 B-clinical_variable
≤ 130 131 728 729 O
to 132 134 730 732 O
3X 135 137 733 735 B-upper_bound
ULN 138 141 736 739 I-upper_bound

Participants 0 12 740 752 O
must 13 17 753 757 O
not 18 21 758 761 O
have 22 26 762 766 O
an 27 29 767 769 O
invasive 30 38 770 778 B-chronic_disease
infection 39 48 779 788 I-chronic_disease
at 49 51 789 791 O
time 52 56 792 796 O
of 57 59 797 799 O
protocol 60 68 800 808 O
entry 69 74 809 814 O

Presence 0 8 815 823 O
of 9 11 824 826 O
metastatic 12 22 827 837 B-cancer
disease 23 30 838 845 I-cancer
or 31 33 846 848 O
gross 34 39 849 854 O
( 40 41 855 856 O
residual 41 49 856 864 O
) 49 50 864 865 O
orbital 51 58 866 873 O
involvement 59 70 874 885 O

Active 0 6 0 6 O
malignancy 7 17 7 17 B-cancer
: 17 18 17 18 O
a 19 20 19 20 O
patient 21 28 21 28 O
with 29 33 29 33 O
a 34 35 34 35 O
history 36 43 36 43 O
of 44 46 44 46 O
any 47 50 47 50 O
invasive 51 59 51 59 B-cancer
malignancy 60 70 60 70 I-cancer
( 71 72 71 72 O
except 72 78 72 78 O
nonmelanoma 79 90 79 90 B-cancer
skin 91 95 91 95 I-cancer
cancer 96 102 96 102 I-cancer
) 102 103 102 103 O
, 103 104 103 104 O
unless 105 111 105 111 O
he 112 114 112 114 O
/ 114 115 114 115 O
she 115 118 115 118 O
has 119 122 119 122 O
been 123 127 123 127 O
treated 128 135 128 135 O
with 136 140 136 140 O
curative 141 149 141 149 O
intent 150 156 150 156 O
and 157 160 157 160 O
there 161 166 161 166 O
has 167 170 167 170 O
been 171 175 171 175 O
no 176 178 176 178 O
clinical 179 187 179 187 O
signs 188 193 188 193 O
or 194 196 194 196 O
symptoms 197 205 197 205 O
of 206 208 206 208 O
the 209 212 209 212 O
malignancy 213 223 213 223 O
for 224 227 224 227 O
at 228 230 228 230 O
least 231 236 231 236 O
five 237 241 237 241 B-lower_bound
years 242 247 242 247 I-lower_bound

Active 0 6 248 254 B-chronic_disease
or 7 9 255 257 O
chronic 10 17 258 265 B-chronic_disease
infection 18 27 266 275 I-chronic_disease
- 28 29 276 277 O
systemic 30 38 278 286 B-chronic_disease
or 39 41 287 289 O
local 42 47 290 295 B-chronic_disease

Age 0 3 296 299 B-age
between 4 11 300 307 O
40 12 14 308 310 B-lower_bound
to 15 17 311 313 O
80 18 20 314 316 B-upper_bound
years 21 26 317 322 I-upper_bound

Appropriate 0 11 323 334 O
candidate 12 21 335 344 O
for 22 25 345 348 O
treatment 26 35 349 358 B-treatment
using 36 41 359 364 O
posterior 42 51 365 374 O
surgical 52 60 375 383 O
approach 61 69 384 392 O

Cauda 0 5 393 398 B-chronic_disease
equina 6 12 399 405 I-chronic_disease
syndrome 13 21 406 414 I-chronic_disease
, 21 22 414 415 O
defined 23 30 416 423 O
as 31 33 424 426 O
neural 34 40 427 433 B-chronic_disease
compression 41 52 434 445 I-chronic_disease
causing 53 60 446 453 O
neurogenic 61 71 454 464 B-chronic_disease
bowel 72 77 465 470 I-chronic_disease
( 78 79 471 472 O
rectal 79 85 472 478 O
incontinence 86 98 479 491 O
) 98 99 491 492 O
or 100 102 493 495 O
bladder 103 110 496 503 B-chronic_disease
( 111 112 504 505 I-chronic_disease
bladder 112 119 505 512 I-chronic_disease
retention 120 129 513 522 I-chronic_disease
or 130 132 523 525 I-chronic_disease
incontinence 133 145 526 538 I-chronic_disease
) 145 146 538 539 I-chronic_disease
dysfunction 147 158 540 551 I-chronic_disease

Chronically 0 11 552 563 O
taking 12 18 564 570 O
medications 19 30 571 582 B-treatment
or 31 33 583 585 I-treatment
any 34 37 586 589 I-treatment
drug 38 42 590 594 I-treatment
known 43 48 595 600 O
to 49 51 601 603 O
potentially 52 63 604 615 O
interfere 64 73 616 625 O
with 74 78 626 630 O
bone 79 83 631 635 O
/ 83 84 635 636 O
soft 84 88 636 640 O
tissue 89 95 641 647 O
healing 96 103 648 655 O
( 104 105 656 657 O
e.g. 105 109 657 661 O
, 109 110 661 662 O
steroids 111 119 663 671 B-treatment
) 119 120 671 672 O
, 120 121 672 673 O
not 122 125 674 677 O
including 126 135 678 687 O
a 136 137 688 689 O
medrol 138 144 690 696 B-treatment
dose 145 149 697 701 I-treatment
pack 150 154 702 706 I-treatment

Degenerative 0 12 707 719 B-chronic_disease
lumbar 13 19 720 726 I-chronic_disease
scoliosis 20 29 727 736 I-chronic_disease
( 30 31 737 738 O
Cobb 31 35 738 742 B-clinical_variable
angle 36 41 743 748 I-clinical_variable
of 42 44 749 751 O
greater 45 52 752 759 O
than 53 57 760 764 O
25 58 60 765 767 B-lower_bound
° 60 61 767 768 I-lower_bound
) 61 62 768 769 O

Disc 0 4 770 774 B-chronic_disease
herniation 5 15 775 785 I-chronic_disease
at 16 18 786 788 O
any 19 22 789 792 O
lumbar 23 29 793 799 O
level 30 35 800 805 O
requiring 36 45 806 815 O
surgical 46 54 816 824 B-treatment
intervention 55 67 825 837 I-treatment

Facet 0 5 838 843 B-chronic_disease
hypertrophy 6 17 844 855 I-chronic_disease
and 18 21 856 859 O
subarticular 22 34 860 872 O
recess 35 41 873 879 B-chronic_disease
stenosis 42 50 880 888 I-chronic_disease
at 51 53 889 891 O
the 54 57 892 895 O
affected 58 66 896 904 O
level(s 67 74 905 912 O
) 74 75 912 913 O

For 0 3 914 917 O
single 4 10 918 924 O
level 11 16 925 930 O
disease 17 24 931 938 O
, 24 25 938 939 O
there 26 31 940 945 O
may 32 35 946 949 O
be 36 38 950 952 O
up 39 41 953 955 O
to 42 44 956 958 O
a 45 46 959 960 O
stable 47 53 961 967 O
Grade 54 59 968 973 B-upper_bound
I 60 61 974 975 I-upper_bound
spondylolisthesis 62 79 976 993 B-chronic_disease
or 80 82 994 996 O
equivalent 83 93 997 1007 O
retrolisthesis 94 108 1008 1022 B-chronic_disease
at 109 111 1023 1025 O
the 112 115 1026 1029 O
affected 116 124 1030 1038 O
level 125 130 1039 1044 O
as 131 133 1045 1047 O
determined 134 144 1048 1058 O
on 145 147 1059 1061 O
flexion 148 155 1062 1069 O
/ 155 156 1069 1070 O
extension 156 165 1070 1079 O
files 166 171 1080 1085 O
by 172 174 1086 1088 O
the 175 178 1089 1092 O
investigator 179 191 1093 1105 O

For 0 3 1106 1109 O
two 4 7 1110 1113 O
level 8 13 1114 1119 O
disease 14 21 1120 1127 O
, 21 22 1127 1128 O
there 23 28 1129 1134 O
may 29 32 1135 1138 O
be 33 35 1139 1141 O
up 36 38 1142 1144 O
to 39 41 1145 1147 O
a 42 43 1148 1149 O
stable 44 50 1150 1156 O
Grade 51 56 1157 1162 B-chronic_disease
I 57 58 1163 1164 I-chronic_disease
spondylolisthesis 59 76 1165 1182 I-chronic_disease
or 77 79 1183 1185 O
equivalent 80 90 1186 1196 O
retrolisthesis 91 105 1197 1211 B-chronic_disease
at 106 108 1212 1214 O
ONLY 109 113 1215 1219 O
ONE 114 117 1220 1223 O
of 118 120 1224 1226 O
the 121 124 1227 1230 O
two 125 128 1231 1234 O
contiguous 129 139 1235 1245 O
affected 140 148 1246 1254 O
levels 149 155 1255 1261 O
as 156 158 1262 1264 O
determined 159 169 1265 1275 O
on 170 172 1276 1278 O
flexion 173 180 1279 1286 O
/ 180 181 1286 1287 O
extension 181 190 1287 1296 O
films 191 196 1297 1302 O
by 197 199 1303 1305 O
the 200 203 1306 1309 O
investigator 204 216 1310 1322 O

Foraminal 0 9 1323 1332 B-chronic_disease
stenosis 10 18 1333 1341 I-chronic_disease
at 19 21 1342 1344 O
the 22 25 1345 1348 O
affected 26 34 1349 1357 O
level(s 35 42 1358 1365 O
) 42 43 1365 1366 O

History 0 7 1367 1374 O
of 8 10 1375 1377 O
significant 11 22 1378 1389 O
peripheral 23 33 1390 1400 B-chronic_disease
neuropathy 34 44 1401 1411 I-chronic_disease

In 0 2 1412 1414 O
active 3 9 1415 1421 O
spinal 10 16 1422 1428 B-chronic_disease
litigation 17 27 1429 1439 O

Isthmic 0 7 1440 1447 B-chronic_disease
spondylolisthesis 8 25 1448 1465 I-chronic_disease
or 26 28 1466 1468 O
spondylolysis 29 42 1469 1482 B-chronic_disease

Known 0 5 1483 1488 O
allergy 6 13 1489 1496 O
to 14 16 1497 1499 O
titanium 17 25 1500 1508 B-allergy_name
, 25 26 1508 1509 O
titanium 27 35 1510 1518 B-allergy_name
alloys 36 42 1519 1525 I-allergy_name
, 42 43 1525 1526 O
or 44 46 1527 1529 O
MR 47 49 1530 1532 B-allergy_name
( 50 51 1533 1534 I-allergy_name
magnetic 51 59 1534 1542 I-allergy_name
resonance 60 69 1543 1552 I-allergy_name
) 69 70 1552 1553 I-allergy_name
contrast 71 79 1554 1562 I-allergy_name
agents 80 86 1563 1569 I-allergy_name

Known 0 5 1570 1575 O
history 6 13 1576 1583 O
of 14 16 1584 1586 O
Paget 17 22 1587 1592 B-chronic_disease
's 22 24 1592 1594 I-chronic_disease
disease 25 32 1595 1602 I-chronic_disease
, 32 33 1602 1603 O
osteomalacia 34 46 1604 1616 B-chronic_disease
, 46 47 1616 1617 O
or 48 50 1618 1620 O
any 51 54 1621 1624 O
other 55 60 1625 1630 O
metabolic 61 70 1631 1640 B-chronic_disease
bone 71 75 1641 1645 I-chronic_disease
disease 76 83 1646 1653 I-chronic_disease

Known 0 5 1654 1659 O
or 6 8 1660 1662 O
documented 9 19 1663 1673 O
history 20 27 1674 1681 O
of 28 30 1682 1684 O
communicable 31 43 1685 1697 O
disease 44 51 1698 1705 O
, 51 52 1705 1706 O
including 53 62 1707 1716 O
AIDS 63 67 1717 1721 B-chronic_disease
, 67 68 1721 1722 O
HIV 69 72 1723 1726 B-chronic_disease
, 72 73 1726 1727 O
active 74 80 1728 1734 O
Hepatitis 81 90 1735 1744 B-chronic_disease

Mild 0 4 1745 1749 B-chronic_disease
lumbar 5 11 1750 1756 I-chronic_disease
scoliosis 12 21 1757 1766 I-chronic_disease
( 22 23 1767 1768 O
Cobb 23 27 1768 1772 B-clinical_variable
angle 28 33 1773 1778 I-clinical_variable
up 34 36 1779 1781 O
to 37 39 1782 1784 O
25º 40 43 1785 1788 B-upper_bound
) 43 44 1788 1789 O

Moderate 0 8 1790 1798 O
stenosis 9 17 1799 1807 B-clinical_variable
is 18 20 1808 1810 O
defined 21 28 1811 1818 O
as 29 31 1819 1821 O
> 32 33 1822 1823 O
25 34 36 1824 1826 B-lower_bound
% 36 37 1826 1827 I-lower_bound
reduction 38 47 1828 1837 O
of 48 50 1838 1840 O
the 51 54 1841 1844 O
antero 55 61 1845 1851 O
- 61 62 1851 1852 O
posterior 62 71 1852 1861 O
dimension 72 81 1862 1871 O
compared 82 90 1872 1880 O
to 91 93 1881 1883 O
the 94 97 1884 1887 O
next 98 102 1888 1892 O
adjacent 103 111 1893 1901 O
normal 112 118 1902 1908 O
level 119 124 1909 1914 O
, 124 125 1914 1915 O
with 126 130 1916 1920 O
nerve 131 136 1921 1926 O
root 137 141 1927 1931 O
crowding 142 150 1932 1940 O
compared 151 159 1941 1949 O
to 160 162 1950 1952 O
the 163 166 1953 1956 O
normal 167 173 1957 1963 O
level 174 179 1964 1969 O
, 179 180 1969 1970 O
as 181 183 1971 1973 O
determined 184 194 1974 1984 O
by 195 197 1985 1987 O
the 198 201 1988 1991 O
investigator 202 214 1992 2004 O
on 215 217 2005 2007 O
computerized 218 230 2008 2020 B-treatment
tomography 231 241 2021 2031 I-treatment
( 242 243 2032 2033 I-treatment
CT 243 245 2033 2035 I-treatment
) 245 246 2035 2036 I-treatment
Scan 247 251 2037 2041 I-treatment
or 252 254 2042 2044 O
MRI 255 258 2045 2048 B-treatment

Morbid 0 6 2049 2055 B-chronic_disease
obesity 7 14 2056 2063 I-chronic_disease
defined 15 22 2064 2071 O
as 23 25 2072 2074 O
a 26 27 2075 2076 O
body 28 32 2077 2081 B-bmi
mass 33 37 2082 2086 I-bmi
index 38 43 2087 2092 I-bmi
> 44 45 2093 2094 O
40 46 48 2095 2097 B-lower_bound

More 0 4 2098 2102 O
than 5 9 2103 2107 O
one 10 13 2108 2111 B-lower_bound
surgical 14 22 2112 2120 B-treatment
procedure 23 32 2121 2130 I-treatment
at 33 35 2131 2133 O
any 36 39 2134 2137 O
combination 40 51 2138 2149 O
of 52 54 2150 2152 O
lumbar 55 61 2153 2159 O
levels 62 68 2160 2166 O

More 0 4 2167 2171 O
than 5 9 2172 2176 O
two 10 13 2177 2180 B-lower_bound
contiguous 14 24 2181 2191 O
vertebral 25 34 2192 2201 O
levels 35 41 2202 2208 O
requiring 42 51 2209 2218 O
surgical 52 60 2219 2227 B-treatment
decompression 61 74 2228 2241 I-treatment

Neurogenic 0 10 2242 2252 B-treatment
claudication 11 23 2253 2265 I-treatment
as 24 26 2266 2268 O
defined 27 34 2269 2276 O
by 35 37 2277 2279 O
leg 38 41 2280 2283 O
/ 41 42 2283 2284 O
buttocks 42 50 2284 2292 O
or 51 53 2293 2295 O
groin 54 59 2296 2301 O
pain 60 64 2302 2306 O
that 65 69 2307 2311 O
can 70 73 2312 2315 O
be 74 76 2316 2318 O
relieved 77 85 2319 2327 O
by 86 88 2328 2330 O
flexion 89 96 2331 2338 O
such 97 101 2339 2343 O
as 102 104 2344 2346 O
sitting 105 112 2347 2354 O
in 113 115 2355 2357 O
a 116 117 2358 2359 O
chair 118 123 2360 2365 O

Osteopenia 0 10 2366 2376 B-chronic_disease
: 10 11 2376 2377 O
A 12 13 2378 2379 O
screening 14 23 2380 2389 O
questionnaire 24 37 2390 2403 O
for 38 41 2404 2407 O
osteopenia 42 52 2408 2418 B-chronic_disease
, 52 53 2418 2419 O
SCORE 54 59 2420 2425 O
( 60 61 2426 2427 O
Simple 61 67 2427 2433 O
Calculated 68 78 2434 2444 O
Osteoporosis 79 91 2445 2457 O
Risk 92 96 2458 2462 O
Estimation 97 107 2463 2473 O
) 107 108 2473 2474 O
, 108 109 2474 2475 O
will 110 114 2476 2480 O
be 115 117 2481 2483 O
used 118 122 2484 2488 O
to 123 125 2489 2491 O
screen 126 132 2492 2498 O
patients 133 141 2499 2507 O
who 142 145 2508 2511 O
require 146 153 2512 2519 O
a 154 155 2520 2521 O
DEXA 156 160 2522 2526 B-treatment
( 161 162 2527 2528 I-treatment
dual 162 166 2528 2532 I-treatment
- 166 167 2532 2533 I-treatment
energy 167 173 2533 2539 I-treatment
x 174 175 2540 2541 I-treatment
- 175 176 2541 2542 I-treatment
ray 176 179 2542 2545 I-treatment
absorptiometry 180 194 2546 2560 I-treatment
) 194 195 2560 2561 I-treatment
bone 196 200 2562 2566 O
mineral 201 208 2567 2574 O
density 209 216 2575 2582 O
measurement 217 228 2583 2594 O

Oswestry 0 8 2595 2603 O
Low 9 12 2604 2607 O
Back 13 17 2608 2612 O
Pain 18 22 2613 2617 O
Disability 23 33 2618 2628 O
Questionnaire 34 47 2629 2642 O
score 48 53 2643 2648 O
of 54 56 2649 2651 O
at 57 59 2652 2654 O
least 60 65 2655 2660 O
20/50 66 71 2661 2666 B-lower_bound
( 72 73 2667 2668 O
40 73 75 2668 2670 O
% 75 76 2670 2671 O
) 76 77 2671 2672 O

Patient 0 7 2673 2680 O
has 8 11 2681 2684 O
undergone 12 21 2685 2694 O
at 22 24 2695 2697 O
least 25 30 2698 2703 O
one 31 34 2704 2707 O
epidural 35 43 2708 2716 B-treatment
injection 44 53 2717 2726 I-treatment
at 54 56 2727 2729 O
any 57 60 2730 2733 O
prior 61 66 2734 2739 O
time 67 71 2740 2744 O
point 72 77 2745 2750 O
, 77 78 2750 2751 O
AND 79 82 2752 2755 O
at 83 85 2756 2758 O
least 86 91 2759 2764 O
6 92 93 2765 2766 B-lower_bound
months 94 100 2767 2773 I-lower_bound
of 101 103 2774 2776 O
prior 104 109 2777 2782 O
conservative 110 122 2783 2795 O
care 123 127 2796 2800 O
without 128 135 2801 2808 O
adequate 136 144 2809 2817 O
and 145 148 2818 2821 O
sustained 149 158 2822 2831 O
symptom 159 166 2832 2839 O
relief 167 173 2840 2846 O

Patients 0 8 2847 2855 O
with 9 13 2856 2860 O
a 14 15 2861 2862 O
primary 16 23 2863 2870 B-cancer
bony 24 28 2871 2875 I-cancer
tumor 29 34 2876 2881 I-cancer

Patients 0 8 2882 2890 O
with 9 13 2891 2895 O
up 14 16 2896 2898 O
to 17 19 2899 2901 O
stable 20 26 2902 2908 O
Grade 27 32 2909 2914 B-chronic_disease
I 33 34 2915 2916 I-chronic_disease
spondylolisthesis 35 52 2917 2934 I-chronic_disease
at 53 55 2935 2937 O
two 56 59 2938 2941 O
contiguous 60 70 2942 2952 O
levels 71 77 2953 2959 O

Pregnant 0 8 2960 2968 B-pregnancy
or 9 11 2969 2971 O
interested 12 22 2972 2982 O
in 23 25 2983 2985 O
becoming 26 34 2986 2994 B-pregnancy
pregnant 35 43 2995 3003 I-pregnancy
in 44 46 3004 3006 O
the 47 50 3007 3010 O
next 51 55 3011 3015 B-upper_bound
three 56 61 3016 3021 I-upper_bound
years 62 67 3022 3027 I-upper_bound

Prior 0 5 3028 3033 B-treatment
fusion 6 12 3034 3040 I-treatment
, 12 13 3040 3041 O
implantation 14 26 3042 3054 B-treatment
of 27 29 3055 3057 I-treatment
a 30 31 3058 3059 I-treatment
total 32 37 3060 3065 I-treatment
disc 38 42 3066 3070 I-treatment
replacement 43 54 3071 3082 I-treatment
, 54 55 3082 3083 O
complete 56 64 3084 3092 B-treatment
laminectomy 65 76 3093 3104 I-treatment
, 76 77 3104 3105 O
or 78 80 3106 3108 O
implantation 81 93 3109 3121 B-treatment
of 94 96 3122 3124 I-treatment
an 97 99 3125 3127 I-treatment
interspinous 100 112 3128 3140 I-treatment
process 113 120 3141 3148 I-treatment
device 121 127 3149 3155 I-treatment
at 128 130 3156 3158 O
index 131 136 3159 3164 O
level 137 142 3165 3170 O

Prior 0 5 3171 3176 B-treatment
surgical 6 14 3177 3185 I-treatment
procedure 15 24 3186 3195 I-treatment
that 25 29 3196 3200 O
resulted 30 38 3201 3209 O
in 39 41 3210 3212 O
translatory 42 53 3213 3224 O
instability 54 65 3225 3236 O
of 66 68 3237 3239 O
the 69 72 3240 3243 O
lumbar 73 79 3244 3250 O
spine 80 85 3251 3256 O
[ 86 87 3257 3258 O
as 87 89 3258 3260 O
defined 90 97 3261 3268 O
by 98 100 3269 3271 O
White 101 106 3272 3277 O
& 107 108 3278 3279 O
Panjabi 109 116 3280 3287 O
( 117 118 3288 3289 O
see 118 121 3289 3292 O
3.4.1 122 127 3293 3298 O
Inclusion 128 137 3299 3308 O
Criteria 138 146 3309 3317 O
, 146 147 3317 3318 O
Item 148 152 3319 3323 O
# 153 154 3324 3325 O
2 154 155 3325 3326 O
) 155 156 3326 3327 O
] 156 157 3327 3328 O

Psychosocially 0 14 3329 3343 O
, 14 15 3343 3344 O
mentally 16 24 3345 3353 O
, 24 25 3353 3354 O
and 26 29 3355 3358 O
physically 30 40 3359 3369 O
able 41 45 3370 3374 O
to 46 48 3375 3377 O
fully 49 54 3378 3383 O
comply 55 61 3384 3390 O
with 62 66 3391 3395 O
this 67 71 3396 3400 O
protocol 72 80 3401 3409 O
, 80 81 3409 3410 O
including 82 91 3411 3420 O
adhering 92 100 3421 3429 O
to 101 103 3430 3432 O
scheduled 104 113 3433 3442 O
visits 114 120 3443 3449 O
, 120 121 3449 3450 O
treatment 122 131 3451 3460 B-treatment
plan 132 136 3461 3465 O
, 136 137 3465 3466 O
completing 138 148 3467 3477 O
forms 149 154 3478 3483 O
, 154 155 3483 3484 O
and 156 159 3485 3488 O
other 160 165 3489 3494 O
study 166 171 3495 3500 O
procedures 172 182 3501 3511 O

Radiographic 0 12 3512 3524 O
confirmation 13 25 3525 3537 O
of 26 28 3538 3540 O
at 29 31 3541 3543 O
least 32 37 3544 3549 O
moderate 38 46 3550 3558 O
lumbar 47 53 3559 3565 B-chronic_disease
stenosis 54 62 3566 3574 I-chronic_disease
, 62 63 3574 3575 O
which 64 69 3576 3581 O
narrows 70 77 3582 3589 O
the 78 81 3590 3593 O
central 82 89 3594 3601 O
spinal 90 96 3602 3608 O
canal 97 102 3609 3614 O
at 103 105 3615 3617 O
one 106 109 3618 3621 O
or 110 112 3622 3624 O
two 113 116 3625 3628 O
contiguous 117 127 3629 3639 O
levels 128 134 3640 3646 O
from 135 139 3647 3651 O
L1 140 142 3652 3654 B-lower_bound
- 142 143 3654 3655 O
L5 143 145 3655 3657 B-upper_bound
that 146 150 3658 3662 O
require 151 158 3663 3670 O
surgical 159 167 3671 3679 B-treatment
decompression 168 181 3680 3693 I-treatment

Radiographic 0 12 3694 3706 B-treatment
confirmation 13 25 3707 3719 O
of 26 28 3720 3722 O
no 29 31 3723 3725 O
angular 32 39 3726 3733 O
or 40 42 3734 3736 O
translatory 43 54 3737 3748 O
instability 55 66 3749 3760 O
of 67 69 3761 3763 O
the 70 73 3764 3767 O
spine 74 79 3768 3773 O
at 80 82 3774 3776 O
index 83 88 3777 3782 O
or 89 91 3783 3785 O
adjacent 92 100 3786 3794 O
levels 101 107 3795 3801 O
( 108 109 3802 3803 O
instability 109 120 3803 3814 O
as 121 123 3815 3817 O
defined 124 131 3818 3825 O
by 132 134 3826 3828 O
White 135 140 3829 3834 O
& 141 142 3835 3836 O
Panjabi 143 150 3837 3844 O
: 150 151 3844 3845 O
Sagittal 152 160 3846 3854 B-clinical_variable
plane 161 166 3855 3860 I-clinical_variable
translation 167 178 3861 3872 I-clinical_variable
> 179 180 3873 3874 O
4.5 180 183 3874 3877 B-lower_bound
mm 183 185 3877 3879 I-lower_bound
or 186 188 3880 3882 O
15 189 191 3883 3885 B-lower_bound
% 191 192 3885 3886 I-lower_bound
or 193 195 3887 3889 O
sagittal 196 204 3890 3898 B-clinical_variable
plane 205 210 3899 3904 I-clinical_variable
rotation 211 219 3905 3913 I-clinical_variable
> 220 221 3914 3915 O
15 221 223 3915 3917 B-lower_bound
° 223 224 3917 3918 I-lower_bound
at 225 227 3919 3921 O
L1 228 230 3922 3924 O
- 230 231 3924 3925 O
L2 231 233 3925 3927 O
, 233 234 3927 3928 O
L2 235 237 3929 3931 O
- 237 238 3931 3932 O
L3 238 240 3932 3934 O
, 240 241 3934 3935 O
and 242 245 3936 3939 O
L3 246 248 3940 3942 O
- 248 249 3942 3943 O
L4 249 251 3943 3945 O
; 251 252 3945 3946 O
> 253 254 3947 3948 O
20 254 256 3948 3950 B-lower_bound
° 256 257 3950 3951 I-lower_bound
at 258 260 3952 3954 O
L4 261 263 3955 3957 O
- 263 264 3957 3958 O
L5 264 266 3958 3960 O
based 267 272 3961 3966 O
on 273 275 3967 3969 O
standing 276 284 3970 3978 O
flexion 285 292 3979 3986 O
/ 292 293 3986 3987 O
extension 293 302 3987 3996 O
X 303 304 3997 3998 O
- 304 305 3998 3999 O
rays 305 309 3999 4003 O
) 309 310 4003 4004 O

Radiographically 0 16 4005 4021 O
compromised 17 28 4022 4033 O
vertebral 29 38 4034 4043 O
bodies 39 45 4044 4050 O
at 46 48 4051 4053 O
any 49 52 4054 4057 O
lumbar 53 59 4058 4064 O
level(s 60 67 4065 4072 O
) 67 68 4072 4073 O
caused 69 75 4074 4080 O
by 76 78 4081 4083 O
current 79 86 4084 4091 O
or 87 89 4092 4094 O
past 90 94 4095 4099 O
trauma 95 101 4100 4106 B-chronic_disease
or 102 104 4107 4109 O
tumor 105 110 4110 4115 B-cancer

Rheumatoid 0 10 4116 4126 B-chronic_disease
arthritis 11 20 4127 4136 I-chronic_disease
or 21 23 4137 4139 O
other 24 29 4140 4145 O
autoimmune 30 40 4146 4156 B-chronic_disease
diseases 41 49 4157 4165 I-chronic_disease

Severe 0 6 4166 4172 O
facet 7 12 4173 4178 B-chronic_disease
hypertrophy 13 24 4179 4190 I-chronic_disease
that 25 29 4191 4195 O
requires 30 38 4196 4204 O
extensive 39 48 4205 4214 O
bone 49 53 4215 4219 O
removal 54 61 4220 4227 O
which 62 67 4228 4233 O
would 68 73 4234 4239 O
cause 74 79 4240 4245 O
instability 80 91 4246 4257 O

Significant 0 11 4258 4269 O
peripheral 12 22 4270 4280 B-chronic_disease
vascular 23 31 4281 4289 I-chronic_disease
disease 32 39 4290 4297 I-chronic_disease
( 40 41 4298 4299 O
e.g. 41 45 4299 4303 O
, 45 46 4303 4304 O
with 47 51 4305 4309 O
diminished 52 62 4310 4320 O
dorsalis 63 71 4321 4329 O
pedis 72 77 4330 4335 O
or 78 80 4336 4338 O
posterior 81 90 4339 4348 O
tibial 91 97 4349 4355 O
pulses 98 104 4356 4362 O
) 104 105 4362 4363 O

Subject 0 7 4364 4371 O
is 8 10 4372 4374 O
currently 11 20 4375 4384 O
involved 21 29 4385 4393 O
in 30 32 4394 4396 O
a 33 34 4397 4398 O
study 35 40 4399 4404 O
of 41 43 4405 4407 O
another 44 51 4408 4415 B-treatment
investigational 52 67 4416 4431 I-treatment
product 68 75 4432 4439 I-treatment
for 76 79 4440 4443 O
similar 80 87 4444 4451 O
purpose 88 95 4452 4459 O

Uncontrolled 0 12 4460 4472 O
diabetes 13 21 4473 4481 B-chronic_disease

Up 0 2 4482 4484 O
to 3 5 4485 4487 O
stable 6 12 4488 4494 O
Grade 13 18 4495 4500 B-upper_bound
I 19 20 4501 4502 I-upper_bound
degenerative 21 33 4503 4515 O
spondylolisthesis 34 51 4516 4533 B-chronic_disease
( 52 53 4534 4535 O
Meyerding 53 62 4535 4544 B-clinical_variable
classification 63 77 4545 4559 O
) 77 78 4559 4560 O
or 79 81 4561 4563 O
equivalent 82 92 4564 4574 O
retrolisthesis 93 107 4575 4589 B-chronic_disease
as 108 110 4590 4592 O
determined 111 121 4593 4603 O
by 122 124 4604 4606 O
flexion 125 132 4607 4614 B-treatment
/ 132 133 4614 4615 O
extension 133 142 4615 4624 B-treatment
X 143 144 4625 4626 I-treatment
ray 145 148 4627 4630 I-treatment

Visual 0 6 4631 4637 B-clinical_variable
Analog 7 13 4638 4644 I-clinical_variable
Scale 14 19 4645 4650 I-clinical_variable
back 20 24 4651 4655 B-chronic_disease
pain 25 29 4656 4660 I-chronic_disease
score 30 35 4661 4666 O
of 36 38 4667 4669 O
at 39 41 4670 4672 O
least 42 47 4673 4678 O
50 48 50 4679 4681 B-lower_bound
mm 51 53 4682 4684 I-lower_bound
on 54 56 4685 4687 O
a 57 58 4688 4689 O
100 59 62 4690 4693 B-upper_bound
mm 63 65 4694 4696 I-upper_bound
scale 66 71 4697 4702 I-upper_bound

compression 0 11 4703 4714 B-chronic_disease
fracture 12 20 4715 4723 I-chronic_disease

osteopenia 0 10 4724 4734 B-chronic_disease

pars 0 4 4735 4739 B-chronic_disease
fracture 5 13 4740 4748 I-chronic_disease

patients 0 8 4749 4757 O
with 9 13 4758 4762 O
up 14 16 4763 4765 O
to 17 19 4766 4768 O
Grade 20 25 4769 4774 B-chronic_disease
I 26 27 4775 4776 I-chronic_disease
stable 28 34 4777 4783 I-chronic_disease
spondylolisthesis 35 52 4784 4801 I-chronic_disease
at 53 55 4802 4804 O
the 56 59 4805 4808 O
adjacent 60 68 4809 4817 O
level 69 74 4818 4823 O

Consume 0 7 0 7 O
> 8 9 8 9 O
14 9 11 9 11 B-lower_bound
( 12 13 12 13 O
men 13 16 13 16 B-gender
) 16 17 16 17 O
or 18 20 18 20 O
> 21 22 21 22 O
7 22 23 22 23 B-lower_bound
( 24 25 24 25 O
women 25 30 25 30 B-gender
) 30 31 30 31 O
standard 32 40 32 40 O
alcohol 41 48 41 48 O
drinks 49 55 49 55 O
per 56 59 56 59 O
week 60 64 60 64 O

Current 0 7 65 72 O
suicidal 8 16 73 81 B-chronic_disease
ideation 17 25 82 90 I-chronic_disease
( 26 27 91 92 O
past 27 31 92 96 B-upper_bound
6 32 33 97 98 I-upper_bound
months 34 40 99 105 I-upper_bound
) 40 41 105 106 O

History 0 7 107 114 O
of 8 10 115 117 O
adverse 11 18 118 125 O
reactions 19 28 126 135 O
to 29 31 136 138 O
varenicline 32 43 139 150 B-allergy_name
( 44 45 151 152 I-allergy_name
VAR 45 48 152 155 I-allergy_name
) 48 49 155 156 I-allergy_name

History 0 7 157 164 O
of 8 10 165 167 O
seizures 11 19 168 176 B-chronic_disease

Smoke 0 5 177 182 O
3 6 7 183 184 B-age
- 7 8 184 185 O
30 8 10 185 187 B-upper_bound
cigarettes 11 21 188 198 O
/ 21 22 198 199 O
day 22 25 199 202 O

at 0 2 203 205 O
least 3 8 206 211 O
8th 9 12 212 215 B-lower_bound
grade 13 18 216 221 O
education 19 28 222 231 O

cirrhosis 0 9 232 241 B-chronic_disease

current 0 7 242 249 B-pregnancy
plans 8 13 250 255 I-pregnancy
to 14 16 256 258 I-pregnancy
become 17 23 259 265 I-pregnancy
pregnant 24 32 266 274 I-pregnancy
in 33 35 275 277 O
next 36 40 278 282 B-upper_bound
three 41 46 283 288 I-upper_bound
months 47 53 289 295 I-upper_bound

currently 0 9 296 305 O
pregnant 10 18 306 314 B-pregnancy

hepatitis 0 9 315 324 B-chronic_disease

history 0 7 325 332 O
of 8 10 333 335 O
major 11 16 336 341 O
suicide 17 24 342 349 B-chronic_disease
attempts 25 33 350 358 I-chronic_disease

psychiatric 0 11 359 370 B-chronic_disease
disorder 12 20 371 379 I-chronic_disease

recent 0 6 380 386 O
major 7 12 387 392 B-chronic_disease
cardiovascular 13 27 393 407 I-chronic_disease
event 28 33 408 413 O

seizure 0 7 414 421 B-chronic_disease
disorder 8 16 422 430 I-chronic_disease

unable 0 6 431 437 B-contraception_consent
to 7 9 438 440 I-contraception_consent
agree 10 15 441 446 I-contraception_consent
to 16 18 447 449 I-contraception_consent
adequate 19 27 450 458 I-contraception_consent
birth 28 33 459 464 I-contraception_consent
control 34 41 465 472 I-contraception_consent
during 42 48 473 479 O
study 49 54 480 485 O
participation 55 68 486 499 O

A 0 1 0 1 O
minimum 2 9 2 9 O
of 10 12 10 12 O
6 13 14 13 14 B-lower_bound
weeks 15 20 15 20 I-lower_bound
is 21 23 21 23 O
required 24 32 24 32 O
following 33 42 33 42 O
prior 43 48 43 48 B-treatment
large 49 54 49 54 I-treatment
field 55 60 55 60 I-treatment
radiation 61 70 61 70 I-treatment
therapy 71 78 71 78 I-treatment
( 79 80 79 80 O
i.e. 80 84 80 84 O
TBI 85 88 85 88 B-chronic_disease
, 88 89 88 89 O
craniospinal 90 102 90 102 B-treatment
therapy 103 110 103 110 I-treatment
, 110 111 110 111 O
whole 112 117 112 117 O
abdomen 118 125 118 125 O
, 125 126 125 126 O
total 127 132 127 132 O
lung 133 137 133 137 O
, 137 138 137 138 O
> 139 140 139 140 O
50 141 143 141 143 B-lower_bound
% 143 144 143 144 I-lower_bound
marrow 145 151 145 151 B-clinical_variable
space 152 157 152 157 I-clinical_variable
) 157 158 157 158 O

Bone 0 4 159 163 O
marrow 5 11 164 170 O
with 12 16 171 175 O
tumor 17 22 176 181 B-cancer
cells 23 28 182 187 O
seen 29 33 188 192 O
on 34 36 193 195 O
routine 37 44 196 203 O
morphology 45 55 204 214 O
( 56 57 215 216 O
not 57 60 216 219 O
by 61 63 220 222 O
NSE 64 67 223 226 O
staining 68 76 227 235 O
only 77 81 236 240 O
) 81 82 240 241 O
of 83 85 242 244 O
bilateral 86 95 245 254 B-treatment
aspirate 96 104 255 263 I-treatment
and/or 105 111 264 270 O
biopsy 112 118 271 277 B-treatment
on 119 121 278 280 O
one 122 125 281 284 O
bone 126 130 285 289 O
marrow 131 137 290 296 O
sample 138 144 297 303 O

CNS 0 3 304 307 O
lesions 4 11 308 315 O
: 11 12 315 316 O
A 13 14 317 318 O
) 14 15 318 319 O
Patients 16 24 320 328 O
with 25 29 329 333 O
CNS 30 33 334 337 B-cancer
parenchymal 34 45 338 349 I-cancer
or 46 48 350 352 O
meningeal 49 58 353 362 B-cancer
- 58 59 362 363 I-cancer
based 59 64 363 368 I-cancer
lesions 65 72 369 376 I-cancer
that 73 77 377 381 O
are 78 81 382 385 O
present 82 89 386 393 O
at 90 92 394 396 O
study 93 98 397 402 O
entry 99 104 403 408 O
are 105 108 409 412 O
NOT 109 112 413 416 O
eligible 113 121 417 425 O
due 122 125 426 429 O
to 126 128 430 432 O
concerns 129 137 433 441 O
regarding 138 147 442 451 O
toxicity 148 156 452 460 O
attribution 157 168 461 472 O

Diseases 0 8 473 481 O
refractory 9 19 482 492 O
/ 19 20 492 493 O
relapsed 20 28 493 501 O
after 29 34 502 507 O
one 35 38 508 511 B-lower_bound
or 39 41 512 514 O
more 42 46 515 519 O
systemic 47 55 520 528 B-treatment
cytotoxic 56 65 529 538 I-treatment
therapies 66 75 539 548 I-treatment

For 0 3 549 552 O
patients 4 12 553 561 O
with 13 17 562 566 O
persistent 18 28 567 577 O
disease 29 36 578 585 O
, 36 37 585 586 O
a 38 39 587 588 O
biopsy 40 46 589 595 B-treatment
of 47 49 596 598 I-treatment
bone 50 54 599 603 I-treatment
marrow 55 61 604 610 I-treatment
, 61 62 610 611 O
or 63 65 612 614 O
bone 66 70 615 619 O
, 70 71 619 620 O
or 72 74 621 623 O
a 75 76 624 625 O
soft 77 81 626 630 B-treatment
tissue 82 88 631 637 I-treatment
site 89 93 638 642 I-treatment
, 93 94 642 643 O
must 95 99 644 648 O
have 100 104 649 653 O
demonstrated 105 117 654 666 O
viable 118 124 667 673 B-cancer
tumor 125 130 674 679 I-cancer

Growth 0 6 680 686 O
factor(s 7 15 687 695 O
): 15 17 695 697 O
Must 18 22 698 702 O
not 23 26 703 706 O
have 27 31 707 711 O
received 32 40 712 720 O
any 41 44 721 724 O
hematopoetic 45 57 725 737 B-treatment
growth 58 64 738 744 I-treatment
factors 65 72 745 752 I-treatment
within 73 79 753 759 O
7 80 81 760 761 B-upper_bound
days 82 86 762 766 I-upper_bound
of 87 89 767 769 O
study 90 95 770 775 O
entry 96 101 776 781 O

Known 0 5 782 787 O
history 6 13 788 795 O
of 14 16 796 798 O
, 16 17 798 799 O
or 18 20 800 802 O
positive 21 29 803 811 O
test 30 34 812 816 O
result 35 41 817 823 O
for 42 45 824 827 O
human 46 51 828 833 B-chronic_disease
immunodeficiency 52 68 834 850 I-chronic_disease
virus 69 74 851 856 I-chronic_disease
( 75 76 857 858 I-chronic_disease
HIV 76 79 858 861 I-chronic_disease
) 79 80 861 862 I-chronic_disease
infection 81 90 863 872 O

Measurable 0 10 873 883 O
is 11 13 884 886 O
defined 14 21 887 894 O
as 22 24 895 897 O
at 25 27 898 900 O
least 28 33 901 906 O
one 34 37 907 910 B-lower_bound
lesion 38 44 911 917 O
20 45 47 918 920 O
mm 48 50 921 923 O
in 51 53 924 926 O
at 54 56 927 929 O
least 57 62 930 935 O
one 63 66 936 939 O
dimension 67 76 940 949 O

Measurable 0 10 950 960 O
tumor 11 16 961 966 B-cancer
on 17 19 967 969 O
MRI 20 23 970 973 B-treatment
or 24 26 974 976 O
CT 27 29 977 979 B-treatment
scan 30 34 980 984 I-treatment

Organ 0 5 985 990 B-treatment
Transplant 6 16 991 1001 I-treatment
: 16 17 1001 1002 O
Patients 18 26 1003 1011 O
may 27 30 1012 1015 O
NOT 31 34 1016 1019 O
be 35 37 1020 1022 O
the 38 41 1023 1026 O
recipients 42 52 1027 1037 O
of 53 55 1038 1040 O
an 56 58 1041 1043 O
organ 59 64 1044 1049 B-treatment
transplant 65 75 1050 1060 I-treatment

Participation 0 13 1061 1074 O
in 14 16 1075 1077 O
any 17 20 1078 1081 O
other 21 26 1082 1087 O
investigational 27 42 1088 1103 B-treatment
treatment 43 52 1104 1113 I-treatment
within 53 59 1114 1120 O
the 60 63 1121 1124 O
6 64 65 1125 1126 B-upper_bound
weeks 66 71 1127 1132 I-upper_bound
prior 72 77 1133 1138 I-upper_bound
to 78 80 1139 1141 O
enrollment 81 91 1142 1152 O
or 92 94 1153 1155 O
concurrent 95 105 1156 1166 O
with 106 110 1167 1171 O
this 111 115 1172 1176 O
study 116 121 1177 1182 O

Patients 0 8 1183 1191 O
concurrently 9 21 1192 1204 O
taking 22 28 1205 1211 O
the 29 32 1212 1215 O
following 33 42 1216 1225 O
drugs 43 48 1226 1231 O
are 49 52 1232 1235 O
excluded 53 61 1236 1244 O
: 61 62 1244 1245 O
antioxidants 63 75 1246 1258 B-treatment
, 75 76 1258 1259 O
herbal 77 83 1260 1266 B-treatment
or 84 86 1267 1269 O
other 87 92 1270 1275 O
alternative 93 104 1276 1287 B-treatment
therapy 105 112 1288 1295 I-treatment
medications 113 124 1296 1307 I-treatment
, 124 125 1307 1308 O
vitamin 126 133 1309 1316 B-treatment
supplements 134 145 1317 1328 I-treatment
( 146 147 1329 1330 O
especially 147 157 1330 1340 O
vitamins 158 166 1341 1349 O
A 167 168 1350 1351 O
, 168 169 1351 1352 O
C 170 171 1353 1354 O
, 171 172 1354 1355 O
and 173 176 1356 1359 O
E 177 178 1360 1361 O
) 178 179 1361 1362 O
other 180 185 1363 1368 O
than 186 190 1369 1373 O
at 191 193 1374 1376 O
standard 194 202 1377 1385 O
multivitamin 203 215 1386 1398 O
doses 216 221 1399 1404 O
, 221 222 1404 1405 O
cyclosporine 223 235 1406 1418 B-treatment
A 236 237 1419 1420 I-treatment
or 238 240 1421 1423 O
analogue 241 249 1424 1432 B-treatment
; 249 250 1432 1433 O
verapamil 251 260 1434 1443 B-treatment
; 260 261 1443 1444 O
tamoxifen 262 271 1445 1454 B-treatment
or 272 274 1455 1457 O
analogue 275 283 1458 1466 O
, 283 284 1466 1467 O
ketoconazole 285 297 1468 1480 B-treatment
, 297 298 1480 1481 O
chlorpromazine 299 313 1482 1496 B-treatment
; 313 314 1496 1497 O
RU486 315 320 1498 1503 B-treatment
; 320 321 1503 1504 O
indomethacin 322 334 1505 1517 B-treatment
; 334 335 1517 1518 O
or 336 338 1519 1521 O
sulfinpyrazone 339 353 1522 1536 B-treatment
, 353 354 1536 1537 O
tetracycline 355 367 1538 1550 B-treatment
, 367 368 1550 1551 O
nalidixic 369 378 1552 1561 B-treatment
acid 379 383 1562 1566 I-treatment
, 383 384 1566 1567 O
nitrofurantoin 385 399 1568 1582 B-treatment
, 399 400 1582 1583 O
phenytoin 401 410 1584 1593 B-treatment
, 410 411 1593 1594 O
sulfonamides 412 424 1595 1607 B-treatment
, 424 425 1607 1608 O
lithium 426 433 1609 1616 B-treatment
, 433 434 1616 1617 O
and 435 438 1618 1621 O
amiodarone 439 449 1622 1632 B-treatment

Patients 0 8 1633 1641 O
must 9 13 1642 1646 O
have 14 18 1647 1651 O
otherwise 19 28 1652 1661 O
recovered 29 38 1662 1671 O
from 39 43 1672 1676 O
toxicities 44 54 1677 1687 B-chronic_disease
of 55 57 1688 1690 O
prior 58 63 1691 1696 B-treatment
therapy 64 71 1697 1704 I-treatment

Patients 0 8 1705 1713 O
must 9 13 1714 1718 O
not 14 17 1719 1722 O
have 18 22 1723 1727 O
received 23 31 1728 1736 O
small 32 37 1737 1742 O
field 38 43 1743 1748 O
( 44 45 1749 1750 O
focal 45 50 1750 1755 O
) 50 51 1755 1756 O
radiation 52 61 1757 1766 B-treatment
for 62 65 1767 1770 O
a 66 67 1771 1772 O
minimum 68 75 1773 1780 O
of 76 78 1781 1783 O
2 79 80 1784 1785 B-upper_bound
weeks 81 86 1786 1791 I-upper_bound
prior 87 92 1792 1797 I-upper_bound
to 93 95 1798 1800 O
study 96 101 1801 1806 O
entry 102 107 1807 1812 O

Patients 0 8 1813 1821 O
who 9 12 1822 1825 O
have 13 17 1826 1830 O
had 18 21 1831 1834 O
major 22 27 1835 1840 B-treatment
non 28 31 1841 1844 I-treatment
- 31 32 1844 1845 I-treatment
biopsy 32 38 1845 1851 I-treatment
surgery 39 46 1852 1859 I-treatment
in 47 49 1860 1862 O
the 50 53 1863 1866 O
last 54 58 1867 1871 B-upper_bound
20 59 61 1872 1874 I-upper_bound
days 62 66 1875 1879 I-upper_bound

Patients 0 8 1880 1888 O
who 9 12 1889 1892 O
have 13 17 1893 1897 O
received 18 26 1898 1906 O
chemotherapy 27 39 1907 1919 B-treatment
within 40 46 1920 1926 O
3 47 48 1927 1928 B-upper_bound
weeks 49 54 1929 1934 I-upper_bound
of 55 57 1935 1937 O
first 58 63 1938 1943 O
fenretinide 64 75 1944 1955 B-treatment
treatment 76 85 1956 1965 I-treatment

Patients 0 8 1966 1974 O
who 9 12 1975 1978 O
have 13 17 1979 1983 O
uncontrolled 18 30 1984 1996 O
systemic 31 39 1997 2005 B-chronic_disease
infections 40 50 2006 2016 I-chronic_disease

Patients 0 8 2017 2025 O
with 9 13 2026 2030 O
an 14 16 2031 2033 O
ECOG 17 21 2034 2038 B-clinical_variable
performance 22 33 2039 2050 I-clinical_variable
status 34 40 2051 2057 I-clinical_variable
of 41 43 2058 2060 O
0 44 45 2061 2062 B-lower_bound
, 45 46 2062 2063 O
1 47 48 2064 2065 O
, 48 49 2065 2066 O
or 50 52 2067 2069 O
2 53 54 2070 2071 B-upper_bound
, 54 55 2071 2072 O
and 56 59 2073 2076 O
estimated 60 69 2077 2086 O
survival 70 78 2087 2095 O
of 79 81 2096 2098 O
> 82 83 2099 2100 O
12 84 86 2101 2103 B-lower_bound
weeks 87 92 2104 2109 I-lower_bound

Patients 0 8 2110 2118 O
with 9 13 2119 2123 O
an 14 16 2124 2126 O
identified 17 27 2127 2137 O
familial 28 36 2138 2146 B-chronic_disease
hyperlipidemia 37 51 2147 2161 I-chronic_disease
disorder 52 60 2162 2170 I-chronic_disease

Patients 0 8 2171 2179 O
with 9 13 2180 2184 O
any 14 17 2185 2188 O
active 18 24 2189 2195 O
hepatitis 25 34 2196 2205 B-chronic_disease
infections 35 45 2206 2216 I-chronic_disease

Patients 0 8 2217 2225 O
with 9 13 2226 2230 O
documented 14 24 2231 2241 O
allergy 25 32 2242 2249 O
to 33 35 2250 2252 O
egg 36 39 2253 2256 B-allergy_name
products 40 48 2257 2265 I-allergy_name

Patients 0 8 2266 2274 O
with 9 13 2275 2279 O
documented 14 24 2280 2290 O
allergy 25 32 2291 2298 O
to 33 35 2299 2301 O
soy 36 39 2302 2305 B-allergy_name
products 40 48 2306 2314 I-allergy_name

Patients 0 8 2315 2323 O
with 9 13 2324 2328 O
fasting 14 21 2329 2336 B-clinical_variable
serum 22 27 2337 2342 I-clinical_variable
triglycerides 28 41 2343 2356 I-clinical_variable
> 42 43 2357 2358 O
300 44 47 2359 2362 B-lower_bound
and/or 48 54 2363 2369 O
with 55 59 2370 2374 O
hypertriglyceridemia 60 80 2375 2395 B-chronic_disease
requiring 81 90 2396 2405 O
medication 91 101 2406 2416 B-treatment

Patients 0 8 2417 2425 O
with 9 13 2426 2430 O
poorly 14 20 2431 2437 O
controlled 21 31 2438 2448 O
diabetes 32 40 2449 2457 B-chronic_disease
mellitus 41 49 2458 2466 I-chronic_disease
with 50 54 2467 2471 O
fasting 55 62 2472 2479 B-clinical_variable
serum 63 68 2480 2485 I-clinical_variable
glucose 69 76 2486 2493 I-clinical_variable
concentration 77 90 2494 2507 I-clinical_variable
over 91 95 2508 2512 O
200 96 99 2513 2516 B-lower_bound
mg 100 102 2517 2519 I-lower_bound
/ 102 103 2519 2520 I-lower_bound
dl 103 105 2520 2522 I-lower_bound
or 106 108 2523 2525 O
a 109 110 2526 2527 O
hemoglobin 111 121 2528 2538 B-clinical_variable
A1C 122 125 2539 2542 I-clinical_variable
over 126 130 2543 2547 O
7.5 131 134 2548 2551 B-lower_bound
% 134 135 2551 2552 I-lower_bound

Patients 0 8 2553 2561 O
with 9 13 2562 2566 O
previously 14 24 2567 2577 O
treated 25 32 2578 2585 O
leptomeningeal 33 47 2586 2600 B-cancer
disease 48 55 2601 2608 I-cancer
or 56 58 2609 2611 O
brain 59 64 2612 2617 B-cancer
metastases 65 75 2618 2628 I-cancer
without 76 83 2629 2636 O
evidence 84 92 2637 2645 O
of 93 95 2646 2648 O
remaining 96 105 2649 2658 O
tumor 106 111 2659 2664 B-cancer
by 112 114 2665 2667 O
PET 115 118 2668 2671 B-treatment
, 118 119 2671 2672 O
MRI 120 123 2673 2676 B-treatment
scan 124 128 2677 2681 I-treatment
, 128 129 2681 2682 O
or 130 132 2683 2685 O
spinal 133 139 2686 2692 O
fluid 140 145 2693 2698 O

Patients 0 8 2699 2707 O
with 9 13 2708 2712 O
uncontrolled 14 26 2713 2725 O
hypertension 27 39 2726 2738 B-chronic_disease

Who 0 3 2739 2742 O
have 4 8 2743 2747 O
active 9 15 2748 2754 O
CNS 16 19 2755 2758 B-chronic_disease
disease 20 27 2759 2766 I-chronic_disease
or 28 30 2767 2769 O
a 31 32 2770 2771 O
history 33 40 2772 2779 O
of 41 43 2780 2782 O
cranial 44 51 2783 2790 B-treatment
irradiation 52 63 2791 2802 I-treatment
are 64 67 2803 2806 O
excluded 68 76 2807 2815 O
due 77 80 2816 2819 O
to 81 83 2820 2822 O
concerns 84 92 2823 2831 O
regarding 93 102 2832 2841 O
toxicity 103 111 2842 2850 O
attribution 112 123 2851 2862 O

Women 0 5 2863 2868 B-gender
who 6 9 2869 2872 O
are 10 13 2873 2876 B-pregnancy
pregnant 14 22 2877 2885 I-pregnancy

coagulation 0 11 2886 2897 B-chronic_disease
disorders 12 21 2898 2907 I-chronic_disease

for 0 3 2908 2911 O
spiral 4 10 2912 2918 B-treatment
CT 11 13 2919 2921 I-treatment
, 13 14 2921 2922 O
measurable 15 25 2923 2933 O
is 26 28 2934 2936 O
defined 29 36 2937 2944 O
as 37 39 2945 2947 O
10 40 42 2948 2950 O
mm 43 45 2951 2953 O
in 46 48 2954 2956 O
at 49 51 2957 2959 O
least 52 57 2960 2965 O
one 58 61 2966 2969 B-lower_bound
dimension 62 71 2970 2979 O

other 0 5 2980 2985 O
major 6 11 2986 2991 B-chronic_disease
medical 12 19 2992 2999 I-chronic_disease
illnesses 20 29 3000 3009 I-chronic_disease
of 30 32 3010 3012 I-chronic_disease
the 33 36 3013 3016 I-chronic_disease
cardiovascular 37 51 3017 3031 I-chronic_disease
or 52 54 3032 3034 O
respiratory 55 66 3035 3046 B-chronic_disease
systems 67 74 3047 3054 I-chronic_disease

patient 0 7 3055 3062 O
who 8 11 3063 3066 O
tested 12 18 3067 3073 O
positive 19 27 3074 3082 O
subsequent 28 38 3083 3093 O
to 39 41 3094 3096 O
their 42 47 3097 3102 O
last 48 52 3103 3107 O
treatment 53 62 3108 3117 B-treatment
regimen 63 70 3118 3125 O

patients 0 8 3126 3134 O
currently 9 18 3135 3144 O
taking 19 25 3145 3151 O
steroids 26 34 3152 3160 B-treatment
as 35 37 3161 3163 O
prophylaxis 38 49 3164 3175 O
against 50 57 3176 3183 O
seizures 58 66 3184 3192 B-chronic_disease

patients 0 8 3193 3201 O
must 9 13 3202 3206 O
have 14 18 3207 3211 O
fully 19 24 3212 3217 O
recovered 25 34 3218 3227 O
from 35 39 3228 3232 O
the 40 43 3233 3236 O
acute 44 49 3237 3242 O
toxic 50 55 3243 3248 O
effects 56 63 3249 3256 O
of 64 66 3257 3259 O
all 67 70 3260 3263 O
prior 71 76 3264 3269 B-treatment
chemotherapy 77 89 3270 3282 I-treatment
, 89 90 3282 3283 O
immunotherapy 91 104 3284 3297 B-treatment
, 104 105 3297 3298 O
or 106 108 3299 3301 O
radiotherapy 109 121 3302 3314 B-treatment
prior 122 127 3315 3320 I-treatment
to 128 130 3321 3323 O
entering 131 139 3324 3332 O
this 140 144 3333 3337 O
study 145 150 3338 3343 O

patients 0 8 3344 3352 O
who 9 12 3353 3356 O
had 13 16 3357 3360 O
a 17 18 3361 3362 O
negative 19 27 3363 3371 O
marrow 28 34 3372 3378 O
within 35 41 3379 3385 O
three 42 47 3386 3391 B-upper_bound
months 48 54 3392 3398 I-upper_bound
of 55 57 3399 3401 O
study 58 63 3402 3407 O
entry 64 69 3408 3413 O

patients 0 8 3414 3422 O
with 9 13 3423 3427 O
hypercholesterolemia 14 34 3428 3448 B-chronic_disease
with 35 39 3449 3453 O
or 40 42 3454 3456 O
without 43 50 3457 3464 O
medication 51 61 3465 3475 B-treatment

who 0 3 3476 3479 O
have 4 8 3480 3484 O
received 9 17 3485 3493 O
investigational 18 33 3494 3509 B-treatment
drugs 34 39 3510 3515 I-treatment
within 40 46 3516 3522 O
6 47 48 3523 3524 B-upper_bound
weeks 49 54 3525 3530 I-upper_bound
of 55 57 3531 3533 O
first 58 63 3534 3539 O
fenretinide 64 75 3540 3551 B-treatment
treatment 76 85 3552 3561 I-treatment

with 0 4 3562 3566 O
histologically 5 19 3567 3581 O
or 20 22 3582 3584 O
cytologically 23 36 3585 3598 O
confirmed 37 46 3599 3608 O
Peripheral 47 57 3609 3619 B-cancer
T 58 59 3620 3621 I-cancer
- 59 60 3621 3622 I-cancer
cell 60 64 3622 3626 I-cancer
lymphoma 65 73 3627 3635 I-cancer
( 74 75 3636 3637 I-cancer
PTCL 75 79 3637 3641 I-cancer
) 79 80 3641 3642 I-cancer

ANC 0 3 0 3 B-clinical_variable
< 4 5 4 5 O
1000 5 9 5 9 B-upper_bound
/ 9 10 9 10 I-upper_bound
mm3 10 13 10 13 I-upper_bound

Active 0 6 14 20 O
fistula 7 14 21 28 B-chronic_disease

Clinical 0 8 29 37 O
and 9 12 38 41 O
microbiologic 13 26 42 55 O
relapse 27 34 56 63 O
of 35 37 64 66 O
C. 38 40 67 69 O
difficile 41 50 70 79 O
associated 51 61 80 90 O
diarrhea 62 70 91 99 B-chronic_disease
after 71 76 100 105 O
at 77 79 106 108 O
least 80 85 109 114 O
one 86 89 115 118 B-lower_bound
course 90 96 119 125 O
of 97 99 126 128 O
adequate 100 108 129 137 O
antibiotic 109 119 138 148 B-treatment
therapy 120 127 149 156 I-treatment
or 128 130 157 159 O
refractory 131 141 160 170 B-cancer
disease 142 149 171 178 O
that 150 154 179 183 O
does 155 159 184 188 O
not 160 163 189 192 O
respond 164 171 193 200 O
to 172 174 201 203 O
treatment 175 184 204 213 O

Contraindications 0 17 214 231 O
to 18 20 232 234 O
anesthesia 21 31 235 245 B-allergy_name
for 32 35 246 249 O
procedure 36 45 250 259 O

Gastrointestinal 0 16 260 276 B-chronic_disease
( 17 18 277 278 I-chronic_disease
GI 18 20 278 280 I-chronic_disease
) 20 21 280 281 I-chronic_disease
contraindications 22 39 282 299 O

Gastroparesis 0 13 300 313 B-chronic_disease

HGB 0 3 314 317 B-clinical_variable
< 4 5 318 319 O
8 5 6 319 320 B-upper_bound
g 7 8 321 322 I-upper_bound
/ 8 9 322 323 I-upper_bound
dL 9 11 323 325 I-upper_bound

HIV 0 3 326 329 B-chronic_disease
infection 4 13 330 339 O
with 14 18 340 344 O
CD4 19 22 345 348 B-clinical_variable
count 23 28 349 354 I-clinical_variable
< 29 30 355 356 O
240 30 33 356 359 B-upper_bound

Hematologic 0 11 360 371 B-cancer
malignancy 12 22 372 382 I-cancer

History 0 7 383 390 O
of 8 10 391 393 O
hematopoietic 11 24 394 407 B-treatment
stem 25 29 408 412 I-treatment
cell 30 34 413 417 I-treatment
transplant 35 45 418 428 I-treatment
( 46 47 429 430 I-treatment
HSCT 47 51 430 434 I-treatment
) 51 52 434 435 I-treatment

Ileus 0 5 436 441 B-chronic_disease

Inflammatory 0 12 442 454 B-chronic_disease
bowel 13 18 455 460 I-chronic_disease
disease 19 26 461 468 I-chronic_disease

Life 0 4 469 473 B-clinical_variable
expectancy 5 15 474 484 I-clinical_variable
of 16 18 485 487 O
> 19 20 488 489 O
3 20 21 489 490 B-lower_bound
months 22 28 491 497 I-lower_bound

PLT 0 3 498 501 B-clinical_variable
< 4 5 502 503 O
50,000 5 11 503 509 B-upper_bound
K 12 13 510 511 I-upper_bound
/ 13 14 511 512 I-upper_bound
mcL 14 17 512 515 I-upper_bound

Patients 0 8 516 524 O
with 9 13 525 529 O
solid 14 19 530 535 B-cancer
organ 20 25 536 541 I-cancer
malignancy 26 36 542 552 I-cancer
who 37 40 553 556 O
have 41 45 557 561 O
received 46 54 562 570 O
chemotherapy 55 67 571 583 B-treatment
within 68 74 584 590 O
the 75 78 591 594 O
past 79 83 595 599 B-upper_bound
six 84 87 600 603 I-upper_bound
months 88 94 604 610 I-upper_bound

Serious 0 7 611 618 O
cardiopulmonary 8 23 619 634 B-chronic_disease
comorbidities 24 37 635 648 I-chronic_disease

Small 0 5 649 654 B-chronic_disease
bowel 6 11 655 660 I-chronic_disease
obstruction 12 23 661 672 I-chronic_disease

≥18 0 3 673 676 O
years 4 9 677 682 I-lower_bound
old 10 13 683 686 O

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 6 7 6 7 O
75 7 9 7 9 B-upper_bound
years 10 15 10 15 I-upper_bound

BMI 0 3 16 19 B-bmi
20 4 6 20 22 B-lower_bound
- 6 7 22 23 O
40 7 9 23 25 B-upper_bound
kg 10 12 26 28 I-upper_bound
/ 12 13 28 29 I-upper_bound
m2 13 15 29 31 I-upper_bound

Coronary 0 8 32 40 O
event 9 14 41 46 O
or 15 17 47 49 O
procedure 18 27 50 59 O
( 28 29 60 61 O
myocardial 29 39 61 71 B-chronic_disease
infarction 40 50 72 82 I-chronic_disease
, 50 51 82 83 O
unstable 52 60 84 92 B-chronic_disease
angina 61 67 93 99 I-chronic_disease
, 67 68 99 100 O
coronary 69 77 101 109 B-treatment
artery 78 84 110 116 I-treatment
bypass 85 91 117 123 I-treatment
, 91 92 123 124 O
surgery 93 100 125 132 B-treatment
or 101 103 133 135 O
coronary 104 112 136 144 B-treatment
angioplasty 113 124 145 156 I-treatment
) 124 125 156 157 O
in 126 128 158 160 O
the 129 132 161 164 O
previous 133 141 165 173 B-upper_bound
four 142 146 174 178 I-upper_bound
weeks 147 152 179 184 I-upper_bound

HIV 0 3 185 188 B-chronic_disease
or 4 6 189 191 O
Hepatitis 7 16 192 201 B-chronic_disease
B 17 18 202 203 I-chronic_disease
or 19 21 204 206 I-chronic_disease
C 22 23 207 208 I-chronic_disease
positive 24 32 209 217 O
status 33 39 218 224 O

HbA1c 0 5 225 230 B-clinical_variable
of 6 8 231 233 O
less 9 13 234 238 O
than 14 18 239 243 O
8.5 19 22 244 247 B-upper_bound
% 22 23 247 248 I-upper_bound

Hepatic 0 7 249 256 B-chronic_disease
disease 8 15 257 264 I-chronic_disease
( 16 17 265 266 O
transaminase 17 29 266 278 B-clinical_variable
> 30 31 279 280 O
3 32 33 281 282 B-lower_bound
times 34 39 283 288 I-lower_bound
normal 40 46 289 295 I-lower_bound
) 46 47 295 296 O
or 48 50 297 299 O
cirrhosis 51 60 300 309 B-chronic_disease

Renal 0 5 310 315 B-chronic_disease
impairment 6 16 316 326 I-chronic_disease
( 17 18 327 328 O
serum 18 23 328 333 B-clinical_variable
eGFR 24 28 334 338 I-clinical_variable
< 29 30 339 340 O
30ml 31 35 341 345 B-upper_bound
/ 35 36 345 346 I-upper_bound
min/1.73m2 36 46 346 356 I-upper_bound
) 46 47 356 357 O

Type 0 4 358 362 B-chronic_disease
1 5 6 363 364 I-chronic_disease
Diabetes 7 15 365 373 I-chronic_disease
on 16 18 374 376 O
continuous 19 29 377 387 O
subcutaneous 30 42 388 400 O
insulin 43 50 401 408 B-treatment
infusion 51 59 409 417 I-treatment
( 60 61 418 419 O
CSII 61 65 419 423 O
; 65 66 423 424 O
also 67 71 425 429 O
known 72 77 430 435 O
as 78 80 436 438 O
insulin 81 88 439 446 B-treatment
pump 89 93 447 451 I-treatment
) 93 94 451 452 O

Type 0 4 453 457 B-chronic_disease
1 5 6 458 459 I-chronic_disease
diabetes 7 15 460 468 I-chronic_disease
for 16 19 469 472 O
less 20 24 473 477 O
than 25 29 478 482 O
6 30 31 483 484 B-upper_bound
months 32 38 485 491 I-upper_bound

Use 0 3 492 495 O
of 4 6 496 498 O
an 7 9 499 501 O
investigational 10 25 502 517 O
agent 26 31 518 523 O
or 32 34 524 526 O
therapeutic 35 46 527 538 O
regimen 47 54 539 546 O
within 55 61 547 553 O
30 62 64 554 556 B-upper_bound
days 65 69 557 561 I-upper_bound
of 70 72 562 564 O
study 73 78 565 570 O

history 0 7 571 578 O
of 8 10 579 581 O
gastroparesis 11 24 582 595 B-chronic_disease

history 0 7 596 603 O
of 8 10 604 606 O
medullary 11 20 607 616 B-chronic_disease
thyroid 21 28 617 624 I-chronic_disease
carcinoma 29 38 625 634 I-chronic_disease
or 39 41 635 637 O
MEN 42 45 638 641 B-chronic_disease
2 46 47 642 643 I-chronic_disease
syndrome 48 56 644 652 I-chronic_disease

history 0 7 653 660 O
of 8 10 661 663 O
pancreatitis 11 23 664 676 B-chronic_disease

multiple 0 8 677 685 O
( 9 10 686 687 O
four 10 14 687 691 O
or 15 17 692 694 O
more 18 22 695 699 O
) 22 23 699 700 O
injections 24 34 701 711 O
of 35 37 712 714 O
insulin 38 45 715 722 B-treatment
per 46 49 723 726 O
day 50 53 727 730 O

non 0 3 731 734 B-chronic_disease
- 3 4 734 735 I-chronic_disease
cardiac 4 11 735 742 I-chronic_disease
disease 12 19 743 750 I-chronic_disease

pregnancy 0 9 751 760 B-pregnancy

Absence 0 7 0 7 O
of 8 10 8 10 O
a 11 12 11 12 O
diagnosis 13 22 13 22 O
of 23 25 23 25 O
WHIMS 26 31 26 31 B-chronic_disease

Absence 0 7 32 39 O
of 8 10 40 42 O
a 11 12 43 44 O
documented 13 23 45 55 O
history 24 31 56 63 O
of 32 34 64 66 O
severe 35 41 67 73 O
infection 42 51 74 83 B-chronic_disease

Clinical 0 8 84 92 O
diagnosis 9 18 93 102 O
of 19 21 103 105 O
WHIMS 22 27 106 111 B-chronic_disease
and 28 31 112 115 O
documented 32 42 116 126 O
severe 43 49 127 133 O
infection 50 59 134 143 B-chronic_disease

Condoms 0 7 144 151 B-contraception_consent
, 7 8 151 152 O
male 9 13 153 157 B-gender
or 14 16 158 160 I-gender
female 17 23 161 167 I-gender
, 23 24 167 168 O
with 25 29 169 173 O
or 30 32 174 176 O
without 33 40 177 184 O
a 41 42 185 186 O
spermicide 43 53 187 197 O

Contraceptive 0 13 198 211 B-contraception_consent
pills 14 19 212 217 I-contraception_consent
or 20 22 218 220 I-contraception_consent
patch 23 28 221 226 I-contraception_consent
, 28 29 226 227 O
Norplant 30 38 228 236 B-contraception_consent
, 38 39 236 237 O
Depo 40 44 238 242 B-contraception_consent
- 44 45 242 243 I-contraception_consent
Provera 45 52 243 250 I-contraception_consent
or 53 55 251 253 O
other 56 61 254 259 O
FDA 62 65 260 263 B-contraception_consent
- 65 66 263 264 I-contraception_consent
approved 66 74 264 272 I-contraception_consent
contraceptive 75 88 273 286 I-contraception_consent
method 89 95 287 293 I-contraception_consent

History 0 7 294 301 O
of 8 10 302 304 O
serious 11 18 305 312 O
cardiac 19 26 313 320 B-chronic_disease
arrhythmia 27 37 321 331 I-chronic_disease
or 38 40 332 334 O
cardiac 41 48 335 342 B-chronic_disease
defects 49 56 343 350 I-chronic_disease
that 57 61 351 355 O
make 62 66 356 360 O
such 67 71 361 365 O
more 72 76 366 370 O
likely 77 83 371 377 O

Male 0 4 378 382 B-gender
partner 5 12 383 390 O
has 13 16 391 394 O
previously 17 27 395 405 O
undergone 28 37 406 415 O
a 38 39 416 417 O
vasectomy 40 49 418 427 B-treatment
for 50 53 428 431 O
which 54 59 432 437 O
there 60 65 438 443 O
is 66 68 444 446 O
documentation 69 82 447 460 O
of 83 85 461 463 O
aspermatogenic 86 100 464 478 O
sterility 101 110 479 488 O

Must 0 4 489 493 O
not 5 8 494 497 O
be 9 11 498 500 O
pregnant 12 20 501 509 B-pregnancy
or 21 23 510 512 O
breastfeeding 24 37 513 526 O

Neutropenia 0 11 527 538 B-chronic_disease
due 12 15 539 542 O
to 16 18 543 545 O
maturation 19 29 546 556 O
defects 30 37 557 564 O
in 38 40 565 567 O
the 41 44 568 571 O
myeloid 45 52 572 579 B-chronic_disease
lineage 53 60 580 587 I-chronic_disease
or 61 63 588 590 O
that 64 68 591 595 O
the 69 72 596 599 O
PI 73 75 600 602 O
feels 76 81 603 608 O
is 82 84 609 611 O
unlikely 85 93 612 620 O
to 94 96 621 623 O
benefit 97 104 624 631 O
from 105 109 632 636 O
this 110 114 637 641 O
medication 115 125 642 652 O

Patient 0 7 653 660 O
is 8 10 661 663 O
less 11 15 664 668 O
than 16 20 669 673 O
18 21 23 674 676 B-upper_bound
years 24 29 677 682 I-upper_bound
old 30 33 683 686 O

Pregnant 0 8 687 695 B-pregnancy
women 9 14 696 701 B-gender
or 15 17 702 704 O
breastfeeding 18 31 705 718 O

Renal 0 5 719 724 B-chronic_disease
failure 6 13 725 732 I-chronic_disease
( 14 15 733 734 O
calculated 15 25 734 744 O
creatinine 26 36 745 755 B-clinical_variable
clearance 37 46 756 765 I-clinical_variable
[ 47 48 766 767 I-clinical_variable
CrCl 48 52 767 771 I-clinical_variable
] 52 53 771 772 I-clinical_variable
< 54 55 773 774 O
15 55 57 774 776 B-upper_bound
mL 58 60 777 779 I-upper_bound
/ 60 61 779 780 I-upper_bound
min 61 64 780 783 I-upper_bound
or 65 67 784 786 O
requiring 68 77 787 796 O
dialysis 78 86 797 805 O
) 86 87 805 806 O

Signs 0 5 807 812 O
or 6 8 813 815 O
symptoms 9 17 816 824 O
of 18 20 825 827 O
active 21 27 828 834 O
microbial 28 37 835 844 B-chronic_disease
infection 38 47 845 854 I-chronic_disease

Subjects 0 8 855 863 O
must 9 13 864 868 O
agree 14 19 869 874 O
not 20 23 875 878 B-pregnancy
to 24 26 879 881 I-pregnancy
become 27 33 882 888 I-pregnancy
pregnant 34 42 889 897 I-pregnancy
or 43 45 898 900 O
to 46 48 901 903 O
impregnate 49 59 904 914 O
a 60 61 915 916 O
female 62 68 917 923 B-gender

Willingness 0 11 924 935 O
to 12 14 936 938 O
interrupt 15 24 939 948 O
medications 25 36 949 960 O
to 37 39 961 963 O
raise 40 45 964 969 O
the 46 49 970 973 O
white 50 55 974 979 B-clinical_variable
count 56 61 980 985 I-clinical_variable
( 62 63 986 987 I-clinical_variable
WBC 63 66 987 990 I-clinical_variable
) 66 67 990 991 I-clinical_variable
such 68 72 992 996 O
as 73 75 997 999 O
G 76 77 1000 1001 B-clinical_variable
- 77 78 1001 1002 I-clinical_variable
CSF 78 81 1002 1005 I-clinical_variable
or 82 84 1006 1008 O
GM 85 87 1009 1011 B-clinical_variable
- 87 88 1011 1012 I-clinical_variable
CSF 88 91 1012 1015 I-clinical_variable
for 92 95 1016 1019 O
at 96 98 1020 1022 O
least 99 104 1023 1028 O
1 105 106 1029 1030 B-lower_bound
week 107 111 1031 1035 I-lower_bound
before 112 118 1036 1042 O
and 119 122 1043 1046 O
while 123 128 1047 1052 O
on 129 131 1053 1055 O
the 132 135 1056 1059 O
study 136 141 1060 1065 B-treatment
drug 142 146 1066 1070 I-treatment

greater 0 7 1071 1078 O
than 8 12 1079 1083 O
or 13 15 1084 1086 O
equal 16 21 1087 1092 O
to 22 24 1093 1095 O
18 25 27 1096 1098 B-lower_bound
and 28 31 1099 1102 O
less 32 36 1103 1107 O
than 37 41 1108 1112 O
or 42 44 1113 1115 O
equal 45 50 1116 1121 O
to 51 53 1122 1124 O
75 54 56 1125 1127 B-upper_bound
years 57 62 1128 1133 I-upper_bound
of 63 65 1134 1136 O
age 66 69 1137 1140 B-age

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Can 0 3 15 18 O
be 4 6 19 21 O
previously 7 17 22 32 O
treated 18 25 33 40 O
with 26 30 41 45 O
Depo 31 35 46 50 B-treatment
- 35 36 50 51 I-treatment
Lupron 36 42 51 57 I-treatment
, 42 43 57 58 O
Depo 44 48 59 63 B-treatment
- 48 49 63 64 I-treatment
Provera 49 56 64 71 I-treatment
, 56 57 71 72 O
Oral 58 62 73 77 B-treatment
Contraceptive 63 76 78 91 I-treatment
pills 77 82 92 97 I-treatment
, 82 83 97 98 O
Mirena 84 90 99 105 B-treatment
IUD 91 94 106 109 I-treatment
, 94 95 109 110 O
endometrial 96 107 111 122 B-treatment
ablation 108 116 123 131 I-treatment
, 116 117 131 132 O
myomectomy 118 128 133 143 B-treatment
, 128 129 143 144 O
oral 130 134 145 149 B-treatment
progestins 135 145 150 160 I-treatment

History 0 7 161 168 O
of 8 10 169 171 O
allergic 11 19 172 180 O
reactions 20 29 181 190 O
attributed 30 40 191 201 O
to 41 43 202 204 O
compounds 44 53 205 214 O
of 54 56 215 217 O
similar 57 64 218 225 O
chemical 65 73 226 234 O
or 74 76 235 237 O
biologic 77 85 238 246 O
composition 86 97 247 258 O
to 98 100 259 261 O
tranexamic 101 111 262 272 B-allergy_name
acid 112 116 273 277 I-allergy_name

Patients 0 8 278 286 O
currently 9 18 287 296 O
undergoing 19 29 297 307 O
treatment 30 39 308 317 O
for 40 43 318 321 O
any 44 47 322 325 O
type 48 52 326 330 O
of 53 55 331 333 O
cancer 56 62 334 340 B-cancer

Patients 0 8 341 349 O
presenting 9 19 350 360 O
for 20 23 361 364 O
hysterectomy 24 36 365 377 B-treatment
for 37 40 378 381 O
any 41 44 382 385 O
benign 45 51 386 392 O
indication 52 62 393 403 O
including 63 72 404 413 O
but 73 76 414 417 O
not 77 80 418 421 O
limited 81 88 422 429 O
to 89 91 430 432 O
abnormal 92 100 433 441 O
uterine 101 108 442 449 B-chronic_disease
bleeding 109 117 450 458 I-chronic_disease
, 117 118 458 459 O
menorrhagia 119 130 460 471 B-chronic_disease
, 130 131 471 472 O
uterine 132 139 473 480 B-chronic_disease
fibroids 140 148 481 489 I-chronic_disease
, 148 149 489 490 O
adenomyosis 150 161 491 502 B-chronic_disease
, 161 162 502 503 O
pelvic 163 169 504 510 B-chronic_disease
pain 170 174 511 515 I-chronic_disease
, 174 175 515 516 O
dysmenorrhea 176 188 517 529 B-chronic_disease
, 188 189 529 530 O
pelvic 190 196 531 537 B-chronic_disease
organ 197 202 538 543 I-chronic_disease
prolapse 203 211 544 552 I-chronic_disease
or 212 214 553 555 O
endometriosis 215 228 556 569 B-chronic_disease

Patients 0 8 570 578 O
undergoing 9 19 579 589 O
hysterectomy 20 32 590 602 B-treatment
for 33 36 603 606 O
endometrial 37 48 607 618 B-chronic_disease
hyperplasia 49 60 619 630 I-chronic_disease
or 61 63 631 633 O
cervical 64 72 634 642 B-chronic_disease
dysplasia 73 82 643 652 I-chronic_disease

Patients 0 8 653 661 O
with 9 13 662 666 O
known 14 19 667 672 O
bleeding 20 28 673 681 B-chronic_disease
/ 28 29 681 682 I-chronic_disease
clotting 29 37 682 690 I-chronic_disease
disorders 38 47 691 700 I-chronic_disease
or 48 50 701 703 O
a 51 52 704 705 O
history 53 60 706 713 O
of 61 63 714 716 O
thromboembolism 64 79 717 732 B-chronic_disease
( 80 81 733 734 O
including 81 90 734 743 O
deep 91 95 744 748 B-chronic_disease
venous 96 102 749 755 I-chronic_disease
thrombosis 103 113 756 766 I-chronic_disease
or 114 116 767 769 O
pulmonary 117 126 770 779 B-chronic_disease
embolism 127 135 780 788 I-chronic_disease
) 135 136 788 789 O

Patients 0 8 790 798 O
with 9 13 799 803 O
known 14 19 804 809 O
or 20 22 810 812 O
suspected 23 32 813 822 O
endometrial 33 44 823 834 B-cancer
/ 44 45 834 835 I-cancer
ovarian 45 52 835 842 I-cancer
/ 52 53 842 843 I-cancer
cervical 53 61 843 851 I-cancer
cancer 62 68 852 858 I-cancer

Patients 0 8 859 867 O
with 9 13 868 872 O
known 14 19 873 878 O
renal 20 25 879 884 B-chronic_disease
failure 26 33 885 892 I-chronic_disease
and/or 34 40 893 899 O
Cr 41 43 900 902 B-clinical_variable
> 44 45 903 904 O
5 46 47 905 906 B-lower_bound
within 48 54 907 913 O
the 55 58 914 917 O
last 59 63 918 922 B-upper_bound
6 64 65 923 924 I-upper_bound
months 66 72 925 931 I-upper_bound

Pre 0 3 932 935 B-clinical_variable
- 3 4 935 936 I-clinical_variable
operative 4 13 936 945 I-clinical_variable
hemoglobin 14 24 946 956 I-clinical_variable
> 25 26 957 958 O
8 26 27 958 959 B-lower_bound
g 28 29 960 961 I-lower_bound
/ 29 30 961 962 I-lower_bound
dl 30 32 962 964 I-lower_bound

Uncontrolled 0 12 965 977 O
current 13 20 978 985 O
illness 21 28 986 993 O
including 29 38 994 1003 O
, 38 39 1003 1004 O
but 40 43 1005 1008 O
not 44 47 1009 1012 O
limited 48 55 1013 1020 O
to 56 58 1021 1023 O
, 58 59 1023 1024 O
ongoing 60 67 1025 1032 O
or 68 70 1033 1035 O
active 71 77 1036 1042 B-chronic_disease
infection 78 87 1043 1052 I-chronic_disease
, 87 88 1052 1053 O
symptomatic 89 100 1054 1065 O
congestive 101 111 1066 1076 B-chronic_disease
heart 112 117 1077 1082 I-chronic_disease
failure 118 125 1083 1090 I-chronic_disease
, 125 126 1090 1091 O
subarachnoid 127 139 1092 1104 B-chronic_disease
hemorrhage 140 150 1105 1115 I-chronic_disease
, 150 151 1115 1116 O
unstable 152 160 1117 1125 B-chronic_disease
angina 161 167 1126 1132 I-chronic_disease
pectoris 168 176 1133 1141 I-chronic_disease
, 176 177 1141 1142 O
cardiac 178 185 1143 1150 B-chronic_disease
arrhythmia 186 196 1151 1161 I-chronic_disease
, 196 197 1161 1162 O
or 198 200 1163 1165 O
psychiatric 201 212 1166 1177 B-chronic_disease
illness 213 220 1178 1185 I-chronic_disease
/ 220 221 1185 1186 O
social 221 227 1186 1192 O
situations 228 238 1193 1203 O
that 239 243 1204 1208 O
would 244 249 1209 1214 O
limit 250 255 1215 1220 O
compliance 256 266 1221 1231 O
with 267 271 1232 1236 O
study 272 277 1237 1242 O
requirements 278 290 1243 1255 O

Willing 0 7 1256 1263 O
to 8 10 1264 1266 O
have 11 15 1267 1271 O
IV 16 18 1272 1274 B-treatment
tranexamic 19 29 1275 1285 I-treatment
acid 30 34 1286 1290 I-treatment
or 35 37 1291 1293 O
a 38 39 1294 1295 O
placebo 40 47 1296 1303 B-treatment
prior 48 53 1304 1309 O
to 54 56 1310 1312 O
hysterectomy 57 69 1313 1325 B-treatment

5 0 1 0 1 B-lower_bound
- 1 2 1 2 O
21 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Females 0 7 18 25 B-gender
with 8 12 26 30 O
a 13 14 31 32 O
positive 15 23 33 41 B-pregnancy
urine 24 29 42 47 I-pregnancy
pregnancy 30 39 48 57 I-pregnancy
test 40 44 58 62 O

Subject 0 7 63 70 O
is 8 10 71 73 O
eligible 11 19 74 82 O
for 20 23 83 86 O
routine 24 31 87 94 B-treatment
chemotherapy 32 44 95 107 I-treatment
and 45 48 108 111 O
routine 49 56 112 119 B-treatment
surgery 57 64 120 127 I-treatment
for 65 68 128 131 O
the 69 72 132 135 O
treatment 73 82 136 145 B-treatment
of 83 85 146 148 O
non 86 89 149 152 B-cancer
- 89 90 152 153 I-cancer
metastatic 90 100 153 163 I-cancer
extremity 101 110 164 173 I-cancer
osteosarcoma 111 123 174 186 I-cancer

Capable 0 7 0 7 O
and 8 11 8 11 O
willing 12 19 12 19 O
to 20 22 20 22 O
record 23 29 23 29 O
symptom 30 37 30 37 O
data 38 42 38 42 O
and 43 46 43 46 O
wood 47 51 47 51 O
stove 52 57 52 57 O
usage 58 63 58 63 O
data 64 68 64 68 O
, 68 69 68 69 O
as 70 72 70 72 O
well 73 77 73 77 O
as 78 80 78 80 O
complete 81 89 81 89 O
pulmonary 90 99 90 99 O
function 100 108 100 108 O
testing 109 116 109 116 O
( 117 118 117 118 O
i.e. 118 122 118 122 O
, 122 123 122 123 O
spirometry 124 134 124 134 B-treatment
) 134 135 134 135 O

cardiovascular 0 14 0 14 B-chronic_disease
disease 15 22 15 22 I-chronic_disease
or 23 25 23 25 O
elevated 26 34 26 34 B-chronic_disease
plasma 35 41 35 41 I-chronic_disease
lipids 42 48 42 48 I-chronic_disease

confirmed 0 9 49 58 O
diagnosis 10 19 59 68 O
of 20 22 69 71 O
VLCAD 23 28 72 77 B-chronic_disease
, 28 29 77 78 O
LCHAD 30 35 79 84 B-chronic_disease
, 35 36 84 85 O
TFP 37 40 86 89 B-chronic_disease
or 41 43 90 92 O
MCAD 44 48 93 97 B-chronic_disease
deficiency 49 59 98 108 I-chronic_disease
or 60 62 109 111 O
same 63 67 112 116 O
gender 68 74 117 123 O
, 74 75 123 124 O
age 76 79 125 128 B-age
and 80 83 129 132 O
BMI 84 87 133 136 B-bmi
as 88 90 137 139 O
a 91 92 140 141 O
subject 93 100 142 149 O
with 101 105 150 154 O
a 106 107 155 156 O
fatty 108 113 157 162 B-chronic_disease
acid 114 118 163 167 I-chronic_disease
oxidation 119 128 168 177 I-chronic_disease
disorder 129 137 178 186 I-chronic_disease

endocrine 0 9 187 196 B-chronic_disease
disorder 10 18 197 205 I-chronic_disease
such 19 23 206 210 O
as 24 26 211 213 O
diabetes 27 35 214 222 B-chronic_disease
or 36 38 223 225 O
untreated 39 48 226 235 B-chronic_disease
thyroid 49 56 236 243 I-chronic_disease
disease 57 64 244 251 I-chronic_disease

hemoglobin 0 10 252 262 B-clinical_variable
< 11 12 263 264 O
10g 12 15 264 267 B-upper_bound
/ 15 16 267 268 I-upper_bound
dl 16 18 268 270 I-upper_bound
, 18 19 270 271 O
international 20 33 272 285 B-clinical_variable
normalized 34 44 286 296 I-clinical_variable
ratio 45 50 297 302 I-clinical_variable
( 51 52 303 304 I-clinical_variable
INR 52 55 304 307 I-clinical_variable
) 55 56 307 308 I-clinical_variable
> 57 58 309 310 O
1.2 58 61 310 313 B-lower_bound
Prothrombin 62 73 314 325 B-clinical_variable
time 74 78 326 330 I-clinical_variable
( 79 80 331 332 I-clinical_variable
PTT 80 83 332 335 I-clinical_variable
) 83 84 335 336 I-clinical_variable
> 85 86 337 338 O
36 86 88 338 340 B-lower_bound
sec 89 92 341 344 I-lower_bound
, 92 93 344 345 O
Platelets 94 103 346 355 B-clinical_variable
< 104 105 356 357 O
150K 105 109 357 361 B-upper_bound
/ 109 110 361 362 I-upper_bound
mm3 110 113 362 365 I-upper_bound

pregnant 0 8 366 374 B-pregnancy
or 9 11 375 377 O
lactating 12 21 378 387 O
females 22 29 388 395 B-gender

regularly 0 9 396 405 O
taking 10 16 406 412 O
meds 17 21 413 417 B-treatment
that 22 26 418 422 O
strongly 27 35 423 431 O
affect 36 42 432 438 O
bleeding 43 51 439 447 O
, 51 52 447 448 O
bruising 53 61 449 457 O
or 62 64 458 460 O
platelets 65 74 461 470 O

3 0 1 0 1 B-upper_bound
months 2 8 2 8 I-upper_bound
< 8 9 8 9 O

Current 0 7 10 17 O
Medications 8 19 18 29 B-treatment
that 20 24 30 34 O
lower 25 30 35 40 O
seizure 31 38 41 48 B-chronic_disease
threshold 39 48 49 58 O

ICD-9 0 5 59 64 O
Diagnosis 6 15 65 74 O
code 16 20 75 79 O
724 21 24 80 83 O
; 24 25 83 84 O
BPI 26 29 85 88 B-clinical_variable
pain 30 34 89 93 I-clinical_variable
on 35 37 94 96 I-clinical_variable
average 38 45 97 104 I-clinical_variable
score>4/10 46 56 105 115 I-clinical_variable
; 56 57 115 116 O
≥3 58 60 117 119 O
months 61 67 120 126 I-lower_bound
duration 68 76 127 135 O
of 77 79 136 138 O
pain 80 84 139 143 O

Latex 0 5 144 149 B-allergy_name
Allergy 6 13 150 157 O

Other 0 5 158 163 O
major 6 11 164 169 B-chronic_disease
medical 12 19 170 177 I-chronic_disease
problem 20 27 178 185 I-chronic_disease
( 28 29 186 187 O
e.g. 29 33 187 191 O
, 33 34 191 192 O
history 35 42 193 200 O
of 43 45 201 203 O
seizures 46 54 204 212 B-chronic_disease
) 54 55 212 213 O

Pregnant 0 8 214 222 B-pregnancy

Prescription 0 12 223 235 O
opiate 13 19 236 242 B-chronic_disease
use 20 23 243 246 I-chronic_disease
disorder 24 32 247 255 I-chronic_disease

Psychiatric 0 11 256 267 B-chronic_disease
Condition 12 21 268 277 I-chronic_disease
Preventing 22 32 278 288 O
successful 33 43 289 299 O
engagement 44 54 300 310 O
in 55 57 311 313 O
CBT 58 61 314 317 B-treatment

Unable 0 6 318 324 O
or 7 9 325 327 O
unwilling 10 19 328 337 O
discontinue 20 31 338 349 O
current 32 39 350 357 O
behavioral 40 50 358 368 B-treatment
therapy 51 58 369 376 I-treatment

ages 0 4 377 381 B-age
18 5 7 382 384 B-lower_bound
through 8 15 385 392 O
65 16 18 393 395 B-upper_bound

past 0 4 396 400 B-upper_bound
6 5 6 401 402 I-upper_bound
months 7 13 403 409 I-upper_bound
; 13 14 409 410 O
COMM 15 19 411 415 B-clinical_variable
score 20 25 416 421 I-clinical_variable
> 26 27 422 423 O
1 27 28 423 424 B-lower_bound

Acute 0 5 0 5 B-chronic_disease
ischemic 6 14 6 14 I-chronic_disease
stroke 15 21 15 21 I-chronic_disease
in 22 24 22 24 O
the 25 28 25 28 O
territory 29 38 29 38 O
of 39 41 39 41 O
the 42 45 42 45 O
anterior 46 54 46 54 O
, 54 55 54 55 O
middle 56 62 56 62 O
, 62 63 62 63 O
or 64 66 64 66 O
posterior 67 76 67 76 O
cerebral 77 85 77 85 O
artery 86 92 86 92 O
, 92 93 92 93 O
on 94 96 94 96 O
either 97 103 97 103 O
side 104 108 104 108 O
of 109 111 109 111 O
the 112 115 112 115 O
brain 116 121 116 121 O

Cognitive 0 9 122 131 B-chronic_disease
impairment 10 20 132 142 I-chronic_disease

History 0 7 143 150 O
of 8 10 151 153 O
any 11 14 154 157 O
neurological 15 27 158 170 B-chronic_disease
disease 28 35 171 178 I-chronic_disease

History 0 7 179 186 O
of 8 10 187 189 O
chronic 11 18 190 197 B-chronic_disease
pulmonary 19 28 198 207 I-chronic_disease
disease 29 36 208 215 I-chronic_disease
such 37 41 216 220 O
as 42 44 221 223 O
asthma 45 51 224 230 B-chronic_disease
or 52 54 231 233 O
chronic 55 62 234 241 B-chronic_disease
obstructive 63 74 242 253 I-chronic_disease
pulmonary 75 84 254 263 I-chronic_disease
disease 85 92 264 271 I-chronic_disease

History 0 7 272 279 O
of 8 10 280 282 O
prior 11 16 283 288 O
stroke 17 23 289 295 B-chronic_disease
or 24 26 296 298 O
transient 27 36 299 308 B-chronic_disease
ischemic 37 45 309 317 I-chronic_disease
attack 46 52 318 324 I-chronic_disease

Pregnancy 0 9 325 334 B-pregnancy

Pregnancy 0 9 335 344 B-pregnancy
( 10 11 345 346 O
urine 11 16 346 351 O
or 17 19 352 354 O
blood 20 25 355 360 O
tests 26 31 361 366 O
will 32 36 367 371 O
not 37 40 372 375 O
be 41 43 376 378 O
performed 44 53 379 388 O
) 53 54 388 389 O

Study 0 5 390 395 O
can 6 9 396 399 O
be 10 12 400 402 O
initiated 13 22 403 412 O
within 23 29 413 419 O
72 30 32 420 422 B-upper_bound
hours 33 38 423 428 I-upper_bound
of 39 41 429 431 O
stroke 42 48 432 438 B-chronic_disease
symptom 49 56 439 446 O
onset 57 62 447 452 O

ALS 0 3 0 3 B-chronic_disease
diagnosed 4 13 4 13 O
as 14 16 14 16 O
probable 17 25 17 25 O
, 25 26 25 26 O
laboratory 27 37 27 37 O
- 37 38 37 38 O
supported 38 47 38 47 O
probable 48 56 48 56 O
or 57 59 57 59 O
definite 60 68 60 68 O
according 69 78 69 78 O
to 79 81 79 81 O
the 82 85 82 85 O
World 86 91 86 91 O
Federation 92 102 92 102 O
of 103 105 103 105 O
Neurology 106 115 106 115 O
El 116 118 116 118 O
Escorial 119 127 119 127 O
revised 128 135 128 135 O
criteria32 136 146 136 146 O
as 147 149 147 149 O
determined 150 160 150 160 O
by 161 163 161 163 O
a 164 165 164 165 O
neurologist 166 177 166 177 O
with 178 182 178 182 O
neuromuscular 183 196 183 196 O
subspecialty 197 209 197 209 O
training 210 218 210 218 O

Age 0 3 219 222 B-age
18 4 6 223 225 B-lower_bound
years 7 12 226 231 I-lower_bound
or 13 15 232 234 O
older 16 21 235 240 O
at 22 24 241 243 O
the 25 28 244 247 O
time 29 33 248 252 O
of 34 36 253 255 O
the 37 40 256 259 O
screening 41 50 260 269 O
visit 51 56 270 275 O

Alanine 0 7 276 283 B-clinical_variable
aminotransferase 8 24 284 300 I-clinical_variable
( 25 26 301 302 I-clinical_variable
ALT 26 29 302 305 I-clinical_variable
) 29 30 305 306 I-clinical_variable
or 31 33 307 309 O
aspartate 34 43 310 319 B-clinical_variable
aminotransferase 44 60 320 336 I-clinical_variable
( 61 62 337 338 I-clinical_variable
AST 62 65 338 341 I-clinical_variable
) 65 66 341 342 I-clinical_variable
greater 67 74 343 350 O
than 75 79 351 355 O
3.0 80 83 356 359 B-lower_bound
times 84 89 360 365 I-lower_bound
the 90 93 366 369 I-lower_bound
upper 94 99 370 375 I-lower_bound
limit 100 105 376 381 I-lower_bound
of 106 108 382 384 I-lower_bound
normal 109 115 385 391 I-lower_bound
for 116 119 392 395 O
the 120 123 396 399 O
NIH 124 127 400 403 O
Clinical 128 136 404 412 O
Center 137 143 413 419 O

Creatine 0 8 420 428 B-clinical_variable
kinase 9 15 429 435 I-clinical_variable
greater 16 23 436 443 O
than 24 28 444 448 O
3.0 29 32 449 452 B-lower_bound
times 33 38 453 458 I-lower_bound
the 39 42 459 462 I-lower_bound
upper 43 48 463 468 I-lower_bound
limit 49 54 469 474 I-lower_bound
of 55 57 475 477 I-lower_bound
normal 58 64 478 484 I-lower_bound
for 65 68 485 488 O
the 69 72 489 492 O
NIH 73 76 493 496 O
Clinical 77 85 497 505 O
Center 86 92 506 512 O

Dementia 0 8 513 521 B-chronic_disease

Dependence 0 10 522 532 O
on 11 13 533 535 O
daytime 14 21 536 543 O
mechanical 22 32 544 554 O
ventilation 33 44 555 566 O
( 45 46 567 568 O
invasive 46 54 568 576 O
or 55 57 577 579 O
non 58 61 580 583 O
- 61 62 583 584 O
invasive 62 70 584 592 O
, 70 71 592 593 O
including 72 81 594 603 O
Continuous 82 92 604 614 B-treatment
Positive 93 101 615 623 I-treatment
Airway 102 108 624 630 I-treatment
Pressure 109 117 631 639 I-treatment
( 118 119 640 641 I-treatment
CPAP 119 123 641 645 I-treatment
) 123 124 645 646 I-treatment
or 125 127 647 649 O
Bilevel 128 135 650 657 B-treatment
Positive 136 144 658 666 I-treatment
Airway 145 151 667 673 I-treatment
Pressure 152 160 674 682 I-treatment
( 161 162 683 684 I-treatment
BiPap 162 167 684 689 I-treatment
) 167 168 689 690 I-treatment
at 169 171 691 693 O
the 172 175 694 697 O
time 176 180 698 702 O
of 181 183 703 705 O
the 184 187 706 709 O
screening 188 197 710 719 O
visit 198 203 720 725 O

Detectable 0 10 726 736 O
HERV 11 15 737 741 B-clinical_variable
- 15 16 741 742 I-clinical_variable
K 16 17 742 743 I-clinical_variable
viral 18 23 744 749 I-clinical_variable
load 24 28 750 754 I-clinical_variable
in 29 31 755 757 O
blood 32 37 758 763 O
at 38 40 764 766 O
a 41 42 767 768 O
minimum 43 50 769 776 O
of 51 53 777 779 O
1000 54 58 780 784 B-lower_bound
copies 59 65 785 791 I-lower_bound
/ 65 66 791 792 I-lower_bound
ml 66 68 792 794 I-lower_bound
as 69 71 795 797 O
measured 72 80 798 806 O
by 81 83 807 809 O
quantitative 84 96 810 822 O
PCR 97 100 823 826 B-treatment
at 101 103 827 829 O
the 104 107 830 833 O
screening 108 117 834 843 O
visit 118 123 844 849 O

Diabetes 0 8 850 858 B-chronic_disease
mellitus 9 17 859 867 I-chronic_disease

Estimated 0 9 868 877 B-clinical_variable
glomerular 10 20 878 888 I-clinical_variable
filtration 21 31 889 899 I-clinical_variable
rate 32 36 900 904 I-clinical_variable
< 37 38 905 906 O
60mg 38 42 906 910 B-upper_bound
/ 42 43 910 911 I-upper_bound
dl 43 45 911 913 I-upper_bound

Hemoglobin 0 10 914 924 B-clinical_variable
< 11 12 925 926 O
10mg 12 16 926 930 B-upper_bound
/ 16 17 930 931 I-upper_bound
dL 17 19 931 933 I-upper_bound

Hemophilia 0 10 934 944 B-chronic_disease

History 0 7 945 952 O
of 8 10 953 955 O
having 11 17 956 962 O
undergone 18 27 963 972 O
gastrostomy 28 39 973 984 B-treatment
at 40 42 985 987 O
the 43 46 988 991 O
time 47 51 992 996 O
of 52 54 997 999 O
screening 55 64 1000 1009 O

History 0 7 1010 1017 O
of 8 10 1018 1020 O
positive 11 19 1021 1029 O
test 20 24 1030 1034 O
or 25 27 1035 1037 O
positive 28 36 1038 1046 O
result 37 43 1047 1053 O
at 44 46 1054 1056 O
screening 47 56 1057 1066 O
for 57 60 1067 1070 O
HIV 61 64 1071 1074 B-chronic_disease
or 65 67 1075 1077 O
HTLV-1 68 74 1078 1084 B-chronic_disease

If 0 2 1085 1087 O
taking 3 9 1088 1094 O
riluzole 10 18 1095 1103 B-treatment
or 19 21 1104 1106 O
edaravone 22 31 1107 1116 B-treatment
, 31 32 1116 1117 O
must 33 37 1118 1122 O
be 38 40 1123 1125 O
on 41 43 1126 1128 O
a 44 45 1129 1130 O
stable 46 52 1131 1137 O
dose 53 57 1138 1142 O
for 58 61 1143 1146 O
at 62 64 1147 1149 O
least 65 70 1150 1155 O
30 71 73 1156 1158 B-lower_bound
days 74 78 1159 1163 I-lower_bound
prior 79 84 1164 1169 I-lower_bound
to 85 87 1170 1172 O
the 88 91 1173 1176 O
screening 92 101 1177 1186 O
visit 102 107 1187 1192 O
, 107 108 1192 1193 O
or 109 111 1194 1196 O
stopped 112 119 1197 1204 O
taking 120 126 1205 1211 O
riluzole 127 135 1212 1220 O
or 136 138 1221 1223 O
edaravone 139 148 1224 1233 O
at 149 151 1234 1236 O
least 152 157 1237 1242 O
30 158 160 1243 1245 O
days 161 165 1246 1250 O
prior 166 171 1251 1256 O
to 172 174 1257 1259 O
the 175 178 1260 1263 O
screening 179 188 1264 1273 O
visit 189 194 1274 1279 O

Known 0 5 1280 1285 O
sulfonamide 6 17 1286 1297 B-allergy_name
allergy 18 25 1298 1305 O

PT 0 2 1306 1308 B-clinical_variable
and 3 6 1309 1312 O
PTT 7 10 1313 1316 B-clinical_variable
> 11 12 1317 1318 O
1.2 12 15 1318 1321 B-lower_bound
times 16 21 1322 1327 I-lower_bound
the 22 25 1328 1331 I-lower_bound
upper 26 31 1332 1337 I-lower_bound
limit 32 37 1338 1343 I-lower_bound
of 38 40 1344 1346 I-lower_bound
normal 41 47 1347 1353 I-lower_bound
for 48 51 1354 1357 O
the 52 55 1358 1361 O
NIH 56 59 1362 1365 O
Clinical 60 68 1366 1374 O
Center 69 75 1375 1381 O

Participation 0 13 1382 1395 O
in 14 16 1396 1398 O
any 17 20 1399 1402 O
other 21 26 1403 1408 B-treatment
investigational 27 42 1409 1424 I-treatment
drug 43 47 1425 1429 I-treatment
trial 48 53 1430 1435 I-treatment
or 54 56 1436 1438 O
using 57 62 1439 1444 O
investigational 63 78 1445 1460 O
drug 79 83 1461 1465 O
( 84 85 1466 1467 O
within 85 91 1467 1473 O
12 92 94 1474 1476 B-upper_bound
weeks 95 100 1477 1482 I-upper_bound
prior 101 106 1483 1488 I-upper_bound
to 107 109 1489 1491 O
Screening 110 119 1492 1501 O
and 120 123 1502 1505 O
thereafter 124 134 1506 1516 O
) 134 135 1516 1517 O

Platelet 0 8 1518 1526 B-clinical_variable
concentration 9 22 1527 1540 I-clinical_variable
of 23 25 1541 1543 O
< 26 27 1544 1545 O
100,000/ 27 35 1545 1553 B-upper_bound
( 36 37 1554 1555 I-upper_bound
micro)l 37 44 1555 1562 I-upper_bound

Positive 0 8 1563 1571 O
Hepatitis 9 18 1572 1581 B-chronic_disease
B 19 20 1582 1583 I-chronic_disease
Surface 21 28 1584 1591 O
Antigen 29 36 1592 1599 O
and 37 40 1600 1603 O
Hepatitis 41 50 1604 1613 B-chronic_disease
C 51 52 1614 1615 I-chronic_disease
Virus 53 58 1616 1621 O
Antibody 59 67 1622 1630 O

Serum 0 5 1631 1636 B-clinical_variable
creatinine 6 16 1637 1647 I-clinical_variable
, 16 17 1647 1648 O
serum 18 23 1649 1654 B-clinical_variable
phosphorous 24 35 1655 1666 I-clinical_variable
, 35 36 1666 1667 O
urine 37 42 1668 1673 B-clinical_variable
glucose 43 50 1674 1681 I-clinical_variable
, 50 51 1681 1682 O
urine 52 57 1683 1688 B-clinical_variable
protein 58 65 1689 1696 I-clinical_variable
, 65 66 1696 1697 O
total 67 72 1698 1703 B-clinical_variable
bilirubin 73 82 1704 1713 I-clinical_variable
, 82 83 1713 1714 O
triglycerides 84 97 1715 1728 B-clinical_variable
, 97 98 1728 1729 O
amylase 99 106 1730 1737 B-clinical_variable
, 106 107 1737 1738 O
or 108 110 1739 1741 O
lipase 111 117 1742 1748 B-clinical_variable
greater 118 125 1749 1756 O
than 126 130 1757 1761 O
2.0 131 134 1762 1765 B-lower_bound
times 135 140 1766 1771 I-lower_bound
the 141 144 1772 1775 I-lower_bound
upper 145 150 1776 1781 I-lower_bound
limit 151 156 1782 1787 I-lower_bound
of 157 159 1788 1790 I-lower_bound
normal 160 166 1791 1797 I-lower_bound
for 167 170 1798 1801 O
the 171 174 1802 1805 O
NIH 175 178 1806 1809 O
Clinical 179 187 1810 1818 O
Center 188 194 1819 1825 O

Time 0 4 1826 1830 B-clinical_variable
from 5 9 1831 1835 I-clinical_variable
symptom 10 17 1836 1843 I-clinical_variable
onset 18 23 1844 1849 I-clinical_variable
less 24 28 1850 1854 O
than 29 33 1855 1859 O
2 34 35 1860 1861 B-upper_bound
years 36 41 1862 1867 I-upper_bound

Unstable 0 8 1868 1876 O
medical 9 16 1877 1884 B-chronic_disease
disease 17 24 1885 1892 I-chronic_disease
( 25 26 1893 1894 O
such 26 30 1894 1898 O
as 31 33 1899 1901 O
unstable 34 42 1902 1910 B-chronic_disease
angina 43 49 1911 1917 I-chronic_disease
or 50 52 1918 1920 O
chronic 53 60 1921 1928 B-chronic_disease
obstructive 61 72 1929 1940 I-chronic_disease
pulmonary 73 82 1941 1950 I-chronic_disease
disease 83 90 1951 1958 I-chronic_disease
) 90 91 1958 1959 O
, 91 92 1959 1960 O
or 93 95 1961 1963 O
active 96 102 1964 1970 B-chronic_disease
infectious 103 113 1971 1981 I-chronic_disease
disease 114 121 1982 1989 I-chronic_disease
( 122 123 1990 1991 O
such 123 127 1991 1995 O
as 128 130 1996 1998 O
Hepatitis 131 140 1999 2008 B-chronic_disease
C 141 142 2009 2010 I-chronic_disease
or 143 145 2011 2013 O
tuberculosis 146 158 2014 2026 B-chronic_disease
) 158 159 2026 2027 O
, 159 160 2027 2028 O
or 161 163 2029 2031 O
current 164 171 2032 2039 O
malignancy 172 182 2040 2050 B-cancer

Unstable 0 8 2051 2059 O
psychiatric 9 20 2060 2071 B-chronic_disease
illness 21 28 2072 2079 I-chronic_disease
defined 29 36 2080 2087 O
as 37 39 2088 2090 O
psychosis 40 49 2091 2100 B-chronic_disease
or 50 52 2101 2103 O
untreated 53 62 2104 2113 O
major 63 68 2114 2119 B-chronic_disease
depression 69 79 2120 2130 I-chronic_disease
within 80 86 2131 2137 O
90 87 89 2138 2140 B-upper_bound
days 90 94 2141 2145 I-upper_bound
of 95 97 2146 2148 O
the 98 101 2149 2152 O
screening 102 111 2153 2162 O
visit 112 117 2163 2168 O

Use 0 3 2169 2172 O
of 4 6 2173 2175 O
contraindicated 7 22 2176 2191 O
medications 23 34 2192 2203 O
: 34 35 2203 2204 O
amiodarone 36 46 2205 2215 B-treatment
, 46 47 2215 2216 O
dronedarone 48 59 2217 2228 B-treatment
, 59 60 2228 2229 O
lovastatin 61 71 2230 2240 B-treatment
, 71 72 2240 2241 O
simvastatin 73 84 2242 2253 B-treatment
, 84 85 2253 2254 O
rifampin 86 94 2255 2263 B-treatment
, 94 95 2263 2264 O
rifapentine 96 107 2265 2276 B-treatment
, 107 108 2276 2277 O
rifabutin 109 118 2278 2287 B-treatment
, 118 119 2287 2288 O
cisapride 120 129 2289 2298 B-treatment
, 129 130 2298 2299 O
pimozide 131 139 2300 2308 B-treatment
, 139 140 2308 2309 O
midazolam 141 150 2310 2319 B-treatment
, 150 151 2319 2320 O
triazolam 152 161 2321 2330 B-treatment
, 161 162 2330 2331 O
dihydroergotamine 163 180 2332 2349 B-treatment
, 180 181 2349 2350 O
ergonovine 182 192 2351 2361 B-treatment
, 192 193 2361 2362 O
ergotamine 194 204 2363 2373 O
, 204 205 2373 2374 O
methylergonovine 206 222 2375 2391 B-treatment
, 222 223 2391 2392 O
St. 224 227 2393 2396 B-treatment
John 228 232 2397 2401 I-treatment
s 233 234 2402 2403 I-treatment
wort 235 239 2404 2408 I-treatment
, 239 240 2408 2409 O
alfuzosin 241 250 2410 2419 B-treatment
, 250 251 2419 2420 O
salmeterol 252 262 2421 2431 B-treatment
, 262 263 2431 2432 O
sildenafil 264 274 2433 2443 B-treatment
for 275 278 2444 2447 O
pulmonary 279 288 2448 2457 B-chronic_disease
arterial 289 297 2458 2466 I-chronic_disease
hypertension 298 310 2467 2479 I-chronic_disease
, 310 311 2479 2480 O
oxcarbazepine 312 325 2481 2494 B-treatment
, 325 326 2494 2495 O
phenobarbital 327 340 2496 2509 B-treatment
, 340 341 2509 2510 O
phenytoin 342 351 2511 2520 B-treatment
or 352 354 2521 2523 O
dofetilide 355 365 2524 2534 B-treatment

competent 0 9 2535 2544 O
caregiver 10 19 2545 2554 O
who 20 23 2555 2558 O
can 24 27 2559 2562 O
and 28 31 2563 2566 O
will 32 36 2567 2571 O
be 37 39 2572 2574 O
responsible 40 51 2575 2586 O
for 52 55 2587 2590 O
administering 56 69 2591 2604 O
study 70 75 2605 2610 B-treatment
drug 76 80 2611 2615 I-treatment

had 0 3 2616 2619 O
neuroimaging 4 16 2620 2632 B-treatment
within 17 23 2633 2639 O
the 24 27 2640 2643 O
last 28 32 2644 2648 B-upper_bound
18 33 35 2649 2651 I-upper_bound
months 36 42 2652 2658 I-upper_bound

hildbearing 0 11 2659 2670 O
potential 12 21 2671 2680 O
must 22 26 2681 2685 O
have 27 31 2686 2690 O
a 32 33 2691 2692 O
negative 34 42 2693 2701 B-pregnancy
pregnancy 43 52 2702 2711 I-pregnancy
test 53 57 2712 2716 O
at 58 60 2717 2719 O
screening 61 70 2720 2729 O
and 71 74 2730 2733 O
be 75 77 2734 2736 O
non 78 81 2737 2740 O
- 81 82 2740 2741 O
lactating 82 91 2741 2750 O

must 0 4 2751 2755 O
not 5 8 2756 2759 B-pregnancy
be 9 11 2760 2762 I-pregnancy
able 12 16 2763 2767 I-pregnancy
to 17 19 2768 2770 I-pregnancy
become 20 26 2771 2777 I-pregnancy
pregnant 27 35 2778 2786 I-pregnancy
( 36 37 2787 2788 O
e.g. 37 41 2788 2792 O
, 41 42 2792 2793 O
post 43 47 2794 2798 O
- 47 48 2798 2799 O
menopausal 48 58 2799 2809 O
for 59 62 2810 2813 O
at 63 65 2814 2816 O
least 66 71 2817 2822 O
one 72 75 2823 2826 B-lower_bound
year 76 80 2827 2831 I-lower_bound
, 80 81 2831 2832 O
surgically 82 92 2833 2843 O
sterile 93 100 2844 2851 O
, 100 101 2851 2852 O
or 102 104 2853 2855 O
using 105 110 2856 2861 B-contraception_consent
adequate 111 119 2862 2870 I-contraception_consent
methods 120 127 2871 2878 I-contraception_consent
of 128 130 2879 2881 I-contraception_consent
contraception 131 144 2882 2895 I-contraception_consent
) 144 145 2895 2896 O
or 146 148 2897 2899 O
breastfeed 149 159 2900 2910 O
for 160 163 2911 2914 O
the 164 167 2915 2918 O
duration 168 176 2919 2927 O
of 177 179 2928 2930 O
the 180 183 2931 2934 O
study 184 189 2935 2940 O
. 189 190 2940 2941 O
Adequate 191 199 2942 2950 O
methods 200 207 2951 2958 O
of 208 210 2959 2961 O
contraception 211 224 2962 2975 O
include 225 232 2976 2983 O
: 232 233 2983 2984 O
implanted 234 243 2985 2994 O
contraception 244 257 2995 3008 O
, 257 258 3008 3009 O
intrauterine 259 271 3010 3022 O
device 272 278 3023 3029 O
in 279 281 3030 3032 O
place 282 287 3033 3038 O
for 288 291 3039 3042 O
at 292 294 3043 3045 O
least 295 300 3046 3051 O
3 301 302 3052 3053 B-lower_bound
months 303 309 3054 3060 I-lower_bound
, 309 310 3060 3061 O
or 311 313 3062 3064 O
barrier 314 321 3065 3072 O
method 322 328 3073 3079 O
in 329 331 3080 3082 O
conjunction 332 343 3083 3094 O
with 344 348 3095 3099 O
spermicide 349 359 3100 3110 O

A 0 1 0 1 O
female 2 8 2 8 B-gender
of 9 11 9 11 O
child 12 17 12 17 O
- 17 18 17 18 O
bearing 18 25 18 25 O
potential 26 35 26 35 O
is 36 38 36 38 O
any 39 42 39 42 O
woman 43 48 43 48 B-gender
( 49 50 49 50 O
regardless 50 60 50 60 O
of 61 63 61 63 O
sexual 64 70 64 70 O
orientation 71 82 71 82 O
, 82 83 82 83 O
having 84 90 84 90 O
undergone 91 100 91 100 O
a 101 102 101 102 O
tubal 103 108 103 108 B-treatment
ligation 109 117 109 117 I-treatment
, 117 118 117 118 O
or 119 121 119 121 O
remaining 122 131 122 131 O
celibate 132 140 132 140 O
by 141 143 141 143 O
choice 144 150 144 150 O
) 150 151 150 151 O

Age 0 3 152 155 B-age
≥ 4 5 156 157 O
18 6 8 158 160 B-lower_bound
years 9 14 161 166 I-lower_bound

Age 0 3 167 170 B-age
≥75 4 7 171 174 O

Biopsy 0 6 175 181 B-treatment
was 7 10 182 185 O
performed 11 20 186 195 O
or 21 23 196 198 O
attempted 24 33 199 208 O
but 34 37 209 212 O
with 38 42 213 217 O
complications 43 56 218 231 O
requiring 57 66 232 241 O
abortion 67 75 242 250 O
of 76 78 251 253 O
procedure 79 88 254 263 O

Cerebral 0 8 264 272 B-chronic_disease
, 8 9 272 273 O
cardiac 10 17 274 281 B-chronic_disease
, 17 18 281 282 O
or 19 21 283 285 O
peripheral 22 32 286 296 B-chronic_disease
vascular 33 41 297 305 I-chronic_disease
disease 42 49 306 313 I-chronic_disease

Chronic 0 7 314 321 B-chronic_disease
heart 8 13 322 327 I-chronic_disease
disease 14 21 328 335 I-chronic_disease

Diabetes 0 8 336 344 B-chronic_disease
mellitus 9 17 345 353 I-chronic_disease
with 18 22 354 358 O
end 23 26 359 362 O
organ 27 32 363 368 O
damage 33 39 369 375 O

FEV1 0 4 376 380 B-clinical_variable
< 5 6 381 382 O
50 6 8 382 384 B-upper_bound
% 8 9 384 385 I-upper_bound

Has 0 3 386 389 O
not 4 7 390 393 O
been 8 12 394 398 O
naturally 13 22 399 408 O
postmenopausal 23 37 409 423 O
for 38 41 424 427 O
at 42 44 428 430 O
least 45 50 431 436 O
12 51 53 437 439 B-lower_bound
consecutive 54 65 440 451 I-lower_bound
months 66 72 452 458 I-lower_bound

Has 0 3 459 462 O
not 4 7 463 466 O
undergone 8 17 467 476 O
a 18 19 477 478 O
hysterectomy 20 32 479 491 B-treatment
or 33 35 492 494 O
bilateral 36 45 495 504 B-treatment
oophorectomy 46 58 505 517 I-treatment

High 0 4 518 522 O
risk 5 9 523 527 O
of 10 12 528 530 O
complications 13 26 531 544 O
from 27 31 545 549 O
transbronchial 32 46 550 564 B-treatment
or 47 49 565 567 O
transthoracic 50 63 568 581 B-treatment
biopsy 64 70 582 588 I-treatment

History 0 7 589 596 O
/ 7 8 596 597 O
Physical 8 16 597 605 O
examination 17 28 606 617 O
by 29 31 618 620 O
an 32 34 621 623 O
experienced 35 46 624 635 O
thoracic 47 55 636 644 O
cancer 56 62 645 651 O
clinician 63 72 652 661 O
( 73 74 662 663 O
thoracic 74 82 663 671 O
surgeon 83 90 672 679 O
, 90 91 679 680 O
interventional 92 106 681 695 O
pulmonologist 107 120 696 709 O
, 120 121 709 710 O
medical 122 129 711 718 O
oncologist 130 140 719 729 O
, 140 141 729 730 O
or 142 144 731 733 O
radiation 145 154 734 743 O
oncologist 155 165 744 754 O
) 165 166 754 755 O
within 167 173 756 762 O
4 174 175 763 764 B-upper_bound
weeks 176 181 765 770 I-upper_bound
prior 182 187 771 776 I-upper_bound
to 188 190 777 779 O
registration 191 203 780 792 O

Multidisciplinary 0 17 793 810 O
tumor 18 23 811 816 B-cancer
board 24 29 817 822 O
determines 30 40 823 833 O
patient 41 48 834 841 O
's 48 50 841 843 O
history 51 58 844 851 O
, 58 59 851 852 O
clinical 60 68 853 861 O
findings 69 77 862 870 O
, 77 78 870 871 O
and 79 82 872 875 O
radiographic 83 95 876 888 O
findings 96 104 889 897 O
are 105 108 898 901 O
consistent 109 119 902 912 O
with 120 124 913 917 O
high 125 129 918 922 O
probability 130 141 923 934 O
of 142 144 935 937 O
malignancy 145 155 938 948 B-cancer

No 0 2 949 951 O
clinical 3 11 952 960 O
or 12 14 961 963 O
radiographic 15 27 964 976 O
evidence 28 36 977 985 O
of 37 39 986 988 O
nodal 40 45 989 994 B-cancer
disease 46 53 995 1002 I-cancer
or 54 56 1003 1005 O
distant 57 64 1006 1013 B-cancer
metastases 65 75 1014 1024 I-cancer

No 0 2 1025 1027 O
previous 3 11 1028 1036 O
local 12 17 1037 1042 B-treatment
therapy 18 25 1043 1050 I-treatment
such 26 30 1051 1055 O
as 31 33 1056 1058 O
external 34 42 1059 1067 B-treatment
beam 43 47 1068 1072 I-treatment
radiotherapy 48 60 1073 1085 I-treatment
, 60 61 1085 1086 O
lobectomy 62 71 1087 1096 B-treatment
, 71 72 1096 1097 O
or 73 75 1098 1100 O
sublobar 76 84 1101 1109 B-treatment
resection 85 94 1110 1119 I-treatment

Patient 0 7 1120 1127 O
declines 8 16 1128 1136 O
surgery 17 24 1137 1144 B-treatment

Patients 0 8 1145 1153 O
who 9 12 1154 1157 O
are 13 16 1158 1161 O
currently 17 26 1162 1171 B-pregnancy
pregnant 27 35 1172 1180 I-pregnancy

Patients 0 8 1181 1189 O
with 9 13 1190 1194 O
a 14 15 1195 1196 O
known 16 21 1197 1202 O
history 22 29 1203 1210 O
of 30 32 1211 1213 O
malignancy 33 43 1214 1224 B-cancer
with 44 48 1225 1229 O
a 49 50 1230 1231 O
disease 51 58 1232 1239 O
- 58 59 1239 1240 O
free 59 63 1240 1244 O
interval 64 72 1245 1253 O
<3 73 75 1254 1256 O
years 76 81 1257 1262 I-upper_bound
prior 82 87 1263 1268 I-upper_bound
to 88 90 1269 1271 O
enrollment 91 101 1272 1282 O

Patients 0 8 1283 1291 O
with 9 13 1292 1296 O
any 14 17 1297 1300 O
prior 18 23 1301 1306 O
history 24 31 1307 1314 O
of 32 34 1315 1317 O
lung 35 39 1318 1322 B-cancer
cancer 40 46 1323 1329 I-cancer

Patients 0 8 1330 1338 O
with 9 13 1339 1343 O
severe 14 20 1344 1350 O
obstructive 21 32 1351 1362 B-chronic_disease
or 33 35 1363 1365 I-chronic_disease
restrictive 36 47 1366 1377 I-chronic_disease
lung 48 52 1378 1382 I-chronic_disease
disease 53 60 1383 1390 I-chronic_disease

Prior 0 5 1391 1396 O
history 6 13 1397 1404 O
of 14 16 1405 1407 O
lung 17 21 1408 1412 B-cancer
cancer 22 28 1413 1419 I-cancer

Prior 0 5 1420 1425 B-treatment
local 6 11 1426 1431 I-treatment
therapy 12 19 1432 1439 I-treatment
( 20 21 1440 1441 O
surgery 21 28 1441 1448 B-treatment
or 29 31 1449 1451 O
radiotherapy 32 44 1452 1464 B-treatment
) 44 45 1464 1465 O
for 46 49 1466 1469 O
the 50 53 1470 1473 O
current 54 61 1474 1481 O
, 61 62 1481 1482 O
clinically 63 73 1483 1493 O
- 73 74 1493 1494 O
diagnosed 74 83 1494 1503 O
NSCLC 84 89 1504 1509 B-cancer

Pulmonary 0 9 1510 1519 B-chronic_disease
hypertension 10 22 1520 1532 I-chronic_disease

Validated 0 9 1533 1542 O
clinical 10 18 1543 1551 O
prediction 19 29 1552 1562 O
model 30 35 1563 1568 O
estimates 36 45 1569 1578 O
probability 46 57 1579 1590 B-clinical_variable
of 58 60 1591 1593 I-clinical_variable
malignancy 61 71 1594 1604 I-clinical_variable
is 72 74 1605 1607 O
≥ 75 76 1608 1609 O
85 77 79 1610 1612 B-lower_bound
% 79 80 1612 1613 I-lower_bound

Whole 0 5 1614 1619 B-treatment
body 6 10 1620 1624 I-treatment
Positron 11 19 1625 1633 I-treatment
Emission 20 28 1634 1642 I-treatment
Tomography 29 39 1643 1653 I-treatment
/ 40 41 1654 1655 O
Computerized 42 54 1656 1668 B-treatment
Tomography 55 65 1669 1679 I-treatment
( 66 67 1680 1681 I-treatment
PET 67 70 1681 1684 I-treatment
/ 70 71 1684 1685 I-treatment
CT 71 73 1685 1687 I-treatment
) 73 74 1687 1688 I-treatment
within 75 81 1689 1695 O
12 82 84 1696 1698 B-upper_bound
weeks 85 90 1699 1704 I-upper_bound
of 91 93 1705 1707 O
registration 94 106 1708 1720 O

Women 0 5 1721 1726 B-gender
of 6 8 1727 1729 O
child 9 14 1730 1735 O
- 14 15 1735 1736 O
bearing 15 22 1736 1743 O
potential 23 32 1744 1753 O
must 33 37 1754 1758 O
undergo 38 45 1759 1766 O
pregnancy 46 55 1767 1776 B-pregnancy
testing 56 63 1777 1784 O
prior 64 69 1785 1790 O
to 70 72 1791 1793 O
enrollment 73 83 1794 1804 O
on 84 86 1805 1807 O
study 87 92 1808 1813 O

baseline 0 8 1814 1822 O
hypoxemia 9 18 1823 1832 B-chronic_disease
and/or 19 25 1833 1839 O
hypercapnia 26 37 1840 1851 B-chronic_disease

cardiac 0 7 1852 1859 B-chronic_disease
arrhythmia 8 18 1860 1870 I-chronic_disease

diffusion 0 9 1871 1880 B-clinical_variable
capacity 10 18 1881 1889 I-clinical_variable
< 19 20 1890 1891 O
50 20 22 1891 1893 B-upper_bound
% 22 23 1893 1894 I-upper_bound

history 0 7 1895 1902 O
of 8 10 1903 1905 O
brain 11 16 1906 1911 B-cancer
metastases 17 27 1912 1922 I-cancer

must 0 4 1923 1927 O
not 5 8 1928 1931 O
have 9 13 1932 1936 O
any 14 17 1937 1940 O
history 18 25 1941 1948 O
of 26 28 1949 1951 O
brain 29 34 1952 1957 B-cancer
metastases 35 45 1958 1968 I-cancer

nursing 0 7 1969 1976 O
due 8 11 1977 1980 O
to 12 14 1981 1983 O
the 15 18 1984 1987 O
potential 19 28 1988 1997 O
for 29 32 1998 2001 O
congenital 33 43 2002 2012 B-chronic_disease
abnormalities 44 57 2013 2026 I-chronic_disease
and 58 61 2027 2030 O
potential 62 71 2031 2040 O
harm 72 76 2041 2045 O
to 77 79 2046 2048 O
nursing 80 87 2049 2056 O
infants 88 95 2057 2064 O

ongoing 0 7 2065 2072 O
or 8 10 2073 2075 O
active 11 17 2076 2082 B-chronic_disease
infection 18 27 2083 2092 I-chronic_disease

positron 0 8 2093 2101 B-treatment
emission 9 17 2102 2110 I-treatment
tomography 18 28 2111 2121 I-treatment
imaging 29 36 2122 2129 I-treatment
clinically 37 47 2130 2140 O
consistent 48 58 2141 2151 O
with 59 63 2152 2156 O
lung 64 68 2157 2161 B-cancer
malignancy 69 79 2162 2172 I-cancer

post 0 4 2173 2177 B-treatment
- 4 5 2177 2178 I-treatment
operative 5 14 2178 2187 I-treatment
predicted 15 24 2188 2197 I-treatment
FEV1<30 25 32 2198 2205 I-treatment
% 32 33 2205 2206 I-upper_bound
predicted 34 43 2207 2216 O

psychiatric 0 11 2217 2228 B-chronic_disease
illness 12 19 2229 2236 I-chronic_disease
/ 19 20 2236 2237 I-chronic_disease
social 20 26 2237 2243 I-chronic_disease
situations 27 37 2244 2254 I-chronic_disease
that 38 42 2255 2259 O
could 43 48 2260 2265 O
limit 49 54 2266 2271 O
compliance 55 65 2272 2282 O
with 66 70 2283 2287 O
study 71 76 2288 2293 O
requirements 77 89 2294 2306 O

severely 0 8 2307 2315 B-chronic_disease
symptomatic 9 20 2316 2327 I-chronic_disease
congestive 21 31 2328 2338 I-chronic_disease
heart 32 37 2339 2344 I-chronic_disease
failure 38 45 2345 2352 I-chronic_disease

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 6 7 6 7 O
80 7 9 7 9 B-upper_bound

Currently 0 9 10 19 O
or 10 12 20 22 O
previously 13 23 23 33 O
managed 24 31 34 41 O
with 32 36 42 46 O
a 37 38 47 48 O
biologic 39 47 49 57 B-treatment
medication 48 58 58 68 I-treatment

Diagnosed 0 9 69 78 O
with 10 14 79 83 O
psoriasis 15 24 84 93 B-chronic_disease
( 25 26 94 95 O
ICD-9 26 31 95 100 O
: 31 32 100 101 O
696.1 33 38 102 107 O
) 38 39 107 108 O

Individuals 0 11 109 120 O
younger 12 19 121 128 O
than 20 24 129 133 O
18 25 27 134 136 B-upper_bound

English 0 7 0 7 B-language_fluency
- 7 8 7 8 I-language_fluency
speaking 8 16 8 16 I-language_fluency
subjects 17 25 17 25 O
only 26 30 26 30 O

Non 0 3 31 34 B-language_fluency
- 3 4 34 35 I-language_fluency
English 4 11 35 42 I-language_fluency
speaking 12 20 43 51 I-language_fluency
subjects 21 29 52 60 O

Patients 0 8 61 69 O
being 9 14 70 75 O
admitted 15 23 76 84 O
to 24 26 85 87 O
the 27 30 88 91 O
hospital 31 39 92 100 O
or 40 42 101 103 O
going 43 48 104 109 O
to 49 51 110 112 O
the 52 55 113 116 O
operating 56 65 117 126 O
room 66 70 127 131 O
for 71 74 132 135 O
incision 75 83 136 144 B-treatment
and 84 87 145 148 I-treatment
drainage 88 96 149 157 I-treatment

Patients 0 8 158 166 O
less 9 13 167 171 O
than 14 18 172 176 O
18 19 21 177 179 B-upper_bound
years 22 27 180 185 I-upper_bound
of 28 30 186 188 O
age 31 34 189 192 B-age

Pregnant 0 8 193 201 B-pregnancy
patients 9 17 202 210 O

A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergic 13 21 13 21 O
reactions 22 31 22 31 O
attributed 32 42 32 42 O
to 43 45 43 45 O
compounds 46 55 46 55 B-allergy_name
of 56 58 56 58 I-allergy_name
similar 59 66 59 66 I-allergy_name
chemical 67 75 67 75 I-allergy_name
or 76 78 76 78 I-allergy_name
biologic 79 87 79 87 I-allergy_name
composition 88 99 88 99 I-allergy_name
to 100 102 100 102 I-allergy_name
palbociclib 103 114 103 114 I-allergy_name
, 114 115 114 115 O
letrozole 116 125 116 125 B-allergy_name
, 125 126 125 126 O
trastuzumab 127 138 127 138 B-allergy_name
, 138 139 138 139 O
any 140 143 140 143 O
other 144 149 144 149 O
aromatase 150 159 150 159 B-allergy_name
inhibitor 160 169 160 169 I-allergy_name
, 169 170 169 170 O
any 171 174 171 174 O
other 175 180 175 180 O
monoclonal 181 191 181 191 B-allergy_name
antibody 192 200 192 200 I-allergy_name
, 200 201 200 201 O
or 202 204 202 204 O
other 205 210 205 210 B-allergy_name
agents 211 217 211 217 I-allergy_name
used 218 222 218 222 I-allergy_name
in 223 225 223 225 I-allergy_name
the 226 229 226 229 I-allergy_name
study 230 235 230 235 I-allergy_name

AST(SGOT)/ALT(SGPT 0 18 236 254 B-clinical_variable
) 18 19 254 255 I-clinical_variable
≤ 20 21 256 257 O
2.5 22 25 258 261 B-upper_bound
x 26 27 262 263 I-upper_bound
IULN 28 32 264 268 I-upper_bound

Absolute 0 8 269 277 B-clinical_variable
neutrophil 9 19 278 288 I-clinical_variable
count 20 25 289 294 I-clinical_variable
≥ 26 27 295 296 O
1,500 28 33 297 302 B-lower_bound
/ 33 34 302 303 I-lower_bound
mcl 34 37 303 306 I-lower_bound

At 0 2 307 309 O
least 3 8 310 315 O
18 9 11 316 318 B-lower_bound
years 12 17 319 324 I-lower_bound
of 18 20 325 327 O
age 21 24 328 331 B-age

Baseline 0 8 332 340 B-clinical_variable
corrected 9 18 341 350 I-clinical_variable
QT 19 21 351 353 I-clinical_variable
interval 22 30 354 362 I-clinical_variable
( 31 32 363 364 I-clinical_variable
QTcF 32 36 364 368 I-clinical_variable
) 36 37 368 369 I-clinical_variable
< 38 39 370 371 O
480 40 43 372 375 B-upper_bound
ms 44 46 376 378 I-upper_bound

Eastern 0 7 379 386 B-clinical_variable
Cooperative 8 19 387 398 I-clinical_variable
Oncology 20 28 399 407 I-clinical_variable
Group 29 34 408 413 I-clinical_variable
( 35 36 414 415 I-clinical_variable
ECOG 36 40 415 419 I-clinical_variable
) 40 41 419 420 I-clinical_variable
performance 42 53 421 432 I-clinical_variable
status 54 60 433 439 I-clinical_variable
≤ 61 62 440 441 O
1 63 64 442 443 B-upper_bound

Indeterminate 0 13 444 457 O
or 14 16 458 460 O
negative 17 25 461 469 O
HER2 26 30 470 474 B-clinical_variable
status 31 37 475 481 I-clinical_variable

Inflammatory 0 12 482 494 B-cancer
breast 13 19 495 501 I-cancer
cancer 20 26 502 508 I-cancer

Known 0 5 509 514 O
hepatitis 6 15 515 524 B-chronic_disease
B 16 17 525 526 I-chronic_disease
or 18 20 527 529 I-chronic_disease
C 21 22 530 531 I-chronic_disease
infection 23 32 532 541 I-chronic_disease

Left 0 4 542 546 B-clinical_variable
ventricular 5 16 547 558 I-clinical_variable
ejection 17 25 559 567 I-clinical_variable
fraction 26 34 568 576 I-clinical_variable
( 35 36 577 578 I-clinical_variable
LVEF 36 40 578 582 I-clinical_variable
) 40 41 582 583 I-clinical_variable
≥ 42 43 584 585 O
50 44 46 586 588 B-lower_bound
% 46 47 588 589 I-lower_bound
by 48 50 590 592 O
transthoracic 51 64 593 606 B-treatment
echocardiogram 65 79 607 621 I-treatment
or 80 82 622 624 O
multigated 83 93 625 635 B-treatment
acquisition 94 105 636 647 I-treatment
scan 106 110 648 652 I-treatment
( 111 112 653 654 I-treatment
MUGA 112 116 654 658 I-treatment
) 116 117 658 659 I-treatment

Leukocytes 0 10 660 670 B-clinical_variable
≥ 11 12 671 672 O
3,000 13 18 673 678 B-lower_bound
/ 18 19 678 679 I-lower_bound
mcL 19 22 679 682 I-lower_bound

Patients 0 8 683 691 O
with 9 13 692 696 O
histologically 14 28 697 711 O
confirmed 29 38 712 721 O
palpable 39 47 722 730 O
lymph 48 53 731 736 O
nodes 54 59 737 742 O
may 60 63 743 746 O
be 64 66 747 749 O
enrolled 67 75 750 758 O
regardless 76 86 759 769 O
of 87 89 770 772 O
breast 90 96 773 779 B-cancer
tumor 97 102 780 785 I-cancer
size 103 107 786 790 O

Platelets 0 9 791 800 B-clinical_variable
≥ 10 11 801 802 O
100,000 12 19 803 810 B-lower_bound
/ 19 20 810 811 I-lower_bound
mcl 20 23 811 814 I-lower_bound

Pregnant 0 8 815 823 B-pregnancy

Tumor 0 5 824 829 B-clinical_variable
size 6 10 830 834 I-clinical_variable
at 11 13 835 837 O
least 14 19 838 843 O
2 20 21 844 845 B-lower_bound
cm 22 24 846 848 I-lower_bound
in 25 27 849 851 O
one 28 31 852 855 O
dimension 32 41 856 865 O
by 42 44 866 868 O
clinical 45 53 869 877 O
or 54 56 878 880 O
radiographic 57 69 881 893 O
exam 70 74 894 898 O
( 75 76 899 900 O
World 76 81 900 905 O
Health 82 88 906 912 O
Organization 89 101 913 925 O
( 102 103 926 927 O
WHO 103 106 927 930 O
) 106 107 930 931 O
criteria 108 116 932 940 O
) 116 117 940 941 O

Uncontrolled 0 12 942 954 O
intercurrent 13 25 955 967 O
illness 26 33 968 975 O
including 34 43 976 985 O
, 43 44 985 986 O
but 45 48 987 990 O
not 49 52 991 994 O
limited 53 60 995 1002 O
to 61 63 1003 1005 O
, 63 64 1005 1006 O
ongoing 65 72 1007 1014 B-chronic_disease
or 73 75 1015 1017 I-chronic_disease
active 76 82 1018 1024 I-chronic_disease
infection 83 92 1025 1034 I-chronic_disease
, 92 93 1034 1035 O
symptomatic 94 105 1036 1047 B-chronic_disease
congestive 106 116 1048 1058 I-chronic_disease
heart 117 122 1059 1064 I-chronic_disease
failure 123 130 1065 1072 I-chronic_disease
, 130 131 1072 1073 O
unstable 132 140 1074 1082 B-chronic_disease
angina 141 147 1083 1089 I-chronic_disease
pectoris 148 156 1090 1098 I-chronic_disease
, 156 157 1098 1099 O
or 158 160 1100 1102 O
cardiac 161 168 1103 1110 B-chronic_disease
arrhythmia 169 179 1111 1121 I-chronic_disease

Women 0 5 1122 1127 B-gender
of 6 8 1128 1130 O
childbearing 9 21 1131 1143 O
potential 22 31 1144 1153 O
must 32 36 1154 1158 O
agree 37 42 1159 1164 O
to 43 45 1165 1167 O
undergo 46 53 1168 1175 O
pregnancy 54 63 1176 1185 O
testing 64 71 1186 1193 O
within 72 78 1194 1200 O
14 79 81 1201 1203 B-upper_bound
days 82 86 1204 1208 I-upper_bound
of 87 89 1209 1211 O
study 90 95 1212 1217 O
entry 96 101 1218 1223 O
and 102 105 1224 1227 O
agree 106 111 1228 1233 B-contraception_consent
to 112 114 1234 1236 I-contraception_consent
use 115 118 1237 1240 I-contraception_consent
adequate 119 127 1241 1249 I-contraception_consent
contraception 128 141 1250 1263 I-contraception_consent
( 142 143 1264 1265 O
barrier 143 150 1265 1272 O
method 151 157 1273 1279 O
of 158 160 1280 1282 O
birth 161 166 1283 1288 O
control 167 174 1289 1296 O
, 174 175 1296 1297 O
abstinence 176 186 1298 1308 O
, 186 187 1308 1309 O
not 188 191 1310 1313 O
hormonal 192 200 1314 1322 O
) 200 201 1322 1323 O
prior 202 207 1324 1329 O
to 208 210 1330 1332 O
study 211 216 1333 1338 O
entry 217 222 1339 1344 O
and 223 226 1345 1348 O
for 227 230 1349 1352 O
the 231 234 1353 1356 O
duration 235 243 1357 1365 O
of 244 246 1366 1368 O
study 247 252 1369 1374 O
participation 253 266 1375 1388 O
as 267 269 1389 1391 O
well 270 274 1392 1396 O
as 275 277 1397 1399 O
chemical 278 286 1400 1408 O
LHRH 287 291 1409 1413 O
Agonist 292 299 1414 1421 O
with 300 304 1422 1426 O
goserelin 305 314 1427 1436 O

Women 0 5 1437 1442 B-gender
of 6 8 1443 1445 O
childbearing 9 21 1446 1458 O
potential 22 31 1459 1468 O
must 32 36 1469 1473 O
have 37 41 1474 1478 O
a 42 43 1479 1480 O
negative 44 52 1481 1489 B-pregnancy
pregnancy 53 62 1490 1499 I-pregnancy
test 63 67 1500 1504 O
within 68 74 1505 1511 O
14 75 77 1512 1514 B-upper_bound
days 78 82 1515 1519 I-upper_bound
of 83 85 1520 1522 O
study 86 91 1523 1528 O
entry 92 97 1529 1534 O

Are 0 3 0 3 O
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound
of 13 15 13 15 O
age 16 19 16 19 B-age
or 20 22 20 22 O
older 23 28 23 28 O

Have 0 4 29 33 O
a 5 6 34 35 O
life 7 11 36 40 B-clinical_variable
expectancy 12 22 41 51 I-clinical_variable
greater 23 30 52 59 O
than 31 35 60 64 O
3 36 37 65 66 B-lower_bound
months 38 44 67 73 I-lower_bound

Have 0 4 74 78 O
active 5 11 79 85 B-chronic_disease
angina 12 18 86 92 I-chronic_disease
pectoris 19 27 93 101 I-chronic_disease
or 28 30 102 104 O
recent 31 37 105 111 O
myocardial 38 48 112 122 B-chronic_disease
infarction 49 59 123 133 I-chronic_disease
( 60 61 134 135 O
within 61 67 135 141 O
6 68 69 142 143 B-upper_bound
months 70 76 144 150 I-upper_bound
) 76 77 150 151 O

Have 0 4 152 156 O
active 5 11 157 163 O
, 11 12 163 164 O
acute 13 18 165 170 O
, 18 19 170 171 O
or 20 22 172 174 O
chronic 23 30 175 182 O
clinically 31 41 183 193 O
significant 42 53 194 205 O
infections 54 64 206 216 B-chronic_disease

Have 0 4 217 221 O
additional 5 15 222 232 O
uncontrolled 16 28 233 245 O
serious 29 36 246 253 O
medical 37 44 254 261 O
or 45 47 262 264 O
psychiatric 48 59 265 276 B-chronic_disease
illness 60 67 277 284 I-chronic_disease

Have 0 4 285 289 O
an 5 7 290 292 O
Eastern 8 15 293 300 B-clinical_variable
Cooperative 16 27 301 312 I-clinical_variable
Oncology 28 36 313 321 I-clinical_variable
Group 37 42 322 327 I-clinical_variable
( 43 44 328 329 I-clinical_variable
ECOG 44 48 329 333 I-clinical_variable
) 48 49 333 334 I-clinical_variable
performance 50 61 335 346 I-clinical_variable
status 62 68 347 353 I-clinical_variable
of 69 71 354 356 O
0 72 73 357 358 B-lower_bound
or 74 76 359 361 O
1 77 78 362 363 B-upper_bound

Have 0 4 364 368 O
any 5 8 369 372 O
medical 9 16 373 380 O
condition 17 26 381 390 O
that 27 31 391 395 O
could 32 37 396 401 O
impair 38 44 402 408 O
the 45 48 409 412 O
administration 49 63 413 427 O
of 64 66 428 430 O
oral 67 71 431 435 O
agents 72 78 436 442 O
including 79 88 443 452 O
significant 89 100 453 464 O
bowel 101 106 465 470 B-treatment
resection 107 116 471 480 I-treatment
, 116 117 480 481 O
inflammatory 118 130 482 494 B-chronic_disease
bowel 131 136 495 500 I-chronic_disease
disease 137 144 501 508 I-chronic_disease
or 145 147 509 511 O
uncontrolled 148 160 512 524 O
nausea 161 167 525 531 O
or 168 170 532 534 O
vomiting 171 179 535 543 O

Have 0 4 544 548 O
chronic 5 12 549 556 B-chronic_disease
atrial 13 19 557 563 I-chronic_disease
fibrillation 20 32 564 576 I-chronic_disease
or 33 35 577 579 O
QTc 36 39 580 583 B-clinical_variable
of 40 42 584 586 O
greater 43 50 587 594 O
than 51 55 595 599 O
470 56 59 600 603 B-lower_bound
msec 60 64 604 608 I-lower_bound
, 64 65 608 609 O
as 66 68 610 612 O
calculated 69 79 613 623 O
by 80 82 624 626 O
Bazett 83 89 627 633 O
's 89 91 633 635 O
correction 92 102 636 646 O
formula 103 110 647 654 O

Have 0 4 655 659 O
clinical 5 13 660 668 O
symptomatic 14 25 669 680 O
congestive 26 36 681 691 B-chronic_disease
heart 37 42 692 697 I-chronic_disease
failure 43 50 698 705 I-chronic_disease
defined 51 58 706 713 O
at 59 61 714 716 O
> 62 63 717 718 O
= 63 64 718 719 O
Class 65 70 720 725 O
II 71 73 726 728 O
of 74 76 729 731 O
the 77 80 732 735 O
New 81 84 736 739 B-clinical_variable
York 85 89 740 744 I-clinical_variable
Heart 90 95 745 750 I-clinical_variable
Association 96 107 751 762 I-clinical_variable
functional 108 118 763 773 I-clinical_variable
classification 119 133 774 788 I-clinical_variable
system 134 140 789 795 O
or 141 143 796 798 O
LVEF 144 148 799 803 B-clinical_variable
< 149 150 804 805 O
50 151 153 806 808 B-upper_bound
% 153 154 808 809 I-upper_bound
at 155 157 810 812 O
baseline 158 166 813 821 O

Have 0 4 822 826 O
had 5 8 827 830 O
major 9 14 831 836 B-treatment
surgery 15 22 837 844 I-treatment
within 23 29 845 851 O
21 30 32 852 854 B-upper_bound
days 33 37 855 859 I-upper_bound
of 38 40 860 862 O
starting 41 49 863 871 O
therapy 50 57 872 879 O

Have 0 4 880 884 O
histologic 5 15 885 895 O
or 16 18 896 898 O
cytological 19 30 899 910 O
proof 31 36 911 916 O
of 37 39 917 919 O
advanced 40 48 920 928 O
cancer 49 55 929 935 B-cancer
that 56 60 936 940 O
has 61 64 941 944 O
progressed 65 75 945 955 O
and 76 79 956 959 O
for 80 83 960 963 O
which 84 89 964 969 O
there 90 95 970 975 O
is 96 98 976 978 O
no 99 101 979 981 O
further 102 109 982 989 O
standard 110 118 990 998 O
anticancer 119 129 999 1009 B-treatment
therapy 130 137 1010 1017 I-treatment
available 138 147 1018 1027 O
in 148 150 1028 1030 O
the 151 154 1031 1034 O
opinion 155 162 1035 1042 O
of 163 165 1043 1045 O
the 166 169 1046 1049 O
investigator 170 182 1050 1062 O

Have 0 4 1063 1067 O
received 5 13 1068 1076 O
radiotherapy 14 26 1077 1089 B-treatment
, 26 27 1089 1090 O
chemotherapy 28 40 1091 1103 B-treatment
, 40 41 1103 1104 O
biological 42 52 1105 1115 B-treatment
therapy 53 60 1116 1123 I-treatment
or 61 63 1124 1126 O
investigational 64 79 1127 1142 B-treatment
treatment 80 89 1143 1152 I-treatment
less 90 94 1153 1157 O
than 95 99 1158 1162 O
four 100 104 1163 1167 B-lower_bound
weeks 105 110 1168 1173 I-lower_bound
( 111 112 1174 1175 O
six 112 115 1175 1178 O
weeks 116 121 1179 1184 O
for 122 125 1185 1188 O
nitrosourea 126 137 1189 1200 B-treatment
or 138 140 1201 1203 O
mitomycin 141 150 1204 1213 B-treatment
C 151 152 1214 1215 I-treatment
) 152 153 1215 1216 O
prior 154 159 1217 1222 O
to 160 162 1223 1225 O
first 163 168 1226 1231 O
dose 169 173 1232 1236 O
of 174 176 1237 1239 O
study 177 182 1240 1245 O
medication 183 193 1246 1256 B-treatment
or 194 196 1257 1259 O
have 197 201 1260 1264 O
not 202 205 1265 1268 O
recovered 206 215 1269 1278 O
from 216 220 1279 1283 O
all 221 224 1284 1287 O
acute 225 230 1288 1293 O
toxicities 231 241 1294 1304 O
from 242 246 1305 1309 O
prior 247 252 1310 1315 B-treatment
treatments 253 263 1316 1326 I-treatment

Have 0 4 1327 1331 O
uncontrolled 5 17 1332 1344 O
severe 18 24 1345 1351 B-chronic_disease
hypertension 25 37 1352 1364 I-chronic_disease

Known 0 5 1365 1370 O
central 6 13 1371 1378 B-cancer
nervous 14 21 1379 1386 I-cancer
system 22 28 1387 1393 I-cancer
metastasis 29 39 1394 1404 I-cancer

Negative 0 8 1405 1413 B-pregnancy
serum 9 14 1414 1419 I-pregnancy
pregnancy 15 24 1420 1429 I-pregnancy
test 25 29 1430 1434 O
with 30 34 1435 1439 O
72 35 37 1440 1442 B-upper_bound
hours 38 43 1443 1448 I-upper_bound
prior 44 49 1449 1454 I-upper_bound
to 50 52 1455 1457 O
start 53 58 1458 1463 O
of 59 61 1464 1466 O
study 62 67 1467 1472 O
drug 68 72 1473 1477 O

Patients 0 8 1478 1486 O
being 9 14 1487 1492 O
treated 15 22 1493 1500 O
with 23 27 1501 1505 O
certain 28 35 1506 1513 O
drugs 36 41 1514 1519 O
not 42 45 1520 1523 O
acceptable 46 56 1524 1534 O
while 57 62 1535 1540 O
receiving 63 72 1541 1550 O
CFI-400945 73 83 1551 1561 B-treatment
fumarate 84 92 1562 1570 I-treatment

Patients 0 8 1571 1579 O
being 9 14 1580 1585 O
treated 15 22 1586 1593 O
with 23 27 1594 1598 O
full 28 32 1599 1603 O
dose 33 37 1604 1608 O
warfarin 38 46 1609 1617 B-treatment

Patients 0 8 1618 1626 O
who 9 12 1627 1630 O
have 13 17 1631 1635 O
received 18 26 1636 1644 O
growth 27 33 1645 1651 B-treatment
factors 34 41 1652 1659 I-treatment
within 42 48 1660 1666 O
14 49 51 1667 1669 B-upper_bound
days 52 56 1670 1674 I-upper_bound
prior 57 62 1675 1680 I-upper_bound
to 63 65 1681 1683 O
initiation 66 76 1684 1694 O
of 77 79 1695 1697 O
dosing 80 86 1698 1704 O
of 87 89 1705 1707 O
CFI-400945 90 100 1708 1718 B-treatment
fumarate 101 109 1719 1727 I-treatment

Patients 0 8 1728 1736 O
with 9 13 1737 1741 O
history 14 21 1742 1749 O
of 22 24 1750 1752 O
deep 25 29 1753 1757 B-chronic_disease
vein 30 34 1758 1762 I-chronic_disease
thrombosis 35 45 1763 1773 I-chronic_disease
or 46 48 1774 1776 O
pulmonary 49 58 1777 1786 B-chronic_disease
embolus 59 66 1787 1794 I-chronic_disease
who 67 70 1795 1798 O
are 71 74 1799 1802 O
being 75 80 1803 1808 O
treated 81 88 1809 1816 O
with 89 93 1817 1821 O
therapeutic 94 105 1822 1833 O
doses 106 111 1834 1839 O
of 112 114 1840 1842 O
low 115 118 1843 1846 B-treatment
molecular 119 128 1847 1856 I-treatment
weight 129 135 1857 1863 I-treatment
heparin 136 143 1864 1871 I-treatment
or 144 146 1872 1874 O
prophylactic 147 159 1875 1887 B-treatment
dose 160 164 1888 1892 I-treatment
anticoagulants 165 179 1893 1907 I-treatment
may 180 183 1908 1911 O
be 184 186 1912 1914 O
enrolled 187 195 1915 1923 O

Placement 0 9 1924 1933 O
of 10 12 1934 1936 O
a 13 14 1937 1938 O
venous 15 21 1939 1945 B-treatment
access 22 28 1946 1952 I-treatment
device 29 35 1953 1959 I-treatment
within 36 42 1960 1966 O
21 43 45 1967 1969 B-upper_bound
days 46 50 1970 1974 I-upper_bound
of 51 53 1975 1977 O
starting 54 62 1978 1986 O
therapy 63 70 1987 1994 B-treatment

Women 0 5 1995 2000 B-gender
and 6 9 2001 2004 I-gender
men 10 13 2005 2008 I-gender
of 14 16 2009 2011 O
child 17 22 2012 2017 O
producing 23 32 2018 2027 O
potential 33 42 2028 2037 O
must 43 47 2038 2042 O
agree 48 53 2043 2048 B-contraception_consent
to 54 56 2049 2051 I-contraception_consent
use 57 60 2052 2055 I-contraception_consent
highly 61 67 2056 2062 I-contraception_consent
effective 68 77 2063 2072 I-contraception_consent
means 78 83 2073 2078 I-contraception_consent
of 84 86 2079 2081 I-contraception_consent
contraception 87 100 2082 2095 I-contraception_consent
during 101 107 2096 2102 O
study 108 113 2103 2108 O
participation 114 127 2109 2122 O
, 127 128 2122 2123 O
and 129 132 2124 2127 O
for 133 136 2128 2131 O
at 137 139 2132 2134 O
least 140 145 2135 2140 O
30 146 148 2141 2143 B-lower_bound
days 149 153 2144 2148 I-lower_bound
after 154 159 2149 2154 O
the 160 163 2155 2158 O
last 164 168 2159 2163 O
administration 169 183 2164 2178 O
of 184 186 2179 2181 O
study 187 192 2182 2187 O
medication 193 203 2188 2198 B-treatment

Women 0 5 2199 2204 B-gender
who 6 9 2205 2208 O
are 10 13 2209 2212 B-pregnancy
pregnant 14 22 2213 2221 I-pregnancy
or 23 25 2222 2224 O
nursing 26 33 2225 2232 O

CLBP 0 4 0 4 B-chronic_disease
lasting 5 12 5 12 O
for 13 16 13 16 O
more 17 21 17 21 O
than 22 26 22 26 O
6 27 28 27 28 B-lower_bound
months 29 35 29 35 I-lower_bound
as 36 38 36 38 O
the 39 42 39 42 O
primary 43 50 43 50 O
complaint 51 60 51 60 O

candidate 0 9 61 70 O
for 10 13 71 74 O
oral 14 18 75 79 B-treatment
opioid 19 25 80 86 I-treatment
therapy 26 33 87 94 I-treatment
as 34 36 95 97 O
assessed 37 45 98 106 O
at 46 48 107 109 O
the 49 52 110 113 O
BWH 53 56 114 117 O
Pain 57 61 118 122 O
Management 62 72 123 133 O
Center 73 79 134 140 O

current 0 7 141 148 O
( 8 9 149 150 O
i.e. 9 13 150 154 O
, 13 14 154 155 O
active 15 21 156 162 O
) 21 22 162 163 O
substance 23 32 164 173 B-chronic_disease
use 33 36 174 177 I-chronic_disease
disorder 37 45 178 186 I-chronic_disease
( 46 47 187 188 I-chronic_disease
SUD 47 50 188 191 I-chronic_disease
) 50 51 191 192 I-chronic_disease

current 0 7 193 200 O
peripheral 8 18 201 211 B-chronic_disease
neuropathy 19 29 212 222 I-chronic_disease

current 0 7 223 230 O
pregnancy 8 17 231 240 B-pregnancy

evidence 0 8 241 249 O
of 9 11 250 252 O
delirium 12 20 253 261 B-chronic_disease
, 20 21 261 262 O
dementia 22 30 263 271 B-chronic_disease
, 30 31 271 272 O
psychosis 32 41 273 282 B-chronic_disease
, 41 42 282 283 O
or 43 45 284 286 O
other 46 51 287 292 O
cognitive 52 61 293 302 B-chronic_disease
impairment 62 72 303 313 I-chronic_disease
preventing 73 83 314 324 O
completion 84 94 325 335 O
of 95 97 336 338 O
study 98 103 339 344 O
procedures 104 114 345 355 O

past 0 4 356 360 O
history 5 12 361 368 O
of 13 15 369 371 O
persistent 16 26 372 382 O
opioid 27 33 383 389 B-treatment
use 34 37 390 393 O
( 38 39 394 395 O
i.e. 39 43 395 399 O
, 43 44 399 400 O
opioid 45 51 401 407 O
use 52 55 408 411 O
for 56 59 412 415 O
more 60 64 416 420 O
than 65 69 421 425 O
6 70 71 426 427 B-lower_bound
months 72 78 428 434 I-lower_bound
) 78 79 434 435 O
given 80 85 436 441 O
that 86 90 442 446 O
this 91 95 447 451 O
could 96 101 452 457 O
affect 102 108 458 464 O
the 109 112 465 468 O
biological 113 123 469 479 O
systems 124 131 480 487 O
of 132 134 488 490 O
interest 135 143 491 499 O
in 144 146 500 502 O
the 147 150 503 506 O
present 151 158 507 514 O
study 159 164 515 520 O

typical 0 7 521 528 B-clinical_variable
pain 8 12 529 533 I-clinical_variable
ratings 13 20 534 541 I-clinical_variable
≥ 21 22 542 543 O
4/10 23 27 544 548 B-lower_bound
on 28 30 549 551 O
a 31 32 552 553 O
visual 33 39 554 560 B-clinical_variable
analogue 40 48 561 569 I-clinical_variable
scale 49 54 570 575 I-clinical_variable

Congestive 0 10 0 10 B-chronic_disease
heart 11 16 11 16 I-chronic_disease
failure 17 24 17 24 I-chronic_disease

Diabetes 0 8 25 33 B-chronic_disease
requiring 9 18 34 43 O
the 19 22 44 47 O
use 23 26 48 51 O
of 27 29 52 54 O
insulin 30 37 55 62 B-treatment

Hemoglobin 0 10 63 73 B-clinical_variable
< 11 12 74 75 O
10 13 15 76 78 B-upper_bound
g 16 17 79 80 I-upper_bound
/ 17 18 80 81 I-upper_bound
dL 18 20 81 83 I-upper_bound
on 21 23 84 86 O
point 24 29 87 92 O
of 30 32 93 95 O
care 33 37 96 100 O
screening 38 47 101 110 O

History 0 7 111 118 O
of 8 10 119 121 O
moderate 11 19 122 130 O
to 20 22 131 133 O
severe 23 29 134 140 B-chronic_disease
Obstructive 30 41 141 152 I-chronic_disease
sleep 42 47 153 158 I-chronic_disease
apnea 48 53 159 164 I-chronic_disease
( 54 55 165 166 I-chronic_disease
OSA 55 58 166 169 I-chronic_disease
) 58 59 169 170 I-chronic_disease

Known 0 5 171 176 O
pregnancy 6 15 177 186 B-pregnancy
, 15 16 186 187 O
by 17 19 188 190 O
urine 20 25 191 196 O
testing 26 33 197 204 O
in 34 36 205 207 O
women 37 42 208 213 B-gender
of 43 45 214 216 O
child 46 51 217 222 O
- 51 52 222 223 O
bearing 52 59 223 230 O
age 60 63 231 234 B-age

Uncontrolled 0 12 235 247 O
hypertension 13 25 248 260 B-chronic_disease
with 26 30 261 265 O
systolic 31 39 266 274 B-clinical_variable
blood 40 45 275 280 I-clinical_variable
pressure 46 54 281 289 I-clinical_variable
> 55 56 290 291 O
170 56 59 291 294 B-lower_bound
or 60 62 295 297 O
diastolic 63 72 298 307 B-clinical_variable
blood 73 78 308 313 I-clinical_variable
pressure 79 87 314 322 I-clinical_variable
> 88 89 323 324 O
110 90 93 325 328 B-lower_bound

Complicating 0 12 0 12 O
medical 13 20 13 20 O
problems 21 29 21 29 O
such 30 34 30 34 O
as 35 37 35 37 O
uncontrolled 38 50 38 50 B-chronic_disease
hypertension 51 63 51 63 I-chronic_disease
, 63 64 63 64 O
diabetes 65 73 65 73 B-chronic_disease
with 74 78 74 78 O
signs 79 84 79 84 O
of 85 87 85 87 O
polyneuropathy 88 102 88 102 B-chronic_disease
, 102 103 102 103 O
severe 104 110 104 110 B-chronic_disease
renal 111 116 111 116 I-chronic_disease
, 116 117 116 117 O
cardiac 118 125 118 125 B-chronic_disease
or 126 128 126 128 O
pulmonary 129 138 129 138 B-chronic_disease
disease 139 146 139 146 I-chronic_disease
, 146 147 146 147 O
or 148 150 148 150 O
evidence 151 159 151 159 O
of 160 162 160 162 O
other 163 168 163 168 O
concurrent 169 179 169 179 O
neurologic 180 190 180 190 O
or 191 193 191 193 O
orthopedic 194 204 194 204 O
conditions 205 215 205 215 O
precluding 216 226 216 226 O
the 227 230 227 230 O
subject 231 238 231 238 O
from 239 243 239 243 O
complying 244 253 244 253 O
with 254 258 254 258 O
the 259 262 259 262 O
study 263 268 263 268 O
protocol 269 277 269 277 O

Evidence 0 8 278 286 O
of 9 11 287 289 O
alcohol 12 19 290 297 O
, 19 20 297 298 O
drug 21 25 299 303 O
abuse 26 31 304 309 O
or 32 34 310 312 O
other 35 40 313 318 O
relevant 41 49 319 327 O
neuropsychiatric 50 66 328 344 B-chronic_disease
condition 67 76 345 354 I-chronic_disease
such 77 81 355 359 O
as 82 84 360 362 O
psychotic 85 94 363 372 B-chronic_disease
illness 95 102 373 380 I-chronic_disease
or 103 105 381 383 O
severe 106 112 384 390 B-chronic_disease
depression 113 123 391 401 I-chronic_disease

History 0 7 402 409 O
of 8 10 410 412 O
surgery 11 18 413 420 B-treatment
or 19 21 421 423 O
other 22 27 424 429 O
significant 28 39 430 441 O
injury 40 46 442 448 O
to 47 49 449 451 O
either 50 56 452 458 O
upper 57 62 459 464 O
extremity 63 72 465 474 O
causing 73 80 475 482 O
mechanical 81 91 483 493 O
limitations 92 103 494 505 O
that 104 108 506 510 O
preclude 109 117 511 519 O
task 118 122 520 524 O
performance 123 134 525 536 O

Previous 0 8 537 545 O
neurological 9 21 546 558 B-chronic_disease
illness 22 29 559 566 I-chronic_disease
such 30 34 567 571 O
as 35 37 572 574 O
head 38 42 575 579 B-chronic_disease
trauma 43 49 580 586 I-chronic_disease
, 49 50 586 587 O
prior 51 56 588 593 O
stroke 57 63 594 600 B-chronic_disease
, 63 64 600 601 O
epilepsy 65 73 602 610 B-chronic_disease
, 73 74 610 611 O
or 75 77 612 614 O
demyelinating 78 91 615 628 B-chronic_disease
disease 92 99 629 636 I-chronic_disease

Severe 0 6 637 643 O
upper 7 12 644 649 B-chronic_disease
extremity 13 22 650 659 I-chronic_disease
spasticity 23 33 660 670 I-chronic_disease
suggested 34 43 671 680 O
by 44 46 681 683 O
an 47 49 684 686 O
Ashworth 50 58 687 695 B-clinical_variable
score 59 64 696 701 I-clinical_variable
of 65 67 702 704 O
> 68 69 705 706 O
3 69 70 706 707 B-lower_bound
at 71 73 708 710 O
any 74 77 711 714 O
joint 78 83 715 720 O

Subjects 0 8 721 729 O
must 9 13 730 734 O
have 14 18 735 739 O
had 19 22 740 743 O
a 23 24 744 745 O
unilateral 25 35 746 756 B-chronic_disease
stroke 36 42 757 763 I-chronic_disease

ability 0 7 764 771 O
to 8 10 772 774 O
comply 11 17 775 781 O
with 18 22 782 786 O
the 23 26 787 790 O
therapy 27 34 791 798 B-treatment
protocol 35 43 799 807 O
as 44 46 808 810 O
assessed 47 55 811 819 O
by 56 58 820 822 O
the 59 62 823 826 O
investigator 63 75 827 839 O
; 75 76 839 840 O
must 77 81 841 845 B-language_fluency
be 82 84 846 848 I-language_fluency
English 85 92 849 856 I-language_fluency
speakin 93 100 857 864 I-language_fluency

Ability 0 7 0 7 B-language_fluency
to 8 10 8 10 I-language_fluency
read 11 15 11 15 I-language_fluency
and 16 19 16 19 I-language_fluency
speak 20 25 20 25 I-language_fluency
fluent 26 32 26 32 I-language_fluency
English 33 40 33 40 I-language_fluency

Age 0 3 41 44 B-age
16 4 6 45 47 B-lower_bound
- 6 7 47 48 O
45 7 9 48 50 B-upper_bound
years 10 15 51 56 I-upper_bound

Comorbid 0 8 57 65 O
attention 9 18 66 75 B-chronic_disease
deficit 19 26 76 83 I-chronic_disease
hyperactivity 27 40 84 97 I-chronic_disease
disorder 41 49 98 106 I-chronic_disease
( 50 51 107 108 I-chronic_disease
ADHD 51 55 108 112 I-chronic_disease
) 55 56 112 113 I-chronic_disease
that 57 61 114 118 O
is 62 64 119 121 O
untreated 65 74 122 131 O

Comorbid 0 8 132 140 B-chronic_disease
personality 9 20 141 152 I-chronic_disease
disorder 21 29 153 161 I-chronic_disease

Diagnosis 0 9 162 171 O
of 10 12 172 174 O
autism 13 19 175 181 B-chronic_disease
, 19 20 181 182 O
Asperger 21 29 183 191 B-chronic_disease
's 29 31 191 193 I-chronic_disease
syndrome 32 40 194 202 I-chronic_disease
, 40 41 202 203 O
or 42 44 204 206 O
pervasive 45 54 207 216 B-chronic_disease
developmental 55 68 217 230 I-chronic_disease
disorder 69 77 231 239 I-chronic_disease
not 78 81 240 243 O
otherwise 82 91 244 253 O
specified 92 101 254 263 O
( 102 103 264 265 O
NOS 103 106 265 268 O
) 106 107 268 269 O
verified 108 116 270 278 O
by 117 119 279 281 O
the 120 123 282 285 O
autism 124 130 286 292 O
diagnostic 131 141 293 303 O
observation 142 153 304 315 O
schedule 154 162 316 324 O
( 163 164 325 326 O
ADOS 164 168 326 330 O
) 168 169 330 331 O
or 170 172 332 334 O
autism 173 179 335 341 O
diagnostic 180 190 342 352 O
interview 191 200 353 362 O
- 200 201 362 363 O
revised 201 208 363 370 O
( 209 210 371 372 O
ADI 210 213 372 375 O
- 213 214 375 376 O
R 214 215 376 377 O
) 215 216 377 378 O

English 0 7 379 386 B-clinical_variable
language 8 16 387 395 I-clinical_variable
skills 17 23 396 402 I-clinical_variable
below 24 29 403 408 O
a 30 31 409 410 O
sixth 32 37 411 416 B-upper_bound
grade 38 43 417 422 I-upper_bound
level 44 49 423 428 I-upper_bound

IQ 0 2 429 431 B-clinical_variable
< 3 4 432 433 O
80 5 7 434 436 B-upper_bound

Intelligence 0 12 437 449 B-clinical_variable
quotient 13 21 450 458 I-clinical_variable
( 22 23 459 460 I-clinical_variable
IQ 23 25 460 462 I-clinical_variable
) 25 26 462 463 I-clinical_variable
greater 27 34 464 471 O
than 35 39 472 476 O
80 40 42 477 479 B-lower_bound

Organic 0 7 480 487 B-chronic_disease
brain 8 13 488 493 I-chronic_disease
syndrome 14 22 494 502 I-chronic_disease

Presence 0 8 503 511 O
of 9 11 512 514 O
significant 12 23 515 526 O
social 24 30 527 533 O
and 31 34 534 537 O
cognitive 35 44 538 547 B-chronic_disease
disability 45 55 548 558 I-chronic_disease
, 55 56 558 559 O
based 57 62 560 565 O
on 63 65 566 568 O
the 66 69 569 572 O
Cognitive 70 79 573 582 O
Style 80 85 583 588 O
and 86 89 589 592 O
Social 90 96 593 599 O
Cognition 97 106 600 609 O
Eligibility 107 118 610 621 O
Interview 119 128 622 631 O
( 129 130 632 633 O
Hogarty 130 137 633 640 O
et 138 140 641 643 O
al 141 143 644 646 O
. 143 144 646 647 O
, 144 145 647 648 O
2004 146 150 649 653 O
) 150 151 653 654 O

disruptive 0 10 655 665 B-chronic_disease
or 11 13 666 668 I-chronic_disease
violent 14 21 669 676 I-chronic_disease
behavior 22 30 677 685 I-chronic_disease

Foley 0 5 0 5 B-clinical_variable
catheter 6 14 6 14 I-clinical_variable
in 15 17 15 17 O
place 18 23 18 23 O
for 24 27 24 27 O
greater 28 35 28 35 O
than 36 40 36 40 O
1 41 42 41 42 B-lower_bound
week 43 47 43 47 I-lower_bound
duration 48 56 48 56 O

Patients 0 8 57 65 O
< 9 10 66 67 O
18 10 12 67 69 B-lower_bound
years 13 18 70 75 I-lower_bound
old 19 22 76 79 O

Patients 0 8 80 88 O
> 9 10 89 90 O
18 10 12 90 92 B-lower_bound
years 13 18 93 98 I-lower_bound
old 19 22 99 102 O

Patients 0 8 103 111 O
currently 9 18 112 121 O
on 19 21 122 124 O
antibiotics 22 33 125 136 B-treatment
immediately 34 45 137 148 O
prior 46 51 149 154 O
to 52 54 155 157 O
the 55 58 158 161 O
procedure 59 68 162 171 O

Previous 0 8 172 180 O
history 9 16 181 188 O
of 17 19 189 191 O
sepsis 20 26 192 198 B-chronic_disease
or 27 29 199 201 O
SIRS 30 34 202 206 B-chronic_disease
from 35 39 207 211 O
stone 40 45 212 217 O
manipulations 46 59 218 231 O

Renal 0 5 232 237 B-chronic_disease
Calculi 6 13 238 245 I-chronic_disease
which 14 19 246 251 O
would 20 25 252 257 O
optimally 26 35 258 267 O
require 36 43 268 275 O
PCNL 44 48 276 280 B-treatment
for 49 52 281 284 O
treatment 53 62 285 294 B-treatment

egative 0 7 295 302 B-clinical_variable
urine 8 13 303 308 I-clinical_variable
culture 14 21 309 316 I-clinical_variable
within 22 28 317 323 O
1 29 30 324 325 B-upper_bound
month 31 36 326 331 I-upper_bound
prior 37 42 332 337 I-upper_bound
to 43 45 338 340 O
procedure 46 55 341 350 O

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease

Patient 0 7 17 24 O
scheduled 8 17 25 34 O
for 18 21 35 38 O
open 22 26 39 43 O
ventral 27 34 44 51 B-treatment
hernia 35 41 52 58 I-treatment
repair 42 48 59 65 I-treatment
at 49 51 66 68 O
LBJ 52 55 69 72 O
General 56 63 73 80 O
Hospital 64 72 81 89 O

Patient 0 7 90 97 O
unlikely 8 16 98 106 O
to 17 19 107 109 O
survive 20 27 110 117 O
with 28 32 118 122 O
the 33 36 123 126 O
next 37 41 127 131 B-upper_bound
2 42 43 132 133 I-upper_bound
years 44 49 134 139 I-upper_bound
based 50 55 140 145 O
upon 56 60 146 150 O
surgeon 61 68 151 158 O
judgment 69 77 159 167 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
cholangiocarcinoma 13 31 13 31 B-cancer

> 0 1 0 1 O
160/90 1 7 1 7 B-lower_bound
mmHg 8 12 8 12 I-lower_bound
despite 13 20 13 20 O
medical 21 28 21 28 B-treatment
therapy 29 36 29 36 I-treatment

AST 0 3 37 40 B-clinical_variable
( 4 5 41 42 I-clinical_variable
SGOT)/ALT 5 14 42 51 I-clinical_variable
( 15 16 52 53 I-clinical_variable
SGPT 16 20 53 57 I-clinical_variable
) 20 21 57 58 I-clinical_variable
≤ 22 23 59 60 O
2.5 24 27 61 64 B-upper_bound
x 28 29 65 66 I-upper_bound
institutional 30 43 67 80 B-clinical_variable
upper 44 49 81 86 I-clinical_variable
limit 50 55 87 92 I-clinical_variable
of 56 58 93 95 I-clinical_variable
normal 59 65 96 102 I-clinical_variable

Absolute 0 8 103 111 B-clinical_variable
neutrophil 9 19 112 122 I-clinical_variable
count 20 25 123 128 I-clinical_variable
( 26 27 129 130 I-clinical_variable
ANC 27 30 130 133 I-clinical_variable
) 30 31 133 134 I-clinical_variable
≥ 32 33 135 136 O
1.5 34 37 137 140 B-lower_bound
x 38 39 141 142 I-lower_bound
109 40 43 143 146 I-lower_bound
/ 43 44 146 147 I-lower_bound
L 44 45 147 148 I-lower_bound
( 46 47 149 150 O
≥ 47 48 150 151 O
1500 49 53 152 156 B-lower_bound
per 54 57 157 160 I-lower_bound
mm3 58 61 161 164 I-lower_bound
) 61 62 164 165 O

Active 0 6 166 172 O
or 7 9 173 175 O
prior 10 15 176 181 O
documented 16 26 182 192 O
autoimmune 27 37 193 203 B-chronic_disease
disease 38 45 204 211 I-chronic_disease
within 46 52 212 218 O
the 53 56 219 222 O
past 57 61 223 227 B-upper_bound
2 62 63 228 229 I-upper_bound
years 64 69 230 235 I-upper_bound

Current 0 7 236 243 O
or 8 10 244 246 O
prior 11 16 247 252 O
use 17 20 253 256 O
of 21 23 257 259 O
immunosuppressive 24 41 260 277 B-treatment
medication 42 52 278 288 I-treatment
within 53 59 289 295 O
28 60 62 296 298 B-upper_bound
days 63 67 299 303 I-upper_bound
before 68 74 304 310 O
the 75 78 311 314 O
first 79 84 315 320 O
dose 85 89 321 325 O
of 90 92 326 328 O
durvalumab 93 103 329 339 B-treatment
, 103 104 339 340 O
with 105 109 341 345 O
the 110 113 346 349 O
exceptions 114 124 350 360 O
of 125 127 361 363 O
intranasal 128 138 364 374 O
and 139 142 375 378 O
inhaled 143 150 379 386 B-treatment
corticosteroids 151 166 387 402 I-treatment
or 167 169 403 405 O
systemic 170 178 406 414 B-treatment
corticosteroids 179 194 415 430 I-treatment
at 195 197 431 433 O
physiological 198 211 434 447 O
doses 212 217 448 453 O
, 217 218 453 454 O
which 219 224 455 460 O
are 225 228 461 464 O
not 229 232 465 468 O
to 233 235 469 471 O
exceed 236 242 472 478 O
10 243 245 479 481 B-upper_bound
mg 246 248 482 484 I-upper_bound
/ 248 249 484 485 I-upper_bound
day 249 252 485 488 I-upper_bound
of 253 255 489 491 O
prednisone 256 266 492 502 B-treatment
, 266 267 502 503 O
or 268 270 504 506 O
an 271 273 507 509 O
equivalent 274 284 510 520 O
corticosteroid 285 299 521 535 O

Eastern 0 7 536 543 B-clinical_variable
Cooperative 8 19 544 555 I-clinical_variable
Oncology 20 28 556 564 I-clinical_variable
Group 29 34 565 570 I-clinical_variable
( 35 36 571 572 I-clinical_variable
ECOG 36 40 572 576 I-clinical_variable
) 40 41 576 577 I-clinical_variable
performance 42 53 578 589 I-clinical_variable
status 54 60 590 596 I-clinical_variable
of 61 63 597 599 O
0 64 65 600 601 B-lower_bound
or 66 68 602 604 O
1 69 70 605 606 B-upper_bound

Estimated 0 9 607 616 B-clinical_variable
creatinine 10 20 617 627 I-clinical_variable
clearance 21 30 628 637 I-clinical_variable
( 31 32 638 639 I-clinical_variable
Clcr 32 36 639 643 I-clinical_variable
) 36 37 643 644 I-clinical_variable
in 38 40 645 647 O
mL 41 43 648 650 O
/ 43 44 650 651 O
min 44 47 651 654 O
by 48 50 655 657 O
the 51 54 658 661 O
Cockcroft 55 64 662 671 O
- 64 65 671 672 O
Gault 65 70 672 677 O
( 71 72 678 679 O
C 72 73 679 680 O
- 73 74 680 681 O
G 74 75 681 682 O
): 75 77 682 684 O
{ 78 79 685 686 O
[ 79 80 686 687 O
140 80 83 687 690 B-upper_bound
− 84 85 691 692 O
age 86 89 693 696 B-age
( 90 91 697 698 O
years)]× 92 100 699 707 O
weight 101 107 708 714 B-clinical_variable
( 108 109 715 716 O
kg)}/{72 109 117 716 724 O
× 118 119 725 726 O
serum 120 125 727 732 B-clinical_variable
creatinine 126 136 733 743 I-clinical_variable
( 137 138 744 745 O
mg 138 140 745 747 O
/ 141 142 748 749 O
dL 143 145 750 752 O
) 145 146 752 753 O
} 146 147 753 754 O
×0.85 148 153 755 760 O
for 154 157 761 764 O
female 158 164 765 771 B-gender
patients 165 173 772 780 I-gender

Evidence 0 8 781 789 O
of 9 11 790 792 O
metastatic 12 22 793 803 B-cancer
renal 23 28 804 809 I-cancer
cell 29 33 810 814 I-cancer
carcinoma 34 43 815 824 I-cancer
on 44 46 825 827 O
imaging 47 54 828 835 O
and/or 55 61 836 842 O
biopsy 62 68 843 849 O

Female 0 6 850 856 B-gender
subjects 7 15 857 865 I-gender
must 16 20 866 870 O
either 21 27 871 877 O
be 28 30 878 880 O
of 31 33 881 883 O
non 34 37 884 887 O
- 37 38 887 888 O
reproductive 38 50 888 900 O
potential 51 60 901 910 O

Female 0 6 911 917 B-gender
subjects 7 15 918 926 I-gender
who 16 19 927 930 O
are 20 23 931 934 B-pregnancy
pregnant 24 32 935 943 I-pregnancy

Glomerular 0 10 944 954 B-clinical_variable
filtration 11 21 955 965 I-clinical_variable
rate 22 26 966 970 I-clinical_variable
> 27 28 971 972 O
40ml 29 33 973 977 B-lower_bound
/ 33 34 977 978 I-lower_bound
min/1.73m2 34 44 978 988 I-lower_bound
as 45 47 989 991 O
estimated 48 57 992 1001 O
by 58 60 1002 1004 O
the 61 64 1005 1008 O
Cockcroft 65 74 1009 1018 O
- 74 75 1018 1019 O
Gault 75 80 1019 1024 O
formula 81 88 1025 1032 O
or 89 91 1033 1035 O
creatinine 92 102 1036 1046 B-clinical_variable
clearance 103 112 1047 1056 I-clinical_variable
> 113 114 1057 1058 O
50ml 114 118 1058 1062 B-lower_bound
/ 118 119 1062 1063 I-lower_bound
min 119 122 1063 1066 I-lower_bound
as 123 125 1067 1069 O
determined 126 136 1070 1080 O
by 137 139 1081 1083 O
24 140 142 1084 1086 O
- 142 143 1086 1087 O
hour 143 147 1087 1091 O
urine 148 153 1092 1097 O
collection 154 164 1098 1108 O

Hemoglobin 0 10 1109 1119 B-clinical_variable
≥ 11 12 1120 1121 O
8.0 13 16 1122 1125 B-lower_bound
g 17 18 1126 1127 I-lower_bound
/ 18 19 1127 1128 I-lower_bound
dL 19 21 1128 1130 I-lower_bound

History 0 7 1131 1138 O
of 8 10 1139 1141 O
allogeneic 11 21 1142 1152 B-treatment
organ 22 27 1153 1158 I-treatment
transplant 28 38 1159 1169 I-treatment

History 0 7 1170 1177 O
of 8 10 1178 1180 O
hypersensitivity 11 27 1181 1197 O
to 28 30 1198 1200 O
tremelimumab 31 43 1201 1213 B-allergy_name
or 44 46 1214 1216 O
any 47 50 1217 1220 O
excipient 51 60 1221 1230 B-allergy_name

History 0 7 1231 1238 O
of 8 10 1239 1241 O
leptomeningeal 11 25 1242 1256 B-chronic_disease
carcinomatosis 26 40 1257 1271 I-chronic_disease

History 0 7 1272 1279 O
of 8 10 1280 1282 O
primary 11 18 1283 1290 B-chronic_disease
immunodeficiency 19 35 1291 1307 I-chronic_disease

In 0 2 1308 1310 O
case 3 7 1311 1315 O
of 8 10 1316 1318 O
clinically 11 21 1319 1329 O
significant 22 33 1330 1341 O
ECG 34 37 1342 1345 O
abnormalities 38 51 1346 1359 O
, 51 52 1359 1360 O
including 53 62 1361 1370 O
a 63 64 1371 1372 O
QTcF 65 69 1373 1377 B-clinical_variable
value 70 75 1378 1383 I-clinical_variable
> 76 77 1384 1385 O
470 77 80 1385 1388 B-lower_bound
ms 81 83 1389 1391 I-lower_bound
, 83 84 1391 1392 O
2 85 86 1393 1394 O
additional 87 97 1395 1405 O
12 98 100 1406 1408 O
- 100 101 1408 1409 O
lead 101 105 1409 1413 O
ECGs 106 110 1414 1418 O
should 111 117 1419 1425 O
be 118 120 1426 1428 O
obtained 121 129 1429 1437 O
over 130 134 1438 1442 O
a 135 136 1443 1444 O
brief 137 142 1445 1450 O
period 143 149 1451 1457 O
( 150 151 1458 1459 O
eg 151 153 1459 1461 O
, 153 154 1461 1462 O
30 155 157 1463 1465 O
minutes 158 165 1466 1473 O
) 165 166 1473 1474 O
to 167 169 1475 1477 O
confirm 170 177 1478 1485 O
the 178 181 1486 1489 O
finding 182 189 1490 1497 O

Mean 0 4 1498 1502 B-clinical_variable
QT 5 7 1503 1505 I-clinical_variable
interval 8 16 1506 1514 I-clinical_variable
corrected 17 26 1515 1524 I-clinical_variable
for 27 30 1525 1528 I-clinical_variable
heart 31 36 1529 1534 I-clinical_variable
rate 37 41 1535 1539 I-clinical_variable
( 42 43 1540 1541 I-clinical_variable
QTc 43 46 1541 1544 I-clinical_variable
) 46 47 1544 1545 I-clinical_variable
≥470 48 52 1546 1550 O
ms 53 55 1551 1553 I-lower_bound
calculated 56 66 1554 1564 O
from 67 71 1565 1569 O
an 72 74 1570 1572 O
electrocardiogram 75 92 1573 1590 B-treatment
( 93 94 1591 1592 I-treatment
ECG 94 97 1592 1595 I-treatment
) 97 98 1595 1596 I-treatment
using 99 104 1597 1602 O
Fridericia 105 115 1603 1613 O
's 115 117 1613 1615 O
Correction 118 128 1616 1626 O
( 129 130 1627 1628 O
QTcF 130 134 1628 1632 O
) 134 135 1632 1633 O

No 0 2 1634 1636 O
previous 3 11 1637 1645 O
treatment 12 21 1646 1655 B-treatment
with 22 26 1656 1660 O
immunotherapy 27 40 1661 1674 B-treatment
for 41 44 1675 1678 O
any 45 48 1679 1682 O
malignancy 49 59 1683 1693 B-cancer
including 60 69 1694 1703 O
cytokine 70 78 1704 1712 B-cancer
, 78 79 1712 1713 O
anti 80 84 1714 1718 B-treatment
- 84 85 1718 1719 I-treatment
tumor 85 90 1719 1724 I-treatment
vaccine 91 98 1725 1732 I-treatment
, 98 99 1732 1733 O
T 100 101 1734 1735 B-chronic_disease
- 101 102 1735 1736 I-chronic_disease
cell 102 106 1736 1740 I-chronic_disease
activator 107 116 1741 1750 I-chronic_disease
, 116 117 1750 1751 O
co 118 120 1752 1754 O
- 120 121 1754 1755 O
stimulator 121 131 1755 1765 O
or 132 134 1766 1768 O
immune 135 141 1769 1775 O
checkpoint 142 152 1776 1786 O
inhibitor 153 162 1787 1796 O

Participation 0 13 1797 1810 O
in 14 16 1811 1813 O
another 17 24 1814 1821 O
clinical 25 33 1822 1830 O
study 34 39 1831 1836 O
with 40 44 1837 1841 O
an 45 47 1842 1844 O
investigational 48 63 1845 1860 O
product 64 71 1861 1868 O
during 72 78 1869 1875 O
the 79 82 1876 1879 O
last 83 87 1880 1884 B-upper_bound
30 88 90 1885 1887 I-upper_bound
days 91 95 1888 1892 I-upper_bound

Platelet 0 8 1893 1901 B-clinical_variable
count 9 14 1902 1907 I-clinical_variable
≥ 15 16 1908 1909 O
100 17 20 1910 1913 B-lower_bound
x 21 22 1914 1915 I-lower_bound
109 23 26 1916 1919 I-lower_bound
/ 26 27 1919 1920 I-lower_bound
L 27 28 1920 1921 I-lower_bound
( 29 30 1922 1923 O
≥100,000 30 38 1923 1931 O
per 39 42 1932 1935 I-lower_bound
mm3 43 46 1936 1939 I-lower_bound
) 46 47 1939 1940 O

Pregnant 0 8 1941 1949 B-pregnancy

Radiographic 0 12 1950 1962 O
evidence 13 21 1963 1971 O
of 22 24 1972 1974 O
renal 25 30 1975 1980 B-cancer
cell 31 35 1981 1985 I-cancer
carcinoma 36 45 1986 1995 I-cancer
( 46 47 1996 1997 O
any 47 50 1997 2000 O
histologic 51 61 2001 2011 B-clinical_variable
subtype 62 69 2012 2019 I-clinical_variable
) 69 70 2019 2020 O
without 71 78 2021 2028 O
evidence 79 87 2029 2037 O
of 88 90 2038 2040 O
distant 91 98 2041 2048 B-cancer
metastatic 99 109 2049 2059 I-cancer
disease 110 117 2060 2067 O

Receipt 0 7 2068 2075 O
of 8 10 2076 2078 O
live 11 15 2079 2083 B-treatment
attenuated 16 26 2084 2094 I-treatment
vaccination 27 38 2095 2106 I-treatment
within 39 45 2107 2113 O
30 46 48 2114 2116 B-upper_bound
days 49 53 2117 2121 I-upper_bound
prior 54 59 2122 2127 I-upper_bound
to 60 62 2128 2130 O
study 63 68 2131 2136 O
entry 69 74 2137 2142 O
or 75 77 2143 2145 O
within 78 84 2146 2152 O
30 85 87 2153 2155 O
days 88 92 2156 2160 O
of 93 95 2161 2163 O
receiving 96 105 2164 2173 O
durvalumab 106 116 2174 2184 B-treatment
or 117 119 2185 2187 O
tremelimumab 120 132 2188 2200 B-treatment

Serum 0 5 2201 2206 B-clinical_variable
bilirubin 6 15 2207 2216 I-clinical_variable
≤ 16 17 2217 2218 O
1.5 18 21 2219 2222 B-upper_bound
x 22 23 2223 2224 I-upper_bound
institutional 24 37 2225 2238 I-upper_bound
upper 38 43 2239 2244 I-upper_bound
limit 44 49 2245 2250 I-upper_bound
of 50 52 2251 2253 I-upper_bound
normal 53 59 2254 2260 I-upper_bound
( 60 61 2261 2262 I-upper_bound
ULN 61 64 2262 2265 I-upper_bound
) 64 65 2265 2266 I-upper_bound

Subjects 0 8 2267 2275 O
with 9 13 2276 2280 O
known 14 19 2281 2286 O
HIV 20 23 2287 2290 B-chronic_disease
, 23 24 2290 2291 O
active 25 31 2292 2298 B-chronic_disease
hepatitis 32 41 2299 2308 I-chronic_disease
B 42 43 2309 2310 I-chronic_disease
, 43 44 2310 2311 O
or 45 47 2312 2314 O
active 48 54 2315 2321 B-chronic_disease
hepatitis 55 64 2322 2331 I-chronic_disease
C 65 66 2332 2333 I-chronic_disease
( 67 68 2334 2335 O
detectable 68 78 2335 2345 O
RNA 79 82 2346 2349 O
) 82 83 2349 2350 O
. 83 84 2350 2351 O
HIV 85 88 2352 2355 O
- 88 89 2355 2356 O
positive 89 97 2356 2364 O
subjects 98 106 2365 2373 O
on 107 109 2374 2376 O
combination 110 121 2377 2388 O
antiretroviral 122 136 2389 2403 B-treatment
therapy 137 144 2404 2411 I-treatment
are 145 148 2412 2415 O
ineligible 149 159 2416 2426 O
because 160 167 2427 2434 O
of 168 170 2435 2437 O
the 171 174 2438 2441 O
potential 175 184 2442 2451 O
for 185 188 2452 2455 O
pharmacokinetic 189 204 2456 2471 O
interactions 205 217 2472 2484 O
with 218 222 2485 2489 O
durvalumab 223 233 2490 2500 B-treatment
and/or 234 240 2501 2507 O
tremelimumab 241 253 2508 2520 B-treatment

active 0 6 2521 2527 O
bleeding 7 15 2528 2536 B-chronic_disease
diathesis 16 25 2537 2546 I-chronic_disease
including 26 35 2547 2556 O
any 36 39 2557 2560 O
subject 40 47 2561 2568 O
known 48 53 2569 2574 O
to 54 56 2575 2577 O
have 57 61 2578 2582 O
evidence 62 70 2583 2591 O
of 71 73 2592 2594 O
acute 74 79 2595 2600 O
or 80 82 2601 2603 O
chronic 83 90 2604 2611 B-chronic_disease
hepatitis 91 100 2612 2621 I-chronic_disease
B 101 102 2622 2623 I-chronic_disease
, 102 103 2623 2624 O
hepatitis 104 113 2625 2634 B-chronic_disease
C 114 115 2635 2636 I-chronic_disease
( 116 117 2637 2638 O
detectable 117 127 2638 2648 O
RNA 128 131 2649 2652 O
) 131 132 2652 2653 O
or 133 135 2654 2656 O
human 136 141 2657 2662 B-chronic_disease
immunodeficiency 142 158 2663 2679 I-chronic_disease
virus 159 164 2680 2685 I-chronic_disease
( 165 166 2686 2687 I-chronic_disease
HIV 166 169 2687 2690 I-chronic_disease
) 169 170 2690 2691 I-chronic_disease

active 0 6 2692 2698 O
peptic 7 13 2699 2705 B-chronic_disease
ulcer 14 19 2706 2711 I-chronic_disease
disease 20 27 2712 2719 I-chronic_disease
or 28 30 2720 2722 O
gastritis 31 40 2723 2732 B-chronic_disease

breastfeeding 0 13 2733 2746 O
women 14 19 2747 2752 B-gender

cardiac 0 7 2753 2760 B-chronic_disease
arrhythmia 8 18 2761 2771 I-chronic_disease

controlled 0 10 2772 2782 B-chronic_disease
atrial 11 17 2783 2789 I-chronic_disease
fibrillation 18 30 2790 2802 I-chronic_disease

female 0 6 2803 2809 B-gender
patients 7 15 2810 2818 I-gender
of 16 18 2819 2821 O
reproductive 19 31 2822 2834 O
potential 32 41 2835 2844 O
who 42 45 2845 2848 O
are 46 49 2849 2852 O
not 50 53 2853 2856 O
employing 54 63 2857 2866 O
an 64 66 2867 2869 O
effective 67 76 2870 2879 O
method 77 83 2880 2886 O
of 84 86 2887 2889 O
birth 87 92 2890 2895 O
control 93 100 2896 2903 O

history 0 7 2904 2911 O
of 8 10 2912 2914 O
bilateral 11 20 2915 2924 B-treatment
oophorectomy 21 33 2925 2937 I-treatment

history 0 7 2938 2945 O
of 8 10 2946 2948 O
bilateral 11 20 2949 2958 B-treatment
tubal 21 26 2959 2964 I-treatment
ligation 27 35 2965 2973 I-treatment

male 0 4 2974 2978 B-gender

must 0 4 2979 2983 O
have 5 9 2984 2988 O
a 10 11 2989 2990 O
negative 12 20 2991 2999 B-pregnancy
serum 21 26 3000 3005 I-pregnancy
pregnancy 27 36 3006 3015 I-pregnancy
test 37 41 3016 3020 O
upon 42 46 3021 3025 O
study 47 52 3026 3031 O
entry 53 58 3032 3037 O

post 0 4 3038 3042 O
- 4 5 3042 3043 O
menopausal 5 15 3043 3053 O
by 16 18 3054 3056 O
history 19 26 3057 3064 O
: 26 27 3064 3065 O
≥60 28 31 3066 3069 O
years 32 37 3070 3075 I-lower_bound
old 38 41 3076 3079 O
and 42 45 3080 3083 O
no 46 48 3084 3086 O
menses 49 55 3087 3093 O
for 56 59 3094 3097 O
≥1 60 62 3098 3100 O
year 63 67 3101 3105 I-lower_bound
without 68 75 3106 3113 O
an 76 78 3114 3116 O
alternative 79 90 3117 3128 O
medical 91 98 3129 3136 O
cause 99 104 3137 3142 O

psychiatric 0 11 3143 3154 B-chronic_disease
illness 12 19 3155 3162 I-chronic_disease
/ 19 20 3162 3163 O
social 20 26 3163 3169 B-chronic_disease
situations 27 37 3170 3180 I-chronic_disease
that 38 42 3181 3185 O
would 43 48 3186 3191 O
limit 49 54 3192 3197 O
compliance 55 65 3198 3208 O
with 66 70 3209 3213 O
study 71 76 3214 3219 O
requirements 77 89 3220 3232 O
or 90 92 3233 3235 O
compromise 93 103 3236 3246 O
the 104 107 3247 3250 O
ability 108 115 3251 3258 O
of 116 118 3259 3261 O
the 119 122 3262 3265 O
subject 123 130 3266 3273 O
to 131 133 3274 3276 O
give 134 138 3277 3281 O
written 139 146 3282 3289 O
informed 147 155 3290 3298 O
consent 156 163 3299 3306 O

unstable 0 8 3307 3315 B-chronic_disease
angina 9 15 3316 3322 I-chronic_disease
pectoris 16 24 3323 3331 I-chronic_disease
( 25 26 3332 3333 O
requiring 26 35 3333 3342 O
nitrates 36 44 3343 3351 B-treatment

Investigator 0 12 0 12 O
deems 13 18 13 18 O
cyst 19 23 19 23 B-chronic_disease
does 24 28 24 28 O
not 29 32 29 32 O
meet 33 37 33 37 O
safety 38 44 38 44 O
or 45 47 45 47 O
need 48 52 48 52 O
for 53 56 53 56 O
cyst 57 61 57 61 B-treatment
ablation 62 70 62 70 I-treatment

Patient 0 7 71 78 O
at 8 10 79 81 O
least 11 16 82 87 O
18 17 19 88 90 B-lower_bound
years 20 25 91 96 I-lower_bound
of 26 28 97 99 O
age 29 32 100 103 B-age

Patients 0 8 104 112 O
referred 9 17 113 121 O
between 18 25 122 129 O
January 26 33 130 137 B-lower_bound
2009 34 38 138 142 I-lower_bound
and 39 42 143 146 O
February 43 51 147 155 B-upper_bound
2016 52 56 156 160 I-upper_bound
to 57 59 161 163 O
EUS 60 63 164 167 O
at 64 66 168 170 O
IUMC 67 71 171 175 O
for 72 75 176 179 O
pancreatic 76 86 180 190 B-treatment
cyst 87 91 191 195 I-treatment
ablation 92 100 196 204 I-treatment
and 101 104 205 208 O
with 105 109 209 213 O
no 110 112 214 216 O
contraindications 113 130 217 234 O
for 131 134 235 238 O
anticipated 135 146 239 250 O
safe 147 151 251 255 O
and 152 155 256 259 O
successful 156 166 260 270 O
performance 167 178 271 282 O
of 179 181 283 285 O
the 182 185 286 289 O
procedure 186 195 290 299 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
: 25 26 25 26 O
for 27 30 27 30 O
infants 31 38 31 38 O
less 39 43 39 43 O
than 44 48 44 48 O
or 49 51 49 51 O
equal 52 57 52 57 O
to 58 60 58 60 O
24 61 63 61 63 O
hours 64 69 64 69 O
old 70 73 70 73 O
, 73 74 73 74 O
less 75 79 75 79 O
than 80 84 80 84 O
4,000 85 90 85 90 B-upper_bound
cells 91 96 91 96 I-upper_bound
/ 96 97 96 97 I-upper_bound
mm^3 97 101 97 101 I-upper_bound
; 101 102 101 102 O
for 103 106 103 106 O
infants 107 114 107 114 O
greater 115 122 115 122 O
than 123 127 123 127 O
24 128 130 128 130 O
hours 131 136 131 136 O
old 137 140 137 140 O
, 140 141 140 141 O
less 142 146 142 146 O
than 147 151 147 151 O
1,250 152 157 152 157 B-upper_bound
cells 158 163 158 163 I-upper_bound
/ 163 164 163 164 I-upper_bound
mm^3 164 168 164 168 I-upper_bound

Allowable 0 9 169 178 O
infant 10 16 179 185 O
age 17 20 186 189 B-age
at 21 23 190 192 O
the 24 27 193 196 O
time 28 32 197 201 O
of 33 35 202 204 O
enrollment 36 46 205 215 O
is 47 49 216 218 O
dependent 50 59 219 228 O
on 60 62 229 231 O
the 63 66 232 235 O
Dose 67 71 236 240 O
Group 72 77 241 246 O
and 78 81 247 250 O
Cohort 82 88 251 257 O

Any 0 3 258 261 O
requirement 4 15 262 273 O
for 16 19 274 277 O
supplemental 20 32 278 290 B-treatment
oxygen 33 39 291 297 I-treatment
beyond 40 46 298 304 O
24 47 49 305 307 B-upper_bound
hours 50 55 308 313 I-upper_bound
of 56 58 314 316 O
life 59 63 317 321 O
or 64 66 322 324 O
requiring 67 76 325 334 O
supplemental 77 89 335 347 O
oxygen 90 96 348 354 O
at 97 99 355 357 O
the 100 103 358 361 O
time 104 108 362 366 O
of 109 111 367 369 O
the 112 115 370 373 O
VRC01 116 121 374 379 B-treatment
, 121 122 379 380 O
VRC01LS 123 130 381 388 B-treatment
, 130 131 388 389 O
or 132 134 390 392 O
VRC07 135 140 393 398 B-treatment
- 140 141 398 399 O
523LS 141 146 399 404 B-treatment
dose 147 151 405 409 O

At 0 2 410 412 O
increased 3 12 413 422 O
risk 13 17 423 427 O
of 18 20 428 430 O
HIV 21 24 431 434 B-chronic_disease
acquisition 25 36 435 446 O
defined 37 44 447 454 O
as 45 47 455 457 O
documentation 48 61 458 471 O
of 62 64 472 474 O
one 65 68 475 478 B-lower_bound
or 69 71 479 481 O
more 72 76 482 486 O
of 77 79 487 489 O
the 80 83 490 493 O
following 84 93 494 503 O
risk 94 98 504 508 O
factors 99 106 509 516 O

Birth 0 5 517 522 B-clinical_variable
weight 6 12 523 529 I-clinical_variable
greater 13 20 530 537 O
than 21 25 538 542 O
or 26 28 543 545 O
equal 29 34 546 551 O
to 35 37 552 554 O
2.0 38 41 555 558 B-lower_bound
kg 42 44 559 561 I-lower_bound

Born 0 4 562 566 O
to 5 7 567 569 O
an 8 10 570 572 O
HIV-1 11 16 573 578 B-chronic_disease
- 16 17 578 579 O
infected 17 25 579 587 O
woman 26 31 588 593 B-gender
who 32 35 594 597 O
meets 36 41 598 603 O
all 42 45 604 607 O
maternal 46 54 608 616 O
inclusion 55 64 617 626 O
/ 64 65 626 627 O
exclusion 65 74 627 636 O
criteria 75 83 637 645 O
listed 84 90 646 652 O
above 91 96 653 658 O

Documentation 0 13 659 672 O
of 14 16 673 675 O
HIV 17 20 676 679 B-chronic_disease
infection 21 30 680 689 I-chronic_disease

Documentation 0 13 690 703 O
of 14 16 704 706 O
HIV-1 17 22 707 712 B-chronic_disease
infection 23 32 713 722 I-chronic_disease
is 33 35 723 725 O
defined 36 43 726 733 O
as 44 46 734 736 O
positive 47 55 737 745 O
results 56 63 746 753 O
from 64 68 754 758 O
two 69 72 759 762 O
samples 73 80 763 770 O
collected 81 90 771 780 O
at 91 93 781 783 O
different 94 103 784 793 O
time 104 108 794 798 O
points 109 115 799 805 O
. 115 116 805 806 O
All 117 120 807 810 O
samples 121 128 811 818 O
tested 129 135 819 825 O
must 136 140 826 830 O
be 141 143 831 833 O
whole 144 149 834 839 O
blood 150 155 840 845 O
, 155 156 845 846 O
serum 157 162 847 852 O
, 162 163 852 853 O
or 164 166 854 856 O
plasma 167 173 857 863 O
. 173 174 863 864 O
For 175 178 865 868 O
this 179 183 869 873 O
protocol 184 192 874 882 O
, 192 193 882 883 O
the 194 197 884 887 O
results 198 205 888 895 O
for 206 209 896 899 O
sample 210 216 900 906 O
# 217 218 907 908 O
2 218 219 908 909 O
may 220 223 910 913 O
be 224 226 914 916 O
pending 227 234 917 924 O
at 235 237 925 927 O
the 238 241 928 931 O
time 242 246 932 936 O
of 247 249 937 939 O
enrollment 250 260 940 950 O
. 260 261 950 951 O
Results 262 269 952 959 O
documented 270 280 960 970 O
in 281 283 971 973 O
the 284 287 974 977 O
clinical 288 296 978 986 O
record 297 303 987 993 O
from 304 308 994 998 O
past 309 313 999 1003 O
testing 314 321 1004 1011 O
may 322 325 1012 1015 O
be 326 328 1016 1018 O
used 329 333 1019 1023 O
to 334 336 1024 1026 O
satisfy 337 344 1027 1034 O
the 345 348 1035 1038 O
criteria 349 357 1039 1047 O
for 358 361 1048 1051 O
documentation 362 375 1052 1065 O
of 376 378 1066 1068 O
HIV-1 379 384 1069 1074 O
infection 385 394 1075 1084 O
. 394 395 1084 1085 O
More 396 400 1086 1090 O
information 401 412 1091 1102 O
on 413 415 1103 1105 O
this 416 420 1106 1110 O
criterion 421 430 1111 1120 O
can 431 434 1121 1124 O
be 435 437 1125 1127 O
found 438 443 1128 1133 O
in 444 446 1134 1136 O
the 447 450 1137 1140 O
protocol 451 459 1141 1149 O

Documented 0 10 1150 1160 O
or 11 13 1161 1163 O
suspected 14 23 1164 1173 O
serious 24 31 1174 1181 B-chronic_disease
medical 32 39 1182 1189 I-chronic_disease
illness 40 47 1190 1197 I-chronic_disease
or 48 50 1198 1200 O
immediate 51 60 1201 1210 O
life 61 65 1211 1215 O
- 65 66 1215 1216 O
threatening 66 77 1216 1227 O
condition 78 87 1228 1237 O
( 88 89 1238 1239 O
other 89 94 1239 1244 O
than 95 99 1245 1249 O
HIV 100 103 1250 1253 B-chronic_disease
infection 104 113 1254 1263 O
) 113 114 1263 1264 O
in 115 117 1265 1267 O
the 118 121 1268 1271 O
mother 122 128 1272 1278 O
that 129 133 1279 1283 O
may 134 137 1284 1287 O
interfere 138 147 1288 1297 O
with 148 152 1298 1302 O
the 153 156 1303 1306 O
ability 157 164 1307 1314 O
to 165 167 1315 1317 O
complete 168 176 1318 1326 O
study 177 182 1327 1332 O
requirements 183 195 1333 1345 O
, 195 196 1345 1346 O
as 197 199 1347 1349 O
judged 200 206 1350 1356 O
by 207 209 1357 1359 O
the 210 213 1360 1363 O
examining 214 223 1364 1373 O
clinician 224 233 1374 1383 O

Documented 0 10 1384 1394 O
or 11 13 1395 1397 O
suspected 14 23 1398 1407 O
serious 24 31 1408 1415 O
medical 32 39 1416 1423 B-chronic_disease
illness 40 47 1424 1431 I-chronic_disease
, 47 48 1431 1432 O
serious 49 56 1433 1440 B-chronic_disease
congenital 57 67 1441 1451 I-chronic_disease
anomaly 68 75 1452 1459 I-chronic_disease
, 75 76 1459 1460 O
or 77 79 1461 1463 O
immediate 80 89 1464 1473 O
life 90 94 1474 1478 B-chronic_disease
- 94 95 1478 1479 I-chronic_disease
threatening 95 106 1479 1490 I-chronic_disease
condition 107 116 1491 1500 I-chronic_disease
in 117 119 1501 1503 O
the 120 123 1504 1507 O
infant 124 130 1508 1514 O
that 131 135 1515 1519 O
may 136 139 1520 1523 O
interfere 140 149 1524 1533 O
with 150 154 1534 1538 O
the 155 158 1539 1542 O
ability 159 166 1543 1550 O
to 167 169 1551 1553 O
complete 170 178 1554 1562 O
study 179 184 1563 1568 O
requirements 185 197 1569 1581 O
, 197 198 1581 1582 O
as 199 201 1583 1585 O
judged 202 208 1586 1592 O
by 209 211 1593 1595 O
the 212 215 1596 1599 O
examining 216 225 1600 1609 O
clinician 226 235 1610 1619 O

Dose 0 4 1620 1624 O
Groups 5 11 1625 1631 O
4 12 13 1632 1633 O
and 14 17 1634 1637 O
5 18 19 1638 1639 O
( 20 21 1640 1641 O
Cohort 21 27 1641 1647 O
1 28 29 1648 1649 O
): 29 31 1649 1651 O
Less 32 36 1652 1656 O
than 37 41 1657 1661 O
72 42 44 1662 1664 B-upper_bound
hours 45 50 1665 1670 I-upper_bound
of 51 53 1671 1673 O
age 54 57 1674 1677 B-age
, 57 58 1677 1678 O
and 59 62 1679 1682 O
anticipated 63 74 1683 1694 O
availability 75 87 1695 1707 O
to 88 90 1708 1710 O
receive 91 98 1711 1718 O
VRC01LS 99 106 1719 1726 B-treatment
or 107 109 1727 1729 O
VRC07 110 115 1730 1735 B-treatment
- 115 116 1735 1736 I-treatment
523LS 116 121 1736 1741 I-treatment
immunization 122 134 1742 1754 O
at 135 137 1755 1757 O
less 138 142 1758 1762 O
than 143 147 1763 1767 O
72 148 150 1768 1770 B-upper_bound
hours 151 156 1771 1776 I-upper_bound
after 157 162 1777 1782 I-upper_bound
birth 163 168 1783 1788 O

Dose 0 4 1789 1793 O
Groups 5 11 1794 1800 O
4 12 13 1801 1802 O
and 14 17 1803 1806 O
5 18 19 1807 1808 O
( 20 21 1809 1810 O
Cohort 21 27 1810 1816 O
2 28 29 1817 1818 O
): 29 31 1818 1820 O
Less 32 36 1821 1825 O
than 37 41 1826 1830 O
or 42 44 1831 1833 O
equal 45 50 1834 1839 O
to 51 53 1840 1842 O
5 54 55 1843 1844 O
days 56 60 1845 1849 O
of 61 63 1850 1852 O
age 64 67 1853 1856 B-age
, 67 68 1856 1857 O
and 69 72 1858 1861 O
anticipated 73 84 1862 1873 O
availability 85 97 1874 1886 O
to 98 100 1887 1889 O
receive 101 108 1890 1897 O
VRC01LS 109 116 1898 1905 B-treatment
or 117 119 1906 1908 O
VRC07 120 125 1909 1914 B-treatment
- 125 126 1914 1915 I-treatment
523LS 126 131 1915 1920 I-treatment
immunization 132 144 1921 1933 I-treatment
no 145 147 1934 1936 O
more 148 152 1937 1941 O
than 153 157 1942 1946 O
5 158 159 1947 1948 O
days 160 164 1949 1953 O
after 165 170 1954 1959 O
birth 171 176 1960 1965 O

Gestational 0 11 1966 1977 B-clinical_variable
age 12 15 1978 1981 I-clinical_variable
, 15 16 1981 1982 O
by 17 19 1983 1985 O
best 20 24 1986 1990 O
obstetrical 25 36 1991 2002 O
, 36 37 2002 2003 O
ultrasound 38 48 2004 2014 O
, 48 49 2014 2015 O
or 50 52 2016 2018 O
infant 53 59 2019 2025 O
exam 60 64 2026 2030 O
, 64 65 2030 2031 O
greater 66 73 2032 2039 O
than 74 78 2040 2044 O
or 79 81 2045 2047 O
equal 82 87 2048 2053 O
to 88 90 2054 2056 O
36 91 93 2057 2059 B-lower_bound
weeks 94 99 2060 2065 I-lower_bound

Greater 0 7 2066 2073 O
than 8 12 2074 2078 O
or 13 15 2079 2081 O
equal 16 21 2082 2087 O
to 22 24 2088 2090 O
18 25 27 2091 2093 B-lower_bound
years 28 33 2094 2099 I-lower_bound
of 34 36 2100 2102 O
age 37 40 2103 2106 B-age

Hemoglobin 0 10 2107 2117 B-clinical_variable
less 11 15 2118 2122 O
than 16 20 2123 2127 O
12.0 21 25 2128 2132 B-upper_bound
g 26 27 2133 2134 I-upper_bound
/ 27 28 2134 2135 I-upper_bound
dL 28 30 2135 2137 I-upper_bound

Mother 0 6 2138 2144 O
received 7 15 2145 2153 O
no 16 18 2154 2156 O
antiretroviral 19 33 2157 2171 B-treatment
therapy 34 41 2172 2179 I-treatment
( 42 43 2180 2181 I-treatment
ART 43 46 2181 2184 I-treatment
) 46 47 2184 2185 I-treatment
during 48 54 2186 2192 O
pregnancy 55 64 2193 2202 B-pregnancy

Mother 0 6 2203 2209 O
with 7 11 2210 2214 O
any 12 15 2215 2218 O
detectable 16 26 2219 2229 O
viral 27 32 2230 2235 O
replication 33 44 2236 2247 O
( 45 46 2248 2249 O
HIV 46 49 2249 2252 B-chronic_disease
RNA 50 53 2253 2256 B-clinical_variable
above 54 59 2257 2262 O
the 60 63 2263 2266 O
limit 64 69 2267 2272 O
of 70 72 2273 2275 O
detection 73 82 2276 2285 O
) 82 83 2285 2286 O
at 84 86 2287 2289 O
last 87 91 2290 2294 O
measurement 92 103 2295 2306 O
prior 104 109 2307 2312 O
to 110 112 2313 2315 O
delivery 113 121 2316 2324 O
determined 122 132 2325 2335 O
within 133 139 2336 2342 O
30 140 142 2343 2345 B-upper_bound
days 143 147 2346 2350 I-upper_bound
of 148 150 2351 2353 O
delivery 151 159 2354 2362 O

Mother 0 6 2363 2369 O
with 7 11 2370 2374 O
documented 12 22 2375 2385 O
* 22 23 2385 2386 O
2 24 25 2387 2388 O
- 25 26 2388 2389 O
class 26 31 2389 2394 O
resistant 32 41 2395 2404 O
HIV 42 45 2405 2408 B-chronic_disease
infection 46 55 2409 2418 I-chronic_disease
, 55 56 2418 2419 O
which 57 62 2420 2425 O
may 63 66 2426 2429 O
include 67 74 2430 2437 O
historical 75 85 2438 2448 O
documentation 86 99 2449 2462 O
of 100 102 2463 2465 O
lack 103 107 2466 2470 O
of 108 110 2471 2473 O
response 111 119 2474 2482 O

Platelet 0 8 2483 2491 B-clinical_variable
count 9 14 2492 2497 I-clinical_variable
less 15 19 2498 2502 O
than 20 24 2503 2507 O
100,000 25 32 2508 2515 B-upper_bound
cells 33 38 2516 2521 I-upper_bound
/ 38 39 2521 2522 I-upper_bound
mm^3 39 43 2522 2526 I-upper_bound

Prior 0 5 2527 2532 O
participation 6 19 2533 2546 O
in 20 22 2547 2549 O
any 23 26 2550 2553 O
HIV-1 27 32 2554 2559 B-treatment
vaccine 33 40 2560 2567 I-treatment
trial 41 46 2568 2573 I-treatment

Prolonged 0 9 2574 2583 O
rupture 10 17 2584 2591 O
of 18 20 2592 2594 O
membranes 21 30 2595 2604 O
( 31 32 2605 2606 O
greater 32 39 2606 2613 O
than 40 44 2614 2618 O
12 45 47 2619 2621 B-lower_bound
hours 48 53 2622 2627 I-lower_bound
) 53 54 2627 2628 O

Receipt 0 7 2629 2636 O
of 8 10 2637 2639 O
any 11 14 2640 2643 O
other 15 20 2644 2649 O
active 21 27 2650 2656 O
or 28 30 2657 2659 O
passive 31 38 2660 2667 O
HIV 39 42 2668 2671 B-treatment
immunotherapy 43 56 2672 2685 I-treatment
or 57 59 2686 2688 O
investigational 60 75 2689 2704 B-treatment
product 76 83 2705 2712 I-treatment
during 84 90 2713 2719 O
this 91 95 2720 2724 O
pregnancy 96 105 2725 2734 B-pregnancy

Receipt 0 7 2735 2742 O
of 8 10 2743 2745 O
any 11 14 2746 2749 O
other 15 20 2750 2755 O
active 21 27 2756 2762 B-treatment
or 28 30 2763 2765 I-treatment
passive 31 38 2766 2773 I-treatment
HIV 39 42 2774 2777 I-treatment
immunotherapy 43 56 2778 2791 I-treatment
or 57 59 2792 2794 O
investigational 60 75 2795 2810 B-treatment
product 76 83 2811 2818 I-treatment
other 84 89 2819 2824 O
than 90 94 2825 2829 O
the 95 98 2830 2833 O
study 99 104 2834 2839 O
vaccine 105 112 2840 2847 B-treatment

Receipt 0 7 2848 2855 O
of 8 10 2856 2858 O
or 11 13 2859 2861 O
anticipated 14 25 2862 2873 O
need 26 30 2874 2878 O
for 31 34 2879 2882 O
blood 35 40 2883 2888 O
products 41 49 2889 2897 O
, 49 50 2897 2898 O
immunoglobulin 51 65 2899 2913 B-treatment
, 65 66 2913 2914 O
or 67 69 2915 2917 O
immunosuppressive 70 87 2918 2935 B-treatment
therapy 88 95 2936 2943 I-treatment
. 95 96 2943 2944 O
This 97 101 2945 2949 O
includes 102 110 2950 2958 O
infants 111 118 2959 2966 O
who 119 122 2967 2970 O
require 123 130 2971 2978 O
hepatitis 131 140 2979 2988 B-treatment
B 141 142 2989 2990 I-treatment
immunoglobulin 143 157 2991 3005 I-treatment
( 158 159 3006 3007 I-treatment
HBIG 159 163 3007 3011 I-treatment
) 163 164 3011 3012 I-treatment
but 165 168 3013 3016 O
does 169 173 3017 3021 O
not 174 177 3022 3025 O
require 178 185 3026 3033 O
exclusion 186 195 3034 3043 O
of 196 198 3044 3046 O
infants 199 206 3047 3054 O
who 207 210 3055 3058 O
receive 211 218 3059 3066 O
hepatitis 219 228 3067 3076 B-treatment
B 229 230 3077 3078 I-treatment
vaccine 231 238 3079 3086 I-treatment
in 239 241 3087 3089 O
the 242 245 3090 3093 O
newborn 246 253 3094 3101 O
period 254 260 3102 3108 O

Serum 0 5 3109 3114 B-clinical_variable
glutamic 6 14 3115 3123 I-clinical_variable
pyruvic 15 22 3124 3131 I-clinical_variable
transaminase 23 35 3132 3144 I-clinical_variable
( 36 37 3145 3146 I-clinical_variable
SGPT 37 41 3146 3150 I-clinical_variable
) 41 42 3150 3151 I-clinical_variable
( 43 44 3152 3153 B-clinical_variable
alanine 44 51 3153 3160 I-clinical_variable
aminotransferase 52 68 3161 3177 I-clinical_variable
[ 69 70 3178 3179 I-clinical_variable
ALT 70 73 3179 3182 I-clinical_variable
] 73 74 3182 3183 I-clinical_variable
) 74 75 3183 3184 I-clinical_variable
greater 76 83 3185 3192 O
than 84 88 3193 3197 O
or 89 91 3198 3200 O
equal 92 97 3201 3206 O
to 98 100 3207 3209 O
1.25 101 105 3210 3214 B-lower_bound
times 106 111 3215 3220 I-lower_bound
upper 112 117 3221 3226 I-lower_bound
limit 118 123 3227 3232 I-lower_bound
of 124 126 3233 3235 O
age 127 130 3236 3239 B-age
adjusted 131 139 3240 3248 O
normal 140 146 3249 3255 O

Women 0 5 3256 3261 B-gender
who 6 9 3262 3265 O
have 10 14 3266 3270 O
a 15 16 3271 3272 O
documented 17 27 3273 3283 O
history 28 35 3284 3291 O
of 36 38 3292 3294 O
virologic 39 48 3295 3304 O
failure 49 56 3305 3312 O
while 57 62 3313 3318 O
on 63 65 3319 3321 O
non 66 69 3322 3325 B-treatment
- 69 70 3325 3326 I-treatment
nucleoside 70 80 3326 3336 I-treatment
reverse 81 88 3337 3344 I-treatment
transcriptase 89 102 3345 3358 I-treatment
inhibitors 103 113 3359 3369 I-treatment
( 114 115 3370 3371 I-treatment
NNRTIs 115 121 3371 3377 I-treatment
) 121 122 3377 3378 I-treatment
but 123 126 3379 3382 O
who 127 130 3383 3386 O
had 131 134 3387 3390 O
no 135 137 3391 3393 O
resistance 138 148 3394 3404 O
testing 149 156 3405 3412 O
at 157 159 3413 3415 O
the 160 163 3416 3419 O
time 164 168 3420 3424 O
of 169 171 3425 3427 O
viral 172 177 3428 3433 O
failure 178 185 3434 3441 O
will 186 190 3442 3446 O
be 191 193 3447 3449 O
considered 194 204 3450 3460 O
to 205 207 3461 3463 O
have 208 212 3464 3468 O
NNRTI 213 218 3469 3474 O
- 218 219 3474 3475 O
documented 219 229 3475 3485 O
resistance 230 240 3486 3496 O

mother 0 6 3497 3503 O
began 7 12 3504 3509 O
or 13 15 3510 3512 O
reinitiated 16 27 3513 3524 O
ART 28 31 3525 3528 B-treatment
( 32 33 3529 3530 O
after 33 38 3530 3535 O
an 39 41 3536 3538 O
interruption 42 54 3539 3551 O
of 55 57 3552 3554 O
greater 58 65 3555 3562 O
than 66 70 3563 3567 O
14 71 73 3568 3570 B-lower_bound
days 74 78 3571 3575 I-lower_bound
) 78 79 3575 3576 O
, 79 80 3576 3577 O
during 81 87 3578 3584 O
the 88 91 3585 3588 O
third 92 97 3589 3594 O
trimester 98 107 3595 3604 O
of 108 110 3605 3607 O
pregnancy 111 120 3608 3617 B-pregnancy

> 0 1 0 1 O
18 1 3 1 3 B-lower_bound
years 4 9 4 9 I-lower_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Anticipated 0 11 17 28 O
replacement 12 23 29 40 O
of 24 26 41 43 O
central 27 34 44 51 O
venous 35 41 52 58 O
catheter 42 50 59 67 O
within 51 57 68 74 O
3 58 59 75 76 B-upper_bound
months 60 66 77 83 I-upper_bound

Catheter 0 8 84 92 O
removal 9 16 93 100 O
> 17 18 101 102 O
1 18 19 102 103 B-lower_bound
month 20 25 104 109 I-lower_bound
prior 26 31 110 115 I-lower_bound
to 32 34 116 118 O
enrollment 35 45 119 129 O

Creatinine 0 10 130 140 B-clinical_variable
clearance 11 20 141 150 I-clinical_variable
> 21 22 151 152 O
30 22 24 152 154 B-lower_bound
ml 25 27 155 157 I-lower_bound
/ 27 28 157 158 I-lower_bound
min 28 31 158 161 I-lower_bound

Current 0 7 162 169 O
hematologic 8 19 170 181 B-chronic_disease

Known 0 5 182 187 O
underlying 6 16 188 198 O
higher 17 23 199 205 O
risk 24 28 206 210 O
thrombophilias 29 43 211 225 B-chronic_disease
including 44 53 226 235 O
antiphospholipid 54 70 236 252 B-chronic_disease
antibody 71 79 253 261 I-chronic_disease
syndrome 80 88 262 270 I-chronic_disease
, 88 89 270 271 O
antithrombin 90 102 272 284 O
, 102 103 284 285 O
protein 104 111 286 293 B-chronic_disease
C 112 113 294 295 I-chronic_disease
or 114 116 296 298 I-chronic_disease
protein 117 124 299 306 I-chronic_disease
S 125 126 307 308 I-chronic_disease
deficiencies 127 139 309 321 I-chronic_disease
, 139 140 321 322 O
or 141 143 323 325 O
homozygosity 144 156 326 338 O
or 157 159 339 341 O
compound 160 168 342 350 B-chronic_disease
heterozygosity 169 183 351 365 I-chronic_disease
for 184 187 366 369 O
prothrombin 188 199 370 381 B-chronic_disease
G20210A 200 207 382 389 I-chronic_disease
or 208 210 390 392 O
Factor 211 217 393 399 B-treatment
V 218 219 400 401 I-treatment
R506Q 220 225 402 407 I-treatment
mutations 226 235 408 417 O

Major 0 5 418 423 O
bleeding 6 14 424 432 O
or 15 17 433 435 O
clinically 18 28 436 446 O
relevant 29 37 447 455 O
non 38 41 456 459 O
- 41 42 459 460 O
major 42 47 460 465 O
bleeding 48 56 466 474 O
in 57 59 475 477 O
the 60 63 478 481 O
preceding 64 73 482 491 O
60 74 76 492 494 B-lower_bound
days 77 81 495 499 I-lower_bound

Participation 0 13 500 513 O
in 14 16 514 516 O
another 17 24 517 524 O
clinical 25 33 525 533 O
trial 34 39 534 539 O
that 40 44 540 544 O
requires 45 53 545 553 O
anticoagulation 54 69 554 569 B-treatment

Platelet 0 8 570 578 B-clinical_variable
count 9 14 579 584 I-clinical_variable
> 15 16 585 586 O
50,000 16 22 586 592 B-lower_bound

Treatment 0 9 593 602 O
with 10 14 603 607 O
thrombolysis 15 27 608 620 B-treatment

Underlying 0 10 621 631 O
medical 11 18 632 639 O
condition 19 28 640 649 O
or 29 31 650 652 O
chemotherapy 32 44 653 665 B-treatment
requiring 45 54 666 675 O
long 55 59 676 680 O
- 59 60 680 681 O
term 60 64 681 685 O
anticoagulation 65 80 686 701 B-treatment

Upper 0 5 702 707 O
extremity 6 15 708 717 O
venous 16 22 718 724 B-chronic_disease
thrombosis 23 33 725 735 I-chronic_disease
associated 34 44 736 746 O
with 45 49 747 751 O
an 50 52 752 754 O
indwelling 53 63 755 765 O
catheter 64 72 766 774 O
documented 73 83 775 785 O
by 84 86 786 788 O
ultrasound 87 97 789 799 B-treatment
, 97 98 799 800 O
CT 99 101 801 803 B-treatment
or 102 104 804 806 O
venography 105 115 807 817 B-treatment

Use 0 3 818 821 O
of 4 6 822 824 O
anticoagulant 7 20 825 838 B-treatment
other 21 26 839 844 O
than 27 31 845 849 O
low 32 35 850 853 B-treatment
- 35 36 853 854 I-treatment
molecular 36 45 854 863 I-treatment
weight 46 52 864 870 I-treatment
heparin 53 60 871 878 I-treatment

solid 0 5 879 884 B-cancer
tumor 6 11 885 890 I-cancer
malignancy 12 22 891 901 I-cancer
undergoing 23 33 902 912 O
chemotherapy 34 46 913 925 B-treatment
, 46 47 925 926 O
surgery 48 55 927 934 B-treatment
, 55 56 934 935 O
radiation 57 66 936 945 B-treatment
or 67 69 946 948 O
hormonal 70 78 949 957 B-treatment
therapy 79 86 958 965 I-treatment
for 87 90 966 969 O
malignancy 91 101 970 980 O

Age 0 3 0 3 B-age
between 4 11 4 11 O
18 12 14 12 14 B-lower_bound
- 15 16 15 16 O
70 17 19 17 19 B-upper_bound
years 20 25 20 25 I-upper_bound

Availability 0 12 26 38 O
of 13 15 39 41 O
Cryopreserved 16 29 42 55 O
peripheral 30 40 56 66 O
blood 41 46 67 72 O
stem 47 51 73 77 O
cells 52 57 78 83 O
with 58 62 84 88 O
a 63 64 89 90 O
CD34 65 69 91 95 B-treatment
dose 70 74 96 100 O
of 75 77 101 103 O
at 78 80 104 106 O
least 81 86 107 112 O
2x106 87 92 113 118 B-lower_bound
/ 92 93 118 119 I-lower_bound
kg 93 95 119 121 I-lower_bound

Diagnosis 0 9 122 131 O
of 10 12 132 134 O
Multiple 13 21 135 143 B-cancer
Myeloma 22 29 144 151 I-cancer

Karnofsky 0 9 152 161 B-clinical_variable
status 10 16 162 168 I-clinical_variable
≥ 17 18 169 170 O
70 19 21 171 173 B-lower_bound
% 21 22 173 174 I-lower_bound

Ongoing 0 7 175 182 O
or 8 10 183 185 O
active 11 17 186 192 O
systemic 18 26 193 201 B-chronic_disease
infection 27 36 202 211 I-chronic_disease
, 36 37 211 212 O
active 38 44 213 219 O
hepatitis 45 54 220 229 B-chronic_disease
B 55 56 230 231 I-chronic_disease
or 57 59 232 234 I-chronic_disease
C 60 61 235 236 I-chronic_disease
virus 62 67 237 242 B-chronic_disease
infection 68 77 243 252 I-chronic_disease
, 77 78 252 253 O
or 79 81 254 256 O
known 82 87 257 262 O
human 88 93 263 268 B-chronic_disease
immunodeficiency 94 110 269 285 I-chronic_disease
virus 111 116 286 291 I-chronic_disease
( 117 118 292 293 I-chronic_disease
HIV 118 121 293 296 I-chronic_disease
) 121 122 296 297 I-chronic_disease
positive 123 131 298 306 O

Patients 0 8 307 315 O
who 9 12 316 319 O
have 13 17 320 324 O
any 18 21 325 328 O
debilitating 22 34 329 341 O
medical 35 42 342 349 B-chronic_disease
or 43 45 350 352 I-chronic_disease
psychiatric 46 57 353 364 I-chronic_disease
illness 58 65 365 372 I-chronic_disease
which 66 71 373 378 O
would 72 77 379 384 O
preclude 78 86 385 393 O
their 87 92 394 399 O
giving 93 99 400 406 O
informed 100 108 407 415 O
consent 109 116 416 423 O
or 117 119 424 426 O
their 120 125 427 432 O
receiving 126 135 433 442 O
optimal 136 143 443 450 O
treatment 144 153 451 460 O
and 154 157 461 464 O
follow 158 164 465 471 O
- 164 165 471 472 O
up 165 167 472 474 O

Poor 0 4 475 479 O
cardiac 5 12 480 487 O
function 13 21 488 496 O
: 21 22 496 497 O
left 23 27 498 502 B-clinical_variable
ventricular 28 39 503 514 I-clinical_variable
ejection 40 48 515 523 I-clinical_variable
fraction 49 57 524 532 I-clinical_variable
< 58 59 533 534 O
40 59 61 534 536 B-upper_bound
% 61 62 536 537 I-upper_bound

Poor 0 4 538 542 O
liver 5 10 543 548 O
function 11 19 549 557 O
: 19 20 557 558 O
bilirubin 21 30 559 568 B-clinical_variable
> 31 32 569 570 O
2.5 32 35 570 573 B-lower_bound
mg 36 38 574 576 I-lower_bound
/ 38 39 576 577 I-lower_bound
dl 39 41 577 579 I-lower_bound
( 42 43 580 581 O
not 43 46 581 584 O
due 47 50 585 588 O
to 51 53 589 591 O
hemolysis 54 63 592 601 B-chronic_disease
, 63 64 601 602 O
Gilbert 65 72 603 610 B-chronic_disease
's 72 74 610 612 I-chronic_disease
or 75 77 613 615 I-chronic_disease
primary 78 85 616 623 I-chronic_disease
malignancy 86 96 624 634 I-chronic_disease
) 96 97 634 635 O
, 97 98 635 636 O
AST 99 102 637 640 B-clinical_variable
/ 102 103 640 641 O
ALT 103 106 641 644 B-clinical_variable
> 107 108 645 646 O
3X 109 111 647 649 B-lower_bound
ULN 112 115 650 653 I-lower_bound

Poor 0 4 654 658 O
pulmonary 5 14 659 668 O
function 15 23 669 677 O
: 23 24 677 678 O
FEV1 25 29 679 683 B-clinical_variable
, 29 30 683 684 O
FVC 31 34 685 688 B-clinical_variable
, 34 35 688 689 O
or 36 38 690 692 O
DLCO 39 43 693 697 B-clinical_variable
< 44 45 698 699 O
40 45 47 699 701 B-upper_bound
% 47 48 701 702 I-upper_bound
predicted 49 58 703 712 O

Poor 0 4 713 717 O
renal 5 10 718 723 O
function 11 19 724 732 O
: 19 20 732 733 O
Creatinine 21 31 734 744 B-clinical_variable
> 32 33 745 746 O
2.0 33 36 746 749 B-lower_bound
mg 37 39 750 752 I-lower_bound
/ 39 40 752 753 I-lower_bound
dl 40 42 753 755 I-lower_bound
or 43 45 756 758 O
creatinine 46 56 759 769 B-clinical_variable
clearance 57 66 770 779 I-clinical_variable
< 67 68 780 781 O
40 69 71 782 784 B-upper_bound
mL 72 74 785 787 I-upper_bound
/ 74 75 787 788 I-upper_bound
min 75 78 788 791 I-upper_bound
( 79 80 792 793 O
calculated 80 90 793 803 O
creatinine 91 101 804 814 O
clearance 102 111 815 824 O
is 112 114 825 827 O
permitted 115 124 828 837 O
) 124 125 837 838 O

Within 0 6 839 845 O
9 7 8 846 847 B-upper_bound
months 9 15 848 854 I-upper_bound
of 16 18 855 857 O
the 19 22 858 861 O
start 23 28 862 867 O
of 29 31 868 870 O
induction 32 41 871 880 O
chemotherapy 42 54 881 893 B-treatment
and 55 58 894 897 O
no 59 61 898 900 O
evidence 62 70 901 909 O
of 71 73 910 912 O
relapse 74 81 913 920 O
or 82 84 921 923 O
progression 85 96 924 935 O

Women 0 5 936 941 B-gender
of 6 8 942 944 O
childbearing 9 21 945 957 O
potential 22 31 958 967 O
who 32 35 968 971 O
currently 36 45 972 981 B-pregnancy
are 46 49 982 985 I-pregnancy
pregnant 50 58 986 994 I-pregnancy
or 59 61 995 997 O
who 62 65 998 1001 O
are 66 69 1002 1005 O
not 70 73 1006 1009 B-contraception_consent
practicing 74 84 1010 1020 I-contraception_consent
adequate 85 93 1021 1029 I-contraception_consent
contraception 94 107 1030 1043 I-contraception_consent

Active 0 6 0 6 O
systemic 7 15 7 15 O
illness 16 23 16 23 O
( 24 25 24 25 O
infection 25 34 25 34 O
including 35 44 35 44 O
viral 45 50 45 50 O
illnesses 51 60 51 60 O
such 61 65 61 65 O
as 66 68 66 68 O
Hepatitis 69 78 69 78 B-chronic_disease
and 79 82 79 82 O
HIV 83 86 83 86 B-chronic_disease
) 86 87 86 87 O

Any 0 3 88 91 O
NSAIDs 4 10 92 98 B-treatment
aspirin 11 18 99 106 I-treatment
or 19 21 107 109 O
omega-3 22 29 110 117 B-treatment
free 30 34 118 122 I-treatment
fatty 35 40 123 128 I-treatment
acid 41 45 129 133 I-treatment
supplementation 46 61 134 149 I-treatment
within 62 68 150 156 O
the 69 72 157 160 O
last 73 77 161 165 B-upper_bound
14 78 80 166 168 I-upper_bound
days 81 85 169 173 I-upper_bound

At 0 2 174 176 O
least 3 8 177 182 O
18 9 11 183 185 B-lower_bound
years 12 17 186 191 I-lower_bound
of 18 20 192 194 O
age 21 24 195 198 B-age

Body 0 4 199 203 B-bmi
mass 5 9 204 208 I-bmi
index 10 15 209 214 I-bmi
of 16 18 215 217 O
30 19 21 218 220 B-lower_bound
or 22 24 221 223 O
greater 25 32 224 231 O

Cachexia 0 8 232 240 B-chronic_disease

Chronic 0 7 241 248 O
use 8 11 249 252 O
of 12 14 253 255 O
NSAIDs 15 21 256 262 B-treatment
( 22 23 263 264 I-treatment
nonsteroidal 23 35 264 276 I-treatment
anti 36 40 277 281 I-treatment
- 40 41 281 282 I-treatment
inflammatory 41 53 282 294 I-treatment
drugs 54 59 295 300 I-treatment
) 59 60 300 301 I-treatment
aspirin 61 68 302 309 I-treatment
or 69 71 310 312 O
omega-3 72 79 313 320 B-treatment
free 80 84 321 325 I-treatment
fatty 85 90 326 331 I-treatment
acid 91 95 332 336 I-treatment
supplementation 96 111 337 352 I-treatment
within 112 118 353 359 O
the 119 122 360 363 O
last 123 127 364 368 B-upper_bound
60 128 130 369 371 I-upper_bound
days 131 135 372 376 I-upper_bound
( 136 137 377 378 O
defined 137 144 378 385 O
as 145 147 386 388 O
greater 148 155 389 396 O
than 156 160 397 401 O
or 161 163 402 404 O
equal 164 169 405 410 O
to 170 172 411 413 O
7 173 174 414 415 B-lower_bound
consecutive 175 186 416 427 I-lower_bound
days 187 191 428 432 I-lower_bound
) 191 192 432 433 O

Estrogen 0 8 434 442 O
receptor 9 17 443 451 O
positive 18 26 452 460 O
breast 27 33 461 467 B-cancer
cancer 34 40 468 474 I-cancer

Scheduled 0 9 475 484 O
date 10 14 485 489 O
of 15 17 490 492 O
surgical 18 26 493 501 O
resection 27 36 502 511 O
that 37 41 512 516 O
would 42 47 517 522 O
limit 48 53 523 528 O
the 54 57 529 532 O
amount 58 64 533 539 O
of 65 67 540 542 O
time 68 72 543 547 O
taking 73 79 548 554 O
the 80 83 555 558 O
intervention 84 96 559 571 O
to 97 99 572 574 O
less 100 104 575 579 O
than 105 109 580 584 O
21 110 112 585 587 B-upper_bound
days 113 117 588 592 I-upper_bound

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
greater 32 39 32 39 O
than 40 44 40 44 O
or 45 47 45 47 O
equal 48 53 48 53 O
to 54 56 54 56 O
1,500 57 62 57 62 B-lower_bound
/ 62 63 62 63 I-lower_bound
mcl 63 66 63 66 I-lower_bound
, 66 67 66 67 O
equivalent 68 78 68 78 O
to 79 81 79 81 O
Common 82 88 82 88 O
Toxicity 89 97 89 97 O
Criteria 98 106 98 106 O
( 107 108 107 108 O
CTCAE 108 113 108 113 O
v4.0 114 118 114 118 O
) 118 119 118 119 O
Grade 120 125 120 125 O
1 126 127 126 127 O
. 127 128 127 128 O
Platelets 129 138 129 138 B-clinical_variable
greater 139 146 139 146 O
than 147 151 147 151 O
or 152 154 152 154 O
equal 155 160 155 160 O
to 161 163 161 163 O
100,000 164 171 164 171 B-lower_bound
/ 171 172 171 172 I-lower_bound
mcl 172 175 172 175 I-lower_bound
( 176 177 176 177 O
CTCAE 177 182 177 182 O
v4.0 183 187 183 187 O
Grade 188 193 188 193 O
0 194 195 194 195 O
- 195 196 195 196 O
1 196 197 196 197 O
) 197 198 197 198 O
. 198 199 198 199 O
Hemoglobin 200 210 200 210 B-clinical_variable
( 211 212 211 212 I-clinical_variable
Hgb 212 215 212 215 I-clinical_variable
) 215 216 215 216 I-clinical_variable
greater 217 224 217 224 O
than 225 229 225 229 O
or 230 232 230 232 O
equal 233 238 233 238 O
to 239 241 239 241 O
9.0g 242 246 242 246 B-lower_bound
/ 246 247 246 247 I-lower_bound
dl 247 249 247 249 I-lower_bound
( 250 251 250 251 O
CTCAE 251 256 251 256 O
v4.0 257 261 257 261 O
Grade 262 267 262 267 O
2 268 269 268 269 O
) 269 270 269 270 O

Bilirubin 0 9 271 280 B-clinical_variable
less 10 14 281 285 O
than 15 19 286 290 O
or 20 22 291 293 O
equal 23 28 294 299 O
to 29 31 300 302 O
1.5 32 35 303 306 B-upper_bound
x 36 37 307 308 I-upper_bound
ULN 38 41 309 312 I-upper_bound
( 42 43 313 314 O
CTCAE 43 48 314 319 O
v4.0 49 53 320 324 O
Grade 54 59 325 330 O
1 60 61 331 332 O
) 61 62 332 333 O
. 62 63 333 334 O
Serum 64 69 335 340 B-clinical_variable
glutamate 70 79 341 350 I-clinical_variable
oxaloacetate 80 92 351 363 I-clinical_variable
transaminase 93 105 364 376 I-clinical_variable
( 106 107 377 378 I-clinical_variable
SGOT 107 111 378 382 I-clinical_variable
) 111 112 382 383 I-clinical_variable
and 113 116 384 387 O
alkaline 117 125 388 396 B-clinical_variable
phosphatase 126 137 397 408 I-clinical_variable
≤ 138 139 409 410 O
2.5 140 143 411 414 B-upper_bound
x 144 145 415 416 I-upper_bound
ULN 146 149 417 420 I-upper_bound
( 150 151 421 422 O
CTCAE 151 156 422 427 O
v4.0 157 161 428 432 O
Grade 162 167 433 438 O
1 168 169 439 440 O
) 169 170 440 441 O

Creatinine 0 10 442 452 B-clinical_variable
less 11 15 453 457 O
than 16 20 458 462 O
or 21 23 463 465 O
equal 24 29 466 471 O
to 30 32 472 474 O
1.5 33 36 475 478 B-upper_bound
x 37 38 479 480 I-upper_bound
institutional 39 52 481 494 I-upper_bound
upper 53 58 495 500 I-upper_bound
limit 59 64 501 506 I-upper_bound
normal 65 71 507 513 I-upper_bound
( 72 73 514 515 I-upper_bound
ULN 73 76 515 518 I-upper_bound
) 76 77 518 519 I-upper_bound
, 77 78 519 520 O
CTCAE 79 84 521 526 O
v4.0 85 89 527 531 O
Grade 90 95 532 537 O
1 96 97 538 539 O

Flaxseed 0 8 540 548 B-treatment
supplementation 9 24 549 564 O
may 25 28 565 568 O
be 29 31 569 571 O
contraindicated 32 47 572 587 O
in 48 50 588 590 O
patients 51 59 591 599 O
with 60 64 600 604 O
acute 65 70 605 610 B-chronic_disease
abdomen 71 78 611 618 I-chronic_disease
, 78 79 618 619 O
esophageal 80 90 620 630 B-chronic_disease
stricture 91 100 631 640 I-chronic_disease
or 101 103 641 643 I-chronic_disease
perforation 104 115 644 655 I-chronic_disease
, 115 116 655 656 O
dysphagia 117 126 657 666 B-chronic_disease
, 126 127 666 667 O
GI 128 130 668 670 B-chronic_disease
obstruction 131 142 671 682 I-chronic_disease
or 143 145 683 685 O
ileus 146 151 686 691 B-chronic_disease
, 151 152 691 692 O
acute 153 158 693 698 B-chronic_disease
intestinal 159 169 699 709 I-chronic_disease
inflammation 170 182 710 722 I-chronic_disease
or 183 185 723 725 O
unexplained 186 197 726 737 O
abdominal 198 207 738 747 O
pain 208 212 748 752 O
. 212 213 752 753 O
Patients 214 222 754 762 O
with 223 227 763 767 O
any 228 231 768 771 O
of 232 234 772 774 O
these 235 240 775 780 O
conditions 241 251 781 791 O
will 252 256 792 796 O
be 257 259 797 799 O
excluded 260 268 800 808 O
from 269 273 809 813 O
this 274 278 814 818 O
trial 279 284 819 824 O
as 285 287 825 827 O
the 288 291 828 831 O
high 292 296 832 836 O
fiber 297 302 837 842 O
content 303 310 843 850 O
of 311 313 851 853 O
flaxseed 314 322 854 862 O
may 323 326 863 866 O
make 327 331 867 871 O
these 332 337 872 877 O
conditions 338 348 878 888 O
worse 349 354 889 894 O

Patient 0 7 895 902 O
has 8 11 903 906 O
received 12 20 907 915 O
other 21 26 916 921 O
investigational 27 42 922 937 O
drugs 43 48 938 943 O
within 49 55 944 950 O
28 56 58 951 953 B-upper_bound
days 59 63 954 958 I-upper_bound
before 64 70 959 965 O
enrollment 71 81 966 976 O

Patients 0 8 977 985 O
concurrently 9 21 986 998 O
using 22 27 999 1004 O
anticoagulants 28 42 1005 1019 B-treatment
/ 42 43 1019 1020 O
antiplatelets 43 56 1020 1033 B-treatment
on 57 59 1034 1036 O
a 60 61 1037 1038 O
DAILY 62 67 1039 1044 O
BASIS 68 73 1045 1050 O
, 73 74 1050 1051 O
including 75 84 1052 1061 O
aspirin 85 92 1062 1069 B-treatment
, 92 93 1069 1070 O
Clopidogrel 94 105 1071 1082 B-treatment
( 106 107 1083 1084 I-treatment
Plavix 107 113 1084 1090 I-treatment
) 113 114 1090 1091 I-treatment
, 114 115 1091 1092 O
Ticlopidine 116 127 1093 1104 B-treatment
( 128 129 1105 1106 I-treatment
Ticlid 129 135 1106 1112 I-treatment
) 135 136 1112 1113 I-treatment
, 136 137 1113 1114 O
and 138 141 1115 1118 O
Coumadin 142 150 1119 1127 B-treatment

Patients 0 8 1128 1136 O
unable 9 15 1137 1143 O
to 16 18 1144 1146 O
tolerate 19 27 1147 1155 O
and/or 28 34 1156 1162 O
allergies 35 44 1163 1172 O
to 45 47 1173 1175 O
flaxseed 48 56 1176 1184 B-allergy_name
or 57 59 1185 1187 I-allergy_name
flaxseed 60 68 1188 1196 I-allergy_name
preparations 69 81 1197 1209 I-allergy_name

Patients 0 8 1210 1218 O
who 9 12 1219 1222 O
are 13 16 1223 1226 O
pregnant 17 25 1227 1235 B-pregnancy

Patients 0 8 1236 1244 O
who 9 12 1245 1248 O
have 13 17 1249 1253 O
received 18 26 1254 1262 O
prior 27 32 1263 1268 O
radiotherapy 33 45 1269 1281 B-treatment
or 46 48 1282 1284 O
chemotherapy 49 61 1285 1297 B-treatment
for 62 65 1298 1301 O
another 66 73 1302 1309 O
malignancy 74 84 1310 1320 B-cancer

Patients 0 8 1321 1329 O
with 9 13 1330 1334 O
Gynecologic 14 25 1335 1346 B-clinical_variable
Oncology 26 34 1347 1355 I-clinical_variable
Group 35 40 1356 1361 I-clinical_variable
( 41 42 1362 1363 I-clinical_variable
GOG 42 45 1363 1366 I-clinical_variable
) 45 46 1366 1367 I-clinical_variable
performance 47 58 1368 1379 I-clinical_variable
status 59 65 1380 1386 I-clinical_variable
> 66 67 1387 1388 O
2 68 69 1389 1390 B-lower_bound

Patients 0 8 1391 1399 O
with 9 13 1400 1404 O
a 14 15 1405 1406 O
diagnosis 16 25 1407 1416 O
of 26 28 1417 1419 O
OC 29 31 1420 1422 B-cancer
including 32 41 1423 1432 O
epithelial 42 52 1433 1443 B-cancer
ovarian 53 60 1444 1451 I-cancer
carcinoma 61 70 1452 1461 I-cancer
, 70 71 1461 1462 O
primary 72 79 1463 1470 B-cancer
peritoneal 80 90 1471 1481 I-cancer
cancer 91 97 1482 1488 I-cancer
or 98 100 1489 1491 O
fallopian 101 110 1492 1501 B-cancer
tube 111 115 1502 1506 I-cancer
cancer 116 122 1507 1513 I-cancer
who 123 126 1514 1517 O
are 127 130 1518 1521 O
currently 131 140 1522 1531 O
in 141 143 1532 1534 O
clinical 144 152 1535 1543 B-treatment
remission 153 162 1544 1553 I-treatment
as 163 165 1554 1556 O
determined 166 176 1557 1567 O
by 177 179 1568 1570 O
the 180 183 1571 1574 O
PI 184 186 1575 1577 O
or 187 189 1578 1580 O
co 190 192 1581 1583 O
- 192 193 1583 1584 O
I 193 194 1584 1585 O
and 195 198 1586 1589 O
are 199 202 1590 1593 O
within 203 209 1594 1600 O
4 210 211 1601 1602 B-upper_bound
months 212 218 1603 1609 I-upper_bound
of 219 221 1610 1612 O
completion 222 232 1613 1623 O
of 233 235 1624 1626 O
cancer 236 242 1627 1633 B-treatment
treatment 243 252 1634 1643 I-treatment

Patients 0 8 1644 1652 O
with 9 13 1653 1657 O
a 14 15 1658 1659 O
diagnosis 16 25 1660 1669 O
of 26 28 1670 1672 O
/ 28 29 1672 1673 O
problems 29 37 1673 1681 O
with 38 42 1682 1686 O
von 43 46 1687 1690 B-chronic_disease
Willebrand 47 57 1691 1701 I-chronic_disease
's 57 59 1701 1703 I-chronic_disease
disease 60 67 1704 1711 I-chronic_disease
or 68 70 1712 1714 O
other 71 76 1715 1720 O
bleeding 77 85 1721 1729 B-chronic_disease
disorders 86 95 1730 1739 I-chronic_disease
( 96 97 1740 1741 O
as 97 99 1741 1743 O
flaxseed 100 108 1744 1752 O
may 109 112 1753 1756 O
slow 113 117 1757 1761 O
blood 118 123 1762 1767 O
clotting 124 132 1768 1776 O
; 132 133 1776 1777 O
the 134 137 1778 1781 O
risk 138 142 1782 1786 O
of 143 145 1787 1789 O
bruising 146 154 1790 1798 O
or 155 157 1799 1801 O
bleeding 158 166 1802 1810 O
in 167 169 1811 1813 O
people 170 176 1814 1820 O
on 177 179 1821 1823 O
anticoagulants 180 194 1824 1838 B-treatment
or 195 197 1839 1841 O
with 198 202 1842 1846 O
bleeding 203 211 1847 1855 O
disorders 212 221 1856 1865 O
may 222 225 1866 1869 O
be 226 228 1870 1872 O
a 229 230 1873 1874 O
concern 231 238 1875 1882 O
) 238 239 1882 1883 O

Patients 0 8 1884 1892 O
with 9 13 1893 1897 O
a 14 15 1898 1899 O
history 16 23 1900 1907 O
of 24 26 1908 1910 O
inflammatory 27 39 1911 1923 B-chronic_disease
bowel 40 45 1924 1929 I-chronic_disease
disease 46 53 1930 1937 I-chronic_disease
, 53 54 1937 1938 O
problems 55 63 1939 1947 O
with 64 68 1948 1952 O
chronic 69 76 1953 1960 B-chronic_disease
diarrhea 77 85 1961 1969 I-chronic_disease
or 86 88 1970 1972 O
history 89 96 1973 1980 O
of 97 99 1981 1983 O
bowel 100 105 1984 1989 B-chronic_disease
obstruction 106 117 1990 2001 I-chronic_disease

Patients 0 8 2002 2010 O
with 9 13 2011 2015 O
a 14 15 2016 2017 O
history 16 23 2018 2025 O
of 24 26 2026 2028 O
uncontrolled 27 39 2029 2041 B-chronic_disease
diabetes 40 48 2042 2050 I-chronic_disease
( 49 50 2051 2052 O
as 50 52 2052 2054 O
flaxseed 53 61 2055 2063 O
can 62 65 2064 2067 O
lower 66 71 2068 2073 O
blood 72 77 2074 2079 O
glucose 78 85 2080 2087 O
levels 86 92 2088 2094 O
and 93 96 2095 2098 O
might 97 102 2099 2104 O
have 103 107 2105 2109 O
additive 108 116 2110 2118 O
effects 117 124 2119 2126 O
when 125 129 2127 2131 O
used 130 134 2132 2136 O
with 135 139 2137 2141 O
anti 140 144 2142 2146 B-treatment
- 144 145 2146 2147 I-treatment
diabetic 145 153 2147 2155 I-treatment
drugs 154 159 2156 2161 I-treatment
) 159 160 2161 2162 O

Patients 0 8 2163 2171 O
with 9 13 2172 2176 O
concurrent 14 24 2177 2187 O
uncontrolled 25 37 2188 2200 B-chronic_disease
illness 38 45 2201 2208 I-chronic_disease

Patients 0 8 2209 2217 O
with 9 13 2218 2222 O
ovarian 14 21 2223 2230 B-cancer
cancer 22 28 2231 2237 I-cancer
of 29 31 2238 2240 O
low 32 35 2241 2244 O
malignant 36 45 2245 2254 O
potential 46 55 2255 2264 O
( 56 57 2265 2266 O
borderline 57 67 2266 2276 B-cancer
cancers 68 75 2277 2284 I-cancer
) 75 76 2284 2285 O

Patients 0 8 2286 2294 O
with 9 13 2295 2299 O
serious 14 21 2300 2307 O
medical 22 29 2308 2315 O
or 30 32 2316 2318 O
psychiatric 33 44 2319 2330 B-chronic_disease
illness 45 52 2331 2338 I-chronic_disease

Renal 0 5 2339 2344 B-chronic_disease
function 6 14 2345 2353 I-chronic_disease

Women 0 5 2354 2359 B-gender
of 6 8 2360 2362 O
childbearing 9 21 2363 2375 O
potential 22 31 2376 2385 O
must 32 36 2386 2390 O
have 37 41 2391 2395 O
a 42 43 2396 2397 O
negative 44 52 2398 2406 B-pregnancy
pregnancy 53 62 2407 2416 I-pregnancy
test 63 67 2417 2421 O

patients 0 8 2422 2430 O
of 9 11 2431 2433 O
any 12 15 2434 2437 O
stage 16 21 2438 2443 O
who 22 25 2444 2447 O
are 26 29 2448 2451 O
in 30 32 2452 2454 O
remission 33 42 2455 2464 O
who 43 46 2465 2468 O
have 47 51 2469 2473 O
undergone 52 61 2474 2483 O
surgical 62 70 2484 2492 B-treatment
debulking 71 80 2493 2502 I-treatment
and 81 84 2503 2506 O
adjuvant 85 93 2507 2515 B-treatment
chemotherapy 94 106 2516 2528 I-treatment

A 0 1 0 1 O
well 2 6 2 6 O
- 6 7 6 7 O
established 7 18 7 18 O
genetic 19 26 19 26 B-chronic_disease
syndrome 27 35 27 35 I-chronic_disease
, 35 36 35 36 O
such 37 41 37 41 O
as 42 44 42 44 O
Fragile 45 52 45 52 B-chronic_disease
X 53 54 53 54 I-chronic_disease

At 0 2 55 57 O
least 3 8 58 63 O
one 9 12 64 67 B-lower_bound
room 13 17 68 72 O
of 18 20 73 75 O
the 21 24 76 79 O
house 25 30 80 85 O
must 31 35 86 90 O
be 36 38 91 93 O
available 39 48 94 103 O
to 49 51 104 106 O
be 52 54 107 109 O
dedicated 55 64 110 119 O
to 65 67 120 122 O
treatment 68 77 123 132 O
during 78 84 133 139 O
session 85 92 140 147 O
times 93 98 148 153 O

Availability 0 12 154 166 O
of 13 15 167 169 O
at 16 18 170 172 O
least 19 24 173 178 O
one 25 28 179 182 B-lower_bound
English 29 36 183 190 B-language_fluency
- 36 37 190 191 I-language_fluency
speaking 37 45 191 199 I-language_fluency
parent 46 52 200 206 O
who 53 56 207 210 O
can 57 60 211 214 O
consistently 61 73 215 227 O
participate 74 85 228 239 O
in 86 88 240 242 O
parent 89 95 243 249 O
training 96 104 250 258 O
and 105 108 259 262 O
research 109 117 263 271 O
measures 118 126 272 280 O

Child 0 5 281 286 O
's 5 7 286 288 O
primary 8 15 289 296 B-language_fluency
language 16 24 297 305 I-language_fluency
other 25 30 306 311 I-language_fluency
than 31 35 312 316 I-language_fluency
English 36 43 317 324 I-language_fluency

Children 0 8 325 333 O
with 9 13 334 338 O
more 14 18 339 343 O
than 19 23 344 348 O
20 24 26 349 351 B-lower_bound
hours 27 32 352 357 I-lower_bound
of 33 35 358 360 O
in 36 38 361 363 B-treatment
- 38 39 363 364 I-treatment
home 39 43 364 368 I-treatment
ABA 44 47 369 372 I-treatment

Clinical 0 8 373 381 B-clinical_variable
Global 9 15 382 388 I-clinical_variable
Impression(CGI 16 30 389 403 I-clinical_variable
) 30 31 403 404 I-clinical_variable
Severity 32 40 405 413 I-clinical_variable
Social 41 47 414 420 I-clinical_variable
Interaction 48 59 421 432 I-clinical_variable
and 60 63 433 436 I-clinical_variable
Communication 64 77 437 450 I-clinical_variable
Integrated 78 88 451 461 I-clinical_variable
Subscale 89 97 462 470 I-clinical_variable
≥4 98 100 471 473 O

Current 0 7 474 481 O
or 8 10 482 484 O
lifetime 11 19 485 493 O
diagnosis 20 29 494 503 O
of 30 32 504 506 O
severe 33 39 507 513 O
psychiatric 40 51 514 525 B-chronic_disease
disorder 52 60 526 534 I-chronic_disease
( 61 62 535 536 O
e.g. 62 66 536 540 O
, 66 67 540 541 O
bipolar 68 75 542 549 B-chronic_disease
disorder 76 84 550 558 I-chronic_disease
, 84 85 558 559 O
etc 86 89 560 563 O
. 89 90 563 564 O
) 90 91 564 565 O

Diagnosis 0 9 566 575 O
of 10 12 576 578 O
Autism 13 19 579 585 B-chronic_disease
Spectrum 20 28 586 594 I-chronic_disease
Disorder 29 37 595 603 I-chronic_disease
based 38 43 604 609 O
on 44 46 610 612 O
Autism 47 53 613 619 O
Diagnostic 54 64 620 630 O
Interview 65 74 631 640 O
Revised 75 82 641 648 O
( 83 84 649 650 O
ADI 84 87 650 653 O
- 87 88 653 654 O
R 88 89 654 655 O
) 89 90 655 656 O
, 90 91 656 657 O
Autism 92 98 658 664 O
Diagnostic 99 109 665 675 O
Observation 110 121 676 687 O
Schedule 122 130 688 696 O
( 131 132 697 698 O
ADOS-2 132 138 698 704 O
) 138 139 704 705 O
, 139 140 705 706 O
DSM-5 141 146 707 712 O
, 146 147 712 713 O
and 148 151 714 717 O
expert 152 158 718 724 O
clinical 159 167 725 733 O
opinion 168 175 734 741 O

Males 0 5 742 747 B-gender

Meet 0 4 748 752 O
the 5 8 753 756 O
cutoff 9 15 757 763 O
for 16 19 764 767 O
Autism 20 26 768 774 B-chronic_disease
on 27 29 775 777 O
the 30 33 778 781 O
ADOS-2 34 40 782 788 O

Stable 0 6 789 795 B-treatment
treatment 7 16 796 805 I-treatment
( 17 18 806 807 O
e.g. 18 22 807 811 O
, 22 23 811 812 O
applied 24 31 813 820 B-treatment
behavior 32 40 821 829 I-treatment
analysis 41 49 830 838 I-treatment
) 49 50 838 839 O
, 50 51 839 840 O
speech 52 58 841 847 B-treatment
therapy 59 66 848 855 I-treatment
, 66 67 855 856 O
psychotropic 68 80 857 869 B-treatment
medication(s 81 93 870 882 I-treatment
) 93 94 882 883 I-treatment
or 95 97 884 886 O
biomedical 98 108 887 897 B-treatment
intervention(s 109 123 898 912 I-treatment
) 123 124 912 913 I-treatment
for 125 128 914 917 O
at 129 131 918 920 O
least 132 137 921 926 O
1 138 139 927 928 B-lower_bound
month 140 145 929 934 I-lower_bound
prior 146 151 935 940 I-lower_bound
to 152 154 941 943 O
baseline 155 163 944 952 O
measurements 164 176 953 965 O
with 177 181 966 970 O
no 182 184 971 973 O
anticipated 185 196 974 985 O
changes 197 204 986 993 O
during 205 211 994 1000 O
study 212 217 1001 1006 O
participation 218 231 1007 1020 O

between 0 7 1021 1028 O
2.0 8 11 1029 1032 B-lower_bound
and 12 15 1033 1036 O
5 16 17 1037 1038 B-upper_bound
years 18 23 1039 1044 I-upper_bound
11 24 26 1045 1047 I-upper_bound
months 27 33 1048 1054 I-upper_bound

females 0 7 1055 1062 B-gender

Active 0 6 0 6 O
GI 7 9 7 9 B-chronic_disease
hemorrhage 10 20 10 20 I-chronic_disease
within 21 27 21 27 O
2 28 29 28 29 B-upper_bound
weeks 30 35 30 35 I-upper_bound
of 36 38 36 38 O
study 39 44 39 44 O
enrollment 45 55 45 55 O

Age 0 3 56 59 B-age
18 4 6 60 62 B-upper_bound
years 7 12 63 68 I-upper_bound
old 13 16 69 72 O

Albumin 0 7 73 80 B-clinical_variable
2.4 8 11 81 84 O
g 12 13 85 86 O
/ 13 14 86 87 O
dL 14 16 87 89 O
; 16 17 89 90 O
Total 18 23 91 96 O
bilirubin 24 33 97 106 B-clinical_variable
2 34 35 107 108 O
mg 36 38 109 111 O
/ 38 39 111 112 O
dL 39 41 112 114 O
; 41 42 114 115 O
INR 43 46 116 119 B-clinical_variable
1.5 47 50 120 123 O

Ascites 0 7 124 131 B-chronic_disease
refractory 8 18 132 142 I-chronic_disease
to 19 21 143 145 O
medical 22 29 146 153 B-treatment
therapy 30 37 154 161 I-treatment

Child 0 5 162 167 B-clinical_variable
- 5 6 167 168 I-clinical_variable
Turcotte 6 14 168 176 I-clinical_variable
- 14 15 176 177 I-clinical_variable
Pugh 15 19 177 181 I-clinical_variable
Classification 20 34 182 196 I-clinical_variable
A 35 36 197 198 B-lower_bound
or 37 39 199 201 O
B 40 41 202 203 B-upper_bound

Contraindication 0 16 204 220 O
to 17 19 221 223 O
contrast 20 28 224 232 O
enhanced 29 37 233 241 O
MRI 38 41 242 245 B-treatment
( 42 43 246 247 O
i.e. 43 47 247 251 O
unable 48 54 252 258 O
to 55 57 259 261 O
undergo 58 65 262 269 O
follow 66 72 270 276 O
- 72 73 276 277 O
up 73 75 277 279 O
imaging 76 83 280 287 O
) 83 84 287 288 O

Contraindication 0 16 289 305 O
to 17 19 306 308 O
receiving 20 29 309 318 O
HCQ 30 33 319 322 B-treatment
or 34 36 323 325 O
TACE 37 41 326 330 B-treatment

Creatinine 0 10 331 341 B-clinical_variable
2.0 11 14 342 345 O
mg 15 17 346 348 O
/ 17 18 348 349 O
dL 18 20 349 351 O
, 20 21 351 352 O
AST 22 25 353 356 B-clinical_variable
121 26 29 357 360 O
IU 30 32 361 363 O
/ 32 33 363 364 O
L 33 34 364 365 O
; 34 35 365 366 O
ALT 36 39 367 370 B-clinical_variable
189 40 43 371 374 O
IU 44 46 375 377 O
/ 46 47 377 378 O
L 47 48 378 379 O

Eastern 0 7 380 387 B-clinical_variable
Clinical 8 16 388 396 I-clinical_variable
Oncology 17 25 397 405 I-clinical_variable
Group 26 31 406 411 I-clinical_variable
performance 32 43 412 423 I-clinical_variable
status 44 50 424 430 I-clinical_variable
0 51 52 431 432 B-lower_bound
or1 53 56 433 436 O

Participation 0 13 437 450 O
in 14 16 451 453 O
another 17 24 454 461 O
concurrent 25 35 462 472 O
treatment 36 45 473 482 B-treatment
protocol 46 54 483 491 O

Patient 0 7 492 499 O
diagnosed 8 17 500 509 O
with 18 22 510 514 O
hepatocellular 23 37 515 529 B-cancer
carcinoma 38 47 530 539 I-cancer
in 48 50 540 542 O
both 51 55 543 547 O
lobes 56 61 548 553 O
of 62 64 554 556 O
the 65 68 557 560 O
liver 69 74 561 566 O
by 75 77 567 569 O
one 78 81 570 573 O
of 82 84 574 576 O
the 85 88 577 580 O
following 89 98 581 590 O
methods 99 106 591 598 O
( 107 108 599 600 O
Pathologically 108 122 600 614 O
confirmed 123 132 615 624 O
HCC 133 136 625 628 B-cancer
by 137 139 629 631 O
biopsy 140 146 632 638 B-treatment
or 147 149 639 641 O
HCC 150 153 642 645 O
2 154 155 646 647 B-lower_bound
cm 156 158 648 650 I-lower_bound
with 159 163 651 655 O
classic 164 171 656 663 O
radiographic 172 184 664 676 O
findings 185 193 677 685 O
of 194 196 686 688 O
arterial 197 205 689 697 O
phase 206 211 698 703 O
enhancement 212 223 704 715 O
with 224 228 716 720 O
venous 229 235 721 727 O
phase 236 241 728 733 O
washout 242 249 734 741 O
and 250 253 742 745 O
pseudocapsule 254 267 746 759 O
formation 268 277 760 769 O
on 278 280 770 772 O
contrast 281 289 773 781 O
enhanced 290 298 782 790 O
MRI 299 302 791 794 B-treatment
or 303 305 795 797 O
CT 306 308 798 800 B-treatment
or 309 311 801 803 O
Lesion 312 318 804 810 B-clinical_variable
greater 319 326 811 818 O
than 327 331 819 823 O
2 332 333 824 825 O
cm 334 336 826 828 O
with 337 341 829 833 O
probable 342 350 834 842 O
imaging 351 358 843 850 O
features 359 367 851 859 O
of 368 370 860 862 O
HCC 371 374 863 866 O
and 375 378 867 870 O
imaging 379 386 871 878 O
findings 387 395 879 887 O
of 396 398 888 890 O
cirrhosis 399 408 891 900 B-chronic_disease
and/or 409 415 901 907 O
portal 416 422 908 914 B-chronic_disease
hypertension 423 435 915 927 I-chronic_disease
or 436 438 928 930 O
a 439 440 931 932 O
serum 441 446 933 938 B-clinical_variable
alphafetoprotein 447 463 939 955 I-clinical_variable
( 464 465 956 957 I-clinical_variable
AFP 465 468 957 960 I-clinical_variable
) 468 469 960 961 I-clinical_variable
greater 470 477 962 969 O
than 478 482 970 974 O
200 483 486 975 978 B-lower_bound
mg 487 489 979 981 I-lower_bound
/ 489 490 981 982 I-lower_bound
mL 490 492 982 984 I-lower_bound

Patient 0 7 985 992 O
not 8 11 993 996 O
candidate 12 21 997 1006 O
for 22 25 1007 1010 O
orthotopic 26 36 1011 1021 B-treatment
liver 37 42 1022 1027 I-treatment
transplantation 43 58 1028 1043 I-treatment
at 59 61 1044 1046 O
the 62 65 1047 1050 O
Hospital 66 74 1051 1059 O
of 75 77 1060 1062 O
the 78 81 1063 1066 O
University 82 92 1067 1077 O
of 93 95 1078 1080 O
Pennsylvania 96 108 1081 1093 O
based 109 114 1094 1099 O
on 115 117 1100 1102 O
review 118 124 1103 1109 O
of 125 127 1110 1112 O
patient 128 135 1113 1120 O
imaging 136 143 1121 1128 O
and 144 147 1129 1132 O
history 148 155 1133 1140 O
at 156 158 1141 1143 O
multidisciplinary 159 176 1144 1161 O
Hepatic 177 184 1162 1169 O
Tumor 185 190 1170 1175 O
Conference 191 201 1176 1186 O
at 202 204 1187 1189 O
the 205 208 1190 1193 O
Hospital 209 217 1194 1202 O
of 218 220 1203 1205 O
the 221 224 1206 1209 O
University 225 235 1210 1220 O
of 236 238 1221 1223 O
Pennsylvania 239 251 1224 1236 O

Prior 0 5 1237 1242 B-treatment
TACE 6 10 1243 1247 I-treatment

Unilobar 0 8 1248 1256 O
HCC 9 12 1257 1260 B-cancer

Women 0 5 1261 1266 B-gender
who 6 9 1267 1270 O
are 10 13 1271 1274 B-pregnancy
pregnant 14 22 1275 1283 I-pregnancy

Karnofsky 0 9 0 9 B-clinical_variable
performance 10 21 10 21 I-clinical_variable
status 22 28 22 28 I-clinical_variable
( 29 30 29 30 I-clinical_variable
PS 30 32 30 32 I-clinical_variable
) 32 33 32 33 I-clinical_variable
≥ 34 35 34 35 O
70 36 38 36 38 B-lower_bound

Patients 0 8 39 47 O
with 9 13 48 52 O
prostatectomy 14 27 53 66 B-treatment
receiving 28 37 67 76 O
post 38 42 77 81 B-treatment
- 42 43 81 82 I-treatment
operative 43 52 82 91 I-treatment
radiotherapy 53 65 92 104 I-treatment

Patients 0 8 105 113 O
with 9 13 114 118 O
uncontrolled 14 26 119 131 B-chronic_disease
inter 27 32 132 137 I-chronic_disease
- 32 33 137 138 I-chronic_disease
current 33 40 138 145 I-chronic_disease
illness 41 48 146 153 I-chronic_disease

cancer 0 6 154 160 B-cancer
involving 7 16 161 170 O
the 17 20 171 174 O
liver 21 26 175 180 O
by 27 29 181 183 O
biopsy 30 36 184 190 B-treatment
or 37 39 191 193 O
radiographic 40 52 194 206 B-treatment
criteria 53 61 207 215 O

prostate 0 8 216 224 B-cancer
cancer 9 15 225 231 I-cancer
by 16 18 232 234 O
biopsy 19 25 235 241 B-treatment
, 25 26 241 242 O
with 27 31 243 247 O
the 32 35 248 251 O
intent 36 42 252 258 O
of 43 45 259 261 O
undergoing 46 56 262 272 O
definitive 57 67 273 283 O
dose 68 72 284 288 O
radiation 73 82 289 298 B-treatment
therapy 83 90 299 306 I-treatment
to 91 93 307 309 O
targets 94 101 310 317 O
within 102 108 318 324 O
the 109 112 325 328 O
liver 113 118 329 334 O
, 118 119 334 335 O
or 120 122 336 338 O
prostate 123 131 339 347 O

psychiatric 0 11 348 359 B-chronic_disease
illness 12 19 360 367 I-chronic_disease
/ 19 20 367 368 I-chronic_disease
social 20 26 368 374 I-chronic_disease
situations 27 37 375 385 I-chronic_disease
that 38 42 386 390 O
would 43 48 391 396 O
limit 49 54 397 402 O
compliance 55 65 403 413 O
with 66 70 414 418 O
study 71 76 419 424 O
requirements 77 89 425 437 O

61 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
old 9 12 9 12 O
and 13 16 13 16 O
above 17 22 17 22 O

between 0 7 23 30 O
the 8 11 31 34 O
ages 12 16 35 39 B-age
of 17 19 40 42 O
18 20 22 43 45 B-lower_bound
- 22 23 45 46 O
60 23 25 46 48 B-upper_bound

fluent 0 6 49 55 B-language_fluency
in 7 9 56 58 I-language_fluency
English 10 17 59 66 I-language_fluency

has 0 3 67 70 O
a 4 5 71 72 O
history 6 13 73 80 O
of 14 16 81 83 O
food 17 21 84 88 B-allergy_name
allergy 22 29 89 96 O

has 0 3 97 100 O
a 4 5 101 102 O
history 6 13 103 110 O
of 14 16 111 113 O
taste 17 22 114 119 O
or 23 25 120 122 O
smell 26 31 123 128 O
loss 32 36 129 133 O
or 37 39 134 136 O
other 40 45 137 142 O
oral 46 50 143 147 O
disorders 51 60 148 157 O
( 61 62 158 159 O
e.g. 62 66 159 163 O
, 66 67 163 164 O
burning 68 75 165 172 B-chronic_disease
mouth 76 81 173 178 I-chronic_disease
syndrome 82 90 179 187 I-chronic_disease
) 90 91 187 188 O

has 0 3 189 192 O
current 4 11 193 200 O
oral 12 16 201 205 B-chronic_disease
lesions 17 24 206 213 I-chronic_disease
, 24 25 213 214 O
canker 26 32 215 221 B-chronic_disease
sores 33 38 222 227 I-chronic_disease
, 38 39 227 228 O
or 40 42 229 231 O
piercings 43 52 232 241 B-chronic_disease

pregnant 0 8 242 250 B-pregnancy
women 9 14 251 256 B-gender

taking 0 6 257 263 O
any 7 10 264 267 O
prescription 11 23 268 280 O
pain/ 24 29 281 286 O
insulin 30 37 287 294 B-treatment
medication 38 48 295 305 I-treatment

History 0 7 0 7 O
of 8 10 8 10 O
prior 11 16 11 16 O
AF 17 19 17 19 B-chronic_disease

Known 0 5 20 25 O
pregnancy 6 15 26 35 B-pregnancy

Male- 0 5 36 41 B-gender
age 6 9 42 45 B-age
≥75 10 13 46 49 O
( 14 15 50 51 O
No 15 17 51 53 O
BNP 18 21 54 57 O
limit 22 27 58 63 O
) 27 28 63 64 O

Patients 0 8 65 73 O
in 9 11 74 76 O
sinus 12 17 77 82 B-chronic_disease
rhythm 18 24 83 89 I-chronic_disease

Patients 0 8 90 98 O
scheduled 9 18 99 108 O
for 19 22 109 112 O
extrapleural 23 35 113 125 B-treatment
pneumonectomy 36 49 126 139 I-treatment

Patients 0 8 140 148 O
with 9 13 149 153 O
stable 14 20 154 160 O
respiratory 21 32 161 172 O
status 33 39 173 179 O
( 40 41 180 181 O
no 41 43 181 183 O
respiratory 44 55 184 195 B-chronic_disease
distress 56 64 196 204 I-chronic_disease
) 64 65 204 205 O

Patients 0 8 206 214 O
≥18 9 12 215 218 O
years 13 18 219 224 I-lower_bound
old 19 22 225 228 O
scheduled 23 32 229 238 O
for 33 36 239 242 O
elective 37 45 243 251 B-treatment
thoracic 46 54 252 260 I-treatment
surgery 55 62 261 268 I-treatment

having 0 6 269 275 O
an 7 9 276 278 O
acute 10 15 279 284 B-chronic_disease
MI 16 18 285 287 I-chronic_disease

not 0 3 288 291 O
in 4 6 292 294 O
cardiogenic 7 18 295 306 B-chronic_disease
shock 19 24 307 312 I-chronic_disease

History 0 7 0 7 O
of 8 10 8 10 O
chronic 11 18 11 18 B-chronic_disease
disease 19 26 19 26 I-chronic_disease
, 26 27 26 27 O
except 28 34 28 34 O
asthma 35 41 35 41 B-chronic_disease
, 41 42 41 42 O
atopic 43 49 43 49 B-chronic_disease
dermatitis 50 60 50 60 I-chronic_disease
, 60 61 60 61 O
autism 62 68 62 68 B-chronic_disease
or 69 71 69 71 O
controlled 72 82 72 82 O
seizure 83 90 83 90 B-chronic_disease
disorder 91 99 91 99 I-chronic_disease

History 0 7 100 107 O
of 8 10 108 110 O
hypersensitivity 11 27 111 127 O
to 28 30 128 130 O
anakinra 31 39 131 139 B-allergy_name

History 0 7 140 147 O
of 8 10 148 150 O
tuberculosis 11 23 151 163 B-chronic_disease
( 24 25 164 165 I-chronic_disease
TB 25 27 165 167 I-chronic_disease
) 27 28 167 168 I-chronic_disease
or 29 31 169 171 I-chronic_disease
TB 32 34 172 174 I-chronic_disease
exposure 35 43 175 183 I-chronic_disease

Infant 0 6 184 190 O
or 7 9 191 193 O
child 10 15 194 199 O
aged 16 20 200 204 B-age
1 21 22 205 206 B-lower_bound
month 23 28 207 212 I-lower_bound
to 29 31 213 215 O
17 32 34 216 218 B-upper_bound
years 35 40 219 224 I-upper_bound

Males 0 5 225 230 B-gender
engaging 6 14 231 239 O
in 15 17 240 242 O
sexual 18 24 243 249 O
activity 25 33 250 258 O
that 34 38 259 263 O
could 39 44 264 269 O
lead 45 49 270 274 O
to 50 52 275 277 O
pregnancy 53 62 278 287 B-pregnancy
willing 63 70 288 295 B-contraception_consent
to 71 73 296 298 I-contraception_consent
use 74 77 299 302 I-contraception_consent
a 78 79 303 304 I-contraception_consent
condom 80 86 305 311 I-contraception_consent

Post 0 4 312 316 O
- 4 5 316 317 O
menarchal 5 14 317 326 O
females 15 22 327 334 B-gender
: 22 23 334 335 O
Negative 24 32 336 344 B-pregnancy
pregnancy 33 42 345 354 I-pregnancy
test 43 47 355 359 O
at 48 50 360 362 O
screening 51 60 363 372 O
and 61 64 373 376 O
willing 65 72 377 384 O
to 73 75 385 387 O
use 76 79 388 391 B-contraception_consent
two 80 83 392 395 I-contraception_consent
forms 84 89 396 401 I-contraception_consent
of 90 92 402 404 I-contraception_consent
contraception 93 106 405 418 I-contraception_consent
during 107 113 419 425 O
the 114 117 426 429 O
study 118 123 430 435 O

Use 0 3 436 439 O
of 4 6 440 442 O
an 7 9 443 445 O
IL-1 10 14 446 450 B-treatment
antagonist 15 25 451 461 I-treatment
within 26 32 462 468 O
the 33 36 469 472 O
3 37 38 473 474 B-upper_bound
months 39 45 475 481 I-upper_bound
prior 46 51 482 487 I-upper_bound
to 52 54 488 490 O
enrollment 55 65 491 501 O

Patients 0 8 0 8 O
who 9 12 9 12 O
meet 13 17 13 17 O
the 18 21 18 21 O
regular 22 29 22 29 O
exclusion 30 39 30 39 O
criteria 40 48 40 48 O
for 49 52 49 52 O
Magnetic 53 61 53 61 B-treatment
Resonance 62 71 62 71 I-treatment
Imaging 72 79 72 79 I-treatment
( 80 81 80 81 I-treatment
MRI 81 84 81 84 I-treatment
) 84 85 84 85 I-treatment
studies 86 93 86 93 O
per 94 97 94 97 O
the 98 101 98 101 O
prescreening 102 114 102 114 O
form 115 119 115 119 O
reviewed 120 128 120 128 O
with 129 133 129 133 O
all 134 137 134 137 O
patients 138 146 138 146 O
prior 147 152 147 152 O
to 153 155 153 155 O
exams 156 161 156 161 O

Patients 0 8 162 170 O
with 9 13 171 175 O
overt 14 19 176 181 O
symptoms 20 28 182 190 O
or 29 31 191 193 O
signs 32 37 194 199 O
of 38 40 200 202 O
anxiety 41 48 203 210 B-chronic_disease
than 49 53 211 215 O
can 54 57 216 219 O
not 57 60 219 222 O
cooperate 61 70 223 232 O
during 71 77 233 239 O
the 78 81 240 243 O
recording 82 91 244 253 O
inside 92 98 254 260 O
the 99 102 261 264 O
scanner 103 110 265 272 O
, 110 111 272 273 O
unless 112 118 274 280 O
consent 119 126 281 288 O
is 127 129 289 291 O
given 130 135 292 297 O
for 136 139 298 301 O
the 140 143 302 305 O
procedure 144 153 306 315 O
to 154 156 316 318 O
be 157 159 319 321 O
performed 160 169 322 331 O
with 170 174 332 336 O
sedation 175 183 337 345 O
by 184 186 346 348 O
the 187 190 349 352 O
anesthesia 191 201 353 363 O
department 202 212 364 374 O

Refractory 0 10 375 385 B-chronic_disease
epilepsy 11 19 386 394 I-chronic_disease
cases 20 25 395 400 O
, 25 26 400 401 O
referred 27 35 402 410 O
by 36 38 411 413 O
the 39 42 414 417 O
service 43 50 418 425 O
of 51 53 426 428 O
Neurology 54 63 429 438 O

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Documented 0 10 15 25 O
diagnosis 11 20 26 35 O
of 21 23 36 38 O
MDS 24 27 39 42 B-chronic_disease
with 28 32 43 47 O
5 33 34 48 49 B-lower_bound
- 34 35 49 50 O
19 35 37 50 52 B-upper_bound
% 37 38 52 53 I-upper_bound
myeloblasts 39 50 54 65 B-clinical_variable

Higher 0 6 66 72 O
Risk 7 11 73 77 O
Myelodysplastic 12 27 78 93 B-cancer
Syndrome 28 36 94 102 I-cancer

Higher 0 6 103 109 O
risk 7 11 110 114 O
Myelodysplastic 12 27 115 130 B-cancer
Syndrome 28 36 131 139 I-cancer

IPSS 0 4 140 144 B-clinical_variable
low 5 8 145 148 O
or 9 11 149 151 O
intermediate-1 12 26 152 166 O
risk 27 31 167 171 O
MDS 32 35 172 175 B-cancer

Major 0 5 176 181 B-treatment
surgery 6 13 182 189 I-treatment
within 14 20 190 196 O
4 21 22 197 198 B-upper_bound
weeks 23 28 199 204 I-upper_bound
before 29 35 205 211 O
C1D1 36 40 212 216 B-treatment

Patients 0 8 217 225 O
believed 9 17 226 234 O
to 18 20 235 237 O
be 21 23 238 240 O
IPSS 24 28 241 245 B-clinical_variable
high 29 33 246 250 O
risk 34 38 251 255 O
, 38 39 255 256 O
without 40 47 257 264 O
clearly 48 55 265 272 O
meeting 56 63 273 280 O
IPSS 64 68 281 285 O
categories 69 79 286 296 O
above 80 85 297 302 O
should 86 92 303 309 O
be 93 95 310 312 O
discussed 96 105 313 322 O
with 106 110 323 327 O
the 111 114 328 331 O
medical 115 122 332 339 O
monitor 123 130 340 347 O
prior 131 136 348 353 O
to 137 139 354 356 O
enrolling 140 149 357 366 O

Patients 0 8 367 375 O
receiving 9 18 376 385 O
granulocyte 19 30 386 397 B-treatment
- 30 31 397 398 I-treatment
colony 31 37 398 404 I-treatment
stimulating 38 49 405 416 I-treatment
factor 50 56 417 423 I-treatment
( 57 58 424 425 I-treatment
G 58 59 425 426 I-treatment
- 59 60 426 427 I-treatment
CSF 60 63 427 430 I-treatment
) 63 64 430 431 I-treatment
or 65 67 432 434 O
granulocyte 68 79 435 446 B-treatment
macrophage 80 90 447 457 I-treatment
- 90 91 457 458 I-treatment
colony 91 97 458 464 I-treatment
stimulating 98 109 465 476 I-treatment
factor 110 116 477 483 I-treatment
( 117 118 484 485 I-treatment
GM 118 120 485 487 I-treatment
- 120 121 487 488 I-treatment
CSF 121 124 488 491 I-treatment
) 124 125 491 492 I-treatment
within 126 132 493 499 O
the 133 136 500 503 O
3 137 138 504 505 B-upper_bound
weeks 139 144 506 511 I-upper_bound
prior 145 150 512 517 I-upper_bound
to 151 153 518 520 O
C1D1 154 158 521 525 B-treatment

Patients 0 8 526 534 O
with 9 13 535 539 O
adequately 14 24 540 550 O
resected 25 33 551 559 B-cancer
basal 34 39 560 565 I-cancer
or 40 42 566 568 I-cancer
squamous 43 51 569 577 I-cancer
cell 52 56 578 582 I-cancer
carcinoma 57 66 583 592 I-cancer
of 67 69 593 595 I-cancer
the 70 73 596 599 I-cancer
skin 74 78 600 604 I-cancer
, 78 79 604 605 O
or 80 82 606 608 O
adequately 83 93 609 619 B-cancer
resected 94 102 620 628 I-cancer
carcinoma 103 112 629 638 I-cancer
in 113 115 639 641 I-cancer
situ 116 120 642 646 I-cancer
( 121 122 647 648 O
i.e. 122 126 648 652 O
cervix 127 133 653 659 O
) 133 134 659 660 O
may 135 138 661 664 O
enroll 139 145 665 671 O
irrespective 146 158 672 684 O
of 159 161 685 687 O
the 162 165 688 691 O
time 166 170 692 696 O
of 171 173 697 699 O
diagnosis 174 183 700 709 O

Patients 0 8 710 718 O
with 9 13 719 723 O
known 14 19 724 729 O
symptomatic 20 31 730 741 B-cancer
brain 32 37 742 747 I-cancer
metastasis 38 48 748 758 I-cancer

Uncontrolled 0 12 759 771 O
active 13 19 772 778 O
severe 20 26 779 785 O
systemic 27 35 786 794 B-chronic_disease
infection 36 45 795 804 I-chronic_disease
requiring 46 55 805 814 O
parenteral 56 66 815 825 B-treatment
antibiotics 67 78 826 837 I-treatment
, 78 79 837 838 O
antivirals 80 90 839 849 B-treatment
, 90 91 849 850 O
or 92 94 851 853 O
antifungals 95 106 854 865 B-treatment
within 107 113 866 872 O
one 114 117 873 876 B-upper_bound
week 118 122 877 881 I-upper_bound
prior 123 128 882 887 I-upper_bound
to 129 131 888 890 O
C1D1 132 136 891 895 O

≥20 0 3 896 899 O
% 3 4 899 900 I-lower_bound
blasts 5 11 901 907 I-lower_bound
in 12 14 908 910 O
bone 15 19 911 915 O
marrow 20 26 916 922 O
or 27 29 923 925 O
peripheral 30 40 926 936 O
blood 41 46 937 942 O

Abnormal 0 8 0 8 O
cardiac 9 16 9 16 B-clinical_variable
valve 17 22 17 22 I-clinical_variable
morphology 23 33 23 33 I-clinical_variable
( 34 35 34 35 O
≥grade 35 41 35 41 O
2 42 43 42 43 I-lower_bound
) 43 44 43 44 O
documented 45 55 45 55 O
by 56 58 56 58 O
echocardiogram 59 73 59 73 B-treatment

All 0 3 74 77 O
prior 4 9 78 83 B-treatment
anti 10 14 84 88 I-treatment
- 14 15 88 89 I-treatment
cancer 15 21 89 95 I-treatment
treatment 22 31 96 105 I-treatment
- 31 32 105 106 O
related 32 39 106 113 O
toxicities 40 50 114 124 O
( 51 52 125 126 O
except 52 58 126 132 O
alopecia 59 67 133 141 B-chronic_disease
and 68 71 142 145 O
laboratory 72 82 146 156 O
values 83 89 157 163 O
as 90 92 164 166 O
listed 93 99 167 173 O
in 100 102 174 176 O
Eligibility 103 114 177 188 O
Criteria 115 123 189 197 O
# 124 125 198 199 O
4 125 126 199 200 O
) 126 127 200 201 O
must 128 132 202 206 O
be 133 135 207 209 O
Grade 136 141 210 215 O
1 142 143 216 217 O
according 144 153 218 227 O
to 154 156 228 230 O
the 157 160 231 234 O
Common 161 167 235 241 O
Terminology 168 179 242 253 O
Criteria 180 188 254 262 O
for 189 192 263 266 O
Adverse 193 200 267 274 O
Events 201 207 275 281 O
version 208 215 282 289 O
4 216 217 290 291 O
( 218 219 292 293 O
CTCAE 219 224 293 298 O
version 225 232 299 306 O
4.03 233 237 307 311 O
, 237 238 311 312 O
2009 239 243 313 317 O
) 243 244 317 318 O
at 245 247 319 321 O
the 248 251 322 325 O
time 252 256 326 330 O
of 257 259 331 333 O
starting 260 268 334 342 O
treatment 269 278 343 352 O

Any 0 3 353 356 O
number 4 10 357 363 O
and 11 14 364 367 O
type 15 19 368 372 O
of 20 22 373 375 O
prior 23 28 376 381 O
anticancer 29 39 382 392 B-treatment
therapies 40 49 393 402 I-treatment

BRAF 0 4 403 407 B-treatment
or 5 7 408 410 O
MEK 8 11 411 414 B-treatment
inhibitors 12 22 415 425 I-treatment

Current 0 7 426 433 O
use 8 11 434 437 O
of 12 14 438 440 O
a 15 16 441 442 O
prohibited 17 27 443 453 O
medication 28 38 454 464 O
as 39 41 465 467 O
described 42 51 468 477 O
in 52 54 478 480 O
Section 55 62 481 488 O
6.3.8 63 68 489 494 O
of 69 71 495 497 O
the 72 75 498 501 O
protocol 76 84 502 510 O
for 85 88 511 514 O
Potential 89 98 515 524 O
for 99 102 525 528 O
Drug 103 107 529 533 O
- 107 108 533 534 O
Drug 108 112 534 538 O
Interaction 113 124 539 550 O
: 124 125 550 551 O
apply 126 131 552 557 O
moisturizing 132 144 558 570 O
creams 145 151 571 577 O
frequently 152 162 578 588 O
, 162 163 588 589 O
topical 164 171 590 597 B-treatment
keratolytics 172 184 598 610 I-treatment
( 185 186 611 612 O
e.g. 186 190 612 616 O
urea 191 195 617 621 B-clinical_variable
20 196 198 622 624 B-lower_bound
- 198 199 624 625 O
40 199 201 625 627 B-upper_bound
% 202 203 628 629 I-upper_bound
cream 204 209 630 635 O
, 209 210 635 636 O
salicylic 211 220 637 646 B-clinical_variable
acid 221 225 647 651 I-clinical_variable
6 226 227 652 653 O
% 227 228 653 654 O
, 228 229 654 655 O
tazarotene 230 240 656 666 B-clinical_variable
0.1 241 244 667 670 O
% 244 245 670 671 O
cream 246 251 672 677 O
, 251 252 677 678 O
fluorouracil 253 265 679 691 B-clinical_variable
5 266 267 692 693 O
% 267 268 693 694 O
cream 269 274 695 700 O
) 274 275 700 701 O
, 275 276 701 702 O
clobetasol 277 287 703 713 B-treatment
propionate 288 298 714 724 I-treatment
0.05 299 303 725 729 O
% 303 304 729 730 O
ointment 305 313 731 739 B-treatment
for 314 317 740 743 O
erythematous 318 330 744 756 O
areas 331 336 757 762 O
, 336 337 762 763 O
topical 338 345 764 771 B-treatment
lidocaine 346 355 772 781 I-treatment
2 356 357 782 783 O
% 357 358 783 784 O
, 358 359 784 785 O
and 360 363 786 789 O
/ 364 365 790 791 O
or 366 368 792 794 O
systemic 369 377 795 803 O
pain 378 382 804 808 B-treatment
medication 383 393 809 819 I-treatment
such 394 398 820 824 O
as 399 401 825 827 O
nonsteroidal 402 414 828 840 B-treatment
anti 415 419 841 845 I-treatment
- 419 420 845 846 I-treatment
inflammatory 420 432 846 858 I-treatment
drugs 433 438 859 864 I-treatment
, 438 439 864 865 O
codeine 440 447 866 873 B-treatment
, 447 448 873 874 O
and 449 452 875 878 O
pregabalin 453 463 879 889 B-treatment
for 464 467 890 893 O
pain 468 472 894 898 O

Current 0 7 899 906 O
≥ 8 9 907 908 O
Class 10 15 909 914 B-lower_bound
II 16 18 915 917 I-lower_bound
congestive 19 29 918 928 B-chronic_disease
heart 30 35 929 934 I-chronic_disease
failure 36 43 935 942 I-chronic_disease
as 44 46 943 945 O
defined 47 54 946 953 O
by 55 57 954 956 O
New 58 61 957 960 B-clinical_variable
York 62 66 961 965 I-clinical_variable
Heart 67 72 966 971 I-clinical_variable
Association 73 84 972 983 I-clinical_variable

Due 0 3 984 987 O
to 4 6 988 990 O
risk 7 11 991 995 O
of 12 14 996 998 O
disease 15 22 999 1006 O
exacerbation 23 35 1007 1019 O
patients 36 44 1020 1028 O
with 45 49 1029 1033 O
porphyria 50 59 1034 1043 B-chronic_disease
or 60 62 1044 1046 O
psoriasis 63 72 1047 1056 B-chronic_disease
are 73 76 1057 1060 O
ineligible 77 87 1061 1071 O
unless 88 94 1072 1078 O
the 95 98 1079 1082 O
disease 99 106 1083 1090 O
is 107 109 1091 1093 O
well 110 114 1094 1098 O
controlled 115 125 1099 1109 O
and 126 129 1110 1113 O
they 130 134 1114 1118 O
are 135 138 1119 1122 O
under 139 144 1123 1128 O
the 145 148 1129 1132 O
care 149 153 1133 1137 O
of 154 156 1138 1140 O
a 157 158 1141 1142 O
specialist 159 169 1143 1153 O
for 170 173 1154 1157 O
the 174 177 1158 1161 O
disorder 178 186 1162 1170 O
who 187 190 1171 1174 O
agrees 191 197 1175 1181 O
to 198 200 1182 1184 O
monitor 201 208 1185 1192 O
the 209 212 1193 1196 O
patient 213 220 1197 1204 O
for 221 224 1205 1208 O
exacerbations 225 238 1209 1222 O

Have 0 4 1223 1227 O
a 5 6 1228 1229 O
known 7 12 1230 1235 O
immediate 13 22 1236 1245 O
or 23 25 1246 1248 O
delayed 26 33 1249 1256 O
hypersensitivity 34 50 1257 1273 O
reaction 51 59 1274 1282 O
or 60 62 1283 1285 O
idiosyncrasy 63 75 1286 1298 O
to 76 78 1299 1301 O
drugs 79 84 1302 1307 O
chemically 85 95 1308 1318 O
related 96 103 1319 1326 O
to 104 106 1327 1329 O
study 107 112 1330 1335 B-treatment
drug 113 117 1336 1340 I-treatment
, 117 118 1340 1341 O
or 119 121 1342 1344 O
excipients 122 132 1345 1355 O
or 133 135 1356 1358 O
to 136 138 1359 1361 O
dimethyl 139 147 1362 1370 B-allergy_name
sulfoxide 148 157 1371 1380 I-allergy_name
( 158 159 1381 1382 I-allergy_name
DMSO 159 163 1382 1386 I-allergy_name
) 163 164 1386 1387 I-allergy_name

History 0 7 1388 1395 O
of 8 10 1396 1398 O
acute 11 16 1399 1404 B-chronic_disease
coronary 17 25 1405 1413 I-chronic_disease
syndromes 26 35 1414 1423 I-chronic_disease
( 36 37 1424 1425 O
including 37 46 1425 1434 O
myocardial 47 57 1435 1445 B-chronic_disease
infarction 58 68 1446 1456 I-chronic_disease
and 69 72 1457 1460 O
unstable 73 81 1461 1469 B-chronic_disease
angina 82 88 1470 1476 I-chronic_disease
) 88 89 1476 1477 O
, 89 90 1477 1478 O
coronary 91 99 1479 1487 B-treatment
angioplasty 100 111 1488 1499 I-treatment
, 111 112 1499 1500 O
or 113 115 1501 1503 O
stenting 116 124 1504 1512 B-treatment
within 125 131 1513 1519 O
6 132 133 1520 1521 B-upper_bound
months 134 140 1522 1528 I-upper_bound
prior 141 146 1529 1534 I-upper_bound
to 147 149 1535 1537 O
randomization 150 163 1538 1551 O

History 0 7 1552 1559 O
of 8 10 1560 1562 O
interstitial 11 23 1563 1575 B-chronic_disease
lung 24 28 1576 1580 I-chronic_disease
disease 29 36 1581 1588 I-chronic_disease
or 37 39 1589 1591 O
chronic 40 47 1592 1599 O
pneumonitis 48 59 1600 1611 B-chronic_disease

History 0 7 1612 1619 O
of 8 10 1620 1622 O
malignancy 11 21 1623 1633 B-cancer
other 22 27 1634 1639 O
than 28 32 1640 1644 O
disease 33 40 1645 1652 O
under 41 46 1653 1658 O
study 47 52 1659 1664 O
within 53 59 1665 1671 O
3 60 61 1672 1673 B-upper_bound
years 62 67 1674 1679 I-upper_bound
of 68 70 1680 1682 O
study 71 76 1683 1688 O
enrollment 77 87 1689 1699 O

History 0 7 1700 1707 O
of 8 10 1708 1710 O
malignancy 11 21 1711 1721 B-cancer
with 22 26 1722 1726 O
confirmed 27 36 1727 1736 O
activating 37 47 1737 1747 O
RAS 48 51 1748 1751 O
mutation 52 60 1752 1760 O
at 61 63 1761 1763 O
any 64 67 1764 1767 O
time 68 72 1768 1772 O

Known 0 5 1773 1778 O
Hepatitis 6 15 1779 1788 B-chronic_disease
B 16 17 1789 1790 I-chronic_disease
Virus 18 23 1791 1796 I-chronic_disease
( 24 25 1797 1798 I-chronic_disease
HBV 25 28 1798 1801 I-chronic_disease
) 28 29 1801 1802 I-chronic_disease
, 29 30 1802 1803 O
or 31 33 1804 1806 O
Hepatitis 34 43 1807 1816 B-chronic_disease
C 44 45 1817 1818 I-chronic_disease
Virus 46 51 1819 1824 I-chronic_disease
( 52 53 1825 1826 I-chronic_disease
HCV 53 56 1826 1829 I-chronic_disease
) 56 57 1829 1830 I-chronic_disease
infection 58 67 1831 1840 I-chronic_disease

Negative 0 8 1841 1849 O
serum 9 14 1850 1855 O
pregnancy 15 24 1856 1865 B-pregnancy
test 25 29 1866 1870 O
within 30 36 1871 1877 O
7 37 38 1878 1879 B-upper_bound
days 39 43 1880 1884 I-upper_bound
prior 44 49 1885 1890 I-upper_bound
to 50 52 1891 1893 O
commencement 53 65 1894 1906 O
of 66 68 1907 1909 O
dosing 69 75 1910 1916 O
in 76 78 1917 1919 O
premenopausal 79 92 1920 1933 O
women 93 98 1934 1939 B-gender

Patients 0 8 1940 1948 O
must 9 13 1949 1953 O
be 14 16 1954 1956 O
able 17 21 1957 1961 O
to 22 24 1962 1964 O
swallow 25 32 1965 1972 O
and 33 36 1973 1976 O
retain 37 43 1977 1983 O
oral 44 48 1984 1988 B-treatment
medication 49 59 1989 1999 I-treatment
and 60 63 2000 2003 O
must 64 68 2004 2008 O
not 69 72 2009 2012 O
have 73 77 2013 2017 O
any 78 81 2018 2021 O
clinically 82 92 2022 2032 O
significant 93 104 2033 2044 O
gastrointestinal 105 121 2045 2061 B-chronic_disease
abnormalities 122 135 2062 2075 I-chronic_disease
that 136 140 2076 2080 O
may 141 144 2081 2084 O
alter 145 150 2085 2090 O
absorption 151 161 2091 2101 O
such 162 166 2102 2106 O
as 167 169 2107 2109 O
malabsorption 170 183 2110 2123 B-chronic_disease
syndrome 184 192 2124 2132 I-chronic_disease
or 193 195 2133 2135 O
major 196 201 2136 2141 O
resection 202 211 2142 2151 B-treatment
of 212 214 2152 2154 I-treatment
the 215 218 2155 2158 I-treatment
stomach 219 226 2159 2166 I-treatment
or 227 229 2167 2169 I-treatment
bowels 230 236 2170 2176 I-treatment

Patients 0 8 2177 2185 O
must 9 13 2186 2190 O
be 14 16 2191 2193 O
at 17 19 2194 2196 O
least 20 25 2197 2202 O
18 26 28 2203 2205 B-lower_bound
years 29 34 2206 2211 I-lower_bound
of 35 37 2212 2214 O
age 38 41 2215 2218 B-age

Patients 0 8 2219 2227 O
must 9 13 2228 2232 O
have 14 18 2233 2237 O
an 19 21 2238 2240 O
ECOG 22 26 2241 2245 B-clinical_variable
performance 27 38 2246 2257 I-clinical_variable
status 39 45 2258 2264 I-clinical_variable
of 46 48 2265 2267 O
0 49 50 2268 2269 B-lower_bound
or 51 53 2270 2272 O
1 54 55 2273 2274 B-upper_bound

Patients 0 8 2275 2283 O
must 9 13 2284 2288 O
have 14 18 2289 2293 O
discontinued 19 31 2294 2306 O
active 32 38 2307 2313 O
immunotherapy 39 52 2314 2327 B-treatment
( 53 54 2328 2329 O
IL-2 54 58 2329 2333 B-treatment
, 58 59 2333 2334 O
interferon 60 70 2335 2345 B-treatment
, 70 71 2345 2346 O
CTLA-4 72 78 2347 2353 B-treatment
, 78 79 2353 2354 O
etc 80 83 2355 2358 O
. 83 84 2358 2359 O
) 84 85 2359 2360 O
or 86 88 2361 2363 O
chemotherapy 89 101 2364 2376 B-treatment
at 102 104 2377 2379 O
least 105 110 2380 2385 O
4 111 112 2386 2387 B-lower_bound
weeks 113 118 2388 2393 I-lower_bound
prior 119 124 2394 2399 I-lower_bound
to 125 127 2400 2402 O
entering 128 136 2403 2411 O
the 137 140 2412 2415 O
study 141 146 2416 2421 O
and 147 150 2422 2425 O
oral 151 155 2426 2430 B-treatment
targeted 156 164 2431 2439 I-treatment
therapy 165 172 2440 2447 I-treatment
at 173 175 2448 2450 O
least 176 181 2451 2456 O
2 182 183 2457 2458 B-lower_bound
weeks 184 189 2459 2464 I-lower_bound
prior 190 195 2465 2470 I-lower_bound
to 196 198 2471 2473 O
entering 199 207 2474 2482 O
the 208 211 2483 2486 O
study 212 217 2487 2492 O

Patients 0 8 2493 2501 O
must 9 13 2502 2506 O
have 14 18 2507 2511 O
histologically 19 33 2512 2526 O
confirmed 34 43 2527 2536 O
diagnosis 44 53 2537 2546 O
of 54 56 2547 2549 O
Stage 57 62 2550 2555 B-cancer
IV 63 65 2556 2558 I-cancer
metastatic 66 76 2559 2569 I-cancer
melanoma 77 85 2570 2578 I-cancer
positive 86 94 2579 2587 O
for 95 98 2588 2591 O
BRAF 99 103 2592 2596 O
V600E 104 109 2597 2602 O
or 110 112 2603 2605 O
V600 113 117 2606 2610 O
K 117 118 2610 2611 O
by 119 121 2612 2614 O
a 122 123 2615 2616 O
CLIA 124 128 2617 2621 B-treatment
approved 129 137 2622 2630 I-treatment
assay 138 143 2631 2636 I-treatment

Patients 0 8 2637 2645 O
must 9 13 2646 2650 O
not 14 17 2651 2654 O
receive 18 25 2655 2662 O
any 26 29 2663 2666 O
other 30 35 2667 2672 O
investigational 36 51 2673 2688 B-treatment
anticancer 52 62 2689 2699 I-treatment
therapy 63 70 2700 2707 I-treatment
during 71 77 2708 2714 O
the 78 81 2715 2718 O
period 82 88 2719 2725 O
on 89 91 2726 2728 O
study 92 97 2729 2734 O
or 98 100 2735 2737 O
the 101 104 2738 2741 O
four 105 109 2742 2746 B-lower_bound
weeks 110 115 2747 2752 I-lower_bound
prior 116 121 2753 2758 I-lower_bound
to 122 124 2759 2761 O
entry 125 130 2762 2767 O

Patients 0 8 2768 2776 O
receiving 9 18 2777 2786 O
concurrent 19 29 2787 2797 B-treatment
therapy 30 37 2798 2805 I-treatment
for 38 41 2806 2809 O
their 42 47 2810 2815 O
tumor 48 53 2816 2821 B-cancer
( 54 55 2822 2823 O
i.e. 55 59 2823 2827 O
chemotherapeutics 60 77 2828 2845 B-treatment
or 78 80 2846 2848 O
investigational 81 96 2849 2864 B-treatment
agents 97 103 2865 2871 I-treatment
) 103 104 2871 2872 O

Patients 0 8 2873 2881 O
receiving 9 18 2882 2891 O
cytochrome 19 29 2892 2902 B-treatment
P450 30 34 2903 2907 I-treatment
enzyme 35 41 2908 2914 I-treatment
- 41 42 2914 2915 I-treatment
inducing 42 50 2915 2923 I-treatment
anticonvulsant 51 65 2924 2938 I-treatment
drugs 66 71 2939 2944 I-treatment
( 72 73 2945 2946 I-treatment
EIADs 73 78 2946 2951 I-treatment
) 78 79 2951 2952 I-treatment
( 80 81 2953 2954 O
i.e. 81 85 2954 2958 O
phenytoin 86 95 2959 2968 B-treatment
, 95 96 2968 2969 O
carbamazepine 97 110 2970 2983 B-treatment
, 110 111 2983 2984 O
Phenobarbital 112 125 2985 2998 B-treatment
, 125 126 2998 2999 O
primidone 127 136 3000 3009 B-treatment
or 137 139 3010 3012 O
oxcarbazepine 140 153 3013 3026 B-treatment
) 153 154 3026 3027 O
within 155 161 3028 3034 O
4 162 163 3035 3036 B-upper_bound
weeks 164 169 3037 3042 I-upper_bound
of 170 172 3043 3045 O
the 173 176 3046 3049 O
start 177 182 3050 3055 O
of 183 185 3056 3058 O
the 186 189 3059 3062 O
study 190 195 3063 3068 O
treatment 196 205 3069 3078 B-treatment

Patients 0 8 3079 3087 O
that 9 13 3088 3092 O
are 14 17 3093 3096 O
asymptomatic 18 30 3097 3109 O
on 31 33 3110 3112 O
low 34 37 3113 3116 B-treatment
dose 38 42 3117 3121 I-treatment
maintenance 43 54 3122 3133 I-treatment
hormone 55 62 3134 3141 I-treatment
replacement 63 74 3142 3153 I-treatment
delivered 75 84 3154 3163 O
at 85 87 3164 3166 O
a 88 89 3167 3168 O
stable 90 96 3169 3175 O
dose 97 101 3176 3180 O
for 102 105 3181 3184 O
prior 106 111 3185 3190 O
toxicities 112 122 3191 3201 O

Patients 0 8 3202 3210 O
who 9 12 3211 3214 O
are 13 16 3215 3218 O
known 17 22 3219 3224 O
to 23 25 3225 3227 O
be 26 28 3228 3230 O
experiencing 29 41 3231 3243 O
an 42 44 3244 3246 O
objective 45 54 3247 3256 O
partial 55 62 3257 3264 O
response 63 71 3265 3273 O
to 72 74 3274 3276 O
immunotherapy 75 88 3277 3290 B-treatment
at 89 91 3291 3293 O
the 92 95 3294 3297 O
time 96 100 3298 3302 O
of 101 103 3303 3305 O
study 104 109 3306 3311 O
enrollment 110 120 3312 3322 O

Patients 0 8 3323 3331 O
who 9 12 3332 3335 O
are 13 16 3336 3339 B-pregnancy
pregnant 17 25 3340 3348 I-pregnancy

Patients 0 8 3349 3357 O
with 9 13 3358 3362 O
a 14 15 3363 3364 O
previously 16 26 3365 3375 O
documented 27 37 3376 3386 O
retinal 38 45 3387 3394 B-chronic_disease
vein 46 50 3395 3399 I-chronic_disease
occlusion 51 60 3400 3409 I-chronic_disease

Patients 0 8 3410 3418 O
with 9 13 3419 3423 O
brain 14 19 3424 3429 B-cancer
metastases 20 30 3430 3440 I-cancer
treated 31 38 3441 3448 O
with 39 43 3449 3453 O
whole 44 49 3454 3459 B-treatment
brain 50 55 3460 3465 I-treatment
radiation 56 65 3466 3475 I-treatment
that 66 70 3476 3480 O
have 71 75 3481 3485 O
been 76 80 3486 3490 O
stable 81 87 3491 3497 O
for 88 91 3498 3501 O
2 92 93 3502 3503 B-upper_bound
months 94 100 3504 3510 I-upper_bound

Patients 0 8 3511 3519 O
with 9 13 3520 3524 O
intra 14 19 3525 3530 B-treatment
- 19 20 3530 3531 I-treatment
cardiac 20 27 3531 3538 I-treatment
defibrillators 28 42 3539 3553 I-treatment

Patients 0 8 3554 3562 O
with 9 13 3563 3567 O
known 14 19 3568 3573 O
serious 20 27 3574 3581 O
concurrent 28 38 3582 3592 O
infection 39 48 3593 3602 B-chronic_disease
or 49 51 3603 3605 O
medical 52 59 3606 3613 O
illness 60 67 3614 3621 O
, 67 68 3621 3622 O
including 69 78 3623 3632 O
psychiatric 79 90 3633 3644 B-chronic_disease
disorders 91 100 3645 3654 I-chronic_disease
, 100 101 3654 3655 O
which 102 107 3656 3661 O
would 108 113 3662 3667 O
jeopardize 114 124 3668 3678 O
the 125 128 3679 3682 O
ability 129 136 3683 3690 O
of 137 139 3691 3693 O
the 140 143 3694 3697 O
patient 144 151 3698 3705 O
to 152 154 3706 3708 O
receive 155 162 3709 3716 O
the 163 166 3717 3720 O
treatment 167 176 3721 3730 B-treatment
outlined 177 185 3731 3739 O
in 186 188 3740 3742 O
this 189 193 3743 3747 O
protocol 194 202 3748 3756 O
with 203 207 3757 3761 O
reasonable 208 218 3762 3772 O
safety 219 225 3773 3779 O

Subjects 0 8 3780 3788 O
with 9 13 3789 3793 O
a 14 15 3794 3795 O
history 16 23 3796 3803 O
of 24 26 3804 3806 O
completely 27 37 3807 3817 O
resected 38 46 3818 3826 O
non 47 50 3827 3830 B-cancer
- 50 51 3830 3831 I-cancer
melanoma 51 59 3831 3839 I-cancer
skin 60 64 3840 3844 I-cancer
cancer 65 71 3845 3851 I-cancer

Subjects 0 8 3852 3860 O
with 9 13 3861 3865 O
controlled 14 24 3866 3876 O
atrial 25 31 3877 3883 B-chronic_disease
fibrillation 32 44 3884 3896 I-chronic_disease
for 45 48 3897 3900 O
> 49 50 3901 3902 O
30 50 52 3902 3904 B-lower_bound
days 53 57 3905 3909 I-lower_bound
prior 58 63 3910 3915 I-lower_bound
to 64 66 3916 3918 O
randomization 67 80 3919 3932 O

Subjects 0 8 3933 3941 O
with 9 13 3942 3946 O
moderate 14 22 3947 3955 O
valvular 23 31 3956 3964 B-chronic_disease
thickening 32 42 3965 3975 I-chronic_disease

Women 0 5 3976 3981 B-gender
must 6 10 3982 3986 O
use 11 14 3987 3990 B-contraception_consent
an 15 17 3991 3993 I-contraception_consent
effective 18 27 3994 4003 I-contraception_consent
method 28 34 4004 4010 I-contraception_consent
of 35 37 4011 4013 I-contraception_consent
contraception 38 51 4014 4027 I-contraception_consent
from 52 56 4028 4032 O
14 57 59 4033 4035 B-upper_bound
days 60 64 4036 4040 I-upper_bound
prior 65 70 4041 4046 I-upper_bound
to 71 73 4047 4049 O
randomization 74 87 4050 4063 O
, 87 88 4063 4064 O
throughout 89 99 4065 4075 O
the 100 103 4076 4079 O
treatment 104 113 4080 4089 B-treatment
period 114 120 4090 4096 O
, 120 121 4096 4097 O
and 122 125 4098 4101 O
for 126 129 4102 4105 O
at 130 132 4106 4108 O
least 133 138 4109 4114 O
6 139 140 4115 4116 B-lower_bound
months 141 147 4117 4123 I-lower_bound
after 148 153 4124 4129 I-lower_bound
the 154 157 4130 4133 O
last 158 162 4134 4138 O
dose 163 167 4139 4143 O
of 168 170 4144 4146 O
study 171 176 4147 4152 B-treatment
treatment 177 186 4153 4162 I-treatment
as 187 189 4163 4165 O
directed 190 198 4166 4174 O
by 199 201 4175 4177 O
their 202 207 4178 4183 O
physician 208 217 4184 4193 O
. 217 218 4193 4194 O
Effective 219 228 4195 4204 O
methods 229 236 4205 4212 O
of 237 239 4213 4215 O
contraception 240 253 4216 4229 O
are 254 257 4230 4233 O
defined 258 265 4234 4241 O
as 266 268 4242 4244 O
those 269 274 4245 4250 O
which 275 280 4251 4256 O
result 281 287 4257 4263 O
in 288 290 4264 4266 O
a 291 292 4267 4268 O
low 293 296 4269 4272 O
failure 297 304 4273 4280 O
rate 305 309 4281 4285 O
( 310 311 4286 4287 O
i.e. 311 315 4287 4291 O
, 315 316 4291 4292 O
less 317 321 4293 4297 O
than 322 326 4298 4302 O
1 327 328 4303 4304 B-upper_bound
% 328 329 4304 4305 I-upper_bound
per 330 333 4306 4309 O
year 334 338 4310 4314 O
) 338 339 4314 4315 O
when 340 344 4316 4320 O
used 345 349 4321 4325 O
consistently 350 362 4326 4338 O
and 363 366 4339 4342 O
correctly 367 376 4343 4352 O
( 377 378 4353 4354 O
for 378 381 4354 4357 O
example 382 389 4358 4365 O
implants 390 398 4366 4374 B-contraception_consent
, 398 399 4374 4375 O
injectables 400 411 4376 4387 B-contraception_consent
, 411 412 4387 4388 O
or 413 415 4389 4391 O
intra 416 421 4392 4397 B-contraception_consent
- 421 422 4397 4398 I-contraception_consent
uterine 422 429 4398 4405 I-contraception_consent
devices 430 437 4406 4413 I-contraception_consent
) 437 438 4413 4414 O
. 438 439 4414 4415 O
At 440 442 4416 4418 O
the 443 446 4419 4422 O
discretion 447 457 4423 4433 O
of 458 460 4434 4436 O
the 461 464 4437 4440 O
investigator 465 477 4441 4453 O
, 477 478 4453 4454 O
acceptable 479 489 4455 4465 O
methods 490 497 4466 4473 O
of 498 500 4474 4476 O
contraception 501 514 4477 4490 O
may 515 518 4491 4494 O
include 519 526 4495 4502 O
total 527 532 4503 4508 O
abstinence 533 543 4509 4519 B-contraception_consent
in 544 546 4520 4522 O
cases 547 552 4523 4528 O
where 553 558 4529 4534 O
the 559 562 4535 4538 O
lifestyle 563 572 4539 4548 O
of 573 575 4549 4551 O
the 576 579 4552 4555 O
patient 580 587 4556 4563 O
ensures 588 595 4564 4571 O
compliance 596 606 4572 4582 O
. 606 607 4582 4583 O
( 608 609 4584 4585 O
Periodic 609 617 4585 4593 B-contraception_consent
abstinence 618 628 4594 4604 I-contraception_consent
[ 629 630 4605 4606 O
e.g. 630 634 4606 4610 O
, 634 635 4610 4611 O
calendar 636 644 4612 4620 B-contraception_consent
, 644 645 4620 4621 O
ovulation 646 655 4622 4631 B-contraception_consent
, 655 656 4631 4632 O
symptothermal 657 670 4633 4646 B-contraception_consent
, 670 671 4646 4647 O
postovulation 672 685 4648 4661 B-contraception_consent
methods 686 693 4662 4669 I-contraception_consent
] 693 694 4669 4670 O
and 695 698 4671 4674 O
withdrawal 699 709 4675 4685 B-contraception_consent
are 710 713 4686 4689 O
not 714 717 4690 4693 O
acceptable 718 728 4694 4704 O
methods 729 736 4705 4712 O
of 737 739 4713 4715 O
contraception 740 753 4716 4729 O
. 753 754 4729 4730 O
) 754 755 4730 4731 O
Hormonal 756 764 4732 4740 B-contraception_consent
- 764 765 4740 4741 I-contraception_consent
based 765 770 4741 4746 I-contraception_consent
methods 771 778 4747 4754 I-contraception_consent
( 779 780 4755 4756 O
e.g. 780 784 4756 4760 O
, 784 785 4760 4761 O
oral 786 790 4762 4766 B-contraception_consent
contraceptives 791 805 4767 4781 I-contraception_consent
) 805 806 4781 4782 O
are 807 810 4783 4786 O
NOT 811 814 4787 4790 O
permitted 815 824 4791 4800 O
as 825 827 4801 4803 O
contraception 828 841 4804 4817 O
due 842 845 4818 4821 O
to 846 848 4822 4824 O
potential 849 858 4825 4834 O
drug 859 863 4835 4839 O
- 863 864 4839 4840 O
drug 864 868 4840 4844 O
interactions 869 881 4845 4857 O
with 882 886 4858 4862 O
dabrafenib 887 897 4863 4873 B-treatment

patients 0 8 4874 4882 O
with 9 13 4883 4887 O
brain 14 19 4888 4893 B-cancer
metastases 20 30 4894 4904 I-cancer
treated 31 38 4905 4912 O
with 39 43 4913 4917 O
gamma 44 49 4918 4923 B-treatment
knife 50 55 4924 4929 I-treatment
or 56 58 4930 4932 O
surgery 59 66 4933 4940 B-treatment
are 67 70 4941 4944 O
allowed 71 78 4945 4952 O
to 79 81 4953 4955 O
participate 82 93 4956 4967 O
after 94 99 4968 4973 B-upper_bound
3 100 101 4974 4975 I-upper_bound
weeks 102 107 4976 4981 I-upper_bound
have 108 112 4982 4986 O
elapsed 113 120 4987 4994 O
since 121 126 4995 5000 O
their 127 132 5001 5006 O
procedure 133 142 5007 5016 O
. 143 144 5017 5018 O
Demonstration 145 158 5019 5032 O
of 159 161 5033 5035 O
brain 162 167 5036 5041 O
stability 168 177 5042 5051 O
by 178 180 5052 5054 O
an 181 183 5055 5057 O
imaging 184 191 5058 5065 O
study 192 197 5066 5071 O
after 198 203 5072 5077 O
the 204 207 5078 5081 O
procedure 208 217 5082 5091 O
is 218 220 5092 5094 O
required 221 229 5095 5103 O
for 230 233 5104 5107 O
gamma 234 239 5108 5113 O
knife 240 245 5114 5119 O
or 246 248 5120 5122 O
CNS 249 252 5123 5126 B-treatment
surgery 253 260 5127 5134 I-treatment
patients 261 269 5135 5143 O

subjects 0 8 5144 5152 O
with 9 13 5153 5157 O
grade 14 19 5158 5163 O
1 20 21 5164 5165 O
abnormalities 22 35 5166 5179 O
[ 36 37 5180 5181 O
i.e. 37 41 5181 5185 O
, 41 42 5185 5186 O
mild 43 47 5187 5191 B-chronic_disease
regurgitation 48 61 5192 5205 I-chronic_disease
/ 61 62 5205 5206 O
stenosis 62 70 5206 5214 B-chronic_disease
] 70 71 5214 5215 O

subjects 0 8 5216 5224 O
with 9 13 5225 5229 O
indolent 14 22 5230 5238 O
second 23 29 5239 5245 O
malignancies 30 42 5246 5258 B-cancer

subjects 0 8 5259 5267 O
with 9 13 5268 5272 O
known 14 19 5273 5278 O
Gilbert 20 27 5279 5286 B-chronic_disease
's 27 29 5286 5288 I-chronic_disease
syndrome 30 38 5289 5297 I-chronic_disease

subjects 0 8 5298 5306 O
with 9 13 5307 5311 O
laboratory 14 24 5312 5322 O
evidence 25 33 5323 5331 O
of 34 36 5332 5334 O
cleared 37 44 5335 5342 O
HBV 45 48 5343 5346 B-chronic_disease
and/or 49 55 5347 5353 O
HCV 56 59 5354 5357 B-chronic_disease

> 0 1 0 1 O
29.99 1 6 1 6 B-lower_bound
years 7 12 7 12 I-lower_bound
of 13 15 13 15 O
age 16 19 16 19 B-age

Age 0 3 20 23 B-age
≤1 4 6 24 26 O
year 7 11 27 31 I-upper_bound

Direct 0 6 32 38 O
bilirubin 7 16 39 48 B-clinical_variable
< 17 18 49 50 O
1.5 19 22 51 54 B-upper_bound
upper 23 28 55 60 I-upper_bound
limit 29 34 61 66 I-upper_bound
of 35 37 67 69 I-upper_bound
normal 38 44 70 76 I-upper_bound
( 45 46 77 78 I-upper_bound
ULN 46 49 78 81 I-upper_bound
) 49 50 81 82 I-upper_bound
for 51 54 83 86 O
age 55 58 87 90 O
, 58 59 90 91 O
and 60 63 92 95 O
SGOT 64 68 96 100 B-clinical_variable
( 69 70 101 102 I-clinical_variable
AST 70 73 102 105 I-clinical_variable
) 73 74 105 106 I-clinical_variable
or 75 77 107 109 O
SGPT 78 82 110 114 B-clinical_variable
( 83 84 115 116 I-clinical_variable
ALT 84 87 116 119 I-clinical_variable
) 87 88 119 120 I-clinical_variable
<3 89 91 121 123 O
x 92 93 124 125 I-upper_bound
ULN 94 97 126 129 I-upper_bound

Ejection 0 8 130 138 B-clinical_variable
fraction 9 17 139 147 I-clinical_variable
of 18 20 148 150 O
> 21 22 151 152 O
50 22 24 152 154 B-lower_bound
% 24 25 154 155 I-lower_bound
by 26 28 156 158 O
radionuclide 29 41 159 171 B-treatment
angiogram 42 51 172 181 I-treatment
or 52 54 182 184 O
echocardiogram 55 69 185 199 B-treatment

Females 0 7 200 207 B-gender
who 8 11 208 211 O
are 12 15 212 215 O
pregnant 16 24 216 224 B-pregnancy
( 25 26 225 226 O
positive 26 34 226 234 O
HCG 35 38 235 238 B-treatment
) 38 39 238 239 O

No 0 2 240 242 O
prior 3 8 243 248 B-treatment
Hodgkin 9 16 249 256 I-treatment
lymphoma 17 25 257 265 I-treatment
directed 26 34 266 274 I-treatment
therapy 35 42 275 282 I-treatment
is 43 45 283 285 O
allowed 46 53 286 293 O
except 54 60 294 300 O
for 61 64 301 304 O
emergent 65 73 305 313 O
mediastinal 74 85 314 325 B-treatment
irradiation 86 97 326 337 I-treatment
( 98 99 338 339 O
< 99 100 339 340 O
1000cGy 100 107 340 347 B-upper_bound
) 107 108 347 348 O
for 109 112 349 352 O
superior 113 121 353 361 B-cancer
vena 122 126 362 366 I-cancer
cava 127 131 367 371 I-cancer
( 132 133 372 373 I-cancer
SVC 133 136 373 376 I-cancer
) 136 137 376 377 I-cancer
syndrome 138 146 378 386 I-cancer

Normal 0 6 387 393 B-clinical_variable
Serum 7 12 394 399 I-clinical_variable
creatinine 13 23 400 410 I-clinical_variable
based 24 29 411 416 O
on 30 32 417 419 O
age 33 36 420 423 B-age
or 37 39 424 426 O
creatinine 40 50 427 437 B-age
clearance 51 60 438 447 I-age
> 61 62 448 449 O
60 62 64 449 451 B-lower_bound
ml 65 67 452 454 I-lower_bound
/ 67 68 454 455 I-lower_bound
min/1.73 68 76 455 463 I-lower_bound
m2 77 79 464 466 I-lower_bound

Shortening 0 10 467 477 B-clinical_variable
fraction 11 19 478 486 I-clinical_variable
> 20 21 487 488 O
27 21 23 488 490 B-lower_bound
% 23 24 490 491 I-lower_bound
by 25 27 492 494 O
echocardiogram 28 42 495 509 O

equivalent 0 10 510 520 O
radioisotope 11 23 521 533 O
glomerular 24 34 534 544 B-clinical_variable
filtration 35 45 545 555 I-clinical_variable
rate 46 50 556 560 I-clinical_variable
( 51 52 561 562 I-clinical_variable
GFR 52 55 562 565 I-clinical_variable
) 55 56 565 566 I-clinical_variable
as 57 59 567 569 O
determined 60 70 570 580 O
by 71 73 581 583 O
the 74 77 584 587 O
institutional 78 91 588 601 O
normal 92 98 602 608 O
range 99 104 609 614 O

patients 0 8 615 623 O
> 9 10 624 625 O
16 11 13 626 628 B-lower_bound
years 14 19 629 634 I-lower_bound
, 19 20 634 635 O
Karnofsky 21 30 636 645 B-clinical_variable
score 31 36 646 651 I-clinical_variable
of 37 39 652 654 O
≥60 40 43 655 658 O

patients 0 8 659 667 O
age 9 12 668 671 B-age
1 13 14 672 673 B-lower_bound
- 14 15 673 674 O
16 15 17 674 676 B-upper_bound
years 18 23 677 682 I-upper_bound
, 23 24 682 683 O
Lansky 25 31 684 690 B-clinical_variable
score 32 37 691 696 I-clinical_variable
of 38 40 697 699 O
≥60 41 44 700 703 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
less 26 30 26 30 O
than 31 35 31 35 O
500 36 39 36 39 B-upper_bound
/ 39 40 39 40 I-upper_bound
microL 40 46 40 46 I-upper_bound

Absolute 0 8 47 55 B-clinical_variable
reticulocyte 9 21 56 68 I-clinical_variable
count 22 27 69 74 I-clinical_variable
less 28 32 75 79 O
than 33 37 80 84 O
60,000 38 44 85 91 B-upper_bound
/ 44 45 91 92 I-upper_bound
microL 45 51 92 98 I-upper_bound

Age 0 3 99 102 B-age
greater 4 11 103 110 O
than 12 16 111 115 O
or 17 19 116 118 O
equal 20 25 119 124 O
to 26 28 125 127 O
2 29 30 128 129 B-lower_bound
years 31 36 130 135 I-lower_bound
old 37 40 136 139 O

Evidence 0 8 140 148 O
of 9 11 149 151 O
a 12 13 152 153 O
clonal 14 20 154 160 B-chronic_disease
disorder 21 29 161 169 I-chronic_disease
on 30 32 170 172 O
cytogenetics 33 45 173 185 O
performed 46 55 186 195 O
within 56 62 196 202 O
12 63 65 203 205 B-upper_bound
weeks 66 71 206 211 I-upper_bound
of 72 74 212 214 O
study 75 80 215 220 O
entry 81 86 221 226 O

Hypersensitivity 0 16 227 243 O
to 17 19 244 246 O
eltrombopag 20 31 247 258 B-allergy_name
or 32 34 259 261 O
its 35 38 262 265 O
components 39 49 266 276 O

Infection 0 9 277 286 O
not 10 13 287 290 O
adequately 14 24 291 301 O
responding 25 35 302 312 O
to 36 38 313 315 O
appropriate 39 50 316 327 O
therapy 51 58 328 335 B-treatment

Known 0 5 336 341 O
diagnosis 6 15 342 351 O
of 16 18 352 354 O
Fanconi 19 26 355 362 B-chronic_disease
anemia 27 33 363 369 I-chronic_disease

Moribund 0 8 370 378 O
status 9 15 379 385 O
or 16 18 386 388 O
concurrent 19 29 389 399 O
hepatic 30 37 400 407 B-chronic_disease
, 37 38 407 408 O
renal 39 44 409 414 B-chronic_disease
, 44 45 414 415 O
cardiac 46 53 416 423 B-chronic_disease
, 53 54 423 424 O
neurologic 55 65 425 435 B-chronic_disease
, 65 66 435 436 O
pulmonary 67 76 437 446 B-chronic_disease
, 76 77 446 447 O
infectious 78 88 448 458 B-chronic_disease
, 88 89 458 459 O
or 90 92 460 462 O
metabolic 93 102 463 472 B-chronic_disease
disease 103 110 473 480 I-chronic_disease
of 111 113 481 483 O
such 114 118 484 488 O
severity 119 127 489 497 O
that 128 132 498 502 O
it 133 135 503 505 O
would 136 141 506 511 O
preclude 142 150 512 520 O
the 151 154 521 524 O
patient 155 162 525 532 O
s 163 164 533 534 O
ability 165 172 535 542 O
to 173 175 543 545 O
tolerate 176 184 546 554 O
protocol 185 193 555 563 B-treatment
therapy 194 201 564 571 I-treatment
, 201 202 571 572 O
or 203 205 573 575 O
that 206 210 576 580 O
death 211 216 581 586 O
within 217 223 587 593 O
7 224 225 594 595 B-lower_bound
- 225 226 595 596 O
10 226 228 596 598 B-upper_bound
days 229 233 599 603 I-upper_bound
is 234 236 604 606 O
likely 237 243 607 613 O

Platelet 0 8 614 622 B-clinical_variable
count 9 14 623 628 I-clinical_variable
less 15 19 629 633 O
than 20 24 634 638 O
20,000 25 31 639 645 B-upper_bound
/ 31 32 645 646 I-upper_bound
microL 32 38 646 652 I-upper_bound

Potential 0 9 653 662 O
subjects 10 18 663 671 O
with 19 23 672 676 O
cancer 24 30 677 683 B-cancer
who 31 34 684 687 O
are 35 38 688 691 O
on 39 41 692 694 O
active 42 48 695 701 B-treatment
chemotherapeutic 49 65 702 718 I-treatment
treatment 66 75 719 728 I-treatment
or 76 78 729 731 O
who 79 82 732 735 O
take 83 87 736 740 O
drugs 88 93 741 746 O
with 94 98 747 751 O
hematological 99 112 752 765 O
effects 113 120 766 773 O

Prior 0 5 774 779 B-treatment
immunosuppressive 6 23 780 797 I-treatment
therapy 24 31 798 805 I-treatment
with 32 36 806 810 O
any 37 40 811 814 O
ATG 41 44 815 818 B-treatment
, 44 45 818 819 O
alemtuzumab 46 57 820 831 B-treatment
, 57 58 831 832 O
or 59 61 833 835 O
high 62 66 836 840 O
dose 67 71 841 845 O
cyclophosphamide 72 88 846 862 B-treatment

SGOT 0 4 863 867 B-clinical_variable
or 5 7 868 870 O
SGPT 8 12 871 875 B-clinical_variable
> 13 14 876 877 O
5 14 15 877 878 B-lower_bound
times 16 21 879 884 I-lower_bound
the 22 25 885 888 I-lower_bound
upper 26 31 889 894 I-lower_bound
limit 32 37 895 900 I-lower_bound
of 38 40 901 903 I-lower_bound
normal 41 47 904 910 I-lower_bound

Severe 0 6 911 917 B-chronic_disease
aplastic 7 15 918 926 I-chronic_disease
anemia 16 22 927 933 I-chronic_disease
characterized 23 36 934 947 O
by 37 39 948 950 O
Bone 40 44 951 955 B-clinical_variable
marrow 45 51 956 962 I-clinical_variable
cellularity 52 63 963 974 I-clinical_variable
less 64 68 975 979 O
than 69 73 980 984 O
30 74 76 985 987 B-upper_bound
percent 77 84 988 995 I-upper_bound

Subjects 0 8 996 1004 O
with 9 13 1005 1009 O
known 14 19 1010 1015 O
liver 20 25 1016 1021 O
cirrhosis 26 35 1022 1031 B-chronic_disease
in 36 38 1032 1034 O
severity 39 47 1035 1043 O
that 48 52 1044 1048 O
would 53 58 1049 1054 O
preclude 59 67 1055 1063 O
tolerability 68 80 1064 1076 O
of 81 83 1077 1079 O
cyclosporine 84 96 1080 1092 B-treatment
and 97 100 1093 1096 O
eltrombopag 101 112 1097 1108 B-treatment
as 113 115 1109 1111 O
evidenced 116 125 1112 1121 O
by 126 128 1122 1124 O
albumin 129 136 1125 1132 B-clinical_variable
< 137 138 1133 1134 O
35g 139 142 1135 1138 B-upper_bound
/ 142 143 1138 1139 I-upper_bound
L 143 144 1139 1140 I-upper_bound

Weight 0 6 1141 1147 B-clinical_variable
greater 7 14 1148 1155 O
than 15 19 1156 1160 O
12 20 22 1161 1163 B-lower_bound
kg 23 25 1164 1166 I-lower_bound

Diagnosed 0 9 0 9 O
with 10 14 10 14 O
stage 15 20 15 20 B-cancer
III 21 24 21 24 I-cancer
/ 24 25 24 25 I-cancer
IV 25 27 25 27 I-cancer
pancreatic 28 38 28 38 I-cancer
cancer 39 45 39 45 I-cancer

Participating 0 13 46 59 O
in 14 16 60 62 O
another 17 24 63 70 B-treatment
clinical 25 33 71 79 I-treatment
trial 34 39 80 85 I-treatment
for 40 43 86 89 O
the 44 47 90 93 O
treatment 48 57 94 103 O
of 58 60 104 106 O
cancer 61 67 107 113 B-cancer
at 68 70 114 116 O
the 71 74 117 120 O
time 75 79 121 125 O
of 80 82 126 128 O
screening 83 92 129 138 O

This 0 4 0 4 O
will 5 9 5 9 O
be 10 12 10 12 O
defined 13 20 13 20 O
as 21 23 21 23 O
the 24 27 24 27 O
presence 28 36 28 36 O
of 37 39 37 39 O
uterine 40 47 40 47 O
contractions 48 60 48 60 O
documented 61 71 61 71 O
on 72 74 72 74 O
the 75 78 75 78 O
tocodynanometer 79 94 79 94 O
and 95 98 95 98 O
cervical 99 107 99 107 B-clinical_variable
dilation 108 116 108 116 I-clinical_variable
greater 117 124 117 124 O
than 125 129 125 129 O
2 130 131 130 131 B-lower_bound
cm 132 134 132 134 I-lower_bound
, 134 135 134 135 O
but 136 139 136 139 O
less 140 144 140 144 O
than 145 149 145 149 O
6 150 151 150 151 B-upper_bound
cm 152 154 152 154 I-upper_bound

We 0 2 155 157 O
will 3 7 158 162 O
also 8 12 163 167 O
exclude 13 20 168 175 O
women 21 26 176 181 B-gender
who 27 30 182 185 O
have 31 35 186 190 O
received 36 44 191 199 O
any 45 48 200 203 O
opioids 49 56 204 211 B-treatment
within 57 63 212 218 O
the 64 67 219 222 O
last 68 72 223 227 B-upper_bound
24 73 75 228 230 I-upper_bound
hours 76 81 231 236 I-upper_bound

contraindications 0 17 237 254 O
to 18 20 255 257 O
acetaminophen 21 34 258 271 B-allergy_name
including 35 44 272 281 O
reported 45 53 282 290 O
elevated 54 62 291 299 O
liver 63 68 300 305 O
function 69 77 306 314 O
tests 78 83 315 320 O
, 83 84 320 321 O
hepatic 85 92 322 329 O
injury 93 99 330 336 O
, 99 100 336 337 O
hepatic 101 108 338 345 B-chronic_disease
disorder 109 117 346 354 I-chronic_disease
, 117 118 354 355 O
active 119 125 356 362 B-chronic_disease
liver 126 131 363 368 I-chronic_disease
disease 132 139 369 376 I-chronic_disease
, 139 140 376 377 O
alcoholism 141 151 378 388 O
, 151 152 388 389 O
chronic 153 160 390 397 B-chronic_disease
malnutrition 161 173 398 410 I-chronic_disease
, 173 174 410 411 O
known 175 180 412 417 O
coagulapathy 181 193 418 430 B-chronic_disease
, 193 194 430 431 O
hemorrhage 195 205 432 442 B-chronic_disease
, 205 206 442 443 O
creatinine 207 217 444 454 B-clinical_variable
> 218 219 455 456 O
1.0 220 223 457 460 B-lower_bound
, 223 224 460 461 O
or 225 227 462 464 O
known 228 233 465 470 O
allergy 234 241 471 478 O
or 242 244 479 481 O
hypersensitivity 245 261 482 498 O
to 262 264 499 501 O
acetaminophen 265 278 502 515 O

less 0 4 516 520 O
than 5 9 521 525 O
16 10 12 526 528 B-upper_bound
weeks 13 18 529 534 I-upper_bound
gestation 19 28 535 544 O

less 0 4 545 549 O
than 5 9 550 554 O
18 10 12 555 557 B-upper_bound
years 13 18 558 563 I-upper_bound
of 19 21 564 566 O
age 22 25 567 570 B-age

pregnant 0 8 571 579 B-pregnancy
women 9 14 580 585 B-gender
greater 15 22 586 593 O
than 23 27 594 598 O
16 28 30 599 601 B-lower_bound
weeks 31 36 602 607 I-lower_bound
of 37 39 608 610 O
pregnancy 40 49 611 620 B-pregnancy
who 50 53 621 624 O
present 54 61 625 632 O
with 62 66 633 637 O
pain 67 71 638 642 O
due 72 75 643 646 O
to 76 78 647 649 O
a 79 80 650 651 O
maternal 81 89 652 660 O
medical 90 97 661 668 O
condition 98 107 669 678 O
including 108 117 679 688 O
sickle 118 124 689 695 B-chronic_disease
cell 125 129 696 700 I-chronic_disease
crisis 130 136 701 707 I-chronic_disease
, 136 137 707 708 O
pyelonephritis 138 152 709 723 B-chronic_disease
, 152 153 723 724 O
pancreatitis 154 166 725 737 B-chronic_disease
, 166 167 737 738 O
cholecystitis 168 181 739 752 B-chronic_disease
, 181 182 752 753 O
nephrolithiasis 183 198 754 769 B-chronic_disease
or 199 201 770 772 O
headache 202 210 773 781 B-chronic_disease
and 211 214 782 785 O
who 215 218 786 789 O
are 219 222 790 793 O
warranting 223 233 794 804 O
treatment 234 243 805 814 B-treatment
with 244 248 815 819 O
intravenous 249 260 820 831 B-treatment
medication 261 271 832 842 I-treatment
for 272 275 843 846 O
pain 276 280 847 851 O
control 281 288 852 859 O
as 289 291 860 862 O
part 292 296 863 867 O
of 297 299 868 870 O
their 300 305 871 876 O
routine 306 313 877 884 B-treatment
treatment 314 323 885 894 I-treatment

pregnant 0 8 895 903 B-pregnancy
women 9 14 904 909 B-gender
greater 15 22 910 917 O
than 23 27 918 922 O
24 28 30 923 925 B-lower_bound
weeks 31 36 926 931 I-lower_bound
of 37 39 932 934 O
pregnancy 40 49 935 944 B-pregnancy
who 50 53 945 948 O
present 54 61 949 956 O
with 62 66 957 961 O
uterine 67 74 962 969 O
contractions 75 87 970 982 O
, 87 88 982 983 O
but 89 92 984 987 O
are 93 96 988 991 O
not 97 100 992 995 O
in 101 103 996 998 O
labor 104 109 999 1004 O
and 110 113 1005 1008 O
who 114 117 1009 1012 O
are 118 121 1013 1016 O
warranting 122 132 1017 1027 O
treatment 133 142 1028 1037 B-treatment
with 143 147 1038 1042 O
intravenous 148 159 1043 1054 O
medication 160 170 1055 1065 O
for 171 174 1066 1069 O
pain 175 179 1070 1074 O
control 180 187 1075 1082 O
as 188 190 1083 1085 O
part 191 195 1086 1090 O
of 196 198 1091 1093 O
their 199 204 1094 1099 O
routine 205 212 1100 1107 B-treatment
treatment 213 222 1108 1117 I-treatment

pregnant 0 8 1118 1126 B-pregnancy
women 9 14 1127 1132 B-gender
greater 15 22 1133 1140 O
than 23 27 1141 1145 O
34 28 30 1146 1148 B-lower_bound
weeks 31 36 1149 1154 I-lower_bound
of 37 39 1155 1157 O
pregnancy 40 49 1158 1167 B-pregnancy
who 50 53 1168 1171 O
present 54 61 1172 1179 O
with 62 66 1180 1184 O
uterine 67 74 1185 1192 O
contractions 75 87 1193 1205 O
and 88 91 1206 1209 O
are 92 95 1210 1213 O
in 96 98 1214 1216 O
the 99 102 1217 1220 O
first 103 108 1221 1226 O
stage 109 114 1227 1232 O
of 115 117 1233 1235 O
labor 118 123 1236 1241 O
and 124 127 1242 1245 O
who 128 131 1246 1249 O
are 132 135 1250 1253 O
warranting 136 146 1254 1264 O
treatment 147 156 1265 1274 O
with 157 161 1275 1279 O
intravenous 162 173 1280 1291 O
medication 174 184 1292 1302 O
for 185 188 1303 1306 O
pain 189 193 1307 1311 O
control 194 201 1312 1319 O
as 202 204 1320 1322 O
part 205 209 1323 1327 O
of 210 212 1328 1330 O
their 213 218 1331 1336 O
routine 219 226 1337 1344 O
treatment 227 236 1345 1354 O

the 0 3 1355 1358 O
cervix 4 10 1359 1365 O
remains 11 18 1366 1373 O
less 19 23 1374 1378 O
than 24 28 1379 1383 O
2 29 30 1384 1385 B-upper_bound
cm 31 33 1386 1388 I-upper_bound
dilated 34 41 1389 1396 O
and 42 45 1397 1400 O
has 46 49 1401 1404 O
not 50 53 1405 1408 O
changed 54 61 1409 1416 O
after 62 67 1417 1422 O
1 68 69 1423 1424 O
hour 70 74 1425 1429 O
after 75 80 1430 1435 O
re 81 83 1436 1438 O
- 83 84 1438 1439 O
examining 84 93 1439 1448 O
her 94 97 1449 1452 O
cervix 98 104 1453 1459 O

with 0 4 1460 1464 O
weight 5 11 1465 1471 B-clinical_variable
less 12 16 1472 1476 O
than 17 21 1477 1481 O
50 22 24 1482 1484 B-upper_bound
kg 25 27 1485 1487 I-upper_bound

women 0 5 1488 1493 B-gender

Abnormal 0 8 0 8 O
bone 9 13 9 13 O
marrow 14 20 14 20 O
function 21 29 21 29 O
[ 30 31 30 31 O
absolute 31 39 31 39 B-clinical_variable
neutrophil 40 50 40 50 I-clinical_variable
count 51 56 51 56 I-clinical_variable
( 57 58 57 58 I-clinical_variable
ANC)<1500 58 67 58 67 I-clinical_variable
/ 67 68 67 68 I-upper_bound
mm3 68 71 68 71 I-upper_bound
, 71 72 71 72 O
platelet 73 81 73 81 B-clinical_variable
count 82 87 82 87 I-clinical_variable
< 88 89 88 89 O
100,000 89 96 89 96 B-upper_bound
/ 96 97 96 97 I-upper_bound
mm3 97 100 97 100 I-upper_bound
, 100 101 100 101 O
hemoglobin 102 112 102 112 B-clinical_variable
< 113 114 113 114 O
9 114 115 114 115 B-upper_bound
g 116 117 116 117 I-upper_bound
/ 117 118 117 118 I-upper_bound
dL 118 120 118 120 I-upper_bound
] 120 121 120 121 O

Abnormal 0 8 122 130 O
liver 9 14 131 136 O
function 15 23 137 145 O
( 24 25 146 147 O
bilirubin 25 34 147 156 B-clinical_variable
> 35 36 157 158 O
ULN 36 39 158 161 O
; 39 40 161 162 O
AST 41 44 163 166 B-clinical_variable
, 44 45 166 167 O
ALT 46 49 168 171 B-clinical_variable
> 50 51 172 173 O
2.5 52 55 174 177 B-lower_bound
x 56 57 178 179 I-lower_bound
upper 58 63 180 185 I-lower_bound
limit 64 69 186 191 I-lower_bound
of 70 72 192 194 I-lower_bound
normal 73 79 195 201 I-lower_bound
) 79 80 201 202 O

Active 0 6 203 209 B-chronic_disease
cardiac 7 14 210 217 I-chronic_disease
disease 15 22 218 225 I-chronic_disease
defined 23 30 226 233 O
as 31 33 234 236 O
active 34 40 237 243 B-chronic_disease
angina 41 47 244 250 I-chronic_disease
, 47 48 250 251 O
symptomatic 49 60 252 263 B-chronic_disease
congestive 61 71 264 274 I-chronic_disease
heart 72 77 275 280 I-chronic_disease
failure 78 85 281 288 I-chronic_disease
, 85 86 288 289 O
or 87 89 290 292 O
myocardial 90 100 293 303 B-chronic_disease
infarction 101 111 304 314 I-chronic_disease
within 112 118 315 321 O
previous 119 127 322 330 B-upper_bound
six 128 131 331 334 I-upper_bound
months 132 138 335 341 I-upper_bound

Age 0 3 342 345 B-age
≥ 4 5 346 347 O
18 6 8 348 350 B-lower_bound
years 9 14 351 356 I-lower_bound

Antiandrogens 0 13 357 370 B-treatment
( 14 15 371 372 O
e.g. 15 19 372 376 O
bicalutamide 20 32 377 389 B-treatment
, 32 33 389 390 O
nilutamide 34 44 391 401 B-treatment
) 44 45 401 402 O

Documented 0 10 403 413 O
histologically 11 25 414 428 O
confirmed 26 35 429 438 O
adenocarcinoma 36 50 439 453 B-cancer
of 51 53 454 456 O
the 54 57 457 460 O
prostate 58 66 461 469 O

Eastern 0 7 470 477 B-clinical_variable
cooperative 8 19 478 489 I-clinical_variable
oncology 20 28 490 498 I-clinical_variable
group 29 34 499 504 I-clinical_variable
( 35 36 505 506 I-clinical_variable
ECOG 36 40 506 510 I-clinical_variable
) 40 41 510 511 I-clinical_variable
performance 42 53 512 523 I-clinical_variable
status 54 60 524 530 I-clinical_variable
≤2 61 63 531 533 O

Evidence 0 8 534 542 O
of 9 11 543 545 O
serious 12 19 546 553 O
and/or 20 26 554 560 O
unstable 27 35 561 569 O
pre 36 39 570 573 O
- 39 40 573 574 O
existing 40 48 574 582 O
medical 49 56 583 590 O
, 56 57 590 591 O
psychiatric 58 69 592 603 B-chronic_disease
or 70 72 604 606 O
other 73 78 607 612 O
condition 79 88 613 622 O
( 89 90 623 624 O
including 90 99 624 633 O
laboratory 100 110 634 644 O
abnormalities 111 124 645 658 O
) 124 125 658 659 O
that 126 130 660 664 O
could 131 136 665 670 O
interfere 137 146 671 680 O
with 147 151 681 685 O
patient 152 159 686 693 O
safety 160 166 694 700 O
or 167 169 701 703 O
provision 170 179 704 713 O
of 180 182 714 716 O
informed 183 191 717 725 O
consent 192 199 726 733 O
to 200 202 734 736 O
participate 203 214 737 748 O
in 215 217 749 751 O
this 218 222 752 756 O
study 223 228 757 762 O

Hormonal 0 8 763 771 B-treatment
therapy 9 16 772 779 I-treatment
( 17 18 780 781 O
e.g. 18 22 781 785 O
leuprolide 23 33 786 796 B-treatment
, 33 34 796 797 O
goserelin 35 44 798 807 B-treatment
, 44 45 807 808 O
triptorelin 46 57 809 820 B-treatment
, 57 58 820 821 O
degarelix 59 68 822 831 B-treatment
) 68 69 831 832 O

Prior 0 5 833 838 O
history 6 13 839 846 O
of 14 16 847 849 O
malignancy 17 27 850 860 B-cancer
in 28 30 861 863 O
the 31 34 864 867 O
past 35 39 868 872 B-upper_bound
3 40 41 873 874 I-upper_bound
years 42 47 875 880 I-upper_bound
with 48 52 881 885 O
the 53 56 886 889 O
exception 57 66 890 899 O
of 67 69 900 902 O
basal 70 75 903 908 B-cancer
cell 76 80 909 913 I-cancer
and 81 84 914 917 I-cancer
squamous 85 93 918 926 I-cancer
cell 94 98 927 931 I-cancer
carcinoma 99 108 932 941 I-cancer
of 109 111 942 944 I-cancer
the 112 115 945 948 I-cancer
skin 116 120 949 953 I-cancer
. 120 121 953 954 O
Other 122 127 955 960 O
malignancies 128 140 961 973 B-cancer
that 141 145 974 978 O
are 146 149 979 982 O
considered 150 160 983 993 O
to 161 163 994 996 O
have 164 168 997 1001 O
a 169 170 1002 1003 O
low 171 174 1004 1007 O
potential 175 184 1008 1017 O
to 185 187 1018 1020 O
progress 188 196 1021 1029 O
may 197 200 1030 1033 O
be 201 203 1034 1036 O
enrolled 204 212 1037 1045 O
at 213 215 1046 1048 O
discretion 216 226 1049 1059 O
of 227 229 1060 1062 O
PI 230 232 1063 1065 O

Prior 0 5 1066 1071 B-treatment
local 6 11 1072 1077 I-treatment
non 12 15 1078 1081 I-treatment
- 15 16 1081 1082 I-treatment
surgical 16 24 1082 1090 I-treatment
therapy 25 32 1091 1098 I-treatment
to 33 35 1099 1101 O
treat 36 41 1102 1107 O
prostate 42 50 1108 1116 B-cancer
cancer 51 57 1117 1123 I-cancer
( 58 59 1124 1125 O
e.g. 59 63 1125 1129 O
radiation 64 73 1130 1139 B-treatment
therapy 74 81 1140 1147 I-treatment
, 81 82 1147 1148 O
brachytherapy 83 96 1149 1162 B-treatment
) 96 97 1162 1163 O

Prior 0 5 1164 1169 O
or 6 8 1170 1172 O
ongoing 9 16 1173 1180 O
systemic 17 25 1181 1189 B-treatment
therapy 26 33 1190 1197 I-treatment
for 34 37 1198 1201 O
prostate 38 46 1202 1210 B-cancer
cancer 47 53 1211 1217 I-cancer

hormone 0 7 1218 1225 B-treatment
therapy 8 15 1226 1233 I-treatment
was 16 19 1234 1237 O
recently 20 28 1238 1246 O
initiated 29 38 1247 1256 O
( 39 40 1257 1258 O
< 40 41 1258 1259 O
90 41 43 1259 1261 B-upper_bound
days 44 48 1262 1266 I-upper_bound
duration 49 57 1267 1275 O
) 57 58 1275 1276 O
) 58 59 1276 1277 O

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
APL 15 18 15 18 B-cancer
based 19 24 19 24 O
on 25 27 25 27 O
the 28 31 28 31 O
presence 32 40 32 40 O
of 41 43 41 43 O
the 44 47 44 47 O
PML 48 51 48 51 B-treatment
- 51 52 51 52 I-treatment
RAR 52 55 52 55 I-treatment
- 55 56 55 56 I-treatment
alpha 56 61 56 61 I-treatment
fusion 62 68 62 68 I-treatment
gene 69 73 69 73 I-treatment
by 74 76 74 76 I-treatment
cytogenetics 77 89 77 89 I-treatment
, 89 90 89 90 O
polymerase 91 101 91 101 B-treatment
chain 102 107 102 107 I-treatment
reaction 108 116 108 116 I-treatment
( 117 118 117 118 I-treatment
PCR 118 121 118 121 I-treatment
) 121 122 121 122 I-treatment
, 122 123 122 123 O
or 124 126 124 126 O
POD 127 130 127 130 B-treatment
test 131 135 131 135 I-treatment

All 0 3 136 139 O
sexually 4 12 140 148 O
active 13 19 149 155 O
subjects 20 28 156 164 O
( 29 30 165 166 O
males 30 35 166 171 B-gender
and 36 39 172 175 O
females 40 47 176 183 B-gender
of 48 50 184 186 O
child 51 56 187 192 O
- 56 57 192 193 O
bearing 57 64 193 200 O
potential 65 74 201 210 O
) 74 75 210 211 O
agree 76 81 212 217 B-contraception_consent
to 82 84 218 220 I-contraception_consent
use 85 88 221 224 I-contraception_consent
2 89 90 225 226 I-contraception_consent
effective 91 100 227 236 I-contraception_consent
methods 101 108 237 244 I-contraception_consent
of 109 111 245 247 I-contraception_consent
contraception 112 125 248 261 I-contraception_consent
for 126 129 262 265 O
the 130 133 266 269 O
duration 134 142 270 278 O
of 143 145 279 281 O
the 146 149 282 285 O
study 150 155 286 291 O

Fridericia 0 10 292 302 O
corrected 11 20 303 312 O
QT 21 23 313 315 B-clinical_variable
( 24 25 316 317 I-clinical_variable
QTcF 25 29 317 321 I-clinical_variable
) 29 30 321 322 I-clinical_variable
interval 31 39 323 331 I-clinical_variable
on 40 42 332 334 O
the 43 46 335 338 O
electrocardiogram 47 64 339 356 B-treatment
( 65 66 357 358 I-treatment
EKG 66 69 358 361 I-treatment
) 69 70 361 362 I-treatment
greater 71 78 363 370 O
than 79 83 371 375 O
480 84 87 376 379 B-lower_bound
milliseconds 88 100 380 392 I-lower_bound

Patients 0 8 393 401 O
in 9 11 402 404 O
whom 12 16 405 409 O
therapy 17 24 410 417 B-treatment
for 25 28 418 421 O
APL 29 32 422 425 B-cancer
was 33 36 426 429 O
initiated 37 46 430 439 O
on 47 49 440 442 O
an 50 52 443 445 O
emergent 53 61 446 454 O
basis 62 67 455 460 O

Patients 0 8 461 469 O
with 9 13 470 474 O
alanine 14 21 475 482 B-clinical_variable
aminotransferase 22 38 483 499 I-clinical_variable
( 39 40 500 501 I-clinical_variable
ALT)/aspartate 40 54 501 515 I-clinical_variable
aminotransferase 55 71 516 532 I-clinical_variable
( 72 73 533 534 I-clinical_variable
AST 73 76 534 537 I-clinical_variable
) 76 77 537 538 I-clinical_variable
> 78 79 539 540 O
3 80 81 541 542 B-lower_bound
times 82 87 543 548 I-lower_bound
upper 88 93 549 554 I-lower_bound
limit 94 99 555 560 I-lower_bound
of 100 102 561 563 I-lower_bound
normal 103 109 564 570 I-lower_bound
unless 110 116 571 577 O
felt 117 121 578 582 O
to 122 124 583 585 O
be 125 127 586 588 O
related 128 135 589 596 O
the 136 139 597 600 O
underlying 140 150 601 611 O
leukemia 151 159 612 620 B-cancer
by 160 162 621 623 O
the 163 166 624 627 O
treating 167 175 628 636 O
physician 176 185 637 646 O
or 186 188 647 649 O
hemolysis 189 198 650 659 O
or 199 201 660 662 O
Gilbert 202 209 663 670 B-chronic_disease
's 209 211 670 672 I-chronic_disease
disease 212 219 673 680 I-chronic_disease

Patients 0 8 681 689 O
with 9 13 690 694 O
creatinine 14 24 695 705 B-clinical_variable
> 25 26 706 707 O
2.5 27 30 708 711 B-lower_bound
times 31 36 712 717 I-lower_bound
upper 37 42 718 723 B-clinical_variable
limit 43 48 724 729 I-clinical_variable
of 49 51 730 732 I-clinical_variable
normal 52 58 733 739 I-clinical_variable
unless 59 65 740 746 O
felt 66 70 747 751 O
to 71 73 752 754 O
be 74 76 755 757 O
related 77 84 758 765 O
the 85 88 766 769 O
underlying 89 99 770 780 O
leukemia 100 108 781 789 B-cancer
by 109 111 790 792 O
the 112 115 793 796 O
treating 116 124 797 805 O
physician 125 134 806 815 O
or 135 137 816 818 O
hemolysis 138 147 819 828 B-chronic_disease
or 148 150 829 831 O
Gilbert 151 158 832 839 O
's 158 160 839 841 O
disease 161 168 842 849 B-chronic_disease

Patients 0 8 850 858 O
with 9 13 859 863 O
total 14 19 864 869 B-clinical_variable
bilirubin 20 29 870 879 I-clinical_variable
> 30 31 880 881 O
= 31 32 881 882 O
2.0 33 36 883 886 B-lower_bound
times 37 42 887 892 I-lower_bound
upper 43 48 893 898 I-lower_bound
limit 49 54 899 904 I-lower_bound
of 55 57 905 907 I-lower_bound
normal 58 64 908 914 I-lower_bound
unless 65 71 915 921 O
felt 72 76 922 926 O
to 77 79 927 929 O
be 80 82 930 932 O
related 83 90 933 940 O
the 91 94 941 944 O
underlying 95 105 945 955 O
leukemia 106 114 956 964 B-cancer
by 115 117 965 967 O
the 118 121 968 971 O
treating 122 130 972 980 O
physician 131 140 981 990 O
or 141 143 991 993 O
hemolysis 144 153 994 1003 B-chronic_disease
or 154 156 1004 1006 O
Gilbert 157 164 1007 1014 B-chronic_disease
's 164 166 1014 1016 I-chronic_disease
disease 167 174 1017 1024 I-chronic_disease

Women 0 5 1025 1030 B-gender
of 6 8 1031 1033 O
child 9 14 1034 1039 O
- 14 15 1039 1040 O
bearing 15 22 1040 1047 O
potential 23 32 1048 1057 O
must 33 37 1058 1062 O
have 38 42 1063 1067 O
a 43 44 1068 1069 O
negative 45 53 1070 1078 B-pregnancy
serum 54 59 1079 1084 I-pregnancy
pregnancy 60 69 1085 1094 I-pregnancy
test 70 74 1095 1099 O
at 75 77 1100 1102 O
screening 78 87 1103 1112 O

all 0 3 1113 1116 O
female 4 10 1117 1123 B-gender
participants 11 23 1124 1136 I-gender
of 24 26 1137 1139 O
childbearing 27 39 1140 1152 O
potential 40 49 1153 1162 O
must 50 54 1163 1167 O
have 55 59 1168 1172 O
a 60 61 1173 1174 O
negative 62 70 1175 1183 B-pregnancy
pregnancy 71 80 1184 1193 I-pregnancy
test 81 85 1194 1198 O
confirmed 86 95 1199 1208 O
within 96 102 1209 1215 O
48 103 105 1216 1218 B-upper_bound
hours 106 111 1219 1224 I-upper_bound
prior 112 117 1225 1230 I-upper_bound
to 118 120 1231 1233 O
dosing 121 127 1234 1240 O
with 128 132 1241 1245 O
the 133 136 1246 1249 O
study 137 142 1250 1255 O
drug 143 147 1256 1260 O

patients 0 8 1261 1269 O
may 9 12 1270 1273 O
have 13 17 1274 1278 O
already 18 25 1279 1286 O
started 26 33 1287 1294 O
treatment 34 43 1295 1304 O
with 44 48 1305 1309 O
ATRA 49 53 1310 1314 B-treatment
, 53 54 1314 1315 O
ATO 55 58 1316 1319 B-treatment
, 58 59 1319 1320 O
and/or 60 66 1321 1327 O
one 67 70 1328 1331 O
dose 71 75 1332 1336 O
of 76 78 1337 1339 O
idarubicin 79 89 1340 1350 B-treatment
due 90 93 1351 1354 O
to 94 96 1355 1357 O
the 97 100 1358 1361 O
urgency 101 108 1362 1369 O
to 109 111 1370 1372 O
start 112 117 1373 1378 O
therapy 118 125 1379 1386 B-treatment
early 126 131 1387 1392 O

All 0 3 0 3 O
subjects 4 12 4 12 O
enrolled 13 21 13 21 O
will 22 26 22 26 O
have 27 31 27 31 O
both 32 36 32 36 O
a 37 38 37 38 O
Clinical 39 47 39 47 B-clinical_variable
Dementia 48 56 48 56 I-clinical_variable
Rating 57 63 57 63 I-clinical_variable
( 64 65 64 65 I-clinical_variable
CDR)=0 65 71 65 71 I-clinical_variable
and 72 75 72 75 O
a 76 77 76 77 O
MMSE≥27 78 85 78 85 B-clinical_variable

All 0 3 86 89 O
subjects 4 12 90 98 O
will 13 17 99 103 O
have 18 22 104 108 O
had 23 26 109 112 O
a 27 28 113 114 O
minimum 29 36 115 122 O
of 37 39 123 125 O
12 40 42 126 128 B-lower_bound
years 43 48 129 134 I-lower_bound
of 49 51 135 137 O
education 52 61 138 147 O

Among 0 5 148 153 O
minority 6 14 154 162 O
subjects 15 23 163 171 O
> 24 25 172 173 O
80 25 27 173 175 B-lower_bound
% 27 28 175 176 I-lower_bound
of 29 31 177 179 O
the 32 35 180 183 O
elderly 36 43 184 191 O
individuals 44 55 192 203 O
coming 56 62 204 210 O
to 63 65 211 213 O
the 66 69 214 217 O
NYU 70 73 218 221 O
- 73 74 221 222 O
ADC 74 77 222 225 O
meet 78 82 226 230 O
this 83 87 231 235 O
criterion 88 97 236 245 O

Geriatric 0 9 246 255 B-clinical_variable
Depression 10 20 256 266 I-clinical_variable
Scale 21 26 267 272 I-clinical_variable
( 27 28 273 274 O
short 28 33 274 279 O
form)>5 34 41 280 287 O

History 0 7 288 295 O
of 8 10 296 298 O
a 11 12 299 300 O
first 13 18 301 306 O
- 18 19 306 307 O
degree 19 25 307 313 O
family 26 32 314 320 O
member 33 39 321 327 O
with 40 44 328 332 O
early 45 50 333 338 O
onset 51 56 339 344 O
( 57 58 345 346 O
age 58 61 346 349 B-age
< 62 63 350 351 O
60 63 65 351 353 B-upper_bound
years 66 71 354 359 I-upper_bound
) 71 72 359 360 O
dementia 73 81 361 369 B-chronic_disease

History 0 7 370 377 O
of 8 10 378 380 O
brain 11 16 381 386 B-cancer
tumor 17 22 387 392 I-cancer

Irregular 0 9 393 402 B-chronic_disease
sleep 10 15 403 408 I-chronic_disease
- 15 16 408 409 I-chronic_disease
wake 16 20 409 413 I-chronic_disease
rhythms 21 28 414 421 I-chronic_disease
( 29 30 422 423 O
based 30 35 423 428 O
on 36 38 429 431 O
the 39 42 432 435 O
actigraphy 43 53 436 446 O
recordings 54 64 447 457 O
) 64 65 457 458 O

MRI 0 3 459 462 O
evidence 4 12 463 471 O
of 13 15 472 474 O
brain 16 21 475 480 B-chronic_disease
damage 22 28 481 487 I-chronic_disease
or 29 31 488 490 I-chronic_disease
brain 32 37 491 496 I-chronic_disease
disease 38 45 497 504 I-chronic_disease
including 46 55 505 514 O
significant 56 67 515 526 O
trauma 68 74 527 533 B-chronic_disease

Male 0 4 534 538 B-gender

Parkinson 0 9 539 548 B-chronic_disease
's 9 11 548 550 I-chronic_disease
disease 12 19 551 558 I-chronic_disease

Presence 0 8 559 567 O
of 9 11 568 570 O
any 12 15 571 574 O
known 16 21 575 580 O
or 22 24 581 583 O
suspected 25 34 584 593 O
obstructive 35 46 594 605 O
disease 47 54 606 613 B-chronic_disease
of 55 57 614 616 I-chronic_disease
the 58 61 617 620 I-chronic_disease
gastrointestinal 62 78 621 637 I-chronic_disease
tract 79 84 638 643 I-chronic_disease

Subjects 0 8 644 652 O
hypomotility 9 21 653 665 B-chronic_disease
disorders 22 31 666 675 I-chronic_disease
of 32 34 676 678 O
the 35 38 679 682 O
gastrointestinal 39 55 683 699 O
tract 56 61 700 705 O
including 62 71 706 715 O
but 72 75 716 719 O
not 76 79 720 723 O
limited 80 87 724 731 O
to 88 90 732 734 O
Ileus 91 96 735 740 O

Subjects 0 8 741 749 O
with 9 13 750 754 O
a 14 15 755 756 O
Fazekas 16 23 757 764 B-clinical_variable
scale 24 29 765 770 I-clinical_variable
> 30 31 771 772 O
2 31 32 772 773 B-lower_bound

bipolar 0 7 774 781 B-chronic_disease

diverticulitis 0 14 782 796 B-chronic_disease
and 15 18 797 800 I-chronic_disease
inflammatory 19 31 801 813 I-chronic_disease
bowel 32 37 814 819 I-chronic_disease
disease 38 45 820 827 I-chronic_disease

female 0 6 828 834 B-gender

hydrocephalus 0 13 835 848 B-chronic_disease

life 0 4 849 853 O
- 4 5 853 854 O
long 5 9 854 858 O
history 10 17 859 866 O
of 18 20 867 869 O
major 21 26 870 875 B-chronic_disease
depression 27 37 876 886 I-chronic_disease

mental 0 6 887 893 B-chronic_disease
retardation 7 18 894 905 I-chronic_disease
or 19 21 906 908 O
other 22 27 909 914 O
serious 28 35 915 922 B-chronic_disease
neurological 36 48 923 935 I-chronic_disease
disorder 49 57 936 944 I-chronic_disease

other 0 5 945 950 O
movement 6 14 951 959 B-chronic_disease
disorders 15 24 960 969 I-chronic_disease

pulmonary 0 9 970 979 B-chronic_disease

schizophrenia 0 13 980 993 B-chronic_disease

seizures 0 8 994 1002 B-chronic_disease

subjects 0 8 1003 1011 O
with 9 13 1012 1016 O
normal 14 20 1017 1023 O
cognition 21 30 1024 1033 O
and 31 34 1034 1037 O
55 35 37 1038 1040 B-lower_bound
- 37 38 1040 1041 O
75 38 40 1041 1043 B-upper_bound
years 41 46 1044 1049 I-upper_bound
of 47 49 1050 1052 O
age 50 53 1053 1056 B-age

Acute 0 5 0 5 O
, 5 6 5 6 O
severe 7 13 7 13 O
, 13 14 13 14 O
or 15 17 15 17 O
unstable 18 26 18 26 O
medical 27 34 27 34 B-chronic_disease
or 35 37 35 37 O
neurological 38 50 38 50 B-chronic_disease
illness 51 58 51 58 I-chronic_disease

Age 0 3 59 62 B-age
> 4 5 63 64 O
59 5 7 64 66 B-lower_bound
years 8 13 67 72 I-lower_bound

Center 0 6 73 79 B-clinical_variable
for 7 10 80 83 I-clinical_variable
Epidemiological 11 26 84 99 I-clinical_variable
Studies 27 34 100 107 I-clinical_variable
Depression 35 45 108 118 I-clinical_variable
( 46 47 119 120 I-clinical_variable
CES 47 50 120 123 I-clinical_variable
- 50 51 123 124 I-clinical_variable
D 51 52 124 125 I-clinical_variable
) 52 53 125 126 I-clinical_variable
Rating 54 60 127 133 I-clinical_variable
Scale 61 66 134 139 I-clinical_variable
> 67 68 140 141 O
9 69 70 142 143 B-lower_bound

Current 0 7 144 151 O
or 8 10 152 154 O
recent 11 17 155 161 O
( 18 19 162 163 O
within 19 25 163 169 O
the 26 29 170 173 O
past 30 34 174 178 B-upper_bound
4 35 36 179 180 I-upper_bound
weeks 37 42 181 186 I-upper_bound
) 42 43 186 187 O
treatment 44 53 188 197 B-treatment
with 54 58 198 202 I-treatment
antidepressants 59 74 203 218 I-treatment
, 74 75 218 219 I-treatment
antipsychotics 76 90 220 234 I-treatment
, 90 91 234 235 I-treatment
dopaminergic 92 104 236 248 I-treatment
agents 105 111 249 255 I-treatment
, 111 112 255 256 I-treatment
or 113 115 257 259 I-treatment
mood 116 120 260 264 I-treatment
stabilizers 121 132 265 276 I-treatment

DSM 0 3 277 280 O
5 4 5 281 282 O
non 6 9 283 286 O
- 9 10 286 287 O
psychotic 10 19 287 296 O
Major 20 25 297 302 B-chronic_disease
Depressive 26 36 303 313 I-chronic_disease
Disorder 37 45 314 322 I-chronic_disease
, 45 46 322 323 O
Dysthymia 47 56 324 333 B-chronic_disease
, 56 57 333 334 O
or 58 60 335 337 O
Depression 61 71 338 348 B-chronic_disease
Not 72 75 349 352 O
Otherwise 76 85 353 362 O
Specified 86 95 363 372 O

Decreased 0 9 373 382 O
processing 10 20 383 393 O
speed 21 26 394 399 O
( 27 28 400 401 O
defined 28 35 401 408 O
as 36 38 409 411 O
0.5 39 42 412 415 B-lower_bound
SD 43 45 416 418 O
below 46 51 419 424 O
age 52 55 425 428 B-age
- 55 56 428 429 O
adjusted 56 64 429 437 O
norms 65 70 438 443 O
on 71 73 444 446 O
the 74 77 447 450 O
Digit 78 83 451 456 O
Symbol 84 90 457 463 O
Test 91 95 464 468 O
) 95 96 468 469 O

Diagnosis 0 9 470 479 O
of 10 12 480 482 O
probable 13 21 483 491 O
Alzheimer 22 31 492 501 B-chronic_disease
's 31 33 501 503 I-chronic_disease
Disease 34 41 504 511 I-chronic_disease
, 41 42 511 512 O
Vascular 43 51 513 521 B-chronic_disease
Dementia 52 60 522 530 I-chronic_disease
, 60 61 530 531 O
or 62 64 532 534 O
PD 65 67 535 537 B-chronic_disease

Diagnosis 0 9 538 547 O
of 10 12 548 550 O
substance 13 22 551 560 O
abuse 23 28 561 566 O
or 29 31 567 569 O
dependence 32 42 570 580 O
( 43 44 581 582 O
excluding 44 53 582 591 O
Tobacco 54 61 592 599 B-chronic_disease
Use 62 65 600 603 I-chronic_disease
Disorder 66 74 604 612 I-chronic_disease
) 74 75 612 613 O
within 76 82 614 620 O
the 83 86 621 624 O
past 87 91 625 629 B-upper_bound
12 92 94 630 632 I-upper_bound
months 95 101 633 639 I-upper_bound

History 0 7 640 647 O
of 8 10 648 650 O
or 11 13 651 653 O
current 14 21 654 661 B-chronic_disease
psychosis 22 31 662 671 I-chronic_disease
, 31 32 671 672 O
psychotic 33 42 673 682 B-chronic_disease
disorder 43 51 683 691 I-chronic_disease
, 51 52 691 692 O
mania 53 58 693 698 B-chronic_disease
, 58 59 698 699 O
or 60 62 700 702 O
bipolar 63 70 703 710 B-chronic_disease
disorder 71 79 711 719 I-chronic_disease

Hypotension 0 11 720 731 B-chronic_disease
( 12 13 732 733 O
SBP<90 13 19 733 739 B-clinical_variable
) 19 20 739 740 O
, 20 21 740 741 O
hypertension 22 34 742 754 B-chronic_disease
( 35 36 755 756 O
SBP 36 39 756 759 O
> 40 41 760 761 O
150 41 44 761 764 B-lower_bound
or 45 47 765 767 O
DBP 48 51 768 771 B-clinical_variable
> 52 53 772 773 O
90 54 56 774 776 O
) 56 57 776 777 O
, 57 58 777 778 O
past 59 63 779 783 O
stroke 64 70 784 790 B-chronic_disease
causing 71 78 791 798 O
sensory 79 86 799 806 B-chronic_disease
or 87 89 807 809 O
movement 90 98 810 818 B-chronic_disease
deficits 99 107 819 827 I-chronic_disease
, 107 108 827 828 O
cardiac 109 116 829 836 B-chronic_disease
arrhythmias 117 128 837 848 I-chronic_disease
, 128 129 848 849 O
or 130 132 850 852 O
any 133 136 853 856 O
other 137 142 857 862 O
severe 143 149 863 869 O
or 150 152 870 872 O
uncontrolled 153 165 873 885 O
cardiovascular 166 180 886 900 B-chronic_disease
disease 181 188 901 908 I-chronic_disease

Mini 0 4 909 913 B-clinical_variable
Mental 5 11 914 920 I-clinical_variable
Status 12 18 921 927 I-clinical_variable
Exam 19 23 928 932 I-clinical_variable
( 24 25 933 934 I-clinical_variable
MMSE 25 29 934 938 I-clinical_variable
) 29 30 938 939 I-clinical_variable
< 31 32 940 941 O
25 33 35 942 944 B-upper_bound

Prefer 0 6 945 951 O
not 7 10 952 955 O
to 11 13 956 958 O
be 14 16 959 961 O
treated 17 24 962 969 O
with 25 29 970 974 O
a 30 31 975 976 O
standard 32 40 977 985 O
treatment 41 50 986 995 O
for 51 54 996 999 O
MDD 55 58 1000 1003 B-chronic_disease
, 58 59 1003 1004 O
Dysthymia 60 69 1005 1014 B-chronic_disease
, 69 70 1014 1015 O
or 71 73 1016 1018 O
Depression 74 84 1019 1029 B-chronic_disease
NOS 85 88 1030 1033 I-chronic_disease
( 89 90 1034 1035 O
e.g. 90 94 1035 1039 O
, 94 95 1039 1040 O
antidepressant 96 110 1041 1055 B-treatment
medication 111 121 1056 1066 I-treatment
or 122 124 1067 1069 O
psychotherapy 125 138 1070 1083 B-treatment
) 138 139 1083 1084 O

Presence 0 8 1085 1093 O
of 9 11 1094 1096 O
a 12 13 1097 1098 O
clinically 14 24 1099 1109 O
significant 25 36 1110 1121 O
brain 37 42 1122 1127 B-chronic_disease
abnormality 43 54 1128 1139 I-chronic_disease
, 54 55 1139 1140 O
significant 56 67 1141 1152 B-chronic_disease
anemia 68 74 1153 1159 I-chronic_disease
, 74 75 1159 1160 O
insulin 76 83 1161 1168 B-chronic_disease
dependent 84 93 1169 1178 I-chronic_disease
diabetes 94 102 1179 1187 I-chronic_disease
, 102 103 1187 1188 O
a 104 105 1189 1190 O
history 106 113 1191 1198 O
of 114 116 1199 1201 O
cardiovascular 117 131 1202 1216 B-chronic_disease
disease 132 139 1217 1224 I-chronic_disease
, 139 140 1224 1225 O
or 141 143 1226 1228 O
uncontrolled 144 156 1229 1241 O
/ 156 157 1241 1242 O
untreated 157 166 1242 1251 O
risk 167 171 1252 1256 O
factors 172 179 1257 1264 O
for 180 183 1265 1268 O
coronary 184 192 1269 1277 B-chronic_disease
artery 193 199 1278 1284 I-chronic_disease
disease 200 207 1285 1292 I-chronic_disease

decreased 0 9 1293 1302 O
gait 10 14 1303 1307 O
speed 15 20 1308 1313 O
( 21 22 1314 1315 O
defined 22 29 1315 1322 O
as 30 32 1323 1325 O
average 33 40 1326 1333 B-clinical_variable
walking 41 48 1334 1341 I-clinical_variable
speed 49 54 1342 1347 I-clinical_variable
over 55 59 1348 1352 I-clinical_variable
15 60 62 1353 1355 I-clinical_variable
' 62 63 1355 1356 I-clinical_variable
course 64 70 1357 1363 I-clinical_variable
< 71 72 1364 1365 O
1 73 74 1366 1367 B-upper_bound
m 75 76 1368 1369 I-upper_bound
/ 76 77 1369 1370 I-upper_bound
s 77 78 1370 1371 I-upper_bound
) 78 79 1371 1372 O

ACR 0 3 0 3 B-clinical_variable
in 4 6 4 6 O
the 7 10 7 10 O
previous 11 19 11 19 B-upper_bound
6 20 21 20 21 I-upper_bound
months 22 28 22 28 I-upper_bound

Age 0 3 29 32 B-age
< 4 5 33 34 O
18 5 7 34 36 B-upper_bound
years 8 13 37 42 I-upper_bound

EBV 0 3 43 46 B-chronic_disease
IgG 4 7 47 50 I-chronic_disease
negative 8 16 51 59 O

Everolimus 0 10 60 70 B-treatment

Maintenance 0 11 71 82 O
immunosuppression 12 29 83 100 B-treatment
of 30 32 101 103 I-treatment
CNI 33 36 104 107 I-treatment
( 37 38 108 109 O
cyclosporine 38 50 109 121 B-treatment
or 51 53 122 124 O
tacrolimus 54 64 125 135 B-treatment
) 64 65 135 136 O

Male 0 4 137 141 B-gender

Proteinuria 0 11 142 153 B-clinical_variable
≥1 12 14 154 156 O
gram 15 19 157 161 I-lower_bound
/ 19 20 161 162 I-lower_bound
day 20 23 162 165 I-lower_bound
in 24 26 166 168 O
spot 27 31 169 173 O
urine 32 37 174 179 O
protein 38 45 180 187 O
/ 45 46 187 188 O
creatinine 46 56 188 198 O
ratio 57 62 199 204 O

Sirolimus 0 9 205 214 B-treatment

active 0 6 215 221 O
acute 7 12 222 227 O
antibody 13 21 228 236 B-chronic_disease
- 21 22 236 237 I-chronic_disease
mediated 22 30 237 245 I-chronic_disease
rejection 31 40 246 255 I-chronic_disease

active 0 6 256 262 O
acute 7 12 263 268 B-chronic_disease
cellular 13 21 269 277 I-chronic_disease
rejection 22 31 278 287 I-chronic_disease
( 32 33 288 289 O
ACR 33 36 289 292 B-chronic_disease
; 36 37 292 293 O
higher 38 44 294 300 O
than 45 49 301 305 O
borderline 50 60 306 316 O
) 60 61 316 317 O

antiproliferative 0 17 318 335 B-treatment
agent 18 23 336 341 I-treatment
( 24 25 342 343 O
azathioprine 25 37 343 355 B-treatment
, 37 38 355 356 O
MMF 39 42 357 360 B-treatment
or 43 45 361 363 O
MPA 46 49 364 367 B-treatment
) 49 50 367 368 O
with 51 55 369 373 O
either 56 62 374 380 O
steroids 63 71 381 389 B-treatment
or 72 74 390 392 O
not 75 78 393 396 O

eGFR 0 4 397 401 B-clinical_variable
≥30 5 8 402 405 O
ml 9 11 406 408 I-lower_bound
/ 11 12 408 409 I-lower_bound
min 12 15 409 412 I-lower_bound

eGFR<30 0 7 413 420 B-clinical_variable
ml 8 10 421 423 I-upper_bound
/ 10 11 423 424 I-upper_bound
min 11 14 424 427 I-upper_bound

female 0 6 428 434 B-gender
adult 7 12 435 440 O

kidney 0 6 441 447 B-treatment
transplant 7 17 448 458 I-treatment
recipients 18 28 459 469 O
older 29 34 470 475 O
than 35 39 476 480 O
18 40 42 481 483 B-lower_bound
years 43 48 484 489 I-lower_bound
old 49 52 490 493 O

patient 0 7 494 501 O
on 8 10 502 504 O
mTOR 11 15 505 509 B-treatment
inhibitor 16 25 510 519 I-treatment

patient 0 7 520 527 O
only 8 12 528 532 O
on 13 15 533 535 O
CNI 16 19 536 539 B-chronic_disease
( 20 21 540 541 O
cyclosporine 21 33 541 553 B-treatment
or 34 36 554 556 O
tacrolimus 37 47 557 567 B-treatment
) 47 48 567 568 O
and 49 52 569 572 O
steroids 53 61 573 581 B-treatment

recurrent 0 9 582 591 O
FSGS 10 14 592 596 B-chronic_disease

≥6 0 2 597 599 O
months 3 9 600 606 I-lower_bound
after 10 15 607 612 I-lower_bound
transplantation 16 31 613 628 B-treatment

Age 0 3 0 3 B-age
: 3 4 3 4 O
> 5 6 5 6 O
= 6 7 6 7 O
18 7 9 7 9 B-lower_bound
years 10 15 10 15 I-lower_bound
of 16 18 16 18 O
age 19 22 19 22 B-age

Patients 0 8 23 31 O
who 9 12 32 35 O
perform 13 20 36 43 O
clean 21 26 44 49 B-treatment
intermittent 27 39 50 62 I-treatment
catheterization 40 55 63 78 I-treatment

Patients 0 8 79 87 O
with 9 13 88 92 O
indwelling 14 24 93 103 O
ureteral 25 33 104 112 O
stents 34 40 113 119 O
placed 41 47 120 126 O
within 48 54 127 133 O
the 55 58 134 137 O
2 59 60 138 139 B-upper_bound
weeks 61 66 140 145 I-upper_bound
prior 67 72 146 151 I-upper_bound
to 73 75 152 154 O
the 76 79 155 158 O
procedure 80 89 159 168 O
visit 90 95 169 174 O
for 96 99 175 178 O
removal 100 107 179 186 O

We 0 2 187 189 O
anticipated 3 14 190 201 O
enrolling 15 24 202 211 O
a 25 26 212 213 O
study 27 32 214 219 O
population 33 43 220 230 O
of 44 46 231 233 O
approximately 47 60 234 247 O
60 61 63 248 250 O
% 63 64 250 251 O
men 65 68 252 255 B-gender
and 69 72 256 259 O
40 73 75 260 262 O
% 75 76 262 263 O
women 77 82 264 269 B-gender
based 83 88 270 275 O
on 89 91 276 278 O
a 92 93 279 280 O
higher 94 100 281 287 O
incidence 101 110 288 297 O
of 111 113 298 300 O
kidney 114 120 301 307 B-chronic_disease
stones 121 127 308 314 I-chronic_disease
among 128 133 315 320 O
men 134 137 321 324 O
in 138 140 325 327 O
NHANES 141 147 328 334 O
data 148 152 335 339 O

percutaneous 0 12 340 352 B-treatment
nephrolithotomy 13 28 353 368 I-treatment
[ 29 30 369 370 I-treatment
PNL 30 33 370 373 I-treatment
] 33 34 373 374 I-treatment

retrograde 0 10 375 385 B-treatment
intrarenal 11 21 386 396 I-treatment
surgery 22 29 397 404 I-treatment
[ 30 31 405 406 I-treatment
RIRS 31 35 406 410 I-treatment
] 35 36 410 411 I-treatment

shockwave 0 9 412 421 B-treatment
lithotripsy 10 21 422 433 I-treatment
[ 22 23 434 435 I-treatment
SWL 23 26 435 438 I-treatment
] 26 27 438 439 I-treatment

ureteroscopy 0 12 440 452 B-treatment
[ 13 14 453 454 I-treatment
URS 14 17 454 457 I-treatment
] 17 18 457 458 I-treatment

women 0 5 459 464 B-gender

Allergy 0 7 0 7 O
to 8 10 8 10 O
penicillin 11 21 11 21 B-allergy_name
plus 22 26 22 26 O
any 27 30 27 30 O
one 31 34 31 34 O
of 35 37 35 37 O
the 38 41 38 41 O
following 42 51 42 51 O

Hypersensitivity 0 16 52 68 O
to 17 19 69 71 O
ciprofloxacin 20 33 72 85 B-allergy_name
and/or 34 40 86 92 O
metronidazole 41 54 93 106 B-allergy_name

Immunocompromized 0 17 107 124 B-chronic_disease
state 18 23 125 130 O

Patient 0 7 131 138 O
taking 8 14 139 145 O
tizanidine 15 25 146 156 B-treatment

Patients 0 8 157 165 O
taking 9 15 166 172 O
theophylline 16 28 173 185 B-treatment

Pregnant 0 8 186 194 B-pregnancy

Pregnant 0 8 195 203 B-pregnancy
women 9 14 204 209 B-gender

Previous 0 8 210 218 O
appendicitis 9 21 219 231 B-chronic_disease

White 0 5 232 237 B-clinical_variable
blood 6 11 238 243 I-clinical_variable
cell 12 16 244 248 I-clinical_variable
count 17 22 249 254 I-clinical_variable
( 23 24 255 256 I-clinical_variable
WBC 24 27 256 259 I-clinical_variable
) 27 28 259 260 I-clinical_variable
> 29 30 261 262 O
15 30 32 262 264 B-lower_bound

ANC 0 3 0 3 B-clinical_variable
≥1000/µL 4 12 4 12 O

Aspartate 0 9 13 22 B-clinical_variable
aminotransferase 10 26 23 39 I-clinical_variable
/ 26 27 39 40 I-clinical_variable
serum 27 32 40 45 I-clinical_variable
glutamic 33 41 46 54 I-clinical_variable
- 41 42 54 55 I-clinical_variable
oxaloacetic 42 53 55 66 I-clinical_variable
transaminase 54 66 67 79 I-clinical_variable
( 67 68 80 81 I-clinical_variable
AST 68 71 81 84 I-clinical_variable
/ 71 72 84 85 I-clinical_variable
SGOT 72 76 85 89 I-clinical_variable
) 76 77 89 90 I-clinical_variable
, 77 78 90 91 O
alanine 79 86 92 99 B-clinical_variable
aminotransferase 87 103 100 116 I-clinical_variable
/ 103 104 116 117 I-clinical_variable
serum 104 109 117 122 I-clinical_variable
glutamic 110 118 123 131 I-clinical_variable
- 118 119 131 132 I-clinical_variable
pyruvic 119 126 132 139 I-clinical_variable
transaminase 127 139 140 152 I-clinical_variable
( 140 141 153 154 I-clinical_variable
ALT 141 144 154 157 I-clinical_variable
/ 144 145 157 158 I-clinical_variable
SGPT 145 149 158 162 I-clinical_variable
) 149 150 162 163 I-clinical_variable
, 150 151 163 164 O
and 152 155 165 168 O
gamma 156 161 169 174 B-clinical_variable
- 161 162 174 175 I-clinical_variable
glutamyltransferase 162 181 175 194 I-clinical_variable
( 182 183 195 196 I-clinical_variable
GGT 183 186 196 199 I-clinical_variable
) 186 187 199 200 I-clinical_variable
≤2.5 188 192 201 205 O
xupper 193 199 206 212 I-upper_bound
limit 200 205 213 218 I-upper_bound
of 206 208 219 221 I-upper_bound
normal 209 215 222 228 I-upper_bound
( 216 217 229 230 I-upper_bound
ULN 217 220 230 233 I-upper_bound
) 220 221 233 234 I-upper_bound
( 222 223 235 236 O
AST 223 226 236 239 O
/ 226 227 239 240 O
ALT 227 230 240 243 O
/ 230 231 243 244 O
GGT 231 234 244 247 O
≤5 235 237 248 250 O
xULN 238 242 251 255 I-upper_bound
if 243 245 256 258 O
documented 246 256 259 269 O
hepatic 257 264 270 277 O
involvement 265 276 278 289 O
with 277 281 290 294 O
lymphoma 282 290 295 303 B-cancer
) 290 291 303 304 O

Creatinine 0 10 305 315 B-clinical_variable
≤2.0 11 15 316 320 O
mg 16 18 321 323 I-upper_bound
/ 18 19 323 324 I-upper_bound
dL 19 21 324 326 I-upper_bound
or 22 24 327 329 O
calculated 25 35 330 340 B-clinical_variable
creatinine 36 46 341 351 I-clinical_variable
clearance 47 56 352 361 I-clinical_variable
≥50 57 60 362 365 O
mL 61 63 366 368 I-lower_bound
/ 63 64 368 369 I-lower_bound
min 64 67 369 372 I-lower_bound

Eastern 0 7 373 380 B-clinical_variable
Cooperative 8 19 381 392 I-clinical_variable
Oncology 20 28 393 401 I-clinical_variable
Group 29 34 402 407 I-clinical_variable
( 35 36 408 409 I-clinical_variable
ECOG 36 40 409 413 I-clinical_variable
) 40 41 413 414 I-clinical_variable
performance 42 53 415 426 I-clinical_variable
status 54 60 427 433 I-clinical_variable
≤2 61 63 434 436 O

Females 0 7 437 444 B-gender
of 8 10 445 447 O
childbearing 11 23 448 460 O
potential 24 33 461 470 O
are 34 37 471 474 O
to 38 40 475 477 O
agree 41 46 478 483 B-contraception_consent
to 47 49 484 486 I-contraception_consent
practice 50 58 487 495 I-contraception_consent
a 59 60 496 497 I-contraception_consent
medically 61 70 498 507 I-contraception_consent
acceptable 71 81 508 518 I-contraception_consent
contraceptive 82 95 519 532 I-contraception_consent
regimen 96 103 533 540 I-contraception_consent
( 104 105 541 542 O
including 105 114 542 551 O
a 115 116 552 553 O
barrier 117 124 554 561 B-contraception_consent
method 125 131 562 568 I-contraception_consent
) 131 132 568 569 O
from 133 137 570 574 O
study 138 143 575 580 B-treatment
treatment 144 153 581 590 I-treatment
initiation 154 164 591 601 O
until 165 170 602 607 O
at 171 173 608 610 O
least 174 179 611 616 O
30 180 182 617 619 B-lower_bound
days 183 187 620 624 I-lower_bound
after 188 193 625 630 O
the 194 197 631 634 O
last 198 202 635 639 O
administration 203 217 640 654 O
of 218 220 655 657 O
Folotyn 221 228 658 665 B-treatment
or 229 231 666 668 O
leucovorin 232 242 669 679 B-treatment
, 242 243 679 680 O
whichever 244 253 681 690 O
is 254 256 691 693 O
last 257 261 694 698 O
, 261 262 698 699 O
and 263 266 700 703 O
are 267 270 704 707 O
to 271 273 708 710 O
have 274 278 711 715 O
a 279 280 716 717 O
negative 281 289 718 726 B-pregnancy
urine 290 295 727 732 I-pregnancy
beta 296 300 733 737 I-pregnancy
human 301 306 738 743 I-pregnancy
chorionic 307 316 744 753 I-pregnancy
gonadotropin 317 329 754 766 I-pregnancy
( 330 331 767 768 I-pregnancy
β 331 332 768 769 I-pregnancy
- 332 333 769 770 I-pregnancy
HCG 333 336 770 773 I-pregnancy
) 336 337 773 774 I-pregnancy
pregnancy 338 347 775 784 I-pregnancy
test 348 352 785 789 O
within 353 359 790 796 O
14 360 362 797 799 B-upper_bound
days 363 367 800 804 I-upper_bound
prior 368 373 805 810 I-upper_bound
to 374 376 811 813 O
the 377 380 814 817 O
first 381 386 818 823 O
day 387 390 824 827 O
of 391 393 828 830 O
study 394 399 831 836 O
treatment 400 409 837 846 O

Male 0 4 847 851 B-gender
patients 5 13 852 860 I-gender
are 14 17 861 864 O
to 18 20 865 867 O
agree 21 26 868 873 B-contraception_consent
to 27 29 874 876 I-contraception_consent
use 30 33 877 880 I-contraception_consent
a 34 35 881 882 I-contraception_consent
barrier 36 43 883 890 I-contraception_consent
method 44 50 891 897 I-contraception_consent
of 51 53 898 900 I-contraception_consent
contraception 54 67 901 914 I-contraception_consent
from 68 72 915 919 O
study 73 78 920 925 O
treatment 79 88 926 935 B-treatment
initiation 89 99 936 946 O
until 100 105 947 952 O
at 106 108 953 955 O
least 109 114 956 961 O
90 115 117 962 964 B-lower_bound
days 118 122 965 969 I-lower_bound
after 123 128 970 975 O
the 129 132 976 979 O
last 133 137 980 984 O
administration 138 152 985 999 O
of 153 155 1000 1002 O
Folotyn 156 163 1003 1010 O

Platelet 0 8 1011 1019 B-clinical_variable
count 9 14 1020 1025 I-clinical_variable
≥100,000/µL 15 26 1026 1037 O

Total 0 5 1038 1043 B-clinical_variable
bilirubin 6 15 1044 1053 I-clinical_variable
≤1.5 16 20 1054 1058 O
mg 21 23 1059 1061 I-upper_bound
/ 23 24 1061 1062 I-upper_bound
dL 24 26 1062 1064 I-upper_bound

active 0 6 1065 1071 B-chronic_disease
uncontrolled 7 19 1072 1084 I-chronic_disease
infection 20 29 1085 1094 I-chronic_disease
, 29 30 1094 1095 O
underlying 31 41 1096 1106 O
medical 42 49 1107 1114 B-chronic_disease
condition 50 59 1115 1124 I-chronic_disease
, 59 60 1124 1125 O
or 61 63 1126 1128 O
other 64 69 1129 1134 O
serious 70 77 1135 1142 B-chronic_disease
illness 78 85 1143 1150 I-chronic_disease
that 86 90 1151 1155 O
would 91 96 1156 1161 O
impair 97 103 1162 1168 O
the 104 107 1169 1172 O
ability 108 115 1173 1180 O
of 116 118 1181 1183 O
the 119 122 1184 1187 O
patient 123 130 1188 1195 O
to 131 133 1196 1198 O
receive 134 141 1199 1206 O
protocol 142 150 1207 1215 O
treatment 151 160 1216 1225 B-treatment

at 0 2 1226 1228 O
least 3 8 1229 1234 O
18 9 11 1235 1237 B-lower_bound
years 12 17 1238 1243 I-lower_bound
of 18 20 1244 1246 O
age 21 24 1247 1250 B-age

congestive 0 10 1251 1261 B-chronic_disease
heart 11 16 1262 1267 I-chronic_disease
failure 17 24 1268 1275 I-chronic_disease
Class 25 30 1276 1281 B-lower_bound
III 31 34 1282 1285 I-lower_bound
/ 34 35 1285 1286 O
IV 35 37 1286 1288 B-upper_bound
according 38 47 1289 1298 O
to 48 50 1299 1301 O
the 51 54 1302 1305 O
New 55 58 1306 1309 B-clinical_variable
York 59 63 1310 1314 I-clinical_variable
Heart 64 69 1315 1320 I-clinical_variable
Association 70 81 1321 1332 I-clinical_variable
( 82 83 1333 1334 I-clinical_variable
NYHA 83 87 1334 1338 I-clinical_variable
) 87 88 1338 1339 I-clinical_variable
Functional 89 99 1340 1350 I-clinical_variable
Classification 100 114 1351 1365 I-clinical_variable

diagnosed 0 9 1366 1375 O
with 10 14 1376 1380 O
hematological 15 28 1381 1394 B-cancer
malignancies 29 41 1395 1407 I-cancer
including 42 51 1408 1417 O
PTCL 52 56 1418 1422 B-chronic_disease
and 57 60 1423 1426 O
CTCL 61 65 1427 1431 B-cancer
and 66 69 1432 1435 O
are 70 73 1436 1439 O
eligible 74 82 1440 1448 O
for 83 86 1449 1452 O
treatment 87 96 1453 1462 B-treatment
with 97 101 1463 1467 O
a 102 103 1468 1469 O
dose 104 108 1470 1474 O
of 109 111 1475 1477 O
30 112 114 1478 1480 O
mg 115 117 1481 1483 O
/ 117 118 1483 1484 O
m^2 118 121 1484 1487 O

had 0 3 1488 1491 O
major 4 9 1492 1497 B-treatment
surgery 10 17 1498 1505 I-treatment
within 18 24 1506 1512 O
14 25 27 1513 1515 B-upper_bound
days 28 32 1516 1520 I-upper_bound
prior 33 38 1521 1526 I-upper_bound
to 39 41 1527 1529 O
enrollment 42 52 1530 1540 O

had 0 3 1541 1544 O
previous 4 12 1545 1553 O
exposure 13 21 1554 1562 O
to 22 24 1563 1565 O
Folotyn 25 32 1566 1573 B-treatment
within 33 39 1574 1580 O
6 40 41 1581 1582 B-upper_bound
months 42 48 1583 1589 I-upper_bound
of 49 51 1590 1592 O
study 52 57 1593 1598 O
enrollment 58 68 1599 1609 O

has 0 3 1610 1613 O
recovered 4 13 1614 1623 O
from 14 18 1624 1628 O
the 19 22 1629 1632 O
toxic 23 28 1633 1638 O
effects 29 36 1639 1646 O
of 37 39 1647 1649 O
prior 40 45 1650 1655 O
therapy 46 53 1656 1663 B-treatment
, 53 54 1663 1664 O
and 55 58 1665 1668 O
is 59 61 1669 1671 O
at 62 64 1672 1674 O
least 65 70 1675 1680 O
30 71 73 1681 1683 B-lower_bound
days 74 78 1684 1688 I-lower_bound
from 79 83 1689 1693 O
the 84 87 1694 1697 O
most 88 92 1698 1702 O
recent 93 99 1703 1709 O
cytotoxic 100 109 1710 1719 B-treatment
therapy 110 117 1720 1727 I-treatment
, 117 118 1727 1728 O
prior 119 124 1729 1734 O
to 125 127 1735 1737 O
enrollment 128 138 1738 1748 O

known 0 5 1749 1754 O
, 5 6 1754 1755 O
uncontrolled 7 19 1756 1768 O
human 20 25 1769 1774 B-chronic_disease
immunodeficiency 26 42 1775 1791 I-chronic_disease
virus 43 48 1792 1797 I-chronic_disease
( 49 50 1798 1799 I-chronic_disease
HIV)-positive 50 63 1799 1812 I-chronic_disease
diagnosis 64 73 1813 1822 O

pregnant 0 8 1823 1831 B-pregnancy

received 0 8 1832 1840 O
prophylactic 9 21 1841 1853 B-treatment
CNS 22 25 1854 1857 I-treatment
treatment 26 35 1858 1867 I-treatment
are 36 39 1868 1871 O
eligible 40 48 1872 1880 O

symptomatic 0 11 1881 1892 O
central 12 19 1893 1900 B-cancer
nervous 20 27 1901 1908 I-cancer
system 28 34 1909 1915 I-cancer
( 35 36 1916 1917 I-cancer
CNS 36 39 1917 1920 I-cancer
) 39 40 1920 1921 I-cancer
metastases 41 51 1922 1932 I-cancer
or 52 54 1933 1935 O
lesions 55 62 1936 1943 O
for 63 66 1944 1947 O
which 67 72 1948 1953 O
treatment 73 82 1954 1963 B-treatment
is 83 85 1964 1966 O
required 86 94 1967 1975 O

uncontrolled 0 12 1976 1988 O
hypertension 13 25 1989 2001 B-chronic_disease

used 0 4 2002 2006 O
any 5 8 2007 2010 O
investigational 9 24 2011 2026 B-treatment
drugs 25 30 2027 2032 I-treatment
, 30 31 2032 2033 O
biologics 32 41 2034 2043 B-treatment
, 41 42 2043 2044 O
or 43 45 2045 2047 O
devices 46 53 2048 2055 B-treatment
within 54 60 2056 2062 O
14 61 63 2063 2065 B-upper_bound
days 64 68 2066 2070 I-upper_bound
prior 69 74 2071 2076 I-upper_bound
to 75 77 2077 2079 O
study 78 83 2080 2085 O
treatment 84 93 2086 2095 B-treatment
or 94 96 2096 2098 O
plans 97 102 2099 2104 O
to 103 105 2105 2107 O
use 106 109 2108 2111 O
any 110 113 2112 2115 O
of 114 116 2116 2118 O
these 117 122 2119 2124 O
during 123 129 2125 2131 O
the 130 133 2132 2135 O
course 134 140 2136 2142 O
of 141 143 2143 2145 O
the 144 147 2146 2149 O
study 148 153 2150 2155 O

Acute 0 5 0 5 B-chronic_disease
or 6 8 6 8 I-chronic_disease
chronic 9 16 9 16 I-chronic_disease
severe 17 23 17 23 I-chronic_disease
renal 24 29 24 29 I-chronic_disease
insufficiency 30 43 30 43 I-chronic_disease

Acute 0 5 44 49 B-chronic_disease
renal 6 11 50 55 I-chronic_disease
dysfunction 12 23 56 67 I-chronic_disease
due 24 27 68 71 O
to 28 30 72 74 O
the 31 34 75 78 O
hepato 35 41 79 85 B-chronic_disease
- 41 42 85 86 I-chronic_disease
renal 42 47 86 91 I-chronic_disease
syndrome 48 56 92 100 I-chronic_disease
or 57 59 101 103 O
in 60 62 104 106 O
the 63 66 107 110 O
perioperative 67 80 111 124 B-treatment
liver 81 86 125 130 I-treatment
transplantation 87 102 131 146 I-treatment
period 103 109 147 153 O

Age 0 3 154 157 B-age
> 4 5 158 159 O
60 6 8 160 162 B-lower_bound

Exposure 0 8 163 171 B-chronic_disease
to 9 11 172 174 I-chronic_disease
gadolinium 12 22 175 185 I-chronic_disease
- 22 23 185 186 I-chronic_disease
based 23 28 186 191 I-chronic_disease
contrast 29 37 192 200 I-chronic_disease
agents 38 44 201 207 I-chronic_disease
increases 45 54 208 217 I-chronic_disease
the 55 58 218 221 I-chronic_disease
risk 59 63 222 226 I-chronic_disease
for 64 67 227 230 I-chronic_disease
nephrogenic 68 79 231 242 I-chronic_disease
systemic 80 88 243 251 I-chronic_disease
fibrosis 89 97 252 260 I-chronic_disease
( 98 99 261 262 I-chronic_disease
NSF 99 102 262 265 I-chronic_disease
) 102 103 265 266 I-chronic_disease
in 104 106 267 269 I-chronic_disease
patients 107 115 270 278 I-chronic_disease
with 116 120 279 283 I-chronic_disease
acute 121 126 284 289 I-chronic_disease
or 127 129 290 292 I-chronic_disease
severe 130 136 293 299 I-chronic_disease
renal 137 142 300 305 I-chronic_disease
dysfunction 143 154 306 317 I-chronic_disease

History 0 7 318 325 O
of 8 10 326 328 O
diabetes 11 19 329 337 B-chronic_disease

History 0 7 338 345 O
of 8 10 346 348 O
hypertension 11 23 349 361 B-chronic_disease

History 0 7 362 369 O
of 8 10 370 372 O
severe 11 17 373 379 O
hepatic 18 25 380 387 B-chronic_disease
disease 26 33 388 395 I-chronic_disease
/ 33 34 395 396 O
liver 34 39 396 401 B-treatment
transplant 40 50 402 412 I-treatment
/ 50 51 412 413 O
pending 51 58 413 420 O
liver 59 64 421 426 O
transplant 65 75 427 437 O

In 0 2 438 440 O
order 3 8 441 446 O
to 9 11 447 449 O
identify 12 20 450 458 O
subjects 21 29 459 467 O
at 30 32 468 470 O
risk 33 37 471 475 O
for 38 41 476 479 O
the 42 45 480 483 O
development 46 57 484 495 O
of 58 60 496 498 O
NSF 61 64 499 502 O
, 64 65 502 503 O
the 66 69 504 507 O
American 70 78 508 516 O
College 79 86 517 524 O
of 87 89 525 527 O
Radiology 90 99 528 537 O
( 100 101 538 539 O
http://acr.org 101 115 539 553 O
) 115 116 553 554 O
recommends 117 127 555 565 O
obtaining 128 137 566 575 O
a 138 139 576 577 O
medical 140 147 578 585 O
history 148 155 586 593 O
and 156 159 594 597 O
a 160 161 598 599 O
glomerular 162 172 600 610 B-clinical_variable
filtration 173 183 611 621 I-clinical_variable
rate 184 188 622 626 I-clinical_variable
( 189 190 627 628 I-clinical_variable
GFR 190 193 628 631 I-clinical_variable
) 193 194 631 632 I-clinical_variable
assessment 195 205 633 643 O
within 206 212 644 650 O
six 213 216 651 654 B-upper_bound
weeks 217 222 655 660 I-upper_bound
of 223 225 661 663 O
MR 226 228 664 666 O

Patients 0 8 667 675 O
can 9 12 676 679 B-pregnancy
not 12 15 679 682 I-pregnancy
be 16 18 683 685 I-pregnancy
pregnant 19 27 686 694 I-pregnancy
and 28 31 695 698 O
prisoners 32 41 699 708 O
will 42 46 709 713 O
not 47 50 714 717 O
be 51 53 718 720 O
considered 54 64 721 731 O
for 65 68 732 735 O
the 69 72 736 739 O
study 73 78 740 745 O

Patients 0 8 746 754 O
with 9 13 755 759 O
a 14 15 760 761 O
lesion 16 22 762 768 B-clinical_variable
< 23 24 769 770 O
2 25 26 771 772 B-upper_bound
mm 27 29 773 775 I-upper_bound

Renal 0 5 776 781 B-chronic_disease
disease 6 13 782 789 I-chronic_disease
( 14 15 790 791 O
including 15 24 791 800 O
solitary 25 33 801 809 B-chronic_disease
kidney 34 40 810 816 I-chronic_disease
, 40 41 816 817 O
renal 42 47 818 823 B-treatment
transplant 48 58 824 834 I-treatment
, 58 59 834 835 O
renal 60 65 836 841 B-cancer
tumor 66 71 842 847 I-cancer
) 71 72 847 848 O

The 0 3 849 852 O
patient 4 11 853 860 O
has 12 15 861 864 O
an 16 18 865 867 O
orbital 19 26 868 875 B-cancer
mass 27 31 876 880 I-cancer
which 32 37 881 886 O
needs 38 43 887 892 O
further 44 51 893 900 O
diagnostic 52 62 901 911 O
evaluation 63 73 912 922 O
before 74 80 923 929 O
treatment 81 90 930 939 B-treatment
or 91 93 940 942 O
for 94 97 943 946 O
monitoring 98 108 947 957 O

The 0 3 958 961 O
patient 4 11 962 969 O
should 12 18 970 976 O
not 19 22 977 980 O
participate 23 34 981 992 O
in 35 37 993 995 O
this 38 42 996 1000 O
study 43 48 1001 1006 O
is 49 51 1007 1009 O
any 52 55 1010 1013 O
of 56 58 1014 1016 O
the 59 62 1017 1020 O
following 63 72 1021 1030 O
applies 73 80 1031 1038 O
to 81 83 1039 1041 O
the 84 87 1042 1045 O
patient 88 95 1046 1053 O
: 95 96 1053 1054 O
the 97 100 1055 1058 O
patients 101 109 1059 1067 O
has 110 113 1068 1071 O
a 114 115 1072 1073 O
pacemaker 116 125 1074 1083 B-treatment
, 125 126 1083 1084 O
metallic 127 135 1085 1093 B-treatment
cardiac 136 143 1094 1101 I-treatment
valve(s 144 151 1102 1109 I-treatment
) 151 152 1109 1110 O
, 152 153 1110 1111 O
magnetic 154 162 1112 1120 O
material 163 171 1121 1129 O
such 172 176 1130 1134 O
as 177 179 1135 1137 O
surgical 180 188 1138 1146 O
clips 189 194 1147 1152 O
, 194 195 1152 1153 O
implanted 196 205 1154 1163 O
electronic 206 216 1164 1174 O
infusion 217 225 1175 1183 O
pumps 226 231 1184 1189 O
or 232 234 1190 1192 O
any 235 238 1193 1196 O
other 239 244 1197 1202 O
condition 245 254 1203 1212 O
that 255 259 1213 1217 O
would 260 265 1218 1223 O
interfere 266 275 1224 1233 O
with 276 280 1234 1238 O
the 281 284 1239 1242 O
MRI 285 288 1243 1246 B-treatment
, 288 289 1246 1247 O
the 290 293 1248 1251 O
patient 294 301 1252 1259 O
has 302 305 1260 1263 O
a 306 307 1264 1265 O
stent 308 313 1266 1271 O
somewhere 314 323 1272 1281 O
in 324 326 1282 1284 O
the 327 330 1285 1288 O
body 331 335 1289 1293 O
, 335 336 1293 1294 O
the 337 340 1295 1298 O
patient 341 348 1299 1306 O
has 349 352 1307 1310 O
a 353 354 1311 1312 O
history 355 362 1313 1320 O
of 363 365 1321 1323 O
allergic 366 374 1324 1332 O
reaction 375 383 1333 1341 O
to 384 386 1342 1344 O
any 387 390 1345 1348 O
metals 391 397 1349 1355 B-allergy_name
, 397 398 1355 1356 O
contrast 399 407 1357 1365 B-allergy_name
agents 408 414 1366 1372 I-allergy_name
, 414 415 1372 1373 O
x 416 417 1374 1375 B-allergy_name
- 417 418 1375 1376 I-allergy_name
ray 418 421 1376 1379 I-allergy_name
dyes 422 426 1380 1384 I-allergy_name
, 426 427 1384 1385 O
the 428 431 1386 1389 O
patient 432 439 1390 1397 O
has 440 443 1398 1401 O
claustrophobia 444 458 1402 1416 B-chronic_disease

glomerular 0 10 1417 1427 B-clinical_variable
filtration 11 21 1428 1438 I-clinical_variable
rate 22 26 1439 1443 I-clinical_variable
< 27 28 1444 1445 O
30 29 31 1446 1448 B-upper_bound
mL 32 34 1449 1451 I-upper_bound
/ 34 35 1451 1452 I-upper_bound
min/1.73 35 43 1452 1460 I-upper_bound
m^2 44 47 1461 1464 I-upper_bound

subjects 0 8 1465 1473 O
with 9 13 1474 1478 O
an 14 16 1479 1481 O
eGFR 17 21 1482 1486 B-clinical_variable
of 22 24 1487 1489 O
< 25 26 1490 1491 O
30 27 29 1492 1494 B-upper_bound
mL 30 32 1495 1497 I-upper_bound
/ 32 33 1497 1498 I-upper_bound
min/1.73 33 41 1498 1506 I-upper_bound
m^2 42 45 1507 1510 I-upper_bound

the 0 3 1511 1514 O
form 4 8 1515 1519 O
will 9 13 1520 1524 O
be 14 16 1525 1527 O
reviewed 17 25 1528 1536 O
to 26 28 1537 1539 O
determine 29 38 1540 1549 O
whether 39 46 1550 1557 O
the 47 50 1558 1561 O
subject 51 58 1562 1569 O
is 59 61 1570 1572 O
at 62 64 1573 1575 O
risk 65 69 1576 1580 O
as 70 72 1581 1583 O
defined 73 80 1584 1591 O
above 81 86 1592 1597 O
and 87 90 1598 1601 O
the 91 94 1602 1605 O
availability 95 107 1606 1618 O
of 108 110 1619 1621 O
an 111 113 1622 1624 O
estimated 114 123 1625 1634 B-clinical_variable
glomerular 124 134 1635 1645 I-clinical_variable
filtration 135 145 1646 1656 I-clinical_variable
rate 146 150 1657 1661 I-clinical_variable
( 151 152 1662 1663 I-clinical_variable
eGFR 152 156 1663 1667 I-clinical_variable
) 156 157 1667 1668 I-clinical_variable
within 158 164 1669 1675 O
six 165 168 1676 1679 B-upper_bound
weeks 169 174 1680 1685 I-upper_bound
of 175 177 1686 1688 O
anticipated 178 189 1689 1700 O
MR 190 192 1701 1703 O
imaging 193 200 1704 1711 O

Pancreatic 0 10 0 10 B-cancer
Cancer 11 17 11 17 I-cancer
Patients 18 26 18 26 O
who 27 30 27 30 O
are 31 34 31 34 O
potentially 35 46 35 46 O
surgically 47 57 47 57 O
resectable 58 68 58 68 O

do 0 2 69 71 O
not 3 6 72 75 O
meet 7 11 76 80 O
the 12 15 81 84 O
criteria 16 24 85 93 O
for 25 28 94 97 O
surgical 29 37 98 106 B-treatment
resection 38 47 107 116 I-treatment

24hr 0 4 0 4 O
urine 5 10 5 10 B-clinical_variable
calcium 11 18 11 18 I-clinical_variable
> 19 20 19 20 O
250mg 20 25 20 25 B-lower_bound
/ 25 26 25 26 I-lower_bound
d 26 27 26 27 I-lower_bound
in 28 30 28 30 O
women 31 36 31 36 B-gender

> 0 1 37 38 O
300mg 1 6 38 43 B-lower_bound
/ 6 7 43 44 I-lower_bound
d 7 8 44 45 I-lower_bound
in 9 11 46 48 O
men 12 15 49 52 B-gender
prior 16 21 53 58 O
to 22 24 59 61 O
indapamide 25 35 62 72 B-treatment
use 36 39 73 76 O

Hypercalciuric 0 14 77 91 B-chronic_disease
CaP 15 18 92 95 O
stone 19 24 96 101 O
formers 25 32 102 109 O

Hypocitraturic 0 14 110 124 B-chronic_disease
CaP 15 18 125 128 O
stone 19 24 129 134 O
formers 25 32 135 142 O

elevated 0 8 143 151 O
pH 9 11 152 154 O
as 12 14 155 157 O
24 15 17 158 160 O
- 17 18 160 161 O
hr 18 20 161 163 O
urine 21 26 164 169 B-clinical_variable
pH 27 29 170 172 I-clinical_variable
above 30 35 173 178 O
6.40 36 40 179 183 B-lower_bound

high 0 4 184 188 O
pH 5 7 189 191 B-clinical_variable
as 8 10 192 194 O
> 11 12 195 196 O
6.40 12 16 196 200 B-lower_bound
in 17 19 201 203 O
the 20 23 204 207 O
absence 24 31 208 215 O
of 32 34 216 218 O
urinary 35 42 219 226 B-chronic_disease
tract 43 48 227 232 I-chronic_disease
infection 49 58 233 242 I-chronic_disease

urine 0 5 243 248 B-clinical_variable
citrate 6 13 249 256 I-clinical_variable
< 14 15 257 258 O
320mg 15 20 258 263 B-upper_bound
/ 20 21 263 264 I-upper_bound
d 21 22 264 265 I-upper_bound

Patients 0 8 0 8 O
must 9 13 9 13 O
be 14 16 14 16 O
available 17 26 17 26 O
for 27 30 27 30 O
at 31 33 31 33 O
least 34 39 34 39 O
1 40 41 40 41 B-lower_bound
month 42 47 42 47 I-lower_bound
post 48 52 48 52 O
procedure 53 62 53 62 B-treatment

Patients 0 8 63 71 O
must 9 13 72 76 O
be 14 16 77 79 O
greater 17 24 80 87 O
than 25 29 88 92 O
or 30 32 93 95 O
equal 33 38 96 101 O
to 39 41 102 104 O
18 42 44 105 107 B-lower_bound
years 45 50 108 113 I-lower_bound
old 51 54 114 117 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
greater 32 39 32 39 O
than 40 44 40 44 O
or 45 47 45 47 O
equal 48 53 48 53 O
to 54 56 54 56 O
1000 57 61 57 61 B-lower_bound
/ 61 62 61 62 I-lower_bound
mm^3 62 66 62 66 I-lower_bound

Adequate 0 8 67 75 O
cardiac 9 16 76 83 O
function 17 25 84 92 O
defined 26 33 93 100 O
as 34 36 101 103 O
: 36 37 103 104 O
normal 38 44 105 111 O
12 45 47 112 114 B-treatment
lead 48 52 115 119 I-treatment
electrocardiogram 53 70 120 137 I-treatment
( 71 72 138 139 I-treatment
EKG 72 75 139 142 I-treatment
) 75 76 142 143 I-treatment
with 77 81 144 148 O
corrected 82 91 149 158 B-clinical_variable
QT 92 94 159 161 I-clinical_variable
interval 95 103 162 170 I-clinical_variable
( 104 105 171 172 I-clinical_variable
QTc 105 108 172 175 I-clinical_variable
) 108 109 175 176 I-clinical_variable
< 110 111 177 178 O
450 112 115 179 182 B-upper_bound
msec 116 120 183 187 I-upper_bound
, 120 121 187 188 O
and 122 125 189 192 O
either 126 132 193 199 O
shortening 133 143 200 210 B-clinical_variable
fraction 144 152 211 219 I-clinical_variable
of 153 155 220 222 O
> 156 157 223 224 O
= 157 158 224 225 O
28 159 161 226 228 B-lower_bound
% 161 162 228 229 I-lower_bound
by 163 165 230 232 O
echocardiogram 166 180 233 247 B-treatment
and 181 184 248 251 O
qualitatively 185 198 252 265 O
normal 199 205 266 272 O
left 206 210 273 277 B-clinical_variable
ventricular 211 222 278 289 I-clinical_variable
function 223 231 290 298 I-clinical_variable
, 231 232 298 299 O
or 233 235 300 302 O
ejection 236 244 303 311 B-clinical_variable
fraction 245 253 312 320 I-clinical_variable
of 254 256 321 323 O
> 257 258 324 325 O
= 258 259 325 326 O
55 260 262 327 329 B-lower_bound
% 262 263 329 330 I-lower_bound
by 264 266 331 333 O
echocardiogram 267 281 334 348 O

Adequate 0 8 349 357 O
pulmonary 9 18 358 367 O
function 19 27 368 376 O
as 28 30 377 379 O
defined 31 38 380 387 O
as 39 41 388 390 O
: 41 42 390 391 O
no 43 45 392 394 O
evidence 46 54 395 403 O
of 55 57 404 406 O
dyspnea 58 65 407 414 B-chronic_disease
at 66 68 415 417 O
rest 69 73 418 422 O
, 73 74 422 423 O
no 75 77 424 426 O
exercise 78 86 427 435 O
intolerance 87 98 436 447 O
, 98 99 447 448 O
and 100 103 449 452 O
a 104 105 453 454 O
pulse 106 111 455 460 B-clinical_variable
oximetry 112 120 461 469 I-clinical_variable
> 121 122 470 471 O
94 123 125 472 474 B-lower_bound
% 125 126 474 475 I-lower_bound
if 127 129 476 478 O
there 130 135 479 484 O
is 136 138 485 487 O
clinical 139 147 488 496 O
indication 148 158 497 507 O
for 159 162 508 511 O
determination 163 176 512 525 O

Age 0 3 526 529 B-age
1 4 5 530 531 B-lower_bound
to 6 8 532 534 O
< 9 10 535 536 O
2 11 12 537 538 B-upper_bound
years 13 18 539 544 I-upper_bound
, 18 19 544 545 O
0.6 20 23 546 549 O
mg 24 26 550 552 O
/ 26 27 552 553 O
dL 27 29 553 555 O
( 30 31 556 557 O
male 31 35 557 561 B-gender
) 35 36 561 562 O
and 37 40 563 566 O
0.6 41 44 567 570 O
mg 45 47 571 573 O
/ 47 48 573 574 O
dL 48 50 574 576 O
( 51 52 577 578 O
female 52 58 578 584 B-gender
) 58 59 584 585 O

Age 0 3 586 589 B-age
> 4 5 590 591 O
10 6 8 592 594 B-lower_bound
and 9 12 595 598 O
< 13 14 599 600 O
13 15 17 601 603 B-upper_bound
years 18 23 604 609 I-upper_bound
, 23 24 609 610 O
1.2 25 28 611 614 B-upper_bound
mg 29 31 615 617 I-upper_bound
/ 31 32 617 618 I-upper_bound
dL 32 34 618 620 I-upper_bound
( 35 36 621 622 O
male 36 40 622 626 B-gender
) 40 41 626 627 O
and 42 45 628 631 O
1.2 46 49 632 635 O
mg 50 52 636 638 O
/ 52 53 638 639 O
dL 53 55 639 641 O
( 56 57 642 643 O
female 57 63 643 649 B-gender
) 63 64 649 650 O

Age 0 3 651 654 B-age
> 4 5 655 656 O
13 6 8 657 659 B-lower_bound
and 9 12 660 663 O
< 13 14 664 665 O
16 15 17 666 668 B-upper_bound
years 18 23 669 674 I-upper_bound
, 23 24 674 675 O
1.5 25 28 676 679 B-upper_bound
mg 29 31 680 682 I-upper_bound
/ 31 32 682 683 I-upper_bound
dL 32 34 683 685 I-upper_bound
( 35 36 686 687 O
male 36 40 687 691 B-gender
) 40 41 691 692 O
and 42 45 693 696 O
1.4 46 49 697 700 B-upper_bound
mg 50 52 701 703 I-upper_bound
/ 52 53 703 704 I-upper_bound
dL 53 55 704 706 I-upper_bound
( 56 57 707 708 O
female 57 63 708 714 B-gender
) 63 64 714 715 O

Age 0 3 716 719 B-age
> 4 5 720 721 O
16 6 8 722 724 B-lower_bound
years 9 14 725 730 I-lower_bound
, 14 15 730 731 O
1.7 16 19 732 735 O
mg 20 22 736 738 O
/ 22 23 738 739 O
dL 23 25 739 741 O
( 26 27 742 743 O
male 27 31 743 747 B-gender
) 31 32 747 748 O
and 33 36 749 752 O
1.4 37 40 753 756 O
mg 41 43 757 759 O
/ 43 44 759 760 O
dL 44 46 760 762 O
( 47 48 763 764 O
female 48 54 764 770 B-gender
) 54 55 770 771 O

Age 0 3 772 775 B-age
> 4 5 776 777 O
2 6 7 778 779 B-age
and 8 11 780 783 O
< 12 13 784 785 O
6 14 15 786 787 B-upper_bound
years 16 21 788 793 I-upper_bound
, 21 22 793 794 O
0.8 23 26 795 798 O
mg 27 29 799 801 O
/ 29 30 801 802 O
dL(male 30 37 802 809 O
) 37 38 809 810 O
and 39 42 811 814 O
0.8 43 46 815 818 O
mg 47 49 819 821 O
/ 49 50 821 822 O
dL 50 52 822 824 O
( 53 54 825 826 O
female 54 60 826 832 B-gender
) 60 61 832 833 O

Age 0 3 834 837 B-age
> 4 5 838 839 O
6 6 7 840 841 B-lower_bound
and 8 11 842 845 O
< 12 13 846 847 O
10 14 16 848 850 B-upper_bound
years 17 22 851 856 I-upper_bound
, 22 23 856 857 O
1.0 24 27 858 861 O
mg 28 30 862 864 O
/ 30 31 864 865 O
dL 31 33 865 867 O
( 34 35 868 869 O
male 35 39 869 873 B-gender
) 39 40 873 874 O
and 41 44 875 878 O
1.0 45 48 879 882 O
mg 49 51 883 885 O
/ 51 52 885 886 O
dL 52 54 886 888 O
( 55 56 889 890 O
female 56 62 890 896 B-gender
) 62 63 896 897 O

All 0 3 898 901 O
post 4 8 902 906 O
- 8 9 906 907 O
menarchal 9 18 907 916 O
females 19 26 917 924 B-gender
must 27 31 925 929 O
have 32 36 930 934 O
a 37 38 935 936 O
negative 39 47 937 945 B-pregnancy
serum 48 53 946 951 I-pregnancy
beta 54 58 952 956 I-pregnancy
- 58 59 956 957 I-pregnancy
human 59 64 957 962 I-pregnancy
chorionic 65 74 963 972 I-pregnancy
gonadotropin 75 87 973 985 I-pregnancy
( 88 89 986 987 I-pregnancy
beta 89 93 987 991 I-pregnancy
HCG 94 97 992 995 I-pregnancy
) 97 98 995 996 I-pregnancy
; 98 99 996 997 O
sexually 100 108 998 1006 O
active 109 115 1007 1013 O
patients 116 124 1014 1022 O
of 125 127 1023 1025 O
childbearing 128 140 1026 1038 O
potential 141 150 1039 1048 O
must 151 155 1049 1053 O
agree 156 161 1054 1059 B-contraception_consent
to 162 164 1060 1062 I-contraception_consent
use 165 168 1063 1066 I-contraception_consent
an 169 171 1067 1069 I-contraception_consent
effective 172 181 1070 1079 I-contraception_consent
method 182 188 1080 1086 I-contraception_consent
of 189 191 1087 1089 I-contraception_consent
contraception 192 205 1090 1103 I-contraception_consent
during 206 212 1104 1110 O
the 213 216 1111 1114 O
study 217 222 1115 1120 O
and 223 226 1121 1124 O
for 227 230 1125 1128 O
at 231 233 1129 1131 O
least 234 239 1132 1137 O
6 240 241 1138 1139 B-lower_bound
months 242 248 1140 1146 I-lower_bound
after 249 254 1147 1152 I-lower_bound

Amiodarone 0 10 1153 1163 B-treatment
, 10 11 1163 1164 O
sotalol 12 19 1165 1172 B-treatment
, 19 20 1172 1173 O
ibutilide 21 30 1174 1183 B-treatment
, 30 31 1183 1184 O
dofetilide 32 42 1185 1195 B-treatment

Angiotensin 0 11 1196 1207 B-treatment
- 11 12 1207 1208 I-treatment
converting 12 22 1208 1218 I-treatment
enzyme 23 29 1219 1225 I-treatment
( 30 31 1226 1227 I-treatment
ACE 31 34 1227 1230 I-treatment
) 34 35 1230 1231 I-treatment
inhibitors 36 46 1232 1242 I-treatment
: 46 47 1242 1243 O
patients 48 56 1244 1252 O
who 57 60 1253 1256 O
are 61 64 1257 1260 O
currently 65 74 1261 1270 O
receiving 75 84 1271 1280 O
ACE 85 88 1281 1284 B-treatment
inhibitors 89 99 1285 1295 I-treatment

Antacids 0 8 1296 1304 B-treatment
: 8 9 1304 1305 O
use 10 13 1306 1309 O
of 14 16 1310 1312 O
H2 17 19 1313 1315 B-treatment
blockers 20 28 1316 1324 I-treatment
and 29 32 1325 1328 O
proton 33 39 1329 1335 B-treatment
pump 40 44 1336 1340 I-treatment
inhibitors 45 55 1341 1351 I-treatment
is 56 58 1352 1354 O
not 59 62 1355 1358 O
recommended 63 74 1359 1370 O
; 74 75 1370 1371 O
patients 76 84 1372 1380 O
who 85 88 1381 1384 O
require 89 96 1385 1392 O
antacids 97 105 1393 1401 B-treatment
should 106 112 1402 1408 O
use 113 116 1409 1412 O
short 117 122 1413 1418 O
acting 123 129 1419 1425 O
, 129 130 1425 1426 O
locally 131 138 1427 1434 O
active 139 145 1435 1441 O
agents 146 152 1442 1448 O
( 153 154 1449 1450 O
e.g. 154 158 1450 1454 O
, 158 159 1454 1455 O
Maalox 160 166 1456 1462 B-treatment
, 166 167 1462 1463 O
Mylanta 168 175 1464 1471 B-treatment
etc 176 179 1472 1475 O
. 179 180 1475 1476 O
) 180 181 1476 1477 O
; 181 182 1477 1478 O
however 183 190 1479 1486 O
, 190 191 1486 1487 O
these 192 197 1488 1493 O
agents 198 204 1494 1500 O
should 205 211 1501 1507 O
not 212 215 1508 1511 O
be 216 218 1512 1514 O
taken 219 224 1515 1520 O
within 225 231 1521 1527 O
either 232 238 1528 1534 O
2 239 240 1535 1536 B-upper_bound
hours 241 246 1537 1542 I-upper_bound
before 247 253 1543 1549 I-upper_bound
or 254 256 1550 1552 O
2 257 258 1553 1554 B-upper_bound
hours 259 264 1555 1560 I-upper_bound
after 265 270 1561 1566 I-upper_bound
the 271 274 1567 1570 O
dasatinib 275 284 1571 1580 B-treatment
dose 285 289 1581 1585 O

Anti 0 4 1586 1590 B-chronic_disease
- 4 5 1590 1591 I-chronic_disease
graft 5 10 1591 1596 I-chronic_disease
- 10 11 1596 1597 I-chronic_disease
versus 11 17 1597 1603 I-chronic_disease
- 17 18 1603 1604 I-chronic_disease
host 18 22 1604 1608 I-chronic_disease
disease 23 30 1609 1616 I-chronic_disease
( 31 32 1617 1618 I-chronic_disease
GVHD 32 36 1618 1622 I-chronic_disease
) 36 37 1622 1623 I-chronic_disease
or 38 40 1624 1626 O
agents 41 47 1627 1633 O
to 48 50 1634 1636 O
prevent 51 58 1637 1644 O
organ 59 64 1645 1650 O
rejection 65 74 1651 1660 O
post 75 79 1661 1665 B-treatment
- 79 80 1665 1666 I-treatment
transplant 80 90 1666 1676 I-treatment
: 90 91 1676 1677 O
patients 92 100 1678 1686 O
who 101 104 1687 1690 O
are 105 108 1691 1694 O
receiving 109 118 1695 1704 O
cyclosporine 119 131 1705 1717 B-treatment
, 131 132 1717 1718 O
tacrolimus 133 143 1719 1729 B-treatment
or 144 146 1730 1732 O
other 147 152 1733 1738 O
agents 153 159 1739 1745 O
to 160 162 1746 1748 O
prevent 163 170 1749 1756 O
either 171 177 1757 1763 O
graft 178 183 1764 1769 O
- 183 184 1769 1770 O
versus 184 190 1770 1776 O
- 190 191 1776 1777 O
host 191 195 1777 1781 O
disease 196 203 1782 1789 O
post 204 208 1790 1794 B-treatment
bone 209 213 1795 1799 I-treatment
marrow 214 220 1800 1806 I-treatment
transplant 221 231 1807 1817 I-treatment
or 232 234 1818 1820 O
organ 235 240 1821 1826 O
rejection 241 250 1827 1836 O
post 251 255 1837 1841 O
- 255 256 1841 1842 O
transplant 256 266 1842 1852 O

Anticoagulants 0 14 1853 1867 B-treatment
/ 14 15 1867 1868 O
anti 15 19 1868 1872 B-treatment
- 19 20 1872 1873 I-treatment
platelets 20 29 1873 1882 I-treatment
: 29 30 1882 1883 O
patients 31 39 1884 1892 O
on 40 42 1893 1895 O
therapeutic 43 54 1896 1907 B-treatment
( 55 56 1908 1909 I-treatment
treatment 56 65 1909 1918 I-treatment
) 65 66 1918 1919 I-treatment
dose 67 71 1920 1924 I-treatment
of 72 74 1925 1927 I-treatment
anticoagulants 75 89 1928 1942 I-treatment
( 90 91 1943 1944 O
e.g. 91 95 1944 1948 O
warfarin 96 104 1949 1957 B-treatment
, 104 105 1957 1958 O
low 106 109 1959 1962 B-treatment
molecular 110 119 1963 1972 I-treatment
- 119 120 1972 1973 I-treatment
weight 120 126 1973 1979 I-treatment
heparin 127 134 1980 1987 I-treatment
) 134 135 1987 1988 O

Aspartate 0 9 1989 1998 B-clinical_variable
aminotransferase 10 26 1999 2015 I-clinical_variable
( 27 28 2016 2017 I-clinical_variable
AST 28 31 2017 2020 I-clinical_variable
) 31 32 2020 2021 I-clinical_variable
and 33 36 2022 2025 O
alanine 37 44 2026 2033 B-clinical_variable
aminotransferase 45 61 2034 2050 I-clinical_variable
( 62 63 2051 2052 I-clinical_variable
ALT 63 66 2052 2055 I-clinical_variable
) 66 67 2055 2056 I-clinical_variable
= 68 69 2057 2058 O
< 69 70 2058 2059 O
3 71 72 2060 2061 B-upper_bound
x 73 74 2062 2063 I-upper_bound
upper 75 80 2064 2069 I-upper_bound
limit 81 86 2070 2075 I-upper_bound
of 87 89 2076 2078 I-upper_bound
normal 90 96 2079 2085 I-upper_bound
for 97 100 2086 2089 I-upper_bound
age 101 104 2090 2093 I-upper_bound
( 105 106 2094 2095 I-upper_bound
ULN 106 109 2095 2098 I-upper_bound
) 109 110 2098 2099 I-upper_bound

Bilirubin 0 9 2100 2109 B-clinical_variable
= 10 11 2110 2111 O
< 11 12 2111 2112 O
1.5 13 16 2113 2116 B-upper_bound
x 17 18 2117 2118 I-upper_bound
ULN 19 22 2119 2122 I-upper_bound

Category 0 8 2123 2131 O
I 9 10 2132 2133 B-treatment
drugs 11 16 2134 2139 I-treatment
that 17 21 2140 2144 O
are 22 25 2145 2148 O
generally 26 35 2149 2158 O
accepted 36 44 2159 2167 O
to 45 47 2168 2170 O
have 48 52 2171 2175 O
a 53 54 2176 2177 O
risk 55 59 2178 2182 O
of 60 62 2183 2185 O
causing 63 70 2186 2193 O
torsades 71 79 2194 2202 O
de 80 82 2203 2205 O
pointes 83 90 2206 2213 O
including 91 100 2214 2223 O
: 100 101 2223 2224 O
( 102 103 2225 2226 O
patients 103 111 2226 2234 O
must 112 116 2235 2239 O
discontinue 117 128 2240 2251 O
drug 129 133 2252 2256 O
at 134 136 2257 2259 O
least 137 142 2260 2265 O
7 143 144 2266 2267 B-lower_bound
days 145 149 2268 2272 I-lower_bound
prior 150 155 2273 2278 I-lower_bound
to 156 158 2279 2281 O
starting 159 167 2282 2290 O
dasatinib 168 177 2291 2300 B-treatment
) 177 178 2300 2301 O

Chlorpromazine 0 14 2302 2316 B-treatment
, 14 15 2316 2317 O
haloperidol 16 27 2318 2329 B-treatment
, 27 28 2329 2330 O
mesoridazine 29 41 2331 2343 B-treatment
, 41 42 2343 2344 O
thioridazine 43 55 2345 2357 B-treatment
, 55 56 2357 2358 O
pimozide 57 65 2359 2367 B-treatment

Cisapride 0 9 2368 2377 B-treatment
, 9 10 2377 2378 O
bepridil 11 19 2379 2387 B-treatment
, 19 20 2387 2388 O
droperidol 21 31 2389 2399 B-treatment
, 31 32 2399 2400 O
arsenic 33 40 2401 2408 B-treatment
, 40 41 2408 2409 O
chloroquine 42 53 2410 2421 B-treatment
, 53 54 2421 2422 O
domperidone 55 66 2423 2434 B-treatment
, 66 67 2434 2435 O
halofantrine 68 80 2436 2448 B-treatment
, 80 81 2448 2449 O
levomethadyl 82 94 2450 2462 B-treatment
, 94 95 2462 2463 O
sparfloxacin 96 108 2464 2476 B-treatment
, 108 109 2476 2477 O
lidoflazine 110 121 2478 2489 B-treatment

Concomitant 0 11 2490 2501 B-treatment
medications 12 23 2502 2513 I-treatment
: 23 24 2513 2514 O
the 25 28 2515 2518 O
following 29 38 2519 2528 O
drugs 39 44 2529 2534 O
need 45 49 2535 2539 O
to 50 52 2540 2542 O
be 53 55 2543 2545 O
stopped 56 63 2546 2553 O
at 64 66 2554 2556 O
the 67 70 2557 2560 O
time 71 75 2561 2565 O
of 76 78 2566 2568 O
beginning 79 88 2569 2578 O
therapy 89 96 2579 2586 B-treatment
: 96 97 2586 2587 O
patient 98 105 2588 2595 O
can 106 109 2596 2599 O
not 109 112 2599 2602 O
be 113 115 2603 2605 O
on 116 118 2606 2608 O
liver 119 124 2609 2614 O
enzyme 125 131 2615 2621 O
inducing 132 140 2622 2630 O
anticonvulsants 141 156 2631 2646 B-treatment
; 156 157 2646 2647 O
patients 158 166 2648 2656 O
must 167 171 2657 2661 O
not 172 175 2662 2665 O
have 176 180 2666 2670 O
received 181 189 2671 2679 O
growth 190 196 2680 2686 O
factors 197 204 2687 2694 O
to 205 207 2695 2697 O
support 208 215 2698 2705 O
the 216 219 2706 2709 O
number 220 226 2710 2716 O
or 227 229 2717 2719 O
function 230 238 2720 2728 O
of 239 241 2729 2731 O
white 242 247 2732 2737 O
cells 248 253 2738 2743 O
or 254 256 2744 2746 O
platelets 257 266 2747 2756 O
within 267 273 2757 2763 O
the 274 277 2764 2767 O
past 278 282 2768 2772 B-upper_bound
7 283 284 2773 2774 I-upper_bound
days 285 289 2775 2779 I-upper_bound
and 290 293 2780 2783 O
pegfilgrastim 294 307 2784 2797 B-treatment
within 308 314 2798 2804 O
the 315 318 2805 2808 O
past 319 323 2809 2813 B-upper_bound
14 324 326 2814 2816 I-upper_bound
days 327 331 2817 2821 I-upper_bound

Creatinine 0 10 2822 2832 B-clinical_variable
clearance 11 20 2833 2842 I-clinical_variable
or 21 23 2843 2845 O
radioisotope 24 36 2846 2858 B-clinical_variable
glomerular 37 47 2859 2869 I-clinical_variable
filtration 48 58 2870 2880 I-clinical_variable
rate 59 63 2881 2885 I-clinical_variable
( 64 65 2886 2887 I-clinical_variable
GFR 65 68 2887 2890 I-clinical_variable
) 68 69 2890 2891 I-clinical_variable
> 70 71 2892 2893 O
70 72 74 2894 2896 B-lower_bound
ml 75 77 2897 2899 I-lower_bound
/ 77 78 2899 2900 I-lower_bound
min/1.73 78 86 2900 2908 I-lower_bound
m^2 87 90 2909 2912 I-lower_bound
OR 91 93 2913 2915 O
serum 94 99 2916 2921 B-clinical_variable
creatinine 100 110 2922 2932 I-clinical_variable
based 111 116 2933 2938 O
on 117 119 2939 2941 O
age 120 123 2942 2945 B-age
/ 123 124 2945 2946 O
gender 124 130 2946 2952 O

Drugs 0 5 2953 2958 O
prolong 6 13 2959 2966 O
QT 14 16 2967 2969 B-clinical_variable
interval 17 25 2970 2978 I-clinical_variable
; 25 26 2978 2979 O
erythromycin 27 39 2980 2992 B-treatment
, 39 40 2992 2993 O
clarithromycin 41 55 2994 3008 B-treatment
, 55 56 3008 3009 O
pentamidine 57 68 3010 3021 B-treatment
, 68 69 3021 3022 O
ondansetron 70 81 3023 3034 B-treatment
, 81 82 3034 3035 O
granisetron 83 94 3036 3047 B-treatment
, 94 95 3047 3048 O
and 96 99 3049 3052 O
methadone 100 109 3053 3062 B-treatment

Hemoglobin 0 10 3063 3073 B-clinical_variable
greater 11 18 3074 3081 O
than 19 23 3082 3086 O
8.0 24 27 3087 3090 B-lower_bound
g 28 29 3091 3092 I-lower_bound
/ 29 30 3092 3093 I-lower_bound
dL 30 32 3093 3095 I-lower_bound
( 33 34 3096 3097 O
transfusion 34 45 3097 3108 B-treatment
independent 46 57 3109 3120 O
; 57 58 3120 3121 O
no 59 61 3122 3124 O
transfusion 62 73 3125 3136 O
for 74 77 3137 3140 O
> 78 79 3141 3142 O
= 79 80 3142 3143 O
7 81 82 3144 3145 B-lower_bound
days 83 87 3146 3150 I-lower_bound
prior 88 93 3151 3156 I-lower_bound
to 94 96 3157 3159 O
study 97 102 3160 3165 O
enrollment 103 113 3166 3176 O
) 113 114 3176 3177 O

History 0 7 3178 3185 O
of 8 10 3186 3188 O
hypersensitivity 11 27 3189 3205 O
to 28 30 3206 3208 O
any 31 34 3209 3212 B-allergy_name
component 35 44 3213 3222 I-allergy_name
of 45 47 3223 3225 I-allergy_name
the 48 51 3226 3229 I-allergy_name
formulation 52 63 3230 3241 I-allergy_name

Inducers 0 8 3242 3250 O
and 9 12 3251 3254 O
Inhibitors 13 23 3255 3265 O
of 24 26 3266 3268 O
cytochrome 27 37 3269 3279 B-treatment
P450 38 42 3280 3284 I-treatment
family 43 49 3285 3291 I-treatment
3 50 51 3292 3293 I-treatment
, 51 52 3293 3294 O
subfamily 53 62 3295 3304 B-treatment
A 63 64 3305 3306 I-treatment
, 64 65 3306 3307 O
polypeptide 66 77 3308 3319 B-treatment
4 78 79 3320 3321 I-treatment
( 80 81 3322 3323 I-treatment
CYP3A4 81 87 3323 3329 I-treatment
): 87 89 3329 3331 I-treatment
patients 90 98 3332 3340 O
required 99 107 3341 3349 O
to 108 110 3350 3352 O
be 111 113 3353 3355 O
on 114 116 3356 3358 O
any 117 120 3359 3362 O
CYP3A4/5 121 129 3363 3371 B-treatment
inhibitors 130 140 3372 3382 O
or 141 143 3383 3385 O
inducers 144 152 3386 3394 O
will 153 157 3395 3399 O
be 158 160 3400 3402 O
excluded 161 169 3403 3411 O
( 170 171 3412 3413 O
with 171 175 3413 3417 O
the 176 179 3418 3421 O
exception 180 189 3422 3431 O
of 190 192 3432 3434 O
dexamethasone 193 206 3435 3448 B-treatment
, 206 207 3448 3449 O
but 208 211 3450 3453 O
all 212 215 3454 3457 O
efforts 216 223 3458 3465 O
should 224 230 3466 3472 O
be 231 233 3473 3475 O
made 234 238 3476 3480 O
to 239 241 3481 3483 O
reduce 242 248 3484 3490 O
the 249 252 3491 3494 O
dose 253 257 3495 3499 O
of 258 260 3500 3502 O
dexamethasone 261 274 3503 3516 O
) 274 275 3516 3517 O
; 275 276 3517 3518 O
patients 277 285 3519 3527 O
must 286 290 3528 3532 O
discontinue 291 302 3533 3544 O
drug 303 307 3545 3549 O
at 308 310 3550 3552 O
least 311 316 3553 3558 O
7 317 318 3559 3560 B-lower_bound
days 319 323 3561 3565 I-lower_bound
prior 324 329 3566 3571 I-lower_bound
to 330 332 3572 3574 O
starting 333 341 3575 3583 O
dasatinib 342 351 3584 3593 B-treatment

Karnofsky 0 9 3594 3603 B-clinical_variable
performance 10 21 3604 3615 I-clinical_variable
status 22 28 3616 3622 I-clinical_variable
> 29 30 3623 3624 O
= 30 31 3624 3625 O
50 32 34 3626 3628 B-lower_bound
for 35 38 3629 3632 O
patients 39 47 3633 3641 O
> 48 49 3642 3643 O
= 49 50 3643 3644 O
16 51 53 3645 3647 O
years 54 59 3648 3653 O
of 60 62 3654 3656 O
age 63 66 3657 3660 B-age
and 67 70 3661 3664 O
a 71 72 3665 3666 O
Lansky 73 79 3667 3673 B-clinical_variable
performance 80 91 3674 3685 I-clinical_variable
status 92 98 3686 3692 I-clinical_variable
> 99 100 3693 3694 O
= 100 101 3694 3695 O
50 102 104 3696 3698 O
for 105 108 3699 3702 O
patients 109 117 3703 3711 O
aged 118 122 3712 3716 B-age
< 123 124 3717 3718 O
16 125 127 3719 3721 O
years 128 133 3722 3727 O

Life 0 4 3728 3732 B-clinical_variable
expectancy 5 15 3733 3743 I-clinical_variable
: 15 16 3743 3744 O
must 17 21 3745 3749 O
be 22 24 3750 3752 O
> 25 26 3753 3754 O
= 26 27 3754 3755 O
12 28 30 3756 3758 B-lower_bound
weeks 31 36 3759 3764 I-lower_bound

Must 0 4 3765 3769 O
not 5 8 3770 3773 O
have 9 13 3774 3778 O
received 14 22 3779 3787 O
bevacizumab 23 34 3788 3799 B-treatment
or 35 37 3800 3802 O
other 38 43 3803 3808 O
monoclonal 44 54 3809 3819 B-treatment
antibody 55 63 3820 3828 I-treatment
therapy 64 71 3829 3836 I-treatment
within 72 78 3837 3843 O
4 79 80 3844 3845 B-upper_bound
weeks 81 86 3846 3851 I-upper_bound
of 87 89 3852 3854 O
study 90 95 3855 3860 O
the 96 99 3861 3864 O
entry 100 105 3865 3870 O

Must 0 4 3871 3875 O
not 5 8 3876 3879 O
have 9 13 3880 3884 O
received 14 22 3885 3893 O
oral 23 27 3894 3898 B-treatment
tyrosine 28 36 3899 3907 I-treatment
kinase 37 43 3908 3914 I-treatment
inhibitors 44 54 3915 3925 I-treatment
( 55 56 3926 3927 O
other 56 61 3927 3932 O
than 62 66 3933 3937 O
dasatinib 67 76 3938 3947 B-treatment
) 76 77 3947 3948 O
or 78 80 3949 3951 O
other 81 86 3952 3957 O
similar 87 94 3958 3965 O
agents 95 101 3966 3972 O
within 102 108 3973 3979 O
3 109 110 3980 3981 B-upper_bound
weeks 111 116 3982 3987 I-upper_bound
of 117 119 3988 3990 O
the 120 123 3991 3994 O
study 124 129 3995 4000 O
entry 130 135 4001 4006 O
and 136 139 4007 4010 O
all 140 143 4011 4014 O
toxicities 144 154 4015 4025 B-clinical_variable
must 155 159 4026 4030 O
have 160 164 4031 4035 O
resolved 165 173 4036 4044 O
to 174 176 4045 4047 O
< 177 178 4048 4049 O
grade 179 184 4050 4055 B-upper_bound
2 185 186 4056 4057 I-upper_bound
prior 187 192 4058 4063 O
to 193 195 4064 4066 O
enrollment 196 206 4067 4077 O

Patients 0 8 4078 4086 O
must 9 13 4087 4091 O
have 14 18 4092 4096 O
had 19 22 4097 4100 O
a 23 24 4101 4102 O
previous 25 33 4103 4111 O
histological 34 46 4112 4124 O
verification 47 59 4125 4137 O
of 60 62 4138 4140 O
a 63 64 4141 4142 O
solid 65 70 4143 4148 B-cancer
tumor 71 76 4149 4154 I-cancer
at 77 79 4155 4157 O
the 80 83 4158 4161 O
original 84 92 4162 4170 O
diagnosis 93 102 4171 4180 O
and/or 103 109 4181 4187 O
recurrence 110 120 4188 4198 O
including 121 130 4199 4208 O
brain 131 136 4209 4214 B-cancer
tumors 137 143 4215 4221 I-cancer
; 143 144 4221 4222 O
for 145 148 4223 4226 O
patients 149 157 4227 4235 O
with 158 162 4236 4240 O
brain 163 168 4241 4246 B-cancer
stem 169 173 4247 4251 I-cancer
gliomas 174 181 4252 4259 I-cancer
and 182 185 4260 4263 O
optic 186 191 4264 4269 B-cancer
pathway 192 199 4270 4277 I-cancer
tumors 200 206 4278 4284 I-cancer
, 206 207 4284 4285 O
the 208 211 4286 4289 O
requirement 212 223 4290 4301 O
for 224 227 4302 4305 O
histological 228 240 4306 4318 O
evaluation 241 251 4319 4329 O
may 252 255 4330 4333 O
be 256 258 4334 4336 O
waived 259 265 4337 4343 O

Patients 0 8 4344 4352 O
must 9 13 4353 4357 O
not 14 17 4358 4361 O
have 18 22 4362 4366 O
received 23 31 4367 4375 O
prior 32 37 4376 4381 B-treatment
therapy 38 45 4382 4389 I-treatment
with 46 50 4390 4394 O
dasatinib 51 60 4395 4404 B-treatment
and 61 64 4405 4408 O
temsirolimus 65 77 4409 4421 B-treatment
for 78 81 4422 4425 O
any 82 85 4426 4429 O
indication 86 96 4430 4440 O

Patients 0 8 4441 4449 O
with 9 13 4450 4454 O
clinically 14 24 4455 4465 O
significant 25 36 4466 4477 O
cardiovascular 37 51 4478 4492 B-chronic_disease
disease 52 59 4493 4500 I-chronic_disease
: 59 60 4500 4501 O
history 61 68 4502 4509 O
of 69 71 4510 4512 O
ischemic 72 80 4513 4521 B-chronic_disease
or 81 83 4522 4524 O
hemorrhagic 84 95 4525 4536 B-chronic_disease
stroke 96 102 4537 4543 I-chronic_disease
within 103 109 4544 4550 O
past 110 114 4551 4555 B-upper_bound
6 115 116 4556 4557 I-upper_bound
months 117 123 4558 4564 I-upper_bound
; 123 124 4564 4565 O
uncontrolled 125 137 4566 4578 B-chronic_disease
hypertension 138 150 4579 4591 I-chronic_disease
, 150 151 4591 4592 O
on 152 154 4593 4595 O
at 155 157 4596 4598 O
least 158 163 4599 4604 O
2 164 165 4605 4606 B-lower_bound
repeated 166 174 4607 4615 O
determinations 175 189 4616 4630 O
on 190 192 4631 4633 O
separate 193 201 4634 4642 O
days 202 206 4643 4647 O
within 207 213 4648 4654 O
past 214 218 4655 4659 B-upper_bound
3 219 220 4660 4661 I-upper_bound
months 221 227 4662 4668 I-upper_bound
; 227 228 4668 4669 O
myocardial 229 239 4670 4680 B-chronic_disease
infarction 240 250 4681 4691 I-chronic_disease
or 251 253 4692 4694 O
unstable 254 262 4695 4703 B-chronic_disease
angina 263 269 4704 4710 I-chronic_disease
within 270 276 4711 4717 O
past 277 281 4718 4722 O
6 282 283 4723 4724 O
months 284 290 4725 4731 O
; 290 291 4731 4732 O
New 292 295 4733 4736 B-clinical_variable
York 296 300 4737 4741 I-clinical_variable
Heart 301 306 4742 4747 I-clinical_variable
Association 307 318 4748 4759 I-clinical_variable
grade 319 324 4760 4765 B-lower_bound
III 325 328 4766 4769 I-lower_bound
or 329 331 4770 4772 O
greater 332 339 4773 4780 O
congestive 340 350 4781 4791 B-chronic_disease
heart 351 356 4792 4797 I-chronic_disease
failure 357 364 4798 4805 I-chronic_disease
, 364 365 4805 4806 O
serious 366 373 4807 4814 O
cardiac 374 381 4815 4822 B-chronic_disease
arrhythmia 382 392 4823 4833 I-chronic_disease
requiring 393 402 4834 4843 O
medication 403 413 4844 4854 B-treatment
, 413 414 4854 4855 O
unstable 415 423 4856 4864 B-chronic_disease
angina 424 430 4865 4871 I-chronic_disease
pectoris 431 439 4872 4880 I-chronic_disease
within 440 446 4881 4887 O
past 447 451 4888 4892 O
6 452 453 4893 4894 O
months 454 460 4895 4901 O
; 460 461 4901 4902 O
clinically 462 472 4903 4913 O
significant 473 484 4914 4925 O
peripheral 485 495 4926 4936 B-chronic_disease
vascular 496 504 4937 4945 I-chronic_disease
disease 505 512 4946 4953 I-chronic_disease
within 513 519 4954 4960 O
past 520 524 4961 4965 O
6 525 526 4966 4967 O
months 527 533 4968 4974 O
; 533 534 4974 4975 O
pulmonary 535 544 4976 4985 B-chronic_disease
embolism 545 553 4986 4994 I-chronic_disease
, 553 554 4994 4995 O
deep 555 559 4996 5000 B-chronic_disease
vein 560 564 5001 5005 I-chronic_disease
thrombosis 565 575 5006 5016 I-chronic_disease
( 576 577 5017 5018 I-chronic_disease
DVT 577 580 5018 5021 I-chronic_disease
) 580 581 5021 5022 I-chronic_disease
, 581 582 5022 5023 O
or 583 585 5024 5026 O
other 586 591 5027 5032 O
thromboembolic 592 606 5033 5047 B-chronic_disease
event 607 612 5048 5053 I-chronic_disease
within 613 619 5054 5060 O
past 620 624 5061 5065 O
6 625 626 5066 5067 O
months 627 633 5068 5074 O
; 633 634 5074 5075 O
diagnosed 635 644 5076 5085 O
congenital 645 655 5086 5096 B-chronic_disease
long 656 660 5097 5101 I-chronic_disease
QT 661 663 5102 5104 I-chronic_disease
syndrome 664 672 5105 5113 I-chronic_disease
; 672 673 5113 5114 O
any 674 677 5115 5118 O
history 678 685 5119 5126 O
of 686 688 5127 5129 O
clinically 689 699 5130 5140 O
significant 700 711 5141 5152 O
ventricular 712 723 5153 5164 B-chronic_disease
arrhythmias 724 735 5165 5176 I-chronic_disease
( 736 737 5177 5178 O
such 737 741 5178 5182 O
as 742 744 5183 5185 O
ventricular 745 756 5186 5197 B-chronic_disease
tachycardia 757 768 5198 5209 I-chronic_disease
, 768 769 5209 5210 O
ventricular 770 781 5211 5222 B-chronic_disease
fibrillation 782 794 5223 5235 I-chronic_disease
, 794 795 5235 5236 O
or 796 798 5237 5239 O
torsades 799 807 5240 5248 B-chronic_disease
de 808 810 5249 5251 I-chronic_disease
pointes 811 818 5252 5259 I-chronic_disease
) 818 819 5259 5260 O
; 819 820 5260 5261 O
prolonged 821 830 5262 5271 B-clinical_variable
QTc 831 834 5272 5275 I-clinical_variable
interval 835 843 5276 5284 I-clinical_variable
on 844 846 5285 5287 O
pre 847 850 5288 5291 B-treatment
- 850 851 5291 5292 I-treatment
entry 851 856 5292 5297 I-treatment
electrocardiogram 857 874 5298 5315 I-treatment
( 875 876 5316 5317 O
> 876 877 5317 5318 O
450 878 881 5319 5322 B-lower_bound
msec 882 886 5323 5327 I-lower_bound
) 886 887 5327 5328 O

Patients 0 8 5329 5337 O
with 9 13 5338 5342 O
evidence 14 22 5343 5351 O
of 23 25 5352 5354 O
recent 26 32 5355 5361 O
intratumoral 33 45 5362 5374 B-chronic_disease
hemorrhage 46 56 5375 5385 I-chronic_disease
( 57 58 5386 5387 O
within 58 64 5387 5393 O
3 65 66 5394 5395 B-upper_bound
months 67 73 5396 5402 I-upper_bound
of 74 76 5403 5405 O
study 77 82 5406 5411 O
enrollment 83 93 5412 5422 O
) 93 94 5422 5423 O
, 94 95 5423 5424 O
gastrointestinal 96 112 5425 5441 B-chronic_disease
bleeding 113 121 5442 5450 I-chronic_disease
, 121 122 5450 5451 O
history 123 130 5452 5459 O
of 131 133 5460 5462 O
coronary 134 142 5463 5471 B-chronic_disease
artery 143 149 5472 5478 I-chronic_disease
disease 150 157 5479 5486 I-chronic_disease
or 158 160 5487 5489 O
on 161 163 5490 5492 O
anticoagulation 164 179 5493 5508 B-treatment
therapy 180 187 5509 5516 I-treatment

Patients 0 8 5517 5525 O
with 9 13 5526 5530 O
known 14 19 5531 5536 O
human 20 25 5537 5542 B-chronic_disease
immunodeficiency 26 42 5543 5559 I-chronic_disease
virus 43 48 5560 5565 I-chronic_disease
( 49 50 5566 5567 I-chronic_disease
HIV 50 53 5567 5570 I-chronic_disease
) 53 54 5570 5571 I-chronic_disease

Platelets 0 9 5572 5581 B-clinical_variable
greater 10 17 5582 5589 O
than 18 22 5590 5594 O
or 23 25 5595 5597 O
equal 26 31 5598 5603 O
to 32 34 5604 5606 O
75,000 35 41 5607 5613 B-lower_bound
/ 41 42 5613 5614 I-lower_bound
mm^3 42 46 5614 5618 I-lower_bound
( 47 48 5619 5620 O
transfusion 48 59 5620 5631 O
independent 60 71 5632 5643 O
; 71 72 5643 5644 O
no 73 75 5645 5647 O
transfusion 76 87 5648 5659 O
for 88 91 5660 5663 O
> 92 93 5664 5665 O
= 93 94 5665 5666 O
7 95 96 5667 5668 B-lower_bound
days 97 101 5669 5673 I-lower_bound
prior 102 107 5674 5679 I-lower_bound
to 108 110 5680 5682 O
study 111 116 5683 5688 O
enrollment 117 127 5689 5699 O
) 127 128 5699 5700 O

Pregnant 0 8 5701 5709 B-pregnancy

Quinidine 0 9 5710 5719 B-treatment
, 9 10 5719 5720 O
procainamide 11 23 5721 5733 B-treatment
, 23 24 5733 5734 O
disopyramide 25 37 5735 5747 B-treatment

Radiotherapy 0 12 5748 5760 B-treatment
( 13 14 5761 5762 I-treatment
XRT 14 17 5762 5765 I-treatment
): 17 19 5765 5767 I-treatment
at 20 22 5768 5770 O
least 23 28 5771 5776 O
4 29 30 5777 5778 B-lower_bound
weeks 31 36 5779 5784 I-lower_bound
for 37 40 5785 5788 O
focal 41 46 5789 5794 B-treatment
XRT 47 50 5795 5798 I-treatment
or 51 53 5799 5801 O
8 54 55 5802 5803 B-upper_bound
weeks 56 61 5804 5809 I-upper_bound
for 62 65 5810 5813 O
craniospinal 66 78 5814 5826 B-treatment
XRT 79 82 5827 5830 I-treatment
must 83 87 5831 5835 O
have 88 92 5836 5840 O
elapsed 93 100 5841 5848 O
prior 101 106 5849 5854 O
to 107 109 5855 5857 O
study 110 115 5858 5863 O
entry 116 121 5864 5869 O

Serum 0 5 5870 5875 B-clinical_variable
cholesterol 6 17 5876 5887 I-clinical_variable
and 18 21 5888 5891 O
serum 22 27 5892 5897 B-clinical_variable
triglyceride 28 40 5898 5910 I-clinical_variable
levels 41 47 5911 5917 I-clinical_variable
must 48 52 5918 5922 O
be 53 55 5923 5925 O
< 56 57 5926 5927 O
grade 58 63 5928 5933 B-upper_bound
2 64 65 5934 5935 I-upper_bound

Stem 0 4 5936 5940 B-treatment
cell 5 9 5941 5945 I-treatment
transplant 10 20 5946 5956 I-treatment
( 21 22 5957 5958 I-treatment
SCT 22 25 5958 5961 I-treatment
): 25 27 5961 5963 I-treatment
at 28 30 5964 5966 O
least 31 36 5967 5972 O
8 37 38 5973 5974 B-lower_bound
weeks 39 44 5975 5980 I-lower_bound
following 45 54 5981 5990 O
autologous 55 65 5991 6001 B-treatment
SCT 66 69 6002 6005 I-treatment
and 70 73 6006 6009 O
12 74 76 6010 6012 B-upper_bound
weeks 77 82 6013 6018 I-upper_bound
for 83 86 6019 6022 O
allogeneic 87 97 6023 6033 B-treatment
SCT 98 101 6034 6037 I-treatment

Surgery 0 7 6038 6045 B-treatment
: 7 8 6045 6046 O
at 9 11 6047 6049 O
least 12 17 6050 6055 O
2 18 19 6056 6057 B-lower_bound
weeks 20 25 6058 6063 I-lower_bound
following 26 35 6064 6073 O
surgery 36 43 6074 6081 B-treatment
including 44 53 6082 6091 O
brain 54 59 6092 6097 O
and 60 63 6098 6101 O
spine 64 69 6102 6107 O
provided 70 78 6108 6116 O
post 79 83 6117 6121 O
- 83 84 6121 6122 O
operative 84 93 6122 6131 O
magnetic 94 102 6132 6140 B-treatment
resonance 103 112 6141 6150 I-treatment
imaging 113 120 6151 6158 I-treatment
( 121 122 6159 6160 I-treatment
MRI 122 125 6160 6163 I-treatment
) 125 126 6163 6164 I-treatment
shows 127 132 6165 6170 O
no 133 135 6171 6173 O
active 136 142 6174 6180 O
bleeding 143 151 6181 6189 O

The 0 3 6190 6193 O
patient 4 11 6194 6201 O
must 12 16 6202 6206 O
have 17 21 6207 6211 O
a 22 23 6212 6213 O
stable 24 30 6214 6220 O
clinical 31 39 6221 6229 O
( 40 41 6230 6231 O
neurologic 41 51 6231 6241 O
in 52 54 6242 6244 O
case 55 59 6245 6249 O
of 60 62 6250 6252 O
brain 63 68 6253 6258 B-cancer
tumors 69 75 6259 6265 I-cancer
) 75 76 6265 6266 O
exam 77 81 6267 6271 O
and 82 85 6272 6275 O
be 86 88 6276 6278 O
on 89 91 6279 6281 O
a 92 93 6282 6283 O
stable 94 100 6284 6290 O
dose 101 105 6291 6295 O
of 106 108 6296 6298 O
steroids 109 117 6299 6307 O
for 118 121 6308 6311 O
at 122 124 6312 6314 O
least 125 130 6315 6320 O
1 131 132 6321 6322 B-lower_bound
week 133 137 6323 6327 I-lower_bound
prior 138 143 6328 6333 I-lower_bound
to 144 146 6334 6336 O
study 147 152 6337 6342 O
entry 153 158 6343 6348 O
; 158 159 6348 6349 O
the 160 163 6350 6353 O
patient 164 171 6354 6361 O
should 172 178 6362 6368 O
have 179 183 6369 6373 O
a 184 185 6374 6375 O
measurable 186 196 6376 6386 O
and/or 197 203 6387 6393 O
evaluable 204 213 6394 6403 O
disease 214 221 6404 6411 O
; 221 222 6411 6412 O
measurable 223 233 6413 6423 O
disease 234 241 6424 6431 O
which 242 247 6432 6437 O
is 248 250 6438 6440 O
defined 251 258 6441 6448 O
as 259 261 6449 6451 O
the 262 265 6452 6455 O
presence 266 274 6456 6464 O
of 275 277 6465 6467 O
at 278 280 6468 6470 O
least 281 286 6471 6476 O
one 287 290 6477 6480 B-lower_bound
lesion 291 297 6481 6487 O
that 298 302 6488 6492 O
can 303 306 6493 6496 O
be 307 309 6497 6499 O
accurately 310 320 6500 6510 O
measured 321 329 6511 6519 O
in 330 332 6520 6522 O
two 333 336 6523 6526 O
dimensions 337 347 6527 6537 O
( 348 349 6538 6539 O
each 349 353 6539 6543 O
measures 354 362 6544 6552 O
at 363 365 6553 6555 O
least 366 371 6556 6561 O
10 372 374 6562 6564 B-lower_bound
mm 375 377 6565 6567 I-lower_bound
) 377 378 6567 6568 O
or 379 381 6569 6571 O
evaluable 382 391 6572 6581 O
disease 392 399 6582 6589 O
which 400 405 6590 6595 O
is 406 408 6596 6598 O
defined 409 416 6599 6606 O
as 417 419 6607 6609 O
at 420 422 6610 6612 O
least 423 428 6613 6618 O
one 429 432 6619 6622 O
lesion 433 439 6623 6629 O
that 440 444 6630 6634 O
can 445 448 6635 6638 O
be 449 451 6639 6641 O
accurately 452 462 6642 6652 O
measured 463 471 6653 6661 O
in 472 474 6662 6664 O
at 475 477 6665 6667 O
least 478 483 6668 6673 O
one 484 487 6674 6677 O
dimension 488 497 6678 6687 O
( 498 499 6688 6689 O
measure 499 506 6689 6696 O
at 507 509 6697 6699 O
least 510 515 6700 6705 O
10 516 518 6706 6708 O
mm 519 521 6709 6711 O
) 521 522 6711 6712 O

Uncontrolled 0 12 6713 6725 O
current 13 20 6726 6733 O
illness 21 28 6734 6741 O
including 29 38 6742 6751 O
, 38 39 6751 6752 O
but 40 43 6753 6756 O
not 44 47 6757 6760 O
limited 48 55 6761 6768 O
to 56 58 6769 6771 O
, 58 59 6771 6772 O
uncontrolled 60 72 6773 6785 B-chronic_disease
infection 73 82 6786 6795 I-chronic_disease
, 82 83 6795 6796 O
need 84 88 6797 6801 O
for 89 92 6802 6805 O
hemodialysis 93 105 6806 6818 B-treatment
, 105 106 6818 6819 O
need 107 111 6820 6824 O
for 112 115 6825 6828 O
ventilatory 116 127 6829 6840 B-treatment
support 128 135 6841 6848 I-treatment
, 135 136 6848 6849 O
psychiatric 137 148 6850 6861 B-chronic_disease
illness 149 156 6862 6869 I-chronic_disease
/ 156 157 6869 6870 O
social 157 163 6870 6876 O
situations 164 174 6877 6887 O
that 175 179 6888 6892 O
would 180 185 6893 6898 O
limit 186 191 6899 6904 O
compliance 192 202 6905 6915 O
with 203 207 6916 6920 O
study 208 213 6921 6926 O
requirements 214 226 6927 6939 O

at 0 2 6940 6942 O
least 3 8 6943 6948 O
3 9 10 6949 6950 B-lower_bound
weeks 11 16 6951 6956 I-lower_bound
must 17 21 6957 6961 O
have 22 26 6962 6966 O
elapsed 27 34 6967 6974 O
from 35 39 6975 6979 O
the 40 43 6980 6983 O
last 44 48 6984 6988 O
dose 49 53 6989 6993 O

breast 0 6 6994 7000 O
- 6 7 7000 7001 O
feeding 7 14 7001 7008 O
women 15 20 7009 7014 B-gender

patients 0 8 7015 7023 O
are 9 12 7024 7027 O
not 13 16 7028 7031 O
allowed 17 24 7032 7039 O
to 25 27 7040 7042 O
take 28 32 7043 7047 O
aspirin 33 40 7048 7055 B-treatment
, 40 41 7055 7056 O
clopidogrel 42 53 7057 7068 B-treatment
, 53 54 7068 7069 O
ticlopidine 55 66 7070 7081 B-treatment
, 66 67 7081 7082 O
Aggrenox 68 76 7083 7091 B-treatment
; 76 77 7091 7092 O
patients 78 86 7093 7101 O
on 87 89 7102 7104 O
prophylactic 90 102 7105 7117 B-treatment
anticoagulation 103 118 7118 7133 I-treatment
may 119 122 7134 7137 O
be 123 125 7138 7140 O
enrolled 126 134 7141 7149 O
and 135 138 7150 7153 O
treated 139 146 7154 7161 O
on 147 149 7162 7164 O
study 150 155 7165 7170 O
as 156 158 7171 7173 O
long 159 163 7174 7178 O
as 164 166 7179 7181 O
their 167 172 7182 7187 O
platelet 173 181 7188 7196 B-clinical_variable
count 182 187 7197 7202 I-clinical_variable
is 188 190 7203 7205 O
monitored 191 200 7206 7215 O
closely 201 208 7216 7223 O
and 209 212 7224 7227 O
maintained 213 223 7228 7238 O
at 224 226 7239 7241 O
> 227 228 7242 7243 O
75,000 229 235 7244 7250 B-lower_bound
while 236 241 7251 7256 O
they 242 246 7257 7261 O
are 247 250 7262 7265 O
receiving 251 260 7266 7275 O
dasatinib 261 270 7276 7285 B-treatment

patients 0 8 7286 7294 O
must 9 13 7295 7299 O
not 14 17 7300 7303 O
be 18 20 7304 7306 O
receiving 21 30 7307 7316 O
any 31 34 7317 7320 O
anti 35 39 7321 7325 B-treatment
- 39 40 7325 7326 I-treatment
thrombotic 40 50 7326 7336 I-treatment
or 51 53 7337 7339 O
anti 54 58 7340 7344 B-treatment
- 58 59 7344 7345 I-treatment
platelet 59 67 7345 7353 I-treatment
agents 68 74 7354 7360 I-treatment
; 74 75 7360 7361 O
patient 76 83 7362 7369 O
can 84 87 7370 7373 O
not 87 90 7373 7376 O
be 91 93 7377 7379 O
on 94 96 7380 7382 O
drugs 97 102 7383 7388 O
that 103 107 7389 7393 O
cause 108 113 7394 7399 O
significant 114 125 7400 7411 O
prolonged 126 135 7412 7421 B-chronic_disease
QT 136 138 7422 7424 I-chronic_disease
( 139 140 7425 7426 O
category 140 148 7426 7434 O
I 149 150 7435 7436 O
drug 151 155 7437 7441 O
) 155 156 7441 7442 O

prior 0 5 7443 7448 B-treatment
treatment 6 15 7449 7458 I-treatment
with 16 20 7459 7463 O
either 21 27 7464 7470 O
dasatinib 28 37 7471 7480 B-treatment
or 38 40 7481 7483 O
temsirolimus 41 53 7484 7496 B-treatment

the 0 3 7497 7500 O
patient 4 11 7501 7508 O
's 11 13 7508 7510 O
disease 14 21 7511 7518 O
must 22 26 7519 7523 O
be 27 29 7524 7526 O
considered 30 40 7527 7537 O
refractory 41 51 7538 7548 O
to 52 54 7549 7551 O
conventional 55 67 7552 7564 B-treatment
/ 67 68 7564 7565 I-treatment
standard 68 76 7565 7573 I-treatment
therapy 77 84 7574 7581 I-treatment
, 84 85 7581 7582 O
or 86 88 7583 7585 O
a 89 90 7586 7587 O
disease 91 98 7588 7595 O
for 99 102 7596 7599 O
which 103 108 7600 7605 O
no 109 111 7606 7608 O
conventional 112 124 7609 7621 B-treatment
therapy 125 132 7622 7629 I-treatment
exists 133 139 7630 7636 O
and 140 143 7637 7640 O
is 144 146 7641 7643 O
progressive 147 158 7644 7655 O

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound
at 15 17 15 17 O
the 18 21 18 21 O
time 22 26 22 26 O
of 27 29 27 29 O
consent 30 37 30 37 O

Because 0 7 38 45 O
there 8 13 46 51 O
is 14 16 52 54 O
an 17 19 55 57 O
unknown 20 27 58 65 O
but 28 31 66 69 O
potential 32 41 70 79 O
risk 42 46 80 84 O
for 47 50 85 88 O
adverse 51 58 89 96 O
events 59 65 97 103 O
in 66 68 104 106 O
nursing 69 76 107 114 O
infants 77 84 115 122 O
secondary 85 94 123 132 O
to 95 97 133 135 O
treatment 98 107 136 145 B-treatment
of 108 110 146 148 O
the 111 114 149 152 O
mother 115 121 153 159 O
, 121 122 159 160 O
breastfeeding 123 136 161 174 O
should 137 143 175 181 O
be 144 146 182 184 O
discontinued 147 159 185 197 O

Evidence 0 8 198 206 O
of 9 11 207 209 O
active 12 18 210 216 O
autoimmune 19 29 217 227 B-chronic_disease
disease 30 37 228 235 I-chronic_disease
requiring 38 47 236 245 O
systemic 48 56 246 254 B-treatment
treatment 57 66 255 264 I-treatment
within 67 73 265 271 O
preceding 74 83 272 281 B-upper_bound
3 84 85 282 283 I-upper_bound
months 86 92 284 290 I-upper_bound
or 93 95 291 293 O
a 96 97 294 295 O
documented 98 108 296 306 O
history 109 116 307 314 O
of 117 119 315 317 O
clinically 120 130 318 328 O
severe 131 137 329 335 O
autoimmune 138 148 336 346 O
disease 149 156 347 354 O
, 156 157 354 355 O
or 158 160 356 358 O
a 161 162 359 360 O
syndrome 163 171 361 369 O
that 172 176 370 374 O
requires 177 185 375 383 O
systemic 186 194 384 392 B-treatment
steroids 195 203 393 401 I-treatment
or 204 206 402 404 O
immunosuppressive 207 224 405 422 B-treatment
agents 225 231 423 429 I-treatment

Females 0 7 430 437 B-gender
of 8 10 438 440 O
childbearing 11 23 441 453 O
potential 24 33 454 463 O
and 34 37 464 467 O
males 38 43 468 473 O
must 44 48 474 478 O
be 49 51 479 481 O
willing 52 59 482 489 O
to 60 62 490 492 O
use 63 66 493 496 O
an 67 69 497 499 O
effective 70 79 500 509 O
method 80 86 510 516 O
of 87 89 517 519 O
contraception 90 103 520 533 B-contraception_consent
( 104 105 534 535 I-contraception_consent
hormonal 105 113 535 543 I-contraception_consent
or 114 116 544 546 I-contraception_consent
barrier 117 124 547 554 I-contraception_consent
method 125 131 555 561 I-contraception_consent
of 132 134 562 564 I-contraception_consent
birth 135 140 565 570 I-contraception_consent
control 141 148 571 578 I-contraception_consent
; 148 149 578 579 I-contraception_consent
abstinence 150 160 580 590 I-contraception_consent
) 160 161 590 591 I-contraception_consent
from 162 166 592 596 O
the 167 170 597 600 O
time 171 175 601 605 O
consent 176 183 606 613 O
is 184 186 614 616 O
signed 187 193 617 623 O
until 194 199 624 629 O
12 200 202 630 632 B-upper_bound
weeks 203 208 633 638 I-upper_bound
after 209 214 639 644 O
treatment 215 224 645 654 B-treatment
discontinuation 225 240 655 670 O

Females 0 7 671 678 B-gender
of 8 10 679 681 O
childbearing 11 23 682 694 O
potential 24 33 695 704 O
must 34 38 705 709 O
have 39 43 710 714 O
a 44 45 715 716 O
negative 46 54 717 725 B-pregnancy
serum 55 60 726 731 I-pregnancy
pregnancy 61 70 732 741 I-pregnancy
test 71 75 742 746 O
within 76 82 747 753 O
14 83 85 754 756 B-upper_bound
days 86 90 757 761 I-upper_bound
prior 91 96 762 767 I-upper_bound
to 97 99 768 770 I-upper_bound
registration 100 112 771 783 O
for 113 116 784 787 O
protocol 117 125 788 796 B-treatment
therapy 126 133 797 804 I-treatment

Gleason 0 7 805 812 B-clinical_variable
score 8 13 813 818 I-clinical_variable
≤ 14 15 819 820 O
7 16 17 821 822 B-upper_bound
prostate 18 26 823 831 B-cancer
cancers 27 34 832 839 I-cancer

History 0 7 840 847 O
of 8 10 848 850 O
allogeneic 11 21 851 861 B-treatment
organ 22 27 862 867 I-treatment
or 28 30 868 870 I-treatment
stem 31 35 871 875 I-treatment
cell 36 40 876 880 I-treatment
transplant 41 51 881 891 I-treatment

History 0 7 892 899 O
of 8 10 900 902 O
hypersensitivity 11 27 903 919 O
to 28 30 920 922 O
durvalumab 31 41 923 933 B-allergy_name
or 42 44 934 936 O
any 45 48 937 940 O
excipient 49 58 941 950 O

History 0 7 951 958 O
of 8 10 959 961 O
psychiatric 11 22 962 973 B-chronic_disease
illness 23 30 974 981 I-chronic_disease
/ 30 31 981 982 I-chronic_disease
social 31 37 982 988 I-chronic_disease
situations 38 48 989 999 I-chronic_disease
that 49 53 1000 1004 O
would 54 59 1005 1010 O
limit 60 65 1011 1016 O
compliance 66 76 1017 1027 O
with 77 81 1028 1032 O
study 82 87 1033 1038 O
requirements 88 100 1039 1051 O
or 101 103 1052 1054 O
compromise 104 114 1055 1065 O
the 115 118 1066 1069 O
ability 119 126 1070 1077 O
of 127 129 1078 1080 O
the 130 133 1081 1084 O
subject 134 141 1085 1092 O
to 142 144 1093 1095 O
give 145 149 1096 1100 O
written 150 157 1101 1108 O
informed 158 166 1109 1117 O
consent 167 174 1118 1125 O

Known 0 5 1126 1131 O
history 6 13 1132 1139 O
of 14 16 1140 1142 O
previous 17 25 1143 1151 O
clinical 26 34 1152 1160 O
diagnosis 35 44 1161 1170 O
of 45 47 1171 1173 O
tuberculosis 48 60 1174 1186 B-chronic_disease

Mean 0 4 1187 1191 O
QT 5 7 1192 1194 O
interval 8 16 1195 1203 B-clinical_variable
corrected 17 26 1204 1213 I-clinical_variable
for 27 30 1214 1217 I-clinical_variable
heart 31 36 1218 1223 I-clinical_variable
rate 37 41 1224 1228 I-clinical_variable
( 42 43 1229 1230 I-clinical_variable
QTc 43 46 1230 1233 I-clinical_variable
) 46 47 1233 1234 I-clinical_variable
> 48 49 1235 1236 O
470 50 53 1237 1240 B-lower_bound
msec 54 58 1241 1245 I-lower_bound
calculated 59 69 1246 1256 O
from 70 74 1257 1261 O
3 75 76 1262 1263 O
ECGs 77 81 1264 1268 O
by 82 84 1269 1271 O
Bazett 85 91 1272 1278 O
's 91 93 1278 1280 O
Correction 94 104 1281 1291 O

Moderate 0 8 1292 1300 O
response 9 17 1301 1309 O
( 18 19 1310 1311 O
Grade 19 24 1311 1316 O
2 25 26 1317 1318 O
, 26 27 1318 1319 O
10 28 30 1320 1322 B-lower_bound
- 30 31 1322 1323 O
50 31 33 1323 1325 B-upper_bound
% 33 34 1325 1326 I-upper_bound
residual 35 43 1327 1335 B-clinical_variable
tumor 44 49 1336 1341 I-clinical_variable
) 49 50 1341 1342 O

No 0 2 1343 1345 O
definite 3 11 1346 1354 O
response 12 20 1355 1363 O
( 21 22 1364 1365 O
Grade 22 27 1365 1370 O
3 28 29 1371 1372 O
, 29 30 1372 1373 O
> 31 32 1374 1375 O
50 32 34 1375 1377 B-lower_bound
% 34 35 1377 1378 I-lower_bound
residual 36 44 1379 1387 O
tumor 45 50 1388 1393 B-cancer
) 50 51 1393 1394 O

No 0 2 1395 1397 O
residual 3 11 1398 1406 B-cancer
tumor 12 17 1407 1412 I-cancer
( 18 19 1413 1414 O
Grade 19 24 1414 1419 O
0 25 26 1420 1421 O
, 26 27 1421 1422 O
complete 28 36 1423 1431 O
response 37 45 1432 1440 O
, 45 46 1440 1441 O
0 47 48 1442 1443 O
% 48 49 1443 1444 O
tumor 50 55 1445 1450 O
) 55 56 1450 1451 O

Patients 0 8 1452 1460 O
receiving 9 18 1461 1470 O
chronic 19 26 1471 1478 B-treatment
systemic 27 35 1479 1487 I-treatment
corticosteroid 36 50 1488 1502 I-treatment
therapy 51 58 1503 1510 I-treatment
or 59 61 1511 1513 O
other 62 67 1514 1519 O
immunosuppressive 68 85 1520 1537 B-treatment
therapy 86 93 1538 1545 I-treatment
within 94 100 1546 1552 O
28 101 103 1553 1555 B-upper_bound
days 104 108 1556 1560 I-upper_bound
prior 109 114 1561 1566 I-upper_bound
to 115 117 1567 1569 O
registration 118 130 1570 1582 O
for 131 134 1583 1586 O
protocol 135 143 1587 1595 O
therapy 144 151 1596 1603 O

Patients 0 8 1604 1612 O
with 9 13 1613 1617 O
diagnosis 14 23 1618 1627 O
of 24 26 1628 1630 O
primary 27 34 1631 1638 B-chronic_disease
immunodeficiency 35 51 1639 1655 I-chronic_disease

Presence 0 8 1656 1664 O
of 9 11 1665 1667 O
interstitial 12 24 1668 1680 B-chronic_disease
lung 25 29 1681 1685 I-chronic_disease
disease 30 37 1686 1693 I-chronic_disease
or 38 40 1694 1696 O
history 41 48 1697 1704 O
of 49 51 1705 1707 O
pneumonitis 52 63 1708 1719 B-chronic_disease
requiring 64 73 1720 1729 O
treatment 74 83 1730 1739 O
with 84 88 1740 1744 O
corticosteroids 89 104 1745 1760 B-treatment

Prior 0 5 1761 1766 B-treatment
therapy 6 13 1767 1774 I-treatment
with 14 18 1775 1779 O
a 19 20 1780 1781 O
PD-1 21 25 1782 1786 B-treatment
, 25 26 1786 1787 O
PD 27 29 1788 1790 B-treatment
- 29 30 1790 1791 I-treatment
L1 30 32 1791 1793 I-treatment
, 32 33 1793 1794 O
or 34 36 1795 1797 O
CTLA-4 37 43 1798 1804 B-treatment
inhibitor 44 53 1805 1814 I-treatment
or 54 56 1815 1817 O
cancer 57 63 1818 1824 B-treatment
- 63 64 1824 1825 I-treatment
specific 64 72 1825 1833 I-treatment
vaccine 73 80 1834 1841 I-treatment
therapy 81 88 1842 1849 I-treatment

Receipt 0 7 1850 1857 O
of 8 10 1858 1860 O
live 11 15 1861 1865 O
attenuated 16 26 1866 1876 B-treatment
vaccine 27 34 1877 1884 I-treatment
within 35 41 1885 1891 O
30 42 44 1892 1894 B-upper_bound
days 45 49 1895 1899 I-upper_bound
prior 50 55 1900 1905 I-upper_bound
to 56 58 1906 1908 O
registration 59 71 1909 1921 O
for 72 75 1922 1925 O
protocol 76 84 1926 1934 O
therapy 85 92 1935 1942 B-treatment

Ventricular 0 11 1943 1954 B-chronic_disease
arrhythmias 12 23 1955 1966 I-chronic_disease
requiring 24 33 1967 1976 O
medication(s 34 46 1977 1989 O
) 46 47 1989 1990 O

adequately 0 10 1991 2001 O
treated 11 18 2002 2009 O
basal 19 24 2010 2015 B-cancer
cell 25 29 2016 2020 I-cancer
or 30 32 2021 2023 I-cancer
squamous 33 41 2024 2032 I-cancer
cell 42 46 2033 2037 I-cancer
skin 47 51 2038 2042 I-cancer
cancer 52 58 2043 2049 I-cancer

in 0 2 2050 2052 O
situ 3 7 2053 2057 B-cancer
cervical 8 16 2058 2066 I-cancer
cancer 17 23 2067 2073 I-cancer

intranasal 0 10 2074 2084 B-treatment
and 11 14 2085 2088 I-treatment
inhaled 15 22 2089 2096 I-treatment
corticosteroids 23 38 2097 2112 I-treatment
or 39 41 2113 2115 O
systemic 42 50 2116 2124 B-treatment
corticosteroids 51 66 2125 2140 I-treatment
at 67 69 2141 2143 O
physiological 70 83 2144 2157 O
doses 84 89 2158 2163 O
, 89 90 2163 2164 O
which 91 96 2165 2170 O
are 97 100 2171 2174 O
not 101 104 2175 2178 O
to 105 107 2179 2181 O
exceed 108 114 2182 2188 O
10 115 117 2189 2191 B-upper_bound
mg 118 120 2192 2194 I-upper_bound
/ 120 121 2194 2195 I-upper_bound
day 121 124 2195 2198 I-upper_bound
of 125 127 2199 2201 O
prednisone 128 138 2202 2212 B-treatment
, 138 139 2212 2213 O
or 140 142 2214 2216 O
an 143 145 2217 2219 O
equivalent 146 156 2220 2230 O
corticosteroid 157 171 2231 2245 O

other 0 5 2246 2251 O
cancer 6 12 2252 2258 B-cancer
for 13 16 2259 2262 O
which 17 22 2263 2268 O
the 23 26 2269 2272 O
subject 27 34 2273 2280 O
has 35 38 2281 2284 O
been 39 43 2285 2289 O
disease 44 51 2290 2297 O
- 51 52 2297 2298 O
free 52 56 2298 2302 O
for 57 60 2303 2306 O
at 61 63 2307 2309 O
least 64 69 2310 2315 O
3 70 71 2316 2317 B-lower_bound
years 72 77 2318 2323 I-lower_bound

vitiligo 0 8 2324 2332 B-chronic_disease
, 8 9 2332 2333 O
resolved 10 18 2334 2342 O
childhood 19 28 2343 2352 O
asthma 29 35 2353 2359 B-chronic_disease
/ 35 36 2359 2360 O
atopy 36 41 2360 2365 B-chronic_disease
, 41 42 2365 2366 O
requirement 43 54 2367 2378 O
of 55 57 2379 2381 O
intermittent 58 70 2382 2394 B-treatment
bronchodilators 71 86 2395 2410 I-treatment
or 87 89 2411 2413 O
local 90 95 2414 2419 B-treatment
steroid 96 103 2420 2427 I-treatment
injections 104 114 2428 2438 I-treatment
, 114 115 2438 2439 O
hypothyroidism 116 130 2440 2454 B-chronic_disease
stable 131 137 2455 2461 O
on 138 140 2462 2464 O
hormone 141 148 2465 2472 O
replacement 149 160 2473 2484 O
, 160 161 2484 2485 O
psoriasis 162 171 2486 2495 B-chronic_disease
not 172 175 2496 2499 O
requiring 176 185 2500 2509 O
systemic 186 194 2510 2518 O
treatment 195 204 2519 2528 O
( 205 206 2529 2530 O
within 206 212 2530 2536 O
the 213 216 2537 2540 O
past 217 221 2541 2545 B-upper_bound
2 222 223 2546 2547 I-upper_bound
years 224 229 2548 2553 I-upper_bound
) 229 230 2553 2554 O
, 230 231 2554 2555 O
Graves 232 238 2556 2562 B-chronic_disease
's 238 240 2562 2564 I-chronic_disease
disease 241 248 2565 2572 I-chronic_disease
and 249 252 2573 2576 O
Sjogren 253 260 2577 2584 B-chronic_disease
's 260 262 2584 2586 I-chronic_disease
syndrome 263 271 2587 2595 I-chronic_disease

Allergy 0 7 0 7 O
to 8 10 8 10 O
lactose 11 18 11 18 B-allergy_name

History 0 7 19 26 O
of 8 10 27 29 O
orthostatic 11 22 30 41 B-chronic_disease
hypotension 23 34 42 53 I-chronic_disease
or 35 37 54 56 O
current 38 45 57 64 O
orthostatic 46 57 65 76 O
hypotension 58 69 77 88 O

History 0 7 89 96 O
of 8 10 97 99 O
spinal 11 17 100 106 B-chronic_disease
trauma 18 24 107 113 I-chronic_disease
, 24 25 113 114 O
spinal 26 32 115 121 B-chronic_disease
infection 33 42 122 131 I-chronic_disease
or 43 45 132 134 O
spinal 46 52 135 141 B-cancer
cord 53 57 142 146 I-cancer
tumor 58 63 147 152 I-cancer

Male 0 4 153 157 B-gender
patient 5 12 158 165 I-gender

Renal 0 5 166 171 B-chronic_disease
failure 6 13 172 179 I-chronic_disease

Serious 0 7 180 187 O
or 8 10 188 190 O
life 11 15 191 195 O
- 15 16 195 196 O
threatening 16 27 196 207 O
allergy 28 35 208 215 O
to 36 38 216 218 O
sulfa 39 44 219 224 B-allergy_name
drugs 45 50 225 230 I-allergy_name

Undergoing 0 10 231 241 O
elective 11 19 242 250 B-treatment
spine 20 25 251 256 I-treatment
surgery 26 33 257 264 I-treatment
at 34 36 265 267 O
least 37 42 268 273 O
5 43 44 274 275 B-lower_bound
days 45 49 276 280 I-lower_bound
after 50 55 281 286 O
enrollment 56 66 287 297 O

age 0 3 298 301 B-age
50 4 6 302 304 B-lower_bound
- 7 8 305 306 O
85 9 11 307 309 B-upper_bound
years 12 17 310 315 I-upper_bound

Listed 0 6 0 6 O
for 7 10 7 10 O
or 11 13 11 13 O
recent 14 20 14 20 O
( 21 22 21 22 O
within 22 28 22 28 O
1 29 30 29 30 B-upper_bound
month 31 36 31 36 I-upper_bound
) 36 37 36 37 O
recipient 38 47 38 47 O
of 48 50 48 50 O
deceased 51 59 51 59 O
or 60 62 60 62 O
living 63 69 63 69 O
donor 70 75 70 75 O
liver 76 81 76 81 O
transplantation 82 97 82 97 O

≥ 0 1 98 99 O
18 2 4 100 102 B-lower_bound
years 5 10 103 108 I-lower_bound
of 11 13 109 111 O
age 14 17 112 115 B-age

< 0 1 0 1 O
1000 1 5 1 5 B-upper_bound
microns 6 13 6 13 I-upper_bound
as 14 16 14 16 O
determined 17 27 17 27 O
by 28 30 28 30 O
angiography 31 42 31 42 O

A 0 1 43 44 O
change 2 8 45 51 O
in 9 11 52 54 O
anti 12 16 55 59 B-treatment
- 16 17 59 60 I-treatment
VEGF 17 21 60 64 I-treatment
agent 22 27 65 70 I-treatment
in 28 30 71 73 O
the 31 34 74 77 O
previous 35 43 78 86 O
two 44 47 87 90 O
administrations 48 63 91 106 O

Active 0 6 107 113 B-chronic_disease
ocular 7 13 114 120 I-chronic_disease
or 14 16 121 123 I-chronic_disease
periocular 17 27 124 134 I-chronic_disease
infection 28 37 135 144 I-chronic_disease
or 38 40 145 147 O
intraocular 41 52 148 159 B-chronic_disease
inflammation 53 65 160 172 I-chronic_disease

Anticipate 0 10 173 183 O
a 11 12 184 185 O
change 13 19 186 192 O
to 20 22 193 195 O
the 23 26 196 199 O
anti 27 31 200 204 B-treatment
- 31 32 204 205 I-treatment
VEGF 32 36 205 209 I-treatment
agent 37 42 210 215 I-treatment
during 43 49 216 222 O
the 50 53 223 226 O
conduct 54 61 227 234 O
of 62 64 235 237 O
the 65 68 238 241 O
study 69 74 242 247 O

BCVA 0 4 248 252 B-clinical_variable
20/63 5 10 253 258 O

Diagnosis 0 9 259 268 O
of 10 12 269 271 O
active 13 19 272 278 B-chronic_disease
CNV 20 23 279 282 I-chronic_disease

Fellow 0 6 283 289 O
eye 7 10 290 293 O
with 11 15 294 298 O
a 16 17 299 300 O
BCVA 18 22 301 305 B-clinical_variable
of 23 25 306 308 O
20/63 26 31 309 314 B-lower_bound
Snellen 32 39 315 322 I-lower_bound
Equivalent 40 50 323 333 I-lower_bound
or 51 53 334 336 O
worse 54 59 337 342 O
, 59 60 342 343 O
with 61 65 344 348 O
advanced 66 74 349 357 O
AMD 75 78 358 361 B-chronic_disease
( 79 80 362 363 O
neovascular 80 91 363 374 B-chronic_disease
or 92 94 375 377 I-chronic_disease
non 95 98 378 381 I-chronic_disease
- 98 99 381 382 I-chronic_disease
exudative 99 108 382 391 I-chronic_disease
AMD 109 112 392 395 I-chronic_disease
with 113 117 396 400 O
foveal 118 124 401 407 O
geographic 125 135 408 418 B-chronic_disease
atrophy 136 143 419 426 I-chronic_disease
) 143 144 426 427 O

Neovascularization 0 18 428 446 B-chronic_disease
other 19 24 447 452 O
than 25 29 453 457 O
due 30 33 458 461 O
to 34 36 462 464 O
AMD 37 40 465 468 B-chronic_disease

Patient 0 7 469 476 O
unsuitable 8 18 477 487 O
for 19 22 488 491 O
IV 23 25 492 494 O
or 26 28 495 497 O
local 29 34 498 503 B-treatment
anesthesia 35 45 504 514 I-treatment

Poor 0 4 515 519 O
or 5 7 520 522 O
non 8 11 523 526 O
- 11 12 526 527 O
responsive 12 22 527 537 O
to 23 25 538 540 O
FDA 26 29 541 544 O
approved 30 38 545 553 O
intravitreal 39 51 554 566 B-treatment
anti 52 56 567 571 I-treatment
- 56 57 571 572 I-treatment
VEGF 57 61 572 576 I-treatment
therapy 62 69 577 584 I-treatment
for 70 73 585 588 O
nAMD 74 78 589 593 B-chronic_disease

Sub 0 3 594 597 B-clinical_variable
- 3 4 597 598 I-clinical_variable
foveal 4 10 598 604 I-clinical_variable
lesion 11 17 605 611 I-clinical_variable
hemorrhage 18 28 612 622 I-clinical_variable
obscuring 29 38 623 632 I-clinical_variable
> 39 40 633 634 O
50 40 42 634 636 B-lower_bound
% 42 43 636 637 I-lower_bound
of 44 46 638 640 O
lesion 47 53 641 647 O

Uncontrolled 0 12 648 660 O
systemic 13 21 661 669 B-chronic_disease
diseases 22 30 670 678 I-chronic_disease
( 31 32 679 680 O
e.g. 32 36 680 684 O
controlled 37 47 685 695 B-chronic_disease
hypertension 48 60 696 708 I-chronic_disease
is 61 63 709 711 O
acceptable 64 74 712 722 O
) 74 75 722 723 O

axial 0 5 724 729 B-clinical_variable
length 6 12 730 736 I-clinical_variable
of 13 15 737 739 O
> 16 17 740 741 O
26.5 17 21 741 745 B-lower_bound
mm 21 23 745 747 I-lower_bound

demonstrated 0 12 748 760 O
myopic 13 19 761 767 B-chronic_disease
degeneration 20 32 768 780 I-chronic_disease

increase 0 8 781 789 O
the 9 12 790 793 O
risk 13 17 794 798 O
of 18 20 799 801 O
structural 21 31 802 812 O
damage 32 38 813 819 O
from 39 43 820 824 O
retrobulbar 44 55 825 836 B-treatment
anesthesia 56 66 837 847 I-treatment
, 66 67 847 848 O
sub 68 71 849 852 B-treatment
- 71 72 852 853 I-treatment
Tenon 72 77 853 858 I-treatment
's 77 79 858 860 I-treatment
anesthesia 80 90 861 871 I-treatment
, 90 91 871 872 O
or 92 94 873 875 O
retrobulbar 95 106 876 887 B-treatment
device 107 113 888 894 I-treatment
positioning 114 125 895 906 I-treatment

other 0 5 907 912 O
co 6 8 913 915 O
- 8 9 915 916 O
morbidities 9 20 916 927 O
that 21 25 928 932 O
in 26 28 933 935 O
the 29 32 936 939 O
investigator 33 45 940 952 O
's 45 47 952 954 O
opinion 48 55 955 962 O
could 56 61 963 968 O
require 62 69 969 976 O
medical 70 77 977 984 O
or 78 80 985 987 O
surgical 81 89 988 996 O
intervention 90 102 997 1009 O
to 103 105 1010 1012 O
prevent 106 113 1013 1020 O
or 114 116 1021 1023 O
treat 117 122 1024 1029 O
visual 123 129 1030 1036 O
loss 130 134 1037 1041 O
or 135 137 1042 1044 O
media 138 143 1045 1050 O
opacity 144 151 1051 1058 O
that 152 156 1059 1063 O
might 157 162 1064 1069 O
result 163 169 1070 1076 O
from 170 174 1077 1081 O
that 175 179 1082 1086 O
condition 180 189 1087 1096 O
( 190 191 1097 1098 O
i.e. 191 195 1098 1102 O
severe 196 202 1103 1109 B-chronic_disease
cataracts 203 212 1110 1119 I-chronic_disease
) 212 213 1119 1120 O

Be 0 2 0 2 O
aged 3 7 3 7 B-age
18 8 10 8 10 B-lower_bound
- 10 11 10 11 O
80 11 13 11 13 B-upper_bound
years 14 19 14 19 I-upper_bound
old 20 23 20 23 O

Be 0 2 24 26 O
aged 3 7 27 31 B-age
55 8 10 32 34 B-lower_bound
- 10 11 34 35 O
80 11 13 35 37 B-upper_bound
years 14 19 38 43 I-upper_bound
old 20 23 44 47 O

Current 0 7 48 55 O
depression 8 18 56 66 B-chronic_disease
( 19 20 67 68 O
score 20 25 68 73 O
more 26 30 74 78 O
than 31 35 79 83 O
7 36 37 84 85 B-lower_bound
on 38 40 86 88 O
the 41 44 89 92 O
Hamilton 45 53 93 101 B-clinical_variable
Depression 54 64 102 112 I-clinical_variable
Rating 65 71 113 119 I-clinical_variable
Scale 72 77 120 125 I-clinical_variable
( 78 79 126 127 I-clinical_variable
HDRS 79 83 127 131 I-clinical_variable
) 83 84 131 132 I-clinical_variable
) 84 85 132 133 O

Has 0 3 134 137 O
a 4 5 138 139 O
contradiction 6 19 140 153 O
to 20 22 154 156 O
TMS 23 26 157 160 B-allergy_name

Have 0 4 161 165 O
intact 5 11 166 172 O
cognitive 12 21 173 182 O
abilities 22 31 183 192 O
( 32 33 193 194 O
score 33 38 194 199 O
higher 39 45 200 206 O
than 46 50 207 211 O
75th 51 55 212 216 B-lower_bound
percentile 56 66 217 227 I-lower_bound
on 67 69 228 230 O
the 70 73 231 234 O
Repeatable 74 84 235 245 B-clinical_variable
Battery 85 92 246 253 I-clinical_variable
for 93 96 254 257 I-clinical_variable
the 97 100 258 261 I-clinical_variable
Assessment 101 111 262 272 I-clinical_variable
of 112 114 273 275 I-clinical_variable
Neuropsychological 115 133 276 294 I-clinical_variable
Status 134 140 295 301 I-clinical_variable
( 141 142 302 303 I-clinical_variable
RBANS 142 147 303 308 I-clinical_variable
) 147 148 308 309 I-clinical_variable
) 148 149 309 310 O

Impaired 0 8 311 319 B-chronic_disease
cognitive 9 18 320 329 I-chronic_disease
abilities 19 28 330 339 I-chronic_disease
( 29 30 340 341 O
score 30 35 341 346 O
lesser 36 42 347 353 O
than 43 47 354 358 O
75th 48 52 359 363 B-upper_bound
percentile 53 63 364 374 I-upper_bound
on 64 66 375 377 O
the 67 70 378 381 O
Repeatable 71 81 382 392 B-clinical_variable
Battery 82 89 393 400 I-clinical_variable
for 90 93 401 404 I-clinical_variable
the 94 97 405 408 I-clinical_variable
Assessment 98 108 409 419 I-clinical_variable
of 109 111 420 422 I-clinical_variable
Neuropsychological 112 130 423 441 I-clinical_variable
Status 131 137 442 448 I-clinical_variable
( 138 139 449 450 I-clinical_variable
RBANS 139 144 450 455 I-clinical_variable
) 144 145 455 456 I-clinical_variable
) 145 146 456 457 O

Inability 0 9 458 467 O
to 10 12 468 470 O
tolerate 13 21 471 479 O
one 22 25 480 483 B-lower_bound
or 26 28 484 486 O
more 29 33 487 491 O
TMS 34 37 492 495 O
strengths 38 47 496 505 O

MEP 0 3 506 509 B-clinical_variable
amplitude 4 13 510 519 I-clinical_variable
must 14 18 520 524 O
increase 19 27 525 533 O
by 28 30 534 536 O
at 31 33 537 539 O
least 34 39 540 545 O
20 40 42 546 548 B-lower_bound
% 42 43 548 549 I-lower_bound
as 44 46 550 552 O
the 47 50 553 556 O
TMS 51 54 557 560 O
intensity 55 64 561 570 O
increases 65 74 571 580 O

MEP 0 3 581 584 B-clinical_variable
can 4 7 585 588 O
not 7 10 588 591 O
be 11 13 592 594 O
evoked 14 20 595 601 O
with 21 25 602 606 O
TMS 26 29 607 610 B-treatment
in 30 32 611 613 O
the 33 36 614 617 O
ECU 37 40 618 621 O
muscle 41 47 622 628 O

Neurological 0 12 629 641 B-chronic_disease
disease 13 20 642 649 I-chronic_disease

No 0 2 650 652 O
contradictions 3 17 653 667 O
to 18 20 668 670 O
Transcranial 21 33 671 683 B-treatment
Magnetic 34 42 684 692 I-treatment
Stimulation 43 54 693 704 I-treatment
( 55 56 705 706 I-treatment
TMS 56 59 706 709 I-treatment
) 59 60 709 710 I-treatment

No 0 2 711 713 O
current 3 10 714 721 O
depression 11 21 722 732 B-chronic_disease
( 22 23 733 734 O
score 23 28 734 739 O
less 29 33 740 744 O
than 34 38 745 749 O
7 39 40 750 751 B-upper_bound
on 41 43 752 754 O
the 44 47 755 758 O
Hamilton 48 56 759 767 B-clinical_variable
Depression 57 67 768 778 I-clinical_variable
Rating 68 74 779 785 I-clinical_variable
Scale 75 80 786 791 I-clinical_variable
( 81 82 792 793 I-clinical_variable
HDRS 82 86 793 797 I-clinical_variable
) 86 87 797 798 I-clinical_variable
) 87 88 798 799 O

No 0 2 800 802 O
current 3 10 803 810 O
depression 11 21 811 821 B-chronic_disease
( 22 23 822 823 O
score 23 28 823 828 O
less 29 33 829 833 O
than 34 38 834 838 O
a 39 40 839 840 O
7 41 42 841 842 B-upper_bound
on 43 45 843 845 O
the 46 49 846 849 O
Hamilton 50 58 850 858 B-clinical_variable
Depression 59 69 859 869 I-clinical_variable
Rating 70 76 870 876 I-clinical_variable
Scale 77 82 877 882 I-clinical_variable
( 83 84 883 884 I-clinical_variable
HDRS 84 88 884 888 I-clinical_variable
) 88 89 888 889 I-clinical_variable
) 89 90 889 890 O

No 0 2 891 893 O
neurological 3 15 894 906 B-chronic_disease
disease 16 23 907 914 I-chronic_disease

The 0 3 915 918 O
subjects 4 12 919 927 O
must 13 17 928 932 O
be 18 20 933 935 O
comfortable 21 32 936 947 O
when 33 37 948 952 O
receiving 38 47 953 962 O
TMS 48 51 963 966 B-treatment
of 52 54 967 969 O
all 55 58 970 973 O
strengths 59 68 974 983 O

Cerebral 0 8 0 8 B-chronic_disease
aneurysm 9 17 9 17 I-chronic_disease
clips 18 23 18 23 O
- 24 25 24 25 O
if 26 28 26 28 O
magnetic 29 37 29 37 O
, 37 38 37 38 O
can 39 42 39 42 O
move 43 47 43 47 O

Cochlear 0 8 48 56 B-treatment
implant 9 16 57 64 I-treatment
- 17 18 65 66 O
malfunction 19 30 67 78 O

Deep 0 4 79 83 B-treatment
brain 5 10 84 89 I-treatment
stimulator 11 21 90 100 I-treatment

Evidence 0 8 101 109 O
cognitive 9 18 110 119 B-chronic_disease
impairment 19 29 120 130 I-chronic_disease
that 30 34 131 135 O
would 35 40 136 141 O
negatively 41 51 142 152 O
impact 52 58 153 159 O
capacity 59 67 160 168 O
to 68 70 169 171 O
understand 71 81 172 182 O
and 82 85 183 186 O
participate 86 97 187 198 O
in 98 100 199 201 O
this 101 105 202 206 O
study 106 111 207 212 O

Have 0 4 213 217 O
an 5 7 218 220 O
educational 8 19 221 232 B-clinical_variable
level 20 25 233 238 I-clinical_variable
between 26 33 239 246 O
14 34 36 247 249 B-lower_bound
- 36 37 249 250 O
18 37 39 250 252 B-upper_bound
years 40 45 253 258 I-upper_bound

Have 0 4 259 263 O
contraindications 5 22 264 281 O
for 23 26 282 285 O
acupuncture 27 38 286 297 B-allergy_name
or 39 41 298 300 O
MRI 42 45 301 304 B-allergy_name

Have 0 4 305 309 O
had 5 8 310 313 O
a 9 10 314 315 O
change 11 17 316 322 O
in 18 20 323 325 O
medication 21 31 326 336 O
over 32 36 337 341 O
two 37 40 342 345 B-upper_bound
weeks 41 46 346 351 I-upper_bound
before 47 53 352 358 O
the 54 57 359 362 O
start 58 63 363 368 O
of 64 66 369 371 O
study 67 72 372 377 O
procedures 73 83 378 388 O
or 84 86 389 391 O
through 87 94 392 399 O
the 95 98 400 403 O
study 99 104 404 409 O
protocol 105 113 410 418 O

IV 0 2 419 421 B-treatment
anticoagulant 3 16 422 435 I-treatment
therapy 17 24 436 443 I-treatment

Magnetic 0 8 444 452 B-treatment
dental 9 15 453 459 I-treatment
implants 16 24 460 468 I-treatment
- 25 26 469 470 O
loss 27 31 471 475 O
of 32 34 476 478 O
magnetic 35 43 479 487 O
hold 44 48 488 492 O
to 49 51 493 495 O
keep 52 56 496 500 O
the 57 60 501 504 O
implant 61 68 505 512 O
in 69 71 513 515 O
place 72 77 516 521 O

Main 0 4 522 526 O
contraindications 5 22 527 544 O
for 23 26 545 548 O
acupcunture 27 38 549 560 B-treatment
in 39 41 561 563 O
this 42 46 564 568 O
study 47 52 569 574 O

Participants 0 12 575 587 O
must 13 17 588 592 O
have 18 22 593 597 O
experienced 23 34 598 609 O
a 35 36 610 611 O
left 37 41 612 616 B-clinical_variable
Cerebrovascular 42 57 617 632 I-clinical_variable
Accident 58 66 633 641 I-clinical_variable
( 67 68 642 643 I-clinical_variable
CVA 68 71 643 646 I-clinical_variable
) 71 72 646 647 I-clinical_variable
at 73 75 648 650 O
least 76 81 651 656 O
one 82 85 657 660 B-lower_bound
year 86 90 661 665 I-lower_bound
prior 91 96 666 671 I-lower_bound
to 97 99 672 674 O
study 100 105 675 680 O
participation 106 119 681 694 O
and 120 123 695 698 O
the 124 127 699 702 O
injury 128 134 703 709 O
timeframe 135 144 710 719 O
is 145 147 720 722 O
1 148 149 723 724 B-lower_bound
- 149 150 724 725 O
10 150 152 725 727 B-upper_bound
years 153 158 728 733 I-upper_bound
post 159 163 734 738 O
stroke 164 170 739 745 B-chronic_disease

Pregnancy 0 9 746 755 B-pregnancy

Swan 0 4 756 760 B-treatment
- 4 5 760 761 I-treatment
Ganz 5 9 761 765 I-treatment
catheter 10 18 766 774 I-treatment

having 0 6 775 781 O
a 7 8 782 783 O
pacemaker 9 18 784 793 B-treatment
, 18 19 793 794 O
defibrillator 20 33 795 808 B-treatment
or 34 36 809 811 O
wires 37 42 812 817 O
other 43 48 818 823 O
than 49 53 824 828 O
sternal 54 61 829 836 B-treatment
wires 62 67 837 842 I-treatment

uncontrolled 0 12 843 855 O
coagulation 13 24 856 867 O
blood 25 30 868 873 B-chronic_disease
disorders 31 40 874 883 I-chronic_disease
like 41 45 884 888 O
haemophilia 46 57 889 900 B-chronic_disease
, 57 58 900 901 I-chronic_disease
malignant 59 68 902 911 B-cancer
tumors 69 75 912 918 I-cancer
, 75 76 918 919 O
and 77 80 920 923 O
fear 81 85 924 928 B-chronic_disease
of 86 88 929 931 I-chronic_disease
needles 89 96 932 939 I-chronic_disease

Confounding 0 11 0 11 O
underlying 12 22 12 22 O
medical 23 30 23 30 B-chronic_disease
illnesses 31 40 31 40 I-chronic_disease
which 41 46 41 46 O
may 47 50 47 50 O
cause 51 56 51 56 O
fatigue 57 64 57 64 O
( 65 66 65 66 O
e.g. 66 70 66 70 O
, 70 71 70 71 O
severe 72 78 72 78 O
Anemia 79 85 79 85 B-chronic_disease
not 86 89 86 89 O
controlled 90 100 90 100 O
by 101 103 101 103 O
medication 104 114 104 114 B-treatment
, 114 115 114 115 O
per 116 119 116 119 O
self 120 124 120 124 O
- 124 125 124 125 O
report 125 131 125 131 O
corroborated 132 144 132 144 O
by 145 147 145 147 O
medical 148 155 148 155 O
chart 156 161 156 161 O
review 162 168 162 168 O
( 169 170 169 170 O
e.g. 170 174 170 174 O
, 174 175 174 175 O
Hb<10gm 176 183 176 183 B-clinical_variable
/ 183 184 183 184 I-upper_bound
dl 184 186 184 186 I-upper_bound
) 186 187 186 187 O

Eye 0 3 188 191 B-chronic_disease
Diseases 4 12 192 200 I-chronic_disease
which 13 18 201 206 O
limit 19 24 207 212 O
the 25 28 213 216 O
ability 29 36 217 224 O
of 37 39 225 227 O
light 40 45 228 233 O
to 46 48 234 236 O
be 49 51 237 239 O
processed 52 61 240 249 O
( 62 63 250 251 O
e.g. 63 67 251 255 O
, 67 68 255 256 O
untreated 69 78 257 266 O
cataracts 79 88 267 276 B-chronic_disease
, 88 89 276 277 O
glaucoma 90 98 278 286 B-chronic_disease
that 99 103 287 291 O
causes 104 110 292 298 O
visual 111 117 299 305 O
impairment 118 128 306 316 O
, 128 129 316 317 O
macular 130 137 318 325 B-chronic_disease
degeneration 138 150 326 338 I-chronic_disease
, 150 151 338 339 O
blindness 152 161 340 349 B-chronic_disease
, 161 162 349 350 O
pupil 163 168 351 356 B-chronic_disease
dilation 169 177 357 365 I-chronic_disease
problems 178 186 366 374 I-chronic_disease
or 187 189 375 377 O
retina 190 196 378 384 B-chronic_disease
damage 197 203 385 391 I-chronic_disease
) 203 204 391 392 O

Pregnancy 0 9 393 402 B-pregnancy

Previous 0 8 403 411 B-treatment
use 9 12 412 415 I-treatment
of 13 15 416 418 I-treatment
light 16 21 419 424 I-treatment
therapy 22 29 425 432 I-treatment
to 30 32 433 435 I-treatment
alleviate 33 42 436 445 I-treatment
fatigue 43 50 446 453 I-treatment
or 51 53 454 456 I-treatment
depressive 54 64 457 467 I-treatment
symptoms 65 73 468 476 I-treatment

Secondary 0 9 477 486 B-cancer
cancer 10 16 487 493 I-cancer
diagnosis 17 26 494 503 O
( 27 28 504 505 O
prior 28 33 505 510 O
or 34 36 511 513 O
current 37 44 514 521 O
) 44 45 521 522 O
within 46 52 523 529 O
the 53 56 530 533 O
past 57 61 534 538 B-upper_bound
5 62 63 539 540 I-upper_bound
years 64 69 541 546 I-upper_bound

Severe 0 6 547 553 O
psychological 7 20 554 567 B-chronic_disease
impairment 21 31 568 578 I-chronic_disease
( 32 33 579 580 O
e.g. 33 37 580 584 O
, 37 38 584 585 O
hospitalization 39 54 586 601 O
for 55 58 602 605 O
depressive 59 69 606 616 O
episode 70 77 617 624 O
in 78 80 625 627 O
the 81 84 628 631 O
past 85 89 632 636 B-upper_bound
12 90 92 637 639 I-upper_bound
months 93 99 640 646 I-upper_bound
) 99 100 646 647 O

Severe 0 6 648 654 O
sleep 7 12 655 660 B-chronic_disease
disorders 13 22 661 670 I-chronic_disease
( 23 24 671 672 O
e.g. 24 28 672 676 O
Narcolepsy 29 39 677 687 B-chronic_disease
) 39 40 687 688 O

Under 0 5 689 694 O
age 6 9 695 698 B-age
18 10 12 699 701 B-upper_bound

Who 0 3 702 705 O
are 4 7 706 709 O
currently 8 17 710 719 O
over 18 22 720 724 O
age 23 26 725 728 B-age
18 27 29 729 731 B-upper_bound
and 30 33 732 735 O
were 34 38 736 740 O
at 39 41 741 743 O
least 42 47 744 749 O
age 48 51 750 753 O
16 52 54 754 756 B-lower_bound
at 55 57 757 759 O
the 58 61 760 763 O
time 62 66 764 768 O
of 67 69 769 771 O
ASCT 70 74 772 776 B-treatment

With 0 4 777 781 O
a 5 6 782 783 O
history 7 14 784 791 O
of 15 17 792 794 O
ASCT 18 22 795 799 B-treatment
as 23 25 800 802 O
treatment 26 35 803 812 O
for 36 39 813 816 O
hematological 40 53 817 830 B-cancer
malignancies 54 66 831 843 I-cancer
such 67 71 844 848 O
as 72 74 849 851 O
MM 75 77 852 854 B-cancer
, 77 78 854 855 O
DLBCL 79 84 856 861 B-cancer
, 84 85 861 862 O
and 86 89 863 866 O
related 90 97 867 874 O
diseases 98 106 875 883 O
and 107 110 884 887 O
who 111 114 888 891 O
are 115 118 892 895 O
between 119 126 896 903 O
three 127 132 904 909 O
months 133 139 910 916 O
and 140 143 917 920 O
five 144 148 921 925 O
years 149 154 926 931 O
post 155 159 932 936 O
- 159 160 936 937 O
transplant 160 170 937 947 O

With 0 4 948 952 O
a 5 6 953 954 O
score 7 12 955 960 O
equal 13 18 961 966 O
to 19 21 967 969 O
or 22 24 970 972 O
less 25 29 973 977 O
than 30 34 978 982 O
35 35 37 983 985 B-upper_bound
on 38 40 986 988 O
the 41 44 989 992 O
FACIT 45 50 993 998 B-clinical_variable
- 50 51 998 999 I-clinical_variable
Fatigue 51 58 999 1006 I-clinical_variable
scale 59 64 1007 1012 I-clinical_variable
( 65 66 1013 1014 O
see 66 69 1014 1017 O
below 70 75 1018 1023 O
) 75 76 1023 1024 O

Allergies 0 9 0 9 O
to 10 12 10 12 O
any 13 16 13 16 O
agent 17 22 17 22 O
used 23 27 23 27 O
in 28 30 28 30 O
either 31 37 31 37 O
treatment 38 47 38 47 B-treatment
regimen 48 55 48 55 I-treatment

Neonate 0 7 56 63 O
has 8 11 64 67 O
anticipated 12 23 68 79 O
stay 24 28 80 84 O
longer 29 35 85 91 O
than 36 40 92 96 O
5 41 42 97 98 B-lower_bound
days 43 47 99 103 I-lower_bound
in 48 50 104 106 O
the 51 54 107 110 O
NICU 55 59 111 115 O

Parent(s 0 8 116 124 O
) 8 9 124 125 O
test 10 14 126 130 O
positive 15 23 131 139 O
for 24 27 140 143 O
S. 28 30 144 146 B-chronic_disease
aureus 31 37 147 153 I-chronic_disease
at 38 40 154 156 O
screening 41 50 157 166 O

admitted 0 8 167 175 O
from 9 13 176 180 O
home 14 18 181 185 O
and 19 22 186 189 O
had 23 26 190 193 O
admission 27 36 194 203 O
screening 37 46 204 213 O
cultures 47 55 214 222 O
for 56 59 223 226 O
S. 60 62 227 229 B-chronic_disease
aureus 63 69 230 236 I-chronic_disease
colonization 70 82 237 249 I-chronic_disease
that 83 87 250 254 O
were 88 92 255 259 O
negative 93 101 260 268 O

greater 0 7 269 276 O
than 8 12 277 281 O
7 13 14 282 283 B-lower_bound
days 15 19 284 288 I-lower_bound
of 20 22 289 291 O
age 23 26 292 295 B-age

ALL 0 3 0 3 B-cancer
without 4 11 4 11 O
curative 12 20 12 20 O
options 21 28 21 28 O
for 29 32 29 32 O
therapy 33 40 33 40 B-treatment
, 40 41 40 41 O
including 42 51 42 51 O
those 52 57 52 57 O
not 58 61 58 61 O
eligible 62 70 62 70 O
for 71 74 71 74 O
allogeneic 75 85 75 85 B-treatment
SCT 86 89 86 89 I-treatment

Active 0 6 90 96 O
hepatitis 7 16 97 106 B-chronic_disease
B 17 18 107 108 I-chronic_disease
or 19 21 109 111 O
hepatitis 22 31 112 121 B-chronic_disease
C 32 33 122 123 I-chronic_disease
infection 34 43 124 133 O

Adequate 0 8 134 142 O
cardiac 9 16 143 150 O
function 17 25 151 159 O
defined 26 33 160 167 O
as 34 36 168 170 O
LVSF 37 41 171 175 B-clinical_variable
≥ 42 43 176 177 O
28 44 46 178 180 B-lower_bound
% 46 47 180 181 I-lower_bound
confirmed 48 57 182 191 O
by 58 60 192 194 O
ECHO 61 65 195 199 O

Adequate 0 8 200 208 B-clinical_variable
performance 9 20 209 220 I-clinical_variable
status 21 27 221 227 I-clinical_variable
( 28 29 228 229 O
Lansky 29 35 229 235 B-clinical_variable
or 36 38 236 238 O
Karnofsky 39 48 239 248 B-clinical_variable
score 49 54 249 254 I-clinical_variable
≥50 55 58 255 258 O
) 58 59 258 259 O

Adequate 0 8 260 268 B-clinical_variable
pulmonary 9 18 269 278 I-clinical_variable
function 19 27 279 287 I-clinical_variable
defined 28 35 288 295 O
as 36 38 296 298 O
< 39 40 299 300 O
Grade 41 46 301 306 B-upper_bound
3 47 48 307 308 I-upper_bound
hypoxia 49 56 309 316 B-chronic_disease

Age 0 3 317 320 B-age
1 4 5 321 322 B-lower_bound
to 6 8 323 325 O
24 9 11 326 328 B-upper_bound
years 12 17 329 334 I-upper_bound

Any 0 3 335 338 O
uncontrolled 4 16 339 351 O
active 17 23 352 358 B-chronic_disease
medical 24 31 359 366 I-chronic_disease
disorder 32 40 367 375 I-chronic_disease
that 41 45 376 380 O
would 46 51 381 386 O
preclude 52 60 387 395 O
participation 61 74 396 409 O
as 75 77 410 412 O
outlined 78 86 413 421 O

Are 0 3 422 425 O
more 4 8 426 430 O
than 9 13 431 435 O
4 14 15 436 437 B-lower_bound
months 16 22 438 444 I-lower_bound
from 23 27 445 449 O
transplant 28 38 450 460 B-treatment
( 39 40 461 462 O
6 40 41 462 463 B-upper_bound
months 42 48 464 470 I-upper_bound
at 49 51 471 473 O
infusion 52 60 474 482 B-treatment
) 60 61 482 483 O

Bilirubin 0 9 484 493 B-clinical_variable
< 10 11 494 495 O
2.0 11 14 495 498 B-upper_bound
mg 15 17 499 501 I-upper_bound
/ 17 18 501 502 I-upper_bound
dl 18 20 502 504 I-upper_bound

CD19 0 4 505 509 O
+ 4 5 509 510 O
leukemia 6 14 511 519 B-cancer

CNS3 0 4 520 524 B-chronic_disease
disease 5 12 525 532 I-chronic_disease
that 13 17 533 537 O
is 18 20 538 540 O
progressive 21 32 541 552 O
on 33 35 553 555 O
therapy 36 43 556 563 B-treatment
, 43 44 563 564 O
or 45 47 565 567 O
with 48 52 568 572 O
CNS 53 56 573 576 O
parenchymal 57 68 577 588 O
lesions 69 76 589 596 O
that 77 81 597 601 O
might 82 87 602 607 O
increase 88 96 608 616 O
the 97 100 617 620 O
risk 101 105 621 625 O
of 106 108 626 628 O
CNS 109 112 629 632 B-chronic_disease
toxicity 113 121 633 641 I-chronic_disease

Concurrent 0 10 642 652 O
use 11 14 653 656 O
of 15 17 657 659 O
systemic 18 26 660 668 B-treatment
steroids 27 35 669 677 I-treatment
at 36 38 678 680 O
the 39 42 681 684 O
time 43 47 685 689 O
of 48 50 690 692 O
cell 51 55 693 697 O
infusion 56 64 698 706 O
or 65 67 707 709 O
cell 68 72 710 714 O
collection 73 83 715 725 O
, 83 84 725 726 O
or 85 87 727 729 O
a 88 89 730 731 O
condition 90 99 732 741 O
, 99 100 741 742 O
in 101 103 743 745 O
the 104 107 746 749 O
treating 108 116 750 758 O
physician 117 126 759 768 O
's 126 128 768 770 O
opinion 129 136 771 778 O
, 136 137 778 779 O
that 138 142 780 784 O
is 143 145 785 787 O
likely 146 152 788 794 O
to 153 155 795 797 O
require 156 163 798 805 O
steroid 164 171 806 813 B-treatment
therapy 172 179 814 821 I-treatment
during 180 186 822 828 O
collection 187 197 829 839 O
or 198 200 840 842 O
after 201 206 843 848 O
infusion 207 215 849 857 O

Creatinine 0 10 858 868 B-clinical_variable
< 11 12 869 870 O
2.5 13 16 871 874 B-upper_bound
mg 17 19 875 877 I-upper_bound
/ 19 20 877 878 I-upper_bound
dl 20 22 878 880 I-upper_bound
and 23 26 881 884 O
less 27 31 885 889 O
than 32 36 890 894 O
2.5x 37 41 895 899 B-upper_bound
normal 42 48 900 906 I-upper_bound
for 49 52 907 910 O
age 53 56 911 914 B-age

Diffuse 0 7 915 922 B-cancer
large 8 13 923 928 I-cancer
cell 14 18 929 933 I-cancer
lymphoma 19 27 934 942 I-cancer
or 28 30 943 945 O
other 31 36 946 951 O
high 37 41 952 956 B-cancer
- 41 42 956 957 I-cancer
grade 42 47 957 962 I-cancer
NHL 48 51 963 966 I-cancer
, 51 52 966 967 O
previously 53 63 968 978 O
identified 64 74 979 989 O
as 75 77 990 992 O
CD19 78 82 993 997 O
+ 82 83 997 998 O
including 84 93 999 1008 O
residual 94 102 1009 1017 B-cancer
disease 103 110 1018 1025 I-cancer
after 111 116 1026 1031 O
primary 117 124 1032 1039 B-treatment
therapy 125 132 1040 1047 I-treatment
and 133 136 1048 1051 O
not 137 140 1052 1055 O
eligible 141 149 1056 1064 O
for 150 153 1065 1068 O
autologous 154 164 1069 1079 B-treatment
SCT 165 168 1080 1083 I-treatment

Expected 0 8 1084 1092 B-clinical_variable
survival 9 17 1093 1101 I-clinical_variable
> 18 19 1102 1103 O
12 20 22 1104 1106 B-lower_bound
weeks 23 28 1107 1112 I-lower_bound

Female 0 6 1113 1119 B-gender
study 7 12 1120 1125 O
participants 13 25 1126 1138 O
of 26 28 1139 1141 O
reproductive 29 41 1142 1154 O
potential 42 51 1155 1164 O
must 52 56 1165 1169 O
have 57 61 1170 1174 O
a 62 63 1175 1176 O
negative 64 72 1177 1185 B-pregnancy
serum 73 78 1186 1191 I-pregnancy
or 79 81 1192 1194 I-pregnancy
urine 82 87 1195 1200 I-pregnancy
pregnancy 88 97 1201 1210 I-pregnancy
test 98 102 1211 1215 O
performed 103 112 1216 1225 O
within 113 119 1226 1232 O
48 120 122 1233 1235 B-upper_bound
hours 123 128 1236 1241 I-upper_bound
before 129 135 1242 1248 O
infusion 136 144 1249 1257 O

For 0 3 1258 1261 O
those 4 9 1262 1267 O
patients 10 18 1268 1276 O
who 19 22 1277 1280 O
require 23 30 1281 1288 O
leukapheresis 31 44 1289 1302 B-treatment
for 45 48 1303 1306 O
T 49 50 1307 1308 O
cell 51 55 1309 1313 O
collection 56 66 1314 1324 O
( 67 68 1325 1326 O
i.e. 68 72 1326 1330 O
no 73 75 1331 1333 O
previously 76 86 1334 1344 O
collected 87 96 1345 1354 O
product 97 104 1355 1362 O
exists 105 111 1363 1369 O
) 111 112 1369 1370 O
, 112 113 1370 1371 O
adequate 114 122 1372 1380 O
venous 123 129 1381 1387 O
access 130 136 1388 1394 O
for 137 140 1395 1398 O
apheresis 141 150 1399 1408 O
or 151 153 1409 1411 O
eligible 154 162 1412 1420 O
for 163 166 1421 1424 O
appropriate 167 178 1425 1436 O
catheter 179 187 1437 1445 B-treatment
placement 188 197 1446 1455 I-treatment
, 197 198 1455 1456 O
and 199 202 1457 1460 O
no 203 205 1461 1463 O
other 206 211 1464 1469 O
contraindications 212 229 1470 1487 O
for 230 233 1488 1491 O
leukapheresis 234 247 1492 1505 O

HIV 0 3 1506 1509 B-chronic_disease
infection 4 13 1510 1519 O

Have 0 4 1520 1524 O
no 5 7 1525 1527 O
active 8 14 1528 1534 O
GVHD 15 19 1535 1539 B-chronic_disease
and 20 23 1540 1543 O
require 24 31 1544 1551 O
no 32 34 1552 1554 O
immunosuppression 35 52 1555 1572 B-treatment

Male 0 4 1573 1577 B-gender

Patient 0 7 1578 1585 O
may 8 11 1586 1589 O
be 12 14 1590 1592 O
in 15 17 1593 1595 O
any 18 21 1596 1599 O
complete 22 30 1600 1608 O
response 31 39 1609 1617 O
, 39 40 1617 1618 O
or 41 43 1619 1621 O
patient 44 51 1622 1629 O
may 52 55 1630 1633 O
have 56 60 1634 1638 O
active 61 67 1639 1645 O
disease 68 75 1646 1653 O
but 76 79 1654 1657 O
responding 80 90 1658 1668 O
or 91 93 1669 1671 O
stable 94 100 1672 1678 O
after 101 106 1679 1684 O
most 107 111 1685 1689 O
recent 112 118 1690 1696 O
therapy 119 126 1697 1704 B-treatment

Patients 0 8 1705 1713 O
previously 9 19 1714 1724 O
treated 20 27 1725 1732 O
with 28 32 1733 1737 O
B 33 34 1738 1739 O
cell 35 39 1740 1744 O
directed 40 48 1745 1753 O
engineered 49 59 1754 1764 O
cell 60 64 1765 1769 B-treatment
therapy 65 72 1770 1777 I-treatment

Pregnant 0 8 1778 1786 B-pregnancy

Presence 0 8 1787 1795 O
of 9 11 1796 1798 O
grade 12 17 1799 1804 B-lower_bound
2 18 19 1805 1806 I-lower_bound
- 19 20 1806 1807 O
4 20 21 1807 1808 B-upper_bound
acute 22 27 1809 1814 O
or 28 30 1815 1817 O
extensive 31 40 1818 1827 O
chronic 41 48 1828 1835 B-chronic_disease
GVHD 49 53 1836 1840 I-chronic_disease

Steroids 0 8 1841 1849 B-treatment
for 9 12 1850 1853 O
disease 13 20 1854 1861 O
treatment 21 30 1862 1871 B-treatment
at 31 33 1872 1874 O
times 34 39 1875 1880 O
other 40 45 1881 1886 O
than 46 50 1887 1891 O
cell 51 55 1892 1896 O
collection 56 66 1897 1907 O
or 67 69 1908 1910 O
at 70 72 1911 1913 O
the 73 76 1914 1917 O
time 77 81 1918 1922 O
of 82 84 1923 1925 O
infusion 85 93 1926 1934 O

Uncontrolled 0 12 1935 1947 O
active 13 19 1948 1954 B-chronic_disease
infection 20 29 1955 1964 I-chronic_disease

Under 0 5 1965 1970 O
treatment 6 15 1971 1980 B-treatment
for 16 19 1981 1984 O
GVHD 20 24 1985 1989 B-chronic_disease

Use 0 3 1990 1993 O
of 4 6 1994 1996 O
physiologic 7 18 1997 2008 O
replacement 19 30 2009 2020 O
hydrocortisone 31 45 2021 2035 B-treatment
or 46 48 2036 2038 O
inhaled 49 56 2039 2046 B-treatment
steroids 57 65 2047 2055 I-treatment

beyond 0 6 2056 2062 O
1st 7 10 2063 2066 O
CR 11 13 2067 2069 O
with 14 18 2070 2074 O
relapsed 19 27 2075 2083 O
or 28 30 2084 2086 O
persistent 31 41 2087 2097 O
disease 42 49 2098 2105 O
and 50 53 2106 2109 O
not 54 57 2110 2113 O
eligible 58 66 2114 2122 O
or 67 69 2123 2125 O
appropriate 70 81 2126 2137 O
for 82 85 2138 2141 O
conventional 86 98 2142 2154 O
allogeneic 99 109 2155 2165 O
or 110 112 2166 2168 O
autologous 113 123 2169 2179 B-treatment
SCT 124 127 2180 2183 I-treatment

female 0 6 2184 2190 B-gender

lactating 0 9 2191 2200 O
women 10 15 2201 2206 B-gender

lymphoma 0 8 2207 2215 B-cancer

partial 0 7 2216 2223 O
response 8 16 2224 2232 O
or 17 19 2233 2235 O
no 20 22 2236 2238 O
response 23 31 2239 2247 O
to 32 34 2248 2250 O
prior 35 40 2251 2256 B-treatment
cell 41 45 2257 2261 I-treatment
therapy 46 53 2262 2269 I-treatment

relapsed 0 8 2270 2278 O
after 9 14 2279 2284 O
prior 15 20 2285 2290 B-treatment
autologous 21 31 2291 2301 I-treatment
SCT 32 35 2302 2305 I-treatment

relapsed 0 8 2306 2314 O
after 9 14 2315 2320 O
prior 15 20 2321 2326 B-treatment
cell 21 25 2327 2331 I-treatment
therapy 26 33 2332 2339 I-treatment

subjects 0 8 2340 2348 O
with 9 13 2349 2353 O
documented 14 24 2354 2364 O
CD19 25 29 2365 2369 B-cancer
+ 29 30 2369 2370 I-cancer
B 31 32 2371 2372 I-cancer
cell 33 37 2373 2377 I-cancer
malignancies 38 50 2378 2390 I-cancer
and 51 54 2391 2394 O
no 55 57 2395 2397 O
available 58 67 2398 2407 O
curative 68 76 2408 2416 B-treatment
treatment 77 86 2417 2426 I-treatment
options 87 94 2427 2434 O
( 95 96 2435 2436 O
such 96 100 2436 2440 O
as 101 103 2441 2443 O
autologous 104 114 2444 2454 B-treatment
or 115 117 2455 2457 O
allogeneic 118 128 2458 2468 B-treatment
SCT 129 132 2469 2472 I-treatment
) 132 133 2472 2473 O
who 134 137 2474 2477 O
have 138 142 2478 2482 O
limited 143 150 2483 2490 O
prognosis 151 160 2491 2500 O
( 161 162 2501 2502 O
several 162 169 2502 2509 O
months 170 176 2510 2516 O
to 177 179 2517 2519 O
< 180 181 2520 2521 O
2 181 182 2521 2522 B-upper_bound
year 183 187 2523 2527 I-upper_bound
survival 188 196 2528 2536 O
) 196 197 2536 2537 O
with 198 202 2538 2542 O
currently 203 212 2543 2552 O
available 213 222 2553 2562 O
therapies 223 232 2563 2572 B-treatment
will 233 237 2573 2577 O
be 238 240 2578 2580 O
enrolled 241 249 2581 2589 O

18 0 2 0 2 B-lower_bound
≤ 3 4 3 4 O
age 5 8 5 8 B-age
≤ 9 10 9 10 O
65 11 13 11 13 B-upper_bound

Clinically 0 10 14 24 O
significant 11 22 25 36 O
cardiovascular 23 37 37 51 B-chronic_disease
or 38 40 52 54 O
neurological 41 53 55 67 B-chronic_disease
conditions 54 64 68 78 O

Current 0 7 79 86 O
substance 8 17 87 96 O
abuse 18 23 97 102 O
( 24 25 103 104 O
last 25 29 104 108 B-upper_bound
6 30 31 109 110 I-upper_bound
months 32 38 111 117 I-upper_bound
) 38 39 117 118 O
or 40 42 119 121 O
past 43 47 122 126 O
dependence 48 58 127 137 O
on 59 61 138 140 O
stimulants 62 72 141 151 O

Currently 0 9 152 161 O
meets 10 15 162 167 O
DSM 16 19 168 171 O
- 19 20 171 172 O
IV 20 22 172 174 O
- 22 23 174 175 O
TR 23 25 175 177 O
criteria 26 34 178 186 O
for 35 38 187 190 O
MDD 39 42 191 194 B-chronic_disease

Currently 0 9 195 204 O
meets 10 15 205 210 O
for 16 19 211 214 O
a 20 21 215 216 O
psychotic 22 31 217 226 B-chronic_disease
episode 32 39 227 234 O

Currently 0 9 235 244 O
taking 10 16 245 251 O
psychotropic 17 29 252 264 B-treatment
or 30 32 265 267 O
other 33 38 268 273 O
systemic 39 47 274 282 B-treatment
medications 48 59 283 294 I-treatment

IQ≥80 0 5 295 300 B-clinical_variable

Non 0 3 301 304 B-language_fluency
- 3 4 304 305 I-language_fluency
English 4 11 305 312 I-language_fluency
speaking 12 20 313 321 I-language_fluency

clinically 0 10 322 332 O
significant 11 22 333 344 O
EKG 23 26 345 348 B-clinical_variable
abnormalities 27 40 349 362 O
, 40 41 362 363 O
or 42 44 364 366 O
serious 45 52 367 374 O
general 53 60 375 382 O
medical 61 68 383 390 O
illness 69 76 391 398 O

opioids 0 7 399 406 B-treatment
or 8 10 407 409 O
other 11 16 410 415 O
potentially 17 28 416 427 O
neurotoxic 29 39 428 438 B-treatment
drugs 40 45 439 444 I-treatment

pregnant 0 8 445 453 B-pregnancy
or 9 11 454 456 O
lactating 12 21 457 466 O

traumatic 0 9 467 476 B-chronic_disease
brain 10 15 477 482 I-chronic_disease
injury 16 22 483 489 I-chronic_disease

uncontrolled 0 12 490 502 O
hypertension 13 25 503 515 B-chronic_disease

Active 0 6 0 6 O
malignancy 7 17 7 17 B-cancer

Ankle 0 5 18 23 B-clinical_variable
pressure 6 14 24 32 I-clinical_variable
( 15 16 33 34 I-clinical_variable
AP 16 18 34 36 I-clinical_variable
) 18 19 36 37 I-clinical_variable
≤70 20 23 38 41 O
mmHg 24 28 42 46 I-upper_bound
or 29 31 47 49 O
TP 32 34 50 52 B-clinical_variable
≤50 35 38 53 56 O
mmHg 39 43 57 61 I-upper_bound
in 44 46 62 64 O
the 47 50 65 68 O
index 51 56 69 74 O
leg 57 60 75 78 O

Aorto 0 5 79 84 B-chronic_disease
- 5 6 84 85 I-chronic_disease
iliac 6 11 85 90 I-chronic_disease
stenosis 12 20 91 99 I-chronic_disease
or 21 23 100 102 O
common 24 30 103 109 B-chronic_disease
femoral 31 38 110 117 I-chronic_disease
artery 39 45 118 124 I-chronic_disease
stenosis 46 54 125 133 I-chronic_disease
≥70 55 58 134 137 O
% 58 59 137 138 I-lower_bound

CLI 0 3 139 142 B-chronic_disease
with 4 8 143 147 I-chronic_disease
major 9 14 148 153 I-chronic_disease
tissue 15 21 154 160 I-chronic_disease
loss 22 26 161 165 I-chronic_disease
( 27 28 166 167 O
Rutherford 28 38 167 177 B-clinical_variable
Category 39 47 178 186 I-clinical_variable
6 48 49 187 188 I-clinical_variable
) 49 50 188 189 O
in 51 53 190 192 O
either 54 60 193 199 O
leg 61 64 200 203 O

CLI 0 3 204 207 B-chronic_disease
, 3 4 207 208 O
with 5 9 209 213 O
minor 10 15 214 219 O
tissue 16 22 220 226 O
loss 23 27 227 231 O
up 28 30 232 234 O
to 31 33 235 237 O
the 34 37 238 241 O
ankle 38 43 242 247 O
level 44 49 248 253 O
( 50 51 254 255 O
Rutherford 51 61 255 265 O
Category 62 70 266 274 O
5 71 72 275 276 O
) 72 73 276 277 O

Concomitant 0 11 278 289 B-treatment
therapy 12 19 290 297 I-treatment
with 20 24 298 302 O
a 25 26 303 304 O
statin 27 33 305 311 O
and 34 37 312 315 O
an 38 40 316 318 O
anti 41 45 319 323 O
- 45 46 323 324 O
platelet 46 54 324 332 O
agent 55 60 333 338 O
for 61 64 339 342 O
at 65 67 343 345 O
least 68 73 346 351 O
2 74 75 352 353 B-lower_bound
weeks 76 81 354 359 I-lower_bound
prior 82 87 360 365 I-lower_bound
to 88 90 366 368 O
randomization 91 104 369 382 O

Current 0 7 383 390 O
or 8 10 391 393 O
history 11 18 394 401 O
of 19 21 402 404 O
proliferative 22 35 405 418 B-chronic_disease
retinopathy 36 47 419 430 I-chronic_disease

Diabetes 0 8 431 439 B-chronic_disease
mellitus 9 17 440 448 I-chronic_disease
with 18 22 449 453 O
HbA1c 23 28 454 459 B-clinical_variable
> 29 30 460 461 O
10 30 32 461 463 B-lower_bound
% 32 33 463 464 I-lower_bound

Hepatitis 0 9 465 474 B-chronic_disease
C 10 11 475 476 I-chronic_disease
virus 12 17 477 482 I-chronic_disease

History 0 7 483 490 O
of 8 10 491 493 O
allergic 11 19 494 502 O
/ 19 20 502 503 O
hypersensitivity 20 36 503 519 O
reaction 37 45 520 528 O
to 46 48 529 531 O
any 49 52 532 535 O
substance 53 62 536 545 O
having 63 69 546 552 O
required 70 78 553 561 O
hospitalization 79 94 562 577 O
and/or 95 101 578 584 O
treatment 102 111 585 594 O
with 112 116 595 599 O
IV 117 119 600 602 B-allergy_name
steroids 120 128 603 611 I-allergy_name
/ 128 129 611 612 O
epinephrine 129 140 612 623 B-allergy_name

Ischemic 0 8 624 632 B-chronic_disease
lesions 9 16 633 640 I-chronic_disease
in 17 19 641 643 O
the 20 23 644 647 O
index 24 29 648 653 O
leg 30 33 654 657 O
stable 34 40 658 664 O
for 41 44 665 668 O
at 45 47 669 671 O
least 48 53 672 677 O
2 54 55 678 679 B-lower_bound
weeks 56 61 680 685 I-lower_bound

Life 0 4 686 690 B-clinical_variable
expectancy 5 15 691 701 I-clinical_variable
of 16 18 702 704 O
less 19 23 705 709 O
than 24 28 710 714 O
6 29 30 715 716 B-upper_bound
months 31 37 717 723 I-upper_bound

Non 0 3 724 727 B-chronic_disease
- 3 4 727 728 I-chronic_disease
atherosclerotic 4 19 728 743 I-chronic_disease
PAD 20 23 744 747 I-chronic_disease
( 24 25 748 749 O
e.g. 25 29 749 753 O
Buerger 30 37 754 761 B-chronic_disease
's 37 39 761 763 I-chronic_disease
disease 40 47 764 771 I-chronic_disease
) 47 48 771 772 O

Planned 0 7 773 780 O
or 8 10 781 783 O
potential 11 20 784 793 O
need 21 25 794 798 O
for 26 29 799 802 O
major 30 35 803 808 B-treatment
/ 35 36 808 809 I-treatment
minor 36 41 809 814 I-treatment
amputation 42 52 815 825 I-treatment
or 53 55 826 828 O
any 56 59 829 832 O
revascularization 60 77 833 850 B-treatment
within 78 84 851 857 O
1 85 86 858 859 B-upper_bound
month 87 92 860 865 I-upper_bound
of 93 95 866 868 O
study 96 101 869 874 O
entry 102 107 875 880 O
upon 108 112 881 885 O
investigator 113 125 886 898 O
's 125 127 898 900 O
judgment 128 136 901 909 O

Severe 0 6 910 916 B-chronic_disease
congestive 7 17 917 927 I-chronic_disease
heart 18 23 928 933 I-chronic_disease
failure 24 31 934 941 I-chronic_disease
symptoms 32 40 942 950 O
( 41 42 951 952 O
New 42 45 952 955 O
York 46 50 956 960 O
Heart 51 56 961 966 O
Association 57 68 967 978 O
[ 69 70 979 980 O
NYHA 70 74 980 984 O
] 74 75 984 985 O
Stage 76 81 986 991 B-chronic_disease
IV 82 84 992 994 I-chronic_disease
) 84 85 994 995 O

Subject 0 7 996 1003 O
having 8 14 1004 1010 O
undergone 15 24 1011 1020 O
surgical 25 33 1021 1029 B-treatment
revascularization 34 51 1030 1047 I-treatment
or 52 54 1048 1050 O
major 55 60 1051 1056 B-treatment
amputation 61 71 1057 1067 I-treatment
less 72 76 1068 1072 O
than 77 81 1073 1077 O
1 82 83 1078 1079 B-upper_bound
month 84 89 1080 1085 I-upper_bound
prior 90 95 1086 1091 I-upper_bound
to 96 98 1092 1094 O
screening 99 108 1095 1104 O

Subjects 0 8 1105 1113 O
with 9 13 1114 1118 O
international 14 27 1119 1132 B-clinical_variable
normalized 28 38 1133 1143 I-clinical_variable
ratio 39 44 1144 1149 I-clinical_variable
( 45 46 1150 1151 I-clinical_variable
INR 46 49 1151 1154 I-clinical_variable
) 49 50 1154 1155 I-clinical_variable
> 51 52 1156 1157 O
2.5 52 55 1157 1160 B-lower_bound

Uncontrolled 0 12 1161 1173 O
severe 13 19 1174 1180 B-chronic_disease
hypertension 20 32 1181 1193 I-chronic_disease

Under 0 5 1194 1199 O
treatment 6 15 1200 1209 B-treatment
for 16 19 1210 1213 O
cardiovascular 20 34 1214 1228 O
risk 35 39 1229 1233 O
factors 40 47 1234 1241 O
: 47 48 1241 1242 O
hypertension 49 61 1243 1255 B-chronic_disease
, 61 62 1255 1256 O
hyperlipidemia 63 77 1257 1271 B-chronic_disease
, 77 78 1271 1272 O
diabetes 79 87 1273 1281 B-chronic_disease
, 87 88 1281 1282 O
in 89 91 1283 1285 O
accordance 92 102 1286 1296 O
with 103 107 1297 1301 O
applicable 108 118 1302 1312 O
guidelines 119 129 1313 1323 O

Use 0 3 1324 1327 O
of 4 6 1328 1330 O
hyperbaric 7 17 1331 1341 B-treatment
oxygen 18 24 1342 1348 I-treatment
therapy 25 32 1349 1356 I-treatment
, 32 33 1356 1357 O
prostanoids 34 45 1358 1369 B-treatment
, 45 46 1369 1370 O
spinal 47 53 1371 1377 B-treatment
cord 54 58 1378 1382 I-treatment
stimulation 59 70 1383 1394 I-treatment
, 70 71 1394 1395 O
lumbar 72 78 1396 1402 B-treatment
sympathectomy 79 92 1403 1416 I-treatment
, 92 93 1416 1417 O
wound 94 99 1418 1423 B-treatment
dressing 100 108 1424 1432 I-treatment
containing 109 119 1433 1443 O
cells 120 125 1444 1449 O
or 126 128 1450 1452 O
growth 129 135 1453 1459 O
factors 136 143 1460 1467 O
, 143 144 1467 1468 O
or 145 147 1469 1471 O
topical 148 155 1472 1479 B-treatment
platelet 156 164 1480 1488 I-treatment
derived 165 172 1489 1496 I-treatment
growth 173 179 1497 1503 I-treatment
factor 180 186 1504 1510 I-treatment

Women 0 5 1511 1516 B-gender
of 6 8 1517 1519 O
childbearing 9 21 1520 1532 O
potential 22 31 1533 1542 O
must 32 36 1543 1547 O
have 37 41 1548 1552 O
a 42 43 1553 1554 O
negative 44 52 1555 1563 B-pregnancy
serum 53 58 1564 1569 I-pregnancy
pregnancy 59 68 1570 1579 I-pregnancy
test 69 73 1580 1584 O
at 74 76 1585 1587 O
screening 77 86 1588 1597 O

acquired 0 8 1598 1606 B-chronic_disease
immunodeficiency 9 25 1607 1623 I-chronic_disease
syndrome 26 34 1624 1632 I-chronic_disease
( 35 36 1633 1634 I-chronic_disease
AIDS 36 40 1634 1638 I-chronic_disease
) 40 41 1638 1639 I-chronic_disease
infections 42 52 1640 1650 I-chronic_disease

between 0 7 1651 1658 O
ages 8 12 1659 1663 B-age
45 13 15 1664 1666 B-lower_bound
- 15 16 1666 1667 O
99 16 18 1667 1669 B-upper_bound
years 19 24 1670 1675 I-upper_bound
of 25 27 1676 1678 O
age 28 31 1679 1682 O

endovascular 0 12 1683 1695 B-treatment
revascularization 13 30 1696 1713 I-treatment

has 0 3 1714 1717 O
not 4 7 1718 1721 O
yet 8 11 1722 1725 O
completed 12 21 1726 1735 O
a 22 23 1736 1737 O
period 24 30 1738 1744 O
of 31 33 1745 1747 O
at 34 36 1748 1750 O
least 37 42 1751 1756 O
30 43 45 1757 1759 B-lower_bound
days 46 50 1760 1764 I-lower_bound
since 51 56 1765 1770 O
ending 57 63 1771 1777 O
another 64 71 1778 1785 O
investigational 72 87 1786 1801 O
device 88 94 1802 1808 O
or 95 97 1809 1811 O
drug 98 102 1812 1816 O
trial(s 103 110 1817 1824 O
) 110 111 1824 1825 O

history 0 7 1826 1833 O
of 8 10 1834 1836 O
malignancy 11 21 1837 1847 B-cancer
within 22 28 1848 1854 O
5 29 30 1855 1856 B-upper_bound
years 31 36 1857 1862 I-upper_bound
prior 37 42 1863 1868 I-upper_bound
to 43 45 1869 1871 O
study 46 51 1872 1877 O
entry 52 57 1878 1883 O

male 0 4 1884 1888 B-gender

minor 0 5 1889 1894 B-treatment
amputation 6 16 1895 1905 I-treatment
less 17 21 1906 1910 O
than 22 26 1911 1915 O
2 27 28 1916 1917 B-upper_bound
weeks 29 34 1918 1923 I-upper_bound
prior 35 40 1924 1929 I-upper_bound
to 41 43 1930 1932 O
screening 44 53 1933 1942 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
microliter 34 44 34 44 I-lower_bound

Creatinine 0 10 45 55 B-clinical_variable
within 11 17 56 62 O
normal 18 24 63 69 O
institutional 25 38 70 83 O
limits 39 45 84 90 O
or 46 48 91 93 O
creatinine 49 59 94 104 B-clinical_variable
clearance 60 69 105 114 I-clinical_variable
> 70 71 115 116 O
60 72 74 117 119 B-lower_bound
mL 75 77 120 122 I-lower_bound
/ 77 78 122 123 I-lower_bound
min/1.73 78 86 123 131 I-lower_bound
m2 87 89 132 134 I-lower_bound
for 90 93 135 138 O
subjects 94 102 139 147 O
with 103 107 148 152 O
creatinine 108 118 153 163 B-clinical_variable
levels 119 125 164 170 I-clinical_variable
about 126 131 171 176 O
institutional 132 145 177 190 O
normal 146 152 191 197 O

HIV 0 3 198 201 B-chronic_disease
- 3 4 201 202 O
positive 4 12 202 210 O
individuals 13 24 211 222 O
on 25 27 223 225 O
combination 28 39 226 237 O
antiretroviral 40 54 238 252 B-treatment
therapy 55 62 253 260 I-treatment
are 63 66 261 264 O
ineligible 67 77 265 275 O
because 78 85 276 283 O
of 86 88 284 286 O
the 89 92 287 290 O
potential 93 102 291 300 O
for 103 106 301 304 O
pharmacokinetic 107 122 305 320 O
interactions 123 135 321 333 O
with 136 140 334 338 O
temozolomide 141 153 339 351 B-treatment

History 0 7 352 359 O
of 8 10 360 362 O
allergic 11 19 363 371 O
reactions 20 29 372 381 O
attributed 30 40 382 392 O
to 41 43 393 395 O
compounds 44 53 396 405 O
of 54 56 406 408 O
similar 57 64 409 416 O
chemical 65 73 417 425 O
or 74 76 426 428 O
biologic 77 85 429 437 O
composition 86 97 438 449 O
to 98 100 450 452 O
temozolomide 101 113 453 465 B-allergy_name

Individuals 0 11 466 477 O
with 12 16 478 482 O
a 17 18 483 484 O
history 19 26 485 492 O
of 27 29 493 495 O
other 30 35 496 501 O
malignancies 36 48 502 514 B-cancer
are 49 52 515 518 O
eligible 53 61 519 527 O
if 62 64 528 530 O
they 65 69 531 535 O
have 70 74 536 540 O
been 75 79 541 545 O
disease 80 87 546 553 O
- 87 88 553 554 O
free 88 92 554 558 O
for 93 96 559 562 O
at 97 99 563 565 O
least 100 105 566 571 O
3 106 107 572 573 B-lower_bound
years 108 113 574 579 I-lower_bound
and 114 117 580 583 O
are 118 121 584 587 O
deemed 122 128 588 594 O
by 129 131 595 597 O
the 132 135 598 601 O
investigator 136 148 602 614 O
to 149 151 615 617 O
be 152 154 618 620 O
at 155 157 621 623 O
low 158 161 624 627 O
risk 162 166 628 632 O
for 167 170 633 636 O
recurrence 171 181 637 647 O
of 182 184 648 650 O
that 185 189 651 655 O
malignancy 190 200 656 666 B-cancer

Individuals 0 11 667 678 O
with 12 16 679 683 O
the 17 20 684 687 O
following 21 30 688 697 O
cancers 31 38 698 705 B-cancer
are 39 42 706 709 O
eligible 43 51 710 718 O
if 52 54 719 721 O
diagnosed 55 64 722 731 O
and 65 68 732 735 O
treated 69 76 736 743 O
within 77 83 744 750 O
the 84 87 751 754 O
past 88 92 755 759 B-upper_bound
5 93 94 760 761 I-upper_bound
years 95 100 762 767 I-upper_bound
: 100 101 767 768 O
cervical 102 110 769 777 B-cancer
cancer 111 117 778 784 I-cancer
in 118 120 785 787 I-cancer
situ 121 125 788 792 I-cancer
, 125 126 792 793 O
and 127 130 794 797 O
basal 131 136 798 803 B-cancer
cell 137 141 804 808 I-cancer
or 142 144 809 811 O
squamous 145 153 812 820 B-cancer
cell 154 158 821 825 I-cancer
carcinoma 159 168 826 835 I-cancer
of 169 171 836 838 I-cancer
the 172 175 839 842 I-cancer
skin 176 180 843 847 I-cancer

Karnofsky 0 9 848 857 B-clinical_variable
performance 10 21 858 869 I-clinical_variable
status 22 28 870 876 I-clinical_variable
> 29 30 877 878 O
60 31 33 879 881 B-lower_bound
( 34 35 882 883 O
ECOG 35 39 883 887 B-clinical_variable
< 40 41 888 889 O
2 42 43 890 891 B-upper_bound
) 43 44 891 892 O

Leukocytes 0 10 893 903 B-clinical_variable
> 11 12 904 905 O
3,000 13 18 906 911 B-lower_bound
/ 18 19 911 912 I-lower_bound
microliter 19 29 912 922 I-lower_bound

Participants 0 12 923 935 O
may 13 16 936 939 O
not 17 20 940 943 O
have 21 25 944 948 O
had 26 29 949 952 O
chemotherapy 30 42 953 965 B-treatment
wafer 43 48 966 971 I-treatment
placement 49 58 972 981 I-treatment
at 59 61 982 984 O
surgery 62 69 985 992 B-treatment

Participants 0 12 993 1005 O
must 13 17 1006 1010 O
be 18 20 1011 1013 O
> 21 22 1014 1015 O
70 23 25 1016 1018 B-lower_bound
years 26 31 1019 1024 I-lower_bound
of 32 34 1025 1027 O
age 35 38 1028 1031 B-age

Participants 0 12 1032 1044 O
must 13 17 1045 1049 O
have 18 22 1050 1054 O
histologically 23 37 1055 1069 O
confirmed 38 47 1070 1079 O
glioblastoma 48 60 1080 1092 B-cancer
/ 60 61 1092 1093 O
gliosarcoma 61 72 1093 1104 B-cancer

Participants 0 12 1105 1117 O
must 13 17 1118 1122 O
have 18 22 1123 1127 O
life 23 27 1128 1132 B-clinical_variable
expectancy 28 38 1133 1143 I-clinical_variable
greater 39 46 1144 1151 O
than 47 51 1152 1156 O
6 52 53 1157 1158 B-lower_bound
months 54 60 1159 1165 I-lower_bound

Participants 0 12 1166 1178 O
must 13 17 1179 1183 O
not 18 21 1184 1187 O
have 22 26 1188 1192 O
had 27 30 1193 1196 O
any 31 34 1197 1200 O
prior 35 40 1201 1206 B-treatment
therapy 41 48 1207 1214 I-treatment
for 49 52 1215 1218 O
glioblastoma 53 65 1219 1231 B-cancer
multiforme 66 76 1232 1242 I-cancer
including 77 86 1243 1252 O
radiation 87 96 1253 1262 B-treatment
or 97 99 1263 1265 O
chemotherapy 100 112 1266 1278 B-treatment

Platelets 0 9 1279 1288 B-clinical_variable
> 10 11 1289 1290 O
100,000 12 19 1291 1298 B-lower_bound
/ 19 20 1298 1299 I-lower_bound
microliter 20 30 1299 1309 I-lower_bound

Total 0 5 1310 1315 B-clinical_variable
bilirubin 6 15 1316 1325 I-clinical_variable
within 16 22 1326 1332 I-clinical_variable
normal 23 29 1333 1339 I-clinical_variable
institutional 30 43 1340 1353 I-clinical_variable
limits 44 50 1354 1360 I-clinical_variable
12 51 53 1361 1363 I-clinical_variable

Tumor 0 5 1364 1369 B-cancer
o6 6 8 1370 1372 B-clinical_variable
- 8 9 1372 1373 I-clinical_variable
methylguanine 9 22 1373 1386 I-clinical_variable
- 22 23 1386 1387 I-clinical_variable
DNA 23 26 1387 1390 I-clinical_variable
- 26 27 1390 1391 I-clinical_variable
methyltransferase 27 44 1391 1408 I-clinical_variable
promoter 45 53 1409 1417 I-clinical_variable
methylation 54 65 1418 1429 I-clinical_variable
status 66 72 1430 1436 I-clinical_variable
must 73 77 1437 1441 O
be 78 80 1442 1444 O
determined 81 91 1445 1455 O

aspartate 0 9 1456 1465 B-clinical_variable
aminotransferase 10 26 1466 1482 I-clinical_variable
test(SGOT)/alanine 27 45 1483 1501 I-clinical_variable
aminotransferase 46 62 1502 1518 I-clinical_variable
test(SGPT 63 72 1519 1528 I-clinical_variable
) 72 73 1528 1529 I-clinical_variable
< 74 75 1530 1531 O
2.5 76 79 1532 1535 B-upper_bound
X 80 81 1536 1537 I-upper_bound
institutional 82 95 1538 1551 I-upper_bound
upper 96 101 1552 1557 I-upper_bound
limit 102 107 1558 1563 I-upper_bound
of 108 110 1564 1566 I-upper_bound
normal 111 117 1567 1573 I-upper_bound

ANC 0 3 0 3 B-clinical_variable
≥1.5 4 8 4 8 O
x 9 10 9 10 I-lower_bound
10 11 13 11 13 I-lower_bound
^ 13 14 13 14 I-lower_bound
9 14 15 14 15 I-lower_bound
/ 15 16 15 16 I-lower_bound
L 16 17 16 17 I-lower_bound

AST 0 3 18 21 B-clinical_variable
and 4 7 22 25 O
ALT 8 11 26 29 B-clinical_variable
≤3× 12 15 30 33 O
ULN 16 19 34 37 I-upper_bound
or 20 22 38 40 O
< 23 24 41 42 O
5 25 26 43 44 B-upper_bound
ULN 27 30 45 48 I-upper_bound
for 31 34 49 52 O
patients 35 43 53 61 O
with 44 48 62 66 O
liver 49 54 67 72 B-cancer
metastases 55 65 73 83 I-cancer

AST 0 3 84 87 B-clinical_variable
and 4 7 88 91 I-clinical_variable
ALT 8 11 92 95 I-clinical_variable
≤3× 12 15 96 99 O
ULN 16 19 100 103 I-upper_bound
or 20 22 104 106 O
≤ 23 24 107 108 O
5 25 26 109 110 B-upper_bound
x 27 28 111 112 I-upper_bound
ULN 29 32 113 116 I-upper_bound
for 33 36 117 120 O
patients 37 45 121 129 O
with 46 50 130 134 O
liver 51 56 135 140 B-cancer
metastases 57 67 141 151 I-cancer

Acute 0 5 152 157 O
or 6 8 158 160 O
currently 9 18 161 170 O
active 19 25 171 177 O
hepatic 26 33 178 185 B-chronic_disease
or 34 36 186 188 O
biliary 37 44 189 196 B-chronic_disease
disease 45 52 197 204 I-chronic_disease
requiring 53 62 205 214 O
antiviral 63 72 215 224 B-treatment
therapy 73 80 225 232 I-treatment

Acute 0 5 233 238 O
or 6 8 239 241 O
currently 9 18 242 251 O
active 19 25 252 258 O
/ 25 26 258 259 O
requiring 26 35 259 268 O
antiviral 36 45 269 278 B-treatment
therapy 46 53 279 286 I-treatment
hepatic 54 61 287 294 B-chronic_disease
or 62 64 295 297 O
biliary 65 72 298 305 B-chronic_disease
disease 73 80 306 313 I-chronic_disease

Adequate 0 8 314 322 O
organ 9 14 323 328 O
function 15 23 329 337 O
as 24 26 338 340 O
defined 27 34 341 348 O
below 35 40 349 354 O
within 41 47 355 361 O
2 48 49 362 363 B-upper_bound
weeks 50 55 364 369 I-upper_bound
of 56 58 370 372 O
registration 59 71 373 385 O

Adequate 0 8 386 394 O
organ 9 14 395 400 O
function 15 23 401 409 O
as 24 26 410 412 O
defined 27 34 413 420 O
below 35 40 421 426 O
within 41 47 427 433 O
8 48 49 434 435 B-upper_bound
weeks 50 55 436 441 I-upper_bound
of 56 58 442 444 O
pre 59 62 445 448 O
- 62 63 448 449 O
registration 63 75 449 461 O

Agree 0 5 462 467 O
to 6 8 468 470 O
provide 9 16 471 478 O
archival 17 25 479 487 O
tumor 26 31 488 493 B-cancer
material 32 40 494 502 O
for 41 44 503 506 O
research 45 53 507 515 O

At 0 2 516 518 O
least 3 8 519 524 O
18 9 11 525 527 B-lower_bound
years 12 17 528 533 I-lower_bound
of 18 20 534 536 O
age 21 24 537 540 B-age

Currently 0 9 541 550 O
receiving 10 19 551 560 O
any 20 23 561 564 O
other 24 29 565 570 O
investigational 30 45 571 586 B-treatment
agents 46 52 587 593 I-treatment
or 53 55 594 596 O
systemic 56 64 597 605 B-treatment
cancer 65 71 606 612 I-treatment
therapy 72 79 613 620 I-treatment

Currently 0 9 621 630 O
taking 10 16 631 637 O
medications 17 28 638 649 O
and 29 32 650 653 O
herbal 33 39 654 660 O
or 40 42 661 663 O
dietary 43 50 664 671 O
supplements 51 62 672 683 O
that 63 67 684 688 O
are 68 71 689 692 O
strong 72 78 693 699 O
cytochrome 79 89 700 710 O
P450 90 94 711 715 B-treatment
( 95 96 716 717 I-treatment
CYP 96 99 717 720 I-treatment
) 99 100 720 721 I-treatment
3A4 101 104 722 725 I-treatment
inducers 105 113 726 734 I-treatment
or 114 116 735 737 O
inhibitors 117 127 738 748 B-treatment

ECOG 0 4 749 753 B-clinical_variable
performance 5 16 754 765 I-clinical_variable
status 17 23 766 772 I-clinical_variable
≤ 24 25 773 774 O
2 26 27 775 776 B-upper_bound

ECOG 0 4 777 781 B-clinical_variable
performance 5 16 782 793 I-clinical_variable
status 17 23 794 800 I-clinical_variable
≤2 24 26 801 803 O

ER 0 2 804 806 B-clinical_variable
and/or 3 9 807 813 O
PR 10 12 814 816 B-clinical_variable
positivity 13 23 817 827 O
by 24 26 828 830 O
institutional 27 40 831 844 O
standard 41 49 845 853 O
is 50 52 854 856 O
required 53 61 857 865 O
on 62 64 866 868 O
pathology 65 74 869 878 O
from 75 79 879 883 O
the 80 83 884 887 O
most 84 88 888 892 O
recent 89 95 893 899 O
tumor 96 101 900 905 B-cancer
specimen 102 110 906 914 O
unless 111 117 915 921 O
the 118 121 922 925 O
tissue 122 128 926 932 O
source 129 135 933 939 O
( 136 137 940 941 O
for 137 140 941 944 O
example 141 148 945 952 O
, 148 149 952 953 O
pleural 150 157 954 961 O
effusion 158 166 962 970 O
or 167 169 971 973 O
ascites 170 177 974 981 O
or 178 180 982 984 O
bone 181 185 985 989 B-treatment
biopsy 186 192 990 996 I-treatment
) 192 193 996 997 O
may 194 197 998 1001 O
yield 198 203 1002 1007 O
false 204 209 1008 1013 O
negative 210 218 1014 1022 O
ER 219 221 1023 1025 O
and/or 222 228 1026 1032 O
PR 229 231 1033 1035 O
result 232 238 1036 1042 O
, 238 239 1042 1043 O
in 240 242 1044 1046 O
which 243 248 1047 1052 O
case 249 253 1053 1057 O
the 254 257 1058 1061 O
pathology 258 267 1062 1071 O
from 268 272 1072 1076 O
an 273 275 1077 1079 O
earlier 276 283 1080 1087 O
time 284 288 1088 1092 O
point 289 294 1093 1098 O
could 295 300 1099 1104 O
be 301 303 1105 1107 O
used 304 308 1108 1112 O
and 309 312 1113 1116 O
a 313 314 1117 1118 O
discussion 315 325 1119 1129 O
with 326 330 1130 1134 O
the 331 334 1135 1138 O
study 335 340 1139 1144 O
chair 341 346 1145 1150 O
is 347 349 1151 1153 O
required 350 358 1154 1162 O

Experiencing 0 12 1163 1175 O
grade 13 18 1176 1181 B-lower_bound
2 19 20 1182 1183 I-lower_bound
or 21 23 1184 1186 O
greater 24 31 1187 1194 O
diarrhea 32 40 1195 1203 B-chronic_disease

HER2 0 4 1204 1208 B-cancer
mutations 5 14 1209 1218 I-cancer
detected 15 23 1219 1227 O
by 24 26 1228 1230 O
Guardant360 27 38 1231 1242 B-treatment

Histologically 0 14 1243 1257 O
or 15 17 1258 1260 O
cytologically 18 31 1261 1274 O
confirmed 32 41 1275 1284 O
HER2 42 46 1285 1289 B-cancer
- 46 47 1289 1290 O
negative 47 55 1290 1298 O
( 56 57 1299 1300 O
0 57 58 1300 1301 O
or 59 61 1302 1304 O
1 62 63 1305 1306 O
+ 63 64 1306 1307 O
by 65 67 1308 1310 O
IHC 68 71 1311 1314 O
or 72 74 1315 1317 O
non 75 78 1318 1321 O
- 78 79 1321 1322 O
amplified 79 88 1322 1331 O
by 89 91 1332 1334 O
FISH 92 96 1335 1339 O
) 96 97 1339 1340 O
breast 98 104 1341 1347 B-cancer
cancer 105 111 1348 1354 I-cancer
that 112 116 1355 1359 O
is 117 119 1360 1362 O
stage 120 125 1363 1368 O
IV 126 128 1369 1371 O

History 0 7 1372 1379 O
of 8 10 1380 1382 O
significant 11 22 1383 1394 O
cardiac 23 30 1395 1402 B-chronic_disease
disease 31 38 1403 1410 I-chronic_disease
, 38 39 1410 1411 O
cardiac 40 47 1412 1419 B-chronic_disease
risk 48 52 1420 1424 I-chronic_disease
factors 53 60 1425 1432 I-chronic_disease
, 60 61 1432 1433 O
or 62 64 1434 1436 O
uncontrolled 65 77 1437 1449 O
arrhythmias 78 89 1450 1461 B-chronic_disease

LVEF 0 4 1462 1466 B-clinical_variable
> 5 6 1467 1468 O
or 7 9 1469 1471 O
= 10 11 1472 1473 O
institutional 12 25 1474 1487 B-clinical_variable
ILLN 26 30 1488 1492 I-clinical_variable
within 31 37 1493 1499 O
4 38 39 1500 1501 B-upper_bound
weeks 40 45 1502 1507 I-upper_bound
of 46 48 1508 1510 O
registration 49 61 1511 1523 O

Men 0 3 1524 1527 B-gender
must 4 8 1528 1532 O
agree 9 14 1533 1538 B-contraception_consent
and 15 18 1539 1542 I-contraception_consent
commit 19 25 1543 1549 I-contraception_consent
to 26 28 1550 1552 I-contraception_consent
use 29 32 1553 1556 I-contraception_consent
a 33 34 1557 1558 I-contraception_consent
barrier 35 42 1559 1566 I-contraception_consent
method 43 49 1567 1573 I-contraception_consent
of 50 52 1574 1576 I-contraception_consent
contraception 53 66 1577 1590 I-contraception_consent
while 67 72 1591 1596 O
on 73 75 1597 1599 O
treatment 76 85 1600 1609 B-treatment
and 86 89 1610 1613 O
for 90 93 1614 1617 O
3 94 95 1618 1619 B-lower_bound
months 96 102 1620 1626 I-lower_bound
after 103 108 1627 1632 O
the 109 112 1633 1636 O
last 113 117 1637 1641 O
dose 118 122 1642 1646 O
of 123 125 1647 1649 O
the 126 129 1650 1653 O
investigational 130 145 1654 1669 O
product 146 153 1670 1677 O

Patients 0 8 1678 1686 O
with 9 13 1687 1691 O
known 14 19 1692 1697 O
brain 20 25 1698 1703 B-cancer
metastasis 26 36 1704 1714 I-cancer
are 37 40 1715 1718 O
eligible 41 49 1719 1727 O
, 49 50 1727 1728 O
but 51 54 1729 1732 O
must 55 59 1733 1737 O
have 60 64 1738 1742 O
received 65 73 1743 1751 O
radiation 74 83 1752 1761 B-treatment
and 84 87 1762 1765 O
be 88 90 1766 1768 O
off 91 94 1769 1772 O
steroids 95 103 1773 1781 B-treatment
and 104 107 1782 1785 O
stable 108 114 1786 1792 O
( 115 116 1793 1794 O
without 116 123 1794 1801 O
evidence 124 132 1802 1810 O
of 133 135 1811 1813 O
disease 136 143 1814 1821 O
progression 144 155 1822 1833 O
by 156 158 1834 1836 O
imaging 159 166 1837 1844 O
or 167 169 1845 1847 O
exam 170 174 1848 1852 O
) 174 175 1852 1853 O
for 176 179 1854 1857 O
3 180 181 1858 1859 B-upper_bound
months 182 188 1860 1866 I-upper_bound

Platelet 0 8 1867 1875 B-clinical_variable
count 9 14 1876 1881 I-clinical_variable
≥100 15 19 1882 1886 O
x 20 21 1887 1888 I-lower_bound
10 22 24 1889 1891 I-lower_bound
^ 24 25 1891 1892 I-lower_bound
9 25 26 1892 1893 I-lower_bound
/ 26 27 1893 1894 I-lower_bound
L 27 28 1894 1895 I-lower_bound

Pregnant 0 8 1896 1904 B-pregnancy

Prior 0 5 1905 1910 B-treatment
treatment 6 15 1911 1920 I-treatment
with 16 20 1921 1925 I-treatment
neratinib 21 30 1926 1935 I-treatment

QTc 0 3 1936 1939 B-clinical_variable
interval 4 12 1940 1948 I-clinical_variable
≤450 13 17 1949 1953 O
msec 18 22 1954 1958 I-upper_bound
for 23 26 1959 1962 O
men 27 30 1963 1966 B-gender
or 31 33 1967 1969 O
< 34 35 1970 1971 O
or 36 38 1972 1974 O
≤ 39 40 1975 1976 O
470 41 44 1977 1980 B-upper_bound
msec 45 49 1981 1985 I-upper_bound
for 50 53 1986 1989 O
women 54 59 1990 1995 B-gender
within 60 66 1996 2002 O
2 67 68 2003 2004 B-upper_bound
weeks 69 74 2005 2010 I-upper_bound
of 75 77 2011 2013 O
registration 78 90 2014 2026 O

Serum 0 5 2027 2032 B-clinical_variable
creatinine 6 16 2033 2043 I-clinical_variable
≤1.5 17 21 2044 2048 O
x 22 23 2049 2050 I-upper_bound
ULN 24 27 2051 2054 I-upper_bound

Symptomatic 0 11 2055 2066 O
intrinsic 12 21 2067 2076 B-chronic_disease
lung 22 26 2077 2081 I-chronic_disease
disease 27 34 2082 2089 I-chronic_disease
or 35 37 2090 2092 O
extensive 38 47 2093 2102 O
tumor 48 53 2103 2108 B-cancer
involvement 54 65 2109 2120 I-cancer
of 66 68 2121 2123 I-cancer
the 69 72 2124 2127 I-cancer
lungs 73 78 2128 2133 I-cancer
resulting 79 88 2134 2143 O
in 89 91 2144 2146 O
dyspnea 92 99 2147 2154 B-chronic_disease
at 100 102 2155 2157 O
rest 103 107 2158 2162 O

Testing 0 7 2163 2170 O
for 8 11 2171 2174 O
LVEF 12 16 2175 2179 B-clinical_variable
is 17 19 2180 2182 O
not 20 23 2183 2186 O
required 24 32 2187 2195 O
for 33 36 2196 2199 O
pre 37 40 2200 2203 O
- 40 41 2203 2204 O
registration 41 53 2204 2216 O
, 53 54 2216 2217 O
but 55 58 2218 2221 O
patient 59 66 2222 2229 O
must 67 71 2230 2234 O
not 72 75 2235 2238 O
have 76 80 2239 2243 O
a 81 82 2244 2245 O
recent 83 89 2246 2252 O
LVEF 90 94 2253 2257 O
< 95 96 2258 2259 O
LLN 97 100 2260 2263 O
or 101 103 2264 2266 O
have 104 108 2267 2271 O
symptoms 109 117 2272 2280 O
of 118 120 2281 2283 O
congestive 121 131 2284 2294 B-chronic_disease
heart 132 137 2295 2300 I-chronic_disease
failure 138 145 2301 2308 I-chronic_disease

The 0 3 2309 2312 O
patient 4 11 2313 2320 O
must 12 16 2321 2325 O
have 17 21 2326 2330 O
completed 22 31 2331 2340 O
radiation 32 41 2341 2350 B-treatment
therapy 42 49 2351 2358 I-treatment
and 50 53 2359 2362 O
be 54 56 2363 2365 O
at 57 59 2366 2368 O
least 60 65 2369 2374 O
1 66 67 2375 2376 B-lower_bound
week 68 72 2377 2381 I-lower_bound
from 73 77 2382 2386 O
the 78 81 2387 2390 O
last 82 86 2391 2395 O
systemic 87 95 2396 2404 B-treatment
chemotherapy 96 108 2405 2417 I-treatment
administration 109 123 2418 2432 O
, 123 124 2432 2433 O
with 125 129 2434 2438 O
adequate 130 138 2439 2447 O
recovery 139 147 2448 2456 O
of 148 150 2457 2459 O
bone 151 155 2460 2464 O
marrow 156 162 2465 2471 O
and 163 166 2472 2475 O
organ 167 172 2476 2481 O
functions 173 182 2482 2491 O
, 182 183 2491 2492 O
before 184 190 2493 2499 O
starting 191 199 2500 2508 O
neratinib 200 209 2509 2518 B-treatment

The 0 3 2519 2522 O
washout 4 11 2523 2530 O
period 12 18 2531 2537 O
must 19 23 2538 2542 O
have 24 28 2543 2547 O
been 29 33 2548 2552 O
completed 34 43 2553 2562 O
prior 44 49 2563 2568 O
to 50 52 2569 2571 O
the 53 56 2572 2575 O
start 57 62 2576 2581 O
of 63 65 2582 2584 O
neratinib 66 75 2585 2594 B-treatment
if 76 78 2595 2597 O
the 79 82 2598 2601 O
patient 83 90 2602 2609 O
was 91 94 2610 2613 O
taking 95 101 2614 2620 O
any 102 105 2621 2624 O
of 106 108 2625 2627 O
these 109 114 2628 2633 O
agents 115 121 2634 2640 O

There 0 5 2641 2646 O
is 6 8 2647 2649 O
no 9 11 2650 2652 O
limitation 12 22 2653 2663 O
on 23 25 2664 2666 O
the 26 29 2667 2670 O
number 30 36 2671 2677 O
of 37 39 2678 2680 O
prior 40 45 2681 2686 O
lines 46 51 2687 2692 O
of 52 54 2693 2695 O
systemic 55 63 2696 2704 B-treatment
therapy 64 71 2705 2712 I-treatment

To 0 2 2713 2715 O
be 3 5 2716 2718 O
eligible 6 14 2719 2727 O
for 15 18 2728 2731 O
the 19 22 2732 2735 O
Part 23 27 2736 2740 O
II 28 30 2741 2743 O
fulvestrant 31 42 2744 2755 B-treatment
- 42 43 2755 2756 O
naïve 43 48 2756 2761 O
ER+ 49 52 2762 2765 O
cohort 53 59 2766 2772 O
, 59 60 2772 2773 O
prior 61 66 2774 2779 B-treatment
treatment 67 76 2780 2789 I-treatment
with 77 81 2790 2794 I-treatment
fulvestrant 82 93 2795 2806 I-treatment
is 94 96 2807 2809 O
not 97 100 2810 2813 O
allowed 101 108 2814 2821 O

To 0 2 2822 2824 O
be 3 5 2825 2827 O
eligible 6 14 2828 2836 O
for 15 18 2837 2840 O
the 19 22 2841 2844 O
Part 23 27 2845 2849 O
II 28 30 2850 2852 O
fulvestrant 31 42 2853 2864 B-treatment
- 42 43 2864 2865 O
treated 43 50 2865 2872 O
ER+ 51 54 2873 2876 O
cohort 55 61 2877 2883 O
, 61 62 2883 2884 O
prior 63 68 2885 2890 O
disease 69 76 2891 2898 O
progression 77 88 2899 2910 O
on 89 91 2911 2913 O
fulvestrant 92 103 2914 2925 O
is 104 106 2926 2928 O
required 107 115 2929 2937 O

Total 0 5 2938 2943 O
bilirubin 6 15 2944 2953 B-clinical_variable
≤1.5 16 20 2954 2958 O
x 21 22 2959 2960 I-upper_bound
ULN 23 26 2961 2964 I-upper_bound

Total 0 5 2965 2970 B-clinical_variable
bilirubin 6 15 2971 2980 I-clinical_variable
≤1.5 16 20 2981 2985 O
× 21 22 2986 2987 I-upper_bound
ULN 23 26 2988 2991 I-upper_bound

Tumor 0 5 2992 2997 B-cancer
tissue 6 12 2998 3004 O
tested 13 19 3005 3011 O
positive 20 28 3012 3020 O
for 29 32 3021 3024 O
HER2 33 37 3025 3029 B-cancer
mutation 38 46 3030 3038 I-cancer

Uncontrolled 0 12 3039 3051 O
intercurrent 13 25 3052 3064 O
illness 26 33 3065 3072 O
including 34 43 3073 3082 O
, 43 44 3082 3083 O
but 45 48 3084 3087 O
not 49 52 3088 3091 O
limited 53 60 3092 3099 O
to 61 63 3100 3102 O
, 63 64 3102 3103 O
ongoing 65 72 3104 3111 O
or 73 75 3112 3114 O
active 76 82 3115 3121 B-chronic_disease
infection 83 92 3122 3131 I-chronic_disease
symptomatic 93 104 3132 3143 O
congestive 105 115 3144 3154 B-chronic_disease
heart 116 121 3155 3160 I-chronic_disease
failure 122 129 3161 3168 I-chronic_disease
, 129 130 3168 3169 O
unstable 131 139 3170 3178 B-chronic_disease
angina 140 146 3179 3185 I-chronic_disease
pectoris 147 155 3186 3194 I-chronic_disease
, 155 156 3194 3195 O
cardiac 157 164 3196 3203 B-chronic_disease
arrhythmia 165 175 3204 3214 I-chronic_disease
, 175 176 3214 3215 O
or 177 179 3216 3218 O
psychiatric 180 191 3219 3230 B-chronic_disease
illness 192 199 3231 3238 I-chronic_disease
/ 199 200 3238 3239 I-chronic_disease
social 200 206 3239 3245 I-chronic_disease
situations 207 217 3246 3256 I-chronic_disease
that 218 222 3257 3261 O
would 223 228 3262 3267 O
limit 229 234 3268 3273 O
compliance 235 245 3274 3284 O
with 246 250 3285 3289 O
study 251 256 3290 3295 O
requirements 257 269 3296 3308 O

Uncontrolled 0 12 3309 3321 O
intercurrent 13 25 3322 3334 B-chronic_disease
illness 26 33 3335 3342 I-chronic_disease
including 34 43 3343 3352 O
, 43 44 3352 3353 O
but 45 48 3354 3357 O
not 49 52 3358 3361 O
limited 53 60 3362 3369 O
to 61 63 3370 3372 O
, 63 64 3372 3373 O
ongoing 65 72 3374 3381 O
or 73 75 3382 3384 O
active 76 82 3385 3391 B-chronic_disease
infection 83 92 3392 3401 I-chronic_disease
, 92 93 3401 3402 O
unstable 94 102 3403 3411 B-chronic_disease
angina 103 109 3412 3418 I-chronic_disease
pectoris 110 118 3419 3427 I-chronic_disease
, 118 119 3427 3428 O
cardiac 120 127 3429 3436 B-chronic_disease
arrhythmia 128 138 3437 3447 I-chronic_disease
, 138 139 3447 3448 O
or 140 142 3449 3451 O
psychiatric 143 154 3452 3463 B-chronic_disease
illness 155 162 3464 3471 I-chronic_disease
/ 162 163 3471 3472 I-chronic_disease
social 163 169 3472 3478 I-chronic_disease
situations 170 180 3479 3489 I-chronic_disease
that 181 185 3490 3494 O
would 186 191 3495 3500 O
limit 192 197 3501 3506 O
compliance 198 208 3507 3517 O
with 209 213 3518 3522 O
study 214 219 3523 3528 O
requirements 220 232 3529 3541 O

Women 0 5 3542 3547 B-gender
of 6 8 3548 3550 O
childbearing 9 21 3551 3563 O
potential 22 31 3564 3573 O

men 0 3 3574 3577 B-gender

must 0 4 3578 3582 O
agree 5 10 3583 3588 B-contraception_consent
to 11 13 3589 3591 I-contraception_consent
use 14 17 3592 3595 I-contraception_consent
adequate 18 26 3596 3604 I-contraception_consent
contraception 27 40 3605 3618 I-contraception_consent
( 41 42 3619 3620 O
hormonal 42 50 3620 3628 B-contraception_consent
or 51 53 3629 3631 I-contraception_consent
barrier 54 61 3632 3639 I-contraception_consent
method 62 68 3640 3646 I-contraception_consent
of 69 71 3647 3649 I-contraception_consent
birth 72 77 3650 3655 I-contraception_consent
control 78 85 3656 3663 I-contraception_consent
, 85 86 3663 3664 O
abstinence 87 97 3665 3675 B-contraception_consent
) 97 98 3675 3676 O
prior 99 104 3677 3682 O
to 105 107 3683 3685 O
study 108 113 3686 3691 O
entry 114 119 3692 3697 O
and 120 123 3698 3701 O
for 124 127 3702 3705 O
the 128 131 3706 3709 O
duration 132 140 3710 3718 O
of 141 143 3719 3721 O
study 144 149 3722 3727 O
participation 150 163 3728 3741 O

Active 0 6 0 6 O
autoimmune 7 17 7 17 B-chronic_disease
disease 18 25 18 25 I-chronic_disease
that 26 30 26 30 O
has 31 34 31 34 O
required 35 43 35 43 O
systemic 44 52 44 52 B-treatment
treatment 53 62 53 62 I-treatment
in 63 65 63 65 O
past 66 70 66 70 B-upper_bound
2 71 72 71 72 I-upper_bound
years 73 78 73 78 I-upper_bound

Active 0 6 79 85 B-chronic_disease
infection 7 16 86 95 I-chronic_disease
requiring 17 26 96 105 O
systemic 27 35 106 114 B-treatment
therapy 36 43 115 122 I-treatment

Advanced 0 8 123 131 O
melanoma 9 17 132 140 B-cancer
or 18 20 141 143 O
PD 21 23 144 146 O
- 23 24 146 147 O
L1 24 26 147 149 O
- 26 27 149 150 O
positive 27 35 150 158 O
advanced 36 44 159 167 O
, 44 45 167 168 O
relapsed 46 54 169 177 O
, 54 55 177 178 O
or 56 58 179 181 O
refractory 59 69 182 192 O
solid 70 75 193 198 B-cancer
tumor 76 81 199 204 I-cancer
or 82 84 205 207 O
lymphoma 85 93 208 216 B-cancer

Any 0 3 217 220 O
number 4 10 221 227 O
of 11 13 228 230 O
prior 14 19 231 236 B-treatment
treatment 20 29 237 246 I-treatment
regimens 30 38 247 255 I-treatment

Between 0 7 256 263 O
6 8 9 264 265 B-lower_bound
months 10 16 266 272 I-lower_bound
and 17 20 273 276 O
< 21 22 277 278 O
18 22 24 278 280 B-upper_bound
years 25 30 281 286 I-upper_bound
of 31 33 287 289 O
age 34 37 290 293 B-age

Currently 0 9 294 303 O
participating 10 23 304 317 O
and 24 27 318 321 O
receiving 28 37 322 331 O
study 38 43 332 337 O
therapy 44 51 338 345 B-treatment
in 52 54 346 348 O
, 54 55 348 349 O
or 56 58 350 352 O
has 59 62 353 356 O
participated 63 75 357 369 O
in 76 78 370 372 O
a 79 80 373 374 O
study 81 86 375 380 O
of 87 89 381 383 O
an 90 92 384 386 O
investigational 93 108 387 402 B-treatment
agent 109 114 403 408 I-treatment
and 115 118 409 412 O
received 119 127 413 421 O
study 128 133 422 427 O
therapy 134 141 428 435 O
or 142 144 436 438 O
used 145 149 439 443 O
an 150 152 444 446 O
investigational 153 168 447 462 B-treatment
device 169 175 463 469 I-treatment

Diagnosis 0 9 470 479 O
of 10 12 480 482 O
immunodeficiency 13 29 483 499 B-chronic_disease
or 30 32 500 502 O
receiving 33 42 503 512 O
systemic 43 51 513 521 B-treatment
steroid 52 59 522 529 I-treatment
therapy 60 67 530 537 I-treatment
or 68 70 538 540 O
any 71 74 541 544 O
other 75 80 545 550 O
form 81 85 551 555 O
of 86 88 556 558 O
immunosuppressive 89 106 559 576 B-treatment
therapy 107 114 577 584 I-treatment

Female 0 6 585 591 B-gender
participants 7 19 592 604 I-gender
of 20 22 605 607 O
childbearing 23 35 608 620 O
potential 36 45 621 630 O
must 46 50 631 635 O
be 51 53 636 638 O
willing 54 61 639 646 B-contraception_consent
to 62 64 647 649 I-contraception_consent
use 65 68 650 653 I-contraception_consent
2 69 70 654 655 I-contraception_consent
methods 71 78 656 663 I-contraception_consent
of 79 81 664 666 I-contraception_consent
contraception 82 95 667 680 I-contraception_consent
or 96 98 681 683 O
be 99 101 684 686 O
surgically 102 112 687 697 O
sterile 113 120 698 705 O

Female 0 6 706 712 B-gender
participants 7 19 713 725 I-gender
of 20 22 726 728 O
childbearing 23 35 729 741 O
potential 36 45 742 751 O
should 46 52 752 758 O
have 53 57 759 763 O
a 58 59 764 765 O
negative 60 68 766 774 B-pregnancy
urine 69 74 775 780 I-pregnancy
or 75 77 781 783 I-pregnancy
serum 78 83 784 789 I-pregnancy
pregnancy 84 93 790 799 I-pregnancy
test 94 98 800 804 O

Has 0 3 805 808 O
a 4 5 809 810 O
history 6 13 811 818 O
of 14 16 819 821 O
( 17 18 822 823 O
non 18 21 823 826 O
- 21 22 826 827 O
infectious 22 32 827 837 O
) 32 33 837 838 O
pneumonitis 34 45 839 850 B-chronic_disease
that 46 50 851 855 O
required 51 59 856 864 O
steroids 60 68 865 873 B-treatment
or 69 71 874 876 O
current 72 79 877 884 O
pneumonitis 80 91 885 896 O

Has 0 3 897 900 O
undergone 4 13 901 910 O
solid 14 19 911 916 B-treatment
organ 20 25 917 922 I-treatment
transplant 26 36 923 933 I-treatment
at 37 39 934 936 O
any 40 43 937 940 O
time 44 48 941 945 O

Hepatitis 0 9 946 955 B-chronic_disease
B 10 11 956 957 I-chronic_disease
or 12 14 958 960 I-chronic_disease
C 15 16 961 962 I-chronic_disease

Histologically- 0 15 963 978 O
or 16 18 979 981 O
cytologically 19 32 982 995 O
- 32 33 995 996 O
documented 33 43 996 1006 O
, 43 44 1006 1007 O
locally 45 52 1008 1015 O
- 52 53 1015 1016 O
advanced 53 61 1016 1024 O
, 61 62 1024 1025 O
or 63 65 1026 1028 O
metastatic 66 76 1029 1039 B-cancer
solid 77 82 1040 1045 I-cancer
malignancy 83 93 1046 1056 I-cancer
or 94 96 1057 1059 O
lymphoma 97 105 1060 1068 B-cancer
that 106 110 1069 1073 O
is 111 113 1074 1076 O
incurable 114 123 1077 1086 O

History 0 7 1087 1094 O
or 8 10 1095 1097 O
current 11 18 1098 1105 O
evidence 19 27 1106 1114 O
of 28 30 1115 1117 O
any 31 34 1118 1121 O
condition 35 44 1122 1131 O
, 44 45 1131 1132 O
therapy 46 53 1133 1140 B-treatment
, 53 54 1140 1141 O
or 55 57 1142 1144 O
laboratory 58 68 1145 1155 O
abnormality 69 80 1156 1167 O

Human 0 5 1168 1173 B-chronic_disease
immunodeficiency 6 22 1174 1190 I-chronic_disease
virus 23 28 1191 1196 I-chronic_disease
( 29 30 1197 1198 I-chronic_disease
HIV 30 33 1198 1201 I-chronic_disease
) 33 34 1201 1202 I-chronic_disease

Karnofsky 0 9 1203 1212 B-clinical_variable
score 10 15 1213 1218 I-clinical_variable
≥50 16 19 1219 1222 O
for 20 23 1223 1226 O
participants 24 36 1227 1239 O
> 37 38 1240 1241 O
16 38 40 1241 1243 B-lower_bound
years 41 46 1244 1249 I-lower_bound
of 47 49 1250 1252 O
age 50 53 1253 1256 B-age

Known 0 5 1257 1262 O
active 6 12 1263 1269 O
central 13 20 1270 1277 B-cancer
nervous 21 28 1278 1285 I-cancer
system 29 35 1286 1292 I-cancer
( 36 37 1293 1294 I-cancer
CNS 37 40 1294 1297 I-cancer
) 40 41 1297 1298 I-cancer
metastases 42 52 1299 1309 I-cancer
and/or 53 59 1310 1316 O
carcinomatous 60 73 1317 1330 B-cancer
meningitis 74 84 1331 1341 I-cancer

Known 0 5 1342 1347 O
additional 6 16 1348 1358 O
malignancy 17 27 1359 1369 B-cancer
that 28 32 1370 1374 O
is 33 35 1375 1377 O
progressing 36 47 1378 1389 O
or 48 50 1390 1392 O
requires 51 59 1393 1401 O
active 60 66 1402 1408 O
treatment 67 76 1409 1418 B-treatment
with 77 81 1419 1423 O
the 82 85 1424 1427 O
exception 86 95 1428 1437 O
of 96 98 1438 1440 O
basal 99 104 1441 1446 B-cancer
cell 105 109 1447 1451 I-cancer
carcinoma 110 119 1452 1461 I-cancer
of 120 122 1462 1464 I-cancer
the 123 126 1465 1468 I-cancer
skin 127 131 1469 1473 I-cancer
, 131 132 1473 1474 O
squamous 133 141 1475 1483 B-cancer
cell 142 146 1484 1488 I-cancer
carcinoma 147 156 1489 1498 I-cancer
of 157 159 1499 1501 I-cancer
the 160 163 1502 1505 I-cancer
skin 164 168 1506 1510 I-cancer
or 169 171 1511 1513 O
carcinoma 172 181 1514 1523 B-cancer
in 182 184 1524 1526 I-cancer
situ 185 189 1527 1531 I-cancer

Known 0 5 1532 1537 O
history 6 13 1538 1545 O
of 14 16 1546 1548 O
active 17 23 1549 1555 B-chronic_disease
tuberculosis 24 36 1556 1568 I-chronic_disease
( 37 38 1569 1570 O
TB 38 40 1570 1572 B-chronic_disease
; 40 41 1572 1573 O
Bacillus 42 50 1574 1582 B-chronic_disease
tuberculosis 51 63 1583 1595 I-chronic_disease
) 63 64 1595 1596 O

Known 0 5 1597 1602 O
psychiatric 6 17 1603 1614 B-chronic_disease
or 18 20 1615 1617 O
substance 21 30 1618 1627 O
abuse 31 36 1628 1633 O
disorders 37 46 1634 1643 O
that 47 51 1644 1648 O
would 52 57 1649 1654 O
interfere 58 67 1655 1664 O
with 68 72 1665 1669 O
the 73 76 1670 1673 O
requirements 77 89 1674 1686 O
of 90 92 1687 1689 O
the 93 96 1690 1693 O
study 97 102 1694 1699 O

Lansky 0 6 1700 1706 B-clinical_variable
Play 7 11 1707 1711 I-clinical_variable
Scale 12 17 1712 1717 I-clinical_variable
≥50 18 21 1718 1721 O
for 22 25 1722 1725 O
participants 26 38 1726 1738 O
from 39 43 1739 1743 O
6 44 45 1744 1745 B-lower_bound
months 46 52 1746 1752 I-lower_bound
up 53 55 1753 1755 O
to 56 58 1756 1758 O
and 59 62 1759 1762 O
including 63 72 1763 1772 O
16 73 75 1773 1775 B-upper_bound
years 76 81 1776 1781 I-upper_bound
of 82 84 1782 1784 O
age 85 88 1785 1788 B-age

Male 0 4 1789 1793 B-gender
participants 5 17 1794 1806 I-gender
of 18 20 1807 1809 O
reproductive 21 33 1810 1822 O
potential 34 43 1823 1832 O
must 44 48 1833 1837 O
agree 49 54 1838 1843 B-contraception_consent
to 55 57 1844 1846 I-contraception_consent
use 58 61 1847 1850 I-contraception_consent
an 62 64 1851 1853 I-contraception_consent
adequate 65 73 1854 1862 I-contraception_consent
method 74 80 1863 1869 I-contraception_consent
of 81 83 1870 1872 I-contraception_consent
contraception 84 97 1873 1886 I-contraception_consent
starting 98 106 1887 1895 O
with 107 111 1896 1900 O
the 112 115 1901 1904 O
first 116 121 1905 1910 O
dose 122 126 1911 1915 O
of 127 129 1916 1918 O
study 130 135 1919 1924 B-treatment
medication 136 146 1925 1935 I-treatment
through 147 154 1936 1943 O
120 155 158 1944 1947 B-upper_bound
days 159 163 1948 1952 I-upper_bound
after 164 169 1953 1958 O
the 170 173 1959 1962 O
last 174 178 1963 1967 O
dose 179 183 1968 1972 O
of 184 186 1973 1975 O
study 187 192 1976 1981 O
medication 193 203 1982 1992 O

Participants 0 12 1993 2005 O
who 13 16 2006 2009 O
have 17 21 2010 2014 O
had 22 25 2015 2018 O
an 26 28 2019 2021 O
allogeneic 29 39 2022 2032 B-treatment
hematopoietic 40 53 2033 2046 I-treatment
transplant 54 64 2047 2057 I-treatment
> 65 66 2058 2059 O
5 66 67 2059 2060 B-lower_bound
years 68 73 2061 2066 I-lower_bound
ago 74 77 2067 2070 I-lower_bound
are 78 81 2071 2074 O
eligible 82 90 2075 2083 O
as 91 93 2084 2086 O
long 94 98 2087 2091 O
as 99 101 2092 2094 O
there 102 107 2095 2100 O
are 108 111 2101 2104 O
no 112 114 2105 2107 O
symptoms 115 123 2108 2116 O
of 124 126 2117 2119 O
Graft 127 132 2120 2125 B-chronic_disease
Versus 133 139 2126 2132 I-chronic_disease
Host 140 144 2133 2137 I-chronic_disease
Disease 145 152 2138 2145 I-chronic_disease
[ 153 154 2146 2147 I-chronic_disease
GVHD 154 158 2147 2151 I-chronic_disease
] 158 159 2151 2152 I-chronic_disease

Participants 0 12 2153 2165 O
with 13 17 2166 2170 O
neuroblastoma 18 31 2171 2184 B-cancer
with 32 36 2185 2189 O
only 37 41 2190 2194 O
metaiodobenzylguanidine 42 65 2195 2218 B-treatment
( 66 67 2219 2220 I-treatment
MIBG)-positive 67 81 2220 2234 I-treatment
evaluable 82 91 2235 2244 O
disease 92 99 2245 2252 O
may 100 103 2253 2256 O
be 104 106 2257 2259 O
enrolled 107 115 2260 2268 O

Pregnant 0 8 2269 2277 B-pregnancy

Prior 0 5 2278 2283 B-treatment
radiotherapy 6 18 2284 2296 I-treatment
within 19 25 2297 2303 O
2 26 27 2304 2305 B-upper_bound
weeks 28 33 2306 2311 I-upper_bound
of 34 36 2312 2314 O
start 37 42 2315 2320 O
of 43 45 2321 2323 O
study 46 51 2324 2329 O
treatment 52 61 2330 2339 B-treatment

Prior 0 5 2340 2345 B-treatment
systemic 6 14 2346 2354 I-treatment
anti 15 19 2355 2359 I-treatment
- 19 20 2359 2360 I-treatment
cancer 20 26 2360 2366 I-treatment
therapy 27 34 2367 2374 I-treatment
including 35 44 2375 2384 O
investigational 45 60 2385 2400 B-treatment
agent 61 66 2401 2406 I-treatment

Prior 0 5 2407 2412 B-treatment
therapy 6 13 2413 2420 I-treatment
with 14 18 2421 2425 O
an 19 21 2426 2428 O
anti 22 26 2429 2433 O
- 26 27 2433 2434 O
programmed 27 37 2434 2444 O
cell 38 42 2445 2449 O
death 43 48 2450 2455 O
( 49 50 2456 2457 O
PD)-1 50 55 2457 2462 O
, 55 56 2462 2463 O
anti 57 61 2464 2468 O
- 61 62 2468 2469 O
PD 62 64 2469 2471 O
- 64 65 2471 2472 O
ligand 65 71 2472 2478 O
1 72 73 2479 2480 O
( 74 75 2481 2482 O
anti 75 79 2482 2486 O
- 79 80 2486 2487 O
PD 80 82 2487 2489 O
- 82 83 2489 2490 O
L1 83 85 2490 2492 O
) 85 86 2492 2493 O
, 86 87 2493 2494 O
anti 88 92 2495 2499 O
- 92 93 2499 2500 O
PD 93 95 2500 2502 O
- 95 96 2502 2503 O
L2 96 98 2503 2505 O
agent 99 104 2506 2511 O

Received 0 8 2512 2520 O
a 9 10 2521 2522 O
live 11 15 2523 2527 O
vaccine 16 23 2528 2535 B-treatment
within 24 30 2536 2542 O
30 31 33 2543 2545 B-upper_bound
days 34 38 2546 2550 I-upper_bound
of 39 41 2551 2553 O
planned 42 49 2554 2561 O
start 50 55 2562 2567 O
of 56 58 2568 2570 O
study 59 64 2571 2576 O
medication 65 75 2577 2587 B-treatment

Severe 0 6 2588 2594 O
hypersensitivity 7 23 2595 2611 O
( 24 25 2612 2613 O
≥ 25 26 2613 2614 O
Grade 27 32 2615 2620 B-lower_bound
3 33 34 2621 2622 I-lower_bound
) 34 35 2622 2623 O
to 36 38 2624 2626 O
pembrolizumab 39 52 2627 2640 B-allergy_name
and/or 53 59 2641 2647 O
any 60 63 2648 2651 O
of 64 66 2652 2654 O
its 67 70 2655 2658 O
excipients 71 81 2659 2669 B-allergy_name

Tissue 0 6 2670 2676 O
( 7 8 2677 2678 O
or 8 10 2678 2680 O
lymph 11 16 2681 2686 B-treatment
node 17 21 2687 2691 I-treatment
biopsy 22 28 2692 2698 I-treatment
for 29 32 2699 2702 O
rrcHL 33 38 2703 2708 B-cancer
participants 39 51 2709 2721 O
) 51 52 2721 2722 O
available 53 62 2723 2732 O
from 63 67 2733 2737 O
an 68 70 2738 2740 O
archival 71 79 2741 2749 O
tissue 80 86 2750 2756 O
sample 87 93 2757 2763 O

Tumor(s 0 7 2764 2771 B-cancer
) 7 8 2771 2772 I-cancer
involving 9 18 2773 2782 O
the 19 22 2783 2786 O
brain 23 28 2787 2792 O
stem 29 33 2793 2797 O

abstain 0 7 2798 2805 O
from 8 12 2806 2810 O
heterosexual 13 25 2811 2823 O
activity 26 34 2824 2832 O
for 35 38 2833 2836 O
the 39 42 2837 2840 O
course 43 49 2841 2847 O
of 50 52 2848 2850 O
the 53 56 2851 2854 O
study 57 62 2855 2860 O
through 63 70 2861 2868 O
120 71 74 2869 2872 B-upper_bound
days 75 79 2873 2877 I-upper_bound
after 80 85 2878 2883 I-upper_bound
the 86 89 2884 2887 O
last 90 94 2888 2892 O
dose 95 99 2893 2897 O
of 100 102 2898 2900 O
study 103 108 2901 2906 O
medication 109 119 2907 2917 B-treatment

between 0 7 2918 2925 O
3 8 9 2926 2927 B-lower_bound
years 10 15 2928 2933 I-lower_bound
and 16 19 2934 2937 O
< 20 21 2938 2939 O
18 21 23 2939 2941 B-upper_bound
years 24 29 2942 2947 I-upper_bound
of 30 32 2948 2950 O
age 33 36 2951 2954 B-age
for 37 40 2955 2958 O
rrcHL 41 46 2959 2964 B-cancer
participants 47 59 2965 2977 O

expecting 0 9 2978 2987 O
to 10 12 2988 2990 O
conceive 13 21 2991 2999 O
or 22 24 3000 3002 O
father 25 31 3003 3009 O
children 32 40 3010 3018 O
within 41 47 3019 3025 O
the 48 51 3026 3029 O
projected 52 61 3030 3039 O
duration 62 70 3040 3048 O
of 71 73 3049 3051 O
the 74 77 3052 3055 O
trial 78 83 3056 3061 O
through 84 91 3062 3069 O
120 92 95 3070 3073 B-upper_bound
days 96 100 3074 3078 I-upper_bound
after 101 106 3079 3084 I-upper_bound
the 107 110 3085 3088 O
last 111 115 3089 3093 O
dose 116 120 3094 3098 O
of 121 123 3099 3101 O
study 124 129 3102 3107 B-treatment
medication 130 140 3108 3118 I-treatment

for 0 3 3119 3122 O
which 4 9 3123 3128 O
no 10 12 3129 3131 O
standard 13 21 3132 3140 O
therapy 22 29 3141 3148 B-treatment
exists 30 36 3149 3155 O

for 0 3 3156 3159 O
which 4 9 3160 3165 O
no 10 12 3166 3168 O
standard 13 21 3169 3177 O
therapy 22 29 3178 3185 B-treatment
is 30 32 3186 3188 O
considered 33 43 3189 3199 O
appropriate 44 55 3200 3211 O

has 0 3 3212 3215 O
failed 4 10 3216 3222 O
prior 11 16 3223 3228 B-treatment
standard 17 25 3229 3237 I-treatment
therapy 26 33 3238 3245 I-treatment

known 0 5 3246 3251 O
severe 6 12 3252 3258 O
hypersensitivity 13 29 3259 3275 O
to 30 32 3276 3278 O
any 33 36 3279 3282 O
component 37 46 3283 3292 B-allergy_name
or 47 49 3293 3295 I-allergy_name
analog 50 56 3296 3302 I-allergy_name
of 57 59 3303 3305 I-allergy_name
the 60 63 3306 3309 I-allergy_name
trial 64 69 3310 3315 I-allergy_name
treatment 70 79 3316 3325 I-allergy_name
, 79 80 3325 3326 O
that 81 85 3327 3331 O
might 86 91 3332 3337 O
confound 92 100 3338 3346 O
the 101 104 3347 3350 O
results 105 112 3351 3358 O
of 113 115 3359 3361 O
the 116 119 3362 3365 O
trial 120 125 3366 3371 O

measurement 0 11 3372 3383 O
must 12 16 3384 3388 O
be 17 19 3389 3391 O
> 20 21 3392 3393 O
15 21 23 3393 3395 B-lower_bound
mm 24 26 3396 3398 I-lower_bound
in 27 29 3399 3401 O
longest 30 37 3402 3409 O
diameter 38 46 3410 3418 O
or 47 49 3419 3421 O
> 50 51 3422 3423 O
10 51 53 3423 3425 B-lower_bound
mm 54 56 3426 3428 I-lower_bound
in 57 59 3429 3431 O
short 60 65 3432 3437 O
axis 66 70 3438 3442 O
] 70 71 3442 3443 O
for 72 75 3444 3447 O
rrcHL 76 81 3448 3453 O
participants 82 94 3454 3466 O

on 0 2 3467 3469 O
day 3 6 3470 3473 O
of 7 9 3474 3476 O
signing 10 17 3477 3484 O
informed 18 26 3485 3493 O
consent 27 34 3494 3501 O
/ 34 35 3501 3502 O
assent 35 41 3502 3508 O
( 42 43 3509 3510 O
the 43 46 3510 3513 O
first 47 52 3514 3519 O
3 53 54 3520 3521 O
participants 55 67 3522 3534 O
dosed 68 73 3535 3540 O
in 74 76 3541 3543 O
Part 77 81 3544 3548 O
1 82 83 3549 3550 O
are 84 87 3551 3554 O
to 88 90 3555 3557 O
be 91 93 3558 3560 O
≥ 94 95 3561 3562 O
6 96 97 3563 3564 B-lower_bound
years 98 103 3565 3570 I-lower_bound
of 104 106 3571 3573 O
age 107 110 3574 3577 B-age
) 110 111 3577 3578 O

prior 0 5 3579 3584 B-treatment
allogeneic 6 16 3585 3595 I-treatment
hematopoietic 17 30 3596 3609 I-treatment
stem 31 35 3610 3614 I-treatment
cell 36 40 3615 3619 I-treatment
transplantation 41 56 3620 3635 I-treatment
within 57 63 3636 3642 O
the 64 67 3643 3646 O
last 68 72 3647 3651 B-upper_bound
5 73 74 3652 3653 I-upper_bound
years 75 80 3654 3659 I-upper_bound

replacement 0 11 3660 3671 B-treatment
therapy 12 19 3672 3679 I-treatment
( 20 21 3680 3681 O
such 21 25 3681 3685 O
as 26 28 3686 3688 O
thyroxine 29 38 3689 3698 B-treatment
, 38 39 3698 3699 O
insulin 40 47 3700 3707 B-treatment
, 47 48 3707 3708 O
or 49 51 3709 3711 O
physiologic 52 63 3712 3723 B-treatment
corticosteroid 64 78 3724 3738 I-treatment
replacement 79 90 3739 3750 I-treatment
therapy 91 98 3751 3758 I-treatment
for 99 102 3759 3762 O
adrenal 103 110 3763 3770 B-chronic_disease
or 111 113 3771 3773 O
pituitary 114 123 3774 3783 B-chronic_disease
insufficiency 124 137 3784 3797 I-chronic_disease
) 137 138 3797 3798 O
is 139 141 3799 3801 O
acceptable 142 152 3802 3812 O

with 0 4 3813 3817 O
potentially 5 16 3818 3829 B-treatment
curative 17 25 3830 3838 I-treatment
therapy 26 33 3839 3846 I-treatment
, 33 34 3846 3847 O
or 35 37 3848 3850 O
in 38 40 3851 3853 B-cancer
situ 41 45 3854 3858 I-cancer
cervical 46 54 3859 3867 I-cancer
cancer 55 61 3868 3874 I-cancer

within 0 6 3875 3881 O
7 7 8 3882 3883 B-upper_bound
days 9 13 3884 3888 I-upper_bound
prior 14 19 3889 3894 I-upper_bound
to 20 22 3895 3897 O
the 23 26 3898 3901 O
date 27 31 3902 3906 O
of 32 34 3907 3909 O
allocation 35 45 3910 3920 O
/ 45 46 3920 3921 O
randomization 46 59 3921 3934 O

within 0 6 3935 3941 O
72 7 9 3942 3944 B-upper_bound
hours 10 15 3945 3950 I-upper_bound
prior 16 21 3951 3956 I-upper_bound
to 22 24 3957 3959 O
receiving 25 34 3960 3969 O
the 35 38 3970 3973 O
first 39 44 3974 3979 O
dose 45 49 3980 3984 O
of 50 52 3985 3987 O
study 53 58 3988 3993 O
medication 59 69 3994 4004 B-treatment

12 0 2 0 2 O
weeks 3 8 3 8 O
from 9 13 9 13 O
the 14 17 14 17 O
completion 18 28 18 28 O
of 29 31 29 31 O
radiation 32 41 32 41 B-treatment

2 0 1 42 43 B-lower_bound
weeks 2 7 44 49 I-lower_bound
from 8 12 50 54 O
administration 13 27 55 69 O
of 28 30 70 72 O
a 31 32 73 74 O
non 33 36 75 78 B-treatment
- 36 37 78 79 I-treatment
cytotoxic 37 46 79 88 I-treatment
, 46 47 88 89 O
FDA 48 51 90 93 B-treatment
- 51 52 93 94 I-treatment
approved 52 60 94 102 I-treatment
agent 61 66 103 108 I-treatment
( 67 68 109 110 O
e.g. 68 72 110 114 O
, 72 73 114 115 O
Tarceva 74 81 116 123 B-treatment
, 81 82 123 124 O
hydroxychloroquine 83 101 125 143 B-treatment
, 101 102 143 144 O
bevacizumab 103 114 145 156 B-treatment
, 114 115 156 157 O
etc 116 119 158 161 O
. 119 120 161 162 O
) 120 121 162 163 O

3 0 1 164 165 B-upper_bound
weeks 2 7 166 171 I-upper_bound
from 8 12 172 176 O
a 13 14 177 178 O
non 15 18 179 182 B-treatment
- 18 19 182 183 I-treatment
nitrosourea 19 30 183 194 I-treatment
chemotherapy 31 43 195 207 I-treatment

4 0 1 208 209 B-lower_bound
weeks 2 7 210 215 I-lower_bound
from 8 12 216 220 O
any 13 16 221 224 O
investigational 17 32 225 240 B-treatment
( 33 34 241 242 I-treatment
not 34 37 242 245 I-treatment
Food 38 42 246 250 I-treatment
and 43 46 251 254 I-treatment
Drug 47 51 255 259 I-treatment
Administration 52 66 260 274 I-treatment
[ 67 68 275 276 I-treatment
FDA]-approved 68 81 276 289 I-treatment
) 81 82 289 290 I-treatment
agents 83 89 291 297 I-treatment

6 0 1 298 299 B-upper_bound
weeks 2 7 300 305 I-upper_bound
from 8 12 306 310 O
a 13 14 311 312 O
nitrosourea 15 26 313 324 B-treatment
chemotherapy 27 39 325 337 I-treatment

Absolute 0 8 338 346 B-clinical_variable
neutrophil 9 19 347 357 I-clinical_variable
count 20 25 358 363 I-clinical_variable
> 26 27 364 365 O
= 27 28 365 366 O
1,500 29 34 367 372 B-lower_bound
/ 34 35 372 373 I-lower_bound
mcL 35 38 373 376 I-lower_bound

Activated 0 9 377 386 B-clinical_variable
partial 10 17 387 394 I-clinical_variable
thromboplastin 18 32 395 409 I-clinical_variable
time 33 37 410 414 I-clinical_variable
( 38 39 415 416 I-clinical_variable
APTT)/partial 39 52 416 429 I-clinical_variable
thromboplastin 53 67 430 444 I-clinical_variable
time 68 72 445 449 I-clinical_variable
( 73 74 450 451 I-clinical_variable
PTT 74 77 451 454 I-clinical_variable
) 77 78 454 455 I-clinical_variable
= 79 80 456 457 O
< 80 81 457 458 O
1.5 82 85 459 462 B-upper_bound
x 86 87 463 464 I-upper_bound
institutional 88 101 465 478 I-upper_bound
upper 102 107 479 484 I-upper_bound
limit 108 113 485 490 I-upper_bound
of 114 116 491 493 I-upper_bound
normal 117 123 494 500 I-upper_bound

Aspartate 0 9 501 510 B-clinical_variable
aminotransferase 10 26 511 527 I-clinical_variable
( 27 28 528 529 I-clinical_variable
AST 28 31 529 532 I-clinical_variable
) 31 32 532 533 I-clinical_variable
( 33 34 534 535 B-clinical_variable
serum 34 39 535 540 I-clinical_variable
glutamic 40 48 541 549 I-clinical_variable
oxaloacetic 49 60 550 561 I-clinical_variable
transaminase 61 73 562 574 I-clinical_variable
[ 74 75 575 576 I-clinical_variable
SGOT])/alanine 75 89 576 590 I-clinical_variable
aminotransferase 90 106 591 607 I-clinical_variable
( 107 108 608 609 I-clinical_variable
ALT 108 111 609 612 I-clinical_variable
) 111 112 612 613 I-clinical_variable
( 113 114 614 615 B-clinical_variable
serum 114 119 615 620 I-clinical_variable
glutamate 120 129 621 630 I-clinical_variable
pyruvate 130 138 631 639 I-clinical_variable
transaminase 139 151 640 652 I-clinical_variable
[ 152 153 653 654 I-clinical_variable
SGPT 153 157 654 658 I-clinical_variable
] 157 158 658 659 I-clinical_variable
) 158 159 659 660 I-clinical_variable
= 160 161 661 662 O
< 161 162 662 663 O
3 163 164 664 665 B-upper_bound
x 165 166 666 667 I-upper_bound
institutional 167 180 668 681 I-upper_bound
upper 181 186 682 687 I-upper_bound
limit 187 192 688 693 I-upper_bound
of 193 195 694 696 I-upper_bound
normal 196 202 697 703 I-upper_bound

Creatinine 0 10 704 714 B-clinical_variable
= 11 12 715 716 O
< 12 13 716 717 O
institutional 14 27 718 731 O
upper 28 33 732 737 O
limit 34 39 738 743 O
of 40 42 744 746 O
normal 43 49 747 753 O
OR 50 52 754 756 O
creatinine 53 63 757 767 B-clinical_variable
clearance 64 73 768 777 I-clinical_variable
> 74 75 778 779 O
= 75 76 779 780 O
60 77 79 781 783 B-lower_bound
ml 80 82 784 786 I-lower_bound
/ 82 83 786 787 I-lower_bound
min/1.73 83 91 787 795 I-lower_bound
m^2 92 95 796 799 I-lower_bound
for 96 99 800 803 O
patients 100 108 804 812 O
with 109 113 813 817 O
creatinine 114 124 818 828 B-clinical_variable
levels 125 131 829 835 I-clinical_variable
above 132 137 836 841 O
institutional 138 151 842 855 O
normal 152 158 856 862 O

Hemoglobin 0 10 863 873 B-clinical_variable
> 11 12 874 875 O
= 12 13 875 876 O
9 14 15 877 878 B-lower_bound
g 16 17 879 880 I-lower_bound
/ 17 18 880 881 I-lower_bound
dL 18 20 881 883 I-lower_bound

Human 0 5 884 889 B-chronic_disease
immunodeficiency 6 22 890 906 I-chronic_disease
virus 23 28 907 912 I-chronic_disease
( 29 30 913 914 I-chronic_disease
HIV)-positive 30 43 914 927 I-chronic_disease
patients 44 52 928 936 O
on 53 55 937 939 O
combination 56 67 940 951 B-treatment
antiretroviral 68 82 952 966 I-treatment
therapy 83 90 967 974 I-treatment
are 91 94 975 978 O
ineligible 95 105 979 989 O
because 106 113 990 997 O
of 114 116 998 1000 O
the 117 120 1001 1004 O
potential 121 130 1005 1014 O
for 131 134 1015 1018 O
pharmacokinetic 135 150 1019 1034 B-treatment
interactions 151 163 1035 1047 I-treatment
with 164 168 1048 1052 O
AZD1775 169 176 1053 1060 O
( 177 178 1061 1062 O
MK-1775 178 185 1062 1069 O
) 185 186 1069 1070 O

Platelets 0 9 1071 1080 B-clinical_variable
> 10 11 1081 1082 O
= 11 12 1082 1083 O
100,000 13 20 1084 1091 B-lower_bound
/ 20 21 1091 1092 I-lower_bound
mcL 21 24 1092 1095 I-lower_bound

Pregnant 0 8 1096 1104 B-pregnancy
women 9 14 1105 1110 B-gender
are 15 18 1111 1114 O
excluded 19 27 1115 1123 O
from 28 32 1124 1128 O
this 33 37 1129 1133 O
study 38 43 1134 1139 O
because 44 51 1140 1147 O
AZD1775 52 59 1148 1155 B-treatment
( 60 61 1156 1157 I-treatment
MK-1775 61 68 1157 1164 I-treatment
) 68 69 1164 1165 I-treatment
has 70 73 1166 1169 O
potential 74 83 1170 1179 O
for 84 87 1180 1183 O
teratogenic 88 99 1184 1195 O
or 100 102 1196 1198 O
abortifacients 103 117 1199 1213 O
effects 118 125 1214 1221 O

Total 0 5 1222 1227 B-clinical_variable
bilirubin 6 15 1228 1237 I-clinical_variable
= 16 17 1238 1239 O
< 17 18 1239 1240 O
institutional 19 32 1241 1254 O
upper 33 38 1255 1260 O
limit 39 44 1261 1266 O
of 45 47 1267 1269 O
normal 48 54 1270 1276 O

Women 0 5 1277 1282 B-gender
of 6 8 1283 1285 O
childbearing 9 21 1286 1298 O
potential 22 31 1299 1308 O
must 32 36 1309 1313 O
have 37 41 1314 1318 O
a 42 43 1319 1320 O
negative 44 52 1321 1329 B-pregnancy
serum 53 58 1330 1335 I-pregnancy
pregnancy 59 68 1336 1345 I-pregnancy
test 69 73 1346 1350 O
prior 74 79 1351 1356 O
to 80 82 1357 1359 O
study 83 88 1360 1365 O
entry 89 94 1366 1371 O

able 0 4 1372 1376 O
to 5 7 1377 1379 O
swallow 8 15 1380 1387 O
whole 16 21 1388 1393 B-treatment
capsules 22 30 1394 1402 I-treatment

enzyme 0 6 1403 1409 B-treatment
- 6 7 1409 1410 I-treatment
inducing 7 15 1410 1418 I-treatment
anti 16 20 1419 1423 I-treatment
- 20 21 1423 1424 I-treatment
epileptic 21 30 1424 1433 I-treatment
drugs 31 36 1434 1439 I-treatment
( 37 38 1440 1441 I-treatment
EIAED 38 43 1441 1446 I-treatment
) 43 44 1446 1447 I-treatment
are 45 48 1448 1451 O
not 49 52 1452 1455 O
eligible 53 61 1456 1464 O
for 62 65 1465 1468 O
treatment 66 75 1469 1478 B-treatment
on 76 78 1479 1481 O
this 79 83 1482 1486 O
protocol 84 92 1487 1495 O

going 0 5 1496 1501 O
on 6 8 1502 1504 O
Arm 9 12 1505 1508 O
1 13 14 1509 1510 O
or 15 17 1511 1513 O
combination 18 29 1514 1525 O
dose 30 34 1526 1530 O
cohort 35 41 1531 1537 O
must 42 46 1538 1542 O
not 47 50 1543 1546 O
have 51 55 1547 1551 O
received 56 64 1552 1560 O
prior 65 70 1561 1566 B-treatment
radiation 71 80 1567 1576 I-treatment
therapy 81 88 1577 1584 I-treatment
, 88 89 1584 1585 O
chemotherapy 90 102 1586 1598 B-treatment
, 102 103 1598 1599 O
immunotherapy 104 117 1600 1613 B-treatment
or 118 120 1614 1616 O
therapy 121 128 1617 1624 B-treatment
with 129 133 1625 1629 I-treatment
biologic 134 142 1630 1638 I-treatment
agent 143 148 1639 1644 I-treatment
( 149 150 1645 1646 I-treatment
including 150 159 1646 1655 I-treatment
immunotoxins 160 172 1656 1668 I-treatment
, 172 173 1668 1669 I-treatment
immunoconjugates 174 190 1670 1686 I-treatment
, 190 191 1686 1687 I-treatment
antisense 192 201 1688 1697 I-treatment
, 201 202 1697 1698 I-treatment
peptide 203 210 1699 1706 I-treatment
receptor 211 219 1707 1715 I-treatment
antagonists 220 231 1716 1727 I-treatment
, 231 232 1727 1728 I-treatment
interferons 233 244 1729 1740 I-treatment
, 244 245 1740 1741 I-treatment
interleukins 246 258 1742 1754 I-treatment
, 258 259 1754 1755 I-treatment
tumor 260 265 1756 1761 I-treatment
infiltrating 266 278 1762 1774 I-treatment
lymphocytes 279 290 1775 1786 I-treatment
[ 291 292 1787 1788 I-treatment
TIL 292 295 1788 1791 I-treatment
] 295 296 1791 1792 I-treatment
, 296 297 1792 1793 I-treatment
lymphokine 298 308 1794 1804 I-treatment
- 308 309 1804 1805 I-treatment
activated 309 318 1805 1814 I-treatment
killer 319 325 1815 1821 I-treatment
[ 326 327 1822 1823 I-treatment
LAK 327 330 1823 1826 I-treatment
] 330 331 1826 1827 I-treatment
or 332 334 1828 1830 I-treatment
gene 335 339 1831 1835 I-treatment
therapy 340 347 1836 1843 I-treatment
) 347 348 1843 1844 I-treatment
, 348 349 1844 1845 O
or 350 352 1846 1848 O
hormonal 353 361 1849 1857 B-treatment
therapy 362 369 1858 1865 I-treatment
for 370 373 1866 1869 O
their 374 379 1870 1875 O
brain 380 385 1876 1881 B-cancer
tumor 386 391 1882 1887 I-cancer

going 0 5 1888 1893 O
on 6 8 1894 1896 O
Arm 9 12 1897 1900 O
2 13 14 1901 1902 O
must 15 19 1903 1907 O
have 20 24 1908 1912 O
received 25 33 1913 1921 O
planned 34 41 1922 1929 O
treatment 42 51 1930 1939 B-treatment
with 52 56 1940 1944 I-treatment
radiation 57 66 1945 1954 I-treatment
therapy 67 74 1955 1962 I-treatment
and 75 78 1963 1966 O
concomitant 79 90 1967 1978 O
temozolomide 91 103 1979 1991 B-treatment
at 104 106 1992 1994 O
least 107 112 1995 2000 O
28 113 115 2001 2003 B-lower_bound
days 116 120 2004 2008 I-lower_bound
but 121 124 2009 2012 O
no 125 127 2013 2015 O
more 128 132 2016 2020 O
than 133 137 2021 2025 O
49 138 140 2026 2028 B-lower_bound
days 141 145 2029 2033 I-lower_bound
prior 146 151 2034 2039 I-lower_bound
to 152 154 2040 2042 O
starting 155 163 2043 2051 O
treatment 164 173 2052 2061 O
on 174 176 2062 2064 O
this 177 181 2065 2069 O
study 182 187 2070 2075 O

have 0 4 2076 2080 O
magnetic 5 13 2081 2089 B-treatment
resonance 14 23 2090 2099 I-treatment
imaging 24 31 2100 2107 I-treatment
( 32 33 2108 2109 I-treatment
MRI 33 36 2109 2112 I-treatment
) 36 37 2112 2113 I-treatment
within 38 44 2114 2120 O
21 45 47 2121 2123 B-upper_bound
days 48 52 2124 2128 I-upper_bound
of 53 55 2129 2131 O
starting 56 64 2132 2140 O
treatment 65 74 2141 2150 B-treatment

have 0 4 2151 2155 O
no 5 7 2156 2158 O
concurrent 8 18 2159 2169 O
malignancy 19 29 2170 2180 B-cancer
except 30 36 2181 2187 O
curatively 37 47 2188 2198 O
treated 48 55 2199 2206 O
basal 56 61 2207 2212 B-cancer
or 62 64 2213 2215 O
squamous 65 73 2216 2224 B-cancer
cell 74 78 2225 2229 I-cancer
carcinoma 79 88 2230 2239 I-cancer
of 89 91 2240 2242 I-cancer
the 92 95 2243 2246 I-cancer
skin 96 100 2247 2251 I-cancer
or 101 103 2252 2254 O
carcinoma 104 113 2255 2264 B-cancer
in 114 116 2265 2267 I-cancer
situ 117 121 2268 2272 I-cancer
of 122 124 2273 2275 I-cancer
the 125 128 2276 2279 I-cancer
cervix 129 135 2280 2286 I-cancer
, 135 136 2286 2287 O
breast 137 143 2288 2294 B-cancer
, 143 144 2294 2295 O
or 145 147 2296 2298 O
bladder 148 155 2299 2306 B-cancer

have 0 4 2307 2311 O
prior 5 10 2312 2317 O
histologically 11 25 2318 2332 O
proven 26 32 2333 2339 O
glioblastoma 33 45 2340 2352 B-cancer
that 46 50 2353 2357 O
is 51 53 2358 2360 O
progressive 54 65 2361 2372 O
or 66 68 2373 2375 O
recurrent 69 78 2376 2385 O
following 79 88 2386 2395 O
radiation 89 98 2396 2405 B-treatment
therapy 99 106 2406 2413 I-treatment
+ 107 108 2414 2415 O
/- 108 110 2415 2417 O
chemotherapy 111 123 2418 2430 B-treatment

histologically 0 14 2431 2445 O
proven 15 21 2446 2452 O
glioblastoma 22 34 2453 2465 B-cancer

history 0 7 2466 2473 O
of 8 10 2474 2476 O
allergic 11 19 2477 2485 O
reactions 20 29 2486 2495 O
attributed 30 40 2496 2506 O
to 41 43 2507 2509 O
compounds 44 53 2510 2519 O
of 54 56 2520 2522 O
similar 57 64 2523 2530 O
chemical 65 73 2531 2539 O
or 74 76 2540 2542 O
biologic 77 85 2543 2551 O
composition 86 97 2552 2563 O
to 98 100 2564 2566 O
temozolomide 101 113 2567 2579 B-allergy_name
or 114 116 2580 2582 O
AZD1775 117 124 2583 2590 B-allergy_name
( 125 126 2591 2592 I-allergy_name
MK-1775 126 133 2592 2599 I-allergy_name
) 133 134 2599 2600 I-allergy_name
are 135 138 2601 2604 O
ineligible 139 149 2605 2615 O

maintained 0 10 2616 2626 O
on 11 13 2627 2629 O
a 14 15 2630 2631 O
stable 16 22 2632 2638 O
corticosteroid 23 37 2639 2653 B-treatment
regimen 38 45 2654 2661 I-treatment
( 46 47 2662 2663 O
no 47 49 2663 2665 O
increase 50 58 2666 2674 O
for 59 62 2675 2678 O
5 63 64 2679 2680 B-upper_bound
days 65 69 2681 2685 I-upper_bound
) 69 70 2685 2686 O
prior 71 76 2687 2692 O
to 77 79 2693 2695 O
the 80 83 2696 2699 O
start 84 89 2700 2705 O
of 90 92 2706 2708 O
treatment 93 102 2709 2718 B-treatment

may 0 3 2719 2722 O
not 4 7 2723 2726 O
be 8 10 2727 2729 O
on 11 13 2730 2732 O
anti 14 18 2733 2737 B-treatment
- 18 19 2737 2738 I-treatment
coagulants 19 29 2738 2748 I-treatment
( 30 31 2749 2750 O
warfarin 31 39 2750 2758 B-treatment
, 39 40 2758 2759 O
etc 41 44 2760 2763 O
. 44 45 2763 2764 O
) 45 46 2764 2765 O
other 47 52 2766 2771 O
than 53 57 2772 2776 O
low 58 61 2777 2780 O
- 61 62 2780 2781 O
molecular 62 71 2781 2790 O
weight 72 78 2791 2797 O
heparin 79 86 2798 2805 B-treatment
( 87 88 2806 2807 O
LMWH 88 92 2807 2811 B-treatment
) 92 93 2811 2812 O

may 0 3 2813 2816 O
not 4 7 2817 2820 O
be 8 10 2821 2823 O
on 11 13 2824 2826 O
drugs 14 19 2827 2832 O
known 20 25 2833 2838 O
to 26 28 2839 2841 O
be 29 31 2842 2844 O
moderate 32 40 2845 2853 B-treatment
or 41 43 2854 2856 I-treatment
potent 44 50 2857 2863 I-treatment
inhibitors 51 61 2864 2874 I-treatment
/ 61 62 2874 2875 I-treatment
inducers 62 70 2875 2883 I-treatment
of 71 73 2884 2886 I-treatment
CYP3A4 74 80 2887 2893 I-treatment
, 80 81 2893 2894 O
sensitive 82 91 2895 2904 B-treatment
substrates 92 102 2905 2915 I-treatment
of 103 105 2916 2918 I-treatment
CYP3A4 106 112 2919 2925 I-treatment
, 112 113 2925 2926 O
or 114 116 2927 2929 O
substrates 117 127 2930 2940 B-treatment
of 128 130 2941 2943 I-treatment
CYP3A4 131 137 2944 2950 I-treatment
with 138 142 2951 2955 I-treatment
narrow 143 149 2956 2962 I-treatment
therapeutic 150 161 2963 2974 I-treatment
windows 162 169 2975 2982 I-treatment

measurable 0 10 2983 2993 O
contrast 11 19 2994 3002 O
- 19 20 3002 3003 O
enhancing 20 29 3003 3012 O
progressive 30 41 3013 3024 O
or 42 44 3025 3027 O
recurrent 45 54 3028 3037 O
glioblastoma 55 67 3038 3050 B-cancer
by 68 70 3051 3053 O
MRI 71 74 3054 3057 B-treatment
within 75 81 3058 3064 O
21 82 84 3065 3067 B-upper_bound
days 85 89 3068 3072 I-upper_bound
of 90 92 3073 3075 O
starting 93 101 3076 3084 O
treatment 102 111 3085 3094 B-treatment

must 0 4 3095 3099 O
have 5 9 3100 3104 O
a 10 11 3105 3106 O
Karnofsky 12 21 3107 3116 B-clinical_variable
performance 22 33 3117 3128 I-clinical_variable
status 34 40 3129 3135 I-clinical_variable
> 41 42 3136 3137 O
= 42 43 3137 3138 O
60 44 46 3139 3141 B-lower_bound
% 46 47 3141 3142 I-lower_bound
( 48 49 3143 3144 O
i.e. 49 53 3144 3148 O
the 54 57 3149 3152 O
patient 58 65 3153 3160 O
must 66 70 3161 3165 O
be 71 73 3166 3168 O
able 74 78 3169 3173 O
to 79 81 3174 3176 O
care 82 86 3177 3181 O
for 87 90 3182 3185 O
himself 91 98 3186 3193 O
/ 98 99 3193 3194 O
herself 99 106 3194 3201 O
with 107 111 3202 3206 O
occasional 112 122 3207 3217 O
help 123 127 3218 3222 O
from 128 132 3223 3227 O
others 133 139 3228 3234 O
) 139 140 3234 3235 O

must 0 4 3236 3240 O
have 5 9 3241 3245 O
a 10 11 3246 3247 O
tumor 12 17 3248 3253 B-cancer
tissue 18 24 3254 3260 O
form 25 29 3261 3265 O
indicating 30 40 3266 3276 O
availability 41 53 3277 3289 O
of 54 56 3290 3292 O
archived 57 65 3293 3301 O
tissue 66 72 3302 3308 O
from 73 77 3309 3313 O
initial 78 85 3314 3321 O
resection 86 95 3322 3331 B-treatment
at 96 98 3332 3334 O
diagnosis 99 108 3335 3344 O
of 109 111 3345 3347 O
glioblastoma 112 124 3348 3360 B-cancer
completed 125 134 3361 3370 O
and 135 138 3371 3374 O
signed 139 145 3375 3381 O
by 146 148 3382 3384 O
a 149 150 3385 3386 O
pathologist 151 162 3387 3398 O

ndergoing 0 9 3399 3408 O
repeat 10 16 3409 3415 B-treatment
surgery 17 24 3416 3423 I-treatment
that 25 29 3424 3428 O
is 30 32 3429 3431 O
clinically 33 43 3432 3442 O
indicated 44 53 3443 3452 O
as 54 56 3453 3455 O
determined 57 67 3456 3466 O
by 68 70 3467 3469 O
their 71 76 3470 3475 O
care 77 81 3476 3480 O
providers 82 91 3481 3490 O

receiving 0 9 3491 3500 O
any 10 13 3501 3504 O
other 14 19 3505 3510 O
investigational 20 35 3511 3526 B-treatment
agents 36 42 3527 3533 I-treatment
are 43 46 3534 3537 O
ineligible 47 57 3538 3548 O

recovered 0 9 3549 3558 O
from 10 14 3559 3563 O
severe 15 21 3564 3570 O
toxicity 22 30 3571 3579 O
of 31 33 3580 3582 O
prior 34 39 3583 3588 B-treatment
therapy 40 47 3589 3596 I-treatment

uncontrolled 0 12 3597 3609 O
intercurrent 13 25 3610 3622 B-chronic_disease
illness 26 33 3623 3630 I-chronic_disease
including 34 43 3631 3640 O
, 43 44 3640 3641 O
but 45 48 3642 3645 O
not 49 52 3646 3649 O
limited 53 60 3650 3657 O
to 61 63 3658 3660 O
, 63 64 3660 3661 O
ongoing 65 72 3662 3669 O
or 73 75 3670 3672 O
active 76 82 3673 3679 B-chronic_disease
infection 83 92 3680 3689 I-chronic_disease
, 92 93 3689 3690 O
symptomatic 94 105 3691 3702 O
congestive 106 116 3703 3713 B-chronic_disease
heart 117 122 3714 3719 I-chronic_disease
failure 123 130 3720 3727 I-chronic_disease
, 130 131 3727 3728 O
unstable 132 140 3729 3737 B-chronic_disease
angina 141 147 3738 3744 I-chronic_disease
pectoris 148 156 3745 3753 I-chronic_disease
, 156 157 3753 3754 O
cardiac 158 165 3755 3762 B-chronic_disease
arrhythmia 166 176 3763 3773 I-chronic_disease
, 176 177 3773 3774 O
or 178 180 3775 3777 O
psychiatric 181 192 3778 3789 B-chronic_disease
illness 193 200 3790 3797 I-chronic_disease
/ 200 201 3797 3798 O
social 201 207 3798 3804 O
situations 208 218 3805 3815 O
that 219 223 3816 3820 O
would 224 229 3821 3826 O
limit 230 235 3827 3832 O
compliance 236 246 3833 3843 O
with 247 251 3844 3848 O
study 252 257 3849 3854 O
requirements 258 270 3855 3867 O
, 270 271 3867 3868 O
are 272 275 3869 3872 O
ineligible 276 286 3873 3883 O

unlimited 0 9 3884 3893 O
number 10 16 3894 3900 O
of 17 19 3901 3903 O
prior 20 25 3904 3909 B-treatment
therapy 26 33 3910 3917 I-treatment
regimens 34 42 3918 3926 I-treatment

0 0 1 0 1 B-lower_bound
- 1 2 1 2 O
84 2 4 2 4 B-upper_bound
days 5 9 5 9 I-upper_bound
postnatal 10 19 10 19 O
age 20 23 20 23 B-age
at 24 26 24 26 O
time 27 31 27 31 O
of 32 34 32 34 O
first 35 40 35 40 O
study 41 46 41 46 O
dose 47 51 47 51 O
or 52 54 52 54 O
when 55 59 55 59 O
enrolled 60 68 60 68 O
into 69 73 69 73 O
the 74 77 74 77 O
non 78 81 78 81 O
- 81 82 81 82 O
intervention 82 94 82 94 O
cohort 95 101 95 101 O

Heart 0 5 102 107 B-clinical_variable
rate 6 10 108 112 I-clinical_variable
< 11 12 113 114 O
100 12 15 114 117 B-upper_bound
beats 16 21 118 123 I-upper_bound
per 22 25 124 127 I-upper_bound
minute 26 32 128 134 I-upper_bound
at 33 35 135 137 O
screening 36 45 138 147 O
visit 46 51 148 153 O

Hemodynamically 0 15 154 169 O
significant 16 27 170 181 O
cardiovascular 28 42 182 196 B-chronic_disease
disease 43 50 197 204 I-chronic_disease
, 50 51 204 205 O
as 52 54 206 208 O
determined 55 65 209 219 O
by 66 68 220 222 O
the 69 72 223 226 O
investigator 73 85 227 239 O

History 0 7 240 247 O
of 8 10 248 250 O
Reactive 11 19 251 259 B-chronic_disease
Airways 20 27 260 267 I-chronic_disease
Disease 28 35 268 275 I-chronic_disease
( 36 37 276 277 I-chronic_disease
RAD 37 40 277 280 I-chronic_disease
) 40 41 280 281 I-chronic_disease

History 0 7 282 289 O
of 8 10 290 292 O
previous 11 19 293 301 O
treatment 20 29 302 311 O
with 30 34 312 316 O
any 35 38 317 320 O
pharmacologic 39 52 321 334 B-treatment
or 53 55 335 337 O
laser 56 61 338 343 B-treatment
therapy 62 69 344 351 I-treatment
for 70 73 352 355 O
IH 74 76 356 358 O

IH 0 2 359 361 B-chronic_disease
that 3 7 362 366 O
requires 8 16 367 375 O
systemic 17 25 376 384 B-treatment
therapy 26 33 385 392 I-treatment
( 34 35 393 394 O
defined 35 42 394 401 O
by 43 45 402 404 O
dynamic 46 53 405 412 B-clinical_variable
complication 54 66 413 425 I-clinical_variable
scale 67 72 426 431 I-clinical_variable
> 73 74 432 433 O
3 74 75 433 434 B-lower_bound
) 75 76 434 435 O

Infants 0 7 436 443 O
with 8 12 444 448 O
more 13 17 449 453 O
than 18 22 454 458 O
one 23 26 459 462 O
hemangioma 27 37 463 473 B-chronic_disease
that 38 42 474 478 O
requires 43 51 479 487 O
therapy 52 59 488 495 B-treatment

Known 0 5 496 501 O
prenatal 6 14 502 510 O
or 15 17 511 513 O
postnatal 18 27 514 523 O
diagnosis 28 37 524 533 O
of 38 40 534 536 O
2nd/3rd 41 48 537 544 B-chronic_disease
degree 49 55 545 551 I-chronic_disease
atrioventricular 56 72 552 568 I-chronic_disease
block 73 78 569 574 I-chronic_disease

Pregnancy 0 9 0 9 B-pregnancy

A 0 1 0 1 O
reasonable 2 12 2 12 O
attempt 13 20 13 20 O
should 21 27 21 27 O
be 28 30 28 30 O
made 31 35 31 35 O
to 36 38 36 38 O
make 39 43 39 43 O
a 44 45 44 45 O
pathologic 46 56 46 56 O
diagnosis 57 66 57 66 O
of 67 69 67 69 O
malignancy 70 80 70 80 B-cancer
( 81 82 81 82 O
ie 82 84 82 84 O
. 84 85 84 85 O
bronchoscopy 86 98 86 98 B-treatment
, 98 99 98 99 O
CT 100 102 100 102 B-treatment
guided 103 109 103 109 I-treatment
lung 110 114 110 114 I-treatment
biopsy 115 121 115 121 I-treatment
) 121 122 121 122 O

Age 0 3 123 126 B-age
> 4 5 127 128 O
/= 5 7 128 130 O
18 8 10 131 133 B-lower_bound
years 11 16 134 139 I-lower_bound

CT 0 2 140 142 O
scan 3 7 143 147 O
of 8 10 148 150 O
the 11 14 151 154 O
chest 15 20 155 160 O
with 21 25 161 165 O
IV 26 28 166 168 O
contrast 29 37 169 177 O
within 38 44 178 184 O
8 45 46 185 186 B-upper_bound
weeks 47 52 187 192 I-upper_bound
of 53 55 193 195 O
registration 56 68 196 208 O

Chemotherapy 0 12 209 221 B-treatment
within 13 19 222 228 O
4 20 21 229 230 B-upper_bound
weeks 22 27 231 236 I-upper_bound
of 28 30 237 239 O
the 31 34 240 243 O
initiation 35 45 244 254 O
of 46 48 255 257 O
SABR 49 53 258 262 B-treatment

ECOG 0 4 263 267 B-clinical_variable
performance 5 16 268 279 I-clinical_variable
status 17 23 280 286 I-clinical_variable
0 24 25 287 288 B-lower_bound
- 25 26 288 289 O
1 26 27 289 290 B-upper_bound

FEV1 0 4 291 295 B-clinical_variable
< 5 6 296 297 O
20 6 8 297 299 B-upper_bound
% 8 9 299 300 I-upper_bound
predicted 10 19 301 310 O
and/or 20 26 311 317 O
DLCO 27 31 318 322 B-clinical_variable
< 32 33 323 324 O
20 33 35 324 326 O
% 35 36 326 327 O
predicted 37 46 328 337 O

Histologically 0 14 338 352 O
proven 15 21 353 359 O
diagnosis 22 31 360 369 O
of 32 34 370 372 O
a 35 36 373 374 O
prior 37 42 375 380 O
thoracic 43 51 381 389 B-cancer
malignancy 52 62 390 400 I-cancer
treated 63 70 401 408 O
with 71 75 409 413 O
thoracic 76 84 414 422 B-treatment
external 85 93 423 431 I-treatment
beam 94 98 432 436 I-treatment
radiotherapy 99 111 437 449 I-treatment
with 112 116 450 454 O
or 117 119 455 457 O
without 120 127 458 465 O
systemic 128 136 466 474 B-treatment
chemotherapy 137 149 475 487 I-treatment

Loco 0 4 488 492 B-treatment
- 4 5 492 493 I-treatment
regional 5 13 493 501 I-treatment
is 14 16 502 504 O
defined 17 24 505 512 O
as 25 27 513 515 O
recurrence 28 38 516 526 O
within 39 45 527 533 O
the 46 49 534 537 O
region 50 56 538 544 O
of 57 59 545 547 O
the 60 63 548 551 O
primary 64 71 552 559 B-cancer
tumor 72 77 560 565 I-cancer
or 78 80 566 568 O
adjacent 81 89 569 577 O
draining 90 98 578 586 O
lymph 99 104 587 592 O
node 105 109 593 597 O
regions 110 117 598 605 O

Negative 0 8 606 614 B-pregnancy
serum 9 14 615 620 I-pregnancy
pregnancy 15 24 621 630 I-pregnancy
test 25 29 631 635 O
within 30 36 636 642 O
2 37 38 643 644 B-upper_bound
weeks 39 44 645 650 I-upper_bound
prior 45 50 651 656 I-upper_bound
to 51 53 657 659 O
registration 54 66 660 672 O
for 67 70 673 676 O
women 71 76 677 682 B-gender
of 77 79 683 685 O
childbearing 80 92 686 698 O
potential 93 102 699 708 O

No 0 2 709 711 O
previously 3 13 712 722 O
reported 14 22 723 731 O
thoracic 23 31 732 740 B-treatment
radiotherapy 32 44 741 753 I-treatment

Pathologic 0 10 754 764 O
or 11 13 765 767 O
clinical 14 22 768 776 O
diagnosis 23 32 777 786 O
of 33 35 787 789 O
a 36 37 790 791 O
new 38 41 792 795 O
or 42 44 796 798 O
loco 45 49 799 803 O
- 49 50 803 804 O
regional 50 58 804 812 O
recurrent 59 68 813 822 O
lung 69 73 823 827 B-cancer
malignancy 74 84 828 838 I-cancer

Plans 0 5 839 844 O
to 6 8 845 847 O
administer 9 19 848 858 O
systemic 20 28 859 867 B-treatment
chemotherapy 29 41 868 880 I-treatment
overlapping 42 53 881 892 O
with 54 58 893 897 O
radiotherapy 59 71 898 910 B-treatment

Pregnant 0 8 911 919 B-pregnancy
women 9 14 920 925 B-gender

Pulmonary 0 9 926 935 B-clinical_variable
function 10 18 936 944 I-clinical_variable
test 19 23 945 949 I-clinical_variable
( 24 25 950 951 I-clinical_variable
PFTs 25 29 951 955 I-clinical_variable
) 29 30 955 956 I-clinical_variable
, 30 31 956 957 O
including 32 41 958 967 O
diffusion 42 51 968 977 O
capacity 52 60 978 986 O
within 61 67 987 993 O
8 68 69 994 995 B-upper_bound
weeks 70 75 996 1001 I-upper_bound
of 76 78 1002 1004 O
registration 79 91 1005 1017 O

Whole 0 5 1018 1023 O
body 6 10 1024 1028 O
PET 11 14 1029 1032 O
scan 15 19 1033 1037 O
within 20 26 1038 1044 O
8 27 28 1045 1046 B-upper_bound
weeks 29 34 1047 1052 I-upper_bound
of 35 37 1053 1055 O
registration 38 50 1056 1068 O

Women 0 5 1069 1074 B-gender
of 6 8 1075 1077 O
childbearing 9 21 1078 1090 O
potential 22 31 1091 1100 O

lactating 0 9 1101 1110 O
women 10 15 1111 1116 B-gender

male 0 4 1117 1121 B-gender
participants 5 17 1122 1134 I-gender
who 18 21 1135 1138 O
are 22 25 1139 1142 O
sexually 26 34 1143 1151 O
active 35 41 1152 1158 O
must 42 46 1159 1163 O
agree 47 52 1164 1169 B-contraception_consent
to 53 55 1170 1172 I-contraception_consent
use 56 59 1173 1176 I-contraception_consent
a 60 61 1177 1178 I-contraception_consent
medically 62 71 1179 1188 I-contraception_consent
effective 72 81 1189 1198 I-contraception_consent
means 82 87 1199 1204 I-contraception_consent
of 88 90 1205 1207 I-contraception_consent
birth 91 96 1208 1213 I-contraception_consent
control 97 104 1214 1221 I-contraception_consent

Active 0 6 0 6 B-chronic_disease
depression 7 17 7 17 I-chronic_disease
( 18 19 18 19 O
BDI 19 22 19 22 B-clinical_variable
> 23 24 23 24 O
20 25 27 25 27 B-lower_bound
) 27 28 27 28 O
or 29 31 29 31 O
other 32 37 32 37 O
untreated 38 47 38 47 B-chronic_disease
or 48 50 48 50 I-chronic_disease
uncontrolled 51 63 51 63 I-chronic_disease
psychiatric 64 75 64 75 I-chronic_disease
illness 76 83 76 83 I-chronic_disease
( 84 85 84 85 O
active 85 91 85 91 B-chronic_disease
general 92 99 92 99 I-chronic_disease
anxiety 100 107 100 107 I-chronic_disease
disorder 108 116 108 116 I-chronic_disease
, 116 117 116 117 O
schizophrenia 118 131 118 131 B-chronic_disease
, 131 132 131 132 O
bipolar 133 140 133 140 B-chronic_disease
disorder 141 149 141 149 I-chronic_disease
, 149 150 149 150 O
obsessive 151 160 151 160 B-chronic_disease
- 160 161 160 161 I-chronic_disease
compulsive 161 171 161 171 I-chronic_disease
disorder 172 180 172 180 I-chronic_disease
( 181 182 181 182 I-chronic_disease
OCD 182 185 182 185 I-chronic_disease
) 185 186 185 186 I-chronic_disease

Age 0 3 187 190 B-age
≥ 4 5 191 192 O
21 6 8 193 195 B-lower_bound
years 9 14 196 201 I-lower_bound

Allergies 0 9 202 211 O
or 10 12 212 214 O
known 13 18 215 220 O
hypersensitivity 19 35 221 237 O
to 36 38 238 240 O
materials 39 48 241 250 O
in 49 51 251 253 O
the 52 55 254 257 O
Activa 56 62 258 264 B-allergy_name
PC+S 63 67 265 269 I-allergy_name
system 68 74 270 276 O
( 75 76 277 278 O
i.e. 76 80 278 282 O
titanium 81 89 283 291 B-allergy_name
, 89 90 291 292 O
polyurethane 91 103 293 305 B-allergy_name
, 103 104 305 306 O
silicone 105 113 307 315 B-allergy_name
, 113 114 315 316 O
polyetherimide 115 129 317 331 B-allergy_name
, 129 130 331 332 O
stainless 131 140 333 342 B-allergy_name
steel 141 146 343 348 I-allergy_name
) 146 147 348 349 O

Aphasia 0 7 350 357 B-chronic_disease
severe 8 14 358 364 O
enough 15 21 365 371 O
to 22 24 372 374 O
limit 25 30 375 380 O
the 31 34 381 384 O
consent 35 42 385 392 O
process 43 50 393 400 O
or 51 53 401 403 O
communication 54 67 404 417 O
between 68 75 418 425 O
the 76 79 426 429 O
investigators 80 93 430 443 O
and 94 97 444 447 O
the 98 101 448 451 O
patient 102 109 452 459 O

Clinical 0 8 460 468 O
diagnosis 9 18 469 478 O
of 19 21 479 481 O
post 22 26 482 486 O
- 26 27 486 487 O
stroke 27 33 487 493 O
pain 34 38 494 498 O
( 39 40 499 500 O
thalamic 40 48 500 508 O
pain 49 53 509 513 O
) 53 54 513 514 O
, 54 55 514 515 O
spinal 56 62 516 522 B-chronic_disease
cord 63 67 523 527 I-chronic_disease
injury 68 74 528 534 I-chronic_disease
or 75 77 535 537 O
phantom 78 85 538 545 O
limb 86 90 546 550 O
pain 91 95 551 555 O
with 96 100 556 560 O
allodynia 101 110 561 570 O
or 111 113 571 573 O
dysesthesia 114 125 574 585 O
with 126 130 586 590 O
pinprick 131 139 591 599 B-treatment
anesthesia 140 150 600 610 I-treatment
or 151 153 611 613 O
hypoesthesia 154 166 614 626 O
on 167 169 627 629 O
the 170 173 630 633 O
affected 174 182 634 642 O
hemibody 183 191 643 651 O
or 192 194 652 654 O
limb 195 199 655 659 O
( 200 201 660 661 O
anesthesia 201 211 661 671 O
dolorosa 212 220 672 680 O
) 220 221 680 681 O

Coagulopathy 0 12 682 694 B-chronic_disease

Has 0 3 695 698 O
an 4 6 699 701 O
implanted 7 16 702 711 O
electronic 17 27 712 722 O
device 28 34 723 729 O
such 35 39 730 734 O
as 40 42 735 737 O
a 43 44 738 739 O
neurostimulator 45 60 740 755 B-treatment
, 60 61 755 756 O
cardiac 62 69 757 764 B-treatment
pacemaker 70 79 765 774 I-treatment
or 80 82 775 777 O
medication 83 93 778 788 B-treatment
pump 94 98 789 793 I-treatment

Inability 0 9 794 803 O
to 10 12 804 806 O
speak 13 18 807 812 B-language_fluency
and 19 22 813 816 I-language_fluency
/ 23 24 817 818 I-language_fluency
or 25 27 819 821 I-language_fluency
read 28 32 822 826 I-language_fluency
English 33 40 827 834 I-language_fluency

Inability 0 9 835 844 O
to 10 12 845 847 O
stop 13 17 848 852 O
Coumadin 18 26 853 861 B-treatment
or 27 29 862 864 O
platelet 30 38 865 873 B-treatment
anti 39 43 874 878 I-treatment
- 43 44 878 879 I-treatment
aggregation 44 55 879 890 I-treatment
therapy 56 63 891 898 I-treatment
for 64 67 899 902 O
surgery 68 75 903 910 B-treatment
and 76 79 911 914 O
after 80 85 915 920 O
surgery 86 93 921 928 O

MRI 0 3 929 932 O
( 4 5 933 934 O
done 5 9 934 938 O
within 10 16 939 945 O
one 17 20 946 949 B-upper_bound
year 21 25 950 954 I-upper_bound
of 26 28 955 957 O
the 29 32 958 961 O
first 33 38 962 967 O
visit 39 44 968 973 O
) 44 45 973 974 O
with 46 50 975 979 O
significant 51 62 980 991 O
abnormalities 63 76 992 1005 O
other 77 82 1006 1011 O
than 83 87 1012 1016 O
those 88 93 1017 1022 O
associated 94 104 1023 1033 O
with 105 109 1034 1038 O
the 110 113 1039 1042 O
neurological 114 126 1043 1055 B-chronic_disease
disorder 127 135 1056 1064 I-chronic_disease
causing 136 143 1065 1072 O
chronic 144 151 1073 1080 O
pain 152 156 1081 1085 O

MRI 0 3 1086 1089 B-treatment
done 4 8 1090 1094 O
within 9 15 1095 1101 O
one 16 19 1102 1105 B-upper_bound
year 20 24 1106 1110 I-upper_bound
not 25 28 1111 1114 O
showing 29 36 1115 1122 O
any 37 40 1123 1126 O
contraindication 41 57 1127 1143 O
to 58 60 1144 1146 O
surgery 61 68 1147 1154 B-treatment
such 69 73 1155 1159 O
as 74 76 1160 1162 O
mass 77 81 1163 1167 O
, 81 82 1167 1168 O
lesion 83 89 1169 1175 O
, 89 90 1175 1176 O
hemorrhage 91 101 1177 1187 O
or 102 104 1188 1190 O
other 105 110 1191 1196 O
abnormality 111 122 1197 1208 O
near 123 127 1209 1213 O
target 128 134 1214 1220 O

MRI 0 3 1221 1224 B-treatment
done 4 8 1225 1229 O
within 9 15 1230 1236 O
one 16 19 1237 1240 B-upper_bound
year 20 24 1241 1245 I-upper_bound
not 25 28 1246 1249 O
showing 29 36 1250 1257 O
contraindication 37 53 1258 1274 O
to 54 56 1275 1277 O
surgery 57 64 1278 1285 B-treatment
such 65 69 1286 1290 O
as 70 72 1291 1293 O
mass 73 77 1294 1298 B-chronic_disease
, 77 78 1298 1299 O
lesion 79 85 1300 1306 B-chronic_disease
, 85 86 1306 1307 O
hemorrhage 87 97 1308 1318 B-chronic_disease
or 98 100 1319 1321 O
other 101 106 1322 1327 O
abnormality 107 118 1328 1339 O
near 119 123 1340 1344 O
target 124 130 1345 1351 O

Major 0 5 1352 1357 O
neurological 6 18 1358 1370 B-chronic_disease
disorder 19 27 1371 1379 I-chronic_disease
other 28 33 1380 1385 O
than 34 38 1386 1390 O
the 39 42 1391 1394 O
one 43 46 1395 1398 O
that 47 51 1399 1403 O
led 52 55 1404 1407 O
to 56 58 1408 1410 O
the 59 62 1411 1414 O
chronic 63 70 1415 1422 O
pain 71 75 1423 1427 O
including 76 85 1428 1437 O
epilepsy 86 94 1438 1446 B-chronic_disease
, 94 95 1446 1447 O
neurodegenerative 96 113 1448 1465 B-chronic_disease
condition 114 123 1466 1475 I-chronic_disease
or 124 126 1476 1478 O
any 127 130 1479 1482 O
history 131 138 1483 1490 O
of 139 141 1491 1493 O
seizure 142 149 1494 1501 B-chronic_disease

Patients 0 8 1502 1510 O
may 9 12 1511 1514 O
be 13 15 1515 1517 O
excluded 16 24 1518 1526 O
from 25 29 1527 1531 O
enrollment 30 40 1532 1542 O
due 41 44 1543 1546 O
to 45 47 1547 1549 O
a 48 49 1550 1551 O
condition 50 59 1552 1561 O
that 60 64 1562 1566 O
, 64 65 1566 1567 O
in 66 68 1568 1570 O
the 69 72 1571 1574 O
judgment 73 81 1575 1583 O
of 82 84 1584 1586 O
the 85 88 1587 1590 O
PI 89 91 1591 1593 O
, 91 92 1593 1594 O
significantly 93 106 1595 1608 O
increases 107 116 1609 1618 O
risk 117 121 1619 1623 O
or 122 124 1624 1626 O
reduces 125 132 1627 1634 O
significantly 133 146 1635 1648 O
the 147 150 1649 1652 O
likelihood 151 161 1653 1663 O
of 162 164 1664 1666 O
benefit 165 172 1667 1674 O
from 173 177 1675 1679 O
DBS 178 181 1680 1683 B-treatment

Patients 0 8 1684 1692 O
taking 9 15 1693 1699 O
these 16 21 1700 1705 O
medications 22 33 1706 1717 B-treatment
will 34 38 1718 1722 O
need 39 43 1723 1727 O
to 44 46 1728 1730 O
discuss 47 54 1731 1738 O
the 55 58 1739 1742 O
need 59 63 1743 1747 O
/ 63 64 1747 1748 O
risk 64 68 1748 1752 O
of 69 71 1753 1755 O
continuing 72 82 1756 1766 O
these 83 88 1767 1772 O
medications 89 100 1773 1784 O
with 101 105 1785 1789 O
their 106 111 1790 1795 O
physicians 112 122 1796 1806 O
and 123 126 1807 1810 O
the 127 130 1811 1814 O
PI 131 133 1815 1817 O
or 134 136 1818 1820 O
study 137 142 1821 1826 O
personnel 143 152 1827 1836 O
may 153 156 1837 1840 O
contact 157 164 1841 1848 O
the 165 168 1849 1852 O
treating 169 177 1853 1861 O
physician(s 178 189 1862 1873 O
) 189 190 1873 1874 O
as 191 193 1875 1877 O
well 194 198 1878 1882 O
to 199 201 1883 1885 O
discuss 202 209 1886 1893 O
the 210 213 1894 1897 O
risks 214 219 1898 1903 O
of 220 222 1904 1906 O
anticoagulation 223 238 1907 1922 B-treatment
/ 239 240 1923 1924 O
antiaggregation 241 256 1925 1940 B-treatment
therapy 257 264 1941 1948 I-treatment
discontinuation 265 280 1949 1964 O

Patients 0 8 1965 1973 O
who 9 12 1974 1977 O
become 13 19 1978 1984 B-pregnancy
pregnant 20 28 1985 1993 I-pregnancy
after 29 34 1994 1999 O
enrollment 35 45 2000 2010 O
may 46 49 2011 2014 O
be 50 52 2015 2017 O
excluded 53 61 2018 2026 O
from 62 66 2027 2031 O
the 67 70 2032 2035 O
study 71 76 2036 2041 O

Phantom 0 7 2042 2049 B-chronic_disease
limb 8 12 2050 2054 I-chronic_disease
pain 13 17 2055 2059 I-chronic_disease

Post 0 4 2060 2064 B-chronic_disease
- 4 5 2064 2065 I-chronic_disease
Stroke 5 11 2065 2071 I-chronic_disease
Pain 12 16 2072 2076 I-chronic_disease

Pregnancy 0 9 2077 2086 B-pregnancy
or 10 12 2087 2089 O
breast 13 19 2090 2096 O
feeding 20 27 2097 2104 O

Previous 0 8 2105 2113 O
ablative 9 17 2114 2122 B-treatment
intracranial 18 30 2123 2135 I-treatment
surgery 31 38 2136 2143 I-treatment
for 39 42 2144 2147 O
the 43 46 2148 2151 O
management 47 57 2152 2162 O
of 58 60 2163 2165 O
the 61 64 2166 2169 O
thalamic 65 73 2170 2178 B-chronic_disease
pain 74 78 2179 2183 I-chronic_disease
syndrome 79 87 2184 2192 I-chronic_disease

Significant 0 11 2193 2204 O
cognitive 12 21 2205 2214 B-chronic_disease
impairment 22 32 2215 2225 I-chronic_disease
or 33 35 2226 2228 O
Dementia 36 44 2229 2237 O
( 45 46 2238 2239 O
MoCA 46 50 2239 2243 B-clinical_variable
< 51 52 2244 2245 O
25 53 55 2246 2248 B-upper_bound
) 55 56 2248 2249 O

Stroke 0 6 2250 2256 B-chronic_disease
of 7 9 2257 2259 I-chronic_disease
ischemic 10 18 2260 2268 I-chronic_disease
etiology 19 27 2269 2277 I-chronic_disease
only 28 32 2278 2282 O

Suicide 0 7 2283 2290 B-clinical_variable
attempt 8 15 2291 2298 I-clinical_variable
< 16 17 2299 2300 O
/= 17 19 2300 2302 O
12 20 22 2303 2305 B-upper_bound
months 23 29 2306 2312 I-upper_bound
or 30 32 2313 2315 O
imminent 33 41 2316 2324 O
suicide 42 49 2325 2332 O
risk 50 54 2333 2337 O

Women 0 5 2338 2343 B-gender
of 6 8 2344 2346 O
childbearing 9 21 2347 2359 O
age 22 25 2360 2363 B-age
must 26 30 2364 2368 O
be 31 33 2369 2371 O
on 34 36 2372 2374 O
regular 37 44 2375 2382 B-contraception_consent
use 45 48 2383 2386 I-contraception_consent
of 49 51 2387 2389 I-contraception_consent
an 52 54 2390 2392 I-contraception_consent
accepted 55 63 2393 2401 I-contraception_consent
contraceptive 64 77 2402 2415 I-contraception_consent
method(s 78 86 2416 2424 I-contraception_consent
) 86 87 2424 2425 I-contraception_consent

personality 0 11 2426 2437 B-chronic_disease
disorders 12 21 2438 2447 I-chronic_disease
( 22 23 2448 2449 O
e.g. 23 27 2449 2453 O
multiple 28 36 2454 2462 B-chronic_disease
personality 37 48 2463 2474 I-chronic_disease
disorder 49 57 2475 2483 I-chronic_disease
, 57 58 2483 2484 O
borderline 59 69 2485 2495 B-chronic_disease
personality 70 81 2496 2507 I-chronic_disease
disorder 82 90 2508 2516 I-chronic_disease
, 90 91 2516 2517 O
etc 92 95 2518 2521 O
. 95 96 2521 2522 O
) 96 97 2522 2523 O
or 98 100 2524 2526 O
other 101 106 2527 2532 O
neuropsychiatric 107 123 2533 2549 B-chronic_disease
conditions 124 134 2550 2560 I-chronic_disease
that 135 139 2561 2565 O
evaluating 140 150 2566 2576 O
psychiatrist 151 163 2577 2589 O
would 164 169 2590 2595 O
recommend 170 179 2596 2605 O
exclusion 180 189 2606 2615 O
of 190 192 2616 2618 O
patient 193 200 2619 2626 O
after 201 206 2627 2632 O
neuropsychiatric 207 223 2633 2649 O
evaluation 224 234 2650 2660 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
more 26 30 26 30 O
or 31 33 31 33 O
equal 34 39 34 39 O
to 40 42 40 42 O
750 43 46 43 46 B-lower_bound
/ 46 47 46 47 I-lower_bound
mL 47 49 47 49 I-lower_bound

Congenital 0 10 50 60 B-chronic_disease
long 11 15 61 65 I-chronic_disease
QT 16 18 66 68 I-chronic_disease
syndrome 19 27 69 77 I-chronic_disease

Creatinine 0 10 78 88 B-clinical_variable
less 11 15 89 93 O
or 16 18 94 96 O
equal 19 24 97 102 O
to 25 27 103 105 O
3 28 29 106 107 B-upper_bound
x 30 31 108 109 I-upper_bound
upper 32 37 110 115 I-upper_bound
limit 38 43 116 121 I-upper_bound
of 44 46 122 124 I-upper_bound
normal 47 53 125 131 I-upper_bound
( 54 55 132 133 I-upper_bound
ULN 55 58 133 136 I-upper_bound
) 58 59 136 137 I-upper_bound

Eastern 0 7 138 145 B-clinical_variable
Cooperative 8 19 146 157 I-clinical_variable
Oncology 20 28 158 166 I-clinical_variable
Group 29 34 167 172 I-clinical_variable
( 35 36 173 174 I-clinical_variable
ECOG 36 40 174 178 I-clinical_variable
) 40 41 178 179 I-clinical_variable
performance 42 53 180 191 I-clinical_variable
status 54 60 192 198 I-clinical_variable
should 61 67 199 205 O
be 68 70 206 208 O
less 71 75 209 213 O
or 76 78 214 216 O
equal 79 84 217 222 O
to 85 87 223 225 O
3 88 89 226 227 B-upper_bound

History 0 7 228 235 O
( 8 9 236 237 O
within 9 15 237 243 O
the 16 19 244 247 O
last 20 24 248 252 B-upper_bound
3 25 26 253 254 I-upper_bound
months 27 33 255 261 I-upper_bound
) 33 34 261 262 O
or 35 37 263 265 O
presence 38 46 266 274 O
of 47 49 275 277 O
stroke 50 56 278 284 B-chronic_disease
/ 56 57 284 285 O
cerebrovascular 57 72 285 300 B-chronic_disease
accident 73 81 301 309 I-chronic_disease

History 0 7 310 317 O
of 8 10 318 320 O
hypersensitivity 11 27 321 337 O
to 28 30 338 340 O
any 31 34 341 344 B-allergy_name
component 35 44 345 354 I-allergy_name
of 45 47 355 357 I-allergy_name
the 48 51 358 361 I-allergy_name
formulation 52 63 362 373 I-allergy_name

History 0 7 374 381 O
of 8 10 382 384 O
hypersensitivity 11 27 385 401 O
to 28 30 402 404 O
sirolimus 31 40 405 414 B-treatment
, 40 41 414 415 O
temsirolimus 42 54 416 428 B-treatment
, 54 55 428 429 O
everolimus 56 66 430 440 B-treatment

History 0 7 441 448 O
of 8 10 449 451 O
hypersensitivity 11 27 452 468 O
to 28 30 469 471 O
vandetanib 31 41 472 482 B-allergy_name
, 41 42 482 483 O
lactose 43 50 484 491 B-allergy_name
, 50 51 491 492 O
murine 52 58 493 499 B-allergy_name
products 59 67 500 508 I-allergy_name
, 67 68 508 509 O
or 69 71 510 512 O
any 72 75 513 516 O
component 76 85 517 526 B-allergy_name
of 86 88 527 529 I-allergy_name
the 89 92 530 533 I-allergy_name
formulation 93 104 534 545 I-allergy_name

Patients 0 8 546 554 O
must 9 13 555 559 O
be 14 16 560 562 O
at 17 19 563 565 O
least 20 25 566 571 O
3 26 27 572 573 B-lower_bound
weeks 28 33 574 579 I-lower_bound
beyond 34 40 580 586 O
their 41 46 587 592 O
previous 47 55 593 601 O
cytotoxic 56 65 602 611 B-treatment
chemotherapy 66 78 612 624 I-treatment
; 78 79 624 625 O
patient 80 87 626 633 O
must 88 92 634 638 O
be 93 95 639 641 O
at 96 98 642 644 O
least 99 104 645 650 O
5 105 106 651 652 B-lower_bound
half 107 111 653 657 O
- 111 112 657 658 O
lives 112 117 658 663 O
or 118 120 664 666 O
3 121 122 667 668 O
weeks 123 128 669 674 O
, 128 129 674 675 O
whichever 130 139 676 685 O
is 140 142 686 688 O
shorter 143 150 689 696 O
, 150 151 696 697 O
from 152 156 698 702 O
their 157 162 703 708 O
previous 163 171 709 717 O
targeted 172 180 718 726 O
or 181 183 727 729 O
biologic 184 192 730 738 B-treatment
therapy 193 200 739 746 I-treatment
; 200 201 746 747 O
in 202 204 748 750 O
addition 205 213 751 759 O
, 213 214 759 760 O
patients 215 223 761 769 O
must 224 228 770 774 O
be 229 231 775 777 O
at 232 234 778 780 O
least 235 240 781 786 O
3 241 242 787 788 O
weeks 243 248 789 794 O
beyond 249 255 795 801 O
the 256 259 802 805 O
last 260 264 806 810 O
session 265 272 811 818 O
of 273 275 819 821 O
radiation 276 285 822 831 B-treatment
therapy 286 293 832 839 I-treatment
; 293 294 839 840 O
local 295 300 841 846 B-treatment
palliative 301 311 847 857 I-treatment
radiation 312 321 858 867 I-treatment
therapy 322 329 868 875 I-treatment
that 330 334 876 880 O
is 335 337 881 883 O
not 338 341 884 887 O
delivered 342 351 888 897 O
to 352 354 898 900 O
all 355 358 901 904 O
target 359 365 905 911 O
lesions 366 373 912 919 O
is 374 376 920 922 O
allowed 377 384 923 930 O
immediately 385 396 931 942 O
before 397 403 943 949 O
or 404 406 950 952 O
during 407 413 953 959 O
treatment 414 423 960 969 B-treatment

Patients 0 8 970 978 O
with 9 13 979 983 O
advanced 14 22 984 992 O
or 23 25 993 995 O
metastatic 26 36 996 1006 B-cancer
cancer 37 43 1007 1013 I-cancer
that 44 48 1014 1018 O
is 49 51 1019 1021 O
refractory 52 62 1022 1032 O
to 63 65 1033 1035 O
standard 66 74 1036 1044 B-treatment
therapy 75 82 1045 1052 I-treatment
, 82 83 1052 1053 O
relapsed 84 92 1054 1062 O
after 93 98 1063 1068 O
standard 99 107 1069 1077 O
therapy 108 115 1078 1085 O
, 115 116 1085 1086 O
or 117 119 1087 1089 O
who 120 123 1090 1093 O
have 124 128 1094 1098 O
no 129 131 1099 1101 O
standard 132 140 1102 1110 O
therapy 141 148 1111 1118 O
available 149 158 1119 1128 O
that 159 163 1129 1133 O
improves 164 172 1134 1142 O
survival 173 181 1143 1151 O
by 182 184 1152 1154 O
at 185 187 1155 1157 O
least 188 193 1158 1163 O
three 194 199 1164 1169 B-lower_bound
months 200 206 1170 1176 I-lower_bound

Platelets 0 9 1177 1186 B-clinical_variable
more 10 14 1187 1191 O
or 15 17 1192 1194 O
equal 18 23 1195 1200 O
to 24 26 1201 1203 O
50,000 27 33 1204 1210 B-lower_bound
/ 33 34 1210 1211 I-lower_bound
mL 34 36 1211 1213 I-lower_bound

Pregnant 0 8 1214 1222 B-pregnancy

Presence 0 8 1223 1231 O
of 9 11 1232 1234 O
cardiac 12 19 1235 1242 B-chronic_disease
disease 20 27 1243 1250 I-chronic_disease
that 28 32 1251 1255 O
, 32 33 1255 1256 O
in 34 36 1257 1259 O
the 37 40 1260 1263 O
opinion 41 48 1264 1271 O
of 49 51 1272 1274 O
the 52 55 1275 1278 O
investigator 56 68 1279 1291 O
, 68 69 1291 1292 O
increases 70 79 1293 1302 O
the 80 83 1303 1306 O
risk 84 88 1307 1311 O
of 89 91 1312 1314 O
ventricular 92 103 1315 1326 B-chronic_disease
arrhythmia 104 114 1327 1337 I-chronic_disease

Total 0 5 1338 1343 B-clinical_variable
bilirubin 6 15 1344 1353 I-clinical_variable
less 16 20 1354 1358 O
than 21 25 1359 1363 O
or 26 28 1364 1366 O
equal 29 34 1367 1372 O
to 35 37 1373 1375 O
3.0 38 41 1376 1379 B-upper_bound

Uncontrolled 0 12 1380 1392 O
intercurrent 13 25 1393 1405 B-chronic_disease
illness 26 33 1406 1413 I-chronic_disease
including 34 43 1414 1423 O
, 43 44 1423 1424 O
but 45 48 1425 1428 O
not 49 52 1429 1432 O
limited 53 60 1433 1440 O
to 61 63 1441 1443 O
, 63 64 1443 1444 O
uncontrolled 65 77 1445 1457 B-chronic_disease
infection 78 87 1458 1467 I-chronic_disease
, 87 88 1467 1468 O
uncontrolled 89 101 1469 1481 B-chronic_disease
asthma 102 108 1482 1488 I-chronic_disease
, 108 109 1488 1489 O
need 110 114 1490 1494 O
for 115 118 1495 1498 O
hemodialysis 119 131 1499 1511 B-treatment
, 131 132 1511 1512 O
need 133 137 1513 1517 O
for 138 141 1518 1521 O
ventilatory 142 153 1522 1533 B-treatment
support 154 161 1534 1541 I-treatment

Age 0 3 0 3 B-age
: 3 4 3 4 O
1 5 6 5 6 B-lower_bound
day 7 10 7 10 I-lower_bound
( 11 12 11 12 O
> 12 13 12 13 O
38 14 16 14 16 B-lower_bound
weeks 17 22 17 22 I-lower_bound
GA 23 25 23 25 I-lower_bound
neonate 26 33 26 33 I-lower_bound
or 34 36 34 36 O
older 37 42 37 42 O
) 42 43 42 43 O
to 44 46 44 46 O
17 47 49 47 49 B-upper_bound
years 50 55 50 55 I-upper_bound

All 0 3 56 59 O
patients 4 12 60 68 O
who 13 16 69 72 O
are 17 20 73 76 O
receiving 21 30 77 86 O
HFNC 31 35 87 91 B-treatment
for 36 39 92 95 O
hypoxia 40 47 96 103 B-chronic_disease

Patient 0 7 104 111 O
who 8 11 112 115 O
the 12 15 116 119 O
medical 16 23 120 127 O
team 24 28 128 132 O
feels 29 34 133 138 O
may 35 38 139 142 O
require 39 46 143 150 O
urgent 47 53 151 157 O
escalation 54 64 158 168 O
of 65 67 169 171 O
non 68 71 172 175 B-treatment
- 71 72 175 176 I-treatment
invasive 72 80 176 184 I-treatment
therapy 81 88 185 192 I-treatment
or 89 91 193 195 O
imminent 92 100 196 204 B-treatment
intubation 101 111 205 215 I-treatment

Patients 0 8 216 224 O
less 9 13 225 229 O
than 14 18 230 234 O
3 19 20 235 236 B-upper_bound
kilograms 21 30 237 246 I-upper_bound

Patients 0 8 247 255 O
less 9 13 256 260 O
than 14 18 261 265 O
38 19 21 266 268 B-upper_bound
weeks 22 27 269 274 I-upper_bound
gestational 28 39 275 286 B-clinical_variable
age 40 43 287 290 I-clinical_variable

Patients 0 8 291 299 O
who 9 12 300 303 O
are 13 16 304 307 O
immunocompromised 17 34 308 325 B-chronic_disease
and/or 35 41 326 332 O
status 42 48 333 339 O
post 49 53 340 344 O
bone 54 58 345 349 B-treatment
marrow 59 65 350 356 I-treatment
transplant 66 76 357 367 I-treatment

Patients 0 8 368 376 O
who 9 12 377 380 O
are 13 16 381 384 O
on 17 19 385 387 O
FIO2 20 24 388 392 B-clinical_variable
> 25 26 393 394 O
0.6 27 30 395 398 B-lower_bound
at 31 33 399 401 O
the 34 37 402 405 O
highest 38 45 406 413 O
level 46 51 414 419 O
of 52 54 420 422 O
flow 55 59 423 427 O
offered 60 67 428 435 O
within 68 74 436 442 O
the 75 78 443 446 O
study 79 84 447 452 O

Patients 0 8 453 461 O
who 9 12 462 465 O
have 13 17 466 470 O
congenital 18 28 471 481 B-chronic_disease
heart 29 34 482 487 I-chronic_disease
defects 35 42 488 495 I-chronic_disease

Currently 0 9 0 9 B-pregnancy
pregnant 10 18 10 18 I-pregnancy

DSM 0 3 19 22 O
- 3 4 22 23 O
V 4 5 23 24 O
moderate 6 14 25 33 O
or 15 17 34 36 O
severe 18 24 37 43 O
opiate 25 31 44 50 B-treatment
( 32 33 51 52 O
heroin 33 39 52 58 O
or 40 42 59 61 O
OA 43 45 62 64 O
) 45 46 64 65 O

Past 0 4 66 70 B-upper_bound
3 5 6 71 72 I-upper_bound
- 6 7 72 73 I-upper_bound
month 7 12 73 78 I-upper_bound
non 13 16 79 82 O
- 16 17 82 83 O
medical 17 24 83 90 O
opioid 25 31 91 97 B-treatment
analgesic 32 41 98 107 I-treatment
( 42 43 108 109 I-treatment
OA 43 45 109 111 I-treatment
) 45 46 111 112 I-treatment
use 47 50 113 116 O

Presenting 0 10 117 127 O
for 11 14 128 131 O
pain 15 19 132 136 O
related 20 27 137 144 O
to 28 30 145 147 O
acute 31 36 148 153 B-treatment
cancer 37 43 154 160 I-treatment
therapy 44 51 161 168 I-treatment

Unable 0 6 169 175 B-language_fluency
to 7 9 176 178 I-language_fluency
read 10 14 179 183 I-language_fluency
/ 14 15 183 184 I-language_fluency
understand 15 25 184 194 I-language_fluency
English 26 33 195 202 I-language_fluency

History 0 7 0 7 O
of 8 10 8 10 O
preterm 11 18 11 18 O
birth 19 24 19 24 O
or 25 27 25 27 O
short 28 33 28 33 O
cervix 34 40 34 40 O
( 41 42 41 42 O
defined 42 49 42 49 O
as 50 52 50 52 O
cervical 53 61 53 61 B-clinical_variable
length 62 68 62 68 I-clinical_variable
≤ 69 70 69 70 O
25 71 73 71 73 B-upper_bound
mm 74 76 74 76 I-upper_bound
at 77 79 77 79 O
18 80 82 80 82 B-lower_bound
- 82 83 82 83 O
24 83 85 83 85 B-upper_bound
weeks 86 91 86 91 I-upper_bound
GA 92 94 92 94 O
necessitating 95 108 95 108 O
progesterone 109 121 109 121 B-treatment
therapy 122 129 122 129 I-treatment

Known 0 5 130 135 O
sensitivity 6 17 136 147 O
or 18 20 148 150 O
listed 21 27 151 157 O
contraindication 28 44 158 174 O
to 45 47 175 177 O
progesterone 48 60 178 190 B-allergy_name
( 61 62 191 192 O
known 62 67 192 197 O
allergy 68 75 198 205 O
or 76 78 206 208 O
hypersensitivity 79 95 209 225 O
to 96 98 226 228 O
progesterone 99 111 229 241 O
, 111 112 241 242 O
severe 113 119 243 249 B-allergy_name
hepatic 120 127 250 257 I-allergy_name
dysfunction 128 139 258 269 I-allergy_name
, 139 140 269 270 O
undiagnosed 141 152 271 282 B-allergy_name
vaginal 153 160 283 290 I-allergy_name
bleeding 161 169 291 299 I-allergy_name
, 169 170 299 300 O
mammary 171 178 301 308 B-allergy_name
or 179 181 309 311 O
genital 182 189 312 319 B-allergy_name
tract 190 195 320 325 I-allergy_name
carcinoma 196 205 326 335 I-allergy_name
, 205 206 335 336 O
thrombophlebitis 207 223 337 353 B-allergy_name
, 223 224 353 354 O
thromboembolic 225 239 355 369 B-allergy_name
disorders 240 249 370 379 I-allergy_name
, 249 250 379 380 O
cerebral 251 259 381 389 B-allergy_name
hemorrhage 260 270 390 400 I-allergy_name
, 270 271 400 401 O
porphyria 272 281 402 411 B-allergy_name
) 281 282 411 412 O

Language 0 8 413 421 B-language_fluency
other 9 14 422 427 I-language_fluency
than 15 19 428 432 I-language_fluency
English 20 27 433 440 I-language_fluency
spoken 28 34 441 447 I-language_fluency
in 35 37 448 450 I-language_fluency
the 38 41 451 454 I-language_fluency
home 42 46 455 459 I-language_fluency

Major 0 5 460 465 O
genetic 6 13 466 473 O
or 14 16 474 476 O
extra 17 22 477 482 O
- 22 23 482 483 O
cardiac 23 30 483 490 O
anomaly 31 38 491 498 O
other 39 44 499 504 O
than 45 49 505 509 O
22q11 50 55 510 515 B-chronic_disease
deletion 56 64 516 524 I-chronic_disease

Maternal 0 8 525 533 O
contraindication 9 25 534 550 O
for 26 29 551 554 O
magnetic 30 38 555 563 B-treatment
resonance 39 48 564 573 I-treatment
imaging 49 56 574 581 I-treatment
( 57 58 582 583 I-treatment
MRI 58 61 583 586 I-treatment
) 61 62 586 587 I-treatment

Maternal 0 8 588 596 O
use 9 12 597 600 O
of 13 15 601 603 O
progesterone 16 28 604 616 B-treatment
within 29 35 617 623 O
30 36 38 624 626 B-upper_bound
days 39 43 627 631 I-upper_bound
of 44 46 632 634 O
enrollment 47 57 635 645 O

Mother 0 6 646 652 O
carrying 7 15 653 661 O
a 16 17 662 663 O
fetus 18 23 664 669 O
with 24 28 670 674 O
CHD 29 32 675 678 B-chronic_disease
( 33 34 679 680 O
maternal 34 42 680 688 B-chronic_disease
- 42 43 688 689 I-chronic_disease
fetal 43 48 689 694 I-chronic_disease
dyad 49 53 695 699 I-chronic_disease
) 53 54 699 700 O
requiring 55 64 701 710 O
surgery 65 72 711 718 B-treatment
with 73 77 719 723 O
cardiopulmonary 78 93 724 739 B-treatment
bypass 94 100 740 746 I-treatment
( 101 102 747 748 I-treatment
CPB 102 105 748 751 I-treatment
) 105 106 751 752 I-treatment
prior 107 112 753 758 O
to 113 115 759 761 O
44 116 118 762 764 B-upper_bound
weeks 119 124 765 770 I-upper_bound
corrected 125 134 771 780 O
gestational 135 146 781 792 B-clinical_variable
age 147 150 793 796 I-clinical_variable
( 151 152 797 798 I-clinical_variable
GA 152 154 798 800 I-clinical_variable
) 154 155 800 801 I-clinical_variable
identified 156 166 802 812 O
prior 167 172 813 818 O
to 173 175 819 821 O
28 176 178 822 824 B-upper_bound
weeks 179 184 825 830 I-upper_bound
GA 185 187 831 833 O

Prescription 0 12 834 846 O
or 13 15 847 849 O
ingestion 16 25 850 859 O
of 26 28 860 862 O
medications 29 40 863 874 B-treatment
known 41 46 875 880 O
to 47 49 881 883 O
interact 50 58 884 892 O
with 59 63 893 897 O
progesterone 64 76 898 910 B-treatment
( 77 78 911 912 O
e.g. 78 82 912 916 O
Bromocriptine 83 96 917 930 B-treatment
, 96 97 930 931 O
Rifamycin 98 107 932 941 B-treatment
, 107 108 941 942 O
Ketoconazole 109 121 943 955 B-treatment
or 122 124 956 958 O
Cyclosporin 125 136 959 970 B-treatment
) 136 137 970 971 O

Subjects 0 8 972 980 O
with 9 13 981 985 O
a 14 15 986 987 O
known 16 21 988 993 O
history 22 29 994 1001 O
of 30 32 1002 1004 O
non 33 36 1005 1008 O
- 36 37 1008 1009 O
compliance 37 47 1009 1019 O
with 48 52 1020 1024 O
medical 53 60 1025 1032 O
therapy 61 68 1033 1040 B-treatment

Patients 0 8 0 8 O
who 9 12 9 12 O
are 13 16 13 16 O
pregnant 17 25 17 25 B-pregnancy
or 26 28 26 28 O
may 29 32 29 32 B-pregnancy
become 33 39 33 39 I-pregnancy
pregnant 40 48 40 48 I-pregnancy

Patients 0 8 49 57 O
with 9 13 58 62 O
cognitive 14 23 63 72 B-chronic_disease
disabilities 24 36 73 85 I-chronic_disease
or 37 39 86 88 O
those 40 45 89 94 O
lacking 46 53 95 102 O
the 54 57 103 106 O
mental 58 64 107 113 O
capacity 65 73 114 122 O
to 74 76 123 125 O
understand 77 87 126 136 O
and 88 91 137 140 O
answer 92 98 141 147 O
questionnaires 99 113 148 162 O

Patients 0 8 163 171 O
with 9 13 172 176 O
degenerative 14 26 177 189 B-chronic_disease
neurological 27 39 190 202 I-chronic_disease
disorders 40 49 203 212 I-chronic_disease
or 50 52 213 215 O
spinal 53 59 216 222 O
cord 60 64 223 227 O
injuries 65 73 228 236 O

Patients 0 8 237 245 O
with 9 13 246 250 O
less 14 18 251 255 O
than 19 23 256 260 O
6 24 25 261 262 B-upper_bound
months 26 32 263 269 I-upper_bound
of 33 35 270 272 O
expected 36 44 273 281 O
battery 45 52 282 289 O
life 53 57 290 294 O
on 58 60 295 297 O
their 61 66 298 303 O
device 67 73 304 310 O
established 74 85 311 322 O
at 86 88 323 325 O
office 89 95 326 332 O
testing 96 103 333 340 O

Patients 0 8 341 349 O
with 9 13 350 354 O
poor 14 18 355 359 O
control 19 26 360 367 O
of 27 29 368 370 O
their 30 35 371 376 O
symptoms 36 44 377 385 O
within 45 51 386 392 O
the 52 55 393 396 O
last 56 60 397 401 B-upper_bound
one 61 64 402 405 I-upper_bound
year 65 69 406 410 I-upper_bound

Women 0 5 411 416 B-gender

aged 0 4 417 421 B-age
18 5 7 422 424 B-lower_bound
- 7 8 424 425 O
85 8 10 425 427 B-upper_bound
with 11 15 428 432 O
who 16 19 433 436 O
have 20 24 437 441 O
previously 25 35 442 452 O
had 36 39 453 456 O
the 40 43 457 460 O
InterStim 44 53 461 470 O
device 54 60 471 477 O
implanted 61 70 478 487 O
and 71 74 488 491 O
have 75 79 492 496 O
experienced 80 91 497 508 O
good 92 96 509 513 O
control 97 104 514 521 O
of 105 107 522 524 O
their 108 113 525 530 O
symptoms 114 122 531 539 O
for 123 126 540 543 O
at 127 129 544 546 O
least 130 135 547 552 O
one 136 139 553 556 B-lower_bound
year 140 144 557 561 I-lower_bound

exclude 0 7 0 7 O
any 8 11 8 11 O
hospital 12 20 12 20 O
staff 21 26 21 26 O
under 27 32 27 32 O
the 33 36 33 36 O
age 37 40 37 40 B-age
of 41 43 41 43 O
18 44 46 44 46 B-lower_bound
years 47 52 47 52 I-lower_bound
old 53 56 53 56 O
from 57 61 57 61 O
this 62 66 62 66 O
study 67 72 67 72 O
as 73 75 73 75 O
well 76 80 76 80 O
as 81 83 81 83 O
hospital 84 92 84 92 O
patients 93 101 93 101 O
and 102 105 102 105 O
non 106 109 106 109 O
- 109 110 109 110 O
hospital 110 118 110 118 O
staff 119 124 119 124 O

subjects 0 8 125 133 O
must 9 13 134 138 O
be 14 16 139 141 O
University 17 27 142 152 O
of 28 30 153 155 O
Chicago 31 38 156 163 O
hospital 39 47 164 172 O
employees 48 57 173 182 O
over 58 62 183 187 O
the 63 66 188 191 O
age 67 70 192 195 B-age
of 71 73 196 198 O
18 74 76 199 201 B-lower_bound
years 77 82 202 207 I-lower_bound
old 83 86 208 211 I-lower_bound

( 0 1 0 1 O
Grade 1 6 1 6 O
3 7 8 7 8 O
) 8 9 8 9 O
at 10 12 10 12 O
least 13 18 13 18 O
28 19 21 19 21 B-lower_bound
days 22 26 22 26 I-lower_bound
apart 27 32 27 32 O
over 33 37 33 37 O
the 38 41 38 41 O
12 42 44 42 44 B-lower_bound
weeks 45 50 45 50 I-lower_bound
before 51 57 51 57 O
study 58 63 58 63 O
entry 64 69 64 69 O

1 0 1 70 71 O
of 2 4 72 74 O
the 5 8 75 78 O
procedures 9 19 79 89 O
is 20 22 90 92 O
performed 23 32 93 102 O
during 33 39 103 109 O
the 40 43 110 113 O
6 44 45 114 115 B-upper_bound
weeks 46 51 116 121 I-upper_bound
before 52 58 122 128 I-upper_bound
study 59 64 129 134 O
start 65 70 135 140 O
( 71 72 141 142 O
C1D1 72 76 142 146 O
) 76 77 146 147 O

> 0 1 148 149 O
10 2 4 150 152 B-upper_bound
% 4 5 152 153 I-upper_bound
weight 6 12 154 160 B-clinical_variable
loss 13 17 161 165 I-clinical_variable
that 18 22 166 170 O
is 23 25 171 173 O
medically 26 35 174 183 O
documented 36 46 184 194 O
over 47 51 195 199 O
the 52 55 200 203 O
preceding 56 65 204 213 B-upper_bound
24 66 68 214 216 I-upper_bound
weeks 69 74 217 222 I-upper_bound
( 75 76 223 224 O
± 76 77 224 225 B-upper_bound
12 78 80 226 228 I-upper_bound
weeks 81 86 229 234 I-upper_bound
) 86 87 234 235 O

> 0 1 236 237 O
5 1 2 237 238 B-lower_bound
× 3 4 239 240 I-lower_bound
ULN 5 8 241 244 I-lower_bound
if 9 11 245 247 O
associated 12 22 248 258 O
with 23 27 259 263 O
clinically 28 38 264 274 O
suspected 39 48 275 284 O
liver 49 54 285 290 B-chronic_disease
infiltration 55 67 291 303 I-chronic_disease
by 68 70 304 306 I-chronic_disease
mastocytosis 71 83 307 319 I-chronic_disease
or 84 86 320 322 O
another 87 94 323 330 O
disease 95 102 331 338 O
for 103 106 339 342 O
which 107 112 343 348 O
the 113 116 349 352 O
patient 117 124 353 360 O
enrolled 125 133 361 369 O
into 134 138 370 374 O
the 139 142 375 378 O
study 143 148 379 384 O

A 0 1 385 386 O
spleen 2 8 387 393 O
that 9 13 394 398 O
is 14 16 399 401 O
palpable 17 25 402 410 O
≥ 26 27 411 412 O
5 28 29 413 414 B-lower_bound
cm 30 32 415 417 I-lower_bound
below 33 38 418 423 O
the 39 42 424 427 O
left 43 47 428 432 O
costal 48 54 433 439 O
margin 55 61 440 446 O

AML 0 3 447 450 B-cancer
, 3 4 450 451 O
MDS 5 8 452 455 B-cancer
that 9 13 456 460 O
is 14 16 461 463 O
very 17 21 464 468 O
high- 22 27 469 474 O
or 28 30 475 477 O
high 31 35 478 482 O
- 35 36 482 483 O
risk 36 40 483 487 O
as 41 43 488 490 O
defined 44 51 491 498 O
by 52 54 499 501 O
the 55 58 502 505 O
IPSS 59 63 506 510 O
- 63 64 510 511 O
R 64 65 511 512 O

Absolute 0 8 513 521 B-clinical_variable
neutrophil 9 19 522 532 I-clinical_variable
count 20 25 533 538 I-clinical_variable
< 26 27 539 540 O
500 27 30 540 543 B-upper_bound
/ 30 31 543 544 I-upper_bound
μL 31 33 544 546 I-upper_bound

Acute 0 5 547 552 B-cancer
myeloid 6 13 553 560 I-cancer
leukemia 14 22 561 569 I-cancer
( 23 24 570 571 I-cancer
AML 24 27 571 574 I-cancer
) 27 28 574 575 I-cancer

Aggressive 0 10 576 586 B-chronic_disease
systemic 11 19 587 595 I-chronic_disease
mastocytosis 20 32 596 608 I-chronic_disease
( 33 34 609 610 I-chronic_disease
ASM 34 37 610 613 I-chronic_disease
) 37 38 613 614 I-chronic_disease

Brain 0 5 615 620 B-cancer
malignancy 6 16 621 631 I-cancer

Cytopenias 0 10 632 642 B-chronic_disease
: 10 11 642 643 O
ANC 12 15 644 647 B-clinical_variable
< 16 17 648 649 O
1.0 18 21 650 653 B-upper_bound
× 22 23 654 655 I-upper_bound
10⁹/L 24 29 656 661 I-upper_bound

Eastern 0 7 662 669 B-clinical_variable
Cooperative 8 19 670 681 I-clinical_variable
Oncology 20 28 682 690 I-clinical_variable
Group 29 34 691 696 I-clinical_variable
( 35 36 697 698 I-clinical_variable
ECOG 36 40 698 702 I-clinical_variable
) 40 41 702 703 I-clinical_variable
performance 42 53 704 715 I-clinical_variable
status 54 60 716 722 I-clinical_variable
of 61 63 723 725 O
0 64 65 726 727 B-lower_bound
- 65 66 727 728 O
3 66 67 728 729 B-upper_bound

Eosinophilia 0 12 730 742 B-chronic_disease
and 13 16 743 746 O
known 17 22 747 752 O
positivity 23 33 753 763 O
for 34 37 764 767 O
the 38 41 768 771 O
FIP1L1 42 48 772 778 O
- 48 49 778 779 O
PGDFRA 49 55 779 785 O
fusion 56 62 786 792 O

Histologically- 0 15 793 808 O
or 16 18 809 811 O
cytologically- 19 33 812 826 O
confirmed 34 43 827 836 O
myeloid 44 51 837 844 B-cancer
malignancy 52 62 845 855 I-cancer
that 63 67 856 860 O
is 68 70 861 863 O
relapsed 71 79 864 872 O
or 80 82 873 875 O
refractory 83 93 876 886 O
to 94 96 887 889 O
standard 97 105 890 898 O
treatments 106 116 899 909 B-treatment

History 0 7 910 917 O
of 8 10 918 920 O
a 11 12 921 922 O
seizure 13 20 923 930 B-chronic_disease
disorder 21 29 931 939 O
or 30 32 940 942 O
requirement 33 44 943 954 O
for 45 48 955 958 O
anti 49 53 959 963 B-treatment
- 53 54 963 964 I-treatment
seizure 54 61 964 971 I-treatment
medication 62 72 972 982 I-treatment

Known 0 5 983 988 O
risk 6 10 989 993 O
of 11 13 994 996 O
intracranial 14 26 997 1009 B-chronic_disease
bleeding 27 35 1010 1018 I-chronic_disease
, 35 36 1018 1019 O
such 37 41 1020 1024 O
as 42 44 1025 1027 O
a 45 46 1028 1029 O
brain 47 52 1030 1035 B-chronic_disease
aneurysm 53 61 1036 1044 I-chronic_disease
or 62 64 1045 1047 O
history 65 72 1048 1055 O
of 73 75 1056 1058 O
subdural 76 84 1059 1067 B-chronic_disease
or 85 87 1068 1070 O
subarachnoid 88 100 1071 1083 B-chronic_disease
bleeding 101 109 1084 1092 I-chronic_disease

MCL 0 3 1093 1096 B-cancer

Mast 0 4 1097 1101 B-cancer
cell 5 9 1102 1106 I-cancer
leukemia 10 18 1107 1115 I-cancer
( 19 20 1116 1117 I-cancer
MCL 20 23 1117 1120 I-cancer
) 23 24 1120 1121 I-cancer

Myelodysplastic 0 15 1122 1137 B-cancer
syndrome 16 24 1138 1146 I-cancer
( 25 26 1147 1148 I-cancer
MDS 26 29 1148 1151 I-cancer
) 29 30 1151 1152 I-cancer
that 31 35 1153 1157 O
is 36 38 1158 1160 O
very 39 43 1161 1165 O
high- 44 49 1166 1171 O
or 50 52 1172 1174 O
high 53 57 1175 1179 O
- 57 58 1179 1180 O
risk 58 62 1180 1184 O
as 63 65 1185 1187 O
defined 66 73 1188 1195 O
by 74 76 1196 1198 O
the 77 80 1199 1202 O
International 81 94 1203 1216 O
prognostic 95 105 1217 1227 O
scoring 106 113 1228 1235 O
system 114 120 1236 1242 O
for 121 124 1243 1246 O
myelodysplastic 125 140 1247 1262 B-cancer
syndromes 141 150 1263 1272 I-cancer
( 151 152 1273 1274 O
IPSS 152 156 1274 1278 O
- 156 157 1278 1279 O
R 157 158 1279 1280 O
) 158 159 1280 1281 O

Philadelphia 0 12 1282 1294 B-cancer
chromosome 13 23 1295 1305 I-cancer
positive 24 32 1306 1314 I-cancer
malignancies 33 45 1315 1327 I-cancer

Platelet 0 8 1328 1336 B-clinical_variable
count 9 14 1337 1342 I-clinical_variable
< 15 16 1343 1344 O
25,000 16 22 1344 1350 B-upper_bound
/ 22 23 1350 1351 I-upper_bound
μL 23 25 1351 1353 I-upper_bound

QT 0 2 1354 1356 B-clinical_variable
interval 3 11 1357 1365 I-clinical_variable
corrected 12 21 1366 1375 I-clinical_variable
using 22 27 1376 1381 I-clinical_variable
Fridericia 28 38 1382 1392 I-clinical_variable
's 38 40 1392 1394 I-clinical_variable
formula 41 48 1395 1402 I-clinical_variable
( 49 50 1403 1404 I-clinical_variable
QTcF 50 54 1404 1408 I-clinical_variable
) 54 55 1408 1409 I-clinical_variable
> 56 57 1410 1411 O
480 57 60 1411 1414 B-lower_bound
milliseconds 61 73 1415 1427 I-lower_bound

SM 0 2 1428 1430 B-cancer
- 2 3 1430 1431 I-cancer
AHN 3 6 1431 1434 I-cancer

Symptomatic 0 11 1435 1446 O
ascites 12 19 1447 1454 B-chronic_disease
or 20 22 1455 1457 O
pleural 23 30 1458 1465 B-chronic_disease
effusion 31 39 1466 1474 I-chronic_disease
requiring 40 49 1475 1484 O
medical 50 57 1485 1492 O
intervention 58 70 1493 1505 O

Systemic 0 8 1506 1514 O
mastocytosis 9 21 1515 1527 B-chronic_disease
with 22 26 1528 1532 O
an 27 29 1533 1535 O
associated 30 40 1536 1546 O
hematologic 41 52 1547 1558 B-cancer
neoplasm 53 61 1559 1567 I-cancer
( 62 63 1568 1569 O
SM 63 65 1569 1571 O
- 65 66 1571 1572 O
AHN 66 69 1572 1575 O
) 69 70 1575 1576 O

Total 0 5 1577 1582 B-clinical_variable
bilirubin 6 15 1583 1592 I-clinical_variable
> 16 17 1593 1594 O
1.5 17 20 1594 1597 B-upper_bound
× 21 22 1598 1599 I-upper_bound
ULN 23 26 1600 1603 I-upper_bound
; 26 27 1603 1604 O
> 28 29 1605 1606 O
3 29 30 1606 1607 B-lower_bound
× 31 32 1608 1609 I-lower_bound
ULN 33 36 1610 1613 I-lower_bound

Transfusion 0 11 1614 1625 B-treatment
- 11 12 1625 1626 I-treatment
dependent 12 21 1626 1635 I-treatment
thrombocytopenia 22 38 1636 1652 B-chronic_disease
, 38 39 1652 1653 O
defined 40 47 1654 1661 O
as 48 50 1662 1664 O
: 50 51 1664 1665 O
transfusion 52 63 1666 1677 O
of 64 66 1678 1680 O
≥ 67 68 1681 1682 O
6 69 70 1683 1684 B-lower_bound
units 71 76 1685 1690 I-lower_bound
of 77 79 1691 1693 O
apheresed 80 89 1694 1703 B-clinical_variable
platelets 90 99 1704 1713 I-clinical_variable
( 100 101 1714 1715 O
or 101 103 1715 1717 O
≥ 104 105 1718 1719 O
6 106 107 1720 1721 B-lower_bound
pools 108 113 1722 1727 I-lower_bound
of 114 116 1728 1730 O
random 117 123 1731 1737 B-clinical_variable
donor 124 129 1738 1743 I-clinical_variable
or 130 132 1744 1746 O
buffy 133 138 1747 1752 B-clinical_variable
coat 139 143 1753 1757 I-clinical_variable
platelets 144 153 1758 1767 I-clinical_variable
) 153 154 1767 1768 O
during 155 161 1769 1775 O
the 162 165 1776 1779 O
12 166 168 1780 1782 B-upper_bound
weeks 169 174 1783 1788 I-upper_bound
preceding 175 184 1789 1798 I-upper_bound
treatment 185 194 1799 1808 B-treatment
( 195 196 1809 1810 I-treatment
C1D1 196 200 1810 1814 I-treatment
) 200 201 1814 1815 I-treatment

alanine 0 7 1816 1823 B-clinical_variable
aminotransferase 8 24 1824 1840 I-clinical_variable
( 25 26 1841 1842 I-clinical_variable
ALT 26 29 1842 1845 I-clinical_variable
) 29 30 1845 1846 I-clinical_variable
> 31 32 1847 1848 O
3 32 33 1848 1849 B-lower_bound
x 34 35 1850 1851 I-lower_bound
the 36 39 1852 1855 I-lower_bound
upper 40 45 1856 1861 I-lower_bound
limit 46 51 1862 1867 I-lower_bound
of 52 54 1868 1870 I-lower_bound
normal 55 61 1871 1877 I-lower_bound
( 62 63 1878 1879 I-lower_bound
ULN 63 66 1879 1882 I-lower_bound
) 66 67 1882 1883 I-lower_bound

alanine 0 7 1884 1891 B-clinical_variable
aminotransferase 8 24 1892 1908 I-clinical_variable
( 25 26 1909 1910 O
ALT 26 29 1910 1913 B-clinical_variable
; 29 30 1913 1914 O
> 31 32 1915 1916 O
3.0 33 36 1917 1920 B-lower_bound
× 37 38 1921 1922 I-lower_bound
ULN 39 42 1923 1926 I-lower_bound
) 42 43 1926 1927 O

alkaline 0 8 1928 1936 B-clinical_variable
phosphatase 9 20 1937 1948 I-clinical_variable
( 21 22 1949 1950 O
> 22 23 1950 1951 O
2.5 24 27 1952 1955 B-lower_bound
× 28 29 1956 1957 I-lower_bound
ULN 30 33 1958 1961 I-lower_bound
) 33 34 1961 1962 O
with 35 39 1963 1967 O
1 40 41 1968 1969 O
of 42 44 1970 1972 O
the 45 48 1973 1976 O
following 49 58 1977 1986 O
present 59 66 1987 1994 O
: 66 67 1994 1995 O
ascites 68 75 1996 2003 O
or 76 78 2004 2006 O
clinically 79 89 2007 2017 O
relevant 90 98 2018 2026 O
portal 99 105 2027 2033 B-chronic_disease
hypertension 106 118 2034 2046 I-chronic_disease
or 119 121 2047 2049 O
liver 122 127 2050 2055 B-chronic_disease
mast 128 132 2056 2060 I-chronic_disease
cell 133 137 2061 2065 I-chronic_disease
infiltration 138 150 2066 2078 I-chronic_disease
that 151 155 2079 2083 O
is 156 158 2084 2086 O
biopsy 159 165 2087 2093 B-treatment
- 165 166 2093 2094 O
proven 166 172 2094 2100 O
or 173 175 2101 2103 O
no 176 178 2104 2106 O
other 179 184 2107 2112 O
identified 185 195 2113 2123 O
cause 196 201 2124 2129 O
of 202 204 2130 2132 O
abnormal 205 213 2133 2141 B-chronic_disease
liver 214 219 2142 2147 I-chronic_disease
function 220 228 2148 2156 I-chronic_disease

aspartate 0 9 2157 2166 B-clinical_variable
aminotransferase 10 26 2167 2183 I-clinical_variable
( 27 28 2184 2185 O
AST 28 31 2185 2188 B-clinical_variable
; 31 32 2188 2189 O
> 33 34 2190 2191 O
3.0 35 38 2192 2195 B-clinical_variable
× 39 40 2196 2197 I-clinical_variable
ULN 41 44 2198 2201 I-clinical_variable
) 44 45 2201 2202 O

at 0 2 2203 2205 O
least 3 8 2206 2211 O
1 9 10 2212 2213 B-lower_bound
C 11 12 2214 2215 O
- 12 13 2215 2216 O
finding 13 20 2216 2223 O
attributable 21 33 2224 2236 O
to 34 36 2237 2239 O
systemic 37 45 2240 2248 B-cancer
mastocytosis 46 58 2249 2261 I-cancer
( 59 60 2262 2263 I-cancer
SM 60 62 2263 2265 I-cancer
) 62 63 2265 2266 I-cancer

hemoglobin 0 10 2267 2277 B-clinical_variable
< 11 12 2278 2279 O
10 13 15 2280 2282 B-upper_bound
g 16 17 2283 2284 I-upper_bound
/ 17 18 2284 2285 I-upper_bound
dL 18 20 2285 2287 I-upper_bound
or 21 23 2288 2290 O
platelet 24 32 2291 2299 B-clinical_variable
count 33 38 2300 2305 I-clinical_variable
< 39 40 2306 2307 O
75 41 43 2308 2310 B-upper_bound
× 44 45 2311 2312 I-upper_bound
10⁹/L 46 51 2313 2318 I-upper_bound

measured 0 8 2319 2327 B-clinical_variable
creatinine 9 19 2328 2338 I-clinical_variable
clearance 20 29 2339 2348 I-clinical_variable
< 30 31 2349 2350 O
40 31 33 2350 2352 B-upper_bound
mL 34 36 2353 2355 I-upper_bound
/ 36 37 2355 2356 I-upper_bound
min 37 40 2356 2359 I-upper_bound

metastases 0 10 2360 2370 B-cancer
to 11 13 2371 2373 I-cancer
the 14 17 2374 2377 I-cancer
brain 18 23 2378 2383 I-cancer

most 0 4 2384 2388 O
recent 5 11 2389 2395 O
transfusion 12 23 2396 2407 B-treatment
occurring 24 33 2408 2417 O
during 34 40 2418 2424 O
the 41 44 2425 2428 O
preceding 45 54 2429 2438 B-upper_bound
4 55 56 2439 2440 I-upper_bound
weeks 57 62 2441 2446 I-upper_bound
and 63 66 2447 2450 O
transfusion 67 78 2451 2462 O
administered 79 91 2463 2475 O
for 92 95 2476 2479 O
hemoglobin 96 106 2480 2490 B-clinical_variable
≤ 107 108 2491 2492 O
8.5 109 112 2493 2496 B-upper_bound
g 113 114 2497 2498 I-upper_bound
/ 114 115 2498 2499 I-upper_bound
dL 115 117 2499 2501 I-upper_bound

other 0 5 2502 2507 O
relapsed 6 14 2508 2516 O
or 15 17 2517 2519 O
refractory 18 28 2520 2530 O
, 28 29 2530 2531 O
potentially 30 41 2532 2543 O
avapritinib 42 53 2544 2555 O
- 53 54 2555 2556 O
responsive 54 64 2556 2566 O
hematologic 65 76 2567 2578 O
neoplasms 77 86 2579 2588 B-cancer
( 87 88 2589 2590 O
e.g. 88 92 2590 2594 O
, 92 93 2594 2595 O
evidence 94 102 2596 2604 O
of 103 105 2605 2607 O
aberrant 106 114 2608 2616 O
KIT 115 118 2617 2620 O
or 119 121 2621 2623 O
platelet 122 130 2624 2632 O
derived 131 138 2633 2640 O
growth 139 145 2641 2647 O
factor 146 152 2648 2654 O
receptor 153 161 2655 2663 O
( 162 163 2664 2665 O
PDGFR 163 168 2665 2670 O
) 168 169 2670 2671 O
signaling 170 179 2672 2681 O
) 179 180 2681 2682 O

reason 0 6 2683 2689 O
for 7 10 2690 2693 O
transfusion 11 22 2694 2705 B-treatment
is 23 25 2706 2708 O
not 26 29 2709 2712 O
bleeding 30 38 2713 2721 B-chronic_disease
, 38 39 2721 2722 O
hemolysis 40 49 2723 2732 B-chronic_disease
, 49 50 2732 2733 O
or 51 53 2734 2736 O
therapy 54 61 2737 2744 B-treatment
- 61 62 2744 2745 O
related 62 69 2745 2752 O

transfusion 0 11 2753 2764 B-treatment
of 12 14 2765 2767 O
≥ 15 16 2768 2769 O
6 17 18 2770 2771 B-lower_bound
units 19 24 2772 2777 I-lower_bound
packed 25 31 2778 2784 O
red 32 35 2785 2788 O
blood 36 41 2789 2794 O
cells 42 47 2795 2800 O
( 48 49 2801 2802 O
PRBCs 49 54 2802 2807 O
) 54 55 2807 2808 O
in 56 58 2809 2811 O
the 59 62 2812 2815 O
12 63 65 2816 2818 B-upper_bound
weeks 66 71 2819 2824 I-upper_bound
before 72 78 2825 2831 I-upper_bound
start 79 84 2832 2837 O
of 85 87 2838 2840 O
treatment 88 97 2841 2850 B-treatment
( 98 99 2851 2852 O
C1D1 99 103 2852 2856 O
) 103 104 2856 2857 O

use 0 3 2858 2861 O
of 4 6 2862 2864 O
diuretics 7 16 2865 2874 B-treatment
( 17 18 2875 2876 O
Grade 18 23 2876 2881 O
2 24 25 2882 2883 B-lower_bound
) 25 26 2883 2884 O
or 27 29 2885 2887 O
≥ 30 31 2888 2889 O
2 32 33 2890 2891 O
therapeutic 34 45 2892 2903 B-treatment
paracenteses 46 58 2904 2916 I-treatment
or 59 61 2917 2919 O
thoracenteses 62 75 2920 2933 B-treatment

≥ 0 1 2934 2935 O
2 2 3 2936 2937 B-lower_bound
units 4 9 2938 2943 I-lower_bound
transfused 10 20 2944 2954 O
during 21 27 2955 2961 O
the 28 31 2962 2965 O
preceding 32 41 2966 2975 O
4 42 43 2976 2977 B-upper_bound
weeks 44 49 2978 2983 I-upper_bound
and 50 53 2984 2987 O
transfusions 54 66 2988 3000 B-treatment
administered 67 79 3001 3013 O
for 80 83 3014 3017 O
platelet 84 92 3018 3026 B-clinical_variable
count 93 98 3027 3032 I-clinical_variable
< 99 100 3033 3034 O
20 101 103 3035 3037 B-upper_bound
× 104 105 3038 3039 I-upper_bound
10⁹/L 106 111 3040 3045 I-upper_bound

≥ 0 1 3046 3047 O
Grade 2 7 3048 3053 B-lower_bound
2 8 9 3054 3055 I-lower_bound
abnormalities 10 23 3056 3069 O
in 24 26 3070 3072 O
direct 27 33 3073 3079 B-clinical_variable
bilirubin 34 43 3080 3089 I-clinical_variable
( 44 45 3090 3091 O
> 45 46 3091 3092 O
1.5 47 50 3093 3096 B-lower_bound
× 51 52 3097 3098 I-lower_bound
upper 53 58 3099 3104 I-lower_bound
limit 59 64 3105 3110 I-lower_bound
of 65 67 3111 3113 I-lower_bound
normal 68 74 3114 3120 I-lower_bound
[ 75 76 3121 3122 I-lower_bound
ULN 76 79 3122 3125 I-lower_bound
] 79 80 3125 3126 I-lower_bound
) 80 81 3126 3127 O

≥ 0 1 3128 3129 O
Grade 2 7 3130 3135 B-lower_bound
2 8 9 3136 3137 I-lower_bound
hypoalbuminemia 10 25 3138 3153 B-clinical_variable
( 26 27 3154 3155 O
< 27 28 3155 3156 O
3.0 29 32 3157 3160 B-upper_bound
g 33 34 3161 3162 I-upper_bound
/ 34 35 3162 3163 I-upper_bound
dL 35 37 3163 3165 I-upper_bound
) 37 38 3165 3166 O

Acute 0 5 0 5 O
cancer 6 12 6 12 B-cancer
treatment 13 22 13 22 B-treatment

Anyone 0 6 23 29 O
with 7 11 30 34 O
1 12 13 35 36 B-lower_bound
or 14 16 37 39 O
more 17 21 40 44 O
characteristics 22 37 45 60 O
of 38 40 61 63 O
frailty 41 48 64 71 O

Currently 0 9 72 81 O
followed 10 18 82 90 O
by 19 21 91 93 O
a 22 23 94 95 O
PCP 24 27 96 99 B-treatment
( 28 29 100 101 O
had 29 32 101 104 O
an 33 35 105 107 O
eval 36 40 108 112 O
in 41 43 113 115 O
last 44 48 116 120 B-upper_bound
6 49 50 121 122 I-upper_bound
- 50 51 122 123 I-upper_bound
months 51 57 123 129 I-upper_bound
) 57 58 129 130 O

Diagnosis 0 9 131 140 O
of 10 12 141 143 O
substance 13 22 144 153 O
abuse 23 28 154 159 O
or 29 31 160 162 O
dependence 32 42 163 173 O
( 43 44 174 175 O
last 44 48 175 179 O
12 49 51 180 182 O
months 52 58 183 189 O
) 58 59 189 190 O
, 59 60 190 191 O
excluding 61 70 192 201 O
Nicotine 71 79 202 210 B-upper_bound
dependence 80 90 211 221 I-upper_bound

End 0 3 222 225 B-chronic_disease
stage 4 9 226 231 I-chronic_disease
medical 10 17 232 239 I-chronic_disease
illness 18 25 240 247 I-chronic_disease
( 26 27 248 249 O
e.g. 27 31 249 253 O
liver 32 37 254 259 B-chronic_disease
, 37 38 259 260 O
kidney 39 45 261 267 B-chronic_disease
, 45 46 267 268 O
pulmonary 47 56 269 278 B-chronic_disease
) 56 57 278 279 O

HRSD>16 0 7 280 287 B-clinical_variable
and 8 11 288 291 O
a 12 13 292 293 O
DSM 14 17 294 297 B-chronic_disease
- 17 18 297 298 I-chronic_disease
IV 18 20 298 300 I-chronic_disease
depressive 21 31 301 311 I-chronic_disease
disorder 32 40 312 320 I-chronic_disease
( 41 42 321 322 O
e.g. 42 46 322 326 O
MDD 47 50 327 330 B-chronic_disease
, 50 51 330 331 O
Dysthymia 52 61 332 341 B-chronic_disease
) 61 62 341 342 O

History 0 7 343 350 O
of 8 10 351 353 O
allergic 11 19 354 362 O
or 20 22 363 365 O
adverse 23 30 366 373 O
reaction 31 39 374 382 O
to 40 42 383 385 O
escitalopram 43 55 386 398 B-allergy_name
or 56 58 399 401 O
duloxetine 59 69 402 412 B-allergy_name
, 69 70 412 413 O
or 71 73 414 416 O
non 74 77 417 420 O
- 77 78 420 421 O
response 78 86 421 429 O
to 87 89 430 432 O
adequate 90 98 433 441 O
trial 99 104 442 447 O
of 105 107 448 450 O
escitalopram 108 120 451 463 O
( 121 122 464 465 O
at 122 124 465 467 O
least 125 130 468 473 O
4 131 132 474 475 B-lower_bound
weeks 133 138 476 481 I-lower_bound
at 139 141 482 484 I-lower_bound
dose 142 146 485 489 I-lower_bound
of 147 149 490 492 I-lower_bound
20 150 152 493 495 I-lower_bound
mg 153 155 496 498 I-lower_bound
) 155 156 498 499 O
or 157 159 500 502 O
duloxetine 160 170 503 513 O
( 171 172 514 515 O
at 172 174 515 517 O
least 175 180 518 523 O
4 181 182 524 525 B-lower_bound
weeks 183 188 526 531 I-lower_bound
at 189 191 532 534 I-lower_bound
dose 192 196 535 539 I-lower_bound
of 197 199 540 542 I-lower_bound
90 200 202 543 545 I-lower_bound
mg 202 204 545 547 I-lower_bound
) 204 205 547 548 O

History 0 7 549 556 O
of 8 10 557 559 O
psychosis 11 20 560 569 B-chronic_disease
or 21 23 570 572 O
psychotic 24 33 573 582 B-chronic_disease
disorder 34 42 583 591 I-chronic_disease
or 43 45 592 594 O
bipolar 46 53 595 602 B-chronic_disease
disorder 54 62 603 611 I-chronic_disease

Mini 0 4 612 616 B-clinical_variable
Mental 5 11 617 623 I-clinical_variable
Exam 12 16 624 628 I-clinical_variable
< 17 18 629 630 O
24 19 21 631 633 B-upper_bound
or 22 24 634 636 O
a 25 26 637 638 O
diagnosis 27 36 639 648 O
of 37 39 649 651 O
dementia 40 48 652 660 B-chronic_disease

Patient 0 7 661 668 O
is 8 10 669 671 O
considered 11 21 672 682 O
a 22 23 683 684 O
significant 24 35 685 696 O
risk 36 40 697 701 B-chronic_disease
of 41 43 702 704 I-chronic_disease
suicide 44 51 705 712 I-chronic_disease

Subject 0 7 713 720 O
is 8 10 721 723 O
considered 11 21 724 734 O
based 22 27 735 740 O
on 28 30 741 743 O
history 31 38 744 751 O
to 39 41 752 754 O
be 42 44 755 757 O
unlikely 45 53 758 766 O
to 54 56 767 769 O
respond 57 64 770 777 O
to 65 67 778 780 O
the 68 71 781 784 O
single 72 78 785 791 O
agent 79 84 792 797 O
antidepressant 85 99 798 812 B-treatment
( 100 101 813 814 O
i.e. 101 105 814 818 O
, 105 106 818 819 O
subjects 107 115 820 828 O
with 116 120 829 833 O
treatment 121 130 834 843 B-treatment
resistant 131 140 844 853 O
depression 141 151 854 864 O
, 151 152 864 865 O
including 153 162 866 875 O
subjects 163 171 876 884 O
with 172 176 885 889 O
previous 177 185 890 898 B-treatment
treatment 186 195 899 908 I-treatment
with 196 200 909 913 O
ECT 201 204 914 917 B-treatment
) 204 205 917 918 O

18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
70 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O

American 0 8 19 27 B-clinical_variable
Spinal 9 15 28 34 I-clinical_variable
Injury 16 22 35 41 I-clinical_variable
Association 23 34 42 53 I-clinical_variable
Impairment 35 45 54 64 I-clinical_variable
Scale 46 51 65 70 I-clinical_variable
( 52 53 71 72 I-clinical_variable
AIS 53 56 72 75 I-clinical_variable
) 56 57 75 76 I-clinical_variable
grade 58 63 77 82 B-lower_bound
A 64 65 83 84 I-lower_bound
- 65 66 84 85 O
D 66 67 85 86 B-upper_bound

above 0 5 87 92 O
L5 6 8 93 95 B-lower_bound
with 9 13 96 100 O
at 14 16 101 103 O
least 17 22 104 109 O
motor 23 28 110 115 O
function 29 37 116 124 O
preserved 38 47 125 134 O
below 48 53 135 140 O
the 54 57 141 144 O
neurologic 58 68 145 155 O
level 69 74 156 161 O

infection 0 9 162 171 B-chronic_disease
( 10 11 172 173 O
e.g. 11 15 173 177 O
bladder 16 23 178 185 B-chronic_disease
) 23 24 185 186 O
, 24 25 186 187 O
hypertension 26 38 188 200 B-chronic_disease
, 38 39 200 201 O
cardiovascular 40 54 202 216 B-chronic_disease
disease 55 62 217 224 I-chronic_disease
, 62 63 224 225 O
pulmonary 64 73 226 235 B-chronic_disease
disease 74 81 236 243 I-chronic_disease
, 81 82 243 244 O
severe 83 89 245 251 B-chronic_disease
osteoporosis 90 102 252 264 I-chronic_disease
( 103 104 265 266 O
history 104 111 266 273 O
of 112 114 274 276 O
fractures 115 124 277 286 O
) 124 125 286 287 O
, 125 126 287 288 O
active 127 133 289 295 O
heterotopic 134 145 296 307 B-chronic_disease
ossification 146 158 308 320 I-chronic_disease
in 159 161 321 323 O
the 162 165 324 327 O
lower 166 171 328 333 O
extremities 172 183 334 345 O
, 183 184 345 346 O
or 185 187 347 349 O
history 188 195 350 357 O
of 196 198 358 360 O
peripheral 199 209 361 371 B-chronic_disease
nerve 210 215 372 377 I-chronic_disease
injury 216 222 378 384 O
in 223 225 385 387 O
the 226 229 388 391 O
legs 230 234 392 396 O

non 0 3 397 400 O
- 3 4 400 401 O
progressive 4 15 401 412 O
etiology 16 24 413 421 O
of 25 27 422 424 O
spinal 28 34 425 431 B-chronic_disease
injury 35 41 432 438 I-chronic_disease

pregnancy 0 9 439 448 B-pregnancy

pulmonary 0 9 449 458 B-chronic_disease
complications 10 23 459 472 I-chronic_disease

score 0 5 473 478 O
less 6 10 479 483 O
than 11 15 484 488 O
24 16 18 489 491 B-upper_bound
on 19 21 492 494 O
Mini 22 26 495 499 B-clinical_variable
- 26 27 499 500 I-clinical_variable
Mental 27 33 500 506 I-clinical_variable
Exam 34 38 507 511 I-clinical_variable

severe 0 6 512 518 B-chronic_disease
autonomic 7 16 519 528 I-chronic_disease
dysreflexia 17 28 529 540 I-chronic_disease

severe 0 6 541 547 B-chronic_disease
concurrent 7 17 548 558 I-chronic_disease
illness 18 25 559 566 I-chronic_disease
or 26 28 567 569 O
pain 29 33 570 574 O
, 33 34 574 575 O
including 35 44 576 585 O
unhealed 45 53 586 594 O
decubiti 54 62 595 603 B-chronic_disease
, 62 63 603 604 O
severe 64 70 605 611 B-chronic_disease
neuropathic 71 82 612 623 I-chronic_disease
or 83 85 624 626 O
chronic 86 93 627 634 B-chronic_disease
pain 94 98 635 639 I-chronic_disease
syndrome 99 107 640 648 I-chronic_disease
, 107 108 648 649 O
infection 109 118 650 659 O
( 119 120 660 661 O
e.g. 120 124 661 665 O
bladder 125 132 666 673 O
) 132 133 673 674 O

spinal 0 6 675 681 B-chronic_disease
cord 7 11 682 686 I-chronic_disease
injury 12 18 687 693 I-chronic_disease
( 19 20 694 695 I-chronic_disease
SCI 20 23 695 698 I-chronic_disease
) 23 24 698 699 I-chronic_disease
at 25 27 700 702 O
or 28 30 703 705 O
below 31 36 706 711 O
C3 37 39 712 714 O
( 40 41 715 716 O
phrenic 41 48 716 723 O
sparing 49 56 724 731 O
) 56 57 731 732 O

timed 0 5 733 738 B-clinical_variable
up 6 8 739 741 I-clinical_variable
- 8 9 741 742 I-clinical_variable
and 9 12 742 745 I-clinical_variable
- 12 13 745 746 I-clinical_variable
go 13 15 746 748 I-clinical_variable

< 0 1 0 1 O
400 1 4 1 4 B-upper_bound
mg 5 7 5 7 I-upper_bound
/ 7 8 7 8 I-upper_bound
dL 8 10 8 10 I-upper_bound
without 11 18 11 18 O
laboratory 19 29 19 29 O
evidence 30 38 30 38 O
of 39 41 39 41 O
diabetic 42 50 42 50 B-chronic_disease
ketoacidosis 51 63 51 63 I-chronic_disease

Blood 0 5 64 69 B-clinical_variable
glucose 6 13 70 77 I-clinical_variable
levels 14 20 78 84 I-clinical_variable
between 21 28 85 92 O
> 29 30 93 94 O
140 30 33 94 97 B-lower_bound
mg 34 36 98 100 I-lower_bound

Clinically 0 10 101 111 O
relevant 11 19 112 120 O
hepatic 20 27 121 128 B-chronic_disease
disease 28 35 129 136 I-chronic_disease

Corticosteroid 0 14 137 151 B-treatment
therapy 15 22 152 159 I-treatment

Hyperglycemia 0 13 160 173 O
without 14 21 174 181 O
a 22 23 182 183 O
history 24 31 184 191 O
of 32 34 192 194 O
diabetes 35 43 195 203 B-chronic_disease

Known 0 5 204 209 O
history 6 13 210 217 O
of 14 16 218 220 O
Type 17 21 221 225 B-chronic_disease
2 22 23 226 227 I-chronic_disease
diabetes 24 32 228 236 I-chronic_disease
mellitus 33 41 237 245 I-chronic_disease
for 42 45 246 249 O
> 46 47 250 251 O
3 47 48 251 252 B-lower_bound
months 49 55 253 259 I-lower_bound

Pregnancy 0 9 260 269 B-pregnancy

Serum 0 5 270 275 B-clinical_variable
creatinine 6 16 276 286 I-clinical_variable
≥ 17 18 287 288 O
3.5 19 22 289 292 B-lower_bound
mg 23 25 293 295 I-lower_bound
/ 25 26 295 296 I-lower_bound
dL 26 28 296 298 I-lower_bound

Subjects 0 8 299 307 O
receiving 9 18 308 317 O
continuous 19 29 318 328 O
insulin 30 37 329 336 B-treatment
infusion 38 46 337 345 I-treatment

Subjects 0 8 346 354 O
with 9 13 355 359 O
acute 14 19 360 365 B-chronic_disease
critical 20 28 366 374 I-chronic_disease
illness 29 36 375 382 I-chronic_disease
admitted 37 45 383 391 O
to 46 48 392 394 O
the 49 52 395 398 O
ICU 53 56 399 402 O
or 57 59 403 405 O
expected 60 68 406 414 O
to 69 71 415 417 O
require 72 79 418 425 O
ICU 80 83 426 429 O
admission 84 93 430 439 O

any 0 3 440 443 O
combination 4 15 444 455 O
of 16 18 456 458 O
oral 19 23 459 463 B-treatment
antidiabetic 24 36 464 476 I-treatment
agents 37 43 477 483 I-treatment

glomerular 0 10 484 494 B-clinical_variable
filtration 11 21 495 505 I-clinical_variable
rate 22 26 506 510 I-clinical_variable
( 27 28 511 512 I-clinical_variable
GFR 28 31 512 515 I-clinical_variable
) 31 32 515 516 I-clinical_variable
< 33 34 517 518 O
30 34 36 518 520 B-upper_bound

insulin 0 7 521 528 B-treatment
therapy 8 15 529 536 I-treatment

non 0 3 537 540 B-treatment
- 3 4 540 541 I-treatment
insulin 4 11 541 548 I-treatment
injectables 12 23 549 560 I-treatment

Alkaline 0 8 0 8 B-clinical_variable
phosphatase 9 20 9 20 I-clinical_variable
< 21 22 21 22 O
2.5 23 26 23 26 B-upper_bound
upper 27 32 27 32 I-upper_bound
limit 33 38 33 38 I-upper_bound
of 39 41 39 41 I-upper_bound
normal 42 48 42 48 I-upper_bound
( 49 50 49 50 I-upper_bound
ULN 50 53 50 53 I-upper_bound
) 53 54 53 54 I-upper_bound
( 55 56 55 56 O
< 56 57 56 57 O
10 58 60 58 60 B-upper_bound
x 61 62 61 62 I-upper_bound
ULN 63 66 63 66 I-upper_bound
in 67 69 67 69 O
presence 70 78 70 78 O
of 79 81 79 81 O
bone 82 86 82 86 B-cancer
metastases 87 97 87 97 I-cancer
) 97 98 97 98 O

Aspartate 0 9 99 108 B-clinical_variable
aminotransferase 10 26 109 125 I-clinical_variable
( 27 28 126 127 I-clinical_variable
AST 28 31 127 130 I-clinical_variable
) 31 32 130 131 I-clinical_variable
< 33 34 132 133 O
5.0 35 38 134 137 B-upper_bound
x 39 40 138 139 I-upper_bound
normal 41 47 140 146 I-upper_bound
institutional 48 61 147 160 I-upper_bound
limits 62 68 161 167 I-upper_bound

Bilirubin 0 9 168 177 B-clinical_variable
( 10 11 178 179 I-clinical_variable
total 11 16 179 184 I-clinical_variable
) 16 17 184 185 I-clinical_variable
< 18 19 186 187 O
2.0 20 23 188 191 B-upper_bound
ml 24 26 192 194 I-upper_bound
/ 26 27 194 195 I-upper_bound
dl 27 29 195 197 I-upper_bound

Creatinine 0 10 198 208 B-clinical_variable
< 11 12 209 210 O
1.5 13 16 211 214 B-upper_bound
mg 17 19 215 217 I-upper_bound
/ 19 20 217 218 I-upper_bound
dl 20 22 218 220 I-upper_bound

Current 0 7 221 228 O
treatment 8 17 229 238 B-treatment
on 18 20 239 241 O
another 21 28 242 249 O
clinical 29 37 250 258 O
trial 38 43 259 264 O

Eastern 0 7 265 272 B-clinical_variable
Cooperative 8 19 273 284 I-clinical_variable
Oncology 20 28 285 293 I-clinical_variable
Group 29 34 294 299 I-clinical_variable
( 35 36 300 301 I-clinical_variable
ECOG 36 40 301 305 I-clinical_variable
) 40 41 305 306 I-clinical_variable
performance 42 53 307 318 I-clinical_variable
status 54 60 319 325 I-clinical_variable
0 61 62 326 327 B-lower_bound
- 62 63 327 328 O
1 63 64 328 329 B-upper_bound

Hemoglobin 0 10 330 340 B-clinical_variable
( 11 12 341 342 I-clinical_variable
Hgb 12 15 342 345 I-clinical_variable
) 15 16 345 346 I-clinical_variable
≥ 17 18 347 348 O
10.0 19 23 349 353 B-lower_bound
gm 24 26 354 356 I-lower_bound
/ 26 27 356 357 I-lower_bound
dl 27 29 357 359 I-lower_bound

Histologically 0 14 360 374 O
confirmed 15 24 375 384 O
breast 25 31 385 391 B-cancer
cancer 32 38 392 398 I-cancer

International 0 13 399 412 B-clinical_variable
normalized 14 24 413 423 I-clinical_variable
ratio 25 30 424 429 I-clinical_variable
( 31 32 430 431 I-clinical_variable
INR 32 35 431 434 I-clinical_variable
) 35 36 434 435 I-clinical_variable
< 37 38 436 437 O
1.5 39 42 438 441 B-upper_bound
, 42 43 441 442 O
except 44 50 443 449 O
for 51 54 450 453 O
subjects 55 63 454 462 O
receiving 64 73 463 472 O
warfarin 74 82 473 481 B-treatment
therapy 83 90 482 489 I-treatment

Known 0 5 490 495 O
human 6 11 496 501 B-chronic_disease
immunodeficiency 12 28 502 518 I-chronic_disease
virus 29 34 519 524 I-chronic_disease
( 35 36 525 526 I-chronic_disease
HIV 36 39 526 529 I-chronic_disease
) 39 40 529 530 I-chronic_disease
or 41 43 531 533 O
acquired 44 52 534 542 B-chronic_disease
immunodeficiency 53 69 543 559 I-chronic_disease
syndrome 70 78 560 568 I-chronic_disease
( 79 80 569 570 I-chronic_disease
AIDS)-related 80 93 570 583 I-chronic_disease
illness 94 101 584 591 O

Other 0 5 592 597 O
severe 6 12 598 604 O
acute 13 18 605 610 O
or 19 21 611 613 O
chronic 22 29 614 621 O
medical 30 37 622 629 B-chronic_disease
or 38 40 630 632 O
psychiatric 41 52 633 644 B-chronic_disease
conditions 53 63 645 655 I-chronic_disease
, 63 64 655 656 O
or 65 67 657 659 O
laboratory 68 78 660 670 O
abnormality 79 90 671 682 O
that 91 95 683 687 O
may 96 99 688 691 O
increase 100 108 692 700 O
the 109 112 701 704 O
risk 113 117 705 709 O
associated 118 128 710 720 O
with 129 133 721 725 O
study 134 139 726 731 O
participation 140 153 732 745 O
or 154 156 746 748 O
study 157 162 749 754 B-treatment
drug 163 167 755 759 I-treatment
administration 168 182 760 774 O
, 182 183 774 775 O
or 184 186 776 778 O
may 187 190 779 782 O
interfere 191 200 783 792 O
with 201 205 793 797 O
the 206 209 798 801 O
interpretation 210 224 802 816 O
of 225 227 817 819 O
study 228 233 820 825 O
results 234 241 826 833 O
, 241 242 833 834 O
and 243 246 835 838 O
in 247 249 839 841 O
the 250 253 842 845 O
judgment 254 262 846 854 O
of 263 265 855 857 O
the 266 269 858 861 O
investigator 270 282 862 874 O
would 283 288 875 880 O
make 289 293 881 885 O
the 294 297 886 889 O
patient 298 305 890 897 O
inappropriate 306 319 898 911 O
for 320 323 912 915 O
entry 324 329 916 921 O
into 330 334 922 926 O
this 335 339 927 931 O
study 340 345 932 937 O

Patients 0 8 938 946 O
may 9 12 947 950 O
have 13 17 951 955 O
treated 18 25 956 963 O
and 26 29 964 967 O
stable 30 36 968 974 O
brain 37 42 975 980 B-cancer
metastases 43 53 981 991 I-cancer
; 53 54 991 992 O
they 55 59 993 997 O
must 60 64 998 1002 O
be 65 67 1003 1005 O
off 68 71 1006 1009 O
steroids 72 80 1010 1018 B-treatment
and 81 84 1019 1022 O
must 85 89 1023 1027 O
have 90 94 1028 1032 O
had 95 98 1033 1036 O
stable 99 105 1037 1043 O
brain 106 111 1044 1049 O
metastases 112 122 1050 1060 O
for 123 126 1061 1064 O
at 127 129 1065 1067 O
least 130 135 1068 1073 O
6 136 137 1074 1075 B-lower_bound
months 138 144 1076 1082 I-lower_bound

Patients 0 8 1083 1091 O
must 9 13 1092 1096 O
have 14 18 1097 1101 O
a 19 20 1102 1103 O
life 21 25 1104 1108 B-clinical_variable
expectancy 26 36 1109 1119 I-clinical_variable
of 37 39 1120 1122 O
> 40 41 1123 1124 O
3 42 43 1125 1126 B-lower_bound
months 44 50 1127 1133 I-lower_bound

Patients 0 8 1134 1142 O
must 9 13 1143 1147 O
have 14 18 1148 1152 O
a 19 20 1153 1154 O
negative 21 29 1155 1163 B-pregnancy
pregnancy 30 39 1164 1173 I-pregnancy
test 40 44 1174 1178 O
by 45 47 1179 1181 O
urinalysis 48 58 1182 1192 O

Patients 0 8 1193 1201 O
must 9 13 1202 1206 O
have 14 18 1207 1211 O
evidence 19 27 1212 1220 O
of 28 30 1221 1223 O
metastatic 31 41 1224 1234 B-cancer
disease 42 49 1235 1242 I-cancer
measurable 50 60 1243 1253 O
by 61 63 1254 1256 O
Response 64 72 1257 1265 O
Evaluation 73 83 1266 1276 O
Criteria 84 92 1277 1285 O
in 93 95 1286 1288 O
Solid 96 101 1289 1294 O
Tumors 102 108 1295 1301 O
( 109 110 1302 1303 O
RECIST 110 116 1303 1309 O
) 116 117 1309 1310 O
criteria 118 126 1311 1319 O
or 127 129 1320 1322 O
non 130 133 1323 1326 O
- 133 134 1326 1327 O
measurable 134 144 1327 1337 O
lytic 145 150 1338 1343 O
or 151 153 1344 1346 O
mixed 154 159 1347 1352 O
( 160 161 1353 1354 O
lytic 161 166 1354 1359 O
+ 167 168 1360 1361 O
blastic 169 176 1362 1369 O
) 176 177 1369 1370 O
bone 178 182 1371 1375 O
lesions 183 190 1376 1383 O
in 191 193 1384 1386 O
the 194 197 1387 1390 O
absence 198 205 1391 1398 O
of 206 208 1399 1401 O
measurable 209 219 1402 1412 O
disease 220 227 1413 1420 O

Platelets 0 9 1421 1430 B-clinical_variable
> 10 11 1431 1432 O
100 12 15 1433 1436 B-lower_bound
x 16 17 1437 1438 I-lower_bound
10 18 20 1439 1441 I-lower_bound
^ 20 21 1441 1442 I-lower_bound
9 21 22 1442 1443 I-lower_bound
/ 22 23 1443 1444 I-lower_bound
L 23 24 1444 1445 I-lower_bound

Pregnancy 0 9 1446 1455 B-pregnancy

Presence 0 8 1456 1464 O
of 9 11 1465 1467 O
bleeding 12 20 1468 1476 B-chronic_disease
diathesis 21 30 1477 1486 I-chronic_disease

Prior 0 5 1487 1492 B-treatment
GEM 6 9 1493 1496 I-treatment
therapy 10 17 1497 1504 I-treatment
is 18 20 1505 1507 O
acceptable 21 31 1508 1518 O
as 32 34 1519 1521 O
long 35 39 1522 1526 O
as 40 42 1527 1529 O
the 43 46 1530 1533 O
last 47 51 1534 1538 O
dose 52 56 1539 1543 O
was 57 60 1544 1547 O
≥ 61 62 1548 1549 O
3 63 64 1550 1551 B-lower_bound
months 65 71 1552 1558 I-lower_bound
from 72 76 1559 1563 O
registration 77 89 1564 1576 O
on 90 92 1577 1579 O
this 93 97 1580 1584 O
study 98 103 1585 1590 O

Serum 0 5 1591 1596 B-clinical_variable
calcium 6 13 1597 1604 I-clinical_variable
≤ 14 15 1605 1606 O
12 16 18 1607 1609 B-upper_bound
mg 19 21 1610 1612 I-upper_bound
/ 21 22 1612 1613 I-upper_bound
dl 22 24 1613 1615 I-upper_bound

There 0 5 1616 1621 O
is 6 8 1622 1624 O
no 9 11 1625 1627 O
limit 12 17 1628 1633 O
to 18 20 1634 1636 O
the 21 24 1637 1640 O
number 25 31 1641 1647 O
of 32 34 1648 1650 O
prior 35 40 1651 1656 B-treatment
systemic 41 49 1657 1665 I-treatment
treatment 50 59 1666 1675 I-treatment
regimens 60 68 1676 1684 I-treatment

Use 0 3 1685 1688 O
of 4 6 1689 1691 O
an 7 9 1692 1694 O
effective 10 19 1695 1704 O
means 20 25 1705 1710 O
of 26 28 1711 1713 O
contraception 29 42 1714 1727 O
( 43 44 1728 1729 O
men 44 47 1729 1732 B-gender
and 48 51 1733 1736 O
women 52 57 1737 1742 B-gender
) 57 58 1742 1743 O
is 59 61 1744 1746 O
mandated 62 70 1747 1755 O
in 71 73 1756 1758 O
subjects 74 82 1759 1767 O
of 83 85 1768 1770 O
child 86 91 1771 1776 O
- 91 92 1776 1777 O
bearing 92 99 1777 1784 O
potential 100 109 1785 1794 O

White 0 5 1795 1800 B-clinical_variable
blood 6 11 1801 1806 I-clinical_variable
cell 12 16 1807 1811 I-clinical_variable
( 17 18 1812 1813 I-clinical_variable
WBC 18 21 1813 1816 I-clinical_variable
) 21 22 1816 1817 I-clinical_variable
> 23 24 1818 1819 O
3.0 25 28 1820 1823 B-lower_bound
x 29 30 1824 1825 I-lower_bound
10 31 33 1826 1828 I-lower_bound
^ 33 34 1828 1829 I-lower_bound
9 34 35 1829 1830 I-lower_bound
/ 35 36 1830 1831 I-lower_bound
L 36 37 1831 1832 I-lower_bound

all 0 3 1833 1836 O
female 4 10 1837 1843 B-gender
patients 11 19 1844 1852 I-gender
with 20 24 1853 1857 O
reproductive 25 37 1858 1870 O
potential 38 47 1871 1880 O
must 48 52 1881 1885 O
have 53 57 1886 1890 O
a 58 59 1891 1892 O
negative 60 68 1893 1901 B-pregnancy
pregnancy 69 78 1902 1911 I-pregnancy
test 79 83 1912 1916 O
( 84 85 1917 1918 O
serum 85 90 1918 1923 O
or 91 93 1924 1926 O
urine 94 99 1927 1932 O
) 99 100 1932 1933 O
prior 101 106 1934 1939 O
to 107 109 1940 1942 O
enrollment 110 120 1943 1953 O

female 0 6 1954 1960 B-gender
patients 7 15 1961 1969 I-gender
must 16 20 1970 1974 O
be 21 23 1975 1977 O
surgically 24 34 1978 1988 O
sterile 35 42 1989 1996 O
or 43 45 1997 1999 O
be 46 48 2000 2002 O
post 49 53 2003 2007 O
- 53 54 2007 2008 O
menopausal 54 64 2008 2018 O
, 64 65 2018 2019 O
or 66 68 2020 2022 O
must 69 73 2023 2027 O
agree 74 79 2028 2033 B-contraception_consent
to 80 82 2034 2036 I-contraception_consent
use 83 86 2037 2040 I-contraception_consent
effective 87 96 2041 2050 I-contraception_consent
contraception 97 110 2051 2064 I-contraception_consent
during 111 117 2065 2071 O
the 118 121 2072 2075 O
period 122 128 2076 2082 O
of 129 131 2083 2085 O
therapy 132 139 2086 2093 B-treatment

female 0 6 2094 2100 B-gender
subjects 7 15 2101 2109 I-gender
will 16 20 2110 2114 O
be 21 23 2115 2117 O
advised 24 31 2118 2125 O
that 32 36 2126 2130 O
they 37 41 2131 2135 O
not 42 45 2136 2139 B-pregnancy
become 46 52 2140 2146 I-pregnancy
pregnant 53 61 2147 2155 I-pregnancy
for 62 65 2156 2159 O
at 66 68 2160 2162 O
least 69 74 2163 2168 O
one 75 78 2169 2172 B-lower_bound
month 79 84 2173 2178 I-lower_bound
after 85 90 2179 2184 I-lower_bound
completing 91 101 2185 2195 O
participation 102 115 2196 2209 O
in 116 118 2210 2212 O
the 119 122 2213 2216 O
study 123 128 2217 2222 O

for 0 3 2223 2226 O
subjects 4 12 2227 2235 O
who 13 16 2236 2239 O
are 17 20 2240 2243 O
receiving 21 30 2244 2253 O
warfarin 31 39 2254 2262 B-treatment
for 40 43 2263 2266 O
prophylaxis 44 55 2267 2278 O
or 56 58 2279 2281 O
treatment 59 68 2282 2291 B-treatment
of 69 71 2292 2294 O
thrombosis 72 82 2295 2305 B-chronic_disease
, 82 83 2305 2306 O
INR 84 87 2307 2310 O
values 88 94 2311 2317 O
should 95 101 2318 2324 O
be 102 104 2325 2327 O
carefully 105 114 2328 2337 O
monitored 115 124 2338 2347 O
while 125 130 2348 2353 O
patients 131 139 2354 2362 O
are 140 143 2363 2366 O
on 144 146 2367 2369 O
study 147 152 2370 2375 O

male 0 4 2376 2380 B-gender
patients 5 13 2381 2389 I-gender
must 14 18 2390 2394 O
be 19 21 2395 2397 O
surgically 22 32 2398 2408 B-contraception_consent
sterile 33 40 2409 2416 I-contraception_consent
or 41 43 2417 2419 I-contraception_consent
must 44 48 2420 2424 I-contraception_consent
agree 49 54 2425 2430 I-contraception_consent
to 55 57 2431 2433 I-contraception_consent
use 58 61 2434 2437 I-contraception_consent
effective 62 71 2438 2447 I-contraception_consent
contraception 72 85 2448 2461 I-contraception_consent
during 86 92 2462 2468 O
the 93 96 2469 2472 O
period 97 103 2473 2479 O
of 104 106 2480 2482 O
therapy 107 114 2483 2490 B-treatment
; 114 115 2490 2491 O
the 116 119 2492 2495 O
definition 120 130 2496 2506 O
of 131 133 2507 2509 O
effective 134 143 2510 2519 O
contraception 144 157 2520 2533 O
will 158 162 2534 2538 O
be 163 165 2539 2541 O
based 166 171 2542 2547 O
on 172 174 2548 2550 O
the 175 178 2551 2554 O
judgment 179 187 2555 2563 O
of 188 190 2564 2566 O
the 191 194 2567 2570 O
principal 195 204 2571 2580 O
investigator 205 217 2581 2593 O
or 218 220 2594 2596 O
a 221 222 2597 2598 O
designated 223 233 2599 2609 O
associate 234 243 2610 2619 O

TBI 0 3 0 3 B-chronic_disease
with 4 8 4 8 O
+ 9 10 9 10 O
loss 11 15 11 15 B-chronic_disease
of 16 18 16 18 I-chronic_disease
consciousness 19 32 19 32 I-chronic_disease
( 33 34 33 34 I-chronic_disease
LOC 34 37 34 37 I-chronic_disease
) 37 38 37 38 I-chronic_disease
less 39 43 39 43 O
than 44 48 44 48 O
24 49 51 49 51 B-upper_bound
hours 52 57 52 57 I-upper_bound

aged 0 4 58 62 B-age
18 5 7 63 65 B-lower_bound
- 7 8 65 66 O
55 8 10 66 68 B-upper_bound

any 0 3 69 72 O
skull 4 9 73 78 B-chronic_disease
defect 10 16 79 85 I-chronic_disease

history 0 7 86 93 O
of 8 10 94 96 O
neurological 11 23 97 109 B-chronic_disease
disease 24 31 110 117 I-chronic_disease
or 32 34 118 120 O
seizures 35 43 121 129 B-chronic_disease

history 0 7 130 137 O
of 8 10 138 140 O
psychosis 11 20 141 150 B-chronic_disease

injured 0 7 151 158 O
between 8 15 159 166 O
3 16 17 167 168 B-lower_bound
months 18 24 169 175 I-lower_bound
and 25 28 176 179 O
5 29 30 180 181 B-upper_bound
years 31 36 182 187 I-upper_bound
ago 37 40 188 191 O

less 0 4 192 196 O
than 5 9 197 201 O
1 10 11 202 203 B-upper_bound
week 12 16 204 208 I-upper_bound
of 17 19 209 211 O
post 20 24 212 216 B-chronic_disease
- 24 25 216 217 I-chronic_disease
traumatic 25 34 217 226 I-chronic_disease
amnesia 35 42 227 234 I-chronic_disease
( 43 44 235 236 I-chronic_disease
PTA 44 47 236 239 I-chronic_disease
) 47 48 239 240 I-chronic_disease

pregnancy 0 9 241 250 B-pregnancy

Contraindications 0 17 0 17 O
for 18 21 18 21 O
MRI 22 25 22 25 O
examinations 26 38 26 38 O
( 39 40 39 40 O
e.g. 40 44 40 44 O
, 44 45 44 45 O
pacemakers 46 56 46 56 B-treatment
or 57 59 57 59 O
ferromagnetic 60 73 60 73 B-treatment
vascular 74 82 74 82 I-treatment
clips 83 88 83 88 I-treatment
) 88 89 88 89 O

Diabetes 0 8 90 98 B-chronic_disease
, 8 9 98 99 O
hypertension 10 22 100 112 B-chronic_disease
, 22 23 112 113 O
smoking 24 31 114 121 O
, 31 32 121 122 O
and 33 36 123 126 O
hyperlipidemia 37 51 127 141 B-chronic_disease
, 51 52 141 142 O
etc 53 56 143 146 O

Hemodynamic 0 11 147 158 B-chronic_disease
instability 12 23 159 170 I-chronic_disease

History 0 7 171 178 O
of 8 10 179 181 O
prior 11 16 182 187 O
cardiovascular 17 31 188 202 B-chronic_disease
disease 32 39 203 210 I-chronic_disease
or 40 42 211 213 O
significant 43 54 214 225 O
risk 55 59 226 230 O
factors 60 67 231 238 O

No 0 2 239 241 O
history 3 10 242 249 O
of 11 13 250 252 O
heart 14 19 253 258 B-chronic_disease
arrhythmia 20 30 259 269 I-chronic_disease

Patients 0 8 270 278 O
diagnosed 9 18 279 288 O
with 19 23 289 293 O
heart 24 29 294 299 B-chronic_disease
arrhythmia 30 40 300 310 I-chronic_disease
scheduled 41 50 311 320 O
for 51 54 321 324 O
routine 55 62 325 332 O
clinical 63 71 333 341 O
MRI 72 75 342 345 B-clinical_variable
examinations 76 88 346 358 O
) 88 89 358 359 O

A 0 1 0 1 O
prolonged 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
cigarette 23 32 23 32 O
smoking 33 40 33 40 O
( 41 42 41 42 O
20 42 44 42 44 O
pk 45 47 45 47 O
/ 47 48 47 48 O
year 48 52 48 52 O
of 53 55 53 55 O
smoking 56 63 56 63 O
within 64 70 64 70 O
the 71 74 71 74 O
past 75 79 75 79 B-upper_bound
2 80 81 80 81 I-upper_bound
years 82 87 82 87 I-upper_bound
) 87 88 87 88 O

Absolute 0 8 89 97 B-clinical_variable
neutrophil 9 19 98 108 I-clinical_variable
count 20 25 109 114 I-clinical_variable
greater 26 33 115 122 O
than 34 38 123 127 O
1000 39 43 128 132 B-lower_bound
/ 43 44 132 133 I-lower_bound
mm(3 44 48 133 137 I-lower_bound
) 48 49 137 138 I-lower_bound
without 50 57 139 146 O
the 58 61 147 150 O
support 62 69 151 158 O
of 70 72 159 161 O
filgrastim 73 83 162 172 B-treatment

Active 0 6 173 179 O
systemic 7 15 180 188 B-chronic_disease
infections 16 26 189 199 I-chronic_disease
, 26 27 199 200 O
( 28 29 201 202 O
e.g. 29 33 202 206 O
: 33 34 206 207 O
requiring 35 44 208 217 O
anti 45 49 218 222 B-treatment
- 49 50 222 223 I-treatment
infective 50 59 223 232 I-treatment
treatment 60 69 233 242 I-treatment
) 69 70 242 243 O
, 70 71 243 244 O
coagulation 72 83 245 256 B-chronic_disease
disorders 84 93 257 266 I-chronic_disease
or 94 96 267 269 O
any 97 100 270 273 O
other 101 106 274 279 O
active 107 113 280 286 O
major 114 119 287 292 O
medical 120 127 293 300 B-chronic_disease
illnesses 128 137 301 310 I-chronic_disease

Age 0 3 311 314 B-age
greater 4 11 315 322 O
than 12 16 323 327 O
or 17 19 328 330 O
equal 20 25 331 336 O
to 26 28 337 339 O
65 29 31 340 342 B-lower_bound
years 32 37 343 348 I-lower_bound
old 38 41 349 352 O

Any 0 3 353 356 O
form 4 8 357 361 O
of 9 11 362 364 O
primary 12 19 365 372 B-chronic_disease
immunodeficiency 20 36 373 389 I-chronic_disease
( 37 38 390 391 O
such 38 42 391 395 O
as 43 45 396 398 O
Severe 46 52 399 405 B-chronic_disease
Combined 53 61 406 414 I-chronic_disease
Immunodeficiency 62 78 415 431 I-chronic_disease
Disease 79 86 432 439 I-chronic_disease
) 86 87 439 440 O

Any 0 3 441 444 O
patient 4 11 445 452 O
known 12 17 453 458 O
to 18 20 459 461 O
have 21 25 462 466 O
an 26 28 467 469 O
LVEF 29 33 470 474 B-clinical_variable
less 34 38 475 479 O
than 39 43 480 484 O
or 44 46 485 487 O
equal 47 52 488 493 O
to 53 55 494 496 O
45 56 58 497 499 B-upper_bound
% 58 59 499 500 I-upper_bound

Clinical 0 8 501 509 O
performance 9 20 510 521 O
status 21 27 522 528 O
of 28 30 529 531 O
ECOG 31 35 532 536 B-clinical_variable
0 36 37 537 538 B-lower_bound
, 37 38 538 539 O
1 39 40 540 541 O
or 41 43 542 544 O
2 44 45 545 546 B-upper_bound

Clinically 0 10 547 557 O
significant 11 22 558 569 O
atrial 23 29 570 576 B-chronic_disease
and 30 33 577 580 O
or 34 36 581 583 O
ventricular 37 48 584 595 B-chronic_disease
arrhythmias 49 60 596 607 I-chronic_disease
including 61 70 608 617 O
but 71 74 618 621 O
not 75 78 622 625 O
limited 79 86 626 633 O
to 87 89 634 636 O
: 89 90 636 637 O
atrial 91 97 638 644 B-chronic_disease
fibrillation 98 110 645 657 I-chronic_disease
, 110 111 657 658 O
ventricular 112 123 659 670 B-chronic_disease
tachycardia 124 135 671 682 I-chronic_disease
, 135 136 682 683 O
second 137 143 684 690 O
or 144 146 691 693 O
third 147 152 694 699 B-chronic_disease
degree 153 159 700 706 I-chronic_disease
heart 160 165 707 712 I-chronic_disease
block 166 171 713 718 I-chronic_disease
or 172 174 719 721 O
history 175 182 722 729 O
of 183 185 730 732 O
ischemic 186 194 733 741 B-chronic_disease
heart 195 200 742 747 I-chronic_disease
disease 201 208 748 755 I-chronic_disease
or 209 211 756 758 O
chest 212 217 759 764 B-chronic_disease
pain 218 222 765 769 I-chronic_disease

Concurrent 0 10 770 780 O
opportunistic 11 24 781 794 B-chronic_disease
infections 25 35 795 805 I-chronic_disease
( 36 37 806 807 O
The 37 40 807 810 O
experimental 41 53 811 823 O
treatment 54 63 824 833 B-treatment
being 64 69 834 839 O
evaluated 70 79 840 849 O
in 80 82 850 852 O
this 83 87 853 857 O
protocol 88 96 858 866 O
depends 97 104 867 874 O
on 105 107 875 877 O
an 108 110 878 880 O
intact 111 117 881 887 O
immune 118 124 888 894 O
system 125 131 895 901 O

Concurrent 0 10 902 912 O
systemic 11 19 913 921 B-treatment
steroid 20 27 922 929 I-treatment
therapy 28 35 930 937 I-treatment

Confirmation 0 12 938 950 O
of 13 15 951 953 O
diagnosis 16 25 954 963 O
of 26 28 964 966 O
metastatic 29 39 967 977 B-cancer
melanoma 40 48 978 986 I-cancer
by 49 51 987 989 O
the 52 55 990 993 O
Laboratory 56 66 994 1004 O
of 67 69 1005 1007 O
Pathology 70 79 1008 1017 O
of 80 82 1018 1020 O
NCI 83 86 1021 1024 O

Documented 0 10 1025 1035 O
FEV1 11 15 1036 1040 B-clinical_variable
less 16 20 1041 1045 O
than 21 25 1046 1050 O
or 26 28 1051 1053 O
equal 29 34 1054 1059 O
to 35 37 1060 1062 O
60 38 40 1063 1065 B-upper_bound
% 40 41 1065 1066 I-upper_bound
predicted 42 51 1067 1076 O
tested 52 58 1077 1083 O
in 59 61 1084 1086 O
patients 62 70 1087 1095 O

Documented 0 10 1096 1106 O
LVEF 11 15 1107 1111 B-clinical_variable
of 16 18 1112 1114 O
less 19 23 1115 1119 O
than 24 28 1120 1124 O
or 29 31 1125 1127 O
equal 32 37 1128 1133 O
to 38 40 1134 1136 O
45 41 43 1137 1139 B-upper_bound
% 43 44 1139 1140 I-upper_bound

Greater 0 7 1141 1148 O
than 8 12 1149 1153 O
or 13 15 1154 1156 O
equal 16 21 1157 1162 O
to 22 24 1163 1165 O
18 25 27 1166 1168 B-lower_bound
years 28 33 1169 1174 I-lower_bound
of 34 36 1175 1177 O
age 37 40 1178 1181 B-age
and 41 44 1182 1185 O
less 45 49 1186 1190 O
than 50 54 1191 1195 O
or 55 57 1196 1198 O
equal 58 63 1199 1204 O
to 64 66 1205 1207 O
70 67 69 1208 1210 B-upper_bound
years 70 75 1211 1216 I-upper_bound
of 76 78 1217 1219 O
age 79 82 1220 1223 O

Hemoglobin 0 10 1224 1234 B-clinical_variable
> 11 12 1235 1236 O
8.0 13 16 1237 1240 B-lower_bound
g 17 18 1241 1242 I-lower_bound
/ 18 19 1242 1243 I-lower_bound
dl 19 21 1243 1245 I-lower_bound

History 0 7 1246 1253 O
of 8 10 1254 1256 O
coronary 11 19 1257 1265 B-treatment
revascularization 20 37 1266 1283 I-treatment
or 38 40 1284 1286 O
ischemic 41 49 1287 1295 B-chronic_disease
symptoms 50 58 1296 1304 I-chronic_disease

History 0 7 1305 1312 O
of 8 10 1313 1315 O
severe 11 17 1316 1322 O
immediate 18 27 1323 1332 O
hypersensitivity 28 44 1333 1349 O
reaction 45 53 1350 1358 O
to 54 56 1359 1361 O
any 57 60 1362 1365 O
of 61 63 1366 1368 O
the 64 67 1369 1372 O
agents 68 74 1373 1379 B-allergy_name
used 75 79 1380 1384 I-allergy_name
in 80 82 1385 1387 I-allergy_name
this 83 87 1388 1392 I-allergy_name
study 88 93 1393 1398 I-allergy_name

Measurable 0 10 1399 1409 O
metastatic 11 21 1410 1420 B-cancer
melanoma 22 30 1421 1429 I-cancer
with 31 35 1430 1434 O
at 36 38 1435 1437 O
least 39 44 1438 1443 O
one 45 48 1444 1447 B-lower_bound
lesion 49 55 1448 1454 O
that 56 60 1455 1459 O
is 61 63 1460 1462 O
resectable 64 74 1463 1473 O
for 75 78 1474 1477 O
TIL 79 82 1478 1481 O
generation 83 93 1482 1492 O
and 94 97 1493 1496 O
at 98 100 1497 1499 O
least 101 106 1500 1505 O
one 107 110 1506 1509 O
other 111 116 1510 1515 O
lesion 117 123 1516 1522 O
that 124 128 1523 1527 O
can 129 132 1528 1531 O
be 133 135 1532 1534 O
measured 136 144 1535 1543 O
by 145 147 1544 1546 O
RECIST 148 154 1547 1553 O
criteria 155 163 1554 1562 O

More 0 4 1563 1567 O
than 5 9 1568 1572 O
four 10 14 1573 1577 B-lower_bound
weeks 15 20 1578 1583 I-lower_bound
must 21 25 1584 1588 O
have 26 30 1589 1593 O
elapsed 31 38 1594 1601 O
since 39 44 1602 1607 O
any 45 48 1608 1611 O
prior 49 54 1612 1617 B-treatment
systemic 55 63 1618 1626 I-treatment
therapy 64 71 1627 1634 I-treatment
at 72 74 1635 1637 O
the 75 78 1638 1641 O
time 79 83 1642 1646 O
the 84 87 1647 1650 O
patient 88 95 1651 1658 O
receives 96 104 1659 1667 O
the 105 108 1668 1671 O
preparative 109 120 1672 1683 B-treatment
regimen 121 128 1684 1691 I-treatment
, 128 129 1691 1692 O
and 130 133 1693 1696 O
patients 134 142 1697 1705 O
toxicities 143 153 1706 1716 O
must 154 158 1717 1721 O
have 159 163 1722 1726 O
recovered 164 173 1727 1736 O
to 174 176 1737 1739 O
a 177 178 1740 1741 O
grade 179 184 1742 1747 B-upper_bound
1 185 186 1748 1749 I-upper_bound
or 187 189 1750 1752 O
less 190 194 1753 1757 O
( 195 196 1758 1759 O
except 196 202 1759 1765 O
for 203 206 1766 1769 O
toxicities 207 217 1770 1780 O
such 218 222 1781 1785 O
as 223 225 1786 1788 O
alopecia 226 234 1789 1797 B-chronic_disease
or 235 237 1798 1800 O
vitiligo 238 246 1801 1809 B-chronic_disease
) 246 247 1809 1810 O
. 247 248 1810 1811 O
Patients 249 257 1812 1820 O
must 258 262 1821 1825 O
have 263 267 1826 1830 O
progressive 268 279 1831 1842 O
disease 280 287 1843 1850 O
after 288 293 1851 1856 O
prior 294 299 1857 1862 B-treatment
treatment 300 309 1863 1872 I-treatment

Patients 0 8 1873 1881 O
may 9 12 1882 1885 O
have 13 17 1886 1890 O
undergone 18 27 1891 1900 O
minor 28 33 1901 1906 B-treatment
surgical 34 42 1907 1915 I-treatment
procedures 43 53 1916 1926 I-treatment
within 54 60 1927 1933 O
the 61 64 1934 1937 O
past 65 69 1938 1942 B-upper_bound
3 70 71 1943 1944 I-upper_bound
weeks 72 77 1945 1950 I-upper_bound
, 77 78 1950 1951 O
as 79 81 1952 1954 O
long 82 86 1955 1959 O
as 87 89 1960 1962 O
all 90 93 1963 1966 O
toxicities 94 104 1967 1977 O
have 105 109 1978 1982 O
recovered 110 119 1983 1992 O
to 120 122 1993 1995 O
grade 123 128 1996 2001 B-upper_bound
1 129 130 2002 2003 I-upper_bound
or 131 133 2004 2006 O
less 134 138 2007 2011 O

Patients 0 8 2012 2020 O
of 9 11 2021 2023 O
both 12 16 2024 2028 O
genders 17 24 2029 2036 O
must 25 29 2037 2041 O
be 30 32 2042 2044 O
willing 33 40 2045 2052 B-contraception_consent
to 41 43 2053 2055 I-contraception_consent
practice 44 52 2056 2064 I-contraception_consent
birth 53 58 2065 2070 I-contraception_consent
control 59 66 2071 2078 I-contraception_consent
from 67 71 2079 2083 O
the 72 75 2084 2087 O
time 76 80 2088 2092 O
of 81 83 2093 2095 O
enrollment 84 94 2096 2106 O
on 95 97 2107 2109 O
this 98 102 2110 2114 O
study 103 108 2115 2120 O
and 109 112 2121 2124 O
for 113 116 2125 2128 O
up 117 119 2129 2131 O
to 120 122 2132 2134 O
four 123 127 2135 2139 B-upper_bound
months 128 134 2140 2146 I-upper_bound
after 135 140 2147 2152 O
treatment 141 150 2153 2162 B-treatment

Patients 0 8 2163 2171 O
who 9 12 2172 2175 O
are 13 16 2176 2179 O
receiving 17 26 2180 2189 O
other 27 32 2190 2195 O
investigational 33 48 2196 2211 B-treatment
agents 49 55 2212 2218 I-treatment

Patients 0 8 2219 2227 O
with 9 13 2228 2232 O
3 14 15 2233 2234 B-upper_bound
or 16 18 2235 2237 O
fewer 19 24 2238 2243 O
brain 25 30 2244 2249 B-cancer
metastases 31 41 2250 2260 I-cancer
that 42 46 2261 2265 O
are 47 50 2266 2269 O
less 51 55 2270 2274 O
than 56 60 2275 2279 O
1 61 62 2280 2281 B-upper_bound
cm 63 65 2282 2284 I-upper_bound
in 66 68 2285 2287 O
diameter 69 77 2288 2296 B-clinical_variable
and 78 81 2297 2300 O
asymptomatic 82 94 2301 2313 O

Platelet 0 8 2314 2322 B-clinical_variable
count 9 14 2323 2328 I-clinical_variable
greater 15 22 2329 2336 O
than 23 27 2337 2341 O
or 28 30 2342 2344 O
equal 31 36 2345 2350 O
to 37 39 2351 2353 O
100,000 40 47 2354 2361 B-lower_bound
/ 47 48 2361 2362 I-lower_bound
mm(3 48 52 2362 2366 I-lower_bound
) 52 53 2366 2367 I-lower_bound

Seronegative 0 12 2368 2380 O
for 13 16 2381 2384 O
HIV 17 20 2385 2388 B-chronic_disease
antibody 21 29 2389 2397 O
. 29 30 2397 2398 O
( 31 32 2399 2400 O
The 32 35 2400 2403 O
experimental 36 48 2404 2416 O
treatment 49 58 2417 2426 B-treatment
being 59 64 2427 2432 O
evaluated 65 74 2433 2442 O
in 75 77 2443 2445 O
this 78 82 2446 2450 O
protocol 83 91 2451 2459 O
depends 92 99 2460 2467 O
on 100 102 2468 2470 O
an 103 105 2471 2473 O
intact 106 112 2474 2480 O
immune 113 119 2481 2487 O
system 120 126 2488 2494 O
. 126 127 2494 2495 O
Patients 128 136 2496 2504 O
who 137 140 2505 2508 O
are 141 144 2509 2512 O
HIV 145 148 2513 2516 B-chronic_disease
seropositive 149 161 2517 2529 I-chronic_disease
can 162 165 2530 2533 O
have 166 170 2534 2538 O
decreased 171 180 2539 2548 O
immune 181 187 2549 2555 O
- 187 188 2555 2556 O
competence 188 198 2556 2566 O
and 199 202 2567 2570 O
thus 203 207 2571 2575 O
are 208 211 2576 2579 O
less 212 216 2580 2584 O
responsive 217 227 2585 2595 O
to 228 230 2596 2598 O
the 231 234 2599 2602 O
experimental 235 247 2603 2615 O
treatment 248 257 2616 2625 O
and 258 261 2626 2629 O
more 262 266 2630 2634 O
susceptible 267 278 2635 2646 O
to 279 281 2647 2649 O
its 282 285 2650 2653 O
toxicities 286 296 2654 2664 O
. 296 297 2664 2665 O
) 297 298 2665 2666 O

Serum 0 5 2667 2672 B-clinical_variable
ALT 6 9 2673 2676 I-clinical_variable
/ 9 10 2676 2677 I-clinical_variable
AST 10 13 2677 2680 I-clinical_variable
less 14 18 2681 2685 O
than 19 23 2686 2690 O
or 24 26 2691 2693 O
equal 27 32 2694 2699 O
to 33 35 2700 2702 O
2.5 36 39 2703 2706 B-upper_bound
times 40 45 2707 2712 I-upper_bound
the 46 49 2713 2716 I-upper_bound
upper 50 55 2717 2722 I-upper_bound
limit 56 61 2723 2728 I-upper_bound
of 62 64 2729 2731 I-upper_bound
normal 65 71 2732 2738 I-upper_bound

Serum 0 5 2739 2744 O
Creatinine 6 16 2745 2755 B-clinical_variable
less 17 21 2756 2760 O
than 22 26 2761 2765 O
or 27 29 2766 2768 O
equal 30 35 2769 2774 O
to 36 38 2775 2777 O
1.6 39 42 2778 2781 B-upper_bound
mg 43 45 2782 2784 I-upper_bound
/ 45 46 2784 2785 I-upper_bound
dl 46 48 2785 2787 I-upper_bound

Symptoms 0 8 2788 2796 O
of 9 11 2797 2799 O
respiratory 12 23 2800 2811 B-chronic_disease
dysfunction 24 35 2812 2823 I-chronic_disease

Total 0 5 2824 2829 B-clinical_variable
bilirubin 6 15 2830 2839 I-clinical_variable
less 16 20 2840 2844 O
than 21 25 2845 2849 O
or 26 28 2850 2852 O
equal 29 34 2853 2858 O
to 35 37 2859 2861 O
1.5 38 41 2862 2865 B-upper_bound
mg 42 44 2866 2868 I-upper_bound
/ 44 45 2868 2869 I-upper_bound
dl 45 47 2869 2871 I-upper_bound
, 47 48 2871 2872 O
except 49 55 2873 2879 O
in 56 58 2880 2882 O
patients 59 67 2883 2891 O
with 68 72 2892 2896 O
Gilbert 73 80 2897 2904 B-chronic_disease
s 81 82 2905 2906 I-chronic_disease
Syndrome 83 91 2907 2915 I-chronic_disease
who 92 95 2916 2919 O
must 96 100 2920 2924 O
have 101 105 2925 2929 O
a 106 107 2930 2931 O
total 108 113 2932 2937 B-clinical_variable
bilirubin 114 123 2938 2947 I-clinical_variable
less 124 128 2948 2952 O
than 129 133 2953 2957 O
3.0 134 137 2958 2961 B-upper_bound
mg 138 140 2962 2964 I-upper_bound
/ 140 141 2964 2965 I-upper_bound
dl 141 143 2965 2967 I-upper_bound

WBC 0 3 2968 2971 B-clinical_variable
greater 4 11 2972 2979 O
than 12 16 2980 2984 O
or 17 19 2985 2987 O
equal 20 25 2988 2993 O
to 26 28 2994 2996 O
3000 29 33 2997 3001 B-lower_bound
/ 33 34 3001 3002 I-lower_bound
mm(3 34 38 3002 3006 I-lower_bound
) 38 39 3006 3007 I-lower_bound

Women 0 5 3008 3013 B-gender
of 6 8 3014 3016 O
child 9 14 3017 3022 O
- 14 15 3022 3023 O
bearing 15 22 3023 3030 O
potential 23 32 3031 3040 O
must 33 37 3041 3045 O
have 38 42 3046 3050 O
a 43 44 3051 3052 O
negative 45 53 3053 3061 B-pregnancy
pregnancy 54 63 3062 3071 I-pregnancy
test 64 68 3072 3076 O
because 69 76 3077 3084 O
of 77 79 3085 3087 O
the 80 83 3088 3091 O
potentially 84 95 3092 3103 O
dangerous 96 105 3104 3113 O
effects 106 113 3114 3121 O
of 114 116 3122 3124 O
the 117 120 3125 3128 O
treatment 121 130 3129 3138 B-treatment
on 131 133 3139 3141 O
the 134 137 3142 3145 O
fetus 138 143 3146 3151 O

Women 0 5 3152 3157 B-gender
of 6 8 3158 3160 O
child 9 14 3161 3166 O
- 14 15 3166 3167 O
bearing 15 22 3167 3174 O
potential 23 32 3175 3184 O
who 33 36 3185 3188 O
are 37 40 3189 3192 O
pregnant 41 49 3193 3201 B-pregnancy
or 50 52 3202 3204 O
breastfeeding 53 66 3205 3218 O
because 67 74 3219 3226 O
of 75 77 3227 3229 O
the 78 81 3230 3233 O
potentially 82 93 3234 3245 O
dangerous 94 103 3246 3255 O
effects 104 111 3256 3263 O
of 112 114 3264 3266 O
the 115 118 3267 3270 O
treatment 119 128 3271 3280 B-treatment
on 129 131 3281 3283 O
the 132 135 3284 3287 O
fetus 136 141 3288 3293 O
or 142 144 3294 3296 O
infant 145 151 3297 3303 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
1500 26 30 26 30 B-lower_bound
/ 30 31 30 31 I-lower_bound
ul 31 33 31 33 I-lower_bound
or 34 36 34 36 O
more 37 41 37 41 O

Any 0 3 42 45 O
diagnosis 4 13 46 55 O
of 14 16 56 58 O
immunodeficiency 17 33 59 75 B-chronic_disease
or 34 36 76 78 O
current 37 44 79 86 B-treatment
immunosuppressive 45 62 87 104 I-treatment
therapy 63 70 105 112 I-treatment
including 71 80 113 122 O
> 81 82 123 124 O
10mg 82 86 124 128 B-lower_bound
/ 86 87 128 129 I-lower_bound
day 87 90 129 132 I-lower_bound
of 91 93 133 135 O
prednisone 94 104 136 146 B-treatment
within 105 111 147 153 O
14 112 114 154 156 B-upper_bound
days 115 119 157 161 I-upper_bound
of 120 122 162 164 O
enrollment 123 133 165 175 O
is 134 136 176 178 O
not 137 140 179 182 O
permitted 141 150 183 192 O

Any 0 3 193 196 O
prior 4 9 197 202 O
chemotherapy 10 22 203 215 B-treatment
or 23 25 216 218 O
radiation 26 35 219 228 B-treatment
therapy 36 43 229 236 I-treatment
for 44 47 237 240 O
the 48 51 241 244 O
current 52 59 245 252 O
diagnosis 60 69 253 262 O

Any 0 3 263 266 O
prior 4 9 267 272 B-treatment
radiotherapy 10 22 273 285 I-treatment
to 23 25 286 288 O
the 26 29 289 292 O
neck 30 34 293 297 O

Any 0 3 298 301 O
prior 4 9 302 307 B-treatment
therapy 10 17 308 315 I-treatment
with 18 22 316 320 O
anti 23 27 321 325 B-treatment
- 27 28 325 326 I-treatment
PD-1 28 32 326 330 I-treatment
, 32 33 330 331 O
anti 34 38 332 336 B-treatment
- 38 39 336 337 I-treatment
PD 39 41 337 339 I-treatment
- 41 42 339 340 I-treatment
L2 42 44 340 342 I-treatment
, 44 45 342 343 O
anti 46 50 344 348 B-treatment
- 50 51 348 349 I-treatment
CTLA-4 51 57 349 355 I-treatment
antibody 58 66 356 364 I-treatment
, 66 67 364 365 O
or 68 70 366 368 O
any 71 74 369 372 O
other 75 80 373 378 O
antibody 81 89 379 387 O
or 90 92 388 390 O
drug 93 97 391 395 O
specifically 98 110 396 408 O
targeting 111 120 409 418 O
T 121 122 419 420 O
- 122 123 420 421 O
cell 123 127 421 425 O
co 128 130 426 428 O
- 130 131 428 429 O
stimulation 131 142 429 440 O
or 143 145 441 443 O
immune 146 152 444 450 O
checkpoint 153 163 451 461 O
pathways 164 172 462 470 O

Bilirubin 0 9 471 480 B-clinical_variable
less 10 14 481 485 O
than 15 19 486 490 O
or 20 22 491 493 O
equal 23 28 494 499 O
to 29 31 500 502 O
1.5 32 35 503 506 B-upper_bound
x 36 37 507 508 I-upper_bound
the 38 41 509 512 I-upper_bound
upper 42 47 513 518 I-upper_bound
limit 48 53 519 524 I-upper_bound
of 54 56 525 527 I-upper_bound
normal 57 63 528 534 I-upper_bound
( 64 65 535 536 O
except 65 71 536 542 O
subjects 72 80 543 551 O
with 81 85 552 556 O
Gilbert 86 93 557 564 B-chronic_disease
syndrome 94 102 565 573 I-chronic_disease
, 102 103 573 574 O
who 104 107 575 578 O
can 108 111 579 582 O
have 112 116 583 587 O
total 117 122 588 593 O
bilirubin 123 132 594 603 B-clinical_variable
< 133 134 604 605 O
3 135 136 606 607 B-upper_bound
mg 137 139 608 610 I-upper_bound
/ 139 140 610 611 I-upper_bound
dl 140 142 611 613 I-upper_bound
) 142 143 613 614 O

Eastern 0 7 615 622 B-clinical_variable
Cooperative 8 19 623 634 I-clinical_variable
Oncology 20 28 635 643 I-clinical_variable
Group 29 34 644 649 I-clinical_variable
( 35 36 650 651 I-clinical_variable
ECOG 36 40 651 655 I-clinical_variable
) 40 41 655 656 I-clinical_variable
performance 42 53 657 668 I-clinical_variable
status 54 60 669 675 I-clinical_variable
0 61 62 676 677 B-lower_bound
- 62 63 677 678 O
1 63 64 678 679 B-upper_bound

Hemoglobin 0 10 680 690 B-clinical_variable
9 11 12 691 692 B-lower_bound
g 13 14 693 694 I-lower_bound
/ 14 15 694 695 I-lower_bound
dl 15 17 695 697 I-lower_bound
or 18 20 698 700 O
more 21 25 701 705 O

Inhaled 0 7 706 713 B-treatment
or 8 10 714 716 I-treatment
topical 11 18 717 724 I-treatment
steroids 19 27 725 733 I-treatment
, 27 28 733 734 O
and 29 32 735 738 O
adrenal 33 40 739 746 B-clinical_variable
replacement 41 52 747 758 I-clinical_variable
steroids 53 61 759 767 I-clinical_variable
< 62 63 768 769 O
/=10 63 67 769 773 O
mg 67 69 773 775 I-upper_bound
daily 70 75 776 781 O
prednisone 76 86 782 792 O
equivalent 87 97 793 803 O
, 97 98 803 804 O
are 99 102 805 808 O
permitted 103 112 809 818 O
in 113 115 819 821 O
the 116 119 822 825 O
absence 120 127 826 833 O
of 128 130 834 836 O
active 131 137 837 843 B-chronic_disease
autoimmune 138 148 844 854 I-chronic_disease
disease 149 156 855 862 I-chronic_disease

Men 0 3 863 866 B-gender
of 4 6 867 869 O
reproductive 7 19 870 882 O
potential 20 29 883 892 O
who 30 33 893 896 O
are 34 37 897 900 O
sexually 38 46 901 909 O
active 47 53 910 916 O
with 54 58 917 921 O
women 59 64 922 927 B-gender
of 65 67 928 930 O
reproductive 68 80 931 943 O
potential 81 90 944 953 O
must 91 95 954 958 O
use 96 99 959 962 B-contraception_consent
any 100 103 963 966 I-contraception_consent
contraceptive 104 117 967 980 I-contraception_consent
method 118 124 981 987 I-contraception_consent
with 125 129 988 992 O
a 130 131 993 994 O
failure 132 139 995 1002 O
rate 140 144 1003 1007 O
of 145 147 1008 1010 O
less 148 152 1011 1015 O
than 153 157 1016 1020 O
1 158 159 1021 1022 B-upper_bound
% 159 160 1022 1023 I-upper_bound
per 161 164 1024 1027 I-upper_bound
year 165 169 1028 1032 I-upper_bound

Oropharyngeal 0 13 1033 1046 B-cancer
primaries 14 23 1047 1056 I-cancer
that 24 28 1057 1061 O
are 29 32 1062 1065 O
HPV 33 36 1066 1069 B-cancer
- 36 37 1069 1070 I-cancer
mediated 37 45 1070 1078 I-cancer
( 46 47 1079 1080 I-cancer
p16 47 50 1080 1083 I-cancer
+ 50 51 1083 1084 I-cancer
) 51 52 1084 1085 I-cancer
must 53 57 1086 1090 O
be 58 60 1091 1093 O
stage 61 66 1094 1099 O
II 67 69 1100 1102 B-lower_bound
- 69 70 1102 1103 O
III 70 73 1103 1106 B-upper_bound

Patients 0 8 1107 1115 O
must 9 13 1116 1120 O
be 14 16 1121 1123 O
18 17 19 1124 1126 B-lower_bound
years 20 25 1127 1132 I-lower_bound
of 26 28 1133 1135 O
age 29 32 1136 1139 B-age
and 33 36 1140 1143 O
older 37 42 1144 1149 O

Patients 0 8 1150 1158 O
that 9 13 1159 1163 O
have 14 18 1164 1168 O
an 19 21 1169 1171 O
active 22 28 1172 1178 O
autoimmune 29 39 1179 1189 B-chronic_disease
disease 40 47 1190 1197 I-chronic_disease
requiring 48 57 1198 1207 O
systemic 58 66 1208 1216 B-treatment
treatment 67 76 1217 1226 I-treatment
within 77 83 1227 1233 O
the 84 87 1234 1237 O
past 88 92 1238 1242 B-upper_bound
3 93 94 1243 1244 I-upper_bound
months 95 101 1245 1251 I-upper_bound
or 102 104 1252 1254 O
a 105 106 1255 1256 O
documented 107 117 1257 1267 O
history 118 125 1268 1275 O
of 126 128 1276 1278 O
clinically 129 139 1279 1289 O
severe 140 146 1290 1296 O
autoimmune 147 157 1297 1307 O
disease 158 165 1308 1315 O

Patients 0 8 1316 1324 O
who 9 12 1325 1328 O
have 13 17 1329 1333 O
participated 18 30 1334 1346 O
in 31 33 1347 1349 O
a 34 35 1350 1351 O
study 36 41 1352 1357 O
with 42 46 1358 1362 O
an 47 49 1363 1365 O
investigational 50 65 1366 1381 O
agent 66 71 1382 1387 O
or 72 74 1388 1390 O
device 75 81 1391 1397 O
within 82 88 1398 1404 O
2 89 90 1405 1406 B-upper_bound
weeks 91 96 1407 1412 I-upper_bound
of 97 99 1413 1415 O
initiation 100 110 1416 1426 O
of 111 113 1427 1429 O
treatment 114 123 1430 1439 O

Patients 0 8 1440 1448 O
with 9 13 1449 1453 O
a 14 15 1454 1455 O
known 16 21 1456 1461 O
human 22 27 1462 1467 B-chronic_disease
immunodeficiency 28 44 1468 1484 I-chronic_disease
virus 45 50 1485 1490 I-chronic_disease
infection 51 60 1491 1500 I-chronic_disease
( 61 62 1501 1502 I-chronic_disease
HIV 62 65 1502 1505 I-chronic_disease
1/2 66 69 1506 1509 I-chronic_disease
antibodies 70 80 1510 1520 I-chronic_disease
) 80 81 1520 1521 I-chronic_disease
or 82 84 1522 1524 O
acquired 85 93 1525 1533 B-chronic_disease
immunodeficiency 94 110 1534 1550 I-chronic_disease
syndrome 111 119 1551 1559 I-chronic_disease
( 120 121 1560 1561 I-chronic_disease
HIV 121 124 1561 1564 I-chronic_disease
/ 124 125 1564 1565 I-chronic_disease
AIDS 125 129 1565 1569 I-chronic_disease
) 129 130 1569 1570 I-chronic_disease

Patients 0 8 1571 1579 O
with 9 13 1580 1584 O
evidence 14 22 1585 1593 O
of 23 25 1594 1596 O
interstitial 26 38 1597 1609 B-chronic_disease
lung 39 43 1610 1614 I-chronic_disease
disease 44 51 1615 1622 I-chronic_disease
or 52 54 1623 1625 O
active 55 61 1626 1632 O
, 61 62 1632 1633 O
non 63 66 1634 1637 B-chronic_disease
- 66 67 1637 1638 I-chronic_disease
infectious 67 77 1638 1648 I-chronic_disease
pneumonitis 78 89 1649 1660 I-chronic_disease

Patients 0 8 1661 1669 O
with 9 13 1670 1674 O
uncontrolled 14 26 1675 1687 O
intercurrent 27 39 1688 1700 B-chronic_disease
illnesses 40 49 1701 1710 I-chronic_disease
including 50 59 1711 1720 O
, 59 60 1720 1721 O
but 61 64 1722 1725 O
not 65 68 1726 1729 O
limited 69 76 1730 1737 O
to 77 79 1738 1740 O
an 80 82 1741 1743 O
active 83 89 1744 1750 B-chronic_disease
infection 90 99 1751 1760 I-chronic_disease
requiring 100 109 1761 1770 O
systemic 110 118 1771 1779 B-treatment
therapy 119 126 1780 1787 I-treatment
or 127 129 1788 1790 O
a 130 131 1791 1792 O
known 132 137 1793 1798 O
psychiatric 138 149 1799 1810 B-chronic_disease
or 150 152 1811 1813 O
substance 153 162 1814 1823 B-chronic_disease
abuse 163 168 1824 1829 I-chronic_disease
disorder(s 169 179 1830 1840 I-chronic_disease
) 179 180 1840 1841 I-chronic_disease
that 181 185 1842 1846 O
would 186 191 1847 1852 O
interfere 192 201 1853 1862 O
with 202 206 1863 1867 O
cooperation 207 218 1868 1879 O
with 219 223 1880 1884 O
the 224 227 1885 1888 O
requirements 228 240 1889 1901 O
of 241 243 1902 1904 O
the 244 247 1905 1908 O
trial 248 253 1909 1914 O

Platelets 0 9 1915 1924 B-clinical_variable
100,000 10 17 1925 1932 B-lower_bound
/ 17 18 1932 1933 I-lower_bound
ul 18 20 1933 1935 I-lower_bound
or 21 23 1936 1938 O
more 24 28 1939 1943 O

Tumor 0 5 1944 1949 B-cancer
sample 6 12 1950 1956 O
must 13 17 1957 1961 O
be 18 20 1962 1964 O
available 21 30 1965 1974 O
for 31 34 1975 1978 O
HPV 35 38 1979 1982 B-cancer
p16 39 42 1983 1986 I-cancer
and 43 46 1987 1990 O
PD 47 49 1991 1993 B-treatment
- 49 50 1993 1994 I-treatment
L1 50 52 1994 1996 I-treatment
testing 53 60 1997 2004 I-treatment

White 0 5 2005 2010 B-clinical_variable
blood 6 11 2011 2016 I-clinical_variable
cells 12 17 2017 2022 I-clinical_variable
2000 18 22 2023 2027 B-lower_bound
/ 22 23 2027 2028 I-lower_bound
ul 23 25 2028 2030 I-lower_bound
or 26 28 2031 2033 O
more 29 33 2034 2038 O

Women 0 5 2039 2044 B-gender
of 6 8 2045 2047 O
reproductive 9 21 2048 2060 O
potential 22 31 2061 2070 O
must 32 36 2071 2075 O
use 37 40 2076 2079 B-contraception_consent
highly 41 47 2080 2086 I-contraception_consent
effective 48 57 2087 2096 I-contraception_consent
contraception 58 71 2097 2110 I-contraception_consent
methods 72 79 2111 2118 I-contraception_consent
to 80 82 2119 2121 O
avoid 83 88 2122 2127 O
pregnancy 89 98 2128 2137 B-pregnancy
for 99 102 2138 2141 O
23 103 105 2142 2144 B-lower_bound
weeks 106 111 2145 2150 I-lower_bound
after 112 117 2151 2156 O
the 118 121 2157 2160 O
last 122 126 2161 2165 O
dose 127 131 2166 2170 O
of 132 134 2171 2173 O
study 135 140 2174 2179 O
drugs 141 146 2180 2185 O

Women 0 5 2186 2191 B-gender
of 6 8 2192 2194 O
reproductive 9 21 2195 2207 O
potential 22 31 2208 2217 O
should 32 38 2218 2224 O
have 39 43 2225 2229 O
a 44 45 2230 2231 O
negative 46 54 2232 2240 B-pregnancy
serum 55 60 2241 2246 I-pregnancy
or 61 63 2247 2249 I-pregnancy
urine 64 69 2250 2255 I-pregnancy
pregnancy 70 79 2256 2265 I-pregnancy
test 80 84 2266 2270 O
( 85 86 2271 2272 O
minimum 86 93 2272 2279 O
sensitivity 94 105 2280 2291 O
25 106 108 2292 2294 B-lower_bound
IU 109 111 2295 2297 I-lower_bound
/ 111 112 2297 2298 I-lower_bound
L 112 113 2298 2299 I-lower_bound
or 114 116 2300 2302 O
equivalent 117 127 2303 2313 O
units 128 133 2314 2319 O
of 134 136 2320 2322 O
human 137 142 2323 2328 B-clinical_variable
chorionic 143 152 2329 2338 I-clinical_variable
gonadotropin 153 165 2339 2351 I-clinical_variable
[ 166 167 2352 2353 I-clinical_variable
HCG 167 170 2353 2356 I-clinical_variable
] 170 171 2356 2357 I-clinical_variable
) 171 172 2357 2358 O
within 173 179 2359 2365 O
24 180 182 2366 2368 B-upper_bound
hours 183 188 2369 2374 I-upper_bound
of 189 191 2375 2377 O
the 192 195 2378 2381 O
start 196 201 2382 2387 O
of 202 204 2388 2390 O
study 205 210 2391 2396 O
drugs 211 216 2397 2402 O

active 0 6 2403 2409 O
hepatitis 7 16 2410 2419 B-chronic_disease
B 17 18 2420 2421 I-chronic_disease
( 19 20 2422 2423 O
e.g. 20 24 2423 2427 O
, 24 25 2427 2428 O
hepatitis 26 35 2429 2438 O
B 36 37 2439 2440 O
surface 38 45 2441 2448 O
antigen 46 53 2449 2456 O
[ 54 55 2457 2458 O
HBsAg 55 60 2458 2463 O
] 60 61 2463 2464 O
reactive 62 70 2465 2473 O
) 70 71 2473 2474 O

hepatitis 0 9 2475 2484 B-chronic_disease
C 10 11 2485 2486 O
( 12 13 2487 2488 O
e.g. 13 17 2488 2492 O
, 17 18 2492 2493 O
hepatitis 19 28 2494 2503 B-chronic_disease
C 29 30 2504 2505 I-chronic_disease
virus 31 36 2506 2511 I-chronic_disease
[ 37 38 2512 2513 I-chronic_disease
HCV 38 41 2513 2516 I-chronic_disease
] 41 42 2516 2517 I-chronic_disease
ribonucleic 43 54 2518 2529 B-clinical_variable
acid 55 59 2530 2534 I-clinical_variable
[ 60 61 2535 2536 I-clinical_variable
RNA 61 64 2536 2539 I-clinical_variable
] 64 65 2539 2540 I-clinical_variable
[ 66 67 2541 2542 O
qualitative 67 78 2542 2553 O
] 78 79 2553 2554 O
is 80 82 2555 2557 O
detected 83 91 2558 2566 O
) 91 92 2566 2567 O

men 0 3 2568 2571 B-gender
who 4 7 2572 2575 O
are 8 11 2576 2579 O
azoospermic 12 23 2580 2591 B-chronic_disease
do 24 26 2592 2594 O
not 27 30 2595 2598 O
require 31 38 2599 2606 O
contraception 39 52 2607 2620 O

men 0 3 2621 2624 B-gender
who 4 7 2625 2628 O
are 8 11 2629 2632 O
receiving 12 21 2633 2642 O
the 22 25 2643 2646 O
study 26 31 2647 2652 O
medications 32 43 2653 2664 O
will 44 48 2665 2669 O
be 49 51 2670 2672 O
instructed 52 62 2673 2683 O
to 63 65 2684 2686 O
adhere 66 72 2687 2693 B-contraception_consent
to 73 75 2694 2696 I-contraception_consent
contraception 76 89 2697 2710 I-contraception_consent
for 90 93 2711 2714 O
31 94 96 2715 2717 B-upper_bound
weeks 97 102 2718 2723 I-upper_bound
after 103 108 2724 2729 O
the 109 112 2730 2733 O
last 113 117 2734 2738 O
dose 118 122 2739 2743 O
of 123 125 2744 2746 O
study 126 131 2747 2752 O
drugs 132 137 2753 2758 O

menopause 0 9 2759 2768 O
is 10 12 2769 2771 O
defined 13 20 2772 2779 O
clinically 21 31 2780 2790 O
as 32 34 2791 2793 O
12 35 37 2794 2796 O
months 38 44 2797 2803 O
of 45 47 2804 2806 O
amenorrhea 48 58 2807 2817 B-chronic_disease
in 59 61 2818 2820 O
a 62 63 2821 2822 O
woman 64 69 2823 2828 B-gender
over 70 74 2829 2833 O
45 75 77 2834 2836 B-lower_bound
in 78 80 2837 2839 O
the 81 84 2840 2843 O
absence 85 92 2844 2851 O
of 93 95 2852 2854 O
other 96 101 2855 2860 O
biological 102 112 2861 2871 O
or 113 115 2872 2874 O
physiological 116 129 2875 2888 O
causes 130 136 2889 2895 O

patients 0 8 2896 2904 O
with 9 13 2905 2909 O
a 14 15 2910 2911 O
history 16 23 2912 2919 O
of 24 26 2920 2922 O
other 27 32 2923 2928 O
prior 33 38 2929 2934 O
malignancy 39 49 2935 2945 B-cancer
must 50 54 2946 2950 O
have 55 59 2951 2955 O
been 60 64 2956 2960 O
treated 65 72 2961 2968 O
with 73 77 2969 2973 O
curative 78 86 2974 2982 B-treatment
intent 87 93 2983 2989 I-treatment
and 94 97 2990 2993 O
must 98 102 2994 2998 O
have 103 107 2999 3003 O
remained 108 116 3004 3012 O
disease 117 124 3013 3020 O
- 124 125 3020 3021 O
free 125 129 3021 3025 O
for 130 133 3026 3029 O
3 134 135 3030 3031 B-upper_bound
years 136 141 3032 3037 I-upper_bound
post 142 146 3038 3042 O
- 146 147 3042 3043 O
diagnosis 147 156 3043 3052 O

squamous 0 8 3053 3061 B-cancer
cell 9 13 3062 3066 I-cancer
carcinoma 14 23 3067 3076 I-cancer
of 24 26 3077 3079 O
the 27 30 3080 3083 O
skin 31 35 3084 3088 O

subjects 0 8 3089 3097 O
with 9 13 3098 3102 O
vitiligo 14 22 3103 3111 B-chronic_disease
, 22 23 3111 3112 O
type 24 28 3113 3117 B-chronic_disease
I 29 30 3118 3119 I-chronic_disease
diabetes 31 39 3120 3128 I-chronic_disease
mellitus 40 48 3129 3137 I-chronic_disease
, 48 49 3137 3138 O
or 50 52 3139 3141 O
resolved 53 61 3142 3150 O
childhood 62 71 3151 3160 O
asthma 72 78 3161 3167 B-chronic_disease
/ 78 79 3167 3168 O
atopy 79 84 3168 3173 B-chronic_disease
would 85 90 3174 3179 O
be 91 93 3180 3182 O
an 94 96 3183 3185 O
exception 97 106 3186 3195 O
to 107 109 3196 3198 O
this 110 114 3199 3203 O
rule 115 119 3204 3208 O

superficial 0 11 3209 3220 B-cancer
bladder 12 19 3221 3228 I-cancer
cancer 20 26 3229 3235 I-cancer
or 27 29 3236 3238 O
in 30 32 3239 3241 B-cancer
situ 33 37 3242 3246 I-cancer
cervical 38 46 3247 3255 I-cancer
cancer 47 53 3256 3262 I-cancer
that 54 58 3263 3267 O
has 59 62 3268 3271 O
undergone 63 72 3272 3281 O
potentially 73 84 3282 3293 O
curative 85 93 3294 3302 B-treatment
therapy 94 101 3303 3310 I-treatment

syndrome 0 8 3311 3319 O
that 9 13 3320 3324 O
requires 14 22 3325 3333 O
systemic 23 31 3334 3342 B-treatment
steroids 32 40 3343 3351 I-treatment
( 41 42 3352 3353 O
> 42 43 3353 3354 O
10 44 46 3355 3357 B-lower_bound
mg 47 49 3358 3360 I-lower_bound
daily 50 55 3361 3366 O
prednisone 56 66 3367 3377 B-treatment
equivalents 67 78 3378 3389 O
) 78 79 3389 3390 O
or 80 82 3391 3393 O
immunosuppressive 83 100 3394 3411 B-treatment
agents 101 107 3412 3418 I-treatment

women 0 5 3419 3424 B-gender
of 6 8 3425 3427 O
reproductive 9 21 3428 3440 O
potential 22 31 3441 3450 O
is 32 34 3451 3453 O
defined 35 42 3454 3461 O
as 43 45 3462 3464 O
any 46 49 3465 3468 O
female 50 56 3469 3475 B-gender
who 57 60 3476 3479 O
has 61 64 3480 3483 O
experienced 65 76 3484 3495 O
menarche 77 85 3496 3504 O
and 86 89 3505 3508 O
who 90 93 3509 3512 O
has 94 97 3513 3516 O
not 98 101 3517 3520 O
undergone 102 111 3521 3530 O
surgical 112 120 3531 3539 O
sterilization 121 134 3540 3553 O
( 135 136 3554 3555 O
hysterectomy 136 148 3555 3567 B-treatment
or 149 151 3568 3570 O
bilateral 152 161 3571 3580 B-treatment
oophorectomy 162 174 3581 3593 I-treatment
) 174 175 3593 3594 O
or 176 178 3595 3597 O
who 179 182 3598 3601 O
is 183 185 3602 3604 O
not 186 189 3605 3608 O
postmenopausal 190 204 3609 3623 O

women 0 5 3624 3629 B-gender
under 6 11 3630 3635 O
the 12 15 3636 3639 O
age 16 19 3640 3643 B-age
of 20 22 3644 3646 O
55 23 25 3647 3649 B-upper_bound
must 26 30 3650 3654 O
have 31 35 3655 3659 O
a 36 37 3660 3661 O
documented 38 48 3662 3672 O
serum 49 54 3673 3678 B-clinical_variable
follicle 55 63 3679 3687 I-clinical_variable
stimulating 64 75 3688 3699 I-clinical_variable
hormone 76 83 3700 3707 I-clinical_variable
( 84 85 3708 3709 I-clinical_variable
FSH 85 88 3709 3712 I-clinical_variable
) 88 89 3712 3713 I-clinical_variable
level 90 95 3714 3719 I-clinical_variable
more 96 100 3720 3724 O
than 101 105 3725 3729 O
40 106 108 3730 3732 B-lower_bound
mIU 109 112 3733 3736 I-lower_bound
/ 112 113 3736 3737 I-lower_bound
mL 113 115 3737 3739 I-lower_bound

Do 0 2 0 2 O
not 3 6 3 6 O
own 7 10 7 10 O
or 11 13 11 13 O
are 14 17 14 17 O
not 18 21 18 21 O
familiar 22 30 22 30 O
with 31 35 31 35 O
the 36 39 36 39 O
use 40 43 40 43 B-technology_access
of 44 46 44 46 I-technology_access
a 47 48 47 48 I-technology_access
smartphone 49 59 49 59 I-technology_access

English 0 7 60 67 B-language_fluency
Speaking 8 16 68 76 I-language_fluency

Have 0 4 77 81 O
dementia 5 13 82 90 B-chronic_disease

Have 0 4 91 95 O
impaired 5 13 96 104 B-chronic_disease
vision 14 20 105 111 I-chronic_disease
that 21 25 112 116 O
prevents 26 34 117 125 O
them 35 39 126 130 O
from 40 44 131 135 O
reading 45 52 136 143 O
instructions 53 65 144 156 O

Have 0 4 157 161 O
no 5 7 162 164 B-technology_access
access 8 14 165 171 I-technology_access
to 15 17 172 174 I-technology_access
a 18 19 175 176 I-technology_access
wifi 20 24 177 181 I-technology_access
/ 25 26 182 183 I-technology_access
or 27 29 184 186 I-technology_access
cellular 30 38 187 195 I-technology_access
data 39 43 196 200 I-technology_access
connection 44 54 201 211 I-technology_access
at 55 57 212 214 O
their 58 63 215 220 O
home 64 68 221 225 O

Own 0 3 226 229 B-technology_access
and 4 7 230 233 I-technology_access
are 8 11 234 237 I-technology_access
familiar 12 20 238 246 I-technology_access
with 21 25 247 251 I-technology_access
use 26 29 252 255 I-technology_access
of 30 32 256 258 I-technology_access
a 33 34 259 260 I-technology_access
smartphone 35 45 261 271 I-technology_access

mental 0 6 272 278 B-chronic_disease
disorder 7 15 279 287 I-chronic_disease

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
fibromyalgia 13 25 13 25 B-chronic_disease

Presence 0 8 26 34 O
of 9 11 35 37 O
an 12 14 38 40 O
underlying 15 25 41 51 O
inflammatory 26 38 52 64 B-chronic_disease
disease 39 46 65 72 I-chronic_disease
in 47 49 73 75 O
the 50 53 76 79 O
affected 54 62 80 88 O
knee 63 67 89 93 O
, 67 68 93 94 O
including 69 78 95 104 O
Rheumatoid 79 89 105 115 B-chronic_disease
Arthritis 90 99 116 125 I-chronic_disease
, 99 100 125 126 O
Psoriatic 101 110 127 136 B-chronic_disease
Arthritis 111 120 137 146 I-chronic_disease
, 120 121 146 147 O
Gout 122 126 148 152 B-chronic_disease
, 126 127 152 153 O
Pseudogout 128 138 154 164 B-chronic_disease
, 138 139 164 165 O
or 140 142 166 168 O
other 143 148 169 174 O
inflammatory 149 161 175 187 O
disease 162 169 188 195 O

While 0 5 196 201 O
this 6 10 202 206 O
supplement 11 21 207 217 O
is 22 24 218 220 O
considered 25 35 221 231 O
very 36 40 232 236 O
safe 41 45 237 241 O
and 46 49 242 245 O
low 50 53 246 249 O
risk 54 58 250 254 O
, 58 59 254 255 O
patients 60 68 256 264 O
with 69 73 265 269 O
underlying 74 84 270 280 O
significant 85 96 281 292 O
cytopenia 97 106 293 302 B-chronic_disease
( 107 108 303 304 O
white 108 113 304 309 B-clinical_variable
blood 114 119 310 315 I-clinical_variable
cell 120 124 316 320 I-clinical_variable
count 125 130 321 326 I-clinical_variable
less 131 135 327 331 O
than 136 140 332 336 O
4.0 141 144 337 340 B-upper_bound
, 144 145 340 341 O
hemoglobin 146 156 342 352 B-clinical_variable
less 157 161 353 357 O
than 162 166 358 362 O
10 167 169 363 365 B-upper_bound
, 169 170 365 366 O
or 171 173 367 369 O
platelets 174 183 370 379 B-clinical_variable
less 184 188 380 384 O
than 189 193 385 389 O
100 194 197 390 393 B-upper_bound
) 197 198 393 394 O
, 198 199 394 395 O
or 200 202 396 398 O
with 203 207 399 403 O
impaired 208 216 404 412 B-chronic_disease
renal 217 222 413 418 I-chronic_disease
function 223 231 419 427 I-chronic_disease
( 232 233 428 429 O
glomerular 233 243 429 439 B-clinical_variable
filtration 244 254 440 450 I-clinical_variable
rate 255 259 451 455 I-clinical_variable
less 260 264 456 460 O
than 265 269 461 465 O
60 270 272 466 468 B-upper_bound
) 272 273 468 469 O
or 274 276 470 472 O
elevated 277 285 473 481 B-chronic_disease
liver 286 291 482 487 I-chronic_disease
enzymes 292 299 488 495 I-chronic_disease
will 300 304 496 500 O
be 305 307 501 503 O
excluded 308 316 504 512 O
as 317 319 513 515 O
well 320 324 516 520 O

Allergies 0 9 0 9 O
to 10 12 10 12 O
any 13 16 13 16 O
foods 17 22 17 22 B-allergy_name
in 23 25 23 25 O
the 26 29 26 29 O
standardized 30 42 30 42 O
diets 43 48 43 48 O

abnormal 0 8 49 57 O
serum 9 14 58 63 B-clinical_variable
phosphate 15 24 64 73 I-clinical_variable
( 25 26 74 75 O
≥ 26 27 75 76 O
4.6 28 31 77 80 B-lower_bound
or 32 34 81 83 O
< 35 36 84 85 O
2.5 37 40 86 89 B-upper_bound
mg 41 43 90 92 I-upper_bound
/ 43 44 92 93 I-upper_bound
dl 44 46 93 95 I-upper_bound
) 46 47 95 96 O

conditions 0 10 97 107 O
affecting 11 20 108 117 O
phosphate 21 30 118 127 O
metabolism 31 41 128 138 O
( 42 43 139 140 O
e.g. 43 47 140 144 O
, 47 48 144 145 O
hyper- 49 55 146 152 B-chronic_disease
or 56 58 153 155 I-chronic_disease
hypothyroidism 59 73 156 170 I-chronic_disease
; 73 74 170 171 O
irregular 75 84 172 181 O
menses 85 91 182 188 O
for 92 95 189 192 O
menstruating 96 108 193 205 O
women 109 114 206 211 B-gender
) 114 115 211 212 O

current 0 7 213 220 O
use 8 11 221 224 O
of 12 14 225 227 O
blood 15 20 228 233 B-treatment
pressure 21 29 234 242 I-treatment
medications 30 41 243 254 I-treatment

eGFR 0 4 255 259 B-clinical_variable
20 5 7 260 262 B-lower_bound
- 7 8 262 263 O
50 8 10 263 265 B-upper_bound
ml 11 13 266 268 I-upper_bound
/ 13 14 268 269 I-upper_bound
min 14 17 269 272 I-upper_bound

extreme 0 7 273 280 O
obesity 8 15 281 288 B-chronic_disease
( 16 17 289 290 O
BMI 17 20 290 293 B-bmi
≥ 21 22 294 295 O
35 23 25 296 298 B-lower_bound
kg 26 28 299 301 I-lower_bound
/ 28 29 301 302 I-lower_bound
m2 29 31 302 304 I-lower_bound
) 31 32 304 305 O

normal 0 6 306 312 O
kidney 7 13 313 319 O
function 14 22 320 328 O
( 23 24 329 330 O
eGFR 24 28 330 334 B-clinical_variable
> 29 30 335 336 O
60 31 33 337 339 B-lower_bound
and 34 37 340 343 O
normal 38 44 344 350 O
urinalysis 45 55 351 361 O
) 55 56 361 362 O

severe 0 6 363 369 B-chronic_disease
anemia 7 13 370 376 I-chronic_disease
( 14 15 377 378 O
hemoglobin 15 25 378 388 B-clinical_variable
< 26 27 389 390 O
8 28 29 391 392 B-upper_bound
g 30 31 393 394 I-upper_bound
/ 31 32 394 395 I-upper_bound
dl 32 34 395 397 I-upper_bound
for 35 38 398 401 O
women 39 44 402 407 B-gender
and 45 48 408 411 O
< 49 50 412 413 O
9 51 52 414 415 B-upper_bound
g 53 54 416 417 I-upper_bound
/ 54 55 417 418 I-upper_bound
dl 55 57 418 420 I-upper_bound
for 58 61 421 424 O
men 62 65 425 428 O
) 65 66 428 429 O

A 0 1 0 1 O
prior 2 7 2 7 O
history 8 15 8 15 O
of 16 18 16 18 O
any 19 22 19 22 O
other 23 28 23 28 O
malignancy 29 39 29 39 B-cancer
except 40 46 40 46 O
basal 47 52 47 52 B-cancer
or 53 55 53 55 O
squamous 56 64 56 64 B-cancer
cell 65 69 65 69 I-cancer
skin 70 74 70 74 I-cancer
cancers 75 82 75 82 I-cancer
, 82 83 82 83 O
strokes 84 91 84 91 B-chronic_disease
, 91 92 91 92 O
diabetes 93 101 93 101 B-chronic_disease
, 101 102 101 102 O
current 103 110 103 110 O
heart 111 116 111 116 B-chronic_disease
disease 117 124 117 124 I-chronic_disease
or 125 127 125 127 O
uncontrolled 128 140 128 140 O
hypertension 141 153 141 153 B-chronic_disease
, 153 154 153 154 O
peripheral 155 165 155 165 B-chronic_disease
vascular 166 174 166 174 I-chronic_disease
disease 175 182 175 182 I-chronic_disease
, 182 183 182 183 O
liver 184 189 184 189 B-chronic_disease
disease 190 197 190 197 I-chronic_disease
, 197 198 197 198 O
autoimmune 199 209 199 209 B-chronic_disease
and/or 210 216 210 216 O
inflammatory 217 229 217 229 B-chronic_disease
diseases 230 238 230 238 I-chronic_disease
including 239 248 239 248 O
rheumatoid 249 259 249 259 B-chronic_disease
arthritis 260 269 260 269 I-chronic_disease
and 270 273 270 273 O
ulcerative 274 284 274 284 B-chronic_disease
colitis 285 292 285 292 I-chronic_disease
, 292 293 292 293 O
and 294 297 294 297 O
other 298 303 298 303 O
medical 304 311 304 311 O
conditions 312 322 312 322 O
that 323 327 323 327 O
would 328 333 328 333 O
limit 334 339 334 339 O
participation 340 353 340 353 O
in 354 356 354 356 O
the 357 360 357 360 O
assessments 361 372 361 372 O
( 373 374 373 374 O
e.g. 374 378 374 378 O
, 378 379 378 379 O
pulmonary 380 389 380 389 B-chronic_disease
disease 390 397 390 397 I-chronic_disease
, 397 398 397 398 O
orthopedic 399 409 399 409 B-chronic_disease
problems 410 418 410 418 I-chronic_disease
, 418 419 418 419 O
major 420 425 420 425 B-chronic_disease
psychiatric 426 437 426 437 I-chronic_disease
illness 438 445 438 445 I-chronic_disease
, 445 446 445 446 O
major 447 452 447 452 O
cognitive 453 462 453 462 B-chronic_disease
dysfunction 463 474 463 474 I-chronic_disease
, 474 475 474 475 O
or 476 478 476 478 O
an 479 481 479 481 O
acute 482 487 482 487 O
medical 488 495 488 495 O
problem 496 503 496 503 O
) 503 504 503 504 O

All 0 3 505 508 O
women 4 9 509 514 B-gender
will 10 14 515 519 O
be 15 17 520 522 O
postmenopausal 18 32 523 537 O

Anemia 0 6 538 544 B-chronic_disease

Medication 0 10 545 555 B-treatment
exclusions 11 21 556 566 O
will 22 26 567 571 O
include 27 34 572 579 O
steroids 35 43 580 588 B-treatment
as 44 46 589 591 O
well 47 51 592 596 O
as 52 54 597 599 O
statins 55 62 600 607 B-treatment
and 63 66 608 611 O
other 67 72 612 617 O
medications 73 84 618 629 B-treatment
with 85 89 630 634 O
anti 90 94 635 639 B-treatment
- 94 95 639 640 I-treatment
inflammatory 95 107 640 652 I-treatment
actions 108 115 653 660 O

Women 0 5 661 666 B-gender
who 6 9 667 670 O
have 10 14 671 675 O
been 15 19 676 680 O
diagnosed 20 29 681 690 O
with 30 34 691 695 O
stage 35 40 696 701 B-lower_bound
I 41 42 702 703 I-lower_bound
- 42 43 703 704 O
IIIA 43 47 704 708 B-upper_bound
breast 48 54 709 715 B-cancer
cancer 55 61 716 722 I-cancer
will 62 66 723 727 O
be 67 69 728 730 O
recruited 70 79 731 740 O
1 80 81 741 742 B-lower_bound
- 81 82 742 743 O
10 82 84 743 745 B-upper_bound
years 85 90 746 751 I-upper_bound
after 91 96 752 757 I-upper_bound
the 97 100 758 761 O
completion 101 111 762 772 O
of 112 114 773 775 O
all 115 118 776 779 O
primary 119 126 780 787 B-treatment
cancer 127 133 788 794 I-treatment
treatment 134 143 795 804 I-treatment
except 144 150 805 811 O
for 151 154 812 815 O
longer 155 161 816 822 B-treatment
- 161 162 822 823 I-treatment
term 162 166 823 827 I-treatment
hormonal 167 175 828 836 I-treatment
therapies 176 185 837 846 I-treatment
( 186 187 847 848 O
tamoxifen 187 196 848 857 B-treatment
, 196 197 857 858 O
aromatase 198 207 859 868 B-treatment
inhibitors 208 218 869 879 I-treatment
) 218 219 879 880 O

Women 0 5 881 886 B-gender
who 6 9 887 890 O
have 10 14 891 895 O
received 15 23 896 904 O
a 24 25 905 906 O
typhoid 26 33 907 914 B-treatment
vaccine 34 41 915 922 I-treatment
within 42 48 923 929 O
the 49 52 930 933 O
last 53 57 934 938 B-upper_bound
three 58 63 939 944 I-upper_bound
years 64 69 945 950 I-upper_bound

Any 0 3 0 3 O
known 4 9 4 9 O
tumor 10 15 10 15 B-cancer
outside 16 23 16 23 I-cancer
of 24 26 24 26 I-cancer
the 27 30 27 30 I-cancer
brain 31 36 31 36 I-cancer

Biopsy 0 6 37 43 B-treatment
with 7 11 44 48 O
less 12 16 49 53 O
than 17 21 54 58 O
20 22 24 59 61 B-upper_bound
% 24 25 61 62 I-upper_bound
of 26 28 63 65 O
tumor 29 34 66 71 B-cancer
removed 35 42 72 79 O

Males 0 5 80 85 B-gender

Newly 0 5 86 91 O
- 5 6 91 92 O
diagnosed 6 15 92 101 O
brain 16 21 102 107 B-cancer
cancer 22 28 108 114 I-cancer
or 29 31 115 117 O
tumor 32 37 118 123 B-cancer
called 38 44 124 130 O
glioblastoma 45 57 131 143 B-cancer
or 58 60 144 146 O
GBM 61 64 147 150 B-cancer

Prior 0 5 151 156 O
treatment 6 15 157 166 O
for 16 19 167 170 O
GBM 20 23 171 174 B-cancer
( 24 25 175 176 O
other 25 30 176 181 O
than 31 35 182 186 O
surgical 36 44 187 195 B-treatment
resection 45 54 196 205 I-treatment
) 54 55 205 206 O

Recurrent 0 9 207 216 O
or 10 12 217 219 O
secondary 13 22 220 229 O
GBM 23 26 230 233 B-cancer

age 0 3 234 237 B-age
≥ 4 5 238 239 O
18 6 8 240 242 B-lower_bound
years 9 14 243 248 I-lower_bound
old 15 18 249 252 O

Allergies 0 9 0 9 O
to 10 12 10 12 O
shell 13 18 13 18 B-allergy_name
fish 19 23 19 23 I-allergy_name
, 23 24 23 24 O
seafood 25 32 25 32 B-allergy_name
, 32 33 32 33 O
eggs 34 38 34 38 B-allergy_name
or 39 41 39 41 O
iodine 42 48 42 48 B-allergy_name

Body 0 4 49 53 B-bmi
Mass 5 9 54 58 I-bmi
Index 10 15 59 64 I-bmi
( 16 17 65 66 I-bmi
BMI 17 20 66 69 I-bmi
) 20 21 69 70 I-bmi
greater 22 29 71 78 O
than 30 34 79 83 O
32 35 37 84 86 B-lower_bound

Diagnosis 0 9 87 96 O
of 10 12 97 99 O
asthma 13 19 100 106 B-chronic_disease

FEV1 0 4 107 111 B-clinical_variable
/ 4 5 111 112 O
FVC<0.7 5 12 112 119 B-clinical_variable

FEV1>80 0 7 120 127 B-clinical_variable
% 7 8 127 128 I-lower_bound
of 9 11 129 131 O
predicted 12 21 132 141 O

FVC 0 3 142 145 B-clinical_variable
greater 4 11 146 153 O
than 12 16 154 158 O
80 17 19 159 161 B-lower_bound
% 19 20 161 162 I-lower_bound
of 21 23 163 165 O
predicted 24 33 166 175 O

Forced 0 6 176 182 B-clinical_variable
Expiratory 7 17 183 193 I-clinical_variable
Flow 18 22 194 198 I-clinical_variable
at 23 25 199 201 I-clinical_variable
25 26 28 202 204 I-clinical_variable
- 28 29 204 205 I-clinical_variable
75 29 31 205 207 I-clinical_variable
% 31 32 207 208 I-clinical_variable
of 33 35 209 211 I-clinical_variable
predicted(FEF25 36 51 212 227 I-clinical_variable
- 51 52 227 228 I-clinical_variable
75 52 54 228 230 I-clinical_variable
) 54 55 230 231 I-clinical_variable
> 56 57 232 233 O
79 58 60 234 236 B-lower_bound
% 60 61 236 237 I-lower_bound
of 62 64 238 240 I-lower_bound
predicted 65 74 241 250 I-lower_bound

Heart 0 5 251 256 B-chronic_disease
disease 6 13 257 264 I-chronic_disease

Pregnant 0 8 265 273 B-pregnancy

Prior 0 5 274 279 O
history 6 13 280 287 O
of 14 16 288 290 O
hypersensitivity 17 33 291 307 O
to 34 36 308 310 O
Sildenafil 37 47 311 321 B-allergy_name

Weight 0 6 322 328 B-clinical_variable
of 7 9 329 331 O
greater 10 17 332 339 O
than 18 22 340 344 O
220 23 26 345 348 B-lower_bound
pounds 27 33 349 355 I-lower_bound
( 34 35 356 357 I-lower_bound
100 35 38 357 360 I-lower_bound
kg 39 41 361 363 I-lower_bound
) 41 42 363 364 I-lower_bound

antihypertensives 0 17 365 382 B-treatment
, 17 18 382 383 O
and 19 22 384 387 O
medications 23 34 388 399 B-treatment
for 35 38 400 403 O
osteoporosis 39 51 404 416 B-chronic_disease
and 52 55 417 420 O
gastrointestinal 56 72 421 437 B-chronic_disease
diseases 73 81 438 446 I-chronic_disease

between 0 7 447 454 O
the 8 11 455 458 O
ages 12 16 459 463 B-age
of 17 19 464 466 O
25 20 22 467 469 B-lower_bound
and 23 26 470 473 O
65 27 29 474 476 B-upper_bound

breastfeeding 0 13 477 490 O
females 14 21 491 498 B-gender

currently 0 9 499 508 O
smoking 10 17 509 516 O
at 18 20 517 519 O
least 21 26 520 525 O
1/2 27 30 526 529 B-lower_bound
pack 31 35 530 534 I-lower_bound
/ 35 36 534 535 I-lower_bound
day 36 39 535 538 I-lower_bound
( 40 41 539 540 O
confirmed 41 50 540 549 O
with 51 55 550 554 O
cotinine 56 64 555 563 O
level 65 70 564 569 O
) 70 71 569 570 O

diabetes 0 8 571 579 B-chronic_disease

kidney 0 6 580 586 B-chronic_disease
disease 7 14 587 594 I-chronic_disease

Clinical 0 8 0 8 O
diagnosis 9 18 9 18 O
of 19 21 19 21 O
HFpEF 22 27 22 27 B-chronic_disease

Current 0 7 28 35 O
non 8 11 36 39 O
- 11 12 39 40 O
smokers 12 19 40 47 O
with 20 24 48 52 O
< 25 26 53 54 O
15 26 28 54 56 B-upper_bound
pack 29 33 57 61 O
year 34 38 62 66 O
history 39 46 67 74 O

Ejection 0 8 75 83 B-clinical_variable
fraction 9 17 84 92 I-clinical_variable
≥40 18 21 93 96 O
% 21 22 96 97 I-lower_bound

Hemoglobin 0 10 98 108 B-clinical_variable
< 11 12 109 110 O
7.0 13 16 111 114 B-upper_bound
g 17 18 115 116 I-upper_bound
/ 18 19 116 117 I-upper_bound
d 19 20 117 118 I-upper_bound

Non 0 3 119 122 B-pregnancy
- 3 4 122 123 I-pregnancy
pregnant 4 12 123 131 I-pregnancy
women 13 18 132 137 B-gender

Patients 0 8 138 146 O
18 9 11 147 149 B-lower_bound
- 11 12 149 150 O
80 12 14 150 152 B-upper_bound
yrs 15 18 153 156 I-upper_bound
old 19 22 157 160 O
with 23 27 161 165 O
a 28 29 166 167 O
history 30 37 168 175 O
stable 38 44 176 182 O
( 45 46 183 184 O
no 46 48 184 186 O
medication 49 59 187 197 O
changes 60 67 198 205 O
in 68 70 206 208 O
past 71 75 209 213 B-upper_bound
6 76 77 214 215 I-upper_bound
weeks 78 83 216 221 I-upper_bound
( 84 85 222 223 O
w 85 86 223 224 O
/ 86 87 224 225 O
duration 87 95 225 233 O
of 96 98 234 236 O
diagnosis 99 108 237 246 O
> 109 110 247 248 O
6 110 111 248 249 B-lower_bound
months 112 118 250 256 I-lower_bound
) 118 119 256 257 O

Significant 0 11 258 269 O
cognitive 12 21 270 279 B-chronic_disease
impairment 22 32 280 290 I-chronic_disease

individuals 0 11 291 302 O
who 12 15 303 306 O
are 16 19 307 310 O
able 20 24 311 315 O
to 25 27 316 318 O
exercise 28 36 319 327 O
( 37 38 328 329 O
i.e. 38 42 329 333 O
without 43 50 334 341 O
orthopedic 51 61 342 352 O
limitations 62 73 353 364 O
or 74 76 365 367 O
neuromuscular 77 90 368 381 B-chronic_disease
disorders 91 100 382 391 I-chronic_disease
) 100 101 391 392 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
1000 34 38 34 38 B-lower_bound
/ 38 39 38 39 I-lower_bound
mm^3 39 43 39 43 I-lower_bound

Any 0 3 44 47 O
corticosteroid 4 18 48 62 B-treatment
therapy 19 26 63 70 I-treatment
for 27 30 71 74 O
indications 31 42 75 86 O
other 43 48 87 92 O
than 49 53 93 97 O
cGvHD 54 59 98 103 B-clinical_variable
at 60 62 104 106 O
doses 63 68 107 112 O
> 69 70 113 114 O
1 71 72 115 116 B-lower_bound
mg 73 75 117 119 I-lower_bound
/ 75 76 119 120 I-lower_bound
kg 76 78 120 122 I-lower_bound
/ 78 79 122 123 I-lower_bound
day 79 82 123 126 I-lower_bound
methylprednisolone 83 101 127 145 B-treatment
or 102 104 146 148 O
equivalent 105 115 149 159 O
within 116 122 160 166 O
7 123 124 167 168 B-upper_bound
days 125 129 169 173 I-upper_bound
of 130 132 174 176 O
Cycle 133 138 177 182 O
1 139 140 183 184 O
Day 141 144 185 188 O
1 145 146 189 190 O

At 0 2 191 193 O
least 3 8 194 199 O
one 9 12 200 203 B-lower_bound
organ 13 18 204 209 O
( 19 20 210 211 O
not 20 23 211 214 O
lung 24 28 215 219 O
) 28 29 219 220 O
with 30 34 221 225 O
a 35 36 226 227 O
score 37 42 228 233 O
of 43 45 234 236 O
2 46 47 237 238 O
, 47 48 238 239 O
3 49 50 240 241 O
or 51 53 242 244 O
more 54 58 245 249 O
organs 59 65 250 256 O
involved 66 74 257 265 O
with 75 79 266 270 O
a 80 81 271 272 O
score 82 87 273 278 O
of 88 90 279 281 O
1 91 92 282 283 O
in 93 95 284 286 O
each 96 100 287 291 O
organ 101 106 292 297 O
, 106 107 297 298 O
or 108 110 299 301 O
lung 111 115 302 306 O
score 116 121 307 312 O
of 122 124 313 315 O
1 125 126 316 317 O

Disease 0 7 318 325 O
persistence 8 19 326 337 O
without 20 27 338 345 O
improvement 28 39 346 357 O
despite 40 47 358 365 O
continued 48 57 366 375 O
treatment 58 67 376 385 B-treatment
with 68 72 386 390 O
prednisone 73 83 391 401 B-treatment
at 84 86 402 404 O
> 87 88 405 406 O
0.5 89 92 407 410 B-lower_bound
mg 93 95 411 413 I-lower_bound
/ 95 96 413 414 I-lower_bound
kg 96 98 414 416 I-lower_bound
/ 98 99 416 417 I-lower_bound
day 99 102 417 420 I-lower_bound
or 103 105 421 423 O
1 106 107 424 425 B-lower_bound
mg 108 110 426 428 I-lower_bound
/ 110 111 428 429 I-lower_bound
kg 111 113 429 431 I-lower_bound
/ 113 114 431 432 I-lower_bound
every 114 119 432 437 I-lower_bound
other 120 125 438 443 I-lower_bound
day 126 129 444 447 I-lower_bound
for 130 133 448 451 O
at 134 136 452 454 O
least 137 142 455 460 O
4 143 144 461 462 B-lower_bound
weeks 145 150 463 468 I-lower_bound

Failed 0 6 469 475 O
prior 7 12 476 481 B-treatment
alloSCT 13 20 482 489 I-treatment
within 21 27 490 496 O
the 28 31 497 500 O
past 32 36 501 505 B-upper_bound
6 37 38 506 507 I-upper_bound
months 39 45 508 514 I-upper_bound
from 46 50 515 519 O
Cycle 51 56 520 525 O
1 57 58 526 527 O
Day 59 62 528 531 O
1 63 64 532 533 O

Have 0 4 534 538 O
undergone 5 14 539 548 O
allogeneic 15 25 549 559 B-treatment
stem 26 30 560 564 I-treatment
cell 31 35 565 569 I-treatment
transplantation 36 51 570 585 I-treatment
( 52 53 586 587 I-treatment
alloSCT 53 60 587 594 I-treatment
) 60 61 594 595 I-treatment
from 62 66 596 600 O
any 67 70 601 604 O
donor 71 76 605 610 O
source 77 83 611 617 O
( 84 85 618 619 O
matched 85 92 619 626 O
unrelated 93 102 627 636 O
donor 103 108 637 642 O
, 108 109 642 643 O
sibling 110 117 644 651 O
, 117 118 651 652 O
haplo 119 124 653 658 O
- 124 125 658 659 O
identical 125 134 659 668 O
) 134 135 668 669 O
using 136 141 670 675 O
bone 142 146 676 680 O
marrow 147 153 681 687 O
, 153 154 687 688 O
peripheral 155 165 689 699 O
blood 166 171 700 705 O
stem 172 176 706 710 O
cells 177 182 711 716 O
, 182 183 716 717 O
or 184 186 718 720 O
cord 187 191 721 725 O
blood 192 197 726 731 O

Participants 0 12 732 744 O
with 13 17 745 749 O
clinically 18 28 750 760 O
diagnosed 29 38 761 770 O
moderate 39 47 771 779 O
to 48 50 780 782 O
severe 51 57 783 789 B-chronic_disease
cGvHD 58 63 790 795 I-chronic_disease
according 64 73 796 805 O
to 74 76 806 808 O
NIH 77 80 809 812 O
Consensus 81 90 813 822 O
Criteria 91 99 823 831 O
prior 100 105 832 837 O
to 106 108 838 840 O
randomization 109 122 841 854 O

Participants 0 12 855 867 O
with 13 17 868 872 O
relapsed 18 26 873 881 O
primary 27 34 882 889 B-cancer
malignancy 35 45 890 900 I-cancer

Patients 0 8 901 909 O
receiving 9 18 910 919 O
up 19 21 920 922 O
to 22 24 923 925 O
30 25 27 926 928 B-upper_bound
mg 28 30 929 931 I-upper_bound
by 31 33 932 934 O
mouth 34 39 935 940 O
once 40 44 941 945 O
a 45 46 946 947 O
day 47 50 948 951 O
of 51 53 952 954 O
hydrocortisone 54 68 955 969 B-treatment
( 69 70 970 971 O
i.e. 70 74 971 975 O
, 74 75 975 976 O
physiologic 76 87 977 988 O
replacement 88 99 989 1000 O
dose 100 104 1001 1005 O
) 104 105 1005 1006 O
of 106 108 1007 1009 O
corticosteroids 109 124 1010 1025 B-treatment

Patients 0 8 1026 1034 O
that 9 13 1035 1039 O
transition 14 24 1040 1050 O
from 25 29 1051 1055 O
active 30 36 1056 1062 O
aGvHD 37 42 1063 1068 B-chronic_disease
to 43 45 1069 1071 O
cGvHD 46 51 1072 1077 B-chronic_disease
without 52 59 1078 1085 O
tapering 60 68 1086 1094 O
off 69 72 1095 1098 O
corticosteroids 73 88 1099 1114 B-treatment
± 89 90 1115 1116 I-treatment
CNI 91 94 1117 1120 I-treatment
and 95 98 1121 1124 O
any 99 102 1125 1128 O
systemic 103 111 1129 1137 O
treatment 112 121 1138 1147 B-treatment

Severe 0 6 1148 1154 B-chronic_disease
cGvHD 7 12 1155 1160 I-chronic_disease

Steroid 0 7 1161 1168 B-treatment
refractory 8 18 1169 1179 O
cGvHD 19 24 1180 1185 B-chronic_disease
occurring 25 34 1186 1195 O
after 35 40 1196 1201 O
a 41 42 1202 1203 O
non 43 46 1204 1207 O
- 46 47 1207 1208 O
scheduled 47 56 1208 1217 O
donor 57 62 1218 1223 B-treatment
lymphocyte 63 73 1224 1234 I-treatment
infusion 74 82 1235 1243 I-treatment
( 83 84 1244 1245 I-treatment
DLI 84 87 1245 1248 I-treatment
) 87 88 1248 1249 I-treatment
administered 89 101 1250 1262 O
for 102 105 1263 1266 O
preemptive 106 116 1267 1277 B-treatment
treatment 117 126 1278 1287 I-treatment
of 127 129 1288 1290 O
malignancy 130 140 1291 1301 B-cancer
recurrence 141 151 1302 1312 O

currently 0 9 1313 1322 O
receiving 10 19 1323 1332 O
systemic 20 28 1333 1341 B-treatment
or 29 31 1342 1344 I-treatment
topical 32 39 1345 1352 I-treatment
corticosteroids 40 55 1353 1368 I-treatment
for 56 59 1369 1372 O
the 60 63 1373 1376 O
treatment 64 73 1377 1386 O
of 74 76 1387 1389 O
cGvHD 77 82 1390 1395 B-chronic_disease
for 83 86 1396 1399 O
a 87 88 1400 1401 O
duration 89 97 1402 1410 O
of 98 100 1411 1413 O
< 101 102 1414 1415 O
12 103 105 1416 1418 B-upper_bound
months 106 112 1419 1425 I-upper_bound
prior 113 118 1426 1431 I-upper_bound
to 119 121 1432 1434 O
Cycle 122 127 1435 1440 O
1 128 129 1441 1442 O
Day 130 133 1443 1446 O
1 134 135 1447 1448 O
( 136 137 1449 1450 O
if 137 139 1450 1452 O
applicable 140 150 1453 1463 O
) 150 151 1463 1464 O

must 0 4 1465 1469 O
accept 5 11 1470 1476 O
to 12 14 1477 1479 O
be 15 17 1480 1482 O
treated 18 25 1483 1490 O
with 26 30 1491 1495 O
only 31 35 1496 1500 O
one 36 39 1501 1504 O
of 40 42 1505 1507 O
the 43 46 1508 1511 O
following 47 56 1512 1521 O
BAT 57 60 1522 1525 O
options 61 68 1526 1533 O
on 69 71 1534 1536 O
Cycle 72 77 1537 1542 O
1 78 79 1543 1544 O
Day 80 83 1545 1548 O
1 84 85 1549 1550 O
( 86 87 1551 1552 O
additions 87 96 1552 1561 O
and 97 100 1562 1565 O
changes 101 108 1566 1573 O
are 109 112 1574 1577 O
allowed 113 120 1578 1585 O
during 121 127 1586 1592 O
the 128 131 1593 1596 O
course 132 138 1597 1603 O
of 139 141 1604 1606 O
the 142 145 1607 1610 O
study 146 151 1611 1616 O
, 151 152 1616 1617 O
but 153 156 1618 1621 O
only 157 161 1622 1626 O
with 162 166 1627 1631 O
BAT 167 170 1632 1635 O
from 171 175 1636 1640 O
the 176 179 1641 1644 O
following 180 189 1645 1654 O
BAT 190 193 1655 1658 O
options 194 201 1659 1666 O
): 201 203 1666 1668 O
extracorporeal 204 218 1669 1683 B-treatment
photopheresis 219 232 1684 1697 I-treatment
( 233 234 1698 1699 I-treatment
ECP 234 237 1699 1702 I-treatment
) 237 238 1702 1703 I-treatment
, 238 239 1703 1704 O
low 240 243 1705 1708 O
- 243 244 1708 1709 O
dose 244 248 1709 1713 O
methotrexate 249 261 1714 1726 B-treatment
( 262 263 1727 1728 I-treatment
MTX 263 266 1728 1731 I-treatment
) 266 267 1731 1732 I-treatment
, 267 268 1732 1733 O
mycophenolate 269 282 1734 1747 B-treatment
mofetil 283 290 1748 1755 I-treatment
( 291 292 1756 1757 I-treatment
MMF 292 295 1757 1760 I-treatment
) 295 296 1760 1761 I-treatment
, 296 297 1761 1762 O
mTOR 298 302 1763 1767 B-treatment
inhibitors 303 313 1768 1778 I-treatment
( 314 315 1779 1780 I-treatment
everolimus 315 325 1780 1790 I-treatment
or 326 328 1791 1793 I-treatment
sirolimus 329 338 1794 1803 I-treatment
) 338 339 1803 1804 I-treatment
, 339 340 1804 1805 O
infliximab 341 351 1806 1816 B-treatment
, 351 352 1816 1817 O
rituximab 353 362 1818 1827 B-treatment
, 362 363 1827 1828 O
pentostatin 364 375 1829 1840 B-treatment
, 375 376 1840 1841 O
imatinib 377 385 1842 1850 B-treatment
, 385 386 1850 1851 O
ibrutinib 387 396 1852 1861 B-treatment

participant 0 11 1862 1873 O
achieved 12 20 1874 1882 O
complete 21 29 1883 1891 O
or 30 32 1892 1894 O
partial 33 40 1895 1902 O
response 41 49 1903 1911 O
and 50 53 1912 1915 O
has 54 57 1916 1919 O
been 58 62 1920 1924 O
off 63 66 1925 1928 O
JAK 67 70 1929 1932 B-treatment
inhibitor 71 80 1933 1942 I-treatment
treatment 81 90 1943 1952 I-treatment
for 91 94 1953 1956 O
at 95 97 1957 1959 O
least 98 103 1960 1965 O
8 104 105 1966 1967 B-lower_bound
weeks 106 111 1968 1973 I-lower_bound
prior 112 117 1974 1979 I-lower_bound
to 118 120 1980 1982 O
Cycle 121 126 1983 1988 O
1 127 128 1989 1990 O
Day 129 132 1991 1994 O
1 133 134 1995 1996 O

platelet 0 8 1997 2005 B-clinical_variable
count 9 14 2006 2011 I-clinical_variable
> 15 16 2012 2013 O
25,000/ 17 24 2014 2021 B-lower_bound
mm^3 25 29 2022 2026 I-lower_bound

who 0 3 2027 2030 O
have 4 8 2031 2035 O
received 9 17 2036 2044 O
2 18 19 2045 2046 B-lower_bound
or 20 22 2047 2049 O
more 23 27 2050 2054 O
systemic 28 36 2055 2063 B-treatment
treatment 37 46 2064 2073 I-treatment
for 47 50 2074 2077 O
cGvHD 51 56 2078 2083 B-chronic_disease
in 57 59 2084 2086 O
addition 60 68 2087 2095 O
to 69 71 2096 2098 O
corticosteroids 72 87 2099 2114 B-treatment
± 88 89 2115 2116 O
CNI 90 93 2117 2120 B-treatment
for 94 97 2121 2124 O
cGvHD 98 103 2125 2130 O

who 0 3 2131 2134 O
have 4 8 2135 2139 O
received 9 17 2140 2148 O
a 18 19 2149 2150 O
scheduled 20 29 2151 2160 O
DLI 30 33 2161 2164 B-treatment
as 34 36 2165 2167 O
part 37 41 2168 2172 O
of 42 44 2173 2175 O
their 45 50 2176 2181 O
transplant 51 61 2182 2192 B-treatment
procedure 62 71 2193 2202 I-treatment
and 72 75 2203 2206 O
not 76 79 2207 2210 O
for 80 83 2211 2214 O
management 84 94 2215 2225 O
of 95 97 2226 2228 O
malignancy 98 108 2229 2239 B-cancer
relapse 109 116 2240 2247 O

who 0 3 2248 2251 O
were 4 8 2252 2256 O
treated 9 16 2257 2264 O
with 17 21 2265 2269 O
prior 22 27 2270 2275 O
JAK 28 31 2276 2279 B-treatment
inhibitors 32 42 2280 2290 I-treatment
for 43 46 2291 2294 O
aGvHD 47 52 2295 2300 B-chronic_disease

Absolute 0 8 0 8 B-clinical_variable
Neutrophil 9 19 9 19 I-clinical_variable
Count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
< 32 33 32 33 O
1.5 33 36 33 36 B-upper_bound
x 37 38 37 38 I-upper_bound
109 39 42 39 42 I-upper_bound
/ 42 43 42 43 I-upper_bound
L 43 44 43 44 I-upper_bound

Aspartate 0 9 45 54 B-clinical_variable
aminotransferase 10 26 55 71 I-clinical_variable
( 27 28 72 73 I-clinical_variable
AST 28 31 73 76 I-clinical_variable
) 31 32 76 77 I-clinical_variable

Documented 0 10 78 88 O
progression 11 22 89 100 O
of 23 25 101 103 O
disease 26 33 104 111 O
according 34 43 112 121 O
to 44 46 122 124 O
RECIST 47 53 125 131 O
v1.1 54 58 132 136 O
following 59 68 137 146 O
primary 69 76 147 154 O
standard 77 85 155 163 O
of 86 88 164 166 O
care 89 93 167 171 O
( 94 95 172 173 O
e.g. 95 99 173 177 O
erlotinib 100 109 178 187 B-treatment
, 109 110 187 188 O
gefitinib 111 120 189 198 B-treatment
) 120 121 198 199 O

Documented 0 10 200 210 O
progression 11 22 211 222 O
of 23 25 223 225 O
disease 26 33 226 233 O
according 34 43 234 243 O
to 44 46 244 246 O
RECIST 47 53 247 253 O
v1.1 54 58 254 258 O
following 59 68 259 268 O
standard 69 77 269 277 O
of 78 80 278 280 O
care 81 85 281 285 O
( 86 87 286 287 O
e.g. 87 91 287 291 O
platinum 92 100 292 300 B-treatment
doublet 101 108 301 308 I-treatment
) 108 109 308 309 O

ECOG 0 4 310 314 B-clinical_variable
performance 5 16 315 326 I-clinical_variable
status 17 23 327 333 I-clinical_variable
≤ 24 25 334 335 O
2 26 27 336 337 B-upper_bound

EGFR 0 4 338 342 B-cancer
T790 5 9 343 347 I-cancer
M 9 10 347 348 I-cancer
NSCLC 11 16 349 354 B-cancer
( 17 18 355 356 O
adenocarcinoma 18 32 356 370 B-cancer
) 32 33 370 371 O

EGFR 0 4 372 376 B-clinical_variable
wild 5 9 377 381 O
- 9 10 381 382 O
type 10 14 382 386 O
NSCLC 15 20 387 392 B-cancer

Hemoglobin 0 10 393 403 B-clinical_variable
( 11 12 404 405 I-clinical_variable
Hgb 12 15 405 408 I-clinical_variable
) 15 16 408 409 I-clinical_variable
< 17 18 410 411 O
9 18 19 411 412 B-upper_bound
g 20 21 413 414 I-upper_bound
/ 21 22 414 415 I-upper_bound
dL 22 24 415 417 I-upper_bound

History 0 7 418 425 O
of 8 10 426 428 O
allergy 11 18 429 436 O
or 19 21 437 439 O
hypersensitivity 22 38 440 456 O
to 39 41 457 459 O
nivolumab 42 51 460 469 B-allergy_name
components 52 62 470 480 I-allergy_name

Platelets 0 9 481 490 B-clinical_variable
< 10 11 491 492 O
100 11 14 492 495 B-upper_bound
x 15 16 496 497 I-upper_bound
109 17 20 498 501 I-upper_bound
/ 20 21 501 502 I-upper_bound
L 21 22 502 503 I-upper_bound

Previous 0 8 504 512 B-treatment
treatment 9 18 513 522 I-treatment
with 19 23 523 527 I-treatment
a 24 25 528 529 I-treatment
c 26 27 530 531 I-treatment
- 27 28 531 532 I-treatment
MET 28 31 532 535 I-treatment
inhibitor 32 41 536 545 I-treatment
or 42 44 546 548 I-treatment
HGF 45 48 549 552 I-treatment
- 48 49 552 553 I-treatment
targeting 49 58 553 562 I-treatment
therapy 59 66 563 570 I-treatment
( 67 68 571 572 O
applies 68 75 572 579 O
only 76 80 580 584 O
to 81 83 585 587 O
Group 84 89 588 593 O
2 90 91 594 595 O
) 91 92 595 596 O

Serum 0 5 597 602 B-clinical_variable
creatinine 6 16 603 613 I-clinical_variable
> 17 18 614 615 O
1.5 18 21 615 618 B-lower_bound
x 22 23 619 620 I-lower_bound
ULN 24 27 621 624 I-lower_bound

Serum 0 5 625 630 B-clinical_variable
lipase 6 12 631 637 I-clinical_variable
> 13 14 638 639 O
ULN 15 18 640 643 O

Total 0 5 644 649 B-clinical_variable
bilirubin 6 15 650 659 I-clinical_variable
> 16 17 660 661 O
1.5 17 20 661 664 B-lower_bound
x 21 22 665 666 I-lower_bound
upper 23 28 667 672 I-lower_bound
limit 29 34 673 678 I-lower_bound
of 35 37 679 681 I-lower_bound
normal 38 44 682 688 I-lower_bound
( 45 46 689 690 I-lower_bound
ULN 46 49 690 693 I-lower_bound
) 49 50 693 694 I-lower_bound

Tumor 0 5 695 700 B-cancer
tissue 6 12 701 707 I-cancer
for 13 16 708 711 O
determination 17 30 712 725 O
and/or 31 37 726 732 O
confirmation 38 50 733 745 O
of 51 53 746 748 O
genetic 54 61 749 756 O
pre 62 65 757 760 O
- 65 66 760 761 O
requisites 66 76 761 771 O
( 77 78 772 773 O
i.e. 78 82 773 777 O
EGFR 83 87 778 782 O
T790 88 92 783 787 O
M 92 93 787 788 O
positivity 94 104 789 799 O
post 105 109 800 804 O
progression 110 121 805 816 O
on 122 124 817 819 O
EGFR 125 129 820 824 B-clinical_variable
TKI 130 133 825 828 I-clinical_variable
for 134 137 829 832 O
Group 138 143 833 838 O
1 144 145 839 840 O
; 145 146 840 841 O
cMet 147 151 842 846 O
status 152 158 847 853 O
for 159 162 854 857 O
Group 163 168 858 863 O
2 169 170 864 865 O
) 170 171 865 866 O
must 172 176 867 871 O
be 177 179 872 874 O
provided 180 188 875 883 O
for 189 192 884 887 O
analysis 193 201 888 896 O

alanine 0 7 897 904 B-clinical_variable
aminotransferase 8 24 905 921 I-clinical_variable
( 25 26 922 923 I-clinical_variable
ALT 26 29 923 926 I-clinical_variable
) 29 30 926 927 I-clinical_variable
> 31 32 928 929 O
3 32 33 929 930 B-lower_bound
x 34 35 931 932 I-lower_bound
ULN 36 39 933 936 I-lower_bound

any 0 3 937 940 O
known 4 9 941 946 O
or 10 12 947 949 O
suspected 13 22 950 959 O
, 22 23 959 960 O
current 24 31 961 968 O
or 32 34 969 971 O
past 35 39 972 976 O
history 40 47 977 984 O
of 48 50 985 987 O
, 50 51 987 988 O
autoimmune 52 62 989 999 B-chronic_disease
disease 63 70 1000 1007 I-chronic_disease

asymptomatic 0 12 1008 1020 O
serum 13 18 1021 1026 O
amylase 19 26 1027 1034 O
> 27 28 1035 1036 O
CTCAE 29 34 1037 1042 B-clinical_variable
Grade 35 40 1043 1048 I-clinical_variable
2 41 42 1049 1050 I-clinical_variable
( 43 44 1051 1052 O
1.5 44 47 1052 1055 B-lower_bound
- 47 48 1055 1056 O
2.0 48 51 1056 1059 B-upper_bound
x 52 53 1060 1061 I-upper_bound
ULN 54 57 1062 1065 I-upper_bound
) 57 58 1065 1066 O

brain 0 5 1067 1072 B-chronic_disease
metastases 6 16 1073 1083 I-chronic_disease

child 0 5 1084 1089 O
bearing 6 13 1090 1097 O
potential 14 23 1098 1107 O
who 24 27 1108 1111 O
refuse 28 34 1112 1118 B-contraception_consent
or 35 37 1119 1121 I-contraception_consent
are 38 41 1122 1125 I-contraception_consent
not 42 45 1126 1129 I-contraception_consent
able 46 50 1130 1134 I-contraception_consent
to 51 53 1135 1137 I-contraception_consent
use 54 57 1138 1141 I-contraception_consent
a 58 59 1142 1143 I-contraception_consent
highly 60 66 1144 1150 I-contraception_consent
effective 67 76 1151 1160 I-contraception_consent
method 77 83 1161 1167 I-contraception_consent
of 84 86 1168 1170 I-contraception_consent
contraception 87 100 1171 1184 I-contraception_consent

condition 0 9 1185 1194 O
requiring 10 19 1195 1204 O
chronic 20 27 1205 1212 O
systemic 28 36 1213 1221 B-treatment
treatment 37 46 1222 1231 I-treatment
with 47 51 1232 1236 O
either 52 58 1237 1243 O
corticosteroids 59 74 1244 1259 B-treatment
( 74 75 1259 1260 O
> 75 76 1260 1261 O
10 77 79 1262 1264 B-lower_bound
mg 80 82 1265 1267 I-lower_bound
daily 83 88 1268 1273 I-lower_bound
prednisone 89 99 1274 1284 B-treatment
equivalent 100 110 1285 1295 O
) 110 111 1295 1296 O

have 0 4 1297 1301 O
been 5 9 1302 1306 O
treated 10 17 1307 1314 O
with 18 22 1315 1319 O
prior 23 28 1320 1325 B-treatment
PD-1 29 33 1326 1330 I-treatment
and 34 37 1331 1334 I-treatment
PD 38 40 1335 1337 I-treatment
- 40 41 1337 1338 I-treatment
L1 41 43 1338 1340 I-treatment
agents 44 50 1341 1347 I-treatment

histologically 0 14 1348 1362 O
documented 15 25 1363 1373 O
locally 26 33 1374 1381 O
advanced 34 42 1382 1390 O
, 42 43 1390 1391 O
recurrent 44 53 1392 1401 O
and/or 54 60 1402 1408 O
metastatic 61 71 1409 1419 B-cancer
NSCLC 72 77 1420 1425 I-cancer

history 0 7 1426 1433 O
of 8 10 1434 1436 O
testing 11 18 1437 1444 O
positive 19 27 1445 1453 O
for 28 31 1454 1457 O
human 32 37 1458 1463 B-chronic_disease
immunodeficiency 38 54 1464 1480 I-chronic_disease
virus 55 60 1481 1486 I-chronic_disease
( 61 62 1487 1488 I-chronic_disease
HIV 62 65 1488 1491 I-chronic_disease
) 65 66 1491 1492 I-chronic_disease
or 67 69 1493 1495 O
known 70 75 1496 1501 O
acquired 76 84 1502 1510 B-chronic_disease
immunodeficiency 85 101 1511 1527 I-chronic_disease
syndrome 102 110 1528 1536 I-chronic_disease
( 111 112 1537 1538 I-chronic_disease
AIDS 112 116 1538 1542 I-chronic_disease
) 116 117 1542 1543 I-chronic_disease

interstitial 0 12 1544 1556 B-chronic_disease
lung 13 17 1557 1561 I-chronic_disease
disease 18 25 1562 1569 I-chronic_disease
that 26 30 1570 1574 O
is 31 33 1575 1577 O
symptomatic 34 45 1578 1589 O
or 46 48 1590 1592 O
may 49 52 1593 1596 O
interfere 53 62 1597 1606 O
with 63 67 1607 1611 O
the 68 71 1612 1615 O
detection 72 81 1616 1625 O
or 82 84 1626 1628 O
management 85 95 1629 1639 O
of 96 98 1640 1642 O
suspected 99 108 1643 1652 O
drug 109 113 1653 1657 O
- 113 114 1657 1658 O
related 114 121 1658 1665 O
pulmonary 122 131 1666 1675 O
toxicity 132 140 1676 1684 O

measured 0 8 1685 1693 O
or 9 11 1694 1696 O
calculated 12 22 1697 1707 O
creatinine 23 33 1708 1718 B-clinical_variable
clearance 34 43 1719 1728 I-clinical_variable
< 44 45 1729 1730 O
75 45 47 1730 1732 B-upper_bound
% 47 48 1732 1733 I-upper_bound
LLN 49 52 1734 1737 I-upper_bound

other 0 5 1738 1743 O
immunosuppressive 6 23 1744 1761 B-treatment
medications 24 35 1762 1773 I-treatment
within 36 42 1774 1780 O
14 43 45 1781 1783 B-upper_bound
days 46 50 1784 1788 I-upper_bound
of 51 53 1789 1791 O
treatment 54 63 1792 1801 B-treatment
start 64 69 1802 1807 O

positive 0 8 1808 1816 O
test 9 13 1817 1821 O
for 14 17 1822 1825 O
hepatitis 18 27 1826 1835 B-chronic_disease
B 28 29 1836 1837 I-chronic_disease
virus 30 35 1838 1843 I-chronic_disease
or 36 38 1844 1846 O
hepatitis 39 48 1847 1856 B-chronic_disease
C 49 50 1857 1858 I-chronic_disease
virus 51 56 1859 1864 I-chronic_disease
indicating 57 67 1865 1875 O
acute 68 73 1876 1881 O
or 74 76 1882 1884 O
chronic 77 84 1885 1892 B-chronic_disease
infection 85 94 1893 1902 I-chronic_disease

pregnant 0 8 1903 1911 B-pregnancy

received 0 8 1912 1920 O
more 9 13 1921 1925 O
than 14 18 1926 1930 O
one 19 22 1931 1934 B-lower_bound
prior 23 28 1935 1940 O
line 29 33 1941 1945 O
of 34 36 1946 1948 O
EGFR 37 41 1949 1953 B-treatment
TKI 42 45 1954 1957 I-treatment
therapy1 46 54 1958 1966 I-treatment
( 55 56 1967 1968 O
applies 56 63 1968 1975 O
only 64 68 1976 1980 O
to 69 71 1981 1983 O
Group 72 77 1984 1989 O
1 78 79 1990 1991 O
) 79 80 1991 1992 O

require 0 7 1993 2000 O
emergent 8 16 2001 2009 O
use 17 20 2010 2013 O
of 21 23 2014 2016 O
systemic 24 32 2017 2025 B-treatment
steroids 33 41 2026 2034 I-treatment
, 41 42 2034 2035 O
chronic 43 50 2036 2043 O
use 51 54 2044 2047 O
of 55 57 2048 2050 O
prednisone 58 68 2051 2061 B-treatment
( 69 70 2062 2063 O
greater 70 77 2063 2070 O
than 78 82 2071 2075 O
10 83 85 2076 2078 B-lower_bound
mg 85 87 2078 2080 I-lower_bound
or 88 90 2081 2083 O
an 91 93 2084 2086 O
equivalent 94 104 2087 2097 O
steroid 105 112 2098 2105 O
dose 113 117 2106 2110 O
daily 118 123 2111 2116 O
) 123 124 2116 2117 O
or 125 127 2118 2120 O
emergent 128 136 2121 2129 B-treatment
surgery 137 144 2130 2137 I-treatment
and/or 145 151 2138 2144 O
radiotherapy 152 164 2145 2157 B-treatment

Adequate 0 8 0 8 B-clinical_variable
performance 9 20 9 20 I-clinical_variable
status 21 27 21 27 I-clinical_variable
( 28 29 28 29 O
ECOG 29 33 29 33 B-clinical_variable
< 34 35 34 35 O
3 36 37 36 37 B-upper_bound
) 37 38 37 38 O

Any 0 3 39 42 O
patient 4 11 43 50 O
with 12 16 51 55 O
both 17 21 56 60 O
metastatic 22 32 61 71 B-cancer
ependymoma 33 43 72 82 I-cancer
and 44 47 83 86 O
age 48 51 87 90 B-age
< 52 53 91 92 O
3 54 55 93 94 B-upper_bound
years 56 61 95 100 I-upper_bound
at 62 64 101 103 O
the 65 68 104 107 O
time 69 73 108 112 O
of 74 76 113 115 O
enrollment 77 87 116 126 O

Interval 0 8 127 135 O
from 9 13 136 140 O
start 14 19 141 146 O
of 20 22 147 149 O
initial 23 30 150 157 O
radiation 31 40 158 167 B-treatment
therapy 41 48 168 175 I-treatment
to 49 51 176 178 O
enrollment 52 62 179 189 O
> 63 64 190 191 O
9 65 66 192 193 B-lower_bound
months 67 73 194 200 I-lower_bound

Patients 0 8 201 209 O
aged 9 13 210 214 B-age
1 14 15 215 216 B-lower_bound
- 15 16 216 217 O
21 16 18 217 219 B-upper_bound
years 19 24 220 225 I-upper_bound
at 25 27 226 228 O
the 28 31 229 232 O
time 32 36 233 237 O
of 37 39 238 240 O
enrollment 40 50 241 251 O

Pregnant 0 8 252 260 B-pregnancy
women 9 14 261 266 B-gender
are 15 18 267 270 O
excluded 19 27 271 279 O
from 28 32 280 284 O
enrollment 33 43 285 295 O
on 44 46 296 298 O
this 47 51 299 303 O
study 52 57 304 309 O
because 58 65 310 317 O
radiation 66 75 318 327 B-treatment
therapy 76 83 328 335 I-treatment
is 84 86 336 338 O
an 87 89 339 341 O
agent 90 95 342 347 O
with 96 100 348 352 O
the 101 104 353 356 O
potential 105 114 357 366 O
for 115 118 367 370 O
teratogenic 119 130 371 382 O
or 131 133 383 385 O
abortifacient 134 147 386 399 O
effects 148 155 400 407 O

Prior 0 5 408 413 B-treatment
craniospinal 6 18 414 426 I-treatment
irradiation 19 30 427 438 I-treatment

Progressive 0 11 439 450 O
intracranial 12 24 451 463 B-cancer
ependymoma 25 35 464 474 I-cancer
after 36 41 475 480 O
prior 42 47 481 486 O
focal 48 53 487 492 B-treatment
irradiation 54 65 493 504 I-treatment

research 0 8 505 513 O
participant 9 20 514 525 O
does 21 25 526 530 O
not 26 29 531 534 O
require 30 37 535 542 O
mechanical 38 48 543 553 B-treatment
ventilation 49 60 554 565 I-treatment

Age 0 3 0 3 B-age
between 4 11 4 11 O
18 12 14 12 14 B-lower_bound
- 14 15 14 15 O
75 15 17 15 17 B-upper_bound
years 18 23 18 23 I-upper_bound

Diagnosis 0 9 24 33 O
of 10 12 34 36 O
unilateral 13 23 37 47 B-chronic_disease
cortical 24 32 48 56 I-chronic_disease
and 33 36 57 60 O
subcortical 37 48 61 72 B-chronic_disease
stroke 49 55 73 79 I-chronic_disease
confirmed 56 65 80 89 O
by 66 68 90 92 O
brain 69 74 93 98 O
CT 75 77 99 101 O
or 78 80 102 104 O
MRI 81 84 105 108 O
scan 85 89 109 113 O

English 0 7 114 121 B-language_fluency
- 7 8 121 122 I-language_fluency
language 8 16 122 130 I-language_fluency
comprehension 17 30 131 144 I-language_fluency
and 31 34 145 148 O
cognitive 35 44 149 158 O
ability 45 52 159 166 O
sufficient 53 63 167 177 O
to 64 66 178 180 O
give 67 71 181 185 O
informed 72 80 186 194 O
consent 81 88 195 202 O
and 89 92 203 206 O
to 93 95 207 209 O
cooperate 96 105 210 219 O
with 106 110 220 224 O
the 111 114 225 228 O
intervention 115 127 229 241 O

No 0 2 242 244 O
condition 3 12 245 254 O
( 13 14 255 256 O
e.g. 14 18 256 260 O
, 18 19 260 261 O
severe 20 26 262 268 B-chronic_disease
arthritis 27 36 269 278 I-chronic_disease
, 36 37 278 279 O
central 38 45 280 287 B-chronic_disease
pain 46 50 288 292 I-chronic_disease
) 50 51 292 293 O
that 52 56 294 298 O
would 57 62 299 304 O
interfere 63 72 305 314 O
with 73 77 315 319 O
valid 78 83 320 325 O
administration 84 98 326 340 O
of 99 101 341 343 O
the 102 105 344 347 O
motor 106 111 348 353 O
function 112 120 354 362 O
tests 121 126 363 368 O

No 0 2 369 371 O
history 3 10 372 379 O
of 11 13 380 382 O
neurolytic 14 24 383 393 B-treatment
procedure 25 34 394 403 I-treatment
to 35 37 404 406 I-treatment
the 38 41 407 410 I-treatment
affected 42 50 411 419 I-treatment
limb 51 55 420 424 I-treatment
in 56 58 425 427 O
the 59 62 428 431 O
past 63 67 432 436 B-upper_bound
four 68 72 437 441 I-upper_bound
months 73 79 442 448 I-upper_bound
and 80 83 449 452 O
no 84 86 453 455 O
planned 87 94 456 463 O
alteration 95 105 464 474 O
in 106 108 475 477 O
upper 109 114 478 483 B-treatment
- 114 115 483 484 I-treatment
extremity 115 124 484 493 I-treatment
therapy 125 132 494 501 I-treatment
or 133 135 502 504 O
medication 136 146 505 515 B-treatment
for 147 150 516 519 I-treatment
muscle 151 157 520 526 I-treatment
tone 158 162 527 531 I-treatment
during 163 169 532 538 O
the 170 173 539 542 O
course 174 180 543 549 O
of 181 183 550 552 O
the 184 187 553 556 O
study 188 193 557 562 O

No 0 2 563 565 O
previous 3 11 566 574 O
clinically 12 22 575 585 O
defined 23 30 586 593 O
stroke 31 37 594 600 B-chronic_disease

Pregnancy 0 9 601 610 B-pregnancy

Previous 0 8 611 619 O
history 9 16 620 627 O
of 17 19 628 630 O
or 20 22 631 633 O
MRI 23 26 634 637 O
findings 27 35 638 646 O
consistent 36 46 647 657 O
with 47 51 658 662 O
brain 52 57 663 668 B-cancer
tumors 58 64 669 675 I-cancer
, 64 65 675 676 O
strokes 66 73 677 684 B-chronic_disease
, 73 74 684 685 O
trauma 75 81 686 692 B-chronic_disease
or 82 84 693 695 O
arterial 85 93 696 704 B-chronic_disease
venous 94 100 705 711 I-chronic_disease
malformations 101 114 712 725 I-chronic_disease

Subacute 0 8 726 734 O
or 9 11 735 737 O
chronic 12 19 738 745 B-chronic_disease
stroke 20 26 746 752 I-chronic_disease
; 26 27 752 753 O
interval 28 36 754 762 O
of 37 39 763 765 O
at 40 42 766 768 O
least 43 48 769 774 O
3month 49 55 775 781 B-lower_bound
and 56 59 782 785 O
interval 60 68 786 794 O
of 69 71 795 797 O
at 72 74 798 800 O
least 75 80 801 806 O
6 81 82 807 808 B-lower_bound
months 83 89 809 815 I-lower_bound
from 90 94 816 820 O
stroke 95 101 821 827 O
to 102 104 828 830 O
time 105 109 831 835 O
of 110 112 836 838 O
enrollment 113 123 839 849 O

Untreated 0 9 850 859 O
depression 10 20 860 870 B-chronic_disease
that 21 25 871 875 O
may 26 29 876 879 O
affect 30 36 880 886 O
motivation 37 47 887 897 O
to 48 50 898 900 O
participate 51 62 901 912 O
in 63 65 913 915 O
the 66 69 916 919 O
study 70 75 920 925 O

Upper 0 5 926 931 O
- 5 6 931 932 O
extremity 6 15 932 941 O
hemiparesis 16 27 942 953 B-chronic_disease
associated 28 38 954 964 O
with 39 43 965 969 O
stroke 44 50 970 976 B-chronic_disease
( 51 52 977 978 O
manual 52 58 978 984 B-clinical_variable
muscle 59 65 985 991 I-clinical_variable
testing 66 73 992 999 I-clinical_variable
score 74 79 1000 1005 I-clinical_variable
of 80 82 1006 1008 O
at 83 85 1009 1011 O
least 86 91 1012 1017 O
2 92 93 1018 1019 B-lower_bound
, 93 94 1019 1020 O
but 95 98 1021 1024 O
no 99 101 1025 1027 O
more 102 106 1028 1032 O
than 107 111 1033 1037 O
4/5 112 115 1038 1041 B-upper_bound
in 116 118 1042 1044 O
the 119 122 1045 1048 O
elbow 123 128 1049 1054 O
and 129 132 1055 1058 O
wrist 133 138 1059 1064 O
flexors 139 146 1065 1072 O
) 146 147 1072 1073 O

age 0 3 1074 1077 B-age
18 4 6 1078 1080 B-lower_bound
- 6 7 1080 1081 O
65 7 9 1081 1083 B-upper_bound

Medical 0 7 0 7 B-chronic_disease
or 8 10 8 10 O
psychological 11 24 11 24 B-chronic_disease
conditions 25 35 25 35 I-chronic_disease
which 36 41 36 41 O
, 41 42 41 42 O
in 43 45 43 45 O
the 46 49 46 49 O
opinion 50 57 50 57 O
of 58 60 58 60 O
the 61 64 61 64 O
investigator 65 77 65 77 O
, 77 78 77 78 O
might 79 84 79 84 O
create 85 91 85 91 O
undue 92 97 92 97 O
risk 98 102 98 102 O
to 103 105 103 105 O
the 106 109 106 109 O
subject 110 117 110 117 O
or 118 120 118 120 O
interfere 121 130 121 130 O
with 131 135 131 135 O
the 136 139 136 139 O
subject 140 147 140 147 O
's 147 149 147 149 O
ability 150 157 150 157 O
to 158 160 158 160 O
comply 161 167 161 167 O
with 168 172 168 172 O
the 173 176 173 176 O
protocol 177 185 177 185 O
requirements 186 198 186 198 O

Patient 0 7 199 206 O
scheduled 8 17 207 216 O
to 18 20 217 219 O
undergo 21 28 220 227 O
thoracic 29 37 228 236 B-treatment
RT 38 40 237 239 I-treatment
at 41 43 240 242 O
Duke 44 48 243 247 O
University 49 59 248 258 O
to 60 62 259 261 O
a 63 64 262 263 O
dose 65 69 264 268 O
of 70 72 269 271 O
at 73 75 272 274 O
least 76 81 275 280 O
20 82 84 281 283 B-lower_bound
Gy 85 87 284 286 I-lower_bound

Respiratory 0 11 287 298 B-chronic_disease
illness 12 19 299 306 I-chronic_disease
of 20 22 307 309 O
a 23 24 310 311 O
bacterial 25 34 312 321 O
or 35 37 322 324 O
viral 38 43 325 330 O
etiology 44 52 331 339 O
within 53 59 340 346 O
30 60 62 347 349 B-upper_bound
days 63 67 350 354 I-upper_bound
of 68 70 355 357 O
MRI 71 74 358 361 O

Subject 0 7 362 369 O
has 8 11 370 373 O
any 12 15 374 377 O
form 16 20 378 382 O
of 21 23 383 385 O
known 24 29 386 391 O
cardiac 30 37 392 399 B-chronic_disease
arrhythmia 38 48 400 410 I-chronic_disease

Subject 0 7 411 418 O
is 8 10 419 421 O
less 11 15 422 426 O
than 16 20 427 431 O
18 21 23 432 434 B-upper_bound
years 24 29 435 440 I-upper_bound
old 30 33 441 444 O

Subject 0 7 445 452 O
is 8 10 453 455 O
pregnant 11 19 456 464 B-pregnancy

Subject 0 7 465 472 O
meets 8 13 473 478 O
all 14 17 479 482 O
criteria 18 26 483 491 O
above 27 32 492 497 O
but 33 36 498 501 O
does 37 41 502 506 O
not 42 45 507 510 O
have 46 50 511 515 O
a 51 52 516 517 O
clinical 53 61 518 526 O
diagnosis 62 71 527 536 O
of 72 74 537 539 O
respiratory 75 86 540 551 B-chronic_disease
disease 87 94 552 559 I-chronic_disease

ASA 0 3 0 3 B-clinical_variable
grades 4 10 4 10 I-clinical_variable
I 11 12 11 12 B-lower_bound
- 12 13 12 13 O
III 13 16 13 16 B-upper_bound

Obstructive 0 11 17 28 B-chronic_disease
sleep 12 17 29 34 I-chronic_disease
apnea 18 23 35 40 I-chronic_disease

Prolonged 0 9 41 50 B-clinical_variable
QTc 10 13 51 54 I-clinical_variable
on 14 16 55 57 O
pre 17 20 58 61 O
- 20 21 61 62 O
operative 21 30 62 71 O
EKG 31 34 72 75 O

Pulmonary 0 9 76 85 B-chronic_disease
disease 10 17 86 93 I-chronic_disease
requiring 18 27 94 103 O
home 28 32 104 108 B-treatment
oxygen 33 39 109 115 I-treatment
therapy 40 47 116 123 I-treatment

Renal 0 5 124 129 B-chronic_disease
failure 6 13 130 137 I-chronic_disease
requiring 14 23 138 147 O
dialysis 24 32 148 156 B-treatment

Severe 0 6 157 163 B-chronic_disease
heart 7 12 164 169 I-chronic_disease
disease 13 20 170 177 I-chronic_disease

Treatment 0 9 178 187 O
with 10 14 188 192 O
other 15 20 193 198 O
NMDA 21 25 199 203 B-treatment
receptor 26 34 204 212 I-treatment
antagonists 35 46 213 224 I-treatment

Undergoing 0 10 225 235 O
lumbar 11 17 236 242 B-treatment
fusion 18 24 243 249 I-treatment
surgery 25 32 250 257 I-treatment

age 0 3 258 261 B-age
between 4 11 262 269 O
18 12 14 270 272 B-lower_bound
- 14 15 272 273 O
80 15 17 273 275 B-upper_bound

body 0 4 276 280 B-bmi
mass 5 9 281 285 I-bmi
index 10 15 286 291 I-bmi
> 16 17 292 293 O
50 18 20 294 296 B-lower_bound
kg 21 23 297 299 I-lower_bound
/ 23 24 299 300 I-lower_bound
m2 24 26 300 302 I-lower_bound

A 0 1 0 1 O
stress 2 8 2 8 B-treatment
cardiac 9 16 9 16 I-treatment
test 17 21 17 21 I-treatment
( 22 23 22 23 O
stress 23 29 23 29 B-treatment
thallium 30 38 30 38 I-treatment
, 38 39 38 39 O
stress 40 46 40 46 B-treatment
MUGA 47 51 47 51 I-treatment
, 51 52 51 52 O
dobutamine 53 63 53 63 B-treatment
echocardiogram 64 78 64 78 I-treatment
or 79 81 79 81 O
other 82 87 82 87 O
stress 88 94 88 94 O
test 95 99 95 99 O
that 100 104 100 104 O
will 105 109 105 109 O
rule 110 114 110 114 O
out 115 118 115 118 O
cardiac 119 126 119 126 B-chronic_disease
ischemia 127 135 127 135 I-chronic_disease
) 135 136 135 136 O
within 137 143 137 143 O
6 144 145 144 145 B-upper_bound
months 146 152 146 152 I-upper_bound
of 153 155 153 155 O
lymphodepletion 156 171 156 171 B-treatment
. 171 172 171 172 O
( 173 174 173 174 O
Turnstile 174 183 174 183 O
II 184 186 184 186 O
- 187 188 187 188 O
Chemotherapy 189 201 189 201 B-treatment
/ 201 202 201 202 I-treatment
Cell 202 206 202 206 I-treatment
Infusion 207 215 207 215 I-treatment
- 215 216 215 216 O
Inclusion 216 225 216 225 O
Criteria 226 234 226 234 O
) 234 235 234 235 O

Absolute 0 8 236 244 B-clinical_variable
neutrophil 9 19 245 255 I-clinical_variable
count 20 25 256 261 I-clinical_variable
greater 26 33 262 269 O
than 34 38 270 274 O
or 39 41 275 277 O
equal 42 47 278 283 O
to 48 50 284 286 O
750 51 54 287 290 B-lower_bound
/ 54 55 290 291 I-lower_bound
mm3 55 58 291 294 I-lower_bound
. 58 59 294 295 O
( 60 61 296 297 O
Turnstile 61 70 297 306 B-treatment
II 71 73 307 309 I-treatment
- 74 75 310 311 I-treatment
Chemotherapy 76 88 312 324 I-treatment
/ 88 89 324 325 I-treatment
Cell 89 93 325 329 I-treatment
Infusion- 94 103 330 339 I-treatment
Inclusion 104 113 340 349 O
Criteria 114 122 350 358 O
) 122 123 358 359 O

Achieves 0 8 360 368 O
PR 9 11 369 371 O
or 12 14 372 374 O
CR 15 17 375 377 O
in 18 20 378 380 O
response 21 29 381 389 O
to 30 32 390 392 O
B 33 34 393 394 B-treatment
- 34 35 394 395 I-treatment
RAF 35 38 395 398 I-treatment
treatment 39 48 399 408 I-treatment
( 49 50 409 410 O
Cohort 50 56 410 416 O
C 57 58 417 418 O
) 58 59 418 419 O

Age 0 3 420 423 B-gender
greater 4 11 424 431 O
than 12 16 432 436 O
or 17 19 437 439 O
equal 20 25 440 445 O
to 26 28 446 448 O
12 29 31 449 451 B-lower_bound
years 32 37 452 457 I-lower_bound
. 37 38 457 458 O
( 39 40 459 460 O
Turnstile 40 49 460 469 O
I 50 51 470 471 O
) 51 52 471 472 O

Any 0 3 473 476 O
active 4 10 477 483 B-chronic_disease
systemic 11 19 484 492 I-chronic_disease
infections 20 30 493 503 I-chronic_disease
requiring 31 40 504 513 O
intravenous 41 52 514 525 B-treatment
antibiotics 53 64 526 537 I-treatment
, 64 65 537 538 O
coagulation 66 77 539 550 B-chronic_disease
disorders 78 87 551 560 I-chronic_disease
or 88 90 561 563 O
other 91 96 564 569 O
major 97 102 570 575 O
medical 103 110 576 583 B-chronic_disease
illnesses 111 120 584 593 I-chronic_disease
of 121 123 594 596 O
the 124 127 597 600 O
cardiovascular 128 142 601 615 B-chronic_disease
, 142 143 615 616 O
respiratory 144 155 617 628 B-chronic_disease
or 156 158 629 631 O
immune 159 165 632 638 B-chronic_disease
system 166 172 639 645 I-chronic_disease
, 172 173 645 646 O
such 174 178 647 651 O
as 179 181 652 654 O
abnormal 182 190 655 663 B-clinical_variable
stress 191 197 664 670 I-clinical_variable
test 198 202 671 675 I-clinical_variable
and/or 203 209 676 682 O
abnormal 210 218 683 691 O
PFT 219 222 692 695 B-clinical_variable
. 222 223 695 696 O
PI 224 226 697 699 O
or 227 229 700 702 O
his 230 233 703 706 O
designee 234 242 707 715 O
shall 243 248 716 721 O
make 249 253 722 726 O
the 254 257 727 730 O
final 258 263 731 736 O
determination 264 277 737 750 O
regarding 278 287 751 760 O
appropriateness 288 303 761 776 O
of 304 306 777 779 O
enrollment.(Turnstile 307 328 780 801 O
II 329 331 802 804 O
- 332 333 805 806 O
Chemotherapy 334 346 807 819 B-treatment
/ 346 347 819 820 O
Cell 347 351 820 824 B-treatment
Infusion 352 360 825 833 I-treatment
Exclusion 361 370 834 843 O
Criteria 371 379 844 852 O
) 379 380 852 853 O

Any 0 3 854 857 O
form 4 8 858 862 O
of 9 11 863 865 O
primary 12 19 866 873 O
or 20 22 874 876 O
secondary 23 32 877 886 O
immunodeficiency 33 49 887 903 B-chronic_disease
. 49 50 903 904 O
Must 51 55 905 909 O
have 56 60 910 914 O
recovered 61 70 915 924 O
immune 71 77 925 931 O
competence 78 88 932 942 O
after 89 94 943 948 O
chemotherapy 95 107 949 961 B-treatment
or 108 110 962 964 O
radiation 111 120 965 974 B-treatment
therapy 121 128 975 982 I-treatment
as 129 131 983 985 O
evidenced 132 141 986 995 O
by 142 144 996 998 O
lymphocyte 145 155 999 1009 B-clinical_variable
counts 156 162 1010 1016 I-clinical_variable
( 163 164 1017 1018 O
> 164 165 1018 1019 O
500 166 169 1020 1023 B-lower_bound
/ 169 170 1023 1024 I-lower_bound
mm3 170 173 1024 1027 I-lower_bound
) 173 174 1027 1028 O
, 174 175 1028 1029 O
WBC 176 179 1030 1033 B-clinical_variable
( 180 181 1034 1035 O
> 181 182 1035 1036 O
3,000 183 188 1037 1042 B-lower_bound
/ 188 189 1042 1043 I-lower_bound
mm3 189 192 1043 1046 I-lower_bound
) 192 193 1046 1047 O
or 194 196 1048 1050 O
absence 197 204 1051 1058 O
of 205 207 1059 1061 O
opportunistic 208 221 1062 1075 B-chronic_disease
infections 222 232 1076 1086 I-chronic_disease
. 232 233 1086 1087 O
( 234 235 1088 1089 O
Turnstile 235 244 1089 1098 O
II 245 247 1099 1101 O
- 248 249 1102 1103 O
Chemotherapy 250 262 1104 1116 B-treatment
/ 262 263 1116 1117 O
Cell 263 267 1117 1121 B-treatment
Infusion 268 276 1122 1130 I-treatment
Exclusion 277 286 1131 1140 O
Criteria 287 295 1141 1149 O
) 295 296 1149 1150 O

Clinical 0 8 1151 1159 O
performance 9 20 1160 1171 O
status 21 27 1172 1178 O
of 28 30 1179 1181 O
ECOG 31 35 1182 1186 B-clinical_variable
0 36 37 1187 1188 B-lower_bound
- 38 39 1189 1190 O
2 40 41 1191 1192 B-upper_bound
at 42 44 1193 1195 O
the 45 48 1196 1199 O
time 49 53 1200 1204 O
of 54 56 1205 1207 O
chemotherapy 57 69 1208 1220 B-treatment
infusion 70 78 1221 1229 I-treatment
. 78 79 1229 1230 O
( 80 81 1231 1232 O
Turnstile 81 90 1232 1241 B-treatment
II 91 93 1242 1244 I-treatment
- 94 95 1245 1246 I-treatment
Chemotherapy 96 108 1247 1259 I-treatment
/ 108 109 1259 1260 I-treatment
Cell 109 113 1260 1264 I-treatment
Infusion 114 122 1265 1273 I-treatment
- 122 123 1273 1274 O
Inclusion 123 132 1274 1283 O
Criteria 133 141 1284 1292 O
) 141 142 1292 1293 O

Clinical 0 8 1294 1302 B-clinical_variable
performance 9 20 1303 1314 I-clinical_variable
status 21 27 1315 1321 I-clinical_variable
of 28 30 1322 1324 O
ECOG 31 35 1325 1329 B-clinical_variable
0 36 37 1330 1331 B-lower_bound
- 37 38 1331 1332 O
2 38 39 1332 1333 B-upper_bound
. 39 40 1333 1334 O
( 41 42 1335 1336 O
Turnstile 42 51 1336 1345 O
I 52 53 1346 1347 O
) 53 54 1347 1348 O

Has 0 3 1349 1352 O
had 4 7 1353 1356 O
prior 8 13 1357 1362 B-treatment
B 14 15 1363 1364 I-treatment
- 15 16 1364 1365 I-treatment
RAF 16 19 1365 1368 I-treatment
or 20 22 1369 1371 O
MEK 23 26 1372 1375 B-treatment
targeted 27 35 1376 1384 I-treatment
therapy 36 43 1385 1392 I-treatment
within 44 50 1393 1399 O
7 51 52 1400 1401 B-upper_bound
days 53 57 1402 1406 I-upper_bound
prior 58 63 1407 1412 I-upper_bound
to 64 66 1413 1415 O
the 67 70 1416 1419 O
start 71 76 1420 1425 O
of 77 79 1426 1428 O
the 80 83 1429 1432 O
lymphodepletion 84 99 1433 1448 B-treatment
regimen 100 107 1449 1456 I-treatment
( 108 109 1457 1458 O
Cohort 109 115 1458 1464 O
A 116 117 1465 1466 O
and 118 121 1467 1470 O
Cohort 122 128 1471 1477 O
B 129 130 1478 1479 O
) 130 131 1479 1480 O

Has 0 3 1481 1484 O
had 4 7 1485 1488 O
prior 8 13 1489 1494 B-treatment
systemic 14 22 1495 1503 I-treatment
cancer 23 29 1504 1510 I-treatment
cytotoxic 30 39 1511 1520 I-treatment
chemotherapy 40 52 1521 1533 I-treatment
within 53 59 1534 1540 O
the 60 63 1541 1544 O
past 64 68 1545 1549 B-upper_bound
four 69 73 1550 1554 I-upper_bound
weeks 74 79 1555 1560 I-upper_bound
at 80 82 1561 1563 O
the 83 86 1564 1567 O
time 87 91 1568 1572 O
of 92 94 1573 1575 O
the 95 98 1576 1579 O
start 99 104 1580 1585 O
of 105 107 1586 1588 O
the 108 111 1589 1592 O
lymphodepletion 112 127 1593 1608 B-treatment
regimen 128 135 1609 1616 O

Hemoglobin 0 10 1617 1627 B-clinical_variable
greater 11 18 1628 1635 O
than 19 23 1636 1640 O
or 24 26 1641 1643 O
equal 27 32 1644 1649 O
to 33 35 1650 1652 O
8.0 36 39 1653 1656 B-lower_bound
g 40 41 1657 1658 I-lower_bound
/ 41 42 1658 1659 I-lower_bound
dl 42 44 1659 1661 I-lower_bound
. 44 45 1661 1662 O
( 46 47 1663 1664 O
Turnstile 47 56 1664 1673 O
II 57 59 1674 1676 O
- 60 61 1677 1678 O
Chemotherapy 62 74 1679 1691 B-treatment
/ 74 75 1691 1692 O
Cell 75 79 1692 1696 B-treatment
Infusion 80 88 1697 1705 I-treatment
) 88 89 1705 1706 O

Is 0 2 1707 1709 O
not 3 6 1710 1713 O
receiving 7 16 1714 1723 O
B 17 18 1724 1725 B-treatment
- 18 19 1725 1726 I-treatment
RAF 19 22 1726 1729 I-treatment
treatment 23 32 1730 1739 I-treatment
( 33 34 1740 1741 O
Cohort 34 40 1741 1747 O
C 41 42 1748 1749 O
) 42 43 1749 1750 O
( 44 45 1751 1752 O
Turnstile 45 54 1752 1761 O
II 55 57 1762 1764 O
- 58 59 1765 1766 O
Chemotherapy 60 72 1767 1779 B-treatment
/ 72 73 1779 1780 O
Cell 73 77 1780 1784 B-treatment
Infusion 78 86 1785 1793 I-treatment
Exclusion 87 96 1794 1803 O
Criteria 97 105 1804 1812 O
) 105 106 1812 1813 O

MRI 0 3 1814 1817 B-treatment
/ 3 4 1817 1818 I-treatment
CT 4 6 1818 1820 I-treatment
of 7 9 1821 1823 I-treatment
the 10 13 1824 1827 I-treatment
brain 14 19 1828 1833 I-treatment
within 20 26 1834 1840 O
42 27 29 1841 1843 B-upper_bound
days 30 34 1844 1848 I-upper_bound
of 35 37 1849 1851 O
lymphodepletion 38 53 1852 1867 B-chronic_disease
. 53 54 1867 1868 O
CT 55 57 1869 1871 B-treatment
scan 58 62 1872 1876 I-treatment
of 63 65 1877 1879 I-treatment
chest 66 71 1880 1885 I-treatment
/ 71 72 1885 1886 I-treatment
abdomen 72 79 1886 1893 I-treatment
/ 79 80 1893 1894 I-treatment
pelvis 80 86 1894 1900 I-treatment
or 87 89 1901 1903 O
PET 90 93 1904 1907 B-treatment
/ 93 94 1907 1908 I-treatment
CT 94 96 1908 1910 I-treatment
within 97 103 1911 1917 O
30 104 106 1918 1920 B-upper_bound
days 107 111 1921 1925 I-upper_bound
of 112 114 1926 1928 O
lymphodepletion 115 130 1929 1944 O

Many 0 4 1945 1949 O
patients 5 13 1950 1958 O
present 14 21 1959 1966 O
with 22 26 1967 1971 O
concomitant 27 38 1972 1983 O
systemic 39 47 1984 1992 B-chronic_disease
disease 48 55 1993 2000 I-chronic_disease
outside 56 63 2001 2008 O
of 64 66 2009 2011 O
the 67 70 2012 2015 O
central 71 78 2016 2023 O
nervous 79 86 2024 2031 O
system 87 93 2032 2038 O

Patients 0 8 2039 2047 O
may 9 12 2048 2051 O
have 13 17 2052 2056 O
brain 18 23 2057 2062 B-chronic_disease
lesions 24 31 2063 2070 I-chronic_disease
which 32 37 2071 2076 O
measure 38 45 2077 2084 O
< 46 47 2085 2086 O
/= 47 49 2086 2088 O
1 50 51 2089 2090 B-upper_bound
cm 51 53 2090 2092 I-upper_bound
each 54 58 2093 2097 O
. 58 59 2097 2098 O
Lesions 60 67 2099 2106 O
that 68 72 2107 2111 O
are 73 76 2112 2115 O
> 77 78 2116 2117 O
1 78 79 2117 2118 B-lower_bound
cm 80 82 2119 2121 I-lower_bound
that 83 87 2122 2126 O
have 88 92 2127 2131 O
been 93 97 2132 2136 O
treated 98 105 2137 2144 O
with 106 110 2145 2149 O
SRS 111 114 2150 2153 B-treatment
and 115 118 2154 2157 O
in 119 121 2158 2160 O
the 122 125 2161 2164 O
opinion 126 133 2165 2172 O
of 134 136 2173 2175 O
the 137 140 2176 2179 O
PI 141 143 2180 2182 O
or 144 146 2183 2185 O
his 147 150 2186 2189 O
designee 151 159 2190 2198 O
no 160 162 2199 2201 O
longer 163 169 2202 2208 O
represents 170 180 2209 2219 O
active 181 187 2220 2226 O
disease 188 195 2227 2234 O
will 196 200 2235 2239 O
also 201 205 2240 2244 O
be 206 208 2245 2247 O
allowed 209 216 2248 2255 O
. 216 217 2255 2256 O
( 218 219 2257 2258 O
Turnstile 219 228 2258 2267 O
II 229 231 2268 2270 O
- 232 233 2271 2272 O
Chemotherapy 234 246 2273 2285 B-treatment
/ 246 247 2285 2286 O
Cell 247 251 2286 2290 B-treatment
Infusion- 252 261 2291 2300 I-treatment
Inclusion 262 271 2301 2310 O
Criteria 272 280 2311 2319 O
) 280 281 2319 2320 O

Patients 0 8 2321 2329 O
must 9 13 2330 2334 O
be 14 16 2335 2337 O
HLA 17 20 2338 2341 O
- 20 21 2341 2342 O
A2 21 23 2342 2344 O
for 24 27 2345 2348 O
cohort 28 34 2349 2355 O
A. 35 37 2356 2358 O
( 38 39 2359 2360 O
Turnstile 39 48 2360 2369 B-treatment
II 49 51 2370 2372 I-treatment
- 51 52 2372 2373 I-treatment
Chemotherapy 52 64 2373 2385 I-treatment
/ 64 65 2385 2386 O
Cell 65 69 2386 2390 B-treatment
Infusion 70 78 2391 2399 I-treatment
- 78 79 2399 2400 O
Inclusion 79 88 2400 2409 O
Criteria 89 97 2410 2418 O
) 97 98 2418 2419 O

Patients 0 8 2420 2428 O
must 9 13 2429 2433 O
be 14 16 2434 2436 O
able 17 21 2437 2441 O
to 22 24 2442 2444 O
undergo 25 32 2445 2452 O
contrast 33 41 2453 2461 B-treatment
- 41 42 2461 2462 I-treatment
enhanced 42 50 2462 2470 I-treatment
MRI 51 54 2471 2474 I-treatment
. 54 55 2474 2475 O
( 56 57 2476 2477 O
Cohort 57 63 2477 2483 O
D 64 65 2484 2485 O
) 65 66 2485 2486 O

Patients 0 8 2487 2495 O
must 9 13 2496 2500 O
be 14 16 2501 2503 O
receiving 17 26 2504 2513 O
a 27 28 2514 2515 O
B 29 30 2516 2517 B-treatment
- 30 31 2517 2518 I-treatment
RAF 31 34 2518 2521 I-treatment
inhibitor 35 44 2522 2531 I-treatment
and 45 48 2532 2535 O
failed 49 55 2536 2542 O
to 56 58 2543 2545 O
achieve 59 66 2546 2553 O
PR 67 69 2554 2556 O
or 70 72 2557 2559 O
CR 73 75 2560 2562 O
or 76 78 2563 2565 O
have 79 83 2566 2570 O
progressive 84 95 2571 2582 O
disease 96 103 2583 2590 O
in 104 106 2591 2593 O
response 107 115 2594 2602 O
to 116 118 2603 2605 O
B 119 120 2606 2607 B-treatment
- 120 121 2607 2608 I-treatment
RAF 121 124 2608 2611 I-treatment
treatment 125 134 2612 2621 I-treatment
( 135 136 2622 2623 O
Cohort 136 142 2623 2629 O
C 143 144 2630 2631 O
) 144 145 2631 2632 O

Patients 0 8 2633 2641 O
must 9 13 2642 2646 O
have 14 18 2647 2651 O
ECOG 19 23 2652 2656 B-clinical_variable
performance 24 35 2657 2668 I-clinical_variable
status 36 42 2669 2675 I-clinical_variable
0 43 44 2676 2677 B-lower_bound
, 44 45 2677 2678 O
1 46 47 2679 2680 O
or 48 50 2681 2683 O
2 51 52 2684 2685 B-upper_bound
and/or 53 59 2686 2692 O
KPS 60 63 2693 2696 B-clinical_variable
> 64 65 2697 2698 O
50 66 68 2699 2701 B-lower_bound

Patients 0 8 2702 2710 O
must 9 13 2711 2715 O
have 14 18 2716 2720 O
a 19 20 2721 2722 O
documented 21 31 2723 2733 O
negative 32 40 2734 2742 B-pregnancy
pregnancy 41 50 2743 2752 I-pregnancy
test 51 55 2753 2757 O
( 56 57 2758 2759 O
urine 57 62 2759 2764 O
or 63 65 2765 2767 O
serum 66 71 2768 2773 O
) 71 72 2773 2774 O
for 73 76 2775 2778 O
women 77 82 2779 2784 B-gender
who 83 86 2785 2788 O
have 87 91 2789 2793 O
menstruation 92 104 2794 2806 O
in 105 107 2807 2809 O
the 108 111 2810 2813 O
past 112 116 2814 2818 B-upper_bound
12 117 119 2819 2821 I-upper_bound
months 120 126 2822 2828 I-upper_bound
and 127 130 2829 2832 O
without 131 138 2833 2840 O
sterilization 139 152 2841 2854 B-treatment
surgery 153 160 2855 2862 I-treatment

Patients 0 8 2863 2871 O
must 9 13 2872 2876 O
have 14 18 2877 2881 O
measurable 19 29 2882 2892 O
metastatic 30 40 2893 2903 B-cancer
melanoma 41 49 2904 2912 I-cancer
. 49 50 2912 2913 O
( 51 52 2914 2915 O
Turnstile 52 61 2915 2924 O
II 62 64 2925 2927 O
- 65 66 2928 2929 O
Chemotherapy 67 79 2930 2942 B-treatment
/ 79 80 2942 2943 O
Cell 80 84 2943 2947 B-treatment
Infusion 85 93 2948 2956 I-treatment
-Inclusion 94 104 2957 2967 O
Criteria 105 113 2968 2976 O
) 113 114 2976 2977 O

Patients 0 8 2978 2986 O
must 9 13 2987 2991 O
have 14 18 2992 2996 O
metastatic 19 29 2997 3007 B-cancer
melanoma 30 38 3008 3016 I-cancer
, 38 39 3016 3017 O
uveal 40 45 3018 3023 B-cancer
melanoma 46 54 3024 3032 I-cancer
or 55 57 3033 3035 O
stage 58 63 3036 3041 B-cancer
III 64 67 3042 3045 I-cancer
in 68 70 3046 3048 I-cancer
- 70 71 3048 3049 I-cancer
transit 71 78 3049 3056 I-cancer
or 79 81 3057 3059 O
regional 82 90 3060 3068 B-chronic_disease
nodal 91 96 3069 3074 I-chronic_disease
disease 97 104 3075 3082 I-chronic_disease
. 104 105 3082 3083 O
( 106 107 3084 3085 O
Turnstile 107 116 3085 3094 O
I 117 118 3095 3096 O
) 118 119 3096 3097 O

Patients 0 8 3098 3106 O
must 9 13 3107 3111 O
receive 14 21 3112 3119 O
an 22 24 3120 3122 O
MRI 25 28 3123 3126 B-treatment
/ 28 29 3126 3127 I-treatment
CT 29 31 3127 3129 I-treatment
of 32 34 3130 3132 I-treatment
the 35 38 3133 3136 I-treatment
brain 39 44 3137 3142 I-treatment
or 45 47 3143 3145 O
PET 48 51 3146 3149 B-treatment
/ 51 52 3149 3150 I-treatment
CT 52 54 3150 3152 I-treatment
within 55 61 3153 3159 O
6 62 63 3160 3161 B-upper_bound
months 64 70 3162 3168 I-upper_bound
of 71 73 3169 3171 O
consenting 74 84 3172 3182 O
. 84 85 3182 3183 O
If 86 88 3184 3186 O
new 89 92 3187 3190 O
lesions 93 100 3191 3198 O
are 101 104 3199 3202 O
present 105 112 3203 3210 O
, 112 113 3210 3211 O
PI 114 116 3212 3214 O
or 117 119 3215 3217 O
his 120 123 3218 3221 O
designee 124 132 3222 3230 O
should 133 139 3231 3237 O
make 140 144 3238 3242 O
final 145 150 3243 3248 O
determination 151 164 3249 3262 O
regarding 165 174 3263 3272 O
enrollment 175 185 3273 3283 O
. 185 186 3283 3284 O
( 187 188 3285 3286 O
Turnstile 188 197 3286 3295 O
I 198 199 3296 3297 O
) 199 200 3297 3298 O

Patients 0 8 3299 3307 O
of 9 11 3308 3310 O
both 12 16 3311 3315 O
genders 17 24 3316 3323 O
must 25 29 3324 3328 O
practice 30 38 3329 3337 B-contraception_consent
birth 39 44 3338 3343 I-contraception_consent
control 45 52 3344 3351 I-contraception_consent
for 53 56 3352 3355 O
four 57 61 3356 3360 B-upper_bound
months 62 68 3361 3367 I-upper_bound
after 69 74 3368 3373 I-upper_bound
receiving 75 84 3374 3383 O
the 85 88 3384 3387 O
preparative 89 100 3388 3399 O
regimen 101 108 3400 3407 O
. 108 109 3407 3408 O
( 110 111 3409 3410 O
Turnstile 111 120 3410 3419 O
II 121 123 3420 3422 O
- 124 125 3423 3424 O
Chemotherapy 126 138 3425 3437 B-treatment
/ 138 139 3437 3438 O
Cell 139 143 3438 3442 B-treatment
Infusion- 144 153 3443 3452 I-treatment
Inclusion 154 163 3453 3462 O
Criteria 164 172 3463 3471 O
) 172 173 3471 3472 O

Patients 0 8 3473 3481 O
previously 9 19 3482 3492 O
treated 20 27 3493 3500 O
with 28 32 3501 3505 O
immunotherapy 33 46 3506 3519 B-treatment
, 46 47 3519 3520 O
targeted 48 56 3521 3529 B-treatment
therapy 57 64 3530 3537 I-treatment
, 64 65 3537 3538 O
or 66 68 3539 3541 O
no 69 71 3542 3544 O
therapy 72 79 3545 3552 O
will 80 84 3553 3557 O
be 85 87 3558 3560 O
eligible 88 96 3561 3569 O
. 96 97 3569 3570 O
Patients 98 106 3571 3579 O
receiving 107 116 3580 3589 O
cytotoxic 117 126 3590 3599 B-treatment
agents 127 133 3600 3606 I-treatment
will 134 138 3607 3611 O
be 139 141 3612 3614 O
evaluated 142 151 3615 3624 O
by 152 154 3625 3627 O
the 155 158 3628 3631 O
PI 159 161 3632 3634 O
or 162 164 3635 3637 O
his 165 168 3638 3641 O
designee 169 177 3642 3650 O
as 178 180 3651 3653 O
to 181 183 3654 3656 O
suitable 184 192 3657 3665 O
eligibility 193 204 3666 3677 O
. 204 205 3677 3678 O
( 206 207 3679 3680 O
Turnstile 207 216 3680 3689 O
I 217 218 3690 3691 O
) 218 219 3691 3692 O

Patients 0 8 3693 3701 O
randomized 9 19 3702 3712 O
to 20 22 3713 3715 O
receive 23 30 3716 3723 O
dendritic 31 40 3724 3733 O
cells 41 46 3734 3739 O
may 47 50 3740 3743 O
have 51 55 3744 3748 O
an 56 58 3749 3751 O
MRI 59 62 3752 3755 B-treatment
of 63 65 3756 3758 O
the 66 69 3759 3762 O
brain 70 75 3763 3768 O
within 76 82 3769 3775 O
30 83 85 3776 3778 B-upper_bound
days 86 90 3779 3783 I-upper_bound
of 91 93 3784 3786 O
lymphodepletion 94 109 3787 3802 B-treatment
. 109 110 3802 3803 O
( 111 112 3804 3805 O
Turnstile 112 121 3805 3814 O
II 122 124 3815 3817 O
- 124 125 3817 3818 O
Chemotherapy 125 137 3818 3830 B-treatment
/ 137 138 3830 3831 O
Cell 138 142 3831 3835 B-treatment
Infusion 143 151 3836 3844 I-treatment
- 151 152 3844 3845 O
Inclusion 152 161 3845 3854 O
Criteria 162 170 3855 3863 O
) 170 171 3863 3864 O

Patients 0 8 3865 3873 O
who 9 12 3874 3877 O
are 13 16 3878 3881 O
currently 17 26 3882 3891 O
being 27 32 3892 3897 O
treated 33 40 3898 3905 O
with 41 45 3906 3910 O
IT 46 48 3911 3913 B-treatment
IL-2 49 53 3914 3918 I-treatment
for 54 57 3919 3922 O
LMD 58 61 3923 3926 B-cancer
are 62 65 3927 3930 O
eligible 66 74 3931 3939 O
. 74 75 3939 3940 O
No 76 78 3941 3943 O
wash 79 83 3944 3948 O
out 84 87 3949 3952 O
period 88 94 3953 3959 O
is 95 97 3960 3962 O
required 98 106 3963 3971 O

Patients 0 8 3972 3980 O
who 9 12 3981 3984 O
have 13 17 3985 3989 O
been 18 22 3990 3994 O
previously 23 33 3995 4005 O
treated 34 41 4006 4013 O
with 42 46 4014 4018 O
other 47 52 4019 4024 O
IT 53 55 4025 4027 O
therapies 56 65 4028 4037 B-treatment
are 66 69 4038 4041 O
eligible 70 78 4042 4050 O
, 78 79 4050 4051 O
as 80 82 4052 4054 O
long 83 87 4055 4059 O
as 88 90 4060 4062 O
there 91 96 4063 4068 O
is 97 99 4069 4071 O
at 100 102 4072 4074 O
least 103 108 4075 4080 O
a 109 110 4081 4082 O
2 111 112 4083 4084 B-lower_bound
week 113 117 4085 4089 I-lower_bound
wash 118 122 4090 4094 O
out 123 126 4095 4098 O
period 127 133 4099 4105 O

Patients 0 8 4106 4114 O
who 9 12 4115 4118 O
have 13 17 4119 4123 O
previously 18 28 4124 4134 O
received 29 37 4135 4143 O
therapy 38 45 4144 4151 B-treatment
with 46 50 4152 4156 O
systemic 51 59 4157 4165 B-treatment
TIL 60 63 4166 4169 I-treatment
therapy 64 71 4170 4177 I-treatment
are 72 75 4178 4181 O
eligible 76 84 4182 4190 O

Patients 0 8 4191 4199 O
with 9 13 4200 4204 O
MRI 14 17 4205 4208 B-treatment
evidence 18 26 4209 4217 O
of 27 29 4218 4220 O
LMD 30 33 4221 4224 B-cancer
, 33 34 4224 4225 O
with 35 39 4226 4230 O
or 40 42 4231 4233 O
without 43 50 4234 4241 O
evidence 51 59 4242 4250 O
of 60 62 4251 4253 O
malignant 63 72 4254 4263 B-cancer
cells 73 78 4264 4269 I-cancer
in 79 81 4270 4272 I-cancer
CSF 82 85 4273 4276 I-cancer
( 86 87 4277 4278 O
positive 87 95 4278 4286 O
cytology 96 104 4287 4295 O
) 104 105 4295 4296 O

Patients 0 8 4297 4305 O
with 9 13 4306 4310 O
VP 14 16 4311 4313 B-treatment
shunts 17 23 4314 4320 I-treatment
must 24 28 4321 4325 O
have 29 33 4326 4330 O
VP 34 36 4331 4333 O
shunts 37 43 4334 4340 O
with 44 48 4341 4345 O
on 49 51 4346 4348 O
/ 51 52 4348 4349 O
off 52 55 4349 4352 O
valves 56 62 4353 4359 O
and 63 66 4360 4363 O
must 67 71 4364 4368 O
be 72 74 4369 4371 O
expected 75 83 4372 4380 O
to 84 86 4381 4383 O
tolerate 87 95 4384 4392 O
VP 96 98 4393 4395 B-treatment
shunt 99 104 4396 4401 I-treatment
valve 105 110 4402 4407 I-treatment
off 111 114 4408 4411 O
for 115 118 4412 4415 O
more 119 123 4416 4420 O
than 124 128 4421 4425 O
6 129 130 4426 4427 B-upper_bound
hours 131 136 4428 4433 I-upper_bound
Patients 137 145 4434 4442 O
who 146 149 4443 4446 O
have 150 154 4447 4451 O
received 155 163 4452 4460 O
CNS 164 167 4461 4464 B-treatment
irradiation 168 179 4465 4476 I-treatment
, 179 180 4476 4477 O
including 181 190 4478 4487 O
whole 191 196 4488 4493 B-treatment
brain 197 202 4494 4499 I-treatment
radiation 203 212 4500 4509 I-treatment
or 213 215 4510 4512 O
stereotactic 216 228 4513 4525 B-treatment
radiosurgery 229 241 4526 4538 I-treatment
, 241 242 4538 4539 O
are 243 246 4540 4543 O
eligible 247 255 4544 4552 O
, 255 256 4552 4553 O
if 257 259 4554 4556 O
they 260 264 4557 4561 O
are 265 268 4562 4565 O
at 269 271 4566 4568 O
least 272 277 4569 4574 O
1 278 279 4575 4576 B-lower_bound
weeks 280 285 4577 4582 I-lower_bound
post 286 290 4583 4587 O
CNS 291 294 4588 4591 B-treatment
- 294 295 4591 4592 I-treatment
irradiation 295 306 4592 4603 I-treatment
( 307 308 4604 4605 O
Cohort 308 314 4605 4611 O
D)Patients 315 325 4612 4622 O
who 326 329 4623 4626 O
are 330 333 4627 4630 O
currently 334 343 4631 4640 O
being 344 349 4641 4646 O
treated 350 357 4647 4654 O
with 358 362 4655 4659 O
IT 363 365 4660 4662 B-clinical_variable
IL-2 366 370 4663 4667 I-clinical_variable
for 371 374 4668 4671 O
LMD 375 378 4672 4675 B-cancer
are 379 382 4676 4679 O
eligible 383 391 4680 4688 O
. 391 392 4688 4689 O
No 393 395 4690 4692 O
wash 396 400 4693 4697 O
out 401 404 4698 4701 O
period 405 411 4702 4708 O
is 412 414 4709 4711 O
required 415 423 4712 4720 O
. 423 424 4720 4721 O
( 425 426 4722 4723 O
Cohort 426 432 4723 4729 O
D 433 434 4730 4731 O
) 434 435 4731 4732 O

Patients 0 8 4733 4741 O
with 9 13 4742 4746 O
concomitant 14 25 4747 4758 O
systemic 26 34 4759 4767 B-chronic_disease
disease 35 42 4768 4775 I-chronic_disease
under 43 48 4776 4781 O
control 49 56 4782 4789 O
with 57 61 4790 4794 O
current 62 69 4795 4802 O
or 70 72 4803 4805 O
prior 73 78 4806 4811 B-treatment
systemic 79 87 4812 4820 I-treatment
treatment 88 97 4821 4830 I-treatment
, 97 98 4830 4831 O
as 99 101 4832 4834 O
per 102 105 4835 4838 O
primary 106 113 4839 4846 O
treating 114 122 4847 4855 O
physician 123 132 4856 4865 O

Patients 0 8 4866 4874 O
with 9 13 4875 4879 O
evidence 14 22 4880 4888 O
of 23 25 4889 4891 O
malignant 26 35 4892 4901 B-cancer
cells 36 41 4902 4907 I-cancer
in 42 44 4908 4910 O
the 45 48 4911 4914 O
CSF 49 52 4915 4918 O
( 53 54 4919 4920 O
positive 54 62 4920 4928 O
cytology 63 71 4929 4937 O
) 71 72 4937 4938 O
, 72 73 4938 4939 O
with 74 78 4940 4944 O
or 79 81 4945 4947 O
without 82 89 4948 4955 O
MRI 90 93 4956 4959 B-treatment
evidence 94 102 4960 4968 O
of 103 105 4969 4971 O
LMD 106 109 4972 4975 O

Patients 0 8 4976 4984 O
with 9 13 4985 4989 O
rapidly 14 21 4990 4997 O
advancing 22 31 4998 5007 O
parenchymal 32 43 5008 5019 O
brain 44 49 5020 5025 B-cancer
metastases 50 60 5026 5036 I-cancer
( 61 62 5037 5038 O
Cohort 62 68 5038 5044 O
D 69 70 5045 5046 O
) 70 71 5046 5047 O

Patients 0 8 5048 5056 O
with 9 13 5057 5061 O
rapidly 14 21 5062 5069 O
advancing 22 31 5070 5079 O
systemic 32 40 5080 5088 B-chronic_disease
disease 41 48 5089 5096 I-chronic_disease
, 48 49 5096 5097 O
especially 50 60 5098 5108 O
those 61 66 5109 5114 O
without 67 74 5115 5122 O
good 75 79 5123 5127 O
options 80 87 5128 5135 O
of 88 90 5136 5138 O
systemic 91 99 5139 5147 B-treatment
treatment 100 109 5148 5157 I-treatment
for 110 113 5158 5161 O
their 114 119 5162 5167 O
disease 120 127 5168 5175 O
outside 128 135 5176 5183 O
the 136 139 5184 5187 O
CNS 140 143 5188 5191 O
. 143 144 5191 5192 O
( 145 146 5193 5194 O
Cohort 146 152 5194 5200 O
D 153 154 5201 5202 O
) 154 155 5202 5203 O

Patients 0 8 5204 5212 O
with 9 13 5213 5217 O
surgically 14 24 5218 5228 O
- 24 25 5228 5229 O
proven 25 31 5229 5235 O
LMD 32 35 5236 5239 B-cancer
( 36 37 5240 5241 O
leptomeningeal 37 51 5241 5255 O
involvement 52 63 5256 5267 O
on 64 66 5268 5270 O
pathology 67 76 5271 5280 O
review 77 83 5281 5287 O
) 83 84 5287 5288 O
+ 85 86 5289 5290 O
/- 86 88 5290 5292 O
MRI 89 92 5293 5296 B-treatment
or 93 95 5297 5299 O
CSF 96 99 5300 5303 O
evidence 100 108 5304 5312 O
by 109 111 5313 5315 O
MRI 112 115 5316 5319 O
or 116 118 5320 5322 O
CSF 119 122 5323 5326 O
cytology 123 131 5327 5335 O
( 132 133 5336 5337 O
Cohort 133 139 5337 5343 O
D 140 141 5344 5345 O
) 141 142 5345 5346 O

Patients 0 8 5347 5355 O
without 9 16 5356 5363 O
any 17 20 5364 5367 O
evidence 21 29 5368 5376 O
of 30 32 5377 5379 O
systemic 33 41 5380 5388 B-chronic_disease
disease 42 49 5389 5396 I-chronic_disease
, 49 50 5396 5397 O
either 51 57 5398 5404 O
receiving 58 67 5405 5414 O
systemic 68 76 5415 5423 B-treatment
treatment 77 86 5424 5433 I-treatment
or 87 89 5434 5436 O
on 90 92 5437 5439 O
active 93 99 5440 5446 O
observation 100 111 5447 5458 O
( 112 113 5459 5460 O
Cohort 113 119 5460 5466 O
D 120 121 5467 5468 O
) 121 122 5468 5469 O

Platelet 0 8 5470 5478 B-clinical_variable
count 9 14 5479 5484 I-clinical_variable
greater 15 22 5485 5492 O
than 23 27 5493 5497 O
or 28 30 5498 5500 O
equal 31 36 5501 5506 O
to 37 39 5507 5509 O
75,000 40 46 5510 5516 B-lower_bound
/ 46 47 5516 5517 I-lower_bound
mm3 47 50 5517 5520 I-lower_bound
. 50 51 5520 5521 O
( 52 53 5522 5523 O
Turnstile 53 62 5523 5532 O
II 63 65 5533 5535 O
- 66 67 5536 5537 O
Chemotherapy 68 80 5538 5550 B-treatment
/ 80 81 5550 5551 O
Cell 81 85 5551 5555 B-treatment
Infusion- 86 95 5556 5565 I-treatment
Inclusion 96 105 5566 5575 O
Criteria 106 114 5576 5584 O
) 114 115 5584 5585 O

Pregnancy 0 9 5586 5595 B-pregnancy
testing 10 17 5596 5603 O
will 18 22 5604 5608 O
be 23 25 5609 5611 O
performed 26 35 5612 5621 O
within 36 42 5622 5628 O
7 43 44 5629 5630 B-upper_bound
days 45 49 5631 5635 I-upper_bound
prior 50 55 5636 5641 I-upper_bound
to 56 58 5642 5644 O
treatment 59 68 5645 5654 B-treatment
. 68 69 5654 5655 O
( 70 71 5656 5657 O
Turnstile 71 80 5657 5666 O
II 81 83 5667 5669 O
) 83 84 5669 5670 O

Pregnant 0 8 5671 5679 B-pregnancy
patients 9 17 5680 5688 O
( 18 19 5689 5690 O
Cohort 19 25 5690 5696 O
D 26 27 5697 5698 O
) 27 28 5698 5699 O

Presence 0 8 5700 5708 O
of 9 11 5709 5711 O
a 12 13 5712 5713 O
significant 14 25 5714 5725 O
psychiatric 26 37 5726 5737 B-chronic_disease
disease 38 45 5738 5745 I-chronic_disease
, 45 46 5745 5746 O
which 47 52 5747 5752 O
in 53 55 5753 5755 O
the 56 59 5756 5759 O
opinion 60 67 5760 5767 O
of 68 70 5768 5770 O
the 71 74 5771 5774 O
principal 75 84 5775 5784 O
investigator 85 97 5785 5797 O
or 98 100 5798 5800 O
his 101 104 5801 5804 O
designee 105 113 5805 5813 O
, 113 114 5813 5814 O
would 115 120 5815 5820 O
prevent 121 128 5821 5828 O
adequate 129 137 5829 5837 O
informed 138 146 5838 5846 O
consent 147 154 5847 5854 O
or 155 157 5855 5857 O
render 158 164 5858 5864 O
immunotherapy 165 178 5865 5878 B-treatment
unsafe 179 185 5879 5885 O
or 186 188 5886 5888 O
contraindicated 189 204 5889 5904 O
. 204 205 5904 5905 O
( 206 207 5906 5907 O
Turnstile 207 216 5907 5916 O
II 217 219 5917 5919 O
- 220 221 5920 5921 O
Chemotherapy 222 234 5922 5934 B-treatment
/ 234 235 5934 5935 O
Cell 235 239 5935 5939 B-treatment
Infusion 240 248 5940 5948 I-treatment
Exclusion 249 258 5949 5958 O
Criteria 259 267 5959 5967 O
) 267 268 5967 5968 O

Pulmonary 0 9 5969 5978 B-clinical_variable
function 10 18 5979 5987 I-clinical_variable
tests 19 24 5988 5993 I-clinical_variable
( 25 26 5994 5995 O
FEV1>65 26 33 5995 6002 B-clinical_variable
% 33 34 6002 6003 I-lower_bound
or 35 37 6004 6006 O
FVC>65%of 38 47 6007 6016 B-clinical_variable
predicted 48 57 6017 6026 O
) 57 58 6026 6027 O
within 59 65 6028 6034 O
6 66 67 6035 6036 B-upper_bound
months 68 74 6037 6043 I-upper_bound
of 75 77 6044 6046 O
lymphodepletion 78 93 6047 6062 B-treatment
. 93 94 6062 6063 O
( 95 96 6064 6065 O
Turnstile 96 105 6065 6074 O
II 106 108 6075 6077 O
- 109 110 6078 6079 O
Chemotherapy 111 123 6080 6092 B-treatment
/ 123 124 6092 6093 O
Cell 124 128 6093 6097 B-treatment
Infusion 129 137 6098 6106 I-treatment
- 138 139 6107 6108 O
Inclusion 140 149 6109 6118 O
Criteria 150 158 6119 6127 O
) 158 159 6127 6128 O

Require 0 7 6129 6136 O
steroid 8 15 6137 6144 B-treatment
therapy 16 23 6145 6152 I-treatment
or 24 26 6153 6155 I-treatment
steroid 27 34 6156 6163 I-treatment
- 34 35 6163 6164 I-treatment
containing 35 45 6164 6174 I-treatment
compounds 46 55 6175 6184 I-treatment
, 55 56 6184 6185 O
or 57 59 6186 6188 O
have 60 64 6189 6193 O
used 65 69 6194 6198 O
systemic 70 78 6199 6207 B-treatment
steroids 79 87 6208 6216 I-treatment
in 88 90 6217 6219 O
the 91 94 6220 6223 O
past 95 99 6224 6228 B-upper_bound
30 100 102 6229 6231 I-upper_bound
days 103 107 6232 6236 I-upper_bound
, 107 108 6236 6237 O
or 109 111 6238 6240 O
have 112 116 6241 6245 O
used 117 121 6246 6250 O
topical 122 129 6251 6258 B-treatment
or 130 132 6259 6261 I-treatment
inhalational 133 145 6262 6274 I-treatment
steroids 146 154 6275 6283 I-treatment
in 155 157 6284 6286 O
the 158 161 6287 6290 O
past 162 166 6291 6295 B-upper_bound
2 167 168 6296 6297 I-upper_bound
weeks 169 174 6298 6303 I-upper_bound
prior 175 180 6304 6309 B-treatment
to 181 183 6310 6312 I-treatment
lymphodepletion 184 199 6313 6328 I-treatment
. 199 200 6328 6329 O
Exception 201 210 6330 6339 O
: 210 211 6339 6340 O
Patients 212 220 6341 6349 O
on 221 223 6350 6352 O
physiologic 224 235 6353 6364 O
dose 236 240 6365 6369 O
of 241 243 6370 6372 O
steroid 244 251 6373 6380 O
( 252 253 6381 6382 O
Turnstile 253 262 6382 6391 O
II 263 265 6392 6394 O
- 266 267 6395 6396 O
Chemotherapy 268 280 6397 6409 B-treatment
/ 280 281 6409 6410 O
Cell 281 285 6410 6414 B-treatment
Infusion 286 294 6415 6423 I-treatment
Exclusion 295 304 6424 6433 O
Criteria 305 313 6434 6442 O
) 313 314 6442 6443 O

Serum 0 5 6444 6449 B-clinical_variable
ALT 6 9 6450 6453 I-clinical_variable
less 10 14 6454 6458 O
than 15 19 6459 6463 O
three 20 25 6464 6469 B-upper_bound
times 26 31 6470 6475 I-upper_bound
the 32 35 6476 6479 I-upper_bound
upper 36 41 6480 6485 I-upper_bound
limit 42 47 6486 6491 I-upper_bound
of 48 50 6492 6494 I-upper_bound
normal 51 57 6495 6501 I-upper_bound
. 57 58 6501 6502 O
( 59 60 6503 6504 O
Turnstile 60 69 6504 6513 O
II 70 72 6514 6516 O
- 73 74 6517 6518 O
Chemotherapy 75 87 6519 6531 B-treatment
/ 87 88 6531 6532 O
Cell 88 92 6532 6536 B-treatment
Infusion- 93 102 6537 6546 I-treatment
Inclusion 103 112 6547 6556 O
Criteria 113 121 6557 6565 O
) 121 122 6565 6566 O

Serum 0 5 6567 6572 B-clinical_variable
creatinine 6 16 6573 6583 I-clinical_variable
less 17 21 6584 6588 O
than 22 26 6589 6593 O
or 27 29 6594 6596 O
equal 30 35 6597 6602 O
to 36 38 6603 6605 O
1.6 39 42 6606 6609 B-upper_bound
mg 43 45 6610 6612 I-upper_bound
/ 45 46 6612 6613 I-upper_bound
dl 46 48 6613 6615 I-upper_bound
. 48 49 6615 6616 O
( 50 51 6617 6618 O
Turnstile 51 60 6618 6627 O
II 61 63 6628 6630 O
- 64 65 6631 6632 O
Chemotherapy 66 78 6633 6645 B-treatment
/ 78 79 6645 6646 O
Cell 79 83 6646 6650 B-treatment
Infusion 84 92 6651 6659 I-treatment
- 92 93 6659 6660 O
Inclusion 93 102 6660 6669 O
Criteria 103 111 6670 6678 O
) 111 112 6678 6679 O

Total 0 5 6680 6685 B-clinical_variable
bilirubin 6 15 6686 6695 I-clinical_variable
less 16 20 6696 6700 O
than 21 25 6701 6705 O
or 26 28 6706 6708 O
equal 29 34 6709 6714 O
to 35 37 6715 6717 O
2.0 38 41 6718 6721 B-upper_bound
mg 42 44 6722 6724 I-upper_bound
/ 44 45 6724 6725 I-upper_bound
dl 45 47 6725 6727 I-upper_bound
, 47 48 6727 6728 O
except 49 55 6729 6735 O
in 56 58 6736 6738 O
patients 59 67 6739 6747 O
with 68 72 6748 6752 O
Gilbert 73 80 6753 6760 B-chronic_disease
's 80 82 6760 6762 I-chronic_disease
Syndrome 83 91 6763 6771 I-chronic_disease
who 92 95 6772 6775 O
must 96 100 6776 6780 O
have 101 105 6781 6785 O
a 106 107 6786 6787 O
total 108 113 6788 6793 B-clinical_variable
bilirubin 114 123 6794 6803 I-clinical_variable
less 124 128 6804 6808 O
than 129 133 6809 6813 O
3.0 134 137 6814 6817 B-upper_bound
mg 138 140 6818 6820 I-upper_bound
/ 140 141 6820 6821 I-upper_bound
dl 141 143 6821 6823 I-upper_bound
. 143 144 6823 6824 O
( 145 146 6825 6826 O
Turnstile 146 155 6826 6835 O
II 156 158 6836 6838 O
- 159 160 6839 6840 O
Chemotherapy 161 173 6841 6853 B-treatment
/ 173 174 6853 6854 O
Cell 174 178 6854 6858 B-treatment
Infusion 179 187 6859 6867 I-treatment
- 188 189 6868 6869 O
Inclusion 190 199 6870 6879 O
Criteria 200 208 6880 6888 O
) 208 209 6888 6889 O

Unless 0 6 6890 6896 O
surgically 7 17 6897 6907 O
sterile 18 25 6908 6915 O
by 26 28 6916 6918 O
bilateral 29 38 6919 6928 O
tubal 39 44 6929 6934 O
ligation 45 53 6935 6943 O
or 54 56 6944 6946 O
vasectomy 57 66 6947 6956 O
of 67 69 6957 6959 O
partner(s 70 79 6960 6969 O
) 79 80 6969 6970 O
, 80 81 6970 6971 O
the 82 85 6972 6975 O
patient 86 93 6976 6983 O
agrees 94 100 6984 6990 B-contraception_consent
to 101 103 6991 6993 I-contraception_consent
continue 104 112 6994 7002 I-contraception_consent
to 113 115 7003 7005 I-contraception_consent
use 116 119 7006 7009 I-contraception_consent
a 120 121 7010 7011 I-contraception_consent
barrier 122 129 7012 7019 I-contraception_consent
method 130 136 7020 7026 I-contraception_consent
of 137 139 7027 7029 I-contraception_consent
contraception 140 153 7030 7043 I-contraception_consent
throughout 154 164 7044 7054 O
the 165 168 7055 7058 O
study 169 174 7059 7064 O
such 175 179 7065 7069 O
as 180 182 7070 7072 O
: 182 183 7072 7073 O
condom 184 190 7074 7080 B-contraception_consent
, 190 191 7080 7081 O
diaphragm 192 201 7082 7091 B-contraception_consent
, 201 202 7091 7092 O
hormonal 203 211 7093 7101 B-contraception_consent
, 211 212 7101 7102 O
IUD 213 216 7103 7106 B-contraception_consent
, 216 217 7106 7107 O
or 218 220 7108 7110 O
sponge 221 227 7111 7117 B-contraception_consent
plus 228 232 7118 7122 I-contraception_consent
spermicide 233 243 7123 7133 I-contraception_consent
. 243 244 7133 7134 O
Abstinence 245 255 7135 7145 O
is 256 258 7146 7148 O
an 259 261 7149 7151 O
acceptable 262 272 7152 7162 O
form 273 277 7163 7167 O
of 278 280 7168 7170 O
birth 281 286 7171 7176 O
control 287 294 7177 7184 O
. 294 295 7184 7185 O
( 296 297 7186 7187 O
Turnstile 297 306 7187 7196 O
II 307 309 7197 7199 O
) 309 310 7199 7200 O

Women 0 5 7201 7206 B-gender

pregnant 0 8 7207 7215 B-pregnancy

will 0 4 7216 7220 O
be 5 7 7221 7223 O
excluded 8 16 7224 7232 O
because 17 24 7233 7240 O
of 25 27 7241 7243 O
the 28 31 7244 7247 O
potentially 32 43 7248 7259 O
dangerous 44 53 7260 7269 O
effects 54 61 7270 7277 O
of 62 64 7278 7280 O
the 65 68 7281 7284 O
preparative 69 80 7285 7296 O
chemotherapy 81 93 7297 7309 B-treatment
on 94 96 7310 7312 O
the 97 100 7313 7316 O
fetus 101 106 7317 7322 O
. 106 107 7322 7323 O
( 108 109 7324 7325 O
Turnstile 109 118 7325 7334 O
II 119 121 7335 7337 O
- 122 123 7338 7339 O
Chemotherapy 124 136 7340 7352 B-treatment
/ 136 137 7352 7353 O
Cell 137 141 7353 7357 B-treatment
Infusion 142 150 7358 7366 I-treatment
Exclusion 151 160 7367 7376 O
Criteria 161 169 7377 7385 O
) 169 170 7385 7386 O

Acquired 0 8 0 8 B-clinical_variable
immune 9 15 9 15 I-clinical_variable
deficiency 16 26 16 26 I-clinical_variable
syndrome 27 35 27 35 I-clinical_variable
( 36 37 36 37 I-clinical_variable
AIDS 37 41 37 41 I-clinical_variable
) 41 42 41 42 I-clinical_variable
based 43 48 43 48 O
upon 49 53 49 53 O
current 54 61 54 61 O
Centers 62 69 62 69 O
for 70 73 70 73 O
Disease 74 81 74 81 O
and 82 85 82 85 O
Control 86 93 86 93 O
( 94 95 94 95 O
CDC 95 98 95 98 O
) 98 99 98 99 O

Acute 0 5 100 105 O
bacterial 6 15 106 115 B-chronic_disease
or 16 18 116 118 O
fungal 19 25 119 125 B-chronic_disease
infection 26 35 126 135 I-chronic_disease
requiring 36 45 136 145 O
intravenous 46 57 146 157 B-treatment
antibiotics 58 69 158 169 I-treatment
at 70 72 170 172 O
the 73 76 173 176 O
time 77 81 177 181 O
of 82 84 182 184 O
registration 85 97 185 197 O

Bone 0 4 198 202 B-treatment
scan 5 9 203 207 I-treatment
completed 10 19 208 217 O
within 20 26 218 224 O
90 27 29 225 227 B-upper_bound
days 30 34 228 232 I-upper_bound

Chronic 0 7 233 240 B-chronic_disease
obstructive 8 19 241 252 I-chronic_disease
pulmonary 20 29 253 262 I-chronic_disease
disease 30 37 263 270 I-chronic_disease
exacerbation 38 50 271 283 O
or 51 53 284 286 O
other 54 59 287 292 O
respiratory 60 71 293 304 B-chronic_disease
illness 72 79 305 312 I-chronic_disease
requiring 80 89 313 322 O
hospitalization 90 105 323 338 O
or 106 108 339 341 O
precluding 109 119 342 352 O
study 120 125 353 358 B-treatment
therapy 126 133 359 366 I-treatment
at 134 136 367 369 O
the 137 140 370 373 O
time 141 145 374 378 O
of 146 148 379 381 O
registration 149 161 382 394 O

Clinical 0 8 395 403 B-clinical_variable
stage 9 14 404 409 I-clinical_variable
a 15 16 410 411 I-clinical_variable
≤ 17 18 412 413 O
T1 19 21 414 416 B-lower_bound
- 21 22 416 417 O
T2a 22 25 417 420 B-upper_bound
( 26 27 421 422 O
American 27 35 422 430 O
Joint 36 41 431 436 O
Committee 42 51 437 446 O
on 52 54 447 449 O
Cancer 55 61 450 456 O
[ 62 63 457 458 O
AJCC 63 67 458 462 O
] 67 68 462 463 O
7th 69 72 464 467 O
edition 73 80 468 475 O
) 80 81 475 476 O

Eastern 0 7 477 484 B-clinical_variable
Cooperative 8 19 485 496 I-clinical_variable
Oncology 20 28 497 505 I-clinical_variable
Group 29 34 506 511 I-clinical_variable
( 35 36 512 513 I-clinical_variable
ECOG 36 40 513 517 I-clinical_variable
) 40 41 517 518 I-clinical_variable
performance 42 53 519 530 I-clinical_variable
status 54 60 531 537 I-clinical_variable
must 61 65 538 542 O
be 66 68 543 545 O
level 69 74 546 551 O
0 75 76 552 553 B-lower_bound
or 77 79 554 556 O
1 80 81 557 558 B-upper_bound
within 82 88 559 565 O
60 89 91 566 568 B-upper_bound
days 92 96 569 573 I-upper_bound
prior 97 102 574 579 I-upper_bound
to 103 105 580 582 O
registration 106 118 583 595 O

Evidence 0 8 596 604 O
of 9 11 605 607 O
distant 12 19 608 615 B-cancer
metastases 20 30 616 626 I-cancer

Gleason 0 7 627 634 B-clinical_variable
scores 8 14 635 641 I-clinical_variable
≤ 15 16 642 643 O
7(3 17 20 644 647 B-upper_bound
+ 20 21 647 648 I-upper_bound
4 21 22 648 649 I-upper_bound
) 22 23 649 650 I-upper_bound

Hepatic 0 7 651 658 B-chronic_disease
insufficiency 8 21 659 672 I-chronic_disease
resulting 22 31 673 682 O
in 32 34 683 685 O
clinical 35 43 686 694 O
jaundice 44 52 695 703 B-chronic_disease
and/or 53 59 704 710 O
coagulation 60 71 711 722 B-chronic_disease
defects 72 79 723 730 I-chronic_disease
; 79 80 730 731 O
note 81 85 732 736 O
, 85 86 736 737 O
however 87 94 738 745 O
, 94 95 745 746 O
that 96 100 747 751 O
laboratory 101 111 752 762 O
tests 112 117 763 768 O
for 118 121 769 772 O
liver 122 127 773 778 O
function 128 136 779 787 O
and 137 140 788 791 O
coagulation 141 152 792 803 O
parameters 153 163 804 814 O

PSA 0 3 815 818 O
should 4 10 819 825 O
not 11 14 826 829 O
be 15 17 830 832 O
obtained 18 26 833 841 O
prior 27 32 842 847 O
to 33 35 848 850 O
30 36 38 851 853 B-upper_bound
days 39 43 854 858 I-upper_bound
after 44 49 859 864 I-upper_bound
stopping 50 58 865 873 O
finasteride 59 70 874 885 B-treatment

PSA 0 3 886 889 O
should 4 10 890 896 O
not 11 14 897 900 O
be 15 17 901 903 O
obtained 18 26 904 912 O
prior 27 32 913 918 O
to 33 35 919 921 O
90 36 38 922 924 B-upper_bound
days 39 43 925 929 I-upper_bound
after 44 49 930 935 O
stopping 50 58 936 944 O
dutasteride 59 70 945 956 B-treatment

PSA 0 3 957 960 B-clinical_variable
should 4 10 961 967 O
not 11 14 968 971 O
be 15 17 972 974 O
obtained 18 26 975 983 O
within 27 33 984 990 O
10 34 36 991 993 B-upper_bound
days 37 41 994 998 I-upper_bound
after 42 47 999 1004 I-upper_bound
prostate 48 56 1005 1013 B-treatment
biopsy 57 63 1014 1020 I-treatment

Previous 0 8 1021 1029 B-treatment
hormonal 9 17 1030 1038 I-treatment
therapy 18 25 1039 1046 I-treatment
, 25 26 1046 1047 O
such 27 31 1048 1052 O
as 32 34 1053 1055 O
luteinizing 35 46 1056 1067 B-treatment
hormone 47 54 1068 1075 I-treatment
- 54 55 1075 1076 I-treatment
releasing 55 64 1076 1085 I-treatment
hormone 65 72 1086 1093 I-treatment
( 73 74 1094 1095 I-treatment
LHRH 74 78 1095 1099 I-treatment
) 78 79 1099 1100 I-treatment
agonists 80 88 1101 1109 I-treatment
( 89 90 1110 1111 O
e.g. 90 94 1111 1115 O
, 94 95 1115 1116 O
goserelin 96 105 1117 1126 B-treatment
, 105 106 1126 1127 O
leuprolide 107 117 1128 1138 B-treatment
) 117 118 1138 1139 O
or 119 121 1140 1142 O
LHRH 122 126 1143 1147 B-treatment
antagonists 127 138 1148 1159 I-treatment
( 139 140 1160 1161 O
e.g. 140 144 1161 1165 O
, 144 145 1165 1166 O
degarelix 146 155 1167 1176 B-treatment
) 155 156 1176 1177 O
, 156 157 1177 1178 O
anti 158 162 1179 1183 B-treatment
- 162 163 1183 1184 I-treatment
androgens 163 172 1184 1193 I-treatment
( 173 174 1194 1195 O
e.g. 174 178 1195 1199 O
, 178 179 1199 1200 O
flutamide 180 189 1201 1210 B-treatment
, 189 190 1210 1211 O
bicalutamide 191 203 1212 1224 B-treatment
) 203 204 1224 1225 O
, 204 205 1225 1226 O
estrogens 206 215 1227 1236 B-treatment
( 216 217 1237 1238 O
e.g. 217 221 1238 1242 O
, 221 222 1242 1243 O
diethylstilbestrol 223 241 1244 1262 B-treatment
[ 242 243 1263 1264 I-treatment
DES 243 246 1264 1267 I-treatment
] 246 247 1267 1268 I-treatment
) 247 248 1268 1269 O
, 248 249 1269 1270 O
or 250 252 1271 1273 O
surgical 253 261 1274 1282 B-treatment
castration 262 272 1283 1293 I-treatment
( 273 274 1294 1295 I-treatment
orchiectomy 274 285 1295 1306 I-treatment
) 285 286 1306 1307 I-treatment

Previous 0 8 1308 1316 B-treatment
or 9 11 1317 1319 I-treatment
concurrent 12 22 1320 1330 I-treatment
cytotoxic 23 32 1331 1340 I-treatment
chemotherapy 33 45 1341 1353 I-treatment
for 46 49 1354 1357 O
prostate 50 58 1358 1366 B-cancer
cancer 59 65 1367 1373 I-cancer

Previous 0 8 1374 1382 B-treatment
pelvic 9 15 1383 1389 I-treatment
irradiation 16 27 1390 1401 I-treatment
, 27 28 1401 1402 O
prostate 29 37 1403 1411 B-treatment
brachytherapy 38 51 1412 1425 I-treatment
, 51 52 1425 1426 O
or 53 55 1427 1429 O
bilateral 56 65 1430 1439 B-treatment
orchiectomy 66 77 1440 1451 I-treatment

Previous 0 8 1452 1460 B-treatment
radical 9 16 1461 1468 I-treatment
surgery 17 24 1469 1476 I-treatment
( 25 26 1477 1478 O
prostatectomy 26 39 1478 1491 B-treatment
) 39 40 1491 1492 O
, 40 41 1492 1493 O
cryosurgery 42 53 1494 1505 B-treatment
, 53 54 1505 1506 O
or 55 57 1507 1509 O
high 58 62 1510 1514 B-treatment
intensity 63 72 1515 1524 I-treatment
focused 73 80 1525 1532 I-treatment
ultrasound 81 91 1533 1543 I-treatment
( 92 93 1544 1545 I-treatment
HIFU 93 97 1545 1549 I-treatment
) 97 98 1549 1550 I-treatment
for 99 102 1551 1554 O
prostate 103 111 1555 1563 B-cancer
cancer 112 118 1564 1570 I-cancer

Prostate 0 8 1571 1579 B-clinical_variable
specific 9 17 1580 1588 I-clinical_variable
antigen 18 25 1589 1596 I-clinical_variable
( 26 27 1597 1598 I-clinical_variable
PSA 27 30 1598 1601 I-clinical_variable
) 30 31 1601 1602 I-clinical_variable
≤ 32 33 1603 1604 O
10 34 36 1605 1607 B-upper_bound
ng 37 39 1608 1610 I-upper_bound
/ 39 40 1610 1611 I-upper_bound
mL 40 42 1611 1613 I-upper_bound
within 43 49 1614 1620 O
90 50 52 1621 1623 B-upper_bound
days 53 57 1624 1628 I-upper_bound
prior 58 63 1629 1634 I-upper_bound
to 64 66 1635 1637 O
registration 67 79 1638 1650 O

Regional 0 8 1651 1659 B-cancer
lymph 9 14 1660 1665 I-cancer
node 15 19 1666 1670 I-cancer
involvement 20 31 1671 1682 O

Serum 0 5 1683 1688 B-clinical_variable
creatinine 6 16 1689 1699 I-clinical_variable
≤ 17 18 1700 1701 O
1.5 19 22 1702 1705 B-upper_bound
times 23 28 1706 1711 I-upper_bound
upper 29 34 1712 1717 I-upper_bound
limit 35 40 1718 1723 I-upper_bound
of 41 43 1724 1726 I-upper_bound
institutional 44 57 1727 1740 I-upper_bound
normal 58 64 1741 1747 I-upper_bound
( 65 66 1748 1749 O
normal 66 72 1749 1755 O
: 72 73 1755 1756 O
≤ 74 75 1757 1758 O
1.17 76 80 1759 1763 B-upper_bound
mL 81 83 1764 1766 I-upper_bound
/ 83 84 1766 1767 I-upper_bound
min/1.73 84 92 1767 1775 I-upper_bound
m^2 93 96 1776 1779 I-upper_bound
) 96 97 1779 1780 O

Transmural 0 10 1781 1791 B-chronic_disease
myocardial 11 21 1792 1802 I-chronic_disease
infarction 22 32 1803 1813 I-chronic_disease
within 33 39 1814 1820 O
the 40 43 1821 1824 O
last 44 48 1825 1829 B-upper_bound
6 49 50 1830 1831 I-upper_bound
months 51 57 1832 1838 I-upper_bound

Unstable 0 8 1839 1847 B-chronic_disease
angina 9 15 1848 1854 I-chronic_disease
and/or 16 22 1855 1861 O
congestive 23 33 1862 1872 B-chronic_disease
heart 34 39 1873 1878 I-chronic_disease
failure 40 47 1879 1886 I-chronic_disease
requiring 48 57 1887 1896 O
hospitalization 58 73 1897 1912 B-treatment
within 74 80 1913 1919 O
the 81 84 1920 1923 O
last 85 89 1924 1928 B-upper_bound
6 90 91 1929 1930 I-upper_bound
months 92 98 1931 1937 I-upper_bound

Use 0 3 1938 1941 O
of 4 6 1942 1944 O
dutasteride 7 18 1945 1956 B-treatment
within 19 25 1957 1963 O
90 26 28 1964 1966 B-upper_bound
days 29 33 1967 1971 I-upper_bound
prior 34 39 1972 1977 I-upper_bound
to 40 42 1978 1980 O
registration 43 55 1981 1993 O

Use 0 3 1994 1997 O
of 4 6 1998 2000 O
finasteride 7 18 2001 2012 B-treatment
within 19 25 2013 2019 O
30 26 28 2020 2022 B-upper_bound
days 29 33 2023 2027 I-upper_bound
prior 34 39 2028 2033 I-upper_bound
to 40 42 2034 2036 O
registration 43 55 2037 2049 O

be 0 2 2050 2052 O
able 3 7 2053 2057 O
to 8 10 2058 2060 O
undergo 11 18 2061 2068 O
an 19 21 2069 2071 O
MRI 22 25 2072 2075 B-treatment
with 26 30 2076 2080 O
contrast 31 39 2081 2089 O

have 0 4 2090 2094 O
a 5 6 2095 2096 O
histological 7 19 2097 2109 O
evaluation 20 30 2110 2120 O
of 31 33 2121 2123 O
the 34 37 2124 2127 O
prostate 38 46 2128 2136 B-treatment
biopsy 47 53 2137 2143 I-treatment
with 54 58 2144 2148 O
assignment 59 69 2149 2159 O
of 70 72 2160 2162 O
a 73 74 2163 2164 O
Gleason 75 82 2165 2172 B-clinical_variable
score 83 88 2173 2178 I-clinical_variable
to 89 91 2179 2181 O
the 92 95 2182 2185 O
biopsy 96 102 2186 2192 O
material 103 111 2193 2201 O

have 0 4 2202 2206 O
a 5 6 2207 2208 O
histologically 7 21 2209 2223 O
confirmed 22 31 2224 2233 O
diagnosis 32 41 2234 2243 O
of 42 44 2244 2246 O
adenocarcinoma 45 59 2247 2261 B-cancer
of 60 62 2262 2264 I-cancer
the 63 66 2265 2268 I-cancer
prostate 67 75 2269 2277 I-cancer

have 0 4 2278 2282 O
a 5 6 2283 2284 O
history 7 14 2285 2292 O
/ 14 15 2292 2293 O
physical 15 23 2293 2301 O
examination 24 35 2302 2313 O
with 36 40 2314 2318 O
digital 41 48 2319 2326 B-treatment
rectal 49 55 2327 2333 I-treatment
examination 56 67 2334 2345 I-treatment
of 68 70 2346 2348 I-treatment
the 71 74 2349 2352 I-treatment
prostate 75 83 2353 2361 I-treatment
within 84 90 2362 2368 O
90 91 93 2369 2371 B-upper_bound
days 94 98 2372 2376 I-upper_bound
prior 99 104 2377 2382 I-upper_bound
to 105 107 2383 2385 O
screening 108 117 2386 2395 O

human 0 5 2396 2401 B-chronic_disease
immunodeficiency 6 22 2402 2418 I-chronic_disease
virus 23 28 2419 2424 I-chronic_disease
( 29 30 2425 2426 I-chronic_disease
HIV 30 33 2426 2429 I-chronic_disease
) 33 34 2429 2430 I-chronic_disease
testing 35 42 2431 2438 O

unable 0 6 2439 2445 O
to 7 9 2446 2448 O
undergo 10 17 2449 2456 O
an 18 20 2457 2459 O
MRI 21 24 2460 2463 B-treatment
with 25 29 2464 2468 O
contrast 30 38 2469 2477 O

willing 0 7 2478 2485 O
and 8 11 2486 2489 O
able 12 16 2490 2494 O
to 17 19 2495 2497 O
complete 20 28 2498 2506 O
the 29 32 2507 2510 O
Expanded 33 41 2511 2519 O
Prostate 42 50 2520 2528 O
Cancer 51 57 2529 2535 O
Index 58 63 2536 2541 O
Composite 64 73 2542 2551 O
( 74 75 2552 2553 O
EPIC 75 79 2553 2557 O
) 79 80 2557 2558 O
questionnaire 81 94 2559 2572 O
( 95 96 2573 2574 O
baseline 96 104 2574 2582 O
, 104 105 2582 2583 O
6 106 107 2584 2585 B-lower_bound
, 107 108 2585 2586 O
12 109 111 2587 2589 O
and 112 115 2590 2593 O
24 116 118 2594 2596 B-upper_bound
months 119 125 2597 2603 I-upper_bound
post 126 130 2604 2608 O
end 131 134 2609 2612 O
of 135 137 2613 2615 O
radiation 138 147 2616 2625 B-treatment
therapy 148 155 2626 2633 I-treatment
) 155 156 2633 2634 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
autism 13 19 13 19 B-chronic_disease
based 20 25 20 25 O
on 26 28 26 28 O
DSM 29 32 29 32 O
- 32 33 32 33 O
IV 33 35 33 35 O
- 35 36 35 36 O
TR 36 38 36 38 O
criteria 39 47 39 47 O

Has 0 3 48 51 O
a 4 5 52 53 O
diagnosis 6 15 54 63 O
of 16 18 64 66 O
ASD 19 22 67 70 B-chronic_disease

Have 0 4 71 75 O
a 5 6 76 77 O
medical 7 14 78 85 O
diagnosis 15 24 86 95 O
that 25 29 96 100 O
causes 30 36 101 107 O
autism 37 43 108 114 B-chronic_disease
like 44 48 115 119 O
symptomology 49 61 120 132 O
( 62 63 133 134 O
e.g. 63 67 134 138 O
, 67 68 138 139 O
Fragile 69 76 140 147 B-chronic_disease
X 77 78 148 149 I-chronic_disease
, 78 79 149 150 O
Down 80 84 151 155 B-chronic_disease
syndrome 85 93 156 164 I-chronic_disease
, 93 94 164 165 O
Angelman 95 103 166 174 B-chronic_disease
's 103 105 174 176 I-chronic_disease
syndrome 106 114 177 185 I-chronic_disease
, 114 115 185 186 O
tuberous 116 124 187 195 B-chronic_disease
sclerosis 125 134 196 205 I-chronic_disease
, 134 135 205 206 O
Rett 136 140 207 211 B-chronic_disease
's 140 142 211 213 I-chronic_disease
disorder 143 151 214 222 I-chronic_disease
) 151 152 222 223 O

Males 0 5 224 229 B-gender

Receiving 0 9 230 239 O
or 10 12 240 242 O
will 13 17 243 247 O
receive 18 25 248 255 O
a 26 27 256 257 O
parent 28 34 258 264 O
delivered 35 44 265 274 O
intervention 45 57 275 287 O
to 58 60 288 290 O
alleviate 61 70 291 300 O
symptoms 71 79 301 309 O
related 80 87 310 317 O
to 88 90 318 320 O
their 91 96 321 326 O
diagnosis 97 106 327 336 O
of 107 109 337 339 O
autistic 110 118 340 348 B-chronic_disease
disorder 119 127 349 357 I-chronic_disease

age 0 3 358 361 B-age
range 4 9 362 367 O
between 10 17 368 375 O
1.6 18 21 376 379 B-lower_bound
and 22 25 380 383 O
17.11 26 31 384 389 B-upper_bound
years 32 37 390 395 I-upper_bound
of 38 40 396 398 O
age 41 44 399 402 O

between 0 7 403 410 O
the 8 11 411 414 O
ages 12 16 415 419 B-age
of 17 19 420 422 O
1.6 20 23 423 426 B-lower_bound
and 24 27 427 430 O
17.11 28 33 431 436 B-upper_bound
years 34 39 437 442 I-upper_bound
of 40 42 443 445 O
age 43 46 446 449 O

females 0 7 450 457 B-gender

medically 0 9 458 467 O
unstable 10 18 468 476 O
( 19 20 477 478 O
e.g. 20 24 478 482 O
, 24 25 482 483 O
more 26 30 484 488 O
than 31 35 489 493 O
one 36 39 494 497 B-lower_bound
seizure 40 47 498 505 B-chronic_disease
a 48 49 506 507 O
month 50 55 508 513 O
) 55 56 513 514 O

12 0 2 0 2 B-lower_bound
to 3 5 3 5 O
36 6 8 6 8 B-upper_bound
months 9 15 9 15 I-upper_bound
of 16 18 16 18 O
age 19 22 19 22 B-age

Anticipated 0 11 23 34 B-treatment
pharmacological 12 27 35 50 I-treatment
intervention 28 40 51 63 I-treatment
or 41 43 64 66 O
procedure 44 53 67 76 O
or 54 56 77 79 O
participation 57 70 80 93 O
in 71 73 94 96 O
other 74 79 97 102 O
studies 80 87 103 110 O
that 88 92 111 115 O
may 93 96 116 119 O
interfere 97 106 120 129 O
with 107 111 130 134 O
this 112 116 135 139 O
study 117 122 140 145 O

Diagnosis 0 9 146 155 O
of 10 12 156 158 O
CP 13 15 159 161 B-chronic_disease
secondary 16 25 162 171 I-chronic_disease
to 26 28 172 174 O
neuronal 29 37 175 183 B-chronic_disease
migration 38 47 184 193 I-chronic_disease

Gross 0 5 194 199 B-clinical_variable
Motor 6 11 200 205 I-clinical_variable
Function 12 20 206 214 I-clinical_variable
Classification 21 35 215 229 I-clinical_variable
System 36 42 230 236 I-clinical_variable
( 43 44 237 238 I-clinical_variable
GMFCS 44 49 238 243 I-clinical_variable
) 49 50 243 244 I-clinical_variable
levels 51 57 245 251 I-clinical_variable
I 58 59 252 253 B-lower_bound
, 59 60 253 254 O
II 61 63 255 257 O
and 64 67 258 261 O
III 68 71 262 265 B-upper_bound

Medical 0 7 266 273 B-chronic_disease
conditions 8 18 274 284 I-chronic_disease
that 19 23 285 289 O
may 24 27 290 293 O
prevent 28 35 294 301 O
the 36 39 302 305 O
administration 40 54 306 320 O
of 55 57 321 323 O
rehabilitation 58 72 324 338 B-treatment
therapies 73 82 339 348 I-treatment
at 83 85 349 351 O
the 86 89 352 355 O
intensity 90 99 356 365 O
required 100 108 366 374 O
by 109 111 375 377 O
the 112 115 378 381 O
study 116 121 382 387 O
, 121 122 387 388 O
or 123 125 389 391 O
that 126 130 392 396 O
may 131 134 397 400 O
compromise 135 145 401 411 O
the 146 149 412 415 O
study 150 155 416 421 O
ability 156 163 422 429 O
to 164 166 430 432 O
maintain 167 175 433 441 O
blindness 176 185 442 451 B-chronic_disease
, 185 186 451 452 O
or 187 189 453 455 O
that 190 194 456 460 O
have 195 199 461 465 O
a 200 201 466 467 O
co 202 204 468 470 O
- 204 205 470 471 O
morbidity 205 214 471 480 O
not 215 218 481 484 O
typically 219 228 485 494 O
associated 229 239 495 505 O
with 240 244 506 510 O
CP 245 247 511 513 O
( 248 249 514 515 O
i.e. 249 253 515 519 O
cancer 254 260 520 526 B-cancer
, 260 261 526 527 O
cystic 262 268 528 534 B-chronic_disease
fibrosis 269 277 535 543 I-chronic_disease
) 277 278 543 544 O

The 0 3 545 548 O
diagnosis 4 13 549 558 O
of 14 16 559 561 O
CP 17 19 562 564 B-chronic_disease
is 20 22 565 567 O
often 23 28 568 573 O
uncertain 29 38 574 583 O
under 39 44 584 589 O
the 45 48 590 593 O
age 49 52 594 597 B-age
of 53 55 598 600 O
12 56 58 601 603 B-lower_bound
months 59 65 604 610 I-lower_bound
. 65 66 610 611 O
The 67 70 612 615 O
cutoff 71 77 616 622 O
at 78 80 623 625 O
36 81 83 626 628 O
months 84 90 629 635 O
is 91 93 636 638 O
to 94 96 639 641 O
have 97 101 642 646 O
a 102 103 647 648 O
population 104 114 649 659 O
of 115 117 660 662 O
young 118 123 663 668 O
children 124 132 669 677 O
when 133 137 678 682 O
the 138 141 683 686 O
brain 142 147 687 692 O
is 148 150 693 695 O
most 151 155 696 700 O
plastic 156 163 701 708 O
and 164 167 709 712 O
most 168 172 713 717 O
susceptible 173 184 718 729 O
to 185 187 730 732 O
reorganization 188 202 733 747 O

insult 0 6 748 754 O
to 7 9 755 757 O
the 10 13 758 761 O
central 14 21 762 769 O
nervous 22 29 770 777 O
system 30 36 778 784 O
that 37 41 785 789 O
caused 42 48 790 796 O
the 49 52 797 800 O
motor 53 58 801 806 O
dysfunction 59 70 807 818 O
must 71 75 819 823 O
have 76 80 824 828 O
occurred 81 89 829 837 O
during 90 96 838 844 O
gestation 97 106 845 854 O
or 107 109 855 857 O
within 110 116 858 864 O
one 117 120 865 868 B-upper_bound
year 121 125 869 873 I-upper_bound
after 126 131 874 879 O
birth 132 137 880 885 O
independent 138 149 886 897 O
of 150 152 898 900 O
gestational 153 164 901 912 B-clinical_variable
age 165 168 913 916 I-clinical_variable

spastic 0 7 917 924 B-chronic_disease
CP 8 10 925 927 I-chronic_disease
confirmed 11 20 928 937 O
by 21 23 938 940 O
a 24 25 941 942 O
pediatric 26 35 943 952 O
neurologist 36 47 953 964 O
or 48 50 965 967 O
pediatric 51 60 968 977 O
rehabilitation 61 75 978 992 O
specialist 76 86 993 1003 O

A 0 1 0 1 O
total 2 7 2 7 B-clinical_variable
bilirubin 8 17 8 17 I-clinical_variable
≤ 18 19 18 19 O
1.5 20 23 20 23 B-upper_bound
ULN 24 27 24 27 I-upper_bound
, 27 28 27 28 O
aspartate 29 38 29 38 B-clinical_variable
aminotransferase 39 55 39 55 I-clinical_variable
( 56 57 56 57 I-clinical_variable
AST 57 60 57 60 I-clinical_variable
) 60 61 60 61 I-clinical_variable
≤ 62 63 62 63 O
2.0 64 67 64 67 B-upper_bound
x 68 69 68 69 I-upper_bound
ULN 70 73 70 73 I-upper_bound

Absolute 0 8 74 82 B-clinical_variable
neutrophil 9 19 83 93 I-clinical_variable
count 20 25 94 99 I-clinical_variable
of 26 28 100 102 O
≥ 29 30 103 104 O
1,500 31 36 105 110 B-lower_bound
and 37 40 111 114 O
platelet 41 49 115 123 B-clinical_variable
count 50 55 124 129 I-clinical_variable
≥ 56 57 130 131 O
100,000 58 65 132 139 B-lower_bound

Cockcroft 0 9 140 149 B-clinical_variable
calculated 10 20 150 160 I-clinical_variable
creatinine 21 31 161 171 I-clinical_variable
clearance 32 41 172 181 I-clinical_variable
of 42 44 182 184 O
≥ 45 46 185 186 O
45 47 49 187 189 B-lower_bound
ml 50 52 190 192 I-lower_bound
/ 52 53 192 193 I-lower_bound
min 53 56 193 196 I-lower_bound
or 57 59 197 199 O
1.5 60 63 200 203 B-lower_bound
x 64 65 204 205 I-lower_bound
the 66 69 206 209 I-lower_bound
upper 70 75 210 215 I-lower_bound
limit 76 81 216 221 I-lower_bound
of 82 84 222 224 I-lower_bound
normal 85 91 225 231 I-lower_bound
( 92 93 232 233 I-lower_bound
ULN 93 96 233 236 I-lower_bound
) 96 97 236 237 I-lower_bound

Histologic 0 10 238 248 O
/ 10 11 248 249 O
cytologic 11 20 249 258 O
documentation 21 34 259 272 O
of 35 37 273 275 O
non 38 41 276 279 B-cancer
- 41 42 279 280 I-cancer
small 42 47 280 285 I-cancer
cell 48 52 286 290 I-cancer
lung 53 57 291 295 I-cancer
cancer 58 64 296 302 I-cancer
( 65 66 303 304 I-cancer
NSCLC 66 71 304 309 I-cancer
) 71 72 309 310 I-cancer

Medical 0 7 311 318 O
contraindications 8 25 319 336 O
to 26 28 337 339 O
thoracic 29 37 340 348 B-allergy_name
irradiation 38 49 349 360 I-allergy_name

Negative 0 8 361 369 B-pregnancy
pregnancy 9 18 370 379 I-pregnancy
test 19 23 380 384 O
in 24 26 385 387 O
women 27 32 388 393 B-gender
of 33 35 394 396 O
child 36 41 397 402 O
- 41 42 402 403 O
bearing 42 49 403 410 O
potential 50 59 411 420 O

Pleural 0 7 421 428 B-chronic_disease
effusion 8 16 429 437 I-chronic_disease
: 16 17 437 438 O
when 18 22 439 443 O
pleural 23 30 444 451 O
fluid 31 36 452 457 O
is 37 39 458 460 O
visible 40 47 461 468 O
on 48 50 469 471 O
both 51 55 472 476 O
CT 56 58 477 479 B-treatment
scan 59 63 480 484 I-treatment
and 64 67 485 488 O
on 68 70 489 491 O
a 71 72 492 493 O
chest 73 78 494 499 B-treatment
x 79 80 500 501 I-treatment
- 80 81 501 502 I-treatment
ray 81 84 502 505 I-treatment
, 84 85 505 506 O
a 86 87 507 508 O
pleuracentesis 88 102 509 523 B-treatment
is 103 105 524 526 O
required 106 114 527 535 O
to 115 117 536 538 O
confirm 118 125 539 546 O
that 126 130 547 551 O
the 131 134 552 555 O
pleural 135 142 556 563 O
fluid 143 148 564 569 O
is 149 151 570 572 O
cytologically 152 165 573 586 O
negative 166 174 587 595 O

Pre 0 3 596 599 O
- 3 4 599 600 O
existing 4 12 600 608 O
sensory 13 20 609 616 B-clinical_variable
neuropathy 21 31 617 627 I-clinical_variable
of 32 34 628 630 I-clinical_variable
grade 35 40 631 636 I-clinical_variable
≥ 41 42 637 638 O
2 43 44 639 640 B-lower_bound

Prior 0 5 641 646 B-treatment
thoracic 6 14 647 655 I-treatment
irradiation 15 26 656 667 I-treatment

Unresectable 0 12 668 680 O
stage 13 18 681 686 B-cancer
II 19 21 687 689 I-cancer
, 21 22 689 690 I-cancer
IIIA 23 27 691 695 I-cancer
, 27 28 695 696 I-cancer
or 29 31 697 699 I-cancer
IIIB 32 36 700 704 I-cancer
disease 37 44 705 712 I-cancer

Zubrod 0 6 713 719 B-clinical_variable
/ 6 7 719 720 I-clinical_variable
ECOG 7 11 720 724 I-clinical_variable
performance 12 23 725 736 I-clinical_variable
status 24 30 737 743 I-clinical_variable
0 31 32 744 745 B-lower_bound
- 32 33 745 746 O
1 33 34 746 747 B-upper_bound

Active 0 6 0 6 B-chronic_disease
ulcerative 7 17 7 17 I-chronic_disease
colitis 18 25 18 25 I-chronic_disease
with 26 30 26 30 O
an 31 33 31 33 O
Adapted 34 41 34 41 B-clinical_variable
Mayo 42 46 42 46 I-clinical_variable
score 47 52 47 52 I-clinical_variable
of 53 55 53 55 O
5 56 57 56 57 B-lower_bound
to 58 60 58 60 O
9 61 62 61 62 B-upper_bound
points 63 69 63 69 O

Appropriate 0 11 70 81 O
documentation 12 25 82 95 O
of 26 28 96 98 O
biopsy 29 35 99 105 B-treatment
results 36 43 106 113 O
consistent 44 54 114 124 O
with 55 59 125 129 O
the 60 63 130 133 O
diagnosis 64 73 134 143 O
of 74 76 144 146 O
UC 77 79 147 149 B-chronic_disease
, 79 80 149 150 O
in 81 83 151 153 O
the 84 87 154 157 O
assessment 88 98 158 168 O
of 99 101 169 171 O
the 102 105 172 175 O
Investigator 106 118 176 188 O
, 118 119 188 189 O
must 120 124 190 194 O
be 125 127 195 197 O
available 128 137 198 207 O

Current 0 7 208 215 O
diagnosis 8 17 216 225 O
of 18 20 226 228 O
fulminant 21 30 229 238 B-chronic_disease
colitis 31 38 239 246 I-chronic_disease
and/or 39 45 247 253 O
toxic 46 51 254 259 B-chronic_disease
megacolon 52 61 260 269 I-chronic_disease

Diagnosis 0 9 270 279 O
of 10 12 280 282 O
ulcerative 13 23 283 293 B-chronic_disease
colitis 24 31 294 301 I-chronic_disease
for 32 35 302 305 O
90 36 38 306 308 B-lower_bound
days 39 43 309 313 I-lower_bound
or 44 46 314 316 O
greater 47 54 317 324 O
prior 55 60 325 330 O
to 61 63 331 333 O
Baseline 64 72 334 342 O
, 72 73 342 343 O
confirmed 74 83 344 353 O
by 84 86 354 356 O
colonoscopy 87 98 357 368 O
during 99 105 369 375 O
the 106 109 376 379 O
Screening 110 119 380 389 O
Period 120 126 390 396 O

Female 0 6 397 403 B-gender
participants 7 19 404 416 O
of 20 22 417 419 O
childbearing 23 35 420 432 O
potential 36 45 433 442 O
must 46 50 443 447 O
have 51 55 448 452 O
a 56 57 453 454 O
negative 58 66 455 463 O
serum 67 72 464 469 O
pregnancy 73 82 470 479 O
test 83 87 480 484 O
at 88 90 485 487 O
the 91 94 488 491 O
Screening 95 104 492 501 O
Visit 105 110 502 507 O
and 111 114 508 511 O
a 115 116 512 513 O
negative 117 125 514 522 O
urine 126 131 523 528 O
pregnancy 132 141 529 538 O
test 142 146 539 543 O
at 147 149 544 546 O
the 150 153 547 550 O
Baseline 154 162 551 559 O
Visit 163 168 560 565 O
prior 169 174 566 571 O
to 175 177 572 574 O
study 178 183 575 580 O
drug 184 188 581 585 O
dosing 189 195 586 592 O

If 0 2 593 595 O
female 3 9 596 602 B-gender
, 9 10 602 603 O
participant 11 22 604 615 O
must 23 27 616 620 O
meet 28 32 621 625 O
the 33 36 626 629 O
criteria 37 45 630 638 O
for 46 49 639 642 O
Contraception 50 63 643 656 O
Recommendations 64 79 657 672 O

Participant 0 11 673 684 O
on 12 14 685 687 O
azathioprine 15 27 688 700 B-treatment
or 28 30 701 703 O
6 31 32 704 705 B-treatment
- 32 33 705 706 I-treatment
mercaptopurine 33 47 706 720 I-treatment
within 48 54 721 727 O
10 55 57 728 730 B-upper_bound
days 58 62 731 735 I-upper_bound
of 63 65 736 738 O
baseline 66 74 739 747 O

Participant 0 11 748 759 O
with 12 16 760 764 O
current 17 24 765 772 O
diagnosis 25 34 773 782 O
of 35 37 783 785 O
Crohn 38 43 786 791 B-chronic_disease
's 43 45 791 793 I-chronic_disease
disease 46 53 794 801 I-chronic_disease
( 54 55 802 803 I-chronic_disease
CD 55 57 803 805 I-chronic_disease
) 57 58 805 806 I-chronic_disease

Participant 0 11 807 818 O
with 12 16 819 823 O
disease 17 24 824 831 O
limited 25 32 832 839 O
to 33 35 840 842 O
the 36 39 843 846 O
rectum 40 46 847 853 O
( 47 48 854 855 O
ulcerative 48 58 855 865 B-chronic_disease
proctitis 59 68 866 875 I-chronic_disease
) 68 69 875 876 O
during 70 76 877 883 O
the 77 80 884 887 O
Screening 81 90 888 897 O
endoscopy 91 100 898 907 B-treatment

Received 0 8 908 916 O
cyclosporine 9 21 917 929 B-treatment
, 21 22 929 930 O
tacrolimus 23 33 931 941 B-treatment
, 33 34 941 942 O
mycophenolate 35 48 943 956 B-treatment
mofetil 49 56 957 964 I-treatment
, 56 57 964 965 O
or 58 60 966 968 O
thalidomide 61 72 969 980 B-treatment
within 73 79 981 987 O
30 80 82 988 990 B-upper_bound
days 83 87 991 995 I-upper_bound
prior 88 93 996 1001 I-upper_bound
to 94 96 1002 1004 O
Baseline 97 105 1005 1013 O

Received 0 8 1014 1022 O
intravenous 9 20 1023 1034 B-treatment
corticosteroids 21 36 1035 1050 I-treatment
within 37 43 1051 1057 O
14 44 46 1058 1060 B-upper_bound
days 47 51 1061 1065 I-upper_bound
prior 52 57 1066 1071 I-upper_bound
to 58 60 1072 1074 O
Screening 61 70 1075 1084 O
or 71 73 1085 1087 O
during 74 80 1088 1094 O
the 81 84 1095 1098 O
Screening 85 94 1099 1108 O
Period 95 101 1109 1115 O

biologic 0 8 1116 1124 B-treatment
therapies 9 18 1125 1134 I-treatment
in 19 21 1135 1137 O
the 22 25 1138 1141 O
opinion 26 33 1142 1149 O
of 34 36 1150 1152 O
the 37 40 1153 1156 O
investigator 41 53 1157 1169 O

corticosteroids 0 15 1170 1185 B-treatment

diagnosis 0 9 1186 1195 O
of 10 12 1196 1198 O
indeterminate 13 26 1199 1212 B-chronic_disease
colitis 27 34 1213 1220 I-chronic_disease
( 35 36 1221 1222 I-chronic_disease
IC 36 38 1222 1224 I-chronic_disease
) 38 39 1224 1225 I-chronic_disease

immunosuppressants 0 18 1226 1244 B-treatment

meet 0 4 1245 1249 O
the 5 8 1250 1253 O
definition 9 19 1254 1264 O
of 20 22 1265 1267 O
Tanner 23 29 1268 1274 B-clinical_variable
Stage 30 35 1275 1280 I-clinical_variable
5 36 37 1281 1282 I-clinical_variable
at 38 40 1283 1285 O
Screening 41 50 1286 1295 O
Visit 51 56 1296 1301 O

oral 0 4 1302 1306 B-treatment
aminosalicylates 5 21 1307 1323 I-treatment

weigh 0 5 1324 1329 B-clinical_variable
> 6 7 1330 1331 O
= 7 8 1331 1332 O
40 9 11 1333 1335 B-lower_bound
kilograms 12 21 1336 1345 I-lower_bound

Alcohol 0 7 0 7 O
or 8 10 8 10 O
drug 11 15 11 15 O
dependence 16 26 16 26 O
currently 27 36 27 36 O
or 37 39 37 39 O
within 40 46 40 46 O
the 47 50 47 50 O
past 51 55 51 55 B-upper_bound
1 56 57 56 57 I-upper_bound
year 58 62 58 62 I-upper_bound

Anticoagulants 0 14 63 77 B-treatment
except 15 21 78 84 O
low 22 25 85 88 O
dose 26 30 89 93 B-clinical_variable
( 31 32 94 95 O
≤ 32 33 95 96 O
325 34 37 97 100 B-upper_bound
mg 38 40 101 103 I-upper_bound
) 40 41 103 104 O
aspirin 42 49 105 112 B-treatment

Are 0 3 113 116 O
within 4 10 117 123 O
-15 11 14 124 127 B-lower_bound
to 15 17 128 130 O
+ 18 19 131 132 O
10 20 22 133 135 O
years 23 28 136 141 O
of 29 31 142 144 O
the 32 35 145 148 O
predicted 36 45 149 158 O
or 46 48 159 161 O
actual 49 55 162 168 O
age 56 59 169 172 B-age
of 60 62 173 175 O
cognitive 63 72 176 185 O
symptom 73 80 186 193 O
onset 81 86 194 199 O
for 87 90 200 203 O
treatment 91 100 204 213 B-treatment
arms 101 105 214 218 O
. 105 106 218 219 O
For 107 110 220 223 O
Cognitive 111 120 224 233 B-treatment
Run 121 124 234 237 I-treatment
- 124 125 237 238 I-treatment
In 125 127 238 240 I-treatment
( 128 129 241 242 I-treatment
CRI 129 132 242 245 I-treatment
): 132 134 245 247 I-treatment
includes 135 143 248 256 O
participants 144 156 257 269 O
who 157 160 270 273 O
are 161 164 274 277 O
younger 165 172 278 285 O
than 173 177 286 290 O
15 178 180 291 293 B-upper_bound
years 181 186 294 299 I-upper_bound
prior 187 192 300 305 O
to 193 195 306 308 O
the 196 199 309 312 O
expected 200 208 313 321 O
age 209 212 322 325 O
of 213 215 326 328 O
cognitive 216 225 329 338 O
symptom 226 233 339 346 O
onset 234 239 347 352 O
, 239 240 352 353 O
in 241 243 354 356 O
addition 244 252 357 365 O
to 253 255 366 368 O
those 256 261 369 374 O
15 262 264 375 377 O
years 265 270 378 383 O
younger 271 278 384 391 O
and 279 282 392 395 O
no 283 285 396 398 O
more 286 290 399 403 O
than 291 295 404 408 O
10 296 298 409 411 O
years 299 304 412 417 O
older 305 310 418 423 O
than 311 315 424 428 O
expected 316 324 429 437 O
or 325 327 438 440 O
actual 328 334 441 447 O
age 335 338 448 451 O
of 339 341 452 454 O
cognitive 342 351 455 464 O
symptom 352 359 465 472 O
onset 360 365 473 478 O

Between 0 7 479 486 O
18 8 10 487 489 B-lower_bound
- 10 11 489 490 O
80 11 13 490 492 B-upper_bound
years 14 19 493 498 I-upper_bound
of 20 22 499 501 O
age 23 26 502 505 B-age

Cognitively 0 11 506 517 O
normal 12 18 518 524 O
or 19 21 525 527 O
with 22 26 528 532 O
mild 27 31 533 537 B-chronic_disease
cognitive 32 41 538 547 I-chronic_disease
impairment 42 52 548 558 I-chronic_disease
or 53 55 559 561 O
mild 56 60 562 566 O
dementia 61 69 567 575 B-chronic_disease
, 69 70 575 576 O
Clinical 71 79 577 585 B-clinical_variable
Dementia 80 88 586 594 I-clinical_variable
Rating 89 95 595 601 I-clinical_variable
( 96 97 602 603 I-clinical_variable
CDR 97 100 603 606 I-clinical_variable
) 100 101 606 607 I-clinical_variable
of 102 104 608 610 O
0 105 106 611 612 B-lower_bound
- 106 107 612 613 O
1 107 108 613 614 B-upper_bound

Have 0 4 615 619 O
been 5 9 620 624 O
exposed 10 17 625 632 O
to 18 20 633 635 O
a 21 22 636 637 O
monoclonal 23 33 638 648 B-treatment
antibody 34 42 649 657 I-treatment
targeting 43 52 658 667 I-treatment
beta 53 57 668 672 I-treatment
amyloid 58 65 673 680 I-treatment
peptide 66 73 681 688 I-treatment
within 74 80 689 695 O
the 81 84 696 699 O
past 85 89 700 704 B-upper_bound
six 90 93 705 708 I-upper_bound
months 94 100 709 715 I-upper_bound

History 0 7 716 723 O
of 8 10 724 726 O
cancer 11 17 727 733 B-cancer
within 18 24 734 740 O
the 25 28 741 744 O
last 29 33 745 749 B-upper_bound
5 34 35 750 751 I-upper_bound
years 36 41 752 757 I-upper_bound
, 41 42 757 758 O
except 43 49 759 765 O
basal 50 55 766 771 B-cancer
cell 56 60 772 776 I-cancer
carcinoma 61 70 777 786 I-cancer
, 70 71 786 787 O
non 72 75 788 791 B-cancer
- 75 76 791 792 I-cancer
squamous 76 84 792 800 I-cancer
skin 85 89 801 805 I-cancer
carcinoma 90 99 806 815 I-cancer
, 99 100 815 816 O
prostate 101 109 817 825 B-cancer
cancer 110 116 826 832 I-cancer
or 117 119 833 835 O
carcinoma 120 129 836 845 B-cancer
in 130 132 846 848 I-cancer
situ 133 137 849 853 I-cancer
with 138 142 854 858 O
no 143 145 859 861 O
significant 146 157 862 873 O
progression 158 169 874 885 O
over 170 174 886 890 O
the 175 178 891 894 O
past 179 183 895 899 B-lower_bound
2 184 185 900 901 I-lower_bound
years 186 191 902 907 I-lower_bound

History 0 7 908 915 O
or 8 10 916 918 O
presence 11 19 919 927 O
of 20 22 928 930 O
clinically 23 33 931 941 O
significant 34 45 942 953 O
cardiovascular 46 60 954 968 B-chronic_disease
disease 61 68 969 976 I-chronic_disease
, 68 69 976 977 O
hepatic 70 77 978 985 B-chronic_disease
/ 77 78 985 986 I-chronic_disease
renal 78 83 986 991 I-chronic_disease
disorders 84 93 992 1001 I-chronic_disease
, 93 94 1001 1002 O
infectious 95 105 1003 1013 B-chronic_disease
disease 106 113 1014 1021 I-chronic_disease
or 114 116 1022 1024 O
immune 117 123 1025 1031 B-chronic_disease
disorder 124 132 1032 1040 I-chronic_disease
, 132 133 1040 1041 O
or 134 136 1042 1044 O
metabolic 137 146 1045 1054 B-chronic_disease
/ 146 147 1054 1055 I-chronic_disease
endocrine 147 156 1055 1064 I-chronic_disease
disorders 157 166 1065 1074 I-chronic_disease

Individuals 0 11 1075 1086 O
who 12 15 1087 1090 O
know 16 20 1091 1095 O
they 21 25 1096 1100 O
have 26 30 1101 1105 O
an 31 33 1106 1108 O
Alzheimer 34 43 1109 1118 B-chronic_disease
's 43 45 1118 1120 I-chronic_disease
disease 46 53 1121 1128 I-chronic_disease
- 53 54 1128 1129 O
causing 54 61 1129 1136 O
mutation 62 70 1137 1145 O
or 71 73 1146 1148 O
are 74 77 1149 1152 O
unaware 78 85 1153 1160 O
of 86 88 1161 1163 O
their 89 94 1164 1169 O
genetic 95 102 1170 1177 O
status 103 109 1178 1184 O
and 110 113 1185 1188 O
have 114 118 1189 1193 O
an 119 121 1194 1196 O
autosomal 122 131 1197 1206 B-chronic_disease
dominant 132 140 1207 1215 I-chronic_disease
Alzheimer 141 150 1216 1225 I-chronic_disease
's 150 152 1225 1227 I-chronic_disease
disease 153 160 1228 1235 I-chronic_disease
( 161 162 1236 1237 I-chronic_disease
ADAD 162 166 1237 1241 I-chronic_disease
) 166 167 1241 1242 I-chronic_disease
mutation 168 176 1243 1251 O
in 177 179 1252 1254 O
their 180 185 1255 1260 O
family 186 192 1261 1267 O

Positive 0 8 1268 1276 B-pregnancy
urine 9 14 1277 1282 I-pregnancy
or 15 17 1283 1285 I-pregnancy
serum 18 23 1286 1291 I-pregnancy
pregnancy 24 33 1292 1301 I-pregnancy
test 34 38 1302 1306 O
or 39 41 1307 1309 O
plans 42 47 1310 1315 B-pregnancy
or 48 50 1316 1318 I-pregnancy
desires 51 58 1319 1326 I-pregnancy
to 59 61 1327 1329 I-pregnancy
become 62 68 1330 1336 I-pregnancy
pregnant 69 77 1337 1345 I-pregnancy
during 78 84 1346 1352 O
the 85 88 1353 1356 O
course 89 95 1357 1363 O
of 96 98 1364 1366 O
the 99 102 1367 1370 O
trial 103 108 1371 1376 O

Presence 0 8 1377 1385 O
of 9 11 1386 1388 O
pacemakers 12 22 1389 1399 B-treatment
, 22 23 1399 1400 O
aneurysm 24 32 1401 1409 B-treatment
clips 33 38 1410 1415 I-treatment
, 38 39 1415 1416 O
artificial 40 50 1417 1427 B-treatment
heart 51 56 1428 1433 I-treatment
valves 57 63 1434 1440 I-treatment
, 63 64 1440 1441 O
ear 65 68 1442 1445 O
implants 69 77 1446 1454 O
, 77 78 1454 1455 O
or 79 81 1456 1458 O
foreign 82 89 1459 1466 O
metal 90 95 1467 1472 O
objects 96 103 1473 1480 O
in 104 106 1481 1483 O
the 107 110 1484 1487 O
eyes 111 115 1488 1492 O
, 115 116 1492 1493 O
skin 117 121 1494 1498 O
or 122 124 1499 1501 O
body 125 129 1502 1506 O
which 130 135 1507 1512 O
would 136 141 1513 1518 O
preclude 142 150 1519 1527 O
MRI 151 154 1528 1531 O
scan 155 159 1532 1536 O

Subjects 0 8 1537 1545 O
unable 9 15 1546 1552 O
to 16 18 1553 1555 O
complete 19 27 1556 1564 O
all 28 31 1565 1568 O
study 32 37 1569 1574 O
related 38 45 1575 1582 O
testing 46 53 1583 1590 O
, 53 54 1590 1591 O
including 55 64 1592 1601 O
implanted 65 74 1602 1611 O
metal 75 80 1612 1617 O
that 81 85 1618 1622 O
can 86 89 1623 1626 O
not 89 92 1626 1629 O
be 93 95 1630 1632 O
removed 96 103 1633 1640 O
for 104 107 1641 1644 O
MRI 108 111 1645 1648 B-treatment
scanning 112 120 1649 1657 I-treatment
, 120 121 1657 1658 O
required 122 130 1659 1667 O
anticoagulation 131 146 1668 1683 B-treatment
and 147 150 1684 1687 O
pregnancy 151 160 1688 1697 B-pregnancy

24 0 2 0 2 B-clinical_variable
- 2 3 2 3 I-clinical_variable
item 3 7 3 7 I-clinical_variable
Hamilton 8 16 8 16 I-clinical_variable
Depression 17 27 17 27 I-clinical_variable
Rating 28 34 28 34 I-clinical_variable
Scale 35 40 35 40 I-clinical_variable
( 41 42 41 42 I-clinical_variable
HDRS 42 46 42 46 I-clinical_variable
) 46 47 46 47 I-clinical_variable
score 48 53 48 53 I-clinical_variable
of 54 56 54 56 O
at 57 59 57 59 O
least 60 65 60 65 O
21 66 68 66 68 B-lower_bound
on 69 71 69 71 O
the 72 75 72 75 O
first 76 81 76 81 O
17 82 84 82 84 O
items 85 90 85 90 O

A 0 1 91 92 O
recurrent 2 11 93 102 O
( 12 13 103 104 O
equal 13 18 104 109 O
or 19 21 110 112 O
> 22 23 113 114 O
4 23 24 114 115 B-lower_bound
episodes 25 33 116 124 I-lower_bound
) 33 34 124 125 O
or 35 37 126 128 O
chronic 38 45 129 136 O
( 46 47 137 138 O
episode 47 54 138 145 B-clinical_variable
duration 55 63 146 154 I-clinical_variable
equal 64 69 155 160 O
or 70 72 161 163 O
higher 73 79 164 170 O
> 80 81 171 172 O
2 81 82 172 173 B-lower_bound
years 83 88 174 179 I-lower_bound
) 88 89 179 180 O
course 90 96 181 187 O
AND 97 100 188 191 O
a 101 102 192 193 O
minimum 103 110 194 201 O
of 111 113 202 204 O
5 114 115 205 206 B-lower_bound
years 116 121 207 212 I-lower_bound
since 122 127 213 218 O
the 128 131 219 222 O
onset 132 137 223 228 O
of 138 140 229 231 O
the 141 144 232 235 O
first 145 150 236 241 O
depressive 151 161 242 252 O
episode 162 169 253 260 O

Adequate 0 8 261 269 O
trials 9 15 270 276 O
( 16 17 277 278 O
equal 17 22 278 283 O
or 23 25 284 286 O
> 26 27 287 288 O
6 27 28 288 289 B-lower_bound
weeks 29 34 290 295 I-lower_bound
at 35 37 296 298 O
the 38 41 299 302 O
maximum 42 49 303 310 O
recommended 50 61 311 322 O
or 62 64 323 325 O
tolerated 65 74 326 335 O
dose 75 79 336 340 O
) 79 80 340 341 O
of 81 83 342 344 O
primary 84 91 345 352 O
antidepressants 92 107 353 368 B-treatment
from 108 112 369 373 O
at 113 115 374 376 O
least 116 121 377 382 O
3 122 123 383 384 B-lower_bound
different 124 133 385 394 O
classes 134 141 395 402 O

Age 0 3 403 406 B-age
22 4 6 407 409 B-lower_bound
- 7 8 410 411 O
65 9 11 412 414 B-upper_bound
years 12 17 415 420 I-upper_bound

An 0 2 421 423 O
adequate 3 11 424 432 O
trial 12 17 433 438 O
of 18 20 439 441 O
ECT 21 24 442 445 B-treatment
( 25 26 446 447 O
> 26 27 447 448 O
6 27 28 448 449 B-lower_bound
bilateral 29 38 450 459 B-treatment
treatments 39 49 460 470 I-treatment
) 49 50 470 471 O
, 50 51 471 472 O
or 52 54 473 475 O
inability 55 64 476 485 O
to 65 67 486 488 O
tolerate 68 76 489 497 O
an 77 79 498 500 O
adequate 80 88 501 509 O
ECT 89 92 510 513 O
trial 93 98 514 519 O

An 0 2 520 522 O
adequate 3 11 523 531 O
trial 12 17 532 537 O
of 18 20 538 540 O
individual 21 31 541 551 O
psychotherapy 32 45 552 565 B-treatment
( 46 47 566 567 O
> 47 48 567 568 O
20 48 50 568 570 B-lower_bound
sessions 51 59 571 579 O
with 60 64 580 584 O
an 65 67 585 587 O
experienced 68 79 588 599 O
psychotherapist 80 95 600 615 O
) 95 96 615 616 O

Any 0 3 617 620 O
clinically 4 14 621 631 O
significant 15 26 632 643 O
abnormality 27 38 644 655 O
on 39 41 656 658 O
preoperative 42 54 659 671 O
magnetic 55 63 672 680 B-treatment
resonance 64 73 681 690 I-treatment
imaging 74 81 691 698 I-treatment
( 82 83 699 700 I-treatment
MRI 83 86 700 703 I-treatment
) 86 87 703 704 I-treatment

Any 0 3 705 708 O
current 4 11 709 716 O
clinically 12 22 717 727 O
significant 23 34 728 739 O
neurological 35 47 740 752 B-chronic_disease
disorder 48 56 753 761 I-chronic_disease
, 56 57 761 762 O
including 58 67 763 772 O
dementia 68 76 773 781 B-chronic_disease
or 77 79 782 784 O
medical 80 87 785 792 O
illness 88 95 793 800 O
affecting 96 105 801 810 O
brain 106 111 811 816 O
function 112 120 817 825 O

Any 0 3 826 829 O
previous 4 12 830 838 B-treatment
surgery 13 20 839 846 I-treatment
to 21 23 847 849 O
destroy 24 31 850 857 O
the 32 35 858 861 O
region 36 42 862 868 O
of 43 45 869 871 O
the 46 49 872 875 O
brain 50 55 876 881 O
that 56 60 882 886 O
will 61 65 887 891 O
be 66 68 892 894 O
the 69 72 895 898 O
target 73 79 899 905 O
of 80 82 906 908 O
treatment 83 92 909 918 B-treatment

Any 0 3 919 922 O
surgical 4 12 923 931 O
contraindications 13 30 932 949 O
to 31 33 950 952 O
undergoing 34 44 953 963 O
DBS 45 48 964 967 B-treatment
, 48 49 967 968 O
including 50 59 969 978 O
labeled 60 67 979 986 O
contraindications 68 85 987 1004 O
for 86 89 1005 1008 O
DBS 90 93 1009 1012 O
and/or 94 100 1013 1019 O
inability 101 110 1020 1029 O
to 111 113 1030 1032 O
undergo 114 121 1033 1040 O
presurgical 122 133 1041 1052 B-treatment
MRI 134 137 1053 1056 I-treatment
( 138 139 1057 1058 O
cardiac 139 146 1058 1065 B-treatment
pacemaker 147 156 1066 1075 I-treatment
, 156 157 1075 1076 O
implantable 158 169 1077 1088 B-treatment
defibrillator 170 183 1089 1102 I-treatment
or 184 186 1103 1105 O
other 187 192 1106 1111 O
implantable 193 204 1112 1123 B-treatment
stimulator 205 215 1124 1134 I-treatment
, 215 216 1134 1135 O
pregnancy 217 226 1136 1145 B-pregnancy
, 226 227 1145 1146 O
metal 228 233 1147 1152 O
in 234 236 1153 1155 O
body 237 241 1156 1160 O
, 241 242 1160 1161 O
severe 243 249 1162 1168 O
claustrophobia 250 264 1169 1183 B-chronic_disease
) 264 265 1183 1184 O
, 265 266 1184 1185 O
infection 267 276 1186 1195 B-chronic_disease
, 276 277 1195 1196 O
coagulopathy 278 290 1197 1209 B-chronic_disease
, 290 291 1209 1210 O
inability 292 301 1211 1220 O
to 302 304 1221 1223 O
undergo 305 312 1224 1231 O
an 313 315 1232 1234 O
awake 316 321 1235 1240 O
operation 322 331 1241 1250 O
, 331 332 1250 1251 O
significant 333 344 1252 1263 O
cardiac 345 352 1264 1271 O
or 353 355 1272 1274 O
other 356 361 1275 1280 O
medical 362 369 1281 1288 O
risk 370 374 1289 1293 O
factors 375 382 1294 1301 O
for 383 386 1302 1305 O
surgery 387 394 1306 1313 B-treatment

Current 0 7 1314 1321 O
or 8 10 1322 1324 O
past 11 15 1325 1329 O
non 16 19 1330 1333 O
- 19 20 1333 1334 O
affective 20 29 1334 1343 O
psychotic 30 39 1344 1353 B-chronic_disease
disorder 40 48 1354 1362 I-chronic_disease
, 48 49 1362 1363 O
Bipolar 50 57 1364 1371 B-chronic_disease
Disorder 58 66 1372 1380 I-chronic_disease
, 66 67 1380 1381 O
Schizophrenia 68 81 1382 1395 B-chronic_disease
, 81 82 1395 1396 O
or 83 85 1397 1399 O
Schizoaffective 86 101 1400 1415 B-chronic_disease
disorder 102 110 1416 1424 I-chronic_disease

Global 0 6 1425 1431 B-clinical_variable
Assessment 7 17 1432 1442 I-clinical_variable
of 18 20 1443 1445 I-clinical_variable
Function 21 29 1446 1454 I-clinical_variable
( 30 31 1455 1456 I-clinical_variable
GAF 31 34 1456 1459 I-clinical_variable
) 34 35 1459 1460 I-clinical_variable
score 36 41 1461 1466 I-clinical_variable
of 42 44 1467 1469 O
45 45 47 1470 1472 B-upper_bound
or 48 50 1473 1475 O
less 51 55 1476 1480 O

History 0 7 1481 1488 O
of 8 10 1489 1491 O
severe 11 17 1492 1498 O
personality 18 29 1499 1510 B-chronic_disease
disorder 30 38 1511 1519 I-chronic_disease
, 38 39 1519 1520 O
where 40 45 1521 1526 O
, 45 46 1526 1527 O
based 47 52 1528 1533 O
on 53 55 1534 1536 O
the 56 59 1537 1540 O
judgment 60 68 1541 1549 O
of 69 71 1550 1552 O
the 72 75 1553 1556 O
investigators 76 89 1557 1570 O
, 89 90 1570 1571 O
the 91 94 1572 1575 O
personality 95 106 1576 1587 O
disorder 107 115 1588 1596 O
will 116 120 1597 1601 O
interfere 121 130 1602 1611 O
with 131 135 1612 1616 O
the 136 139 1617 1620 O
patient 140 147 1621 1628 O
's 147 149 1628 1630 O
ability 150 157 1631 1638 O
to 158 160 1639 1641 O
complete 161 169 1642 1650 O
the 170 173 1651 1654 O
follow 174 180 1655 1661 O
- 180 181 1661 1662 O
up 181 183 1662 1664 O
protocol 184 192 1665 1673 O
, 192 193 1673 1674 O
e.g. 194 198 1675 1679 O
borderline 199 209 1680 1690 B-chronic_disease
personality 210 221 1691 1702 I-chronic_disease
disorder 222 230 1703 1711 I-chronic_disease

Imminent 0 8 1712 1720 O
risk 9 13 1721 1725 O
of 14 16 1726 1728 O
suicide 17 24 1729 1736 B-chronic_disease

Major 0 5 1737 1742 B-chronic_disease
Depression 6 16 1743 1753 I-chronic_disease
Disorder 17 25 1754 1762 I-chronic_disease
( 26 27 1763 1764 I-chronic_disease
MDD 27 30 1764 1767 I-chronic_disease
) 30 31 1767 1768 I-chronic_disease
diagnosed 32 41 1769 1778 O
by 42 44 1779 1781 O
Structured 45 55 1782 1792 O
Clinical 56 64 1793 1801 O
Interview 65 74 1802 1811 O
for 75 78 1812 1815 O
DSM 79 82 1816 1819 O
- 82 83 1819 1820 O
IV 83 85 1820 1822 O
( 86 87 1823 1824 O
SCID 87 91 1824 1828 O
I 92 93 1829 1830 O
/ 93 94 1830 1831 O
DSM 94 97 1831 1834 O
- 97 98 1834 1835 O
IV 98 100 1835 1837 O
) 100 101 1837 1838 O
, 101 102 1838 1839 O
judged 103 109 1840 1846 O
to 110 112 1847 1849 O
be 113 115 1850 1852 O
of 116 118 1853 1855 O
disabling 119 128 1856 1865 O
severity 129 137 1866 1874 O

Major 0 5 1875 1880 O
impairment 6 16 1881 1891 O
in 17 19 1892 1894 O
functioning 20 31 1895 1906 O
or 32 34 1907 1909 O
potentially 35 46 1910 1921 O
severe 47 53 1922 1928 O
medical 54 61 1929 1936 O
outcomes 62 70 1937 1945 O
( 71 72 1946 1947 O
repeated 72 80 1947 1955 O
hospitalizations 81 97 1956 1972 B-treatment
, 97 98 1972 1973 O
serious 99 106 1974 1981 O
suicidal 107 115 1982 1990 B-chronic_disease
or 116 118 1991 1993 O
other 119 124 1994 1999 O
self 125 129 2000 2004 O
- 129 130 2004 2005 O
injurious 130 139 2005 2014 O
behavior 140 148 2015 2023 O
) 148 149 2023 2024 O

No 0 2 2025 2027 O
alcohol 3 10 2028 2035 O
and/or 11 17 2036 2042 O
substance 18 27 2043 2052 O
abuse 28 33 2053 2058 O
or 34 36 2059 2061 O
dependence 37 47 2062 2072 O
in 48 50 2073 2075 O
the 51 54 2076 2079 O
past 55 59 2080 2084 B-upper_bound
6 60 61 2085 2086 I-upper_bound
months 62 68 2087 2093 I-upper_bound

No 0 2 2094 2096 O
changes 3 10 2097 2104 O
in 11 13 2105 2107 O
medication 14 24 2108 2118 B-treatment
treatment 25 34 2119 2128 I-treatment
during 35 41 2129 2135 O
participation 42 55 2136 2149 O
in 56 58 2150 2152 O
study 59 64 2153 2158 O

On 0 2 2159 2161 O
a 3 4 2162 2163 O
stable 5 11 2164 2170 O
drug 12 16 2171 2175 O
regimen 17 24 2176 2183 O
of 25 27 2184 2186 O
psychotropic 28 40 2187 2199 B-treatment
medication 41 51 2200 2210 I-treatment
for 52 55 2211 2214 O
at 56 58 2215 2217 O
least 59 64 2218 2223 O
6 65 66 2224 2225 B-lower_bound
weeks 67 72 2226 2231 I-lower_bound
at 73 75 2232 2234 O
the 76 79 2235 2238 O
time 80 84 2239 2243 O
of 85 87 2244 2246 O
entry 88 93 2247 2252 O
into 94 98 2253 2257 O
the 99 102 2258 2261 O
study 103 108 2262 2267 O

Participation 0 13 2268 2281 O
in 14 16 2282 2284 O
another 17 24 2285 2292 B-treatment
drug 25 29 2293 2297 I-treatment
, 29 30 2297 2298 I-treatment
device 31 37 2299 2305 I-treatment
, 37 38 2305 2306 I-treatment
or 39 41 2307 2309 I-treatment
biologics 42 51 2310 2319 I-treatment
trial 52 57 2320 2325 I-treatment
within 58 64 2326 2332 O
the 65 68 2333 2336 O
preceding 69 78 2337 2346 B-upper_bound
30 79 81 2347 2349 I-upper_bound
days 82 86 2350 2354 I-upper_bound

Patients 0 8 2355 2363 O
who 9 12 2364 2367 O
suffer 13 19 2368 2374 O
from 20 24 2375 2379 O
generalized 25 36 2380 2391 O
anxiety 37 44 2392 2399 B-chronic_disease
disorder 45 53 2400 2408 I-chronic_disease

Pregnancy 0 9 2409 2418 B-pregnancy

Presence 0 8 2419 2427 O
of 9 11 2428 2430 O
a 12 13 2431 2432 O
condition 14 23 2433 2442 O
requiring 24 33 2443 2452 O
diathermy 34 43 2453 2462 B-treatment

Presence 0 8 2463 2471 O
of 9 11 2472 2474 O
a 12 13 2475 2476 O
condition 14 23 2477 2486 O
requiring 24 33 2487 2496 O
routine 34 41 2497 2504 O
MRIs 42 46 2505 2509 B-treatment

Refusal 0 7 2510 2517 O
of 8 10 2518 2520 O
an 11 13 2521 2523 O
adequate 14 22 2524 2532 O
trial 23 28 2533 2538 O
of 29 31 2539 2541 O
ECT 32 35 2542 2545 B-treatment

Subject 0 7 2546 2553 O
is 8 10 2554 2556 O
on 11 13 2557 2559 O
anticoagulant 14 27 2560 2573 B-treatment
medication 28 38 2574 2584 O

Terminal 0 8 2585 2593 O
illness 9 16 2594 2601 O
associated 17 27 2602 2612 O
with 28 32 2613 2617 O
expected 33 41 2618 2626 B-clinical_variable
survival 42 50 2627 2635 I-clinical_variable
of 51 53 2636 2638 O
< 54 55 2639 2640 O
12 55 57 2640 2642 B-upper_bound
months 58 64 2643 2649 I-upper_bound

adequate 0 8 2650 2658 O
trials 9 15 2659 2665 O
( 16 17 2666 2667 O
equal>4 18 25 2668 2675 O
weeks 26 31 2676 2681 I-lower_bound
at 32 34 2682 2684 O
the 35 38 2685 2688 O
usually 39 46 2689 2696 O
recommended 47 58 2697 2708 O
or 59 61 2709 2711 O
maximum 62 69 2712 2719 O
tolerated 70 79 2720 2729 O
dose 80 84 2730 2734 O
) 84 85 2734 2735 O
of 86 88 2736 2738 O
augmentation 89 101 2739 2751 O
/ 101 102 2751 2752 O
combination 102 113 2752 2763 O
of 114 116 2764 2766 O
a 117 118 2767 2768 O
primary 119 126 2769 2776 O
antidepressant 127 141 2777 2791 B-treatment
using 142 147 2792 2797 O
at 148 150 2798 2800 O
least 151 156 2801 2806 O
2 157 158 2807 2808 B-lower_bound
different 159 168 2809 2818 O
augmenting 169 179 2819 2829 O
/ 179 180 2829 2830 O
combination 180 191 2830 2841 O
agents 192 198 2842 2848 O
( 199 200 2849 2850 O
lithium 200 207 2850 2857 B-treatment
, 207 208 2857 2858 O
T3 209 211 2859 2861 B-treatment
, 211 212 2861 2862 O
stimulants 213 223 2863 2873 B-treatment
, 223 224 2873 2874 O
neuroleptics 225 237 2875 2887 B-treatment
, 237 238 2887 2888 O
anticonvulsants 239 254 2889 2904 B-treatment
, 254 255 2904 2905 O
buspirone 256 265 2906 2915 B-treatment
, 265 266 2915 2916 O
or 267 269 2917 2919 O
a 270 271 2920 2921 O
second 272 278 2922 2928 B-treatment
primary 279 286 2929 2936 I-treatment
antidepressant 287 301 2937 2951 I-treatment
) 301 302 2951 2952 O

not 0 3 2953 2956 B-contraception_consent
using 4 9 2957 2962 I-contraception_consent
effective 10 19 2963 2972 I-contraception_consent
contraception 20 33 2973 2986 I-contraception_consent

women 0 5 2987 2992 B-gender
of 6 8 2993 2995 O
childbearing 9 21 2996 3008 O
age 22 25 3009 3012 B-age

Active 0 6 0 6 O
vaginal 7 14 7 14 B-clinical_variable
bleeding 15 23 15 23 I-clinical_variable
greater 24 31 24 31 O
than 32 36 32 36 O
spotting 37 45 37 45 O
at 46 48 46 48 O
the 49 52 49 52 O
time 53 57 53 57 O
of 58 60 58 60 O
randomization 61 74 61 74 O
, 74 75 74 75 O
because 76 83 76 83 O
of 84 86 84 86 O
potential 87 96 87 96 O
exacerbation 97 109 97 109 O
due 110 113 110 113 O
to 114 116 114 116 O
pessary 117 124 117 124 B-treatment
placement 125 134 125 134 I-treatment

Active 0 6 135 141 O
, 6 7 141 142 O
unhealed 8 16 143 151 O
herpetic 17 25 152 160 B-chronic_disease
lesion 26 32 161 167 I-chronic_disease
on 33 35 168 170 I-chronic_disease
labia 36 41 171 176 I-chronic_disease
minora 42 48 177 183 I-chronic_disease
, 48 49 183 184 O
vagina 50 56 185 191 B-chronic_disease
, 56 57 191 192 O
or 58 60 193 195 O
cervix 61 67 196 202 B-chronic_disease
due 68 71 203 206 O
to 72 74 207 209 O
the 75 78 210 213 O
potential 79 88 214 223 O
for 89 92 224 227 O
significant 93 104 228 239 O
patient 105 112 240 247 O
discomfort 113 123 248 258 O
or 124 126 259 261 O
increasing 127 137 262 272 O
genital 138 145 273 280 O
tract 146 151 281 286 O
viral 152 157 287 292 O
spread 158 164 293 299 O
. 164 165 299 300 O
Once 166 170 301 305 O
lesion(s 171 179 306 314 O
) 179 180 314 315 O
heal 181 185 316 320 O
and 186 189 321 324 O
the 190 193 325 328 O
patient 194 201 329 336 O
is 202 204 337 339 O
asymptomatic 205 217 340 352 O
, 217 218 352 353 O
she 219 222 354 357 O
may 223 226 358 361 O
be 227 229 362 364 O
randomized 230 240 365 375 O

Allergy 0 7 376 383 O
to 8 10 384 386 O
progesterone 11 23 387 399 B-allergy_name
, 23 24 399 400 O
silicone 25 33 401 409 B-allergy_name
, 33 34 409 410 O
or 35 37 411 413 O
excipients 38 48 414 424 O
in 49 51 425 427 O
the 52 55 428 431 O
study 56 61 432 437 B-treatment
drug 62 66 438 442 I-treatment
, 66 67 442 443 O
including 68 77 444 453 O
peanuts 78 85 454 461 B-allergy_name
or 86 88 462 464 O
peanut 89 95 465 471 B-allergy_name
oil 96 99 472 475 I-allergy_name
in 100 102 476 478 O
the 103 106 479 482 O
study 107 112 483 488 O
drug 113 117 489 493 O
or 118 120 494 496 O
placebo 121 128 497 504 B-allergy_name

Any 0 3 505 508 O
fetal 4 9 509 514 B-chronic_disease
/ 9 10 514 515 O
maternal 10 18 515 523 B-chronic_disease
condition 19 28 524 533 I-chronic_disease
which 29 34 534 539 O
would 35 40 540 545 O
require 41 48 546 553 O
invasive 49 57 554 562 O
in 58 60 563 565 O
- 60 61 565 566 O
utero 61 66 566 571 O
assessment 67 77 572 582 O
or 78 80 583 585 O
treatment 81 90 586 595 B-treatment
, 90 91 595 596 O
for 92 95 597 600 O
example 96 103 601 608 O
significant 104 115 609 620 O
red 116 119 621 624 O
cell 120 124 625 629 O
antigen 125 132 630 637 O
sensitization 133 146 638 651 O
or 147 149 652 654 O
neonatal 150 158 655 663 B-chronic_disease
alloimmune 159 169 664 674 I-chronic_disease
thrombocytopenia 170 186 675 691 I-chronic_disease

Cervical 0 8 692 700 O
dilation 9 17 701 709 O
( 18 19 710 711 O
internal 19 27 711 719 O
os 28 30 720 722 O
) 30 31 722 723 O
3 32 33 724 725 B-lower_bound
cm 34 36 726 728 I-lower_bound
or 37 39 729 731 O
greater 40 47 732 739 O
on 48 50 740 742 O
digital 51 58 743 750 B-treatment
examination 59 70 751 762 I-treatment
or 71 73 763 765 O
evidence 74 82 766 774 O
of 83 85 775 777 O
prolapsed 86 95 778 787 O
membranes 96 105 788 797 O
beyond 106 112 798 804 O
the 113 116 805 808 O
external 117 125 809 817 O
cervical 126 134 818 826 O
os 135 137 827 829 O
either 138 144 830 836 O
at 145 147 837 839 O
the 148 151 840 843 O
time 152 156 844 848 O
of 157 159 849 851 O
the 160 163 852 855 O
qualifying 164 174 856 866 O
cervical 175 183 867 875 B-treatment
ultrasound 184 194 876 886 I-treatment
examination 195 206 887 898 I-treatment
or 207 209 899 901 O
at 210 212 902 904 O
a 213 214 905 906 O
cervical 215 223 907 915 O
exam 224 228 916 920 O
immediately 229 240 921 932 O
before 241 247 933 939 O
randomization 248 261 940 953 O
. 261 262 953 954 O
There 263 268 955 960 O
is 269 271 961 963 O
no 272 274 964 966 O
lower 275 280 967 972 O
threshold 281 290 973 982 O
of 291 293 983 985 O
cervical 294 302 986 994 O
length 303 309 995 1001 O
measurement 310 321 1002 1013 O
threshold 322 331 1014 1023 O
on 332 334 1024 1026 O
ultrasound 335 345 1027 1037 O

Cervical 0 8 1038 1046 O
length 9 15 1047 1053 O
on 16 18 1054 1056 O
transvaginal 19 31 1057 1069 B-treatment
examination 32 43 1070 1081 I-treatment
of 44 46 1082 1084 O
less 47 51 1085 1089 O
than 52 56 1090 1094 O
30 57 59 1095 1097 B-upper_bound
mm 60 62 1098 1100 I-upper_bound
within 63 69 1101 1107 O
10 70 72 1108 1110 B-upper_bound
days 73 77 1111 1115 I-upper_bound
prior 78 83 1116 1121 I-upper_bound
to 84 86 1122 1124 O
randomization 87 100 1125 1138 O
by 101 103 1139 1141 O
a 104 105 1142 1143 O
study 106 111 1144 1149 O
certified 112 121 1150 1159 O
sonographer 122 133 1160 1171 O

Evidence 0 8 1172 1180 O
of 9 11 1181 1183 O
severe 12 18 1184 1190 B-chronic_disease
IUGR 19 23 1191 1195 I-chronic_disease
( 24 25 1196 1197 I-chronic_disease
intrauterine 25 37 1197 1209 I-chronic_disease
growth 38 44 1210 1216 I-chronic_disease
restriction 45 56 1217 1228 I-chronic_disease
) 56 57 1228 1229 I-chronic_disease
( 58 59 1230 1231 O
< 59 60 1231 1232 O
5th 60 63 1232 1235 B-upper_bound
percentile 64 74 1236 1246 I-upper_bound
for 75 78 1247 1250 O
gestational 79 90 1251 1262 B-clinical_variable
age 91 94 1263 1266 I-clinical_variable
) 94 95 1266 1267 O
in 96 98 1268 1270 O
either 99 105 1271 1277 O
fetus 106 111 1278 1283 O

Fetal 0 5 1284 1289 B-chronic_disease
anomaly 6 13 1290 1297 I-chronic_disease
in 14 16 1298 1300 O
either 17 23 1301 1307 O
twin 24 28 1308 1312 O
or 29 31 1313 1315 O
imminent 32 40 1316 1324 O
fetal 41 46 1325 1330 O
demise 47 53 1331 1337 O
. 53 54 1337 1338 O
This 55 59 1339 1343 O
includes 60 68 1344 1352 O
lethal 69 75 1353 1359 B-chronic_disease
anomalies 76 85 1360 1369 I-chronic_disease
, 85 86 1369 1370 O
or 87 89 1371 1373 O
anomalies 90 99 1374 1383 O
that 100 104 1384 1388 O
may 105 108 1389 1392 O
lead 109 113 1393 1397 O
to 114 116 1398 1400 O
early 117 122 1401 1406 O
delivery 123 131 1407 1415 O
or 132 134 1416 1418 O
increased 135 144 1419 1428 O
risk 145 149 1429 1433 O
of 150 152 1434 1436 O
neonatal 153 161 1437 1445 O
death 162 167 1446 1451 O
e.g. 168 172 1452 1456 O
, 172 173 1456 1457 O
gastroschisis 174 187 1458 1471 B-chronic_disease
, 187 188 1471 1472 O
spina 189 194 1473 1478 B-chronic_disease
bifida 195 201 1479 1485 I-chronic_disease
, 201 202 1485 1486 O
serious 203 210 1487 1494 O
karyotypic 211 221 1495 1505 B-chronic_disease
abnormalities 222 235 1506 1519 I-chronic_disease
) 235 236 1519 1520 O
. 236 237 1520 1521 O
An 238 240 1522 1524 O
ultrasound 241 251 1525 1535 O
examination 252 263 1536 1547 O
from 264 268 1548 1552 O
14 269 271 1553 1555 B-lower_bound
weeks 272 277 1556 1561 I-lower_bound
0 278 279 1562 1563 I-lower_bound
days 280 284 1564 1568 I-lower_bound
to 285 287 1569 1571 O
23 288 290 1572 1574 B-upper_bound
weeks 291 296 1575 1580 I-upper_bound
6 297 298 1581 1582 I-upper_bound
days 299 303 1583 1587 I-upper_bound
by 304 306 1588 1590 O
project 307 314 1591 1598 O
EDC 315 318 1599 1602 O
( 319 320 1603 1604 O
estimated 320 329 1604 1613 O
date 330 334 1614 1618 O
of 335 337 1619 1621 O
conception 338 348 1622 1632 O
) 348 349 1632 1633 O
must 350 354 1634 1638 O
be 355 357 1639 1641 O
performed 358 367 1642 1651 O
prior 368 373 1652 1657 O
to 374 376 1658 1660 O
randomization 377 390 1661 1674 O
to 391 393 1675 1677 O
evaluate 394 402 1678 1686 O
the 403 406 1687 1690 O
fetuses 407 414 1691 1698 O
for 415 418 1699 1702 O
anomalies 419 428 1703 1712 O

Gestational 0 11 1713 1724 B-clinical_variable
age 12 15 1725 1728 I-clinical_variable
at 16 18 1729 1731 O
randomization 19 32 1732 1745 O
between 33 40 1746 1753 O
16 41 43 1754 1756 B-lower_bound
weeks 44 49 1757 1762 I-lower_bound
0 50 51 1763 1764 I-lower_bound
days 52 56 1765 1769 I-lower_bound
and 57 60 1770 1773 O
23 61 63 1774 1776 B-upper_bound
weeks 64 69 1777 1782 I-upper_bound
6 70 71 1783 1784 I-upper_bound
days 72 76 1785 1789 I-upper_bound
based 77 82 1790 1795 O
on 83 85 1796 1798 O
clinical 86 94 1799 1807 O
information 95 106 1808 1819 O
and 107 110 1820 1823 O
evaluation 111 121 1824 1834 O
of 122 124 1835 1837 O
the 125 128 1838 1841 O
earliest 129 137 1842 1850 O
ultrasound 138 148 1851 1861 O

History 0 7 1862 1869 O
of 8 10 1870 1872 O
herpes 11 17 1873 1879 B-chronic_disease

Known 0 5 1880 1885 O
liver 6 11 1886 1891 B-chronic_disease
dysfunction 12 23 1892 1903 I-chronic_disease
or 24 26 1904 1906 O
disease 27 34 1907 1914 O
because 35 42 1915 1922 O
liver 43 48 1923 1928 B-chronic_disease
disease 49 56 1929 1936 I-chronic_disease
is 57 59 1937 1939 O
a 60 61 1940 1941 O
contraindication 62 78 1942 1958 O
to 79 81 1959 1961 O
the 82 85 1962 1965 O
active 86 92 1966 1972 O
study 93 98 1973 1978 B-treatment
medication 99 109 1979 1989 I-treatment

Known 0 5 1990 1995 O
major 6 11 1996 2001 O
Mullerian 12 21 2002 2011 B-chronic_disease
anomaly 22 29 2012 2019 I-chronic_disease
of 30 32 2020 2022 I-chronic_disease
the 33 36 2023 2026 I-chronic_disease
uterus 37 43 2027 2033 I-chronic_disease
( 44 45 2034 2035 O
specifically 45 57 2035 2047 O
bicornuate 58 68 2048 2058 B-chronic_disease
, 68 69 2058 2059 O
unicornuate 70 81 2060 2071 B-chronic_disease
, 81 82 2071 2072 O
or 83 85 2073 2075 O
uterine 86 93 2076 2083 B-chronic_disease
septum 94 100 2084 2090 I-chronic_disease
not 101 104 2091 2094 O
resected 105 113 2095 2103 O
) 113 114 2103 2104 O
due 115 118 2105 2108 O
to 119 121 2109 2111 O
increased 122 131 2112 2121 O
risk 132 136 2122 2126 O
of 137 139 2127 2129 O
preterm 140 147 2130 2137 O
delivery 148 156 2138 2146 O
which 157 162 2147 2152 O
is 163 165 2153 2155 O
unlikely 166 174 2156 2164 O
to 175 177 2165 2167 O
be 178 180 2168 2170 O
affected 181 189 2171 2179 O
by 190 192 2180 2182 O
progesterone 193 205 2183 2195 B-treatment

Known 0 5 2196 2201 O
, 5 6 2201 2202 O
suspected 7 16 2203 2212 O
or 17 19 2213 2215 O
history 20 27 2216 2223 O
of 28 30 2224 2226 O
breast 31 37 2227 2233 B-cancer
cancer 38 44 2234 2240 I-cancer
because 45 52 2241 2248 O
breast 53 59 2249 2255 O
cancer 60 66 2256 2262 O
is 67 69 2263 2265 O
a 70 71 2266 2267 O
contraindication 72 88 2268 2284 O
to 89 91 2285 2287 O
the 92 95 2288 2291 O
active 96 102 2292 2298 O
study 103 108 2299 2304 O
medication 109 119 2305 2315 B-treatment

Major 0 5 2316 2321 O
maternal 6 14 2322 2330 O
medical 15 22 2331 2338 O
illness 23 30 2339 2346 O
associated 31 41 2347 2357 O
with 42 46 2358 2362 O
increased 47 56 2363 2372 O
risk 57 61 2373 2377 O
for 62 65 2378 2381 O
adverse 66 73 2382 2389 O
pregnancy 74 83 2390 2399 B-pregnancy
outcome 84 91 2400 2407 O
or 92 94 2408 2410 O
indicated 95 104 2411 2420 O
preterm 105 112 2421 2428 O
birth 113 118 2429 2434 O
( 119 120 2435 2436 O
treated 120 127 2436 2443 O
hypertension 128 140 2444 2456 B-chronic_disease
requiring 141 150 2457 2466 O
more 151 155 2467 2471 O
than 156 160 2472 2476 O
one 161 164 2477 2480 B-lower_bound
agent 165 170 2481 2486 O
, 170 171 2486 2487 O
pre 172 175 2488 2491 B-treatment
- 175 176 2491 2492 I-treatment
gestational 176 187 2492 2503 I-treatment
treatment 188 197 2504 2513 I-treatment
for 198 201 2514 2517 O
diabetes 202 210 2518 2526 B-chronic_disease
prior 211 216 2527 2532 O
to 217 219 2533 2535 O
pregnancy 220 229 2536 2545 O
, 229 230 2545 2546 O
chronic 231 238 2547 2554 O
renal 239 244 2555 2560 B-chronic_disease
insufficiency 245 258 2561 2574 I-chronic_disease
failure 259 266 2575 2582 O
defined 267 274 2583 2590 O
by 275 277 2591 2593 O
creatinine 278 288 2594 2604 B-clinical_variable
> 289 290 2605 2606 O
1.4 290 293 2606 2609 B-lower_bound
mg 294 296 2610 2612 I-lower_bound
/ 296 297 2612 2613 I-lower_bound
dL 297 299 2613 2615 I-lower_bound
, 299 300 2615 2616 O
carcinoma 301 310 2617 2626 B-cancer
of 311 313 2627 2629 I-cancer
the 314 317 2630 2633 I-cancer
breast 318 324 2634 2640 I-cancer
, 324 325 2640 2641 O
conditions 326 336 2642 2652 O
treated 337 344 2653 2660 O
with 345 349 2661 2665 O
chronic 350 357 2666 2673 B-treatment
oral 358 362 2674 2678 I-treatment
glucocorticoid 363 377 2679 2693 I-treatment
therapy 378 385 2694 2701 I-treatment

Monoamniotic 0 12 2702 2714 O
gestation 13 22 2715 2724 O
, 22 23 2724 2725 O
due 24 27 2726 2729 O
to 28 30 2730 2732 O
increased 31 40 2733 2742 O
risk 41 45 2743 2747 O
of 46 48 2748 2750 O
adverse 49 56 2751 2758 O
pregnancy 57 66 2759 2768 B-pregnancy
outcome 67 74 2769 2776 O

More 0 4 2777 2781 O
than 5 9 2782 2786 O
six 10 13 2787 2790 B-lower_bound
contractions 14 26 2791 2803 O
per 27 30 2804 2807 O
hour 31 35 2808 2812 O
reported 36 44 2813 2821 O
or 45 47 2822 2824 O
documented 48 58 2825 2835 O
prior 59 64 2836 2841 O
to 65 67 2842 2844 O
randomization 68 81 2845 2858 O
. 81 82 2858 2859 O
It 83 85 2860 2862 O
is 86 88 2863 2865 O
not 89 92 2866 2869 O
necessary 93 102 2870 2879 O
to 103 105 2880 2882 O
place 106 111 2883 2888 O
the 112 115 2889 2892 O
patient 116 123 2893 2900 O
on 124 126 2901 2903 O
a 127 128 2904 2905 O
tocodynamometer 129 144 2906 2921 B-treatment

Participation 0 13 2922 2935 O
in 14 16 2936 2938 O
another 17 24 2939 2946 B-treatment
interventional 25 39 2947 2961 I-treatment
study 40 45 2962 2967 I-treatment
that 46 50 2968 2972 O
influences 51 61 2973 2983 O
gestational 62 73 2984 2995 B-clinical_variable
age 74 77 2996 2999 I-clinical_variable
at 78 80 3000 3002 O
delivery 81 89 3003 3011 O
or 90 92 3012 3014 O
neonatal 93 101 3015 3023 O
morbidity 102 111 3024 3033 O
or 112 114 3034 3036 O
mortality 115 124 3037 3046 O

Participation 0 13 3047 3060 O
in 14 16 3061 3063 O
this 17 21 3064 3068 O
trial 22 27 3069 3074 O
in 28 30 3075 3077 O
a 31 32 3078 3079 O
previous 33 41 3080 3088 O
pregnancy 42 51 3089 3098 B-pregnancy

Patients 0 8 3099 3107 O
who 9 12 3108 3111 O
were 13 17 3112 3116 O
screened 18 26 3117 3125 O
in 27 29 3126 3128 O
a 30 31 3129 3130 O
previous 32 40 3131 3139 O
pregnancy 41 50 3140 3149 B-pregnancy
, 50 51 3149 3150 O
but 52 55 3151 3154 O
not 56 59 3155 3158 O
randomized 60 70 3159 3169 O

Placenta 0 8 3170 3178 B-chronic_disease
previa 9 15 3179 3185 I-chronic_disease
, 15 16 3185 3186 O
because 17 24 3187 3194 O
of 25 27 3195 3197 O
risk 28 32 3198 3202 O
of 33 35 3203 3205 O
bleeding 36 44 3206 3214 O
and 45 48 3215 3218 O
high 49 53 3219 3223 O
potential 54 63 3224 3233 O
for 64 67 3234 3237 O
indicated 68 77 3238 3247 O
preterm 78 85 3248 3255 O
birth 86 91 3256 3261 O

Planned 0 7 3262 3269 O
cerclage 8 16 3270 3278 B-treatment
or 17 19 3279 3281 O
cerclage 20 28 3282 3290 O
already 29 36 3291 3298 O
in 37 39 3299 3301 O
place 40 45 3302 3307 O
since 46 51 3308 3313 O
it 52 54 3314 3316 O
would 55 60 3317 3322 O
preclude 61 69 3323 3331 O
placement 70 79 3332 3341 O
of 80 82 3342 3344 O
a 83 84 3345 3346 O
pessary 85 92 3347 3354 B-treatment

Planned 0 7 3355 3362 O
or 8 10 3363 3365 O
actual 11 17 3366 3372 O
progesterone 18 30 3373 3385 B-treatment
treatment 31 40 3386 3395 I-treatment
of 41 43 3396 3398 O
any 44 47 3399 3402 O
type 48 52 3403 3407 O
or 53 55 3408 3410 O
form 56 60 3411 3415 O
after 61 66 3416 3421 B-upper_bound
14 67 69 3422 3424 I-upper_bound
weeks 70 75 3425 3430 I-upper_bound
6 76 77 3431 3432 I-upper_bound
days 78 82 3433 3437 I-upper_bound
during 83 89 3438 3444 O
the 90 93 3445 3448 O
current 94 101 3449 3456 B-pregnancy
pregnancy 102 111 3457 3466 I-pregnancy

Rupture 0 7 3467 3474 O
of 8 10 3475 3477 O
membranes 11 20 3478 3487 O
due 21 24 3488 3491 O
to 25 27 3492 3494 O
likelihood 28 38 3495 3505 O
of 39 41 3506 3508 O
pregnancy 42 51 3509 3518 B-pregnancy
loss 52 56 3519 3523 O
and 57 60 3524 3527 O
preterm 61 68 3528 3535 O
delivery 69 77 3536 3544 O
as 78 80 3545 3547 O
well 81 85 3548 3552 O
as 86 88 3553 3555 O
the 89 92 3556 3559 O
risk 93 97 3560 3564 O
of 98 100 3565 3567 O
ascending 101 110 3568 3577 O
infection 111 120 3578 3587 B-chronic_disease
which 121 126 3588 3593 O
could 127 132 3594 3599 O
be 133 135 3600 3602 O
increased 136 145 3603 3612 O
with 146 150 3613 3617 O
pessary 151 158 3618 3625 O
placement 159 168 3626 3635 O

Specifically 0 12 3636 3648 O
, 12 13 3648 3649 O
patients 14 22 3650 3658 O
with 23 27 3659 3663 O
seizure 28 35 3664 3671 B-chronic_disease
disorders 36 45 3672 3681 I-chronic_disease
, 45 46 3681 3682 O
HIV 47 50 3683 3686 B-chronic_disease
, 50 51 3686 3687 O
and 52 55 3688 3691 O
other 56 61 3692 3697 O
medical 62 69 3698 3705 O
conditions 70 80 3706 3716 O
not 81 84 3717 3720 O
specifically 85 97 3721 3733 O
associated 98 108 3734 3744 O
with 109 113 3745 3749 O
an 114 116 3750 3752 O
increased 117 126 3753 3762 O
risk 127 131 3763 3767 O
of 132 134 3768 3770 O
indicated 135 144 3771 3780 O
preterm 145 152 3781 3788 O
birth 153 158 3789 3794 O
are 159 162 3795 3798 O
not 163 166 3799 3802 O
excluded 167 175 3803 3811 O
. 175 176 3811 3812 O
Prior 177 182 3813 3818 B-treatment
cervical 183 191 3819 3827 I-treatment
cone 192 196 3828 3832 I-treatment
/ 196 197 3832 3833 O
LOOP 197 201 3833 3837 B-treatment
/ 201 202 3837 3838 O
LEEP 202 206 3838 3842 B-treatment

Twin 0 4 3843 3847 B-chronic_disease
- 4 5 3847 3848 I-chronic_disease
twin 5 9 3848 3852 I-chronic_disease
transfusion 10 21 3853 3864 I-chronic_disease
syndrome 22 30 3865 3873 I-chronic_disease
, 30 31 3873 3874 O
due 32 35 3875 3878 O
to 36 38 3879 3881 O
increased 39 48 3882 3891 O
risk 49 53 3892 3896 O
of 54 56 3897 3899 O
adverse 57 64 3900 3907 O
pregnancy 65 74 3908 3917 B-pregnancy
outcome 75 82 3918 3925 O

Age 0 3 0 3 B-age
: 3 4 3 4 O
≥ 5 6 5 6 O
18 7 9 7 9 B-lower_bound
years 10 15 10 15 I-lower_bound

On 0 2 16 18 O
long 3 7 19 23 O
- 7 8 23 24 O
term 8 12 24 28 O
steroid 13 20 29 36 B-treatment
or 21 23 37 39 O
anti 24 28 40 44 B-treatment
- 28 29 44 45 I-treatment
inflammatory 29 41 45 57 I-treatment
drugs 42 47 58 63 I-treatment

Receiving 0 9 64 73 O
behavioral 10 20 74 84 B-treatment
therapy 21 28 85 92 I-treatment
or 29 31 93 95 O
medications 32 43 96 107 O
for 44 47 108 111 O
the 48 51 112 115 O
anxiety 52 59 116 123 B-chronic_disease
disorder 60 68 124 132 I-chronic_disease

Undergoing 0 10 133 143 O
catheter 11 19 144 152 B-treatment
ablation 20 28 153 161 I-treatment
for 29 32 162 165 O
paroxysmal 33 43 166 176 B-chronic_disease
or 44 46 177 179 O
persistent 47 57 180 190 B-chronic_disease
AF 58 60 191 193 I-chronic_disease

female 0 6 194 200 B-gender

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1.0 35 38 35 38 B-lower_bound
x 39 40 39 40 I-lower_bound
10 41 43 41 43 I-lower_bound
^ 43 44 43 44 I-lower_bound
9 44 45 44 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
L 46 47 46 47 I-lower_bound

Acute 0 5 48 53 O
infection 6 15 54 63 B-chronic_disease
requiring 16 25 64 73 O
systemic 26 34 74 82 B-treatment
anti 35 39 83 87 I-treatment
- 39 40 87 88 I-treatment
infectives 40 50 88 98 I-treatment
, 50 51 98 99 O
antivirals 52 62 100 110 B-treatment
, 62 63 110 111 O
or 64 66 112 114 O
antifungals 67 78 115 126 B-treatment
within 79 85 127 133 O
two 86 89 134 137 B-upper_bound
weeks 90 95 138 143 I-upper_bound
prior 96 101 144 149 I-upper_bound
to 102 104 150 152 O
first 105 110 153 158 O
dose 111 115 159 163 O

Agree 0 5 164 169 B-contraception_consent
to 6 8 170 172 I-contraception_consent
practice 9 17 173 181 I-contraception_consent
effective 18 27 182 191 I-contraception_consent
barrier 28 35 192 199 I-contraception_consent
contraception 36 49 200 213 I-contraception_consent
during 50 56 214 220 O
the 57 60 221 224 O
entire 61 67 225 231 O
study 68 73 232 237 B-treatment
treatment 74 83 238 247 I-treatment
period 84 90 248 254 O
and 91 94 255 258 O
through 95 102 259 266 B-upper_bound
90 103 105 267 269 I-upper_bound
days 106 110 270 274 I-upper_bound
after 111 116 275 280 O
the 117 120 281 284 O
last 121 125 285 289 O
dose 126 130 290 294 O
of 131 133 295 297 O
study 134 139 298 303 B-treatment
drug 140 144 304 308 I-treatment

Any 0 3 309 312 O
measurable 4 14 313 323 B-cancer
residual 15 23 324 332 I-cancer
disease 24 31 333 340 I-cancer
at 32 34 341 343 O
the 35 38 344 347 O
time 39 43 348 352 O
of 44 46 353 355 O
screening 47 56 356 365 O
for 57 60 366 369 O
the 61 64 370 373 O
study 65 70 374 379 O

Any 0 3 380 383 O
serious 4 11 384 391 O
medical 12 19 392 399 O
or 20 22 400 402 O
psychiatric 23 34 403 414 B-cancer
illness 35 42 415 422 I-cancer
that 43 47 423 427 O
could 48 53 428 433 O
, 53 54 433 434 O
in 55 57 435 437 O
the 58 61 438 441 O
investigator 62 74 442 454 O
's 74 76 454 456 O
opinion 77 84 457 464 O
, 84 85 464 465 O
potentially 86 97 466 477 O
interfere 98 107 478 487 O
with 108 112 488 492 O
the 113 116 493 496 O
completion 117 127 497 507 O
of 128 130 508 510 O
treatment 131 140 511 520 B-treatment
according 141 150 521 530 O
to 151 153 531 533 O
this 154 158 534 538 O
protocol 159 167 539 547 O

Are 0 3 548 551 O
postmenopausal 4 18 552 566 O
for 19 22 567 570 O
at 23 25 571 573 O
least 26 31 574 579 O
1 32 33 580 581 B-lower_bound
year 34 38 582 586 I-lower_bound
before 39 45 587 593 O
the 46 49 594 597 O
screening 50 59 598 607 O
visit 60 65 608 613 O

Aspartate 0 9 614 623 B-clinical_variable
aminotransferase 10 26 624 640 I-clinical_variable
( 27 28 641 642 I-clinical_variable
AST 28 31 642 645 I-clinical_variable
) 31 32 645 646 I-clinical_variable
and 33 36 647 650 O
alanine 37 44 651 658 B-clinical_variable
aminotransferase 45 61 659 675 I-clinical_variable
( 62 63 676 677 I-clinical_variable
ALT 63 66 677 680 I-clinical_variable
) 66 67 680 681 I-clinical_variable
= 68 69 682 683 O
< 69 70 683 684 O
3 71 72 685 686 B-upper_bound
x 73 74 687 688 I-upper_bound
ULN 75 78 689 692 I-upper_bound

Bilirubin 0 9 693 702 B-clinical_variable
= 10 11 703 704 O
< 11 12 704 705 O
1.5 12 15 705 708 B-upper_bound
x 16 17 709 710 I-upper_bound
upper 18 23 711 716 I-upper_bound
limit 24 29 717 722 I-upper_bound
of 30 32 723 725 I-upper_bound
normal 33 39 726 732 I-upper_bound
( 40 41 733 734 I-upper_bound
ULN 41 44 734 737 I-upper_bound
) 44 45 737 738 I-upper_bound

Calculated 0 10 739 749 B-clinical_variable
creatinine 11 21 750 760 I-clinical_variable
clearance 22 31 761 770 I-clinical_variable
( 32 33 771 772 O
by 33 35 772 774 O
Cockroft 36 44 775 783 O
- 44 45 783 784 O
Gault 45 50 784 789 O
) 50 51 789 790 O
> 52 53 791 792 O
= 53 54 792 793 O
50 55 57 794 796 B-lower_bound
ml 58 60 797 799 I-lower_bound
/ 60 61 799 800 I-lower_bound
min 61 64 800 803 I-lower_bound
or 65 67 804 806 O
serum 68 73 807 812 B-clinical_variable
creatinine 74 84 813 823 I-clinical_variable
below 85 90 824 829 O
2 91 92 830 831 B-upper_bound
g 93 94 832 833 I-upper_bound
/ 94 95 833 834 I-upper_bound
dL 95 97 834 836 I-upper_bound

Central 0 7 837 844 B-chronic_disease
nervous 8 15 845 852 I-chronic_disease
system 16 22 853 859 I-chronic_disease
involvement 23 34 860 871 O

Diagnosed 0 9 872 881 O
or 10 12 882 884 O
treated 13 20 885 892 O
for 21 24 893 896 O
another 25 32 897 904 O
malignancy 33 43 905 915 B-cancer
within 44 50 916 922 O
2 51 52 923 924 B-upper_bound
years 53 58 925 930 I-upper_bound
before 59 65 931 937 O
study 66 71 938 943 O
enrollment 72 82 944 954 O
or 83 85 955 957 O
previously 86 96 958 968 O
diagnosed 97 106 969 978 O
with 107 111 979 983 O
another 112 119 984 991 O
malignancy 120 130 992 1002 O
and 131 134 1003 1006 O
have 135 139 1007 1011 O
any 140 143 1012 1015 O
evidence 144 152 1016 1024 O
of 153 155 1025 1027 O
residual 156 164 1028 1036 B-cancer
disease 165 172 1037 1044 I-cancer

Diarrhea 0 8 1045 1053 B-clinical_variable
> 9 10 1054 1055 O
grade 11 16 1056 1061 B-lower_bound
1 17 18 1062 1063 I-lower_bound
in 19 21 1064 1066 O
the 22 25 1067 1070 O
absence 26 33 1071 1078 O
of 34 36 1079 1081 O
anti 37 41 1082 1086 B-treatment
- 41 42 1086 1087 I-treatment
diarrheals 42 52 1087 1097 I-treatment

Eastern 0 7 1098 1105 B-clinical_variable
Cooperative 8 19 1106 1117 I-clinical_variable
Oncology 20 28 1118 1126 I-clinical_variable
Group 29 34 1127 1132 I-clinical_variable
( 35 36 1133 1134 I-clinical_variable
ECOG 36 40 1134 1138 I-clinical_variable
) 40 41 1138 1139 I-clinical_variable
performance 42 53 1140 1151 I-clinical_variable
status 54 60 1152 1158 I-clinical_variable
of 61 63 1159 1161 O
0 64 65 1162 1163 B-lower_bound
- 65 66 1163 1164 O
2 66 67 1164 1165 B-upper_bound

Evidence 0 8 1166 1174 O
of 9 11 1175 1177 O
MRD 12 15 1178 1181 B-cancer
at 16 18 1182 1184 O
the 19 22 1185 1188 O
time 23 27 1189 1193 O
of 28 30 1194 1196 O
screening 31 40 1197 1206 O
for 41 44 1207 1210 O
this 45 49 1211 1215 O
study 50 55 1216 1221 O
by 56 58 1222 1224 O
multi 59 64 1225 1230 B-treatment
- 64 65 1230 1231 I-treatment
color 65 70 1231 1236 I-treatment
flow 71 75 1237 1241 I-treatment
cytometry 76 85 1242 1251 I-treatment
( 86 87 1252 1253 O
bone 87 91 1253 1257 O
marrow 92 98 1258 1264 O
procedure 99 108 1265 1274 O
at 109 111 1275 1277 O
screening 112 121 1278 1287 O
required 122 130 1288 1296 O
) 130 131 1296 1297 O

Evidence 0 8 1298 1306 O
of 9 11 1307 1309 O
current 12 19 1310 1317 O
uncontrolled 20 32 1318 1330 O
cardiovascular 33 47 1331 1345 B-treatment
conditions 48 58 1346 1356 I-treatment
, 58 59 1356 1357 O
including 60 69 1358 1367 O
uncontrolled 70 82 1368 1380 O
cardiac 83 90 1381 1388 B-treatment
conditions 91 101 1389 1399 I-treatment
such 102 106 1400 1404 O
as 107 109 1405 1407 O
hypertension 110 122 1408 1420 B-treatment
, 122 123 1420 1421 O
or 124 126 1422 1424 O
cardiac 127 134 1425 1432 B-chronic_disease
arrhythmias 135 146 1433 1444 I-chronic_disease
, 146 147 1444 1445 O
or 148 150 1446 1448 O
New 151 154 1449 1452 B-clinical_variable
York 155 159 1453 1457 I-clinical_variable
Heart 160 165 1458 1463 I-clinical_variable
Association 166 177 1464 1475 I-clinical_variable
stage 178 183 1476 1481 I-clinical_variable
III 184 187 1482 1485 B-lower_bound
and 188 191 1486 1489 O
IV 192 194 1490 1492 B-upper_bound
congestive 195 205 1493 1503 B-chronic_disease
heart 206 211 1504 1509 I-chronic_disease
failure 212 219 1510 1517 I-chronic_disease
, 219 220 1517 1518 O
or 221 223 1519 1521 O
unstable 224 232 1522 1530 B-chronic_disease
angina 233 239 1531 1537 I-chronic_disease
or 240 242 1538 1540 O
myocardial 243 253 1541 1551 B-chronic_disease
infarction 254 264 1552 1562 I-chronic_disease
within 265 271 1563 1569 O
the 272 275 1570 1573 O
past 276 280 1574 1578 B-upper_bound
6 281 282 1579 1580 I-upper_bound
months 283 289 1581 1587 I-upper_bound

Evidence 0 8 1588 1596 O
of 9 11 1597 1599 O
progressive 12 23 1600 1611 B-chronic_disease
disease 24 31 1612 1619 I-chronic_disease
on 32 34 1620 1622 O
lenalidomide 35 47 1623 1635 B-treatment
maintenance 48 59 1636 1647 O
as 60 62 1648 1650 O
per 63 66 1651 1654 O
IMWG 67 71 1655 1659 O
criteria 72 80 1660 1668 O

Female 0 6 1669 1675 B-gender
patients 7 15 1676 1684 I-gender

Female 0 6 1685 1691 B-gender
patients 7 15 1692 1700 I-gender
who 16 19 1701 1704 O
are 20 23 1705 1708 O
lactating 24 33 1709 1718 O
or 34 36 1719 1721 O
have 37 41 1722 1726 O
a 42 43 1727 1728 O
positive 44 52 1729 1737 B-pregnancy
serum 53 58 1738 1743 I-pregnancy
pregnancy 59 68 1744 1753 I-pregnancy
test 69 73 1754 1758 O
during 74 80 1759 1765 O
the 81 84 1766 1769 O
screening 85 94 1770 1779 O
period 95 101 1780 1786 O

Hemoglobin 0 10 1787 1797 B-clinical_variable
> 11 12 1798 1799 O
= 12 13 1799 1800 O
8 14 15 1801 1802 B-lower_bound
g 16 17 1803 1804 I-lower_bound
/ 17 18 1804 1805 I-lower_bound
dL 18 20 1805 1807 I-lower_bound

History 0 7 1808 1815 O
of 8 10 1816 1818 O
allergy 11 18 1819 1826 O
to 19 21 1827 1829 O
mannitol 22 30 1830 1838 B-allergy_name

Known 0 5 1839 1844 O
allergy 6 13 1845 1852 O
to 14 16 1853 1855 O
any 17 20 1856 1859 O
of 21 23 1860 1862 O
the 24 27 1863 1866 O
study 28 33 1867 1872 B-allergy_name
medications 34 45 1873 1884 I-allergy_name
, 45 46 1884 1885 O
their 47 52 1886 1891 O
analogues 53 62 1892 1901 O
, 62 63 1901 1902 O
or 64 66 1903 1905 O
excipients 67 77 1906 1916 O
in 78 80 1917 1919 O
the 81 84 1920 1923 O
various 85 92 1924 1931 O
formulations 93 105 1932 1944 O
of 106 108 1945 1947 O
any 109 112 1948 1951 O
agent 113 118 1952 1957 O

Known 0 5 1958 1963 O
gastrointestinal 6 22 1964 1980 B-chronic_disease
( 23 24 1981 1982 I-chronic_disease
GI 24 26 1982 1984 I-chronic_disease
) 26 27 1984 1985 I-chronic_disease
disease 28 35 1986 1993 I-chronic_disease
or 36 38 1994 1996 O
GI 39 41 1997 1999 B-treatment
procedure 42 51 2000 2009 I-treatment
that 52 56 2010 2014 O
could 57 62 2015 2020 O
interfere 63 72 2021 2030 O
with 73 77 2031 2035 O
the 78 81 2036 2039 O
oral 82 86 2040 2044 O
absorption 87 97 2045 2055 O
or 98 100 2056 2058 O
tolerance 101 110 2059 2068 O
of 111 113 2069 2071 O
ixazomib 114 122 2072 2080 B-treatment
including 123 132 2081 2090 O
difficulty 133 143 2091 2101 O
swallowing 144 154 2102 2112 O

Life 0 4 2113 2117 B-clinical_variable
expectancy 5 15 2118 2128 I-clinical_variable
of 16 18 2129 2131 O
more 19 23 2132 2136 O
than 24 28 2137 2141 O
3 29 30 2142 2143 B-lower_bound
months 31 37 2144 2150 I-lower_bound

Major 0 5 2151 2156 B-treatment
surgery 6 13 2157 2164 I-treatment
within 14 20 2165 2171 O
14 21 23 2172 2174 B-upper_bound
days 24 28 2175 2179 I-upper_bound
before 29 35 2180 2186 I-upper_bound
enrollment 36 46 2187 2197 O

Male 0 4 2198 2202 B-gender
patients 5 13 2203 2211 I-gender

No 0 2 2212 2214 O
evidence 3 11 2215 2223 O
of 12 14 2224 2226 O
progressive 15 26 2227 2238 B-chronic_disease
disease 27 34 2239 2246 I-chronic_disease
on 35 37 2247 2249 O
lenalidomide 38 50 2250 2262 B-treatment

Ongoing 0 7 2263 2270 O
or 8 10 2271 2273 O
active 11 17 2274 2280 B-chronic_disease
systemic 18 26 2281 2289 I-chronic_disease
infection 27 36 2290 2299 I-chronic_disease
, 36 37 2299 2300 O
active 38 44 2301 2307 O
hepatitis 45 54 2308 2317 B-chronic_disease
B 55 56 2318 2319 I-chronic_disease
or 57 59 2320 2322 I-chronic_disease
C 60 61 2323 2324 I-chronic_disease
virus 62 67 2325 2330 I-chronic_disease
infection 68 77 2331 2340 I-chronic_disease
, 77 78 2340 2341 O
or 79 81 2342 2344 O
known 82 87 2345 2350 O
human 88 93 2351 2356 B-chronic_disease
immunodeficiency 94 110 2357 2373 I-chronic_disease
virus 111 116 2374 2379 I-chronic_disease
( 117 118 2380 2381 I-chronic_disease
HIV 118 121 2381 2384 I-chronic_disease
) 121 122 2384 2385 I-chronic_disease
positive 123 131 2386 2394 O

Participation 0 13 2395 2408 O
in 14 16 2409 2411 O
other 17 22 2412 2417 B-treatment
clinical 23 31 2418 2426 I-treatment
trials 32 38 2427 2433 I-treatment
, 38 39 2433 2434 O
including 40 49 2435 2444 O
those 50 55 2445 2450 O
with 56 60 2451 2455 O
other 61 66 2456 2461 O
investigational 67 82 2462 2477 B-treatment
agents 83 89 2478 2484 I-treatment
not 90 93 2485 2488 O
included 94 102 2489 2497 O
in 103 105 2498 2500 O
this 106 110 2501 2505 O
trial 111 116 2506 2511 O
, 116 117 2511 2512 O
within 118 124 2513 2519 O
30 125 127 2520 2522 B-upper_bound
days 128 132 2523 2527 I-upper_bound
of 133 135 2528 2530 O
the 136 139 2531 2534 O
start 140 145 2535 2540 O
of 146 148 2541 2543 O
this 149 153 2544 2548 O
trial 154 159 2549 2554 O
and 160 163 2555 2558 O
throughout 164 174 2559 2569 O
the 175 178 2570 2573 O
duration 179 187 2574 2582 O
of 188 190 2583 2585 O
this 191 195 2586 2590 O
trial 196 201 2591 2596 O

Patient 0 7 2597 2604 O
has 8 11 2605 2608 O
> 12 13 2609 2610 O
= 13 14 2610 2611 O
grade 15 20 2612 2617 B-lower_bound
3 21 22 2618 2619 I-lower_bound
peripheral 23 33 2620 2630 B-clinical_variable
neuropathy 34 44 2631 2641 I-clinical_variable
, 44 45 2641 2642 O
or 46 48 2643 2645 O
grade 49 54 2646 2651 B-upper_bound
2 55 56 2652 2653 I-upper_bound
with 57 61 2654 2658 O
pain 62 66 2659 2663 O
on 67 69 2664 2666 O
clinical 70 78 2667 2675 O
examination 79 90 2676 2687 O
during 91 97 2688 2694 O
the 98 101 2695 2698 O
screening 102 111 2699 2708 O
period 112 118 2709 2715 O

Patients 0 8 2716 2724 O
must 9 13 2725 2729 O
be 14 16 2730 2732 O
receiving 17 26 2733 2742 O
lenalidomide 27 39 2743 2755 B-treatment
10 40 42 2756 2758 B-lower_bound
mg 43 45 2759 2761 I-lower_bound
or 46 48 2762 2764 O
15 49 51 2765 2767 B-upper_bound
mg 52 54 2768 2770 I-upper_bound
and 55 58 2771 2774 O
be 59 61 2775 2777 O
able 62 66 2778 2782 O
to 67 69 2783 2785 O
tolerate 70 78 2786 2794 O
dose 79 83 2795 2799 O
escalation 84 94 2800 2810 O
to 95 97 2811 2813 O
25 98 100 2814 2816 O
mg 101 103 2817 2819 O
daily 104 109 2820 2825 O

Patients 0 8 2826 2834 O
must 9 13 2835 2839 O
have 14 18 2840 2844 O
initiated 19 28 2845 2854 O
lenalidomide 29 41 2855 2867 B-treatment
maintenance 42 53 2868 2879 O
at 54 56 2880 2882 O
approximately 57 70 2883 2896 O
3 71 72 2897 2898 B-lower_bound
months 73 79 2899 2905 I-lower_bound
post 80 84 2906 2910 B-treatment
autologous 85 95 2911 2921 I-treatment
stem 96 100 2922 2926 I-treatment
transplant 101 111 2927 2937 I-treatment
( 112 113 2938 2939 O
preferably 113 123 2939 2949 O
70 124 126 2950 2952 B-lower_bound
- 126 127 2952 2953 O
90 127 129 2953 2955 B-upper_bound
but 130 133 2956 2959 O
not 134 137 2960 2963 O
more 138 142 2964 2968 O
than 143 147 2969 2973 O
120 148 151 2974 2977 B-lower_bound
days 152 156 2978 2982 I-lower_bound
) 156 157 2982 2983 O

Patients 0 8 2984 2992 O
must 9 13 2993 2997 O
have 14 18 2998 3002 O
received 19 27 3003 3011 O
lenalidomide 28 40 3012 3024 B-treatment
maintenance 41 52 3025 3036 O
for 53 56 3037 3040 O
3 57 58 3041 3042 B-lower_bound
months 59 65 3043 3049 I-lower_bound
( 66 67 3050 3051 O
+1 67 69 3051 3053 O
month 70 75 3054 3059 O
window 76 82 3060 3066 O
for 83 86 3067 3070 O
a 87 88 3071 3072 O
maximum 89 96 3073 3080 O
of 97 99 3081 3083 O
4 100 101 3084 3085 B-upper_bound
months 102 108 3086 3092 I-upper_bound
lenalidomide 109 121 3093 3105 O
prior 122 127 3106 3111 O
to 128 130 3112 3114 O
enrollment 131 141 3115 3125 O
) 141 142 3125 3126 O

Patients 0 8 3127 3135 O
who 9 12 3136 3139 O
completed 13 22 3140 3149 O
induction 23 32 3150 3159 B-treatment
treatment 33 42 3160 3169 I-treatment
followed 43 51 3170 3178 O
by 52 54 3179 3181 O
autologous 55 65 3182 3192 B-treatment
stem 66 70 3193 3197 I-treatment
cell 71 75 3198 3202 I-treatment
transplant 76 86 3203 3213 I-treatment
as 87 89 3214 3216 O
initial 90 97 3217 3224 B-treatment
therapy 98 105 3225 3232 I-treatment
for 106 109 3233 3236 O
symptomatic 110 121 3237 3248 O
myeloma 122 129 3249 3256 B-cancer
as 130 132 3257 3259 O
per 133 136 3260 3263 O
IMWG 137 141 3264 3268 O
criteria 142 150 3269 3277 O
and 151 154 3278 3281 O
initiated 155 164 3282 3291 O
Revlimid 165 173 3292 3300 B-treatment
( 174 175 3301 3302 O
lenalidomide 175 187 3302 3314 B-treatment
) 187 188 3314 3315 O
maintenance 189 200 3316 3327 O

Patients 0 8 3328 3336 O
who 9 12 3337 3340 O
have 13 17 3341 3345 O
already 18 25 3346 3353 O
started 26 33 3354 3361 O
or 34 36 3362 3364 O
received 37 45 3365 3373 O
multi 46 51 3374 3379 B-treatment
- 51 52 3379 3380 I-treatment
drug 52 56 3380 3384 I-treatment
consolidation 57 70 3385 3398 I-treatment
regimen 71 78 3399 3406 I-treatment
post 79 83 3407 3411 O
- 83 84 3411 3412 O
transplant 84 94 3412 3422 O
expect 95 101 3423 3429 O
for 102 105 3430 3433 O
lenalidomide 106 118 3434 3446 B-treatment
maintenance 119 130 3447 3458 I-treatment

Platelet 0 8 3459 3467 B-clinical_variable
count 9 14 3468 3473 I-clinical_variable
> 15 16 3474 3475 O
= 16 17 3475 3476 O
75 18 20 3477 3479 B-lower_bound
x 21 22 3480 3481 I-lower_bound
10 23 25 3482 3484 I-lower_bound
^ 25 26 3484 3485 I-lower_bound
9 26 27 3485 3486 I-lower_bound
/ 27 28 3486 3487 I-lower_bound
L 28 29 3487 3488 I-lower_bound

Radiotherapy 0 12 3489 3501 B-treatment
within 13 19 3502 3508 O
14 20 22 3509 3511 B-upper_bound
days 23 27 3512 3516 I-upper_bound
before 28 34 3517 3523 I-upper_bound
randomization 35 48 3524 3537 O

Rate 0 4 3538 3542 B-clinical_variable
- 4 5 3542 3543 I-clinical_variable
corrected 5 14 3543 3552 I-clinical_variable
QT 15 17 3553 3555 I-clinical_variable
interval 18 26 3556 3564 I-clinical_variable
of 27 29 3565 3567 I-clinical_variable
electrocardiograph 30 48 3568 3586 I-clinical_variable
( 49 50 3587 3588 I-clinical_variable
QTc 50 53 3588 3591 I-clinical_variable
) 53 54 3591 3592 I-clinical_variable
> 55 56 3593 3594 O
470 57 60 3595 3598 B-lower_bound
msec 61 65 3599 3603 I-lower_bound
on 66 68 3604 3606 O
a 69 70 3607 3608 O
12 71 73 3609 3611 B-treatment
- 73 74 3611 3612 I-treatment
lead 74 78 3612 3616 I-treatment
electrocardiogram 79 96 3617 3634 I-treatment
( 97 98 3635 3636 I-treatment
ECG 98 101 3636 3639 I-treatment
) 101 102 3639 3640 I-treatment
during 103 109 3641 3647 O
screening 110 119 3648 3657 O

SPEP 0 4 3658 3662 B-treatment
/ 4 5 3662 3663 O
IFIX 5 9 3663 3667 B-treatment
- 10 11 3668 3669 O
negative 12 20 3670 3678 O
and 21 24 3679 3682 O
Freelite- 25 34 3683 3692 O
negative 35 43 3693 3701 O
but 44 47 3702 3705 O
MRD 48 51 3706 3709 B-chronic_disease
- 51 52 3709 3710 O
positive 52 60 3710 3718 O
disease 61 68 3719 3726 O
is 69 71 3727 3729 O
allowed 72 79 3730 3737 O

Systemic 0 8 3738 3746 B-treatment
treatment 9 18 3747 3756 I-treatment
, 18 19 3756 3757 O
within 20 26 3758 3764 O
14 27 29 3765 3767 B-upper_bound
days 30 34 3768 3772 I-upper_bound
before 35 41 3773 3779 I-upper_bound
the 42 45 3780 3783 O
first 46 51 3784 3789 O
dose 52 56 3790 3794 O
of 57 59 3795 3797 O
ixazomib 60 68 3798 3806 B-treatment

Uncontrolled 0 12 3807 3819 B-chronic_disease
diabetes 13 21 3820 3828 I-chronic_disease

agree 0 5 3829 3834 B-contraception_consent
to 6 8 3835 3837 I-contraception_consent
practice 9 17 3838 3846 I-contraception_consent
2 18 19 3847 3848 I-contraception_consent
effective 20 29 3849 3858 I-contraception_consent
methods 30 37 3859 3866 I-contraception_consent
of 38 40 3867 3869 I-contraception_consent
contraception 41 54 3870 3883 I-contraception_consent

available 0 9 3884 3893 O
deoxyribonucleic 10 26 3894 3910 O
acid 27 31 3911 3915 O
( 32 33 3916 3917 O
DNA 33 36 3917 3920 O
) 36 37 3920 3921 O
sample 38 44 3922 3928 O
will 45 49 3929 3933 O
be 50 52 3934 3936 O
used 53 57 3937 3941 O
for 58 61 3942 3945 O
calibration 62 73 3946 3957 O
step 74 78 3958 3962 O
for 79 82 3963 3966 O
MRD 83 86 3967 3970 B-cancer
evaluation 87 97 3971 3981 O
by 98 100 3982 3984 O
gene 101 105 3985 3989 O
sequencing 106 116 3990 4000 O

patients 0 8 4001 4009 O
with 9 13 4010 4014 O
nonmelanoma 14 25 4015 4026 B-cancer
skin 26 30 4027 4031 I-cancer
cancer 31 37 4032 4038 I-cancer
or 38 40 4039 4041 O
carcinoma 41 50 4042 4051 B-cancer
in 51 53 4052 4054 I-cancer
situ 54 58 4055 4059 I-cancer
of 59 61 4060 4062 O
any 62 65 4063 4066 O
type 66 70 4067 4071 O
are 71 74 4072 4075 O
not 75 78 4076 4079 O
excluded 79 87 4080 4088 O
if 88 90 4089 4091 O
they 91 95 4092 4096 O
have 96 100 4097 4101 O
undergone 101 110 4102 4111 O
complete 111 119 4112 4120 O
resection 120 129 4121 4130 B-treatment

Cardiac 0 7 0 7 B-chronic_disease
disease 8 15 8 15 I-chronic_disease

Diabetes 0 8 16 24 B-chronic_disease
mellitus 9 17 25 33 I-chronic_disease

Respiratory 0 11 34 45 B-chronic_disease
disease 12 19 46 53 I-chronic_disease

